PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Du, XM; Zadoorian, A; Lukmantara, IE; Qi, YF; Brown, AJ; Yang, HY				Du, Ximing; Zadoorian, Armella; Lukmantara, Ivan E.; Qi, Yanfei; Brown, Andrew J.; Yang, Hongyuan			Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation by activation of mTORC1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOSOMAL CHOLESTEROL TRAFFICKING; ENDOPLASMIC-RETICULUM; PHOSPHATIDYLSERINE; TRANSPORT; CANCER; OSBP; CONTACTS; PATHWAY; FAMILY; TARGET	Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) constitute a large family of proteins that mainly function in lipid transport and sensing. ORP5 is an endoplasmic reticulum (ER)-anchored protein implicated in lipid transfer at the contact sites between the ER and other membranes. Recent studies indicate that ORP5 is also involved in cancer cell invasion and tumor progression. However, the molecular mechanism underlying ORP5's involvement in cancer is unclear. Here, we report that ORP5 promotes cell proliferation and motility of HeLa cells, an effect that depends on its functional OSBP-related domain (ORD). We also found that ORP5 depletion or substitutions of key residues located within ORP5-ORD and responsible for interactions with lipids interfered with cell proliferation, migration, and invasion. ORP5 interacted with the protein mechanistic target of rapamycin (mTOR), and this interaction also required ORP5-ORD. Of note, whereas ORP5 overexpression induced mTOR complex 1 (mTORC1) activity, ORP5 down-regulation had the opposite effect. Finally, ORP5-depleted cells exhibited impaired mTOR localization to lysosomes, which may have accounted for the blunted mTORC1 activation. Together, our results suggest that ORP5 expression is positively correlated with mTORC1 signaling and that ORP5 stimulates cell proliferation, at least in part, by activating mTORC1.	[Du, Ximing; Zadoorian, Armella; Lukmantara, Ivan E.; Qi, Yanfei; Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Du, XM; Yang, HY (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	x.r.du@unsw.edu.au; h.rob.yang@unsw.edu.au	Qi, Yanfei/ABC-1242-2021; Yang, Hongyuan/AAR-1326-2020	Qi, Yanfei/0000-0003-1391-4111; Yang, Hongyuan/0000-0002-8482-6031; Lukmantara, Ivan/0000-0001-9759-5669	National Health and Medical Research Council, Australia [1041301, 1078117]; Australian Research Council [DP130100457]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by Grants 1041301 and 1078117 from the National Health and Medical Research Council, Australia, and by Grant DP130100457 from the Australian Research Council. Senior Research Fellow of the National Health and Medical Research Council. To whom correspondence may be addressed. Tel.: 61-2-93858133; Fax: 61-2-93851483; E-mail: h.rob.yang@unsw.edu.au.	Bridges D, 2012, MOL BIOL CELL, V23, P2955, DOI 10.1091/mbc.E11-12-1034; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Du X., 2017, SEMIN CELL DEV BIOL, V2017; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fei WH, 2011, BIOCHEM BIOPH RES CO, V415, P455, DOI 10.1016/j.bbrc.2011.10.091; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Guo XH, 2017, ONCOL RES, V25, P799, DOI 10.3727/096504016X14783691306605; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Koga Y, 2008, CANCER SCI, V99, P2387, DOI 10.1111/j.1349-7006.2008.00987.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li JW, 2016, ONCOTARGET, V7, P65849, DOI 10.18632/oncotarget.11671; Li JW, 2016, J LIPID RES, V57, P1845, DOI 10.1194/jlr.M069906; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Nagano K, 2015, INT J ONCOL, V47, P195, DOI 10.3892/ijo.2015.3000; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200	36	19	19	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3806	3818		10.1074/jbc.RA117.001558	http://dx.doi.org/10.1074/jbc.RA117.001558			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358326	Green Published, hybrid			2022-12-26	WOS:000427030200032
J	Thurman, SM; Wasylyshyn, N; Roy, H; Lieberman, G; Garcia, JO; Asturias, A; Okafor, GN; Elliott, JC; Giesbrecht, B; Grafton, ST; Mednick, SC; Vettel, JM				Thurman, Steven M.; Wasylyshyn, Nick; Roy, Heather; Lieberman, Gregory; Garcia, Javier O.; Asturias, Alex; Okafor, Gold N.; Elliott, James C.; Giesbrecht, Barry; Grafton, Scott T.; Mednick, Sara C.; Vettel, Jean M.			Individual differences in compliance and agreement for sleep logs and wrist actigraphy: A longitudinal study of naturalistic sleep in healthy adults	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE; ELECTRONIC DIARIES; DEPRIVATION; POLYSOMNOGRAPHY; MOOD; RESTRICTION; ADOLESCENTS; PERFORMANCE; EMOTION; CONSEQUENCES	There is extensive laboratory research studying the effects of acute sleep deprivation on biological and cognitive functions, yet much less is known about naturalistic patterns of sleep loss and the potential impact on daily or weekly functioning of an individual. Longitudinal studies are needed to advance our understanding of relationships between naturalistic sleep and fluctuations in human health and performance, but it is first necessary to understand the efficacy of current tools for long-term sleep monitoring. The present study used wrist actigraphy and sleep log diaries to obtain daily measurements of sleep from 30 healthy adults for up to 16 consecutive weeks. We used non-parametric Bland-Altman analysis and correlation coefficients to calculate agreement between subjectively and objectively measured variables including sleep onset time, sleep offset time, sleep onset latency, number of awakenings, the amount of wake time after sleep onset, and total sleep time. We also examined compliance data on the submission of daily sleep logs according to the experimental protocol. Overall, we found strong agreement for sleep onset and sleep offset times, but relatively poor agreement for variables related to wakefulness including sleep onset latency, awakenings, and wake after sleep onset. Compliance tended to decrease significantly over time according to a linear function, but there were substantial individual differences in overall compliance rates. There were also individual differences in agreement that could be explained, in part, by differences in compliance. Individuals who were consistently more compliant over time also tended to show the best agreement and lower scores on behavioral avoidance scale (BIS). Our results provide evidence for convergent validity in measuring sleep onset and sleep offset with wrist actigraphy and sleep logs, and we conclude by proposing an analysis method to mitigate the impact of non-compliance and measurement errors when the two methods provide discrepant estimates.	[Thurman, Steven M.; Wasylyshyn, Nick; Roy, Heather; Lieberman, Gregory; Garcia, Javier O.; Vettel, Jean M.] US Army, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD 21005 USA; [Garcia, Javier O.; Vettel, Jean M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Asturias, Alex; Okafor, Gold N.; Elliott, James C.; Giesbrecht, Barry; Grafton, Scott T.; Vettel, Jean M.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Mednick, Sara C.] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Pennsylvania; University of California System; University of California Santa Barbara; University of California System; University of California Irvine	Thurman, SM (corresponding author), US Army, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD 21005 USA.	steven.m.thurman3.civ@mail.mil		Thurman, Steven/0000-0003-3962-8447	U.S. Army Research Laboratory; Army Research Office [W911NF-10-D-0022, W911NF-10-D-0002]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office	This research was supported by mission funding to the U.S. Army Research Laboratory as well as sponsored by the Army Research Office and accomplished under Cooperative Agreement Numbers W911NF-10-D-0022 and W911NF-10-D-0002. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler AB, 2017, SLEEP HEALTH, V3, P126, DOI 10.1016/j.sleh.2017.01.001; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Ancoli-Israel S, 2003, SLEEP J SLEEP SLEEP; Auger RR, 2013, NAT SCI SLEEP, V5, P125, DOI 10.2147/NSS.S48970; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125; Beattie L, 2015, SLEEP MED REV, V24, P83, DOI 10.1016/j.smrv.2014.12.005; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Caia J, 2018, J SPORT SCI, V36, P1492, DOI 10.1080/02640414.2017.1398885; Carney Colleen E, 2004, Behav Sleep Med, V2, P134, DOI 10.1207/s15402010bsm0203_2; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chen ZY, 2013, INT CONF PER COMP, P145, DOI 10.4108/icst.pervasivehealth.2013.252148; Cho K, 2016, PSYCHOL SCI; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Driller M, 2016, SLEEP SCI, V9, P198, DOI 10.1016/j.slsci.2016.08.003; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Green AS, 2006, PSYCHOL METHODS, V11, P87, DOI 10.1037/1082-989X.11.1.87; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; Iwasaki M, 2010, J EPIDEMIOL, V20, P143, DOI 10.2188/jea.JE20090054; Jean-Louis G, 2001, PHYSIOL BEHAV, V72, P21, DOI 10.1016/S0031-9384(00)00355-3; Kaplan KA, 2012, BIPOLAR DISORD, V14, P870, DOI 10.1111/bdi.12021; Killgore WDS, 2012, CHRONOBIOL INT, V29, P43, DOI 10.3109/07420528.2011.635230; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kortelainen JM, 2012, COMPUT CARDIOL CONF, V39, P313; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Loomis AL, 1937, J EXP PSYCHOL, V21, P127, DOI 10.1037/h0057431; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Matsumoto K, 2003, BIOL RHYTHM RES, V34, P265, DOI 10.1076/brhm.34.3.265.18812; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; MONK TH, 1994, J SLEEP RES, V3, P111, DOI 10.1111/j.1365-2869.1994.tb00114.x; Monk TH, 1999, SLEEP, V22, P948; Moturu S. T., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P208, DOI 10.1109/PASSAT/SocialCom.2011.200; Muris P, 2011, J CHILD FAM STUD, V20, P157, DOI 10.1007/s10826-010-9365-8; Nishyama M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528008; Patanaik A, 2015, SLEEP, V38, P723, DOI 10.5665/sleep.4664; Penzel T, 2000, SLEEP MED REV, V4, P131, DOI 10.1053/smrv.1999.0087; Pollak CP, 2001, SLEEP, V24, P957, DOI 10.1093/sleep/24.8.957; Roca J, 2012, ACTA PSYCHOL, V140, P164, DOI 10.1016/j.actpsy.2012.03.007; Russell C., 2000, VALIDATION FATIGUE S; SADEH A, 1994, J CONSULT CLIN PSYCH, V62, P63, DOI 10.1037/0022-006X.62.1.63; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Short MA, 2012, SLEEP MED, V13, P378, DOI 10.1016/j.sleep.2011.11.005; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; So K, 2007, J SLEEP RES, V16, P181, DOI 10.1111/j.1365-2869.2007.00582.x; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stone AA, 2003, CONTROL CLIN TRIALS, V24, P182, DOI 10.1016/S0197-2456(02)00320-3; Stone AA, 2002, ANN BEHAV MED, V24, P236, DOI 10.1207/S15324796ABM2403_09; TOTTERDELL P, 1994, SLEEP, V17, P466, DOI 10.1093/sleep/17.5.466; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	64	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191883	10.1371/journal.pone.0191883	http://dx.doi.org/10.1371/journal.pone.0191883			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	29377925	Green Published, gold			2022-12-26	WOS:000423514700038
J	Wang, LX; Li, Y; Chen, GZ				Wang, Li-xin; Li, Yang; Chen, Guan-zhi			Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CELLS; MELANOGENESIS; ENHANCEMENT; LYMPHOCYTES; MELANOCYTES	Metastatic melanoma is an aggressive skin cancer and is one of the global malignancies with high mortality and morbidity. It is essential to identify and verify diagnostic biomarkers of early metastatic melanoma. Previous studies have systematically assessed protein biomarkers and mRNA-based expression characteristics. However, molecular markers for the early diagnosis of metastatic melanoma have not been identified. To explore potential regulatory targets, we have analyzed the gene microarray expression profiles of malignant melanoma samples by co-expression analysis based on the network approach. The differentially expressed genes (DEGs) were screened by the EdgeR package of R software. A weighted gene co-expression network analysis (WGCNA) was used for the identification of DEGs in the special gene modules and hub genes. Subsequently, a protein-protein interaction network was constructed to extract hub genes associated with gene modules. Finally, twenty-four important hub genes (RASGRP2, IKZF1, CXCR5, LTB, BLK, LINGO3, CCR6, P2RY10, RHOH, JUP, KRT14, PLA2G3, SPRR1A, KRT78, SFN, CLDN4, IL1RN, PKP3, CBLC, KRT16, TMEM79, KLK8, LYPD3 and LYPD5) were treated as valuable factors involved in the immune response and tumor cell development in tumorigenesis. In addition, a transcriptional regulatory network was constructed for these specific modules or hub genes, and a few core transcriptional regulators were found to be mostly associated with our hub genes, including GATA1, STAT1, SP1, and PSG1. In summary, our findings enhance our understanding of the biological process of malignant melanoma metastasis, enabling us to identify specific genes to use for diagnostic and prognostic markers and possibly for targeted therapy.	[Wang, Li-xin; Chen, Guan-zhi] Qingdao Univ, Dept Dermatol, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Li, Yang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Li, Yang] Chinese Acad Med Sci, Peking Union Med Coll, Skin Hosp, Nanjing, Jiangsu, Peoples R China	Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, GZ (corresponding author), Qingdao Univ, Dept Dermatol, Affiliated Hosp, Qingdao, Shandong, Peoples R China.	chenguanzhi@outlook.com						Biswas S, 2016, BREAST CANCER RES TR, V155, P615, DOI 10.1007/s10549-016-3713-3; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRIEDMANN PS, 1987, J CELL PHYSIOL, V133, P88, DOI 10.1002/jcp.1041330111; GIGI O, 1982, EMBO J, V1, P1429, DOI 10.1002/j.1460-2075.1982.tb01334.x; HOLBROOK KA, 1989, ANAT EMBRYOL, V180, P443, DOI 10.1007/BF00305119; Howard OMZ, 2005, BLOOD, V105, P4207, DOI 10.1182/blood-2004-07-2697; Institute NC, 2016, MEL TREATM HLTH PROF; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; JIMBOW K, 1993, J INVEST DERMATOL, V100, pS259, DOI 10.1111/1523-1747.ep12470103; Kanavy HE, 2011, ULTRAVIOLET RAD MELA, P222; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lau E, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6479; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee YJ, 2009, J HARD TISSUE BIOL, V13, P87; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Lenzi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-121; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Meredith P, 2004, PHOTOCHEM PHOTOBIOL, V79, P211, DOI 10.1562/0031-8655(2004)079<0211:RCRQYF>2.0.CO;2; Mitkin NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09330; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; OSBORN M, 1982, METHOD CELL BIOL, V24, P97; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Robinson PN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-144; Sarna M, 2014, EXP DERMATOL, V23, P813, DOI 10.1111/exd.12535; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Singh Shailesh, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P68; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; SLOMINSKI A, 1988, J CELL SCI, V89, P287; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski RM, 2015, EXP DERMATOL, V24, P258, DOI 10.1111/exd.12618; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	41	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0190447	10.1371/journal.pone.0190447	http://dx.doi.org/10.1371/journal.pone.0190447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377892	Green Submitted, gold, Green Published			2022-12-26	WOS:000423514700005
J	Sswat, M; Stiasny, MH; Jutfelt, F; Riebesell, U; Clemmesen, C				Sswat, Michael; Stiasny, Martina H.; Jutfelt, Fredrik; Riebesell, Ulf; Clemmesen, Catriona			Growth performance and survival of larval Atlantic herring, under the combined effects of elevated temperatures and CO2	PLOS ONE			English	Article							CLUPEA-HARENGUS L.; EARLY-LIFE HISTORY; OCEAN ACIDIFICATION; RNA/DNA RATIOS; FISH BEHAVIOR; CARBONIC-ACID; GADUS-MORHUA; OTOLITH; SIZE; SEAWATER	In the coming decades, environmental change like warming and acidification will affect life in the ocean. While data on single stressor effects on fish are accumulating rapidly, we still know relatively little about interactive effects of multiple drivers. Of particular concern in this context are the early life stages of fish, for which direct effects of increased CO2 on growth and development have been observed. Whether these effects are further modified by elevated temperature was investigated here for the larvae of Atlantic herring (Clupea harengus), a commercially important fish species. Over a period of 32 days, larval survival, growth in size and weight, and instantaneous growth rate were assessed in a crossed experimental design of two temperatures (10 degrees C and 12 degrees C) with two CO2 levels (400 mu atm and 900 mu atm CO2) at food levels mimicking natural levels using natural prey. Elevated temperature alone led to increased swimming activity, as well as decreased survival and instantaneous growth rate (Gi). The comparatively high sensitivity to elevated temperature in this study may have been influenced by low food levels offered to the larvae. Larval size, Gi and swimming activity were not affected by CO2, indicating tolerance of this species to projected "end of the century" CO2 levels. A synergistic effect of elevated temperature and CO2 was found for larval weight, where no effect of elevated CO2 concentrations was detected in the 12 degrees C treatment, but a negative CO2 effect was found in the 10 degrees C treatment. Contrasting CO2 effects were found for survival between the two temperatures. Under ambient CO2 conditions survival was increased at 12 degrees C compared to 10 degrees C. In general, CO2 effects were minor and considered negligible compared to the effect of temperature under these mimicked natural food conditions. These findings emphasize the need to include biotic factors such as energy supply via prey availability in future studies on interactive effects of multiple stressors.	[Sswat, Michael; Stiasny, Martina H.; Riebesell, Ulf; Clemmesen, Catriona] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Stiasny, Martina H.] Univ Kiel, Dept Econ, Kiel, Germany; [Jutfelt, Fredrik] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Jutfelt, Fredrik] Univ Gothenburg, Dept Biol, Kristineberg Ctr Marine Sci, Fiskebackskil, Sweden	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Norwegian University of Science & Technology (NTNU); University of Gothenburg	Sswat, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	msswat@geomar.de	Riebesell, Ulf/AAC-9717-2020; Jutfelt, Fredrik/B-6988-2014; Clemmesen, Catriona/B-1480-2014; Sswat, Michael/B-7944-2019; Stiasny, Martina/O-4988-2018	Jutfelt, Fredrik/0000-0001-9838-3991; Clemmesen, Catriona/0000-0003-4102-7341; Sswat, Michael/0000-0002-5957-4792; Stiasny, Martina/0000-0001-6365-2610	Association of European Marine Biological Laboratories ASSEMBLE [227799]; Federal Ministry of Education and Research BMBF [FKZ 03F06550]	Association of European Marine Biological Laboratories ASSEMBLE; Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	The study was jointly funded by Association of European Marine Biological Laboratories (http://www.assemblemarine.org) ASSEMBLE grant no. 227799 given to C. Clemmesen and M. Sswat and the Federal Ministry of Education and Research BMBF (FKZ 03F06550) in the framework of the coordinated projects BIOACID II (http://www.bioacid.de).; We thank the Sven Loven Centre for Marine Sciences in Kristineberg for providing us with a professional working environment. We are grateful for the crucial help by the team from the Biological Station Drobak lead by Hans Erik Karlsen in catching the fish for this experiment. Since this study was conducted in parallel to the KOSMOS experiment we want to acknowledge the great support by the team on-site as well as at GEOMAR in Kiel. The study was jointly funded by Association of European Marine Biological Laboratories (hhp:/www.assemblemarine.org) ASSEMBLE grant no. 227799 given to C. Clemmesen and M. Sswat and the Federal Ministry of Education and Research BMBF (FKZ 03F06550) in the framework of the coordinated projects BIOACID H (http://www.bioacid.de).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALMATAR SM, 1984, MAR BIOL, V80, P117, DOI 10.1007/BF02180178; [Anonymous], CLIM CHANG 2013 PHYS, DOI DOI 10.1017/CB09781107415324; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bignami S, 2014, AQUAT BIOL, V21, P249, DOI 10.3354/ab00598; Bodenstein S, 2012, EFFECTS OCEAN ACIDIF; Brown D.J.A., 1989, Society for Experimental Biology Seminar Series, P31; Buckley LJ, 2008, MAR ECOL PROG SER, V371, P221, DOI 10.3354/meps07648; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; CHECKLEY DM, 1982, MAR ECOL PROG SER, V9, P245, DOI 10.3354/meps009245; China V, 2014, P NATL ACAD SCI USA, V111, P8083, DOI 10.1073/pnas.1323205111; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; CLEMMESEN C, 1994, MAR BIOL, V118, P377, DOI 10.1007/BF00350294; COHEN RE, 1983, MAR ECOL PROG SER, V10, P211, DOI 10.3354/meps010211; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dlugokencky E, 2015, RECENT GLOBAL CO2; DOYLE MJ, 1977, J MAR BIOL ASSOC UK, V57, P859, DOI 10.1017/S0025315400025212; Feet PO, 2002, FISH RES, V56, P59, DOI 10.1016/S0165-7836(01)00313-7; Fey DP, 2001, J FISH BIOL, V58, P1257, DOI [10.1006/jfbi.2000.1529, 10.1111/j.1095-8649.2001.tb02284.x]; Finn RN., 2008, FISH LARVAL PHYSL, DOI 10.1086/650279; Folkvord A, 2004, SARSIA, V89, P297, DOI 10.1080/00364820410002532; Folkvord A, 1997, J FISH BIOL, V51, P250, DOI 10.1111/j.1095-8649.1997.tb06102.x; Forsgren E, 2013, ECOL EVOL, V3, P3637, DOI 10.1002/ece3.709; Fox CJ, 2003, MAR ECOL PROG SER, V264, P83, DOI 10.3354/meps264083; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Fuiman LA, 1998, COPEIA, P602, DOI 10.2307/1447790; Green L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0538; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hoie H, 1999, J EXP MAR BIOL ECOL, V234, P167, DOI 10.1016/S0022-0981(98)00154-3; Houde E.D., 1987, American Fisheries Society Symposium, P17; Howes EL, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00036; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Illing B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129344; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; Johnson DW, 2014, ECOL LETT, V17, P743, DOI 10.1111/ele.12273; Jutfelt F, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0104-2; Jutfelt F, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-81; Kikkawa T, 2004, MAR POLLUT BULL, V48, P108, DOI 10.1016/S0025-326X(03)00367-9; KIORBOE T, 1986, ENVIRON BIOL FISH, V17, P133, DOI 10.1007/BF00001743; KIORBOE T, 1987, MAR ECOL PROG SER, V40, P1, DOI 10.3354/meps040001; Koenigstein S, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00093; Kreiss CM, 2015, J COMP PHYSIOL B, V185, P767, DOI 10.1007/s00360-015-0923-7; Last J. M., 1980, FOOD 20 SPECIES FISH; Laurence GC, 1982, CONTRIB FISH ECOL, VIII; Malzahn AM, 2003, MAR ECOL PROG SER, V259, P285, DOI 10.3354/meps259285; Maneja RH, 2014, MAR POLLUT B, P2; Maneja RH, 2012, MAR BIOL; Maneja RH, 2015, J EXP MAR BIOL ECOL, V466, P42, DOI 10.1016/j.jembe.2015.02.008; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Mehner T, 2012, MAR BIOL, V159, P2583, DOI 10.1007/s00227-012-1922-9; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Moriarty R, 2014, EARTH SYST SCI DATA, V7, P521, DOI DOI 10.5194/ESSDD-7-521-2014; Munday PL, 2013, MAR BIOL, V160, P2137, DOI 10.1007/s00227-012-2111-6; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; Naslund J, 2015, MAR FRESHWATER RES, V66, P877, DOI 10.1071/MF14144; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Oeberst R, 2009, ICES J MAR SCI, V66, P1696, DOI 10.1093/icesjms/fsp193; Peck MA, 2012, ICES J MAR SCI; Pierrot D., 2006, ORNLCDIAC105A US DEP; Pimentel M, 2014, MAR BIOL, V161, P725, DOI 10.1007/s00227-013-2365-7; Pimentel MS, 2014, J EXP BIOL; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Pope E.C., 2013, BIOGEOSCIENCES DISCU, V10, P17043; Reid RN, 1999, NMFSTM12 NOAA; Riebesell U, 2010, EUR COMM, P181; Rosenthal H, S MARINE FOOD CHAINS; Schade FM, 2014, MAR BIOL, V161, P1667, DOI 10.1007/s00227-014-2450-6; SHEPHERD JG, 1980, J CONSEIL, V39, P160; Sherman K, 1971, T AM FISH SOC; Stiasny MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155448; Sundin J, 2016, ICES J MAR SCI, V73, P620, DOI 10.1093/icesjms/fsv101; Suneetha KB, 1999, ENVIRON BIOL FISH, V54, P191, DOI 10.1023/A:1007419012642; von Dewitz B, 2012, HIST RECONSTRUCTION; Wales W, 1996, J FISH BIOL, V49, P801, DOI 10.1006/jfbi.1996.0212; Welch MJ, 2014, NAT CLIM CHANGE, V4, P1086, DOI 10.1038/NCLIMATE2400; WERNER RG, 1980, CAN J FISH AQUAT SCI, V37, P1063, DOI 10.1139/f80-138; Whitehead P. J. P., 1985, FAO FISH SYN 1, V7, P303	84	25	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191947	10.1371/journal.pone.0191947	http://dx.doi.org/10.1371/journal.pone.0191947			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370273	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000423416600118
J	Uhe, M; Hogekamp, C; Hartmann, RM; Hohnjec, N; Kuster, H				Uhe, Marian; Hogekamp, Claudia; Hartmann, Rico M.; Hohnjec, Natalija; Kuester, Helge			The mycorrhiza-dependent defensin MtDefMd1 of Medicago truncatula acts during the late restructuring stages of arbuscule-containing cells	PLOS ONE			English	Article							GENE-EXPRESSION; PLANT DEFENSIN; PHOSPHATE TRANSPORTER; ROOT-NODULES; BACTEROID DIFFERENTIATION; N-2-FIXING SYMBIOSOMES; TRANSCRIPTION FACTOR; LEGUME SYMBIOSIS; VICIA-HIRSUTA; PEPTIDES	Different symbiotic and pathogenic plant-microbe interactions involve the production of cysteine-rich antimicrobial defensins. In Medicago truncatula, the expression of four MtDefMd genes, encoding arbuscular mycorrhiza-dependent defensins containing an N-terminal signal peptide and exhibiting some differences to non-symbiotic defensins, raised over the time of fungal colonization. Whereas the MtDefMd1 and MtDefMd2 promoters were inactive in cells containing young arbuscules, cells with fully developed arbuscules displayed different levels of promoter activities, indicating an up-regulation towards later stages of arbuscule formation. MtDefMd1 and MtDefMd2 expression was absent or strongly down-regulated in mycorrhized ram1-1 and pt4-2 mutants, known for defects in arbuscule branching or premature arbuscule degeneration, respectively. A 97% knock-down of MtDefMd1/MtDefMd2 expression did not significantly affect arbuscule size. Although overexpression of MtDefMd1 in arbuscule-containing cells led to an up-regulation of MtRam1, encoding a key transcriptional regulator of arbuscule formation, no morphological changes were evident. Co-localization of an MtDefMd1-mGFP6 fusion with additional, subcellular markers revealed that this defensin is associated with arbuscules in later stages of their life-cycle. MtDefMd1-mGFP6 was detected in cells with older arbuscules about to collapse, and ultimately in vacuolar compartments. Comparisons with mycorrhized roots expressing a tonoplast marker indicated that MtDefMd1 acts during late restructuring processes of arbuscule-containing cells, upon their transition into a post-symbiotic state.	[Uhe, Marian; Hogekamp, Claudia; Hartmann, Rico M.; Hohnjec, Natalija; Kuester, Helge] Leibniz Univ Hannover, Inst Plant Genet, Unit Plant Genom 4, Hannover, Germany	Leibniz University Hannover	Kuster, H (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Unit Plant Genom 4, Hannover, Germany.	helge.kuester@genetik.uni-hannover.de	Küster, Helge/A-4487-2013	Küster, Helge/0000-0002-9197-9802; Uhe, Marian/0000-0002-3325-9110	Deutsche Forschungsgemeinschaft [GRK1798]; Open Access Fund of the Leibniz Universitat Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Fund of the Leibniz Universitat Hannover	The authors wish to thank the Deutsche Forschungsgemeinschaft (http://www.dfg.de) for financial support in frame of GRK1798 "Signaling at the Plant-Soil Interface". The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alunni B, 2016, NEW PHYTOL, V211, P411, DOI 10.1111/nph.14025; [Anonymous], 1996, ACIAR MONOGRAPH; Arnon DI, 1940, SOIL SCI, V50, P463; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bonneau L, 2013, NEW PHYTOL, V199, P188, DOI 10.1111/nph.12234; Briesemeister S, 2009, J PROTEOME RES, V8, P5363, DOI 10.1021/pr900665y; Carro L, 2016, MICROBIOL-SGM, V162, P1173, DOI 10.1099/mic.0.000291; Carro L, 2015, ISME J, V9, P1723, DOI 10.1038/ismej.2014.257; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; COX G, 1976, NEW PHYTOL, V77, P371, DOI 10.1111/j.1469-8137.1976.tb01526.x; Devers EA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-82; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Farkas A, 2014, P NATL ACAD SCI USA, V111, P5183, DOI 10.1073/pnas.1404169111; Floss DS, 2017, CURR BIOL, V27, P1206, DOI 10.1016/j.cub.2017.03.003; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Genre A, 2005, PLANT CELL, V17, P3489, DOI 10.1105/tpc.105.035410; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hanks JN, 2005, PLANT MOL BIOL, V58, P385, DOI 10.1007/s11103-005-5567-7; Harrison MJ, 2017, CURR OPIN PLANT BIOL, V38, P101, DOI 10.1016/j.pbi.2017.04.019; Harrison MJ, 1997, TRENDS PLANT SCI, V2, P54, DOI 10.1016/S1360-1385(97)82563-0; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hause B, 2005, PLANTA, V221, P184, DOI 10.1007/s00425-004-1436-x; Hayes BME, 2013, ANTIMICROB AGENTS CH, V57, P3667, DOI 10.1128/AAC.00365-13; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Hohnjec N, 2009, MOL PLANT MICROBE IN, V22, P63, DOI 10.1094/MPMI-22-1-0063; Huisman R, 2016, NEW PHYTOL, V211, P1338, DOI 10.1111/nph.13973; Islam KT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16508-w; Ivanov S, 2014, PLANT J, V80, P1151, DOI 10.1111/tpj.12706; Ivanov S, 2012, P NATL ACAD SCI USA, V109, P8316, DOI 10.1073/pnas.1200407109; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2011, PLANT J, V68, P954, DOI 10.1111/j.1365-313X.2011.04746.x; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kobae Y, 2014, PLANT CELL PHYSIOL, V55, P1945, DOI 10.1093/pcp/pcu123; Kobae Y, 2010, PLANT CELL PHYSIOL, V51, P341, DOI 10.1093/pcp/pcq013; Krajinski F, 2014, PLANT CELL, V26, P1808, DOI 10.1105/tpc.113.120436; Krishnakumar V, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu179; Kuster H, 1995, PLANT MOL BIOL, V29, P759, DOI 10.1007/BF00041166; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Limpens E, 2004, J EXP BOT, V55, P983, DOI 10.1093/jxb/erh122; Limpens E, 2009, PLANT CELL, V21, P2811, DOI 10.1105/tpc.108.064410; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Maroti G, 2015, CURR OPIN PLANT BIOL, V26, P57, DOI 10.1016/j.pbi.2015.05.031; Maroti G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00326; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Park HJ, 2015, PLANT PHYSIOL, V169, P2774, DOI 10.1104/pp.15.01155; Penterman J, 2014, P NATL ACAD SCI USA, V111, P3561, DOI 10.1073/pnas.1400450111; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierre O, 2013, PLANT CELL ENVIRON, V36, P2059, DOI 10.1111/pce.12116; PLADYS D, 1993, PLANT PHYSIOL, V103, P379, DOI 10.1104/pp.103.2.379; PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1; Provorov NA, 2002, J THEOR BIOL, V214, P215, DOI 10.1006/jtbi.2001.2453; Pumplin N, 2012, P NATL ACAD SCI USA, V109, pE665, DOI 10.1073/pnas.1110215109; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Sagaram US, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082485; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Strack D, 2003, J CHEM ECOL, V29, P1955, DOI 10.1023/A:1025695032113; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Thevissen K, 2000, MOL PLANT MICROBE IN, V13, P54, DOI 10.1094/MPMI.2000.13.1.54; Thevissen K, 2012, MOL MICROBIOL, V84, P166, DOI 10.1111/j.1365-2958.2012.08017.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Van der Weerden NL, 2013, FUNGAL BIOL REV, V26, P121, DOI 10.1016/j.fbr.2012.08.004; Vieweg MF, 2004, MOL PLANT MICROBE IN, V17, P62, DOI 10.1094/MPMI.2004.17.1.62; Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Zhang XC, 2015, CURR BIOL, V25, P2189, DOI 10.1016/j.cub.2015.06.075	88	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191841	10.1371/journal.pone.0191841	http://dx.doi.org/10.1371/journal.pone.0191841			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370287	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600106
J	Mellouk, N; Rame, C; Marchand, M; Staub, C; Touze, JL; Venturi, E; Mercerand, F; Travel, A; Chartrin, P; Lecompte, F; Ma, LL; Froment, P; Dupont, J				Mellouk, Namya; Rame, Christelle; Marchand, Maxime; Staub, Christophe; Touze, Jean-Luc; Venturi, Eric; Mercerand, Frederic; Travel, Angelique; Chartrin, Pascal; Lecompte, Francois; Ma, Linlin; Froment, Pascal; Dupont, Joelle			Effect of different levels of feed restriction and fish oil fatty acid supplementation on fat deposition by using different techniques, plasma levels and mRNA expression of several adipokines in broiler breeder hens	PLOS ONE			English	Article							DIET-INDUCED OBESITY; EICOSAPENTAENOIC ACID; BODY-COMPOSITION; N-3 ENRICHMENT; CHICKEN MEAT; DOCOSAHEXAENOIC ACID; METABOLIC HORMONES; FOOD-DEPRIVATION; COUNTRY CHICKENS; ADIPONECTIN GENE	Background Reproductive hens are subjected to a restricted diet to limit the decline in fertility associated with change in body mass. However, endocrine and tissue responses to diet restriction need to be documented. Objective We evaluated the effect of different levels of feed restriction, with or without fish oil supplementation, on metabolic parameters and adipokine levels in plasma and metabolic tissues of reproductive hens. Methods We designed an in vivo protocol involving 4 groups of hens; RNS: restricted (Rt) unsupplemented, ANS: ad libitum (Ad, receiving an amount of feed 1.7 times greater than animals on the restricted diet) unsupplemented, RS: Rt supplemented, and AS: Ad supplemented. The fish oil supplement was used at 1% of the total diet composition. Results Hens fed with the Rt diet had a significantly (P < 0.0001) lower growth than Ad hens, while the fish oil supplementation had no effect on these parameters. Furthermore, the bioelectrical impedance analysis (BIA) and the fat ultrasonographic examinations produced similar results to the other methods that required animals to be killed (carcass analysis and weight of adipose tissue). In addition, the Rt diet significantly (P < 0.05) decreased plasma levels of triglycerides, phospholipids, glucose and ADIPOQ, and fish oil supplementation decreased plasma levels of RARRES2. We also showed a positive correlation between insulin values and ADIPOQ or NAMPT or RARRES2 values, and a negative correlation of fat percentage to RARRES2 values. Moreover, the effects of the Rt diet and fish oil supplementation on the mRNA expression depended on the factors tested and the hen age. Conclusions Rt diet and fish oil supplementation are able to modulate metabolic parameters and the expression of adipokines and their receptors in metabolic tissue.	[Mellouk, Namya; Rame, Christelle; Lecompte, Francois; Ma, Linlin; Froment, Pascal; Dupont, Joelle] INRA UMR85 Physiol Reprod & Comportements, Nouzilly, France; [Mellouk, Namya; Rame, Christelle; Lecompte, Francois; Ma, Linlin; Froment, Pascal; Dupont, Joelle] CNRS, UMR7247 Physiol Reprod & Comportements, Nouzilly, France; [Mellouk, Namya; Rame, Christelle; Lecompte, Francois; Ma, Linlin; Froment, Pascal; Dupont, Joelle] Univ Francois Rabelais Tours, Tours, France; [Mellouk, Namya; Rame, Christelle; Lecompte, Francois; Ma, Linlin; Froment, Pascal; Dupont, Joelle] IFCE Nouzilly, Nouzilly, France; [Marchand, Maxime; Mercerand, Frederic] INRA, UEPEAT, Nouzilly, France; [Staub, Christophe; Touze, Jean-Luc; Venturi, Eric] INRA, UEPAO 1297, Nouzilly, France; [Travel, Angelique] Ctr INRA Ctr Val Loire, ITAVI, Nouzilly, France; [Chartrin, Pascal] INRA, URA, Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; INRAE; INRAE; INRAE	Dupont, J (corresponding author), INRA UMR85 Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), CNRS, UMR7247 Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), Univ Francois Rabelais Tours, Tours, France.; Dupont, J (corresponding author), IFCE Nouzilly, Nouzilly, France.	jdupont@tours.fr	Mellouk, Namya/AAL-7583-2021		Region Centre Val de Loire grant "Adipofertikines" [32000407]; MENRT	Region Centre Val de Loire grant "Adipofertikines"; MENRT	This work has been supported by Region Centre Val de Loire grant "Adipofertikines" No 32000407. Namya Mellouk is a PhD student supported by the MENRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Broiler M J. A., 2002, WORLDS POULTRY SCI J, V58, P23; Bruggeman V, 1999, POULTRY SCI, V78, P1424, DOI 10.1093/ps/78.10.1424; Buyse J, 2000, BRIT POULTRY SCI, V41, P107, DOI 10.1080/00071660086493; Cachaldora P, 2006, BRIT POULTRY SCI, V47, P43, DOI 10.1080/00071660500475541; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Carre B, 2013, ANIMAL, V7, P1246, DOI 10.1017/S1751731113000359; Chabrolle C, 2007, DOMEST ANIM ENDOCRIN, V33, P480, DOI 10.1016/j.domaniend.2006.08.002; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; Chen LR, 2007, ANIM REPROD SCI, V100, P172, DOI 10.1016/j.anireprosci.2006.07.005; Cheshmehkani A, 2015, INFLAMM RES, V64, P809, DOI 10.1007/s00011-015-0864-3; Cornall LM, 2011, CELL PHYSIOL BIOCHEM, V28, P949, DOI 10.1159/000335820; de Jong IC, 2002, BRIT POULTRY SCI, V43, P157, DOI 10.1080/00071660120121355; DECUYPERE E, 1988, Acta Physiologica Polonica, V39, P380; Diot M, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0081-5; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; Geier MS, 2009, POULTRY SCI, V88, P2399, DOI 10.3382/ps.2009-00126; Ghazanfari S, 2011, ASIAN J ANIM VET ADV, V6, P429, DOI 10.3923/ajava.2011.429.439; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; Hocking PM, 1996, BRIT POULTRY SCI, V37, P263, DOI 10.1080/00071669608417858; Joseph NS, 2000, POULTRY SCI, V79, P1790, DOI 10.1093/ps/79.12.1790; Kita K, 2002, J NUTR, V132, P145, DOI 10.1093/jn/132.2.145; Koppenol A, 2014, POULTRY SCI, V93, P564, DOI 10.3382/ps.2013-03320; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Li J, 2012, POULTRY SCI, V91, P2885, DOI 10.3382/ps.2012-02315; Lopez-Ferrer S, 1999, POULTRY SCI, V78, P356, DOI 10.1093/ps/78.3.356; Lopez-Ferrer S, 2001, POULTRY SCI, V80, P741, DOI 10.1093/ps/80.6.741; Lopez-Ferrer S, 2001, POULTRY SCI, V80, P753, DOI 10.1093/ps/80.6.753; Lorente-Cebrian S, 2009, CLIN SCI, V117, P243, DOI 10.1042/CS20090020; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oster RT, 2010, APPL PHYSIOL NUTR ME, V35, P783, DOI 10.1139/H10-076; Pan YE, 2014, ANIM REPROD SCI, V151, P229, DOI 10.1016/j.anireprosci.2014.10.003; PEARCE J, 1977, J ENDOCRINOL, V75, P343, DOI 10.1677/joe.0.0750343; Poniedzialek-Czajkowska E, 2014, CURR PHARM BIOTECHNO, V15, P84, DOI 10.2174/1389201015666140330195614; Ramachandran R, 2013, GEN COMP ENDOCR, V190, P88, DOI 10.1016/j.ygcen.2013.05.004; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Richards MP, 2007, POULTRY SCI, V86, P1478, DOI 10.1093/ps/86.7.1478; ROBBINS KR, 1986, POULTRY SCI, V65, P2226, DOI 10.3382/ps.0652226; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Schreiner M, 2005, J SCI FOOD AGR, V85, P219, DOI 10.1002/jsfa.1948; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Seroussi E, 2016, ENDOCRINOLOGY, V157, P737, DOI 10.1210/en.2015-1634; Shils M. E., 2006, MODERN NUTR HLTH DIS, V10th, P92; Sledzinski T, 2013, J ENDOCRINOL INVEST, V36, P428, DOI 10.3275/8770; Sun JM, 2006, POULTRY SCI, V85, P1173, DOI 10.1093/ps/85.7.1173; Tahmoorespur M, 2010, POULTRY SCI, V89, P2092, DOI 10.3382/ps.2010-00772; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; van Krimpen MM, 2014, WORLD POULTRY SCI J, V70, P139, DOI 10.1017/S0043933914000129; Vu JP, 2015, J MOL NEUROSCI, V56, P377, DOI 10.1007/s12031-015-0556-z; Yan J, 2013, MOL BIOL REP, V40, P7017, DOI 10.1007/s11033-013-2821-y; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077716	55	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191121	10.1371/journal.pone.0191121	http://dx.doi.org/10.1371/journal.pone.0191121			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364913	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500036
J	Saitoh, S; Okano, S; Nohara, H; Nakano, H; Shirasawa, N; Naito, A; Yamamoto, M; Kelly, VP; Takahashi, K; Tanaka, T; Nakajima, M; Nakajima, O				Saitoh, Shinichi; Okano, Satoshi; Nohara, Hidekazu; Nakano, Hiroshi; Shirasawa, Nobuyuki; Naito, Akira; Yamamoto, Masayuki; Kelly, Vincent P.; Takahashi, Kiwamu; Tanaka, Tohru; Nakajima, Motowo; Nakajima, Osamu			5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; REV-ERB-ALPHA; SKELETAL-MUSCLE; HEME DEFICIENCY; NONSPECIFIC FORM; RAT-LIVER; DYSFUNCTION; EXPRESSION; INHIBITION; METABOLISM	In vertebrates, the initial step in heme biosynthesis is the production of 5-aminolevulinic acid (ALA) by ALA synthase (ALAS). ALA formation is believed to be the rate-limiting step for cellular heme production. Recently, several cohort studies have demonstrated the potential of ALA as a treatment for individuals with prediabetes and type-2 diabetes mellitus. These studies imply that a mechanism exists by which ALA or heme can control glucose metabolism. The ALAS1 gene encodes a ubiquitously expressed isozyme. Mice heterozygous null for ALAS1 (A1(+/-)s) experience impaired glucose tolerance (IGT) and insulin resistance (IR) beyond 20-weeks of age (aged A1(+/-)s). IGT and IR were remedied in aged A1(+/-)s by the oral administration of ALA for 1 week. However, the positive effect of ALA proved to be reversible and was lost upon termination of ALA administration. In the skeletal muscle of aged A1(+/-)s an attenuation of mitochondrial function is observed, coinciding with IGT and IR. Oral administration of ALA for 1-week brought about only a partial improvement in mitochondrial activity however, a 6-week period of ALA treatment was sufficient to remedy mitochondrial function. Studies on differentiated C2C12 myocytes indicate that the impairment of glucose metabolism is a cell autonomous effect and that ALA deficiency ultimately leads to heme depletion. This sequela is evidenced by a reduction of glucose uptake in C2C12 cells following the knockdown of ALAS1 or the inhibition of heme biosynthesis by succinylacetone. Our data provide in vivo proof that ALA deficiency attenuates mitochondrial function, and causes IGT and IR in an age-dependent manner. The data reveals an unexpected metabolic link between heme and glucose that is relevant to the pathogenesis of IGT/IR.	[Saitoh, Shinichi; Okano, Satoshi; Nohara, Hidekazu; Nakano, Hiroshi; Nakajima, Osamu] Yamagata Univ, Fac Med, Res Ctr Mol Genet, Inst Promot Med Sci Res, Yamagata, Yamagata, Japan; [Shirasawa, Nobuyuki; Naito, Akira] Yamagata Univ, Fac Med, Dept Anat & Struct Sci, Yamagata, Yamagata, Japan; [Yamamoto, Masayuki] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Kelly, Vincent P.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Takahashi, Kiwamu; Tanaka, Tohru; Nakajima, Motowo] SBI Pharmaceut Co Ltd, Tokyo, Japan	Yamagata University; Yamagata University; Tohoku University; Trinity College Dublin; SBI Pharmaceuticals	Nakajima, O (corresponding author), Yamagata Univ, Fac Med, Res Ctr Mol Genet, Inst Promot Med Sci Res, Yamagata, Yamagata, Japan.	nakajima@med.id.yamagata-u.ac.jp	Kelly, Vincent P/I-2151-2017; Yamamoto, Masayuki/A-4873-2010	Kelly, Vincent P/0000-0001-7067-5407; Yamamoto, Masayuki/0000-0002-9073-9436; Saitoh, Shinichi/0000-0001-7523-8177	JSPS KAKENHI [25670158]; SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan); SBI Pharmaceuticals Co., Ltd., Tokyo, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan); SBI Pharmaceuticals Co., Ltd., Tokyo, Japan	This study was supported by JSPS KAKENHI (Grant-in-Aid for Challenging Exploratory Research) Grant Number 25670158 and was a cooperative research effort with SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan), who provided financial support for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A part of the study was financially supported by SBI Pharmaceuticals Co., Ltd., Tokyo, Japan. The authors who are employees of SBI Pharmaceuticals Co., Ltd. have committed to study design, supply of materials, result analysis, discussion and manuscript preparation but not to data collection by executing the experiments. In particular, they performed a critical role in the design of the study.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Bakhtiyari S, 2010, LIPIDS, V45, P237, DOI 10.1007/s11745-010-3394-3; BISHOP DF, 1990, NUCLEIC ACIDS RES, V18, P7187, DOI 10.1093/nar/18.23.7187; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujii C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03917-0; Fuse Y, 2015, GENES CELLS, V20, P590, DOI 10.1111/gtc.12249; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Higashikawa F, 2013, NUTRITION, V29, P1030, DOI 10.1016/j.nut.2013.02.008; Hoeks J, 2012, TRENDS ENDOCRIN MET, V23, P444, DOI 10.1016/j.tem.2012.05.007; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIKUCHI G, 1981, MOL CELL BIOCHEM, V37, P27, DOI 10.1007/BF02355885; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; MORITA Y, 1994, IND HEALTH, V32, P85, DOI 10.2486/indhealth.32.85; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nakajima O, 2006, GENES CELLS, V11, P685, DOI 10.1111/j.1365-2443.2006.00973.x; Oishi H, 1996, J ANAL TOXICOL, V20, P106, DOI 10.1093/jat/20.2.106; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rodriguez BL, 2012, CTS-CLIN TRANSL SCI, V5, P314, DOI 10.1111/j.1752-8062.2012.00421.x; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033426; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yamada M, 1988, JPN J LAB AUTO, V13, P659; Yamamoto M, 2000, INT J HEMATOL, V72, P157; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3702, DOI 10.1073/pnas.82.11.3702; YAMAMOTO M, 1982, BIOCHEM BIOPH RES CO, V105, P985, DOI 10.1016/0006-291X(82)91067-1; YAMAMOTO M, 1983, BIOCHEM BIOPH RES CO, V115, P225, DOI 10.1016/0006-291X(83)90993-2; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YOMOGIDA K, 1993, J BIOCHEM-TOKYO, V113, P364, DOI 10.1093/oxfordjournals.jbchem.a124052	48	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189593	10.1371/journal.pone.0189593	http://dx.doi.org/10.1371/journal.pone.0189593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364890	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500005
J	Carrillo, JB; Gomez-Casati, DF; Martin, M; Busi, MV				Carrillo, Julieta B.; Gomez-Casati, Diego F.; Martin, Mariana; Busi, Maria V.			Identification and analysis of OsttaDSP, a phosphoglucan phosphatase from &ITOstreococcus tauri&IT	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GLUCAN PHOSPHATASES; SEX FOUR2; STARCH DEPHOSPHORYLATION; 3-DIMENSIONAL STRUCTURES; ARABIDOPSIS-THALIANA; LAFORA DISEASE; GREEN-ALGAE; R1 PROTEIN; METABOLISM	Ostreococcus tauri, the smallest free-living (non-symbiotic) eukaryote yet described, is a unicellular green alga of the Prasinophyceae family. It has a very simple cellular organization and presents a unique starch granule and chloroplast. However, its starch metabolism exhibits a complexity comparable to higher plants, with multiple enzyme forms for each metabolic reaction. Glucan phosphatases, a family of enzymes functionally conserved in animals and plants, are essential for normal starch or glycogen degradation in plants and mammals, respectively. Despite the importance of O. tauri microalgae in evolution, there is no information available concerning the enzymes involved in reversible phosphorylation of starch. Here, we report the molecular cloning and heterologous expression of the gene coding for a dual specific phosphatase from O. tauri (OsttaDSP), homologous to Arabidopsis thaliana LSF2. The recombinant enzyme was purified to electrophoretic homogeneity to characterize its oligomeric and kinetic properties accurately. OsttaDSP is a homodimer of 54.5 kDa that binds and dephosphorylates amylopectin. Also, we also determined that residue C162 is involved in catalysis and possibly also in structural stability of the enzyme. Our results could contribute to better understand the role of glucan phosphatases in the metabolism of starch in green algae.	[Carrillo, Julieta B.; Gomez-Casati, Diego F.; Martin, Mariana; Busi, Maria V.] Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Martin, M; Busi, MV (corresponding author), Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Santa Fe, Argentina.	martin@cefobi-conicet.gov.ar; busi@cefobi-conicet.gov.ar		Busi, Maria Victoria/0000-0003-3638-7043	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP00134-2012, PIP0476-2015]; Agencia Nacional de Investigaciones Cienntificas y Tecnologicas [PICT 2011-0982, PICT 2013-2438]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Investigaciones Cienntificas y Tecnologicas	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP00134-2012; PIP0476-2015. (www.conicet.gov.ar) and Agencia Nacional de Investigaciones Cienntificas y Tecnologicas PICT 2011-0982; PICT 2013-2438 (www.agencia.mincyt.gob.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball S, 2015, TRANSITION GLYCOGEN, P93; Barchiesi Julieta, 2015, BMC Research Notes, V8, P613, DOI 10.1186/s13104-015-1598-6; Blennow A, 2000, INT J BIOL MACROMOL, V27, P211, DOI 10.1016/S0141-8130(00)00121-5; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Busi MV, 2014, STARCH-STARKE, V66, P28, DOI 10.1002/star.201200211; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Carrillo JB, 2017, ANAL BIOCHEM, V517, P36, DOI 10.1016/j.ab.2016.11.005; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; Dukhande VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024040; Emanuelle S, 2016, CELL MOL LIFE SCI, V73, P2765, DOI 10.1007/s00018-016-2249-3; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2016, CURR OPIN STRUC BIOL, V40, P62, DOI 10.1016/j.sbi.2016.07.015; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Hofmann NR, 2013, PLANT CELL, V25, P1915, DOI 10.1105/tpc.113.250614; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maliandi MV, 2007, PROTEIN EXPRES PURIF, V51, P157, DOI 10.1016/j.pep.2006.06.007; Meekins DA, 2015, J BIOL CHEM, V290, P23361, DOI 10.1074/jbc.M115.658203; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Meekins DA, 2013, PLANT CELL, V25, P2302, DOI 10.1105/tpc.113.112706; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach PJ, 2015, MOL ASPECTS MED, V46, P78, DOI 10.1016/j.mam.2015.08.003; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Serratosa J M, 1999, Neurologia, V14, P325; Sherwood AR, 2013, CLIN BIOCHEM, V46, P1869, DOI 10.1016/j.clinbiochem.2013.08.016; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tester RF, 2004, WORLD POULTRY SCI J, V60, P186, DOI [10.1079/WPS200312, 10.1079/WPS200412, 10.1079/WPS20040014]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Turowski VR, 2012, MOL PLANT, V5, P1001, DOI 10.1093/mp/sss037; Westcott KR, 1997, Q REV BIOL, V72, P200; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkens C, 2016, FEBS LETT, V590, P118, DOI 10.1002/1873-3468.12027; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191621	10.1371/journal.pone.0191621	http://dx.doi.org/10.1371/journal.pone.0191621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360855	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800042
J	Shayegani, R; Song, KW; Amuan, ME; Jaramillo, CA; Eapen, BC; Pugh, MJ				Shayegani, Ramona; Song, Kangwon; Amuan, Megan E.; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo			Patterns of zolpidem use among Iraq and Afghanistan veterans: A retrospective cohort analysis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; NIGHTLY ZOLPIDEM; BEHAVIORAL TREATMENT; DRUG OVERDOSE; INSOMNIA; RISK; HYPNOTICS; DEATHS; PRESCRIPTIONS; MORTALITY	Background & para;& para;Although concern exists regarding the adverse effects and rate of zolpidem use, especially long-term use, limited information is available concerning patterns of zolpidem use.& para;& para; Objective & para;& para;To examine the prevalence and correlates of zolpidem exposure in Iraq and Afghanistan Veterans (IAVs).& para;& para;Methods & para;& para;A retrospective cohort study of zolpidem prescriptions was performed with National Veterans Health Administration (VHA) data. We gathered national VA inpatient, outpatient, and pharmacy data files for IAV's who received VA care between fiscal years (FY) 2013 and 2014. The VA pharmacy database was used to identify the prevalence of long term (>30 days), high-dose zolpidem exposure (>10mg immediate-release; >12.5mg extended-release) and other medications received in FY14. Baseline characteristics (demographics, diagnoses) were identified in FY13. Bivariate and multivariable analyses were used to examine the demographic, clinical, and medication correlates of zolpidem use.& para;& para;Results & para;& para;Of 493,683 IAVs who received VHA care in FY 2013 and 2014, 7.6% (n = 37,422) were prescribed zolpidem in FY 2014. Women had lower odds of high-dose zolpidem exposure than men. The majority (77.3%) of IAVs who received zolpidem prescriptions had long-term use with an average days' supply of 189.3 days and a minority (0.9%) had high-dose exposure. In multivariable analyses, factors associated with long-term zolpidem exposure included age greater than 29 years old, PTSD, insomnia, Selim Index, physical 2-3 conditions, opioids, antidepressants, benzodiazepines, atypical antipsychotics, and stimulants. High dose exposure was associated with PTSD, depression, substance use disorder, insomnia, benzodiazepines, atypical antipsychotics, and stimulant prescriptions.& para;& para;Conclusion & para;& para;The current practices of insomnia pharmacotherapy in IAVs fall short of the clinical guidelines and may reflect high-risk zolpidem prescribing practices that put Iraq and Afghanistan Veterans at risk for adverse effects of zolpidem and poor health outcomes.	[Shayegani, Ramona] VA Southern Nevada Healthcare Syst, North Las Vegas, NV USA; [Song, Kangwon; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo] South Texas Vet Hlth Care Syst, San Antonio, TX 78228 USA; [Song, Kangwon; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Amuan, Megan E.] Edith Nourse Rogers Mem Vet Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah Hlth, Div Epidemiol, Salt Lake City, UT 84112 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78228 USA.; Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.; Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah Hlth, Div Epidemiol, Salt Lake City, UT 84112 USA.	pughm@uthscsa.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Song, Kangwon/0000-0001-6642-8753	VA, Office of Research and Development; VA Health Services Research and Development Services [1I01HX001304-01, 1I01HX000717-01]; Department of Veterans Affairs (VA) Health Services Research and Development Services [DHI 09-237]; Chronic Effects of Neurotrauma Consortium award [W81XWH-12-04 PHTBI-CENC]; VA Introduction Rehabilitation Research and Development Service [I21 RX002060-01]	VA, Office of Research and Development; VA Health Services Research and Development Services; Department of Veterans Affairs (VA) Health Services Research and Development Services(US Department of Veterans Affairs); Chronic Effects of Neurotrauma Consortium award; VA Introduction Rehabilitation Research and Development Service	This study was funded by the Department of Veterans Affairs (VA) Health Services Research and Development Services (DHI 09-237) [Pugh]. Dr. Pugh receives additional funding from the VA, Office of Research and Development, VA Health Services Research and Development Services (1I01HX001304-01, 1I01HX000717-01), VA Introduction Rehabilitation Research and Development Service (I21 RX002060-01) and the Chronic Effects of Neurotrauma Consortium award (W81XWH-12-04 PHTBI-CENC).	Anderson BJ, 2014, PEDIATR ANESTH, V24, P549, DOI 10.1111/pan.12421; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Blom K, 2016, SLEEP, V39, P1267, DOI 10.5665/sleep.5850; Bohnert ASB, 2013, INJURY PREV, V19, P326, DOI 10.1136/injuryprev-2012-040631; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Collett GA., 2016, DRUGS-REAL WOR OUTC, V3, P45; Copeland LA, 2016, MED CARE, V55, P1078, DOI 10.1097/MLR.0000000000000588; Drug Abuse Warning Network, 2011, NAT EST DRUG REL EM; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Finley EP, 2010, MIL MED, V175, P953, DOI 10.7205/MILMED-D-10-00040; Hajak G, 2003, ADDICTION, V98, P1371, DOI 10.1046/j.1360-0443.2003.00491.x; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; Ho FYY, 2015, SLEEP MED REV, V19, P17, DOI 10.1016/j.smrv.2014.06.010; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Kaufmann CN, 2016, PHARMACOEPIDEM DR S, V25, P637, DOI 10.1002/pds.3951; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Kripke DF, 2016, DRUG SAFETY, V39, P93, DOI 10.1007/s40264-015-0362-0; Lai MM, 2014, MAYO CLIN PROC, V89, P589, DOI 10.1016/j.mayocp.2014.01.021; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Lund BC, 2012, J CLIN PSYCHIAT, V73, P292, DOI 10.4088/JCP.10m06775; MALCOLM R, 1993, J PSYCHOACTIVE DRUGS, V25, P315, DOI 10.1080/02791072.1993.10472289; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Management of Concussion-mild Traumatic Brain Injury (mTBI), 2016, VA DOD CLIN PRACT GU; Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU, P1; Morgenthaler T, 2006, SLEEP, V29, P1415; Morgenthaler TI, 2014, MAYO CLIN PROC, V89, P579, DOI 10.1016/j.mayocp.2014.03.006; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Randall S, 2012, SLEEP, V35, P1551, DOI 10.5665/sleep.2208; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Roehrs TA, 2012, J PSYCHOPHARMACOL, V26, P1088, DOI 10.1177/0269881111424455; Roehrs TA, 2011, SLEEP, V34, P207, DOI 10.1093/sleep/34.2.207; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Seyffert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149139; Sun EC, 2017, BMJ; Tjagvad C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0881-y; Turner BJ, 2015, J GEN INTERN MED, V30, P1081, DOI 10.1007/s11606-015-3199-4; Verster JC, 2002, J CLIN PSYCHOPHARM, V22, P576, DOI 10.1097/00004714-200212000-00007; Victorri-Vigneau C, 2013, EUR J CLIN PHARMACOL, V69, P1965, DOI 10.1007/s00228-013-1557-x; Vincent N, 2013, J CLIN SLEEP MED, V9, P227, DOI 10.5664/jcsm.2484; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Weaver Michael F., 2015, Yale Journal of Biology and Medicine, V88, P247; Yang Z, 2015, J PAIN, V16, P445, DOI 10.1016/j.jpain.2015.01.475; Ye YY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010707; Yoon JR, 2010, J INT MED RES, V38, P1795, DOI 10.1177/147323001003800526; Zedler B, 2014, PAIN MED, V15, P1911, DOI 10.1111/pme.12480; Zosel A, 2011, AM J THER, V18, P305, DOI 10.1097/MJT.0b013e3181d169ed	55	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190022	10.1371/journal.pone.0190022	http://dx.doi.org/10.1371/journal.pone.0190022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360821	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800006
J	Mujibi, FD; Okoth, E; Cheruiyot, EK; Onzere, C; Bishop, RP; Fevre, EM; Thomas, L; Masembe, C; Plastow, G; Rothschild, M				Mujibi, Fidalis Denis; Okoth, Edward; Cheruiyot, Evans K.; Onzere, Cynthia; Bishop, Richard P.; Fevre, Eric M.; Thomas, Lian; Masembe, Charles; Plastow, Graham; Rothschild, Max			Genetic diversity, breed composition and admixture of Kenyan domestic pigs	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; GENOME; ASSOCIATION; SELECTION; ANCESTRY; VIRUS	The genetic diversity of African pigs, whether domestic or wild has not been widely studied and there is very limited published information available. Available data suggests that African domestic pigs originate from different domestication centers as opposed to international commercial breeds. We evaluated two domestic pig populations in Western Kenya, in order to characterize the genetic diversity, breed composition and admixture of the pigs in an area known to be endemic for African swine fever (ASF). One of the reasons for characterizing these specific populations is the fact that a proportion of indigenous pigs have tested ASF virus (ASFv) positive but do not present with clinical symptoms of disease indicating some form of tolerance to infection. Pigs were genotyped using either the porcine SNP60 or SNP80 chip. Village pigs were sourced from Busia and Homabay counties in Kenya. Because bush pigs (Potamochoerus larvatus) and warthogs (Phacochoerus spp.) are known to be tolerant to ASFv infection (exhibiting no clinical symptoms despite infection), they were included in the study to assess whether domestic pigs have similar genomic signatures. Additionally, samples representing European wild boar and international commercial breeds were included as references, given their potential contribution to the genetic make-up of the target domestic populations. The data indicate that village pigs in Busia are a non-homogenous admixed population with significant introgression of genes from international commercial breeds. Pigs from Homabay by contrast, represent a homogenous population with a "local indigenous' composition that is distinct from the international breeds, and clusters more closely with the European wild boar than African wild pigs. Interestingly, village pigs from Busia that tested negative by PCR for ASFv genotype IX, had significantly higher local ancestry (> 54%) compared to those testing positive, which contained more commercial breed gene introgression. This may have implication for breed selection and utilization in ASF endemic areas. A genome wide scan detected several regions under preferential selection with signatures for pigs from Busia and Homabay being very distinct. Additionally, there was no similarity in specific genes under selection between the wild pigs and domestic pigs despite having some broad areas under similar selection signatures. These results provide a basis to explore possible genetic determinants underlying tolerance to infection by ASFv genotypes and suggests multiple pathways for genetically mediated ASFv tolerance given the diversity of selection signatures observed among the populations studied.	[Mujibi, Fidalis Denis] Nelson Mandela Africa Inst Sci & Technol, Arusha, Tanzania; [Mujibi, Fidalis Denis; Cheruiyot, Evans K.] USOMI Ltd, Nairobi, Kenya; [Okoth, Edward; Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya; [Onzere, Cynthia; Bishop, Richard P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Cheshire, England; [Thomas, Lian] Univ Edinburgh, Ctr Infect Immun & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Masembe, Charles] Makerere Univ, Coll Nat Sci, Kampala, Uganda; [Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Rothschild, Max] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Nelson Mandela African Institution of Science & Technology; CGIAR; International Livestock Research Institute (ILRI); Washington State University; University of Liverpool; University of Edinburgh; Makerere University; University of Alberta; Iowa State University	Mujibi, FD (corresponding author), Nelson Mandela Africa Inst Sci & Technol, Arusha, Tanzania.; Mujibi, FD (corresponding author), USOMI Ltd, Nairobi, Kenya.	fmujibi@gmail.com	Thomas, Lian/H-2818-2019; Mujibi, Denis Fidalis/AAJ-2740-2020	Thomas, Lian/0000-0001-8447-1210; Mujibi, Denis Fidalis/0000-0002-1478-9001; Fevre, Eric/0000-0001-8931-4986; Masembe, Charles/0000-0002-9581-0414	AusAID; Wellcome trust [085308, 105684/Z/14/Z]; University of Edinburgh Innovation Initiative Grant fund; USDA/FAS [58-3148-1-252]; Swedish Research Links Programme (Swedish research council); Ensminger Endowment; US Pig Genome Coordination Program; State of Iowa; Hatch funding; USOMI Limited; Biotechnology and Biological Sciences Research Council [BB/L019019/1] Funding Source: researchfish; BBSRC [BB/L019019/1] Funding Source: UKRI	AusAID(Australian Aid (AusAID)); Wellcome trust(Wellcome TrustEuropean Commission); University of Edinburgh Innovation Initiative Grant fund; USDA/FAS(United States Department of Agriculture (USDA)); Swedish Research Links Programme (Swedish research council); Ensminger Endowment; US Pig Genome Coordination Program; State of Iowa; Hatch funding; USOMI Limited; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Porcine sample collection was funded by AusAID, the Wellcome trust (grant #085308) and The University of Edinburgh Innovation Initiative Grant fund. Bush pig sample collection in Uganda was made possible with financial support obtained through the USDA/FAS cooperative agreement 58-3148-1-252 and the Swedish Research Links Programme (Swedish research council) and the Wellcome Trust [105684/Z/14/Z]. Genotyping was made possible thanks to funds provided by the Ensminger Endowment and the US Pig Genome Coordination Program, State of Iowa and Hatch funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [Peter Bishop, Edward Okoth, Charles Masembe, Cynthia Onzere] and reagents, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. USOMI Limited provided support in the form of salaries for authors [FM, EC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguero M, 2003, J CLIN MICROBIOL, V41, P4431, DOI 10.1128/JCM.41.9.4431-4434.2003; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amills M, 2010, ENCY LIFE SCI; [Anonymous], 2010, VET REC, V166, P546, DOI [10.1136/vr.c2373, 10.1136/yr.c2373]; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Blench RM, ORIGINS DEV AFRICAN; Briggs H.M., 1969, MODERN BREEDS LIVEST; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Holness D. H., 1974, RHOD J AGR RES, V73, P59; Jia X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14605; Herrero-Medrano JM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-106; Noce A, 2015, ANIM GENET, V46, P433, DOI 10.1111/age.12305; Oliver WL., 1993, PIGS PECCARIES HIPPO; Oura CAL, 1998, J GEN VIROL, V79, P1439, DOI 10.1099/0022-1317-79-6-1439; Penrith M.L., 2004, INFECT DIS LIVESTOCK, P1087; Porter V., 1993, PIGS HDB BREEDS WORL; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Thomas LF, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0830-5; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	24	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190080	10.1371/journal.pone.0190080	http://dx.doi.org/10.1371/journal.pone.0190080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357367	gold, Green Published, Green Submitted			2022-12-26	WOS:000422919500003
J	Garcia-Ruiz, E; Loureiro, I; Farinos, GP; Gomez, P; Gutierrez, E; Sanchez, FJ; Escorial, MC; Ortego, F; Chueca, MC; Castanera, P				Garcia-Ruiz, Esteban; Loureiro, Inigo; Farinos, Gema P.; Gomez, Pablo; Gutierrez, Elena; Javier Sanchez, Francisco; Concepcion Escorial, Maria; Ortego, Felix; Cristina Chueca, Maria; Castanera, Pedro			Weeds and ground-dwelling predators' response to two different weed management systems in glyphosate-tolerant cotton: A farm-scale study	PLOS ONE			English	Article							MODIFIED HERBICIDE-TOLERANT; INVERTEBRATE RESPONSES; PLANT DIVERSITY; SUGAR-BEET; CROPS; POPULATIONS; ABUNDANCE; IMPACTS; MAIZE; FIELD	The use of glyphosate, as a post-emergence broad-spectrum herbicide in genetically modified glyphosate-tolerant (GT) cotton, supposes a big change in weed management programs with respect to a conventional regime. Thus, alterations in arable flora and arthropod fauna must be considered when evaluating their potential impacts. A 3-year farm-scale study was conducted in a 2-ha GT cotton crop, in southern Spain, to compare the effects of conventional and glyphosate herbicide regimes on weed abundance and diversity and their consequences for ground-dwelling predators. Surveys reveal that weed density was relatively low within all treatments with a few dominant species, with significantly higher weed densities and modifications of the floristic composition in glyphosate-treated plots that led to an increase in the abundance of Portulaca oleracea and to a reduction in plant diversity. The activity-density of the main predatory arthropod taxa (spiders, ground beetles, rove beetles and earwigs) varied among years, but no significant differences were obtained between conventional and glyphosate herbicide regimes. However, significant differences between treatments were obtained for ground beetles species richness and diversity, being higher under the glyphosate herbicide regime, and a positive correlation with weed density could be established for both parameters. The implications of these findings to weed control in GT cotton are discussed.	[Garcia-Ruiz, Esteban; Loureiro, Inigo; Gomez, Pablo; Gutierrez, Elena; Javier Sanchez, Francisco; Concepcion Escorial, Maria; Cristina Chueca, Maria] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Protecc Vegetal, Lab Malherbol, Madrid, Spain; [Farinos, Gema P.; Ortego, Felix; Castanera, Pedro] CSIC, Ctr Invest Biol, Dept Biol Medioambiental, Lab Interacc Planta Insecto, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Loureiro, I (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Protecc Vegetal, Lab Malherbol, Madrid, Spain.	loureiro@inia.es	Loureiro, Iñigo/F-2451-2010; Escorial, María Concepción/ABG-2982-2020; Ortego, Félix/F-9402-2011; FARINÓS, GEMA P./D-9849-2015	Loureiro, Iñigo/0000-0003-3022-2002; Ortego, Félix/0000-0002-7778-8508; FARINÓS, GEMA P./0000-0002-4952-5372; Escorial Bonet, Maria Concepcion/0000-0001-5507-5956	Spanish Ministry for Environment, Marine and Rural Affairs [AEG 06-038]	Spanish Ministry for Environment, Marine and Rural Affairs	This work was supported by the Spanish Ministry for Environment, Marine and Rural Affairs (grant AEG 06-038) to MCC.	Albajes R., 2014, Journal of Agricultural Science (Toronto), V6, P67; Albajes R, 2009, ENVIRON ENTOMOL, V38, P944, DOI 10.1603/022.038.0349; [Anonymous], 2001, PLANT STRATEGIES VEG; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bonny S, 2016, ENVIRON MANAGE, V57, P31, DOI 10.1007/s00267-015-0589-7; Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; BRUST GE, 1990, PESTIC SCI, V30, P309, DOI 10.1002/ps.2780300308; Buckelew LD, 2000, J ECON ENTOMOL, V93, P1437, DOI 10.1603/0022-0493-93.5.1437; Cao MX, 2011, J AGR FOOD CHEM, V59, P5830, DOI 10.1021/jf104233h; Carpenter Janet E, 2011, GM Crops, V2, P7, DOI 10.4161/gmcr.2.1.15086; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Coble HD, 1992, WEEDS COTTON CHARACT, P73; Culpepper AS, 2006, WEED TECHNOL, V20, P277, DOI 10.1614/WT-04-155R.1; DEFRA, 2005, FARM SCAL EV MAN GM; Dewar AM, 2009, PEST MANAG SCI, V65, P1047, DOI 10.1002/ps.1806; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Dotray, 2008, TEXAS J AGR NAT RESO, V21, P1; European Commission, 2007, STUD COTT SECT EUR U; Evans SC, 2010, ECOTOXICOLOGY, V19, P1249, DOI 10.1007/s10646-010-0509-9; Gaupp-Berghausen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12886; Griesinger LM, 2011, CHEMOSPHERE, V84, P1461, DOI 10.1016/j.chemosphere.2011.04.044; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hagler JR, 2016, FOOD WEBS, V4, P8; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; Haughton AJ, 2001, PEST MANAG SCI, V57, P1037, DOI 10.1002/ps.389; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Hilgenfeld KL, 2004, WEED TECHNOL, V18, P284, DOI 10.1614/WT-03-045R1; Hodge MA, 1999, J ARACHNOL, V27, P351; Holland J.M., 2000, Integrated Pest Management Reviews, V5, P109, DOI 10.1023/A:1009619309424; Huang ZY, 2004, J ECON ENTOMOL, V97, P1517, DOI 10.1603/0022-0493-97.5.1517; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Johnson WG, 2009, EUR J AGRON, V31, P162, DOI 10.1016/j.eja.2009.03.008; Junta de Andalucia, 2017, NETW AGR STAT JUND D; Kudsk P., 1998, DJF Rapport, Markbrug, P125; Kulkarni SS, 2015, WEED SCI, V63, P355, DOI 10.1614/WS-D-14-00067.1; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Moreno F, 2001, AGR WATER MANAGE, V48, P133, DOI 10.1016/S0378-3774(00)00120-7; Morjan WE, 2002, J ECON ENTOMOL, V95, P1275, DOI 10.1603/0022-0493-95.6.1275; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Owen MDK, 2008, PEST MANAG SCI, V64, P377, DOI 10.1002/ps.1539; Palinkas Z, 2016, CROP PROT, V80, P87, DOI 10.1016/j.cropro.2015.11.001; Petit S, 2011, AGRON SUSTAIN DEV, V31, P309, DOI 10.1051/agro/2010020; Puricelli E, 2005, CROP PROT, V24, P533, DOI 10.1016/j.cropro.2004.10.005; Radosevich SR, 1997, IMPLICATIONS MANAGEM; Saska P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27801; Scursoni JA, 2007, CROP PROT, V26, P212, DOI 10.1016/j.cropro.2006.04.028; Showler AT, 2003, ENVIRON ENTOMOL, V32, P39, DOI 10.1603/0046-225X-32.1.39; Snyder WE, 1999, BIOL CONTROL, V15, P283, DOI 10.1006/bcon.1999.0723; Strandberg B, 2005, AGR ECOSYST ENVIRON, V105, P243, DOI 10.1016/j.agee.2004.03.005; Svobodova Z, 2018, AGR ECOSYST ENVIRON, V251, P171, DOI 10.1016/j.agee.2017.09.018; Tuesca D, 2007, CROP PROT, V26, P1765, DOI 10.1016/j.cropro.2007.03.008; Umeda K, 2002, TIMING GLYPHOSATE AP; USDA, 2016, AD GEN ENG CROPS US; Waltz E, 2010, NAT BIOTECHNOL, V28, P537, DOI 10.1038/nbt0610-537; Webster TM, 2010, WEED SCI, V58, P73, DOI 10.1614/WS-09-058.1; Werth J, 2013, CROP PASTURE SCI, V64, P791, DOI 10.1071/CP13167; Wilson RG, 2007, WEED TECHNOL, V21, P900, DOI 10.1614/WT-06-199.1; Wrinn KM, 2012, CHEMOSPHERE, V87, P390, DOI 10.1016/j.chemosphere.2011.12.030; Zimdahl L.R., 2007, FUNDAMENTALS WEED SC, V3rd	62	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191408	10.1371/journal.pone.0191408	http://dx.doi.org/10.1371/journal.pone.0191408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351549	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300085
J	Li, J; Tian, YX; Guo, SM; Gu, HF; Yuan, QT; Xie, X				Li, Jing; Tian, Yanxin; Guo, Shimeng; Gu, Haifeng; Yuan, Qianting; Xie, Xin			Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms	PLOS ONE			English	Article							THERAPEUTIC AGENTS; OUTLET OBSTRUCTION; BLADDER; ANTAGONISTS; HORMONE; GROWTH; PATHOPHYSIOLOGY; MICTURITION; PREVALENCE; PRESSURE	Benign prostatic hyperplasia (BPH) is an age-related disease, affecting a majority of elderly men worldwide. Medical management of BPH is an alternative to surgical treatment of this disease. Currently, alpha(1)-adrenergic receptor (alpha(1)-AR) antagonists are among the first line drugs to treat BPH by reducing the tension of urinary track and thus the obstructive symptoms in voiding. In drug development, old male dogs with spontaneous BPH are considered the golden standard of the animal models. However, old dogs (>6 years) are expensive and not all old dogs develop BPH. So it is necessary to develop more accessible animal models for drug efficacy evaluation. Here we describe the development of testosterone-induced BPH models in both rats and young adult dogs and their applications in the in vivo evaluation of alpha 1-AR antagonist. The BPH rats and dogs induced by chronic testosterone treatment have significantly increased micturition frequency and reduced mean voided volume, very similar to the clinical symptoms of BPH patients. Silodosin, an alpha 1-AR antagonist, significantly reduces the urinary frequency and increases the voided volume in BPH model animals in a dose-dependent manner. The results demonstrate that testosterone-induced BPH rat and dog models might provide a more efficient way to evaluate micturition behavior in anti-BPH drug studies.	[Li, Jing; Tian, Yanxin; Guo, Shimeng; Gu, Haifeng; Yuan, Qianting; Xie, Xin] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai, Peoples R China; [Xie, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, J; Xie, X (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai, Peoples R China.; Xie, X (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lijing@simm.ac.cn; xxie@simm.ac.cn			National Natural Sciences Foundation of China [81425024, 81573442]; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12040212]; Shanghai Commission of Science and Technology [16431901500]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2017ZX09101004-012-008]; Institutes for Drug Discovery and Development, Chinese Academy of Sciences [CASIM M0120151007]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; Institutes for Drug Discovery and Development, Chinese Academy of Sciences	Project was supported by grants from the National Natural Sciences Foundation of China (81425024, 81573442), "Personalized Medicines Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences, Grant (XDA12040212), Shanghai Commission of Science and Technology (16431901500), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2017ZX09101004-012-008), and Institutes for Drug Discovery and Development, Chinese Academy of Sciences (CASIM M0120151007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Project was supported by grants from the National Natural Sciences Foundation of China (81425024, 81573442), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2017ZX09101004-012-008), "Personalized Medicines-Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences, Grant (XDA12040212), Shanghai Commission of Science and Technology (16431901500), and Institutes for Drug Discovery and Development, Chinese Academy of Sciences (CASIMM0120151007).	BERRY SJ, 1986, PROSTATE, V9, P363, DOI 10.1002/pros.2990090406; BRADING AF, 1994, BRIT J UROL, V73, P3, DOI 10.1111/j.1464-410X.1994.tb07447.x; BRENDLER CB, 1983, J CLIN INVEST, V71, P1114, DOI 10.1172/JCI110861; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; CLAUS S, 1993, UROL RES, V21, P305, DOI 10.1007/BF00296825; Constantinou CE, 1996, PROSTATE, V29, P30; DEBIECRYCHTER M, 1994, IN VIVO, V8, P449; DEKLERK DP, 1979, J CLIN INVEST, V64, P842, DOI 10.1172/JCI109532; Drake M., 2006, Autonomic & Autacoid Pharmacology, V26, P261, DOI 10.1111/j.1474-8673.2006.00363.x; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; GUESS HA, 1990, PROSTATE, V17, P241, DOI 10.1002/pros.2990170308; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Lee JZ, 1998, NEUROUROL URODYNAM, V17, P55, DOI 10.1002/(SICI)1520-6777(1998)17:1<55::AID-NAU8>3.0.CO;2-C; MAGGI CA, 1989, GEN PHARMACOL-VASC S, V20, P345, DOI 10.1016/0306-3623(89)90271-1; Mahapokai W, 2000, PROSTATE CANCER P D, V3, P28, DOI 10.1038/sj.pcan.4500391; MCNEAL JE, 1978, INVEST UROL, V15, P340; Michel MC, 2010, J PHARMACOL SCI, V112, P151, DOI 10.1254/jphs.09R15FM; Milani S, 2005, BJU INT, V95, P29, DOI 10.1111/j.1464-410X.2005.05485.x; NEVALAINEN MT, 1991, ENDOCRINOLOGY, V129, P612, DOI 10.1210/endo-129-2-612; Ohtake A, 2006, EUR J PHARMACOL, V545, P185, DOI 10.1016/j.ejphar.2006.06.054; Okutsu H, 2010, UROLOGY, V75, P235, DOI 10.1016/j.urology.2009.05.045; OTTO U, 1992, UROL INT, V48, P167, DOI 10.1159/000282323; Pagano E, 2014, PHYTOTHER RES, V28, P949, DOI 10.1002/ptr.5084; Pampinella F, 1997, J UROLOGY, V157, P677, DOI 10.1016/S0022-5347(01)65249-2; Pulito VL, 2000, J PHARMACOL EXP THER, V294, P224; Rosini M, 2007, CURR TOP MED CHEM, V7, P147, DOI 10.2174/156802607779318244; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Schwinn DA, 2001, BJU INT, V88, P27, DOI 10.1046/j.1464-410X.2001.00116.x; Schwinn DA, 2008, INT J UROL, V15, P193, DOI 10.1111/j.1442-2042.2007.01956.x; Steiner MS, 1999, J UROLOGY, V162, P1454, DOI 10.1016/S0022-5347(05)68340-1; Suzuki Y, 1999, EUR J PHARMACOL, V374, P495, DOI 10.1016/S0014-2999(99)00344-1; Thorpe A, 2003, LANCET, V361, P1359, DOI 10.1016/S0140-6736(03)13073-5; Tiwari A, 2005, EXPERT OPIN INV DRUG, V14, P1359, DOI 10.1517/13543784.14.11.1359; Turner WH, 1997, PHARMACOL THERAPEUT, V75, P77, DOI 10.1016/S0163-7258(97)00038-7; Yazaki J, 2011, NEUROUROL URODYNAM, V30, P461, DOI 10.1002/nau.20984	36	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191469	10.1371/journal.pone.0191469	http://dx.doi.org/10.1371/journal.pone.0191469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351556	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300094
J	Oyinlola, MA; Reygondeau, G; Wabnitz, CCC; Troell, M; Cheung, WWL				Oyinlola, Muhammed A.; Reygondeau, Gabriel; Wabnitz, Colette C. C.; Troell, Max; Cheung, William W. L.			Global estimation of areas with suitable environmental conditions for mariculture species	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; DISTRIBUTION MODELS; SITE SELECTION; SHELLFISH AQUACULTURE; CARRYING-CAPACITY; GROWTH-RATE; FISH-MEAL; FOOD; ECOSYSTEM; IMPACTS	Aquaculture has grown rapidly over the last three decades expanding at an average annual growth rate of 5.8% (2005-2014), down from 8.8% achieved between 1980 and 2010. The sector now produces 44% of total food fish production. Increasing demand and consumption from a growing global population are driving further expansion of both inland and marine aquaculture (i.e., mariculture, including marine species farmed on land). However, the growth of mariculture is dependent on the availability of suitable farming areas for new facilities, particularly for open farming practices that rely on the natural oceanic environmental parameters such as temperature, oxygen, chlorophyll etc. In this study, we estimated the marine areas within the exclusive economic zones of all countries that were suitable for potential open ocean mariculture activities. To this end, we quantify the environmental niche and inferred the global habitat suitability index (HSI) of the 102 most farmed marine species using four species distribution models. The average weighted HSI across the four models suggests that 72,000,000 km(2) of ocean are to be environmentally suitable to farm one or more species. About 92% of the predicted area (66,000,000 km(2)) is environmentally suitable for farming finfish, 43% (31,000,000 km(2)) for molluscs and 54% (39,000,000 km(2)) for crustaceans. These predictions do not consider technological feasibility that can limit crustaceans farming in open waters. Suitable mariculture areas along the Atlantic coast of South America and West Africa appear to be most under-utilized for farming. Our results suggest that factors other than environmental considerations such as the lack of socio-economic and technological capacity, as well as aqua feed supply are currently limiting the potential for mariculture expansion in many areas.	[Oyinlola, Muhammed A.; Reygondeau, Gabriel; Wabnitz, Colette C. C.; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program & Changing Ocean Res Un, Vancouver, BC, Canada; [Troell, Max] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Troell, Max] Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden	University of British Columbia; Stockholm University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Oyinlola, MA (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program & Changing Ocean Res Un, Vancouver, BC, Canada.	m.oyinlola@oceans.ubc.ca	Troell, Max/I-1724-2019; Oyinlola, Muhammed Alolade/B-4363-2019	Troell, Max/0000-0002-7509-8140; Oyinlola, Muhammed Alolade/0000-0001-5177-854X; Wabnitz, Colette C.C./0000-0002-5076-9163	Nippon Foundation-Nereus Program, an interdisciplinary ocean research program; Natural Sciences and Engineering Research Council of Canada; Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program	Nippon Foundation-Nereus Program, an interdisciplinary ocean research program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program	This study is a contribution by the Nippon Foundation-Nereus Program (http://www. nereusprogram.org/), an interdisciplinary ocean research program to WC. W. Cheung also acknowledges funding support from the Natural Sciences and Engineering Research Council of Canada.; This study is a contribution by the Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program.	Akinrotimi OA, 2007, AGR J, V2, P600; [Anonymous], WORLD EC SOC SURV SU; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Belton B, 2014, GLOB FOOD SECUR-AGR, V3, P59, DOI 10.1016/j.gfs.2013.10.001; Benetti DD, 2010, MAR TECHNOL SOC J, V44, P22, DOI 10.4031/MTSJ.44.3.11; Besson M, 2016, AQUACULTURE, V462, P47, DOI 10.1016/j.aquaculture.2016.04.030; Beveridge MCM, 2013, J FISH BIOL, V83, P1067, DOI 10.1111/jfb.12187; Borja A, 2009, AQUACULTURE, V293, P231, DOI 10.1016/j.aquaculture.2009.04.037; Broitman BR, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00015; Brown N, 2010, REV FISH SCI, V10, P403; Burbridge P, 2001, J APPL ICHTHYOL, V17, P194, DOI 10.1046/j.1439-0426.2001.00316.x; Busby J., 1991, PLANT PROTECTION Q A; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Byron C, 2011, ECOL MODEL, V222, P1743, DOI 10.1016/j.ecolmodel.2011.03.010; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Campbell B, 2013, MAR POLICY, V39, P94, DOI 10.1016/j.marpol.2012.10.009; Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149; Cashion T, 2017, FISH FISHERIES; CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christophersen G, 2003, AQUACULTURE, V215, P79, DOI 10.1016/S0044-8486(02)00094-7; Clements JC, 2016, REV AQUACULTURE; Cochrane K., 2009, FAO FISHERIES AQUACU; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Crawley MJ, 2005, STAT INTRO USING R; Delgado CL, 2003, FISH 2020 SUPPLY DEM, P62; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Easterling W., 2007, FOOD FIBRE FOREST PR; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evans W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130384; FAO, 2011, STAT WORLD FISH AQ O; FAO, 2016, CONTR FOOD SEC NUTR, P200; Ferreira JG, 2008, AQUACULTURE, V275, P138, DOI 10.1016/j.aquaculture.2007.12.018; Ferreira JG, 2007, AQUACULTURE, V264, P160, DOI 10.1016/j.aquaculture.2006.12.017; Foucher E, 2016, EUROPEAN SCALLOP FIS, V40, P781; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gentry RR, 2017, NAT ECOL EVOL, V1, P1317, DOI 10.1038/s41559-017-0257-9; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halwart M., 2007, CAGE AQUACULTURE REG, V498, P42; Hermansen O., 2008, CAPTURE BASED AQUACU; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hishamunda N, 2003, 427 FAO, V427; Hishamunda N, 2001, PROMOTION SUSTAINABL, P401; Hofherr J, 2015, OCEAN COAST MANAGE, V116, P27, DOI 10.1016/j.ocecoaman.2015.06.010; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Imsland AK, 1996, J FISH BIOL, V49, P926; Islam MS, 2005, MAR POLLUT BULL, V50, P48, DOI 10.1016/j.marpolbul.2004.08.008; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Jones MC, 2013, AQUAT CONSERV, V23, P710, DOI 10.1002/aqc.2364; Kapetsky J.M., 2013, GLOBAL ASSESSMENT OF; Kapetsky JM, 2013, GLOBAL ASSESSMENT PO; Karthik M, 2005, AQUACULT ENG, V32, P285, DOI 10.1016/j.aquaeng.2004.05.009; Kristensen V, 2000, CAHIERS OPTIONS MEDI; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd, P24; Longdill PC, 2008, OCEAN COAST MANAGE, V51, P612, DOI 10.1016/j.ocecoaman.2008.06.010; Mallya Y.J., 2007, EFFECTS DISSOLVED OX, P30; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; Merino GE, 2007, AQUACULTURE, V265, P176, DOI 10.1016/j.aquaculture.2007.01.028; Merino G, 2012, GLOBAL ENVIRON CHANG, V22, P795, DOI 10.1016/j.gloenvcha.2012.03.003; Moe H, 2007, AQUAC RES, V38, P91, DOI 10.1111/j.1365-2109.2006.01638.x; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Newell RIE, 2004, J SHELLFISH RES, V23, P51; NMFS NOAA Commerce UDo, IMPL PLAN COD COND R; Ottolenghi F., 2004, FATTENING EELS GROUP; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pickering T. D., 2011, VULNERABILITY TROPIC, P647; Pilditch CA, 2001, CAN J FISH AQUAT SCI, V58, P241, DOI 10.1139/cjfas-58-2-241; Pillay T.V.R., 2008, AQUACULTURE ENV, DOI DOI 10.1002/9780470995730; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Roos N, 2007, J NUTR, V137, P1106, DOI 10.1093/jn/137.4.1106; ROSS LG, 1993, AQUACULTURE, V112, P165, DOI 10.1016/0044-8486(93)90442-2; Sing T, 2007, TECHNICAL REPORT; Tacon AGJ, 2013, REV FISH SCI, V21, P22, DOI 10.1080/10641262.2012.753405; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tal Y, 2009, AQUACULTURE, V286, P28, DOI 10.1016/j.aquaculture.2008.08.043; Tandler A, 1995, AQUACULTURE, V135, P343, DOI 10.1016/0044-8486(95)01029-7; Theodorou JA, 2010, REV FISH SCI, V10, P529; Tidwell JH, 2001, EMBO REP, V2, P958, DOI 10.1093/embo-reports/kve236; Toufique KA, 2014, WORLD DEV, V64, P609, DOI 10.1016/j.worlddev.2014.06.035; Troell M, 2017, NAT ECOL EVOL, V1, P1224, DOI 10.1038/s41559-017-0304-6; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; Troell M, 2009, AQUACULTURE, V297, P1, DOI 10.1016/j.aquaculture.2009.09.010; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Turchini G. M., 2010, FISH OIL REPLACEMENT; van Rijn J, 2013, AQUACULT ENG, V53, P49, DOI 10.1016/j.aquaeng.2012.11.010; VanHoutte A, 2000, TECHN P C AQ 3 MILL, P20; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Watson RA, 2017, FISH FISH, V18, P105, DOI 10.1111/faf.12128	102	45	47	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191086	10.1371/journal.pone.0191086	http://dx.doi.org/10.1371/journal.pone.0191086			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29357374	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300047
J	Rachid, TL; Silva-Veiga, FM; Graus-Nunes, F; Bringhenti, I; Mandarim-de-Lacerda, CA; Souza-Mello, V				Rachid, Tamiris Lima; Silva-Veiga, Flavia Maria; Graus-Nunes, Francielle; Bringhenti, Isabele; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa			Differential actions of PPAR-alpha and PPAR-beta/delta on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; BROWN-FAT; PEROXISOME PROLIFERATORS; ENERGY-EXPENDITURE; CLASSICAL BROWN; ENDOCRINE ORGAN; DEFICIENT MICE; LIVER-DISEASE; ADULT HUMANS	Background and aims Obesity compromises adipocyte physiology. PPARs are essential to adipocyte plasticity, but its isolated role in the browning phenomenon is not clear. This study aimed to examine whether activation of PPAR-a or PPAR-beta/delta could induce beige cell depots in the subcutaneous white adipose tissue of diet-induced obese mice. Material and methods Sixty animals were randomly assigned to receive a control diet (C, 10% lipids) or a high-fat diet (HF, 50% lipids) for ten weeks. Then each group was re-divided to begin the treatments that lasted 4 weeks, totalizing six groups: C, C-alpha (C plus PPAR-alpha agonist, 2.5 mg/ kg BM), C-beta (C plus PPAR-beta/delta agonist, 1 mg/ kg BM), HF, HF-alpha (HF plus PPAR-alpha agonist), HF-beta (HF plus PPAR-beta/delta agonist). Results HF animals presented with overweight, glucose intolerance and subcutaneous white adipocyte hypertrophy. Both treatments significantly attenuated these parameters. Browning, verified by UCP1 positive beige cells and enhanced body temperature, was just observed in PPAR-alpha treated groups. PPAR-alpha agonism also elicited an enhanced gene expression of the thermogenesis effector UCP1, the beige-selective gene TMEM26 and the PRDM16, an essential gene for brown-like phenotype maintenance in the beige adipocytes when compared to their counterparts. The enhanced CIDEA and the reduced UCP1 gene levels might justify the white phenotype predominance after the treatment with the PPAR-alpha/delta agonist. Conclusions This work provides evidence that the PPAR-beta/delta agonist ameliorated metabolic disorders through enhanced beta-oxidation and better tolerance to glucose, whereas the PPAR-alpha agonism was confirmed as a promising therapeutic target for treating metabolic diseases via beige cell induction and enhanced thermogenesis.	[Rachid, Tamiris Lima; Silva-Veiga, Flavia Maria; Graus-Nunes, Francielle; Bringhenti, Isabele; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Souza-Mello, V (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	souzamello.uerj@gmail.com	Souza-Mello, Vanessa/E-3463-2014; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Souza-Mello, Vanessa/D-5092-2013; Mandarim-de-Lacerda, Carlos A/F-7125-2012	Souza-Mello, Vanessa/0000-0002-2510-9569; Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Nunes, Francielle/0000-0002-6212-3116; Veiga, Flavia Maria S/0000-0002-3320-5825	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.888/2015, E-26/010.001576/2016]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br), award numbers: E-26/202.888/2015 and E-26/010.001576/2016 for V.S-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Barbosa-da-Silva S, 2015, LIFE SCI, V127, P73, DOI 10.1016/j.lfs.2015.02.003; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brenmoehl J, 2017, J COMP PHYSIOL B, V187, P361, DOI 10.1007/s00360-016-1036-7; Chung Nana, 2017, J Exerc Nutrition Biochem, V21, P39, DOI 10.20463/jenb.2017.0020; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Corton JC, 2000, MUTAT RES-FUND MOL M, V448, P139, DOI 10.1016/S0027-5107(99)00232-8; CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148, DOI 10.1152/ajplung.1990.258.4.L148; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gray SL, 2010, ENDOCRINOLOGY, V151, P4178, DOI 10.1210/en.2010-0102; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Harrington WW, 2007, PPAR RES, V2007, DOI 10.1155/2007/97125; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jiang L, 2010, MOL CELL BIOCHEM, V343, P249, DOI 10.1007/s11010-010-0520-8; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Kalinovich AV, 2017, BIOCHIMIE, V134, P127, DOI 10.1016/j.biochi.2017.01.007; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Luo X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050795; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rachid TL, 2015, CELL BIOCHEM FUNCT, V33, P249, DOI 10.1002/cbf.3111; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ricquier D, 2000, INT J OBESITY, V24, pS86, DOI 10.1038/sj.ijo.0801286; Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rost TH, 2009, BBA-MOL CELL BIOL L, V1791, P1076, DOI 10.1016/j.bbalip.2009.06.005; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Stanford KI, 2015, DIABETES, V64, P2361, DOI 10.2337/db15-0227; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Varela-Rodriguez BM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29898; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wingfield HL, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0010-3; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	59	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191365	10.1371/journal.pone.0191365	http://dx.doi.org/10.1371/journal.pone.0191365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351550	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300076
J	Vreemann, S; Gubern-Merida, A; Borelli, C; Bult, P; Karssemeijer, N; Mann, RM				Vreemann, Suzan; Gubern-Merida, Albert; Borelli, Cristina; Bult, Peter; Karssemeijer, Nico; Mann, Ritse M.			The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; CARCINOMA IN-SITU; COST-EFFECTIVENESS; MENSTRUAL-CYCLE; FOLLOW-UP; RISK; WOMEN; MAMMOGRAPHY; RECEPTOR	Purpose Higher background parenchymal enhancement (BPE) could be used for stratification of MRI screening programs since it might be related to a higher breast cancer risk. Therefore, the purpose of this study is to correlate BPE to patient and tumor characteristics in women with unilateral MRI-screen detected breast cancer who participated in an intermediate and high risk screening program. As BPE in the affected breast may be difficult to discern from enhancing cancer, we assumed that BPE in the contralateral breast is a representative measure for BPE in women with unilateral breast cancer. Materials and methods This retrospective study was approved by our local institutional board and a waiver for consent was granted. MR-examinations of women with unilateral breast cancers screen-detected on breast MRI were evaluated by two readers. BPE in the contralateral breast was rated according to BI-RADS. Univariate analyses were performed to study associations. Observer variability was computed. Results Analysis included 77 breast cancers in 76 patients (age: 48 +/- 9.8 years), including 62 invasive and 15 pure ductal carcinoma in-situ cases. A negative association between BPE and tumor grade (p <= 0.016) and a positive association with progesterone status (p <= 0.021) was found. The correlation was stronger when only considering invasive disease. Inter-reader agreement was substantial. Conclusion Lower BPE in the contralateral breast in women with unilateral breast cancer might be associated to higher tumor grade and progesterone receptor negativity. Great care should be taken using BPE for stratification of patients to tailored screening programs.	[Vreemann, Suzan; Gubern-Merida, Albert; Karssemeijer, Nico; Mann, Ritse M.] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Geert Grootepl 10, Nijmegen, Netherlands; [Borelli, Cristina] Casa Sollievo Sofferenza, Dept Radiol, San Giovanni Rotondo Fog, Italy; [Bult, Peter] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; IRCCS Casa Sollievo Della Sofferenza; Radboud University Nijmegen	Mann, RM (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Geert Grootepl 10, Nijmegen, Netherlands.	Ritse.Mann@radboudumc.nl	Bult, Peter/L-4236-2015; Karssemeijer, N./H-8058-2014; Mann, R.M./L-4502-2015	Bult, Peter/0000-0001-6427-9889; Mann, R.M./0000-0001-8111-1930	European Union's Seventh Framework Program for research, technological development and demonstration [601040]	European Union's Seventh Framework Program for research, technological development and demonstration	This work received funding from the European Union's Seventh Framework Program for research, technological development and demonstration (grant agreement no 601040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BREAST CANC GUID; Baek JE, 2014, EUR J RADIOL, V83, P1356, DOI 10.1016/j.ejrad.2014.05.007; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bulut N, 2015, INT J CLIN EXP MED, V8, P21454; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Delille JP, 2005, BREAST J, V11, P236, DOI 10.1111/j.1075-122X.2005.21499.x; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Dmitriev I, 2015, RADIOLOGY; Edwards SD, 2013, MAGN RESON IMAGING C, V21, P483, DOI 10.1016/j.mric.2013.02.005; Ellis RL, 2009, AM J ROENTGENOL, V193, P1738, DOI 10.2214/AJR.09.2657; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Erbas B, 2004, CANCER EPIDEM BIOMAR, V13, P1569; Feig S, 2010, RADIOL CLIN N AM, V48, P879, DOI 10.1016/j.rcl.2010.06.002; Giess CS, 2014, RADIOGRAPHICS, V34, P234, DOI 10.1148/rg.341135034; Gubern-Merida A, 2015, MED IMAGE ANAL, V20, P265, DOI 10.1016/j.media.2014.12.001; Hambly NM, 2011, AM J ROENTGENOL, V196, P218, DOI 10.2214/AJR.10.4550; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hu YF, 2009, INT J BIOL SCI, V5, P20; Kim MY, 2015, CLIN RADIOL, V70, P706, DOI 10.1016/j.crad.2015.02.017; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Millet I, 2012, BRIT J RADIOL, V85, P197, DOI 10.1259/bjr/47213729; Moelans CB, 2011, CELL ONCOL, V34, P475, DOI 10.1007/s13402-011-0043-7; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Morris Elizabeth A, 2010, Magn Reson Imaging Clin N Am, V18, P57, DOI 10.1016/j.mric.2009.09.005; Park SY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140638; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Saadatmand S, 2013, JNCI-J NATL CANCER I, V105, P1314, DOI 10.1093/jnci/djt203; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Tabar L, 1996, INT J CANCER, V66, P413, DOI 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z; Telegrafo M, 2016, DIAGN INTERV IMAG, V97, P313, DOI 10.1016/j.diii.2015.12.006; Telegrafo M, 2016, MAGN RESON IMAGING, V34, P173, DOI 10.1016/j.mri.2015.10.014; Uematsu T, 2012, BREAST CANCER-TOKYO, V19, P259, DOI 10.1007/s12282-011-0279-0; Uematsu T, 2012, AM J ROENTGENOL, V198, pW611, DOI 10.2214/AJR.11.7463; van Zelst JCM, 2017, ULTRASOUND MED BIOL, V43, P1820, DOI 10.1016/j.ultrasmedbio.2017.03.019; Vinnicombe S, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0078-0	40	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191399	10.1371/journal.pone.0191399	http://dx.doi.org/10.1371/journal.pone.0191399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351560	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300083
J	Xue, YF; Chen, BJ; Win, AN; Fu, C; Lian, JP; Liu, X; Wang, R; Zhang, XC; Chai, YR				Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong			Omega-3 fatty acid desaturase gene family from two omega-3 sources, Salvia hispanica and Perilla frutescens: Cloning, characterization and expression	PLOS ONE			English	Article							ANTISENSE-MEDIATED DEPLETION; ENHANCES THERMAL TOLERANCE; FATTY-ACID DESATURATION; LINOLENIC ACID; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; BRASSICA-NAPUS; FUNCTIONAL-CHARACTERIZATION; CONSENSUS PREDICTION; TRANSGENIC TOBACCO	Omega-3 fatty acid desaturase (omega-3 FAD, D15D) is a key enzyme for alpha-linolenic acid (ALA) biosynthesis. Both chia (Salvia hispanica) and perilla (Perilla frutescens) contain high levels of ALA in seeds. In this study, the omega-3 FAD gene family was systematically and comparatively cloned from chia and perilla. Perilla FAD3, FAD7, FAD8 and chia FAD7 are encoded by single-copy (but heterozygous) genes, while chia FAD3 is encoded by 2 distinct genes. Only 1 chia FAD8 sequence was isolated. In these genes, there are 1 to 6 transcription start sites, 1 to 8 poly(A) tailing sites, and 7 introns. The 5' UTRs of PfFAD8a/b contain 1 to 2 purine-stretches and 2 pyrimidine-stretches. An alternative splice variant of ShFAD7a/ b comprises a 5' UTR intron. Their encoded proteins harbor an FA_desaturase conserved domain together with 4 trans-membrane helices and 3 histidine boxes. Phylogenetic analysis validated their identity of dicot microsomal or plastidial omega-3 FAD proteins, and revealed some important evolutionary features of plant omega-3 FAD genes such as convergent evolution across different phylums, single-copy status in algae, and duplication events in certain taxa. The qRT-PCR assay showed that the omega-3 FAD genes of two species were expressed at different levels in various organs, and they also responded to multiple stress treatments. The functionality of the ShFAD3 and PfFAD3 enzymes was confirmed by yeast expression. The systemic molecular and functional features of the omega-3 FAD gene family from chia and perilla revealed in this study will facilitate their use in future studies on genetic improvement of ALA traits in oilseed crops.	[Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Chai, Yourong] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Chai, Yourong] Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Chongqing Key Lab Crop Qual Improvement, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China; Southwest University - China; Southwest University - China; Southwest University - China	Chai, YR (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Chongqing Key Lab Crop Qual Improvement, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China.	chaiyourong2@163.com		Xue, Yufei/0000-0001-7041-5517; Lian, Jianping/0000-0003-2453-2266; Chai, Yourong/0000-0001-6611-624X	Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0143]; National Key R&D Program of China [2016YFD0100506]; Fundamental Research Funds for the Central Universities [XDJK2014D009]; National Basic Research Program of China (973 Program) [2015CB150201]	Chongqing Research Program of Basic Research and Frontier Technology; National Key R&D Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Chongqing Research Program of Basic Research and Frontier Technology (cstc2015jcyjBX0143), National Key R&D Program of China (2016YFD0100506), Fundamental Research Funds for the Central Universities (XDJK2014D009), and National Basic Research Program of China (973 Program, 2015CB150201).	Abdel-Reheem M, 2013, TURK J BIOL, V37, P591, DOI 10.3906/biy-1301-32; Andreu V, 2010, J EXP BOT, V61, P3371, DOI 10.1093/jxb/erq158; [Anonymous], 2012, EUR J LIPID SCI TECH, V114, P794; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Avila CA, 2012, PLANT PHYSIOL, V158, P2028, DOI 10.1104/pp.111.191262; Baker EJ, 2016, PROG LIPID RES, V64, P30, DOI 10.1016/j.plipres.2016.07.002; Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Banno N, 2004, BIOSCI BIOTECH BIOCH, V68, P85, DOI 10.1271/bbb.68.85; Berberich T, 1998, PLANT MOL BIOL, V36, P297, DOI 10.1023/A:1005993408270; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Chung CH, 1999, PLANT CELL PHYSIOL, V40, P114, DOI 10.1093/oxfordjournals.pcp.a029468; Collados R, 2006, FEBS LETT, V580, P4934, DOI 10.1016/j.febslet.2006.07.087; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ESTILAI A, 1990, HORTSCIENCE, V25, P1646, DOI 10.21273/HORTSCI.25.12.1646; Farmer EE, 1998, PLANTA, V206, P167, DOI 10.1007/s004250050388; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Guo HH, 2014, J SCI FOOD AGR, V94, P482, DOI 10.1002/jsfa.6273; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Hernandez ML, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv159; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; IBA K, 1993, J BIOL CHEM, V268, P24099; Ito M, 2008, J NAT MED, V62, P387, DOI 10.1007/s11418-008-0262-z; Ixtaina VY, 2008, IND CROP PROD, V28, P286, DOI 10.1016/j.indcrop.2008.03.009; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim HU, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2805-0; Kim MJ, 2006, MOL GENET GENOMICS, V276, P351, DOI 10.1007/s00438-006-0148-2; Kirsch C, 1997, P NATL ACAD SCI USA, V94, P2079, DOI 10.1073/pnas.94.5.2079; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; Kwon JH, 2000, MOL CELLS, V10, P493, DOI 10.1007/s10059-000-0493-7; Lee KR, 2016, PLANT CELL REP, V35, P2523, DOI 10.1007/s00299-016-2053-4; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Lewandowska-Gnatowska E, 2011, PHYTOCHEMISTRY, V72, P1285, DOI 10.1016/j.phytochem.2011.01.030; Liu HL, 2012, J EXP BOT, V63, P3279, DOI 10.1093/jxb/ers051; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lu H, 2009, MOL BIOL REP, V36, P2291, DOI 10.1007/s11033-009-9447-0; Luke GA, 2012, INNOVATIONS BIOTECHN, P67; Ma QP, 2014, ACTA PHYSIOL PLANT, V36, P2345, DOI 10.1007/s11738-014-1607-8; Martz F, 2006, J EXP BOT, V57, P897, DOI 10.1093/jxb/erj075; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Murphy DJ, 1999, CURR OPIN BIOTECH, V10, P175, DOI 10.1016/S0958-1669(99)80031-7; Nguyen HM, 2013, PLANT PHYSIOL, V163, P914, DOI 10.1104/pp.113.223941; Nishiuchi T, 1995, PLANT MOL BIOL, V29, P599, DOI 10.1007/BF00020987; Nishiuchi T, 1998, J PLANT RES, V111, P481, DOI 10.1007/BF02507782; Nishiuchi T, 1997, PLANT CELL, V9, P1701, DOI 10.1105/tpc.9.10.1701; NISHIUCHI T, 1994, PLANT PHYSIOL, V105, P767, DOI 10.1104/pp.105.2.767; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Radovanovic N, 2014, MOL BIOTECHNOL, V56, P609, DOI 10.1007/s12033-014-9737-1; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Roman A, 2015, MOL PLANT, V8, P1599, DOI 10.1016/j.molp.2015.06.004; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; SHIN HS, 1994, J AM OIL CHEM SOC, V71, P619, DOI 10.1007/BF02540589; Singh AK, 2011, MOL PLANT MICROBE IN, V24, P506, DOI 10.1094/MPMI-09-10-0201; Sreedhar RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123580; Tang SY, 2007, BIOTECHNOL LETT, V29, P1417, DOI 10.1007/s10529-007-9391-9; Teixeira MC, 2010, J AGR FOOD CHEM, V58, P1870, DOI 10.1021/jf902684v; Torres-Franklin ML, 2009, ENVIRON EXP BOT, V65, P162, DOI 10.1016/j.envexpbot.2008.12.010; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Venegas-Caleron M, 2006, PLANT PHYSIOL BIOCH, V44, P517, DOI 10.1016/j.plaphy.2006.09.005; Venegas-Caleron M, 2010, PHYTOCHEMISTRY, V71, P1050, DOI 10.1016/j.phytochem.2010.04.017; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang HS, 2014, PLANT CELL REP, V33, P131, DOI 10.1007/s00299-013-1517-z; Wang HS, 2010, J INTEGR PLANT BIOL, V52, P568, DOI 10.1111/j.1744-7909.2010.00957.x; Wang WJ, 2014, J EXP BOT, V65, P2147, DOI 10.1093/jxb/eru084; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Xiao G, 2014, GENE, V545, P45, DOI 10.1016/j.gene.2014.05.008; Xue YF, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2390-0; Xue YF, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2377-x; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhang YM, 2011, BIOTECHNOL LETT, V33, P395, DOI 10.1007/s10529-010-0432-4; ZOU JT, 1995, PLANT PHYSIOL, V108, P563, DOI 10.1104/pp.108.2.563	88	33	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191432	10.1371/journal.pone.0191432	http://dx.doi.org/10.1371/journal.pone.0191432			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351555	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300090
J	Sato'o, Y; Hisatsune, J; Yu, LS; Sakuma, T; Yamamoto, T; Sugai, M				Sato'o, Yusuke; Hisatsune, Junzo; Yu, Liansheng; Sakuma, Tetsushi; Yamamoto, Takashi; Sugai, Motoyuki			Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference	PLOS ONE			English	Article							SEQUENCE-SPECIFIC CONTROL; RESISTANCE; PROTEIN; IDENTIFICATION; ENDONUCLEASE; EPIDEMIOLOGY; EXPRESSION; REPRESSION; GENOME	Preparing the genetically modified organisms have required much time and labor, making it the rate-limiting step but CRISPR/Cas9 technology appearance has changed this difficulty. Although reports on CRISPR/Cas9 technology such as genome editing and CRISPR interference (CRISPRi) in eukaryotes increased, those in prokaryotes especially in Staphylococci were limited. Thus, its potential in the bacteriology remains unexplored. This is attributed to ecological difference between eukaryotes and prokaryotes. Here, we constructed a novel CRISPRi plasmid vector, pBACi for Staphylococcus aureus. The transformation efficiency of S. aureus was similar to 10(4) CFU/mu g DNA using a vector extracted from dcm negative, which encoded one of DNA modification genes, E. coli. Further, pBACi was introduced into various clinical isolates including that not accepting the conventional temperature-sensitive vector. dcas9 in the vector was expressed throughout the growth phases of S. aureus and this vector decreased various gene mRNA expressions based on the crRNA targeting sequences and altered the knockdown strains' phenotypes. The targeted genes included various virulence and antibiotic resistant genes. Bioinformatics suggest this vector can be introduced into wide range of low-GC Gram-positive bacteria. Because this new CRISPR/Cas9-based vector can easily prepare knockdown strains, we believe the novel vector will facilitate the characterization of the function of genes from S. aureus and other Gram-positive bacteria.	[Sato'o, Yusuke; Hisatsune, Junzo; Yu, Liansheng; Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Hiroshima, Japan; [Sato'o, Yusuke] Jichi Med Univ, Dept Infect & Immun, Div Bacteriol, Shimotsuke, Tochigi, Japan	Hiroshima University; Hiroshima University; Jichi Medical University	Sugai, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Japan.	sugai@hiroshima-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903; Yu, Liansheng/0000-0002-3520-8907	Ministry of Health, Labor and Welfare (MHLW) in Japan [201322025A]; Japan Agency for Medical Research and Development (AMED) [924711]	Ministry of Health, Labor and Welfare (MHLW) in Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MS received a Grant (201322025A) from Ministry of Health, Labor and Welfare (MHLW) in Japan(http://www.mhlw.go.jp/english/), and a grant (924711) from Japan Agency for Medical Research and Development (AMED)(http://www.amed.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; Cui BT, 2015, J MICROBIOL METH, V109, P25, DOI 10.1016/j.mimet.2014.11.012; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x; Hiramatsu K, 1998, DRUG RESIST UPDATE, V1, P135, DOI 10.1016/S1368-7646(98)80029-0; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119487; Kernodle DS, 1997, INFECT IMMUN, V65, P179, DOI 10.1128/IAI.65.1.179-184.1997; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lindsay JA, 2014, INT J MED MICROBIOL, V304, P103, DOI 10.1016/j.ijmm.2013.11.010; Liu X, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167449; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Monk IR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00049; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; O'Halloran DP, 2015, INFECT IMMUN, V83, P1598, DOI 10.1128/IAI.03122-14; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sato'o Y, 2015, APPL ENVIRON MICROB, V81, P7782, DOI 10.1128/AEM.01936-15; Sato'o Y, 2014, J CLIN MICROBIOL, V52, P2637, DOI 10.1128/JCM.00661-14; Shinagawa K, 1975, Nihon Saikingaku Zasshi, V30, P683; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Wang YB, 2014, PATHOG DIS, V72, P19, DOI 10.1111/2049-632X.12175; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Yu LS, 2017, MBIO, V8, DOI 10.1128/mBio.02282-16; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004	51	19	19	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0185987	10.1371/journal.pone.0185987	http://dx.doi.org/10.1371/journal.pone.0185987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377933	Green Published, gold			2022-12-26	WOS:000423514700002
J	Chadly, DM; Best, J; Ran, C; Bruska, M; Wozniak, W; Kempisty, B; Schwartz, M; LaFleur, B; Kerns, BJ; Kessler, JA; Matsuoka, AJ				Chadly, Duncan M.; Best, Jennifer; Ran, Cong; Bruska, Malgorzata; Wozniak, Witold; Kempisty, Bartosz; Schwartz, Mark; LaFleur, Bonnie; Kerns, B. J.; Kessler, John A.; Matsuoka, Akihiro J.			Developmental profiling of microRNAs in the human embryonic inner ear	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; PROGRESSIVE HEARING-LOSS; CARDIO-FACIAL SYNDROME; B-CELL LYMPHOMA; GENE-EXPRESSION; TARGETS; DIFFERENTIATION; NEURONS; MIR-96; MICE	Due to the extreme inaccessibility of fetal human inner ear tissue, defining of the microRNAs (miRNAs) that regulate development of the inner ear has relied on animal tissue. In the present study, we performed the first miRNA sequencing of otic precursors in human specimens. Using HTG miRNA Whole Transcriptome assays, we examined miRNA expression in the cochleovestibular ganglion (CVG), neural crest (NC), and otic vesicle (OV) from paraffin embedded (FFPE) human specimens in the Carnegie developmental stages 13-15. We found that in human embryonic tissues, there are different patterns of miRNA expression in the CVG, NC and OV. In particular, members of the miR-183 family (miR-96, miR-182, and miR-183) are differentially expressed in the CVG compared to NC and OV at Carnegie developmental stage 13. We further identified transcription factors that are differentially targeted in the CVG compared to the other tissues from stages 13-15, and we performed gene set enrichment analyses to determine differentially regulated pathways that are relevant to CVG development in humans. These findings not only provide insight into the mechanisms governing the development of the human inner ear, but also identify potential signaling pathways for promoting regeneration of the spiral ganglion and other components of the inner ear.	[Chadly, Duncan M.; Best, Jennifer; Ran, Cong; Matsuoka, Akihiro J.] Northwestern Univ, Dept Otolaryngol & Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Bruska, Malgorzata; Wozniak, Witold; Kempisty, Bartosz] Poznan Univ, Dept Anat, Poznan, Poland; [Schwartz, Mark; LaFleur, Bonnie; Kerns, B. J.] HTG Mol Diagnost Inc, Tucson, AZ USA; [Kessler, John A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Matsuoka, Akihiro J.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA; [Matsuoka, Akihiro J.] Northwestern Univ, Hugh Knowles Ctr Hearing Res, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Adam Mickiewicz University; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Matsuoka, AJ (corresponding author), Northwestern Univ, Dept Otolaryngol & Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA.; Matsuoka, AJ (corresponding author), Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA.; Matsuoka, AJ (corresponding author), Northwestern Univ, Hugh Knowles Ctr Hearing Res, Evanston, IL 60208 USA.	amatsuoka@nm.org	LaFleur, Bonnie J/GPJ-9592-2022	LaFleur, Bonnie J/0000-0002-4939-9337; Bruska, Malgorzata/0000-0002-2899-3943; Chadly, Duncan/0000-0002-8417-1522	Eleanor Wood-Price Grants Initiative: The Woman's Board of Northwestern Memorial Hospital; Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; Woman's Board of Northwestern Memorial Hospital; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC013829] Funding Source: NIH RePORTER	Eleanor Wood-Price Grants Initiative: The Woman's Board of Northwestern Memorial Hospital; Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; Woman's Board of Northwestern Memorial Hospital; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Eleanor Wood-Price Grants Initiative: The Woman's Board of Northwestern Memorial Hospital [AJM] and the Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University [AJM]. HTG Molecular Diagnostics, Inc. provided support in the form of salaries for authors MS, BL, and BJK. MS had a role in Methodology and Investigation (performed HTG Edgeseq miRNA whole transcriptome assay), BL had a role in Software (wrote initial R code for our differential expression analysis), and BJK had a role in Project Administration. The specific roles of these authors are also articulated in the 'author contributions' section.; Authors thank William E. Ditrick (Emily), Marleana Cross, and Cara Crosby (the Woman's Board of Northwestern Memorial Hospital) for their special guidance towards our funding source; Drs. Miho Tanaka-Matakatsu and Adam Piortowski for their work at the initial phase of this study; and Drs. Maki Motobu and Junko Motobu for an effort to establish a communication channel with our collaborating team at Poznan University.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Antoine MW, 2017, J NEUROSCI, V37, P5144, DOI 10.1523/JNEUROSCI.3545-16.2017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowl MR, 2015, GERONTOLOGY, V61, P149, DOI 10.1159/000368399; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Chu YM, 2017, J DIGEST DIS, V18, P169, DOI 10.1111/1751-2980.12463; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Csardi G., 2006, INT J COMPLEX SYST, V2006, P1695, DOI DOI 10.1093/NAR/; Davis B, 2017, J VET INTERN MED, V31, P854, DOI 10.1111/jvim.14686; Digilio MC, 1999, BRIT J AUDIOL, V33, P329, DOI 10.3109/03005369909090116; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fishilevich S, 2017, DATABASE, V2017, DOI DOI 10.1093/DATABASE/BAX028; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Garcia F, 2016, BIOINFORMATICS, V32, P2809, DOI 10.1093/bioinformatics/btw334; Godard P, 2015, NUCLEIC ACIDS RES, V43, P3490, DOI 10.1093/nar/gkv249; Goodrich L V, 2016, HDB AUDITORY RES, V52; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Henshaw SK, 2009, MANAGEMENT UNINTENDE; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Ivashchenko AT, 2015, RECENT ADV BIOMED CH, P102; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Koehler KR, 2014, DEV AUDITORY VESTIBU, P213; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lassiter RNT, 2014, DEV BIOL, V389, P39, DOI 10.1016/j.ydbio.2013.11.025; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leon Y, 1999, HORM METAB RES, V31, P126, DOI 10.1055/s-2007-978709; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Lin D, 1998, P 15 INT C MACH LEAR; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Mahmoudian-sani MR, 2017, EUR ARCH OTO-RHINO-L, V274, P2373, DOI 10.1007/s00405-017-4470-6; Matsuoka AJ, 2017, STEM CELL TRANSL MED, V6, P923, DOI 10.1002/sctm.16-0032; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Meyers EA, 2017, COLD SPRING HARB PER, P1; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817; R Development Core Team, 2016, R LANG ENV STAT COMP; Reyes MRT, 1999, INT J PEDIATR OTORHI, V47, P227, DOI 10.1016/S0165-5876(98)00180-3; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Rudnicki A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-484; Rudnicki A, 2012, EMBO MOL MED, V4, P849, DOI 10.1002/emmm.201100922; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schlicker A, 2008, NUCLEIC ACIDS RES, V36, pD434, DOI 10.1093/nar/gkm806; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swillen A, 1999, GENET COUNSEL, V10, P79; Tai Y., 2007, TIMECOURSE STAT ANAL; Ushakov K, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00052; Van den Ackerveken P, 2017, CELL DEATH DIFFER, V24, P2054, DOI 10.1038/cdd.2017.127; Van Eynde C, 2016, J SPEECH LANG HEAR R, V59, P583, DOI 10.1044/2015_JSLHR-H-15-0098; Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216; Wang E, 2014, NONSMALL CELL LUNG C; Wang JF, 2017, AM J PATHOL, V187, P1700, DOI 10.1016/j.ajpath.2017.04.009; Wang XR, 2012, HEARING RES, V286, P55, DOI 10.1016/j.heares.2012.02.005; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002	67	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191452	10.1371/journal.pone.0191452	http://dx.doi.org/10.1371/journal.pone.0191452			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373586	Green Published, gold, Green Submitted			2022-12-26	WOS:000423425400013
J	Grimm, I; Dumke, J; Dreier, J; Knabbe, C; Vollmer, T				Grimm, Imke; Dumke, Jessika; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja			Biofilm formation and transcriptome analysis of Streptococcus gallolyticus subsp gallolyticus in response to lysozyme	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; SURVIVAL STRATEGY; BOVIS; ASSOCIATION; INFECTION; ENDOCARDITIS; RESISTANCE; VIABILITY; ADHERENCE; BACTERIA	Streptococcus gallolyticus subsp. gallolyticus is a commensal bacterium of the human gastrointestinal tract, and a pathogen causing infective endocarditis and other biofilm-associated infections via exposed collagen. This study focuses on the characterization of the biofilm formation and collagen adhesion of S. gallolyticus subsp. gallolyticus under different conditions. In this study, it has been observed that the isolate UCN 34 is resistant to 20 mg/ml lysozyme in BHI medium, whereas the strain BAA-2069 builds more biofilm in the presence of lysozyme compared to in a control of BHI without lysozyme. A transcriptome analysis with whole genome microarrays of these two isolates in BHI medium with lysozyme compared to control without lysozyme revealed changes in gene expression levels. In the isolate BAA-2069, 67 genes showed increased expression in the presence of lysozyme, while in the isolate UCN 34, 165 genes showed increased expression and 30 genes showed decreased expression through lysozyme treatment. Products of genes which were higher expressed are in involved in transcription and translation, in cell-wall modification, in hydrogen peroxide resistance and in bacterial immunity. Furthermore, the adhesion ability of different strains of S. gallolyticus subsp. gallolyticus to collagen type I and IV was analyzed. Thereby, we compared the adhesion of 46 human isolates with 23 isolates from animals. It was shown that the adhesion ability depends significantly on whether the isolate was isolated from human or animal. For example, high adhesion ability was observed for strain UCN 34 isolated from an infective endocarditis patient, whereas strain DSM 16831 isolated from koala feces adhered only marginally to collagen. Full genome microarray analysis of these two strains revealed strain-dependent gene expression due to adhesion. The expression of 25 genes of a transposon and 15 genes of a phage region in strain DSM 16831 were increased, which corresponds to horizontal gene transfer. Adherence to collagen in strain UCN 34 led to higher expression of 27 genes and lower expression of 31 genes. This was suggestive of a change in nutrient uptake.	[Grimm, Imke; Dumke, Jessika; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja] Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein Westfalen, Univ Klinikum, Bad Oeynhausen, Germany	Ruhr University Bochum	Vollmer, T (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabet Zentrum Nordrhein Westfalen, Univ Klinikum, Bad Oeynhausen, Germany.	tvollmer@hdz-nrw.de	Vollmer, Tanja/F-1149-2013	Vollmer, Tanja/0000-0001-7032-5423				Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Abeni Chiara, 2013, J Med Case Rep, V7, P185, DOI 10.1186/1752-1947-7-185; Alvarez G, 2010, J BACTERIOL, V192, P2006, DOI 10.1128/JB.01693-09; Balasubramanian D, 2009, HUM GENOME, V3, P1; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Bleibel W, 2007, DIGEST DIS SCI, V52, P2336, DOI 10.1007/s10620-006-9287-x; Boleij A, 2013, LANCET INFECT DIS, V13, P719, DOI 10.1016/S1473-3099(13)70107-5; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Brenciani A, 2012, ANTIMICROB AGENTS CH; Brenciani A, 2014, ICESP1116 GENETIC EL; Chaussee MA, 2008, ARCH MICROBIOL, V189, P27, DOI 10.1007/s00203-007-0290-1; Consortium U, 2014, NUCL ACIDS RES GKU98; Danne C, 2011, J INFECT DIS, V204, P1960, DOI 10.1093/infdis/jir666; DARJEE R, 1993, J CLIN PATHOL, V46, P1116, DOI 10.1136/jcp.46.12.1116; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Deviri E, 2007, EUR J INFLAMM, V5, P57, DOI 10.1177/1721727X0700500201; Dong XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142918; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Galbavy S, 2002, ACTA HISTOCHEM, V104, P331, DOI 10.1078/0065-1281-00680; Grimm I, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00108-17; Grimm I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180044; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Helal R, 2012, PHARMAZIE, V67, P564, DOI 10.1691/ph.2012.1785; Helal R, 2010, IN VITRO CELL DEV-AN, V46, P492, DOI 10.1007/s11626-010-9273-7; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Hinse D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-400; Jang IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21121; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Karuppiah V, 2014, J BIOL CHEM, V289, P33187, DOI 10.1074/jbc.M114.608448; Kokare CR, 2009, INDIAN J BIOTECHNOL, V8, P159; Lazarovitch T, 2013, INFECTION, V41, P329, DOI 10.1007/s15010-012-0314-x; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Liddle AD, 2012, KNEE SURG SPORT TR A, V20, P1069, DOI 10.1007/s00167-011-1646-2; Liew YK, 2015, CLIN VACCINE IMMUNOL, V22, P593, DOI 10.1128/CVI.00493-14; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Mair RW, 2012, FEMS MICROBIOL LETT, V331, P44, DOI 10.1111/j.1574-6968.2012.02550.x; Sanchez-Diaz AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159159; McCormick NE, 2011, MICROBIOL-SGM, V157, P2248, DOI 10.1099/mic.0.048140-0; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nocek B, 2012, J MOL BIOL, V420, P366, DOI 10.1016/j.jmb.2012.04.011; Oh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087312; Papadimitriou K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-272; Prakash B, 2003, CURR SCI INDIA, V85, P1299; Rajaraman S., 2014, INT J BIOSCI BIOTECH, V6, P99, DOI [10.14257/ijbsbt.2014.6.2.10, DOI 10.14257/IJBSBT.2014.6.2.10]; Romero-Hernandez B, 2015, ANTIMICROB AGENTS CH, V59, P2006, DOI 10.1128/AAC.04083-14; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Sillanpaa J, 2008, FEMS MICROBIOL LETT, V289, P104, DOI 10.1111/j.1574-6968.2008.01378.x; Sjollema J, 2011, APPL ENVIRON MICROB, V77, P5027, DOI 10.1128/AEM.00178-11; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sudagidan M, 2012, J FOOD PROTECT, V75, P1627, DOI 10.4315/0362-028X.JFP-12-001; Suntharalingam P, 2005, TRENDS MICROBIOL, V13, P3, DOI 10.1016/j.tim.2004.11.009; Tiwari R, 2009, VET MICROBIOL, V135, P304, DOI 10.1016/j.vetmic.2008.09.064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vince KG, 2003, J ARTHROPLASTY, V18, P813, DOI 10.1016/S0883-5403(03)00268-7; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; Wang C, 2009, TAIWAN GERIATR GERON, V4, P274; Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174; Yan X, 2015, CURR MICROBIOL, V70, P156, DOI 10.1007/s00284-014-0691-8; Zhou Y, 2011, NUCLEIC ACIDS RES; Zwick JV, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.403	63	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191705	10.1371/journal.pone.0191705	http://dx.doi.org/10.1371/journal.pone.0191705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373594	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400020
J	Haller, N; Helmig, S; Taenny, P; Petry, J; Schmidt, S; Simon, P				Haller, Nils; Helmig, Susanne; Taenny, Pascal; Petry, Julian; Schmidt, Sebastian; Simon, Perikles			Circulating, cell-free DNA as a marker for exercise load in intermittent sports	PLOS ONE			English	Article							FREE PLASMA DNA; MUSCLE DAMAGE; TIME-COURSE; OXIDATIVE STRESS; MAXIMAL EXERCISE; INFLAMMATION; FATIGUE; RELEASE; GENES; BLOOD	Background Attempts to establish a biomarker reflecting individual player load in intermittent sports such as football have failed so far. Increases in circulating DNA (cfDNA) have been demonstrated in various endurance sports settings. While it has been proposed that cfDNA could be a suitable marker for player load in intermittent sports, the effects on cfDNA of repeated sprinting as an essential feature in intermittent sports are unknown. For the first time, we assessed both alterations of cfDNA due to repeated maximal sprints and due to a professional football game. Methods Nine participants were subjected to a standardised sprint training session with cross-over design of five maximal sprints of 40 meters with either "short" (1 minute) or "long" pauses (5 minutes). Capillary cfDNA and lactate were measured after every sprint and venous cfDNA before and after each series of sprints. Moreover, capillary cfDNA and lactate values were taken in 23 professional football players before and after incremental exercise testing, during the course of a training week at rest (baseline) and in all 17 enrolled players following a season game. Results Lactate and venous cfDNA increased more pronounced during "short" compared to "long" (1.4-fold, p = 0.032 and 1.7-fold, p = 0.016) and cfDNA correlated significantly with lactate (r = 0.69; p < 0.001). Incremental exercise testing increased cfDNA 7.0-fold (p < 0.001). The season game increased cfDNA 22.7-fold (p < 0.0001), while lactate showed a 2.0-fold (p = 0.09) increase compared to baseline. Fold-changes in cfDNA correlated with distance covered during game (spearman's r = 0.87, p = 0.0012), while no correlation between lactate and the tracking data could be found. Discussion We show for the first time that cfDNA could be an objective marker for distance covered in elite intermittent sports. In contrast to the potential of more established blood-based markers like IL-6, CK, or CRP, cfDNA shows by far the strongest fold-change and a high correlation with a particular load related aspect in professional football.	[Haller, Nils; Helmig, Susanne; Taenny, Pascal; Petry, Julian; Schmidt, Sebastian; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, Mainz, Germany	Johannes Gutenberg University of Mainz	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, Mainz, Germany.	simonpe@uni-mainz.de	Simon, Perikles D/B-2293-2013; Smith, Sebastian/HCI-8671-2022; Haller, Nils/AAF-1107-2021	Simon, Perikles D/0000-0002-7996-4034; Haller, Nils/0000-0002-7066-7615				Akenhead R, 2016, INT J SPORT PHYSIOL, V11, P587, DOI 10.1123/ijspp.2015-0331; Andersson H, 2010, SCAND J MED SCI SPOR, V20, P740, DOI 10.1111/j.1600-0838.2009.00989.x; Ascensao A, 2008, CLIN BIOCHEM, V41, P841, DOI 10.1016/j.clinbiochem.2008.04.008; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; Beiter T, 2014, J APPL PHYSIOL, V117, P325, DOI 10.1152/japplphysiol.00173.2014; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Breitbach S, 2014, J APPL PHYSIOL, V117, P119, DOI 10.1152/japplphysiol.00002.2014; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Chatzinikolaou A, 2014, J SPORT SCI, V32, P870, DOI 10.1080/02640414.2013.865251; Coutts AJ, 2009, J SCI MED SPORT, V12, P79, DOI 10.1016/j.jsams.2007.08.005; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, J STRENGTH COND RES, V24, P3278, DOI 10.1519/JSC.0b013e3181b60444; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Hallou Nabil, 2016, INT J PARALLEL PROG, P1; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Helmig S, 2015, EUR J APPL PHYSIOL, V115, P2271, DOI 10.1007/s00421-015-3207-8; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; Marques-Jimenez D., 2017, OPEN SPORTS SCI J, V10, P52, DOI [10.2174/1875399X01710010052, DOI 10.2174/1875399X01710010052]; Nedelec M, 2012, SPORTS MED, V42, P997, DOI 10.2165/11635270-000000000-00000; OSNES JB, 1972, J APPL PHYSIOL, V32, P59, DOI 10.1152/jappl.1972.32.1.59; Romagnoli M, 2016, J SPORT MED PHYS FIT, V56, P1198; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Thorpe R, 2012, J STRENGTH COND RES, V26, P2783, DOI 10.1519/JSC.0b013e318241e174; Tug S, 2016, INT J SPORT PHYSIOL, P1; Tug S, 2015, EXERC IMMUNOL REV, V21, P164; Velders M, 2014, CLIN BIOCHEM, V47, P471, DOI 10.1016/j.clinbiochem.2013.12.017; Villa F., 2015, DETECTION CIRCULATIN	34	41	42	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191915	10.1371/journal.pone.0191915	http://dx.doi.org/10.1371/journal.pone.0191915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370268	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600117
J	Zhang, YY; Han, X; Liu, Y; Chen, J; Hua, L; Ma, Q; Huang, YYX; Tang, QY; Zhang, Z				Zhang, Ying-Ying; Han, Xue; Liu, Ye; Chen, Jian; Hua, Lei; Ma, Qian; Huang, Yang-Yu-Xin; Tang, Qiong-Yao; Zhang, Zhe			+mRNA expression of LRRC55 protein (leucine-rich repeat-containing protein 55) in the adult mouse brain	PLOS ONE			English	Article							BK CHANNEL ACTIVATION; K+ CHANNEL; POTASSIUM CHANNELS; SLO3; SUBUNIT; CALCIUM; DEFICIENCY; EPILEPSY; DOMAIN; CELLS	LRRC55 (leucine-rich repeat-containing protein 55) protein is an auxiliary. subunit of BK (Big conductance potassium channel) channels, which leftward shifts GVs of BK channels around 50 mV in the absence of cytosolic Ca2+. LRRC55 protein is also the only. subunit of BK channels that is expressed in mammalian nervous system. However, the expression pattern of LRRC55 gene in adult mammalian brain remains elusive. In this study, we investigated the distribution of LRRC55 mRNA in the adult mouse brain by using in situ hybridization. We found that LRRC55 mRNA is richly expressed in the adult mouse medial habenula nucleus (MHb), cerebellum and pons. However, the potential role of LRRC55 in MHb and cerebellum could be different based on the function of BK channels in these brain regions.	[Zhang, Ying-Ying; Han, Xue; Chen, Jian; Hua, Lei; Ma, Qian; Huang, Yang-Yu-Xin; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Sch Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Liu, Ye; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Liu, Ye; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Zhang, Z (corresponding author), Xuzhou Med Univ, Sch Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China.	zhangzhe70@xzhmu.edu.cn	Zhang, Zhe/C-5068-2011	Zhang, Zhe/0000-0001-7295-6894	Important Project of Natural Science in Colleges and Universities in Jiangsu Province [14KJA320002]; Jiangsu; Natural Science Foundation of China (NSFC) [81471314, 81671090]; Natural Science Foundation of Jiangsu Province [SBK201502515]; Xuzhou Science and Technology Program [16631635]; NSFC [C110307]; Training programs of innovation and Entrepreneurship for undergraduates of Jiangsu Province [201410313065X]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Special Program of Medical Science [BL2014029]	Important Project of Natural Science in Colleges and Universities in Jiangsu Province; Jiangsu; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Xuzhou Science and Technology Program; NSFC(National Natural Science Foundation of China (NSFC)); Training programs of innovation and Entrepreneurship for undergraduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Special Program of Medical Science	This work was supported by The Important Project of Natural Science in Colleges and Universities in Jiangsu Province to Z.Z. (14KJA320002), Jiangsu specially appointed professorship to Z.Z. and Q.-Y.T., Natural Science Foundation of China (NSFC) grant to Z.Z. (81471314, 81671090), Natural Science Foundation of Jiangsu Province to Z.Z (SBK201502515). Xuzhou Science and Technology Program (16631635) to Z.Z. NSFC grant to Q.-Y.T. (C110307). Training programs of innovation and Entrepreneurship for undergraduates of Jiangsu Province in 2014 (201410313065X). We also appreciated the grant support from the Priority Academic Program Development of Jiangsu Higher Education Institutions and from the Jiangsu Provincial Special Program of Medical Science (BL2014029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brody MJ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00337; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Geng YY, 2017, J BIOL CHEM, V292, P8978, DOI 10.1074/jbc.M117.776013; Hsu YWA, 2014, J NEUROSCI, V34, P11366, DOI 10.1523/JNEUROSCI.1861-14.2014; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liu Y, 2011, J NEUROPHYSIOL, V106, P144, DOI 10.1152/jn.01107.2010; Martinez-Espinosa PL, 2014, J GEN PHYSIOL, V144, P275, DOI 10.1085/jgp.201411253; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Pratt CP, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00337; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Shi XZ, 2017, FISH SHELLFISH IMMUN, V61, P130, DOI 10.1016/j.fsi.2016.12.029; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tatematsu M, 2015, J IMMUNOL, V195, P4933, DOI 10.4049/jimmunol.1501305; Torres YP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00383; Viswanath H, 2013, STILL NEGLECTED FRON, V7, P931, DOI DOI 10.3389/FNHUM.2013.00931; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xu H, 2015, J HYPERTENS, V33, P1611, DOI 10.1097/HJH.0000000000000590; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang CT, 2017, P NATL ACAD SCI USA, V114, pE3739, DOI 10.1073/pnas.1703081114; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Zhang Y, 2017, NEURON, V95, P1103, DOI 10.1016/j.neuron.2017.08.010; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191749	10.1371/journal.pone.0191749	http://dx.doi.org/10.1371/journal.pone.0191749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370300	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600092
J	Puehringer-Sturmayr, V; Wascher, CAF; Loretto, MC; Palme, R; Stoewe, M; Kotrschal, K; Frigerio, D				Puehringer-Sturmayr, Verena; Wascher, Claudia A. F.; Loretto, Matthias-Claudio; Palme, Rupert; Stoewe, Mareike; Kotrschal, Kurt; Frigerio, Didone			Seasonal differences of corticosterone metabolite concentrations and parasite burden in northern bald ibis (Geronticus eremita): The role of affiliative interactions	PLOS ONE			English	Article							GEESE ANSER-ANSER; IMMUNE FUNCTION; GREYLAG GEESE; GLUCOCORTICOID METABOLITES; CORTISOL METABOLITES; EXCRETION PATTERNS; SEX-DIFFERENCES; SOCIAL SUPPORT; GRAYLAG GEESE; MATE CHOICE	The reproductive season is energetically costly as revealed by elevated glucocorticoid concentrations, constrained immune functions and an increased risk of infections. Social allies and affiliative interactions may buffer physiological stress responses and thereby alleviate associated effects. In the present study, we investigated the seasonal differences of immune reactive corticosterone metabolite concentrations, endoparasite burden (nematode eggs and coccidian oocysts) and affiliative interactions in northern bald ibis (Geronticus eremita), a critically endangered bird. In total, 43 individually marked focal animals from a freeranging colony were investigated. The analyses included a description of initiated and received affiliative interactions, pair bond status as well as seasonal patterns of hormone and endoparasite levels. During the reproductive season, droppings contained parasite eggs more often and corticosterone metabolite levels were higher as compared to the period after reproduction. The excretion rate of endoparasite products was lower in paired individuals than in unpaired ones, but paired animals exhibited higher corticosterone metabolite concentrations than unpaired individuals. Furthermore, paired individuals initiated affiliative behaviour more frequently than unpaired ones. This suggests that the reproductive season influences the excretion patterns of endoparasite products and corticosterone metabolites and that affiliative interactions between pair partners may positively affect endoparasite burden during periods of elevated glucocorticoid levels. Being embedded in a pair bond may have a positive impact on individual immune system and parasite resistance.	[Puehringer-Sturmayr, Verena; Wascher, Claudia A. F.; Loretto, Matthias-Claudio; Kotrschal, Kurt; Frigerio, Didone] Univ Vienna, Core Facil Konrad Lorenz Forsch Stelle Behav & Co, Grunau Im Almtal, Austria; [Puehringer-Sturmayr, Verena; Kotrschal, Kurt; Frigerio, Didone] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wascher, Claudia A. F.] Anglia Ruskin Univ, Dept Biol, Cambridge, England; [Loretto, Matthias-Claudio] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Palme, Rupert; Stoewe, Mareike] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, Vienna, Austria	University of Vienna; University of Vienna; Anglia Ruskin University; University of Vienna; University of Veterinary Medicine Vienna	Puehringer-Sturmayr, V (corresponding author), Univ Vienna, Core Facil Konrad Lorenz Forsch Stelle Behav & Co, Grunau Im Almtal, Austria.; Puehringer-Sturmayr, V (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	verena.puehringer-sturmayr@univie.ac.at	Loretto, Matthias-Claudio/J-1560-2019; Wascher, Claudia/I-4060-2019; Palme, Rupert/A-3499-2008	Loretto, Matthias-Claudio/0000-0002-1940-3470; Wascher, Claudia/0000-0003-4360-363X; Palme, Rupert/0000-0001-9466-3662; Puehringer-Sturmayr, Verena/0000-0003-2979-9314; Frigerio, Didone/0000-0001-5866-0413	Sparkling Science grant [SPA-05/026]; Verein der Forderer der Konrad Lorenz Forschungsstelle; Herzog von Cumberland Stiftung; University of Vienna	Sparkling Science grant; Verein der Forderer der Konrad Lorenz Forschungsstelle; Herzog von Cumberland Stiftung; University of Vienna	This study was funded by a Sparkling Science grant (SPA-05/026, https://www.sparklingscience.at/) to DF, VP-S and M-CL. Permanent support is provided by the Verein der Forderer der Konrad Lorenz Forschungsstelle, and the Herzog von Cumberland Stiftung. Open access funding provided by University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EM, 2009, ENVIRON TOXICOL CHEM, V28, P982, DOI 10.1897/08-253.1; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1993, ANIM BEHAV, V46; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barton K., 2016, MUMIN MULTIMODEL INF; Bohm C., 1999, 2 INT EEP STUDBOOK, P73; Bohm C, 2011, DER WALDRAPP; Breuner CW, 2001, J NEUROENDOCRINOL, V13, P412, DOI 10.1046/j.1365-2826.2001.00646.x; Brown TT, 2006, CAN J ZOOL, V84, P1833, DOI 10.1139/Z06-183; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110; Corlatti L, 2012, ANIM BEHAV, V84, P1061, DOI 10.1016/j.anbehav.2012.08.005; DEMARAIS S, 1987, J WILDLIFE DIS, V23, P256, DOI 10.7589/0090-3558-23.2.256; Deviche P, 2000, GEN COMP ENDOCR, V118, P425, DOI 10.1006/gcen.2000.7478; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dwyer CM, 2004, ANIM WELFARE, V13, P293; Eberhardt AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070382; Edgar J, 2015, ANIM BEHAV, V105, P11, DOI 10.1016/j.anbehav.2015.04.007; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Frigerio D, 2004, GEN COMP ENDOCR, V137, P29, DOI 10.1016/j.ygcen.2004.02.013; Frigerio D, 2003, CAN J ZOOL, V81, P1746, DOI 10.1139/Z03-149; Frigerio D, 2016, J ORNITHOL, V157, P839, DOI 10.1007/s10336-015-1317-z; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; HEPP GR, 1989, BEHAVIOUR, V109, P222, DOI 10.1163/156853989X00240; Hiepe T, 1981, LEHRBUCH PARASITOLOG; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; KOMERS PE, 1989, ANIM BEHAV, V37, P645, DOI 10.1016/0003-3472(89)90043-2; Kotrschal K, 1998, ANIM BEHAV, V55, P171, DOI 10.1006/anbe.1997.0597; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martinez-Padilla J, 2012, AM NAT, V179, P811, DOI 10.1086/665664; Aviles JM, 2009, ANIM BEHAV, V78, P993, DOI 10.1016/j.anbehav.2009.07.020; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pap PL, 2015, PHYSIOL BIOCHEM ZOOL, V88, P395, DOI 10.1086/681243; Papazahariadou M, 2008, J NAT HIST, V42, P381, DOI 10.1080/00222930701835357; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pegoraro K., 1992, ETHOLOGIE WALDRAPPS; Pimm SL, 2015, TRENDS ECOL EVOL, V30, P685, DOI 10.1016/j.tree.2015.08.008; R Core Team, 2021, R LANG ENV STAT; Radford AN, 2012, BIOL LETTERS, V8, P24, DOI 10.1098/rsbl.2011.0559; Raouf SA, 2006, ANIM BEHAV, V71, P39, DOI 10.1016/j.anbehav.2005.03.027; Remage-Healey L, 2003, HORM BEHAV, V43, P108, DOI 10.1016/S0018-506X(02)00012-0; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rowley I., 1985, MATE CHOICE, P331; Rukstalis M, 2005, HORM BEHAV, V47, P1, DOI 10.1016/j.yhbeh.2004.09.004; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; SALTZMAN W, 1991, PHYSIOL BEHAV, V50, P271, DOI 10.1016/0031-9384(91)90066-W; SATO S, 1993, J ETHOL, V11, P149, DOI 10.1007/BF02350048; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Skaug H., 2016, GEN LINEAR MIXED MOD; Sorato E, 2006, GEN COMP ENDOCR, V146, P265, DOI 10.1016/j.ygcen.2005.11.020; Stowe M, 2013, WIEN TIERARZTL MONAT, V100, P271; Stowe M, 2008, HORM BEHAV, V53, P208, DOI 10.1016/j.yhbeh.2007.09.021; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Trigunaite A, 2015, CELL IMMUNOL, V294, P87, DOI 10.1016/j.cellimm.2015.02.004; Tripet F, 1997, OIKOS, V78, P557, DOI 10.2307/3545617; Tuckova Klara, 1998, Oeko-L, V20, P3; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Vitlic A, 2014, AGE, V36, P1169, DOI 10.1007/s11357-014-9631-6; Wascher CAF, 2012, BEHAV ECOL, V23, P1276, DOI 10.1093/beheco/ars113; Wilcoxen TE, 2011, GEN COMP ENDOCR, V173, P461, DOI 10.1016/j.ygcen.2011.07.007; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wittig RM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13361; Young C, 2014, P NATL ACAD SCI USA, V111, P18195, DOI 10.1073/pnas.1411450111; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; Zuk M, 1998, ANIM BEHAV, V56, P493, DOI 10.1006/anbe.1998.0807	80	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191441	10.1371/journal.pone.0191441	http://dx.doi.org/10.1371/journal.pone.0191441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364951	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500047
J	Sawai, A; Tochigi, Y; Kavaliova, N; Zaboronok, A; Warashina, Y; Mathis, BJ; Mesaki, N; Shiraki, H; Watanabe, K				Sawai, Akemi; Tochigi, Yuriko; Kavaliova, Nadzeya; Zaboronok, Alexander; Warashina, Yuki; Mathis, Bryan J.; Mesaki, Noboru; Shiraki, Hitoshi; Watanabe, Koichi			MRI reveals menstrually-related muscle edema that negatively affects athletic agility in young women	PLOS ONE			English	Article							CYCLE PHASE; PREMENSTRUAL-SYNDROME; DYSPHORIC DISORDER; RESPONSES; SYMPTOMS; EXERCISE; PROGESTERONE; PREVALENCE; ENDURANCE; STRENGTH	Context About 10% of Japanese female athletes are afflicted by menstrually-related edema, mainly in the lower limbs, and, with few studies on this problem, the effect on performance remains unclear. Objective To quantitatively evaluate fluid retention in the calf in female students over their menstrual cycle using magnetic resonance imaging (MRI) and to determine the relationship of MRI changes and athletic performance. Design The menstrual cycle was divided into 5 phases: menstrual, follicular, ovulatory, early luteal, and late luteal with sampling done in either morning (AM) or afternoon (PM) sessions. At each phase, MRI of the calf (7: 00 +/- 8: 00, 14: 00 +/- 16: 00), body composition and hormones (7: 00 +/- 8: 00), and athletic performance (14: 00 +/- 16: 00) were evaluated. Participants 13 adult healthy Japanese female students with eumenorrhea. Results Estradiol levels decreased significantly in the menstrual phase and the follicular phase compared to the early luteal phase (P = 0.001, P = 0.024 respectively). Menstrual phase estradiol levels were significantly lower compared to the ovulatory phase (P = 0.015), and the late luteal phase (P = 0.003). Progesterone levels decreased significantly in the menstrual phase and the follicular phase compared to the ovulatory phase (P = 0.012, P = 0.009 respectively), the early luteal phase (both P = 0.007), and the late luteal phase (P = 0.028, P = 0.029 respectively), and it along with a significant decrease in the ovulatory phase compared to the early luteal phase (P = 0.010). AM T2 signals were significantly lower in the menstrual phase compared to the ovulatory phase (P = 0.043) but not other phases. PM T2 signals increased significantly in the menstrual phase compared to the follicular phase (P = 0.003), ovulatory phase (P = 0.009), and the late luteal phase (P = 0.032), and the difference between the AM and PM values increased significantly in the menstrual phase compared to the other 4 phases (P<0.01). A negative correlation between fluid retention and agility was observed. Conclusion In female students fluid retention during the menstrual phase could be a factor that influences athletic agility.	[Sawai, Akemi; Tochigi, Yuriko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kavaliova, Nadzeya] Univ Tsukuba Hosp, Tsukuba, Ibaraki, Japan; [Zaboronok, Alexander; Mathis, Bryan J.] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Warashina, Yuki; Mesaki, Noboru; Shiraki, Hitoshi; Watanabe, Koichi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Zaboronok, A (corresponding author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.; Watanabe, K (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan.	a.zaboronok@md.tsukuba.ac.jp; watanabe.koichi.ga@u.tsukuba.ac.jp	Zaboronok, Alexander/W-4119-2019	Mathis, Bryan/0000-0002-9879-8289; Zaboronok, Alexander/0000-0002-6833-9866				Bale P., 1985, AUST J SCI MED SPORT, V17, P19; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; BONEN A, 1979, EUR J APPL PHYSIOL O, V42, P15, DOI 10.1007/BF00421100; Cho S, 2002, AM J MED, V113, P580, DOI 10.1016/S0002-9343(02)01322-0; Czajkowska M, 2015, J PEDIATR ADOL GYNEC, V28, P492, DOI 10.1016/j.jpag.2015.02.113; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; de Jonge XAKJ, 2001, J PHYSIOL-LONDON, V530, P161, DOI 10.1111/j.1469-7793.2001.0161m.x; Direkvand-Moghadam A, 2014, J CLIN DIAGN RES, V8, P106, DOI 10.7860/JCDR/2014/8024.4021; Elliott KJ, 2003, CLIN SCI, V105, P663, DOI 10.1042/CS20020360; Fekr L. Z., 2012, EURO J EXP BIO, V2, P944; Giacomoni M, 2000, MED SCI SPORT EXER, V32, P486, DOI 10.1097/00005768-200002000-00034; Hashimoto Y, 2001, J JAPANESE SOC PSYCH, V6, P108; Hayashi C, 2004, JPN J PHYS FIT SPORT, V53, P197; Hess CT, 2011, ADV SKIN WOUND CARE, V24, P192, DOI 10.1097/01.ASW.0000396300.04173.ec; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1902, DOI 10.1152/jappl.1985.59.6.1902; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1911, DOI 10.1152/jappl.1985.59.6.1911; Japan Institute of Sports Sciences, 2013, HDB FEM ATHL COND; JURKOWSKI JE, 1978, J APPL PHYSIOL, V44, P109, DOI 10.1152/jappl.1978.44.1.109; LEBRUN CM, 1993, SPORTS MED, V16, P400, DOI 10.2165/00007256-199316060-00005; LEBRUN CM, 1994, CLIN SPORT MED, V13, P419; May DA, 2000, RADIOGRAPHICS, V20, pS295, DOI 10.1148/radiographics.20.suppl_1.g00oc18s295; Nakamura M., 2012, JAPANESE J CLIN SPOR, V20, P252; Olson BR, 1996, ANN INTERN MED, V125, P564, DOI 10.7326/0003-4819-125-7-199610010-00005; PETROFSKY JS, 1976, EUR J APPL PHYSIOL O, V35, P1, DOI 10.1007/BF00444652; Phillips SK, 1996, J PHYSIOL-LONDON, V496, P551, DOI 10.1113/jphysiol.1996.sp021706; POSTHUMA BW, 1987, AM J OBSTET GYNECOL, V156, P275, DOI 10.1016/0002-9378(87)90267-5; Rasheed P, 2003, ANN SAUDI MED, V23, P381, DOI 10.5144/0256-4947.2003.381; Rezaeian N., 2015, INT J PUBLIC HLTH RE, V3, P234; Saito C, 2005, YAMAGATA J HLTH SCI, V8, P53; Sarwar R, 1996, J PHYSIOL-LONDON, V493, P267, DOI 10.1113/jphysiol.1996.sp021381; SHETTY A, 1989, Journal of Orthopaedic and Sports Physical Therapy, V11, P198; Sica Domenic A, 2003, J Clin Hypertens (Greenwich), V5, P291, DOI 10.1111/j.1524-6175.2003.02402.x; Stachenfeld NS, 2008, EXERC SPORT SCI REV, V36, P152, DOI 10.1097/JES.0b013e31817be928; Stachenfeld NS, 2004, J APPL PHYSIOL, V96, P1011, DOI 10.1152/japplphysiol.01032.2003; Sudo M, 2010, JAPANESE J PHYS ANTH, V15, P21; Tacani PM, 2015, INT J WOMENS HEALTH, V7, P297, DOI 10.2147/IJWH.S74251; Takeda T, 2015, J PEDIATR ADOL GYNEC, V28, P215, DOI 10.1016/j.jpag.2014.07.006; TAYLOR JW, 1979, ACTA PSYCHIAT SCAND, V60, P87, DOI 10.1111/j.1600-0447.1979.tb00268.x; The International Olympic Committee, 2016, FACTSH GAM OL; The Ministry of Education Culture Sports Science and Technology of Japan (MEXT), 1999, PHYS FITN MOT SKILLS; Tulin A, 2012, HEALTHMED, V6, P3035; Vaiksaar S, 2011, J STRENGTH COND RES, V25, P1571, DOI 10.1519/JSC.0b013e3181df7fd2; Vaiksaar S, 2011, EUR J APPL PHYSIOL, V111, P1027, DOI 10.1007/s00421-010-1730-1; White CP, 2011, OBSTET GYNECOL INT, V2011, DOI 10.1155/2011/138451; Woolley CS, 1999, CURR OPIN NEUROBIOL, V9, P349, DOI 10.1016/S0959-4388(99)80051-8; Young SL, 1987, J HOME EC JAPAN, V38, P205	46	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191022	10.1371/journal.pone.0191022	http://dx.doi.org/10.1371/journal.pone.0191022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364948	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500033
J	Henry, R; Galbraith, P; Coutts, S; Prosser, T; Boyce, J; McCarthy, DT				Henry, Rebekah; Galbraith, Penelope; Coutts, Scott; Prosser, Toby; Boyce, John; McCarthy, David T.			What's the risk? Identifying potential human pathogens within grey-headed flying foxes faeces	PLOS ONE			English	Article							BACTERIAL COMMUNITY; RESERVOIR HOSTS; FRUIT BATS; SALMONELLA; DIVERSITY; SURVIVAL; IDENTIFICATION; CONTAMINATION; TYPHIMURIUM; MICROBIOTA	Pteropus poliocephalus (grey-headed flying foxes) are recognised vectors for a range of potentially fatal human pathogens. However, to date research has primarily focused on viral disease carriage, overlooking bacterial pathogens, which also represent a significant human disease risk. The current study applied 16S rRNA amplicon sequencing, community analysis and a multi-tiered database OTU picking approach to identify faecal-derived zoo-notic bacteria within two colonies of P. poliocephalus from Victoria, Australia. Our data show that sequences associated with Enterobacteriaceae (62.8% +/- 24.7%), Pasteurellaceae (19.9% +/- 25.7%) and Moraxellaceae (9.4% +/- 11.8%) dominate flying fox faeces. Further colony specific differences in bacterial faecal colonisation patterns were also identified. In total, 34 potential pathogens, representing 15 genera, were identified. However, species level definition was only possible for Clostridium perfringens, which likely represents a low infectious risk due to the low proportion observed within the faeces and high infectious dose required for transmission. In contrast, sequences associated with other pathogenic species clusters such as Haemophilus haemolyticus-H. influenzae and Salmonella bongori-S. enterica, were present at high proportions in the faeces, and due to their relatively low infectious doses and modes of transmissions, represent a greater potential human disease risk. These analyses of the microbial community composition of Pteropus poliocephalus have significantly advanced our understanding of the potential bacterial disease risk associated with flying foxes and should direct future epidemiological and quantitative microbial risk assessments to further define the health risks presented by these animals.	[Henry, Rebekah; Galbraith, Penelope; McCarthy, David T.] Monash Univ, Dept Civil Engn, EPHM Lab, Clayton, Vic, Australia; [Coutts, Scott] Monash Univ, Dept Microbiol, Micromon, Clayton, Vic, Australia; [Prosser, Toby] Melbourne Water, Docklands, Vic, Australia; [Boyce, John] Monash Univ, Dept Microbiol, Clayton, Vic, Australia	Monash University; Monash University; Monash University	McCarthy, DT (corresponding author), Monash Univ, Dept Civil Engn, EPHM Lab, Clayton, Vic, Australia.	david.mccarthy@monash.edu	Boyce, John D/F-5058-2012	Boyce, John D/0000-0002-8614-3074; Galbraith, Penelope/0000-0003-3595-8190; McCarthy, David/0000-0001-8845-6501; Henry, Rebekah/0000-0001-6530-8557	Australian Research Council [LP160100408, LP120100718]; Environmental Protection Authority; Melbourne Water	Australian Research Council(Australian Research Council); Environmental Protection Authority; Melbourne Water	DTM wished to acknowledge funding received from Melbourne Water, Environmental Protection Authority and the Australian Research Council (LP160100408 and LP120100718).& para;& para;We would like to acknowledge support from the Australian Research Council through the Linkage Program (LP120100718 and LP160100408). The authors would also like to gratefully acknowledge the data contribution from Melbourne Water, in particular Rhys Coleman, and the Environmental Protection Authority. We would also like to thank Ms Christelle Schang, Mr. Peter Kolotelo and Mr Richard Williamson for their technical support during this study.	Abia ALK, 2016, MICROB ECOL, V72, P881, DOI 10.1007/s00248-016-0784-y; Adesiyun AA, 2009, J WILDLIFE DIS, V45, P952, DOI 10.7589/0090-3558-45.4.952; Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; Australia S, 2016, 12892112005R2016 AS; Banskar S, 2016, MICROBIOL RES, V182, P99, DOI 10.1016/j.micres.2015.10.006; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRYGOO ER, 1971, CR SOC BIOL, V165, P1203; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caroline J, 2003, PAK J BIOL SCI, V6, P1564, DOI DOI 10.3923/PJBS.2003.1564.1573; Christensen H, 2008, PASTEURELLACEAE BIOL; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; Cole JR, 2014, RNA BIOL, V11, P239, DOI 10.4161/rna.28306; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Daniel DS, 2013, MICROBIOL RES, V168, P485, DOI 10.1016/j.micres.2013.04.001; De Mandal S, 2015, GENOM DATA, V4, P99, DOI 10.1016/j.gdata.2015.04.001; De Souza Luiz Carlos, 2002, Veterinaria e Zootecnia, V11, P123; Decuypere S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004470; Dietrich M, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw284; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Mejri S, 2012, J FOOD SAFETY, V32, P270, DOI 10.1111/j.1745-4565.2012.00377.x; Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1; Flynn JM, 2015, ECOL EVOL, V5, P2252, DOI 10.1002/ece3.1497; Fujita M., 1991, FLYING FOX CHIROPTE; Garcia-Mazcorro JF, 2017, MICROB ECOL, V73, P224, DOI 10.1007/s00248-016-0840-7; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Gutman N, 2016, LETT APPL MICROBIOL, V62, P237, DOI 10.1111/lam.12545; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heard DJ, 1997, J ZOO WILDLIFE MED, V28, P471; Henry R, 2016, WATER RES, V93, P242, DOI 10.1016/j.watres.2016.02.029; Ionescu D., 2016, MANUAL ENV MICROBIOL; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Grilli DJ, 2016, ANAEROBE, V42, P17, DOI 10.1016/j.anaerobe.2016.07.002; Johnson EA, 2007, CLOSTRIDIUM; Kooser A, 2015, BIORXIV; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mackenzie JS, 2003, J APPL MICROBIOL, V94, p59S; Menke S, 2015, METHODS ECOL EVOL, V6, P1080, DOI 10.1111/2041-210X.12394; Moriarty EM, 2011, APPL ENVIRON MICROB, V77, P1797, DOI 10.1128/AEM.01329-10; Musher DM., 1996, HAEMOPHILUS SPECIES; Myer PR, 2016, J MICROBIOL METH, V127, P132, DOI 10.1016/j.mimet.2016.06.004; Neuweiler G., 2000, BIOL BATS; Norskov-Lauritsen N, 2011, MICROBIOL-SGM, V157, P1050, DOI 10.1099/mic.0.047233-0; Oladeinde A, 2014, APPL ENVIRON MICROB, V80, P110, DOI 10.1128/AEM.02203-13; Quinn EK, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-144; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanchez CA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004411; Schang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155848; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Seeliger H, 1974, ANN MICROBIOLOGI; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SLEMONS RD, 1978, AVIAN DIS, V22, P367, DOI 10.2307/1589291; Smith CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109522; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; van der Ree Rodney, 2004, P195; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Voidarou C, 2011, ANAEROBE, V17, P320, DOI 10.1016/j.anaerobe.2011.05.004; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yilmaz P., 2013, NUCL ACIDS RES; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	71	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191301	10.1371/journal.pone.0191301	http://dx.doi.org/10.1371/journal.pone.0191301			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360880	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800022
J	Berejikian, BA; Van Doornik, DM				Berejikian, Barry A.; Van Doornik, Donald M.			Increased natural reproduction and genetic diversity one generation after cessation of a steelhead trout (Oncorhynchus mykiss) conservation hatchery program	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; COMPUTER-PROGRAM; CHINOOK SALMON; COHO SALMON; WILD; CALIFORNIA; WASHINGTON; PACIFIC; SUCCESS; DEPRESSION	Spatial and temporal fluctuations in productivity and abundance confound assessments of captive propagation programs aimed at recovery of Threatened and Endangered populations. We conducted a 17 year before-after-control-impact experiment to determine the effects of a captive rearing program for anadromous steelhead trout (Oncorhynchus mykiss) on a key indicator of natural spawner abundance (naturally produced nests or 'redds'). The supplemented population exhibited a significant (2.6-fold) increase in redd abundance in the generation following supplementation. Four non-supplemented (control) populations monitored over the same 17 year period exhibited stable or decreasing trends in redd abundance. Expected heterozygosity in the supplemented population increased significantly. Allelic richness increased, but to a lesser (non-significant) degree. Estimates of the effective number of breeders increased from a harmonic mean of 24.4 in the generation before supplementation to 38.9 after supplementation. Several non-conventional aspects of the captive rearing program may have contributed to the positive response in the natural population.	[Berejikian, Barry A.] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Port Orchard, WA 98366 USA; [Van Doornik, Donald M.] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Conservat Biol Div, Port Orchard, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Berejikian, BA (corresponding author), NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Port Orchard, WA 98366 USA.	barry.berejikian@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	Washington State Interagency Committee [01-042]; NOAA Fisheries, Northwest Fisheries Science Center	Washington State Interagency Committee; NOAA Fisheries, Northwest Fisheries Science Center(National Oceanic Atmospheric Admin (NOAA) - USA)	Initial funding was provided by the Washington State Interagency Committee for Outdoor Recreation Grant #01-042 (original URL no longer available; current web address for this organization is http://www.rco.wa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Subsequent funding was provided by NOAA Fisheries, Northwest Fisheries Science Center.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Berejikian B, 2005, T AM FISH SOC, V134, P1236, DOI 10.1577/T04-192.1; Berejikian BA, 2008, CAN J FISH AQUAT SCI, V65, P754, DOI 10.1139/F08-014; Berejikian BA, 2013, CAN J FISH AQUAT SCI, V70, P756, DOI 10.1139/cjfas-2012-0491; Berejikian BA, 2011, T AM FISH SOC, V140, P549, DOI 10.1080/00028487.2011.583540; Bingham DM, 2014, N AM J FISH MANAGE, V34, P609, DOI 10.1080/02755947.2014.901257; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Chaput G, 2012, ICES J MAR SCI, V69, P1538, DOI 10.1093/icesjms/fss013; Christie MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10676; Christie MR, 2014, EVOL APPL, V7, P883, DOI 10.1111/eva.12183; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Ford MJ, 2011, NMFSNWFSC113; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Gallagher SP, 2005, N AM J FISH MANAGE, V25, P284, DOI 10.1577/M04-016.1; Hedrick PW, 2016, TRENDS ECOL EVOL, V31, P940, DOI 10.1016/j.tree.2016.09.005; Hess MA, 2012, MOL ECOL, V21, P5236, DOI 10.1111/mec.12046; Horne JS, 2016, BIOL CONSERV, V196, P133, DOI 10.1016/j.biocon.2016.02.005; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kanghae H, 2016, ZOO BIOL, V35, P454, DOI 10.1002/zoo.21318; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Kinsel C., 2009, 0912 FPA WASH DEP FI; Kline PA, 2014, FISHERIES, V39, P488, DOI 10.1080/03632415.2014.966087; Kuligowski DR, 2005, T AM FISH SOC, V134, P1202, DOI 10.1577/T04-187.1; Lagios EL, 2015, ORYX, V49, P321, DOI 10.1017/S0030605313000690; McClure MM, 2008, EVOL APPL, V1, P356, DOI 10.1111/j.1752-4571.2008.00034.x; Meretsky V, 2001, CONSERV BIOL, V15, P1449, DOI 10.1046/j.1523-1739.2001.01004.x; Moore M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073427; Moore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049645; Moore ME, 2015, MAR ECOL PROG SER, V537, P217, DOI 10.3354/meps11460; Naish KA, ADV MAR BIOL, P61; Neff BD, 2011, CAN J FISH AQUAT SCI, V68, P1139, DOI [10.1139/F2011-029, 10.1139/f2011-029]; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PSSTRT (Puget Sound Steelhead Technical Recovery Team), 2013, ID HIST POP STEELH P; Rand PS, 2012, ENVIRON BIOL FISH, V94, P343, DOI 10.1007/s10641-012-9988-2; Rollinson N, 2014, CONSERV BIOL, V28, P529, DOI 10.1111/cobi.12188; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Santymire RM, 2014, ADV EXP MED BIOL, V753, P119, DOI 10.1007/978-1-4939-0820-2_7; Scheuerell MD, 2015, ECOL EVOL, V5, P2115, DOI 10.1002/ece3.1509; Small MP, 2009, CAN J FISH AQUAT SCI, V66, P1216, DOI 10.1139/F09-068; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Van Doornik DM, 2015, ENVIRON BIOL FISH, V98, P637, DOI 10.1007/s10641-014-0301-4; Van Doornik DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079931; Van Doornik DM, 2010, CAN J FISH AQUAT SCI, V67, P1449, DOI 10.1139/F10-073; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 1999, FISHERIES, V24, P12, DOI 10.1577/1548-8446(1999)024<0012:DSMAH>2.0.CO;2; Warton DI, 2016, METHODS ECOL EVOL, V7, P882, DOI 10.1111/2041-210X.12552; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Wootton JT, 2014, ECOL APPL, V24, P1251, DOI 10.1890/13-1323.1; Zimmerman MS, 2015, MAR COAST FISH, V7, P116, DOI 10.1080/19425120.2015.1012246	55	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190799	10.1371/journal.pone.0190799	http://dx.doi.org/10.1371/journal.pone.0190799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351326	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300026
J	Dislich, C; Hettig, E; Salecker, J; Heinonen, J; Lay, J; Meyer, KM; Wiegand, K; Tarigan, S				Dislich, Claudia; Hettig, Elisabeth; Salecker, Jan; Heinonen, Johannes; Lay, Jann; Meyer, Katrin M.; Wiegand, Kerstin; Tarigan, Suria			Land-use change in oil palm dominated tropical landscapes-An agent-based model to explore ecological and socio-economic trade-offs	PLOS ONE			English	Article							USE DYNAMICS; BIODIVERSITY; ECOSYSTEM; EXPANSION; PROTOCOL; SUMATRA; FOREST	Land-use changes have dramatically transformed tropical landscapes. We describe an ecological- economic land-use change model as an integrated, exploratory tool used to analyze how tropical land-use change affects ecological and socio-economic functions. The model analysis seeks to determine what kind of landscape mosaic can improve the ensemble of ecosystem functioning, biodiversity, and economic benefit based on the synergies and trade-offs that we have to account for. More specifically, (1) how do specific ecosystem functions, such as carbon storage, and economic functions, such as household consumption, relate to each other? (2) How do external factors, such as the output prices of crops, affect these relationships? (3) How do these relationships change when production inefficiency differs between smallholder farmers and learning is incorporated? We initialize the ecological-economic model with artificially generated land-use maps parameterized to our study region. The economic sub-model simulates smallholder land-use management decisions based on a profit maximization assumption. Each household determines factor inputs for all household fields and decides on land-use change based on available wealth. The ecological sub-model includes a simple account of carbon sequestration in above-ground and below-ground vegetation. We demonstrate model capabilities with results on household consumption and carbon sequestration from different output price and farming efficiency scenarios. The overall results reveal complex interactions between the economic and ecological spheres. For instance, model scenarios with heterogeneous crop-specific household productivity reveal a comparatively high inertia of land-use change. Our model analysis even shows such an increased temporal stability in landscape composition and carbon stocks of the agricultural area under dynamic price trends. These findings underline the utility of ecological- economic models, such as ours, to act as exploratory tools which can advance our understanding of the mechanisms underlying the trade-offs and synergies of ecological and economic functions in tropical landscapes.	[Dislich, Claudia; Salecker, Jan; Heinonen, Johannes; Meyer, Katrin M.; Wiegand, Kerstin] Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany; [Hettig, Elisabeth; Lay, Jann] Univ Goettingen, Fac Econ Sci, Gottingen, Germany; [Hettig, Elisabeth; Lay, Jann] GIGA German Inst Global & Area Studies, Hamburg, Germany; [Wiegand, Kerstin] Univ Goettingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Tarigan, Suria] Bogor Agr Univ, Soil & Nat Resources Management, Bogor, Indonesia; [Dislich, Claudia] Grad Sch HIGRADE, Helmholtz Ctr Environm Res UFZ, Leipzig, Germany	University of Gottingen; University of Gottingen; German Institute of Global & Area Studies; University of Gottingen; Bogor Agricultural University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Salecker, J (corresponding author), Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany.	jsaleck@gwdg.de	Meyer, Katrin M/E-6839-2013; Lay, Jann/AAP-7896-2020; Tarigan, Suria/ACN-8691-2022	Meyer, Katrin M/0000-0002-9990-4047; Tarigan, Suria/0000-0003-0153-0399; Lay, Jann/0000-0002-0784-3807; Wiegand, Kerstin/0000-0003-4854-0607; Salecker, Jan/0000-0002-9000-4229	German Research Foundation (DFG) in the framework of the collaborative German Indonesian research project EFForTS, Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)	German Research Foundation (DFG) in the framework of the collaborative German Indonesian research project EFForTS, Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)(German Research Foundation (DFG))	This study was financed by the German Research Foundation (DFG, http://www.dfg.de/) in the framework of the collaborative German Indonesian research project EFForTS (https://www.uni-goettingen.de/efforts), Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia).	Adelman I., 2003, REV ECON HOUSEHOLD, V1, P33, DOI [10.1023/A:1021847430758, DOI 10.1023/A:1021847430758]; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Berger T, 2001, AGR ECON-BLACKWELL, V25, P245, DOI 10.1111/j.1574-0862.2001.tb00205.x; Clough Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13137; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Dislich C, 2016, BIOL REV IN PRESS; Drescher J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0275; Euler M, 2017, WORLD DEV, V93, P219, DOI 10.1016/j.worlddev.2016.12.019; Euler M, 2016, AGR SYST, V146, P111, DOI 10.1016/j.agsy.2016.04.007; Evans MR, 2013, TRENDS ECOL EVOL, V28, P578, DOI 10.1016/j.tree.2013.05.022; Faust H, 2013, EFFORTS DISCUSSION P, V1; Feintrenie L, 2010, ECOL SOC, V15; Fischer R, 2016, ECOL MODEL, V326, P124, DOI 10.1016/j.ecolmodel.2015.11.018; Gatto M, 2015, LAND USE POLICY, V46, P292, DOI 10.1016/j.landusepol.2015.03.001; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hettig E, 2016, LAND-BASEL, V5, DOI 10.3390/land5040032; Holdo RM, 2010, ECOL APPL, V20, P381, DOI 10.1890/08-0780.1; Jeltsch F, 2013, BASIC APPL ECOL, V14, P93, DOI 10.1016/j.baae.2013.01.001; Kelley H, 2011, ECOL ECON, V70, P1075, DOI 10.1016/j.ecolecon.2010.12.009; Kelly RA, 2013, ENVIRON MODELL SOFTW, V47, P159, DOI 10.1016/j.envsoft.2013.05.005; Kiesling E, 2012, CENT EUR J OPER RES, V20, P183, DOI 10.1007/s10100-011-0210-y; Klasen S, 2013, AGR ECON-BLACKWELL, V44, P349, DOI 10.1111/agec.12015; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4; Krishna V, 2017, AGR ECON-BLACKWELL, V48, P639, DOI 10.1111/agec.12363; Laniak GF, 2013, ENVIRON MODELL SOFTW, V39, P3, DOI 10.1016/j.envsoft.2012.09.006; Le QB, 2008, ECOL INFORM, V3, P135, DOI 10.1016/j.ecoinf.2008.04.003; Le QB, 2010, ECOL INFORM, V5, P203, DOI 10.1016/j.ecoinf.2010.02.001; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Mumme S, 2015, BIOL CONSERV, V191, P750, DOI 10.1016/j.biocon.2015.08.033; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Powell LL, 2015, BIOL CONSERV, V188, P100, DOI 10.1016/j.biocon.2015.01.028; Prabowo WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154876; Railsback S., 2012, AGENT BASED INDIVIDU; Sayer J, 2012, GLOB FOOD SECUR-AGR, V1, P114, DOI 10.1016/j.gfs.2012.10.003; Schouten M, 2014, ENVIRON MODELL SOFTW, V54, P196, DOI 10.1016/j.envsoft.2014.01.003; Singh Inderjit, 1986, AGR HOUSEHOLD MODELS; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; Villamor GB, 2014, ENVIRON MODELL SOFTW, V61, P151, DOI 10.1016/j.envsoft.2014.07.013; Zhang H, 2016, ARXIV160808517PHYSIC	42	16	17	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190506	10.1371/journal.pone.0190506	http://dx.doi.org/10.1371/journal.pone.0190506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351290	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300019
J	Faigle, R; Carrese, JA; Cooper, LA; Urrutia, VC; Gottesman, RF				Faigle, Roland; Carrese, Joseph A.; Cooper, Lisa A.; Urrutia, Victor C.; Gottesman, Rebecca F.			Minority race and male sex as risk factors for non-beneficial gastrostomy tube placements after stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; HEALTH-CARE PROFESSIONALS; RESUSCITATE ORDERS; GUIDELINES; DIAGNOSIS; GENDER; ASSOCIATION; DISPARITIES; WITHDRAWAL	Background Percutaneous endoscopic gastrostomy (PEG) tubes are widely used for enteral feeding after stroke; however, PEG tubes placed in patients in whom death is imminent are considered non-beneficial. Aim We sought to determine whether placement of non-beneficial PEG tubes differs by race and sex. Design and setting/participants In this retrospective cohort study, inpatient admissions for stroke patients who underwent palliative/withdrawal of care, were discharged to hospice, or died during the hospitalization, were identified from the Nationwide Inpatient Sample between 2007 and 2011. Logistic regression was used to evaluate the association between race and sex with PEG placement. Results Of 36,109 stroke admissions who underwent palliative/withdrawal of care, were discharge to hospice, or experienced in-hospital death, a PEG was placed in 2,258 (6.3%). Among PEG recipients 41.1% were of a race other than white, while only 22.0% of patients without PEG were of a minority race (p< 0.001). The proportion of men was higher among those with compared to without a PEG tube (50.0% vs. 39.2%, p < 0.001). Minority race was associated with PEG placement compared to whites (OR 1.75, 95% CI 1.57 +/- 1.96), and men had 1.27 times higher odds of PEG compared to women (95% CI 1.16 +/- 1.40). Racial differences were most pronounced among women: ethnic/racial minority women had over 2-fold higher odds of a PEG compared to their white counterparts (OR 2.09, 95% CI 1.81 +/- 2.41), while male ethnic/racial minority patients had 1.44 increased odds of a PEG when compared to white men (95% CI 1.24 +/- 1.67, p-value for interaction < 0.001). Conclusion Minority race and male sex are risk factors for non-beneficial PEG tube placements after stroke.	[Faigle, Roland; Urrutia, Victor C.; Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Carrese, Joseph A.; Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Carrese, Joseph A.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Faigle, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	rfaigle1@jhmi.edu	Urrutia, Victor/AAH-6683-2021; Faigle, Roland/ABB-9082-2020; Gottesman, Rebecca/ABA-8468-2020	Urrutia, Victor/0000-0002-4995-6949; Faigle, Roland/0000-0002-9074-1915; 	NINDS Career Development Award [K23 NS101124]; National Heart, Lung, and Blood Institute [K24HL083113]; National Institute on Aging [K24AG052573]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS101124] Funding Source: NIH RePORTER	NINDS Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Faigle is supported by an NINDS Career Development Award (K23 NS101124). Dr. Cooper is supported by a grant from the National Heart, Lung, and Blood Institute (K24HL083113). Dr Gottesman is supported by a grant from the National Institute on Aging (K24AG052573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Bookwala J, 2001, DEATH STUD, V25, P127, DOI 10.1080/074811801461919; Brown F, 2011, ICD 9 CM CODING HDB; Corrigan ML, 2011, NUTR CLIN PRACT, V26, P242, DOI 10.1177/0884533611405795; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; EDWARDS N, 1994, HEALTH CARE FINANC R, V16, P45; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; George BP, 2017, STROKE, V48, P420, DOI 10.1161/STROKEAHA.116.015119; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; James A, 1998, AGE AGEING, V27, P671, DOI 10.1093/ageing/27.6.671; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Kent JA, 2012, MT SINAI J MED, V79, P555, DOI 10.1002/msj.21336; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; Mack JW, 2010, ARCH INTERN MED, V170, P1533, DOI 10.1001/archinternmed.2010.322; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Perkins HS, 2002, J GEN INTERN MED, V17, P48, DOI 10.1046/j.1525-1497.2002.01032.x; Qureshi AI, 2013, MED CARE, V51, P1094, DOI 10.1097/MLR.0b013e3182a95db4; Reeves M, 2009, STROKE, V40, P1743, DOI 10.1161/STROKEAHA.108.543181; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Stroud M, 2003, GUT, V52, P1; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Towfighi A, 2013, J STROKE CEREBROVASC, V22, pE347, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.018; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Wilmskoetter J, 2016, J STROKE CEREBROVASC, V25, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.017; Xian Y, 2012, STROKE, V43, P1687, DOI 10.1161/STROKEAHA.111.648600; Zaide GB, 2013, PALLIAT SUPPORT CARE, V11, P5, DOI 10.1017/S1478951512000417	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191293	10.1371/journal.pone.0191293	http://dx.doi.org/10.1371/journal.pone.0191293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351343	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300068
J	Kropf, J; Rossler, W				Kropf, Jan; Roessler, Wolfgang			In-situ recording of ionic currents in projection neurons and Kenyon cells in the olfactory pathway of the honeybee	PLOS ONE			English	Article							ANTENNAL-LOBE NEURONS; APIS-MELLIFERA-L; MUSHROOM BODY; BEE BRAIN; K+-CURRENTS; SUBSYSTEMS; ANATOMY; BODIES; REPRESENTATION; ORGANIZATION	The honeybee olfactory pathway comprises an intriguing pattern of convergence and divergence: similar to 60.000 olfactory sensory neurons (OSN) convey olfactory information on similar to 900 projection neurons (PN) in the antennal lobe (AL). To transmit this information reliably, PNs employ relatively high spiking frequencies with complex patterns. PNs project via a dual olfactory pathway to the mushroom bodies (MB). This pathway comprises the medial (m-ALT) and the lateral antennal lobe tract (l-ALT). PNs from both tracts transmit information from a wide range of similar odors, but with distinct differences in coding properties. In the MBs, PNs form synapses with many Kenyon cells (KC) that encode odors in a spatially and temporally sparse way. The transformation from complex information coding to sparse coding is a well-known phenomenon in insect olfactory coding. Intrinsic neuronal properties as well as GABAergic inhibition are thought to contribute to this change in odor representation. In the present study, we identified intrinsic neuronal properties promoting coding differences between PNs and KCs using in-situ patch-clamp recordings in the intact brain. We found very prominent K+ currents in KCs clearly differing from the PN currents. This suggests that odor coding differences between PNs and KCs may be caused by differences in their specific ion channel properties. Comparison of ionic currents of m-and l-ALT PNs did not reveal any differences at a qualitative level.	[Kropf, Jan; Roessler, Wolfgang] Univ Wurzburg, Behav Physiol & Sociobiol Zool 2, Biozentrum, Wurzburg, Germany; [Kropf, Jan] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England	University of Wurzburg; University of Oxford	Kropf, J (corresponding author), Univ Wurzburg, Behav Physiol & Sociobiol Zool 2, Biozentrum, Wurzburg, Germany.; Kropf, J (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England.	jan.kropf@cncb.ox.ac.uk	Rössler, Wolfgang/E-9526-2019	Rössler, Wolfgang/0000-0002-5195-8214; Kropf, Jan/0000-0002-4179-0446	Deutsche Forschungsgemeinschaft (DFG); DFG Priority Program Integrative Analysis of Olfaction [SPP 1392, RO1177/5-2]; DFG; University of Wurzburg in the funding program Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Priority Program Integrative Analysis of Olfaction(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wurzburg in the funding program Open Access Publishing	This work was supported by the Deutsche Forschungsgemeinschaft (DFG); DFG Priority Program SPP 1392 Integrative Analysis of Olfaction (RO1177/5-2) to Wolfgang Rossler. This publication was funded by the DFG and the University of Wurzburg in the funding program Open Access Publishing; http://www.dfg.de/en/research_funding/announcements_proposals/2011/info_wissenschaft_11_26/index.html, https://www.uni-konstanz.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bradler C, 2016, J NEUROPHYSIOL, V115, P2330, DOI 10.1152/jn.00840.2015; Brill MF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00208; Brill MF, 2013, J NEUROSCI, V33, P2443, DOI 10.1523/JNEUROSCI.4268-12.2013; Carcaud J, 2015, J NEUROSCI, V35, P4157, DOI 10.1523/JNEUROSCI.0734-14.2015; Carcaud J, 2012, J NEUROPHYSIOL, V108, P1106, DOI 10.1152/jn.01034.2011; Demmer H, 2009, J NEUROPHYSIOL, V102, P1538, DOI 10.1152/jn.00183.2009; Derst C, 2003, EUR J NEUROSCI, V17, P1197, DOI 10.1046/j.1460-9568.2003.02550.x; Dubnau J, 2012, SCIENCE, V335, P664, DOI 10.1126/science.1218171; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; Froese A, 2014, J COMP PHYSIOL A, V200, P183, DOI 10.1007/s00359-013-0877-8; Galizia CG, 2012, J INSECT PHYSIOL, V58, P743, DOI 10.1016/j.jinsphys.2012.02.010; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Grolleau F, 2000, J EXP BIOL, V203, P1633; GROLLEAU F, 1994, NEUROSCI LETT, V167, P46, DOI 10.1016/0304-3940(94)91024-3; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 2003, J EXP BIOL, V206, P117, DOI 10.1242/jeb.00053; Gupta N, 2011, CURR OPIN NEUROBIOL, V21, P768, DOI 10.1016/j.conb.2011.05.005; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kropf J, 2014, CELL TISSUE RES, V357, P583, DOI 10.1007/s00441-014-1892-y; Lei H, 2016, FRONT PHYSIOL, V8, P1; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Leinwand SG, 2011, CURR OPIN GENET DEV, V21, P806, DOI 10.1016/j.gde.2011.07.006; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Meyer A, 2012, J COMP PHYSIOL A, V198, P159, DOI 10.1007/s00359-011-0696-8; Muller D, 2002, J COMP PHYSIOL A, V188, P359, DOI 10.1007/s00359-002-0310-1; Palmer MJ, 2014, J NEUROPHYSIOL, V112, P2026, DOI 10.1152/jn.00180.2014; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pelz C, 1999, J NEUROPHYSIOL, V81, P1749, DOI 10.1152/jn.1999.81.4.1749; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perk CG, 2006, J NEUROPHYSIOL, V95, P1147, DOI 10.1152/jn.01220.2004; Rossler W, 2013, J COMP PHYSIOL A, V199, P981, DOI 10.1007/s00359-013-0821-y; Rossler W, 2011, ARTHROPOD STRUCT DEV, V40, P349, DOI 10.1016/j.asd.2010.12.001; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SCHAFER S, 1994, J NEUROSCI, V14, P4600; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Tanaka NK, 2012, J COMP NEUROL, V520, P4131, DOI 10.1002/cne.23149; Wicher D, 2006, J NEUROPHYSIOL, V95, P311, DOI 10.1152/jn.00904.2005; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Wustenberg DG, 2004, J NEUROPHYSIOL, V92, P2589, DOI 10.1152/jn.01259.2003	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191425	10.1371/journal.pone.0191425	http://dx.doi.org/10.1371/journal.pone.0191425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351552	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300089
J	Merrick, BA; Chang, JS; Phadke, DP; Bostrom, MA; Shah, RR; Wang, XG; Gordon, O; Wright, GM				Merrick, B. Alex; Chang, Justin S.; Phadke, Dhiral P.; Bostrom, Meredith A.; Shah, Ruchir R.; Wang, Xinguo; Gordon, Oksana; Wright, Garron M.			HAfTs are novel lncRNA transcripts from aflatoxin exposure	PLOS ONE			English	Article							LONG NONCODING RNAS; HEPATOCELLULAR-CARCINOMA; SPLICE VARIANTS; HEPATIC TRANSCRIPTOME; HUMAN HEPATOCYTES; GENE-EXPRESSION; B-1; CANCER; PATHOGENESIS; EVOLUTION	The transcriptome can reveal insights into precancer biology. We recently conducted RNA-Seq analysis on liver RNA from male rats exposed to the carcinogen, aflatoxin B1 (AFB1), for 90 days prior to liver tumor onset. Among > 1,000 differentially expressed transcripts, several novel, unannotated Cufflinks-assembled transcripts, or HAfTs (Hepatic Aflatoxin Transcripts) were found. We hypothesized PCR-cloning and RACE (rapid amplification of cDNA ends) could further HAfT identification. Sanger data was obtained for 6 transcripts by PCR and 16 transcripts by 5'- and 3'-RACE. BLAST alignments showed, with two exceptions, HAfT transcripts were lncRNAs, >200nt without apparent long open reading frames. Six rat HAfT transcripts were classified as 'novel' without RefSeq annotation. Sequence alignment and genomic synteny showed each rat lncRNA had a homologous locus in the mouse genome and over half had homologous loci in the human genome, including at least two loci (and possibly three others) that were previously unannotated. While HAfT functions are not yet clear, coregulatory roles may be possible from their adjacent orientation to known coding genes with altered expression that include 8 HAfT-gene pairs. For example, a unique rat HAfT, homologous to Pvt1, was adjacent to known genes controlling cell proliferation. Additionally, PCR and RACE Sanger sequencing showed many alternative splice variants and refinements of exon sequences compared to Cufflinks assembled transcripts and gene prediction algorithms. Presence of multiple splice variants and short tandem repeats found in some HAfTs may be consequential for secondary structure, transcriptional regulation, and function. In summary, we report novel, differentially expressed lncRNAs after exposure to the genotoxicant, AFB1, prior to neoplastic lesions. Complete cloning and sequencing of such transcripts could pave the way for a new set of sensitive and early prediction markers for chemical hepatocarcinogens.	[Merrick, B. Alex; Chang, Justin S.] NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Phadke, Dhiral P.; Shah, Ruchir R.] Sciome LLC, Res Triangle Pk, NC USA; [Bostrom, Meredith A.; Wang, Xinguo; Gordon, Oksana; Wright, Garron M.] David H Murdock Res Inst, Genom Lab, Kannapolis, NC USA; [Chang, Justin S.] Columbia Univ, Columbia Coll, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University	Merrick, BA (corresponding author), NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.	merrick@niehs.nih.gov			Division of the National Toxicology Program at the National Institute of Environmental Health Sciences of the NIH; Division of the Intramural Research at the National Institute of Environmental Health Sciences of the NIH; NIEHS;  [HHSN273201100016C];  [HHSN273201700001C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	Division of the National Toxicology Program at the National Institute of Environmental Health Sciences of the NIH; Division of the Intramural Research at the National Institute of Environmental Health Sciences of the NIH; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Divisions of the National Toxicology Program and Intramural Research at the National Institute of Environmental Health Sciences of the NIH. A portion of work was performed under Contract HHSN273201100016C and HHSN273201700001C. The funder [NIEHS] provided support in the form of salaries for authors [MAB, DPP, RRS, XW, OG, GMW], but they did not have any additional role in the study design, decision to publish, or preparation of the manuscript. MAB, XW, OG and GMW provided a portion of data and analysis. DP and RRS provided a portion of data analysis. The specific roles of these authors are articulated in the 'author contributions' section.	Auerbach SS, 2015, J APPL TOXICOL, V35, P766, DOI 10.1002/jat.3068; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bussotti G, 2013, INT J MOL SCI, V14, P15423, DOI 10.3390/ijms140815423; BUTLER WH, 1981, J PATHOL, V134, P157, DOI 10.1002/path.1711340206; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Chawanthayatham S, 2015, INT J CANCER, V136, P1254, DOI 10.1002/ijc.29102; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Cui M, 2016, BIOCHEM BIOPH RES CO, V471, P10, DOI 10.1016/j.bbrc.2015.12.101; Dayalu P, 2015, NEUROL CLIN, V33, P101, DOI 10.1016/j.ncl.2014.09.003; De Ruyck K, 2015, MUTAT RES-REV MUTAT, V766, P32, DOI 10.1016/j.mrrev.2015.07.003; DEGEN GH, 1981, CARCINOGENESIS, V2, P299, DOI 10.1093/carcin/2.4.299; Dempsey JL, 2017, TOXICOL SCI, V155, P3, DOI 10.1093/toxsci/kfw203; Deng N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068352; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Ellinger-Ziegelbauer H, 2004, TOXICOL SCI, V77, P19, DOI 10.1093/toxsci/kfh016; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gong BS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.21; Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016; Gross-Steinmeyer K, 2010, TOXICOL SCI, V116, P422, DOI 10.1093/toxsci/kfq135; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hacisuleyman E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11021; Hagerman PJ, 2015, ANN NY ACAD SCI, V1338, P58, DOI 10.1111/nyas.12693; Hamid AS, 2013, ONCOL LETT, V5, P1087, DOI 10.3892/ol.2013.1169; Harris AJ, 2004, MUTAT RES-FUND MOL M, V549, P79, DOI 10.1016/j.mrfmmm.2003.11.014; Howald C, 2012, GENOME RES, V22, P1698, DOI 10.1101/gr.134478.111; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067043; Hubley R., 2013, REPEATMASKER OPEN 40; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Hutchins AP, 2012, GENOMICS, V100, P303, DOI 10.1016/j.ygeno.2012.07.014; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Johnson NM, 2014, CANCER PREV RES, V7, P658, DOI 10.1158/1940-6207.CAPR-13-0430; Kaya M, 2016, ANIM BIOTECHNOL, V27, P238, DOI 10.1080/10495398.2016.1178139; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kim HP, 2014, ONCOGENE, V33, P5434, DOI 10.1038/onc.2013.490; Kumar RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2872; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu AY, 2012, CELL TISSUE RES, V348, P589, DOI 10.1007/s00441-012-1383-y; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu SP, 2011, INT J CANCER, V128, P511, DOI 10.1002/ijc.25386; Liu S, 2016, MOL CANCER THER, V15, P2977, DOI 10.1158/1535-7163.MCT-16-0320; Lu XY, 2013, FOOD CHEM TOXICOL, V55, P444, DOI 10.1016/j.fct.2013.01.020; Mehravar M, 2017, GENE, V603, P27, DOI 10.1016/j.gene.2016.12.008; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Monson MS, 2016, TOXINS, V8, DOI 10.3390/toxins8010016; Monson M, 2015, IMMUNOGENETICS, V67, P163, DOI 10.1007/s00251-014-0825-y; Monson MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100930; National Toxicology Program, 2011, Rep Carcinog, V12, P32; Nault JC, 2014, BEST PRACT RES CL GA, V28, P937, DOI 10.1016/j.bpg.2014.08.006; Pacheco-Marin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23373; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Plaza S, 2017, ANNU REV CELL DEV BI, V33, P391, DOI 10.1146/annurev-cellbio-100616-060516; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ratajewski M, 2011, TOXICOL LETT, V205, P146, DOI 10.1016/j.toxlet.2011.05.1034; Ray MK, 2016, J BIOL CHEM, V291, P19558, DOI 10.1074/jbc.M116.730853; Rothe B, 2015, MOL CELL BIOL, V35, P3339, DOI 10.1128/MCB.00341-15; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Shi JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31898; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Souvorov A., 2010, GNOMON NCBI EUKARYOT; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Takai A, 2014, INT J MOL SCI, V15, P11142, DOI 10.3390/ijms150611142; Teoh WW, 2015, DIS MODEL MECH, V8, P743, DOI 10.1242/dmm.017624; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Tsuiji H, 2011, GENES CELLS, V16, P479, DOI 10.1111/j.1365-2443.2011.01502.x; Wang XQD, 2017, NUCLEIC ACIDS RES, V45, P1091, DOI 10.1093/nar/gkw966; Ward Melanie, 2015, J Hum Transcr, V1, P2; WOGAN GN, 1974, FOOD COSMET TOXICOL, V12, P681, DOI 10.1016/0015-6264(74)90239-9; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yang WQ, 2014, TOXICOL LETT, V226, P140, DOI 10.1016/j.toxlet.2014.01.021; Yarru LP, 2009, POULTRY SCI, V88, P360, DOI 10.3382/ps.2008-00258; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang NY, 2016, TOXICON, V111, P69, DOI 10.1016/j.toxicon.2015.12.022; Zhao YH, 2014, ACTA BIOCH BIOPH SIN, V46, P180, DOI 10.1093/abbs/gmt147; Zhou CC, 2016, HEPATOLOGY, V63, P850, DOI 10.1002/hep.28393; Zhou W, 2014, EXP MOL PATHOL, V97, P550, DOI 10.1016/j.yexmp.2014.11.005	84	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190992	10.1371/journal.pone.0190992	http://dx.doi.org/10.1371/journal.pone.0190992			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351317	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300036
J	Passera, A; Marcolungo, L; Casati, P; Brasca, M; Quaglino, F; Cantaloni, C; Delledonne, M				Passera, Alessandro; Marcolungo, Luca; Casati, Paola; Brasca, Milena; Quaglino, Fabio; Cantaloni, Chiara; Delledonne, Massimo			Hybrid genome assembly and annotation of Paenibacillus pasadenensis strain R16 reveals insights on endophytic life style and antifungal activity	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; PLANT-DISEASE; GROWTH; CHITINASE; BACTERIA; FARNESOL	Bacteria of the Paenibacillus genus are becoming important in many fields of science, including agriculture, for their positive effects on the health of plants. However, there are little information available on this genus compared to other bacteria (such as Bacillus or Pseudomonas), especially when considering genomic information. Sequencing the genomes of plant-beneficial bacteria is a crucial step to identify the genetic elements underlying the adaptation to life inside a plant host and, in particular, which of these features determine the differences between a helpful microorganism and a pathogenic one. In this study, we have characterized the genome of Paenibacillus pasadenensis, strain R16, recently investigated for its antifungal activities and plant-associated features. An hybrid assembly approach was used integrating the very precise reads obtained by Illumina technology and long fragments acquired with Oxford Nanopore Technology (ONT) sequencing. De novo genome assembly based solely on Illumina reads generated a relatively fragmented assembly of 5.72 Mbp in 99 ungapped sequences with an N50 length of 544 Kbp; hybrid assembly, integrating Illumina and ONT reads, improved the assembly quality, generating a genome of 5.75 Mbp, organized in 6 contigs with an N50 length of 3.4 Mbp. Annotation of the latter genome identified 4987 coding sequences, of which 1610 are hypothetical proteins. Enrichment analysis identified pathways of particular interest for the endophyte biology, including the chitin-utilization pathway and the incomplete siderophore pathway which hints at siderophore parasitism. In addition the analysis led to the identification of genes for the production of terpenes, as for example farnesol, that was hypothesized as the main antifungal molecule produced by the strain. The functional analysis on the genome confirmed several plant-associated, plant-growth promotion, and biocontrol traits of strain R16, thus adding insights in the genetic bases of these complex features, and of the Paenibacillus genus in general.	[Passera, Alessandro; Casati, Paola; Quaglino, Fabio] Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenerg, Milan, Italy; [Marcolungo, Luca; Cantaloni, Chiara; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Verona, Italy; [Brasca, Milena] Inst Sci Food Prod, Italian Natl Res Council, Milan, Italy	University of Milan; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Casati, P (corresponding author), Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenerg, Milan, Italy.	paola.casati@unimi.it	Brasca, Milena/AAE-7819-2021; Delledonne, Massimo/O-8685-2017; Brasca, Milena/AAY-5763-2020; QUAGLINO, FABIO/A-6519-2009	Brasca, Milena/0000-0002-8821-0787; Marcolungo, Luca/0000-0002-2366-5684; QUAGLINO, FABIO/0000-0001-8866-0633; Casati, Paola/0000-0001-6152-8712; Delledonne, Massimo/0000-0002-7100-4581				Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chakdar H, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0457-z; Chandler JC, 2011, J BACTERIOL, V193, P3265, DOI 10.1128/JB.00093-11; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cotoras M, 2013, MYCOLOGIA, V105, P28, DOI 10.3852/12-012; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Faramarzi M. A., 2009, Biotechnology, V8, P93; Feng XX, 2014, CHEM BIOL, V21, P1557, DOI 10.1016/j.chembiol.2014.08.018; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kokalis-Burelle N, 2006, APPL SOIL ECOL, V31, P91, DOI 10.1016/j.apsoil.2005.03.007; Krom BP, 2016, ISR J CHEM, V56, P295, DOI 10.1002/ijch.201500025; Langford ML, 2010, ANTIMICROB AGENTS CH, V54, P940, DOI 10.1128/AAC.01214-09; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Loni PP, 2014, J BASIC MICROB, V54, P1080, DOI 10.1002/jobm.201300533; Lorek J, 2008, J BASIC MICROB, V48, P99, DOI 10.1002/jobm.200700292; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Monnet V, 2016, CRIT REV MICROBIOL, V42, P339, DOI 10.3109/1040841X.2014.948804; Montes MJ, 2004, INT J SYST EVOL MICR, V54, P1521, DOI 10.1099/ijs.0.63078-0; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Parray JA, 2016, J PLANT GROWTH REGUL, V35, P877, DOI 10.1007/s00344-016-9583-4; Passera A, 2017, MICROBIOL RES, V198, P16, DOI 10.1016/j.micres.2017.02.001; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rybakova D, 2016, PLANT SOIL, V405, P125, DOI 10.1007/s11104-015-2526-1; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sarethy IP, 2011, J IND MICROBIOL BIOT, V38, P769, DOI 10.1007/s10295-011-0968-x; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Shaheen M, 2011, CHEM BIOL, V18, P1640, DOI 10.1016/j.chembiol.2011.09.017; Sheibani-Tezerji R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00440; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Venturi V, 2013, ANNU REV PHYTOPATHOL, V51, P17, DOI 10.1146/annurev-phyto-082712-102239; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Weber T, 2015, NUC AC RES; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x	50	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189993	10.1371/journal.pone.0189993	http://dx.doi.org/10.1371/journal.pone.0189993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351296	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300013
J	Ullah, A; Malik, SA; Alimgeer, KS				Ullah, Azmat; Malik, Suheel Abdullah; Alimgeer, Khurram Saleem			Evolutionary algorithm based heuristic scheme for nonlinear heat transfer equations	PLOS ONE			English	Article							HOMOTOPY-PERTURBATION; NUMERICAL-SOLUTION	In this paper, a hybrid heuristic scheme based on two different basis functions i.e. Log Sigmoid and Bernstein Polynomial with unknown parameters is used for solving the nonlinear heat transfer equations efficiently. The proposed technique transforms the given nonlinear ordinary differential equation into an equivalent global error minimization problem. Trial solution for the given nonlinear differential equation is formulated using a fitness function with unknown parameters. The proposed hybrid scheme of Genetic Algorithm (GA) with Interior Point Algorithm (IPA) is opted to solve the minimization problem and to achieve the optimal values of unknown parameters. The effectiveness of the proposed scheme is validated by solving nonlinear heat transfer equations. The results obtained by the proposed scheme are compared and found in sharp agreement with both the exact solution and solution obtained by Haar Wavelet-Quasilinearization technique which witnesses the effectiveness and viability of the suggested scheme. Moreover, the statistical analysis is also conducted for investigating the stability and reliability of the presented scheme.	[Ullah, Azmat] OGDCL, Instrumentat, Islamabad, Pakistan; [Malik, Suheel Abdullah] Int Islamic Univ, Fac Engn & Technol, Dept Elect Engn, Islamabad, Pakistan; [Alimgeer, Khurram Saleem] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan	International Islamic University, Pakistan; COMSATS University Islamabad (CUI)	Ullah, A (corresponding author), OGDCL, Instrumentat, Islamabad, Pakistan.	ad80kw@gmail.com	Alimgeer, Khurram S/AGW-9805-2022; Alimgeer, Khurram S/F-4911-2011; Saleem, Khurram/N-9547-2019	Alimgeer, Khurram S/0000-0001-5732-2463; Ullah, Azmat/0000-0002-4519-5222				Abo-Hammour Z, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/401696; Abu Arqub O, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/205391; Abu-Arqub O, 2014, APPL MATH INFORM SCI, V8, P235; Ahmad H., 2018, NONLINEAR SCI LETT A, V9, P27; Atangana A, 2014, NEURAL COMPUT APPL, V25, P1021, DOI 10.1007/s00521-014-1586-0; Danish M, 2011, ENG LETT, V19; Dehghan M, 2015, RENEW ENERG, V74, P448, DOI 10.1016/j.renene.2014.08.044; Ganji DD, 2007, J COMPUT APPL MATH, V207, P24, DOI 10.1016/j.cam.2006.07.030; Juan-Cheng Y, 2015, CHINESE PHYS B, V24; Kadri MB, 2014, SCI WORLD J, DOI 10.1155/2014/451274; Khan JA, 2009, PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON ENVIRONMENTAL AND COMPUTER SCIENCE, P141, DOI 10.1109/ICECS.2009.85; Khan RA, 2009, APPL MATH COMPUT, V212, P287, DOI 10.1016/j.amc.2009.02.028; Malik S., 2013, RES J RECENT SCI, V2, P47; Malik SA., 2014, ADV STUD BIOL, V6, P99, DOI 10.12988/asb.2014.4520; Malik SA, 2015, MAGNT RES REPORT, V3, P21; Malik SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121728; Owolabi KM, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16335-8; Rafiq M, 2017, NONLINEAR SCI LETT A, V8, P389; Raja MAZ, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/675075; Saeed U, 2014, APPL COMPUT INTELL S, V2014, DOI 10.1155/2014/454231	20	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191103	10.1371/journal.pone.0191103	http://dx.doi.org/10.1371/journal.pone.0191103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351304	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300049
J	Logue, JS; Cartagena-Rivera, AX; Chadwick, RS				Logue, Jeremy S.; Cartagena-Rivera, Alexander X.; Chadwick, Richard S.			c-Src activity is differentially required by cancer cell motility modes	ONCOGENE			English	Article							FOCAL ADHESION KINASE; PHASE-II TRIAL; SARACATINIB AZD0530; INHIBITOR SARACATINIB; BREAST-CANCER; MIGRATION; FAK; PROTEOLYSIS; BMS-354825; DASATINIB	Cancer cell migration requires that cells respond and adapt to their surroundings. In the absence of extracellular matrix cues, cancer cells will undergo a mesenchymal to ameboid transition, whereas a highly confining space will trigger a switch to "leader bleb-based" migration. To identify oncogenic signaling pathways mediating these transitions, we undertook a targeted screen using clinically useful inhibitors. Elevated Src activity was found to change actin and focal adhesion dynamics, whereas inhibiting Src triggered focal adhesion disassembly and blebbing. On non-adherent substrates and in collagen matrices, amoeboid-like, blebbing cells having high Src activity formed protrusions of the plasma membrane. To evaluate the role of Src in confined cells, we use a novel approach that places cells under a slab of polydimethylsiloxane (PDMS), which is held at a defined height. Using this method, we find that leader bleb-based migration is resistant to Src inhibition. High Src activity was found to markedly change the architecture of cortical actomyosin, reduce cell mechanical properties, and the percentage of cells that undergo leader bleb-based migration. Thus, Src is a signal transducer that can potently influence transitions between migration modes with implications for the rational development of metastasis inhibitors.	[Logue, Jeremy S.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Logue, Jeremy S.; Cartagena-Rivera, Alexander X.; Chadwick, Richard S.] NIDCD, NIH, Bethesda, MD 20892 USA; [Logue, Jeremy S.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Albany Medical College	Logue, JS (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.; Logue, JS (corresponding author), NIDCD, NIH, Bethesda, MD 20892 USA.; Logue, JS (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA.	loguej@mail.amc.edu	Cartagena-Rivera, Alexander X./I-6101-2016	Cartagena-Rivera, Alexander X./0000-0001-6227-2499	intramural research program at the NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000033] Funding Source: NIH RePORTER	intramural research program at the NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Clare Waterman (NHLBI) and members of the Waterman Lab for insightful discussions and for the use of spinning disk confocal microscopes. We thank the NHLBI Light Microscopy Core Facility for use of the Zeiss LSM 880 Airyscan. This work was supported by funds from the intramural research program at the NIH.	Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Cartagena-Rivera AX, 2016, BIOPHYS J, V110, P2528, DOI 10.1016/j.bpj.2016.04.034; Case LB, 2015, NAT CELL BIOL, V17, P955, DOI 10.1038/ncb3191; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ferrando IM, 2012, MOL CELL PROTEOMICS, V11, P355, DOI 10.1074/mcp.M111.015750; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fury MG, 2011, ANTICANCER RES, V31, P249; Gangadhar TC, 2013, INVEST NEW DRUG, V31, P769, DOI 10.1007/s10637-012-9897-4; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Horton ER, 2016, J CELL BIOL, V212, P349, DOI 10.1083/jcb.201508080; ILLC D, 1995, NATURE, V377, P539; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kluger HM, 2011, CANCER-AM CANCER SOC, V117, P2202, DOI 10.1002/cncr.25766; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mackay HJ, 2012, INVEST NEW DRUG, V30, P1158, DOI 10.1007/s10637-011-9650-4; Mayer EL, 2011, CLIN CANCER RES, V17, P6897, DOI 10.1158/1078-0432.CCR-11-0070; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Molina JR, 2014, LUNG CANCER, V85, P245, DOI 10.1016/j.lungcan.2014.03.004; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Schilder RJ, 2012, GYNECOL ONCOL, V127, P70, DOI 10.1016/j.ygyno.2012.06.009; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Sharma MR, 2012, INVEST NEW DRUG, V30, P1211, DOI 10.1007/s10637-011-9681-x; Shin W., 2010, LIVE CELL IMAGING LA, P119; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wong SY, 2006, CELL CYCLE, V5, P812, DOI 10.4161/cc.5.8.2646; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	45	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2104	2121		10.1038/s41388-017-0071-5	http://dx.doi.org/10.1038/s41388-017-0071-5			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29379163	hybrid, Green Published			2022-12-26	WOS:000430589000003
J	Zhang, JC; Huang, YJ; Chen, J; Zhu, HN; Whiteheart, SW				Zhang, Jinchao; Huang, Yunjie; Chen, Jing; Zhu, Haining; Whiteheart, Sidney W.			Dynamic cycling of t-SNARE acylation regulates platelet exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; MOLECULAR-MECHANISMS; CERULENIN ANALOGS; SYNTAXIN 11; SNAP-23; CHOLESTEROL; SECRETION; FUSION; PHOSPHORYLATION	Platelets regulate vascular integrity by secreting a host of molecules that promote hemostasis and its sequelae. Given the importance of platelet exocytosis, it is critical to understand how it is controlled. The t-SNAREs, SNAP-23 and syntaxin-11, lack classical transmembrane domains (TMDs), yet both are associated with platelet membranes and redistributed into cholesterol-dependent lipid rafts when platelets are activated. Using metabolic labeling and hydroxylamine (HA)/HCl treatment, we showed that both contain thioester-linked acyl groups. Mass spectrometry mapping further showed that syntaxin-11 was modified on cysteine 275, 279, 280, 282, 283, and 285, and SNAP-23 was modified on cysteine 79, 80, 83, 85, and 87. Interestingly, metabolic labeling studies showed incorporation of [3H] palmitate into the t-SNAREs increased although the protein levels were unchanged, suggesting that acylation turns over on the two t-SNAREs in resting platelets. Exogenously added fatty acids did compete with [3H] palmitate for t-SNARE labeling. To determine the effects of acylation, we measured aggregation, ADP/ATP release, as well as P-selectin exposure in platelets treated with the acyltransferase inhibitor cerulenin or the thioesterase inhibitor palmostatin B. We found that cerulenin pretreatment inhibited t-SNARE acylation and platelet function in a dose- and time-dependent manner whereas palmostatin B had no detectable effect. Interestingly, pretreatment with palmostatin B blocked the inhibitory effects of cerulenin, suggesting that maintaining the acylation state is important for platelet function. Thus, our work shows that t-SNARE acylation is actively cycling in platelets and suggests that the enzymes regulating protein acylation could be potential targets to control platelet exocytosis in vivo.	[Zhang, Jinchao; Huang, Yunjie; Chen, Jing; Zhu, Haining; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Huang, Yunjie] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA	University of Kentucky; Cincinnati Children's Hospital Medical Center	Whiteheart, SW (corresponding author), 741 South Limestone,BBSRB271, Lexington, KY 40536 USA.	whitehe@uky.edu	Huang, Yunjie/AAW-8751-2021; Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Huang, Yunjie/0000-0002-2151-9499	NHLBI, National Institutes of Health [HL56652, HL138179]; American Heart Association [AHA16GRNT27620001]; Veterans Affairs Merit Award; NIGMS, National Institutes of Health [P30GM110787]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138179, R01HL056652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Veterans Affairs Merit Award(US Department of Veterans Affairs); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants HL56652 and HL138179; American Heart Association Grant-in-Aid AHA16GRNT27620001; and Veterans Affairs Merit Award (to S. W. W.). This study was also supported in part by NIGMS, National Institutes of Health Grant P30GM110787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Arneson LN, 2007, J IMMUNOL, V179, P3397, DOI 10.4049/jimmunol.179.6.3397; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Chen D, 1999, BIOCHEM BIOPH RES CO, V255, P340, DOI 10.1006/bbrc.1999.0173; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; De Vos ML, 2001, BIOCHEM PHARMACOL, V62, P985, DOI 10.1016/S0006-2952(01)00739-0; Dowal L, 2011, BLOOD, V118, pE62, DOI 10.1182/blood-2011-05-353078; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Ge SC, 2010, ACS CHEM BIOL, V5, P819, DOI 10.1021/cb100130b; Golebiewska EM, 2015, J BIOL CHEM, V290, P1536, DOI 10.1074/jbc.M114.602615; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Grgurevich S, 2003, J THROMB HAEMOST, V1, P576, DOI 10.1046/j.1538-7836.2003.00087.x; Gue YX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091850; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Hellewell AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098900; HUANG EM, 1989, BIOCHIM BIOPHYS ACTA, V1011, P134, DOI 10.1016/0167-4889(89)90200-0; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Joshi S, 2017, PLATELETS, V28, P129, DOI 10.1080/09537104.2016.1240768; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Koseoglu S, 2015, BLOOD, V126, P651, DOI 10.1182/blood-2014-12-618744; Kreutzberger AJB, 2015, BIOPHYS J, V109, P319, DOI 10.1016/j.bpj.2015.06.022; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lawrence DS, 1999, J MED CHEM, V42, P4932, DOI 10.1021/jm980591s; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mancuso ME, 2017, BRIT J HAEMATOL, V178, P209, DOI 10.1111/bjh.14653; Martin BR, 2013, CURR PROTOC PROTEIN, V73, P5; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Menter DG, 2017, CANCER METAST REV, V36, P199, DOI 10.1007/s10555-017-9682-0; Munday AD, 2007, ARTERIOSCL THROM VAS, V27, P1496, DOI 10.1161/ATVBAHA.106.136226; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Shiraishi M, 2010, J VET MED SCI, V72, P285, DOI 10.1292/jvms.09-0385; Sim DS, 2007, ARTERIOSCL THROM VAS, V27, P1478, DOI 10.1161/ATVBAHA.106.139287; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Valdez AC, 1999, J CELL SCI, V112, P845; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	61	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3593	3606		10.1074/jbc.RA117.000140	http://dx.doi.org/10.1074/jbc.RA117.000140			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352103	Green Published, hybrid			2022-12-26	WOS:000427030200015
J	Abebe, F; Belay, M; Legesse, M; Franken, KLMC; Ottenhoff, THM				Abebe, Fekadu; Belay, Mulugeta; Legesse, Mengistu; Franken, K. L. M. C.; Ottenhoff, Tom H. M.			IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; ANTIBODY-RESPONSES; IFN-GAMMA; LIPOARABINOMANNAN; ALPHA; POLYSACCHARIDES; SERODIAGNOSIS; COMBINATION; DIAGNOSIS; CHILDREN	As part of a major project to investigate protective and diagnostic immune markers against tuberculosis (TB), we measured antibody isotype responses to Mycobacterium tuberculosis (Mtb) antigens (LAM, Rv2031, and HBHA) in cohorts of 149 pulmonary tuberculosis patients (PTBP), 148 household contacts (HHCs), and 68 community controls (CCs) in an endemic setting. ELISA was used to measure levels of IgA, IgG, and IgM from sera of cohorts at baseline, and at 6 and 12 months from entry. The results show that there were significant differences in IgA, IgG, and IgM responses to the different antigens and in the three cohorts. At baseline, the level of IgM against RV2031 and LAM did not vary between cohorts, but the levels of IgA and IgG against Rv2031 were significantly higher in PTB patients than HHCs and CCs, followed by HHCs, and the lowest in CCs. In patients, there was a significant variation in antibody responses before and after chemotherapy. The levels of IgA and IgG against HBHA, and IgA against Rv2031 decreased significantly and remained low, while IgA and IgG against LAM increased significantly and remained high following chemotherapy. However, the levels of IgM against Rv2031 and LAM increased at 6 months but decreased again at 12 months. IgM against HBHA did not show any significant variation before and after chemotherapy. Similarly, there were also significant variations in antibody responses in HHCs over time. Our results show that there are significant variations in IgA, IgG and IgM responses to the different antigens and in the three cohorts, implying that not all antibody isotype responses are markers of clinical TB. In addition, the current and previous studies consistently show that IgA and IgG against Rv2031 discriminate between clinical disease, Mtb-infected and non-infected individuals.	[Abebe, Fekadu] Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Fac Med, Oslo, Norway; [Belay, Mulugeta] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Immunobiol, London, England; [Legesse, Mengistu] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Franken, K. L. M. C.; Ottenhoff, Tom H. M.] Leiden Med Ctr, Dept Infect Dis, Leiden, Netherlands	University of Oslo; University of London; Queen Mary University London; Addis Ababa University; Leiden University; Leiden University Medical Center (LUMC)	Abebe, F (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Fac Med, Oslo, Norway.	fekadu.abebe@medisin.uio.no	Franken, Kees/ABA-7095-2021	Franken, Kees/0000-0002-4747-6060; Abebe, Fekadu/0000-0002-4368-1593	Research Council of Norway (GLOBVAC PROJECT) [196397/S50]	Research Council of Norway (GLOBVAC PROJECT)(Research Council of Norway)	This work was supported by The Research Council of Norway (GLOBVAC PROJECT: 196397/S50).	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Abebe F, 2017, CLIN EXP IMMUNOL; Anchkar JM, 2015, IMMUNOL REV, V264, P167, DOI DOI 10.1111/IMR.12276; Athman JJ, 2017, J IMMUNOL, V198, P2028, DOI 10.4049/jimmunol.1601199; Awoniyi DO, 2017, ONCOTARGET, V8, P37525, DOI 10.18632/oncotarget.16401; Baumann R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/364758; Baumann R, 2013, TUBERCULOSIS, V93, P239, DOI 10.1016/j.tube.2012.09.003; Belay M, 2015, LIPOARABINOMANNA SPE; Belay M, 2016, J INFECTION, V72, P189, DOI 10.1016/j.jinf.2015.09.040; Belay M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124134; Belay M, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0654-5; Blattes E, 2013, P NATL ACAD SCI USA, V110, P8795, DOI 10.1073/pnas.1221708110; Chan ED, 2000, AM J RESP CRIT CARE, V161, P1713, DOI 10.1164/ajrccm.161.5.9908125; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; DAVID HL, 1992, INT J LEPROSY, V60, P208; Delogu G, 2016, SCAND J IMMUNOL, V84, P344, DOI 10.1111/sji.12493; FAIRCHOK MP, 1995, CLIN DIAGN LAB IMMUN, V2, P443, DOI 10.1128/CDLI.2.4.443-447.1995; Fujita Y, 2005, MICROBIOL-SGM, V151, P2065, DOI 10.1099/mic.0.27790-0; Fukui M, 2015, MICROBIOL IMMUNOL, V59, P735, DOI 10.1111/1348-0421.12340; Imaz MS, 2001, INT J TUBERC LUNG D, V5, P1036; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Julian E, 1997, J CLIN MICROBIOL, V35, P2663; Julian E, 2004, CLIN DIAGN LAB IMMUN, V11, P70, DOI 10.1128/CDLI.11.1.70-76.2004; Kaufmann SHE, 2017, INT J INFECT DIS, V56, P263, DOI 10.1016/j.ijid.2016.10.018; Kaufmann SHE, 2016, TUBERCULOSIS, V99, pS8, DOI 10.1016/j.tube.2016.05.010; Kaushik A, 2012, INDIAN J MED RES, V135, P771; Kunnath-Velayudhan S, 2012, J INFECT DIS, V206, P697, DOI 10.1093/infdis/jis421; Legesse M, 2013, HUMAN IMMUNOL; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; Limongi LC, J BRASPNEUMOL, V37, P302; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; MOH, 2007, GUID HIV COUNS TEST; MOH, 2012, GUID CLIN PROGR MAN; MORENO C, 1988, CLIN EXP IMMUNOL, V74, P206; Mutapi F, 1998, J INFECT DIS, V178, P289, DOI 10.1086/517456; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Raja A, 2009, INDIAN J MED RES, V56, P255; RASTOGI N, 1986, ANN INST PASTEUR MIC, V137A, P135, DOI 10.1016/S0769-2609(86)80018-7; Robertson BD, 2012, TUBERCULOSIS, V92, P447, DOI 10.1016/j.tube.2012.06.004; ROOK GAW, 1989, LYMPHOKINE RES, V8, P323; Sande OJ, 2016, J IMMUNOL, V196, P691, DOI 10.4049/jimmunol.1500710; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Scott L, 2017, CURR OPIN HIV AIDS, V12, P129, DOI [10.1097/COH.0000000000000345, 10.1097/coh.0000000000000345]; SIBLEY LD, 1988, INFECT IMMUN, V56, P1232, DOI 10.1128/IAI.56.5.1232-1236.1988; Sireci G, 2007, CLIN VACCINE IMMUNOL, V14, P1231, DOI 10.1128/CVI.00057-07; Wen HL, 2017, EUR J CLIN MICROBIOL, V36, P1415, DOI 10.1007/s10096-017-2948-1; Wilen A, 2008, IMMUN, V76, P2882; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Zheng Q, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00033; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0190989	10.1371/journal.pone.0190989	http://dx.doi.org/10.1371/journal.pone.0190989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373577	Green Published, gold			2022-12-26	WOS:000423425400006
J	Bassand, JP; Accetta, G; Al Mahmeed, W; Corbalan, R; Eikelboom, J; Fitzmaurice, DA; Fox, KAA; Gao, HY; Goldhaber, SZ; Goto, S; Haas, S; Kayani, G; Pieper, K; Turpie, AGG; van Eickels, M; Verheugt, FWA; Kakkar, AK; Camm, AJ; Hacke, W; Mantovani, LG; Misselwitz, F; Pieper, KS; Luciardi, HL; Gibbs, H; Brodmann, M; Cools, F; Barretto, ACP; Connolly, SJ; Spyropoulos, A; Hu, DY; Jansky, P; Nielsen, JD; Ragy, H; Raatikainen, P; Le Heuzey, JY; Darius, H; Keltai, M; Kakkar, S; Sawhney, JPS; Agnelli, G; Ambrosio, G; Koretsune, Y; Diaz, CJS; Ten Cate, H; Atar, D; Stepinska, J; Panchenko, E; Lim, TW; Jacobson, B; Oh, S; Vinolas, X; Rosenqvist, M; Steffel, J; Angchaisuksiri, P; Oto, A; Parkhomenko, A; Fitzmaurice, D; Gersh, BJ; Chen, KN; Zhao, YS; Zhang, HQ; Chen, JZ; Cao, SP; Wang, DW; Yang, YJ; Li, WH; Yin, YH; Tao, GZ; Yang, P; Chen, YM; He, SH; Wang, Y; Wang, Y; Fu, GS; Li, X; Wu, TG; Cheng, XS; Yan, XW; Zhao, RP; Chen, MS; Xiong, LG; Chen, P; Jiao, Y; Guo, Y; Xue, L; Wang, FZ; Li, H; Yang, ZM; Bai, CL; Chen, J; Chen, JY; Chen, X; Feng, S; Fu, QH; Gao, XJ; Guo, WN; He, RH; He, XA; Hu, XS; Huang, XF; Li, B; Li, J; Li, L; Li, YH; Liu, TT; Liu, WL; Liu, YY; Lu, ZC; Luo, XL; Ma, TY; Peng, JQ; Sheng, X; Shi, XJ; Sun, YH; Tian, G; Wang, K; Wang, L; Wu, RN; Xie, Q; Xu, RY; Yang, JS; Yang, LL; Yang, Q; Yang, YJ; Ye, Y; Yu, HY; Yu, JH; Yu, T; Zhai, H; Zhan, Q; Zhang, GS; Zhang, Q; Zhang, R; Zhang, Y; Zheng, WY; Zhou, B; Zhou, ZH; Zhu, XY; Jadhav, P; Durgaprasad, R; Shankar, AGR; Rajput, RK; Bhargava, K; Sarma, R; Srinivas, A; Roy, D; Nagamalesh, UM; Chopda, M; Kishore, R; Kulkarni, G; Chandwani, P; Pothiwala, RA; Purayil, MP; Shah, S; Chawla, K; Kothiwale, VA; Raghuraman, B; Vijayaraghavan, G; Vijan, VM; Bantwal, G; Bisne, V; Khan, A; Gupta, JB; Kumar, S; Jain, D; Abraham, S; Adak, D; Barai, A; Begum, H; Bhattacharjee, P; Dargude, M; Davies, D; Deshpande, B; Dhakrao, P; Dhyani, V; Duhan, S; Earath, M; Ganatra, A; Giradkar, S; Jain, V; Karthikeyan, R; Kasala, L; Kaur, S; Krishnappa, S; Lawande, A; Lokesh, B; Madarkar, N; Meena, R; More, P; Naik, D; Prashanth, K; Rao, M; Rao, N; Sadhu, N; Shah, D; Sharma, M; Shiva, P; Singhal, S; Suresh, S; Vanajakshamma, V; Panse, SG; Kanamori, S; Yamamoto, K; Kumagai, K; Katsuda, Y; Sadamatsu, K; Toyota, F; Mizuno, Y; Misumi, I; Noguchi, H; Ando, S; Suetsugu, T; Minamoto, M; Oda, H; Shiraishi, K; Adachi, S; Chiba, K; Norita, H; Tsuruta, M; Koyanagi, T; Yamamoto, K; Ando, H; Higashi, T; Okada, K; Azakami, S; Komaki, S; Kumeda, K; Murayama, T; Matsumura, J; Oba, Y; Sonoda, R; Goto, K; Minoda, K; Haraguchi, Y; Suefuji, H; Miyagi, H; Kato, H; Nakamura, T; Nakamura, T; Nandate, H; Zaitsu, R; Fujiura, Y; Yoshimura, A; Numata, H; Ogawa, J; Tatematsu, H; Kamogawa, Y; Murakami, K; Wakasa, Y; Yamasawa, M; Maekawa, H; Abe, S; Kihara, H; Tsunoda, S; Saito, K; Fudo, T; Obunai, K; Tachibana, H; Oba, I; Kuwahata, T; Higa, S; Gushiken, M; Eto, T; Yoshida, H; Ikeda, D; Fujiura, Y; Ishizawa, M; Nakatsuka, M; Murata, K; Ogurusu, C; Shimoyama, M; Akutsu, M; Takamura, I; Hoshino, F; Yokota, N; Iwao, T; Tsuchida, K; Takeuchi, M; Hatori, Y; Kitami, Y; Nakamura, Y; Oyama, R; Ageta, M; Oda, H; Go, Y; Mishima, K; Unoki, T; Morii, S; Shiga, Y; Sumi, H; Nagatomo, T; Sanno, K; Fujisawa, K; Atsuchi, Y; Nagoshi, T; Seto, T; Tabuchi, T; Kameko, M; Nii, K; Oshiro, K; Takezawa, H; Nagano, S; Miyamoto, N; Iwaki, M; Nakamura, Y; Fujii, M; Okawa, M; Abe, M; Abe, M; Abe, M; Saito, T; Mito, T; Nagao, K; Minami, J; Mita, T; Sakuma, I; Taguchi, T; Marusaki, S; Doi, H; Tanaka, M; Fujito, T; Matsuta, M; Kusumoto, T; Kakinoki, S; Ashida, K; Yoshizawa, N; Agata, J; Arasaki, O; Manita, M; Ikemura, M; Fukuoka, S; Murakami, H; Matsukawa, S; Hata, Y; Taniguchi, T; Ko, T; Kubo, H; Imamaki, M; Akiyama, M; Inagaki, M; Odakura, H; Ueda, T; Katsube, Y; Nakata, A; Watanabe, H; Techigawara, M; Igarashi, M; Taga, K; Kimura, T; Tomimoto, S; Shibuya, M; Nakano, M; Ito, K; Seo, T; Hiramitsu, S; Hosokawa, H; Hoshiai, M; Hibino, M; Miyagawa, K; Horie, H; Sugishita, N; Shiga, Y; Soma, A; Neya, K; Yoshida, T; Yoshida, T; Mizuguchi, M; Ishiguro, M; Minagawa, T; Wada, M; Mukawa, H; Okuda, F; Nagasaka, S; Abe, Y; Adachi, S; Adachi, S; Adachi, T; Akahane, K; Amano, T; Aoki, K; Aoyama, T; Arai, H; Arima, S; Arino, T; Asano, H; Asano, T; Azuma, J; Baba, T; Betsuyaku, T; Chibana, H; Date, H; Doiuchi, J; Emura, Y; Endo, M; Fujii, Y; Fujiki, R; Fujisawa, A; Fujisawa, Y; Fukuda, T; Fukui, T; Furukawa, N; Furukawa, T; Furumoto, W; Goto, T; Hamaoka, M; Hanazono, N; Hasegawa, K; Hatsuno, T; Hayashi, Y; Higuchi, K; Hirasawa, K; Hirayama, H; Hirose, M; Hirota, S; Honda, M; Horie, H; Ido, T; Iiji, O; Ikeda, H; Ikeda, K; Ikeoka, K; Imaizumi, M; Inaba, H; Inoue, T; Iseki, F; Ishihara, A; Ishioka, N; Ito, N; Iwase, T; Kakuda, H; Kamata, J; Kanai, H; Kanda, H; Kaneko, M; Kano, H; Kasai, T; Kato, T; Kato, Y; Kawada, Y; Kawai, K; Kawakami, K; Kawakami, S; Kawamoto, T; Kawano, S; Kim, J; Kira, T; Kitazawa, H; Kitazumi, H; Kito, T; Kobayashi, T; Koeda, T; Kojima, J; Komatsu, H; Komatsu, I; Koshibu, Y; Kotani, T; Kozuka, T; Kumai, Y; Kumazaki, T; Maeda, I; Maeda, K; Maruyama, Y; Matsui, S; Matsushita, K; Matsuura, Y; Mineoi, K; Mitsuhashi, H; Miura, N; Miyaguchi, S; Miyajima, S; Miyamoto, H; Miyashita, A; Miyata, S; Mizuguchi, I; Mizuno, A; Mori, T; Moriai, O; Morishita, K; Murai, O; Nagai, S; Nagai, S; Nagata, E; Nagata, H; Nakagomi, A; Nakahara, S; Nakamura, M; Nakamura, R; Nakanishi, N; Nakayama, T; Nakazato, R; Nanke, T; Nariyama, J; Niijima, Y; Niinuma, H; Nishida, Y; Nishihata, Y; Nishino, K; Nishioka, H; Nishizawa, K; Niwa, I; Nomura, K; Nomura, S; Nozoe, M; Ogawa, T; Ohara, N; Okada, M; Okamoto, K; Okita, H; Okuyama, M; Ono, H; Ono, T; Pearce, YO; Oriso, S; Ota, A; Otaki, E; Saito, Y; Sakai, H; Sakamoto, N; Sakamoto, Y; Samejima, Y; Sasagawa, Y; Sasaguri, H; Sasaki, A; Sasaki, T; Sato, K; Sato, K; Sawano, M; Seki, S; Sekine, Y; Seta, Y; Sezaki, K; Shibata, N; Shiina, Y; Shimono, H; Shimoyama, Y; Shindo, T; Shinohara, H; Shinohe, R; Shinozuka, T; Shirai, T; Shiraiwa, T; Shozawa, Y; Suga, T; Sugimoto, C; Suzuki, K; Suzuki, K; Suzuki, S; Suzuki, S; Suzuki, S; Suzuki, Y; Tada, M; Taguchi, A; Takagi, T; Takagi, Y; Takahashi, K; Takahashi, S; Takai, H; Takanaka, C; Take, S; Takeda, H; Takei, K; Takenaka, K; Tana, T; Tanabe, G; Taya, K; Teragawa, H; Tohyo, S; Toru, S; Tsuchiya, Y; Tsuji, T; Tsuzaki, K; Uchiyama, H; Ueda, O; Ueda, T; Ueyama, Y; Wakaki, N; Wakiyama, T; Washizuka, T; Watanabe, M; Yamada, T; Yamagishi, T; Yamaguchi, H; Yamamoto, K; Yamamoto, K; Yamamoto, K; Yamamoto, T; Yamaura, M; Yamazoe, M; Yasui, K; Yokoyama, Y; Yoshida, K; Lim, TW; Ching, CK; Foo, CG; Chow, JH; Chen, DD; Jaufeerally, FR; Lee, YM; Lim, G; Lim, WT; Thng, S; Yap, SY; Yeo, C; Oh, S; Pak, HN; Kim, JB; Kim, JH; Jang, SW; Kim, DH; Ryu, DR; Park, SW; Kim, DK; Choi, DJ; Oh, YS; Cho, MC; Kim, SH; Jeon, HK; Shin, DG; Park, JS; Park, HK; Han, SJ; Sung, JH; Cho, JG; Nam, GB; On, YK; Lim, HE; Kwak, JJ; Cha, TJ; Hong, TJ; Park, SH; Yoon, JH; Kim, NH; Kim, KS; Jung, BC; Hwang, GS; Kim, CJ; Kim, DB; Ahn, JJ; An, HJ; Bae, H; Baek, AL; Chi, WJ; Choi, EA; Choi, EH; Choi, HK; Choi, HS; Han, S; Heo, ES; Her, KO; Hwang, SW; Jang, EM; Jang, HS; Jang, S; Jeon, HG; Jeon, SR; Jeon, YR; Jeong, HK; Jung, IA; Kim, HJ; Kim, HJ; Kim, JS; Kim, JS; Kim, JA; Kim, KT; Kim, MS; Kim, SH; Kim, SH; Kim, YI; Lee, CS; Lee, EH; Lee, GH; Lee, HY; Lee, HY; Lee, KH; Lee, KR; Lee, MS; Lee, MY; Lee, RW; Lee, SE; Lee, SH; Lee, S; Lee, WY; Noh, IK; Park, AR; Park, BR; Park, HN; Park, JH; Park, M; Park, Y; Seo, SY; Shim, J; Sim, JH; Sohn, YM; Son, WS; Son, YS; Song, HJ; Wi, HK; Woo, JJ; Ye, S; Yim, KH; Yoo, KM; Yoon, EJ; Yun, SY; Angchaisuksiri, P; Chawanadelert, S; Mongkolwongroj, P; Kanokphatcharakun, K; Cheewatanakornkul, S; Laksomya, T; Pattanaprichakul, S; Chantrarat, T; Rungaramsin, S; Silaruks, S; Wongcharoen, W; Siriwattana, K; Likittanasombat, K; Katekangplu, P; Boonyapisit, W; Cholsaringkarl, D; Chatlaong, B; Chattranukulchai, P; Santanakorn, Y; Hutayanon, P; Khunrong, P; Bunyapipat, T; Jai-Aue, S; Kaewsuwanna, P; Bamungpong, P; Gunaparn, S; Hongsuppinyo, S; Inphontan, R; Khattaroek, R; Khunkong, K; Kitmapawanont, U; Kongsin, C; Naratreekoon, B; Ninwaranon, S; Phangyota, J; Phrommintikul, A; Phunpinyosak, P; Pongmorakot, K; Poomiphol, S; Pornnimitthum, N; Pumprueg, S; Ratchasikaew, S; Sanit, K; Sawanyawisuth, K; Silaruks, B; Sirichai, R; Sriwichian, A; Suebjaksing, W; Sukklad, P; Suttana, T; Tangsirira, A; Thangpet, O; Tiyanon, W; Vorasettakarnkij, Y; Wisaratapong, T; Wongtheptien, W; Wutthimanop, A; Yawila, S; Altun, A; Ozdogru, I; Ozdemir, K; Yilmaz, O; Aydinlar, A; Yilmaz, MB; Yeter, E; Ongen, Z; Cayli, M; Pekdemir, H; Ozdemir, M; Sucu, M; Sayin, T; Demir, M; Yorgun, H; Ersanli, M; Okuyan, E; Aras, D; Abdelrahman, H; Aktas, O; Alpay, D; Aras, F; Bireciklioglu, MF; Budeyri, S; Buyukpapuc, M; Caliskan, S; Oto, A; Esen, M; Felekoglu, MA; Genc, D; Ikitimur, B; Karaayvaz, EB; Karatas, SK; Okutucu, S; Ozcelik, E; Quisi, A; Sag, H; Sahiner, L; Sayin, BY; Seker, T; Alkan, DU; Yildirim, E; Yildirim, R; Yilmaz, F; Yuksekdag, V; Luciardi, HL; Vensentini, N; Ingaramo, AC; Sambadaro, GA; Caputi, VF; Berman, SG; Dragotto, P; Kleiban, AJ; Centurion, N; Giacomi, G; Guerrero, RAA; Conde, D; Zapata, G; Di Paola, LA; Ramos, JL; Dran, RD; Egido, J; Fernandez, AA; Fosco, MJ; Sassone, S; Sinisi, VA; Cartasegna, LR; Berli, MA; Vilamajo, OAG; Ferroni, F; Alaguibe, ED; D'Amelio, AA; Arabetti, C; Arias, L; Belardi, JA; Bergesio, L; Berli, F; Berli, M; Borchowiec, S; Buzzetti, C; Cabrini, R; Campisi, V; Cappi, AL; Carrizo, R; Berra, FC; Costabel, JP; Costamagna, OJA; Damonte, AA; De Urquiza, IN; Diez, F; Eden, MF; Fanuele, M; Voena, FF; Torres, MF; Funosas, C; Giacomi, MP; Gimenez, CH; Gurfinkel, EP; Had, MDM; Hansen, V; Hrabar, AD; Ingratta, M; Lopez, A; Maehara, G; Maffei, L; Martinelli, A; Martinelli, C; Matkovich, J; Mautner, B; Meirino, A; Munguia, R; Navarro, A; Novas, V; Prados, GP; Pontoriero, J; Potito, RN; Ricotti, C; Rodriguez, MA; Rolandi, F; Palladino, MES; Salinger, M; Sanziani, LS; Schygiel, PO; Sossich, A; Tinto, JF; Tonelli, L; Tufare, AL; Vallejo, M; Yunis, ME; Zillo, M; Zurbrigk, FJ; Barretto, ACP; Sobral, DC; Jaber, J; Armaganijan, D; Neto, JF; Steffens, A; de Souza, WKSB; Neto, JDD; Ribeiro, JM; Teixeira, MS; Rossi, PRF; Pires, L; Moreira, D; Jorge, JCM; Lorga, AM; Bodanese, LC; Montera, MW; Del Carlo, CH; Rodrigues, TD; da Costa, FAA; Lopes, A; Lopes, R; Araujo, GR; Manenti, ERF; Saraiva, JFK; Braga, JCF; Negri, A; Souto, L; Moncada, C; Precoma, DB; Roquette, F; Reis, G; Ramos, RA; Figueiredo, EL; Botelho, RV; Tavares, CMD; Frack, CRC; Saad, JA; Finimundi, HC; Pisani, C; Chemello, D; Martins, MP; Franca, CCB; Alban, F; Rosito, GBA; Moraes, JBDX; Tumelero, RT; Maia, LN; de Almeida, RS; Borges, NCD; Ferreira, LGG; Agliardi, P; Gomes, JAD; Araujo, V; Nakazone, MA; Barbosa, T; Barroso, S; Falchetto, EB; Lopes, HB; Lemos, MABT; Biazus, G; Queiroz, LB; Camazzola, FE; Caporale, M; Boscato, SC; Chieza, F; Chokr, MO; Mingireanov, RC; Goes, NC; Correa, C; Costa, M; Ortiz, CC; da Silva, LS; Paulitsch, FD; da Silveira, JA; Daros, E; de Araujo, GR; Del Monaco, MI; Dias, C; Dias, MA; Wainstein, APD; Pizzato, PE; Esteves, DC; Fabri, P; Fonseca, TFL; Fernandes, E; Fonseca, C; Costantini, CRF; Ferraz, RF; Freire, F; Gottardo, P; Guanaes, D; Guizzardi, S; Magedanz, EH; Igansi, F; Jannuzzi, F; Junior, G; Komar, D; Lino, EG; Lopes, D; da Silva, OL; Lustosa, E; Macagnan, AP; Marinho, MC; Mazzoni, M; Melo, G; Mortari, L; Mouco, OMCC; Vital, CN; Ormundo, C; Emmer, SO; Palmegiani, E; Pavani, R; Pereira, L; Pereira, VL; Perreira, R; Poletti, S; Fortunato, SCQ; Queirantes, C; Pereira, NR; Rech, RL; Ribeiro, S; Rodrigues, A; Roesch, H; Reichert, TR; Santos, D; Santos, I; Santos, M; Seroqui, MV; Silva, S; Soares, L; Spolaor, L; Stoll, C; Duda, NT; Trama, L; Unterkircher, B; Valois, MV; Vargas, T; Viana, T; Vicente, C; Armaganijan, LV; Homem, RV; Torres, LGV; Boas, LV; Guimaraes, FV; Corbalan, R; Eggers, G; Gutierrez, CB; Arriagada, G; Cardenas, SP; Fernandez, BAJS; Conejeros, C; Houzvic, C; Cuevas, PM; Montecinos, H; Forero, A; Lanas, F; Gomez, ML; Vilches, GC; Rey, C; Astudillo, C; Aguilar, J; Campisto, Y; Lara, C; Molina, E; Oyarzon, JM; Olguin, V; Vergara, M; Villan, C; Diaz, CJS; Diaz, JI; Cantu, RL; Zavala, MGR; Jardines, RC; Zavaleta, NE; Umana, SV; Rosas, EL; Esperon, GL; Pozas, G; Munoz, EC; Hernandez, NM; Rendon, AL; Hernandez, NG; Ibarra, MD; Carrillo, LV; Villezca, DL; Herrera, CH; Prieto, JJL; Rodriguez, RG; Espinosa, EV; Martinez, DF; Barcena, JV; Yong, R; Briones, IR; Pons, JLL; Lopez, HA; Ruiz, RO; de la Vega, CD; Brito, CC; Valenzuela, EC; Reyes-Sanchez, R; Ruiz, AB; Flores, ON; Gonzalez, MB; Nava, RA; Cerda, JDM; Fierro, OF; Campos, PF; Alfaro, TAA; Bellorin, SA; Avena, R; Chavarria, M; Espinosa, I; Silva, FF; Nava, RHG; Godoy, K; Felix, EJG; Garcia, CLG; Salas, LGG; Guajardo, P; Gonzalez, SH; Izquierdo, T; Ortiz, MCM; Vasquez, DM; Mendoza, N; Morales, J; Nikitina, N; Aybar, SO; Ortiz, A; Macias, PP; Perez, F; Sanchez, JAP; Toledano, SP; Gonzalez, MR; Ramos, CR; Castro, VR; Cardona, GR; Cornejo, MR; Salinas, A; Santana, G; Perez, PS; Castaneda, ACT; Cortes, RT; Brodmann, M; Lenz, K; Drexel, H; Foechterle, J; Hagn, C; Podczeck-Schweighofer, A; Huber, K; Winkler, M; Schneeweiss, B; Gegenhuber, A; Lang, W; Eichinger-Hasenauer, S; Kaserer, P; Sykora, J; Rasch, H; Pichler, M; Schaflinger, E; Strohmer, B; Breier, R; Ebner, KM; Eischer, L; Freihoff, F; Lischka-Lindner, A; Mark, T; Mirtl, A; Said, A; Stocklocker, C; Vogel, B; Vonbank, A; Wohrer, C; Zanolin, D; Cools, F; Paparella, G; Vandergoten, P; Parque, JL; Capiau, L; Vervoort, G; Wollaert, B; Desfontaines, P; Mairesse, G; Boussy, T; Godart, P; De Wolf, A; Voet, J; Heyse, A; Hollanders, G; Ann, W; Vercammen, J; Purnode, P; Blankoff, I; Faes, D; Balthazar, Y; Beutels, M; Marechal, P; Verstraete, S; Xhaet, O; Striekwold, H; Thoeng, J; Hermans, K; Alzand, B; Ascoop, AK; Banaeian, F; Barbuto, AM; Billiaux, AC; Blockmans, M; Bouvy, C; Brike, C; Capiau, H; Casier, T; Bolado, ACY; De Cleen, D; De Coninck, M; de Vos, M; de Weerdt, N; Delforge, M; Delvigne, M; Denie, D; Derycker, K; Deweerd, E; Dormal, F; Drieghe, S; Everaert, M; Eykerman, T; Feys, E; Ghekiere, M; Gits, F; Hellemans, S; Helvasto, L; Jacobs, C; Lips, S; Mestdagh, I; Nimmegeers, J; Piamonte, V; Pollet, P; Postolache, A; Raepers, M; Raymenants, E; Richa, J; Rombouts, H; Salembier, J; Scheurwegs, C; Semeraro, O; Simons, N; Smessaert, C; Smolders, W; Stockman, I; Tahon, S; Thyssen, V; Tincani, G; Van Durme, F; Van Lier, D; Vandekerckhove, H; Vandekerckhove, Y; Vandenbroeck, D; Vandorpe, A; Vanhalst, E; Vanhauwaert, B; Vantomme, C; Vergauwen, L; Verloove, H; Vydt, T; Weyn, T; Jansky, P; Reichert, P; Spacek, R; Machova, V; Zidkova, E; Ludka, O; Olsr, J; Kotik, L; Plocova, K; Racz, B; Ferkl, R; Hubac, J; Kotik, I; Monhart, Z; Burianova, H; Jerabek, O; Pisova, J; Petrova, I; Dedek, V; Honkova, M; Podrazil, P; Spinar, J; Vitovec, J; Novak, M; Lastuvka, J; Durdil, V; Antonova, P; Bockova, L; Bultas, J; Chlumsky, J; Dastychova, L; Drasnar, T; Honek, J; Horejsi, M; Hubacova, V; Janska, L; Kopeckova, I; Kratochvilova, R; Krcova, E; Labrova, R; Lindourkova, A; Lipoldova, J; Lubanda, H; Ludkova, A; Mahdalikova, L; Majernikova, M; Michalik, D; Potuznik, P; Prochazkova, E; Sulc, A; Sveceny, J; Valtova, M; Zidek, M; Zika, J; Nielsen, J; Nielsen, H; Husted, S; Hintze, U; Rasmussen, S; Bremmelgaard, A; Markenvard, J; Boerger, J; Solgaard, J; Simonsen, P; Loekkegaard, T; Bruun, M; Mertz, J; Dominguez, H; Skagen, K; Egstrup, K; Ibsen, H; Raymond, I; Bang-Hansen, T; Ellervik, C; Eriksen, E; Jensen, L; Jensen, M; Leth, M; Nygaard, A; Park, J; Schou, M; Therkelsen, A; Tilma, J; Vesterager, K; Raatikainen, P; Airaksinen, J; Arola, O; Koistinen, J; Nappila, H; Peltomaki, K; Rasanen, V; Vasankari, T; Le Heuzey, JY; Galinier, M; Gottwalles, Y; Paganelli, F; Loiselet, P; Muller, JJ; Koujan, MB; Marquand, A; Destrac, S; Piot, O; Delarche, N; Cebron, JP; Boveda, S; Guenoun, M; Guedj-Meynier, D; Galley, D; Ohayon, J; Assouline, S; Zuber, M; Amarenco, P; Ellie, E; Kadouch, J; Fournier, PY; Huberman, JP; Lemaire, M; Rodier, G; Milandre, L; Vandamme, X; Sibon, I; Neau, JP; Mahagne, MH; Mielot, A; Bonnefoy, M; Churet, JB; Navarre, V; Sellem, F; Monniot, G; Boyes, JP; Doucet, B; Martelet, M; Obadia, D; Crousillat, B; Mouallem, J; Bearez, E; Nazeyrollas, P; Brugnaux, JP; Fedorowsky, A; Casassus, F; Berneau, JB; Chemin, F; Falvo, N; Perron, JM; Poulard, JE; Barreau, A; Beltra, C; Corrihons, E; Decarsin, N; Dubois, B; Ducasse, E; Giry, X; Kemmel, A; Ledure, S; Lemaire, N; Robin, F; Rosolin, N; Sanchez, D; Suissa, A; Darius, H; Koniger, G; Purr, J; Gerbaulet, U; Kellner, BT; Kopf, A; Schafer, T; Zauzig, H; Riegel, P; Hohensee, H; Eissfeller, E; Eder, W; Rehling, G; Glatzel, D; Zutz, S; Heinz, GU; Menke, H; Pustelnik, A; Sandow, P; Ludwig, N; Wiswedel, H; Wildenauer, W; Axthelm, C; Schwarz, T; Babyesiza, A; Stuchlik, G; Zimny, HH; Kropp, M; Kahl, F; Caspar, A; Omankowsky, S; Laessig, T; Hartmann, HJ; Lehmann, G; Bindig, HW; Hergdt, G; Reimer, D; Hauk, J; Dorsch, W; Dshabrailov, J; Michel, H; Rapp, KA; Vormann, R; Mayer, P; Horstmeier, U; Eissing, V; Hey, H; Leuchtgens, H; Lilienweiss, V; Kolitsch, K; Schubert, C; Lauer, H; Buchner, T; Brauer, G; Kamin, S; Muller, K; Abdel-Qader, M; Baumbach, S; Ebert, HH; Schwencke, C; Schellong, S; Bernhardt, P; Karolyi, L; Sievers, B; Haverkamp, W; Salbach, P; Rohnisch, JU; Schoen, S; Erdle, W; Mueller, T; Mueller, H; Mitrovic, V; Babjakova, Z; Bergner, K; Boehme, S; Bonin, K; Buckert, D; Busch, F; Dichristin, U; Diez, S; Fleck, A; Flint, K; Floegel, H; Fritz, C; Frommhold, R; Gehre, J; Geyer, J; Grytzmann, A; Hahn, M; Helgert, K; Hubert, K; Kirchner-Volker, K; Klein, V; Kroll, D; Krueger, A; Lehmann, R; Mann, L; Maselli, A; Menken, G; Mikes, K; Mortan, H; Nasser, N; Nicolaus, D; Plauskat, A; Pomper, L; Quietzsch, A; Ravenhorst, C; Reichelt, C; Reimer, C; Schaefer, B; Scharrer, S; Schirmer, K; Schmidt, K; Schoene, R; Schulze, J; Schuppe, M; Simon, S; Sommer, S; Spranger, K; Talkenberger, A; Tauber, K; Tetlak, A; Toennishoff, T; Voelkel-Babyesiza, R; Voigts, B; Weiser, U; Wesendorf, S; Wildenauer, S; Wolf, T; Wurziger, J; Zak, J; Zauzig, HD; Ziefle, S; Zincke, S; Keltai, M; Vangel, S; Szalai, G; Merkely, B; Kancz, S; Boda, Z; Nagy, A; Laszlo, Z; Matoltsy, A; Gaszner, B; Polgar, P; Habon, T; Noori, E; Juhasz, G; Kanakaridisz, N; Szentpeteri, I; Juhasz, F; Vertes, A; Papp, A; May, Z; Ferenczi, J; Egyutt, M; Kis, E; Engelthaler, G; Szantai, G; Fulop, E; Gombos, P; Gulyas, D; Jen, P; Gyorke, EK; Kovacs, M; Levang, SK; Marianna, S; Radics, Z; Sydo, N; Szalo, R; Szilagyi, A; Sztanyik, F; Vandrus, B; Agnelli, G; Ambrosio, G; Tiraferri, E; Santoro, R; Testa, S; Di Minno, G; Moia, M; Caimi, TM; Martini, G; Tessitori, M; Cappelli, R; Poli, D; Quintavalla, R; Melone, F; Cosmi, F; Pizzini, A; Piseddu, G; Fanelli, R; Latella, C; Santi, R; Pancaldi, L; De Cristofaro, R; Palareti, G; De Blasio, A; Uriarte, JS; Minetti, F; Pogliani, EM; Lonati, LM; Accogli, M; Ciampani, N; Malengo, S; Feola, M; Raisaro, A; Fattore, L; Grilli, P; Germini, F; Settimi, M; Alunni, M; Duranti, G; Tedeschi, L; Baglioni, G; Avanzino, G; Berardi, M; Pannacci, V; Giombolini, A; Nicoli, S; Scarponi, T; Allasia, B; Ricciarini, P; Nasorri, R; Argena, A; Bossolasco, P; Ronchini, P; Filippi, A; Tradati, F; Bulla, C; Donzelli, L; Foppa, L; Bottarelli, ML; Tomasello, A; Mauric, A; Femiano, C; Reggio, R; Lillo, F; Mariani, A; Forcignano, F; Volpe, M; D'Avino, M; Bongiorni, MG; Severi, S; Capucci, A; Lodigiani, C; Salomone, E; Serviddio, G; Tondo, C; Golino, P; Mazzone, C; Iacopino, S; Pengo, V; Galvani, M; Moretti, L; Ambrosino, P; Banfi, E; Biagioli, V; Bianchi, A; Boggian, G; Breschi, M; Brusorio, S; Calcagnoli, F; Campagna, G; Carpenedo, M; Ciabatta, C; Ciliberti, G; Cimmino, G; D'Arienzo, C; Di Gennaro, L; Fedele, M; Ferrini, PM; Granzow, K; Guazzaloca, G; Guerra, F; Lo Buglio, A; Longo, S; Macellari, F; Mesolella, E; Poeta, EM; Occhilupo, P; Oriana, V; Rangel, G; Salomone, L; Scaccianoce, A; Scarone, C; Segreti, L; Sottilota, G; Villani, R; Zecca, C; ten Cate, H; Ruiter, JH; Klomps, H; Bongaerts, M; Pieterse, MGC; Guldener, C; Herrman, JP; Lochorn, G; Lucassen, A; Adriaansen, H; The, SHK; Nierop, PR; Hoogslag, PAM; Hermans, W; Groenemeijer, BE; Terpstra, W; Buiks, C; Boersma, LVA; Boersma-Slootweg, M; Bosman, F; Bosschaert, M; Bruin, S; Danse, I; De Graaf, J; de Graauw, J; Debordes, M; Dols, S; Geerlings, F; Gorrebeeck, K; Jerzewski, A; Jetten, W; Kelderman, M; Kloosterman, T; Koomen, EM; Krikken, J; Melman, P; Mulder, R; Pronk, A; Stallinga-de Vos, A; te Kaat, J; Tonino, P; Uppelschoten, B; van de Loo, R; van der Kley, T; van Leeuwen, G; van Putten, JJ; Westerman, L; Atar, D; Berge, E; Sirnes, PA; Gjertsen, E; Hole, T; Erga, K; Hallaraker, A; Skjelvan, G; Ostrem, A; Ghezai, B; Svilaas, A; Christersson, P; Oien, T; Henrichsen, SH; Berg-Johansen, J; Otterstad, JE; Antonsen, H; Ausen, K; Claussen, H; Dominguez, I; Jekthammer, A; Lensebraaten, AB; Nilsen, V; O'Donovan, M; Ringdalen, K; Strand, S; Stepinska, J; Korzeniak, R; Gieroba, A; Biedrzycka, M; Ogorek, M; Wozakowska-Kaplon, B; Loboz-Grudzien, K; Kosior, J; Supinski, W; Kuzniar, J; Zaluska, R; Hiczkiewicz, J; Swiatkowska-Byczynska, L; Kucharski, L; Gruchala, M; Minc, P; Olszewski, M; Kania, G; Krzciuk, M; Lajkowski, Z; Ostrowska-Pomian, B; Lewczuk, J; Zinka, E; Karczmarczyk, A; Chmielnicka-Pruszczynska, M; Trusz-Gluza, M; Opolski, G; Bronisz, M; Ogorek, M; Glanowska, G; Ruszkowski, P; Jaworska, K; Sciborski, R; Okopien, B; Kukla, P; Wozniak-Skowerska, I; Galbas, K; Cymerman, K; Jurowiecki, J; Miekus, P; Myszka, W; Mazur, S; Lysek, R; Baszak, J; Rusicka-Piekarz, T; Raczak, G; Domanska, E; Nessler, J; Lesnik, J; Ambicka, M; Andrzejewski, D; Araminowicz, J; Barszcz, A; Bartkowiak, R; Bartnik, J; Basiak, M; Bekieszczuk, E; Bernat, L; Biedrzycki, L; Biernacka, A; Blaszczyk, D; Broton, E; Brzozowski, W; Brzustowska, M; Bzymek, R; Chmielowski, A; Chojnowski, P; Cichomski, R; Cieslak, K; Cieszynska, A; Curyllo, B; Czamara, M; Danilowicz-Szymanowicz, L; Dolecka, B; Drelich, L; Dudzik-Richter, B; Dybala, T; Dziuba, M; Faron, W; Figura-Chmielewska, M; Frankiewicz, A; Gadzinski, W; Gasior, E; Gosciniecka, B; Gutknecht, P; Guziewicz, M; Jackun-Podlesna, A; Jaguszewska, G; Jankielewicz, J; Jaremczuk-Kaczmarczyk, A; Jargiello-Baszak, M; Jarzebowski, A; Jaskulska-Niedziela, E; Jaworska-Drozdowska, M; Kabat, J; Kaczmarzyk-Radka, A; Kalin, K; Kaliszczak, R; Kiliszek, M; Klata, M; Kluczewski, M; Kobielusz-Gembala, I; Kochanska, E; Kociolek, D; Kolodzinska, A; Komlo, A; Konopka, A; Korczowska, E; Kowal, E; Kowalczyk, HK; Kremis, E; Kruczyk, D; Krzesiak-Lodyga, A; Krzyzanowski, M; Kurdzielewicz, W; Kustrzycka-Kratochwil, D; Lesniewska-Krynska, D; Leszczynski, J; Lewicka, E; Lichota, E; Lip, K; Loboz-Rudnicka, M; Luka, J; Lysek-Jozefowicz, A; Machnikowska, M; Majewska, K; Mariankowski, R; Markiewicz, A; Mazur, M; Metzgier-Gumiela, A; Miedlar, E; Mielcarek, M; Neubauer-Geryk, J; Niedek, J; Niemirycz-Makurat, A; Nowak, A; Nowak, S; Opielowska-Nowak, B; Ozgowicz, M; Pawelska-Buczen, A; Pawlik-Rak, E; Piotrowicz, R; Ptaszynski, P; Raczynska, A; Rogowski, W; Romanek, J; Romaszkiewicz, R; Rostoff, P; Roszczyk, N; Rozewska-Furmanek, D; Rychta, J; Rzyczkowska, B; Sidor, A; Skalska, J; Smichura, M; Splawski, M; Staneta, P; Staniszewska, E; Starak-Marciniak, J; Stopyra-Poczatek, M; Sukiennik-Kujawa, M; Szafranski, J; Szalecki, P; Szczepanska, A; Szkrobka, W; Szuchnik, E; Szulowska, A; Szumczyk-Muszytowska, G; Szwoch, M; Traczyk, T; Troszczynska, M; Trzcinski, G; Tybura, S; Walasik, P; Wegrzynowska, M; Wesolowska, K; Wieczorek, W; Wierzbicka, A; Wilczewski, P; Wilgat-Szecowka, M; Wojewoda, P; Wojnowski, L; Wrobel, M; Zakutynska-Kowalczyk, K; Zyczynska-Szmon, M; Panchenko, E; Eltishcheva, V; Libis, R; Tereshchenko, S; Popov, S; Kamalov, G; Belenky, D; Zateyshchikova, A; Kropacheva, E; Kolesnikova, A; Nikolaev, K; Egorova, L; Khokhlov, A; Yakupov, E; Poltavskaya, M; Zateyshchikov, D; Drapkina, O; Vishnevsky, A; Barbarash, O; Miller, O; Aleksandrova, E; Chizhov, P; Sergeev, M; Shutemova, E; Mazur, E; Zrazhevskiy, K; Novikova, T; Kostenko, V; Moiseeva, Y; Polkanova, E; Sobolev, K; Rossovskaya, M; Zubeeva, G; Shapovalova, Y; Nagibovich, O; Edin, A; Agakhanyan, A; Batalov, R; Belenkova, Y; Bitakova, F; Chugunnaya, S; Dumikyan, A; Erofeeva, S; Gorbunova, E; Gorshkova, T; Gubanov, A; Gurmach, M; Ivanova, Y; Kolesova, T; Konyushenko, D; Korneeva, O; Kropova, O; Kuchuk, P; Kungurtseva, O; Kupriyanova, T; Kurylo, B; Kuvanova, M; Lebedeva, O; Lileeva, E; Machilskaya, O; Medvedeva, T; Monako, G; Motylev, I; Nagibovich, G; Novikova, E; Orlov, Y; Osmolovskaya, Y; Ovsannikova, A; Platonov, D; Rachkova, S; Sinitsina, O; Speshilova, S; Suslova, O; Ushakov, A; Volodicheva, O; Zemlianskaia, O; Zhirov, I; Zhuravleva, E; Zotova, I; Vinolas, X; Garcia, PA; Fernandez, MFL; Tercedor, L; Iparraguirre, ST; Monserrat, PT; Contreras, EM; Rafecas, JI; Carrasco, JM; Pavia, PG; Pajuelo, CG; Serrano, CM; Alonso, LFI; Ruiz, AG; Klein, JM; Juanatey, JRG; Esquivias, GB; Collado, IM; Piquero, HP; Cuixart, CB; Morato, MR; Llibre, JBI; Vicente, CC; Gutierrez, MV; Gonzalo, FE; Fernandez, CAA; Plana, ND; Montserrat, EE; Alia, JJM; Gonzalez, MB; Oliva, MAM; Sanmartin, JI; Gonzalez, MJ; Alvarez, MR; Melenchon, JH; Vera, TR; Soriano, FR; Riesco, LG; Macian, MDM; Granado, JQ; Navarro, MJ; Sales, JC; Perez, JVV; Caamano, MV; Torres, MFA; Gomez, GM; Romo, AI; Diaz, MAP; Alonso, C; Alonso, C; Alvarez, D; Alvarez, M; Amaro, M; Andere, N; Villar, JA; Ochoa, RA; Austria, A; Barbeira, S; Feu, EB; Bartes, A; Munoz, VB; Jimenez, FJB; Tijuan, AB; Ramirez, JC; Ramos, MC; Martinez, EC; Moreno, MC; Corchado, GC; Gil, MC; Orive, MC; Fernandez, DC; del Misterio, MC; Alsina, RC; Cabrera, AC; de Faria, JCPP; Costas, S; Marco, MIC; Dachs, M; Lopez, CMD; Borras, AD; Madariaga, AE; Espallargas, A; Fernandez, M; Escobar, EF; Mas, EF; Ferrer, A; Fosch, J; Bermudez, MG; Millan, VG; Saenz, MG; Garcia, CG; Gomez, C; Perez, YG; Segovia, AG; Gonzalez, P; Grigorian, L; Molina, AG; del Val, MDG; Maeso, BH; Rodriguez, EH; Garcia, AI; Fernandez, MJJ; Besa, BJ; Salvadores, PJ; Bouzamayor, MBL; Lasuncion, I; Gort, LEL; Molina, ML; Lopez, M; Rey, AM; Guerra, JM; Marcus, S; Vila, AM; Mena, MM; Mazon, P; Zurita, FM; Millan, G; Molina, M; Alia, PM; Montes, D; Gonzalez, MM; Munoz, RBN; Palma, AN; Figueroa, HNO; Ortega, VM; Cortes, CO; Tomera, DO; Merchan, NP; Ibar, IP; Garcia, EP; Armayor, MP; Carasa, MP; Prieto, I; Quintern, V; Renom, R; Diaz, LMR; Rios, V; Sola, LR; Rivera, R; Robiro, XR; Roca, M; Saumell, CR; Rodrigo, C; Rodriguez, E; Garcia, MR; Jimenez, SS; Calderon, PS; Mendez, LS; Parra, SS; Santolaya, C; Sanz, MRS; Blanco, AS; Serralvo, E; Sierra, N; Valero, CS; Lopez, JS; Fontanillas, MT; Riera, MT; Tobajas, G; Torres, C; Marques, JT; Pastor, MU; Rosenqvist, M; Wirdby, A; Linden, J; Henriksson, K; Elmersson, M; Egilsson, A; Borjesson, U; Svard, G; Liu, B; Lindh, A; Olsson, LB; Gustavsson, M; Andersson, L; Andersson, L; Benson, L; Bothin, C; Hajimirsadeghi, A; Kadir, K; Ericsson, M; Ohlsson, A; Lindvall, H; Svensson, P; Thorne, K; Handel, H; Platonov, P; Eriksson, B; Timberg, I; Romberg, K; Crisby, M; Karlsson, JE; Jensen, SA; Andersson, A; Malmqvist, L; Martinsson, B; Bernsten, F; Engdahl, J; Thulin, J; Hot-Bjelac, A; Stalby, P; Aaroe, H; Ahbeck, E; Ahlmark, H; Al-Khalili, F; Bonkowski, G; Dzeletovic, S; Ekstrand, AB; Eriksson, GB; Floren, K; Grassjo, C; Hahn, S; Jaensson, P; Jansson, B; Jansson, JH; Kangert, RM; Koch, A; Kusiak, D; Lettenstrom, A; Lindberg, A; Lindholm, CJ; Mannermyr, A; Mansson, K; Millborg, M; Nilsson, C; Ohlin, AM; Olofsson, A; Osberg, A; Pedersen, A; Risbecker, K; Rosenberg, K; Samuelsson, J; Shayesteh, M; Skoglund, K; Stjernberg, M; Thorsen, C; Steffel, J; Beer, JH; Debrunner, J; Amstutz, D; Bruegger, J; Elise, G; Grau, A; Guinand, A; Henriette, I; Saga, E; Winnik, S; Parkhomenko, A; Rudyk, I; Tseluyko, V; Karpenko, O; Zhurba, S; Kraiz, I; Kupnovytska, I; Serediuk, N; Mostovoy, Y; Ushakov, O; Koval, O; Kovalskyi, I; Svyshchenko, Y; Sychov, O; Stanislavchuk, M; Kraydashenko, O; Yagensky, A; Tykhonova, S; Fushtey, I; Belegai, R; Berko, G; Burdeuna, L; Chabanna, O; Daniuk, I; Ivanov, A; Kamenska, E; Kaplan, P; Khyzhnyak, O; Kizim, S; Matova, O; Medentseva, O; Mochonyi, V; Mospan, M; Nemtsova, V; Ovdiienko, T; Palamarchuk, O; Pavelko, M; Petrovskyy, R; Plevak, D; Proshak, O; Pyvovar, S; Rasputina, L; Romanenko, O; Romanova, O; Sapatyi, A; Shumakov, O; Stets, R; Todoriuk, L; Varenov, V; Fitzmaurice, D; Chauhan, N; Goodwin, D; Saunders, P; Evans, R; Leese, J; Jhittay, PS; Ross, A; Kainth, MS; Pickavance, G; McDonnell, J; Williams, A; Gooding, T; Wagner, H; Suryani, S; Singal, A; Sircar, S; Bilas, R; Hutchinson, P; Wakeman, A; Stokes, M; Paul, N; Aziz, M; Ramesh, C; Wilson, P; Franklin, S; Fairhead, S; Thompson, J; St Joseph, V; Taylor, G; Tragen, D; Seamark, D; Paul, C; Richardson, M; Jefferies, A; Sharp, H; Jones, H; Giles, C; Page, M; Oginni, O; Aldegather, J; Wetherwell, S; Lumb, W; Evans, P; Scouller, F; Macey, N; Stipp, Y; West, R; Thurston, S; Wadeson, P; Matthews, J; Pandya, P; Gallagher, A; Railton, T; Sinha, B; Russell, D; Davies, JA; Ainsworth, P; Jones, CP; Weeks, P; Eden, J; Kernick, D; Murdoch, W; Lumley, L; Patel, RP; Wong, SW; Saigol, M; Ladha, K; Douglas, K; Cumberlidge, DF; Bradshaw, C; Van Zon, G; Jones, KP; Thomas, MJ; Watson, E; Sarai, B; Ahmad, N; Willcock, W; Cairns, J; Sathananthan, S; de Kare-Silver, N; Gilliland, A; Strieder, E; Howitt, A; Vishwanathan, B; Bird, N; Gray, D; Clark, M; Bisatt, J; Litchfield, J; Fisher, E; Fooks, T; Kelsall, AR; Alborough, E; Wakeling, J; Parfitt, M; Milne, K; Rogers, S; Priyadharshan, R; Oliver, JL; Davies, E; Abushal, S; Jacobs, M; Hutton, C; Walls, NI; Thompson, R; Chigbo, C; Zaidi, SMA; Howard, M; Butter, KC; Barrow, S; Little, H; Haq, IU; Gibbons, L; Glencross, S; McLeod, AJ; Poland, K; Mulholland, C; Warke, A; Conn, P; Burns, G; Smith, RN; Lowe, S; Kamath, R; Dau, HS; Webster, J; Hodgins, I; Vercoe, S; Roome, PC; Pinnock, H; Patel, JRA; Ali, A; Hart, N; Davies, R; Stuart, E; Neden, CA; Danielsen, M; Heath, R; Sharma, P; Galloway, S; Hawkins, C; Oliver, R; Aylward, M; Mannion, S; Braddick, M; Edwards, D; Rothwell, AC; Sabir, A; Choudhary, F; Khalaque, S; Wilson, A; Peters, S; Coulson, W; Roberts, N; Heer, A; Coates, S; Ward, B; Jackson, D; Walton, S; Shepherd, D; Sterry, M; Wong, T; Boon, M; Bunney, R; Haria-Shah, R; Baron, RT; Davies, S; Schatzberger, T; Hargreaves, N; Stephenson, T; Choi, H; Batson, R; Lucraft, L; Myhill, T; Estifano, S; Geatch, D; Wilkinson, J; Veale, R; Forshaw, K; Davies, T; Zaman, K; Vinson, P; Liley, C; Bandrapalli, M; McGinty, P; Wastling, R; McEleny, P; Beattie, A; Cooke, P; Wong, M; Gunasegaram, J; Pugsley, M; Ahmad, S; A'Court, C; Ayers, J; Bennett, J; Cartwright, S; Dobson, S; Dooldeniya, C; Flynn, A; Fox, R; Goram, J; Halpin, A; Hay, A; Jacobs, P; Jeffers, L; Lomax, L; Munro, I; Muvva, R; Nadaph, M; Powell, K; Randfield, S; Redpath, D; Reed, R; Rickenbach, M; Rogers, G; Saunders, PB; Seamark, C; Shewring, J; Simmons, P; Simper, H; Stoddart, H; Sword, A; Thomas, N; Thomson, A; Gibbs, H; Blenkhorn, A; Singh, B; Van Gaal, W; Abhayaratna, W; Lehman, R; Roberts-Thomson, P; Kilian, J; Coulshed, D; Catanchin, A; Colquhoun, D; Kiat, H; Eccleston, D; French, J; Zimmett, L; Ayres, B; Phan, T; Blombery, P; Crimmins, D; O'Donnell, D; Choi, A; Astridge, P; Arstall, M; Jepson, N; Binnekamp, M; Lee, A; Rogers, J; Starmer, G; Carroll, P; Faunt, J; Aggarwala, A; Barry, L; Batta, C; Beveridge, R; Black, A; Bonner, M; Boys, J; Buckley, E; Campo, M; Carlton, L; Connelly, A; Conway, B; Cresp, D; Dimitri, H; Dixon, S; Dolman, M; Duroux, M; Eskandari, M; Eslick, R; Ferreira-Jardim, A; Fetahovic, T; Fitzpatrick, D; Geraghty, R; Gibbs, J; Grabek, T; Modi, MH; Hayes, K; Hegde, MP; Hesketh, L; Hoffmann, B; Jacobson, B; Johnson, K; Juergens, C; Kassam, I; Lawlor, V; Lehman, M; Lehman, S; Leung, D; Mackay, S; MacKenzie, M; McCarthy, C; McIntosh, C; McKeon, L; Morrison, H; Mussap, C; Myers, JD; Nagalingam, V; Oldfield, G; O'May, V; Palmer, J; Parsons, L; Patching, K; Patching, T; Paul, V; Plotz, M; Preston, S; Rashad, H; Ratcliffe, M; Raynes, S; Rose, J; Sanders, L; Seremetkoska, M; Setio, H; Shone, S; Shrestha, P; Singh, C; Singleton, C; Stoyanov, N; Sutcliffe, S; Swaraj, K; Tarrant, J; Thompson, S; Tsay, IM; Vorster, M; Waldman, A; Wallis, L; Wilford, E; Wong, K; Connolly, SJ; Spyropoulos, A; Eikelboom, J; Luton, R; Gupta, M; Pandey, AS; Cheung, S; Leader, R; Beaudry, P; Ayala-Paredes, F; Berlingieri, J; Heath, J; Poirier, G; Du Preez, M; Nadeau, R; Dresser, G; Dhillon, R; Hruczkowski, T; Schweitzer, B; Coutu, B; Angaran, P; MacDonald, P; Vizel, S; Fikry, S; Parkash, R; Lavoie, A; Cha, J; Ramjattan, B; Bonet, J; Ahmad, K; Aro, L; Aves, T; Beaudry, K; Bergeron, C; Bigcanoe, J; Bignell, N; Breakwell, L; Burke, E; Carroll, L; Clarke, B; Cleveland, T; Daheb, S; Dehghani, P; Denis, I; Djaidani, Z; Dorian, P; Douglass, S; Dunnigan, J; Ewert, A; Farquhar, D; Fearon, A; Ferleyko, L; Fournier, D; Fox, B; Grenier, MC; Gulliver, W; Haveman, K; Hines, C; Hines, K; Jackson, AM; Jean, C; Jethoo, G; Kahlon, R; Kelly, S; Kim, R; Korley, V; Kornder, J; Kwan, L; Largy, J; Lewis, C; Lewis, S; Mangat, I; Moor, R; Navratil, J; Neas, I; Otis, J; Otis, R; Pandey, M; Petrie, F; Pinter, A; Raines, M; Roberts, P; Robinson, M; Sas, G; Schulman, S; Snell, L; Spearson, S; Stevenson, J; Trahey, T; Wong, S; Wright, D; Ragy, H; Abd El-Aziz, A; Abou Seif, SK; El Din, MG; El Etriby, S; Elbahry, A; El-Etreby, A; Elkhadem, M; Katta, A; Khairy, T; Mowafy, A; Nawar, M; Ohanissian, A; Reda, A; Reda, M; Salem, H; Sami, N; Samir, S; Setiha, M; Sobhy, M; Soliman, A; Taha, N; Tawfik, M; Zaatout, E; Kettles, D; Bayat, J; Siebert, H; Horak, A; Kelfkens, Y; Garda, R; Pillay, T; Guerra, M; van Zyl, L; Theron, H; Murray, A; Louw, R; Greyling, D; Mntla, P; Ueckermann, V; Loghdey, R; Ismail, S; Ahmed, F; Engelbrecht, J; Ramdass, A; Maharajh, S; Oosthuysen, W; Angel, G; Bester, C; Booysen, M; Boshoff, C; Cannon, C; Cassimjee, S; Chami, C; Conway, G; Davids, A; de Meyer, L; Du Plessis, G; Ellis, T; Henley, L; Karsten, M; Loyd, E; Marks, J; Mavhusa, L; Mostert, M; Page, A; Rikhotso, L; Salie, M; Sasto, J; Shaik, F; Skein, A; Smith, L; Tarr, G; Tau, T; van Zyl, F; Al Mahmeed, W; Yousef, G; Agrawal, A; Nathani, M; Ibrahim, M; Esheiba, EM; Singh, R; Naguib, A; Abu-Mahfouz, M; Al Omairi, M; Al Naeemi, A; Maruthanayagam, R; Bazargani, N; Wassef, A; Gupta, R; Khan, M; Subbaraman, B; Abdul, A; Al Mulla, A; El Bardisy, S; Haridas, P; Jadhav, S; Magdaluyo, K; Makdad, M; Maqsood, I; Mohamed, R; Sharma, N; Sharma, R; Thanzeel, M; Goldhaber, SZ; Canosa, R; Rama, P; Blumberg, E; Garcia, J; Mullen, P; Wilson, V; Quick, A; Ferrick, K; Kutayli, WM; Cox, M; Franco, M; Falkowski, S; Mendelson, R; Williams, M; Miller, S; Beach, S; Alfieri, A; Gutowski, T; Haque, I; Reddy, R; Ahmed, W; Delafontaine, P; Diercks, D; Theodoro, D; Remmel, K; Alberts, M; Ison, R; Noveck, H; Duffy, P; Pitta, S; Nishijima, D; Treasure, C; Asafu-Adjaye, N; Ball, K; Bartlett, M; Bentley, M; Bowers, S; Brown, A; Browne, A; Cameron-Watts, J; Canova, M; Cassidy, D; Cervellione, K; Congal, S; DePauw, J; Dickerson, A; Eley, M; Evans, L; Felpel, S; Ferdinand, K; Fielder, D; Gentry, P; Haideri, A; Hakimi, F; Harbour, T; Hartranft, E; Hawkins, B; Headlee, M; Henson, L; Herrick, C; Hicks, T; Jasinski, S; Jones, A; Jones, L; Jones, P; Karl, S; Keeling, M; Kerr, J; Knowles, P; Langdon, J; Lay, M; Lee, JA; Lincoln, T; Malone, E; Merliss, A; Merritt, D; Minardo, J; Mooso, B; Orosco, C; Palumbo, V; Parker, M; Parrott, T; Paserchia, S; Pearl, G; Peterson, J; Pickelsimer, N; Purcell, T; Raynor, J; Raziano, S; Richard, C; Richardson, T; Robertson, C; Sage, A; Sanghera, T; Shaw, P; Shoemaker, J; Smith, K; Stephanie, B; Thatcher, A; Theobald, H; Thompson, N; Treasure, L; Tripti, T; Verdi, C; Worthy, V				Bassand, Jean-Pierre; Accetta, Gabriele; Al Mahmeed, Wael; Corbalan, Ramon; Eikelboom, John; Fitzmaurice, David A.; Fox, Keith A. A.; Gao, Haiyan; Goldhaber, Samuel Z.; Goto, Shinya; Haas, Sylvia; Kayani, Gloria; Pieper, Karen; Turpie, Alexander G. G.; van Eickels, Martin; Verheugt, Freek W. A.; Kakkar, Ajay K.; Camm, A. John; Hacke, Werner; Mantovani, Lorenzo G.; Misselwitz, Frank; Pieper, Karen S.; Lucas Luciardi, Hector; Gibbs, Harry; Brodmann, Marianne; Cools, Frank; Pereira Barretto, Antonio Carlos; Connolly, Stuart J.; Spyropoulos, Alex; Hu, Dayi; Jansky, Petr; Nielsen, Jorn Dalsgaard; Ragy, Hany; Raatikainen, Pekka; Le Heuzey, Jean-Yves; Darius, Harald; Keltai, Matyas; Kakkar, Sanjay; Sawhney, Jitendra Pal Singh; Agnelli, Giancarlo; Ambrosio, Giuseppe; Koretsune, Yukihiro; Sanchez Diaz, Carlos Jerjes; Ten Cate, Hugo; Atar, Dan; Stepinska, Janina; Panchenko, Elizaveta; Lim, Toon Wei; Jacobson, Barry; Oh, Seil; Vinolas, Xavier; Rosenqvist, Marten; Steffel, Jan; Angchaisuksiri, Pantep; Oto, Ali; Parkhomenko, Alex; Fitzmaurice, David; Gersh, Bernard J.; Chen, K. N.; Zhao, Y. S.; Zhang, H. Q.; Chen, J. Z.; Cao, S. P.; Wang, D. W.; Yang, Y. J.; Li, W. H.; Yin, Y. H.; Tao, G. Z.; Yang, P.; Chen, Y. M.; He, S. H.; Wang, Y. (Ying); Wang, Y. (Yong); Fu, G. S.; Li, X.; Wu, T. G.; Cheng, X. S.; Yan, X. W.; Zhao, R. P.; Chen, M. S.; Xiong, L. G.; Chen, P.; Jiao, Y.; Guo, Y.; Xue, L.; Wang, F. Z.; Li, H.; Yang, Z. M.; Bai, C. L.; Chen, J.; Chen, J. Y.; Chen, X.; Feng, S.; Fu, Q. H.; Gao, X. J.; Guo, W. N.; He, R. H.; He, X. A.; Hu, X. S.; Huang, X. F.; Li, B.; Li, J.; Li, L.; Li, Y. H.; Liu, T. T.; Liu, W. L.; Liu, Y. Y.; Lu, Z. C.; Luo, X. L.; Ma, T. Y.; Peng, J. Q.; Sheng, X.; Shi, X. J.; Sun, Y. H.; Tian, G.; Wang, K.; Wang, L.; Wu, R. N.; Xie, Q.; Xu, R. Y.; Yang, J. S.; Yang, L. L.; Yang, Q.; Yang, Y. J.; Ye, Y.; Yu, H. Y.; Yu, J. H.; Yu, T.; Zhai, H.; Zhan, Q.; Zhang, G. S.; Zhang, Q.; Zhang, R.; Zhang, Y.; Zheng, W. Y.; Zhou, B.; Zhou, Z. H.; Zhu, X. Y.; Jadhav, P.; Durgaprasad, R.; Shankar, A. G. Ravi; Rajput, R. K.; Bhargava, K.; Sarma, R.; Srinivas, A.; Roy, D.; Nagamalesh, U. M.; Chopda, M.; Kishore, R.; Kulkarni, G.; Chandwani, P.; Pothiwala, R. A.; Purayil, M. Padinhare; Shah, S.; Chawla, K.; Kothiwale, V. A.; Raghuraman, B.; Vijayaraghavan, G.; Vijan, V. M.; Bantwal, G.; Bisne, V.; Khan, A.; Gupta, J. B.; Kumar, S.; Jain, D.; Abraham, S.; Adak, D.; Barai, A.; Begum, H.; Bhattacharjee, P.; Dargude, M.; Davies, D.; Deshpande, B.; Dhakrao, P.; Dhyani, V.; Duhan, S.; Earath, M.; Ganatra, A.; Giradkar, S.; Jain, V.; Karthikeyan, R.; Kasala, L.; Kaur, S.; Krishnappa, S.; Lawande, A.; Lokesh, B.; Madarkar, N.; Meena, R.; More, P.; Naik, D.; Prashanth, K.; Rao, M.; Rao, N. M.; Sadhu, N.; Shah, D.; Sharma, M.; Shiva, P.; Singhal, S.; Suresh, S.; Vanajakshamma, V.; Panse, S. G.; Kanamori, S.; Yamamoto, K.; Kumagai, K.; Katsuda, Y.; Sadamatsu, K.; Toyota, F.; Mizuno, Y.; Misumi, I.; Noguchi, H.; Ando, S.; Suetsugu, T.; Minamoto, M.; Oda, H. (Hiroshi); Shiraishi, K.; Adachi, S.; Chiba, K.; Norita, H.; Tsuruta, M.; Koyanagi, T.; Yamamoto, K.; Ando, H.; Higashi, T.; Okada, K.; Azakami, S.; Komaki, S.; Kumeda, K.; Murayama, T.; Matsumura, J.; Oba, Y.; Sonoda, R.; Goto, K.; Minoda, K.; Haraguchi, Y.; Suefuji, H.; Miyagi, H.; Kato, H.; Nakamura, T. (Tadashi); Nakamura, T. (Tsugihiro); Nandate, H.; Zaitsu, R.; Fujiura, Y. (Yoshihisa); Yoshimura, A.; Numata, H.; Ogawa, J.; Tatematsu, H.; Kamogawa, Y.; Murakami, K.; Wakasa, Y.; Yamasawa, M.; Maekawa, H.; Abe, S.; Kihara, H.; Tsunoda, S.; Saito, K. (Katsumi); Fudo, T.; Obunai, K.; Tachibana, H.; Oba, I.; Kuwahata, T.; Higa, S.; Gushiken, M.; Eto, T.; Yoshida, H.; Ikeda, D.; Fujiura, Y. (Yoshitake); Ishizawa, M.; Nakatsuka, M.; Murata, K.; Ogurusu, C.; Shimoyama, M.; Akutsu, M.; Takamura, I.; Hoshino, F.; Yokota, N.; Iwao, T.; Tsuchida, K.; Takeuchi, M.; Hatori, Y.; Kitami, Y.; Nakamura, Y. (Yoichi); Oyama, R.; Ageta, M.; Oda, H. (Hiroyuki); Go, Y.; Mishima, K.; Unoki, T.; Morii, S.; Shiga, Y. (Yuhei); Sumi, H.; Nagatomo, T.; Sanno, K.; Fujisawa, K.; Atsuchi, Y.; Nagoshi, T.; Seto, T.; Tabuchi, T.; Kameko, M.; Nii, K.; Oshiro, K.; Takezawa, H.; Nagano, S.; Miyamoto, N.; Iwaki, M.; Nakamura, Y. (Yuichiro); Fujii, M.; Okawa, M.; Abe, M. (Masahiko); Abe, M. (Masatake); Abe, M. (Mitsunori); Saito, T.; Mito, T.; Nagao, K.; Minami, J.; Mita, T.; Sakuma, I.; Taguchi, T.; Marusaki, S.; Doi, H.; Tanaka, M.; Fujito, T.; Matsuta, M.; Kusumoto, T.; Kakinoki, S.; Ashida, K.; Yoshizawa, N.; Agata, J.; Arasaki, O.; Manita, M.; Ikemura, M.; Fukuoka, S.; Murakami, H.; Matsukawa, S.; Hata, Y.; Taniguchi, T.; Ko, T.; Kubo, H.; Imamaki, M.; Akiyama, M.; Inagaki, M.; Odakura, H.; Ueda, T.; Katsube, Y.; Nakata, A.; Watanabe, H.; Techigawara, M.; Igarashi, M.; Taga, K.; Kimura, T.; Tomimoto, S.; Shibuya, M.; Nakano, M.; Ito, K.; Seo, T.; Hiramitsu, S.; Hosokawa, H.; Hoshiai, M.; Hibino, M.; Miyagawa, K.; Horie, H. (Hajime); Sugishita, N.; Shiga, Y. (Yukio); Soma, A.; Neya, K.; Yoshida, T. (Tetsuro); Yoshida, T. (Tomoki); Mizuguchi, M.; Ishiguro, M.; Minagawa, T.; Wada, M.; Mukawa, H.; Okuda, F.; Nagasaka, S.; Abe, Y.; Adachi, S. (Sen); Adachi, S. (Susumu); Adachi, T.; Akahane, K.; Amano, T.; Aoki, K.; Aoyama, T.; Arai, H.; Arima, S.; Arino, T.; Asano, H.; Asano, T.; Azuma, J.; Baba, T.; Betsuyaku, T.; Chibana, H.; Date, H.; Doiuchi, J.; Emura, Y.; Endo, M.; Fujii, Y.; Fujiki, R.; Fujisawa, A.; Fujisawa, Y.; Fukuda, T.; Fukui, T.; Furukawa, N.; Furukawa, T.; Furumoto, W.; Goto, T.; Hamaoka, M.; Hanazono, N.; Hasegawa, K.; Hatsuno, T.; Hayashi, Y.; Higuchi, K.; Hirasawa, K.; Hirayama, H.; Hirose, M.; Hirota, S.; Honda, M.; Horie, H. (Hideki); Ido, T.; Iiji, O.; Ikeda, H.; Ikeda, K.; Ikeoka, K.; Imaizumi, M.; Inaba, H.; Inoue, T.; Iseki, F.; Ishihara, A.; Ishioka, N.; Ito, N.; Iwase, T.; Kakuda, H.; Kamata, J.; Kanai, H.; Kanda, H.; Kaneko, M.; Kano, H.; Kasai, T.; Kato, T.; Kato, Y.; Kawada, Y.; Kawai, K.; Kawakami, K.; Kawakami, S.; Kawamoto, T.; Kawano, S.; Kim, J.; Kira, T.; Kitazawa, H.; Kitazumi, H.; Kito, T.; Kobayashi, T.; Koeda, T.; Kojima, J.; Komatsu, H.; Komatsu, I.; Koshibu, Y.; Kotani, T.; Kozuka, T.; Kumai, Y.; Kumazaki, T.; Maeda, I.; Maeda, K.; Maruyama, Y.; Matsui, S.; Matsushita, K.; Matsuura, Y.; Mineoi, K.; Mitsuhashi, H.; Miura, N.; Miyaguchi, S.; Miyajima, S.; Miyamoto, H.; Miyashita, A.; Miyata, S.; Mizuguchi, I.; Mizuno, A.; Mori, T.; Moriai, O.; Morishita, K.; Murai, O.; Nagai, S. (Sho); Nagai, S. (Shunichi); Nagata, E.; Nagata, H.; Nakagomi, A.; Nakahara, S.; Nakamura, M.; Nakamura, R.; Nakanishi, N.; Nakayama, T.; Nakazato, R.; Nanke, T.; Nariyama, J.; Niijima, Y.; Niinuma, H.; Nishida, Y.; Nishihata, Y.; Nishino, K.; Nishioka, H.; Nishizawa, K.; Niwa, I.; Nomura, K.; Nomura, S.; Nozoe, M.; Ogawa, T.; Ohara, N.; Okada, M.; Okamoto, K.; Okita, H.; Okuyama, M.; Ono, H.; Ono, T.; Pearce, Y. Onuki; Oriso, S.; Ota, A.; Otaki, E.; Saito, Y.; Sakai, H.; Sakamoto, N.; Sakamoto, Y.; Samejima, Y.; Sasagawa, Y.; Sasaguri, H.; Sasaki, A.; Sasaki, T.; Sato, K. (Kazuki); Sato, K. (Kiyoharu); Sawano, M.; Seki, S.; Sekine, Y.; Seta, Y.; Sezaki, K.; Shibata, N.; Shiina, Y.; Shimono, H.; Shimoyama, Y.; Shindo, T.; Shinohara, H.; Shinohe, R.; Shinozuka, T.; Shirai, T.; Shiraiwa, T.; Shozawa, Y.; Suga, T.; Sugimoto, C.; Suzuki, K. (Kazuo); Suzuki, K. (Keita); Suzuki, S. (Shu); Suzuki, S. (Shunji); Suzuki, S. (Susumu); Suzuki, Y.; Tada, M.; Taguchi, A.; Takagi, T.; Takagi, Y.; Takahashi, K.; Takahashi, S.; Takai, H.; Takanaka, C.; Take, S.; Takeda, H.; Takei, K.; Takenaka, K.; Tana, T.; Tanabe, G.; Taya, K.; Teragawa, H.; Tohyo, S.; Toru, S.; Tsuchiya, Y.; Tsuji, T.; Tsuzaki, K.; Uchiyama, H.; Ueda, O.; Ueda, T.; Ueyama, Y.; Wakaki, N.; Wakiyama, T.; Washizuka, T.; Watanabe, M.; Yamada, T.; Yamagishi, T.; Yamaguchi, H.; Yamamoto, K. (Kenichi); Yamamoto, K. (Kentaro); Yamamoto, K. (Kunihiko); Yamamoto, T.; Yamaura, M.; Yamazoe, M.; Yasui, K.; Yokoyama, Y.; Yoshida, K.; Lim, T. W.; Ching, C. K.; Foo, C. G.; Chow, J. H.; Chen, D. D.; Jaufeerally, F. R.; Lee, Y. M.; Lim, G.; Lim, W. T.; Thng, S.; Yap, S. Y.; Yeo, C.; Oh, S.; Pak, H. N.; Kim, J-B; Kim, J. H.; Jang, S-W; Kim, D. H.; Ryu, D. R.; Park, S. W.; Kim, D-K; Choi, D. J.; Oh, Y. S.; Cho, M-C; Kim, S-H; Jeon, H-K; Shin, D-G; Park, J. S.; Park, H. K.; Han, S-J; Sung, J. H.; Cho, J-G; Nam, G-B; On, Y. K.; Lim, H. E.; Kwak, J. J.; Cha, T-J; Hong, T. J.; Park, S. H.; Yoon, J. H.; Kim, N-H; Kim, K-S; Jung, B. C.; Hwang, G-S; Kim, C-J; Kim, D. B.; Ahn, J. J.; An, H. J.; Bae, H.; Baek, A. L.; Chi, W. J.; Choi, E. A.; Choi, E. H.; Choi, H. K.; Choi, H. S.; Han, S.; Heo, E. S.; Her, K. O.; Hwang, S. W.; Jang, E. M.; Jang, H-S; Jang, S.; Jeon, H-G; Jeon, S. R.; Jeon, Y. R.; Jeong, H. K.; Jung, I-A; Kim, H. J. (Hyeon Jeong); Kim, H. J. (Hyun Ju); Kim, J. S. (Ji Seon); Kim, J. S. (Jung Sook); Kim, J. A.; Kim, K. T.; Kim, M. S.; Kim, S. H. (Sang Hee); Kim, S. H. (Sang Hyun); Kim, Y-, I; Lee, C. S.; Lee, E. H.; Lee, G. H.; Lee, H. Y.; Lee, H-Y; Lee, K. H.; Lee, K. R.; Lee, M. S.; Lee, M-Y; Lee, R. W.; Lee, S. E.; Lee, S. H.; Lee, S.; Lee, W. Y.; Noh, I. K.; Park, A. R.; Park, B. R.; Park, H. N.; Park, J. H.; Park, M.; Park, Y.; Seo, S-Y; Shim, J.; Sim, J. H.; Sohn, Y. M.; Son, W. S.; Son, Y. S.; Song, H. J.; Wi, H. K.; Woo, J. J.; Ye, S.; Yim, K. H.; Yoo, K. M.; Yoon, E. J.; Yun, S. Y.; Angchaisuksiri, P.; Chawanadelert, S.; Mongkolwongroj, P.; Kanokphatcharakun, K.; Cheewatanakornkul, S.; Laksomya, T.; Pattanaprichakul, S.; Chantrarat, T.; Rungaramsin, S.; Silaruks, S.; Wongcharoen, W.; Siriwattana, K.; Likittanasombat, K.; Katekangplu, P.; Boonyapisit, W.; Cholsaringkarl, D.; Chatlaong, B.; Chattranukulchai, P.; Santanakorn, Y.; Hutayanon, P.; Khunrong, P.; Bunyapipat, T.; Jai-Aue, S.; Kaewsuwanna, P.; Bamungpong, P.; Gunaparn, S.; Hongsuppinyo, S.; Inphontan, R.; Khattaroek, R.; Khunkong, K.; Kitmapawanont, U.; Kongsin, C.; Naratreekoon, B.; Ninwaranon, S.; Phangyota, J.; Phrommintikul, A.; Phunpinyosak, P.; Pongmorakot, K.; Poomiphol, S.; Pornnimitthum, N.; Pumprueg, S.; Ratchasikaew, S.; Sanit, K.; Sawanyawisuth, K.; Silaruks, B.; Sirichai, R.; Sriwichian, A.; Suebjaksing, W.; Sukklad, P.; Suttana, T.; Tangsirira, A.; Thangpet, O.; Tiyanon, W.; Vorasettakarnkij, Y.; Wisaratapong, T.; Wongtheptien, W.; Wutthimanop, A.; Yawila, S.; Altun, A.; Ozdogru, I; Ozdemir, K.; Yilmaz, O.; Aydinlar, A.; Yilmaz, M. B.; Yeter, E.; Ongen, Z.; Cayli, M.; Pekdemir, H.; Ozdemir, M.; Sucu, M.; Sayin, T.; Demir, M.; Yorgun, H.; Ersanli, M.; Okuyan, E.; Aras, D.; Abdelrahman, H.; Aktas, O.; Alpay, D.; Aras, F.; Bireciklioglu, M. F.; Budeyri, S.; Buyukpapuc, M.; Caliskan, S.; Oto, A.; Esen, M.; Felekoglu, M. A.; Genc, D.; Ikitimur, B.; Karaayvaz, E. B.; Karatas, S. Kilic; Okutucu, S.; Ozcelik, E.; Quisi, A.; Sag, H.; Sahiner, L.; Sayin, B. Y.; Seker, T.; Alkan, D. Uzun; Yildirim, E.; Yildirim, R.; Yilmaz, F.; Yuksekdag, V; Luciardi, H. L.; Vensentini, N.; Ingaramo, A. C.; Sambadaro, G. A.; Fernandez Caputi, V; Berman, S. G.; Dragotto, P.; Kleiban, A. J.; Centurion, N.; Giacomi, G.; Ahuad Guerrero, R. A.; Conde, D.; Zapata, G.; Di Paola, L. A.; Ramos, J. L.; Dran, R. D.; Egido, J.; Fernandez, A. A.; Fosco, M. J.; Sassone, S.; Sinisi, V. A.; Cartasegna, L. R.; Berli, M. A.; Gomez Vilamajo, O. A.; Ferroni, F.; Alaguibe, E. D.; Alvarez D'Amelio, A.; Arabetti, C.; Arias, L.; Belardi, J. A.; Bergesio, L.; Berli, F.; Berli, M.; Borchowiec, S.; Buzzetti, C.; Cabrini, R.; Campisi, V; Cappi, A. L.; Carrizo, R.; Colombo Berra, F.; Costabel, J. P.; Costamagna, O. J. A.; Damonte, A. A.; De Urquiza, I. N.; Diez, F.; Eden, M. F.; Fanuele, M.; Fernandez Voena, F.; Foa Torres, M.; Funosas, C.; Giacomi, M. P.; Gimenez, C. H.; Gurfinkel, E. P.; Had, M. de L. M.; Hansen, V; Hrabar, A. D.; Ingratta, M.; Lopez, A.; Maehara, G.; Maffei, L.; Martinelli, A.; Martinelli, C.; Matkovich, J.; Mautner, B.; Meirino, A.; Munguia, R.; Navarro, A.; Novas, V; Perez Prados, G.; Pontoriero, J.; Potito, R. N.; Ricotti, C.; Rodriguez, M. A.; Rolandi, F.; Said Palladino, M. E.; Salinger, M.; Sanziani, L. S.; Schygiel, P. O.; Sossich, A.; Tinto, J. F.; Tonelli, L.; Tufare, A. L.; Vallejo, M.; Yunis, M. E.; Zillo, M.; Zurbrigk, F. J.; Barretto, A. C. P.; Sobral Filho, D. C.; Jaber, J.; Armaganijan, D.; Faria Neto, J.; Steffens, A.; Kunz Sebba Barroso de Souza, W.; de Souza Neto, J. D.; Ribeiro, J. M.; Silveira Teixeira, M.; Ferreira Rossi, P. R.; Pires, L.; Moreira, D.; Moura Jorge, J. C.; Menezes Lorga Filho, A.; Bodanese, L. C.; Westerlund Montera, M.; Del Carlo, C. H.; Da Rocha Rodrigues, T.; Alves da Costa, F. A.; Lopes, A.; Lopes, R.; Araujo, G. R.; Fernandes Manenti, E. R.; Kerr Saraiva, J. F.; Ferreira Braga, J. C.; Negri, A.; Souto, L.; Moncada, C.; Bertolim Precoma, D.; Roquette, F.; Reis, G.; Ramos Filho, R. A.; Lanna Figueiredo, E.; Vieira Botelho, R.; Munhoz da Fontoura Tavares, C.; Costantini Frack, C. R.; Abdalla Saad, J.; Finimundi, H. C.; Pisani, C.; Chemello, D.; Pereira Martins, M.; Broilo Franca, C. C.; Alban, F.; Aranha Rosito, G. B.; de Moura Xavier Moraes Junior, J. B.; Tumelero, R. T.; Nigro Maia, L.; Simoes de Almeida, R.; do Carmo Borges, N. C.; Gomes Ferreira, L. G.; Agliardi, P.; Alves de Oliveira Gomes, J.; Araujo, V; Arruda Nakazone, M.; Barbosa, T.; Barroso, S.; Belisario Falchetto, E.; Bellotti Lopes, H.; Benez Teixeira Lemos, M. A.; Biazus, G.; Borges Queiroz, L.; Camazzola, F. E.; Caporale, M.; Cardoso Boscato, S.; Chieza, F.; Chokr, M. O.; Clemente Mingireanov, R.; Codonho Goes, N.; Correa, C.; Costa, M.; Costantini Ortiz, C.; da Silva, L. S.; da Silva Paulitsch, F.; da Silveira, J. A.; Daros, E.; de Araujo, G. R.; Del Monaco, M., I; Dias, C.; Dias, M. A.; Drummond Wainstein, A. P.; Ely Pizzato, P.; Esteves, D. C.; Fabri, P.; Felix Lorenzato Fonseca, T.; Fernandes, E.; Fonseca, C.; Frack Costantini, C. R.; Franchin Ferraz, R.; Freire, F.; Gottardo, P.; Guanaes, D.; Guizzardi, S.; Hettwer Magedanz, E.; Igansi, F.; Jannuzzi, F.; Junior, G.; Komar, D.; Lino, E. G.; Lopes, D.; Lourenco da Silva Junior, O.; Lustosa, E.; Macagnan, A. P.; Marinho, M. C.; Mazzoni, M.; Melo, G.; Mortari, L.; Mouco, O. M. C. C.; Nanzer Vital, C.; Ormundo, C.; Oss Emmer, S.; Palmegiani, E.; Pavani, R.; Pereira, L.; Pereira, V. L.; Perreira, R.; Poletti, S.; Quaia Fortunato, S. C.; Queirantes, C.; Ramos Pereira, N.; Rech, R. L.; Ribeiro, S.; Rodrigues, A.; Roesch, H.; Ruaro Reichert, T.; Santos, D.; Santos, I; Santos, M.; Seroqui, M., V; Silva, S.; Soares, L.; Spolaor, L.; Stoll, C.; Toazza Duda, N.; Trama, L.; Unterkircher, B.; Valois, M. V.; Vargas, T.; Viana, T.; Vicente, C.; Vidal Armaganijan, L.; Vieira Homem, R.; Vieira Torres, L. G.; Vila Boas, L.; Villaca Guimaraes Filho, F.; Corbalan, R.; Eggers, G.; Bugueno Gutierrez, C.; Arriagada, G.; Potthoff Cardenas, S.; Stockins Fernandez, B. A. J.; Conejeros, C.; Houzvic, C.; Marin Cuevas, P.; Montecinos, H.; Forero, A.; Lanas, F.; Larico Gomez, M.; Charme Vilches, G.; Rey, C.; Astudillo, C.; Aguilar, J.; Campisto, Y.; Lara, C.; Molina, E.; Munoz Oyarzon, J.; Olguin, V; Vergara, M.; Villan, C.; Sanchez Diaz, C. J.; Illescas Diaz, J.; Leal Cantu, R.; Ramos Zavala, M. G.; Cabrera Jardines, R.; Espinola Zavaleta, N.; Villarreal Umana, S.; Lopez Rosas, E.; Llamas Esperon, G.; Pozas, G.; Cardona Munoz, E.; Matadamas Hernandez, N.; Leyva Rendon, A.; Garcia Hernandez, N.; de los Rios Ibarra, M.; Virgen Carrillo, L.; Lopez Villezca, D.; Hernandez Herrera, C.; Lopez Prieto, J. J.; Gaona Rodriguez, R.; Villeda Espinosa, E.; Flores Martinez, D.; Velasco Barcena, J.; Yong, R.; Rodriguez Briones, I; Leiva Pons, J. L.; Alvarez Lopez, H.; Olvera Ruiz, R.; Diaz de la Vega, C.; Cantu Brito, C.; Chuquiure Valenzuela, E.; Reyes-Sanchez, R.; Bazzoni Ruiz, A.; Nandayapa Flores, O.; Benavides Gonzalez, M.; Arriaga Nava, R.; Morales Cerda, J. D.; Fierro Fierro, O.; Fajardo Campos, P.; Alfaro, T. A. A.; Altamirano Bellorin, S.; Avena, R.; Chavarria, M.; Espinosa, I; Flores Silva, F.; Garcia Nava, R. H.; Godoy, K.; Gonzalez Felix, E. J.; Gonzalez Garcia, C. L.; Gonzalez Salas, L. G.; Guajardo, P.; Hernandez Gonzalez, S.; Izquierdo, T.; Mancilla Ortiz, M. C.; Martinez Vasquez, D.; Mendoza, N.; Morales, J.; Nikitina, N.; Ochoa Aybar, S.; Ortiz, A.; Padilla Macias, P.; Perez, F.; Perez Sanchez, J. A.; Pina Toledano, S.; Ramos Gonzalez, M.; Rivera Ramos, C.; Roa Castro, V; Romero Cardona, G.; Ruiz Cornejo, M.; Salinas, A.; Santana, G.; Sida Perez, P.; Tovar Castaneda, A. C.; Trujillo Cortes, R.; Brodmann, M.; Lenz, K.; Drexel, H.; Foechterle, J.; Hagn, C.; Podczeck-Schweighofer, A.; Huber, K.; Winkler, M.; Schneeweiss, B.; Gegenhuber, A.; Lang, W.; Eichinger-Hasenauer, S.; Kaserer, P.; Sykora, J.; Rasch, H.; Pichler, M.; Schaflinger, E.; Strohmer, B.; Breier, R.; Ebner, K-M; Eischer, L.; Freihoff, F.; Lischka-Lindner, A.; Mark, T.; Mirtl, A.; Said, A.; Stoeckloecker, C.; Vogel, B.; Vonbank, A.; Woehrer, C.; Zanolin, D.; Cools, F.; Paparella, G.; Vandergoten, P.; Parque, J-L; Capiau, L.; Vervoort, G.; Wollaert, B.; Desfontaines, P.; Mairesse, G.; Boussy, T.; Godart, P.; De Wolf, A.; Voet, J.; Heyse, A.; Hollanders, G.; Ann, W.; Vercammen, J.; Purnode, P.; Blankoff, I; Faes, D.; Balthazar, Y.; Beutels, M.; Marechal, P.; Verstraete, S.; Xhaet, O.; Striekwold, H.; Thoeng, J.; Hermans, K.; Alzand, B.; Ascoop, A-K; Banaeian, F.; Barbuto, A-M; Billiaux, A. C.; Blockmans, M.; Bouvy, C.; Brike, C.; Capiau, H.; Casier, T.; Conde Y Bolado, A.; De Cleen, D.; De Coninck, M.; de Vos, M.; de Weerdt, N.; Delforge, M.; Delvigne, M.; Denie, D.; Derycker, K.; Deweerd, E.; Dormal, F.; Drieghe, S.; Everaert, M.; Eykerman, T.; Feys, E.; Ghekiere, M.; Gits, F.; Hellemans, S.; Helvasto, L.; Jacobs, C.; Lips, S.; Mestdagh, I; Nimmegeers, J.; Piamonte, V; Pollet, P.; Postolache, A.; Raepers, M.; Raymenants, E.; Richa, J.; Rombouts, H.; Salembier, J.; Scheurwegs, C.; Semeraro, O.; Simons, N.; Smessaert, C.; Smolders, W.; Stockman, I; Tahon, S.; Thyssen, V; Tincani, G.; Van Durme, F.; Van Lier, D.; Vandekerckhove, H.; Vandekerckhove, Y.; Vandenbroeck, D.; Vandorpe, A.; Vanhalst, E.; Vanhauwaert, B.; Vantomme, C.; Vergauwen, L.; Verloove, H.; Vydt, T.; Weyn, T.; Jansky, P.; Reichert, P.; Spacek, R.; Machova, V; Zidkova, E.; Ludka, O.; Olsr, J.; Kotik, L.; Plocova, K.; Racz, B.; Ferkl, R.; Hubac, J.; Kotik, I; Monhart, Z.; Burianova, H.; Jerabek, O.; Pisova, J.; Petrova, I; Dedek, V; Honkova, M.; Podrazil, P.; Spinar, J.; Vitovec, J.; Novak, M.; Lastuvka, J.; Durdil, V; Antonova, P.; Bockova, L.; Bultas, J.; Chlumsky, J.; Dastychova, L.; Drasnar, T.; Honek, J.; Horejsi, M.; Hubacova, V; Janska, L.; Kopeckova, I; Kratochvilova, R.; Krcova, E.; Labrova, R.; Lindourkova, A.; Lipoldova, J.; Lubanda, H.; Ludkova, A.; Mahdalikova, L.; Majernikova, M.; Michalik, D.; Potuznik, P.; Prochazkova, E.; Sulc, A.; Sveceny, J.; Valtova, M.; Zidek, M.; Zika, J.; Nielsen, J.; Nielsen, H.; Husted, S.; Hintze, U.; Rasmussen, S.; Bremmelgaard, A.; Markenvard, J.; Boerger, J.; Solgaard, J.; Simonsen, P.; Loekkegaard, T.; Bruun, M.; Mertz, J.; Dominguez, H.; Skagen, K.; Egstrup, K.; Ibsen, H.; Raymond, I; Bang-Hansen, T.; Ellervik, C.; Eriksen, E.; Jensen, L.; Jensen, M.; Leth, M.; Nygaard, A.; Park, J.; Schou, M.; Therkelsen, A.; Tilma, J.; Vesterager, K.; Raatikainen, P.; Airaksinen, J.; Arola, O.; Koistinen, J.; Nappila, H.; Peltomaki, K.; Rasanen, V; Vasankari, T.; Le Heuzey, J-Y; Galinier, M.; Gottwalles, Y.; Paganelli, F.; Loiselet, P.; Muller, J-J; Koujan, M. B.; Marquand, A.; Destrac, S.; Piot, O.; Delarche, N.; Cebron, J-P; Boveda, S.; Guenoun, M.; Guedj-Meynier, D.; Galley, D.; Ohayon, J.; Assouline, S.; Zuber, M.; Amarenco, P.; Ellie, E.; Kadouch, J.; Fournier, P-Y; Huberman, J-P; Lemaire, M.; Rodier, G.; Milandre, L.; Vandamme, X.; Sibon, I; Neau, J-P; Mahagne, M. H.; Mielot, A.; Bonnefoy, M.; Churet, J-B; Navarre, V; Sellem, F.; Monniot, G.; Boyes, J-P; Doucet, B.; Martelet, M.; Obadia, D.; Crousillat, B.; Mouallem, J.; Bearez, E.; Nazeyrollas, P.; Brugnaux, J. P.; Fedorowsky, A.; Casassus, F.; Berneau, J-B; Chemin, F.; Falvo, N.; Perron, J-M; Poulard, J-E; Barreau, A.; Beltra, C.; Corrihons, E.; Decarsin, N.; Dubois, B.; Ducasse, E.; Giry, X.; Kemmel, A.; Ledure, S.; Lemaire, N.; Robin, F.; Rosolin, N.; Sanchez, D.; Suissa, A.; Darius, H.; Koeniger, G.; Purr, J.; Gerbaulet, U.; Kellner, B-T; Kopf, A.; Schaefer, T.; Zauzig, H.; Riegel, P.; Hohensee, H.; Eissfeller, E.; Eder, W.; Rehling, G.; Glatzel, D.; Zutz, S.; Heinz, G-U; Menke, H.; Pustelnik, A.; Sandow, P.; Ludwig, N.; Wiswedel, H.; Wildenauer, W.; Axthelm, C.; Schwarz, T.; Babyesiza, A.; Stuchlik, G.; Zimny, H-H; Kropp, M.; Kahl, F.; Caspar, A.; Omankowsky, S.; Laessig, T.; Hartmann, H-J; Lehmann, G.; Bindig, H-W; Hergdt, G.; Reimer, D.; Hauk, J.; Dorsch, W.; Dshabrailov, J.; Michel, H.; Rapp, K-A; Vormann, R.; Mayer, P.; Horstmeier, U.; Eissing, V; Hey, H.; Leuchtgens, H.; Lilienweiss, V; Kolitsch, K.; Schubert, C.; Lauer, H.; Buchner, T.; Brauer, G.; Kamin, S.; Mueller, K.; Abdel-Qader, M.; Baumbach, S.; Ebert, H-H; Schwencke, C.; Schellong, S.; Bernhardt, P.; Karolyi, L.; Sievers, B.; Haverkamp, W.; Salbach, P.; Roehnisch, J-U; Schoen, S.; Erdle, W.; Mueller, T.; Mueller, H.; Mitrovic, V; Babjakova, Z.; Bergner, K.; Boehme, S.; Bonin, K.; Buckert, D.; Busch, F.; Dichristin, U.; Diez, S.; Fleck, A.; Flint, K.; Floegel, H.; Fritz, C.; Frommhold, R.; Gehre, J.; Geyer, J.; Grytzmann, A.; Hahn, M.; Helgert, K.; Hubert, K.; Kirchner-Volker, K.; Klein, V; Kroll, D.; Krueger, A.; Lehmann, R.; Mann, L.; Maselli, A.; Menken, G.; Mikes, K.; Mortan, H.; Nasser, N.; Nicolaus, D.; Plauskat, A.; Pomper, L.; Quietzsch, A.; Ravenhorst, C.; Reichelt, C.; Reimer, C.; Schaefer, B.; Scharrer, S.; Schirmer, K.; Schmidt, K.; Schoene, R.; Schulze, J.; Schuppe, M.; Simon, S.; Sommer, S.; Spranger, K.; Talkenberger, A.; Tauber, K.; Tetlak, A.; Toennishoff, T.; Voelkel-Babyesiza, R.; Voigts, B.; Weiser, U.; Wesendorf, S.; Wildenauer, S.; Wolf, T.; Wurziger, J.; Zak, J.; Zauzig, H-D; Ziefle, S.; Zincke, S.; Keltai, M.; Vangel, S.; Szalai, G.; Merkely, B.; Kancz, S.; Boda, Z.; Nagy, A.; Laszlo, Z.; Matoltsy, A.; Gaszner, B.; Polgar, P.; Habon, T.; Noori, E.; Juhasz, G.; Kanakaridisz, N.; Szentpeteri, I; Juhasz, F.; Vertes, A.; Papp, A.; May, Z.; Ferenczi, J.; Egyutt, M.; Kis, E.; Engelthaler, G.; Szantai, G.; Fulop, E.; Gombos, P.; Gulyas, D.; Jen, P.; Gyorke, E. Kiralyhazine; Kovacs, M.; Levang, S. Kovacsne; Marianna, S.; Radics, Z.; Sydo, N.; Szalo, R.; Szilagyi, A.; Sztanyik, F.; Vandrus, B.; Agnelli, G.; Ambrosio, G.; Tiraferri, E.; Santoro, R.; Testa, S.; Di Minno, G.; Moia, M.; Caimi, T. M.; Martini, G.; Tessitori, M.; Cappelli, R.; Poli, D.; Quintavalla, R.; Melone, F.; Cosmi, F.; Pizzini, A.; Piseddu, G.; Fanelli, R.; Latella, C.; Santi, R.; Pancaldi, L.; De Cristofaro, R.; Palareti, G.; De Blasio, A.; Uriarte, J. Salerno; Minetti, F.; Pogliani, E. M.; Lonati, L. M.; Accogli, M.; Ciampani, N.; Malengo, S.; Feola, M.; Raisaro, A.; Fattore, L.; Grilli, P.; Germini, F.; Settimi, M.; Alunni, M.; Duranti, G.; Tedeschi, L.; Baglioni, G.; Avanzino, G.; Berardi, M.; Pannacci, V; Giombolini, A.; Nicoli, S.; Scarponi, T.; Allasia, B.; Ricciarini, P.; Nasorri, R.; Argena, A.; Bossolasco, P.; Ronchini, P.; Filippi, A.; Tradati, F.; Bulla, C.; Donzelli, L.; Foppa, L.; Bottarelli, M. L.; Tomasello, A.; Mauric, A.; Femiano, C.; Reggio, R.; Lillo, F.; Mariani, A.; Forcignano, F.; Volpe, M.; D'Avino, M.; Bongiorni, M. G.; Severi, S.; Capucci, A.; Lodigiani, C.; Salomone, E.; Serviddio, G.; Tondo, C.; Golino, P.; Mazzone, C.; Iacopino, S.; Pengo, V; Galvani, M.; Moretti, L.; Ambrosino, P.; Banfi, E.; Biagioli, V; Bianchi, A.; Boggian, G.; Breschi, M.; Brusorio, S.; Calcagnoli, F.; Campagna, G.; Carpenedo, M.; Ciabatta, C.; Ciliberti, G.; Cimmino, G.; D'Arienzo, C.; Di Gennaro, L.; Fedele, M.; Ferrini, P. M.; Granzow, K.; Guazzaloca, G.; Guerra, F.; Lo Buglio, A.; Longo, S.; Macellari, F.; Mesolella, E.; Poeta, E. Mollica; Occhilupo, P.; Oriana, V; Rangel, G.; Salomone, L.; Scaccianoce, A.; Scarone, C.; Segreti, L.; Sottilota, G.; Villani, R.; Zecca, C.; ten Cate, H.; Ruiter, J. H.; Klomps, H.; Bongaerts, M.; Pieterse, M. G. C.; Guldener, C.; Herrman, J-P; Lochorn, G.; Lucassen, A.; Adriaansen, H.; The, S. H. K.; Nierop, P. R.; Hoogslag, P. A. M.; Hermans, W.; Groenemeijer, B. E.; Terpstra, W.; Buiks, C.; Boersma, L. V. A.; Boersma-Slootweg, M.; Bosman, F.; Bosschaert, M.; Bruin, S.; Danse, I; De Graaf, J.; de Graauw, J.; Debordes, M.; Dols, S.; Geerlings, F.; Gorrebeeck, K.; Jerzewski, A.; Jetten, W.; Kelderman, M.; Kloosterman, T.; Koomen, E. M.; Krikken, J.; Melman, P.; Mulder, R.; Pronk, A.; Stallinga-de Vos, A.; te Kaat, J.; Tonino, P.; Uppelschoten, B.; van de Loo, R.; van der Kley, T.; van Leeuwen, G.; van Putten, J. J.; Westerman, L.; Atar, D.; Berge, E.; Sirnes, P. A.; Gjertsen, E.; Hole, T.; Erga, K.; Hallaraker, A.; Skjelvan, G.; Ostrem, A.; Ghezai, B.; Svilaas, A.; Christersson, P.; Oien, T.; Henrichsen, S. Hoegh; Berg-Johansen, J.; Otterstad, J. E.; Antonsen, H.; Ausen, K.; Claussen, H.; Dominguez, I; Jekthammer, A.; Lensebraaten, A. B.; Nilsen, V; O'Donovan, M.; Ringdalen, K.; Strand, S.; Stepinska, J.; Korzeniak, R.; Gieroba, A.; Biedrzycka, M.; Ogorek, M. (Marcin); Wozakowska-Kaplon, B.; Loboz-Grudzien, K.; Kosior, J.; Supinski, W.; Kuzniar, J.; Zaluska, R.; Hiczkiewicz, J.; Swiatkowska-Byczynska, L.; Kucharski, L.; Gruchala, M.; Minc, P.; Olszewski, M.; Kania, G.; Krzciuk, M.; Lajkowski, Z.; Ostrowska-Pomian, B.; Lewczuk, J.; Zinka, E.; Karczmarczyk, A.; Chmielnicka-Pruszczynska, M.; Trusz-Gluza, M.; Opolski, G.; Bronisz, M.; Ogorek, M. (Michal); Glanowska, G.; Ruszkowski, P.; Jaworska, K.; Sciborski, R.; Okopien, B.; Kukla, P.; Wozniak-Skowerska, I; Galbas, K.; Cymerman, K.; Jurowiecki, J.; Miekus, P.; Myszka, W.; Mazur, S.; Lysek, R.; Baszak, J.; Rusicka-Piekarz, T.; Raczak, G.; Domanska, E.; Nessler, J.; Lesnik, J.; Ambicka, M.; Andrzejewski, D.; Araminowicz, J.; Barszcz, A.; Bartkowiak, R.; Bartnik, J.; Basiak, M.; Bekieszczuk, E.; Bernat, L.; Biedrzycki, L.; Biernacka, A.; Blaszczyk, D.; Broton, E.; Brzozowski, W.; Brzustowska, M.; Bzymek, R.; Chmielowski, A.; Chojnowski, P.; Cichomski, R.; Cieslak, K.; Cieszynska, A.; Curyllo, B.; Czamara, M.; Danilowicz-Szymanowicz, L.; Dolecka, B.; Drelich, L.; Dudzik-Richter, B.; Dybala, T.; Dziuba, M.; Faron, W.; Figura-Chmielewska, M.; Frankiewicz, A.; Gadzinski, W.; Gasior, E.; Gosciniecka, B.; Gutknecht, P.; Guziewicz, M.; Jackun-Podlesna, A.; Jaguszewska, G.; Jankielewicz, J.; Jaremczuk-Kaczmarczyk, A.; Jargiello-Baszak, M.; Jarzebowski, A.; Jaskulska-Niedziela, E.; Jaworska-Drozdowska, M.; Kabat, J.; Kaczmarzyk-Radka, A.; Kalin, K.; Kaliszczak, R.; Kiliszek, M.; Klata, M.; Kluczewski, M.; Kobielusz-Gembala, I; Kochanska, E.; Kociolek, D.; Kolodzinska, A.; Komlo, A.; Konopka, A.; Korczowska, E.; Kowal, E.; Kowalczyk, H. K.; Kremis, E.; Kruczyk, D.; Krzesiak-Lodyga, A.; Krzyzanowski, M.; Kurdzielewicz, W.; Kustrzycka-Kratochwil, D.; Lesniewska-Krynska, D.; Leszczynski, J.; Lewicka, E.; Lichota, E.; Lip, K.; Loboz-Rudnicka, M.; Luka, J.; Lysek-Jozefowicz, A.; Machnikowska, M.; Majewska, K.; Mariankowski, R.; Markiewicz, A.; Mazur, M.; Metzgier-Gumiela, A.; Miedlar, E.; Mielcarek, M.; Neubauer-Geryk, J.; Niedek, J.; Niemirycz-Makurat, A.; Nowak, A.; Nowak, S.; Opielowska-Nowak, B.; Ozgowicz, M.; Pawelska-Buczen, A.; Pawlik-Rak, E.; Piotrowicz, R.; Ptaszynski, P.; Raczynska, A.; Rogowski, W.; Romanek, J.; Romaszkiewicz, R.; Rostoff, P.; Roszczyk, N.; Rozewska-Furmanek, D.; Rychta, J.; Rzyczkowska, B.; Sidor, A.; Skalska, J.; Smichura, M.; Splawski, M.; Staneta, P.; Staniszewska, E.; Starak-Marciniak, J.; Stopyra-Poczatek, M.; Sukiennik-Kujawa, M.; Szafranski, J.; Szalecki, P.; Szczepanska, A.; Szkrobka, W.; Szuchnik, E.; Szulowska, A.; Szumczyk-Muszytowska, G.; Szwoch, M.; Traczyk, T.; Troszczynska, M.; Trzcinski, G.; Tybura, S.; Walasik, P.; Wegrzynowska, M.; Wesolowska, K.; Wieczorek, W.; Wierzbicka, A.; Wilczewski, P.; Wilgat-Szecowka, M.; Wojewoda, P.; Wojnowski, L.; Wrobel, M.; Zakutynska-Kowalczyk, K.; Zyczynska-Szmon, M.; Panchenko, E.; Eltishcheva, V; Libis, R.; Tereshchenko, S.; Popov, S.; Kamalov, G.; Belenky, D.; Zateyshchikova, A.; Kropacheva, E.; Kolesnikova, A.; Nikolaev, K.; Egorova, L.; Khokhlov, A.; Yakupov, E.; Poltavskaya, M.; Zateyshchikov, D.; Drapkina, O.; Vishnevsky, A.; Barbarash, O.; Miller, O.; Aleksandrova, E.; Chizhov, P.; Sergeev, M.; Shutemova, E.; Mazur, E.; Zrazhevskiy, K.; Novikova, T.; Kostenko, V; Moiseeva, Y.; Polkanova, E.; Sobolev, K.; Rossovskaya, M.; Zubeeva, G.; Shapovalova, Y.; Nagibovich, O.; Edin, A.; Agakhanyan, A.; Batalov, R.; Belenkova, Y.; Bitakova, F.; Chugunnaya, S.; Dumikyan, A.; Erofeeva, S.; Gorbunova, E.; Gorshkova, T.; Gubanov, A.; Gurmach, M.; Ivanova, Y.; Kolesova, T.; Konyushenko, D.; Korneeva, O.; Kropova, O.; Kuchuk, P.; Kungurtseva, O.; Kupriyanova, T.; Kurylo, B.; Kuvanova, M.; Lebedeva, O.; Lileeva, E.; Machilskaya, O.; Medvedeva, T.; Monako, G.; Motylev, I; Nagibovich, G.; Novikova, E.; Orlov, Y.; Osmolovskaya, Y.; Ovsannikova, A.; Platonov, D.; Rachkova, S.; Sinitsina, O.; Speshilova, S.; Suslova, O.; Ushakov, A.; Volodicheva, O.; Zemlianskaia, O.; Zhirov, I; Zhuravleva, E.; Zotova, I; Vinolas, X.; Alvarez Garcia, P.; Lopez Fernandez, M. F.; Tercedor, L.; Tranche Iparraguirre, S.; Toran Monserrat, P.; Marquez Contreras, E.; Isart Rafecas, J.; Motero Carrasco, J.; Garcia Pavia, P.; Gomez Pajuelo, C.; Moro Serrano, C.; Iglesias Alonso, L. F.; Grande Ruiz, A.; Merce Klein, J.; Gonzalez Juanatey, J. R.; Baron Esquivias, G.; Monte Collado, I; Palacin Piquero, H.; Brotons Cuixart, C.; Rodriguez Morato, M.; Llibre, J. Bayo, I; Corros Vicente, C.; Vida Gutierrez, M.; Epelde Gonzalo, F.; Almeida Fernandez, C. A.; Del Val Plana, N.; Escriva Montserrat, E.; Montero Alia, J. J.; Barreda Gonzalez, M.; Moleiro Oliva, M. A.; Iglesias Sanmartin, J.; Jimenez Gonzalez, M.; Rodriguez Alvarez, M.; Herreros Melenchon, J.; Ripoll Vera, T.; Ridocci Soriano, F.; Garcia Riesco, L.; Marco Macian, M. D.; Quiles Granado, J.; Jimenez Navarro, M.; Cosin Sales, J.; Vaquer Perez, J. V.; Vazquez Caamano, M.; Arcocha Torres, M. F.; Marcos Gomez, G.; Iniguez Romo, A.; Prieto Diaz, M. A.; Alonso, C. (Carmela); Alonso, C. (Concepcion); Alvarez, D.; Alvarez, M.; Amaro, M.; Andere, N.; Aracil Villar, J.; Armitano Ochoa, R.; Austria, A.; Barbeira, S.; Barraquer Feu, E.; Bartes, A.; Becerra Munoz, V; Bermudez Jimenez, F. J.; Branjovich Tijuan, A.; Cabeza Ramirez, J.; Cabrera Ramos, M.; Calvo Martinez, E.; Campo Moreno, M.; Cancho Corchado, G.; Casanova Gil, M.; Castillo Orive, M.; Castro Fernandez, D.; Cebollada del Misterio, M.; Codinachs Alsina, R.; Cortada Cabrera, A.; Prego de Faria, J. Costa Pinto; Costas, S.; Cotilla Marco, M., I; Dachs, M.; Diaz Lopez, C. M.; Domenech Borras, A.; Elorriaga Madariaga, A.; Espallargas, A.; Fernandez, M.; Fernandez Escobar, E.; Fernandez Mas, E.; Ferrer, A.; Fosch, J.; Garcia Bermudez, M.; Garcia Millan, V; Gavira Saenz, M.; Gines Garcia, C.; Gomez, C.; Gomez Perez, Y.; Gonzales Segovia, A.; Gonzalez, P.; Grigorian, L.; Guerrero Molina, A.; Gutierrez del Val, M. del C.; Herrero Maeso, B.; Hevia Rodriguez, E.; Iglesias Garcia, A.; Jimenez Fernandez, M. J.; Jimeno Besa, B.; Juan Salvadores, P.; Lage Bouzamayor, M. B.; Lasuncion, I; Lezcano Gort, L. E.; Llobet Molina, M.; Lopez, M.; Manzanal Rey, A.; Mara Guerra, J.; Marcus, S.; Martin Vila, A.; Martinez Mena, M.; Mazon, P.; Mendez Zurita, F.; Millan, G.; Molina, M.; Montero Alia, P.; Montes, D.; Moure Gonzalez, M.; Munoz Munoz, R. B.; Negrete Palma, A.; Orellana Figueroa, H. N.; Ortega, V. M.; Ortiz Cortes, C.; Otero Tomera, D.; Palomo Merchan, N.; Pareja Ibar, I.; Pena Garcia, E.; Pereda Armayor, M.; Perez Carasa, M.; Prieto, I; Quintern, V; Renom, R.; Rincon Diaz, L. M.; Rios, V; Riquelme Sola, L.; Rivera, R.; Robiro Robiro, X.; Roca, M.; Roca Saumell, C.; Rodrigo, C.; Rodriguez, E.; Rodriguez Garcia, M.; Saez Jimenez, S.; Sanchez Calderon, P.; Sanchez Mendez, L.; Sanchez Parra, S.; Santolaya, C.; Senan Sanz, M. R.; Seoane Blanco, A.; Serralvo, E.; Sierra, N.; Simon Valero, C.; Sorribes Lopez, J.; Teixido Fontanillas, M.; Terns Riera, M.; Tobajas, G.; Torres, C.; Torres Marques, J.; Ubeda Pastor, M.; Rosenqvist, M.; Wirdby, A.; Linden, J.; Henriksson, K.; Elmersson, M.; Egilsson, A.; Borjesson, U.; Svard, G.; Liu, B.; Lindh, A.; Olsson, L-B; Gustavsson, M.; Andersson, L. (Lars); Andersson, L. (Lisbeth); Benson, L.; Bothin, C.; Hajimirsadeghi, A.; Kadir, K.; Ericsson, M.; Ohlsson, A.; Lindvall, H.; Svensson, P.; Thorne, K.; Handel, H.; Platonov, P.; Eriksson, B.; Timberg, I; Romberg, K.; Crisby, M.; Karlsson, J-E; Jensen, S. A.; Andersson, A.; Malmqvist, L.; Martinsson, B.; Bernsten, F.; Engdahl, J.; Thulin, J.; Hot-Bjelac, A.; Stalby, P.; Aaroe, H.; Ahbeck, E.; Ahlmark, H.; Al-Khalili, F.; Bonkowski, G.; Dzeletovic, S.; Ekstrand, A-B; Eriksson, G-B; Floren, K.; Grassjo, C.; Hahn, S.; Jaensson, P.; Jansson, B.; Jansson, J-H; Kangert, R-M; Koch, A.; Kusiak, D.; Lettenstrom, A.; Lindberg, A.; Lindholm, C-J; Mannermyr, A.; Mansson, K.; Millborg, M.; Nilsson, C.; Ohlin, A-M; Olofsson, A.; Osberg, A.; Pedersen, A.; Risbecker, K.; Rosenberg, K.; Samuelsson, J.; Shayesteh, M.; Skoglund, K.; Stjernberg, M.; Thorsen, C.; Steffel, J.; Beer, J. H.; Debrunner, J.; Amstutz, D.; Bruegger, J.; Elise, G.; Grau, A.; Guinand, A.; Henriette, I; Saga, E.; Winnik, S.; Parkhomenko, A.; Rudyk, I; Tseluyko, V; Karpenko, O.; Zhurba, S.; Kraiz, I; Kupnovytska, I; Serediuk, N.; Mostovoy, Y.; Ushakov, O.; Koval, O.; Kovalskyi, I; Svyshchenko, Y.; Sychov, O.; Stanislavchuk, M.; Kraydashenko, O.; Yagensky, A.; Tykhonova, S.; Fushtey, I; Belegai, R.; Berko, G.; Burdeuna, L.; Chabanna, O.; Daniuk, I; Ivanov, A.; Kamenska, E.; Kaplan, P.; Khyzhnyak, O.; Kizim, S.; Matova, O.; Medentseva, O.; Mochonyi, V; Mospan, M.; Nemtsova, V; Ovdiienko, T.; Palamarchuk, O.; Pavelko, M.; Petrovskyy, R.; Plevak, D.; Proshak, O.; Pyvovar, S.; Rasputina, L.; Romanenko, O.; Romanova, O.; Sapatyi, A.; Shumakov, O.; Stets, R.; Todoriuk, L.; Varenov, V.; Fitzmaurice, D.; Chauhan, N.; Goodwin, D.; Saunders, P.; Evans, R.; Leese, J.; Jhittay, P. S.; Ross, A.; Kainth, M. S.; Pickavance, G.; McDonnell, J.; Williams, A.; Gooding, T.; Wagner, H.; Suryani, S.; Singal, A.; Sircar, S.; Bilas, R.; Hutchinson, P.; Wakeman, A.; Stokes, M.; Paul, N.; Aziz, M.; Ramesh, C.; Wilson, P.; Franklin, S.; Fairhead, S.; Thompson, J.; St Joseph, V; Taylor, G.; Tragen, D.; Seamark, D.; Paul, C.; Richardson, M.; Jefferies, A.; Sharp, H.; Jones, H.; Giles, C.; Page, M.; Oginni, O.; Aldegather, J.; Wetherwell, S.; Lumb, W.; Evans, P.; Scouller, F.; Macey, N.; Stipp, Y.; West, R.; Thurston, S.; Wadeson, P.; Matthews, J.; Pandya, P.; Gallagher, A.; Railton, T.; Sinha, B.; Russell, D.; Davies, J. A.; Ainsworth, P.; Jones, C. P.; Weeks, P.; Eden, J.; Kernick, D.; Murdoch, W.; Lumley, L.; Patel, R. P.; Wong, S. W.; Saigol, M.; Ladha, K.; Douglas, K.; Cumberlidge, D. F.; Bradshaw, C.; Van Zon, G.; Jones, K. P.; Thomas, M. J.; Watson, E.; Sarai, B.; Ahmad, N.; Willcock, W.; Cairns, J.; Sathananthan, S.; de Kare-Silver, N.; Gilliland, A.; Strieder, E.; Howitt, A.; Vishwanathan, B.; Bird, N.; Gray, D.; Clark, M.; Bisatt, J.; Litchfield, J.; Fisher, E.; Fooks, T.; Kelsall, A. R.; Alborough, E.; Wakeling, J.; Parfitt, M.; Milne, K.; Rogers, S.; Priyadharshan, R.; Oliver, J. L.; Davies, E.; Abushal, S.; Jacobs, M.; Hutton, C.; Walls, N., I; Thompson, R.; Chigbo, C.; Zaidi, S. M. A.; Howard, M.; Butter, K. C.; Barrow, S.; Little, H.; Haq, I. U.; Gibbons, L.; Glencross, S.; McLeod, A. J.; Poland, K.; Mulholland, C.; Warke, A.; Conn, P.; Burns, G.; Smith, R. N.; Lowe, S.; Kamath, R.; Dau, H. S.; Webster, J.; Hodgins, I; Vercoe, S.; Roome, P. C.; Pinnock, H.; Patel, J. R. A.; Ali, A.; Hart, N.; Davies, R.; Stuart, E.; Neden, C. A.; Danielsen, M.; Heath, R.; Sharma, P.; Galloway, S.; Hawkins, C.; Oliver, R.; Aylward, M.; Mannion, S.; Braddick, M.; Edwards, D.; Rothwell, A. C.; Sabir, A.; Choudhary, F.; Khalaque, S.; Wilson, A.; Peters, S.; Coulson, W.; Roberts, N.; Heer, A.; Coates, S.; Ward, B.; Jackson, D.; Walton, S.; Shepherd, D.; Sterry, M.; Wong, T.; Boon, M.; Bunney, R.; Haria-Shah, R.; Baron, R. T.; Davies, S.; Schatzberger, T.; Hargreaves, N.; Stephenson, T.; Choi, H.; Batson, R.; Lucraft, L.; Myhill, T.; Estifano, S.; Geatch, D.; Wilkinson, J.; Veale, R.; Forshaw, K.; Davies, T.; Zaman, K.; Vinson, P.; Liley, C.; Bandrapalli, M.; McGinty, P.; Wastling, R.; McEleny, P.; Beattie, A.; Cooke, P.; Wong, M.; Gunasegaram, J.; Pugsley, M.; Ahmad, S.; A'Court, C.; Ayers, J.; Bennett, J.; Cartwright, S.; Dobson, S.; Dooldeniya, C.; Flynn, A.; Fox, R.; Goram, J.; Halpin, A.; Hay, A.; Jacobs, P.; Jeffers, L.; Lomax, L.; Munro, I; Muvva, R.; Nadaph, M.; Powell, K.; Randfield, S.; Redpath, D.; Reed, R.; Rickenbach, M.; Rogers, G.; Saunders, P. B.; Seamark, C.; Shewring, J.; Simmons, P.; Simper, H.; Stoddart, H.; Sword, A.; Thomas, N.; Thomson, A.; Gibbs, H.; Blenkhorn, A.; Singh, B.; Van Gaal, W.; Abhayaratna, W.; Lehman, R.; Roberts-Thomson, P.; Kilian, J.; Coulshed, D.; Catanchin, A.; Colquhoun, D.; Kiat, H.; Eccleston, D.; French, J.; Zimmett, L.; Ayres, B.; Phan, T.; Blombery, P.; Crimmins, D.; O'Donnell, D.; Choi, A.; Astridge, P.; Arstall, M.; Jepson, N.; Binnekamp, M.; Lee, A.; Rogers, J.; Starmer, G.; Carroll, P.; Faunt, J.; Aggarwala, A.; Barry, L.; Batta, C.; Beveridge, R.; Black, A.; Bonner, M.; Boys, J.; Buckley, E.; Campo, M.; Carlton, L.; Connelly, A.; Conway, B.; Cresp, D.; Dimitri, H.; Dixon, S.; Dolman, M.; Duroux, M.; Eskandari, M.; Eslick, R.; Ferreira-Jardim, A.; Fetahovic, T.; Fitzpatrick, D.; Geraghty, R.; Gibbs, J.; Grabek, T.; Modi, M. H.; Hayes, K.; Hegde, M. P.; Hesketh, L.; Hoffmann, B.; Jacobson, B.; Johnson, K.; Juergens, C.; Kassam, I; Lawlor, V; Lehman, M.; Lehman, S.; Leung, D.; Mackay, S.; MacKenzie, M.; McCarthy, C.; McIntosh, C.; McKeon, L.; Morrison, H.; Mussap, C.; Myers, J-D; Nagalingam, V; Oldfield, G.; O'May, V; Palmer, J.; Parsons, L.; Patching, K.; Patching, T.; Paul, V; Plotz, M.; Preston, S.; Rashad, H.; Ratcliffe, M.; Raynes, S.; Rose, J.; Sanders, L.; Seremetkoska, M.; Setio, H.; Shone, S.; Shrestha, P.; Singh, C.; Singleton, C.; Stoyanov, N.; Sutcliffe, S.; Swaraj, K.; Tarrant, J.; Thompson, S.; Tsay, I. M.; Vorster, M.; Waldman, A.; Wallis, L.; Wilford, E.; Wong, K.; Connolly, S. J.; Spyropoulos, A.; Eikelboom, J.; Luton, R.; Gupta, M.; Pandey, A. S.; Cheung, S.; Leader, R.; Beaudry, P.; Ayala-Paredes, F.; Berlingieri, J.; Heath, J.; Poirier, G.; Du Preez, M.; Nadeau, R.; Dresser, G.; Dhillon, R.; Hruczkowski, T.; Schweitzer, B.; Coutu, B.; Angaran, P.; MacDonald, P.; Vizel, S.; Fikry, S.; Parkash, R.; Lavoie, A.; Cha, J.; Ramjattan, B.; Bonet, J.; Ahmad, K.; Aro, L.; Aves, T.; Beaudry, K.; Bergeron, C.; Bigcanoe, J.; Bignell, N.; Breakwell, L.; Burke, E.; Carroll, L.; Clarke, B.; Cleveland, T.; Daheb, S.; Dehghani, P.; Denis, I; Djaidani, Z.; Dorian, P.; Douglass, S.; Dunnigan, J.; Ewert, A.; Farquhar, D.; Fearon, A.; Ferleyko, L.; Fournier, D.; Fox, B.; Grenier, M-C; Gulliver, W.; Haveman, K.; Hines, C.; Hines, K.; Jackson, A. M.; Jean, C.; Jethoo, G.; Kahlon, R.; Kelly, S.; Kim, R.; Korley, V; Kornder, J.; Kwan, L.; Largy, J.; Lewis, C.; Lewis, S.; Mangat, I; Moor, R.; Navratil, J.; Neas, I; Otis, J.; Otis, R.; Pandey, M.; Petrie, F.; Pinter, A.; Raines, M.; Roberts, P.; Robinson, M.; Sas, G.; Schulman, S.; Snell, L.; Spearson, S.; Stevenson, J.; Trahey, T.; Wong, S.; Wright, D.; Ragy, H.; Abd El-Aziz, A.; Abou Seif, S. K.; El Din, M. G.; El Etriby, S.; Elbahry, A.; El-Etreby, A.; Elkhadem, M.; Katta, A.; Khairy, T.; Mowafy, A.; Nawar, M.; Ohanissian, A.; Reda, A.; Reda, M.; Salem, H.; Sami, N.; Samir, S.; Setiha, M.; Sobhy, M.; Soliman, A.; Taha, N.; Tawfik, M.; Zaatout, E.; Kettles, D.; Bayat, J.; Siebert, H.; Horak, A.; Kelfkens, Y.; Garda, R.; Pillay, T.; Guerra, M.; van Zyl, L.; Theron, H.; Murray, A.; Louw, R.; Greyling, D.; Mntla, P.; Ueckermann, V; Loghdey, R.; Ismail, S.; Ahmed, F.; Engelbrecht, J.; Ramdass, A.; Maharajh, S.; Oosthuysen, W.; Angel, G.; Bester, C.; Booysen, M.; Boshoff, C.; Cannon, C.; Cassimjee, S.; Chami, C.; Conway, G.; Davids, A.; de Meyer, L.; Du Plessis, G.; Ellis, T.; Henley, L.; Karsten, M.; Loyd, E.; Marks, J.; Mavhusa, L.; Mostert, M.; Page, A.; Rikhotso, L.; Salie, M.; Sasto, J.; Shaik, F.; Skein, A.; Smith, L.; Tarr, G.; Tau, T.; van Zyl, F.; Al Mahmeed, W.; Yousef, G.; Agrawal, A.; Nathani, M.; Ibrahim, M.; Esheiba, E. M.; Singh, R.; Naguib, A.; Abu-Mahfouz, M.; Al Omairi, M.; Al Naeemi, A.; Maruthanayagam, R.; Bazargani, N.; Wassef, A.; Gupta, R.; Khan, M.; Subbaraman, B.; Abdul, A.; Al Mulla, A.; El Bardisy, S.; Haridas, P.; Jadhav, S.; Magdaluyo, K.; Makdad, M.; Maqsood, I; Mohamed, R.; Sharma, N.; Sharma, R.; Thanzeel, M.; Goldhaber, S. Z.; Canosa, R.; Rama, P.; Blumberg, E.; Garcia, J.; Mullen, P.; Wilson, V; Quick, A.; Ferrick, K.; Kutayli, W. M.; Cox, M.; Franco, M.; Falkowski, S.; Mendelson, R.; Williams, M.; Miller, S.; Beach, S.; Alfieri, A.; Gutowski, T.; Haque, I; Reddy, R.; Ahmed, W.; Delafontaine, P.; Diercks, D.; Theodoro, D.; Remmel, K.; Alberts, M.; Ison, R.; Noveck, H.; Duffy, P.; Pitta, S.; Nishijima, D.; Treasure, C.; Asafu-Adjaye, N.; Ball, K.; Bartlett, M.; Bentley, M.; Bowers, S.; Brown, A.; Browne, A.; Cameron-Watts, J.; Canova, M.; Cassidy, D.; Cervellione, K.; Congal, S.; DePauw, J.; Dickerson, A.; Eley, M.; Evans, L.; Felpel, S.; Ferdinand, K.; Fielder, D.; Gentry, P.; Haideri, A.; Hakimi, F.; Harbour, T.; Hartranft, E.; Hawkins, B.; Headlee, M.; Henson, L.; Herrick, C.; Hicks, T.; Jasinski, S.; Jones, A.; Jones, L.; Jones, P.; Karl, S.; Keeling, M.; Kerr, J.; Knowles, P.; Langdon, J.; Lay, M.; Lee, J. A.; Lincoln, T.; Malone, E.; Merliss, A.; Merritt, D.; Minardo, J.; Mooso, B.; Orosco, C.; Palumbo, V; Parker, M.; Parrott, T.; Paserchia, S.; Pearl, G.; Peterson, J.; Pickelsimer, N.; Purcell, T.; Raynor, J.; Raziano, S.; Richard, C.; Richardson, T.; Robertson, C.; Sage, A.; Sanghera, T.; Shaw, P.; Shoemaker, J.; Smith, K.; Stephanie, B.; Thatcher, A.; Theobald, H.; Thompson, N.; Treasure, L.; Tripti, T.; Verdi, C.; Worthy, V		GARFIELD-AF Investigators; GARFIELD-AF Investigators	Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GUIDELINE-RECOMMENDED THERAPIES; 2016 ESC GUIDELINES; CLINICAL-PRACTICE; HEART-FAILURE; ORAL ANTICOAGULATION; OUTCOMES; PERSISTENT; MORTALITY; ADHERENCE	Background The factors influencing three major outcomes +/- death, stroke/systemic embolism (SE), and major bleeding +/- have not been investigated in a large international cohort of unselected patients with newly diagnosed atrial fibrillation (AF). Methods and results In 28,628 patients prospectively enrolled in the GARFIELD-AF registry with 2-year followup, we aimed at analysing: (1) the variables influencing outcomes; (2) the extent of implementation of guideline-recommended therapies in comorbidities that strongly affect outcomes. Median (IQR) age was 71.0 (63.0 to 78.0) years, 44.4% of patients were female, median (IQR) CHA(2)DS(2)-VASc score was 3.0 (2.0 to 4.0); 63.3% of patients were on anticoagulants (ACs) with or without antiplatelet (AP) therapy, 24.5% AP monotherapy, and 12.2% no antithrombotic therapy. At 2 years, rates (95% CI) of death, stroke/SE, and major bleeding were 3.84 (3.68; 4.02), 1.27 (1.18; 1.38), and 0.71 (0.64; 0.79) per 100 person-years. Age, history of stroke/SE, vascular disease (VascD), and chronic kidney disease (CKD) were associated with the risks of all three outcomes. Congestive heart failure (CHF) was associated with the risks of death and stroke/SE. Smoking, non-paroxysmal forms of AF, and history of bleeding were associated with the risk of death, female sex and heavy drinking with the risk of stroke/SE. Asian race was associated with lower risks of death and major bleeding versus other races. AC treatment was associated with 30% and 28% lower risks of death and stroke/SE, respectively, compared with no AC treatment. Rates of prescription of guideline-recommended drugs were suboptimal in patients with CHF, VascD, or CKD. Conclusions Our data show that several variables are associated with the risk of one or more outcomes, in terms of death, stroke/SE, and major bleeding. Comprehensive management of AF should encompass, besides anticoagulation, improved implementation of guideline-recommended therapies for comorbidities strongly associated with outcomes, namely CHF, VascD, and CKD.	[Bassand, Jean-Pierre] Univ Besancon, EA 3920, Dept Cardiol, Besancon, France; [Bassand, Jean-Pierre; Accetta, Gabriele; Gao, Haiyan; Kayani, Gloria; Pieper, Karen; Kakkar, Ajay K.] Thrombosis Res Inst, London, England; [Al Mahmeed, Wael] Cleveland Clin Abu Dhabi, Cardiol Heart & Vasc Inst, Abu Dhabi, U Arab Emirates; [Corbalan, Ramon] Catholic Univ, Sch Med, Dept Cardiol, Santiago, Chile; [Eikelboom, John; Turpie, Alexander G. G.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Fitzmaurice, David A.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Goldhaber, Samuel Z.] Harvard Med Sch, Boston, MA USA; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Tokyo, Kanagawa, Japan; [Haas, Sylvia] Tech Univ Munich, Formerly Klinikum Rechts Isar, Munich, Germany; [Pieper, Karen] Duke Clin Res Inst, Durham, NC USA; [van Eickels, Martin] Bayer AG, Berlin, Germany; [Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; [Kakkar, Ajay K.] UCL, London, England	Universite de Franche-Comte; Thrombosis Research Institute; Cleveland Clinic Foundation; Pontificia Universidad Catolica de Chile; McMaster University; University of Warwick; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tokai University; Technical University of Munich; Duke University; Bayer AG; Onze Lieve Vrouwe Gasthuis Hospital; University of London; University College London	Bassand, JP (corresponding author), Univ Besancon, EA 3920, Dept Cardiol, Besancon, France.; Bassand, JP (corresponding author), Thrombosis Res Inst, London, England.	jpbassand@tri-london.ac.uk	galvani, marcello/AAQ-3210-2020; D'ARIENZO, CARMELA/AAC-3171-2022; Pekdemir, Hasan/ABI-6096-2020; ikitimur, b/GWN-0163-2022; Rasputina, Lesia/AAE-5764-2019; Airaksinen, Juhani/AAC-7857-2021; Ovsyannikova, Alla/I-9002-2014; Ushakov, Alexei V/P-4465-2015; Moiseeva, Yulia/GRN-8132-2022; Poltavskaya, Maria/M-4652-2017; Poltavskaya, Maria/ABD-5518-2021; Sergey, Tereshchenko/AAA-9455-2021; Cate, Hugo ten/AAM-4000-2021; Brotons, Carlos/AAG-8365-2020; Fox, keith A A/I-3742-2013; Matova, Olena/AAL-8219-2020; Reis, Gökçe Pınar/AAL-7851-2021; Drapkina, Oxana/G-8443-2016; Khokhlov, Alexander L./E-2765-2017; Goto, Shinya/AAU-6045-2020; Sucu, Murat/A-4303-2017; Lipoldová, Jolana/GRF-6472-2022; Xhaet, Olivier/AAB-1459-2020; Ersanlı, Murat/D-8315-2019; Eikelboom, John/AAG-6117-2019; Chemello, Diego/AIC-5762-2022; Ellervik, Christina/H-2977-2019; Danilowicz-Szymanowicz, Ludmila/AAG-7732-2019; Drapkina, Oksana/AAE-5376-2021; Zhirov, Igor V/I-3405-2016; Epelde, Francisco/AAT-7213-2021; YILMAZ, Mehmet Birhan/Y-1372-2019; Guerra, Federico/P-6635-2017; Buglio, Aurelio Lo/ABC-5292-2020; Rostoff, Pawel/U-5657-2018; Iparraguirre, Salvador Tranche/N-7319-2019; Torres, Maria/GVU-3391-2022; TONDO, CLAUDIO/GZM-6859-2022; Quiles, Juan/B-9663-2009; Ciliberti, Giuseppe/AAX-8027-2020; Ambrosio, Giuseppe/C-6596-2013; Sahiner, Levent/AAK-6087-2020; Iacopino, Saverio/A-8658-2019; falvo, nicolas/AAT-1864-2021; SIBON, IGOR/AAJ-2503-2020; Ptaszynski, Pawel Andrzej/S-9684-2016; Durdil, V/AEO-8322-2022; Teragawa, Hiroki/AAJ-5116-2020; Eltishcheva, Vera/AAX-6033-2020; Maia, Lilia Nigro/AAV-6938-2021; Altun, Armagan/ABB-5844-2020; Chemello, Diego/AAF-4253-2019; Zateyshchikov, Dmitry A/D-6575-2012; Kaplan, Pavlo/AAZ-3341-2021; Segreti, Luca/ADB-7236-2022; Silaruks, Songkwan/AAB-4166-2022; Nakazone, Marcelo Arruda/H-2719-2012; Aydınlar, Ali/AAI-6632-2021; Kraidashenko, Oleksandr/AAT-8167-2020; Ripoll-Vera, Tomas/AAT-3535-2021; Heyse, Alex/X-8629-2019; Filho, Dario Sobral/H-8624-2019; Batalov, Roman E./J-1707-2017; Panchenko, Elizaveta/AAN-1884-2020; Karaayvaz, Ekrem Bilal/AAE-5991-2020; Stanislavchuk, Mykola/GRX-8902-2022; Khyzhnyak, Olena/GQY-5805-2022; Germini, Federico/K-6881-2016; Habon, Tamas/S-9289-2019; Shumakov, Oleksandr/GLU-3025-2022; Lewicka, Ewa/T-9676-2018; Precoma, Dalton B/D-5674-2013; Kropacheva, Ekaterina/AAN-1691-2020; Kasala, Latheef/AAU-1077-2021; Nikolaev, Konstantin/P-4750-2017; Tykhonova, Susanna/GQP-1859-2022; Ambrosino, Pasquale/AAD-1934-2020; Kaliszczak, Robert/A-6153-2016; Basiak, Marcin/GLV-6022-2022; Hiczkiewicz, Jarosław/ABC-5678-2021; Mantovani, Lorenzo Giovanni/AAC-4263-2021; Ching, Chi Keong/AAR-8968-2021; villani, rosanna/K-5753-2018; Hacke, Werner/ABE-8661-2020; Nagibovich, Oleg Alexandrovich/J-4049-2013; Volpe, Massimo/K-5240-2016; Ueckermann, Veronica/GXV-4532-2022; Seredyuk, Nestor/W-6794-2018; Popov, Sergey/F-1751-2014; Reis, Gilmar/I-4500-2013	galvani, marcello/0000-0001-5897-667X; Pekdemir, Hasan/0000-0002-4913-5120; Rasputina, Lesia/0000-0003-1230-4039; Airaksinen, Juhani/0000-0002-0193-568X; Ovsyannikova, Alla/0000-0002-9669-745X; Ushakov, Alexei V/0000-0002-7020-4442; Moiseeva, Yulia/0000-0002-5000-5454; Poltavskaya, Maria/0000-0003-4463-2897; Sergey, Tereshchenko/0000-0001-9234-6129; Brotons, Carlos/0000-0001-9388-6581; Drapkina, Oxana/0000-0002-4453-8430; Khokhlov, Alexander L./0000-0002-0032-0341; Goto, Shinya/0000-0002-6821-1504; Sucu, Murat/0000-0002-3695-5461; Xhaet, Olivier/0000-0002-4133-0191; Ersanlı, Murat/0000-0003-1847-3087; Eikelboom, John/0000-0003-4126-1285; Chemello, Diego/0000-0003-2051-2321; Ellervik, Christina/0000-0002-3088-4375; Danilowicz-Szymanowicz, Ludmila/0000-0002-2269-1880; Drapkina, Oksana/0000-0002-4453-8430; Zhirov, Igor V/0000-0002-9519-6717; Epelde, Francisco/0000-0001-5547-4025; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Guerra, Federico/0000-0001-5394-1312; Rostoff, Pawel/0000-0003-4942-4587; Quiles, Juan/0000-0002-3458-6260; Ciliberti, Giuseppe/0000-0001-8698-5848; Ambrosio, Giuseppe/0000-0002-9677-980X; Iacopino, Saverio/0000-0002-2131-1110; SIBON, IGOR/0000-0002-1171-4215; Ptaszynski, Pawel Andrzej/0000-0001-6084-7324; Teragawa, Hiroki/0000-0002-0183-2541; Altun, Armagan/0000-0002-3233-8263; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Nakazone, Marcelo Arruda/0000-0002-0449-7056; Aydınlar, Ali/0000-0002-8974-8837; Kraidashenko, Oleksandr/0000-0002-8911-3292; Heyse, Alex/0000-0002-6364-6074; Filho, Dario Sobral/0000-0002-5301-7741; Batalov, Roman E./0000-0002-8100-098X; Germini, Federico/0000-0002-0802-3616; Habon, Tamas/0000-0002-4816-857X; Lewicka, Ewa/0000-0002-0162-2659; Kropacheva, Ekaterina/0000-0002-3092-8593; Kasala, Latheef/0000-0002-4212-9756; Nikolaev, Konstantin/0000-0003-4601-6203; Ambrosino, Pasquale/0000-0002-9398-0428; Kaliszczak, Robert/0000-0001-5586-260X; Basiak, Marcin/0000-0003-0674-5612; villani, rosanna/0000-0001-9875-019X; Nagibovich, Oleg Alexandrovich/0000-0002-1520-0860; Volpe, Massimo/0000-0002-9642-8380; Wozniak-Skowerska, Iwona/0000-0003-0335-961X; Shumakov, Olexandr/0000-0002-1427-2344; Mostovoy, Yuriy/0000-0002-7041-1230; HIGA, SATOSHI/0000-0002-5735-6249; Pisani, Cristiano/0000-0003-3457-1605; Angaran, Paul/0000-0003-2697-173X; Nemtsova, Valeriya/0000-0001-7916-3168; Rudyk, Iurii/0000-0002-3363-868X; Boersma, Lucas/0000-0003-4591-4220; Kaplan, Pavel/0000-0003-0455-2630; Cimmino, Giovanni/0000-0002-3802-7052; lodigiani, corrado/0000-0002-9152-9385; Khyzhnyak, Olena/0000-0003-0942-2261; Wongcharoen, Wanwarang/0000-0002-2418-329X; Pyvovar, Sergiy/0000-0002-9991-8027; DEL CARLO, CARLOS HENRIQUE/0000-0002-8946-7509; Maria del Mar, Rodriguez/0000-0002-3588-5449; Seredyuk, Nestor/0000-0002-3616-2445; Phrommintikul, Arintaya/0000-0003-3986-1951; Popov, Sergey/0000-0002-9050-4493; Shutemova, Elena/0000-0002-5324-3570; Romanova, Elena/0000-0003-4653-4326; Abhayaratna, Walter/0000-0002-4908-0641; De Cristofaro, Raimondo/0000-0002-8066-8849; Reis, Gilmar/0000-0002-4847-1034; Berko, Galyna/0000-0003-1701-9667; Eltishcheva, Vera/0000-0001-7498-8128; Fox, Keith/0000-0002-0140-2752; Segreti, Luca/0000-0002-1421-9033; Tondo, Claudio/0000-0002-8500-8313; Sadamatsu, Kenji/0000-0003-2614-9447; GALINIER, Michel/0000-0003-1735-3390; Burdeina, Liudmyla/0000-0001-7450-7777; Aves, Theresa/0000-0002-9153-511X; Santoro, Rita/0000-0002-5081-8201	Bayer AG, Berlin, Germany	Bayer AG, Berlin, Germany	This work was supported by an unrestricted research grant from Bayer AG, Berlin, Germany (http://pharma.bayer.com) to the Thrombosis Research Institute, London, UK (A.K.K.), which sponsors the GARFIELD-AF registry. Martin van Eickels is employed by Bayer AG and is a non-voting member of the GARFIELDAF Steering Committee. Bayer AG provided support in the form of salary for author M.v.E., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Allen NB, 2012, STROKE, V43, P1858, DOI 10.1161/STROKEAHA.112.652305; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Bassand JP, 2016, EUR HEART J, V37, P2882, DOI 10.1093/eurheartj/ehw233; Boriani G, 2016, EUROPACE, V18, P648, DOI 10.1093/europace/euv390; Chen DC, 2015, VASC HEALTH RISK MAN, V11, P185, DOI 10.2147/VHRM.S76651; Chiang CE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P632, DOI 10.1161/CIRCEP.112.970749; Estrella MM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-230; Fauchier L, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000290; Fonarow GC, 2012, J AM HEART ASSOC, V1, P16, DOI 10.1161/JAHA.111.000018; Fox KAA, 2017, EUR HEART J-QUAL CAR, V3, P114, DOI 10.1093/ehjqcco/qcw058; Friberg L, 2010, EUR HEART J, V31, P967, DOI 10.1093/eurheartj/ehn599; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Heras M, 2006, HEART, V92, P1571, DOI 10.1136/hrt.2005.079673; Hijazi Z, 2016, EUR HEART J, V37, P1582, DOI 10.1093/eurheartj/ehw054; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inoue H, 2013, J CARDIOL, V61, P1, DOI 10.1016/j.jjcc.2012.08.012; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Link MS, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004267; Massera D, 2017, EUROPACE, V19, P929, DOI 10.1093/europace/euw110; Mathur R, 2013, HEART, V99, P1087, DOI 10.1136/heartjnl-2013-303767; Mehta RH, 2015, CIRCULATION, V131, P980, DOI 10.1161/CIRCULATIONAHA.114.013451; Nieuwlaat R, 2008, EUR HEART J, V29, P915, DOI 10.1093/eurheartj/ehn101; O'Brien EC, 2014, AM HEART J, V167, P601, DOI 10.1016/j.ahj.2013.12.014; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Philipneri MD, 2008, CLIN EXP NEPHROL, V12, P41, DOI 10.1007/s10157-007-0016-3; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Pokorney SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002197; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Putera M, 2015, AM HEART J, V169, P266, DOI 10.1016/j.ahj.2014.09.015; Puymirat E, 2017, EUR HEART J-ACUTE CA, V6, P26, DOI 10.1177/2048872615610893; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Senoo K, 2016, HEART, V102, P1878, DOI 10.1136/heartjnl-2016-309741; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Turner GM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002169; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E	44	56	59	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191592	10.1371/journal.pone.0191592	http://dx.doi.org/10.1371/journal.pone.0191592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370229	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600064
J	Guo, S; Wang, YH; Chou, SR; Cui, HJ; Li, DN; Li, B				Guo, Shuang; Wang, Yuehua; Chou, Shurui; Cui, Huijun; Li, Dongnan; Li, Bin			In vitro antioxidant capacities of eight different kinds of apples and their effects on lipopolysaccharide-induced oxidative damage in mice	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; LIPID-PEROXIDATION; POLYPHENOLIC COMPOUNDS; CARBON-TETRACHLORIDE; LIVER-MITOCHONDRIA; VITAMIN-C; L. LEAVES; RAT-LIVER; STRESS; EXTRACTS	In the present study, the DPPH and ABTS(+) radical scavenging activity of eight types of apples decreased (P < 0.05) during the 70-day storage at 4 E C. The Fushi (F2) apples from Xin Jiang showed the highest radical scavenging activity. For in vivo study, 40 male Kunming mice (body weight 20 +/- 25 g) were selected and randomly assigned to four groups (10 mice per group). The F2 groups (F2S, F2 + sterile saline and F2L, F2 + lipopolysaccharide) were administered with 0.3 mL F2 filtrate via gastric intubation daily for 28 days. The control groups (CS, CON + sterile saline and CL, CON + lipopolysaccharide) were treated with sterile saline at the same volume. At day 29, mice of F2L and CL groups were injected with 100 mu g/ kg body weight of lipopolysaccharide (LPS) intraperitoneally, while those of F2S and CS groups were injected equal volume of sterile saline. In comparison to the CS group, the CL group showed a decrease (P < 0.05) in serum, liver, and hepatic mitochondrial antioxidant capacity, reduction (P < 0.05) in the expression of hepatic antioxidant-related genes, and an increase (P < 0.05) in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA), protein carbonyl (PC), and reactive oxygen species (ROS). In comparison to the CL group, the F2L group showed lower (P < 0.05) levels of serum ALT, AST, and ROS, higher (P < 0.05) level of serum, liver, and hepatic mitochondrial antioxidant capacity, increased mitochondrial membrane potential (MMP), and enhanced (P < 0.05) expression of hepatic antioxidant-related genes. These results suggest that F2 may exert protective effect against LPS-induced oxidative damage by improving the antioxidant capacity.	[Guo, Shuang; Wang, Yuehua; Chou, Shurui; Cui, Huijun; Li, Dongnan; Li, Bin] Shenyang Agr Univ, Coll Food Sci, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Li, B (corresponding author), Shenyang Agr Univ, Coll Food Sci, Shenyang, Liaoning, Peoples R China.	libinsyau2017@163.com			National Key Research and Development Plan Grant [2016YFD0400200]; Youth Scientific and Technological Innovation Talents Cultivation Plant in Agricultural Sector of Liaoning Province, China [2014041]; Agricultural Science and Technology Key Project of Science and Technology Bureau of Shenyang, Liaoning Province, China [2017-171267]	National Key Research and Development Plan Grant; Youth Scientific and Technological Innovation Talents Cultivation Plant in Agricultural Sector of Liaoning Province, China; Agricultural Science and Technology Key Project of Science and Technology Bureau of Shenyang, Liaoning Province, China	This work was supported by the National Key Research and Development Plan (Grant number: 2016YFD0400200), the Youth Scientific and Technological Innovation Talents Cultivation Plant in Agricultural Sector of Liaoning Province, China (Grant number: 2014041), and the Agricultural Science and Technology Key Project of Science and Technology Bureau of Shenyang, Liaoning Province, China (Grant number: 2017-171267).	Amakura Y, 2000, J AGR FOOD CHEM, V48, P6292, DOI 10.1021/jf000849z; Bai KW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155393; Banerjee A, 2008, CHEM-BIOL INTERACT, V174, P134, DOI 10.1016/j.cbi.2008.05.009; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Bonarska-Kujawa D, 2011, J MED PLANTS RES, V5, P2339; Bonarska-Kujawa D, 2011, FOOD BIOPHYS, V6, P58, DOI 10.1007/s11483-010-9175-y; Bondet V, 1997, FOOD SCI TECHNOL-LEB, V30, P609; Brun P, 2008, DIGEST LIVER DIS, V40, pA122; Cadenas S, 1998, PHARMACOL TOXICOL, V82, P11, DOI 10.1111/j.1600-0773.1998.tb01391.x; CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8; Chung HK, 2005, FOOD SCI BIOTECHNOL, V14, P715; Colle D, 2012, J MED FOOD, V15, P549, DOI 10.1089/jmf.2011.0282; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Gulcin I, 2012, ARAB J CHEM, V5, P489, DOI 10.1016/j.arabjc.2010.09.016; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hsu DZ, 2004, CRIT CARE MED, V32, P227, DOI 10.1097/01.CCM.0000104947.16669.29; Huang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039656; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Kim JS, 2009, FOOD CHEM, V116, P227, DOI 10.1016/j.foodchem.2009.02.038; Koc M, 2003, J RADIAT RES, V44, P211, DOI 10.1269/jrr.44.211; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Liu DH, 2008, LWT-FOOD SCI TECHNOL, V41, P1344, DOI 10.1016/j.lwt.2007.08.001; Liu J, 2012, P 15 IEEE INT S ISOR, P7; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Naito Y, 1994, J CLIN GASTROENTEROL, V21, pS82; Naruszewicz M, 2007, ATHEROSCLEROSIS, V194, pE179, DOI 10.1016/j.atherosclerosis.2006.12.032; Pajk T, 2006, NUTRITION, V22, P376, DOI 10.1016/j.nut.2005.08.010; Queiroz C, 2011, FOOD RES INT, V44, P1459, DOI 10.1016/j.foodres.2011.03.021; Ramesh B., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P895, DOI 10.1016/S2221-1691(12)60249-4; Ravikumar V, 2005, MOL CELL BIOCHEM, V269, P131, DOI 10.1007/s11010-005-3443-z; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Shirazi A, 2013, CELL J, V14, P292; Siddhuraju P, 2007, FOOD CHEM, V105, P950, DOI 10.1016/j.foodchem.2007.04.040; Skupien K, 2008, PHYTOTHER RES, V22, P689, DOI 10.1002/ptr.2411; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Tang XH, 2006, J NUTR BIOCHEM, V17, P177, DOI 10.1016/j.jnutbio.2005.06.008; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Tsao R, 2005, J AGR FOOD CHEM, V53, P4989, DOI 10.1021/jf048289h; Wang J, 2012, ENVIRON TOXICOL, V27, P503, DOI 10.1002/tox.20664; Wei QY, 2006, BBA-GEN SUBJECTS, V1760, P70, DOI 10.1016/j.bbagen.2005.09.008; Wojdylo A, 2008, J AGR FOOD CHEM, V56, P6520, DOI 10.1021/jf800510j; Wu JH, 2007, FOOD CHEM, V103, P88, DOI 10.1016/j.foodchem.2006.07.030; Zhang H, 2016, CURR OPIN FOOD SCI, V8, P33, DOI 10.1016/j.cofs.2016.02.002	47	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191762	10.1371/journal.pone.0191762	http://dx.doi.org/10.1371/journal.pone.0191762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370253	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600094
J	Kearney, MF; Spindler, J; Wiegand, A; Shao, W; Haubrich, R; Riddler, S; Lalama, CM; Hughes, MD; Coffin, JM; Mellors, JW				Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann; Shao, Wei; Haubrich, Richard; Riddler, Sharon; Lalama, Christina M.; Hughes, Michael D.; Coffin, John M.; Mellors, John W.			Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults	PLOS ONE			English	Article							DRUG-RESISTANT HIV-1; TREATMENT-NAIVE; EXPERIENCED PATIENTS; VARIANTS; THERAPY; MUTATIONS; INFECTION; INDIVIDUALS; NEVIRAPINE; PROTEASE	Background Identifying pre-ART factors associated with the emergence of HIV-1 drug resistance is critical for optimizing strategies to prevent virologic failure. A previous study reported that lower pre-ART HIV-1 pol diversity was associated with higher risk of virologic failure in HIV-1-infected children. To investigate this association in adults, we measured HIV-1 diversity with deep sequencing in pre-ART samples from adults with well-characterized virologic outcomes in a study (A5142) of initial ART conducted by the AIDS Clinical Trials Group (ACTG). Methods We identified 22 cases in ACTG A5142 who experienced virologic failure with drug resistance mutations in RT and 44 matched controls who did not experience virologic failure. cDNA was synthesized from plasma HIV-1 RNA. Each cDNA molecule was tagged with a unique primer ID and RT codons 41-103 were amplified and deep sequenced. Sequences with the same tag were aligned and a consensus was generated to reduce PCR and sequencing errors. Diversity was calculated by measuring average pairwise distance (APD) of the consensus sequences. An exact conditional logistic regression model with percent APD as the risk factor estimated the odds ratio for VF and the corresponding 95% confidence interval. Results Consensus single-genome sequences and diversity estimates of pol were obtained for pre-ART samples from 21 cases and 42 controls. The median (IQR) pre-ART percent APD was 0.71 (0.31-1.13) in cases and 0.58 (0.32-0.94) in controls. A possible trend was found for higher diversity being associated with greater risk of virologic failure in adults (OR = 2.2 per one percent APD increase, 95% CI = [0.8, 7.2]; p = 0.15). Conclusions This study in adults suggests there is a positive association between higher pre-ART pol diversity and the risk of virologic failure in adults rather than an inverse relationship reported in children.	[Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann] NCI, HIV Dynam & Replicat Program, Frederick, MD 21701 USA; [Shao, Wei] Leidos Biomed Res Inc, Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Frederick, MD USA; [Haubrich, Richard] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA; [Haubrich, Richard] Gilead Sci, Foster City, CA USA; [Riddler, Sharon; Mellors, John W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Lalama, Christina M.; Hughes, Michael D.] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; Gilead Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Tufts University	Kearney, MF (corresponding author), NCI, HIV Dynam & Replicat Program, Frederick, MD 21701 USA.	kearneym@ncifcrf.gov	Kearney, Mary/AAU-8132-2020	Kearney, Mary/0000-0003-3839-6576	NIH; National Cancer Institute; NIH [HHSN261200800001E, UM1A1106701]; Leidos Biomedical Research, Inc. through the National Cancer Institute [12XS547, 13SX110]; National Institute of Allergy and Infectious Diseases [U01A1068636, UM1 Al068634]; National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR); NATIONAL CANCER INSTITUTE [ZIABC011699, R35CA200421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069494, UM1AI106701, U01AI068634, UM1AI068636, UM1AI068634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leidos Biomedical Research, Inc. through the National Cancer Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural NIH funding including the National Cancer Institute and NIH Contract No. HHSN261200800001E, by NIH UM1A1106701 to the Pittsburgh Virology Specialty Laboratory, by Leidos Biomedical Research, Inc., subcontract 12XS547 to JWM and 13SX110 to JMC through the National Cancer Institute, and by Award Number U01A1068636 and UM1 Al068634 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR).	Boltz VF, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0321-6; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Bruner KM, 2016, RAP ACC DEF PROV COM; Buckton AJ, 2011, ANTIVIR THER, V16, P9, DOI 10.3851/IMP1687; Carr JM, 2009, J MED VIROL, V81, P1983, DOI 10.1002/jmv.21628; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Ekici H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111042; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keys J, 2015, PRIMER ID INFORMS NE; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Nwobegahay J, 2011, SAMJ S AFR MED J, V101, P335, DOI 10.7196/SAMJ.4391; Odaibo G N, 2012, Afr J Med Med Sci, V41 Suppl, P61; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paolucci S, 2001, J MED VIROL, V65, P207, DOI 10.1002/jmv.2022; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sachdeva Naresh, 2005, MedGenMed, V7, P68, DOI 10.1186/1758-2652-7-3-68; Shao W, 2014, J VIROL METHODS, V203, P73, DOI 10.1016/j.jviromet.2014.03.008; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Zhou ST, 2015, J VIROL, V89, P8540, DOI 10.1128/JVI.00522-15	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190438	10.1371/journal.pone.0190438	http://dx.doi.org/10.1371/journal.pone.0190438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370196	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600010
J	Chan, GC; Divers, J; Russell, GB; Langefeld, CD; Wagenknecht, LE; Xu, JZ; Smith, SC; Bowden, DW; Register, TC; Carr, JJ; Lenchik, L; Freedman, BI				Chan, Gary C.; Divers, Jasmin; Russell, Gregory B.; Langefeld, Carl D.; Wagenknecht, Lynne E.; Xu, Jianzhao; Smith, S. Carrie; Bowden, Donald W.; Register, Thomas C.; Carr, J. Jeffrey; Lenchik, Leon; Freedman, Barry I.			Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes	PLOS ONE			English	Article							VISCERAL FAT; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; BODY-COMPOSITION; ASSOCIATION; FRACTURE; ADULTS; MASS; OBESITY; RISK	Changes in select adipose tissue volumes may differentially impact bone mineral density. This study was performed to assess cross-sectional and longitudinal relationships between computed tomography-determined visceral (VAT), subcutaneous (SAT), inter-muscular (IMAT), and pericardial adipose tissue (PAT) volumes with respective changes in thoracic vertebral and lumbar vertebral volumetric trabecular bone mineral density (vBMD) in African Americans with type 2 diabetes. Generalized linear models were fitted to test relationships between baseline and change in adipose volumes with change in vBMD in 300 African American-Diabetes Heart Study participants; adjustment was performed for age, sex, diabetes duration, study interval, smoking, hypertension, BMI, kidney function, and medications. Participants were 50% female with mean +/- SD age 55.1 +/- 9.0 years, diabetes duration 10.2 +/- 7.2 years, and BMI 34.7 +/- 7.7 kg/m(2). Over 5.3 +/- 1.4 years, mean vBMD decreased in thoracic/lumbar spine, while mean adipose tissue volumes increased in SAT, IMAT, and PAT, but not VAT depots. In fully-adjusted models, changes in lumbar and thoracic vBMD were positively associated with change in SAT (beta[SE] 0.045[0.011], p<0.0001; 0.40[0.013], p = 0.002, respectively). Change in thoracic vBMD was positively associated with change in IMAT (p = 0.029) and VAT (p = 0.016); and change in lumbar vBMD positively associated with baseline IMAT (p<0.0001). In contrast, vBMD was not associated with change in PAT. After adjusting for BMI, baseline and change in volumes of select adipose depots were associated with increases in thoracic and lumbar trabecular vBMD in African Americans. Effects of adiposity on trabecular bone appear to be site-specific and related to factors beyond mechanical load.	[Chan, Gary C.; Freedman, Barry I.] Wake Forest Sch Med, Dept Internal Med, Sect Nephrol, Winston Salem, NC 27101 USA; [Chan, Gary C.] Univ Hong Kong, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Divers, Jasmin; Russell, Gregory B.; Langefeld, Carl D.; Wagenknecht, Lynne E.] Wake Forest Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Xu, Jianzhao; Smith, S. Carrie; Bowden, Donald W.] Wake Forest Sch Med, Ctr Diabet Res, Ctr Genom & Personalized Med Res, Dept Biochem, Winston Salem, NC USA; [Register, Thomas C.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Carr, J. Jeffrey] Vanderbilt Univ, Sch Med, Dept Radiol, Nashville, TN 37212 USA; [Lenchik, Leon] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; University of Hong Kong; Wake Forest University; Wake Forest University; Wake Forest University; Vanderbilt University; Wake Forest University	Freedman, BI (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Nephrol, Winston Salem, NC 27101 USA.	bfreedma@wakehealth.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Register, Thomas/0000-0002-4078-0166	National Institutes of Health [R01 DK071891, AR48797, HL67348]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by the National Institutes of Health R01 DK071891 (BF), AR48797 (JC), HL67348 (DB).	Berger C, 2009, J BONE MINER RES, V24, P361, DOI [10.1359/jbmr.081004, 10.1359/JBMR.081004]; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Choi HS, 2010, CALCIFIED TISSUE INT, V87, P218, DOI 10.1007/s00223-010-9398-4; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Freedman BI, 2015, J CLIN ENDOCR METAB, V100, P3693, DOI 10.1210/jc.2015-2167; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Hetemaki N, 2017, J CLIN ENDOCR METAB, V102, P4588, DOI 10.1210/jc.2017-01474; Hoffman DJ, 2005, OBES RES, V13, P66, DOI 10.1038/oby.2005.9; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136; Kim CJ, 2009, CLIN ENDOCRINOL, V71, P18, DOI 10.1111/j.1365-2265.2008.03452.x; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Lenchik L, 2004, J COMPUT ASSIST TOMO, V28, P134, DOI 10.1097/00004728-200401000-00023; Lenchik L, 2003, BONE, V33, P646, DOI 10.1016/S8756-3282(03)00237-0; Liu CT, 2017, J BONE MINER RES, V32, P143, DOI 10.1002/jbmr.2931; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Ng AC, 2013, BONE, V55, P119, DOI 10.1016/j.bone.2013.02.006; Ochs-Balcom HM, 2013, J CLIN ENDOCR METAB, V98, pE713, DOI 10.1210/jc.2012-3921; Register TC, 2013, J CLIN ENDOCR METAB, V98, P1916, DOI 10.1210/jc.2012-4126; Russell M, 2010, J CLIN ENDOCR METAB, V95, P1247, DOI 10.1210/jc.2009-1475; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Szulc P, 2010, J BONE MINER RES, V25, P1446, DOI 10.1002/jbmr.13; Upadhyay J, 2015, METABOLISM, V64, P105, DOI 10.1016/j.metabol.2014.10.021; Walsh JS, 2017, CALCIFIED TISSUE INT, V100, P528, DOI 10.1007/s00223-016-0229-0; Warming L, 2003, AM J OBSTET GYNECOL, V188, P349, DOI 10.1067/mob.2003.93; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; Zhang P, 2015, AM J CLIN NUTR, V101, P337, DOI 10.3945/ajcn.113.081778; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	31	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191674	10.1371/journal.pone.0191674	http://dx.doi.org/10.1371/journal.pone.0191674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364924	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500066
J	Nowak, M; Boos, A; Kowalewski, MP				Nowak, Marta; Boos, Alois; Kowalewski, Mariusz P.			Luteal and hypophyseal expression of the canine relaxin (RLN) system during pregnancy: Implications for luteotropic function	PLOS ONE			English	Article							ANTERIOR-PITUITARY-CELLS; ENDOTHELIAL GROWTH-FACTOR; CORPUS-LUTEUM; PROLACTIN SECRETION; INDUCED PARTURITION; CYCLIC DOG; IN-VITRO; PROGESTERONE; HORMONE; LOCALIZATION	By acting through its receptors (RXFP1, RXFP2), relaxin (RLN) exerts species-specific effects during pregnancy; possible luteotropic effects through stimulation of prolactin (PRL) release have been suggested. In the domestic dog (Canis lupus familiaris) serum PRL increases in pregnant bitches shortly after RLN appears in the circulation, and a possible functional relationship between the RLN and the PRL systems in regulating progesterone secretion has been implied. Therefore, here (Study 1) the luteal expression and localization of the RLN system was investigated by immunohistochemistry using custom-made antibodies and semi-quantitative PCR, at selected time points during gestation: pre-implantation (d. 8-12), post-implantation (d. 18-25), mid-gestation (d. 35-40) and at normal and antigestagen-induced luteolysis. Further, (Study 2) hypophyseal expression of the RLN system and its spatial association with PRL was assessed. Luteal expression of RLN, but not of its receptors, was time-dependent: it increased significantly following implantation towards mid-gestation and decreased at prepartum. Antigestagen treatment resulted in downregulation of RLN and RXFP2. Whereas RLN was localized in steroidogenic cells, RXFP1 and RXFP2 also stained strongly in macrophages and vascular endothelial cells. The RLN system was detected in the canine adenohypophysis and was co-localized with PRL in hypophyseal lactotrophs. The intraluteal RLN seems to be involved in regulating the canine corpus luteum (CL) in a time-dependent manner. The presence of RLN family members in the adenohypophysis implies their possible involvement in regulating the availability of PRL and other pituitary hormones.	[Nowak, Marta; Boos, Alois; Kowalewski, Mariusz P.] Univ Zurich, Vetsuisse Fac, Inst Vet Anat, Zurich, Switzerland	University of Zurich	Kowalewski, MP (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Vet Anat, Zurich, Switzerland.	kowalewskipl@yahoo.de		Boos, Alois/0000-0003-2461-1706; Kowalewski, Mariusz P./0000-0002-4565-7714	Swiss National Science Foundation (SNSF) [31003A_160251]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by the Swiss National Science Foundation (SNSF), grant no. 31003A_160251 to MPK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1952, MARSHALLS PHYSL REPR; BAGNELL CA, 1993, J REPROD FERTIL, P127; BANI G, 1988, HISTOL HISTOPATHOL, V3, P337; Bartsch O, 2004, J CLIN ENDOCR METAB, V89, P324, DOI 10.1210/jc.2003-030498; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bathgate RAD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P679; BETHEA CL, 1989, J CLIN ENDOCR METAB, V69, P956, DOI 10.1210/jcem-69-5-956; BRANNSTROM M, 1993, HUM REPROD, V8, P1011; Bryant-Greenwood G, 1987, Adv Exp Med Biol, V219, P709; BUKOVSKY A, 1995, BIOL REPROD, V53, P1373, DOI 10.1095/biolreprod53.6.1373; Concannon P, 2001, J REP FER S, P169; Concannon PW, 2009, REPROD DOMEST ANIM, V44, P3, DOI 10.1111/j.1439-0531.2009.01414.x; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; CRONIN MJ, 1989, J MOL ENDOCRINOL, V3, P175, DOI 10.1677/jme.0.0030175; CRONIN MJ, 1987, BIOCHEM BIOPH RES CO, V148, P1246, DOI 10.1016/S0006-291X(87)80266-8; Gram A, 2015, GEN COMP ENDOCR, V223, P54, DOI 10.1016/j.ygcen.2015.09.020; Gram A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109918; Gunzel-Apel AR, 2009, REPROD DOMEST ANIM, V44, P174, DOI 10.1111/j.1439-0531.2009.01381.x; HOFFMANN B, 1994, EXP CLIN ENDOCRINOL, V102, P185, DOI 10.1055/s-0029-1211280; Horton JS, 2011, BIOL REPROD, V85, P788, DOI 10.1095/biolreprod.110.089201; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hwang JJ, 1996, BIOL REPROD, V55, P1276, DOI 10.1095/biolreprod55.6.1276; KEHRER A, 1973, Z ANAT ENTWICKLUNGS, V143, P25, DOI 10.1007/BF00519908; Kooistra HS, 2001, REPROD DOMEST ANIM, V36, P115, DOI 10.1046/j.1439-0531.2001.d01-42.x; Kowalewski MP, 2006, J STEROID BIOCHEM, V101, P254, DOI 10.1016/j.jsbmb.2006.06.029; Kowalewski MP, 2006, THERIOGENOLOGY, V66, P1423, DOI 10.1016/j.theriogenology.2006.01.039; Kowalewski MP, 2011, THERIOGENOLOGY, V75, P877, DOI 10.1016/j.theriogenology.2010.10.030; Kowalewski MP, 2010, REPRODUCTION, V139, P655, DOI 10.1530/REP-09-0140; Kowalewski MP, 2009, ANIM REPROD SCI, V116, P129, DOI 10.1016/j.anireprosci.2008.12.011; Leo CH, 2016, BRIT J PHARMACOL, V173, P1005, DOI 10.1111/bph.13404; LI YF, 1993, ENDOCRINOLOGY, V133, P1205, DOI 10.1210/en.133.3.1205; Nishiyama T, 1999, ANAT HISTOL EMBRYOL, V28, P125, DOI 10.1046/j.1439-0264.1999.00170.x; Nowaczyk RM, 2017, THERIOGENOLOGY, V98, P123, DOI 10.1016/j.theriogenology.2017.05.003; Nowak M, 2017, REPRODUCTION, V154, P415, DOI [10.1530/REP-17-0135, 10.1530/rep-17-0135]; OKKENS AC, 1990, VET QUART, V12, P193, DOI 10.1080/01652176.1990.9694266; OKKENS AC, 1986, J REPROD FERTIL, V77, P187, DOI 10.1530/jrf.0.0770187; ONCLIN K, 1993, J REPROD FERTIL, P403; Onclin K, 1997, DOMEST ANIM ENDOCRIN, V14, P25, DOI 10.1016/S0739-7240(96)00093-8; Ryan PL, 1997, J REPROD FERTIL, V110, P329, DOI 10.1530/jrf.0.1100329; Schafer-Somi S, 2007, THERIOGENOLOGY, V68, P889, DOI 10.1016/j.theriogenology.2007.07.012; Shirota K, 2005, J CLIN ENDOCR METAB, V90, P516, DOI 10.1210/jc.2004-0130; SORTINO MA, 1989, ENDOCRINOLOGY, V124, P2013, DOI 10.1210/endo-124-4-2013; STEINETZ BG, 1989, AM J VET RES, V50, P68; STEINETZ BG, 1987, BIOL REPROD, V37, P719, DOI 10.1095/biolreprod37.3.719; Tamada H, 2010, J VET MED SCI, V72, P1383, DOI 10.1292/jvms.09-0485; TSUTSUI T, 1991, J VET MED SCI, V53, P1025, DOI 10.1292/jvms.53.1025; Unemori EN, 1999, HUM REPROD, V14, P800, DOI 10.1093/humrep/14.3.800; VandeVoort CA, 2000, BIOL REPROD, V62, P200, DOI 10.1095/biolreprod62.1.200; Verstegen-Onclin K, 2008, THERIOGENOLOGY, V70, P291, DOI 10.1016/j.theriogenology.2008.04.038; Willcox JM, 2013, J ENDOCRINOL, V218, P179, DOI 10.1530/JOE-13-0115	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191374	10.1371/journal.pone.0191374	http://dx.doi.org/10.1371/journal.pone.0191374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364921	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500044
J	Xu, SX; Leontyev, D; Kaul, R; Gray-Owen, SD				Xu, Stacey X.; Leontyev, Danila; Kaul, Rupert; Gray-Owen, Scott D.			&ITNeisseria gonorrhoeae&IT co-infection exacerbates vaginal HIV shedding without affecting systemic viral loads in human CD34(+) engrafted mice	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; GENITAL-TRACT; ANTIRETROVIRAL THERAPY; TRANSMISSION; INFECTION; URETHRITIS; CELLS; SEX; MEN; EXPRESSION	HIV synergy with sexually transmitted co-infections is well-documented in the clinic. Co-infection with Neisseria gonorrhoeae in particular, increases genital HIV shedding and mucosal transmission. However, no animal model of co-infection currently exists to directly explore this relationship or to bridge the gap in understanding between clinical and in vitro studies of this interaction. This study aims to test the feasibility of using a humanized mouse model to overcome this barrier. Combining recent in vivo modelling advancements in both HIV and gonococcal research, we developed a co infection model by engrafting immunodeficient NSG mice with human CD34(+) hematopoietic stem cells to generate humanized mice that permit both systemic HIV infection and genital N. gonorrhoeae infection. Systemic plasma and vaginal lavage titres of HIV were measured in order to assess the impact of gonococcal challenge on viral plasma titres and genital shedding. Engrafted mice showed human CD45(+) leukocyte repopulation in blood and mucosal tissues. Systemic HIV challenge resulted in 10(4)-10(5) copies/mL of viral RNA in blood by week 4 post-infection, as well as vaginal shedding of virus. Subsequent gonococcal challenge resulted in unchanged as vaginal shedding of virus. Subsequent gonococcal challenge resulted in unchanged plasma HIV levels but higher viral shedding in the genital tract, which reflects published clinical observations. Thus, human CD34(+) stem cell-transplanted NSG mice represent an experimentally tractable animal model in which to study HIV shedding during gonococcal co-infection, allowing dissection of molecular and immunological interactions between these pathogens, and providing a platform to assess future therapeutics aimed at reducing HIV transmission.	[Xu, Stacey X.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Leontyev, Danila; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Department of Medicine Challenge Fund; Canadian Institutes of Health Research (CIHR) [HOP-137697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125421] Funding Source: NIH RePORTER	Department of Medicine Challenge Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the Department of Medicine Challenge Fund and the Canadian Institutes of Health Research (CIHR) operating grants HOP-137697, http://www.cihr-irsc.gc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Champredon D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0961-5; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cone RA, 2014, J INFECT DIS, V210, pS616, DOI 10.1093/infdis/jiu459; Denton PW, 2011, AIDS REV, V13, P135; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Dobson-Belaire WN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018133; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gaudet RG, 2015, SCIENCE; Islam EA, 2016, MUCOSAL IMMUNOL, V9, P1051, DOI 10.1038/mi.2015.122; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Kaul R, 2002, J INFECT DIS, V185, P1525, DOI 10.1086/340214; Liu XY, 2006, J INFECT DIS, V194, P751, DOI 10.1086/506360; Malott RJ, 2013, P NATL ACAD SCI USA, V110, P10234, DOI 10.1073/pnas.1303738110; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Meditz AL, 2012, JAIDS-J ACQ IMM DEF, V59, P221, DOI 10.1097/QAI.0b013e31823fd215; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sadiq ST, 2005, SEX TRANSM INFECT, V81, P120, DOI 10.1136/sti.2004.010249; Sheung A, 2008, AIDS, V22, P1729, DOI 10.1097/QAD.0b013e32830baf5e; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Song W, 2008, VACCINE; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P171, DOI 10.1111/aji.12235; Yu QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056705; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191672	10.1371/journal.pone.0191672	http://dx.doi.org/10.1371/journal.pone.0191672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360873	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800049
J	Chang, W; Lajko, M; Fawzi, AA				Chang, William; Lajko, Michelle; Fawzi, Amani A.			Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; EPIRETINAL MEMBRANES; FIBROVASCULAR MEMBRANES; CELL-PROLIFERATION; ETB-RECEPTOR; EXPRESSION; FIBROCYTES; RETINA; BETA	Purpose To characterize the relationship between endothelin-1 and fibrosis in epiretinal membranes in proliferative diabetic retinopathy and explore the role of endothelial-mesenchymal transition in these membranes. Methods Membranes were obtained from eyes undergoing pars plana vitrectomy for complicated proliferative diabetic retinopathy or idiopathic epiretinal membrane. Through standard immunohistochemical techniques, we labeled membranes to explore the distribution of endothelin-1 and endothelin receptor B, comparing proliferative diabetic retinopathy and idiopathic epiretinal membranes. In addition, membranes were also labeled with markers for fibroblasts, endothelial, and glial cells and studied with confocal laser scanning microscopy. The intensity of endothelin-1 labeling was quantified using standard image analysis software. Results Fourteen membranes were included in the analysis, nine from eyes with proliferative diabetic retinopathy and five idiopathic membranes. Flatmount diabetic membranes showed co-localization of endothelin-1 with S100A4 and CD31. Immunohistochemistry and quantitative analysis of cross-sectional membranes showed significantly higher endothelin-1 labeling in proliferative diabetic retinopathy membranes compared to idiopathic membranes (p<0.05). Diabetic membranes showed more elements staining positive for S100A4 compared to idiopathic membranes. Conclusion Epiretinal membrane formation in proliferative diabetic retinopathy involves higher tissue levels of endothelin-1 and fibroblastic activity. Furthermore, endothelin-1, endothelial and fibroblastic staining appear to be correlated, suggestive of endothelial-to-mesenchymal transition in proliferative diabetic retinopathy.	[Chang, William; Lajko, Michelle; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	Research to Prevent Blindness, Inc; Illinois Society for the Prevention of Blindness; NCI [CCSG P30 CA060553]	Research to Prevent Blindness, Inc(Research to Prevent Blindness (RPB)); Illinois Society for the Prevention of Blindness; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by unrestricted funds from Research to Prevent Blindness, Inc (to the Department of Ophthalmology, Northwestern University Feinberg School of Medicine), and from the Illinois Society for the Prevention of Blindness (WC). Confocal Microscopy was performed at the Northwestern University Center for Advanced Microscopy, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013; Cao YA, 2014, INVEST OPHTH VIS SCI, V55, P7321, DOI 10.1167/iovs.14-15167; Chakrabarti S, 1998, CURR EYE RES, V17, P301, DOI 10.1076/ceyr.17.3.301.5216; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Cooley B. C, 2014, SCI TRANSL MED, V6; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kelland NF, 2010, CAN J PHYSIOL PHARM, V88, P644, DOI 10.1139/Y10-041; Kertes PJ, 2007, EVIDENCE BASED EYE C, pxiv; Kim LA, 2015, MOL VIS, V21, P673; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lim JI, 2010, RETINA-J RET VIT DIS, V30, P1472, DOI 10.1097/IAE.0b013e3181d6df09; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Mititelu M, 2013, JAMA OPHTHALMOL, V131, P1187, DOI 10.1001/jamaophthalmol.2013.4244; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Oberstein SYL, 2011, MOL VIS, V17, P1794; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Roldan-Pallares M, 2007, RETINA-J RET VIT DIS, V27, P222, DOI 10.1097/01.iae.0000231376.76601.40; Ross B, 2010, AM J RESP CELL MOL, V42, P16, DOI 10.1165/rcmb.2009-0175TR; Sanchez-Duffhues G, 2016, J PATHOL, V238, P378, DOI 10.1002/path.4653; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Swigris JJ, 2010, BIODRUGS, V24, P49, DOI 10.2165/11319550-000000000-00000; Tamaki K, 2016, INVEST OPHTH VIS SCI, V57, P4999, DOI 10.1167/iovs.16-19798; TONNESSEN T, 1995, CIRC RES, V76, P767; Vereb Z, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/492376; Wang XW, 2015, J MOL CELL CARDIOL, V80, P101, DOI 10.1016/j.yjmcc.2015.01.001; Wang ZL, 2010, EXP EYE RES, V91, P670, DOI 10.1016/j.exer.2010.08.008; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	45	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191285	10.1371/journal.pone.0191285	http://dx.doi.org/10.1371/journal.pone.0191285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351334	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300066
J	Babbar, M; Huang, Y; An, J; Landas, SK; Sheikh, MS				Babbar, Mansi; Huang, Ying; An, Jie; Landas, Steve K.; Sheikh, M. Saeed			CHTM1, a novel metabolic marker deregulated in human malignancies	ONCOGENE			English	Article							CREB; ACTIVATION; COACTIVATOR; OXIDATION; COMPLEX; CELLS	A better understanding of the link between cellular metabolism and tumorigenesis is needed. Here, we report characterization of a novel protein named coiled-coil helix tumor and metabolism 1 (CHTM1). We have found that CHTM1 is associated with cancer and cellular metabolism. CHTM1 localizes to mitochondria and cytosol, and its deficiency in cancer cells results in decreased mitochondrial oxygen consumption and ATP levels as well as oxidative stress indicating mitochondrial dysfunction. CHTM1-deficient cancer cells display poor growth under glucose/glutamine-deprived conditions, whereas cells expressing increased levels of exogenous CHTM1 exhibit enhanced proliferation and survival under similar conditions. CHTM1 deficiency also leads to defects in lipid metabolism resulting in fatty acid accumulation, which explains poor growth of CHTM1-deficient cells under glucose/glutamine deprivation since nutrient deprivation increases dependency on lipids for energy generation. We also demonstrate that CHTM1 mediates its effect via the PKC, CREB, and PGC-1alpha signaling axis, and cytosolic accumulation of CHTM1 during nutrient deprivation appears to be important for its effect on cellular signaling events. Furthermore, analyses of tissue specimens from 71 breast and 97 colon cancer patients show CHTM1 expression to be upregulated in the majority of tumor specimens representing these malignancies. Collectively, our findings are highly significant because CHTM1 is a novel metabolic marker that is important for the growth of tumorigenic cells under limiting nutrient supplies and thus, links cellular metabolism and tumorigenesis.	[Babbar, Mansi; Huang, Ying; An, Jie; Sheikh, M. Saeed] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Landas, Steve K.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA; [An, Jie] Gulfstream Diagnost Genom, Dallas, TX USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sheikh, MS (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	sheikhm@upstate.edu	Babbar, Mansi/AAP-7320-2020; Babbar, Mansi/P-1698-2019	BABBAR, MANSI/0000-0002-9690-8974	Carol M. Baldwin breast cancer fund; NIH [CA150132]; NATIONAL CANCER INSTITUTE [R03CA150132] Funding Source: NIH RePORTER	Carol M. Baldwin breast cancer fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Daniel P. Kelly, Sanford- Burnham Medical Research Institute, FL for providing the anti-PGC-1 alpha anti-body and Dr. Michael Shuen, York University, Ontario, Canada for pGL3-PGC-1 alpha promoter construct. Dr. David M. Markovitz (Department of Internal Medicine, University of Michigan Medical Center) kindly provided UACC-62 melanoma cells (originally from Dr. Maria S. Soengas, Melanoma Laboratory, Spanish National Cancer Research Center). This work was supported in part by Carol M. Baldwin breast cancer fund and NIH grant CA150132.	Agarwal NR, 2016, CELL BIOL INT, V40, P821, DOI 10.1002/cbin.10619; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Babbar Mansi, 2013, Mol Cell Pharmacol, V5, P109; Banci L, 2012, J STRUCT BIOL, V180, P190, DOI 10.1016/j.jsb.2012.07.007; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Hao YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11971; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Li BL, 2006, BIOCHEM BIOPH RES CO, V350, P179, DOI 10.1016/j.bbrc.2006.09.016; Lucchesi C, 2016, ONCOGENE, V35, P2565, DOI 10.1038/onc.2015.339; Luo XJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0646-3; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Simoes RV, 2015, NEOPLASIA, V17, P671, DOI 10.1016/j.neo.2015.08.005; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Yang J, 2012, J CLIN INVEST, V122, P600, DOI 10.1172/JCI58780; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200	29	3	3	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					2052	2066		10.1038/s41388-017-0051-9	http://dx.doi.org/10.1038/s41388-017-0051-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29371680	Green Accepted			2022-12-26	WOS:000429899400008
J	Elgeti, M; Kazmin, R; Rose, AS; Szczepek, M; Hildebrand, PW; Bartl, FJ; Scheerer, P; Hofmann, KP				Elgeti, Matthias; Kazmin, Roman; Rose, Alexander S.; Szczepek, Michal; Hildebrand, Peter W.; Bartl, Franz J.; Scheerer, Patrick; Hofmann, Klaus Peter			The arrestin-1 finger loop interacts with two distinct conformations of active rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DOMINANT RETINITIS-PIGMENTOSA; CARBOXYLIC-ACID GROUP; CRYSTAL-STRUCTURE; METARHODOPSIN-II; TRANSDUCIN ACTIVATION; TRANSMEMBRANE HELICES; PROTON UPTAKE; GPCR; COMPLEX	Signaling of the prototypical G protein-coupled receptor (GPCR) rhodopsin through its cognate G protein transducin (G(t)) is quenched when arrestin binds to the activated receptor. Although the overall architecture of the rhodopsin/arrestin complex is known, many questions regarding its specificity remain unresolved. Here, using FTIR difference spectroscopy and a dual pH/peptide titration assay, we show that rhodopsin maintains certain flexibility upon binding the "finger loop" of visual arrestin (prepared as synthetic peptide ArrFL-1). We found that two distinct complexes can be stabilized depending on the protonation state of E3.49 in the conserved (D) ERY motif. Both complexes exhibit different interaction modes and affinities of ArrFL-1 binding. The plasticity of the receptor within the rhodopsin/ArrFL-1 complex stands in contrast to the complex with the C terminus of the G(t) alpha-subunit (G alpha CT), which stabilizes only one specific substate out of the conformational ensemble. However, G(t) alpha-subunit binding and both ArrFL-1-binding modes involve a direct interaction to conserved R3.50, as determined by site-directed mutagenesis. Our findings highlight the importance of receptor conformational flexibility and cytoplasmic proton uptake for modulation of rhodopsin signaling and thereby extend the picture provided by crystal structures of the rhodopsin/arrestin and rhodopsin/ArrFL-1 complexes. Furthermore, the two binding modes of ArrFL-1 identified here involve motifs of conserved amino acids, which indicates that our results may have elucidated a common modulation mechanism of class A GPCR-G protein/-arrestin signaling.	[Elgeti, Matthias; Kazmin, Roman; Rose, Alexander S.; Szczepek, Michal; Hildebrand, Peter W.; Bartl, Franz J.; Scheerer, Patrick; Hofmann, Klaus Peter] Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany; [Rose, Alexander S.] Humboldt Univ, Grp Proteinformat, Invalidenstr 42, D-10115 Berlin, Germany; [Szczepek, Michal; Scheerer, Patrick] Humboldt Univ, Grp Prot Xray Crystallog & Signal Transduct, Invalidenstr 42, D-10115 Berlin, Germany; [Bartl, Franz J.] Humboldt Univ, Inst Biol, Biophys Chem, Invalidenstr 42, D-10115 Berlin, Germany; [Hildebrand, Peter W.] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Leipzig University	Elgeti, M (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.; Elgeti, M (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	melgeti@ucla.edu		Scheerer, Patrick/0000-0001-5028-2075; Rose, Alexander/0000-0002-0893-5551	Deutsche Forschungsgemeinschaft [EL 779, SFB 1078, D3/E3-1, SFB 740]; European Research Council TUDOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council TUDOR	This work was supported by the Deutsche Forschungsgemeinschaft EL 779 (to M.E.), SFB 1078 (to F.J.B. and P.S.), Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3-1 (to P.S.), and SFB 740 to (P.W.H., P.S., and K.P.H.), and the European Research Council TUDOR (to K.P.H.). The authors declare that they have no conflicts of interest with the contents of this article.	ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beck M, 1998, BIOCHEMISTRY-US, V37, P7630, DOI 10.1021/bi9801560; Beyriere F, 2015, J BIOL CHEM, V290, P12919, DOI 10.1074/jbc.M114.620898; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; FAHMY K, 1995, BIOPHYS CHEM, V56, P171, DOI 10.1016/0301-4622(95)00030-2; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hauser K, 2002, J PHYS CHEM A, V106, P3553, DOI 10.1021/jp012926e; Hoersch D, 2008, BIOCHEMISTRY-US, V47, P11518, DOI 10.1021/bi801397e; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MIN KC, 1993, J BIOL CHEM, V268, P9400; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerert P, 2017, CURR OPIN STRUC BIOL, V45, P160, DOI 10.1016/j.sbi.2017.05.001; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shi W, 1998, BIOCHEMISTRY-US, V37, P4869, DOI 10.1021/bi9731100; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Sommer ME, 2015, METHOD ENZYMOL, V556, P563, DOI 10.1016/bs.mie.2014.12.014; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Van Eps N., 2017, P NATL ACAD SCI USA; Vogel R, 2006, BIOCHEMISTRY-US, V45, P1640, DOI 10.1021/bi052196r; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2007, J MOL BIOL, V366, P1580, DOI 10.1016/j.jmb.2006.12.019; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	54	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4403	4410		10.1074/jbc.M117.817890	http://dx.doi.org/10.1074/jbc.M117.817890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29363577	hybrid, Green Published			2022-12-26	WOS:000428204300012
J	Hayama, R; Sparks, S; Hecht, LM; Dutta, K; Karp, JM; Cabana, CM; Rout, MP; Cowburn, D				Hayama, Ryo; Sparks, Samuel; Hecht, Lee M.; Dutta, Kaushik; Karp, Jerome M.; Cabana, Christina M.; Rout, Michael P.; Cowburn, David			Thermodynamic characterization of the multivalent interactions underlying rapid and selective translocation through the nuclear pore complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUZZY COMPLEXES; NUCLEOPORINS; TRANSPORT; PROTEINS; COMPENSATION; DIFFUSION; ENTROPY; REPEATS; BINDING; NTF2	Intrinsically disordered proteins (IDPs) play important roles in many biological systems. Given the vast conformational space that IDPs can explore, the thermodynamics of the interactions with their partners is closely linked to their biological functions. Intrinsically disordered regions of Phe-Gly nucleoporins (FG Nups) that contain multiple phenylalanine-glycine repeats are of particular interest, as their interactions with transport factors (TFs) underlie the paradoxically rapid yet also highly selective transport of macromolecules mediated by the nuclear pore complex. Here, we used NMR and isothermal titration calorimetry to thermodynamically characterize these multivalent interactions. These analyses revealed that a combination of low per-FG motif affinity and the enthalpy-entropy balance prevents high-avidity interaction between FG Nups and TFs, whereas the large number of FG motifs promotes frequent FG-TF contacts, resulting in enhanced selectivity. Our thermodynamic model underlines the importance of functional disorder of FG Nups. It helps explain the rapid and selective translocation of TFs through the nuclear pore complex and further expands our understanding of the mechanisms of "fuzzy" interactions involving IDPs.	[Hayama, Ryo; Hecht, Lee M.; Cabana, Christina M.; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA; [Sparks, Samuel; Karp, Jerome M.; Cowburn, David] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sparks, Samuel; Karp, Jerome M.; Cowburn, David] Albert Einstein Coll Med, Depts Physiol & Biophys, Bronx, NY 10461 USA; [Dutta, Kaushik] New York Struct Biol Ctr, New York, NY 10027 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA.; Cowburn, D (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.; Cowburn, D (corresponding author), Albert Einstein Coll Med, Depts Physiol & Biophys, Bronx, NY 10461 USA.	rout@mail.rockefeller.edu; cowburn@cowburnlab.org	Rout, Michael/Y-7090-2018; Sparks, Samuel/GZB-0815-2022	Cowburn, David/0000-0001-6770-7172; Cabana, Christina/0000-0002-0420-9552; Karp, Jerome/0000-0001-7266-0946; Hayama, Ryo/0000-0001-8706-213X	National Institutes of Health [R01 GM112108, P41 GM109824, U01 GM098256, R01 GM117212, S10 OD016305, P30 CA013330, T32 GM007288-39]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098256, R01GM117212, T32GM007288, R01GM112108, P41GM109824] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 GM112108, P41 GM109824, and U01 GM098256 (to M. P. R.); R01 GM117212 and S10 OD016305 (to D. C.); and P30 CA013330. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32 GM007288-39.	Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Cloninger M. J., 2012, ANONYMOUS SUPRAMOLEC, P95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gargano JM, 2001, J AM CHEM SOC, V123, P12909, DOI 10.1021/ja016305a; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; GRANOT J, 1983, J MAGN RESON, V55, P216, DOI 10.1016/0022-2364(83)90234-2; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lim RYH, 2015, NUCLEUS-PHILA, V6, P366, DOI 10.1080/19491034.2015.1090061; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martinez-Veracoechea FJ, 2011, P NATL ACAD SCI USA, V108, P10963, DOI 10.1073/pnas.1105351108; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Moussavi-Baygi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29991; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Raveh B, 2016, P NATL ACAD SCI USA, V113, pE2489, DOI 10.1073/pnas.1522663113; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Shekhtman A, 2002, FEBS LETT, V524, P177, DOI 10.1016/S0014-5793(02)03051-X; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Tetenbaum-Novatt J, 2010, COLD SH Q B, V75, P567, DOI 10.1101/sqb.2010.75.033; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vovk A, 2016, ELIFE, V5, DOI 10.7554/eLife.10785; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weber M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739501; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201	44	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4555	4563		10.1074/jbc.AC117.001649	http://dx.doi.org/10.1074/jbc.AC117.001649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29374059	hybrid, Green Published			2022-12-26	WOS:000428204300026
J	Ding, KS; Tan, S; Huang, X; Wang, XN; Li, XC; Fan, R; Zhu, Y; Lobie, PE; Wang, WB; Wu, ZS				Ding, Keshuo; Tan, Sheng; Huang, Xing; Wang, Xiaonan; Li, Xiaocan; Fan, Rong; Zhu, Yong; Lobie, Peter E.; Wang, Wenbin; Wu, Zhengsheng			GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORTER 1; CELL-PROLIFERATION; BREAST-CANCER; CD98 EXPRESSION; MIGRATION; INVASION; LAT1; CONTRIBUTES; PROMOTES; FAMILY	Gastric cancer remains a malignancy with poor survival outcome. We herein report that GSE1, a proline-rich protein, possesses a role in the progression of human gastric cancer. The expression of GSE1 was observed to be much higher in human gastric cancer tissues compared with normal gastric tissues, and GSE1 expression correlated positively with lymph node metastasis, histological grade, depth of invasion, and clinical stage in gastric cancer patients. Moreover, GSE1 expression was also associated with decreased post-operative relapse-free survival and overall survival in the cohort. The forced expression of GSE1 in gastric cancer cell lines resulted in increased cell proliferation, increased colony formation, enhanced cell migration, and invasion. Furthermore, forced expression of GSE1 also increased tumor size and enhanced lung metastasis in xenograft models. The depletion of endogenous GSE1 with shRNAs decreased the oncogenicity and invasiveness of gastric cancer cells both in vitro and in vivo. In addition, GSE1 was determined to be a direct target of miR-200b and miR-200c. Furthermore, GSE1 positively regulated the downstream gene SLC7A5 (also known as LAT-1), which was scanned and verified from mRNA sequencing. GSE1 therefore possesses an oncogenic role in human gastric cancer, and targeted therapeutic approaches to inhibit GSE1 function in gastric cancer warrant further consideration.	[Ding, Keshuo; Wang, Wenbin] Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, 372 Tunxi Rd, Hefei 230022, Anhui, Peoples R China; [Ding, Keshuo; Li, Xiaocan; Wu, Zhengsheng] Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China; [Wang, Xiaonan] Anhui Med Univ, Lab Pathogen Microbiol & Immunol, Hefei 230032, Anhui, Peoples R China; [Tan, Sheng; Fan, Rong; Zhu, Yong] Univ Sci & Technol China, Sch Life Sci, Lab Mol Tumor Pathol, Hefei 230027, Anhui, Peoples R China; [Huang, Xing] Zhejiang Univ, Key Lab Precis Diag & Treatment Hepatobiliary & P, Affiliated Hosp 1, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China; [Huang, Xing] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch, Div Life Sci & Hlth, Shenzhen 518055, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Natl Univ Hlth Syst, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Pharmacol, Singapore 117599, Singapore	Anhui Medical University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang University; Southeast University - China; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; National University of Singapore	Wang, WB (corresponding author), Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, 372 Tunxi Rd, Hefei 230022, Anhui, Peoples R China.; Wu, ZS (corresponding author), Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China.	nihao22009256@163.com; woozson@yahoo.com	黄, 星/AAB-2241-2019; tan, sheng/GSN-2599-2022	黄, 星/0000-0002-8886-2777; 	National Nature Science Foundation of China [81472493, 81500373, 81502282, 81672609, 81502975]; Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant [2013xkj006]; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant [2016H074]; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant [gxyqZD2016046]; Natural Science Foundation of Anhui Province Grant [1608085MH193]; Scientific Research Foundation of Anhui Medical University Grant [2015xkj043]; China Postdoctoral Science Foundation Grants [2016T90413, 2015M581693]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant; Natural Science Foundation of Anhui Province Grant(Natural Science Foundation of Anhui Province); Scientific Research Foundation of Anhui Medical University Grant; China Postdoctoral Science Foundation Grants(China Postdoctoral Science Foundation)	This work was supported in part by National Nature Science Foundation of China Grants 81472493, 81500373, 81502282, 81672609, and 81502975; Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant 2013xkj006; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant 2016H074; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant gxyqZD2016046; Natural Science Foundation of Anhui Province Grant 1608085MH193; Scientific Research Foundation of Anhui Medical University Grant 2015xkj043; and China Postdoctoral Science Foundation Grants 2016T90413 and 2015M581693. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad P, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/8245345; Chai P, 2016, BIOCHEM BIOPH RES CO, V471, P123, DOI 10.1016/j.bbrc.2016.01.168; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen LT, 2017, CANCER RES TREAT, V49, P851, DOI 10.4143/crt.2016.176; Oliveira KCD, 2016, WORLD J GASTROENTERO, V22, P7951, DOI 10.3748/wjg.v22.i35.7951; Damiano V, 2017, GENE CHROMOSOME CANC, V56, P147, DOI 10.1002/gcc.22422; Ding KS, 2017, ENDOCRINOLOGY, V158, P1595, DOI 10.1210/en.2016-1903; Ding KH, 2017, PATHOL RES PRACT, V213, P467, DOI 10.1016/j.prp.2017.01.026; Ding L, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0516-2; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Gui ZF, 2017, INT J ONCOL, V50, P111, DOI 10.3892/ijo.2016.3772; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0603-1; He L, 2017, MOL MED REP, V15, P3055, DOI 10.3892/mmr.2017.6347; Hong H, 2016, MED SCI MONITOR, V22, P1946, DOI 10.12659/MSM.896551; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Li GP, 2016, CELL RES, V26, P655, DOI 10.1038/cr.2016.32; Li Nan, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P809, DOI 10.3969/j.issn.1672-7347.2013.08.009; Li YR, 2016, FEBS OPEN BIO, V6, P1257, DOI 10.1002/2211-5463.12142; Lin Y, 2017, ONCOTARGET, V8, P11990, DOI 10.18632/oncotarget.14467; Liu YQ, 2017, ONCOL REP, V37, P2441, DOI 10.3892/or.2017.5488; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Luu HN, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0206-6; Oliveto Stefania, 2017, World J Biol Chem, V8, P45, DOI 10.4331/wjbc.v8.i1.45; Paik Woo Hyun, 2015, Korean J Gastroenterol, V66, P215, DOI 10.4166/kjg.2015.66.4.215; Pan Q, 2017, CANCER LETT, V392, P26, DOI 10.1016/j.canlet.2017.01.039; Rosilio C, 2015, LEUKEMIA, V29, P1253, DOI 10.1038/leu.2014.338; Shennan DB, 2008, ONCOL REP, V20, P885, DOI 10.3892/or_00000087; Shi RL, 2014, FRONT MED-PRC, V8, P456, DOI 10.1007/s11684-014-0353-z; Shimizu A, 2015, MELANOMA RES, V25, P399, DOI 10.1097/CMR.0000000000000181; Takeuchi K, 2010, LUNG CANCER, V68, P58, DOI 10.1016/j.lungcan.2009.05.020; Tan S, 2017, J BIOL CHEM, V292, P13551, DOI 10.1074/jbc.M117.780973; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang JQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166147; Wang JQ, 2013, BIOMED PHARMACOTHER, V67, P693, DOI 10.1016/j.biopha.2013.05.003; Xu MH, 2016, J UROLOGY, V195, P1588, DOI 10.1016/j.juro.2015.11.071; Yothaisong S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694545; Yu BQ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3096-9; Zhang HC, 2017, BIOMED PHARMACOTHER, V88, P285, DOI 10.1016/j.biopha.2017.01.023; Zhang S, 2017, ONCOTARGET, V8, P18848, DOI 10.18632/oncotarget.14473; Zhang Z, 2016, ONCOTARGET, V7, P37993, DOI 10.18632/oncotarget.9366; Zhao M, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691682; Zhou XL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0428-3	48	31	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3949	3964		10.1074/jbc.RA117.001103	http://dx.doi.org/10.1074/jbc.RA117.001103			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367342	hybrid, Green Published			2022-12-26	WOS:000427587500009
J	Kotani, H; Adachi, Y; Kitai, H; Tomida, S; Bando, H; Faber, AC; Yoshino, T; Voon, DC; Yano, S; Ebi, H				Kotani, Hiroshi; Adachi, Yuta; Kitai, Hidenori; Tomida, Shuta; Bando, Hideaki; Faber, Anthony C.; Yoshino, Takayuki; Voon, Dominic C.; Yano, Seiji; Ebi, Hiromichi			Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers	ONCOGENE			English	Article							MEK INHIBITION; C-RAF; B-RAF; FEEDBACK ACTIVATION; COLORECTAL CANCERS; PHASE-2 TRIAL; OPEN-LABEL; WILD-TYPE; MUTATIONS; SENSITIVITY	BRAF is one of the most frequently mutated genes across a number of different cancers, with the best-characterized mutation being V600E. Despite the successes of treating BRAF mutant V600E lung cancer with BRAF pathway inhibitors, treatment strategies targeting tumors with non-V600E mutations are yet to be established. We studied cellular signaling differences between lung cancers with different BRAF mutations and determined their sensitivities to BRAF pathway inhibitors. Here, we observed that MEK inhibition induced feedback activation of the receptor tyrosine kinase (RTK) EGFR, and in some cases the RTK FGFR, resulting in transient suppression of ERK phosphorylation in BRAF non-V600E, but not BRAF V600E, mutant cells. Furthermore, we found that both EGFR and FGFR activated the MEK/ERK pathway, despite the presence of BRAF non-V600E mutations with elevated kinase activity. Moreover, in BRAF non-V600E mutants with impaired kinase activities, EGFR had even greater control over the MEK/ERK pathway, essentially contributing completely to the tonic mitogen-activated protein kinase (MAPK) signal. Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer. Furthermore, the results were recapitulated with a clinically relevant dual inhibitor of EGFR and RAF, BGB-283. Overall, although BRAF V600E mutant cells are sensitive to BRAF inhibition, non-V600E mutant cancer cells are reliant on RTKs for their MAPK activation and inhibiting both MEK and RTKs are necessary in these cancers. Our findings provide evidence of critical survival signals in BRAF non-V600E mutant cancers, which could pave the way for effective treatment of these cancers.	[Kotani, Hiroshi; Adachi, Yuta; Kitai, Hidenori; Yano, Seiji; Ebi, Hiromichi] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan; [Tomida, Shuta] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biobank, Okayama, Japan; [Bando, Hideaki; Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Chiba, Japan; [Faber, Anthony C.] Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res, Richmond, VA USA; [Faber, Anthony C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Voon, Dominic C.; Ebi, Hiromichi] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan	Kanazawa University; Okayama University; National Cancer Center - Japan; Virginia Commonwealth University; Virginia Commonwealth University; Kanazawa University	Ebi, H (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan.; Ebi, H (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan.	hebi@staff.kanazawa-u.ac.jp	Ebi, Hiromichi/AAA-7358-2019; 雄太, 足立/N-6838-2019; Kitai, Hidenori/AAD-4168-2022	Ebi, Hiromichi/0000-0003-3155-7576; Voon, Dominic Chih-Cheng/0000-0002-2963-9305; Kotani, Hiroshi/0000-0002-6001-0636; tomida, shuta/0000-0003-3786-936X; KITAI, HIDENORI/0000-0001-6372-846X	Japan Society for the Promotion of Science [26830105, 16K07164, 21390256]; Japan Agency for Medical Research and Development [16cm0106513h0001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work is supported by Grants-in-Aid for Scientific Research (H. Ebi, 26830105 and 16K07164; S. Yano, 21390256) from Japan Society for the Promotion of Science, and Grant-in-Aid to Project for Cancer Research and Therapeutics Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (H. Ebi and S. Yano, 16cm0106513h0001). A.C.F. is a George and Lavinia Blick Scholar and a Harrison Endowed Scholar in Cancer Research.	Bates DM, 2012, CLASSES; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Carter J, 2015, AM J CLIN PATHOL, V144, P620, DOI 10.1309/AJCP85ATMJOZOUDJ; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Langen AJ, 2017, THER ADV MED ONCOL, V9, P46, DOI 10.1177/1758834016670555; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Desai J, 2017, AACR ANN M; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Joshi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118210; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Laquerre S, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B88; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nieto P, 2017, NATURE, V548, P239, DOI 10.1038/nature23297; Noeparast A, 2017, ONCOTARGET, V8, P60094, DOI 10.18632/oncotarget.11635; Okimoto RA, 2016, P NATL ACAD SCI USA, V113, P13456, DOI 10.1073/pnas.1610456113; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Tang ZY, 2015, MOL CANCER THER, V14, P2187, DOI 10.1158/1535-7163.MCT-15-0262; Team RC, 2016, LANG ENV STAT COMP; Tu NN, 2015, J THORAC ONCOL, V10, P1396, DOI 10.1097/JTO.0000000000000644; Van Cutsem E, 2015, ANN ONCOL, V26, P149, DOI 10.1093/annonc/mdu496; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	45	19	21	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1775	1787		10.1038/s41388-017-0035-9	http://dx.doi.org/10.1038/s41388-017-0035-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29348459				2022-12-26	WOS:000428632600007
J	Caixeta, DC; Teixeira, RR; Peixoto, LG; Machado, HL; Baptista, NB; de Souza, AV; Vilela, DD; Franci, CR; Espindola, FS				Caixeta, Douglas Carvalho; Teixeira, Renata Roland; Peixoto, Leonardo Gomes; Machado, Helen Lara; Baptista, Nathalia Belele; de Souza, Adriele Vieira; Vilela, Danielle Diniz; Franci, Celso Rodrigues; Espindola, Foued Salmen			Adaptogenic potential of royal jelly in liver of rats exposed to chronic stress	PLOS ONE			English	Article							RESTRAINT STRESS; LIPID-PEROXIDATION; OXIDATIVE STRESS; ANTIOXIDANT DEFENSE; PROTEIN OXIDATION; COLD-STRESS; BODY-WEIGHT; IN-VITRO; CORTICOSTERONE; INJURY	Restraint and cold stress increase both corticosterone and glycemia, which lead to oxidative damages in hepatic tissue. This study assessed the effect of royal jelly (RJ) supplementation on the corticosterone level, glycemia, plasma enzymes and hepatic antioxidant system in restraint and cold stressed rats. Wistar rats were allocated into no-stress, stress, no stress supplemented with RJ and stress supplemented with RJ groups. Initially, RJ (200mg/Kg) was administered for fourteen days and stressed groups were submitted to chronic stress from the seventh day. The results showed that RJ supplementation decreases corticosterone levels and improves glycemia control after stress induction. RJ supplementation also decreased the body weight, AST, ALP and GGT. Moreover, RJ improved total antioxidant capacity, SOD activity and reduced GSH, GR and lipoperoxidation in the liver. Thus, RJ supplementation reestablished the corticosterone levels and the hepatic antioxidant system in stressed rats, indicating an adaptogenic and hepatoprotective potential of RJ.	[Caixeta, Douglas Carvalho; Teixeira, Renata Roland; Peixoto, Leonardo Gomes; Machado, Helen Lara; Baptista, Nathalia Belele; de Souza, Adriele Vieira; Vilela, Danielle Diniz; Espindola, Foued Salmen] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil; [Franci, Celso Rodrigues] Univ Sao Paulo, Dept Physiol, Ribeirao Preto, MG, Brazil	Universidade Federal de Uberlandia; Universidade de Sao Paulo	Espindola, FS (corresponding author), Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil.	foued@ufu.br	Teixeira, Renata/AAE-1421-2019; Espindola, Foued Salmen/C-5324-2013; de Souza, Adriele Vieira/F-2330-2018	Espindola, Foued Salmen/0000-0002-6937-1411; de Souza, Adriele Vieira/0000-0002-0533-7441; Caixeta, Douglas Carvalho/0000-0002-2363-6584; Peixoto, Leonardo/0000-0002-4201-7076; Espindola, Foued/0000-0001-7565-1164	Foundation of Support Research of the State of Minas Gerais (FAPEMIG); National Council for Scientific and Technological Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	Foundation of Support Research of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors received funding support for this work by Foundation of Support Research of the State of Minas Gerais (FAPEMIG), National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, PHYSIOL BEHAV, V103, P321, DOI 10.1016/j.physbeh.2011.02.014; Arnold M, 2010, PHYSIOL BEHAV, V99, P592, DOI 10.1016/j.physbeh.2010.01.021; Bali A, 2013, J RENIN-ANGIO-ALDO S, V14, P197, DOI 10.1177/1470320312456579; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREKHMAN II, 1969, ANNU REV PHARMACOLOG, V9, P419, DOI 10.1146/annurev.pa.09.040169.002223; Budni J, 2013, EXP NEUROL, V240, P112, DOI 10.1016/j.expneurol.2012.10.024; Cavusoglu K, 2011, J MED FOOD, V14, P1229, DOI 10.1089/jmf.2010.0219; Celikbilek A, 2014, ACTA NEUROPSYCHIATR, V26, P51, DOI 10.1017/neu.2013.32; Cemek M, 2010, FOOD CHEM TOXICOL, V48, P2827, DOI 10.1016/j.fct.2010.07.013; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Djordjevic J, 2003, PHYSIOL RES, V52, P67; Fontella F, 2005, NEUROCHEM RES, V30, P105, DOI 10.1007/s11064-004-9691-6; FUJII A, 1990, JPN J PHARMACOL, V53, P331, DOI 10.1254/jjp.53.331; Ghanbari E, 2016, CELL J, V18, P362; Guo H, 2008, J NUTR SCI VITAMINOL, V54, P191, DOI 10.3177/jnsv.54.191; Guo H, 2007, J NUTR SCI VITAMINOL, V53, P345, DOI 10.3177/jnsv.53.345; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; HIDALGO J, 1991, HORM METAB RES, V23, P104, DOI 10.1055/s-2007-1003626; Jafari M, 2014, EXCLI J, V13, P161; Kamakura M, 2006, J PHARM PHARMACOL, V58, P1683, DOI 10.1211/jpp.58.12.0017; Kanbur M, 2009, EXP TOXICOL PATHOL, V61, P123, DOI 10.1016/j.etp.2008.06.003; Karaali A, 2015, STUDIES COMPOSITION; Karadeniz A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/981793; Kashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105073; Klenerova V, 2003, BEHAV BRAIN RES, V142, P143, DOI 10.1016/S0166-4328(02)00401-1; Kolayli S, 2015, J EVID BASED COMPLEM; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; MLEKUSCH W, 1981, HORM METAB RES, V13, P612, DOI 10.1055/s-2007-1019352; Nagai T, 2006, J MED FOOD, V9, P363, DOI 10.1089/jmf.2006.9.363; Nirupama R, 2012, STRESS, V15, P262, DOI 10.3109/10253890.2011.619604; Oishi K, 2009, DIFFERENT EFFECTS IM; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; Paula-Freire LIG, 2013, J ETHNOPHARMACOL, V145, P647, DOI 10.1016/j.jep.2012.12.004; Piato AL, 2010, PHYTOMEDICINE, V17, P248, DOI 10.1016/j.phymed.2009.07.001; Pourmoradian S, 2012, HEALTH PROMOT PERSPE, V2, P231, DOI 10.5681/hpp.2012.028; Reis FMCV, 2012, STRESS, V15, P318, DOI 10.3109/10253890.2011.623740; Sahin E, 2004, INT J BIOMETEOROL, V48, P165, DOI 10.1007/s00484-004-0205-7; Sahin E, 2007, CLIN EXP PHARMACOL P, V34, P425, DOI 10.1111/j.1440-1681.2007.04584.x; Samarghandian S, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/2645237; Sierra Mauricio, 2008, Expert Rev Neurother, V8, P19; Solin AV, 2014, B EXP BIOL MED+, V157, P571, DOI 10.1007/s10517-014-2617-7; Spiers JG, 2016, PSYCHONEUROENDOCRINO, V67, P104, DOI 10.1016/j.psyneuen.2016.02.005; Su DX, 2016, FOOD FUNCT, V7, P508, DOI 10.1039/c5fo00975h; Teixeira RR, 2017, NEUROSCI LETT, V655, P179, DOI 10.1016/j.neulet.2017.07.010; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Vilela DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6978625; Yang Y, 2016, BIOL TRACE ELEM RES, V173, P126, DOI 10.1007/s12011-016-0627-1; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168	50	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191889	10.1371/journal.pone.0191889	http://dx.doi.org/10.1371/journal.pone.0191889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377921	Green Submitted, Green Published, gold			2022-12-26	WOS:000423514700041
J	DeBerg, HA; Zaidi, MB; Altman, MC; Khaenam, P; Gersuk, VH; Campos, FD; Perez-Martinez, I; Meza-Segura, M; Chaussabel, D; Banchereau, J; Estrada-Garcia, T; Linsley, PS				DeBerg, Hannah A.; Zaidi, Mussaret B.; Altman, Matthew C.; Khaenam, Prasong; Gersuk, Vivian H.; Campos, Freddy D.; Perez-Martinez, Iza; Meza-Segura, Mario; Chaussabel, Damien; Banchereau, Jacques; Estrada-Garcia, Teresa; Linsley, Peter S.			Shared and organism-specific host responses to childhood diarrheal diseases revealed by whole blood transcript profiling	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; ESCHERICHIA-COLI; COMPLEMENT; INFECTION; MULTIPLEX; BACTERIAL; SIGNATURE; CHILDREN; INFANTS; BURDEN	Globally, diarrheal diseases are a leading cause of death in children under five and disproportionately affect children in developing countries. Children who contract diarrheal diseases are rarely screened to identify the etiologic agent due to time and cost considerations associated with pathogen-specific screening and hence pathogen-directed therapy is uncommon. The development of biomarkers to rapidly identify underlying pathogens could improve treatment options and clinical outcomes in childhood diarrheal diseases. Here, we perform RNA sequencing on blood samples collected from children evaluated in an emergency room setting with diarrheal disease where the pathogen(s) present are known. We determine host response gene signatures specific to Salmonella, Shigella and rotavirus, but not E. coli, infections that distinguish them from each other and from healthy controls. Specifically, we observed differential expression of genes related to chemokine receptors or inflammasome signaling in Shigella cases, such as CCR3, CXCR8, and NLRC4, and interferon response genes, such as IF144 and OASL, in rotavirus cases. Our findings add insight into the host peripheral immune response to these pathogens, and suggest strategies and limitations for the use host response transcript signatures for diagnosing the etiologic agent of childhood diarrheal diseases.	[DeBerg, Hannah A.; Altman, Matthew C.; Khaenam, Prasong; Gersuk, Vivian H.; Chaussabel, Damien; Linsley, Peter S.] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Zaidi, Mussaret B.; Campos, Freddy D.] Hosp Gen OHoran, Infect Dis Res Unit, Merida, Yucatan, Mexico; [Zaidi, Mussaret B.; Campos, Freddy D.] Hosp Gen OHoran, Pediat Emergency Dept, Merida, Yucatan, Mexico; [Zaidi, Mussaret B.] Michigan State Univ, Dept Epidemiol & Biostat, Lansing, MI USA; [Altman, Matthew C.] Univ Washington, Sch Med, Dept Med, Seattle, WA USA; [Perez-Martinez, Iza; Meza-Segura, Mario; Estrada-Garcia, Teresa] CINVESTAV IPN, Dept Mol Biomed, Mexico City, DF, Mexico; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Khaenam, Prasong] Mahidol Univ, Fac Med Technol, Salaya, Nakhon Pathom, Thailand	Benaroya Research Institute; Virginia Mason Medical Center; Michigan State University; University of Washington; University of Washington Seattle; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Jackson Laboratory; Mahidol University	DeBerg, HA; Linsley, PS (corresponding author), Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA.	hdeberg@benaroyaresearch.org; plinsley@benaroyaresearch.org	Martínez, Iza Pérez/AAF-5378-2020; Chaussabel, Damien/AAX-1909-2020; Zaidi, Mussaret Bano/AAD-8497-2022	Zaidi, Mussaret Bano/0000-0001-5342-2395; Meza Segura, Mario/0000-0002-4647-2308; perez-martinez, iza/0000-0002-2701-642X; DeBerg, Hannah/0000-0002-5263-158X	National Institute of Allergy and Infectious Diseases [U01A1082110]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by grant number U01A1082110 from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) to Peter Linsley and Damien Chaussabel. The funders had no role in study design, data collection	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15; Cerna JF, 2003, J CLIN MICROBIOL, V41, P2138, DOI 10.1128/JCM.41.5.2138-2140.2003; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Esfandyarpour R, 2017, P NATL ACAD SCI USA, V114, pE1306, DOI 10.1073/pnas.1621318114; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; Kim S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13919; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Lopez-Saucedo C, 2003, EMERG INFECT DIS, V9, P127, DOI 10.3201/eid0901.010507; Mahajan P, 2016, JAMA-J AM MED ASSOC, V316, P846, DOI 10.1001/jama.2016.9207; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Patzi-Vargas S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003510; Patzi-Vargas S, 2013, J MED MICROBIOL, V62, P1907, DOI 10.1099/jmm.0.062349-0; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Secretaria De Salud, 2012, PERF EP ENF INF INT; Secretaria De Salud, 2012, CAUS MORT MEN 1 AN 1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SINAVE/DGE/SALUD, 2010, PERF EP INF MEX 2010; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang YH, 2007, J VIROL, V81, P3904, DOI 10.1128/JVI.01887-06; Wetterstrand K.A., DNA SEQUENCING COSTS; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293	46	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0192082	10.1371/journal.pone.0192082	http://dx.doi.org/10.1371/journal.pone.0192082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377961	gold, Green Submitted, Green Published			2022-12-26	WOS:000423514700053
J	Grasso, R; Musumeci, F; Gulino, M; Scordino, A				Grasso, Rosaria; Musumeci, Francesco; Gulino, Marisa; Scordino, Agata			Exploring the behaviour of water in glycerol solutions by using delayed luminescence	PLOS ONE			English	Article							LOW-DENSITY WATER; LIQUID WATER; TEMPERATURE; SPECTROSCOPY; MODEL	The crucial role of water in the engine of life have encouraged many researchers in studying, both theoretically and experimentally, the possible "structure" of water. Many properties of water have been related to the interplay between two distinct and interconverting structural species, namely the low-density water (LDW) and the high-density water (HDW). Supported by the results obtained with other aqueous solutions, this paper deals with the possibility of using the ultra-weak delayed luminescence (DL) to investigate water structuring in a mixture with glycerol, characterized only by hydrogen bonds between the various molecules. Spectral and temporal characteristics of DL decays give information on the two components of the mixture, by evidencing the contribution of water at glycerol concentrations close to the values used in cryopreservation. DL results have shown a correlation with LDW clusters size as determined by other researchers on the basis of neutron diffraction experiments and computational modelling, as reported in Literature.	[Grasso, Rosaria; Musumeci, Francesco; Scordino, Agata] Catania Univ, Dept Phys & Astron, Catania, Italy; [Grasso, Rosaria; Musumeci, Francesco; Gulino, Marisa; Scordino, Agata] Ist Nazl Fis Nucl, Lab Nazl Sud, Catania, Italy; [Gulino, Marisa] Univ Enna Kore, Fac Ingn & Architettura, Enna, Italy	University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); Universita Kore di ENNA	Grasso, R (corresponding author), Catania Univ, Dept Phys & Astron, Catania, Italy.; Grasso, R (corresponding author), Ist Nazl Fis Nucl, Lab Nazl Sud, Catania, Italy.	grasso@lns.infn.it	Gulino, Marisa/AAC-4620-2021; Grasso, Rosaria/A-9143-2012; Grasso, Rosaria/AAH-1726-2019	Grasso, Rosaria/0000-0003-4864-9880; 				[Anonymous], 2014, NAT MATER, V13, P663, DOI 10.1038/nmat4029; Baran I, 2012, OXID MED CELL LONGEV, V2012; Baran I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127006; Baran I, 2010, CELL BIOCHEM BIOPHYS, V58, P169, DOI 10.1007/s12013-010-9104-1; Berberan-Santos MN, 2005, CHEM PHYS, V317, P57, DOI 10.1016/j.chemphys.2005.05.026; Branca C, 2002, APPL PHYS A-MATER, V74, pS450, DOI 10.1007/s003390201521; Brizhik L, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021902; Brizhik L, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031902; Carlton TS, 2007, J PHYS CHEM B, V111, P13398, DOI 10.1021/jp074143k; Chai BH, 2008, J PHYS CHEM A, V112, P2242, DOI 10.1021/jp710105n; Chaplin M., WATER STRUCTURE SCI; Chaplin MF, 2000, BIOPHYS CHEM, V83, P211, DOI 10.1016/S0301-4622(99)00142-8; Chen C, 2009, J MOL LIQ, V146, P23, DOI 10.1016/j.molliq.2009.01.009; Cho CH, 1996, PHYS REV LETT, V76, P1651, DOI 10.1103/PhysRevLett.76.1651; Colleoni C, 2016, PHYS CHEM CHEM PHYS, V18, P772, DOI 10.1039/c5cp03420e; Costanzo E, 2008, EUR BIOPHYS J BIOPHY, V37, P235, DOI 10.1007/s00249-007-0221-8; D'Errico G, 2004, J CHEM ENG DATA, V49, P1665, DOI 10.1021/je049917u; Elton DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10193; Ermolin SV, 2012, RUSS J PHYS CHEM A+, V86, P1029, DOI 10.1134/S003602441206009X; Errington JR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215503; Frauenfelder H, 1999, REV MOD PHYS, V71, pS419, DOI 10.1103/RevModPhys.71.S419; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Grasso R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167998; Gulino M, 2010, CHEM PHYS LETT, V497, P99, DOI 10.1016/j.cplett.2010.07.100; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Jansson H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.017802; Johnson ME, 2009, J PHYS CHEM B, V113, P4082, DOI 10.1021/jp806183v; Jursinic P.A., 1986, LIGHT EMISSION PLANT, V1st ed., P291; Kirichek O, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150655; Langford VS, 2000, ACCOUNTS CHEM RES, V33, P665, DOI 10.1021/ar990145e; Lanzano L, 2009, LUMINESCENCE, V24, P409, DOI 10.1002/bio.1127; LIBNAU FO, 1994, J AM CHEM SOC, V116, P8311, DOI 10.1021/ja00097a043; Lobyshev VI, 1999, J MOL LIQ, V82, P73, DOI 10.1016/S0167-7322(99)00043-4; Mik EG, 2008, BIOPHYS J, V95, P3977, DOI 10.1529/biophysj.107.126094; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Musumeci F, 2005, J PHOTOCH PHOTOBIO B, V79, P93, DOI 10.1016/j.jphotobiol.2004.12.002; Musumeci F, 2012, J BIOL PHYS, V38, P181, DOI 10.1007/s10867-011-9245-5; Nucci NV, 2008, J MOL LIQ, V143, P160, DOI 10.1016/j.molliq.2008.07.010; Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4; Scordino A, 2000, J PHOTOCH PHOTOBIO B, V56, P181, DOI 10.1016/S1011-1344(00)00078-6; Scordino A, 1996, J PHOTOCH PHOTOBIO B, V32, P11, DOI 10.1016/1011-1344(95)07213-6; Scordino A, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155507; Scordino A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.117005; Scordino A, 2014, J PHOTOCH PHOTOBIO B, V139, P76, DOI 10.1016/j.jphotobiol.2014.03.027; Scordino A, 2010, INT J QUANTUM CHEM, V110, P221, DOI 10.1002/qua.22010; Sedlak M, 2006, J PHYS CHEM B, V110, P13976, DOI 10.1021/jp061919t; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Shalaev E, 2016, J PHYS CHEM B, V120, P7289, DOI 10.1021/acs.jpcb.6b06157; Strassle T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067801; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Takamura K, 2012, J PETROL SCI ENG, V98-99, P50, DOI 10.1016/j.petrol.2012.09.003; Tanaka H, 2000, J CHEM PHYS, V112, P799, DOI 10.1063/1.480609; Tokushima T, 2008, CHEM PHYS LETT, V460, P387, DOI 10.1016/j.cplett.2008.04.077; Towey JJ, 2016, J PHYS CHEM B, V120, P4439, DOI 10.1021/acs.jpcb.6b01185; Towey JJ, 2012, J PHYS CHEM B, V116, P13898, DOI 10.1021/jp3093034; Towey JJ, 2012, J PHYS CHEM B, V116, P1633, DOI 10.1021/jp2093862; Tudisco S, 2003, REV SCI INSTRUM, V74, P4485, DOI 10.1063/1.1611997; Urquidi J, 1999, J MOL STRUCT, V485, P363, DOI 10.1016/S0022-2860(99)00052-6; Vallee P, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1860553; Wiggins P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001406; WIGGINS PM, 1995, PROG POLYM SCI, V20, P1121, DOI 10.1016/0079-6700(95)00015-8	61	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191861	10.1371/journal.pone.0191861	http://dx.doi.org/10.1371/journal.pone.0191861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377914	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700035
J	Qi, J; Kim, M; Sanchez, R; Ziaee, SM; Kohtz, JD; Koh, S				Qi, Jin; Kim, Minjung; Sanchez, Russell; Ziaee, Saba M.; Kohtz, Jhumku D.; Koh, Sookyong			Enhanced susceptibility to stress and seizures in GAD65 deficient mice	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; MEDIAL GANGLIONIC EMINENCE; SEVERE MYOCLONIC EPILEPSY; GAMMA-AMINOBUTYRIC-ACID; REDUCED SODIUM CURRENT; NEUROPEPTIDE-Y; GABAERGIC INTERNEURONS; LEARNING IMPAIRMENTS; ANXIETY DISORDERS; SEX-DIFFERENCES	Reduced gamma-aminobutyric acid (GABA) inhibition has been implicated in both anxiety and epilepsy. GAD65(-/-) (NOD/LtJ) mice have significantly decreased basal GABA levels in the brain and a lowered threshold for seizure generation. One fifth of GAD65 mice experienced stress-induced seizures upon exposure to an open field at 4 weeks of age. In each successive week until 8 weeks of age, the latency to seizures decreased with prior seizure experience. 100% of GAD65(-/-) mice exhibited stress-induced seizures by the end of 8 weeks. GAD65(-/-) mice also exhibited marked impairment in open field exploratory behavior and deficits in spatial learning acquisition on a Barnes maze. Anxiety-like behavior in an open field was observed prior to seizure onset and was predictive of subsequent seizures. Immunohistochemical characterization of interneuron subtypes in GAD65(-/-) mice showed a selective decrease in GABA and neuropeptide Y (NPY) levels and no change in calbindin (CLB) or calretinin (CLR) immunoreactivity in the hippocampus. Stem cells from the medial ganglionic eminence (MGE) were injected into the hippocampal hilus to restore GABAergic interneurons. One week after transplantation, MGE-transplanted mice demonstrated significant seizure resistance compared to sham surgical controls. The percent area of GFP(+) MGE graft in the hippocampus correlated significantly with the increase in seizure latency. Our data indicate that impaired GABAergic neurotransmission can cause anxiety-like behavior and stress-induced seizures that can be rescued by MGE stem cell transplantation.	[Qi, Jin; Kim, Minjung; Ziaee, Saba M.; Kohtz, Jhumku D.; Koh, Sookyong] Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60614 USA; [Sanchez, Russell; Koh, Sookyong] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kohtz, Jhumku D.] Stanley Manne Childrens Res Inst, Dev Biol, Chicago, IL USA	Emory University	Koh, S (corresponding author), Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60614 USA.; Koh, S (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	Sookyong.koh@emory.edu		Koh, Sookyong/0000-0002-2717-6888	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS073768]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094653, R01MH111267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094999, R01NS073768] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov/, R01 NS073768 (SK) Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2005, EPILEPSY BEHAV, V6, P342, DOI 10.1016/j.yebeh.2004.12.011; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Alwash RH, 2000, SEIZURE-EUR J EPILEP, V9, P412, DOI 10.1053/seiz.2000.0427; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Auger ML, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu013; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Barbalho CA, 2009, BRAIN RES, V1267, P65, DOI 10.1016/j.brainres.2009.02.042; Bellavite P, 2009, HOMEOPATHY, V98, P208, DOI 10.1016/j.homp.2009.09.005; Bergin PS, 2000, EPILEPSIA, V41, P231, DOI 10.1111/j.1528-1157.2000.tb00145.x; Beyenburg S, 2005, EPILEPSY BEHAV, V7, P161, DOI 10.1016/j.yebeh.2005.05.014; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Camp BW, 2012, EUR J NEUROSCI, V36, P3086, DOI 10.1111/j.1460-9568.2012.08194.x; Caplan R, 2005, EPILEPSIA, V46, P720, DOI 10.1111/j.1528-1167.2005.43604.x; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; CHRISTGAU S, 1991, J BIOL CHEM, V266, P23516; Clary HMM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0445-9; Davies S, 2003, DEV MED CHILD NEUROL, V45, P292, DOI 10.1017/S0012162203000550; de Curtis M, 2016, EPILEPSIA, V57, P679, DOI 10.1111/epi.13370; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P472, DOI 10.1037//0735-7044.116.3.472; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; FORSGREN L, 1990, EPILEPSY RES, V6, P66, DOI 10.1016/0920-1211(90)90010-S; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Harro J, 2006, AMINO ACIDS, V31, P215, DOI 10.1007/s00726-006-0334-x; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Hughes J, 1993, Seizure, V2, P201, DOI 10.1016/S1059-1311(05)80128-1; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Jones JE, 2007, DEV MED CHILD NEUROL, V49, P493, DOI 10.1111/j.1469-8749.2007.00493.x; Jones JE, 2014, SEIZURE-EUR J EPILEP, V23, P780, DOI 10.1016/j.seizure.2014.06.011; Jung ME, 2002, NEUROSCI BIOBEHAV R, V26, P429, DOI 10.1016/S0149-7634(02)00010-6; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; KASA K, 1982, BIOL PSYCHIAT, V17, P877; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kendell SF, 2005, EXPERT OPIN THER TAR, V9, P153, DOI 10.1517/14728222.9.1.153; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee CL, 2001, NEUROSCIENCE, V107, P71, DOI 10.1016/S0306-4522(01)00327-X; Loney JC, 2008, PEDIATR NEUROL, V39, P236, DOI 10.1016/j.pediatrneurol.2008.07.005; Lucchi C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00676; Lugo JN, 2014, EXP NEUROL, V256, P74, DOI 10.1016/j.expneurol.2014.03.014; Luine V, 2017, PHARMACOL BIOCHEM BE, V152, P13, DOI 10.1016/j.pbb.2016.08.005; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marques-Carneiro JE, 2014, EPILEPSIA, V55, P1460, DOI 10.1111/epi.12738; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Mula M, 2009, EPILEPTIC DISORD, V11, P1, DOI 10.1684/epd.2009.0238; Namchuk M, 1997, J BIOL CHEM, V272, P1548, DOI 10.1074/jbc.272.3.1548; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Pearson JN, 2014, EPILEPSY RES, V108, P1032, DOI 10.1016/j.eplepsyres.2014.04.003; Petty F, 1999, MOL PSYCHIATR, V4, P587, DOI 10.1038/sj.mp.4000569; PETTY F, 1984, J AFFECT DISORDERS, V6, P131, DOI 10.1016/0165-0327(84)90018-1; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Sajdyk TJ, 1999, EUR J PHARMACOL, V368, P143, DOI 10.1016/S0014-2999(99)00018-7; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Scharfman HE, 2014, NEUROBIOL DIS, V72, P180, DOI 10.1016/j.nbd.2014.07.004; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Velissaris SL, 2009, EPILEPSIA, V50, P1012, DOI 10.1111/j.1528-1167.2008.01893.x; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wierenga CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015915; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zhang W, 2009, J NEUROSCI, V29, P7846, DOI 10.1523/JNEUROSCI.6199-08.2009	79	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191794	10.1371/journal.pone.0191794	http://dx.doi.org/10.1371/journal.pone.0191794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377906	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700031
J	Zhang, SF; Tuo, JL; Huang, XB; Zhu, X; Zhang, DM; Zhou, K; Yuan, L; Luo, HJ; Zheng, BJ; Yuen, KY; Li, MF; Cao, KY; Xu, L				Zhang, Su-fen; Tuo, Jiu-ling; Huang, Xu-bin; Zhu, Xun; Zhang, Ding-mei; Zhou, Kai; Yuan, Lei; Luo, Hong-jiao; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan; Xu, Lin			Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou	PLOS ONE			English	Article							REAL-TIME PCR; TRACT INFECTIONS; SYNCYTIAL VIRUS; IDENTIFICATION; SARS; NL63; EVOLUTION; GENOTYPES; CHILDREN	Human coronavirus (HCoV) is one of the most common causes of respiratory tract infection throughout the world. To investigate the epidemiological and genetic variation of HCoV in Guangzhou, south China, we collected totally 13048 throat and nasal swab specimens from adults and children with fever and acute upper respiratory infection symptoms in Gunazhou, south China between July 2010 and June 2015, and the epidemiological features of HCoV and its species were studied. Specimens were screened for HCoV by real-time RT-PCR, and 7 other common respiratory viruses were tested simultaneously by PCR or real-time PCR. HCoV was detected in 294 cases (2.25%) of the 13048 samples, with most of them inpatients (251 cases, 85.4% of HCoV positive cases) and young children not in nursery (53.06%, 156 out of 294 HCoV positive cases). Four HCoVs, as OC43, 229E, NL63 and HKU1 were detected prevalent during 2010-2015 in Guangzhou, and among the HCoV positive cases, 60.20% were OC43, 16.67% were 229E, 14.97% were NL63 and 7.82% were HKU1. The month distribution showed that totally HCoV was prevalent in winter, but differences existed in different species. The 5 year distribution of HCoV showed a peak-valley distribution trend, with the detection rate higher in 2011 and 2013 whereas lower in 2010, 2012 and 2014. The age distribution revealed that children (especially those <3 years old) and old people (>50 years) were both high risk groups to be infected by HCoV. Of the 294 HCoV positive patients, 34.69% (101 cases) were co-infected by other common respiratory viruses, and influenza virus was the most common co-infecting virus (30/101, 29.70%). Fifteen HCoV-OC43 positive samples of 2013-2014 were selected for S gene sequencing and phylogenetic analysis, and the results showed that the 15 strains could be divided into 2 clusters in the phylogenetic tree, 12 strains of which formed a separate cluster that was closer to genotype G found in Malaysia. It was revealed for the first time that genotype B and genotype G of HCoV-OC43 co-circulated and the newly defined genotype G was epidemic as a dominant genotype during 2013-2014 in Guanzhou, south China.	[Zhang, Su-fen; Tuo, Jiu-ling; Zhu, Xun; Zhang, Ding-mei; Zhou, Kai; Yuan, Lei; Luo, Hong-jiao; Li, Meng-feng; Cao, Kai-yuan; Xu, Lin] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Su-fen; Tuo, Jiu-ling; Zhu, Xun; Zhang, Ding-mei; Zhou, Kai; Yuan, Lei; Luo, Hong-jiao; Li, Meng-feng; Cao, Kai-yuan; Xu, Lin] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Zhang, Su-fen] Women & Childrens Healthcare Hosp Zhuhai City, Clin Lab, Zhuhai, Guangdong, Peoples R China; [Zhang, Su-fen] Women & Childrens Healthcare Hosp Zhuhai City, Inst Med Genet, Zhuhai, Guangdong, Peoples R China; [Tuo, Jiu-ling; Zhu, Xun; Zhang, Ding-mei; Zhou, Kai; Yuan, Lei; Luo, Hong-jiao; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan; Xu, Lin] Sun Yat Sen Univ, Sun Yat Sen Univ Univ Hong Kong Joint Lab Infect D, Guangzhou, Guangdong, Peoples R China; [Huang, Xu-bin] Sun Yat Sen Univ, Affiliated Hosp 1, Med ICU, Guangzhou, Guangdong, Peoples R China; [Zheng, Bo-jian; Yuen, Kwok-yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong	Cao, KY; Xu, L (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.; Cao, KY; Xu, L (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.; Cao, KY; Xu, L (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Univ Univ Hong Kong Joint Lab Infect D, Guangzhou, Guangdong, Peoples R China.	caoky@mail.sysu.edu.cn; Xulin@mail.sysu.edu.cn	Zhang, Dingmei/ABC-7476-2020; meng, li/GVT-2063-2022	Yuen, Kwok-yung/0000-0002-2083-1552	National Major Projects of Major infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China [2009ZX10004-213, 2012ZX10004213-001, 2017ZX10103011]	National Major Projects of Major infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China	This research was supported by National Major Projects of Major infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China (grant number 2009ZX10004-213, 2012ZX10004213-001 and 2017ZX10103011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2014, CURR OPIN INFECT DIS, V27, P411, DOI 10.1097/QCO.0000000000000089; [Anonymous], 2015, METHODS MOL BIOL, DOI DOI 10.1007/978-1-4939-2438-7_1; Berry M, 2015, VIRUSES-BASEL, V7, P996, DOI 10.3390/v7030996; Chidlow GR, 2009, VIRUSES-BASEL, V1, P42, DOI 10.3390/v1010042; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Crossley BM, 2012, VIRUSES-BASEL, V4, P3689, DOI 10.3390/v4123689; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gerna G, 2006, J MED VIROL, V78, P938, DOI 10.1002/jmv.20645; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003; Kon M, 2012, JPN J INFECT DIS, V65, P270, DOI 10.7883/yoken.65.270; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11; Liao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138684; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Lu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038638; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Lu YQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/869521; Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Oong XY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.132; Pyrc K, 2007, EXPERT REV ANTI-INFE, V5, P245, DOI 10.1586/14787210.5.2.245; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo P C Y, 2012, Hong Kong Med J, V18 Suppl 2, P22; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; World Health Organization, 2009, CDC PROT REAL TIM RT; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044876; Yip CCY, 2016, VIROL SIN, V31, P41, DOI 10.1007/s12250-016-3714-8; Zhang DM, 2014, INT J INFECT DIS, V25, P159, DOI 10.1016/j.ijid.2014.02.019; Zhang YN, 2015, CHIN AUTOM CONGR, P70, DOI 10.1109/CAC.2015.7382473	38	81	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191789	10.1371/journal.pone.0191789	http://dx.doi.org/10.1371/journal.pone.0191789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377913	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700030
J	Lim, S; Lee, K; Kang, J				Lim, Sangrak; Lee, Kyubum; Kang, Jaewoo			Drug drug interaction extraction from the literature using a recursive neural network	PLOS ONE			English	Article								Detecting drug-drug interactions (DDI) is important because information on DDIs can help prevent adverse effects from drug combinations. Since there are many new DDI-related papers published in the biomedical domain, manually extracting DDI information from the literature is a laborious task. However, text mining can be used to find DDIs in the biomedical literature. Among the recently developed neural networks, we use a Recursive Neural Network to improve the performance of DDI extraction. Our recursive neural network model uses a position feature, a subtree containment feature, and an ensemble method to improve the performance of DDI extraction. Compared with the state-of-the-art models, the DDI detection and type classifiers of our model performed 4.4% and 2.8% better, respectively, on the DDIExtraction Challenge' 13 test data. We also validated our model on the PK DDI corpus that consists of two types of DDIs data: in vivo DDI and in vitro DDI. Compared with the existing model, our detection classifier performed 2.3% and 6.7% better on in vivo and in vitro data respectively. The results of our validation demonstrate that our model can automatically extract DDIs better than existing models.	[Lim, Sangrak; Lee, Kyubum; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Jaewoo] Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea; [Lee, Kyubum] NIH, NCBI, NLM, Bldg 10, Bethesda, MD 20892 USA	Korea University; Korea University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kang, J (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.; Kang, J (corresponding author), Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea.	kangj@korea.ac.kr	Lee, Kyubum/G-9601-2013	Lee, Kyubum/0000-0003-2015-3939; Kang, Jaewoo/0000-0001-6798-9106	National Research Foundation of Korea [NRF-2016M3A9A7916996, 2015M3A9D7031070, 2014M3C9A3063543]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the National Research Foundation of Korea (http:// www.nrf.re.kr/) grants (NRF-2016M3A9A7916996, 2015M3A9D7031070, 2014M3C9A3063543 to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; [Anonymous], 2017, FDAS ADVERSE EVENT R; Bahdanau D., 2014, NEURAL MACHINE TRANS; Baxter K., 2015, STOCKLEYS DRUG INTER; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bjorne J., 2013, P 7 INT WORKSHOP SEM, V2, P651; CHEN D, 2014, P 2014 C EMP METH NA, V2014, P740, DOI DOI 10.3115/V1/D14-1082; Chowdhury MFM., 2013, SEMEVAL NAACL HLT, V351, P53; Drugs.com, 2000, PRESCR DRUG INF INT; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Kadlec R., 2016, PREPRINT; Kim S, 2015, J BIOMED INFORM, V55, P23, DOI 10.1016/j.jbi.2015.03.002; Kim Y., 2014, PREPRINT; Kingma DP., 2014, ADAM METHOD STOCHAST; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164680; Liu SY, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6918381; Looks M., 2017, PREPRINT; Magro L, 2012, EXPERT OPIN DRUG SAF, V11, P83, DOI 10.1517/14740338.2012.631910; Medline.com, MEDLINE CONT J CIT A; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Moen SPFGH, 2013, P LBM 2013, P39; Quan C., 2016, BIOMED RES INT; Rehurek R., 2010, P LREC 2010 WORKSH N; Sahu SK., PREPRINT; Semeniuta S., 2016, PREPRINT; Socher R, 2012, P EMNLP, P1201, DOI DOI 10.1162/153244303322533223; Socher R, 2011, INT C MACHINE LEARNI; Suarez-Paniagua V., 2016, 6 INT WORKSH COMB IN, P65; Suarez-Paniagua V, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax019; Tai KS., 2015, PREPRINT; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wu HY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-35; Zeng D., 2014, COLING; Zhang Y, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0311-2; Zhao ZH, 2016, BIOINFORMATICS, V32, P3444, DOI 10.1093/bioinformatics/btw486	38	42	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0190926	10.1371/journal.pone.0190926	http://dx.doi.org/10.1371/journal.pone.0190926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373599	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400005
J	Xu, K; Zhao, Q; Wen, XT; Wu, R; Wen, YP; Huang, XB; Huang, Y; Yan, QG; Han, XF; Ma, XP; Chang, YF; Cao, SJ				Xu, Kui; Zhao, Qin; Wen, Xintian; Wu, Rui; Wen, Yiping; Huang, Xiaobo; Huang, Yong; Yan, Qigui; Han, Xinfeng; Ma, Xiaoping; Chang, Yung-Fu; Cao, Sanjie			A trivalent Apx-fusion protein delivered by E-coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model	PLOS ONE			English	Article							DETERMINANT; BIOGENESIS; IMMUNITY; VACCINE; GAMMA; GENE; PIGS	Actinobacillus pleuropneumoniae (APP) causes serious economic losses in the swine industry, and is the etiologic agent of porcine pleuropneumonia. In this study we have engineered a trivalent Apx fusion protein enclosed in outer membrane vesicles (Apxr-OMV) and studied its immunoprotective efficacy against APP serotypes 1 and 7 challenge in mice. The results showed that the IgG levels in the Apxr-OMVs immune group were significantly higher than those of the negative control (P < 0.05). Up-regulation of both Th1 (IFN-gamma, IL-2) and Th2 (IL-4) cytokines were detected in splenocytes of Apxr-OMVs immune group. The survival rates 87.5% and 62.5% were observed against APP strain 1516 of serotype 7 and APP strain 2701 of serotype 1 in the groups of Apxr-OMVs immune group, respectively. Histopathological lesions of the pulmonary structure alveoli were found to be minimal in APXOMV group challenged with APP serotypes 1 and 7. These results strongly indicated that engineered OMVs could effectively induce specific humoral or cellular immune responses. Moreover, Apxr-OMVs used as novel vaccine provides cross-protective immunity against different serotype 1 and 7 of APP infection in a mouse model. In contrast, the OMV-empty and PBS as negative controls or inactivated strain of APP-2701 and APP-1516 as positive controls for the animal study cannot provide protection or cross-protection.	[Xu, Kui; Zhao, Qin; Wen, Xintian; Wu, Rui; Wen, Yiping; Huang, Xiaobo; Huang, Yong; Yan, Qigui; Han, Xinfeng; Ma, Xiaoping; Cao, Sanjie] Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu, Sichuan, Peoples R China; [Huang, Xiaobo; Cao, Sanjie] Minist Agr, Sichuan Sci Observat Expt Stn Vet Drugs & Vet Dia, Chengdu, Sichuan, Peoples R China; [Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Cao, Sanjie] Sichuan Agr Univ, Natl Teaching & Expt Ctr Anim, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Cornell University; Sichuan Agricultural University	Cao, SJ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Res Ctr Swine Dis, Chengdu, Sichuan, Peoples R China.; Cao, SJ (corresponding author), Minist Agr, Sichuan Sci Observat Expt Stn Vet Drugs & Vet Dia, Chengdu, Sichuan, Peoples R China.; Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.; Cao, SJ (corresponding author), Sichuan Agr Univ, Natl Teaching & Expt Ctr Anim, Chengdu, Sichuan, Peoples R China.	yc42@cornell.edu; csanjie@sicau.edu.cn						Angen O, 2008, VET MICROBIOL, V132, P312, DOI 10.1016/j.vetmic.2008.05.010; CHANG YF, 1995, DNA SEQUENCE, V5, P291, DOI 10.3109/10425179509030983; CHANG YF, 1989, FEMS MICROBIOL LETT, V60, P169, DOI 10.1111/j.1574-6968.1989.tb03439.x; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; CHANG YF, 1989, DNA-J MOLEC CELL BIO, V8, P635, DOI 10.1089/dna.1.1989.8.635; CHANG YF, 1991, J BACTERIOL, V173, P5151, DOI 10.1128/jb.173.16.5151-5158.1991; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Chen L, 2016, P NATL ACAD SCI USA, V113, pE3609, DOI 10.1073/pnas.1518311113; Chen XB, 2012, J MICROBIOL, V50, P978, DOI 10.1007/s12275-012-2214-2; Collins BS, 2011, DISCOV MED, V11, P7; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39530; FREY J, 1993, J GEN MICROBIOL, V139, P1723, DOI 10.1099/00221287-139-8-1723; Fu SL, 2013, VACCINE, V31, P347, DOI 10.1016/j.vaccine.2012.11.003; Habijanic J, 2015, NEW BIOTECHNOL, V32, P85, DOI 10.1016/j.nbt.2014.07.007; Haesebrouck F, 1997, VET MICROBIOL, V58, P239, DOI 10.1016/S0378-1135(97)00162-4; Hozbor DF, 2017, EXPERT REV VACCINES, V16, P193, DOI 10.1080/14760584.2017.1276832; Huang WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37242; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kim OY, 2013, J IMMUNOL, V190, P4092, DOI 10.4049/jimmunol.1200742; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Liu JL, 2015, VET MICROBIOL, V177, P184, DOI 10.1016/j.vetmic.2015.02.033; Metcalfe SM, 2012, TRENDS MOL MED, V18, P72, DOI 10.1016/j.molmed.2011.11.002; Mittal KR, 1985, CANADIAN VET J REV V, V26, P86; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nielsen R, 1997, VET MICROBIOL, V54, P35, DOI 10.1016/S0378-1135(96)01267-9; Prachayasittikul V, 2007, ACTA BIOCH BIOPH SIN, V39, P901, DOI 10.1111/j.1745-7270.2007.00350.x; Quast S, 2005, CELL IMMUNOL, V237, P28, DOI 10.1016/j.cellimm.2005.09.002; Rappazzo CG, 2016, VACCINE, V34, P1252, DOI 10.1016/j.vaccine.2016.01.028; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Rosenthal JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112802; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Sillanpaa M, 2005, SCI TOTAL ENVIRON, V350, P119, DOI 10.1016/j.scitotenv.2005.01.024; Sjostrom AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15329; Stenken JA, 2015, ANAL CHIM ACTA, V853, P95, DOI 10.1016/j.aca.2014.10.009; Yates A, 2000, J THEOR BIOL, V206, P539, DOI 10.1006/jtbi.2000.2147; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373	41	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191286	10.1371/journal.pone.0191286	http://dx.doi.org/10.1371/journal.pone.0191286			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373591	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400007
J	Goncalves, VF; Giamberardino, SN; Crowley, JJ; Vawter, MP; Saxena, R; Bulik, CM; Yilmaz, Z; Hultman, CM; Sklar, P; Kennedy, JL; Sullivan, PF; Knight, J				Goncalves, Vanessa F.; Giamberardino, Stephanie N.; Crowley, James J.; Vawter, Marquis P.; Saxena, Richa; Bulik, Cynthia M.; Yilmaz, Zeynep; Hultman, Christina M.; Sklar, Pamela; Kennedy, James L.; Sullivan, Patrick F.; Knight, Jo			Examining the role of common and rare mitochondrial variants in schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HAN CHINESE; HAPLOGROUPS; CLASSIFICATION; SUSCEPTIBILITY; POLYMORPHISMS; RISK; LOCI; HV	Oxidative phosphorylation within mitochondria is the main source of aerobic energy for neuronal functioning, and the key genes are located in mitochondrial DNA. Deficits in oxidative phosphorylation functioning have been reported for schizophrenia, but efforts in the identification of genetic markers within the mitochondrial DNA that predispose to schizophrenia have been limited. We genotyped a set of mitochondrial SNPs using Illumina HumanExome arrays and tested for association in the Swedish schizophrenia sample (N> 10,000). We developed a novel approach for mitochondrial DNA imputation in order to increase the number of common SNPs available for association analysis. The most significant findings were for the mitochondrial SNPs C15452A (GRCh38.p10; rs527236209; p = 0.007; gene MT-CYB; defining haplogroup JT); A11251G (rs869096886; p = 0.007; gene MT-ND4; defining haplogroup JT), and T4216C (rs1599988; p = 0.008, gene MT-ND1, defining haplogroup R2' JT). We also conducted rare variant burden analyses and obtained a p-value of 0.007. For multimarker haplotypes analysis, the most significant finding was for the J group (OR: 0.86, p = 0.02). We conducted the largest association study of mitochondrial DNA variants and schizophrenia but did not find an association that survived multiple testing correction. Analysis of a larger sample is required and will allow a better understanding of the role of mitochondria in schizophrenia.	[Goncalves, Vanessa F.; Kennedy, James L.; Knight, Jo] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Goncalves, Vanessa F.; Kennedy, James L.; Knight, Jo] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Crowley, James J.; Vawter, Marquis P.; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA; [Saxena, Richa] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Bulik, Cynthia M.; Yilmaz, Zeynep; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Bulik, Cynthia M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Bulik, Cynthia M.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Inst Genom & Multiscale Biol, Div Psychiat Genom, New York, NY 10029 USA; [Knight, Jo] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Knight, Jo] Univ Toronto, Dalla Lana Sch Publ Hlth, Biostat Div, Toronto, ON, Canada; [Knight, Jo] Univ Lancaster, Data Sci Inst, Lancaster LA1 4YW, England; [Knight, Jo] Univ Lancaster, Sch Med, Lancaster LA1 4YW, England	University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; University of Toronto; University of Toronto; Lancaster University; Lancaster University	Goncalves, VF (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; Goncalves, VF (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada.	vanessafar@gmail.com	Saxena, Richa/AAG-7279-2020; Kennedy, James Lowery/AAZ-6947-2020	Kennedy, James Lowery/0000-0002-8733-3806; Knight, Joanne/0000-0002-7148-1660; Saxena, Richa/0000-0003-2233-1065; Bulik, Cynthia/0000-0001-7772-3264	NIMH [R21MH099440-01, R01MH085801]; Pritzker Neuropsychiatric Disorders Research Consortium; National Institutes of Health [T32MH076694]; NIH [K01MH109782, R01MH105500]; NARSAD [21902]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109528, T32MH076694] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Neuropsychiatric Disorders Research Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Vawters work on mitochondria and psychiatric disorders is supported by NIMH (R21MH099440-01 and R01MH085801). Dr. Vawter also receives support from the Pritzker Neuropsychiatric Disorders Research Consortium. Dr. Yilmaz is supported by the National Institutes of Health grant T32MH076694 (PI Bulik) and NIH K01MH109782 (PI: Yilmaz). Dr. Goncalves is supported by NARSAD Distinguished Investigator Award 21902 (PI: Kennedy). Dr. Crowley is supported by NIH R01MH105500 (PI: Crowley).	Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Bertolin C, 2011, J HUM GENET, V56, P869, DOI 10.1038/jhg.2011.111; Bi R, 2016, SCHIZOPHR RES, V171, P200, DOI 10.1016/j.schres.2016.01.011; Goncalves VF, 2014, HUM GENET; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Magri C, 2007, AM J MED GENET B, V144B, P496, DOI 10.1002/ajmg.b.30496; Morrison WGJ, 2006, QUANTO 1 1 COMPUTER; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Szatkiewicz JP, 2013, MOL PSYCHIATR, V18, P1178, DOI 10.1038/mp.2013.98; Torrell H, 2014, AM J MED GENET B, V165, P607, DOI 10.1002/ajmg.b.32264; Torroni A, 1996, GENETICS, V144, P1835; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267; Wang GX, 2013, PSYCHIAT RES, V209, P279, DOI 10.1016/j.psychres.2013.01.001; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Xu FL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182769; Zhang W, 2014, J GENET GENOMICS, V41, P397, DOI 10.1016/j.jgg.2014.05.004	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191153	10.1371/journal.pone.0191153	http://dx.doi.org/10.1371/journal.pone.0191153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370225	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600041
J	Lefrancois, P; Zummo-Soucy, M; Olivie, D; Billiard, JS; Gilbert, G; Garel, J; Visee, E; Manchec, P; Tang, A				Lefrancois, Philippe; Zummo-Soucy, Mathieu; Olivie, Damien; Billiard, Jean-Sebastien; Gilbert, Guillaume; Garel, Juliette; Visee, Emmanuel; Manchec, Perrine; Tang, An			Diagnostic performance of intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for assessment of anal fistula activity	PLOS ONE			English	Article							CROHNS-DISEASE; PERIANAL FISTULAS; IN-ANO; SINUS TRACTS; CLASSIFICATION; ULTRASOUND; PERFUSION; UPDATE	Objective To evaluate intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) sequences for quantitative characterization of anal fistula activity. Methods This retrospective study was approved by the institutional review board. One hundred and two patients underwent MRI for clinical suspicion of anal fistula. Forty-three patients with demonstrable anal fistulas met the inclusion criteria. Quantitative analysis included measurement of DCE and IVIM parameters. The reference standard was clinical activity based on medical records. Statistical analyses included Bayesian analysis with Markov Chain Monte Carlo, multivariable logistic regression, and receiver operating characteristic analyses. Results Brevity of enhancement, defined as the time difference between the wash-in and wash-out, was longer in active than inactive fistulas (p = 0.02). Regression coefficients of multivariable logistic regression analysis revealed that brevity of enhancement increased and normalized perfusion area under curve decreased with presence of active fistulas (p = 0.03 and p = 0.04, respectively). By cross-validation, a logistic regression model that included quantitative perfusion parameters (DCE and IVIM) performed significantly better than IVIM only (p < 0.001). Area under the curves for distinguishing patients with active from those with inactive fistulas were 0.669 (95% confidence interval [CI]: 0.500, 0.838) for a model with IVIM only, 0.860 (95% CI: 0.742, 0.977) for a model with IVIM and brevity of enhancement, and 0.921 (95% CI: 0.846, 0.997) for a model with IVIM and all DCE parameters. Conclusion The inclusion of brevity of enhancement measured by DCE-MRI improved assessment of anal fistula activity over IVIM-DWI only.	[Lefrancois, Philippe; Zummo-Soucy, Mathieu; Olivie, Damien; Billiard, Jean-Sebastien; Gilbert, Guillaume; Garel, Juliette; Visee, Emmanuel; Manchec, Perrine; Tang, An] CHUM, Dept Radiol, Montreal, PQ, Canada; [Gilbert, Guillaume] Philips Healthcare Canada, MR Clin Sci, Markham, ON, Canada; [Visee, Emmanuel] Ctr Hosp Dept Vendee, Les Oudairies, La Roche Sur Yo, France; [Manchec, Perrine] Norimagerie, 1,3 Chemin Penthod, Caluire Et Cuire, France; [Tang, An] CRCHUM, Montreal, PQ, Canada	Universite de Montreal; Philips; Philips Healthcare; CHD Vendee; Universite de Montreal	Tang, A (corresponding author), CHUM, Dept Radiol, Montreal, PQ, Canada.; Tang, A (corresponding author), CRCHUM, Montreal, PQ, Canada.	an.tang@umontreal.ca	Lefrancois, Philippe/J-1440-2019; Tang, An/E-5333-2016	Lefrancois, Philippe/0000-0003-2939-7956; Tang, An/0000-0001-8967-5503	Fonds de Recherche du Quebec en Sante; Fondation de l'association des radiologistes du Quebec [34939]	Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Fondation de l'association des radiologistes du Quebec	An Tang was supported by a research scholarship from the Fonds de Recherche du Quebec en Sante (http://www.frgs.gouv.qc.ca/en/) and Fondation de l'association des radiologistes du Quebec (http://www.arg.qc.ca/) (FRQS-ARQ #34939). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan S, 2015, IRAN J RADIOL, V12, DOI 10.5812/iranjradiol.29084; Beckingham IJ, 1996, BRIT J SURG, V83, P1396, DOI 10.1002/bjs.1800831022; Buchanan G, 2002, LANCET, V360, P1661, DOI 10.1016/S0140-6736(02)11605-9; Buchanan GN, 2004, RADIOLOGY, V233, P674, DOI 10.1148/radiol.2333031724; Burdan F, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-014-0078-0; Criado JD, 2012, RADIOGRAPHICS, V32, P175, DOI 10.1148/rg.321115040; Dohan A, 2016, J MAGNETIC RESONANCE; Dohan A, 2014, EUR RADIOL, V24, P2906, DOI 10.1007/s00330-014-3302-y; Florie J, 2006, AM J ROENTGENOL, V186, P1384, DOI 10.2214/AJR.04.1454; Gage KL, 2013, ABDOM IMAGING, V38, P1033, DOI 10.1007/s00261-012-9965-4; Gecse KB, 2014, GUT, V63, P1381, DOI 10.1136/gutjnl-2013-306709; Giusti S, 2010, ABDOM IMAGING, V35, P646, DOI 10.1007/s00261-010-9624-6; Gordon Y, 2014, CARDIOVASC DIAGN THE, V4, P147, DOI 10.3978/j.issn.2223-3652.2014.03.01; Guiu B, 2011, EUR RADIOL, V21, P463, DOI 10.1007/s00330-010-2017-y; Halligan S, 2006, RADIOLOGY, V239, P18, DOI 10.1148/radiol.2391041043; Hori M, 2009, J MAGN RESON IMAGING, V30, P1021, DOI 10.1002/jmri.21934; Horsthuis K, 2011, CLIN IMAG, V35, P360, DOI 10.1016/j.clinimag.2010.09.003; Hussain SM, 1996, RADIOLOGY, V200, P475, DOI 10.1148/radiology.200.2.8685344; Joyce Myles, 2008, Clin Colon Rectal Surg, V21, P213, DOI 10.1055/s-2008-1081000; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Kiryu S, 2009, J MAGN RESON IMAGING, V29, P880, DOI 10.1002/jmri.21725; KOELBEL G, 1989, AM J ROENTGENOL, V152, P999, DOI 10.2214/ajr.152.5.999; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LUNNISS PJ, 1992, LANCET, V340, P394, DOI 10.1016/0140-6736(92)91472-K; Morris J, 2000, RADIOGRAPHICS, V20, P35; Oto A, 2011, J MAGN RESON IMAGING, V33, P615, DOI 10.1002/jmri.22435; Pinson C, 2016, EUR RADIOL; Plumb AA, 2015, RADIOLOGY, V276, P147, DOI 10.1148/radiol.15141662; SAINIO P, 1984, ANN CHIR GYNAECOL FE, V73, P219; Schaefer O, 2004, J MAGN RESON IMAGING, V19, P91, DOI 10.1002/jmri.10436; Schmid-Tannwald C, 2012, J MAGN RESON IMAGING, V35, P125, DOI 10.1002/jmri.22804; Schwartz DA, 2001, GASTROENTEROLOGY, V121, P1064, DOI 10.1053/gast.2001.28676; Sheedy SP, 2017, RADIOLOGY, V282, P628, DOI 10.1148/radiol.2016151491; Shellock FG, 2008, AM J ROENTGENOL, V191, P1129, DOI 10.2214/AJR.08.1038.1; Spencer JA, 1996, AM J ROENTGENOL, V167, P735, DOI 10.2214/ajr.167.3.8751692; Tabry H, 2011, CAN J GASTROENTEROL, V25, P675, DOI 10.1155/2011/931316; Nguyen TLF, 2013, J COMPUT ASSIST TOMO, V37, P971, DOI 10.1097/RCT.0b013e31828bea16; Van Assche G, 2003, AM J GASTROENTEROL, V98, P332, DOI 10.1016/S0002-9270(02)05909-9; Wang L, 2008, ACTA RADIOL, V49, P6, DOI 10.1080/02841850701630300; Yoshizako T, 2012, EUR J RADIOL, V81, P2049, DOI 10.1016/j.ejrad.2011.06.052; Ziech MLW, 2013, AM J ROENTGENOL, V200, pW170, DOI 10.2214/AJR.11.8276	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191822	10.1371/journal.pone.0191822	http://dx.doi.org/10.1371/journal.pone.0191822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370278	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600103
J	Paolieri, D; Marful, A; Morales, L; Bajo, MT				Paolieri, Daniela; Marful, Alejandra; Morales, Luis; Teresa Bajo, Maria			The modulating effect of education on semantic interference during healthy aging	PLOS ONE			English	Article							OLDER-ADULTS RETRIEVAL; THE-TONGUE EXPERIENCES; PROPER-NAMES; AGE-DIFFERENCES; INDIVIDUAL-DIFFERENCES; SPEECH PRODUCTION; NAMING OBJECTS; LEXICAL ACCESS; WORD RETRIEVAL; MEMORY	Aging has traditionally been related to impairments in name retrieval. These impairments have usually been explained by a phonological transmission deficit hypothesis or by an inhibitory deficit hypothesis. This decline can, however, be modulated by the educational level of the sample. This study analyzed the possible role of these approaches in explaining both object and face naming impairments during aging. Older adults with low and high educational level and young adults with high educational level were asked to repeatedly name objects or famous people using the semantic-blocking paradigm. We compared naming when exemplars were presented in a semantically homogeneous or in a semantically heterogeneous context. Results revealed significantly slower rates of both face and object naming in the homogeneous context (i.e., semantic interference), with a stronger effect for face naming. Interestingly, the group of older adults with a lower educational level showed an increased semantic interference effect during face naming. These findings suggest the joint work of the two mechanisms proposed to explain age-related naming difficulties, i.e., the inhibitory deficit and the transmission deficit hypothesis. Therefore, the stronger vulnerability to semantic interference in the lower educated older adult sample would possibly point to a failure in the inhibitory mechanisms in charge of interference resolution, as proposed by the inhibitory deficit hypothesis. In addition, the fact that this interference effect was mainly restricted to face naming and not to object naming would be consistent with the increased age-related difficulties during proper name retrieval, as suggested by the transmission deficit hypothesis.	[Paolieri, Daniela; Teresa Bajo, Maria] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Marful, Alejandra] Univ Jaen, Dept Psychol, Jaen, Spain; [Morales, Luis] Univ Loyola Andalucia, Dept Psychol, Seville, Spain	University of Granada; Universidad de Jaen; Universidad Loyola Andalucia	Paolieri, D (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain.	dpaolieri@ugr.es	MARFUL, ALEJANDRA/AAT-8785-2020; Bajo, Teresa/D-9927-2011; Morales, Luis/K-9297-2014; Marful, Alejandra/B-5738-2012; Paolieri, Daniela/G-9817-2015	Bajo, Teresa/0000-0003-2996-8261; Morales, Luis/0000-0003-3966-9214; Paolieri, Daniela/0000-0002-3964-7405	Spanish Ministry of Economy and Competitiveness [PSI2013-46033-P, PSI2015-65502-C2-1-P, PCIN-2015-165-C02-01, PSI2017-89324-C2-1-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was supported by grants PSI2013-46033-P to A.M., PSI2015-65502-C2-1-P to M.T.B., PCIN-2015-165-C02-01 to D.P., PSI2017-89324-C2-1-P to DP from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 1999, PSYCHOL AGING, V14, P314, DOI 10.1037/0882-7974.14.2.314; Aguirre C, 2014, PSYCHOL AGING, V29, P128, DOI 10.1037/a0035598; Alameda J.R., 1995, DICCIONARIO FRECUENC; [Anonymous], 2002, PSYCH SOFTW TOOLS E; Belke E, 2005, COGNITION, V96, pB45, DOI 10.1016/j.cognition.2004.11.006; Belke E, 2005, Q J EXP PSYCHOL-A, V58, P667, DOI 10.1080/02724980443000142; Belke E, 2017, J EXP PSYCHOL LEARN; Belke E, 2007, LANG COGNITIVE PROC, V22, P1178, DOI 10.1080/01690960701461541; Biegler KA, 2008, COGN NEUROPSYCHOL, V25, P493, DOI 10.1080/02643290701862316; Boelens H, 2017, BRIT J DEV PSYCHOL, V35, P310, DOI 10.1111/bjdp.12178; BOLLA KI, 1991, ARCH NEUROL-CHICAGO, V48, P61, DOI 10.1001/archneur.1991.00530130069022; Brown AS, 1996, AM J PSYCHOL, V109, P79, DOI 10.2307/1422928; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Burke DM, 2000, DEBATES PSYCHOL, P204; COHEN G, 1986, BRIT J DEV PSYCHOL, V4, P187, DOI 10.1111/j.2044-835X.1986.tb01010.x; Connor LT, 2004, J GERONTOL B-PSYCHOL, V59, pP203, DOI 10.1093/geronb/59.5.P203; Corral M, 2006, DEV NEUROPSYCHOL, V29, P479, DOI 10.1207/s15326942dn2903_6; Craik F. I. M., 1992, HDB AGING COGNITION, P51, DOI DOI 10.1016/S0022-5371(72)80001-X; Cross ES, 2004, BRAIN LANG, V89, P174, DOI 10.1016/S0093-934X(03)00363-8; Crowther JE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00009; Damian MF, 2005, J EXP PSYCHOL LEARN, V31, P1372, DOI 10.1037/0278-7393.31.6.1372; Damian MF, 2001, COGNITION, V81, pB77, DOI 10.1016/S0010-0277(01)00135-4; Diaz MT, 2016, LANG LINGUIST COMPAS, V10, P314, DOI 10.1111/lnc3.12199; Diaz MT, 2014, J COGNITIVE NEUROSCI, V26, P2798, DOI 10.1162/jocn_a_00665; Drag L. L., 2009, J GERIATR PSYCHIAT, V23, P75, DOI DOI 10.1177/0891988709358590; Evrard M, 2002, BRAIN LANG, V81, P174, DOI 10.1006/brln.2001.2515; Fogler KA, 2007, J GERONTOL B-PSYCHOL, V62, pP201, DOI 10.1093/geronb/62.4.P201; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gordon JK, 2013, COGN NEUROPSYCHOL, V30, P476, DOI 10.1080/02643294.2013.877437; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Heine MK, 1999, PSYCHOL AGING, V14, P445, DOI 10.1037/0882-7974.14.3.445; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; James LE, 2006, J GERONTOL B-PSYCHOL, V61, pP180, DOI 10.1093/geronb/61.3.P180; James LE, 2004, PSYCHOL AGING, V19, P515, DOI 10.1037/0882-7974.19.3.515; Juncos-Rabadan O, 2006, PSICOTHEMA, V18, P501; Kemper S, 1992, HDB AGING COGNITION, P213; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34; Le Dorze G., 1992, J SPEECH LANG PATHOL, V16, P21; LeDorze G, 1998, J COMMUN DISORD, V31, P53, DOI 10.1016/S0021-9924(97)00051-8; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; LOVELACE EA, 1990, B PSYCHONOMIC SOC, V28, P115; MacKay D.G., 1990, AGING COGNITION KNOW, V71, P213, DOI [10.1016/S0166-4115(08)60159-4, DOI 10.1016/S0166-4115(08)60159-4]; Marful A, 2000, PSICOLOGICA, V31, P219; Marful A, 2015, EXP AGING RES, V41, P39, DOI 10.1080/0361073X.2015.978205; Marful A, 2014, MEM COGNITION, V42, P525, DOI 10.3758/s13421-013-0376-8; Maylor EA, 1997, AGING NEUROPSYCHOL C, V4, P211, DOI 10.1080/13825589708256648; MAYLOR EA, 1990, J GERONTOL, V45, pP215, DOI 10.1093/geronj/45.6.P215; Mortensen L, 2006, LANG COGNITIVE PROC, V21, P238, DOI 10.1080/01690960444000278; Navarrete E, 2014, J MEM LANG, V76, P253, DOI 10.1016/j.jml.2014.05.003; Neumann Y, 2009, APHASIOLOGY, V23, P1028, DOI 10.1080/02687030802661630; Obler L, 1985, HDB PSYCHOL AGING, P463; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Ortega A, 2012, J EXP PSYCHOL LEARN, V38, P178, DOI 10.1037/a0024510; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pelamatti G, 2003, CORTEX, V39, P97, DOI 10.1016/S0010-9452(08)70077-7; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pike KE, 2012, J CLIN EXP NEUROPSYC, V34, P269, DOI 10.1080/13803395.2011.633498; Rahman RA, 2007, J EXP PSYCHOL LEARN, V33, P604, DOI 10.1037/0278-7393.33.3.604; Rendell PG, 2005, Q J EXP PSYCHOL-A, V58, P54, DOI 10.1080/02724980443000188; Reuter-Lorenz P, LIFESPAN DEV BRAIN P; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; ROSINSKI RR, 1975, CHILD DEV, V46, P247, DOI 10.2307/1128859; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; SALTHOUSE TA, 1992, ACTA PSYCHOL, V79, P155, DOI 10.1016/0001-6918(92)90030-H; Schnur TT, 2006, J MEM LANG, V54, P199, DOI 10.1016/j.jml.2005.10.002; Semenza C, 2006, CORTEX, V42, P884, DOI 10.1016/S0010-9452(08)70432-5; Shao ZS, 2013, MEM COGNITION, V41, P1200, DOI 10.3758/s13421-013-0332-7; Shao ZS, 2012, Q J EXP PSYCHOL, V65, P1927, DOI 10.1080/17470218.2012.670252; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Speranza F, 2000, PSYCHOL AGING, V15, P253, DOI 10.1037/0882-7974.15.2.253; Van Dijk KRA, 2008, PSYCHOL AGING, V23, P119, DOI 10.1037/0882-7974.23.1.119; Verhaeghen P, 2003, PSYCHOL AGING, V18, P332, DOI 10.1037/0882-7974.18.2.332; Vitevitch MS, 2003, MEM COGNITION, V31, P491, DOI 10.3758/BF03196091; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; White KK, 2002, PSYCHOL AGING, V17, P226, DOI 10.1037//0882-7974.17.2.226	84	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191656	10.1371/journal.pone.0191656	http://dx.doi.org/10.1371/journal.pone.0191656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370252	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600073
J	Liu, ZX; Zhu, JF; Yang, XY; Wu, HW; Wei, Q; Wei, HR; Zhang, HX				Liu, Zhengxiang; Zhu, Jianfeng; Yang, Xiuyan; Wu, Haiwen; Wei, Qi; Wei, Hairong; Zhang, Huaxin			Growth performance, organ-level ionic relations and organic osmoregulation of &ITElaeagnus angustifolia&IT in response to salt stress	PLOS ONE			English	Article							PHOTOSYNTHETIC CHARACTERISTICS; SALINITY TOLERANCE; WATER RELATIONS; MECHANISMS; ACCUMULATION; ARABIDOPSIS; TRANSPORT; MARITIMA; NACL	Elaeagnus angustifolia is one of the most extensively afforested tree species in environment-harsh regions of northern China. Despite its exceptional tolerance to saline soil, the intrinsic adaptive physiology has not been revealed. In this study, we investigated the growth, organ-level ionic relations and organic osmoregulation of the seedlings hydroponically treated with 0, 100 and 200 mM NaCl for 30 days. We found that the growth characteristics and the whole-plant dry weight were not obviously stunted, but instead, were even slightly stimulated by the treatment of 100 mM NaCl. In contrast, these traits were significantly inhibited by 200 mM NaCl treatment. Interestingly, as compared with the control (0 mM NaCl), both 100 and 200 mM NaCl treatments had a promotional effect on root growth as evidenced by 26.3% and 2.4% increases in root dry weight, respectively. Roots had the highest Na+ and Cl- concentrations and obviously served as the sink for the net increased Na+ and while, stems might maintain the capacity of effective Na+ constraint, resulting in reduced Na+ transport to the leaves. K+, Ca2+ and Mg2+ concentrations in three plant organs of NaCl-treated seedlings presented a substantial decline, eventually leading to an enormously drop of K+/Na+ ratio. As the salt concentration increased, proline and soluble protein contents continuously exhibited a prominent and a relatively tardy accumulation, respectively, whereas soluble sugar firstly fell to a significant level and then regained to a level that is close to that of the control. Taken together, our results provided quantitative measures that revealed some robust adaptive physiological mechanisms underpinning E. angustifolia's moderately high salt tolerance, and those mechanisms comprise scalable capacity for root Na+ and Cl- storage, effectively constrained transportation of Na+ from stems to leaves, root compensatory growth, as well as an immediate and prominent leaf proline accumulation.	[Liu, Zhengxiang; Zhu, Jianfeng; Yang, Xiuyan; Wu, Haiwen; Zhang, Huaxin] Chinese Acad Forestry, Res Ctr Saline & Alkali Land State Forestry Adm, Beijing, Peoples R China; [Wei, Qi] Gen Forestry Stn Beijing Municipal, Beijing, Peoples R China; [Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Chinese Academy of Forestry; Research Center of Saline & Alkali Land of State Forestry Administration, CAF; Michigan Technological University	Liu, ZX; Zhang, HX (corresponding author), Chinese Acad Forestry, Res Ctr Saline & Alkali Land State Forestry Adm, Beijing, Peoples R China.	xiangzilz@163.com; zhanghx1998@126.com	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QB052]; National Natural Science Foundation of China [31400571]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by grants from the National Natural Science Foundation of China (31400571), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (CAFYBB2014QB052). The funders had no role in experimental design and conduct, data collection and analysis, decision to publish, or preparation of the manuscript.	Abideen Z, 2014, ENVIRON EXP BOT, V105, P70, DOI 10.1016/j.envexpbot.2014.04.009; Ahmed MZ, 2013, FUNCT PLANT BIOL, V40, P860, DOI 10.1071/FP12346; Ailijiang Maimaiti, 2008, Xinjiang Agricultural Sciences, V45, P1069; Al Hassan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160236; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britto DT, 2006, TRENDS PLANT SCI, V11, P529, DOI 10.1016/j.tplants.2006.09.011; Chartzoulakis KS, 2005, AGR WATER MANAGE, V78, P108, DOI 10.1016/j.agwat.2005.04.025; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Cramer GR, 2002, FUNCT PLANT BIOL, V29, P561, DOI 10.1071/PP01132; Cristiano G, 2016, FORESTS, V7, DOI 10.3390/f7080156; Cuartero J, 2006, J EXP BOT, V57, P1045, DOI 10.1093/jxb/erj102; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Gadallah MAA, 1999, BIOL PLANTARUM, V42, P249, DOI 10.1023/A:1002164719609; Gong Q, 2008, J XINJIANG AGR U, V31, P46; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Henderson SW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0273-8; Jaarsma R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060183; James JJ, 2006, J EXP BOT, V57, P139, DOI 10.1093/jxb/erj016; Li JG, 2014, J GEOGR SCI, V24, P943, DOI 10.1007/s11442-014-1130-2; Li L, 2013, PHYSIOL PLANTARUM, V147, P477, DOI 10.1111/j.1399-3054.2012.01676.x; Liu BaoYu, 2007, Bulletin of Botanical Research, V27, P721; Liu Zheng-xiang, 2014, Forest Research, V27, P186; Liu ZhengXiang, 2014, Scientia Silvae Sinicae, V50, P32; Liu ZX, 2013, COMMUN SOIL SCI PLAN, V44, P3187, DOI 10.1080/00103624.2013.832289; Lv SL, 2012, PLANT PHYSIOL BIOCH, V51, P47, DOI 10.1016/j.plaphy.2011.10.015; M'rah S, 2006, J PLANT PHYSIOL, V163, P1022, DOI 10.1016/j.jplph.2005.07.015; Mullet JE, 1996, PLANT GROWTH REGUL, V20, P119, DOI 10.1007/BF00024008; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Naidoo G, 2012, AFR J AQUAT SCI, V37, P81, DOI 10.2989/16085914.2012.666377; PARRONDO RT, 1978, BOT GAZ, V139, P102, DOI 10.1086/336975; [邱念伟 Qiu Nianwei], 2014, [生态学报, Acta Ecologica Sinica], V34, P6147; Song J, 2011, PHYSIOL PLANTARUM, V141, P343, DOI 10.1111/j.1399-3054.2011.01445.x; Tattini M, 2006, NEW PHYTOL, V170, P779, DOI 10.1111/j.1469-8137.2006.01723.x; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Volkov V, 2004, PLANT CELL ENVIRON, V27, P1, DOI 10.1046/j.0016-8025.2003.01116.x; [王树凤 Wang Shufeng], 2010, [生态学报, Acta Ecologica Sinica], V30, P4609; Wei QJ, 2015, BIOL PLANTARUM, V59, P645, DOI 10.1007/s10535-015-0532-z; Wu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171451; Xu H., 2004, HALOPHYTE ECOLOGICAL; [杨升 Yang Sheng], 2013, [林业科学, Scientia Silvae Sinicae], V49, P91; YEO AR, 1980, J EXP BOT, V31, P1171, DOI 10.1093/jxb/31.4.1171; [张华新 ZHANG Hua-Xin], 2009, [生态学报, Acta Ecologica Sinica], V29, P2263; Zhang WW, 2015, PLANT PHYSIOL BIOCH, V89, P85, DOI 10.1016/j.plaphy.2015.02.012; Zhang Yi, 2010, Forest Research, V23, P920; Zhao KF, 2011, PLANT SOIL, V342, P495, DOI 10.1007/s11104-010-0470-7	51	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191552	10.1371/journal.pone.0191552	http://dx.doi.org/10.1371/journal.pone.0191552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360848	Green Published, gold			2022-12-26	WOS:000423161800036
J	Lucas-de la Cruz, L; Martin-Espinosa, N; Cavero-Redondo, I; Gonzalez-Garcia, A; Diez-Fernandez, A; Martinez-Vizcaino, V; Notario-Pacheco, B				Lucas-de la Cruz, Lidia; Martin-Espinosa, Noelia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Martinez-Vizcaino, Vicente; Notario-Pacheco, Blanca			Sleep patterns and cardiometabolic risk in schoolchildren from Cuenca, Spain	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; DURATION; CHILDREN; OVERWEIGHT; BEDTIME; IMPACT; LINK	Sleep seems to have a significant influence on the metabolic syndrome (MetS). However, results in this association are still inconsistent in children. The aim of this study was to examine the influence of sleep characteristics in the MetS (index and factors) in Spanish children. Cross-sectional study including a sample of 210 children aged 8-to-1l-years belonging to 20 schools from the province of Cuenca, Spain was conducted. Cardiometabolic risk and actigraphy sleep patterns were determined and analysed using correlation coefficients, ANCOVA models and a propensity score derivation model. Overall, children in the lower time in bed category and those who went to bed later (> 23:15h) showed worse values in the cardiometabolic profile and risk index. Differences were observed when the total time in bed was below 9h 15mins. Our study shows that short sleep duration could be a risk factor for cardiometabolic risk in children, and bedtime may independently influence this risk. In addition, our data suggests that children's sleep hygiene should be incorporated in parenting educational programs.	[Lucas-de la Cruz, Lidia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain; [Lucas-de la Cruz, Lidia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Martinez-Vizcaino, Vicente; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Martin-Espinosa, Noelia] Univ Castilla La Mancha, Fac Nursing, Toledo, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Cavero-Redondo, I (corresponding author), Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain.; Cavero-Redondo, I (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.	Ivan.Cavero@uclm.es	Cavero Redondo, Iván/HII-7855-2022; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Diez-Fernandez, Ana/Z-3348-2019; Cavero-Redondo, Ivan/R-4818-2019; Notario Pacheco, Blanca/G-2583-2016	Cavero Redondo, Iván/0000-0003-2617-0430; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Diez-Fernandez, Ana/0000-0002-7673-986X; Gonzalez-Garcia, Alberto/0000-0001-7314-1435; Notario Pacheco, Blanca/0000-0001-8406-6952; Martin Espinosa, Noelia Maria/0000-0002-1298-6976	Ministry of Health [FIS PI081297]; Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, P0II10-0208-5325]; Research Network on Preventative Activities and Health Promotion [RD06/0018/0038]	Ministry of Health; Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha (PII1I09-0259-9898 and P0II10-0208-5325), and Ministry of Health (FIS PI081297). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref.- RD06/0018/0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2016, J PEDIAT; Asarnow LD, 2015, SLEEP, V38, P1523, DOI 10.5665/sleep.5038; Au CT, 2014, PEDIATRICS, V133, pE64, DOI 10.1542/peds.2013-1379; Bathory E, 2017, CURR PROB PEDIATR AD, V47, P29, DOI 10.1016/j.cppeds.2016.12.001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Deb S, 2016, CAN J CARDIOL, V32, P259, DOI 10.1016/j.cjca.2015.05.015; Fatima Y, 2015, OBES REV, V16, P137, DOI 10.1111/obr.12245; Gangwisch JE, 2014, AM J HYPERTENS, V27, P1235, DOI 10.1093/ajh/hpu071; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Gutin B, 2011, PEDIATR EXERC SCI, V23, P169, DOI 10.1123/pes.23.2.169; Hjorth MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104677; Hjorth MF, 2012, SLEEP BIOL RHYTHMS, V10, P328, DOI 10.1111/j.1479-8425.2012.00578.x; Hunsberger M, 2015, NUTRIENTS, V7, P10223, DOI 10.3390/nu7125529; Javaheri S, 2011, J PEDIATR-US, V158, P617, DOI 10.1016/j.jpeds.2010.09.080; Kong AP, 2011, SLEEP MED, V12, P659, DOI 10.1016/j.sleep.2010.12.015; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Magee CA, 2013, J DEV BEHAV PEDIATR, V34, P165, DOI [10.1097/DBP.0b013e318289aa51., 10.1097/DBP.0b013e318289aa51]; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; McDonald L, 2014, SLEEP MED, V15, P536, DOI 10.1016/j.sleep.2014.01.005; McNeil J, 2013, CAN J DIABETES, V37, P103, DOI 10.1016/j.jcjd.2013.02.060; Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Quist JS, 2016, SLEEP MED REV, V29, P76, DOI 10.1016/j.smrv.2015.09.001; Ruger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sayin FK, 2016, CHILD OBES, V12, P272, DOI 10.1089/chi.2015.0126; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Urban D, 2013, INTEGR BLOOD PRESS C, V6, P119, DOI 10.2147/IBPC.S33958; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191637	10.1371/journal.pone.0191637	http://dx.doi.org/10.1371/journal.pone.0191637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360869	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800047
J	Bzhalava, Z; Hultin, E; Dillner, J				Bzhalava, Zurab; Hultin, Emilie; Dillner, Joakim			Extension of the viral ecology in humans using viral profile hidden Markov models	PLOS ONE			English	Article							SKIN-CANCER; TRANSPLANT RECIPIENTS; HUMAN PAPILLOMAVIRUSES; CYSTIC-FIBROSIS; HUMAN VIROME; DNA VIRUSES; GENOME; INDIVIDUALS; GENERATION; DIVERSITY	When human samples are sequenced, many assembled contigs are "unknown", as conventional alignments find no similarity to known sequences. Hidden Markov models (HMM) exploit the positions of specific nucleotides in protein-encoding codons in various microbes. The algorithm HMMER3 implements HMM using a reference set of sequences encoding viral proteins, "vFam". We used HMMER3 analysis of "unknown" human sample-derived sequences and identified 510 contigs distantly related to viruses (Anelloviridae (n = 1), Baculoviridae (n = 34), Circoviridae (n = 35), Caulimoviridae (n = 3), Closteroviridae (n = 5), Geminiviridae (n = 21), Herpesviridae (n = 10), Iridoviridae (n = 12), Marseillevirus (n = 26), Mimiviridae (n = 80), Phycodnaviridae (n = 165), Poxviridae (n = 23), Retroviridae (n = 6) and 89 contigs related to described viruses not yet assigned to any taxonomic family). In summary, we find that analysis using the HMMER3 algorithm and the "vFam" database greatly extended the detection of viruses in biospecimens from humans.	[Bzhalava, Zurab; Hultin, Emilie; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	joakim.dillner@ki.se			Swedish Research Council [K2015-57X-21044-07-3]; NordForsk [62721]	Swedish Research Council(Swedish Research CouncilEuropean Commission); NordForsk	This work was supported by the Swedish Research Council, www.vr.se, Grant number: K2015-57X-21044-07-3 and the NordForsk, www.nordforsk.org, Grant number: 62721 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Bzhalava D DJ, 2013, J DATA MINING GENOMI, V4; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Bzhalava D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05807; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Delaroque N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-110; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grazziotin AL, 2017, NUCLEIC ACIDS RES, V45, pD491, DOI 10.1093/nar/gkw975; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Johansson H., 2013, VIROLOGY; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; La Rosa G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052391; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lecuit M, 2013, TRENDS MICROBIOL, V21, P510, DOI 10.1016/j.tim.2013.07.001; Lehtinen M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015867; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Manso CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02239-5; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Mercalli A, 2012, DIABETOLOGIA, V55, P2479, DOI 10.1007/s00125-012-2591-4; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Miyashita H, 2014, PROTEIN PEPTIDE LETT, V21, P292, DOI 10.2174/09298665113206660112; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Omland T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099114; Paez-Espino D, 2017, NAT PROTOC, V12, P1673, DOI 10.1038/nprot.2017.063; Pappalardo M, 2016, CONSERVED DIFFERENCE, V6, P23743; Roux S, 2015, VIRSORTER MINING VIR; Schulz TF, 2009, INT J CANCER, V125, P1755, DOI 10.1002/ijc.24741; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Sherif F, 2011, CLASSIFICATION HUMAN; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Smelov V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25235; Sundstrom P, 2004, ALTERED IMMUNE RESPO, P2277; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Zhang YP, 1998, VIROLOGY, V240, P366, DOI 10.1006/viro.1997.8936	56	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190938	10.1371/journal.pone.0190938	http://dx.doi.org/10.1371/journal.pone.0190938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351302	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300033
J	Hammami, P; Lancelot, R; Domenech, J; Lesnoff, M				Hammami, Pachka; Lancelot, Renaud; Domenech, Joseph; Lesnoff, Matthieu			Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa	PLOS ONE			English	Article							ANTIBODY DYNAMICS; SHEEP; IMMUNITY; GOATS; POPULATION; OUTBREAK; DISTRICT; VACCINES; SENEGAL	Background Peste des petits ruminants (PPR) is a highly contagious and widespread viral infection of small ruminants (goats and sheep), causing heavy economic losses in many developing countries. Therefore, its progressive control and global eradication by 2030 was defined as a priority by international organizations addressing animal health. The control phase of the global strategy is based on mass vaccination of small ruminant populations in endemic regions or countries. It is estimated that a 70% post-vaccination immunity rate (PVIR) is needed in a given epidemiological unit to prevent PPR virus spread. However, implementing mass vaccination is difficult and costly in smallholder farming systems with scattered livestock and limited facilities. Regarding this, controlling PPR is a special challenge in subSaharan Africa. In this study, we focused on this region to assess the effect of several variables of PVIR in two contrasted smallholder farming systems. Methods Using a seasonal matrix population model of PVIR, we estimated its decay in goats reared in sub-humid areas, and sheep reared in semi-arid areas, over a 4-year vaccination program. Assuming immunologically naive and PPR-free epidemiological unit, we assessed the ability of different vaccination scenarios to reach the 70% PVIR throughout the program. The tested scenarios differed in i) their overall schedule, ii) their delivery month and iii) their vaccination coverage. Results In sheep reared in semi-arid areas, the vaccination month did affect the PVIR decay though it did not in goats in humid regions. In both cases, our study highlighted i) the importance of targeting the whole eligible population at least during the two first years of the vaccination program and ii) the importance of reaching a vaccination coverage as high as 80% of this population. This study confirmed the relevance of the vaccination schedules recommended by international organizations.	[Hammami, Pachka; Lancelot, Renaud] Ctr Cooperat Int Rech Agronom Dev CIRAD, Animals Hlth Terr Risks & Ecosyst ASTRE, UMR 117, Campus Int Baillarguet, F-34398 Montpellier, France; [Hammami, Pachka; Lancelot, Renaud] INRA, ASTRE, UMR 117, F-34398 Montpellier, France; [Lesnoff, Matthieu] CIRAD, UMR Syst Elevage Mediterraneens & Trop SELMET, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] INRA, UMR SELMET, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Montpellier SUPAGRO, UMR SELMET, Campus Int Baillarguet, F-34398 Montpellier, France	CIRAD; Universite de Montpellier; INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro	Hammami, P (corresponding author), Ctr Cooperat Int Rech Agronom Dev CIRAD, Animals Hlth Terr Risks & Ecosyst ASTRE, UMR 117, Campus Int Baillarguet, F-34398 Montpellier, France.; Hammami, P (corresponding author), INRA, ASTRE, UMR 117, F-34398 Montpellier, France.	pachka.hammami@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; Hammami, Pachka/0000-0002-7490-6257	Bill and Melinda Gates Foundation; OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	This study was conducted in the frame of the project "Vaccine Standard and Pilot Approach for the Progressive Control and Eradication of PPR in Africa" (VSPA), funded by the Bill and Melinda Gates Foundation, the OIE World Animal Health and Welfare Fund, and Cirad. Small ruminant demographic data were collected during the joint research programme "Pathologie et Productivite des Petits Ruminants" co-funded by the Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal), the Directorate of Veterinary Services (DSV, Dakar, Senegal), and Cirad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar Muhammad, 2015, Journal of Animal Science and Technology, V57, P2, DOI 10.1186/s40781-014-0036-y; Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Alary V, 2011, WORLD DEV, V39, P1638, DOI 10.1016/j.worlddev.2011.02.008; Albina E, 2013, VET MICROBIOL, V165, P38, DOI 10.1016/j.vetmic.2012.12.013; ALSABBAGH TA, 1995, J ANIM SCI, V73, P2860; [Anonymous], 2006, CARBON LAND WATER GL; Anyamba A, 2014, REMOTE SENS-BASEL, V6, P3101, DOI 10.3390/rs6043101; ATA FA, 1989, VET REC, V124, P590, DOI 10.1136/vr.124.22.590; Awa DN, 2002, PREV VET MED, V55, P265, DOI 10.1016/S0167-5877(02)00013-2; Balamurugan Vinayagamurthy, 2012, Virologica Sinica, V27, P228, DOI 10.1007/s12250-012-3249-6; Baron MD, 2016, ADV VIRUS RES, V95; Bidjeh Kebkiba, 1999, Cahiers Agricultures, V8, P219; Bodjo SC, 2006, BIOKEMISTRI, V18; Buczkowski H, 2014, VACCINE, V32, P3155, DOI 10.1016/j.vaccine.2014.03.053; Caswell, 2000, MATRIX POPULATION MO; Cetre-Sossah C, 2014, TRANSBOUND EMERG DIS; Clement V., 1997, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V50, P235; Cosseddu GM, 2016, TRANSBOUND EMERG DIS, V63, pE447, DOI 10.1111/tbed.12314; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Diallo A., 2006, Journal of Veterinary Medicine. Series B, V53, P11, DOI 10.1111/j.1439-0450.2006.01012.x; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; El Arbi AS, 2014, EMERG INFECT DIS, V20, P334, DOI 10.3201/eid2002.131345; El-Yuguda A-D., 2014, WORLD J VACCINES, V04, P1, DOI [10.4236/wjv.2014.41001, DOI 10.4236/WJV.2014.41001]; Ettair M., 2012, REMESA ATELIER CONJO, P1; FAO OIE, 2015, GLOB STRAT PROGR CON; Faugere O., 1990, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V43, P249; Faugere O, 1990, REV ELEV MED VET PAY, V43; Geiger R, 1999, P RES COORD M FAO IA; Goossens B, 1997, INT J PARASITOL, V27, P1579, DOI 10.1016/S0020-7519(97)00094-5; Hammami P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161769; Hashemi M, 2008, SMALL RUMINANT RES, V75, P204, DOI 10.1016/j.smallrumres.2007.11.002; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Kairu-Wanyoike SW, 2014, PREV VET MED, V115, P130, DOI 10.1016/j.prevetmed.2014.03.028; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Lancelot R., 1998, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V51, P135; Lancelot R, 2014, VACCINE STANDARDS PI; Lancelot R, 2017, P NATL ACAD SCI USA, V114, P938, DOI 10.1073/pnas.1607948114; Lefevre PC, 2010, INFECT PARASITIC DIS; Lesnoff M, 1999, AGR SYST, V61, P207, DOI 10.1016/S0308-521X(99)00053-0; Lesnoff M, 2009, EPIDEMIOL INFECT, V137, P1405, DOI 10.1017/S0950268809002453; Lesnoff M, 2014, CALCULATION DEMOGRAP; Liu FX, 2014, VET RES COMMUN, V38, P307, DOI 10.1007/s11259-014-9618-x; Liu W, 2013, TRANSBOUND EMERG DIS, V60, P63, DOI 10.1111/tbed.12136; Ly C, 1998, REV SCI TECH OIE, V17, P767, DOI 10.20506/rst.17.3.1133; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; Moulin CH, 1993, ANIMAL PERFORMANCE B, P2864; Niewiesk S., 2014, FRONT IMMUNOL, P5; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; Provost A, 1982, Rev Sci Tech, V1, P589, DOI 10.20506/rst.1.3.88; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Sarr J, 1994, RES COORD M FAO AEA, P195; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Texeira M, 2008, ECOL MODEL, V217, P197, DOI 10.1016/j.ecolmodel.2008.06.027; Trabucco A, 2009, CGIAR CONSORT SPATIA; Wemike K, 2014, VET MICROBIOL, V172, P140, DOI 10.1016/j.vetmic.2014.05.010; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Zahur AB, 2009, PAK VET J, V29, P174; Zahur A.B., 2014, J BIOSCI MED, V2, P27, DOI DOI 10.4236/JBM.2014.26005	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190296	10.1371/journal.pone.0190296	http://dx.doi.org/10.1371/journal.pone.0190296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351277	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300016
J	He, HJ; Zhang, CY; Zhao, XH; Fousseni, F; Wang, JS; Dai, HJ; Yang, S; Zuo, Q				He, Huaijiang; Zhang, Chunyu; Zhao, Xiuhai; Fousseni, Folega; Wang, Jinsong; Dai, Haijun; Yang, Song; Zuo, Qiang			Allometric biomass equations for 12 tree species in coniferous and broadleaved mixed forests, Northeastern China	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; NET PRIMARY PRODUCTION; ABOVEGROUND BIOMASS; ALLOCATION; PINE; ROOT; PATTERNS; STORAGE; HEIGHT; MODELS	Understanding forest carbon budget and dynamics for sustainable resource management and ecosystem functions requires quantification of above- and below-ground biomass at individual tree species and stand levels. In this study, a total of 122 trees (9 +/- 12 per species) were destructively sampled to determine above-and below-ground biomass of 12 tree species (Acer mandshuricum, Acer mono, Betula platyphylla, Carpinus cordata, Fraxinus mandshurica, Juglans mandshurica, Maackia amurensis, P. koraiensis, Populus ussuriensis, Quercus mongolica, Tilia amurensis and Ulmus japonica) in coniferous and broadleaved mixed forests of Northeastern China, an area of the largest natural forest in the country. Biomass allocation was examined and biomass models were developed using diameter as independent variable for individual tree species and all species combined. The results showed that the largest biomass allocation of all species combined was on stems (57.1%), followed by coarse root (21.3%), branch (18.7%), and foliage (2.9%). The log-transformed model was statistically significant for all biomass components, although predicting power was higher for species-specific models than for all species combined, general biomass models, and higher for stems, roots, above-ground biomass, and total tree biomass than for branch and foliage biomass. These findings supplement the previous studies on this forest type by additional sample trees, species and locations, and support biomass research on forest carbon budget and dynamics by management activities such as thinning and harvesting in the northeastern part of China.	[He, Huaijiang; Zhang, Chunyu; Zhao, Xiuhai; Fousseni, Folega; Wang, Jinsong; Dai, Haijun; Yang, Song; Zuo, Qiang] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc, Beijing, Peoples R China; [Fousseni, Folega] Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo; [Wang, Jinsong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, CY (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc, Beijing, Peoples R China.	zcy_0520@163.com	Zhang, Chun-yu/HDP-5776-2022; Wang, Jinsong/AAO-3115-2021; Zhang, Chunyu/GYA-2925-2022	Wang, Jinsong/0000-0002-3425-7387; Zhang, Chunyu/0000-0003-3091-5060	Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China [41330530]; National Basic Research Program of China (973 Program) [2011CB403203]	Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research is supported by the Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China (41330530) and the National Basic Research Program of China (973 Program: 2011CB403203).	Avsar M. D., 2004, Journal of Biological Sciences, V4, P437; Bond-Lamberty B, 2002, CAN J FOREST RES, V32, P1441, DOI [10.1139/x02-063, 10.1139/X02-063]; Bond-Lamberty B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050441; Cai S, 2013, ANN FOR RES, V56, P105; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Conti G, 2013, ANN FOREST SCI, V70, P515, DOI 10.1007/s13595-013-0285-9; Cushman KC, 2014, METHODS ECOL EVOL, V5, P573, DOI 10.1111/2041-210X.12187; Fatemi FR, 2011, CAN J FOREST RES, V41, P881, DOI [10.1139/X10-248, 10.1139/x10-248]; Gahagan A, 2015, FOREST ECOL MANAG, V337, P88, DOI 10.1016/j.foreco.2014.10.037; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Grote R, 2002, SILVA FENNICA, V36; HAASE R, 1995, FOREST ECOL MANAG, V73, P29, DOI 10.1016/0378-1127(94)03509-U; Henry M, 2010, FOREST ECOL MANAG, V260, P1375, DOI 10.1016/j.foreco.2010.07.040; Hosoda K, 2010, J FOREST RES-JPN, V15, P299, DOI 10.1007/s10310-010-0192-y; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Jenkins JC, 2003, FOREST SCI, V49, P12; Karlik JF, 2014, BIOMASS BIOENERG, V62, P228, DOI 10.1016/j.biombioe.2013.11.018; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kralicek K, 2017, FOREST ECOL MANAG, V390, P147, DOI 10.1016/j.foreco.2017.01.030; Kuyah S, 2013, BIOMASS BIOENERG, V55, P276, DOI 10.1016/j.biombioe.2013.02.011; Li CP, 2007, J ARID ENVIRON, V70, P195, DOI 10.1016/j.jaridenv.2006.12.017; Litton CM, 2003, CAN J FOREST RES, V33, P351, DOI 10.1139/X02-181; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087600; Martin JG, 1998, CAN J FOREST RES, V28, P1648, DOI 10.1139/cjfr-28-11-1648; Mate R, 2014, FORESTS, V5, P535, DOI 10.3390/f5030535; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mosseler A, 2014, FOREST ECOL MANAG, V320, P190, DOI 10.1016/j.foreco.2014.02.027; Packard GC, 2011, BIOL REV, V86, P549, DOI 10.1111/j.1469-185X.2010.00160.x; PASTOR J, 1984, FOREST ECOL MANAG, V7, P265, DOI 10.1016/0378-1127(84)90003-3; Paul KI, 2013, FOREST ECOL MANAG, V310, P483, DOI 10.1016/j.foreco.2013.08.054; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Shaiek O, 2011, ANN FOREST SCI, V68, P443, DOI 10.1007/s13595-011-0044-8; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Tumwebaze SB, 2013, AGROFOREST SYST, V87, P781, DOI 10.1007/s10457-013-9596-y; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang JS, 2013, EUR J FOREST RES, V132, P313, DOI 10.1007/s10342-012-0676-8; Wang JS, 2011, SILVA FENN, V45, P211, DOI 10.14214/sf.113; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; Wang XP, 2013, FOREST ECOL MANAG, V293, P149, DOI 10.1016/j.foreco.2013.01.001; Xiao CW, 2003, TREE PHYSIOL, V23, P505, DOI 10.1093/treephys/23.8.505; Xu JD, 2014, J FOREST ECON, V36, P6; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhang CY, 2012, EUR J FOREST RES, V131, P1287, DOI 10.1007/s10342-012-0598-5; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15997; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1; Zianis D, 2003, ANN FOREST SCI, V60, P439, DOI 10.1051/forest:2003036	49	32	39	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0186226	10.1371/journal.pone.0186226	http://dx.doi.org/10.1371/journal.pone.0186226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351291	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300004
J	Samoilys, M; Roche, R; Koldewey, H; Turner, J				Samoilys, Melita; Roche, Ronan; Koldewey, Heather; Turner, John			Patterns in reef fish assemblages: Insights from the Chagos Archipelago	PLOS ONE			English	Article							CORAL-REEFS; COMMUNITY STRUCTURE; INDIAN-OCEAN; HERBIVOROUS FISHES; PHASE-SHIFTS; MARINE; RESILIENCE; HABITAT; SHELF; PARROTFISHES	Understanding the drivers of variability in the composition of fish assemblages across the Indo-Pacific region is crucial to support coral reef ecosystem resilience. Whilst numerous relationships and feedback mechanisms between the functional roles of coral reef fishes and reef benthic composition have been investigated, certain key groups, such as the herbivores, are widely suggested to maintain reefs in a coral-dominated state. Examining links between fishes and reef benthos is complicated by the interactions between natural processes, disturbance events and anthropogenic impacts, particularly fishing pressure. This study examined fish assemblages and associated benthic variables across five atolls within the Chagos Archipelago, where fishing pressure is largely absent, to better understand these relationships. We found high variability in fish assemblages among atolls and sites across the archipelago, especially for key groups such as a suite of grazer-detritivore surgeonfish, and the parrotfishes which varied in density over 40-fold between sites. Differences in fish assemblages were significantly associated with variable levels of both live and recently dead coral cover and rugosity. We suggest these results reflect differing coral recovery trajectories following coral bleaching events and a strong influence of 'bottom-up' control mechanisms on fish assemblages. Species level analyses revealed that Scarus niger, Acanthurus nigrofuscus and Chlorurus strongylocephalos were key species driving differences in fish assemblage structure. Clarifying the trophic roles of herbivorous and detritivorous reef fishes will require species-level studies, which also examine feeding behaviour, to fully understand their contribution in maintaining reef resilience to climate change and fishing impacts.	[Samoilys, Melita] CORDIO East Africa, Mombasa, Kenya; [Samoilys, Melita] Univ Oxford, Dept Zool, Oxford, England; [Roche, Ronan; Turner, John] Bangor Univ, Sch Ocean Sci, Bangor, Gwynedd, Wales; [Koldewey, Heather] Zool Soc London, Conservat Programmes, London, England; [Koldewey, Heather] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England	University of Oxford; Bangor University; Zoological Society of London; University of Exeter	Samoilys, M (corresponding author), CORDIO East Africa, Mombasa, Kenya.; Samoilys, M (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	melita.samoilys@gmail.com	Roche, Ronan/AAX-1395-2020	Roche, Ronan/0000-0002-6342-9571; Samoilys, Melita/0000-0003-1933-357X	Coastal Oceans Research and Development Indian Ocean (CORDIO); Perivoli Trust fellowship at the University of Oxford; DEFRA Darwin Initiative grant [19-027]; University of Warwick; Zoological Society of London; Bertarelli Foundation	Coastal Oceans Research and Development Indian Ocean (CORDIO); Perivoli Trust fellowship at the University of Oxford; DEFRA Darwin Initiative grant; University of Warwick; Zoological Society of London; Bertarelli Foundation	MS was supported by Coastal Oceans Research and Development Indian Ocean (CORDIO) and a Perivoli Trust fellowship at the University of Oxford; http://cordioea.net. The project was funded by DEFRA Darwin Initiative grant 19-027 to Bangor University, University of Warwick and the Zoological Society of London; https://www.gov.uk/government/groups/the-darwin-initiative. HK was supported by the Bertarelli Foundation; https://www.fondation-bertarelli.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Andrefouet S., 2009, ATLAS W INDIAN OCEAN; [Anonymous], 2014, R LANG ENV STAT COMP; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood DR, 2017, BIOL REV, V92, P878, DOI 10.1111/brv.12259; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonaldo RM, 2014, OCEANOGR MAR BIOL, V52, P81; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chabanet P, 2015, ACTA OECOL, P1; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clements KD, 2017, BIOL J LINN SOC, V120, P729, DOI 10.1111/bij.12914; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Crochelet E, 2016, REG STUD MAR SCI, V7, P159, DOI 10.1016/j.rsma.2016.06.007; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duff H, 2015, OTC2015WPEB1148 MAR; Dumbraveanu D., 1999, ECOLOGY CHAGOS ARCHI, V2, P351; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedman ST, 2016, J EVOLUTION BIOL, V29, P965, DOI 10.1111/jeb.12837; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Green A.L., 2009, MONITORING FUNCTIONA; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; Heenan A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1716; Hobson E.S., 1991, P69; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2014, STATUS AND TRENDS OF; Jeffries TC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15383; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; Letourneur Y, 1998, LENGTH WEIGHT RELATI, P37; Lieske E, 1996, CORAL REEF FISHES; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; McClanahan TR, 2016, PLOS ONE, V11, P1; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nash KL, 2012, MAR ECOL PROG SER, V457, P113, DOI 10.3354/meps09742; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Oksanen J, 2005, THE VEGAN PACKAGE R, P1; Osuka K, 2016, J MAR BIOL ASSOC UK, P1; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Reese ES., 1993, P C GLOB ASP COR REE, P59; RUSS G, 1984, MAR ECOL PROG SER, V20, P35, DOI 10.3354/meps020035; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Samoilys MA, 2000, ENV BIOL FISHES, V57; Samoilys Melita, 2011, RAP Bulletin of Biological Assessment, V61, P29; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Spalding M.D., 1999, Linnean Society Occasional Publication, V2, P119; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Taylor BM, 2015, ECOGRAPHY, V38, P520, DOI 10.1111/ecog.01093; Turner J, 2005, PHILOS T R SOC A, V363, P229, DOI 10.1098/rsta.2004.1489; Whitaker D, 2010, CLUSTSIG SIMILARITY; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Winterbottom R., 1999, Linnean Society Occasional Publication, V2, P101	75	20	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191448	10.1371/journal.pone.0191448	http://dx.doi.org/10.1371/journal.pone.0191448			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351566	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300091
J	Sigauque, B; Kobayashi, M; Vubil, D; Nhacolo, A; Chauque, A; Moaine, B; Massora, S; Mandomando, I; Nhampossa, T; Bassat, Q; Pimenta, F; Menendez, C; Carvalho, MD; Macete, E; Schrag, SJ				Sigauque, Betuel; Kobayashi, Miwako; Vubil, Delfino; Nhacolo, Ariel; Chauque, Alberto; Moaine, Benild; Massora, Sergio; Mandomando, Inacio; Nhampossa, Tacilta; Bassat, Quique; Pimenta, Fabiana; Menendez, Clara; Carvalho, Maria da Gloria; Macete, Eusebio; Schrag, Stephanie J.			Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015	PLOS ONE			English	Article							NEWBORN BABIES; PREVENTION; SEPSIS; EPIDEMIOLOGY; INFECTIONS; STILLBIRTH; MANHICA; HIV	Background Maternal group B streptococcal (GBS) vaccines under development hold promise to prevent GBS disease in young infants. Sub-Saharan Africa has the highest estimated disease burden, although data on incidence and circulating strains are limited. We described invasive bacterial disease (IBD) trends among infants <90 days in rural Mozambique during 2001-2015, with a focus on GBS epidemiology and strain characteristics. Methods Community-level birth and mortality data were obtained from Manhica's demographic surveillance system. IBD cases were captured through ongoing surveillance at Manhica district hospital. Stored GBS isolates from cases underwent serotyping by multiplex PCR, antimicrobial susceptibility testing, and whole genome sequencing. Results There were 437 IBD cases, including 57 GBS cases. Significant declines in overall IBD, neonatal mortality, and stillbirth rates were observed (P<0.0001), but not for GBS (P = 0.17). In 2015, GBS was the leading cause of young infant IBD (2.7 per 1,000 live births). Among 35 GBS isolates available for testing, 31 (88.6%) were highly related serotype III isolates within multilocus sequence types (STs) 17 (68.6%) or 109 (20.0%). All seven ST109 isolates (21.9%) had elevated minimum inhibitory concentration (MIC) to penicillin (>= 0.12 mu g/mL) associated with penicillin-binding protein (PBP) 2x substitution G398A. Epidemiologic and molecular data suggest this is a well-established clone. Conclusion A notable young infant GBS disease burden persisted despite improvements in overall maternal and neonatal health. We report an established strain with pbp2x point mutation, a first-step mutation associated with reduced penicillin susceptibility within a well-known virulent lineage in rural Mozambique. Our findings further underscores the need for non-antibiotic GBS prevention strategies.	[Sigauque, Betuel; Vubil, Delfino; Nhacolo, Ariel; Chauque, Alberto; Moaine, Benild; Massora, Sergio; Mandomando, Inacio; Nhampossa, Tacilta; Bassat, Quique; Menendez, Clara; Macete, Eusebio] Ctr Invest Sau Manh, Maputo, Mozambique; [Sigauque, Betuel] John Snow Inc, USAID Grantee, MCSP, Maputo, Mozambique; [Kobayashi, Miwako; Pimenta, Fabiana; Macete, Eusebio; Schrag, Stephanie J.] Natl Ctr Immunizat & Resp Dis, Cr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Bassat, Quique; Menendez, Clara] ISGlobal, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Bassat, Quique; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Menendez, Clara] Consorcio Investd Red Epidemiol & Salud Publ, Barcelona, Spain	Centro de Investigacao em Saude de Manhica; United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Sigauque, B (corresponding author), Ctr Invest Sau Manh, Maputo, Mozambique.; Sigauque, B (corresponding author), John Snow Inc, USAID Grantee, MCSP, Maputo, Mozambique.	betuel.sigauque@manhica.net	Mandomando, Inacio/ABD-8007-2020; Bassat, Quique/P-2341-2016; Menéndez, Clara/Q-3446-2016	Mandomando, Inacio/0000-0002-1078-2187; Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907	Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain); PATH [GAT.770-790-01350-LPS]; Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine [S00957]; United States Agency for International Development mission in Mozambique [AID-656-F-12-00001, RFA-656-12-000003]; Johns Snow, Inc.	Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain); PATH; Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine; United States Agency for International Development mission in Mozambique(United States Agency for International Development (USAID)); Johns Snow, Inc.	This study was funded by CISM core funding provided by the Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain). This study was also partly supported by funds from PATH through to the pneumonia and pneumococcus surveillance study (GAT.770-790-01350-LPS), Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine (Grant: S00957) and the United States Agency for International Development mission in Mozambique through to Fixed Obligation Grant No. AID-656-F-12-00001, under RFA-656-12-000003. Johns Snow, Inc. currently provides support in the form of salary for author B.S. None of the funders have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO;2; BAKER CJ, 1978, J PEDIATR-US, V93, P124, DOI 10.1016/S0022-3476(78)80623-4; Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; BOYER KM, 1986, NEW ENGL J MED, V314, P1665, DOI 10.1056/NEJM198606263142603; Clinical & Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Donders GGG, 2016, OBSTET GYNECOL, V127, P213, DOI 10.1097/AOG.0000000000001190; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Heyderman RS, 2016, LANCET INFECT DIS; International Vaccine Access Center (IVAC), JHBSOPH VIEW HUB; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Kobayashi M., 2016, VACCINE; Kobayashi Miwako, 2016, F1000Res, V5, P2355; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Longtin J, 2011, ANTIMICROB AGENTS CH, V55, P2983, DOI 10.1128/AAC.01243-10; Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Metcalf BJ, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.021; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, P60; Nagano N, 2008, ANTIMICROB AGENTS CH, V52, P4258, DOI 10.1128/AAC.00596-08; Nan C, 2015, BJOG-INT J OBSTET GY, V122, P1437, DOI 10.1111/1471-0528.13527; Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Seale AC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.67, 10.1038/NMICROBIOL.2016.67]; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sinha AK, 2016, PEDIATR INFECT DIS J, V35, P401, DOI 10.1097/INF.0000000000001019; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; TUPPURAINEN N, 1989, OBSTET GYNECOL, V73, P583; UNICEF, 2010, MOZ EL MAT NEON TET; Valkenburg-van den Berg AW, 2009, ACTA OBSTET GYN SCAN, V88, P958, DOI 10.1080/00016340903176800; World Health Organization Regional Office for Africa, MAK PREGN SAF MOZ	43	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191193	10.1371/journal.pone.0191193	http://dx.doi.org/10.1371/journal.pone.0191193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351318	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300055
J	van Nes, EH; Staal, A; Hantson, S; Holmgren, M; Pueyo, S; Bernardi, RE; Flores, BM; Xu, C; Scheffer, M				van Nes, Egbert H.; Staal, Arie; Hantson, Stijn; Holmgren, Milena; Pueyo, Salvador; Bernardi, Rafael E.; Flores, Bernardo M.; Xu, Chi; Scheffer, Marten			Fire forbids fifty-fifty forest	PLOS ONE			English	Article							TROPICAL FOREST; STABLE STATES; TREE COVER; PERCOLATION THRESHOLDS; EXPERIMENTAL DROUGHT; POSITIVE FEEDBACKS; GLOBAL SAVANNAS; EASTERN AMAZON; LINKING THEORY; LAND-USE	Recent studies have interpreted patterns of remotely sensed tree cover as evidence that forest with intermediate tree cover might be unstable in the tropics, as it will tip into either a closed forest or a more open savanna state. Here we show that across all continents the frequency of wildfires rises sharply as tree cover falls below similar to 40%. Using a simple empirical model, we hypothesize that the steepness of this pattern causes intermediate tree cover (30 +/- 60%) to be unstable for a broad range of assumptions on tree growth and fire-driven mortality. We show that across all continents, observed frequency distributions of tropical tree cover are consistent with this hypothesis. We argue that percolation of fire through an open landscape may explain the remarkably universal rise of fire frequency around a critical tree cover, but we show that simple percolation models cannot predict the actual threshold quantitatively. The fire-driven instability of intermediate states implies that tree cover will not change smoothly with climate or other stressors and shifts between closed forest and a state of low tree cover will likely tend to be relatively sharp and difficult to reverse.	[van Nes, Egbert H.; Staal, Arie; Bernardi, Rafael E.; Flores, Bernardo M.; Scheffer, Marten] Wageningen Univ, Environm Sci Dept, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Hantson, Stijn] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Atmospher Environm Res, Garmisch Partenkirchen, Germany; [Holmgren, Milena; Bernardi, Rafael E.; Flores, Bernardo M.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Pueyo, Salvador] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Catalonia, Spain; [Bernardi, Rafael E.] Univ Republ, CURE, Maldonado, Uruguay; [Flores, Bernardo M.] Univ Fed Rio Grande do Norte, Ctr Biosci, Ecol Dept, Natal, RN, Brazil; [Xu, Chi] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China	Wageningen University & Research; Helmholtz Association; Karlsruhe Institute of Technology; Wageningen University & Research; University of Barcelona; Universidad de la Republica, Uruguay; Universidade Federal do Rio Grande do Norte; Nanjing University	van Nes, EH (corresponding author), Wageningen Univ, Environm Sci Dept, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands.	egbert.vannes@wur.nl	van Nes, Egbert H/F-2681-2011; Flores, Bernardo Monteiro/O-8570-2018; Hantson, Stijn/H-4785-2019	Flores, Bernardo Monteiro/0000-0003-4555-5598; Hantson, Stijn/0000-0003-4607-9204; van Nes, Egbert/0000-0002-6345-104X; Staal, Arie/0000-0001-5409-1436; Xu, Chi/0000-0002-1841-9032	European Union [643073]; SENSE Research School; EU FP7 project BACCHUS [603445]; EU FP7 project LUC4C [603542]	European Union(European Commission); SENSE Research School; EU FP7 project BACCHUS; EU FP7 project LUC4C	This work was carried out under the programme of the Netherlands Earth System Science Centre (NESSC) to EHN and received funding from the European Union's Horizon 2020 research and innovation Programme under the Marie Sklodowska-Curie grant agreement No 643073 to MS. A.S. was supported by SENSE Research School. S.H. acknowledges support by the EU FP7 projects BACCHUS (grant agreement no. 603445) and LUC4C (grant ag. No. 603542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abades SR, 2014, J ECOL, V102, P1386, DOI 10.1111/1365-2745.12321; Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; [Anonymous], 2004, HDB STOCHASTIC METHO; Archibald S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0309; Archibald S, 2012, P NATL ACAD SCI USA, V109, P847, DOI 10.1073/pnas.1118648109; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Bernardi RE, 2016, FOREST ECOL MANAG, V363, P212, DOI 10.1016/j.foreco.2015.12.032; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2015, TRENDS ECOL EVOL, V30, P255, DOI 10.1016/j.tree.2015.03.005; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Dantas VD, 2016, ECOL LETT, V19, P12, DOI 10.1111/ele.12537; Dantas VD, 2013, ECOLOGY, V94, P2454, DOI 10.1890/12-1629.1; DeAngelis DL., 1986, POSITIVE FEEDBACK NA, DOI 10.1007/978-3-642-82625-2; DiMiceli C. M., 2017, ANN GLOBAL AUTOMATED; Furley PA, 2008, PROG PHYS GEOG, V32, P611, DOI 10.1177/0309133308101383; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; GILBERT EN, 1961, J SOC IND APPL MATH, V9, P533, DOI 10.1137/0109045; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Grasman J, 2010, ASYMPTOTIC METHODS F, DOI [10.1073/pnas.1118648109, DOI 10.1073/PNAS.1118648109]; Hanan NP, 2015, GLOBAL ECOL BIOGEOGR, V24, P988, DOI 10.1111/geb.12321; Hanan NP, 2014, GLOBAL ECOL BIOGEOGR, V23, P259, DOI 10.1111/geb.12122; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2003, J ECOL, V91, P475, DOI 10.1046/j.1365-2745.2003.00777.x; Hoffmann WA, 2012, AUSTRAL ECOL, V37, P634, DOI 10.1111/j.1442-9993.2011.02324.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Lasslop G, 2016, GEOPHYS RES LETT, V43, P6324, DOI 10.1002/2016GL069365; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; MACKAY G, 1984, J PHYS A-MATH GEN, V17, pL757, DOI 10.1088/0305-4470/17/14/006; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MARKHAM CG, 1970, ANN ASSOC AM GEOGR, V60, P593, DOI 10.1111/j.1467-8306.1970.tb00743.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pausas JG, 2013, GLOBAL ECOL BIOGEOGR, V22, P728, DOI 10.1111/geb.12043; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Scanlon TM, 2007, NATURE, V449, P209, DOI 10.1038/nature06060; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheiter S, 2007, AM NAT, V170, P587, DOI 10.1086/521317; Schertzer E, 2015, J MATH BIOL, V70, P329, DOI 10.1007/s00285-014-0757-z; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Staal A, 2015, ECOL COMPLEX, V22, P65, DOI 10.1016/j.ecocom.2015.01.003; Staver AC, 2012, AM NAT, V180, P211, DOI 10.1086/666648; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Suding PN, 1999, PHYS REV E, V60, P275, DOI 10.1103/PhysRevE.60.275; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; van Nes EH, 2016, TRENDS ECOL EVOL, V31, P902, DOI 10.1016/j.tree.2016.09.011; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; WARING RH, 1981, FORESTRY, V54, P126, DOI 10.1093/forestry/54.2.129; Wuyts B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15519; Xu C, 2016, ECOLOGY, V97, P2518, DOI 10.1002/ecy.1470; Zemp DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14681	68	31	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191027	10.1371/journal.pone.0191027	http://dx.doi.org/10.1371/journal.pone.0191027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351323	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300039
J	Deryugina, EI; Zajac, E; Zilberberg, L; Muramatsu, T; Joshi, G; Dabovic, B; Rifkin, D; Quigley, JP				Deryugina, Elena I.; Zajac, Ewa; Zilberberg, Lior; Muramatsu, Tomoki; Joshi, Grishma; Dabovic, Branka; Rifkin, Daniel; Quigley, James P.			LTBP3 promotes early metastatic events during cancer cell dissemination	ONCOGENE			English	Article							BETA BINDING-PROTEIN; TGF-BETA; VASCULAR INTRAVASATION; TUMOR ANGIOGENESIS; SIGNALING PATHWAY; GROWTH; MECHANISMS; MUTATIONS; DOMAIN; EXPRESSION	Latent transforming growth factor beta(TGF beta)-binding proteins (LTBPs) are important for the secretion, activation, and function of mature TGF beta, especially so in cancer cell physiology. However, specific roles of the LTBPs remain understudied in the context of the primary tumor microenvironment. Herein, we investigated the role of LTBP3 in the distinct processes involved in cancer metastasis. By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade. Knockdown of LTBP3 in all tested cell lines led to significant inhibition of tumor cell intravasation, but did not affect primary tumor growth. LTBP3 was dispensable in the late steps of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization. However, LTBP3 depletion diminished the angiogenesis-inducing potential of HEp-3 cells in vivo, which was restorable by exogenous delivery of LTBP3 protein. A similar compensatory approach rescued the dampened intravasation of LTBP3-deficient HEp3 cells, suggesting that LTBP3 regulates the induction of the intravasation-supporting angiogenic vasculature within developing primary tumors. Using our recently developed microtumor model, we confirmed that LTBP3 loss resulted in the development of intratumoral vessels with an abnormal microarchitecture incompatible with efficient intravasation of HEp-3 carcinoma cells. Collectively, these findings demonstrate that LTBP3 represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination. Our experimental data are also consistent with the survival prognostic value of LTBP3 expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease.	[Deryugina, Elena I.; Zajac, Ewa; Muramatsu, Tomoki; Quigley, James P.] Scripps Res Inst, La Jolla, CA 92037 USA; [Zilberberg, Lior; Joshi, Grishma; Dabovic, Branka; Rifkin, Daniel] NYU, Sch Med, New York, NY USA	Scripps Research Institute; New York University	Deryugina, EI (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	deryugin@scripps.edu			National Institutes of Health [R01CA157792, R01CA105412, R01CA034282]; NATIONAL CANCER INSTITUTE [R01CA157792, R01CA105412, R01CA034282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants R01CA157792 (E.I.D.), R01CA105412 (J.P.Q.), and R01CA034282 (D.R.) from the National Institutes of Health. This is manuscript no. 29589 from TSRI.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chandramouli A, 2011, J MAMMARY GLAND BIOL, V16, P67, DOI 10.1007/s10911-011-9215-3; Chen H, 2017, ONCOGENE, V36, P4415, DOI 10.1038/onc.2017.73; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conn EM, 2009, AM J PATHOL, V175, P1638, DOI 10.2353/ajpath.2009.090384; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dabovic B, 2015, J CELL PHYSIOL, V230, P226, DOI 10.1002/jcp.24704; Dell Ralph B, 2002, ILAR J, V43, P207; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Deryugina EI, 2017, CELL REP, V19, P601, DOI 10.1016/j.celrep.2017.03.064; Deryugina EI, 2016, METHODS MOL BIOL, V1430, P283, DOI 10.1007/978-1-4939-3628-1_19; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Dongre A, 2017, CANCER RES, V77, P3982, DOI 10.1158/0008-5472.CAN-16-3292; EKLOV S, 1993, CANCER RES, V53, P3193; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HENRIKSEN R, 1995, LAB INVEST, V73, P213; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inoue T, 2014, HUM MOL GENET, V23, P5672, DOI 10.1093/hmg/ddu283; Isogai M, 2003, MOL PLANT MICROBE IN, V16, P188, DOI 10.1094/MPMI.2003.16.3.188; Jilani SM, 2003, J HISTOCHEM CYTOCHEM, V51, P597, DOI 10.1177/002215540305100505; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Massague J, 2017, MOL ONCOL, V11, P3, DOI 10.1002/1878-0261.12024; Minder P, 2015, NEOPLASIA, V17, P634, DOI 10.1016/j.neo.2015.08.002; Miyazono Kohei, 1992, Journal of Dermatology (Tokyo), V19, P644; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Naba A, 2014, ELIFE, V3, DOI 10.7554/eLife.01308; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Penttinen C, 2002, J CELL SCI, V115, P3457; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Roth-Eichhorn S, 2001, SCAND J GASTROENTERO, V36, P1204; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Schepers D, 2015, EUR J HUM GENET, V23, P224, DOI 10.1038/ejhg.2014.61; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Tanaka T, 2012, CANCER SCI, V103, P455, DOI 10.1111/j.1349-7006.2011.02174.x; Vehvilainen P, 2011, HUM PATHOL, V42, P269, DOI 10.1016/j.humpath.2010.07.005; Vincent-Chong VK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174865; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wan FQ, 2017, ONCOL RES, V25, P503, DOI 10.3727/096504016X14755368915591; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	59	11	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1815	1829		10.1038/s41388-017-0075-1	http://dx.doi.org/10.1038/s41388-017-0075-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29348457	Green Accepted			2022-12-26	WOS:000429303300001
J	Robles, M; Nouveau, E; Gautier, C; Mendoza, L; Dubois, C; Dahirel, M; Lagofun, B; Aubriere, MC; Lejeune, JP; Caudron, I; Guenon, I; Viguie, C; Wimel, L; Bouraima-Lelong, H; Serteyn, D; Couturier-Tarrade, A; Chavatte-Palmer, P				Robles, M.; Nouveau, E.; Gautier, C.; Mendoza, L.; Dubois, C.; Dahirel, M.; Lagofun, B.; Aubriere, M-C; Lejeune, J-P; Caudron, I.; Guenon, I.; Viguie, C.; Wimel, L.; Bouraima-Lelong, H.; Serteyn, D.; Couturier-Tarrade, A.; Chavatte-Palmer, P.			Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age	PLOS ONE			English	Article							BODY CONDITION SCORE; PASTURE-ASSOCIATED LAMINITIS; RISK-FACTORS; ADIPOKINE CONCENTRATIONS; DEVELOPMENTAL ORIGINS; LIPID CONCENTRATIONS; INCREASED ADIPOSITY; OWNERS PERCEPTIONS; GLUCOSE-TOLERANCE; BREED DIFFERENCES	Introduction Obesity is a growing concern in horses. The effects of maternal obesity on maternal metabolism and low-grade inflammation during pregnancy, as well as offspring growth, metabolism, low-grade inflammation, testicular maturation and osteochondrotic lesions until 18 months of age were investigated. Material and methods Twenty-four mares were used and separated into two groups at insemination according to body condition score (BCS): Normal (N, n = 10, BCS <= 4) and Obese (O, n = 14, BCS >= 4.25). BCS and plasma glucose, insulin, triglyceride, urea, non-esterified fatty acid, serum amyloid A (SAA), leptin and adiponectin concentrations were monitored throughout gestation. At 300 days of gestation, a Frequently Sampled Intravenous Glucose Tolerance Test (FSIGT) was performed. After parturition, foals' weight and size were monitored until 18 months of age with plasma SAA, leptin, adiponectin, triiodothyronine (T3), thyroxine (T4) and cortisol concentrations measured at regular intervals. At 6, 12 and 18 months of age, FSIGT and osteoarticular examinations were performed. Males were gelded at one year and expression of genes involved in testicular maturation analysed by RT-qPCR. Results Throughout the experiment, maternal BCS was higher in O versus N mares. During gestation, plasma urea and adiponectin were decreased and SAA and leptin increased in O versus N mares. O mares were also more insulin resistant than N mares with a higher glucose effectiveness. Postnatally, there was no difference in offspring growth between groups. Nevertheless, plasma SAA concentrations were increased in O versus N foals until 6 months, with O foals being consistently more insulin resistant with a higher glucose effectiveness. At 12 months of age, O foals were significantly more affected by osteochondrosis than N foals. All other parameters were not different between groups. Conclusion In conclusion, maternal obesity altered metabolism and increased low-grade inflammation in both dams and foals. The risk of developing osteochondrosis at 12 months of age was also higher in foals born to obese dams.	[Robles, M.; Nouveau, E.; Dahirel, M.; Lagofun, B.; Aubriere, M-C; Couturier-Tarrade, A.; Chavatte-Palmer, P.] Univ Paris Saclay, UMR BDR, INRA, ENVA, Jouy En Josas, France; [Gautier, C.; Guenon, I.; Bouraima-Lelong, H.] Normandie Univ, UNICAEN, OeReCa, EA2608,USC INRA, Caen, France; [Mendoza, L.; Lejeune, J-P; Caudron, I.; Serteyn, D.] Univ Liege, Fac Med Vet, Clin Equine, Liege, Belgium; [Dubois, C.; Wimel, L.] IFCE, Stn Expt Valade, Chamberet, France; [Viguie, C.] INRA, Res Ctr Food Toxicol, UMR Toxalim, Toulouse, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Caen Normandie; University of Liege; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chavatte-Palmer, P (corresponding author), Univ Paris Saclay, UMR BDR, INRA, ENVA, Jouy En Josas, France.	pascale.chavatte-palmer@inra.fr	Robles, Morgane/AAA-4407-2020; Chavatte-Palmer, Pascale/K-7349-2012	Robles, Morgane/0000-0003-4821-4684; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Couturier-Tarrade, Anne/0000-0003-1559-5476; Gautier, Camille/0000-0002-3604-4836	Institut Francais du Cheval et de l'Equitation; "Fonds Eperon" (FOETALIM project)	Institut Francais du Cheval et de l'Equitation; "Fonds Eperon" (FOETALIM project)	This work was funded by grants from the "Institut Francais du Cheval et de l'Equitation" and by the "Fonds Eperon" (FOETALIM project). The funders had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript.; This work was funded by grants from the "Institut Francais du Cheval et de l'Equitation" and by the "Fonds Eperon" (FOETALIM project). The funders had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The authors are grateful to the staff of the Institut Francais du Cheval et de l'Equitation (IFCE) experimental farm (Domaine de la Valade, Chamberet, France) for care and management of animals.	Almeida J, 2012, THERIOGENOLOGY, V77, P847, DOI 10.1016/j.theriogenology.2011.09.007; Almeida J, 2011, REPRODUCTION, V141, P841, DOI 10.1530/REP-10-0499; Arnaud MG., 1997, NOTATION ETAT CORPOR, V1, P40; Arnold W, 2006, J EXP BIOL, V209, P4566, DOI 10.1242/jeb.02536; Ball BA, 2008, ANIM REPROD SCI, V107, P257, DOI 10.1016/j.anireprosci.2008.04.014; Bamford NJ, 2016, VET J, V214, P14, DOI 10.1016/j.tvjl.2016.02.002; Bamford NJ, 2016, EQUINE VET J, V48, P368, DOI 10.1111/evj.12434; Bamford NJ, 2014, DOMEST ANIM ENDOCRIN, V47, P101, DOI 10.1016/j.domaniend.2013.11.001; BARBER T, 1985, BIOCHEM J, V230, P675, DOI 10.1042/bj2300675; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Buff PR, 2002, J ANIM SCI, V80, P2942; Carter RA, 2010, AM J VET RES, V71, P314, DOI 10.2460/ajvr.71.3.314; Cartmill JA, 2003, J ANIM SCI, V81, P2311; Cavinder C. A., 2012, Professional Animal Scientist, V28, P344; Chavatte-Palmer P, 2016, REPROD FERT DEVELOP, V28, P94, DOI 10.1071/RD15353; Christie JL, 2006, CAN VET J, V47, P136; Cymbaluk NF, 1996, DOMEST ANIM ENDOCRIN, V13, P197, DOI 10.1016/0739-7240(96)00014-8; Dawson MJ, 2012, AUSTRAL ECOL, V37, P97, DOI 10.1111/j.1442-9993.2011.02247.x; Deardorff J, 2017, AM J PREV MED, V53, P432, DOI 10.1016/j.amepre.2017.05.013; Denoix J. M., 1990, Pratique Veterinaire Equine, V22, P14; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Fernandes K. A., 2015, Proceedings of the New Zealand Society of Animal Production, V75, P195; Fitzgerald BP, 2000, BIOL REPROD, V63, P335, DOI 10.1095/biolreprod63.1.335; Fox J, 2011, AN R COMPANION TO AP; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; Frank N, 2003, AM J VET RES, V64, P1052, DOI 10.2460/ajvr.2003.64.1052; Frank N, 2010, J VET INTERN MED, V19, P1; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; FURR MO, 1992, EQUINE VET J, V24, P37, DOI 10.1111/j.2042-3306.1992.tb02776.x; Gentry LR, 2002, J ANIM SCI, V80, P2695; Giles S, 2012, RECENT ADV ANIMAL WE, P33; Giles SL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0327-7; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Hansen AM, 2015, J EQUINE VET SCI, V35, P389, DOI DOI 10.1016/J.JEVS.2015.03.024; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Harker I.J., 2011, J EQUINE VET SCI, V31, P253, DOI [10.1016/j.jevs.2011.03.058, DOI 10.1016/J.JEVS.2011.03.058]; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; HENNEKE DR, 1984, THERIOGENOLOGY, V21, P897, DOI 10.1016/0093-691X(84)90383-2; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Henson FMD, 1997, EQUINE VET J, V29, P441, DOI 10.1111/j.2042-3306.1997.tb03156.x; HINES KK, 1987, THERIOGENOLOGY, V28, P815, DOI 10.1016/0093-691X(87)90033-1; Hitchens PL, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0242-3; Hoffman RM, 2003, J ANIM SCI, V81, P2333; HONORE EK, 1994, J EQUINE VET SCI, V14, P424, DOI 10.1016/S0737-0806(06)82009-5; Hughes CK, 2017, DOMEST ANIM ENDOCRIN, V58, P84, DOI 10.1016/j.domaniend.2016.09.001; Ireland JL, 2013, RES VET SCI, V95, P418, DOI 10.1016/j.rvsc.2013.05.007; Ireland JL, 2012, EQUINE VET J, V44, P94, DOI 10.1111/j.2042-3306.2011.00394.x; IRVINE CHG, 1975, J REPROD FERTIL, P709; Jansson A, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0258-8; Jensen R, 2015, ACTA VET SCAND, V57, P2015; Jensen RB, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0240-5; Kaneshiro S, 2014, J BONE MINER METAB, V32, P378, DOI 10.1007/s00774-013-0514-1; Kearns CF, 2002, VET J, V163, P260, DOI 10.1053/tvjl.2001.0656; Kearns CF, 2006, VET J, V172, P460, DOI 10.1016/j.tvjl.2005.05.002; Kedzierski W, 2011, REPROD DOMEST ANIM, V46, P275, DOI 10.1111/j.1439-0531.2010.01658.x; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; KUBIAK JR, 1991, J EQUINE VET SCI, V11, P158, DOI 10.1016/S0737-0806(07)80038-4; KUBIAK JR, 1988, J EQUINE VET SCI, V8, P135, DOI 10.1016/S0737-0806(88)80035-2; LAWRENCE L, 1992, J EQUINE VET SCI, V12, P320, DOI 10.1016/S0737-0806(06)81345-6; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Luna D, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7080056; Malinowski K, 1996, J ANIM SCI, V74, P1936; MAOR G, 1993, CALCIFIED TISSUE INT, V52, P291, DOI 10.1007/BF00296654; Martin-Rosset W., 2008, NUTR EXERCISING HORS, P167; Martin-Rosset W, 2012, NUTR ALIMENTATION CH, P624; McMullen S, 2009, P NUTR SOC, V68, P306, DOI 10.1017/S0029665109001396; Mendoza L, 2016, PREV VET MED, V127, P10, DOI 10.1016/j.prevetmed.2016.03.003; Menzies-Gow NJ, 2010, VET REC, V167, P364, DOI 10.1136/vr.c3206; Mera P, 2016, CELL METAB, V23, P1078, DOI 10.1016/j.cmet.2016.05.004; Morley SA, 2014, J EQUINE VET SCI, V34, P842, DOI 10.1016/j.jevs.2014.04.001; Morrison P, 2015, ACTA VET SCAND, V57, P2015; MURRAY MJ, 1993, EQUINE VET J, V25, P237, DOI 10.1111/j.2042-3306.1993.tb02951.x; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Pagan J.D., 2001, P AM ASS EQUINE PRAC, V47, P322; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Peugnet P, 2016, THERIOGENOLOGY; Peugnet P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122596; Peugnet P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102044; Phornphutkul C, 2006, MOL CELL ENDOCRINOL, V249, P107, DOI 10.1016/j.mce.2006.02.002; Pinheiro J., 2021, CRAN, V3, P1; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Pleasant RS, 2013, J VET INTERN MED, V27, P576, DOI 10.1111/jvim.12056; Potter SJ, 2016, AUST VET J, V94, P427, DOI 10.1111/avj.12506; Powell DM, 2002, EQUINE VET J, V34, P81; Pramojanee SN, 2013, J DENT RES, V92, P560, DOI 10.1177/0022034513485600; Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168; Ralston SL, 1996, PFERDEHEILKUNDE, V12, P320; Robin CA, 2015, EQUINE VET J, V47, P196, DOI 10.1111/evj.12275; Robles M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169295; Rode K, 2015, THERIOGENOLOGY, V84, P763, DOI 10.1016/j.theriogenology.2015.05.009; ROSSDALE PD, 1976, P ROY SOC MED, V69, P631, DOI 10.1177/003591577606900901; Serteyn D, 2010, J ORTHOP RES, V28, P965, DOI 10.1002/jor.21089; Smith S, 2017, EQUINE VET J, V49, P461, DOI 10.1111/evj.12645; Stephenson HM, 2011, VET REC, V168, P131, DOI 10.1136/vr.c6281; Suagee JK, 2013, J VET INTERN MED, V27, P157, DOI 10.1111/jvim.12021; SUTTON EI, 1977, CAN J ANIM SCI, V57, P551, DOI 10.4141/cjas77-071; Thatcher CD, 2012, J VET INTERN MED, V26, P1413, DOI 10.1111/j.1939-1676.2012.00995.x; Treiber KH, 2006, JAVMA-J AM VET MED A, V228, P1538, DOI 10.2460/javma.228.10.1538; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Weeren P. R. van, 2006, Clinical Techniques in Equine Practice, V5, P248, DOI 10.1053/j.ctep.2006.08.002; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Wilsher S, 2006, EQUINE VET J, V38, P549, DOI 10.2746/042516406X156497; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wood S, 2016, EUR EQ HLTH NUTR C, P124; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Wyse CA, 2008, VET REC, V162, P590, DOI 10.1136/vr.162.18.590; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	119	18	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0190309	10.1371/journal.pone.0190309	http://dx.doi.org/10.1371/journal.pone.0190309			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373573	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400003
J	Wei, X; Wang, SJ; Ji, HB; Shi, ZH				Wei, Xiao; Wang, Shijie; Ji, Hongbing; Shi, Zhenhua			Strontium isotopes reveal weathering processes in lateritic covers in southern China with implications for paleogeographic reconstructions	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; SR-87/SR-86 RATIOS; IRON-OXIDES; PHOSPHATE ADSORPTION; SOIL CHRONOSEQUENCE; REE FRACTIONATION; MAJOR ELEMENTS; RELEASE RATES; PLATE MOTIONS; SR	The isotope ratios of Sr are useful tracers for studying parent material sources, weathering processes, and biogeochemical cycling. Mineralogical and geochemical investigations of two lateritic weathering covers, in an area close to the Tropic of Cancer (Guangxi Province, southern China), were undertaken to study the regional weathering processes and Sr isotopic sources. We found that weathering and decomposition of Rb-and Sr-bearing minerals change the Sr isotopic composition in weathering products (lateritic soils). Weathering of illite lowered the Sr-87/Sr-86 ratio whereas dissolving and leaching of carbonate minerals increased the Sr-87/Sr-86 ratio. An Fe nodular horizon is widely developed on the top of the weathering covers in the studied area and it differs from the lateritic soil horizon in mineral composition, construction, and elemental concentration. Furthermore, both Fe2O3 and P2O5 (concentrations) are negatively correlated with the Sr-87/Sr-86 ratios, suggesting fixation of apatite by Fe oxides is a controlling factor of the Sr isotopic composition in the Fe nodular horizon. The Sr-87/Sr-86 and Nb/Sr ratios imply the contents and proportions of Fe nodules and clay are critical in controlling the changes of Sr isotopic composition in the Fe nodular horizon. The two stages of the weathering process of carbonate rocks are revealed by the Sr-87/Sr-86 versus Nb/Sr diagram. The Sr-87/Sr-86 and Rb/Sr ratios suggest that Sr isotopes in the weathering covers within the studied area are derived mainly from parent rock weathering and that the contributions from allothogenic Sr isotopes are limited. A comparison of Sr isotopic composition signatures in the weathering covers of the studied area and Guizhou Province provided insight into the Sr isotopic source and paleogeographic evolution of southern China. From the Permian to the Triassic, the continental fragment sources of the South China sedimentary basin changed significantly. In the Permian, Southern China presented the paleogeographic pattern that the north was higher (in elevation) than the south.	[Wei, Xiao; Wang, Shijie; Ji, Hongbing] Chinese Acad Sci, State Key Lab Environm Geochem, Inst Geochem, Guiyang, Guizhou, Peoples R China; [Wei, Xiao] Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China; [Wang, Shijie] Chinese Acad Sci, Puding Karst Ecosyst Res Stn, Puding, Peoples R China; [Ji, Hongbing] Univ Sci & Technol Beijing, Civil & Environm Engn Sch, Beijing, Peoples R China; [Shi, Zhenhua] Guizhou Geol Survey, Guiyang, Guizhou, Peoples R China	Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Guizhou University; Chinese Academy of Sciences; University of Science & Technology Beijing	Ji, HB (corresponding author), Chinese Acad Sci, State Key Lab Environm Geochem, Inst Geochem, Guiyang, Guizhou, Peoples R China.; Ji, HB (corresponding author), Univ Sci & Technol Beijing, Civil & Environm Engn Sch, Beijing, Peoples R China.	ji.hongbing@hotmail.com			National Key Basic Research and Development Program [2013CB956702]; National Natural Science Foundation of China (NSFC) [41473122, 41073096, 41473027]; Hundred Talents Program of the Chinese Academy of Sciences; Orientation Project of Knowledge Innovation Program of the Chinese Academy of Sciences [kzcx2-yw-306]	National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Orientation Project of Knowledge Innovation Program of the Chinese Academy of Sciences	This work was supported by The National Key Basic Research and Development Program (2013CB956702) in http://www.most.gov.cn to Dr. Hongbing JI; The National Natural Science Foundation of China (NSFC) grants (No. 41473122, and 41073096) in: http://www.nsfc.gov.cn to Dr. Hongbing JI; The National Natural Science Foundation of China (NSFC) grants (No. 41473027) in: http://www.nsfc.gov.cr to Dr. XW; The Hundred Talents Program of the Chinese Academy of Sciences in: http://www.cas.cn to Dr. Hongbing Ji; The Orientation Project of Knowledge Innovation Program of the Chinese Academy of Sciences (kzcx2-yw-306) in: http://www.cas.cn to Dr. Shijie Wang.	ABERG G, 1989, J HYDROL, V109, P65, DOI 10.1016/0022-1694(89)90007-3; ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; ACKER JG, 1992, GEOCHIM COSMOCHIM AC, V56, P3073, DOI 10.1016/0016-7037(92)90290-Y; [Anonymous], 1989, STABLE ISOTOPES ECOL, P491; Aubert D, 2001, GEOCHIM COSMOCHIM AC, V65, P387, DOI 10.1016/S0016-7037(00)00546-9; Axe L, 1998, J COLLOID INTERF SCI, V199, P44, DOI 10.1006/jcis.1997.5347; BAIN DC, 1994, CATENA, V22, P201, DOI 10.1016/0341-8162(94)90002-7; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; BLUM JD, 1995, NATURE, V373, P415, DOI 10.1038/373415a0; BLUM JD, 1993, GEOCHIM COSMOCHIM AC, V57, P5019, DOI 10.1016/S0016-7037(05)80014-6; Blum JD, 1997, GEOCHIM COSMOCHIM AC, V61, P3193, DOI 10.1016/S0016-7037(97)00148-8; Borg LE, 1996, GEOCHIM COSMOCHIM AC, V60, P4193, DOI 10.1016/S0016-7037(96)00252-9; BORGGAARD OK, 1983, J SOIL SCI, V34, P333, DOI 10.1111/j.1365-2389.1983.tb01039.x; Bouchard M, 2000, GEOMORPHOLOGY, V32, P213, DOI 10.1016/S0169-555X(99)00098-7; Brantley SL, 1998, GEOCHIM COSMOCHIM AC, V62, P1493, DOI 10.1016/S0016-7037(98)00082-9; BRASS GW, 1975, GEOCHIM COSMOCHIM AC, V39, P1647, DOI 10.1016/0016-7037(75)90086-1; Braun JJ, 2012, GEOCHIM COSMOCHIM AC, V99, P243, DOI 10.1016/j.gca.2012.09.024; BRAUN JJ, 1990, GEOCHIM COSMOCHIM AC, V54, P781, DOI 10.1016/0016-7037(90)90373-S; Bullen T, 1997, GEOCHIM COSMOCHIM AC, V61, P291, DOI 10.1016/S0016-7037(96)00344-4; Bullen TD, 1996, GEOCHIM COSMOCHIM AC, V60, P1807, DOI 10.1016/0016-7037(96)00052-X; BURNS RG, 1975, NATURE, V255, P130, DOI 10.1038/255130a0; Cartwright I, 2007, CHEM GEOL, V246, P107, DOI 10.1016/j.chemgeo.2007.09.006; Castorina F, 2014, J GEOCHEM EXPLOR, V142, P138, DOI 10.1016/j.gexplo.2014.01.028; Chen J, 2004, GEOCHEMISTRY, P145; CHESWORTH W, 1981, GEOCHIM COSMOCHIM AC, V45, P1235, DOI 10.1016/0016-7037(81)90147-2; Chung CH, 2009, J MARINE SYST, V76, P433, DOI 10.1016/j.jmarsys.2007.09.013; Cidu R, 2013, GEODERMA, V193, P52, DOI 10.1016/j.geoderma.2012.10.009; CLAUER N, 1981, CHEM GEOL, V31, P325; CRERAR DA, 1974, GEOCHIM COSMOCHIM AC, V38, P279, DOI 10.1016/0016-7037(74)90111-2; DASCH EJ, 1969, GEOCHIM COSMOCHIM AC, V33, P1521, DOI 10.1016/0016-7037(69)90153-7; Derry LA, 1996, EARTH PLANET SC LETT, V142, P59, DOI 10.1016/0012-821X(96)00091-X; Dessert C, 2003, CHEM GEOL, V202, P257, DOI 10.1016/j.chemgeo.2002.10.001; Dixon JL, 2012, EARTH PLANET SC LETT, V323, P40, DOI 10.1016/j.epsl.2012.01.010; DOUGLAS GB, 1995, GEOCHIM COSMOCHIM AC, V59, P3799, DOI 10.1016/0016-7037(95)00266-3; Drouet T, 2005, GEODERMA, V126, P203, DOI 10.1016/j.geoderma.2004.09.010; Dubinin AV, 2017, LITHOL MINER RESOUR+, V52, P81, DOI 10.1134/S0024490217020043; EDMOND JM, 1992, SCIENCE, V258, P1594, DOI 10.1126/science.258.5088.1594; Erel Y, 2004, GEOCHIM COSMOCHIM AC, V68, P4649, DOI 10.1016/j.gca.2004.04.022; Faure G., 1977, PRINCIPLES ISOTOPE G, P177; Faure G., 1986, PRINCIPLES ISOTOPE G, P309; FEDO CM, 1995, GEOLOGY, V23, P921, DOI 10.1130/0091-7613(1995)023<0921:UTEOPM>2.3.CO;2; Feng Zengzhao, 1993, ACTA SEDIMENTOL SIN, V11, P13; GILKES RJ, 1979, CLAY CLAY MINER, V27, P349, DOI 10.1346/CCMN.1979.0270505; Goldich SS, 1966, EARTH PLANET SC LETT, V1, P372; GROMET LP, 1983, GEOCHIM COSMOCHIM AC, V47, P925; Harley AD, 2000, NUTR CYCL AGROECOSYS, V56, P11, DOI 10.1023/A:1009859309453; Hartman G, 2014, GEOCHIM COSMOCHIM AC, V126, P250, DOI 10.1016/j.gca.2013.11.015; Hissler C, 2015, APPL GEOCHEM, V54, P85, DOI 10.1016/j.apgeochem.2015.01.011; HODELL DA, 1989, EARTH PLANET SC LETT, V92, P165, DOI 10.1016/0012-821X(89)90044-7; Gonzalez FJ, 2012, CHEM GEOL, V310, P56, DOI 10.1016/j.chemgeo.2012.03.030; Ji H, 2003, ACTA GEOSCIENTIA SIN, V24, P38; JOHNSON TM, 1994, WATER RESOUR RES, V30, P1571, DOI 10.1029/94WR00157; Kazin PE, 2003, Z ANORG ALLG CHEM, V629, P344, DOI 10.1002/zaac.200390055; Klaus JS, 2007, HYDROGEOL J, V15, P745, DOI 10.1007/s10040-007-0175-z; Kohler SJ, 2005, CHEM GEOL, V222, P168, DOI 10.1016/j.chemgeo.2005.07.011; Krabbenhoft A, 2010, GEOCHIM COSMOCHIM AC, V74, P4097, DOI 10.1016/j.gca.2010.04.009; Land M, 2000, APPL GEOCHEM, V15, P311, DOI 10.1016/S0883-2927(99)00054-2; LIN JL, 1985, NATURE, V313, P444, DOI 10.1038/313444a0; Liu C, 2000, CAN J SOIL SCI, V80, P445, DOI 10.4141/S99-079; Liu WJ, 2013, J ASIAN EARTH SCI, V67-68, P138, DOI 10.1016/j.jseaes.2013.02.017; Lohr SC, 2013, SOIL RES, V51, P77, DOI 10.1071/SR12372; Ma Y, 2001, SCI CHINA SER D, V31, P634; MADRID L, 1985, J SOIL SCI, V36, P523, DOI 10.1111/j.1365-2389.1985.tb00355.x; McLennan S.M., 1993, PROCESSES CONTROLLIN, V285, P21; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Muhs DR, 2008, ARCT ANTARCT ALP RES, V40, P396, DOI 10.1657/1523-0430(07-022)[MUHS]2.0.CO;2; MUSGROVE M, 1993, SCIENCE, V259, P1877, DOI 10.1126/science.259.5103.1877; NAGASAWA H, 1970, EARTH PLANET SC LETT, V9, P359, DOI 10.1016/0012-821X(70)90136-6; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; NESBITT HW, 1992, AM J SCI, V292, P740, DOI 10.2475/ajs.292.10.740; OHR M, 1994, GEOCHIM COSMOCHIM AC, V58, P289, DOI 10.1016/0016-7037(94)90465-0; Ovchinnikova GV, 2013, DOKL EARTH SCI, V451, P798, DOI 10.1134/S1028334X13080047; Palumbo B, 2001, CHEM GEOL, V173, P257, DOI 10.1016/S0009-2541(00)00284-9; Pett-Ridge JC, 2009, GEOCHIM COSMOCHIM AC, V73, P25, DOI 10.1016/j.gca.2008.09.032; Qin J, 1998, LITHOFACIES PALEOGEO, V18, P19; Raiber M, 2009, J HYDROL, V367, P188, DOI 10.1016/j.jhydrol.2008.12.020; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Schulz MS, 2010, SOIL SCI SOC AM J, V74, P550, DOI 10.2136/sssaj2009.0144; SCOTESE CR, 1979, J GEOL, V87, P217, DOI 10.1086/628416; Shang C, 1993, SOIL SCI TRENDS AGR, V1, P137; Shijie Wang, 2001, CHINESE J GEOLOGY, V36, P474; STEINER M, 1989, J GEOPHYS RES-SOLID, V94, P7343, DOI 10.1029/JB094iB06p07343; Stille P, 2009, CHEM GEOL, V264, P173, DOI 10.1016/j.chemgeo.2009.03.005; Taylor S.R., 1985, CONTINENTAL CRUST IT, DOI DOI 10.1002/GJ.3350210116; TIESSEN H, 1993, PLANT SOIL, V153, P113, DOI 10.1007/BF00010550; Tripathi JK, 2007, GEOCHIM COSMOCHIM AC, V71, P1674, DOI 10.1016/j.gca.2007.01.001; Wang SJ, 1999, SCI CHINA SER D, V42, P572, DOI 10.1007/BF02877784; Weber ET, 1998, GEOCHIM COSMOCHIM AC, V62, P1735, DOI 10.1016/S0016-7037(98)00102-1; Wei GJ, 2013, CHEM GEOL, V343, P67, DOI 10.1016/j.chemgeo.2013.02.004; Wei X, 2014, CATENA, V118, P55, DOI 10.1016/j.catena.2014.01.019; WHITE AF, 1985, GEOCHIM COSMOCHIM AC, V49, P1263, DOI 10.1016/0016-7037(85)90015-8; White AF, 2001, GEOCHIM COSMOCHIM AC, V65, P847, DOI 10.1016/S0016-7037(00)00577-9; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; Williamson T, 2012, CRETACEOUS RES, V36, P24, DOI 10.1016/j.cretres.2012.02.001; Yang YH, 2014, CHEM GEOL, V385, P35, DOI 10.1016/j.chemgeo.2014.07.012; Yin HF, 1994, EARTH SCI J CHINA U, V19, P627; Zhou D.Q., 1999, SCI CHINA SER D, V29, P504; Zhou F, 1992, LIGHT MENTAL, V11, P1; 季宏兵, 2008, [自然科学进展, Progress in Natural Science], V18, P1128	99	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191780	10.1371/journal.pone.0191780	http://dx.doi.org/10.1371/journal.pone.0191780			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373592	Green Submitted, gold, Green Published			2022-12-26	WOS:000423425400024
J	Borg, SA; Buckley, H; Owen, R; Marin, AC; Lu, YT; Eyles, D; Lacroix, D; Reilly, GC; Skerry, TM; Bishop, NJ				Borg, Stephanie A.; Buckley, Harriet; Owen, Robert; Marin, Ana Campos; Lu, Yongtau; Eyles, Darryl; Lacroix, Damien; Reilly, Gwendolen C.; Skerry, Tim M.; Bishop, Nick J.			Early life vitamin D depletion alters the postnatal response to skeletal loading in growing and mature bone	PLOS ONE			English	Article							DRIED BLOOD SPOTS; D DEFICIENCY; 25-HYDROXYVITAMIN D; HEART-DISEASE; CORTICAL BONE; FETAL BONE; MALE-MICE; PREGNANCY; MASS; ADAPTATION	There is increasing evidence of persistent effects of early life vitamin D exposure on later skeletal health; linking low levels in early life to smaller bone size in childhood as well as increased fracture risk later in adulthood, independently of later vitamin D status. A major determinant of bone mass acquisition across all ages is mechanical loading. We tested the hypothesis in an animal model system that early life vitamin D depletion results in abrogation of the response to mechanical loading, with consequent reduction in bone size, mass and strength during both childhood and adulthood. A murine model was created in which pregnant dams were either vitamin D deficient or replete, and their offspring moved to a vitamin D replete diet at weaning. Tibias of the offspring were mechanically loaded and bone structure, extrinsic strength and growth measured both during growth and after skeletal maturity. Offspring of vitamin D deplete mice demonstrated lower bone mass in the non loaded limb and reduced bone mass accrual in response to loading in both the growing skeleton and after skeletal maturity. Early life vitamin D depletion led to reduced bone strength and altered bone biomechanical properties. These findings suggest early life vitamin D status may, in part, determine the propensity to osteoporosis and fracture that blights later life in many individuals.	[Borg, Stephanie A.; Buckley, Harriet; Bishop, Nick J.] Univ Sheffield, Dept Oncol & Metab, Acad Unit Child Hlth, Sheffield, S Yorkshire, England; [Owen, Robert; Marin, Ana Campos; Lacroix, Damien; Reilly, Gwendolen C.] Univ Sheffield, INSIGNEO Inst Silico Med, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England; [Lu, Yongtau] Dalian Univ Technol, Dept Engn Mech, Dalian, Peoples R China; [Eyles, Darryl] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Eyles, Darryl] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia; [Skerry, Tim M.] Univ Sheffield, Dept Oncol & Metab, Acad Unit Bone Biol, Sheffield, S Yorkshire, England; [Bishop, Nick J.] Sheffield Childrens NHS Fdn Trust, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; Dalian University of Technology; University of Queensland; Queensland Centre for Mental Health Research; University of Sheffield; Sheffield Children's NHS Foundation Trust	Borg, SA (corresponding author), Univ Sheffield, Dept Oncol & Metab, Acad Unit Child Hlth, Sheffield, S Yorkshire, England.	s.borg@sheffield.ac.uk	Owen, Robert/J-2553-2019; Eyles, Darryl W/X-3386-2018; Lu, Yongtao/AAC-2394-2021; Lacroix, Damien/G-3230-2010	Owen, Robert/0000-0003-1961-0733; Eyles, Darryl W/0000-0002-5023-7095; Lu, Yongtao/0000-0002-8511-6111; Lacroix, Damien/0000-0002-5482-6006; Borg, Stephanie/0000-0003-4880-9135	Medical research Council [MR/L002191/1]; MRC [MR/L002191/1] Funding Source: UKRI	Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SB has received a training fellowship from the Medical research Council which has funded this study in full. Grant reference MR/L002191/1 (www.mrc.ac.uk). The funder have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen Bo, 2012, Front Endocrinol (Lausanne), V3, P2, DOI 10.3389/fendo.2012.00002; Amundson LA, 2016, BRIT J NUTR, V116, P774, DOI 10.1017/S0007114516002658; Baird J, 2011, OSTEOPOROSIS INT, V22, P1323, DOI 10.1007/s00198-010-1344-9; BARKER DJP, 1986, LANCET, V1, P1077; Bonjour JP, 2014, ENDOCR REV, V35, P820, DOI 10.1210/er.2014-1007; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cooper C, 2001, OSTEOPOROSIS INT, V12, P623, DOI 10.1007/s001980170061; Cooper C, 2016, LANCET DIABETES ENDO, V4, P393, DOI 10.1016/S2213-8587(16)00044-9; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Finch SL, 2010, J NUTR, V140, P1574, DOI 10.3945/jn.109.113977; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Hendrickx G, 2015, NAT REV RHEUMATOL, V11, P462, DOI 10.1038/nrrheum.2015.48; Holguin N, 2013, CALCIFIED TISSUE INT, V93, P211, DOI 10.1007/s00223-013-9744-4; Holmlund-Suila E, 2012, J CLIN ENDOCR METAB, V97, P4139, DOI 10.1210/jc.2012-1575; Ioannou C, 2012, J CLIN ENDOCR METAB, V97, pE2070, DOI 10.1210/jc.2012-2538; Jahani R, 2014, MOL NUTR FOOD RES, V58, P1491, DOI 10.1002/mnfr.201300928; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kimball S, 2008, CRIT REV CL LAB SCI, V45, P339, DOI [10.1080/10408360802165295, 10.1080/10408360802165295 ]; Kvaskoff D, 2016, CLIN CHEM, V62, P639, DOI 10.1373/clinchem.2015.251538; Lanham SA, 2013, J DEV ORIG HLTH DIS, V4, P49, DOI 10.1017/S2040174412000542; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; Mahon P, 2010, J BONE MINER RES, V25, P14, DOI 10.1359/jbmr.090701; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Tabatabaei N, 2014, J NUTR, V144, P1985, DOI 10.3945/jn.114.197806; Viljakainen HT, 2011, OSTEOPOROSIS INT, V22, P883, DOI 10.1007/s00198-010-1499-4; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; Villa CR, 2016, INT J OBES; Weatherholt AM, 2013, BONE, V52, P372, DOI 10.1016/j.bone.2012.10.026; Weiler H, 2005, CAN MED ASSOC J, V172, P757, DOI 10.1503/cmaj.1040508; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Xue J, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0276-4; Yu XD, 2013, BONE, V53, P306, DOI 10.1016/j.bone.2012.12.012; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	38	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190675	10.1371/journal.pone.0190675	http://dx.doi.org/10.1371/journal.pone.0190675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370213	Green Accepted, Green Published, gold			2022-12-26	WOS:000423416600016
J	Komaki-Yasuda, K; Vincent, JP; Nakatsu, M; Kato, Y; Ohmagari, N; Kano, S				Komaki-Yasuda, Kanako; Vincent, Jeanne Perpetue; Nakatsu, Masami; Kato, Yasuyuki; Ohmagari, Norio; Kano, Shigeyuki			A novel PCR-based system for the detection of four species of human malaria parasites and Plasmodium knowlesi	PLOS ONE			English	Article							INFECTIONS; CULTURE	A microscopy-based diagnosis is the gold standard for the detection and identification of malaria parasites in a patient's blood. However, the detection of cases involving a low number of parasites and the differentiation of species sometimes requires a skilled microscopist. Although PCR-based diagnostic methods are already known to be very powerful tools, the time required to apply such methods is still much longer in comparison to traditional microscopic observation. Thus, improvements to PCR systems are sought to facilitate the more rapid and accurate detection of human malaria parasites Plasmodium falciparum, P. vivax, P. ovale, and P. malariae, as well as P. knowlesi, which is a simian malaria parasite that is currently widely distributed in Southeast Asia. A nested PCR that targets the small subunit ribosomal RNA genes of malaria parasites was performed using a fast PCR enzyme. In the first PCR, universal primers for all parasite species were used. In the second PCR, inner- specific primers, which targeted sequences from P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, were used. The PCR reaction time was reduced with the use of the-fast PCR enzyme, with only 65 minutes required to perform the first and second PCRs. The specific primers only reacted with the sequences of their targeted parasite species and never cross-reacted with sequences from other species under the defined PCR conditions. The diagnoses of 36 clinical samples that were obtained using this new PCR system were highly consistent with the microscopic diagnoses.	[Komaki-Yasuda, Kanako; Vincent, Jeanne Perpetue; Nakatsu, Masami; Kano, Shigeyuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan; [Vincent, Jeanne Perpetue; Kano, Shigeyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Kato, Yasuyuki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tsukuba; National Center for Global Health & Medicine - Japan	Kano, S (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan.; Kano, S (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	kano@ri.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; VINCENT, Jeanne/0000-0003-2448-2908	Grant for National Center for Global Health and Medicine [27A1401]	Grant for National Center for Global Health and Medicine	SK was supported by The Grant for National Center for Global Health and Medicine (27A1401).	Baird JK, 2009, TRAVEL MED INFECT DI, V7, P269, DOI 10.1016/j.tmaid.2009.06.004; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Makler MT, 2009, AM J TROP MED HYG, V81, P921, DOI 10.4269/ajtmh.2009.09-0202; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Ta TH, MALAR J, V13, P68; Tanizaki R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-128; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411; World Health Organization, 2017, DEPRESSION; World Health Organization, 2015, GUID TREATM MAL, Vthird	17	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191886	10.1371/journal.pone.0191886	http://dx.doi.org/10.1371/journal.pone.0191886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370297	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600113
J	Martinez-Ramos, E; Beltran, AM; Martin-Borras, C; Lasaosa-Medina, L; Real, J; Trujillo, JM; Sola-Gonfaus, M; Puigdomenech, E; Castillo-Ramos, E; Puig-Ribera, A; Gine-Garriga, M; Serra-Paya, N; Rodriguez-Roca, B; Gascon-Catalan, A; Martin-Cantera, C				Martinez-Ramos, Elena; Beltran, Angela-Maria; Martin-Borras, Carme; Lasaosa-Medina, Lourdes; Real, Jordi; Trujillo, Jose-Manuel; Sola-Gonfaus, Merce; Puigdomenech, Elisa; Castillo-Ramos, Eva; Puig-Ribera, Anna; Gine-Garriga, Maria; Serra-Paya, Noemi; Rodriguez-Roca, Beatriz; Gascon-Catalan, Ana; Martin-Cantera, Carlos		SEDESTACTIV Grp	Patterns of sedentary behavior in overweight and moderately obese users of the Catalan primary-health care system	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SITTING TIME; US ADULTS; DESCRIPTIVE EPIDEMIOLOGY; CARDIOVASCULAR-DISEASE; AUSTRALIAN ADULTS; RISK; MORTALITY; COHORT; SPENT	Background and objectives Prolonged sitting time (ST) has negative consequences on health. Changing this behavior is paramount in overweight/obese individuals because they are more sedentary than those with normal weight. The aim of the study was to establish the pattern of sedentary behavior and its relationship to health, socio-demographics, occupation, and education level in Catalan overweight/obese individuals. Methods A descriptive study was performed at 25 healthcare centers in Catalonia (Spain) with 464 overweight/moderately obese patients, aged25 to 65 years. Exclusion criteria were chronic diseases which contraindicated physical activity and language barriers. Face-to-face interviews were conducted to collect data on age, gender, educational level, social class, and marital status. Main outcome was 'sitting time' (collected by the Marshall questionnaire); chronic diseases and anthropometric measurements were registered. Results 464 patients, 58.4% women, mean age 51.9 years (SD 10.1), 76.1% married, 60% manual workers, and 48.7% had finished secondary education. Daily sitting time was 6.2 hours on working days (374 minutes/day, SD: 190), and about 6 hours on non-working ones (357 minutes/day, SD: 170). 50% of participants were sedentary >= 6 hours. The most frequent sedentary activities were: working/academic activities around 2 hours (128 minutes, SD: 183), followed by watching television, computer use, and commuting. Men sat longer than women (64 minutes more on working days and 54 minutes on non-working days), and individuals with office jobs (91 minutes), those with higher levels of education (42 minutes), and younger subjects (25 to 35 years) spent more time sitting. Conclusions In our study performed in overweight/moderately obese patients the mean sitting time was around 6 hours which was mainly spent doing work/academic activities and watching television. Men, office workers, individuals with higher education, and younger subjects had longer sitting time. Our results may help design interventions targeted at these sedentary patients to decrease sitting time.	[Martinez-Ramos, Elena] ICS, Primary Healthcare Ctr Vilanova 1, Barcelona, Spain; [Martinez-Ramos, Elena; Beltran, Angela-Maria; Martin-Borras, Carme; Puigdomenech, Elisa; Martin-Cantera, Carlos] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Lifestyles Study Grp, RedIAPP, Barcelona, Spain; [Martin-Borras, Carme; Gine-Garriga, Maria] URL, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain; [Martin-Borras, Carme; Gine-Garriga, Maria] URL, FCS Blanquerna, Dept Phys Therapy, Barcelona, Spain; [Martin-Borras, Carme; Serra-Paya, Noemi] Univ Pompeu Fabra, Escuela Super Ciencias Salud TecnoCampus Mataro M, Barcelona, Spain; [Lasaosa-Medina, Lourdes; Martin-Cantera, Carlos] ICS, Primary Healthcare Ctr Passeig St Joan, Barcelona, Spain; [Real, Jordi] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca, Barcelona, Spain; [Real, Jordi] Univ Int Catalunya, Fac Med & Ciencies Salut, Sant Cugat Del Valles, Spain; [Trujillo, Jose-Manuel] Primary Healthcare Ctr Cuevas del Almanzora, Almeria, Spain; [Sola-Gonfaus, Merce] ICS, Primary Healthcare Ctr Planes, Barcelona, Spain; [Puigdomenech, Elisa; Martin-Cantera, Carlos] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Castillo-Ramos, Eva] ICS, Primary Healthcare Ctr Moli Nou, Barcelona, Spain; [Puig-Ribera, Anna] Univ Vic Univ Cent Catalunya UVic UCC, Res Grp Sport & Phys Act, Hlth & Social Studies Ctr, Vic, Spain; [Rodriguez-Roca, Beatriz; Gascon-Catalan, Ana] Univ Zaragoza, Dept Physiatry & Nursing, Zaragoza, Spain	Universitat Ramon Llull; Universitat Ramon Llull; Pompeu Fabra University; Universitat Internacional de Catalunya (UIC); Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Zaragoza	Martinez-Ramos, E (corresponding author), ICS, Primary Healthcare Ctr Vilanova 1, Barcelona, Spain.; Martinez-Ramos, E; Martin-Borras, C (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Lifestyles Study Grp, RedIAPP, Barcelona, Spain.; Martin-Borras, C (corresponding author), URL, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain.; Martin-Borras, C (corresponding author), URL, FCS Blanquerna, Dept Phys Therapy, Barcelona, Spain.; Martin-Borras, C (corresponding author), Univ Pompeu Fabra, Escuela Super Ciencias Salud TecnoCampus Mataro M, Barcelona, Spain.	sedestactiv@gmail.com; mariacarmenmb@blanquerna.url.edu	Giné-Garriga, Maria/F-4089-2016; Serra, Noemi/AAB-7629-2019; Giné-Garriga, Maria/AAF-9828-2019; Gascon, Ana/AAH-1376-2020; Martín-Borràs, Carme/AAB-7605-2019; Martin-Cantera, Carlos/D-2693-2011	Giné-Garriga, Maria/0000-0003-4449-3524; Serra, Noemi/0000-0002-1048-9546; Giné-Garriga, Maria/0000-0003-4449-3524; Gascon, Ana/0000-0003-0335-0404; Martín-Borràs, Carme/0000-0002-4479-5410; Sola Gonfaus, Merce/0000-0002-8568-4418; Martin-Cantera, Carlos/0000-0003-0656-8126; Real, Jordi/0000-0002-5979-8948	Fondo de Investigacion Sanitaria, Institute de Salud Carlos III [PI11/01082]; VI Catedra of the European University of Madrid, Sociedad Espanola de Medicina Familiar y Comunitaria-semFYC; IDIAP Jordi Gol	Fondo de Investigacion Sanitaria, Institute de Salud Carlos III(Instituto de Salud Carlos III); VI Catedra of the European University of Madrid, Sociedad Espanola de Medicina Familiar y Comunitaria-semFYC; IDIAP Jordi Gol	The study was supported by research grants from Fondo de Investigacion Sanitaria, Institute de Salud Carlos III (PI11/01082) and VI Catedra of the European University of Madrid, Sociedad Espanola de Medicina Familiar y Comunitaria-semFYC and IDIAP Jordi Gol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Australian Bureau of Statistics, 2008, AUSTR US THEIR TIM 2; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107; Bertrais S, 2004, AM J PUBLIC HEALTH, V94, P1560, DOI 10.2105/AJPH.94.9.1560; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Domingo-Salvany A, 2000, Aten Primaria, V25, P350; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; European Commission, 412 EUR COMM; Farinola M, 2011, RED NACL ACTIVIDAD F, V95; Golubic R, 2015, INT J OBESITY, V39, P142, DOI 10.1038/ijo.2014.66; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harrington DM, 2014, J SCI MED SPORT, V17, P371, DOI 10.1016/j.jsams.2013.07.017; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King AC, 2010, AM J PREV MED, V38, P17, DOI 10.1016/j.amepre.2009.08.032; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Martin-Borras C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-228; Martinez-Ramos E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125739; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Nielson Media Research, 2009, A2 M2 3 SCREEN REP; Office for National Statistics, 2005, THE TIM US SURV; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Proper KI, 2007, INT J OBESITY, V31, P169, DOI 10.1038/sj.ijo.0803357; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Shaw M, 2007, HDB INEQUALITY SOCIO; Sparling PB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h100; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Van Dyck D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-668; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; World Health Organization, 2016, BOD MASS IND CLASS; World Health Organization Media Centre, 2013, OB OV	42	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190750	10.1371/journal.pone.0190750	http://dx.doi.org/10.1371/journal.pone.0190750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370176	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600019
J	Mishra, S; Goldman, JD; Sahyoun, NR; Moshfegh, AJ				Mishra, Suruchi; Goldman, Joseph D.; Sahyoun, Nadine R.; Moshfegh, Alanna J.			Association between dietary protein intake and grip strength among adults aged 51 years and over: What We Eat in America, National Health and Nutrition Examination Survey 2011-2014	PLOS ONE			English	Article							LEAN MASS; PHYSICAL FUNCTION; MUSCLE STRENGTH; OLDER-ADULTS; INGESTION; RISK	Introduction Distributing daily protein intake evenly across meals (similar to 25-30g/meal) has been suggested to improve muscle mass. The aim of this research is to examine the association between grip strength, total protein intake and its distribution across day's meals in older adults. Methods Nationally representative dietary intake data of adults aged 51 years and older (n = 4,123) who participated in What We Eat in America, NHANES 2011-2014 were analyzed. Protein intake per day and per eating occasion (breakfast, lunch, dinner, and snack) were determined. Combined grip strength was calculated and expressed in kilograms. Grip strength of individuals consuming >= 25g protein at 1 eating occasion was compared with those consuming same level of protein at 2 and 3 or more eating occasions. Grip strength of individuals in quartile 1 of daily protein intake was compared to those in the other quartiles. All associations were examined without and with adjustment for age, race/ethnicity, physical activity, health status, and smoking status. The comparison involving eating occasions and protein intake quartiles were further adjusted for daily protein intake and energy intake, respectively. Results Only 33% of men and 19% of women had protein intake of >= 25g at 2 or more eating occasions. These individuals also had higher grip strength and daily protein intake. Grip strength was positively associated with consumption of >= 25g protein at 2 eating occasions as compared to consumption of same level of protein at 1 eating occasion (p<0.05) in unadjusted model, but not when adjusted. Grip strength was positively associated with daily protein intake among women in quartiles 3 and 4 (p<0.05) of protein intake in both unadjusted and adjusted models compared to lowest protein intake. Among men, grip strength was associated with daily protein intake in quartiles 3 and 4 (p<0.05) in the unadjusted model, but not when adjusted. Conclusion In a nationally representative sample of older adults, consuming >= 25g protein at 2 or more eating occasions was not associated with grip strength. However, higher daily protein intake was positively associated with grip strength in women.	[Mishra, Suruchi; Sahyoun, Nadine R.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Goldman, Joseph D.; Moshfegh, Alanna J.] ARS, USDA, Beltsville Human Nutr Res Ctr, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Mishra, S (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	Suruchi.mishra@ars.usda.gov		Mishra, Suruchi/0000-0002-6885-8391				Arnal MA, 1999, AM J CLIN NUTR, V69, P1202; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Bollwein J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-109; Bouillanne O, 2013, CLIN NUTR, V32, P186, DOI 10.1016/j.clnu.2012.08.015; CASTANEDA C, 1995, AM J CLIN NUTR, V62, P30, DOI 10.1093/ajcn/62.1.30; Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics, 2011, NHANES 2009 2010 PUB; Centers for Disease Control and Prevention National Center for Health Statistics, 2013, NHANES 2011 2012 AN; Christina Brogardh, 2015, PHYSIOTHERAPY, V101, pe177; Farsijani S, 2017, AM J CLIN NUTR; Farsijani S, 2016, AM J CLIN NUTR, V104, P694, DOI 10.3945/ajcn.116.130716; Genaro PD, 2010, NUTR REV, V68, P616, DOI 10.1111/j.1753-4887.2010.00321.x; Gregorio L, 2014, J NUTR HEALTH AGING, V18, P155, DOI 10.1007/s12603-013-0391-2; Hamwi GJ., 1964, THERAPY CHANGING DIE; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Isanejad M, 2016, BRIT J NUTR, V115, P1281, DOI 10.1017/S000711451600012X; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kim IY, 2015, AM J PHYSIOL-ENDOC M, V308, pE21, DOI 10.1152/ajpendo.00382.2014; Loenneke JP, 2016, CLIN NUTR, V35, P1506, DOI 10.1016/j.clnu.2016.04.002; Mamerow MM, 2014, J NUTR, V144, P876, DOI 10.3945/jn.113.185280; McLean RR, 2016, J GERONTOL A-BIOL, V71, P356, DOI 10.1093/gerona/glv184; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Munger RG, 1999, AM J CLIN NUTR, V69, P147; Murphy CH, 2015, AM J PHYSIOL-ENDOC M, V308, pE734, DOI 10.1152/ajpendo.00550.2014; Norton C, 2016, J NUTR, V146, P65, DOI 10.3945/jn.115.219022; Oksuzyan A, 2010, J AGING HEALTH, V22, P589, DOI 10.1177/0898264310366752; Phillips S.M., 2016, APPL PHYSIOL NUTR ME, V41, P1; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Taekema DG, 2011, EUR J ENDOCRINOL, V164, P189, DOI 10.1530/EJE-10-0703; U.S. Department of Agriculture Agricultural Research Service, 2014, USDA FOOD NUTR DAT D; US Department of Agriculture Agricultural Research Service, 2016, USDA FOOD NUTR DAT D; Volpi E, 2003, AM J CLIN NUTR, V78, P250, DOI 10.1093/ajcn/78.2.250; Wall BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140903	34	24	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191368	10.1371/journal.pone.0191368	http://dx.doi.org/10.1371/journal.pone.0191368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364939	Green Published, gold			2022-12-26	WOS:000423412500042
J	Mucke, D; Hermes, A; Roettger, TB; Becker, J; Niemann, H; Dembek, TA; Timmermann, L; Visser-Vandewalle, V; Fink, GR; Grice, M; Barbe, MT				Muecke, Doris; Hermes, Anne; Roettger, Timo B.; Becker, Johannes; Niemann, Henrik; Dembek, Till A.; Timmermann, Lars; Visser-Vandewalle, Veerle; Fink, Gereon R.; Grice, Martine; Barbe, Michael T.			The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study	PLOS ONE			English	Article							VOICE ONSET TIME; PARKINSONS-DISEASE; ORAL DIADOCHOKINESIS; SUBTHALAMIC NUCLEUS; MOTOR CONTROL; COARTICULATION; GAIT; ARTICULATION; PERCEPTION; DYSARTHRIA	Acoustic studies have revealed that patients with Essential Tremor treated with thalamic Deep Brain Stimulation (DBS) may suffer from speech deterioration in terms of imprecise oral articulation and reduced voicing control. Based on the acoustic signal one cannot infer, however, whether this deterioration is due to a general slowing down of the speech motor system (e.g., a target undershoot of a desired articulatory goal resulting from being too slow) or disturbed coordination (e.g., a target undershoot caused by problems with the relative phasing of articulatory movements). To elucidate this issue further, we here investigated both acoustics and articulatory patterns of the labial and lingual system using Electromagnetic Articulography (EMA) in twelve Essential Tremor patients treated with thalamic DBS and twelve age- and sex-matched controls. By comparing patients with activated (DBS-ON) and inactivated stimulation (DBS-OFF) with control speakers, we show that critical changes in speech dynamics occur on two levels: With inactivated stimulation (DBS-OFF), patients showed coordination problems of the labial and lingual system in terms of articulatory imprecision and slowness. These effects of articulatory discoordination worsened under activated stimulation, accompanied by an additional overall slowing down of the speech motor system. This leads to a poor performance of syllables on the acoustic surface, reflecting an aggravation either of pre-existing cerebellar deficits and/or the affection of the upper motor fibers of the internal capsule.	[Muecke, Doris; Hermes, Anne; Roettger, Timo B.; Niemann, Henrik; Grice, Martine] Univ Cologne, IfL Phonet, Cologne, Germany; [Becker, Johannes; Dembek, Till A.; Visser-Vandewalle, Veerle; Fink, Gereon R.; Barbe, Michael T.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Timmermann, Lars] Univ Hosp Marburg, Dept Neurol, Marburg, Germany; [Fink, Gereon R.] Univ Hosp Cologne, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany	University of Cologne; University of Cologne; University Hospital of Giessen & Marburg; University of Cologne	Mucke, D (corresponding author), Univ Cologne, IfL Phonet, Cologne, Germany.	doris.muecke@uni-koeln.de	Dembek, Till Anselm/J-4160-2019; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012; Hermes, Anne/A-3260-2015; Roettger, Timo/L-9503-2019	Dembek, Till Anselm/0000-0001-7023-146X; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Hermes, Anne/0000-0003-1111-0005; Roettger, Timo/0000-0003-1400-2739; Timmermann, Lars/0000-0002-5301-3580; Barbe, Michael T./0000-0003-1149-8054; Grice, Martine/0000-0003-4973-4059	German Research Foundation (DFG) [SFB 1252]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) as part of the SFB 1252 "Prominence in Language" in the project A04 "Dynamic modelling of prosodic prominence" at the University of Cologne.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Arkadir D, 2013, THER ADV NEUROL DISO, V6, P229, DOI 10.1177/1756285612471415; Baese-Berk M, 2009, LANG COGNITIVE PROC, V24, P527, DOI 10.1080/01690960802299378; Barbe MT, 2011, J NEUROL, V258, P434, DOI 10.1007/s00415-010-5773-3; Becker J, 2017, NEUROMODULATION, V20, P223, DOI 10.1111/ner.12546; Beckman M, GESTURE SEGMENT PROS, P68; Boersma P., 2010, PRAAT DOING PHONETIC; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Cassidy S, 2001, SPEECH COMMUN, V33, P61, DOI 10.1016/S0167-6393(00)00069-8; Chenausky K., 2011, PARKINSONS DIS, V2011, P13; Cho T., 2006, LAB PHONOLOGY, V8, P519; Darley FL, 1975, MOTOR SPEECH DISORDE, P171; DEJONG KJ, 1995, J ACOUST SOC AM, V97, P491, DOI 10.1121/1.412275; Deuschl G, 2009, MOVEMENT DISORD, V24, P2033, DOI 10.1002/mds.22755; Dromey C, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/796205; Farnetari E, 1997, HDB PHONETIC SCI, P316; Fasano A, 2010, BRAIN, V133, P3635, DOI 10.1093/brain/awq267; Flora ED, 2010, MOVEMENT DISORD, V25, P1550, DOI 10.1002/mds.23195; Fougeron C, 1997, J ACOUST SOC AM, V101, P3728, DOI 10.1121/1.418332; Frost E, 2010, INT J SPEECH-LANG PA, V12, P399, DOI 10.3109/17549507.2010.497560; Groppa S, 2014, BRAIN, V137, P109, DOI 10.1093/brain/awt304; Hall KC, MESSAGE SHA IN PRESS; Harrington J., 2000, PAPERS LAB PHONOLOGY, P40; Hartinger M, 2010, EFFECTS MED SUBTHALA, V25, P210; Hawkins S., 1992, PAPERS LAB PHONOLOGY, P9, DOI DOI 10.1017/CBO9780511519918.002; Helmchen C, 2003, BRAIN, V126, P1319, DOI 10.1093/brain/awg132; Iskarous K, 2010, J PHONETICS, V38, P625, DOI 10.1016/j.wocn.2010.09.004; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Karlsson F, 2012, J MED SPEECH-LANG PA, V20, P65; Karlsson F, 2014, J SPEECH LANG HEAR R, V57, P1178, DOI 10.1044/2014_JSLHR-S-13-0010; Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; Klebe S, 2005, NEUROLOGY, V65, P96, DOI 10.1212/01.wnl.0000167550.97413.1f; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Krack P, 2002, MOVEMENT DISORD, V17, pS2, DOI 10.1002/mds.10136; Kronenbuerger M, 2007, BRAIN, V130, P1538, DOI 10.1093/brain/awm081; Kronenbuerger M, 2009, CEREBELLUM, V8, P389, DOI 10.1007/s12311-009-0111-y; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; LOGEMANN JA, 1981, J SPEECH HEAR DISORD, V46, P348, DOI 10.1044/jshd.4604.348; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Mai J.K., 2015, ATLAS HUMAN BRAIN, Vfourth; Montgomery EB., 2010, PROGRAMMING PRINCIPL; Mucke D, 2014, J SPEECH LANG HEAR R, V57, P1206, DOI 10.1044/2014_JSLHR-S-13-0155; Mucke D, 2014, J PHONETICS, V44, P1, DOI 10.1016/j.wocn.2014.03.001; MUNHALL KG, 1985, J EXP PSYCHOL HUMAN, V11, P457, DOI 10.1037/0096-1523.11.4.457; Nelson NR, 2017, J PHONETICS, V64, P51, DOI 10.1016/j.wocn.2017.01.008; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; PARDO B, 1993, MOVEMENT DISORD, V8, P278, DOI 10.1002/mds.870080305; Patri JF, 2015, BIOL CYBERN, V109, P611, DOI 10.1007/s00422-015-0664-4; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Putzer M, 2007, J VOICE, V21, P741, DOI 10.1016/j.jvoice.2006.05.007; R Core Team, 2013, R LANG ENV STAT COMP; Roon K., 2007, P 16 INT C PHON SCI, P409; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; Saltzman E, 1975, STATUS REPORT SPEECH, P1; Scarborough R, 2013, J PHONETICS, V41, P491, DOI 10.1016/j.wocn.2013.09.004; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Singer C, 2004, MOVEMENT DISORD, V9, P193; Staiger A, 2017, J MOTOR BEHAV, V49, P482, DOI 10.1080/00222895.2016.1241747; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Weismer G., 1992, INTELLIGIBILITY SPEE, P67; Weismer Gary., 1984, SEMIN SPEECH LANG, V5, P293, DOI [10.1055/s-2008-1064291, DOI 10.1055/S-2008-1064291]; ZIEGLER W, 1986, BRAIN LANG, V29, P34, DOI 10.1016/0093-934X(86)90032-5; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614	69	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191359	10.1371/journal.pone.0191359	http://dx.doi.org/10.1371/journal.pone.0191359			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360867	Green Published, gold, Green Submitted			2022-12-26	WOS:000423161800026
J	Hoang, TT; Goldmuntz, E; Roberts, AE; Chung, WK; Kline, JK; Deanfield, JE; Giardini, A; Aleman, A; Gelb, BD; Mac Neal, M; Porter, GA; Kim, R; Brueckner, M; Lifton, RP; Edman, S; Woyciechowski, S; Mitchell, LE; Agopian, AJ				Hoang, Thanh T.; Goldmuntz, Elizabeth; Roberts, Amy E.; Chung, Wendy K.; Kline, Jennie K.; Deanfield, John E.; Giardini, Alessandro; Aleman, Adolfo; Gelb, Bruce D.; Mac Neal, Meghan; Porter, George A., Jr.; Kim, Richard; Brueckner, Martina; Lifton, Richard P.; Edman, Sharon; Woyciechowski, Stacy; Mitchell, Laura E.; Agopian, A. J.			The Congenital Heart Disease Genetic Network Study: Cohort description	PLOS ONE			English	Article							DE-NOVO MUTATIONS; BIRTH-DEFECTS; UNITED-STATES; METROPOLITAN ATLANTA; MATERNAL SMOKING; PREVALENCE; OUTCOMES; CHILDREN; INFANT; SEX	The Pediatric Cardiac Genomics Consortium (PCGC) designed the Congenital Heart Disease Genetic Network Study to provide phenotype and genotype data for a large congenital heart defects (CHDs)cohort. This article describes the PCGC cohort, overall and by major types of CHDs (e.g., conotruncaldefects) and subtypes of conotrucal heart defects (e.g., tetralogy of Fallot) and left ventricular outflow tract obstructions (e.g., hypoplastic left heart syndrome). Cases with CHDs were recruited through ten sites, 2010 +/- 2014. Information on cases (N = 9,727) and their parents was collected through interviews and medical record abstraction. Four case characteristics, eleven parental characteristics, and thirteen parentreported neurodevelopment outcomes were summarized using counts and frequencies and compared across CHD types and subtypes. Eleven percent of cases had a genetic diagnosis. Among cases without a genetic diagnosis, the majority had conotruncal heart defects (40%) or left ventricular outflow tract obstruction (21%). Across CHD types, there were significant differences (p<0.05) in the distribution of all four case characteristics (e.g., sex), four parental characteristics (e.g., maternal pregestational diabetes), and five neurodevelopmental outcomes (e.g., learning disabilities). Several characteristics (e.g., sex) were also significantly different across CHD subtypes. The PCGC cohort is one of the largest CHD cohorts available for the study of genetic determinants of risk and outcomes. The majority of cases do not have a genetic diagnosis. This description of the PCGC cohort, including differences across CHD types and subtypes, provides a reference work for investigators who are interested in collaborating with or using publically available resources from the PCGC.	[Hoang, Thanh T.; Mitchell, Laura E.; Agopian, A. J.] UTHealth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Goldmuntz, Elizabeth; Edman, Sharon; Woyciechowski, Stacy] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Roberts, Amy E.] Childrens Hosp Boston, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Kline, Jennie K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Deanfield, John E.; Giardini, Alessandro] Great Ormond St Hosp Sick Children, Cardiothorac Unit, London, England; [Deanfield, John E.] UCL, Inst Cardiovasc Sci, London, England; [Aleman, Adolfo; Gelb, Bruce D.; Mac Neal, Meghan] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Porter, George A., Jr.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Kim, Richard] Univ Southern Calif, Keck Sch Med, Sect Cardiothorac Surg, Los Angeles, CA 90033 USA; [Brueckner, Martina; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Mendelian Gen, New Haven, CT USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Columbia University; Columbia University; Columbia University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Rochester; University of Southern California; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Agopian, AJ (corresponding author), UTHealth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	a.j.agopian@uth.tmc.edu	Aleman, Adolfo/GPG-1788-2022; Porter, George/E-7315-2013	Porter, George/0000-0003-0726-9988; Deanfield, John/0000-0001-8806-6052; Gelb, Bruce/0000-0001-8527-5027	National Institutes of Health (NIH); National Heart, Lung, and Blood Institute; Pediatric Cardiac Genomics Consortium [U01-HL098123, U01-HL098147, U01-HL098153, U01-HL098162, U01-HL098163, U01-HL098188, P50-HL74731, R21HL-098844, R01HL-076773, R01-HL74094]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454]; National Center for Advancing Translational Sciences [UL1TR000003]; National Institute of Environmental Health Sciences [R21-E5024895]; Cardiovascular Development Consortium [U01-HL098166]; National Human Genome Research Institute [U54HG006504]; Columbia University's CTSA grant [UL1-RR024156]; American Heart Association Award [16GRNT29660001]; Howard Hughes Medical Institute; Children's Hospital of Philadelphia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL098147, UM1HL098123, U01HL131003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pediatric Cardiac Genomics Consortium; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cardiovascular Development Consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Columbia University's CTSA grant; American Heart Association Award(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Children's Hospital of Philadelphia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute, including the Pediatric Cardiac Genomics Consortium [U01-HL098123, U01-HL098147, U01-HL098153, U01-HL098162, U01-HL098163, U01-HL098188, P50-HL74731, R21HL-098844, R01HL-076773, R01-HL74094]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454]; the National Center for Research Resources [UL1RR024134, M01-RR-000240] (now the National Center for Advancing Translational Sciences [UL1TR000003]); National Institute of Environmental Health Sciences [R21-E5024895]; the Cardiovascular Development Consortium [U01-HL098166]; the National Human Genome Research Institute [U54HG006504]; Columbia University's CTSA grant [UL1-RR024156]; American Heart Association Award [16GRNT29660001]; and the Howard Hughes Medical Institute. GWAS genotyping was funded by an Institutional Development Fund to The Center for Applied Genomics from The Children's Hospital of Philadelphia. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Conners C.K., 1997, CONNERS RATING SCALE; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Dykes JC, 2016, HEART, V102, P634, DOI 10.1136/heartjnl-2015-308650; FERENCZ C, 1997, GENETIC ENV RISK FAC; Gaynor JW, 2015, PEDIATRICS, V135, P816, DOI 10.1542/peds.2014-3825; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Khodr ZG, 2014, BIRTH DEFECTS RES A, V100, P472, DOI 10.1002/bdra.23238; Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070; Leirgul E, 2014, AM HEART J, V168, P956, DOI 10.1016/j.ahj.2014.07.030; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Masho SW, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1002-0; Razzaghi H, 2015, J PEDIATR-US, V166, P119, DOI 10.1016/j.jpeds.2014.09.006; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; STORCH TG, 1992, TERATOLOGY, V46, P271, DOI 10.1002/tera.1420460311; Tinker SC, 2012, BIRTH DEFECTS RES A, V103, P517, DOI DOI 10.1002/BDRA.23378; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang Y, 2015, J PEDIATR-US, V166, P819, DOI 10.1016/j.jpeds.2014.12.025; Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083; Yang QH, 2006, BIRTH DEFECTS RES A, V76, P706, DOI 10.1002/bdra.20308; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	26	47	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191319	10.1371/journal.pone.0191319	http://dx.doi.org/10.1371/journal.pone.0191319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351346	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300072
J	Estrada, DF				Estrada, D. Fernando			The cytochrome P450 24A1 interaction with adrenodoxin relies on multiple recognition sites that vary among species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENODOXIN; ELECTRON-TRANSFER; STRUCTURAL BASIS; BINDING; MUTATIONS; CYP24A1; FERREDOXIN; REDUCTASE; DOMAIN; 17A1	Mitochondrial cytochromes P450 (P450s) are responsible for important metabolic reactions, including steps involved in steroid and vitamin D metabolism. The mitochondrial P450 24A1 (CYP24A1) is responsible for deactivation of the bioactive form of vitamin D, 1,25(OH) 2D3. Its function relies on formation of a P450-redox partner complex with the ferredoxin and electron donor adrenodoxin (Adx). However, very little is known about how the Adx-CYP24A1 complex forms. In this study, we report the results of solution NMR in which we monitor isotopically labeled full-length Adx as it binds CYP24A1 in complex with the P450 inhibitor clotrimazole. The NMR titration data suggested a mode for P450-Adx interactions in which formation of the complex relies on contributions from multiple recognition sites on the Adx core domain, some of which have not previously been reported. To evaluate differences among CYP24A1-Adx complexes from different mammalian species and displaying distinct regioselectivity for 1,25(OH) (D)3, all bound spectra were acquired in parallel for human (carbon-23 and -24 hydroxylase), rat (carbon-24 hydroxylase), and opossum (carbon-23 hydroxylase) CYP24A1 isoforms. Binding data from a series of single and double charge-neutralizing substitutions of Adx confirmed that species-specific CYP24A1 isoforms differ in binding to Adx, providing evidence that variations in redox partner interactions correlate with P450 regioselectivity. In summary, these findings reveal that CYP24A1-Adx interactions rely on several recognition sites and that variations in CYP24A1 isoforms modulate formation of the complex, thus providing insight into the variable and complex nature of mitochondrial P450-Adx interactions.	[Estrada, D. Fernando] Univ Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 3435 Main St, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Estrada, DF (corresponding author), Univ Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 3435 Main St, Buffalo, NY 14214 USA.	dfestrad@buffalo.edu			National Institutes of Health [R00 GM112862]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM112862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R00 GM112862 (to D. F. E.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Annalora A, 2004, ARCH BIOCHEM BIOPHYS, V425, P133, DOI 10.1016/j.abb.2004.01.025; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Behlke J, 2007, BIOPHYS CHEM, V125, P159, DOI 10.1016/j.bpc.2006.07.011; Beilke D, 2002, BIOCHEMISTRY-US, V41, P7969, DOI 10.1021/bi0160361; Bureik M, 2005, BIOCHEMISTRY-US, V44, P3821, DOI 10.1021/bi047697b; CHEN KS, 1993, P NATL ACAD SCI USA, V90, P4543, DOI 10.1073/pnas.90.10.4543; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; COGHLAN VM, 1992, J BIOL CHEM, V267, P8932; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Hartfield KA, 2013, J STEROID BIOCHEM, V136, P47, DOI 10.1016/j.jsbmb.2012.11.001; Heinz A, 2005, BIOCHEM BIOPH RES CO, V338, P491, DOI 10.1016/j.bbrc.2005.08.077; Hollingsworth SA, 2016, P NATL ACAD SCI USA, V113, P8723, DOI 10.1073/pnas.1606474113; HUANG JJ, 1973, BIOCHEMISTRY-US, V12, P406, DOI 10.1021/bi00727a007; Ishizuka S, 2005, ENDOCRINOLOGY, V146, P2023, DOI 10.1210/en.2004-1140; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; LAMBETH JD, 1980, J BIOL CHEM, V255, P4667; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Miller WL, 2017, J STEROID BIOCHEM, V165, P101, DOI 10.1016/j.jsbmb.2016.04.001; Mizwicki MT, 2009, J BIOL CHEM, V284, P36292, DOI 10.1074/jbc.M109.042069; O'Keeffe DT, 2016, OSTEOPOROSIS INT, V27, P3121, DOI 10.1007/s00198-016-3615-6; OHYAMA Y, 1989, FEBS LETT, V255, P405, DOI 10.1016/0014-5793(89)81133-0; Peng HM, 2017, BIOCHEMISTRY-US, V56, P2282, DOI 10.1021/acs.biochem.7b00034; Pikuleva IA, 2000, ARCH BIOCHEM BIOPHYS, V373, P44, DOI 10.1006/abbi.1999.1536; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Ritter CS, 2006, KIDNEY INT, V70, P654, DOI 10.1038/sj.ki.5000394; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Streeten EA, 2011, NEW ENGL J MED, V365, P1741, DOI 10.1056/NEJMc1110226; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; Weiss R, 2000, J BIOMOL NMR, V17, P355, DOI 10.1023/A:1008338800548; Yasutake Y, 2013, CHEMBIOCHEM, V14, P2284, DOI 10.1002/cbic.201300386; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08392	41	7	7	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4167	4179		10.1074/jbc.RA117.001145	http://dx.doi.org/10.1074/jbc.RA117.001145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29371396	Green Published, hybrid			2022-12-26	WOS:000427587500027
J	Grither, WR; Divine, LM; Meller, EH; Wilke, DJ; Desai, RA; Loza, AJ; Zhao, PN; Lohrey, A; Longmore, GD; Fuh, KC				Grither, Whitney R.; Divine, Laura M.; Meller, Eric H.; Wilke, Daniel J.; Desai, Riva A.; Loza, Andrew J.; Zhao, Peinan; Lohrey, Anne; Longmore, Gregory D.; Fuh, Katherine C.			TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL METASTASIS; UP-REGULATION; INVASION; CARCINOMA; COLLAGEN; FIBRONECTIN; MATRIX; FIBROBLASTS; ACTIVATION	The mesenchymal gene program has been shown to promote the metastatic progression of ovarian cancer; however, specific proteins induced by this program that lead to these metastatic behaviors have not been identified. Using patient derived tumor cells and established human ovarian tumor cell lines, we find that the Epithelial-to-Mesenchymal Transition inducing factor TWIST1 drives expression of discoidin domain receptor 2 (DDR2), a receptor tyrosine kinase (RTK) that recognizes fibrillar collagen as ligand. The expression and action of DDR2 was critical for mesothelial cell clearance, invasion and migration in ovarian tumor cells. It does so, in part, by upregulating expression and activity of matrix remodeling enzymes that lead to increased cleavage of fibronectin and spreading of tumor cells. Additionally, DDR2 stabilizes SNAIL1, allowing for sustained mesenchymal phenotype. In patient derived ovarian cancer specimens, DDR2 expression correlated with enhanced invasiveness. DDR2 expression was associated with advanced stage ovarian tumors and metastases. In vivo studies demonstrated that the presence of DDR2 is critical for ovarian cancer metastasis. These findings indicate that the collagen receptor DDR2 is critical for multiple steps of ovarian cancer progression to metastasis, and thus, identifies DDR2 as a potential new target for the treatment of metastatic ovarian cancer.	[Grither, Whitney R.; Loza, Andrew J.; Lohrey, Anne; Longmore, Gregory D.] Washington Univ, ICCE Inst, St Louis, MO USA; [Divine, Laura M.; Meller, Eric H.; Wilke, Daniel J.; Desai, Riva A.; Fuh, Katherine C.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA; [Meller, Eric H.; Wilke, Daniel J.; Desai, Riva A.; Lohrey, Anne; Fuh, Katherine C.] Washington Univ, Ctr Reprod Hlth Sci CRepHS, St Louis, MO 63130 USA; [Zhao, Peinan] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Clin Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fuh, KC (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA.; Fuh, KC (corresponding author), Washington Univ, Ctr Reprod Hlth Sci CRepHS, St Louis, MO 63130 USA.	kfuh@wudosis.wustl.edu		Fuh, Katherine/0000-0002-7693-2694	Cancer Frontier Fund [8002-88];  [2K12HD000849-28];  [NIHCA196205]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA196205, P30CA091842] Funding Source: NIH RePORTER	Cancer Frontier Fund; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	2K12HD000849-28 (KCF); NIHCA196205 (GDL); Cancer Frontier Fund 8002-88 (KCF and GDL).	Bildsoe H, 2016, DEV BIOL, V418, P189, DOI 10.1016/j.ydbio.2016.08.016; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Chen DY, 2013, INT J GYNECOL CANCER, V23, P1357, DOI 10.1097/IGC.0b013e3182a5e760; Cho A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00245; Chua HH, 2008, HEAD NECK-J SCI SPEC, V30, P427, DOI 10.1002/hed.20724; Coelho NM, 2017, CELL REP, V18, P1774, DOI 10.1016/j.celrep.2017.01.061; Corsa CAS, 2016, CELL REP, V15, P2510, DOI 10.1016/j.celrep.2016.05.033; Davidowitz RA, 2012, JOVE, V60; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Fan Y, 2016, AM J TRANSL RES, V8, P2845; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kenny HA, 2009, CANCER TREAT RES, V149, P335, DOI 10.1007/978-0-387-98094-2_16; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majkowska I, 2017, J BIOL CHEM, V292, P6633, DOI 10.1074/jbc.M116.770057; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Nadiarnykh O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-94; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Rodrigues R, 2007, ONCOL REP, V18, P917; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Terauchi M, 2007, CLIN EXP METASTAS, V24, P329, DOI 10.1007/s10585-007-9070-1; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24606; Wang YL, 2015, INT J CLIN EXP MED, V8, P7388; Xie BH, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0218-6; Xu DB H, 2012, PLOS ONE, V7; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu JK, 2014, CANCER BIOL THER, V15, P612, DOI 10.4161/cbt.28181; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Yeh JE, 2013, CURR OPIN ONCOL, V25, P652, DOI 10.1097/01.cco.0000432528.88101.1a; Yeung TL, 2015, AM J PHYSIOL-CELL PH, V309, pC444, DOI 10.1152/ajpcell.00188.2015; Zhang K, 2016, J CELL SCI, V129, P1989, DOI 10.1242/jcs.180539; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang XR, 2012, CARTILAGE, V3, P267, DOI 10.1177/1947603511435273; Zhang Y, 2014, BBA-MOL BASIS DIS, V1842, P1350, DOI 10.1016/j.bbadis.2014.04.018	52	35	36	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1714	1729		10.1038/s41388-017-0043-9	http://dx.doi.org/10.1038/s41388-017-0043-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29348456	Green Accepted			2022-12-26	WOS:000428632600003
J	Belousov, MV; Bondarev, SA; Kosolapova, AO; Antonets, KS; Sulatskaya, AI; Sulatsky, MI; Zhouravleva, GA; Kuznetsova, IM; Turoverov, KK; Nizhnikov, AA				Belousov, Mikhail V.; Bondarev, Stanislav A.; Kosolapova, Anastasiia O.; Antonets, Kirill S.; Sulatskaya, Anna I.; Sulatsky, Maksim I.; Zhouravleva, Galina A.; Kuznetsova, Irina M.; Turoverov, Konstantin K.; Nizhnikov, Anton A.			M60-like metalloprotease domain of the Escherichia coli YghJ protein forms amyloid fibrils	PLOS ONE			English	Article							SECRETED METALLOPROTEASE; THIOFLAVIN T; PRION; ALGORITHM; HISTORY; SYSTEM	Amyloids are protein fibrils with a characteristic spatial structure. Amyloids were long perceived as the pathogens involved in a set of lethal diseases in humans and animals. In recent decades, it has become clear that amyloids represent a quaternary protein structure that is not only pathological but also functionally important and is widely used by different organisms, ranging from archaea to animals, to implement diverse biological functions. The greatest biological variety of amyloids is found in prokaryotes, where they control the formation of biofilms and cell wall sheaths, facilitate the overcoming of surface tension, and regulate the metabolism of toxins. Several amyloid proteins were identified in the important model, biotechnological and pathogenic bacterium Escherichia coli. In previous studies, using a method for the proteomic screening and identification of amyloids, we identified 61 potentially amyloidogenic proteins in the proteome of E. coli. Among these proteins, YghJ was the most enriched with bioinformatically predicted amyloidogenic regions. YghJ is a lipoprotein with a zinc metalloprotease M60-like domain that is involved in mucin degradation in the intestine as well as in proinflammatory responses. In this study, we analyzed the amyloid properties of the YghJ M60-like domain and demonstrated that it forms amyloid-like fibrils in vitro and in vivo.	[Belousov, Mikhail V.; Bondarev, Stanislav A.; Kosolapova, Anastasiia O.; Antonets, Kirill S.; Zhouravleva, Galina A.; Nizhnikov, Anton A.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Bondarev, Stanislav A.; Zhouravleva, Galina A.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg, Russia; [Kosolapova, Anastasiia O.; Antonets, Kirill S.; Nizhnikov, Anton A.] ARRIAM, Lab Prote Supra Organismal Syst, St Petersburg, Russia; [Sulatskaya, Anna I.; Sulatsky, Maksim I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, St Petersburg, Russia; [Turoverov, Konstantin K.] Peter Great St Petersburg Polytechn Univ, St Petersburg, Russia; [Nizhnikov, Anton A.] Russian Acad Sci, Vavilov Inst Gen Gene, St Petersburg Branch, St Petersburg, Russia	Saint Petersburg State University; Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University; Russian Academy of Sciences	Nizhnikov, AA (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia.; Nizhnikov, AA (corresponding author), ARRIAM, Lab Prote Supra Organismal Syst, St Petersburg, Russia.; Nizhnikov, AA (corresponding author), Russian Acad Sci, Vavilov Inst Gen Gene, St Petersburg Branch, St Petersburg, Russia.	ant.nizhnikov@gmail.com	Antonets, Kirill/C-5593-2014; Bondarev, Stanislav/AAD-5124-2022; Kuznetsova, Irina M./R-9844-2017; Belousov, Mikhail V./K-6017-2014; Kosolapova, Anastasiia O/B-4682-2019; Sulatskaya, Anna/I-6042-2014; Sulatsky, Maksim/AAE-9008-2021; Nizhnikov, Anton A./H-9983-2013	Antonets, Kirill/0000-0002-8575-2601; Bondarev, Stanislav/0000-0003-3137-944X; Kuznetsova, Irina M./0000-0002-3336-4834; Belousov, Mikhail V./0000-0002-7856-9075; Kosolapova, Anastasiia O/0000-0003-1674-8809; Sulatskaya, Anna/0000-0002-1207-3384; Sulatsky, Maksim/0000-0003-4665-3181; Nizhnikov, Anton A./0000-0002-8338-3494	Russian Foundation for Basic Research [16-34-60153]; Russian Federation [MK-3240.2017.4, MK-512.2017.4]; St. Petersburg State University [1.37.291.2015]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); St. Petersburg State University	This work was supported by the Russian Foundation for Basic Research (16-34-60153 to AAN), http://www.rfbr.ru/rffi/ru/, and the Grants of the President of the Russian Federation (MK-3240.2017.4 to AAN, MK-512.2017.4 to MVB), https://grants.extech.ru/. We are grateful to St. Petersburg State University for a grant (1.37.291.2015 to GAZ), http://spbu.ru/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Antonets KS, 2016, BIOCHEMISTRY-MOSCOW+, V81, P34, DOI 10.1134/S0006297916010041; Antonets KS, 2013, EVOL BIOINFORM, V9, P263, DOI 10.4137/EBO.S12299; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bavdek A, 2012, FEBS J, V279, P126, DOI 10.1111/j.1742-4658.2011.08405.x; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; Carneiro KMM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23105; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Danoff EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132301; Divry P, 1927, SOC BIOL, P1808; Dueholm MS, 2015, J BIOL CHEM, V290, P20590, DOI 10.1074/jbc.M115.654780; Fonin AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103878; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hung C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086009; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Kuznetsova IM, 2016, ANAL CHEM, V88, P718, DOI 10.1021/acs.analchem.5b02747; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Luo QW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003446; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Nizhnikov AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006504; Nizhnikov AA, 2016, PRION, V10, P182, DOI 10.1080/19336896.2016.1181253; Nizhnikov AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116003; O'Connor D. V., 1984, TIME CORRELATED SING; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Rajan JJS, 2016, BIOTECHNOL LETT, V38, P689, DOI 10.1007/s10529-015-2025-8; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Serio TR, 1999, METHOD ENZYMOL, V309, P649; Shahnawaz M, 2012, J BIOL CHEM, V287, P11665, DOI 10.1074/jbc.M111.282533; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Sivanathan V, 2013, NAT PROTOC, V8, P1381, DOI 10.1038/nprot.2013.081; Sivanathan V, 2012, GENE DEV, V26, P2659, DOI 10.1101/gad.205310.112; Strozen TG, 2012, INFECT IMMUN, V80, P2608, DOI 10.1128/IAI.06394-11; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Syed AK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00401; Tapader R, 2017, MICROB PATHOGENESIS, V105, P96, DOI 10.1016/j.micpath.2017.02.020; Tapader R, 2016, INT J MED MICROBIOL, V306, P554, DOI 10.1016/j.ijmm.2016.06.003; TINOCO I, 1980, ANNU REV BIOPHYS BIO, V9, P107, DOI 10.1146/annurev.bb.09.060180.000543	58	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191317	10.1371/journal.pone.0191317	http://dx.doi.org/10.1371/journal.pone.0191317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381728	Green Published, gold			2022-12-26	WOS:000423617800017
J	Abur, D; Lester-Smith, RA; Daliri, A; Lupiani, AA; Guenther, FH; Stepp, CE				Abur, Defne; Lester-Smith, Rosemary A.; Daliri, Ayoub; Lupiani, Ashling A.; Guenther, Frank H.; Stepp, Cara E.			Sensorimotor adaptation of voice fundamental frequency in Parkinson's disease	PLOS ONE			English	Article							AUDITORY-MOTOR REPRESENTATIONS; VISUOMOTOR ADAPTATION; SOMATOSENSORY FEEDBACK; SPEECH PRODUCTION; PITCH FEEDBACK; NEURAL-CONTROL; LEVODOPA; DISCRIMINATION; SPEAKERS; TIME	Objective This study examined adaptive responses to auditory perturbation of fundamental frequency (f(o)) in speakers with Parkinson's disease (PD) and control speakers. Method Sixteen speakers with PD and nineteen control speakers produced sustained vowels while they received perturbed auditory feedback (i.e., fo shifted upward or downward). Speakers' pitch acuity was quantified using a just-noticeable-difference (JND) paradigm. Twelve listeners provided estimates of the speech intelligibility for speakers with PD. Results Fifteen responses from each speaker group for each shift direction were included in analyses. While control speakers generally showed consistent adaptive responses opposing the perturbation, speakers with PD showed no compensation on average, with individual PD speakers showing highly variable responses. In the PD group, the degree of compensation was not significantly correlated with age, disease progression, pitch acuity, or intelligibility. Conclusions These findings indicate reduced adaptation to sustained f(o) perturbation and higher variability in PD compared to control participants. No significant differences were seen in pitch acuity between groups, suggesting that the fo adaptation deficit in PD is not the result of purely perceptual mechanisms.	[Abur, Defne; Lester-Smith, Rosemary A.; Daliri, Ayoub; Lupiani, Ashling A.; Guenther, Frank H.; Stepp, Cara E.] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Guenther, Frank H.; Stepp, Cara E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Stepp, Cara E.] Boston Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Stepp, CE (corresponding author), Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA.; Stepp, CE (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Stepp, CE (corresponding author), Boston Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Boston, MA 02215 USA.	cstepp@bu.edu	Daliri, Ayoub/AAM-5004-2020; Stepp, Cara/AAQ-6425-2020	Daliri, Ayoub/0000-0003-3793-2947; Lester-Smith, Rosemary/0000-0002-9111-7399; Stepp, Cara/0000-0002-8045-252X	National Institute on Deafness and Other Communication Disorders [DC015570, DC002852, DC007683, DC004663]; Boston Rehabilitation Outcomes Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD065688]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007683, R01DC002852] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Boston Rehabilitation Outcomes Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants DC015570 (CES), DC002852 (FHG), DC007683 (FHG), and DC004663 from the National Institute on Deafness and Other Communication Disorders (NIDCD; https://www.nidcd.nih.gov/) and a pilot grant from the Boston Rehabilitation Outcomes Center, supported by grant HD065688 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2015, J SPEECH LANG HEAR R, V58, P1134, DOI 10.1044/2015_JSLHR-S-14-0243; Ballard CG, 2002, NEUROLOGY, V59, P1714, DOI 10.1212/01.WNL.0000036908.39696.FD; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Banai Karen, 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P209; Bowen Leah K, 2013, J Med Speech Lang Pathol, V21, P235; BROWN RG, 1991, BRAIN, V114, P215; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Burnett TA, 2002, J ACOUST SOC AM, V112, P1058, DOI 10.1121/1.1487844; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Cai S., 2008, P 8 ISSP, P65; Canter G. J., 1963, J SPEECH HEARING DIS; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chen X, 2013, BRAIN RES, V1527, P99, DOI 10.1016/j.brainres.2013.06.030; CONTIN M, 1994, NEUROLOGY, V44, P1287, DOI 10.1212/WNL.44.7.1287; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; CORNELISSE LE, 1991, EAR HEARING, V12, P47, DOI 10.1097/00003446-199102000-00006; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Duffy J. R., 2013, MOTOR SPEECH DISORDE; Dujardin K, 2013, PARKINSONISM RELAT D, V19, P300, DOI 10.1016/j.parkreldis.2012.11.001; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Feng YQ, 2011, J NEUROPHYSIOL, V106, P667, DOI 10.1152/jn.00638.2010; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Fox C, 1997, AM J SPEECH-LANG PAT, V6, P85, DOI DOI 10.1044/1058-0360.0602.85; Fox CM, 2002, AM J SPEECH-LANG PAT, V11, P111, DOI 10.1044/1058-0360(2002/012); Fucetola R, 1997, ACTA PSYCHOL, V95, P255, DOI 10.1016/S0001-6918(96)00043-1; Garcia JM, 1998, J SPEECH LANG HEAR R, V41, P1282, DOI 10.1044/jslhr.4106.1282; Goberman A, 2002, J COMMUN DISORD, V35, P217, DOI 10.1016/S0021-9924(01)00072-7; Goberman AM, 2005, J MED SPEECH-LANG PA, V13, P51; Goberman AM, 2005, J COMMUN DISORD, V38, P215, DOI 10.1016/j.jcomdis.2004.10.001; Goetz CG, 2000, MOVEMENT DISORD, V15, P479, DOI 10.1002/1531-8257(200005)15:3<479::AID-MDS1009>3.0.CO;2-P; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Guenther F. H., 2016, NEURAL CONTROL SPEEC; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; HIXON TJ, 1971, J ACOUST SOC AM, V49, P105, DOI 10.1121/1.1975555; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Huang XY, 2016, HUM BRAIN MAPP, V37, P4248, DOI 10.1002/hbm.23306; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Humbert IA, 2013, DYSPHAGIA, V28, P1, DOI 10.1007/s00455-012-9432-y; Hustad KC, 2003, J SPEECH LANG HEAR R, V46, P462, DOI 10.1044/1092-4388(2003/038); Jaywant A, 2010, J INT NEUROPSYCH SOC, V16, P49, DOI 10.1017/S1355617709990919; JESTEADT W, 1977, J ACOUST SOC AM, V61, P169, DOI 10.1121/1.381278; Jiang J, 1999, LARYNGOSCOPE, V109, P1287, DOI 10.1097/00005537-199908000-00019; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Jones JA, 2002, J PHONETICS, V30, P303, DOI 10.1006/jpho.2001.0160; Jones JA, 2008, EXP BRAIN RES, V190, P279, DOI 10.1007/s00221-008-1473-y; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Keough D, 2009, J ACOUST SOC AM, V126, P837, DOI 10.1121/1.3158600; Kiran S, 2001, J SPEECH LANG HEAR R, V44, P975, DOI 10.1044/1092-4388(2001/076); Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kishore A, 2012, BRAIN; Klawans H L, 1986, Mov Disord, V1, P187, DOI 10.1002/mds.870010304; KLOCKGETHER T, 1994, MOVEMENT DISORD, V9, P48, DOI 10.1002/mds.870090108; Lametti DR, 2012, J NEUROSCI, V32, P9351, DOI 10.1523/JNEUROSCI.0404-12.2012; Lane H, 1995, J ACOUST SOC AM, V98, P3096, DOI 10.1121/1.413798; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Larson CR, 2001, J ACOUST SOC AM, V110, P2845, DOI 10.1121/1.1417527; Lee S-H, 2017, J VOICE; LESSER RP, 1979, NEUROLOGY, V29, P1253, DOI 10.1212/WNL.29.9_Part_1.1253; Liu H, 2012, PUBLIC LIB SCI ONE, V7; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Macmillan N. A., 2004, DETECTION THEORY USE, P269; Max L, 2015, NEUROSCI LETT, V591, P25, DOI 10.1016/j.neulet.2015.02.012; McNamara P, 2003, BRAIN LANG, V84, P414, DOI 10.1016/S0093-934X(02)00558-8; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mollaei, 2016, BRAIN RES; Mollaei F, 2013, MOVEMENT DISORD, V28, P1668, DOI 10.1002/mds.25588; Mongeon D, 2013, BRAIN COGNITION, V81, P271, DOI 10.1016/j.bandc.2012.12.001; MONRADKROHN GH, 1947, BRAIN, V70, P405, DOI 10.1093/brain/70.4.405; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Munhall KG, 2009, J ACOUST SOC AM, V125, P384, DOI 10.1121/1.3035829; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Niethammer M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009274; Paquet F, 2008, EXP BRAIN RES, V185, P227, DOI 10.1007/s00221-007-1147-1; Patel R, 2011, J SPEECH LANG HEAR R, V54, P1051, DOI 10.1044/1092-4388(2010/10-0162); PEKKONEN E, 1994, NEUROREPORT, V5, P2537, DOI 10.1097/00001756-199412000-00033; Pell MD, 2006, BRAIN LANG, V97, P123, DOI 10.1016/j.bandl.2005.08.010; Perkell JS, 2007, J ACOUST SOC AM, V121, P2296, DOI 10.1121/1.2642349; Perkell JS, 2000, J PHONETICS, V28, P233, DOI 10.1006/jpho.2000.0116; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; Rickards C, 1997, BRAIN, V120, P977, DOI 10.1093/brain/120.6.977; Robertson EM, 1999, NEUROREPORT, V10, P1029, DOI 10.1097/00001756-199904060-00025; Rosenblith Walter A., 1953, HDB ACOUSTIC NOISE C, V2; Sanabria J, 2001, CLIN NEUROPHARMACOL, V24, P99, DOI 10.1097/00002826-200103000-00006; Scheerer, 2015, J NEUROPHYSIOL; Scheerer NE, 2012, NEUROSCI LETT, V529, P128, DOI 10.1016/j.neulet.2012.09.012; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; SCHOW RL, 1991, EAR HEARING, V12, P337, DOI 10.1097/00003446-199110000-00006; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Skodda S, 2012, PUBLIC LIB SCI ONE, V7; Skodda S, 2011, J VOICE, V25, pE199, DOI 10.1016/j.jvoice.2010.04.007; Skodda S, 2009, MOVEMENT DISORD, V24, P716, DOI 10.1002/mds.22430; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; STERN Y, 1984, J NEUROL NEUROSUR PS, V47, P983, DOI 10.1136/jnnp.47.9.983; Stuart A, 2002, J ACOUST SOC AM, V111, P2237, DOI 10.1121/1.1466868; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Troche J, 2012, AM J SPEECH-LANG PAT, V21, P258, DOI 10.1044/1058-0360(2012/11-0007); Tumber AK, 2014, PUBLIC LIB SCI ONE, V9; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116; Venkatakrishnan A, 2011, HUM MOVEMENT SCI, V30, P760, DOI 10.1016/j.humov.2010.08.020; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Woodward TS, 2002, NEUROPSYCHOLOGIA, V40, P1948, DOI 10.1016/S0028-3932(02)00068-4; Yorkson KM, 2007, SPEECH INTELLIGIBILI	114	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191839	10.1371/journal.pone.0191839	http://dx.doi.org/10.1371/journal.pone.0191839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8TF	29373589	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400027
J	Sanchez-Lopez, J; Silva-Pereyra, J; Fernandez, T; Alatorre-Cruz, GC; Castro-Chavira, SA; Gonzalez-Lopez, M; Sanchez-Moguel, SM				Sanchez-Lopez, Javier; Silva-Pereyra, Juan; Fernandez, Thalia; Alatorre-Cruz, Graciela C.; Castro-Chavira, Susana A.; Gonzalez-Lopez, Mauricio; Sanchez-Moguel, Sergio M.			High levels of incidental physical activity are positively associated with cognition and EEG activity in aging	PLOS ONE			English	Article							HEALTHY OLDER-ADULTS; RESISTANCE-EXERCISE; CARDIORESPIRATORY FITNESS; ALZHEIMERS-DISEASE; ELDERLY SUBJECTS; BRAIN VOLUME; LIFE-STYLE; DEMENTIA; DECLINE; ELECTROENCEPHALOGRAM	High levels of physical activity seem to positively influence health and cognition across the lifespan. Several studies have found that aerobic exercise enhances cognition and likely prevents cognitive decline in the elderly. Nevertheless, the association of incidental physical activity (IPA) with health and cognition during aging has not been studied. Thus, the aim of this study was to evaluate the association of IPA level with cognitive functions and resting electroencephalogram (EEG) in healthy old participants. Participants (n = 97) with normal scores on psychometric and neuropsychological tests and normal values in blood analyses were included. A cluster analysis based on the scores of the Yale Physical Activity Scale (YPAS) allowed the formation of two groups: active, with high levels of IPA, and passive, with low levels of IPA. Eyes-closed resting EEG was recorded from the participants; the fast Fourier transform was used offline to calculate absolute power (AP), relative power (RP), and mean frequency (MF) measures. There were no differences in socioeconomic status, cognitive reserve, general cognitive status, or lipid and TSH profiles between the groups. The results of cognitive tests revealed significant differences in the performance variables of the WAIS scores (p =.015), with advantages for the active group. The resting EEG exhibited significantly slower activity involving the frontal, central, and temporal regions in the passive group (p <.05). Specifically, higher delta RP (F7, T3), lower delta MF (F4, C4, T4, T6, Fz, Cz), higher theta AP (C4), higher theta RP (F4, C4, T3, Fz), lower alpha AP (F3, F7, T3), lower alpha RP (F7), and lower total MF (F3, F7, T3, T5, Fz) were found. Altogether, these results suggest that IPA induces a neuroprotective effect, which is reflected both in behavioral and electrophysiological variables during aging.	[Sanchez-Lopez, Javier; Fernandez, Thalia; Alatorre-Cruz, Graciela C.; Castro-Chavira, Susana A.; Gonzalez-Lopez, Mauricio; Sanchez-Moguel, Sergio M.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico; [Sanchez-Lopez, Javier] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Silva-Pereyra, Juan; Alatorre-Cruz, Graciela C.] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, Estado De Mexic, Mexico; [Castro-Chavira, Susana A.] Norges Arktiske Univ, Univ Tromso, Helsevitenskapelige Fak, Inst Psykol, Tromso, Norway; [Sanchez-Moguel, Sergio M.] Univ Autonoma Estado Hidalgo, Escuela Super Atotonilco Tula, Hidalgo, Mexico	Universidad Nacional Autonoma de Mexico; University of Verona; Universidad Nacional Autonoma de Mexico; UiT The Arctic University of Tromso; Universidad Autonoma del Estado de Hidalgo	Fernandez, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico.	thaliafh@yahoo.com.mx	Sanchez-Lopez, Javier/AAD-2006-2019; Alatorre-Cruz, Graciela C./ABS-1760-2022; Fernandez, Thalia/AGI-6073-2022; Castro-Chavira, Susana A/C-3465-2019; González-López, Mauricio/AAO-2810-2021; Alatorre-Cruz, Graciela C./AAF-5001-2022; Castro-Chavira, Susana A./AAD-5347-2019	Sanchez-Lopez, Javier/0000-0002-4291-0315; Castro-Chavira, Susana A/0000-0002-1117-6605; González-López, Mauricio/0000-0001-8256-9636; Alatorre Cruz, Graciela Catalina/0000-0003-4455-530X; Silva-Pereyra, Juan/0000-0002-2982-1457	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General de Asuntos del Personal Academico (DGAPA) [IN225414, IN200817]; Universidad Nacional Autonoma de Mexico (UNAM)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	This work was supported by grants IN225414 and IN200817 from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadizad S, 2005, J SPORT SCI, V23, P243, DOI 10.1080/02640410410001730151; Barnes DE, 2003, J AM GERIATR SOC, V51, P459, DOI 10.1046/j.1532-5415.2003.51153.x; Best JR, 2015, J INT NEUROPSYCH SOC, V21, P745, DOI 10.1017/S1355617715000673; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; BUCCOLA VA, 1975, RES QUART, V46, P134, DOI 10.1080/10671315.1975.10615315; Castro-Chavira SA, 2016, NEUROREPORT, V27, P710, DOI 10.1097/WNR.0000000000000602; Chang YK, 2012, J AGING PHYS ACTIV, V20, P497, DOI 10.1123/japa.20.4.497; Cho SH, 2017, ARCH GERONTOL GERIAT, V70, P141, DOI 10.1016/j.archger.2017.01.011; Chu CH, 2015, PSYCHOL AGING, V30, P842, DOI 10.1037/pag0000047; COBEN LA, 1990, ELECTROEN CLIN NEURO, V75, P148, DOI 10.1016/0013-4694(90)90168-J; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; De Abajo S, 2001, J SPORT MED PHYS FIT, V41, P479; Donaire-Gonzalez D, 2011, ARCH BRONCONEUMOL, V47, P552, DOI 10.1016/j.arbres.2011.07.002; Eggenberger P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00066; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Frantzidis CA, 2014, INT J PSYCHOPHYSIOL, V93, P1, DOI 10.1016/j.ijpsycho.2014.01.007; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gajewski PD, 2016, EUR REV AGING PHYS A, V13, DOI 10.1186/s11556-016-0161-3; Galan L, 1997, ELECTROEN CLIN NEURO, V102, P240, DOI 10.1016/S0013-4694(96)95155-3; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; GIAQUINTO S, 1986, ELECTROEN CLIN NEURO, V63, P540, DOI 10.1016/0013-4694(86)90141-0; Hernandez J L, 1994, Int J Neurosci, V76, P267; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Ikudome S., 2016, J APPL GERONTOL; Instituto Nacional de Estadistica y Geografia (INEGI), 2016, MOD PRACT DEP EJ FIS; John E.R., 1987, HDB ELECTROENCEPHALO, VVolume I, P449; Katz JN, 2014, BMC MUSCULOSKEL DIS, V15, P1471; Kirk-Sanchez NJ, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S39506; Lardon MT, 1996, BIOL PSYCHOL, V44, P19, DOI 10.1016/S0301-0511(96)05198-8; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Monteiro RS, 2016, NEURAL REGEN RES, V11, P201, DOI 10.4103/1673-5374.177709; Moraes H, 2011, EUR J APPL PHYSIOL, V111, P67, DOI 10.1007/s00421-010-1627-z; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Otero GA, 1997, ELECTROEN CLIN NEURO, V102, P512, DOI 10.1016/S0013-4694(97)95213-9; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; PRICHEP LS, 1994, NEUROBIOL AGING, V15, P85, DOI 10.1016/0197-4580(94)90147-3; Prichep LS, 2006, NEUROBIOL AGING, V27, P471, DOI 10.1016/j.neurobiolaging.2005.07.021; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Roca-Stappung M, 2012, NEUROSCI LETT, V510, P115, DOI 10.1016/j.neulet.2012.01.015; Ross R, 2011, MED SCI SPORT EXER, V43, P2189, DOI 10.1249/MSS.0b013e31821e4ff2; Savela Salla, 2015, Duodecim, V131, P1719; Schomer D. L, 2011, NIEDERMEYERS ELECTRO; Smiley-Oyen AL, 2008, ANN BEHAV MED, V36, P280, DOI 10.1007/s12160-008-9064-5; Smolarek AD, 2016, CLIN INTERV AGING, V11, P749, DOI 10.2147/CIA.S102126; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Styliadis C, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/172192; TORRES F, 1983, ELECTROEN CLIN NEURO, V56, P391, DOI 10.1016/0013-4694(83)90220-1; U. S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; VALDES P, 1992, Brain Topography, V4, P259, DOI 10.1007/BF01135563; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Viru?s T., 1990, BRAIN TOPOGRAPHY, V3, P281; Vogt T, 2010, NEUROSCI LETT, V485, P134, DOI 10.1016/j.neulet.2010.09.001; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler D., 2003, ESCALA WECHSLER INTE; Woo M, 2009, INT J PSYCHOPHYSIOL, V72, P166, DOI 10.1016/j.ijpsycho.2008.12.003; Yu JT, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.02	62	19	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191561	10.1371/journal.pone.0191561	http://dx.doi.org/10.1371/journal.pone.0191561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370215	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600063
J	Davey, DLJ; Wall, KM; Kilembe, W; Khu, NH; Brill, I; Vwalika, B; Chomba, E; Mulenga, J; Tichacek, A; Gorbach, PM; Allen, S				Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Chomba, Elwyn; Mulenga, Joseph; Tichacek, Amanda; Gorbach, Pamina M.; Allen, Susan			Difficult decisions: Evaluating individual and couple-level fertility intentions and HIV acquisition among HIV serodiscordant couples in Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; DISCORDANT COUPLES; POSITIVE WOMEN; ANTIRETROVIRAL THERAPY; GENITAL INFLAMMATION; SOUTH-AFRICA; HEALTH-CARE; RISK; TRANSMISSION	Introduction Attempts to conceive and pregnancy may increase HIV transmission to sex partners and infants. Our study evaluated the association between fertility intentions and HIV acquisition among Zambian HIV-serodiscordant couples. Methods We collected demographic, behavioral, clinical exposures, and data on fertility intentions in a cohort of HIV-serodiscordant couples in Lusaka, Zambia from 2005 to 2012. We evaluated factors associated with fertility intentions stratified by gender using multivariable logistic regression. Multivariable Cox proportional hazard models were used to evaluate the associations between fertility intentions and HIV acquisition controlling for a priori confounders and covariates that substantially (> 10%) changed the effect estimates in univariate analyses. Results Among 1,029 serodiscordant couples, 311 agreed that they wanted children in the future (30%), 368 agreed they did not want children (36%), and 344 couples disagreed about having children (34%), with men more likely than women to want children. Women wanting child (ren) was associated with increased odds of baseline pregnancy (adjusted odds ratio [aOR] = 4.80 (95% confidence interval [CI] = 2.93, 7.85)), fewer previous pregnancies (aOR = 0.85 per additional pregnancy (95% CI = 0.78, 0.93)), and partner fertility intention (aOR = 2.89 (95% CI = 2.14, 3.91)) adjusting for woman's age, literacy, years cohabiting and HIV status. Men wanting child(ren) was associated with younger age (aOR = 0.96 per year (95% CI = 0.93, 0.99)), fewer years cohabiting (aOR = 0.95 (95% CI = 0.92, 0.98)), number of previous partners' pregnancies (aOR = 0.90 (95% CI = 0.82, 0.98)), and partner fertility intention (aOR = 3.00 (95% CI = 2.21, 4.07)) adjusting for partner's age, literacy, HIV status and partner's baseline pregnancy. In adjusted survival analyses, HIV-negative women were more likely to seroconvert if they themselves wanted children (aHR = 2.36 (95% CI = 1.41, 3.96)) vs. did not want children, or if their partner wanted children (aHR = 2.34 (95% CI = 1.33, 4.11)) vs. did not want children, or if the couple agreed that they wanted children (aHR = 2.08 (95% CI = 1.01, 4.30)), adjusting for women's age, women's literacy, previous pregnancies and time in study. HIV-negative men were more likely to seroconvert if their female partner wanted a child in the next 12-months (aHR = 1.94 (95% CI = 1.02, 3.68)) vs. did not want children, and when both partners wanted children (aHR = 2.02 (CI = 1.09, 3.73)) vs. they did not want children, adjusting for men's age and literacy, couple income, number of live children, male circumcision status and time in study. Conclusion Women had increased risk of HIV acquisition if they and/or their partner wanted a child, while men had increased risk of HIV acquisition when their partner or if both partners agreed that they wanted children. Safer-conception interventions are needed to protect HIV uninfected women and men from HIV acquisition in HIV-serodiscordant couples who want children.	[Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Mulenga, Joseph; Tichacek, Amanda; Allen, Susan] Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA; [Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Mulenga, Joseph; Tichacek, Amanda; Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Davey, Dvora Leah Joseph; Gorbach, Pamina M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Davey, Dvora Leah Joseph] Univ Cape Town, Sch Publ Hlth & Family Med, Dept Biostat & Epidemiol, Cape Town, South Africa; [Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Laney Grad Sch, Atlanta, GA 30322 USA; [Brill, Ilene] Univ Alabama Birmingham, Ryals Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Vwalika, Bellington] Univ Zambia, Sch Med, Dept Gynecol & Obstet, Lusaka, Zambia; [Chomba, Elwyn] Univ Zambia, Sch Med, Dept Pediat, Lusaka, Zambia	Emory University; Emory University; Rollins School Public Health; University of California System; University of California Los Angeles; University of Cape Town; Emory University; Rollins School Public Health; University of Alabama System; University of Alabama Birmingham; University of Zambia; University of Zambia	Davey, DLJ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA.; Davey, DLJ (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.; Davey, DLJ (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.; Davey, DLJ (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Dept Biostat & Epidemiol, Cape Town, South Africa.	dvoradavey@ucla.edu		Joseph-Davey, Dvora/0000-0001-6290-9293	National Institute of Child Health and Development [NICHD RO1 HD40125]; National Institute of Mental Health [NIMH R01 66767]; AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; Emory Center for AIDS Research [P30 AI050409]; National Institute of Allergy and Infectious Diseases [NIAID R01 AI51231, NIAID R01 AI040951, NIAID R01 AI023980, NIAID R01 AI64060, NIAID R37 AI51231]; US Centers for Disease Control and Prevention [5U2GPS000758]; International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID);  [NIH-NIAID-T32DA023356];  [NIH/FIC R25TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS000758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040951, R37AI051231, R01AI023980, R01AI064060, R01AI051231, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634, R01MH066767] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Emory Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Child Health and Development (NICHD RO1 HD40125); National Institute of Mental Health (NIMH R01 66767); the AIDS International Training and Research Program Fogarty International Center (D43 TW001042); the Emory Center for AIDS Research (P30 AI050409); National Institute of Allergy and Infectious Diseases (NIAID R01 AI51231; NIAID R01 AI040951; NIAID R01 AI023980; NIAID R01 AI64060; NIAID R37 AI51231); the US Centers for Disease Control and Prevention (5U2GPS000758); and the International AIDS Vaccine Initiative. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. Co-authors were funded in part by all fund sources at one time or another, except for the lead author. Dr. Joseph Davey had funding support, including salary from NIH-NIAID-T32DA023356 and NIH/FIC R25TW009340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Berhan Y., BMC PUBLIC HLTH, V13, P409; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Brown J, 2016, AIDS EDUC PREV, V28, P524, DOI 10.1521/aeap.2016.28.6.524; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; Chetty T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1421-6; Cook R, 2014, CULT HEALTH SEX, V16, P741, DOI 10.1080/13691058.2014.902103; Demissie DB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0382-2; Fiore JR, 2005, FERTIL STERIL, V84, P232, DOI 10.1016/j.fertnstert.2004.12.060; Keating MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039109; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kendall T, 2014, JAIDS-J ACQ IMM DEF, V67, pS169, DOI 10.1097/QAI.0000000000000382; Khu NH, 2013, CONTRACEPTION, V88, P74, DOI 10.1016/j.contraception.2012.10.004; Kinuthia J, 2010, CURR HIV RES, V8, P510, DOI 10.2174/157016210793499213; Mantell JE, 2014, JAIDS-J ACQ IMM DEF, V67, pS202, DOI 10.1097/QAI.0000000000000369; Marston M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082219; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Melka AS, 2014, AFR J REPROD HEALTH, V18, P54; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Savasi V, 2013, HUM REPROD UPDATE, V19, P136, DOI 10.1093/humupd/dms046; Schaan MM, 2012, AIDS CARE, V24, P1120, DOI 10.1080/09540121.2012.672814; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schwartz SR, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21291; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Schwartz SR, 2015, INT J STD AIDS; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; UNAIDS, 2013, REP GLOB AIDS EP; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127; Wall KM, 2017, INT J EPIDEMIOL, V46, P1593, DOI 10.1093/ije/dyx045; Wall KM, 2017, SEX TRANSM INFECT, V93, P259, DOI 10.1136/sextrans-2016-052743; Wall KM, 2015, CONTRACEPTION, V91, P480, DOI 10.1016/j.contraception.2015.02.004; Wall KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001171; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189869	10.1371/journal.pone.0189869	http://dx.doi.org/10.1371/journal.pone.0189869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364895	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500006
J	Kang, BK; Kim, JS; Ryun, S; Chung, CK				Kang, Byeong Keun; Kim, June Sic; Ryun, Seokyun; Chung, Chun Kee			Prediction of movement intention using connectivity within motor-related network: An electrocorticography study	PLOS ONE			English	Article							PREFRONTAL CORTEX; GAMMA-OSCILLATIONS; WORKING-MEMORY; POTENTIALS; PREMOTOR; AREAS; GRASP; REACH; TASK; HAND	Most brain-machine interface (BMI) studies have focused only on the active state of which a BMI user performs specific movement tasks. Therefore, models developed for predicting movements were optimized only for the active state. The models may not be suitable in the idle state during resting. This potential maladaptation could lead to a sudden accident or unintended movement resulting from prediction error. Prediction of movement intention is important to develop a more efficient and reasonable BMI system which could be selectively operated depending on the user's intention. Physical movement is performed through the serial change of brain states: idle, planning, execution, and recovery. The motor networks in the primary motor cortex and the dorsolateral prefrontal cortex are involved in these movement states. Neuronal communication differs between the states. Therefore, connectivity may change depending on the states. In this study, we investigated the temporal dynamics of connectivity in dorsolateral prefrontal cortex and primary motor cortex to predict movement intention. Movement intention was successfully predicted by connectivity dynamics which may reflect changes in movement states. Furthermore, dorsolateral prefrontal cortex is crucial in predicting movement intention to which primary motor cortex contributes. These results suggest that brain connectivity is an excellent approach in predicting movement intention.	[Kang, Byeong Keun; Kim, June Sic; Ryun, Seokyun; Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Human Brain Funct Lab, Seoul, South Korea; [Kang, Byeong Keun; Ryun, Seokyun; Chung, Chun Kee] Seoul Natl Univ, Interdisciplinary Program Neurosci, Coll Nat Sci, Seoul, South Korea; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Human Brain Funct Lab, Seoul, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea.	junesic.kim@gmail.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2015R1A2A2A03004026, 2016M3C7A1904984]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was partly supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (grant no. 2015R1A2A2A03004026) to JSK and (grant no. 2016M3C7A1904984) to CKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2015R1A2A2A03004026) and (2016M3C7A1904984)	Aggarwal V, 2013, J NEUROPHYSIOL, V109, P3067, DOI 10.1152/jn.01038.2011; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Benz HL, 2012, IEEE T NEUR SYS REH, V20, P143, DOI 10.1109/TNSRE.2011.2175309; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Bundy DT, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026021; Carmena Jose M, 2003, PLoS Biol, V1, pE42; Cheyne D, 2008, NEUROIMAGE, V42, P332, DOI 10.1016/j.neuroimage.2008.04.178; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crone NE, 2011, INT J PSYCHOPHYSIOL, V79, P9, DOI 10.1016/j.ijpsycho.2010.10.013; Flamary R, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00029; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kim K, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00180; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Muralidharan A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046003; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pistohl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054658; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Senkowski D, 2015, BIOL PSYCHIAT, V77, P1010, DOI 10.1016/j.biopsych.2015.02.034; Shannon CE, 1949, THE MATHEMATICAL THE; Spuler M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/066008; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Velliste M, 2014, J NEUROSCI, V34, P6011, DOI 10.1523/JNEUROSCI.3520-13.2014; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062789; Wang Zuoguan, 2012, Front Neuroeng, V5, P15, DOI 10.3389/fneng.2012.00015; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yeom HG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026006; Zhang HJ, 2010, IEEE ENG MED BIO, P130, DOI 10.1109/IEMBS.2010.5627179	44	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191480	10.1371/journal.pone.0191480	http://dx.doi.org/10.1371/journal.pone.0191480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364932	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500051
J	Sala, A; Cabassi, CS; Santospirito, D; Polverini, E; Flisi, S; Cavirani, S; Taddei, S				Sala, Andrea; Cabassi, Clotilde Silvia; Santospirito, Davide; Polverini, Eugenia; Flisi, Sara; Cavirani, Sandro; Taddei, Simone			Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; PSEUDOMONAS-AERUGINOSA; MEMBRANE INTERACTIONS; LIPID-BILAYERS; MECHANISMS; RESISTANCE; BACTERIA; PATHOGENS; RESIDUES	Naja atra subsp. atra cardiotoxin 1 (CTX-1), produced by Chinese cobra snakes, belonging to Elapidae family, is included in the three-finger toxin family and exerts high cytotoxicity and antimicrobial activity too. Using as template mainly the tip and the subsequent beta-strand of the first "finger" of this toxin, different sequences of 20 amino acids linear peptides have been designed in order to avoid toxic effects but to maintain or even strengthen the partial antimicrobial activity already seen for the complete toxin. As a result, the sequence NCP-0 (Naja Cardiotoxin Peptide-0) was designed as ancestor and subsequently 4 other variant sequences of NCP-0 were developed. These synthesized variant sequences have shown microbicidal activity towards a panel of reference and field strains of Gram-positive and Gram-negative bacteria. The sequence named NCP-3, and its variants NCP-3a and NCP-3b, have shown the best antimicrobial activity, together with low cytotoxicity against eukaryotic cells and low hemolytic activity. Bactericidal activity has been demonstrated by minimum bactericidal concentration (MBC) assay at values below 10 mu g/ml for most of the tested bacterial strains. This potent antimicrobial activity was confirmed even for unicellular fungi Candida albicans, Candida glabrata and Malassezia pachydermatis (MBC 50-6.3 mu g/ml), and against the fast-growing mycobacteria Mycobacterium smegmatis and Mycobacterium fortuitum. Moreover, NCP-3 has shown virucidal activity on Bovine Herpesvirus 1 (BoHV1) belonging to Herpesviridae family. The bactericidal activity is maintained even in a high salt concentration medium (125 and 250 mM NaCl) and phosphate buffer with 20% Mueller Hinton (MH) medium against E. coli, methicillin resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa reference strains. Considering these in vitro obtained data, the search for active sequences within proteins presenting an intrinsic microbicidal activity could provide a new way for discovering a large number of novel and promising antimicrobial peptides families.	[Sala, Andrea; Cabassi, Clotilde Silvia; Santospirito, Davide; Flisi, Sara; Cavirani, Sandro; Taddei, Simone] Univ Parma, Dept Vet Sci, Parma, Italy; [Polverini, Eugenia] Univ Parma, Dept Math Phys & Comp Sci, Parma, Italy	University of Parma; University of Parma	Cabassi, CS (corresponding author), Univ Parma, Dept Vet Sci, Parma, Italy.	clotildesilvia.cabassi@unipr.it		Cabassi, Clotilde Silvia/0000-0002-1936-9858				Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Autelitano DJ, 2006, DRUG DISCOV TODAY, V11, P306, DOI 10.1016/j.drudis.2006.02.003; Bates IR, 2003, J BIOL CHEM, V278, P29041, DOI 10.1074/jbc.M302766200; Ben Ghorbal SK, 2013, CURR MICROBIOL, V67, P112, DOI 10.1007/s00284-013-0342-5; Bi X, 2013, J APPL MICROBIOL, V115, P663, DOI 10.1111/jam.12262; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cabassi CS, 2015, PAK VET J, V35, P522; Chen LW, 2011, TOXICON, V58, P46, DOI 10.1016/j.toxicon.2011.04.021; Chia CSB, 2002, FEBS LETT, V512, P47, DOI 10.1016/S0014-5793(01)03313-0; Dubovskii PV, 2015, CELL MOL LIFE SCI, V72, P4501, DOI 10.1007/s00018-015-2016-x; DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519; Efremov RG, 2002, BIOPHYS J, V83, P144, DOI 10.1016/S0006-3495(02)75156-4; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Francey T, 2000, J VET INTERN MED, V14, P177, DOI 10.1892/0891-6640(2000)014&lt;0177:TROBAA&gt;2.3.CO;2; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gautam A, 2015, METHODS MOL BIOL, V1324, P59, DOI 10.1007/978-1-4939-2806-4_4; Gofman Y, 2012, NUCLEIC ACIDS RES, V40, pW358, DOI 10.1093/nar/gks577; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Gorai B, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3113-y; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARVEY AL, 1982, TOXICON, V20, P379, DOI 10.1016/0041-0101(82)90001-0; Hiemstra P. S., 2013, ANTIMICROBIAL PEPTID; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Khandelia H, 2006, PEPTIDES, V27, P1192, DOI 10.1016/j.peptides.2005.10.022; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Mackessy S.P., 2021, HDB VENOMS TOXINS RE, V2nd; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; Markey B, 2013, CLIN VET MICROBIOLOG, V2nd; Nathan C, 2014, NEW ENGL J MED, V371, P1761, DOI 10.1056/NEJMp1408040; Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Petersen AD, 2002, J AM ANIM HOSP ASSOC, V38, P407, DOI 10.5326/0380407; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Romani AA, 2013, J PEPT SCI, V19, P554, DOI 10.1002/psc.2532; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; Sharma VK, 2015, SOFT MATTER, V11, P6755, DOI 10.1039/c5sm01562f; Slaninova J, 2012, PEPTIDES, V33, P18, DOI 10.1016/j.peptides.2011.11.002; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Watts JL, 2008, CLSI, V3, pM31; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams SC, 1998, J MICROBIOL METH, V32, P225, DOI 10.1016/S0167-7012(98)00014-1; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	59	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190778	10.1371/journal.pone.0190778	http://dx.doi.org/10.1371/journal.pone.0190778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364903	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500023
J	Garcia-Sanjuan, S; Lillo-Crespo, M; Richert-Martinez, M; Sanjuan-Quiles, A				Garcia-Sanjuan, Sofia; Lillo-Crespo, Manuel; Richert-Martinez, Miguel; Sanjuan-Quiles, Angela			Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SOCIAL SUPPORT; OF-LIFE; GASTROENTEROLOGISTS; PERCEPTIONS; MANAGEMENT; PEOPLE; GUIDELINES; NURSES; ROLES	Crohn's Disease (CD) in Spain lacks of a unified National Clinical Pathway and not even any early detection program and professional follow-up outpatient attention once it has been diagnosed. Little is known about the Spanish health professionals' views of the experiences of individuals living with Crohn's Disease nationwide and also about how the Spanish Health System faces this situation. A qualitative research method was conducted to explore this topic through in-depth interviews with eleven healthcare professionals, who represented different clinics treating people with CD from the province of Alicante (Spain). Three topics and seven sub-topics were derived from the analysis of the content emerging from the interviews. The three main topics were: the healthcare system as a hindrance for ongoing treatment of CD, the impact of the disease, support networks. The knowledge of CD gained by healthcare professionals, in the contexts studied here within, with regards to the psychosocial aspects and the experience of those living with the disease and their immediate circles, is poor, if not null on an academic level, becoming experiential on their incorporation into the professional field. Additionally, a priori, they lack the tools to address the doubts and concerns of patients from the moment of diagnosis through the ongoing care of the patient. Organizational hindrances, such as the lack of time and consensual guidelines for adequately monitoring CD patients in Alicante (Spain), further restrict the patient-professional relationship. Due to the consensus established by the National Agency regulating the contents of the Health Professions' Education and Training across the country, we are assuming that the phenomenon highlighted may be similar in other parts of Spain. Therefore, it can be said that healthcare professionals have a limited understanding of the impact of CD on the day-today life of those affected, not being considered a part of the CD patients' formal support network. Nonetheless, they are conscious of this limitation and advocate for multidisciplinary teams as the best means of attending to people living with CD. Our study outcomes may represent the first step onto identifying strategies and best practices for establishing an effective therapeutic relationship, as well as any hindering factors.	[Garcia-Sanjuan, Sofia; Lillo-Crespo, Manuel; Richert-Martinez, Miguel; Sanjuan-Quiles, Angela] Univ Alicante, Hlth Sci Fac, Nursing Dept, San Vicente Del Raspeig, Spain	Universitat d'Alacant	Garcia-Sanjuan, S (corresponding author), Univ Alicante, Hlth Sci Fac, Nursing Dept, San Vicente Del Raspeig, Spain.	sofia.garcia@ua.es	Richert, Maria/T-4989-2018; , sofia/A-4995-2019; LILLO-CRESPO, MANUEL/J-3260-2017	Richert, Maria/0000-0002-2256-4654; , sofia/0000-0001-7985-7864; LILLO-CRESPO, MANUEL/0000-0003-2053-2808	ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER); project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos", State plan I+D+I Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad [704753085-53085-45-514]	ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER); project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos", State plan I+D+I Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad	This study was funded by project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos" (704753085-53085-45-514) integrated into the State plan I+D+I 2013-2016 Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad and co-funded by ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela J.A., 2002, TECNICAS ANALISIS CO; Andreu M, 2014, J CROHNS COLITIS, V8, P234, DOI 10.1016/j.crohns.2013.08.010; Belmartino S., 1987, PRIMERAS JORNADAS AT, P197; Bennett AL, 2015, WORLD J GASTROENTERO, V21, P4457, DOI 10.3748/wjg.v21.i15.4457; Bernabeu-Wittel M, 2014, REV CLIN ESP, V214, P328, DOI 10.1016/j.rce.2014.04.001; Bray J, CAN J GASTROENTEROL; Avila-Morales JC, 2017, IATREIA, V30, P216, DOI 10.17533/udea.iatreia.v30n2a11; Casellas F, 2003, REV ESP ENFERM DIG, V95, P476; Jorda FC, 2012, REV ESP ENFERM DIG, V104, P16, DOI 10.4321/s1130-01082012000100004; Corrales-Nevado D, 2012, GAC SANIT, V26, P63, DOI 10.1016/j.gaceta.2011.09.032; Czuber-Dochan W, 2014, J CROHNS COLITIS, V8, P835, DOI 10.1016/j.crohns.2014.01.004; De la Cuesta Benjumea C., 2001, INDEX ENFERM, V10, P20; De la Salud Asamblea Mundial., 2013, PROYECT PLAN ACC PRE; Dibley L, 2017, J CROHNS COLITIS, V11, P353, DOI 10.1093/ecco-jcc/jjw164; Dickman R, 2011, EUR J GASTROEN HEPAT, V23, P813, DOI 10.1097/MEG.0b013e328348a552; Dolak F, 2014, NEUROENDOCRINOL LETT, V35, P19; Dupuis M, 2009, CAN J GASTROENTEROL, V23, P805, DOI 10.1155/2009/384926; Ernst & Young Global Limited, 2016, ENF INFL INT SIT ACT; Fernandez A, 2015, GASTROENT HEPAT-BARC, V38, P534, DOI 10.1016/j.gastrohep.2015.03.001; Ferrer C, 2012, ESTRATEGIA ABORDAJE; Garcia-Sanjuan S, 2016, SALUD PUBLICA MEXICO, V58, P49, DOI 10.21149/spm.v58i1.7667; Garcia-Sanjuan S, 2016, CLIN NURS RES, V25, P79, DOI 10.1177/1054773814543828; Gassull MA, 2002, ENFERMEDAD INFLAMATO; Guba E, 1994, HDB QUALITATIVE RES, V6, P105; Hernandez AS, 2002, ATEN PRIM, V29, P522; Jelsness-Jorgensen LP, 2011, GASTROENT RES PRACT, V2011, P4920; Lesnovska KP, 2017, J CLIN NURS; Levy S, 2014, EUR J GASTROEN HEPAT, V26, P40, DOI 10.1097/MEG.0b013e328365ac70; Marteau P, 2013, EMC TRATADO MED, V17, P1, DOI DOI 10.1016/S1636-5410(13)65895-X; Martin-De-Carpi J, 2012, INFLAMM BOWEL DIS; Mayberry JF, 2013, ALIMENT PHARM THER, V37, P195, DOI 10.1111/apt.12102; Menendez SR, 2012, MED PROGRAMA FORMACI, V11, P293, DOI DOI 10.1016/S0304-5412(12)70301-3; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moskovitz DN, 2000, DIS COLON RECTUM, V43, P517, DOI 10.1007/BF02237197; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; O'Connor M, 2013, J CROHNS COLITIS, V7, P744, DOI 10.1016/j.crohns.2013.06.004; Paley J, 1997, J ADV NURS, V26, P187, DOI 10.1046/j.1365-2648.1997.1997026187.x; Rabeharisoa V, 2002, REV INT CIENCIAS SOC, P171; Ricci C, 2008, DIGEST LIVER DIS, V40, pS285, DOI 10.1016/S1590-8658(08)60539-3; Rodriguez A., 2006, ARS MED, V12, P95; Sewitch MJ, 2001, AM J GASTROENTEROL, V96, P1470; Subasinghe D, 2010, SINGAP MED J, V51, P484; Sung JJY, 2010, J GASTROEN HEPATOL, V25, P183, DOI 10.1111/j.1440-1746.2009.06024.x; Teja LM., 2006, PERCEPCIONES ENFERMO, V7; Tew GA, 2016, INFLAMM BOWEL DIS, V22, P2933, DOI 10.1097/MIB.0000000000000962; Herrera AT, 2009, GASTROENT HEPAT-BARC, V32, P77, DOI 10.1016/j.gastrohep.2008.09.015; Vaucher C, 2016, SCAND J GASTROENTERO, V51, P1056, DOI 10.3109/00365521.2016.1147065; Vega-Angarita OM., 2011, AQUICHAN, V11; Vega-Angarita OM, 2009, ENFERM GLOB, V16	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190980	10.1371/journal.pone.0190980	http://dx.doi.org/10.1371/journal.pone.0190980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360881	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800013
J	Yang, YJ; Xu, HX; Lu, YH; Wang, CY; Lu, ZX				Yang, Yajun; Xu, Hongxing; Lu, Yanhui; Wang, Caiyun; Lu, Zhongxian			Midgut transcriptomal response of the rice leaffolder, &ITCnaphalocrocis medinalis&IT (Guenee) to Cry1C toxin	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; CNAPHALOCROCIS-MEDINALIS; DELTA-ENDOTOXIN; ALKALINE-PHOSPHATASE; MANDUCA-SEXTA; LEPIDOPTERA-PYRALIDAE; BT RICE; RESISTANCE; RECEPTOR; TRANSPORTER	Cnaphalocrocis medinalis (Guenee) is one of the important insect pests in rice field. Bt agents were recommended in the C. medinalis control and Bt rice is bred as a tactic to control this insect. However, the tolerance or resistance of insect to Bt protein is a main threat to the application of Bt protein. In order to investigate the response of C. medinalis transcriptome in defending a Cry1C toxin, high-through RNA-sequencing was carried in the C. medinalis larvae treated with and without Cry1C toxin. A total of 35,586 high-quality unigenes was annotated in the transcriptome of C. medinalis midgut. The comparative analysis identified 6,966 differently expressed unigenes (DEGs) between the two treatments. GO analysis showed that these genes involved in proteolysis and extracellular region. Among these DEGs, carboxylesterase, glutathione S-transferase and P450 were differently expressed in the treated C. medinalis midgut. Furthermore, trypsin, chymotrypsin, and carboxypeptidase were identified in DEGs, and most of them upregulated. In addition, thirteen ABC transporters were downregulated and three upregulated in Cry1C-treated C. medinalis mid-gut. Based on the pathway analysis, antigen processing and presentation pathway, and chronic myeloid leukemia pathway were significant in C. medinalis treated with Cry1C toxin. These results indicated that serine protease, detoxification enzymes and ABC transporter, antigen processing and presentation pathway, and chronic myeloid leukemia pathway may involved in the response of C. medinalis to Cry1C toxin. This study provides a transcriptomal foundation for the identification and functional characterization of genes involved in the toxicity of Bt Cry protein against C. medinalis, and provides potential clues to the studies on the tolerance or resistance of an agriculturally important insect pest C. medinalis to Cry1C toxin.	[Yang, Yajun; Xu, Hongxing; Lu, Yanhui; Wang, Caiyun; Lu, Zhongxian] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable P, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable P, Hangzhou, Zhejiang, Peoples R China.	luzxmh@163.com	Yang, Yajun/HGC-2463-2022		earmarked fund for China Agriculture Research System [CARS-01-36]; National Special Key Project of China [2016ZX08001-001]; National Natural Science Foundation of China [31501669]; Zhejiang Provincial Natural Science Foundation of China [LY15C140003]	earmarked fund for China Agriculture Research System; National Special Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by National Natural Science Foundation of China (31501669), the earmarked fund for China Agriculture Research System (CARS-01-36), National Special Key Project of China (2016ZX08001-001), and Zhejiang Provincial Natural Science Foundation of China (LY15C140003).	Ali S, 2010, AFR J BIOTECHNOL, V9, P2022; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Barrion A.T., 1991, Philippine Entomologist, V8, P987; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brunet JF, 2010, J INVERTEBR PATHOL, V104, P203, DOI 10.1016/j.jip.2010.04.007; Chen JY, 2015, J COGN CULT, V15, P1, DOI 10.1163/15685373-12342137; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Cheng J.A., 1996, RICE PESTS; Coates BS, 2015, INSECT BIOCHEM MOLEC, V63, P86, DOI 10.1016/j.ibmb.2015.06.003; Cohen Michael B., 2008, V5, P223, DOI 10.1007/978-1-4020-8373-0_8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; DEJONG PD, 1992, ENTOMOL EXP APPL, V63, P101, DOI 10.1007/BF00350352; Elleuch J, 2015, MICROBIOL RES, V176, P48, DOI 10.1016/j.micres.2015.04.007; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; EWART GD, 1994, J BIOL CHEM, V269, P10370; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JY, 2011, SCI CHINA LIFE SCI, V54, P152, DOI 10.1007/s11427-010-4133-y; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Holland I. B., 2003, ABC PROTEINS BACTERI; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Lei YY, 2014, GENE, V533, P180, DOI 10.1016/j.gene.2013.09.091; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linser PJ, 2014, ADV INSECT PHYSIOL, V47, P1, DOI 10.1016/B978-0-12-800197-4.00001-4; Liu S, 2015, ARCH INSECT BIOCHEM, V90, P1, DOI 10.1002/arch.21240; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Z X, 2017, PICTORIAL HDB SUSTAI; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miranda R, 2001, INSECT BIOCHEM MOLEC, V31, P1155, DOI 10.1016/S0965-1748(01)00061-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Shi GQ, 2012, ARCH INSECT BIOCHEM, V79, P87, DOI 10.1002/arch.21014; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Veegala RB, 2015, NEW HORIZONS INSECT, P95; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; WU Zhi-hong, 2015, Zhongguo Shuidao Kexue, V29, P417, DOI 10.3969/j.issn.1001-7216.2015.04.011; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yamazaki T, 2011, PESTIC BIOCHEM PHYS, V101, P125, DOI 10.1016/j.pestbp.2011.09.001; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YaJun, 2015, Acta Phytophylacica Sinica, V42, P691; Yang YJ, 2012, J ECON ENTOMOL, V105, P2122, DOI 10.1603/EC12236; Yang Z, 2011, PEST MANAG SCI, V67, P414, DOI 10.1002/ps.2079; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang X, 2008, COMP BIOCHEM PHYS B, V149, P581, DOI 10.1016/j.cbpb.2007.12.006; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhang ZG, 2011, BIOTECHNOL B, V51, P148; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	66	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191686	10.1371/journal.pone.0191686	http://dx.doi.org/10.1371/journal.pone.0191686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360856	gold, Green Submitted, Green Published			2022-12-26	WOS:000423161800052
J	Seraj, Z; Seyedarabi, A; Saboury, AA; Habibi-Rezaei, M; Ahmadian, S; Ghasemi, A				Seraj, Zahra; Seyedarabi, Arefeh; Saboury, Ali Akbar; Habibi-Rezaei, Mehran; Ahmadian, Shahin; Ghasemi, Atiyeh			Unraveling the novel effects of aroma from small molecules in preventing hen egg white lysozyme amyloid fibril formation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN AGGREGATION; ALPHA-SYNUCLEIN; ESSENTIAL OIL; INHIBITION; INACTIVATION; POLYPHENOLS; INHALATION	This study investigated for the first time the molecular effectiveness of 'aroma' from three small molecules including a phenol (phenyl ethyl alcohol; PEA) and an aldehyde (cinnamaldehyde; Cin) both containing an aromatic ring, and a diamine (N, N, N, N '-Tetramethylethylene-diamine; TEMED) at two different amounts (small; S and large; L) in preventing hen egg white lysozyme (HEWL) amyloid fibril formation using Thioflavin T and Nile red fluorescence assays, circular dichroism spectroscopy, SDS-polyacrylamide gel electrophoresis, atomic force microscopy, dynamic light scattering and HEWL activity test. Interestingly, the results revealed that (1) the aroma of PEA, identified as an active constituent of Rosa damascena, prevented fibril formation since PEA-L was able to trap the oligomeric form of HEWL in contrast to PEA-S where protofibrils but not mature fibrils were formed; (2) Cin, previously shown to prevent fibril formation in the liquid form, was also shown to do so in the aroma form by producing protofibrils and not mature fibrils in both Cin-L and Cin-S aroma forms and (3) the aroma of TEMED-L was able to retain HEWL's native structure completely and prevented both aggregation and fibril formation, while TEMED-S prevented HEWL fibril formation and instead directed the pathway towards amorphous aggregate formation. Furthermore, the ability to trap oligomeric species (by PEA-L aroma) is of great importance for further research as it provides routes for preventing the formation of toxic oligomeric intermediates along the fibrillation pathway. Last but not least, the novelty of this in vitro study on the effect of aroma at the molecular level with a unique experimental set-up using HEWL as a model protein in assessing amyloid fibril formation paves the way for more and detailed studies on the importance of aroma producing molecules and their effects.	[Seraj, Zahra; Seyedarabi, Arefeh; Saboury, Ali Akbar; Ahmadian, Shahin; Ghasemi, Atiyeh] Univ Tehran, Dept Biochem, Inst Biochem & Biophys, Tehran, Iran; [Habibi-Rezaei, Mehran] Univ Tehran, Sch Biol, Univ Coll Sci, Tehran, Iran	University of Tehran; University of Tehran	Seyedarabi, A (corresponding author), Univ Tehran, Dept Biochem, Inst Biochem & Biophys, Tehran, Iran.	a.seyedarabi@ut.ac.ir	Ahmadian, Shahin -/U-1582-2018; Saboury, Ali Akbar/L-6136-2019; Ahmadian, Shahin/Q-7578-2019	Ahmadian, Shahin -/0000-0002-3436-465X; Ahmadian, Shahin/0000-0002-3436-465X; rezaee, mehran/0000-0002-3720-4221; Saboury, Ali Akbar/0000-0003-0604-9465	research council of the University of Tehran	research council of the University of Tehran(University of Tehran)	This study was funded by the research council of the University of Tehran.; We thank Dr. Azam Rahimipour, for her advice on polyamines. We also appreciate Ms Malihe Behzadi for her advice on HEWL incubation method to obtain fibrillation in 24 hours using a Duran bottle. We acknowledge the financial support of the research council of the University of Tehran.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Borana MS, 2014, BBA-PROTEINS PROTEOM, V1844, P670, DOI 10.1016/j.bbapap.2014.01.009; Boskabady MH, 2011, IRAN J BASIC MED SCI, V14, P295; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Emadi S, 2014, BIOCHEM BIOPH RES CO, V450, P1339, DOI 10.1016/j.bbrc.2014.06.133; Esfandiary Ebrahim, 2015, Adv Biomed Res, V4, P131, DOI 10.4103/2277-9175.161512; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Forrester LT, 2014, AROMATHERAPY DEMENTI; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Koo BS, 2004, BIOL PHARM BULL, V27, P515, DOI 10.1248/bpb.27.515; Koo BS, 2003, BIOL PHARM BULL, V26, P978, DOI 10.1248/bpb.26.978; Kudou M, 2003, EUR J BIOCHEM, V270, P4547, DOI 10.1046/j.1432-1033.2003.03850.x; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu R, 2012, CURR MED CHEM, V19, P4157, DOI 10.2174/092986712802430018; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Mach H, 1995, ULTRAVIOLET ABSORPTI, P91; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; National Center for Biotechnology Information, PUBCHEM COMP DAT; Okanojo M, 2005, J BIOSCI BIOENG, V100, P556, DOI 10.1263/jbb.100.556; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Ramshini H, 2015, BASIC CLIN NEUROSCI, V6, P29; Rebek J, 2009, P NATL ACAD SCI USA, V106, P10423, DOI 10.1073/pnas.0905341106; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; SHIRAHAM.T, 1973, J IMMUNOL, V110, P21; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang SSS, 2009, BIOCHEM BIOPH RES CO, V381, P639, DOI 10.1016/j.bbrc.2009.02.103; Wang SSS, 2009, BIOPHYS CHEM, V144, P78, DOI 10.1016/j.bpc.2009.06.010; Wawer J, 2014, INT J BIOL MACROMOL, V70, P214, DOI 10.1016/j.ijbiomac.2014.06.057	46	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0189754	10.1371/journal.pone.0189754	http://dx.doi.org/10.1371/journal.pone.0189754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357364	Green Published, Green Submitted, gold			2022-12-26	WOS:000422919500002
J	Hu, TX; Chong, YT; Qin, HY; Kitamura, E; Chang, CS; Silva, J; Ren, MQ; Cowell, JK				Hu, Tianxiang; Chong, Yating; Qin, Haiyan; Kitamura, Eiko; Chang, Chang-Sheng; Silva, Jeane; Ren, Mingqiang; Cowell, John K.			The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase	ONCOGENE			English	Article							8P11 MYELOPROLIFERATIVE SYNDROME; T-CELL LYMPHOMA; MYELOID-LEUKEMIA; MICRORNAS; CANCER; GENE; ACTIVATION; FGFR1; OVEREXPRESSION; ASSOCIATION	MicroRNAs (miRNAs) have pathogenic roles in the development of a variety of leukemias. Here we identify miRNAs that have important roles in the development of B lymphomas resulting from the expression of the chimeric BCR-FGFR1 kinase. The miR-17/92 cluster was particularly implicated and forced expression resulted in increased cell proliferation, while inhibiting its function using miRNA sponges reduced cell growth and induced apoptosis. Cells treated with the potent BGJ389 FGFR1 inhibitor led to miR-17/92 downregulation, suggesting regulation by FGFR1. Transient luciferase reporter assays and qRT-PCR detection of endogenous miR-17/92 expression in stable transduced cell lines demonstrated that BCR-FGFR1 can regulate miR-17/92 expression. This positive association of miR-17/92 with BCR-FGFR1 was also confirmed in primary mouse SCLL tissues and primary human CLL samples. miR-17/92 promotes cell proliferation and survival by targeting CDKN1A and PTEN in B-lymphoma cell lines and primary tumors. An inverse correlation in expression levels was seen between miR-17/92 and both CDKN1A and PTEN in two cohorts of CLL patients. Finally, in vivo engraftment studies demonstrated that manipulation of miR-17/92 was sufficient to affect BCR-FGFR1-driven leukemogenesis. Overall, our results define miR-17/92 as a downstream effector of FGFR1 in BCR-FGFR1-driven B-cell lymphoblastic leukemia.	[Hu, Tianxiang; Chong, Yating; Qin, Haiyan; Kitamura, Eiko; Chang, Chang-Sheng; Silva, Jeane; Ren, Mingqiang; Cowell, John K.] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA; [Cowell, John K.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Mil & Emergency Med, Bethesda, MD 20814 USA	University System of Georgia; Augusta University; Uniformed Services University of the Health Sciences - USA	Cowell, JK (corresponding author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.; Cowell, JK (corresponding author), Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Mil & Emergency Med, Bethesda, MD 20814 USA.	jcowell@augusta.edu	Hu, TianXiang/Q-2099-2019	Hu, TianXiang/0000-0002-5127-9211; Silva, PhD, MPA, EdS, EdD, MB(ASCP)CM, Jeane/0000-0003-3368-3963	National Institutes of Health [CA076167]; NATIONAL CANCER INSTITUTE [R01CA076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA076167 from the National Institutes of Health.	Agerstam H, 2010, BLOOD, V116, P2103, DOI 10.1182/blood-2009-05-217182; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cowell JK, 2016, BRIT J HAEMATOL, V175, P542, DOI 10.1111/bjh.13877; Demiroglu A, 2001, BLOOD, V98, P3778, DOI 10.1182/blood.V98.13.3778; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Gao J, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/719179; Guasch G, 2004, BLOOD, V103, P309, DOI 10.1182/blood-2003-05-1690; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Jackson CC, 2010, HUM PATHOL, V41, P461, DOI 10.1016/j.humpath.2009.11.003; Jiang X, 2016, CANCER RES, V76, P4470, DOI 10.1158/0008-5472.CAN-15-2949; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kim Kang Ho, 2015, Curr Protoc Mol Biol, V111, DOI 10.1002/0471142727.mb2806s111; Kluiver J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029275; Kumar KR, 2015, AM J CLIN PATHOL, V143, P738, DOI 10.1309/AJCPUD6W1JLQQMNA; Lai NS, 2014, J CLIN NEUROSCI, V21, P755, DOI 10.1016/j.jocn.2013.06.024; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Maura F, 2015, LEUKEMIA LYMPHOMA, V56, P3150, DOI 10.3109/10428194.2015.1028051; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mihailovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9725; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pan YY, 2014, CURR PHARM DESIGN, V20, P5260, DOI 10.2174/1381612820666140128211724; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Qin HY, 2016, HAEMATOLOGICA, V101, pE91, DOI 10.3324/haematol.2015.137695; Ren MQ, 2016, INT J CANCER, V139, P836, DOI 10.1002/ijc.30100; Ren MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038265; Ren MQ, 2011, CANCER RES, V71, P7312, DOI 10.1158/0008-5472.CAN-11-1109; Ren MQ, 2011, BLOOD, V117, P6837, DOI 10.1182/blood-2010-07-295725; Ren MQ, 2009, BLOOD, V114, P1576, DOI 10.1182/blood-2009-03-212704; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; Teng Y, 2014, ONCOGENE, V33, P203, DOI 10.1038/onc.2012.565; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wu Q, 2016, ONCOTARGET, V7, P49733, DOI 10.18632/oncotarget.10438; Xiao FQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-195; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Xu SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7764; Yang ZH, 2013, J BIOL CHEM, V288, P28893, DOI 10.1074/jbc.M113.502682; Zhou L, 2016, ONCOTARGET, V7, P51943, DOI 10.18632/oncotarget.10460	50	11	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1926	1938		10.1038/s41388-017-0091-1	http://dx.doi.org/10.1038/s41388-017-0091-1			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29367757	Green Accepted			2022-12-26	WOS:000429303300009
J	Goreczny, GJ; Forsythe, IJ; Turner, CE				Goreczny, Gregory J.; Forsythe, Ian J.; Turner, Christopher E.			Hic-5 regulates fibrillar adhesion formation to control tumor extracellular matrix remodeling through interaction with tensin1	ONCOGENE			English	Article							FOCAL-ADHESION; BREAST-CANCER; IN-VIVO; PAXILLIN; INTEGRINS; PROTEIN; FIBRONECTIN; BINDING; KINASE; ACTIN	The linearization of the stromal extracellular matrix (ECM) by cancer-associated fibroblasts (CAFs) facilitates tumor cell growth and metastasis. However, the mechanism by which the ECM is remodeled is not fully understood. Hic-5 (TGF beta 1i1), a focal adhesion scaffold protein, has previously been reported to be crucial for stromal ECM deposition and remodeling in vivo. Herein we show that CAFs lacking Hic-5 exhibit a significant reduction in the ability to form fibrillar adhesions, a specialized form of focal adhesion that promote fibronectin fibrillogenesis. Hic-5 was found to promote fibrillar adhesion formation through a newly characterized interaction with tensin1. Furthermore, Src-dependent phosphorylation of Hic-5 facilitated the interaction with tensin1 to prevent beta 1 integrin internalization and trafficking to the lysosome. The interaction between Hic-5 and tensin1 was mechanosensitive, promoting fibrillar adhesion formation and fibronectin fibrillogenesis in a rigidity-dependent fashion. Importantly, this Src-dependent mechanism was conserved in three-dimensional (3D) ECM environments. Immunohistochemistry of tensin1 showed enrichment in CAFs in vivo, which was abrogated upon deletion of Hic-5. Interestingly, elevated Hic-5 expression correlates with reduced distant metastasis-free survival in patients with basal-like, HER2+ and grade 3 tumors. Thus, we have identified Hic-5 as a crucial regulator of ECM remodeling in CAFs by promoting fibrillar adhesion formation through a novel interaction with tensin1.	[Goreczny, Gregory J.; Forsythe, Ian J.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Turner, CE (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	turnerce@upstate.edu			National Institutes of Health [R01 CA163296, R01 GM047607]; Carol M Baldwin Breast Cancer Research Fund of CNY; NATIONAL CANCER INSTITUTE [R01CA163296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol M Baldwin Breast Cancer Research Fund of CNY; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of the Turner lab for helpful discussions and critical reading of this manuscript and thank Theresa Stowell for performing the qPCR analyses. Financial Support: National Institutes of Health Grant R01 CA163296 and R01 GM047607 to CET and the Carol M Baldwin Breast Cancer Research Fund of CNY awards to CET.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carraher CL, 2013, J BIOL CHEM, V288, P14805, DOI 10.1074/jbc.M112.435271; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAVIS S, 1991, SCIENCE, V252, P712, DOI 10.1126/science.1708917; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; Doyle AD, 2016, EXP CELL RES, V343, P60, DOI 10.1016/j.yexcr.2015.10.033; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Georgiadou M, 2017, J CELL BIOL, V216, P1107, DOI 10.1083/jcb.201609066; Goreczny GJ, 2017, ONCOGENE, V36, P2693, DOI 10.1038/onc.2016.422; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Pignatelli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046228; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rainero E, 2015, CELL REP, V10, P398, DOI 10.1016/j.celrep.2014.12.037; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Stutchbury B, 2017, J CELL SCI, V130, P1612, DOI 10.1242/jcs.195362; Tchou J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-39; Thomas SM, 1999, J CELL SCI, V112, P181; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Volberg T, 2001, J CELL SCI, V114, P2279; Wormer DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091815; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zhao ZH, 2016, BIOL OPEN, V5, P499, DOI 10.1242/bio.016428	53	25	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1699	1713		10.1038/s41388-017-0074-2	http://dx.doi.org/10.1038/s41388-017-0074-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29348458	Green Accepted			2022-12-26	WOS:000428632600002
J	Budzyn, M; Iskra, M; Turkiewicz, W; Krasinski, Z; Gryszczynska, B; Kasprzak, MP				Budzyn, Magdalena; Iskra, Maria; Turkiewicz, Wojciech; Krasinski, Zbigniew; Gryszczynska, Bogna; Kasprzak, Magdalena Paulina			Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SOLUBLE P-SELECTIN; TYPE-2 DIABETES-MELLITUS; VON-WILLEBRAND-FACTOR; VARICOSE-VEINS; RISK-FACTORS; VE-CADHERIN; CARDIOVASCULAR RISK; ELDERLY POPULATION; CLINICAL-PRACTICE	Background Although the endothelial dysfunction is considered to be implicated in the pathogenesis of chronic venous insufficiency (CVI) the endothelial status in patients with venous disorders is still not fully evaluated. Therefore the aim of the study was to measure the concentration of selected markers of endothelial dysfunction: von Willebrand factor (vWf), soluble P-selectin (sP-selectin), soluble thrombomodulin (sTM) and soluble VE-cadherin (sVE-cadherin) in CVI women who constitute the most numerous group of patients suffering from venous disease. Materials and methods Forty four women with CVI were involved in the study and divided into subgroups based on CEAP classification. Concentration of vWf, sP-selectin, sTM and sVE-cadherin were measured and compared with those obtained in 25 healthy age and sex-matched women. Results It was found that the concentration of sTM increased and sVEcadherin decreased along with disease severity in CVI women. A significant rise of sTM was observed especially in CVI women, with the highest inflammation status reflected by hsCRP or elastase concentration, and in CVI women with a high oxidative stress manifested by an increased plasma MDA. A significant fall of circulating sVE-cadherin was reported in CVI women with moderate to highest intensity of inflammation and oxidative stress. There was no change in vWF and sP-selectin concentration at any stage of CVI severity. Conclusions The results of the present study demonstrate the presence of endothelial dysfunction in women suffering from CVI which seems to progress with the disease severity and may be associated with inflammation and enhanced oxidative stress.	[Budzyn, Magdalena; Iskra, Maria; Gryszczynska, Bogna; Kasprzak, Magdalena Paulina] Poznan Univ Med Sci, Dept Gen Chem, Chair Chem & Clin Biochem, Poznan, Poland; [Turkiewicz, Wojciech] Med Ctr HCP, Dept Gen Surg, Poznan, Poland; [Krasinski, Zbigniew] Poznan Univ Med Sci, Dept Gen & Vasc Surg, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Budzyn, M (corresponding author), Poznan Univ Med Sci, Dept Gen Chem, Chair Chem & Clin Biochem, Poznan, Poland.	magdalena.budzyn@wp.pl	Gryszczyńska, Bogna/AAE-9896-2019; Kasprzak, Magdalena Paulina/ACG-3705-2022; Budzyń, Magdalena/AAK-2364-2021	Kasprzak, Magdalena Paulina/0000-0002-7169-0331; Budzyn, Magdalena/0000-0003-2296-3599; Iskra, Maria/0000-0002-9352-0333	University of Medical Science in Poznan [501-01-02228370-03102-50564]	University of Medical Science in Poznan	The study was supported by the University of Medical Science in Poznan (Grant no. 501-01-02228370-03102-50564). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaisi M, 2008, VASC HEALTH RISK MAN, V4, P647, DOI 10.2147/VHRM.S2769; Alexander JS, 2000, INFLAMMATION, V24, P99, DOI 10.1023/A:1007025325451; Andor M, 2014, ATHEROSCLEROSIS, V235, pE136, DOI 10.1016/j.atherosclerosis.2014.05.380; Arrebola-Moreno AL, 2012, REV ESP CARDIOL, V65, P80, DOI [10.1016/j.recesp.2011.09.012, 10.1016/j.rec.2011.10.004]; Bergan J, 2007, ANN VASC SURG, V21, P260, DOI 10.1016/j.avsg.2007.03.011; Blann AD., 1993, BRIT J HAEMATOL ONCO, V15, P338; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Boehme MWJ, 2000, CLIN EXP IMMUNOL, V119, P250, DOI 10.1046/j.1365-2249.2000.01108.x; Brevetti G, 2003, J VASC SURG, V38, P374, DOI 10.1016/S0741-5214(03)00124-1; Bryan LJ, 2012, THROMB RES, V130, P716, DOI 10.1016/j.thromres.2012.07.012; Budzyn M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2791082; Budzyn M, 2011, MED SCI MONITOR, V17, pCR719, DOI 10.12659/MSM.882132; Canonico S, 1998, ANGIOLOGY, V49, P129, DOI 10.1177/000331979804900205; Capitao L M, 1995, Acta Med Port, V8, P485; Carrasco OF, 2009, ANGIOLOGY, V60, P763, DOI 10.1177/0003319709332108; Chen T, 2014, RHEUMATOL INT, V34, P1139, DOI 10.1007/s00296-014-2949-7; Chong AY, 2003, QJM-INT J MED, V96, P253, DOI 10.1093/qjmed/hcg037; Condezo-Hoyos L, 2013, J VASC SURG, V57, P205, DOI 10.1016/j.jvs.2012.05.085; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Herrera MD, 2010, AGEING RES REV, V9, P142, DOI 10.1016/j.arr.2009.07.002; Doulgere J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005659; Ebihara I, 2014, THER APHER DIAL, V18, P272, DOI 10.1111/1744-9987.12215; Elhadd TA, 2001, J CLIN ENDOCR METAB, V86, P4223, DOI 10.1210/jc.86.9.4223; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Flemming S, 2015, CARDIOVASC RES, V107, P32, DOI 10.1093/cvr/cvv144; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Georgescu A, 2009, J THROMB HAEMOST, V7, P1566, DOI 10.1111/j.1538-7836.2009.03525.x; Glowinski J, 2002, EUR J VASC ENDOVASC, V23, P550, DOI 10.1053/ejvs.2002.1656; Grotto D, 2009, QUIMICA NOVA, V32; Gungor ZB, 2017, J MED BIOCHEM, V36, P62, DOI 10.1515/jomb-2016-0030; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; KAIKITA K, 1995, CIRCULATION, V92, P1726, DOI 10.1161/01.CIR.92.7.1726; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karatepe O, 2010, ANGIOLOGY, V61, P283, DOI 10.1177/0003319709343177; Katusic ZS, 2007, CIRC RES, V101, P640, DOI 10.1161/CIRCRESAHA.107.162701; Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074; KLOCZKO J, 1994, CLIN RHEUMATOL, V13, P34, DOI 10.1007/BF02229862; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; Komarow W, 2015, INT ANGIOL, V34, P36; KOMSUOGLU B, 1994, GERONTOLOGY, V40, P25; LAURIKKA J, 1995, J CLIN EPIDEMIOL, V48, P1175, DOI 10.1016/0895-4356(95)00012-S; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Merten A, 2004, Z KARDIOL, V93, P855, DOI 10.1007/s00392-004-0146-5; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Musil D, 2011, BIOMED PAP, V155, P367, DOI 10.5507/bp.2011.054; Nicolaides AN, 2008, INT ANGIOL, V27, P1; Ojdana D, 2009, FOLIA HISTOCHEM CYTO, V47, P185, DOI 10.2478/v10042-009-0029-8; Ostrowski SR, 2013, J CRIT CARE, V28, P586, DOI 10.1016/j.jcrc.2013.04.010; Pascarella L, 2005, ANGIOLOGY, V56, pS3, DOI 10.1177/00033197050560i102; Pocock ES, 2014, VASC CELL, V6, DOI 10.1186/s13221-014-0024-5; Poggesi A, 2016, J CEREBR BLOOD F MET, V36, P72, DOI 10.1038/jcbfm.2015.116; Pulerwitz T, 2006, AM J CARDIOL, V97, P68, DOI 10.1016/j.amjcard.2005.07.125; Rabe E, 2012, INT ANGIOL, V31, P105; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Rivera-Chavez F, 1998, J TRAUMA, V45, P440, DOI 10.1097/00005373-199809000-00003; Saharay M, 1998, EUR J VASC ENDOVASC, V15, P342, DOI 10.1016/S1078-5884(98)80039-7; Semenov AV, 2000, TERAPEVT ARKH, V72, P15; Sidibe A., 2014, MOL MECH ANGIOGENESI, P461; Soeki T, 2004, CIRC J, V68, P1, DOI 10.1253/circj.68.1; Staffa R, 2002, Bratisl Lek Listy, V103, P166; Storch Amanda Sampaio, 2017, Int. J. Cardiovasc. Sci., V30, P262, DOI 10.5935/2359-4802.20170034; THIES RL, 1991, ARCH BIOCHEM BIOPHYS, V286, P353, DOI 10.1016/0003-9861(91)90051-J; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Tisato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039543; van Wetering S, 2002, J CELL SCI, V115, P1837; Widmer RJ, 2014, GLOB CARDIOL SCI PRA, V2014, P291, DOI DOI 10.5339/GCSP.2014.43; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256; Yasim A, 2008, PHLEBOLOGY, V23, P15, DOI 10.1258/phleb.2007.007014; Zhao XY, 2001, AM J PHYSIOL-LUNG C, V281, pL879, DOI 10.1152/ajplung.2001.281.4.L879	76	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191902	10.1371/journal.pone.0191902	http://dx.doi.org/10.1371/journal.pone.0191902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377939	gold, Green Published, Green Submitted			2022-12-26	WOS:000423514700043
J	Gedling, CR; Smith, CM; LeMoine, CMR; Cassone, BJ				Gedling, Cassidy R.; Smith, Charlotte M.; LeMoine, Christophe M. R.; Cassone, Bryan J.			The Mexican bean beetle (Epilachna varivestis) regurgitome and insights into beetle-borne virus specificity	PLOS ONE			English	Article							PLANT DEFENSE; TRANSCRIPTOME ANALYSIS; SALIVARY-GLANDS; APHID; TRANSMISSION; GENES; EXPRESSION; IDENTIFICATION; RIBONUCLEASE; COLEOPTERA	For nearly 400 million years, insects and plants have been embattled in an evolutionary arms race. Insects have developed diverse feeding strategies and behaviors in an effort to circumvent and overcome an extensive collection of plant defense tactics. Sap-sucking insects often inject saliva into hosts plants, which contains a suite of effector proteins and even microbial communities that can alter the plant's defenses. Lacking salivary glands, leaf-feeding beetles represent an interesting group of phytophagous insects. Feeding beetles regurgitate onto leaf surfaces and it is thought that these oral secretions influence insect-plant interactions and even play a role in virus-vector specificity. Since the molecular and biological makeup of the regurgitant is virtually unknown, we carried out RNA sequencing and 16S rDNA analysis on a major soybean pest, Epilachna varivestis, to generate the first ever beetle "regurgitome" and characterize its microbiome. Interestingly, the regurgitant is comprised of a rich molecular assortment of genes encoding putative extracellular proteins involved in digestion, molting, immune defense, and detoxification. By carrying out plant inoculation assays, we reinforced the fundamental role of the regurgitant in beetle borne virus specificity. Ultimately, these studies begin to characterize the importance of regurgitant in virus transmission and beetle-plant interactions.	[Gedling, Cassidy R.] Ohio State Univ, Dept Plant Pathol, Wooster, OH USA; [Smith, Charlotte M.; LeMoine, Christophe M. R.; Cassone, Bryan J.] Brandon Univ, Dept Biol, Brandon, MB, Canada	University System of Ohio; Ohio State University; Brandon University	Cassone, BJ (corresponding author), Brandon Univ, Dept Biol, Brandon, MB, Canada.	cassoneb@brandonu.ca	LeMoine, christophe/S-4408-2019	LeMoine, Christophe/0000-0003-3536-5897	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program award [RGPIN-2016-04335]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program award	Funding for the project was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program awarded to Bryan Cassone (RGPIN-2016-04335). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo FE, 2017, MOL PLANT MICROBE IN, V30, P127, DOI 10.1094/MPMI-11-16-0240-R; Auclair J. L., 1959, ANN SOC ENTOMOL QUE, V5, P18; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chung SH, 2013, P NATL ACAD SCI USA, V110, P15728, DOI 10.1073/pnas.1308867110; Cooper GM, 2000, CELL MOL APPROACH; D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012; Daniel H, 2015, EXP PHYSIOL, V100, P1441, DOI 10.1113/EP085029; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Elzinga DA, 2014, MOL PLANT MICROBE IN, V27, P747, DOI 10.1094/MPMI-01-14-0018-R; Engel P, 2016, MBIO, V7, DOI 10.1128/mBio.02164-15; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; FAN YQ, 1992, J ECON ENTOMOL, V85, P1762, DOI 10.1093/jee/85.5.1762; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Fulton J.P., 1980, P115; Fulton J.P., 1974, P AM PHYTOPATH SOC, V1, P159; Furch ACU, 2015, J EXP BOT, V66, P533, DOI 10.1093/jxb/eru487; Gergerich R.C., 1991, Advances in Disease Vector Research, V8, P1; GERGERICH RC, 1983, PHYTOPATHOLOGY, V73, P936, DOI 10.1094/Phyto-73-936; GERGERICH RC, 1988, J GEN VIROL, V69, P2935, DOI 10.1099/0022-1317-69-11-2935; GERGERICH RC, 1986, J GEN VIROL, V67, P367, DOI 10.1099/0022-1317-67-2-367; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Haruta M, 2001, PLANT MOL BIOL, V46, P347, DOI 10.1023/A:1010654711619; Heckel DG, 2014, ANN PLANT REV, V47; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kaur R, 2015, BIOCH ANAL BIOCH, V4, P4; Kettles GJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01142; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; KRAMER KJ, 1986, INSECT BIOCHEM, V16, P851, DOI 10.1016/0020-1790(86)90059-4; Kramer KJ, 1997, INSECT BIOCHEM MOLEC, V27, P887, DOI 10.1016/S0965-1748(97)00078-7; LANGHAM MAC, 1990, PHYTOPATHOLOGY, V80, P900, DOI 10.1094/Phyto-80-900; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Louie R, 2004, MAYDICA, V49, P231; MARASCUILO LA, 1967, PSYCHOL BULL, V67, P401, DOI 10.1037/h0020421; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mello Marcia O., 2002, Braz. J. Plant Physiol., V14, P71, DOI 10.1590/S1677-04202002000200001; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; MONIS J, 1986, PHYTOPATHOLOGY, V76, P808, DOI 10.1094/Phyto-76-808; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Musser RO, 2003, J INSECT BEHAV, V16, P247, DOI 10.1023/A:1023919902976; Musser RO, 2002, J CHEM ECOL, V28, P1691, DOI 10.1023/A:1019985417720; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Nakamura H., 2007, REPORT INVESTIGATION; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Padron A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-636; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SCOTT HA, 1978, VIROLOGY, V84, P207, DOI 10.1016/0042-6822(78)90235-0; SCOTT HA, 1979, PHYTOPATHOLOGY, V69, P346, DOI 10.1094/Phyto-69-346; Smith CM, 2017, GENOME BIOL EVOL, V9, P714, DOI 10.1093/gbe/evx033; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Srivastava U. S., 1959, Proceedings of the Royal Entomological Society of London (A), V34, P57; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Sugio A, 2015, J EXP BOT, V66, P467, DOI 10.1093/jxb/eru435; Swevers L, 2013, INSECT MOL BIOL, V22, P668, DOI 10.1111/imb.12054; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; Todd JC, 2010, PHYTOPATHOLOGY, V100, P1138, DOI 10.1094/PHYTO-05-10-0144; Usha Rani P, 2010, ACTA PHYSIOL PLANT, V32, P695, DOI DOI 10.1007/S11738-009-0449-2; Walling LL., 2008, ADV BOT RES PLANT IN, P552; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xu XL, 2016, INFECT GENET EVOL, V38, P62, DOI 10.1016/j.meegid.2015.12.005; Zhang Jianhua, 2016, PLoS One, V11, pe0155254, DOI 10.1371/journal.pone.0155254; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zibaee Arash, 2014, Archives of Phytopathology and Plant Protection, V47, P2187, DOI 10.1080/03235408.2013.870112	84	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0192003	10.1371/journal.pone.0192003	http://dx.doi.org/10.1371/journal.pone.0192003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377955	Green Submitted, Green Published, gold			2022-12-26	WOS:000423514700051
J	Ikezono, T; Matsumura, T; Matsuda, H; Shikaze, S; Saitoh, S; Shindo, S; Hasegawa, S; Oh, SH; Hagiwara, Y; Ogawa, Y; Ogawa, H; Sato, H; Tono, T; Araki, R; Maeda, Y; Usami, S; Kase, Y				Ikezono, Tetsuo; Matsumura, Tomohiro; Matsuda, Han; Shikaze, Satomi; Saitoh, Shiho; Shindo, Susumu; Hasegawa, Setsuo; Oh, Seung Ha; Hagiwara, Yoshiaki; Ogawa, Yasuo; Ogawa, Hiroshi; Sato, Hiroaki; Tono, Tetsuya; Araki, Ryuichiro; Maeda, Yukihide; Usami, Shin-ichi; Kase, Yasuhiro			The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage	PLOS ONE			English	Article							INNER-EAR; FISTULA; IDENTIFICATION; MANAGEMENT; PROTEIN; FLUID; ASSAY	Perilymphatic fistula is defined as an abnormal communication between the perilymph-filled space and the middle ear, or cranial spaces. The manifestations include a broad spectrum of neuro-otological symptoms such as hearing loss, vertigo/dizziness, disequilibrium, aural fullness, tinnitus, and cognitive dysfunction. By sealing the fistula, perilymphatic fistula is a surgically correctable disease. Also, appropriate recognition and treatment of perilymphatic fistula can improve a patient's condition and hence the quality of life. However, the difficulty in making a definitive diagnosis due to the lack of an appropriate biomarker to detect perilymph leakage has caused a long-standing debate regarding its management. We have reported a clinical test for the diagnosis of perilymphatic fistula by detecting a perilymph specific protein, Cochlin-tomoprotein, as a diagnostic marker using a western blot. The aim of this study is to establish an ELISA-based human Cochlin-tomoprotein detection test and to evaluate its diagnostic accuracy in clinical subjects. The results of ELISA showed good dilution reproducibility. The mean concentration was 49.7 +/- 9.4 of 10 perilymph samples. The ROC curve in differentiating the perilymph leakage condition from the normal middle ear was significant (P < 0.001) with an area under the curve (AUC) of 0.918 (95% CI 0.824-0.100). We defined the diagnostic criteria as follows: CTP<0.4 negative; 0.4 <= CTP<0.8 intermediate; 0.8 <= CTP(ng/m1) positive in the clinical usage of the hCTP ELISA, and sensitivity and specificity were 86.4% and 100%, respectively. We further tested the expression specificity of the Cochlin-tomoprotein by testing blood and CSF samples. The concentration was below the detection limit (0.2 ng/ml) in 38 of the 40 blood, and 14 of the 19 CSF samples. We report the accuracy of this test for the diagnosis of perilymphatic fistula. Using ELISA, we can improve the throughput of the test. Furthermore, it is useful for a large-scale study to characterize the clinical picture and delineate the management of this medical condition.	[Ikezono, Tetsuo; Matsuda, Han; Saitoh, Shiho; Shindo, Susumu; Kase, Yasuhiro] Saitama Med Univ, Dept Otorhinolaryngol, Saitama, Japan; [Matsumura, Tomohiro; Saitoh, Shiho] Nippon Med Sch, Grad Sch Med, Dept Biochem & Mol Biol, Tokyo, Japan; [Shikaze, Satomi] Mitsubishi Chem Medience Corp, R&D & Business Dev Segment, Tokyo, Japan; [Hasegawa, Setsuo] Hoeikai Med Corp, Sekino Clin Pharmacol Clin, Tokyo, Japan; [Oh, Seung Ha] Seoul Natl Univ Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Hagiwara, Yoshiaki] IBL Co Ltd, Fujioka, Gunma, Japan; [Ogawa, Yasuo] Tokyo Med Univ, Dept Otolaryngol, Hachioji Med Ctr, Tokyo, Japan; [Ogawa, Hiroshi] Fukushima Med Univ, Dept Otorhinolaryngol, Med Ctr, Aizu Wakamatsu, Fukushima, Japan; [Sato, Hiroaki] Iwate Med Univ, Dept Otolaryngol Head & Neck Surg, Morioka, Iwate, Japan; [Tono, Tetsuya] Univ Miyazaki, Fac Med, Dept Otolaryngol, Miyazaki, Japan; [Araki, Ryuichiro] Saitama Med Univ, Community Hlth Sci Ctr, Saitama, Japan; [Maeda, Yukihide] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Usami, Shin-ichi] Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Nagano, Japan	Saitama Medical University; Nippon Medical School; Seoul National University (SNU); Seoul National University Hospital; Tokyo Medical University; Iwate Medical University; University of Miyazaki; Saitama Medical University; Okayama University; Shinshu University	Ikezono, T (corresponding author), Saitama Med Univ, Dept Otorhinolaryngol, Saitama, Japan.	tikez@saitama-med.ac.jp		Ikezono, Tetsuo/0000-0002-6929-5084	Ministry of Health and Welfare, Japan [H26-Nanchitou (Nan)-Ippan-032]; MEXT of Japan [S1311002]	Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Health and Welfare, Japan (H26-Nanchitou (Nan)-Ippan-032) (littp.//www.mhlw.go.jp/english/) (T.I.) and a Grant-in-Aid for the Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine from MEXT of Japan (S1311002). (http://www.mext.go.jp/english/)(T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann G, 2002, NEUROSURGERY, V50, P571, DOI 10.1097/00006123-200203000-00027; Buchman CA, 1999, AM J OTOL, V20, P174; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Friedland DR, 1999, AM J OTOL, V20, P261; Hornibrook J, 2012, ISRN OTOLARYNGOL; HUGHES GB, 1990, OTOLARYNG HEAD NECK, V102, P111, DOI 10.1177/019459989010200203; Ikezono T, 2004, BIOCHEM BIOPH RES CO, V314, P440, DOI 10.1016/j.bbrc.2003.12.106; Ikezono T, 2011, ACTA OTO-LARYNGOL, V131, P937, DOI 10.3109/00016489.2011.575795; Ikezono T, 2010, ACTA OTO-LARYNGOL, V130, P881, DOI 10.3109/00016480903508910; Ikezono T, 2010, AUDIOL NEURO-OTOL, V15, P168, DOI 10.1159/000241097; Ikezono T, 2009, AUDIOL NEURO-OTOL, V14, P338, DOI 10.1159/000212113; Jackler R., 2005, NEUROTOLOGY, V2; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; Kataoka Y, 2013, AURIS NASUS LARYNX, V40, P422, DOI 10.1016/j.anl.2012.08.001; KOHUT RI, 1986, ANN OTO RHINOL LARYN, V95, P466, DOI 10.1177/000348948609500506; Maitland C G, 2001, Curr Neurol Neurosci Rep, V1, P486, DOI 10.1007/s11910-001-0111-x; Matsuda H, 2017, ACTA OTO-LARYNGOL, P1; Minor Lloyd B, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P340, DOI 10.1097/00020840-200310000-00006; NOMURA Y, 1994, ACTA OTO-LARYNGOL, P52; SCHUKNECHT HF, 1992, AM J OTOL, V13, P124; Wackym PA, 2016, OTOL NEUROTOL, V37, P70, DOI 10.1097/MAO.0000000000000928	22	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191498	10.1371/journal.pone.0191498	http://dx.doi.org/10.1371/journal.pone.0191498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377910	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700016
J	Killiny, N; Jones, SE				Killiny, Nabil; Jones, Shelley E.			Metabolic alterations in the nymphal instars of Diaphorina citri induced by Candidatus Liberibacter asiaticus, the putative pathogen of huanglongbing	PLOS ONE			English	Article							PHLOEM-SAP; INOSITOL; MYOINOSITOL; VECTOR; HEMOLYMPH; VIRULENCE; SEQUENCE	Currently, huanglongbing is the most damaging disease of citrus causing huge economic losses. The disease is caused by the Gram- negative bacterium Candidatus Liberibacter asiaticus (CLas). The pathogen is transmitted in a persistent propagative circulative manner within its vector, the Asian citrus psyllid, Diaphorina citri. Exploring the metabolic alteration in the vector may lead to a better understanding of the nutritional needs of CLas and to designing an artificial medium for culturing the pathogen. It has been shown that the nymphal stages have a greater role in transmission mainly because they feed on plants more actively than adults. In this study, we carried out an untargeted comparative metabolomic analysis for healthy and CLas-infected 4th / 5th instar nymphs. The metabolic analysis was performed using trimethylsilylation and methyl chloroformate derivatization followed by Gas Chromatography-Mass Spectrometry (GC-MS). Overall, the changes in the nymph metabolism due to the infection with CLas were more pronounced than in adults, as we previously published. Nymphs reared on CLas-infected Valencia sweet orange were higher in many metabolites, mainly those of the TCA cycle, C16 and C18 fatty acids, glucose, sucrose, L-proline, L-serine, pyroglutamic acid, saccharic acid, threonic acid and myo-inositol than those reared on healthy plants. In contrast, CLas-infected nymphs were lower in putrescine, glycine, L-phenylalanine, L-tyrosine, L-valine, and chiro-inositol. The information provided from this study may contribute in acceleration of the availability of CLas in culture and consequent screening of antibacterial compounds to discover a definitive solution for huanglongbing.	[Killiny, Nabil; Jones, Shelley E.] Univ Florida, Citrus Res & Educ Ctr, Dept Plant Pathol, IFAS, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Killiny, N (corresponding author), Univ Florida, Citrus Res & Educ Ctr, Dept Plant Pathol, IFAS, Lake Alfred, FL 33850 USA.	nabilkilliny@ufl.edu		Killiny, Nabil/0000-0002-3895-6943	NIFA-USDA [2016-70016-24824]	NIFA-USDA(United States Department of Agriculture (USDA))	This study was generously supported by the grant number 2016-70016-24824 from NIFA-USDA received by NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2016, PLOS ONE, V4, P11; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bonnemain J., 2013, SALICYLIC ACID PLANT, P43, DOI DOI 10.1007/978-94-007-6428-6; Bove JM, 2006, J PLANT PATHOL, V88, P7; Davis MJ, 2008, PLANT DIS, V92, P1547, DOI 10.1094/PDIS-92-11-1547; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fagen JR, 2014, INT J SYST EVOL MICR, V64, P2461, DOI 10.1099/ijs.0.063255-0; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; George J, 2016, ENT SOC AM DENV CO N, V7; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guo W, 2015, MICROB PATHOGENESIS, V78, P87, DOI 10.1016/j.micpath.2014.11.007; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HAMBY SE, 2011, BMC MICROBIOL, V11, DOI DOI 10.1094/MPMI-09-12-0211-R; Hocquellet A, 1999, MOL CELL PROBE, V11, P13; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Jones SE, 2012, PROC FL STATE HORTIC, V125, P75; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Killiny N, 2013, MOL PLANT MICROBE IN, V26, P1044, DOI 10.1094/MPMI-09-12-0211-R; KILLINY N, 2016, PLANT SIGNAL BEHAV, V11, DOI DOI 10.1080/15592324.2016.1171449; Killiny Nabil, 2018, Virulence, V9, P99, DOI 10.1080/21505594.2017.1339008; Killiny N, 2017, MOL PLANT MICROBE IN, V30, P666, DOI 10.1094/MPMI-05-17-0106-R; Killiny N, 2017, PHYSIOL ENTOMOL, V42, P134, DOI 10.1111/phen.12183; Killiny N, 2017, PHYSIOL MOL PLANT P, V97, P20, DOI 10.1016/j.pmpp.2016.11.004; Killiny N, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1249080; Kohler PRA, 2010, APPL ENVIRON MICROB, V76, P7972, DOI 10.1128/AEM.01972-10; Kruse A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179531; Lai K-K, 2016, FRONTIERS MICROBIOLO, P7; Li JY, 2017, MOL PLANT MICROBE IN, V30, P620, DOI [10.1094/mpmi-12-16-0257-r, 10.1094/MPMI-12-16-0257-R]; Lu H, 2009, PLANT SIGNAL BEHAV, V4, P713, DOI 10.4161/psb.4.8.9173; MaT Rangel, 2012, CELL BIOL IN LIP; Morita YS, 2011, BBA-GEN SUBJECTS, V1810, P630, DOI 10.1016/j.bbagen.2011.03.017; Moriwaki N, 2003, APPL ENTOMOL ZOOL, V38, P359, DOI 10.1303/aez.2003.359; Parker JK, 2014, PHYTOPATHOLOGY, V104, P15, DOI 10.1094/PHYTO-05-13-0119-R; RABATEL A, 2013, BMC GENOMICS, V14, DOI DOI 10.1038/NPROT.2010.108; Ramsey JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140826; RAMSEY JS, 2017, ROYAL SOC OPEN SCI, P4, DOI DOI 10.1146/ANNUREV-PHYTO-073009-114418; Rangel MaT, 2012, CARBOHYDRATES COMPRE; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rothhardt JE, 2014, MOL MICROBIOL, V94, P700, DOI 10.1111/mmi.12788; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Stanley David, 2012, Insects, V3, P492, DOI 10.3390/insects3020492; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x	45	15	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191871	10.1371/journal.pone.0191871	http://dx.doi.org/10.1371/journal.pone.0191871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370262	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600109
J	Schrijnders, D; Hendriks, SH; Kleefstra, N; Vissers, PAJ; Johnson, JA; de Bock, GH; Bilo, HJG; Landman, GWD				Schrijnders, Dennis; Hendriks, Steven H.; Kleefstra, Nanne; Vissers, Pauline A. J.; Johnson, Jeffrey A.; de Bock, Geertruida H.; Bilo, Henk J. G.; Landman, Gijs W. D.			Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)	PLOS ONE			English	Article							BODY-MASS INDEX; BREAST-CANCER; SOCIOECONOMIC-STATUS; DETECTION BIAS; INCREASED RISK; WEIGHT-GAIN; WOMEN; MELLITUS; DISEASE; METAANALYSIS	Background Diabetes and obesity seem to be partly overlapping risk factors for the development of obesity- related cancer (mainly breast, prostate and colorectal cancer) in patients with type 2 diabetes (T2DM). In the general population, women have a lower risk for obesity-related cancer compared to men. Previous studies involving cardiovascular disease have shown that T2DM eliminates a female advantage of lower CVD risk in the general population compared to men. It is unclear whether the same could be true for obesity-related cancer. This study aimed to this investigate obesity-related cancer incidence in women and men known with T2DM as compared to the Dutch general population. Methods This study included 69,583 patients with T2DM selected from a prospective primary care cohort, which was linked to the Dutch National Cancer Registry to obtain cancer specific data. Obesity-related cancers included liver, kidney, colorectal, gallbladder, pancreas, ovarian, endometrial, advanced prostate cancer, post-menopausal breast cancer and oesophageal adenocarcinoma. Primary outcome was sex-stratified, age and year of cancer diagnosis adjusted standardized incidence ratios (SIRs) for three time periods: 5 years before, the year after diagnosis and the next 4 years after T2DM diagnosis. The Dutch general population was used as reference group. Results Women with T2DM were at an increased risk for obesity-related cancer compared to women in the general population already 5 years before diabetes diagnosis (SIR 1.77; 95% CI: 1.63 +/- 1.91). In both men and women, there was a peak in obesity-related cancer incidence following diabetes diagnosis (SIR: 1.38; 95% CI 1.11 +/- 1.64 and SIR: 2.21; 95% CI 1.94-2.30, respectively). From the second to the fifth year after diabetes diagnosis the obesity-related cancer incidence was higher in women compared to women in the general population (SIR: 2.12; 95% CI 1.94 +/- 2.30). Conclusions Women with T2DM seem to have a substantially higher obesity-related cancer risk. As opposed to men, in women this risk was already increased years before diabetes diagnosis. These results could imply that a relative advantage of women in the general population with regard to cancer risk is lost in women with T2DM.	[Schrijnders, Dennis; Kleefstra, Nanne; Landman, Gijs W. D.] Langerhans Med Res Grp, Zwolle, Netherlands; [Schrijnders, Dennis; Hendriks, Steven H.; Bilo, Henk J. G.] Diabet Ctr, Zwolle, Netherlands; [Kleefstra, Nanne; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Vissers, Pauline A. J.] Netherlands Comprehens Canc Org, Utrecht, Netherlands; [Johnson, Jeffrey A.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Bilo, Henk J. G.] Dept Internal Med, Zwolle, Netherlands; [Landman, Gijs W. D.] Gelre Hosp, Dept Internal Med, Apeldoorn, Netherlands	Langerhans Medical Research Group; University of Groningen; University of Alberta; University of Groningen; Gelre Hospitals	Schrijnders, D (corresponding author), Langerhans Med Res Grp, Zwolle, Netherlands.; Schrijnders, D (corresponding author), Diabet Ctr, Zwolle, Netherlands.	d.schrijnders@rug.nl	Landman, Gijs/AAJ-5540-2021; Vissers, Pauline/AAT-2291-2020; de Bock, Geertruida H./F-6529-2014	Landman, Gijs/0000-0002-6852-6450; de Bock, Geertruida H./0000-0003-3104-4471; Kleefstra, Nanne/0000-0003-1473-8519	Netherlands Organization for Health Research and Development (ZonMw) [836041017]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was supported by a research grant (grant number 836041017) of the research programme Good Use of Medication from the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the registration teams of the Comprehensive Cancer Centre Netherlands for the collection of data for the Netherlands Cancer Registry and for the opportunity to link the Registry with the ZODIAC cohort. We would like to thank dr. Klaas Groenier (Department of General Practice, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands) for his advice with regard to the analyses. This study was supported by a research grant (grant number 836041017) of the research programme Good Use of Medication from the Netherlands Organization for Health Research and Development (ZonMw).	Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; Baan Caroline A, 2009, Ned Tijdschr Geneeskd, V153, pA580; Bansal D, 2013, PROSTATE CANCER P D, V16, P151, DOI 10.1038/pcan.2012.40; Boyle P, STAT METHODS REGISTR; Campbell PT, 2010, GASTROENTEROLOGY, V139, P1138, DOI 10.1053/j.gastro.2010.06.072; Carstensen B, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0535-8; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Chan W, 2014, DIABETIC MED, V31, P806, DOI 10.1111/dme.12422; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Colmers IN, 2013, DIABETES CARE, V36, P3070, DOI 10.2337/dc13-0045; Dankner R, 2016, AM J EPIDEMIOL, V183, P1098, DOI 10.1093/aje/kwv290; De Bruijn KMJ, 2014, EUR J CANCER, V50, P2449, DOI 10.1016/j.ejca.2014.06.019; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Derks IPM, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0553-7; Drake I, 2017, INT J CANCER, V141, P1170, DOI 10.1002/ijc.30824; Franssens BT, 2015, DIABETES CARE, V38, P1945, DOI 10.2337/dc15-0684; Friedman AM, 2012, OBESITY, V20, P1611, DOI 10.1038/oby.2012.50; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Haghighatdoost F, 2017, WORLD J DIABETES, V8, P365, DOI 10.4239/wjd.v8.i7.365; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Hendriks SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145907; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; Johnson JL, 2010, ENDOCR PRACT, V16, P47, DOI 10.4158/EP09031.OR; Kleefstra N, 2016, J DIABETES, V8, P863, DOI 10.1111/1753-0407.12370; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Lega IC, 2016, CANCER; Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P303, DOI 10.1007/s10549-006-9166-3; Louwman WJ, 2007, BREAST CANCER RES TR, V105, P369, DOI 10.1007/s10549-006-9464-9; Salinas-Martinez AM, 2014, ARCH MED RES, V45, P432, DOI 10.1016/j.arcmed.2014.06.004; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Moon JH, 2015, J CLIN ENDOCR METAB, V100, P3548, DOI 10.1210/JC.2015-1113; Moore LL, 2014, CANCER EPIDEM BIOMAR, V23, P2057, DOI 10.1158/1055-9965.EPI-14-0240; Naing N N, 2000, Malays J Med Sci, V7, P10; Nijenhuis-Rosien L, 2017, J DIABETES COMPLICAT, V31, P675, DOI 10.1016/j.jdiacomp.2017.01.015; Oberaigner W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1058; OLEFSKY JM, 1977, DIABETES, V26, P680, DOI 10.2337/diab.26.7.680; Onitilo AA, 2014, EUR J CANCER PREV, V23, P76, DOI 10.1097/CEJ.0b013e32836162aa; Onitilo AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070426; Orgel E, 2013, CURR DIABETES REP, V13, P213, DOI 10.1007/s11892-012-0356-6; Peeters K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01019-z; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Puolakka E, 2016, DIABETES CARE, V39, P2311, DOI 10.2337/dc16-1565; Rahmanian Karamatollah, 2015, Glob J Health Sci, V8, P95, DOI 10.5539/gjhs.v8n4p95; RIVM, LAND EV BEV BAARM LE; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tao XM, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0376-7; Teoh SL, 2016, TUMOR BIOL, V37, P14363, DOI 10.1007/s13277-016-5357-7; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; Verlato G, 2003, DIABETES CARE, V26, P1047, DOI 10.2337/diacare.26.4.1047; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; World Cancer Research Fund, 2015, CANC LINK GREAT BOD	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190870	10.1371/journal.pone.0190870	http://dx.doi.org/10.1371/journal.pone.0190870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370205	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600025
J	Dolka, I; Czopowicz, M; Gruk-Jurka, A; Wojtkowska, A; Sapierzynski, R; Jurka, P				Dolka, Izabella; Czopowicz, Michal; Gruk-Jurka, Anna; Wojtkowska, Agata; Sapierzynski, Rafal; Jurka, Piotr			Diagnostic efficacy of smear cytology and Robinson's cytological grading of canine mammary tumors with respect to histopathology, cytomorphometry, metastases and overall survival	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; INVASIVE BREAST-CARCINOMA; GLAND TUMORS; NUCLEAR MORPHOMETRY; PROGNOSTIC VALUE; CANCER; BIOPSY; DIFFERENTIATION; PREDICTOR; ACCURACY	Cytology is a simple, rapid, and inexpensive method used for pre-operative diagnosis of canine mammary tumors (CMTs) in veterinary practice. Studies related to human breast cancer showed the Robinson's grading system-established for invasive ductal carcinoma, not otherwise specified (IDC, NOS) and used on cytological material-to not only closely correspond to the histopathological grading but also be helpful in assessing prognosis and selecting most suitable treatments before surgery. The objectives of this study were: to evaluate the accuracy of cytological diagnosis and cytological Robinson's grading system compared to the histopathological examination of CMTs; to compare of cytological features and cytomorphometric parameters with tumor behavior, as well as cytological and histological grading; and to determine an association of the Robinson's grading system and cytological background details with metastases, and patients' survival. We report substantial diagnostic accuracy in detecting simple types and high grade tumors. Cytological diagnosis of tumor behavior showed relatively low sensitivity and specificity compared to human studies, and this might be caused by the heterogeneous morphology of CMTs. The presence of mucosecretory material and extracellular matrix was not significantly associated with tumor behavior. We report a positive correlation between both grading systems and cytological features (included in Robinson's grading), the presence of necrotic debris, inflammation, and red blood cells. A negative correlation was determined only for the presence of extracellular matrix. The univariate and multivariate analyses confirmed a significantly higher risk of developing metastasis and shorter overall survival for dogs with tumors of grade 2 or 3 on cytology. In addition, these tumors were the most common cause of CMT-related deaths in dogs. Taken together, our findings suggest that the Robinson's method of cytological grading applied for malignant CMTs evaluated in cytological smears regardless of tumor type can be adapted to veterinary cytology. Additionally, some background features seem to aid malignancy assessment.	[Dolka, Izabella; Sapierzynski, Rafal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Czopowicz, Michal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland; [Gruk-Jurka, Anna; Wojtkowska, Agata; Jurka, Piotr] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Small Anim Dis Clin, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Dolka, I (corresponding author), Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.	izabella_dolka@sggw.pl	Czopowicz, Michał/U-5452-2018	Czopowicz, Michał/0000-0002-4238-8360; Jurka, Piotr/0000-0002-3321-4844; /0000-0002-6904-0700	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food" [05-1/KNOW2/2015]; Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland [505-10-023700-L00182-99]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland	Research was supported by grant no 505-10-023700-L00182-99 received by Izabella Dolka from Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland. The costs of manuscript publication were funded by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abati A, 1997, DIAGN CYTOPATHOL, V16, P295; ALLEN SW, 1986, VET PATHOL, V23, P649, DOI 10.1177/030098588602300601; Allison RW, 2007, DIAGNOSTIC CYTOLOGY, P112; Altman E. I., 2000, PREDICTING FINANCIAL, P15; Barra ADA, 2008, DIAGN CYTOPATHOL, V36, P26, DOI 10.1002/dc.20748; Cassali GD, 2007, CYTOPATHOLOGY, V18, P191, DOI 10.1111/j.1365-2303.2007.00412.x; Cassali GD, 2015, VET CLIN PATH, V44, P448, DOI 10.1111/vcp.12269; Colodel M. M., 2012, Veterinaria e Zootecnia, V19, P557; Das AK, 2003, INDIAN J MED RES, V118, P247; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; De Vico G, 2007, VET RES COMMUN, V31, P1005, DOI 10.1007/s11259-006-0108-7; Dennis MM, 2011, VET PATHOL, V48, P73, DOI 10.1177/0300985810388820; Dias MLD, 2016, PESQUI VET BRASIL, V36, P181, DOI 10.1590/S0100-736X2016000300006; Dutra AP, 2008, ARQ BRAS MED VET ZOO, V60, P1403, DOI 10.1590/S0102-09352008000600015; Einstien D, 2014, ISRN ONCOLOGY, P1; GILCHRIST KW, 1993, J CLIN ONCOL, V11, P1929, DOI 10.1200/JCO.1993.11.10.1929; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Gore CR, 2013, INT J PHARM BIOL SCI, V3, P564; Haziroglu R, 2010, REV MED VET-TOULOUSE, V161, P212; HELLMEN E, 1989, J COMP PATHOL, V101, P443, DOI 10.1016/0021-9975(89)90027-3; Jayaram G, 2005, ACTA CYTOL, V49, P605, DOI 10.1159/000326247; Kalhan S, 2010, J CYTOL, V27, P16, DOI 10.4103/0970-9371.66694; Karayannopoulou M, 2005, J COMP PATHOL, V133, P246, DOI 10.1016/j.jcpa.2005.05.003; Karim BO, 2008, VET CLIN PATH, V37, P229, DOI 10.1111/j.1939-165X.2008.00030.x; Khan MZ, 2003, DIAGN CYTOPATHOL, V29, P185, DOI 10.1002/dc.10285; Khan N, 2009, J CYTOL, V26, P65, DOI 10.4103/0970-9371.55224; Kocaay Akin Firat, 2016, Niger Med J, V57, P77, DOI 10.4103/0300-1652.182078; Krishnakanth GVRN, 2016, ANN PATHOL LAB MED, V3, P190; Lale S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-7; Lana S.E, 2007, SMALL ANIMAL CLIN ON, P619; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maiorano E, 2010, BREAST CANCER RES TR, V121, P211, DOI 10.1007/s10549-009-0360-y; Meinkoth JH, 2007, DIAGNOSTIC CYTOLOGY, P37; Miskovic J, 2016, ACTA CLIN CROAT, V55, P625, DOI 10.20471/acc.2016.55.04.13; Moe L, 2001, J REP FER S, P439; Pal S, 2016, J CYTOL, V33, P182, DOI 10.4103/0970-9371.190449; Park S., 2010, BASIC APPL PATHOL, V3, P1, DOI DOI 10.1186/1754-6834-3-10; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Phukan JP, 2015, SOUTH ASIAN J CANCER, V4, P32, DOI 10.4103/2278-330X.149948; Pierini A, 2017, J VET DIAGN INVEST, V29, P869, DOI 10.1177/1040638717718886; Queiroga FL, 2011, IN VIVO, V25, P455; ROBINSON IA, 1994, LANCET, V343, P947, DOI 10.1016/S0140-6736(94)90066-3; ROBINSON IA, 1995, DIAGN CYTOPATHOL, V13, P260, DOI 10.1002/dc.2840130315; Saha K, 2013, J CYTOL, V30, P87, DOI 10.4103/0970-9371.112647; Salas Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127381; Sapierzynski R, 2017, J SMALL ANIM PRACT, V58, P73, DOI 10.1111/jsap.12598; Schiller AB, 2001, AM J CLIN PATHOL, V115, P219; Shivani Bhalla, 2011, Brazilian Journal of Veterinary Pathology, V4, P13; Simeonov R., 2006, Bulgarian Journal of Veterinary Medicine, V9, P211; Simeonov R, 2006, VET CLIN PATH, V35, P88, DOI 10.1111/j.1939-165X.2006.tb00093.x; Simon D, 2009, VET CLIN PATH, V38, P521, DOI 10.1111/j.1939-165X.2009.00150.x; Skrbinc B, 2001, CYTOPATHOLOGY, V12, P15, DOI 10.1046/j.1365-2303.2001.00297.x; Solano-Gallego L, 2009, CANINE FELINE CYTOLO, P274; Sontas BH, 2012, REPROD DOMEST ANIM, V47, P125, DOI 10.1111/j.1439-0531.2011.01810.x; Sood Neelam, 2013, Patholog Res Int, V2013, P146542, DOI 10.1155/2013/146542; Taniguchi E, 2000, ACTA CYTOL, V44, P587, DOI 10.1159/000328533; Vascellari M, 2016, PREV VET MED, V126, P183, DOI 10.1016/j.prevetmed.2016.02.008; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Yildirim F, 2012, REV MED VET-TOULOUSE, V163, P116; Yu GH, 1998, AM J CLIN PATHOL, V109, P315, DOI 10.1093/ajcp/109.3.315; Zuccari D. A. P. de C., 2001, Brazilian Journal of Veterinary Research and Animal Science, V38, P38, DOI 10.1590/S1413-95962001000100007	61	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191595	10.1371/journal.pone.0191595	http://dx.doi.org/10.1371/journal.pone.0191595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360854	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800039
J	Yuan, XC; Si, YT; Lin, WS; Yang, JQ; Wang, Z; Zhang, QF; Qian, W; Chen, YM; Yang, YS				Yuan, Xiaochun; Si, Youtao; Lin, Weisheng; Yang, Jingqing; Wang, Zheng; Zhang, Qiufang; Qian, Wei; Chen, Yuehmin; Yang, Yusheng			Effects of short-term warming and nitrogen addition on the quantity and quality of dissolved organic matter in a subtropical &ITCunninghamia&IT &ITlanceolate &ITplantation	PLOS ONE			English	Article							SOIL CARBON; ELEVATION GRADIENT; MICROBIAL BIOMASS; FLUORESCENCE; DEPOSITION; TEMPERATE; CO2; CLIMATE; FOREST; UV	Increasing temperature and nitrogen (N) deposition are two large-scale changes projected to occur over the coming decades. The effects of these changes on dissolved organic matter (DOM) are largely unknown. This study aimed to assess the effects of warming and N addition on the quantity and quality of DOM from a subtropical Cunninghamia lanceolata plantation. Between 2014 and 2016, soil solutions were collected from 0-15, 15-30, and 30-60 cm depths by using a negative pressure sampling method. The quantity and quality of DOM were measured under six different treatments. The spectra showed that the DOM of the forest soil solution mainly consisted of aromatic protein-like components, microbial degradation products, and negligible amounts of humic-like substances. Warming, N addition, and warming + N addition significantly inhibited the concentration of dissolved organic carbon (DOC) in the surface (0-15 cm) soil solution. Our results suggested that warming reduced the amount of DOM originating from microbes. The decrease in protein and carboxylic acid contents was mostly attributed to the reduction of DOC following N addition. The warming + N addition treatment showed an interactive effect rather than an additive effect. Thus, short-term warming and warming + N addition decreased the quantity of DOM and facilitated the migration of nutrients to deeper soils. Further, N addition increased the complexity of the DOM structure. Hence, the loss of soil nutrients and the rational application of N need to be considered in order to prevent the accumulation of N compounds in soil.	[Yuan, Xiaochun; Si, Youtao; Lin, Weisheng; Yang, Jingqing; Wang, Zheng; Zhang, Qiufang; Qian, Wei; Chen, Yuehmin; Yang, Yusheng] Fujian Normal Univ, Sch Geograph Sci, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China; [Si, Youtao; Lin, Weisheng; Qian, Wei; Chen, Yuehmin; Yang, Yusheng] Fujian Normal Univ, Inst Geog Sci, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Normal University	Chen, YM; Yang, YS (corresponding author), Fujian Normal Univ, Sch Geograph Sci, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China.; Chen, YM; Yang, YS (corresponding author), Fujian Normal Univ, Inst Geog Sci, Fuzhou, Fujian, Peoples R China.	ymchen@fjnu.edu.cn; geoyys@fjnu.edu.cn	Zhang, qiufang/AFP-9827-2022; Qian, Wei/B-8231-2013		National Natural Science Foundation of China [U1505233, 31670620, 31570606, 41401555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Nos. U1505233, 31670620, 31570606, and 41401555).	Abouelwafa R, 2008, BIORESOURCE TECHNOL, V99, P8571, DOI 10.1016/j.biortech.2008.04.007; Artz RRE, 2008, SOIL BIOL BIOCHEM, V40, P515, DOI 10.1016/j.soilbio.2007.09.019; Birdwell JE, 2010, ORG GEOCHEM, V41, P270, DOI 10.1016/j.orggeochem.2009.11.002; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Camino-Serrano M, 2014, GLOBAL BIOGEOCHEM CY, V28, P497, DOI 10.1002/2013GB004726; Chang Chen-hui, 2016, Yingyong Shengtai Xuebao, V27, P663, DOI 10.13287/j.1001-9332.201603.019; Chen H, 2015, ENVIRON POLLUT, V206, P352, DOI 10.1016/j.envpol.2015.07.033; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Cook S, 2017, WATER RES, V115, P229, DOI 10.1016/j.watres.2017.02.059; Dilling J, 2002, WATER RES, V36, P5037, DOI 10.1016/S0043-1354(02)00365-2; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Freppaz M, 2012, APPL SOIL ECOL, V62, P131, DOI 10.1016/j.apsoil.2012.06.006; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; Froberg M, 2013, GEODERMA, V200, P172, DOI 10.1016/j.geoderma.2013.02.002; [傅平青 Fu Pingqing], 2004, [第四纪研究, Quaternary Sciences], V24, P695; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gao JK, 2017, CHEMOSPHERE, V176, P108, DOI 10.1016/j.chemosphere.2017.02.104; Graham SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091204; Guo XJ, 2012, ENVIRON SCI POLLUT R, V19, P2079, DOI 10.1007/s11356-011-0704-0; Hu LG, 2009, FIXED POINT THEORY A, DOI 10.1155/2009/491583; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Ishii SKL, 2012, ENVIRON SCI TECHNOL, V46, P2006, DOI 10.1021/es2043504; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kane ES, 2016, HUMIC ACID, V119, P161; Komada T, 2002, MAR CHEM, V79, P81, DOI 10.1016/S0304-4203(02)00056-7; Lawaetz AJ, 2009, APPL SPECTROSC, V63, P936, DOI 10.1366/000370209788964548; Li PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130852; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060441; Li Q, 2017, FRONT EARTH SCI-PRC, V11, P76, DOI 10.1007/s11707-016-0568-1; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Liu XF, 2017, AGR FOREST METEOROL, V246, P78, DOI 10.1016/j.agrformet.2017.06.010; Lv FL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172382; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nie ZY, 2016, ENVIRON SCI POLLUT R, V23, P8756, DOI 10.1007/s11356-016-6110-x; Nimptsch J, 2014, LIMNOLOGICA, V48, P57, DOI 10.1016/j.limno.2014.06.003; Nottingham AT, 2015, BIOSCIENCE, V65, P906, DOI 10.1093/biosci/biv109; Ohno T, 2002, ENVIRON SCI TECHNOL, V36, P742, DOI 10.1021/es0155276; Peuravuori J, 2005, TALANTA, V65, P408, DOI 10.1016/j.talanta.2004.06.042; Pisani O, 2015, BIOGEOCHEMISTRY, V123, P391, DOI 10.1007/s10533-015-0073-8; Rappegeorge MO, 2012, BIOGEOSCIENCES DISCU, V9, P1365; Reid JP, 2012, ECOSYSTEMS, V15, P580, DOI 10.1007/s10021-012-9532-4; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Spring GM, 1996, FUNCT ECOL, V10, P541, DOI 10.2307/2389948; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Torn MS, 2015, SOIL-GERMANY, V1, P575, DOI 10.5194/soil-1-575-2015; VANBREEMEN N, 1984, NATURE, V307, P599, DOI 10.1038/307599a0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verstraeten A, 2016, SCI TOTAL ENVIRON, V553, P107, DOI 10.1016/j.scitotenv.2016.02.060; Vourlitis GL, 2007, SOIL SCI SOC AM J, V71, P836, DOI 10.2136/sssaj2006.0339; Vourlitis GL, 2015, J ARID ENVIRON, V122, P37, DOI 10.1016/j.jaridenv.2015.06.007; Wang XG, 2016, J MT SCI-ENGL, V13, P95, DOI 10.1007/s11629-015-3556-0; Wang Y, 2014, CHEMOSPHERE, V95, P353, DOI 10.1016/j.chemosphere.2013.09.044; Webb EE, 2016, J GEOPHYS RES-BIOGEO, V121, P249, DOI 10.1002/2014JG002795; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Xu X, 2010, IEEE INFOCOM SER; Xu XK, 2009, GEODERMA, V151, P370, DOI 10.1016/j.geoderma.2009.05.008; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; Yin HJ, 2012, SOIL BIOL BIOCHEM, V50, P77, DOI 10.1016/j.soilbio.2012.03.004; Zhang QF, 2017, PLANT SOIL, V411, P395, DOI 10.1007/s11104-016-3037-4; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Ziegler SE, 2013, SOIL BIOL BIOCHEM, V60, P23, DOI 10.1016/j.soilbio.2013.01.001	67	12	16	10	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191403	10.1371/journal.pone.0191403	http://dx.doi.org/10.1371/journal.pone.0191403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360853	Green Submitted, gold, Green Published			2022-12-26	WOS:000423161800028
J	Zhou, XJ; Desai, R; Zhang, YH; Stec, WJ; Miller, KW; Jounaidi, Y				Zhou, Xiaojuan; Desai, Rooma; Zhang, Yinghui; Stec, Wojciech J.; Miller, Keith W.; Jounaidi, Youssef			High-level production and purification in a functional state of an extrasynaptic gammaaminobutyric acid type A receptor containing alpha 4 beta 3 delta subunits	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; GABA(A) RECEPTORS; DELTA-SUBUNIT; PHARMACOLOGICAL CHARACTERIZATION; EXPRESSION; RECOMBINANT; ALPHA-1-BETA-3-DELTA; STOICHIOMETRY; ARRANGEMENT; ACTIVATION	The inhibitory.-aminobutyric acid type A receptors are implicated in numerous physiological processes, including cognition and inhibition of neurotransmission, rendering them important molecular targets for many classes of drugs. Functionally, the entire GABA(A)R family of receptors can be subdivided into phasic, fast acting synaptic receptors, composed of alpha-, beta- and gamma-subunits, and tonic extrasynaptic receptors, many of which contain the delta-subunit in addition to a-and beta-subunits. Whereas the subunit arrangement of the former group is agreed upon, that of the alpha beta delta GABA(A)Rs remains unresolved by electrophysiological and pharmacological research. To resolve such issues will require biophysical techniques that demand quantities of receptor that have been previously unavailable. Therefore, we have engineered a stable cell line with tetracycline inducible expression of human alpha 4-, beta 3- and Nterminally Flag-tagged delta-subunits. This cell line achieved a specific activity between 15 and 20 pmol[H-3] muscimol sites/mg of membrane protein, making it possible to obtain 1 nmole of purified alpha 4 beta 3 delta GABAAR from sixty 15 +/- cm culture dishes. When induced, these cells exhibited agonist +/- induced currents with characteristics comparable to those previously reported for this receptor and a pharmacology that included strong modulation by etomidate and the d-subunit-specific ligand, DS2. Immunoaffinity purification and reconstitution in CHAPS/asolectin micelles resulted in the retention of equilibrium allosteric interactions between the separate agonist, anesthetic and DS2 sites. Moreover, all three subunits retained glycosylation. The establishment of this well +/- characterized cell line will allow molecular level studies of tonic receptors to be undertaken.	[Zhou, Xiaojuan; Desai, Rooma; Zhang, Yinghui; Stec, Wojciech J.; Miller, Keith W.; Jounaidi, Youssef] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Miller, KW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	kwmiller@mgh.harvard.edu			National Institute of General Medical Sciences [GM 58448]; Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; National Institutes of Health Grant [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institute of General Medical Sciences GM 58448 (to KWM) and by the Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital (to YJ, RD and KWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health Grant GM-58448 and by the Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Chiara DC, 2016, J BIOL CHEM, V291, P26529, DOI 10.1074/jbc.M116.753335; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Forman SA, 1999, BIOCHEMISTRY-US, V38, P14559, DOI 10.1021/bi9914457; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Lee HJ, 2016, BRAIN RES, V1644, P222, DOI 10.1016/j.brainres.2016.05.019; Liu K, 2015, NEUROSCIENCE, V300, P307, DOI 10.1016/j.neuroscience.2015.05.051; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wongsamitkul N, 2016, J BIOL CHEM, V291, P18474, DOI 10.1074/jbc.M116.738906; Zhang YH, 2014, BIOPHYS J, V106, p547A, DOI 10.1016/j.bpj.2013.11.3044	34	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191583	10.1371/journal.pone.0191583	http://dx.doi.org/10.1371/journal.pone.0191583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352320	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300117
J	Chiarelli, N; Carini, G; Zoppi, N; Ritelli, M; Colombi, M				Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina			Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SYNDROME TYPE-IV; UNFOLDED PROTEIN RESPONSE; EXTRACELLULAR-MATRIX; ENDOPLASMIC-RETICULUM; CONNECTIVE TISSUES; COLLAGEN; HAPLOINSUFFICIENCY; SPECIFICITY; FIBRONECTIN	Vascular Ehlers-Danlos syndrome (vEDS) is a dominantly inherited connective tissue disorder caused by mutations in the COL3A1 gene that encodes type III collagen (COLLIII), which is the major expressed collagen in blood vessels and hollow organs. The majority of disease-causing variants in COL3A1 are glycine substitutions and in-frame splice mutations in the triple helix domain that through a dominant negative effect are associated with the severe clinical spectrum potentially lethal of vEDS, characterized by fragility of soft connective tissues with arterial and organ ruptures. To shed lights into molecular mechanisms underlying vEDS, we performed gene expression profiling in cultured skin fibroblasts from three patients with different structural COL3A1 mutations. Transcriptome analysis revealed significant changes in the expression levels of several genes involved in maintenance of cell redox and endoplasmic reticulum (ER) homeostasis, COLLs folding and extracellular matrix (ECM) organization, formation of the proteasome complex, and cell cycle regulation. Protein analyses showed that aberrant COLLIII expression is associated with the disassembly of many structural ECM constituents, such as fibrillins, EMILINs, and elastin, as well as with the reduction of the proteoglycans perlecan, decorin, and versican, all playing an important role in the vascular system. Furthermore, the altered distribution of the ER marker protein disulfide isomerase PDI and the strong reduction of the COLLs-modifying enzyme FKBP22 are consistent with the disturbance of ER-related homeostasis and COLLs biosynthesis and post-translational modifications, indicated by microarray analysis. Our findings add new insights into the pathophysiology of this severe vascular disorder, since they provide a picture of the gene expression changes in vEDS skin fibroblasts and highlight that dominant negative mutations in COL3A1 also affect post-translational modifications and deposition into the ECM of several structural proteins crucial to the integrity of soft connective tissues.	[Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina] Univ Brescia, Dept Mol & Translat Med, Div Biol & Genet, Brescia, Italy	University of Brescia	Colombi, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Div Biol & Genet, Brescia, Italy.	marina.colombi@unibs.it	Carini, Giulia/AAA-8800-2022; Chiarelli, Nicola/T-4923-2019	Carini, Giulia/0000-0001-8096-9417; RITELLI, Marco/0000-0002-7025-2495; Chiarelli, Nicola/0000-0002-1760-5079; Colombi, Marina/0000-0002-3105-5990; ZOPPI, Nicoletta/0000-0003-0197-8927				Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aziz J, 2016, SKIN PHARMACOL PHYS, V29, P190, DOI 10.1159/000447017; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Busch A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0491-2; Byers PH, 2017, AM J MED GENET C, V175, P40, DOI 10.1002/ajmg.c.31553; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; De Palma S, 2014, J PROTEOME RES, V13, P5022, DOI 10.1021/pr500675e; DEPAEPE A, 1987, BRIT J DERMATOL, V117, P89; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Dordoni C, 2016, AM J MED GENET A, V170, P2031, DOI 10.1002/ajmg.a.37728; Drera B, 2011, J DERMATOL SCI, V64, P237, DOI 10.1016/j.jdermsci.2011.09.002; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Frank M, 2015, EUR J HUM GENET, V23, P1657, DOI 10.1038/ejhg.2015.32; Giunta C, 2017, GENET MED; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HOLBROOK KA, 1981, LAB INVEST, V44, P342; Hughes A, 2017, INT J MOL SCI, V18; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Leistritz DF, 2011, GENET MED, V13, P717, DOI 10.1097/GIM.0b013e3182180c89; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu M, 2016, ONCOL RES, V23, P267, DOI 10.3727/096504016X14549667333963; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marthandan S, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0095-2; Masuno M, 2012, CONGENIT ANOM, V52, P207, DOI 10.1111/j.1741-4520.2011.00353.x; Meirelles T, 2016, INT J BIOCHEM CELL B, V71, P81, DOI 10.1016/j.biocel.2015.12.009; Melnyk Armin, 2015, Subcell Biochem, V78, P179, DOI 10.1007/978-3-319-11731-7_9; Morissette R, 2014, CIRC-CARDIOVASC GENE, V7, P80, DOI 10.1161/CIRCGENETICS.113.000280; Murray ML, 2014, AM J MED GENET A, V164, P1750, DOI 10.1002/ajmg.a.36492; Ong KT, 2010, LANCET, V376, P1476, DOI 10.1016/S0140-6736(10)60960-9; Parkin J. D, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0175582; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin MG, 2014, GENET MED, V16, P881, DOI 10.1038/gim.2014.72; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Randell A, 2017, J AM SOC HYPERTENS, V11, P437, DOI 10.1016/j.jash.2017.04.010; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ritelli M, 2015, MOLEC GENET METAB RE, V2, P1, DOI 10.1016/j.ymgmr.2014.11.005; Rodriguez-Vita J, 2005, CIRC RES, V97, P125, DOI 10.1161/01.RES.0000174614.74469.83; Schoenhoff FS, 2009, CIRCULATION, V120, pS1048; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Smith LB, 2011, CARDIOVASC RES, V90, P182, DOI 10.1093/cvr/cvq356; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Stepanov GA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/206849; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Villani GRD, 2012, J INHERIT METAB DIS, V35, P479, DOI 10.1007/s10545-011-9403-8; Wan GH, 2014, ANTIOXID REDOX SIGN, V20, P655, DOI 10.1089/ars.2013.5514; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003; Zoppi N, 2015, HUM MOL GENET, V24, P6769, DOI 10.1093/hmg/ddv382; Zoppi N, 2012, BBA-GEN SUBJECTS, V1820, P1576, DOI 10.1016/j.bbagen.2012.06.004	72	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191220	10.1371/journal.pone.0191220	http://dx.doi.org/10.1371/journal.pone.0191220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346445	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500037
J	Hang, W; Yin, ZX; Liu, G; Zeng, QH; Shen, XF; Sun, QH; Li, DD; Jian, YP; Zhang, YH; Wang, YS; Quan, CS; Zhao, RX; Li, YL; Xu, ZX				Hang, Wei; Yin, Zhi-Xian; Liu, Gang; Zeng, Qinghua; Shen, Xiang-Feng; Sun, Qian-Hui; Li, Dong-Dong; Jian, Yong-Ping; Zhang, Yang-He; Wang, Yi-Shu; Quan, Cheng-Shi; Zhao, Rui-Xun; Li, Yu-Lin; Xu, Zhi-Xiang			Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1	ONCOGENE			English	Article							MUTANT P53 REACTIVATION; CANCER-CELLS; DOWN-REGULATION; STEM-CELLS; HEAD; DRUG; INHIBITION; CARCINOMA; MECHANISM; APOPTOSIS	TP53 mutations frequently occur in head and neck squamous cell carcinoma (HNSCC) patients without human papillomavirus infection. The recurrence rate for these patients is distinctly high. It has been actively explored to identify agents that target TP53 mutations and restore wild-type (WT) TP53 activities in HNSCC. PRIMA-1 (p53-reactivation and induction of massive apoptosis-1) and its methylated analogue PRIMA-1(Met) (also called APR-246) were found to be able to reestablish the DNA-binding activity of p53 mutants and reinstate the functions of WT p53. Herein we report that piperlongumine (PL), an alkaloid isolated from Piper longum L., synergizes with APR-246 to selectively induce apoptosis and autophagic cell death in HNSCC cells, whereas primary and immortalized mouse embryonic fibroblasts and spontaneously immortalized non-tumorigenic human skin keratinocytes (HaCat) are spared from the damage by the co-treatment. Interestingly, PL-sensitized HNSCC cells to APR-246 are TP53 mutation-independent. Instead, we demonstrated that glutathione S-transferase pi 1 (GSTP1), a GST family member that catalyzes the conjugation of GSH with electrophilic compounds to fulfill its detoxification function, is highly expressed in HNSCC tissues. Administration of PL and APR-246 significantly suppresses GSTP1 activity, resulting in the accumulation of ROS, depletion of GSH, elevation of GSSG, and DNA damage. Ectopic expression of GSTP1 or pre-treatment with antioxidant N-acetyl-L-cysteine (NAC) abrogates the ROS elevation and decreases DNA damage, apoptosis, and autophagic cell death prompted by PL/APR-246. In addition, administration of PL and APR-246 impedes UMSCC10A xenograft tumor growth in SCID mice. Taken together, our data suggest that HNSCC cells are selectively sensitive to the combination of PL and APR-246 due to a remarkably synergistic effect of the co-treatment in the induction of ROS by suppression of GSTP1.	[Hang, Wei; Yin, Zhi-Xian; Liu, Gang] Tianjin Huanhu Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tianjin, Peoples R China; [Zeng, Qinghua; Zhao, Rui-Xun; Xu, Zhi-Xiang] Univ Alabama Birmingham, Ctr Comprehens Canc, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Zeng, Qinghua; Shen, Xiang-Feng; Sun, Qian-Hui; Li, Dong-Dong; Jian, Yong-Ping; Zhang, Yang-He; Wang, Yi-Shu; Quan, Cheng-Shi; Li, Yu-Lin; Xu, Zhi-Xiang] Jilin Univ, Norman Bethune Coll Med, Minist Educ, Key Lab Pathobiol, Changchun, Jilin, Peoples R China	University of Alabama System; University of Alabama Birmingham; Jilin University	Hang, W (corresponding author), Tianjin Huanhu Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tianjin, Peoples R China.	hangwei2627@126.com			National Natural Science Foundation of China [81573087, 81572139, 81772924]; U.S. National Institutes of Health [R01CA133053]; NATIONAL CANCER INSTITUTE [R01CA133053] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Natural Science Foundation of China (Grant Nos: 81573087, 81572139, and 81772924) and the U.S. National Institutes of Health (Grant No: R01CA133053).	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alpay M, 2016, J CANCER RES THER, V12, P556, DOI 10.4103/0973-1482.151936; Basak D, 2016, INT J ONCOL, V48, P1426, DOI 10.3892/ijo.2016.3372; Bentz BG, 2000, LARYNGOSCOPE, V110, P1642, DOI 10.1097/00005537-200010000-00013; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; Bharadwaj U, 2015, ONCOGENE, V34, P1341, DOI 10.1038/onc.2014.72; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Bykov VJN, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00021; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chou TC, 2007, COMPUSYN SOFTWARE DR, P1; Cosenza M, 2017, APOPTOSIS, V22, P827, DOI 10.1007/s10495-017-1364-4; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; Deben C, 2016, CANCER LETT, V375, P313, DOI 10.1016/j.canlet.2016.03.017; Fitzgerald AL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.44; Gersey ZC, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3058-2; Glasauer A, 2014, BIOCHEM PHARMACOL, V92, P90, DOI 10.1016/j.bcp.2014.07.017; Harshbarger W, 2017, J BIOL CHEM, V292, P112, DOI 10.1074/jbc.M116.750299; Hientz K, 2017, ONCOTARGET, V8, P8921, DOI 10.18632/oncotarget.13475; Huang BK, 2016, ANTIOXID REDOX SIGN, V24, P924, DOI 10.1089/ars.2015.6482; Huang XM, 2016, CANCER CELL, V30, P940, DOI 10.1016/j.ccell.2016.11.006; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Kim EH, 2011, CANCER PREV RES, V4, P425, DOI 10.1158/1940-6207.CAPR-10-0153; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Meegan MJ, 2017, EUR J MED CHEM, V125, P453, DOI 10.1016/j.ejmech.2016.09.048; Moreira FD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33646; Patel K, 2015, J PHARM SCI-US, V104, P4417, DOI 10.1002/jps.24637; Peng X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.417; Pignanelli C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01230-4; Prasad S, 2016, CURR PHARM DESIGN, V22, P4151, DOI 10.2174/1381612822666160601103027; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Roh JL, 2014, ONCOTARGET, V5, P9227, DOI 10.18632/oncotarget.2402; Satoh T, 2013, FREE RADICAL BIO MED, V65, P645, DOI 10.1016/j.freeradbiomed.2013.07.022; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tan JK, 2016, NUTR CANCER, V68, P507, DOI 10.1080/01635581.2016.1153671; Tanaka N, 2015, CLIN CANCER RES, V21, P4831, DOI 10.1158/1078-0432.CCR-15-0279; Tessoulin B, 2014, BLOOD, V124, P1626, DOI 10.1182/blood-2014-01-548800; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang HB, 2017, EUR J MED CHEM, V126, P517, DOI 10.1016/j.ejmech.2016.11.034; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.358; Wang YW, 2016, CANCER PREV RES, V9, P234, DOI 10.1158/1940-6207.CAPR-15-0306; Xi Y, 2015, J CANCER, V6, P327, DOI 10.7150/jca.11185; Xu HG, 2015, ONCOGENE, V34, P3848, DOI 10.1038/onc.2014.315; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zeng Q, 2017, ONCOGENE, V36, P1245, DOI 10.1038/onc.2016.290; Zeng QH, 2016, P NATL ACAD SCI USA, V113, P9333, DOI 10.1073/pnas.1606801113; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024; Zou P, 2016, CANCER LETT, V375, P114, DOI 10.1016/j.canlet.2016.02.058	55	30	30	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	25					3384	3398		10.1038/s41388-017-0110-2	http://dx.doi.org/10.1038/s41388-017-0110-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TC	29348462	Green Accepted			2022-12-26	WOS:000436411300005
J	Alpsoy, A; Dykhuizen, EC				Alpsoy, Aktan; Dykhuizen, Emily C.			Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERACTOME; CANCER; BRD4; COMPLEX; DISCOVERY; PROTEINS; BROMODOMAIN; REVEALS; TARGETS; BINDING	The mammalian SWI/SNF chromatin remodeling complex is a heterogeneous collection of related protein complexes required for gene regulation and genome integrity. It contains a central ATPase (BRM or BRG1) and various combinations of 10-14 accessory subunits (BAFs for BRM/BRG1 Associated Factors). Two distinct complexes differing in size, BAF and the slightly larger polybromo-BAF (PBAF), share many of the same core subunits but are differentiated primarily by having either AT-rich interaction domain 1A/B (ARID1A/B in BAF) or ARID2 (in PBAF). Using density gradient centrifugation and immunoprecipitation, we have identified and characterized a third and smaller SWI/SNF subcomplex. We termed this complex GBAF because it incorporates two mutually exclusive paralogs, GLTSCR1 (glioma tumor suppressor candidate region gene 1) or GLTSCR1L (GLTSCR1-like), instead of an ARID protein. In addition toGLTSCR1 or GLTSCR1L, the GBAF complex contains BRD9 (bromodomain-containing 9) and the BAF subunits BAF155, BAF60, SS18, BAF53a, and BRG1/BRM. We observed that GBAF does not contain the core BAF subunits BAF45, BAF47, or BAF57. Even without these subunits, GBAF displayed in vitro ATPase activity and bulk chromatin affinity comparable to those of BAF. GBAF associated with BRD4, but, unlike BRD4, the GBAF component GLTSCR1 was not required for the viability of the LNCaP prostate cancer cell line. In contrast, GLTSCR1 or GLTSCR1L knockouts in the metastatic prostate cancer cell line PC3 resulted in a loss in proliferation and colony-forming ability. Taken together, our results provide evidence for a compositionally novel SWI/SNF subcomplex with cell type-specific functions.	[Alpsoy, Aktan; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dykhuizen, EC (corresponding author), Dept Med Chem & Mol Pharmacol, HANS105A,201 S Univ St, W Lafayette, IN 47907 USA.	edykhui@purdue.edu		Alpsoy, Aktan/0000-0002-8940-8277	National Institutes of Health Grant [CA207532]; V Foundation for Cancer Research [V2014-004, D2016-030]; Lilly Foundation; National Institutes of Health through the Purdue University Center [P30 CA023168]; NATIONAL CANCER INSTITUTE [U01CA207532, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Lilly Foundation; National Institutes of Health through the Purdue University Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported with National Institutes of Health Grant CA207532, V Foundation for Cancer Research Grants V2014-004 and D2016-030 ( to E.C.D.), a graduate endowment from the Lilly Foundation (to A.A.), and National Institutes of Health Grant P30 CA023168 through the Purdue University Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Cardoso DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185409; Conrad RJ, 2017, MOL CELL, V67, P1001, DOI 10.1016/j.molcel.2017.07.025; Crowe BL, 2016, P NATL ACAD SCI USA, V113, P2086, DOI 10.1073/pnas.1516813113; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hohmann AF, 2016, NAT CHEM BIOL, V12, P672, DOI 10.1038/nchembio.2115; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kelso TWR, 2017, ELIFE, V6, DOI [10.7554/eLife.30506.001, 10.7554/eLife.30506]; Karmer KF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071537; Mani U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184445; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; Mathies LD, 2017, ALCOHOL CLIN EXP RES, V41, P2033, DOI 10.1111/acer.13514; Mathies LD, 2015, P NATL ACAD SCI USA, V112, P3032, DOI 10.1073/pnas.1413451112; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Mayes K, 2014, ADV CANCER RES, V121, P183, DOI 10.1016/B978-0-12-800249-0.00005-6; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Porter EG, 2017, JOVE-J VIS EXP, DOI 10.3791/55369; Porter EG, 2017, J BIOL CHEM, V292, P2601, DOI 10.1074/jbc.M116.746875; Raab JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005748; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Staahl BT, 2013, J NEUROSCI, V33, P10348, DOI 10.1523/JNEUROSCI.1258-13.2013; Stanton B. Z., 2017, GEN NONRADIOACTIVE A; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wurster AL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-9; Zinzalla G, 2016, CHEMBIOCHEM, V17, P677, DOI 10.1002/cbic.201500565; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	92	96	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3892	3903		10.1074/jbc.RA117.001065	http://dx.doi.org/10.1074/jbc.RA117.001065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374058	Green Published, hybrid			2022-12-26	WOS:000427587500004
J	Rosa, F; Busato, S; Avaroma, FC; Linville, K; Trevisi, E; Osorio, JS; Bionaz, M				Rosa, Fernanda; Busato, Sebastiano; Avaroma, Fatima C.; Linville, Kali; Trevisi, Erminio; Osorio, Johan S.; Bionaz, Massimo			Transcriptional changes detected in fecal RNA of neonatal dairy calves undergoing a mild diarrhea are associated with inflammatory biomarkers	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION PROFILES; PREPARTAL ENERGY-INTAKE; ACUTE-PHASE PROTEINS; GASTROINTESTINAL-TRACT; BLOOD METABOLITES; EPITHELIAL-CELLS; HOLSTEIN CALVES; MESSENGER-RNA; TNF-ALPHA	After birth, a newborn calf has to adapt to an extrauterine life characterized by several physiological changes. In particular, maturation of the gastrointestinal tract in a new environment loaded with potential pathogens, which can predispose neonatal calves to develop diarrhea, and is a major cause of morbidity and mortality during the first 4 wks of life. We aimed to investigate the inflammatory adaptations at a transcriptomic level in the gastrointestinal (GI) tract to a mild diarrhea in neonatal dairy calves using RNA isolated from fresh fecal samples. Eight newborn Jersey male calves were used from birth to 5 wks of age and housed in individual pens. After birth, calves received 1.9 L of colostrum from their respective dams. Calves had ad-libitum access to water and starter grain (22% CP) and were fed twice daily a total of 5.6 L pasteurized whole milk. Starter intake, body weight (BW), fecal score, withers height (WH), and rectal temperature (RT) were recorded throughout the experiment. Blood samples were collected weekly for metabolic and inflammatory profiling from wk 0 to wk 5. Fresh fecal samples were collected weekly and immediately flash frozen until RNA was extracted using a Trizol-based method, and subsequently, an RT-qPCR analysis was performed. Orthogonal contrasts were used to evaluate linear or quadratic effects over time. Starter intake, BW, and WH increased over time. Fecal score was greatest (2.6 +/- 0.3) during wk 2. The concentrations of IL-6, ceruloplasmin, and haptoglobin had a positive quadratic effect with maximal concentrations during wk 2, which corresponded to the maximal fecal score observed during the same time. The concentration of serum amyloid A decreased over time. The mRNA expression of the proinflammatory related genes TLR4, TNFA, IL8, and IL1B had a positive quadratic effect of time. A time effect was observed for the cell membrane sodium-dependent glucose transporter SLC5A1, for the major carbohydrate facilitated transporter SLC2A2, and water transport function AQP3, where SLC5A1 and AQP3 had a negative quadratic effect over time. Our data support the use of the fecal RNA as a noninvasive tool to investigate intestinal transcriptomic profiling of dairy calves experiencing diarrhea, which would be advantageous for future research including nutritional effects and health conditions.	[Rosa, Fernanda; Busato, Sebastiano; Osorio, Johan S.; Bionaz, Massimo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Avaroma, Fatima C.] Escuela Agr Panamer El Zamorano, El Zamorano, Francisco Moraz, Honduras; [Linville, Kali] South Dakota State Univ, Dept Dairy & Food Sci, Brookings, SD USA; [Trevisi, Erminio] Univ Cattolica Sacro Cuore, Fac Sci Agr Alimentari & Ambientali, Ist Zootecn, Piacenza, Italy	Oregon State University; South Dakota State University; Catholic University of the Sacred Heart	Osorio, JS (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	Johan.Osorio@sdstate.edu	Osorio, Johan/J-3703-2019; Rosa, Fernanda/AAA-6140-2022; Busato, Sebastiano/AAN-4228-2021; Bionaz, Massimo/I-4222-2018	Osorio, Johan/0000-0001-6192-0917; Busato, Sebastiano/0000-0002-2542-3443; Bionaz, Massimo/0000-0002-0674-1892; Rosa, Fernanda/0000-0002-8906-4056	United State Department of Agriculture - National Institute of Food and Agriculture - Oregon Agricultural Experiment Station [ORE00144]; Oregon Agricultural Experiment Station	United State Department of Agriculture - National Institute of Food and Agriculture - Oregon Agricultural Experiment Station; Oregon Agricultural Experiment Station	This work was supported by United State Department of Agriculture - National Institute of Food and Agriculture - Oregon Agricultural Experiment Station - Project No. ORE00144 to JSO. http://agsci.oregoustate.edu/research/ahout-research-college-agriculturagriculturalal-sciences/oregon-experiment-station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the Oregon Agricultural Experiment Station for supporting this research. The authors thank Seth Spencer of the Oregon State University Dairy Research Center staff for the help with animal management.	Adjei-Fremah S, 2016, GENOM DATA, V10, P15, DOI 10.1016/j.gdata.2016.08.016; Alugongo GM, 2016, J DAIRY SCI, V10; Amador P, 2007, J CELL BIOCHEM, V101, P99, DOI 10.1002/jcb.21168; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Barrenetxe J, 2013, CYTOKINE, V64, P181, DOI 10.1016/j.cyto.2013.07.004; Barton BE, 1997, CLIN IMMUNOL IMMUNOP, V85, P16, DOI 10.1006/clin.1997.4420; Batistel F, 2017, J DAIRY SCI; Berchtold J, 2009, VET CLIN N AM-FOOD A, V25, P73, DOI 10.1016/j.cvfa.2008.10.001; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bertoni G, 2009, ITAL J ANIM SCI, V8, P595, DOI 10.4081/ijas.2009.s2.595; Bertrand K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/534139; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Blum JW, 2000, LIVEST PROD SCI, V66, P151, DOI 10.1016/S0301-6226(00)00222-0; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Cepinskas G, 2002, FREE RADICAL BIO MED, V33, P433, DOI 10.1016/S0891-5849(02)00962-0; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Chapkin RS, 1998, NUTR CANCER, V32, P107, DOI 10.1080/01635589809514727; da Silva DG, 2011, PESQUI VET BRASIL, V31, P551, DOI [10.1590/S0100-736X2011000700001, 10.1590/S0100-736X2011000700007]; DAVIDSON LA, 1995, CANCER EPIDEM BIOMAR, V4, P643; Davidson LA, 2003, BIOMARKERS, V8, P51, DOI 10.1080/1354750021000042268; Deignan T, 2000, RES VET SCI, V69, P153, DOI 10.1053/rvsc.2000.0403; Donovan SM, 2014, FEBS LETT, V588, P4112, DOI 10.1016/j.febslet.2014.07.008; Fischer S, 2016, J DAIRY SCI, V99, P6563, DOI 10.3168/jds.2015-10740; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Graugnard DE, 2013, J DAIRY SCI, V96, P918, DOI 10.3168/jds.2012-5676; Guilloteau P, 1997, J VET MED A, V44, P1, DOI 10.1111/j.1439-0442.1997.tb01082.x; Guttman JA, 2008, TRENDS MICROBIOL, V16, P535, DOI 10.1016/j.tim.2008.08.004; Hayashi H, 2006, J DAIRY SCI, V89, P1654, DOI 10.3168/jds.S0022-0302(06)72232-9; Jacometo CB, 2016, J DAIRY SCI, V99, P6753, DOI 10.3168/jds.2016-11018; Jacometo CB, 2015, J DAIRY SCI, V98, P7717, DOI 10.3168/jds.2015-9359; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Kaeffer B, 2007, PEDIATR RES, V62, P564, DOI 10.1203/PDR.0b013e318155a402; Kamra A, 2005, J NUTR, V135, P2719, DOI 10.1093/jn/135.11.2719; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Khan MA, 2007, J DAIRY SCI, V90, P5259, DOI 10.3168/jds.2007-0338; Klotz JL, 2006, J DAIRY SCI, V89, P3587, DOI 10.3168/jds.S0022-0302(06)72398-0; Knowles TG, 2000, VET REC, V147, P593, DOI 10.1136/vr.147.21.593; Malmuthuge N, 2012, VET IMMUNOL IMMUNOP, V146, P18, DOI 10.1016/j.vetimm.2012.01.010; Mitchell SF, 2016, METHODS MOL BIOL, V1421, P153, DOI 10.1007/978-1-4939-3591-8_13; Moyes KM, 2014, J DAIRY SCI, V97, P2165, DOI 10.3168/jds.2013-7433; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nonnecke BJ, 2014, J DAIRY SCI, V97, P5566, DOI 10.3168/jds.2014-8293; Ontsouka EC, 2016, J DAIRY SCI, V99, P4111, DOI 10.3168/jds.2015-9741; Osorio JS, 2012, J DAIRY SCI, V95, P5831, DOI 10.3168/jds.2011-5042; Pritts T, 2002, AM J SURG, V183, P372, DOI 10.1016/S0002-9610(02)00812-7; QUIGLEY JD, 1991, J DAIRY SCI, V74, P258, DOI 10.3168/jds.S0022-0302(91)78168-X; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ricanek P, 2015, CLIN EXP GASTROENTER, V8, P49, DOI 10.2147/CEG.S70119; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Slebodzinski AB, 2002, RES VET SCI, V72, P17, DOI 10.1053/rvsc.2001.0514; Stanley CC, 2002, J DAIRY SCI, V85, P2335, DOI 10.3168/jds.S0022-0302(02)74313-0; Steinhoff-Wagner J, 2011, J DAIRY SCI, V94, P5111, DOI 10.3168/jds.2011-4355; Steinhoff-Wagner J, 2014, J DAIRY SCI, V97, P6358, DOI 10.3168/jds.2014-8391; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; STREETER RN, 1995, AM J VET RES, V56, P1322; Tahmasbi AM, 2014, J DAIRY SCI, V97, P363, DOI 10.3168/jds.2012-6356; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Trevisi E, 2010, J DAIRY RES, V77, P310, DOI 10.1017/S0022029910000178; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Wang P, 2011, CAN J MICROBIOL, V57, P590, DOI [10.1139/w11-048, 10.1139/W11-048]; Weintraub AS, 2015, J PERINATOL, V35, P401, DOI 10.1038/jp.2014.232; Wright EM, 2003, BEST PRACT RES CL GA, V17, P943, DOI 10.1016/S1521-6918(03)00107-0; Yoho WSB, 2013, J DAIRY SCI, V96, P2494, DOI 10.3168/jds.2012-6099; Zhao C, 2009, CANCER PREV RES, V2, P590, DOI 10.1158/1940-6207.CAPR-08-0233; Zhao GX, 2014, BIOCHEM BIOPH RES CO, V443, P161, DOI 10.1016/j.bbrc.2013.11.067; Zhou Z, 2016, J DAIRY SCI, V99, P8956, DOI 10.3168/jds.2016-10986	72	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191599	10.1371/journal.pone.0191599	http://dx.doi.org/10.1371/journal.pone.0191599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373601	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400016
J	Tobin, RL; Kulmatiski, A				Tobin, Rebecca L.; Kulmatiski, Andrew			Plant identity and shallow soil moisture are primary drivers of stomatal conductance in the savannas of Kruger National Park	PLOS ONE			English	Article							WATER-USE; PHOTOSYNTHESIS; MODEL; RESPONSES; CARBON; CO2; TRANSPIRATION; BEHAVIOR; DROUGHT; FLUXES	Our goal was to describe stomatal conductance (g(s)) and the site-scale environmental parameters that best predict g(s) in Kruger National Park (KNP), South Africa. Dominant grass and woody species were measured over two growing seasons in each of four study sites that represented the natural factorial combination of mean annual precipitation [ wet (750 mm) or dry (450 mm)] and soil type (clay or sand) found in KNP. A machine-learning (random forest) model was used to describe g(s) as a function of plant type (species or functional group) and site-level environmental parameters (CO2, season, shortwave radiation, soil type, soil moisture, time of day, vapor pressure deficit and wind speed). The model explained 58% of the variance among 6,850 gs measurements. Species, or plant functional group, and shallow (0-20 cm) soil moisture had the greatest effect on g(s). Atmospheric drivers and soil type were less important. When parameterized with three years of observed environmental data, the model estimated mean daytime growing season gs as 68 and 157 mmol m(-2) sec(-1) for grasses and woody plants, respectively. The model produced here could, for example, be used to estimate gs and evapotranspiration in KNP under varying climate conditions. Results from this field-based study highlight the role of species identity and shallow soil moisture as primary drivers of g(s) in savanna ecosystems of KNP.	[Kulmatiski, Andrew] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu	kulmatiski, andrew/J-2072-2015	kulmatiski, andrew/0000-0001-9977-5508	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University; Office of Research and Graduate Studies; Kruger National Park [213896412]; Utah Agricultural Experiment Station; Utah State University	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University; Office of Research and Graduate Studies; Kruger National Park; Utah Agricultural Experiment Station; Utah State University	Research was funded by the Andrew Mellon Foundation, the Utah Agricultural Experiment Station, Utah State University, and the Office of Research and Graduate Studies, and approved as journal paper number 8958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study would not have been possible without the cooperation of South African National Parks and Kruger National Park (project registration number 213896412). Research was funded by the Andrew Mellon Foundation, the Utah Agricultural Experiment Station, Utah State University, and the Office of Research and Graduate Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research approved by the Utah Agricultural Experiment Station as journal paper number 8958. Thanks to Thomas C. Edwards for assistance in statistical analyses and modeling and to Karen H. Beard and Bruce Bugbee for reviewing the manuscript. Thank you also to the field managers: M. Keretetse, S. Heath, L. Hierl, M. Cooper, and M. Mazzacavallo and the field/laboratory assistants: W. Sabuyi, R. Mashele, V. Sabuyi, and M. Rogers.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; AMUNDSON RG, 1995, J ARID ENVIRON, V29, P139, DOI 10.1016/S0140-1963(05)80085-0; Anderegg WRL, 2015, SCIENCE, V349, P528, DOI 10.1126/science.aab1833; AVISSAR R, 1985, AGR FOREST METEOROL, V34, P21, DOI 10.1016/0168-1923(85)90051-6; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Beerling DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0311; Bellasio C, 2017, PLANT PHYSIOL, V175, P104, DOI 10.1104/pp.17.00666; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Berry RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175402; Bonan GB, 2014, GEOSCI MODEL DEV, V7, P2193, DOI 10.5194/gmd-7-2193-2014; Buckley TN, 2013, PLANT CELL ENVIRON, V36, P1691, DOI 10.1111/pce.12140; Buitenwerf R, 2014, KOEDOE, P56; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Damour G, 2010, PLANT CELL ENVIRON, V33, P1419, DOI 10.1111/j.1365-3040.2010.02181.x; Ding RS, 2015, AGR WATER MANAGE, V150, P1, DOI 10.1016/j.agwat.2014.11.010; Du Toit J, 2004, KRUGER EXPERIENCE EC; Ehrlinger J, 2015, ARXIV150107196STATCO; Flexas J, 2014, PLANT SCI, V226, P41, DOI 10.1016/j.plantsci.2014.06.011; Flint AL, 2002, SOIL SCI SOC AM J, V66, P1439, DOI 10.2136/sssaj2002.1439; Gao JG, 2015, AGR FOREST METEOROL, V200, P258, DOI 10.1016/j.agrformet.2014.10.007; Gao Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084200; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gimeno TE, 2016, FUNCT ECOL, V30, P700, DOI 10.1111/1365-2435.12532; Goldstein G, 2008, TREE PHYSIOL, V28, P395, DOI 10.1093/treephys/28.3.395; Hasper TB, 2016, FUNCT ECOL, V30, P690, DOI 10.1111/1365-2435.12546; Hiyama T, 2005, ECOL RES, V20, P333, DOI 10.1007/s11284-005-0049-6; Jarvis AJ, 1999, PLANT CELL ENVIRON, V22, P639, DOI 10.1046/j.1365-3040.1999.00407.x; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kirkham MB, 2008, VADOSE ZONE J, V7, P1125, DOI 10.2136/vzj2007.0097; Klein T, 2014, FUNCT ECOL, V28, P1313, DOI 10.1111/1365-2435.12289; Kropp H, 2015, OECOLOGIA, V177, P345, DOI 10.1007/s00442-014-3187-0; Kulmatiski Andrew, 2013, Oecologia, V171, P25, DOI 10.1007/s00442-012-2390-0; Kulmatiski A, 2013, NAT CLIM CHANGE, V3, P833, DOI [10.1038/nclimate1904, 10.1038/NCLIMATE1904]; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Kutsch WL, 2008, BIOGEOSCIENCES, V5, P1797, DOI 10.5194/bg-5-1797-2008; Leffler AJ, 2005, ECOLOGY, V86, P633, DOI 10.1890/04-0854; Lin YS, 2015, NAT CLIM CHANGE, V5, P459, DOI [10.1038/nclimate2550, 10.1038/NCLIMATE2550]; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Lu YJ, 2016, J THEOR BIOL, V394, P160, DOI 10.1016/j.jtbi.2016.01.003; Mazzacavallo MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144300; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Miner GL, 2017, PLANT CELL ENVIRON, V40, P1214, DOI 10.1111/pce.12871; Powell TL, 2013, NEW PHYTOL, V200, P350, DOI 10.1111/nph.12390; R Core Research Team A, 2004, R LANG ENV STAT COMP; Ramoelo A, 2014, REMOTE SENS-BASEL, V6, P7406, DOI 10.3390/rs6087406; Reich PB, 2014, NAT GEOSCI, V7, P920, DOI [10.1038/NGEO2284, 10.1038/ngeo2284]; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Simioni G, 2004, PLANT ECOL, V173, P233, DOI 10.1023/B:VEGE.0000029323.74523.80; Sperry JS, 2016, NEW PHYTOL, V212, P577, DOI 10.1111/nph.14059; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Thomas DS, 2002, AUST J BOT, V50, P229, DOI 10.1071/BT01045; Tuzet A, 2003, PLANT CELL ENVIRON, V26, P1097, DOI 10.1046/j.1365-3040.2003.01035.x; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Volk M, 2000, OECOLOGIA, V125, P380, DOI 10.1007/s004420000454; Wang RL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14454; Wehr R, 2017, BIOGEOSCIENCES, V14, P389, DOI 10.5194/bg-14-389-2017; Williams CA, 2009, OECOLOGIA, V161, P469, DOI 10.1007/s00442-009-1405-y; Wolz KJ, 2017, NAT ECOL EVOL, V1, P1292, DOI 10.1038/s41559-017-0238-z; Xu LK, 2003, TREE PHYSIOL, V23, P865, DOI 10.1093/treephys/23.13.865; Zhang YJ, 2013, PLANT CELL ENVIRON, V36, P149, DOI 10.1111/j.1365-3040.2012.02563.x	65	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191396	10.1371/journal.pone.0191396	http://dx.doi.org/10.1371/journal.pone.0191396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373605	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400011
J	Waqas, M; Shahzad, R; Hamayun, M; Asaf, S; Khan, AL; Kang, SM; Yun, S; Kim, KM; Lee, IJ				Waqas, Muhammad; Shahzad, Raheem; Hamayun, Muhammad; Asaf, Sajjad; Khan, Abdul Latif; Kang, Sang-Mo; Yun, Sopheap; Kim, Kyung-Min; Lee, In-Jung			Biochar amendment changes jasmonic acid levels in two rice varieties and alters their resistance to herbivory	PLOS ONE			English	Article							PLANTHOPPER SOGATELLA-FURCIFERA; SEWAGE-SLUDGE BIOCHAR; WHITE-BACKED PLANTHOPPER; WHITEBACKED PLANTHOPPER; ORYZA-SATIVA; OVICIDAL RESPONSE; MAIZE YIELD; PADDY SOIL; BROWN PEAT; GROWTH	Biochar addition to soil not only sequesters carbon for the long-term but enhances agricultural productivity. Several well-known benefits arise from biochar amendment, including constant provision of nutrients, increased soil moisture retention, decreased soil bulk density, and sometimes the induction of systemic resistance against foliar and soil borne plant pathogens. However, no research has investigated the potential of biochar to increase resistance against herbivory. The white-backed plant hopper (WBPH) (Sogatella furcifera Horva A th) is a serious agricultural pest that targets rice (Oryza sativa L.), a staple crop that feeds half of the world's human population. Therefore, we investigated the (1) optimization of biochar amendment levels for two rice varieties ('Cheongcheong' and 'Nagdong') and (2) subsequent effects of different biochar amendments on resistance and susceptibility of these two varieties to WBPH infestation. Initial screening results for the optimization level revealed that the application of biochar 10% (w/w) to the rooting media significantly improved plant physiological characteristics of both rice varieties. However, levels of biochar amendment, mainly 1, 2, 3, and 20%, resulted in negative effects on plant growth characteristics. Cheongcheong and Nagdong rice plants grown with the optimum biochar level showed contrasting reactions to WBPH infestation. Specifically, biochar application significantly increased plant growth characteristics of Nagdong when exposed to WBPH infestation and significantly decreased these characteristics in Cheongcheong. The amount of WBPH-induced damage to plants was significantly lower and higher in Nagdong and Cheongcheong, respectively, compared to that in the controls. Higher levels of jasmonic acid caused by the biochar priming effect could have accumulated in response to WBPH infestation, resulting in a maladaptive response to stress, negatively affecting growth and resistance to WBPH in Cheongcheong. This study highlights the importance of investigating the effects of biochar on different rice varieties before application on a commercial scale to avoid potential crop losses.	[Waqas, Muhammad; Shahzad, Raheem; Kang, Sang-Mo; Yun, Sopheap; Kim, Kyung-Min; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Waqas, Muhammad] Govt Khyber Pakhtunkhwa, Dept Agr Extens, Buner, Pakistan; [Hamayun, Muhammad] Abdul Wali Khan Univ Mardan, Dept Bot, Mardan, Pakistan; [Asaf, Sajjad; Khan, Abdul Latif] Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman	Kyungpook National University; University of Nizwa	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	ijlee@knu.ac.kr	Hamayun, Muhammad/B-1694-2010; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021	Hamayun, Muhammad/0000-0003-4264-5870; Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; Khan, Abdul Latif/0000-0001-9700-8903; Waqas, Muhammad/0000-0002-6344-785X	National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program [2014R1A1A2A10058022]	National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program	This work was financially supported by the National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program (2014R1A1A2A10058022) to IJL.; This work was financially supported by the National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future-Planning through Basic-Science Research Program (2014R1A1A2A10058022).	Abbasi MK, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131592, 10.1371/journal.pone.0131]; ANGELES ER, 1981, CROP SCI, V21, P47, DOI 10.2135/cropsci1981.0011183X002100010014x; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; De Tender CA, 2016, APPL SOIL ECOL, V107, P1, DOI 10.1016/j.apsoil.2016.05.001; Deenik JL, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020131; Dong D, 2015, J SOIL SEDIMENT, V15, P153, DOI 10.1007/s11368-014-0984-3; Elad Y, 2011, PHYTOPATHOL MEDITERR, V50, P335; Elad Y, 2010, PHYTOPATHOLOGY, V100, P913, DOI 10.1094/PHYTO-100-9-0913; Fan RQ, 2015, PEDOSPHERE, V25, P737, DOI 10.1016/S1002-0160(15)30055-2; Fujita D, 2013, CRIT REV PLANT SCI, V32, P162, DOI 10.1080/07352689.2012.735986; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Hadfield P., 1993, NEW SCI, V13, P5; Han XG, 2016, SCI REP-UK, V6, DOI 10.1038/srep24731; Harel YM, 2012, PLANT SOIL, V357, P245, DOI 10.1007/s11104-012-1129-3; HERNANDEZ J E, 1981, Oryza, V18, P44; Horgan FG, 2016, CROP PROT, V89, P223, DOI 10.1016/j.cropro.2016.07.033; Huang WK, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0654-7; Jaiswal AK, 2015, PLANT SOIL, V395, P125, DOI 10.1007/s11104-014-2331-2; KAJIMURA T, 1993, JPN J APPL ENTOMOL Z, V37, P137, DOI 10.1303/jjaez.37.137; KAMMANN CI, 2015, SCI REP UK, V5; Kanno H, 2012, APPL ENTOMOL ZOOL, V47, P27, DOI 10.1007/s13355-011-0085-3; Kaudal BB, 2016, BIOMASS BIOENERG, V84, P49, DOI 10.1016/j.biombioe.2015.11.012; Khan S, 2013, ENVIRON SCI TECHNOL, V47, P8624, DOI 10.1021/es400554x; KHAN ZR, 1986, J ECON ENTOMOL, V79, P928, DOI 10.1093/jee/79.4.928; Kim TH, 2013, PHILIPP J CROP SCI, V38, P30; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liu XH, 2016, INT J AGRIC BIOL, V18, P630, DOI 10.17957/IJAB/15.0138; Liu Z, 2015, RICE, V8, DOI 10.1186/s12284-015-0042-9; Machado RAR, 2017, NEW PHYTOL, V215, P803, DOI 10.1111/nph.14597; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Belda RM, 2016, IND CROP PROD, V94, P132, DOI 10.1016/j.indcrop.2016.08.024; McCloud ES, 1997, PLANTA, V203, P430, DOI 10.1007/s004250050210; Mendez A, 2017, BIOL AGRIC HORTIC, V33, P40, DOI 10.1080/01448765.2016.1185645; Mendez A, 2015, SCI HORTIC-AMSTERDAM, V193, P225, DOI 10.1016/j.scienta.2015.07.032; Mia S, 2014, AGR ECOSYST ENVIRON, V191, P83, DOI 10.1016/j.agee.2014.03.011; Mishra H. P., 2006, Indian Journal of Entomology, V68, P338; Nagadhara D, 2004, THEOR APPL GENET, V109, P1399, DOI 10.1007/s00122-004-1750-5; NAIR RV, 1982, THEOR APPL GENET, V61, P19, DOI 10.1007/BF00261504; Nieto A, 2016, SCI HORTIC-AMSTERDAM, V199, P142, DOI 10.1016/j.scienta.2015.12.012; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Ogawa S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40175; Pathak H., 2011, Current Advances in Agricultural Sciences, V3, P77; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Pratiwi EPA, 2016, PADDY WATER ENVIRON, V14, P521, DOI 10.1007/s10333-015-0521-z; Prendergast-Miller MT, 2014, EUR J SOIL SCI, V65, P173, DOI 10.1111/ejss.12079; Saini R. S., 1982, Crop Protection, V1, P289, DOI 10.1016/0261-2194(82)90004-7; SALIM M, 1991, CROP SCI, V31, P797, DOI 10.2135/cropsci1991.0011183X003100030051x; SIDHU GS, 1979, EUPHYTICA, V28, P227, DOI 10.1007/BF00056579; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; [宋小玲 Song Xiaoling], 2002, [南京农业大学学报, Journal of Nanjing Agricultural University], V25, P5; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Steiner C, 2014, SOLID EARTH, V5, P995, DOI 10.5194/se-5-995-2014; Sui He, 2011, Yingyong Shengtai Xuebao, V22, P3021; Tanaka K, 2014, PLANT SIGNAL BEHAV, V9, P7; Uzoma KC, 2011, SOIL USE MANAGE, V27, P205, DOI 10.1111/j.1475-2743.2011.00340.x; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; Ventura M, 2013, J ENVIRON QUAL, V42, P76, DOI 10.2134/jeq2012.0250; Vicheka T, 2017, CEREAL RES COMMUN, V45, P456, DOI 10.1556/0806.45.2017.025; Viger M, 2015, GCB BIOENERGY, V7, P658, DOI 10.1111/gcbb.12182; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Waqas M, 2017, J ZHEJIANG UNIV-SC B, V18, P109, DOI 10.1631/jzus.B1500262; Waqas M, 2014, BIOL FERT SOILS, V50, P1155, DOI 10.1007/s00374-014-0937-4; Wardle DA, 1998, OECOLOGIA, V115, P419, DOI 10.1007/s004420050536; WU CF, 1985, CROP SCI, V25, P505, DOI 10.2135/cropsci1985.0011183X002500030017x; Xu CY, 2015, ENVIRON SCI POLLUT R, V22, P6112, DOI 10.1007/s11356-014-3820-9; Yamasaki M, 2003, MOL BREEDING, V12, P133, DOI 10.1023/A:1026018821472; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yeboah E, 2016, ENRGY PROCED, V93, P14, DOI 10.1016/j.egypro.2016.07.143; Yue Y, 2017, CHEMOSPHERE, V173, P551, DOI 10.1016/j.chemosphere.2017.01.096; Yun S, 2016, INT J AGRIC BIOL, V18, P844, DOI 10.17957/IJAB/15.0181	70	22	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191296	10.1371/journal.pone.0191296	http://dx.doi.org/10.1371/journal.pone.0191296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373575	gold, Green Submitted, Green Published			2022-12-26	WOS:000423425400008
J	Gouignard, N; Schon, T; Holmgren, C; Strate, I; Tasoz, E; Wetzel, F; Maccarana, M; Pera, EM				Gouignard, Nadege; Schon, Tanja; Holmgren, Christian; Strate, Ina; Tasoz, Emirhan; Wetzel, Franziska; Maccarana, Marco; Pera, Edgar M.			Gene expression of the two developmentally regulated dermatan sulfate epimerases in the Xenopus embryo	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; CHONDROITIN SULFATE/DERMATAN SULFATE; NEURAL CREST; TRANSCRIPTION FACTOR; HATCHING GLAND; IDURONIC ACID; SPINAL-CORD; BRAIN; LAEVIS; CELLS	Chondroitin sulfate (CS)/dermatan sulfate (DS) proteoglycans are abundant on the cell surface and in the extracellular matrix and have important functions in matrix structure, cellmatrix interaction and signaling. The DS epimerases 1 and 2, encoded by Dse and Dsel, respectively, convert CS to a CS/DS hybrid chain, which is structurally and conformationally richer than CS, favouring interaction with matrix proteins and growth factors. We recently showed that Xenopus Dse is essential for the migration of neural crest cells by allowing cell surface CS/DS proteoglycans to adhere to fibronectin. Here we investigate the expression of Dse and Dsel in Xenopus embryos. We show that both genes are maternally expressed and exhibit partially overlapping activity in the eyes, brain, trigeminal ganglia, neural crest, adenohypophysis, sclerotome, and dorsal endoderm. Dse is specifically expressed in the epidermis, anterior surface ectoderm, spinal nerves, notochord and dermatome, whereas Dsel mRNA alone is transcribed in the spinal cord, epibranchial ganglia, prechordal mesendoderm and myotome. The expression of the two genes coincides with sites of cell differentiation in the epidermis and neural tissue. Several expression domains can be linked to previously reported phenotypes of knockout mice and clinical manifestations, such as the Musculocontractural Ehlers- Danlos syndrome and psychiatric disorders.	[Gouignard, Nadege; Schon, Tanja; Holmgren, Christian; Strate, Ina; Tasoz, Emirhan; Wetzel, Franziska; Pera, Edgar M.] Lund Univ, Lund Stem Cell Ctr, Dept Lab Med, Lund, Sweden; [Maccarana, Marco] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University	Pera, EM (corresponding author), Lund Univ, Lund Stem Cell Ctr, Dept Lab Med, Lund, Sweden.	edgar.pera@med.lu.se	Gouignard, Nadege/AHC-3750-2022; maccarana, marco/AAB-4764-2021	Gouignard, Nadege/0000-0001-8787-2503; Maccarana, Marco/0000-0003-3549-8921; Pera, Edgar/0000-0002-0625-0006; Tasoz, Emirhan/0000-0003-2025-3366	Swedish Research Council [2009-4951]; Swedish Childhood Cancer Foundation [PROJ11/101, NBCNSPDHEL12/012]; Swedish Cancer Foundation [140530]; Director Albert Pahlsson's Foundation; Edla Johansson's Scientific Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Foundation; Director Albert Pahlsson's Foundation; Edla Johansson's Scientific Foundation	This work was financially supported by the Swedish Research Council (https://www.vr.se) to E.M.P. (2009-4951), Swedish Childhood Cancer Foundation (https://www.bamcancerfonden.se) to E.M.P. (PROJ11/101) and to N.G. (NBCNSPDHEL12/012), Swedish Cancer Foundation (https://www.cancerfonden.se) to M.M. (140530), Director Albert Pahlsson's Foundation (http://www.pahlssonsstiftelse.se) to E.M.P., and O.E. and Edla Johansson's Scientific Foundation (http://www.oejvetstift.se) to E.M.P.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu C, 2011, GLYCOBIOLOGY, V21, P565, DOI 10.1093/glycob/cwq208; Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Chalmers AD, 2006, MECH DEVELOP, V123, P702, DOI 10.1016/j.mod.2006.04.006; DRYSDALE TA, 1991, DEVELOPMENT, V111, P469; ESPESETH A, 1995, MOL CELL NEUROSCI, V6, P199, DOI 10.1006/mcne.1995.1017; Gilbert SF, 2016, DEV BIOL, P528; Goossens D, 2003, MOL PSYCHIATR, V8, P83, DOI 10.1038/sj.mp.4001190; Gouignard N, 2016, DIS MODEL MECH, V9, P607, DOI 10.1242/dmm.024661; Gustafsson R, 2014, BIRTH DEFECTS RES A, V100, P712, DOI 10.1002/bdra.23300; Habicher J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121957; HARTENSTEIN V, 1989, NEURON, V3, P399, DOI 10.1016/0896-6273(89)90200-6; HARTENSTEIN V, 1993, J COMP NEUROL, V328, P213, DOI 10.1002/cne.903280205; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Kosho T, 2016, PEDIATR INT, V58, P88, DOI 10.1111/ped.12878; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MAYOR R, 1995, DEVELOPMENT, V121, P767; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Nagasawa T, 2016, ZOOL SCI, V33, P272, DOI 10.2108/zs150183; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Park BY, 2010, DEV BIOL; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Pera EM, 2015, NEUROMETHODS, V99, P151, DOI 10.1007/978-1-4939-2303-8_8; Pera EM, 2016, J RARE DIS RES TREAT, V1, P79; Ramachandra R, 2017, GLYCOBIOLOGY, V27, P438, DOI 10.1093/glycob/cwx010; Scaal M, 2016, SEMIN CELL DEV BIOL, V49, P83, DOI 10.1016/j.semcdb.2015.11.003; Schlosser G, 2015, CURR TOP DEV BIOL, V111, P235, DOI 10.1016/bs.ctdb.2014.11.008; Sanchez RS, 2013, DEV DYNAM, V242, P572, DOI 10.1002/dvdy.23945; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; Sun CY, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150277; Syx D, 2015, HUM MUTAT, V36, P535, DOI 10.1002/humu.22774; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Wilde JJ, 2014, ANNU REV GENET, V48, P583, DOI 10.1146/annurev-genet-120213-092208; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191751	10.1371/journal.pone.0191751	http://dx.doi.org/10.1371/journal.pone.0191751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370293	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600093
J	Obiri-Yeboah, D; Awuku, YA; Adu, J; Pappoe, F; Obboh, E; Nsiah, P; Amoako-Sakyi, D; Simpore, J				Obiri-Yeboah, Dorcas; Awuku, Yaw Asante; Adu, Joseph; Pappoe, Faustina; Obboh, Evans; Nsiah, Paul; Amoako-Sakyi, Daniel; Simpore, Jacques			Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana	PLOS ONE			English	Article							NON-B HEPATITIS; NON-A; TRANSMISSION; EPIDEMIC; INDIA	Background Hepatitis E virus is an emerging infection in Africa with poor maternal and foetal outcomes. There is scanty data on the sero-prevalence of HEV infection among pregnant women in Ghana. This study highlighted the prevalence and risk factors associated with HEV infection among pregnant women in Cape Coast Metropolis, Central Region of Ghana. Methods A multicenter (3 selected sites) analytical cross sectional study involving 398 pregnant women in the Cape Coast metropolis was conducted. HEV (Anti-HEV IgG and Anti-HEV IgM) ELISA was performed. Sero-positive women had liver chemistries done and data collected on maternal and neonatal outcomes. Data analyses were performed using Stata version 13 software (STATA Corp, Texas USA). Results Mean age was 28.01 (+/- 5.93) years. HEV sero-prevalence was 12.2% (n = 48) for IgG and 0.2% (n = 1) for IgM with overall of 12.3%. The odds of being HEV sero-positive for women aged 26 +/- 35 years was 3.1 (95% CI: 1.1 +/- 8.1), p = 0.02 and >= 36 years it was 10.7 (95% CI; 3.4 +/- 33.5), p = 0.0001. Living in urban settlement was associated with lowest odds of HEV infection {OR 0.4 (95% CI; 0.2 +/- 0.8), p = 0.01}. Factors with no statistical evidence of association include main source of drinking water and history of blood transfusion. The sero-prevalence of HEV IgG increased progressively across trimesters with the highest among women in their third trimester (55.3%). None of the 49 HEV sero-positive women had elevated ALT level. Ten (N = 41) of the neonates born to sero-positive women developed jaundice in the neonatal period. The mean birth weight was 3.1kg (SD 0.4). Conclusion HEV sero-prevalence among pregnant women in the Cape Coast Metropolis is high enough to deserve more attention than it has received so far. It is therefore important to conduct further research on the potential impact on maternal and neonatal mortality and morbidity in Ghana.	[Obiri-Yeboah, Dorcas; Pappoe, Faustina; Obboh, Evans; Amoako-Sakyi, Daniel] Univ Cape Coast, Sch Med Sci, Dept Microbiol & Immunol, Cape Coast, Ghana; [Awuku, Yaw Asante] Univ Cape Coast, Sch Med Sci, Dept Internal Med & Therapeut, Cape Coast, Ghana; [Adu, Joseph] Univ Cape Coast, Sch Med Sci, Dept Obstet & Gynecol, Cape Coast, Ghana; [Nsiah, Paul] Univ Cape Coast, Sch Med Sci, Dept Chem Pathol, Cape Coast, Ghana; [Simpore, Jacques] Univ Ouagadougou, Lab Mol Biol & Genet LABIOGENE, Ouagadougou, Burkina Faso	University of Cape Coast; University of Cape Coast; University of Cape Coast; University of Cape Coast	Obiri-Yeboah, D (corresponding author), Univ Cape Coast, Sch Med Sci, Dept Microbiol & Immunol, Cape Coast, Ghana.	d.obiri-yeboah@uccsms.edu.gh	SIMPORE, Jacques/ABA-4873-2020; Nsiah, Paul/Y-7880-2019; Nsiah, Paul/GON-7685-2022; Obiri-Yeboah, Dorcas/AAE-7672-2019	SIMPORE, Jacques/0000-0002-0415-9161; OBIRI-YEBOAH, DORCAS/0000-0003-4562-9294; Nsiah, Paul/0000-0002-9925-1015	Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana	Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana	The authors wish to acknowledge the financial support of the Directorate of Research, Innovation and Consultancy (DRIC), University of Cape Coast, Ghana. This agency contributed financially without making intellectual inputs. They did not contribute to the design, data collection, analysis not manuscript writing.	Abdoulaye Traore Kuan, 2012, PLOS ONE, V7; Abebe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180078; Adjei AA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-336; Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Ahmed Al-Tayeb Zuhal, 2004, AM J RECOMMUNICATI, V2; Begum N, 2009, INDIAN J MED RES, V130, P709; Bonney Joseph Humphrey Kofi, 2012, BMC Res Notes, V5, P478, DOI 10.1186/1756-0500-5-478; Caron M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-254; Caron M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-64; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Colson P, 2007, EMERGING INFECT DIS, V13; Colson P, 2009, J CLIN VIROL, V45, P269, DOI 10.1016/j.jcv.2009.06.002; Dalton HR, 2009, NEW ENGLAND J MED, V361; Echevarria JM, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/481016; Feldt T, J CLIN VIROLOGY, V58, P18; Florence K., 2016, INT J RECENT ADV MUL, V3, P15; Ghana AIDS Commission, 2016, GHAN NAT HIV AIDS ST; Goumba Charles M, 2010, BMC Res Notes, V3, P103, DOI 10.1186/1756-0500-3-103; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Khuroo MS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090253; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; Latora V, 2006, J MED VIROL, V78, P724, DOI 10.1002/jmv.20614; Marano G, 2015, BLOOD TRANSFUS-ITALY, V13, P6, DOI 10.2450/2014.0063-14; Meldal BHM, 2013, VOX SANG, V104, P30, DOI 10.1111/j.1423-0410.2012.01637.x; Mirazo S, 2014, HEPATIC MED-EVID RES, V6, P45, DOI 10.2147/HMER.S63417; Ofori-Asenso R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0239-9; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Shao ZL, 2017, CLEV CLIN J MED, V84, P202, DOI 10.3949/ccjm.84a.15139; Sharma S, 2017, J VIRAL HEPATITIS, V24, P1067, DOI 10.1111/jvh.12730; Shinde NR, 2014, ANN MED HEALTH SCI R, V4, P133, DOI 10.4103/2141-9248.138033; Song YJ, 2014, CLIN EXP VACCINE RES, V3, P29, DOI 10.7774/cevr.2014.3.1.29; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Perez-Gracia MT, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1929; Thoden J, 2008, AIDS LONDON ENGLAND, V22; WHO, 2010, GLOB PREV HEP E VIR; WONG DC, 1980, LANCET, V2, P876; Zaki ME, 2013, AM J CLIN PATHOL, V140, P721, DOI 10.1309/AJCPT55TDMJNPLLV	39	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191685	10.1371/journal.pone.0191685	http://dx.doi.org/10.1371/journal.pone.0191685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370271	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600080
J	Prchal, M; Kause, A; Vandeputte, M; Gela, D; Allamellou, JM; Kumar, G; Bestin, A; Bugeon, J; Zhao, JF; Kocour, M				Prchal, Martin; Kause, Antti; Vandeputte, Marc; Gela, David; Allamellou, Jean-Michel; Kumar, Girish; Bestin, Anastasia; Bugeon, Jerome; Zhao, Jinfeng; Kocour, Martin			The genetics of overwintering performance in two-year old common carp and its relation to performance until market size	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; LARGE RAINBOW-TROUT; SALMON SALMO-SALAR; ATLANTIC SALMON; LIPID-CONTENT; WEIGHT-LOSS; INDIRECT SELECTION; FATTY-ACIDS; GROWTH; SURVIVAL	Using farmed common carp, we investigated the genetic background of the second year overwintering performance and its relation to the performance during the third growing season and at market size. The experimental stock was established by partial factorial design with a series of 4 factorial matings of 5 dams and 10 sires each. The families were reared communally and pedigree was re-constructed with 93.6% success using 12 microsatellites on 2008 offspring. Three successive recordings (second autumn, third spring, and third autumn-market size) covering two periods (second overwintering, third growing season) were included. Body weight, Fulton's condition factor and percent muscle fat content were recorded at all times and headless carcass yield and fillet yield were recorded at market size. Specific growth rate, absolute and relative fat change and overall survival were calculated for each period. Heritability estimates were significantly different from zero and almost all traits were moderately to highly heritable (h(2) = 0.36 +/- 1.00), except survival in both periods and fat change (both patterns) during overwintering (h(2) = 0.12 +/- 0.15). Genetic and phenotypic correlations imply that selection against weight loss and fat loss during overwintering is expected to lead to a better winter survival, together with a positive effect on growth in the third growing season. Interestingly, higher muscle fat content was genetically correlated to lower survival in the following period (r(g) = -0.59; -0.53, respectively for winter and the third summer). On the other hand, higher muscle fat was also genetically linked to better slaughter yields. Moreover, selection for higher condition factor would lead to better performance during winter, growing season and at market size.	[Prchal, Martin; Gela, David; Kumar, Girish; Zhao, Jinfeng; Kocour, Martin] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Kause, Antti] Nat Resources Inst Finland, Jokioinen, Finland; [Vandeputte, Marc; Bugeon, Jerome] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Vandeputte, Marc] IFREMER, Palavas Les Flots, France; [Allamellou, Jean-Michel] LABOGENA DNA, Jouy En Josas, France; [Bestin, Anastasia] SYSAAF, Rennes, France	University of South Bohemia Ceske Budejovice; Natural Resources Institute Finland (Luke); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ifremer	Prchal, M (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic.	mprchal@frov.jcu.cz	Kocour, Martin/C-1239-2017; Vandeputte, Marc/A-4734-2011; Kumar, Girish/G-4757-2015; Vandeputte, Marc/I-7218-2019; Prchal, Martin/F-8339-2015	Kocour, Martin/0000-0003-2984-1412; Vandeputte, Marc/0000-0001-9929-4587; Vandeputte, Marc/0000-0001-9929-4587; Prchal, Martin/0000-0002-5059-2812; Bestin, Anastasia/0000-0002-1777-338X	Ministry of Education, Youth, and Sports of the Czech Republic [CENAKVA - CZ.1.05/2.1.00/01.0024, CENAKVA II - LO1205]; European Union's Seventh Framework Programme [KBBE.2013.1.2-10, 613611 FISHBOOST]; Grant Agency of the University of South Bohemia [125/2016/Z]; Czech NAAR (NAZV) [QK1710310]	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Union's Seventh Framework Programme; Grant Agency of the University of South Bohemia; Czech NAAR (NAZV)	This study was supported by the Ministry of Education, Youth, and Sports of the Czech Republic (projects CENAKVA - CZ.1.05/2.1.00/01.0024 and CENAKVA II - LO1205 under the NPU I program), European Union's Seventh Framework Programme (KBBE.2013.1.2-10) under grant agreement no. 613611 FISHBOOST (http://www.fishboost.eu/), the Grant Agency of the University of South Bohemia (project no. 125/2016/Z) and project of the Czech NAAR (NAZV) no. QK1710310. The projects/grants provided financial support for people working on the study, data collection and analysis but had no role in decision to publish and to prepare the manuscript.	Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; [Anonymous], 2013, DMU VERSION 6; [Anonymous], 1997, J INDIAN SOC AGR STA; [Anonymous], 1998, FISCH TEICHWIRT; Bauer C, 2004, AQUACULTURE, V241, P301, DOI 10.1016/j.aquaculture.2004.08.010; Bell RJ, 2012, T AM FISH SOC, V141, P855, DOI 10.1080/00028487.2012.675896; Bernard Gerry, 1997, North American Journal of Fisheries Management, V17, P581, DOI 10.1577/1548-8675(1997)017<0581:EOBSAP>2.3.CO;2; Biro PA, 2004, CAN J FISH AQUAT SCI, V61, P1513, DOI 10.1139/F04-083; BLASCO J, 1992, J COMP PHYSIOL B, V162, P539; Boichard D, 2014, 10 WCGALP; Brodersen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090294; Bugeon J, 2010, J MUSCLE FOODS, V21, P702, DOI 10.1111/j.1745-4573.2010.00214.x; Charo-Karisa H, 2006, AQUACULTURE, V261, P479, DOI 10.1016/j.aquaculture.2006.07.007; Crespel A, 2013, GENETICA, V141, P51, DOI 10.1007/s10709-013-9705-x; Daule S, 2014, AQUACULTURE, V420, pS42, DOI 10.1016/j.aquaculture.2013.05.036; DEMPSTER ER, 1950, GENETICS, V35, P212; Dickmann Fritz, 1998, WESTFALISCHE FRIEDE, V7; Dong ZJ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0256-2; Eckmann R, 2004, J FISH BIOL, V65, P1498, DOI 10.1111/j.0022-1112.2004.00553.x; Edenhofer O., 2014, CLIMATE CHANGE 2014; Einen O, 1998, AQUACULTURE, V166, P85, DOI 10.1016/S0044-8486(98)00279-8; Flajshans M., 2015, 3 INT C COMMON CARP, P21; Geldhauser F, 2003, DER TEICHWIRT; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Gjerde B, 2004, AQUACULTURE, V236, P167, DOI 10.1016/j.aquaculture.2004.03.004; Grima L, 2010, AQUACULTURE, V302, P169, DOI 10.1016/j.aquaculture.2010.02.016; Grima L, 2010, AQUACULTURE, V300, P50, DOI 10.1016/j.aquaculture.2010.01.003; Haffray P, 2013, AQUACULTURE, V410, P236, DOI 10.1016/j.aquaculture.2013.06.016; Haffray P, 2012, AQUACULTURE, V368, P145, DOI 10.1016/j.aquaculture.2012.09.023; Horvath L., 1992, CARP POND FISH CULTU; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Jobling M, 1999, AQUAC RES, V30, P473, DOI 10.1046/j.1365-2109.1999.00358.x; Jobling M, 2010, AQUACULT INT, V18, P501, DOI 10.1007/s10499-009-9260-8; Johansen SJS, 2002, AQUAC RES, V33, P515, DOI 10.1046/j.1365-2109.2002.00736.x; Kause A, 2007, J ANIM SCI, V85, P3218, DOI 10.2527/jas.2007-0332; Kause A, 2011, J ANIM SCI, V89, P959, DOI 10.2527/jas.2010-2981; Kause A, 2016, BRIT J NUTR, V116, P1656, DOI 10.1017/S0007114516003603; Kocour M, 1992, AQUA 2012 C GLOB AQ, P356; Kocour M, 2007, AQUACULTURE, V270, P43, DOI 10.1016/j.aquaculture.2007.03.001; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Mas-Munoz J, 2013, AQUACULTURE, V410, P230, DOI 10.1016/j.aquaculture.2013.06.012; Mraz J, 2012, J APPL ICHTHYOL, V28, P238, DOI 10.1111/j.1439-0426.2011.01904.x; Ninh NH, 2011, AQUACULTURE, V322, P39, DOI 10.1016/j.aquaculture.2011.09.031; Nielsen HM, 2010, AQUACULTURE, V304, P14, DOI 10.1016/j.aquaculture.2010.03.016; Piackova V, 2013, J FISH DIS, V36, P75, DOI 10.1111/jfd.12007; Pratt TC, 2002, T AM FISH SOC, V131, P885, DOI 10.1577/1548-8659(2002)131<0885:IOPROT>2.0.CO;2; Reichle G, 1998, FISCHER TEICHWIRT, V49, P439; RYE M, 1990, AQUACULTURE, V89, P209, DOI 10.1016/0044-8486(90)90126-8; Sae-Lim P, 2013, AQUACULTURE, V372, P89, DOI 10.1016/j.aquaculture.2012.10.031; SCHAPERCLAUS W, 1961, LEHRBUCH TEICHWIRTSC; Sogard SM, 2000, J FISH BIOL, V56, P1; Steffens W, 1996, ARCH ANIM NUTR, V49, P93, DOI 10.1080/17450399609381867; THOMPSON JM, 1991, T AM FISH SOC, V120, P346, DOI 10.1577/1548-8659(1991)120<0346:ROSCAL>2.3.CO;2; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Urbanek M, 2010, AQUACULT NUTR, V16, P511, DOI 10.1111/j.1365-2095.2009.00690.x; Vandeputte M, 2004, AQUACULTURE, V235, P223, DOI 10.1016/j.aquaculture.2003.12.019; Vandeputte M, 2008, AQUACULTURE, V277, P7, DOI 10.1016/j.aquaculture.2008.02.009; Vandeputte M, 2017, AQUACULTURE, V470, P40, DOI 10.1016/j.aquaculture.2016.12.014; Vehvilainen H, 2008, GENETICS, V180, P507, DOI 10.1534/genetics.108.089896; Vehvilainen H, 2012, EVOL APPL, V5, P732, DOI 10.1111/j.1752-4571.2012.00251.x; Virk P, 2003, BIORESOURCE TECHNOL, V86, P25, DOI 10.1016/S0960-8524(02)00139-6; Zajic T, 2013, AQUACULTURE, V400, P111, DOI 10.1016/j.aquaculture.2013.03.004; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	63	14	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191624	10.1371/journal.pone.0191624	http://dx.doi.org/10.1371/journal.pone.0191624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370279	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600070
J	Tranah, GJ; Yaffe, K; Nievergelt, CM; Parimi, N; Glymour, MM; Ensrud, KE; Cauley, JA; Ancoli-Israel, S; Mariani, S; Redline, S; Stone, KL				Tranah, Gregory J.; Yaffe, Kristine; Nievergelt, Caroline M.; Parimi, Neeta; Glymour, M. Maria; Ensrud, Kristine E.; Cauley, Jane A.; Ancoli-Israel, Sonia; Mariani, Sara; Redline, Susan; Stone, Katie L.		Osteoporotic Fractures Men Study	APOE epsilon 4 and slow wave sleep in older adults	PLOS ONE			English	Article							APOE EPSILON-4 ALLELE; MINI-MENTAL-STATE; WAKING COGNITIVE PERFORMANCE; CARDIOVASCULAR RISK-FACTORS; APOLIPOPROTEIN-E EPSILON-4; SELF-REPORTED SLEEP; EYE-MOVEMENT SLEEP; OSTEOPOROTIC FRACTURES; ALZHEIMERS-DISEASE; DAYTIME SLEEPINESS	Slow wave (or stage N3) sleep has been linked to a variety of cognitive processes. However, the role of stage N3 in the elderly is debated. The link between stage N3 and episodic memory may be weakened or changed in the older adult population, possibly due to several altered mechanisms impacting the cellular structure of the brain. The bases for the agerelated dissociation between stage N3 and cognition are not understood. Since APOE epsilon 4 status is the strongest genetic risk factor for cognitive decline, we assessed whether the epsilon 4 allele is associated with stage N3 sleep. Participants were from the population-based Osteoporotic Fractures in Men (MrOS) cohort with polysomnography and APOE epsilon 4 genotype data (n = 2,302, 100% male, mean age 76.6 years). Sleep stages were objectively measured using overnight in-home polysomnography and central electroencephalogram data were used to score stage N3 sleep. Cognitive function was assessed using the Modified Mini Mental State Exam (3MS). The APOE rs429358 single nucleotide polymorphism, which defines the APOE epsilon 4 allele, was genotyped using a custom genotyping array. Total time in stage N3 sleep was significantly higher (p< 0.0001) among the 40 MrOS participants carrying two copies of the e4 allele (62 +/- 5.2 minutes) compared with 43 +/- 1.5 minutes for carriers of one epsilon 4 allele (n = 515) and 40 +/- 0.8 minutes for epsilon 4 non-carriers (n = 1747). All results were independent of sleep efficiency, number of sleep cycles, and apnea hypopnea index. These findings support an association between APOE epsilon 4 genotype and sleep stage N3 in the elderly. Increased total stage N3 duration among e4/ e4 carriers does not appear to reflect compensation for prior cognitive decline and may reflect overactive downscaling of synapses during sleep. If confirmed, these results might in part explain the high risk of agerelated cognitive decline and AD among APOE epsilon 4/epsilon 4 carriers.	[Tranah, Gregory J.; Parimi, Neeta; Stone, Katie L.; Osteoporotic Fractures Men Study] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94115 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] San Francisco VA, Med Ctr, San Francisco, CA USA; [Yaffe, Kristine; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nievergelt, Caroline M.; Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Ensrud, Kristine E.] Minneapolis VA Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mariani, Sara] Harvard Med Sch, Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Boston, MA USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Redline, Susan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tranah, GJ (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94115 USA.	gtranah@sfcc-cpmc.net		Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health (NIH) funding; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Center for Research Resources (NCRR); NIH Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01- AG027810, UL1 RR024140]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, R01 HL070839]; NIAMS [R01-AR051124]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR066160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG042143, R01AG005407, U01AG042145, U01AG042140, U01AG027810, U01AG042124, R01AG026720, U01AG042168] Funding Source: NIH RePORTER	National Institutes of Health (NIH) funding(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health (NIH) funding. The following institutes provide support: the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and NIH Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01- AG027810, and UL1 RR024140. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study Outcomes of Sleep Disorders in Older Men under the following grant numbers: R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and R01 HL070839. NIAMS provides funding for the MrOS ancillary study Replication of candidate gene associations and bone strength phenotype in MrOS under the grant number R01-AR051124, which funded the creation and maintenance of MrOS DNA collections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health (NIH) funding. The following institutes provide support: the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and NIH Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study "Outcomes of Sleep Disorders in Older Men" under the following grant numbers: RO1 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and RO1 HL070839. NIAMS provides funding for the MrOS ancillary study "Replication of candidate gene associations and bone strength phenotype in MrOS" under the grant number R01AR051124, which funded the creation and maintenance of MrOS DNA collections.	Aeschbach D, 2008, J NEUROSCI, V28, P2766, DOI 10.1523/JNEUROSCI.5548-07.2008; Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; Alessi C, 2005, AM J GERIAT PSYCHIAT, V13, P341; ANCOLIISRAEL S, 1993, SLEEP, V16, pS25, DOI 10.1093/sleep/16.suppl_8.S25; ANCOLIISRAEL S, 1995, AM J RESP CRIT CARE, V152, P1946, DOI 10.1164/ajrccm.152.6.8520760; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, BIOFEEDBACK SELF-REG, V16, P349, DOI 10.1007/BF00999989; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Blackwell T, 2006, J GERONTOL A-BIOL, V61, P405, DOI 10.1093/gerona/61.4.405; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Blackwell T, 2011, J AM GERIATR SOC, V59, P2217, DOI 10.1111/j.1532-5415.2011.03731.x; BONNET MH, 1993, SLEEP, V16, pS65, DOI 10.1093/sleep/16.suppl_8.S65; Buechel HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018387; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; CAI ZJ, 1995, BEHAV BRAIN RES, V69, P187, DOI 10.1016/0166-4328(95)00005-E; Caselli RJ, 2002, SLEEP, V25, P447; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Cirelli C, 2012, GERONTOLOGY, V58, P441, DOI 10.1159/000336149; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino FII, 2008, SLEEP MED, V9, P831, DOI 10.1016/j.sleep.2007.10.015; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Craig D, 2006, SLEEP, V29, P1003, DOI 10.1093/sleep/29.8.1003; Crenshaw MC, 1999, PHYSIOL BEHAV, V66, P485, DOI 10.1016/S0031-9384(98)00316-3; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dealberto MJ, 1996, J AM GERIATR SOC, V44, P1287, DOI 10.1111/j.1532-5415.1996.tb01397.x; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Edinger JD, 2000, PHYSIOL BEHAV, V70, P127, DOI 10.1016/S0031-9384(00)00238-9; EEG arousals: Scoring rules and examples, 1992, SLEEP, V15, P173, DOI DOI 10.1093/SLEEP/15.2.173; Elmasry A, 2000, J INTERN MED, V248, P13, DOI 10.1046/j.1365-2796.2000.00683.x; Engleman HM, 2000, SLEEP, V23, pS102; Evans DS, 2013, SLEEP, V36, P431, DOI 10.5665/sleep.2466; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Foley DJ, 2001, JAMA-J AM MED ASSOC, V286, P1447, DOI 10.1001/jama.286.12.1447; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOULKES D, 1993, J SLEEP RES, V2, P199, DOI 10.1111/j.1365-2869.1993.tb00090.x; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Gozal D, 2007, NEUROLOGY, V69, P243, DOI 10.1212/01.wnl.0000265818.88703.83; GRANAT P, 1990, J FAM PRACTICE, V30, P632; GRUNSTEIN RR, 1995, INT J OBESITY, V19, P410; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hori T, 2001, PSYCHIAT CLIN NEUROS, V55, P305; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Kalra M, 2008, SLEEP MED, V9, P260, DOI 10.1016/j.sleep.2007.05.001; Khan A, 2013, J CLIN SLEEP MED, V9, P191, DOI 10.5664/jcsm.2474; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Landsness EC, 2009, SLEEP, V32, P1273; Larkin EK, 2006, GENET EPIDEMIOL, V30, P101, DOI 10.1002/gepi.20127; Lim YY, 2017, NEUROLOGY; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Manabe K, 2000, GERONTOLOGY, V46, P318, DOI 10.1159/000022184; MANT A, 1995, SLEEP, V18, P433, DOI 10.1093/sleep/18.6.433; Mazzoni G, 1999, J SLEEP RES, V8, P185, DOI 10.1046/j.1365-2869.1999.00154.x; MCCANN UD, 1992, BIOL PSYCHIAT, V31, P1082, DOI 10.1016/0006-3223(92)90153-Q; MEGURO K, 1995, SLEEP, V18, P109, DOI 10.1093/sleep/18.2.109; Mehra R, 2007, J AM GERIATR SOC, V55, P1356, DOI 10.1111/j.1532-5415.2007.01290.x; Newman AB, 1997, J AM GERIATR SOC, V45, P1; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Ohayon MM, 2002, ARCH INTERN MED, V162, P201, DOI 10.1001/archinte.162.2.201; Pace-Schott EF, 2011, PROG BRAIN RES, V191, P75, DOI 10.1016/B978-0-444-53752-2.00012-6; Peters KR, 2008, J SLEEP RES, V17, P23, DOI 10.1111/j.1365-2869.2008.00634.x; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Redline S, 1998, SLEEP, V21, P759; Rockwood K, 2001, J AM GERIATR SOC, V49, P639, DOI 10.1046/j.1532-5415.2001.49125.x; Saarelainen S, 1998, CLIN GENET, V53, P147; Scullin MK, 2013, PSYCHOL AGING, V28, P105, DOI 10.1037/a0028830; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; SOUDMAND R, 1982, NEUROLOGY, V32, P407, DOI 10.1212/WNL.32.4.407; SPIEGEL R, 1986, SLEEP, V9, P66, DOI 10.1093/sleep/9.1.66; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; TENG EL, 1987, J CONSULT CLIN PSYCH, V55, P96, DOI 10.1037/0022-006X.55.1.96; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; WEISGRABER KH, 1988, P NATL ACAD SCI USA, V85, P9758, DOI 10.1073/pnas.85.24.9758; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; YAROUSH R, 1971, J EXP PSYCHOL, V88, P361, DOI 10.1037/h0030914; Yesavage JA, 2004, J GERIATR PSYCH NEUR, V17, P20, DOI 10.1177/0891988703261994	95	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191281	10.1371/journal.pone.0191281	http://dx.doi.org/10.1371/journal.pone.0191281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370207	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600046
J	Hameed, Z; Saleem, S; Mirza, J; Mustafa, MS; Qamar-Ul-Islam				Hameed, Zabit; Saleem, Saqib; Mirza, Jawad; Mustafa, Muhammad Salman; Qamar-Ul-Islam			Characterisation of ictal and interictal states of epilepsy: A system dynamic approach of principal dynamic modes analysis	PLOS ONE			English	Article							IMPAIRED CONSCIOUSNESS; BRAIN SYSTEMS; EEG; SEIZURE; COHERENCE; DISEASES; ABSENCE; ONSET	Epilepsy is a brain disorder characterised by the recurrent and unpredictable interruptions of normal brain function, called epileptic seizures. The present study attempts to derive new diagnostic indices which may delineate between ictal and interictal states of epilepsy. To achieve this, the nonlinear modeling approach of global principal dynamic modes (PDMs) is adopted to examine the functional connectivity of the temporal and frontal lobes with the occipital brain segment using an ensemble of paediatric EEGs having the presence of epileptic seizure. The distinct spectral characteristics of global PDMs are found to be in line with the neural rhythms of brain dynamics. Moreover, we find that the linear trends of associated nonlinear functions (ANFs) associated with the 2nd and 4th global PDMs (representing delta, theta and alpha bands) of Fp1-F3 may differentiate between ictal and interictal states of epilepsy. These findings suggest that global PDMs and their associated ANFs may offer potential utility as diagnostic neural measures for ictal and interictal states of epilepsy.	[Hameed, Zabit; Qamar-Ul-Islam] Inst Space Technol, Dept Elect Engn, Islamabad, Pakistan; [Saleem, Saqib] COMSATS Inst Informat Technol, Dept Elect Engn, Sahiwal, Pakistan; [Saleem, Saqib] Univ Otago, Dept Surg & Anaesthesia, Ctr Translat Physiol, Wellington, New Zealand; [Mirza, Jawad] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan; [Mustafa, Muhammad Salman] COMSATS Inst Informat Technol, Dept Mech Engn, Sahiwal, Pakistan	COMSATS University Islamabad (CUI); University of Otago; COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Saleem, S (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Sahiwal, Pakistan.; Saleem, S (corresponding author), Univ Otago, Dept Surg & Anaesthesia, Ctr Translat Physiol, Wellington, New Zealand.	ssaleem@ciitsahiwal.edu.pk	Hameed, Zabit/AAG-9952-2019; Mirza, Jawad/AAS-7597-2021; Saleem, Saqib/M-4377-2016	Hameed, Zabit/0000-0003-2514-1064; 				Adebimpe A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00143; Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Al-Jumeily D., 2015, SCI WORLD J, V2015; Altunay S, 2010, EXPERT SYST APPL, V37, P5661, DOI 10.1016/j.eswa.2010.02.045; Angarita-Jaimes N, 2014, MED ENG PHYS, V36, P607, DOI 10.1016/j.medengphy.2013.12.012; Austin JK, 2011, EPILEPSY BEHAV, V21, P373, DOI 10.1016/j.yebeh.2011.05.028; Barnes GN, 2008, NAT CLIN PRACT NEURO, V4, P650, DOI 10.1038/ncpneuro0947; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bhattacharyya A, 2017, IEEE T BIO-MED ENG, V64, P2003, DOI 10.1109/TBME.2017.2650259; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Bromfield EB, 2006, INTRO EPILEPSY; CAO YZ, 2016, CHAOS, V26, DOI DOI 10.1063/1.4967734; Chang NF, 2012, IEEE ENG MED BIO, P5162, DOI 10.1109/EMBC.2012.6347156; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Coben R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00194; Costa JCG, 2014, COMPUTATIONAL MATH M, V2014; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Devinsky O, 1993, NEUROLOGIC CLIN; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Fan DG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12618; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gotman J, 1997, ELECTROEN CLIN NEURO, V103, P356, DOI 10.1016/S0013-4694(97)00003-9; Greene BR, 2008, CLIN NEUROPHYSIOL, V119, P1248, DOI 10.1016/j.clinph.2008.02.001; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Holler Y, 2015, FRONTIERS HUMAN NEUR, V9; Kang Y, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2401005; Kitayama M, 2003, PEDIATR NEUROL, V29, P326, DOI 10.1016/S0887-8994(03)00277-7; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LIU A, 1992, ELECTROEN CLIN NEURO, V82, P30, DOI 10.1016/0013-4694(92)90179-L; Marmarelis VZ, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0180; Marmarelis VZ, 2013, ANN BIOMED ENG, V41, P1029, DOI 10.1007/s10439-012-0736-8; Marmarelis V.Z., 2004, NONLINEAR DYNAMIC MO, V10; Marmarelis VZ, 2013, J COMPUT NEUROSCI, V34, P73, DOI 10.1007/s10827-012-0407-7; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; Marmarelis VZ, 1997, ANN BIOMED ENG, V25, P239, DOI 10.1007/BF02648038; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Mitsis GD, 2002, ANN BIOMED ENG, V30, P272, DOI 10.1114/1.1458591; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Saab ME, 2005, CLIN NEUROPHYSIOL, V116, P427, DOI 10.1016/j.clinph.2004.08.004; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Sakkalis V, 2009, IEEE T INF TECHNOL B, V13, P433, DOI 10.1109/TITB.2008.923141; Saleem S, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00685; Saleem S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139470; Sankari Z, 2012, CLIN EEG NEUROSCI, V43, P268, DOI 10.1177/1550059412444970; Schmidt H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003947; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shoeb A, 2004, EPILEPSY BEHAV, V5, P483, DOI 10.1016/j.yebeh.2004.05.005; Shoeb A. H., 2010, P 27 INT C INT C MAC, P975, DOI DOI 10.0RG/PAPERS/; Shoeb A. Hossam, 2009, APPL MACHINE LEARNIN; Song D, 2013, J COMPUT NEUROSCI, V35, P335, DOI 10.1007/s10827-013-0455-7; Stretton J, 2012, EPILEPSY RES, V98, P1, DOI 10.1016/j.eplepsyres.2011.10.009; Subasi A, 2010, EXPERT SYST APPL, V37, P8659, DOI 10.1016/j.eswa.2010.06.065; Taylor PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114316; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Thodoroff P., 2016, MACHINE LEARNING HEA, P178, DOI DOI 10.1016/J.CLINPH.2018.10.010; Vingerhoets G, 2006, SEIZURE-EUR J EPILEP, V15, P221, DOI 10.1016/j.seizure.2006.02.012; Wang Z, 2017, FRONTIERS COMPUTATIO, V11; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; WHO, 2001, WHO INT CLASS FUNCT; Yaffe RB, 2015, CLIN NEUROPHYSIOL, V126, P227, DOI 10.1016/j.clinph.2014.09.009	68	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191392	10.1371/journal.pone.0191392	http://dx.doi.org/10.1371/journal.pone.0191392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351559	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300082
J	Nardo, AE; Anon, MC; Parisi, G				Nardo, Agustina E.; Cristina Anon, M.; Parisi, Gustavo			Large-scale mapping of bioactive peptides in structural and sequence space	PLOS ONE			English	Article							BIOLOGICALLY-ACTIVE PEPTIDES; PROTEIN SUPERFAMILIES; FOOD PROTEINS; CATH DATABASE; PREDICTION; PLANT; IDENTIFICATION; PURIFICATION; PRECURSORS; GENERATION	Health-enhancing potential bioactive peptide (BP) has driven an interest in food proteins as well as in the development of predictive methods. Research in this area has been especially active to use them as components in functional foods. Apparently, BPs do not have a given biological function in the containing proteins and they do not evolve under independent evolutionary constraints. In this work we performed a large-scale mapping of BPs in sequence and structural space. Using well curated BP deposited in BIOPEP database, we searched for exact matches in non-redundant sequences databases. Proteins containing BPs, were used in fold-recognition methods to predict the corresponding folds and BPs occurrences were mapped. We found that fold distribution of BP occurrences possibly reflects sequence relative abundance in databases. However, we also found that proteins with 5 or more than 5 BP in their sequences correspond to well populated protein folds, called superfolds. Also, we found that in well populated superfamilies, BPs tend to adopt similar locations in the protein fold, suggesting the existence of hotspots. We think that our results could contribute to the development of new bioinformatics pipeline to improve BP detection.	[Nardo, Agustina E.; Parisi, Gustavo] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Bernal, Argentina; [Nardo, Agustina E.; Cristina Anon, M.] Univ Nacl La Plata, Fac Ciencias Exactas, Comis Invest Cientif CONICET, Ctr Invest & Desarrollo Criotecnol Alimentos, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Parisi, G (corresponding author), Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Bernal, Argentina.	gusparisi@gmail.com	Nardo, Agustina E./C-7712-2017	Nardo, Agustina E./0000-0001-9003-6004; parisi, gustavo/0000-0001-7444-1624	Agencia de Ciencia y Tecnologia [PICT-2014-3430]; Universidad Nacional de Quilmes [1402/15]	Agencia de Ciencia y Tecnologia; Universidad Nacional de Quilmes	This work was supported by grants from Agencia de Ciencia y Tecnologia (PICT-2014-3430) and Universidad Nacional de Quilmes (1402/15) to GP, GP, MCA are researchers and AEN a Postdoctoral fellow of CONICET.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arroume N, 2016, CURR OPIN FOOD SCI, V7, P101, DOI 10.1016/j.cofs.2016.02.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bougle D, 2017, CRIT REV FOOD SCI, V57, P335, DOI 10.1080/10408398.2013.873766; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cicero A.F.G., 2016, BR J PHARM; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Dave LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098922; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Dziuba J, 2004, ACTA ALIMENT HUNG, V33, P227, DOI 10.1556/AAlim.33.2004.3.3; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A, 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1]; Furnham N, 2012, NUCLEIC ACIDS RES, V40, pD776, DOI 10.1093/nar/gkr852; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Iwaniak A, 2009, FOOD SCI TECHNOL INT, V15, P179, DOI 10.1177/1082013208106320; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Karelin AA, 1998, FEBS LETT, V428, P7, DOI 10.1016/S0014-5793(98)00486-4; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; Ladunga I, 1997, PROTEIN ENG, V10, P187, DOI 10.1093/protein/10.3.187; Li YW, 2011, J MOL STRUCT, V998, P53, DOI 10.1016/j.molstruc.2011.05.011; Magner A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08166; Martirosyan DM, 2015, FUNCT FOODS HEALTH D, V5, P209; Meisel H, 2004, BIOFACTORS, V21, P55, DOI 10.1002/biof.552210111; Miner-Williams WM, 2014, NUTR RES REV, V27, P308, DOI 10.1017/S0954422414000225; Minkiewicz P, 2008, J AOAC INT, V91, P965; Minkiewicz P, 2015, INT J MOL SCI, V16, P20748, DOI 10.3390/ijms160920748; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Mooney C, 2013, BIOINFORMATICS, V29, P1120, DOI 10.1093/bioinformatics/btt103; Orengo C A, 2003, Methods Biochem Anal, V44, P249; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Orengo CA, 1999, NUCLEIC ACIDS RES, V27, P275, DOI 10.1093/nar/27.1.275; Pak VV, 2012, AMINO ACIDS, V43, P2015, DOI 10.1007/s00726-012-1276-0; Pownall TL, 2011, FOOD RES INT, V44, P1069, DOI 10.1016/j.foodres.2011.03.017; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Shahidi F, 2008, J AOAC INT, V91, P914; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; de Castro RJS, 2015, FOOD RES INT, V74, P185, DOI 10.1016/j.foodres.2015.05.013; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Udenigwe CC, 2017, TRENDS FOOD SCI TECH, V69, P74, DOI 10.1016/j.tifs.2017.09.001; Udenigwe CC, 2013, PROCESS BIOCHEM, V48, P1794, DOI 10.1016/j.procbio.2013.08.013; Udenigwe CC, 2012, J FOOD SCI, V77, pR11, DOI 10.1111/j.1750-3841.2011.02455.x; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Yoshikawa M, 2015, PEPTIDES, V72, P208, DOI 10.1016/j.peptides.2015.07.013; ZIOUDROU C, 1979, J BIOL CHEM, V254, P2446	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191063	10.1371/journal.pone.0191063	http://dx.doi.org/10.1371/journal.pone.0191063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351315	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300043
J	Padmakumar, M; Brain, KL; Young, JS; Manchanda, R				Padmakumar, Mithun; Brain, Keith L.; Young, John S.; Manchanda, Rohit			A four-component model of the action potential in mouse detrusor smooth muscle cell	PLOS ONE			English	Article							URINARY-BLADDER; PURINERGIC NEUROTRANSMISSION; MECHANICAL-ACTIVITY; EVOKED-POTENTIALS; NEURONS; ACETYLCHOLINE; INHIBITION; ACTIVATION; DECREASE; RAT	Background and hypothesis Detrusor smooth muscle cells (DSMCs) of the urinary bladder are electrically connected to one another via gap junctions and form a three dimensional syncytium. DSMCs exhibit spontaneous electrical activity, including passive depolarizations and action potentials. The shapes of spontaneous action potentials (sAPs) observed from a single DSM cell can vary widely. The biophysical origins of this variability, and the precise components which contribute to the complex shapes observed are not known. To address these questions, the basic components which constitute the sAPs were investigated. We hypothesized that linear combinations of scaled versions of these basic components can produce sAP shapes observed in the syncytium. Methods and results The basic components were identified as spontaneous evoked junction potentials (sEJP), native AP (nAP), slow after hyperpolarization (sAHP) and very slow after hyperpolarization (vsAHP). The experimental recordings were grouped into two sets: a training data set and a testing data set. A training set was used to estimate the components, and a test set to evaluate the efficiency of the estimated components. We found that a linear combination of the identified components when appropriately amplified and time shifted replicated various AP shapes to a high degree of similarity, as quantified by the root mean square error (RMSE) measure. Conclusions We conclude that the four basic components D sEJP, nAP, sAHP, and vsAHP D identified and isolated in this work are necessary and sufficient to replicate all varieties of the sAPs recorded experimentally in DSMCs. This model has the potential to generate testable hypotheses that can help identify the physiological processes underlying various features of the sAPs. Further, this model also provides a means to classify the sAPs into various shape classes.	[Padmakumar, Mithun; Manchanda, Rohit] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai, Maharashtra, India; [Brain, Keith L.] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Young, John S.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Birmingham; University of Portsmouth	Brain, KL (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England.	k.l.brain@bham.ac.uk	Brain, Keith L./AFU-7168-2022; Young, John S./J-2529-2013	Brain, Keith L./0000-0002-0906-7012; Young, John S./0000-0002-2711-9701; Padmakumar, Mithun/0000-0002-5305-4542	Department of Biotechnology (DBT), India [BT/PR12973/MED/122/47/2016]; UKIERI [UKUTP20110055]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); UKIERI(UK Research & Innovation (UKRI))	The work was supported by grants from the Department of Biotechnology (DBT, http://www.dbtindia.nic.in/), India (BT/PR12973/MED/122/47/2016) to Rohit Manchanda and the UKIERI (UKUTP20110055, http://www.ukieri.org/) to Rohit Manchanda and Keith L. Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian M, 1996, NEUROSCI LETT, V218, P103, DOI 10.1016/S0304-3940(96)13129-3; [Anonymous], 1998, PHYSL EXCITABLE CELL; Appukuttan S, 2015, J COMPUT NEUROSCI, V38, P167, DOI 10.1007/s10827-014-0532-6; BENNETT MR, 1973, PHILOS T ROY SOC B, V265, P25, DOI 10.1098/rstb.1973.0006; Bennett MR, 1972, AUTONOMIC NEUROMUSCU; CALLAHAN SM, 1981, BRIT J PHARMACOL, V74, P353, DOI 10.1111/j.1476-5381.1981.tb09978.x; COWAN WD, 1983, CAN J PHYSIOL PHARM, V61, P1236, DOI 10.1139/y83-182; CREED KE, 1983, J PHYSIOL-LONDON, V338, P149, DOI 10.1113/jphysiol.1983.sp014666; De Biasi M, 2000, EUR J PHARMACOL, V393, P137, DOI 10.1016/S0014-2999(00)00008-X; DODD J, 1983, J PHYSIOL-LONDON, V334, P271, DOI 10.1113/jphysiol.1983.sp014494; Drake MJ, 2017, BJU INT, V119, P22, DOI 10.1111/bju.13598; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Fry C H, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P291, DOI 10.1007/BF01901509; FUJII K, 1990, BRIT J PHARMACOL, V99, P779, DOI 10.1111/j.1476-5381.1990.tb13006.x; GILPIN CJ, 1983, J ANAT, V137, P705; Guyton A.C., 2006, TXB MED PHYSL; Hanani Menachem, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P321; HARTZELL HC, 1977, J PHYSIOL-LONDON, V271, P817, DOI 10.1113/jphysiol.1977.sp012027; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; HORN JP, 1981, NATURE, V292, P625, DOI 10.1038/292625a0; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; MANCHANDA R, 1995, CURR SCI INDIA, V69, P140; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; MILNER P, 1991, NEUROSCIENCE, V43, P661, DOI 10.1016/0306-4522(91)90324-H; Ochodnicky P, 2013, ACTA PHYSIOL, V207, P16, DOI 10.1111/apha.12010; Padmakumar M, 2017, INT J COMPUTER THEOR, V9, P115; Padmakumar M., 2012, SIGN PROC COMM SPCOM, P1; Padmakumar M, 2016, 2016 INTERNATIONAL CONFERENCE ON SYSTEMS IN MEDICINE AND BIOLOGY (ICSMB), P148, DOI 10.1109/ICSMB.2016.7915109; Padmakumar M, 2015, PROCEEDINGS OF THE 2015 IEEE RECENT ADVANCES IN INTELLIGENT COMPUTATIONAL SYSTEMS (RAICS), P212, DOI 10.1109/RAICS.2015.7488416; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Takagi H, 2016, EUR J PHARMACOL, V789, P179, DOI 10.1016/j.ejphar.2016.07.041; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Trenado C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168151; URSILLO RC, 1961, AM J PHYSIOL, V201, P408, DOI 10.1152/ajplegacy.1961.201.3.408; VIDAL JJ, 1977, P IEEE, V65, P633, DOI 10.1109/PROC.1977.10542; Wuest M, 2005, J UROLOGY, V173, P2182, DOI 10.1097/01.ju.0000158126.53702.e4; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190016	10.1371/journal.pone.0190016	http://dx.doi.org/10.1371/journal.pone.0190016			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351282	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300014
J	Zhuang, H; Yago, M; Settele, J; Li, X; Ueshima, R; Grishin, NV; Wang, M				Zhuang, Hailing; Yago, Masaya; Settele, Josef; Li, Xiushan; Ueshima, Rei; Grishin, Nick V.; Wang, Min			Species richness of Eurasian Zephyrus hairstreaks (Lepidoptera: Lycaenidae: Theclini) with implications on historical biogeography: An NDM/VNDM approach	PLOS ONE			English	Article							PLANT DIVERSITY; DISTRIBUTION PATTERNS; ENDEMISM; AREAS; BIODIVERSITY; CONSERVATION; REFUGIA; CHINA; GENUS	Aim A database based on distributional records of Eurasian Zephyrus hairstreaks (Lepidoptera: Lycaenidae: Theclini) was compiled to analyse their areas of endemism (AoEs), species richness and distribution patterns, to explore their locations of past glacial refugia and dispersal routes. Methods Over 2000 Zephyrus hairstreaks occurrences are analysed using the NDM/VNDM algorithm, for the recognition of AoEs. Species richness was calculated by using the option 'Number of different classes' to count the different classes of a variable presented in each 3.0 degrees x 3.0 degrees grid cell, and GIS software was used to visualize distribution patterns of endemic species. Results Centres of species richness of Zephyrus hairstreaks are situated in the eastern Qinghai-Tibet Plateau (EQTP), Hengduan Mountain Region (HDMR) and the Qinling Mountain Region (QLMR). Latitudinal gradients in species richness show normal distribution with the peak between 25 degrees N and 35 degrees N in the temperate zone, gradually decreasing towards the poles. Moreover, most parts of central and southern China, especially the area of QLMR-EQTP-HDMR, were identified as AoEs that may have played a significant role as refugia during Quaternary global cooling. There are four major distributional patterns of Zephyrus hairstreaks in Eurasia: Sino-Japanese, Sino-Himalayan, high-mountain and a combined distribution covering all three patterns. Conclusions Zephyrus hairstreaks probably originated at least 23-24 Myr ago in E. Asia between 25 degrees N to 35 degrees N in the temperate zone. Cenozoic orogenies caused rapid speciation of this tribe and extrusion of the Indochina block resulted in vicariance between the Sino-Japanese and the Sino-Himalayan patterns. The four distribution patterns provided two possible dispersal directions: Sino-Japanese dispersal and Sino-Himalayan dispersal.	[Zhuang, Hailing; Wang, Min] South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Zhuang, Hailing; Yago, Masaya] Univ Tokyo, Univ Museum, Tokyo, Japan; [Settele, Josef; Li, Xiushan] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saxony Anhalt, Germany; [Settele, Josef] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Settele, Josef] Univ Philippines Los Banos, Inst Biol Sci, Laguna, Philippines; [Ueshima, Rei] Univ Tokyo, Grad Sch Sci, Inst Biol Sci, Tokyo, Japan; [Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	South China Agricultural University; University of Tokyo; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of the Philippines System; University of the Philippines Los Banos; University of Tokyo; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, M (corresponding author), South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	minwang@scau.edu.cn	Settele, Josef/A-6371-2009; Li, Xiushan/AAA-3856-2021	Settele, Josef/0000-0002-8624-4983; 	Chinese National Natural Science Foundation [40971037]; CSC (China Scholarship Council, Liujinfa) [[2015] 3022];  [26440207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127390] Funding Source: NIH RePORTER	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CSC (China Scholarship Council, Liujinfa); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported Grant-in-Aid for Scientific Research (C) (No. 26440207 to MY), (http://www.um.u-tokyo.ac.jp/people/faculty_yago.html). This funder provided the idea, fund and resources and participated writing original draft and revision. This work was also supported by the Chinese National Natural Science Foundation (No. 40971037 to MW). This funder provided the idea, fund, resource and participated filed survey, confirmed test. Lastly, it was funded by the CSC (China Scholarship Council, Liujinfa [2015] 3022 to HZ. This funder conducted almost all aspects of this research expect, resources and validation.	Asano S, 2014, GEKKAN MUSHI, V521, P6; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; do Prado JR, 2015, J BIOGEOGR, V42, P540, DOI 10.1111/jbi.12424; Ebach MC, 2006, J BIOGEOGR, V33, P761, DOI 10.1111/j.1365-2699.2006.01477.x; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; Escalante T, 2013, BIOL J LINN SOC, V110, P485, DOI 10.1111/bij.12142; Fortey R. A., 1998, P43; Glasby CJ, 1999, J BIOGEOGR, V26, P507, DOI 10.1046/j.1365-2699.1999.00297.x; Goloboff P, 2005, NDM VNDM VER 2 5 SOF; Harada Motohiro, 2012, Gekkan-Mushi, V497, P9; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasegawa Takashi, 2014, Butterflies (Teinopalpus), V67, P4; Hasegawa Takashi, 2013, Butterflies (Teinopalpus), V63, P4; Hasegawa Takashi, 2009, Gekkan-Mushi, V461, P9; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; HOLLOWAY JD, 1987, BIOL J LINN SOC, V30, P325, DOI 10.1111/j.1095-8312.1987.tb00306.x; Holloway JD, 1998, HDB ZOOLOGY NATURAL, V1, P423; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Hsu YF, 2015, ZOOTAXA, V4027, P130, DOI 10.11646/zootaxa.4027.1.6; Hsu YF, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.1983.1.3; Huang XL, 2008, J BIOGEOGR, V35, P230, DOI 10.1111/j.1365-2699.2007.01776.x; Katayama Toshihiko, 2011, Butterflies (Teinopalpus), V59, P8; Kim S, 2006, J LEPID SOC, V16, P33; Kim S, 2009, J LEPID SOC, V18, P1; Koiwaya S, 2007, MUSHI SHAS ICONOGRAP, V5; Koiwaya S., 2013, GEKKAN MUSHI, V509, P4; Koiwaya S., 2013, GEKKAN MUSHI, V512, P10; Koiwaya Satoshi, 2012, Gekkan-Mushi, V502, P28; Koiwaya Satoshi, 2014, Gekkan-Mushi, V521, P21; Koiwaya Satoshi, 2011, Gekkan-Mushi, V485, P4; Koiwaya Satoshi, 2010, Butterflies (Teinopalpus), V56, P4; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Li Heng, 1999, Acta Botanica Yunnanica, V21, P407; Li XW, 1997, ANN MO BOT GARD, V84, P888, DOI 10.2307/2992033; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu J, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON ENERGY, P16, DOI 10.1109/AMS.2013.9; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Metcalfe Ian, 1998, P25; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakamura Norio, 2011, Butterflies (Teinopalpus), V57, P22; Platnick N., 1991, AUSTR SYSTEMATIC BOT, V4, P11; SAIGUSA T, 1982, ENTOMOL GEN, V8, P59; Saito Motoki, 2011, Butterflies (Teinopalpus), V57, P57; Scheldeman X., 2010, TRAINING MANUAL SPAT; Shirozu T., 1956, Sieboldia Fukuoka, V1, P329; Shirozu T, 1980, ZEPHYRUS HAIRSTREAKS; Shizuya Hideo, 2010, Gekkan-Mushi, V473, P13; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Singh Arun P., 2009, Journal of Threatened Taxa, V1, P37; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Tanaka T, 1954, REVISIO AURANTIACEAR, VIX, P141; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wallace AR, 2010, PHYS GEOGRAPHY MALAY; WANG M., 2012, BUTTERFLIES GUANGXI; Wang M, 2009, BUTTERFLIES MOTHS, V60, P125; Whitmore T.C., 1987, BIOGEOGRAPHICAL EVOL, P5; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; Yokochi Takashi, 2015, Butterflies (Teinopalpus), V70, P17; Yokochi Takashi, 2015, Butterflies (Teinopalpus), V69, P9; Zhu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068283; [朱华 Zhu Hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P870; Zhuang HL, 2015, ZOOTAXA, V3985, P142, DOI 10.11646/zootaxa.3985.1.8	74	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191049	10.1371/journal.pone.0191049	http://dx.doi.org/10.1371/journal.pone.0191049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351314	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300041
J	Fendrich, V; Jendryschek, F; Beeck, S; Albers, M; Lauth, M; Esni, F; Heeger, K; Dengler, J; Slater, EP; Holler, JPN; Baier, A; Bartsch, DK; Waldmann, J				Fendrich, Volker; Jendryschek, Frederike; Beeck, Saskia; Albers, Max; Lauth, Matthias; Esni, Farzad; Heeger, Kristin; Dengler, Janina; Slater, Emily P.; Holler, Julia P. N.; Baier, Aninja; Bartsch, Detlef K.; Waldmann, Jens			Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CANCER CELL-LINE; INTRAEPITHELIAL NEOPLASIA; IN-VIVO; METASTASIS; EXPRESSION; MOUSE; CHEMORESISTANCE; GENERATION	Pancreatic cancer (PDAC) is one of the most dismal of human malignancies. Inhibiting or delaying the progression of precursor lesions of PDAC, pancreatic intraepthial neoplasia (PanINs), to invasive cancer, would be a major step. In the present study, we used a transgenic murine model of pancreatic cancer to evaluate the impact of a conditional knockout of the transcription factor Snail1, a major factor in epithelial-to-mesenchymal transition, on acinar-to-ductal formation and on PanIN progression. By interbreeding conditional LsL-Snail(floxf/wt); LsL-Kras(G12D) and Pdx1-Cre strains, we obtained LsL-KrasG12D; Pdx1-Cre(KP) mice, Snail1 heterozygous knockout LsL-KrasG12D; LsL-Snail(flox/-); Pdx1-Cre(KPShet) mice or Snail1 homozygous knockout LsL-Kras(G12D); LsL-Snail(flox/flox); Pdx1-Cre(KPS) mice. Mice were then followed in a longitudinal study for 2, 4, 6, 8, 10, and 12 months. Furthermore, in mice with a genetic or pharmacological inhibition of Snail1, using the Snail1 inhibitor GN25, a model of pancreatic injury by administration of cerulein was introduced to evaluate ADM formation in this setting. A translational approach with a tissue microarray (TMA) of human PanINs and an in vivo nude mouse platform to test GN25 in human pancreatic adenocarcinoma was then adopted. Quantification of PanINs showed delayed initiation and progression of PanIN lesions at all ages in both homozygous and heterozygous Snaildel1; Pdx-1-Cre; LSL-Kras(G12D/+)-Mice. PanINs at TMA revealed snail expression in the majority of cases. GN25 showed growth inhibition in 2/2 human pancreatic adenocarcinomas using a nude mice in vivo platform. Genetic and pharmacologic abrogation of Snail1 signaling in exocrine pancreas impairs development of acinar-to-ductal metaplasia following cerulein-mediated pancreatic injury. The present study suggests a fundamental new approach to delay the progression of PDAC.	[Fendrich, Volker; Jendryschek, Frederike; Beeck, Saskia; Albers, Max; Dengler, Janina; Slater, Emily P.; Baier, Aninja; Bartsch, Detlef K.; Waldmann, Jens] Univ Marburg, Dept Surg, Marburg, Germany; [Lauth, Matthias] IMT, Marburg, Germany; [Esni, Farzad] Univ Pittsburgh, Dept Surg, John G Rangos Res Ctr, Pittsburgh, PA USA; [Heeger, Kristin] Univ Hosp Giessen & Marburg, Dept Internal Med, Div Gastroenterol, Campus Marburg, Marburg, Germany; [Holler, Julia P. N.] Univ Hosp Giessen & Marburg, Dept Surg, Campus Giessen, Giessen, Germany	Philipps University Marburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Fendrich, V (corresponding author), Univ Marburg, Dept Surg, Marburg, Germany.	v.fendrich@web.de	Albers, Max/GZA-3575-2022; Esni, Farzad/AAX-1136-2021	Esni, Farzad/0000-0002-0342-6862; Lauth, Matthias/0000-0001-5922-5384	Sander Stiftung	Sander Stiftung	Grant support: VF and ML were supported by a Research Grant from the Sander Stiftung	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Fendrich V, 2014, NEUROENDOCRINOLOGY, V100, P300, DOI 10.1159/000368610; Fendrich V, 2010, GUT, V59, P630, DOI 10.1136/gut.2009.188961; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murray SA, 2006, GENESIS, V44, P7, DOI 10.1002/gene.20178; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhim AD, 2013, PANCREATOLOGY, V13, P114, DOI 10.1016/j.pan.2013.01.004; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Zhang S, 2015, PANCREAS, V44, P1121, DOI 10.1097/MPA.0000000000000418; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	29	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1845	1856		10.1038/s41388-017-0100-4	http://dx.doi.org/10.1038/s41388-017-0100-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29367759				2022-12-26	WOS:000429303300003
J	Liao, YN; Xia, XH; Liu, NN; Cai, JY; Guo, ZQ; Li, YL; Jiang, LL; Dou, QP; Tang, DL; Huang, HB; Liu, JB				Liao, Yuning; Xia, Xiaohong; Liu, Ningning; Cai, Jianyu; Guo, Zhiqiang; Li, Yanling; Jiang, Lili; Dou, Q. Ping; Tang, Daolin; Huang, Hongbiao; Liu, Jinbao			Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; PROSTATE-CANCER; ENZYME USP14; E3 LIGASE; ASSOCIATION; DEGRADATION; ACTIVATION; EXPRESSION; AURANOFIN	It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60% of breast tumors, which promotes the growth of estrogen receptor-negative (ER-)/AR-positive (AR(+)) breast cancer cells. Thus, AR might be a potential therapeutic target for AR-positive/ER-negative breast cancer patients. Previously we reported that in prostate cancer cells proteasome-associated deubiquitinase ubiquitin-specific protease 14 (USP14) stabilized AR protein level by removing its ubiquitin chain. In the current study, we studied the USP14-AR protein interaction and cell proliferation status after USP14 reduction or inhibition in breast cancer cells, and our results support the conclusion that targeting USP14 is a novel strategy for treating AR-responsive breast cancer. We found that inhibition of USP14 accelerated the K48-ubiquitination and proteasome-mediated degradation of AR protein. Additionally, both genetic and pharmacological inhibition of USP14 significantly suppressed cell proliferation in AR-responsive breast cancer cells by blocking G(0)/G(1) to S phase transition and inducing apoptosis. Moreover, AR overexpression inhibited USP14 inhibition-induced events, suggesting that AR deubiquitination by USP14 is critical for breast cancer growth and USP14 inhibition is a possible strategy to treat AR-positive breast cancer.	[Liao, Yuning; Xia, Xiaohong; Cai, Jianyu; Guo, Zhiqiang; Li, Yanling; Jiang, Lili; Dou, Q. Ping; Huang, Hongbiao; Liu, Jinbao] Guangzhou Med Univ, Affiliated Canc Hosp, Prot Modificat & Degradat Lab, SKLRD,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Ningning] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Dou, Q. Ping] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Tang, Daolin] Guangzhou Med Univ, Affiliated Hosp 3, Ctr DAMP Biol,Prot Modificat & Degradat Lab, Key Lab Major Obstet Dis Guangdong Prov,Key Lab R, Guangzhou, Guangdong, Peoples R China; [Tang, Daolin] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Guangzhou Medical University; Guangzhou Medical University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Guangzhou Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huang, HB; Liu, JB (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp, Prot Modificat & Degradat Lab, SKLRD,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.	hhb800616@126.com; jliu@gzhmu.edu.cn	li, yan/GTI-4638-2022; Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021	Tang, Daolin/0000-0002-1903-6180; Liu, Ningning/0000-0002-9587-2332; Dou, Qingping/0000-0002-6465-1473	National Natural Science Foundation of China [81472390, 81472762, 31671435]; National Funds for Developing Local Colleges and Universities [B16056001]; Science and Technology Program of Guangzhou [201604020001]; Pearl River S&T Nova Program of Guangzhou [201506010071]; Innovative Academic Team of Guangzhou Education System [1201610014]; Guangzhou Education Commission [1201610098]; Science and Technology Planning Project of Guangdong Province, China [2014A020212691, 2016A030308]; Research Award Fund for Outstanding Young Teachers in Guangdong Provincial Higher Education Institutions [YQ2015136]; Project of Department of Education of Guangdong Province [2016KTSCX118, 2016KTSCX119]; Research Scholar Grant from the American Cancer Society [RSG-16-014-01-CDD]; National Institutes of Health, USA [R01CA160417, R01GM115366]; Natural Science Foundation of Guangdong Province [2016A030308011]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE [R01CA160417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115366] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Funds for Developing Local Colleges and Universities; Science and Technology Program of Guangzhou; Pearl River S&T Nova Program of Guangzhou; Innovative Academic Team of Guangzhou Education System; Guangzhou Education Commission; Science and Technology Planning Project of Guangdong Province, China; Research Award Fund for Outstanding Young Teachers in Guangdong Provincial Higher Education Institutions; Project of Department of Education of Guangdong Province; Research Scholar Grant from the American Cancer Society(American Cancer Society); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christine Heiner (Department of Surgery, University of Pittsburgh) for her critical reading of the manuscript. The study was supported by the National Natural Science Foundation of China (81472390, 81472762, and 31671435), the National Funds for Developing Local Colleges and Universities (B16056001), the Science and Technology Program of Guangzhou (201604020001), Pearl River S&T Nova Program of Guangzhou (201506010071), Innovative Academic Team of Guangzhou Education System (1201610014), General Project (1201610098) from Guangzhou Education Commission, the Science and Technology Planning Project of Guangdong Province, China (2014A020212691 and 2016A030308), a Research Award Fund for Outstanding Young Teachers in Guangdong Provincial Higher Education Institutions (YQ2015136), the Project of Department of Education of Guangdong Province(2016KTSCX118, 2016KTSCX119), a Research Scholar Grant from the American Cancer Society (RSG-16-014-01-CDD), the National Institutes of Health, USA (R01CA160417 and R01GM115366), the Natural Science Foundation of Guangdong Province (2016A030308011), and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2017). We thank the Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University for flow cytometry analysis.	Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Chen ST, 2015, J BIOL CHEM, V290, P21713, DOI 10.1074/jbc.M114.628255; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Collins LC, 2011, MODERN PATHOL, V24, P924, DOI 10.1038/modpathol.2011.54; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang HB, 2016, ONCOTARGET, V7, P2796, DOI 10.18632/oncotarget.6425; Huang HBA, 2014, TOXICOL LETT, V228, P170, DOI 10.1016/j.toxlet.2014.05.012; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang HB, 2011, CANCER LETT, V301, P221, DOI 10.1016/j.canlet.2010.12.015; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liao YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.477; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Liu NN, 2014, ONCOTARGET, V5, P5453, DOI 10.18632/oncotarget.2113; McClurg UL, 2015, ONCOTARGET, V6, P9657, DOI 10.18632/oncotarget.3922; Mialki RK, 2013, J BIOL CHEM, V288, P15437, DOI 10.1074/jbc.C112.446682; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Shi XP, 2014, CLIN CANCER RES, V20, P151, DOI 10.1158/1078-0432.CCR-13-1063; Shinji S, 2006, ONCOL REP, V15, P539; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Wang YY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0379-8; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	40	73	76	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1896	1910		10.1038/s41388-017-0069-z	http://dx.doi.org/10.1038/s41388-017-0069-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29353883	hybrid, Green Published			2022-12-26	WOS:000429303300007
J	O'Brien, KP; Khan, S; Gilligan, KE; Zafar, H; Lalor, P; Glynn, C; O'Flatharta, C; Ingoldsby, H; Dockery, P; De Bhulbh, A; Schweber, JR; St John, K; Leahy, M; Murphy, JM; Gallagher, WM; O'Brien, T; Kerin, MJ; Dwyer, RM				O'Brien, K. P.; Khan, S.; Gilligan, K. E.; Zafar, H.; Lalor, P.; Glynn, C.; O'Flatharta, C.; Ingoldsby, H.; Dockery, P.; De Bhulbh, A.; Schweber, J. R.; St John, K.; Leahy, M.; Murphy, J. M.; Gallagher, W. M.; O'Brien, T.; Kerin, M. J.; Dwyer, R. M.			Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379	ONCOGENE			English	Article							BREAST-CANCER; CYCLOOXYGENASE-2 EXPRESSION; STROMAL CELLS; EXOSOMES; METASTASIS; MECHANISM; APOPTOSIS; THERAPY; MIR-379; BRAIN	Adult Mesenchymal Stem Cells (MSCs) have a well-established tumor-homing capacity, highlighting potential as tumor-targeted delivery vehicles. MSCs secrete extracellular vesicle (EV)-encapsulated microRNAs, which play a role in intercellular communication. The aim of this study was to characterize a potential tumor suppressor microRNA, miR-379, and engineer MSCs to secrete EVs enriched with miR-379 for in vivo therapy of breast cancer. miR-379 expression was significantly reduced in lymph node metastases compared to primary tumor tissue from the same patients. A significant reduction in the rate of tumor formation and growth in vivo was observed in T47D breast cancer cells stably expressing miR-379. In more aggressive HER2-amplified HCC-1954 cells, HCC-379 and HCC-NTC tumor growth rate in vivo was similar, but increased tumor necrosis was observed in HCC-379 tumors. In response to elevated miR-379, COX-2 mRNA and protein was also significantly reduced in vitro and in vivo. MSCs were successfully engineered to secrete EVs enriched with miR-379, with the majority found to be of the appropriate size and morphology of exosomal EVs. Administration of MSC-379 or MSC-NTC cells, or EVs derived from either cell population, resulted in no adverse effects in vivo. While MSC-379 cells did not impact tumor growth, systemic administration of cell-free EVs enriched with miR-379 was demonstrated to have a therapeutic effect. The data presented support miR-379 as a potent tumor suppressor in breast cancer, mediated in part through regulation of COX-2. Exploiting the tumor-homing capacity of MSCs while engineering the cells to secrete EVs enriched with miR-379 holds exciting potential as an innovative therapy for metastatic breast cancer.	[O'Brien, K. P.; Khan, S.; Gilligan, K. E.; Glynn, C.; De Bhulbh, A.; Schweber, J. R.; St John, K.; Kerin, M. J.; Dwyer, R. M.] Natl Univ Ireland Galway, Lambe Inst Translat Res, Sch Med, Discipline Surg, Galway, Ireland; [Zafar, H.] Natl Univ Ireland Galway, Sch Med, Cardiovasc Res Ctr Galway, Galway, Ireland; [Lalor, P.; Dockery, P.] Natl Univ Ireland Galway, Sch Med, Discipline Anat, Galway, Ireland; [O'Flatharta, C.; Murphy, J. M.; O'Brien, T.] Natl Univ Ireland Galway, CURAM, Regenerat Med Inst REMEDI, Galway, Ireland; [Ingoldsby, H.] Univ Hosp Galway, Div Anat Pathol, Galway, Ireland; [Leahy, M.] Natl Univ Ireland Galway, Sch Phys, Tissue Opt & Microcirculat Imaging Grp, Galway, Ireland; [Gallagher, W. M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Canc Biol & Therapeut Lab, Dublin, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University College Dublin	Dwyer, RM (corresponding author), Natl Univ Ireland Galway, Lambe Inst Translat Res, Sch Med, Discipline Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	leahy, martin j/C-8383-2009; Dwyer, Roisin M/C-6654-2013	leahy, martin j/0000-0003-1558-4574; Dwyer, Roisin M/0000-0002-5854-0339; O'Brien, Killian/0000-0002-4340-6858; Gallagher, William/0000-0002-4307-5999; Gilligan, Katie/0000-0001-5669-293X; Dockery, Peter/0000-0001-5103-6589; Kerin, Michael/0000-0003-4164-5561	Irish Cancer Society BREAST-PREDICT collaborative cancer research center [CCRGAL13]; Irish Research Council (IRC) Postgraduate Scholarship [GOIPG/2016/978]; IRC Enterprise Partnership Scheme Postdoctoral Research Fellowship [EPSPD/2016/20]; Wellcome Trust biomedical vacation scholarship; Health Research Board summer scholarship [SS-2015-1365]; Science Foundation Ireland from the European Union's 7th Framework Programme [09/SRC/B1794, 12/RI/2338, HEALTH-2007-B-223298]; charity Breast Cancer Research	Irish Cancer Society BREAST-PREDICT collaborative cancer research center; Irish Research Council (IRC) Postgraduate Scholarship(Irish Research Council for Science, Engineering and Technology); IRC Enterprise Partnership Scheme Postdoctoral Research Fellowship; Wellcome Trust biomedical vacation scholarship(Wellcome Trust); Health Research Board summer scholarship; Science Foundation Ireland from the European Union's 7th Framework Programme(Science Foundation Ireland); charity Breast Cancer Research	KPO'B and SK: Irish Cancer Society BREAST-PREDICT collaborative cancer research center CCRGAL13; KEG: Irish Research Council (IRC) Postgraduate Scholarship GOIPG/2016/978; HZ: IRC Enterprise Partnership Scheme Postdoctoral Research Fellowship EPSPD/2016/20. JRS and KSJ: Wellcome Trust biomedical vacation scholarship; ADB: Health Research Board summer scholarship SS-2015-1365. This research was also supported by Science Foundation Ireland grants 09/SRC/B1794 and 12/RI/2338, funding from the European Union's 7th Framework Programme under grant agreement no. HEALTH-2007-B-223298 (PurStem), and the charity Breast Cancer Research.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen J S, 2016, Zhonghua Yi Xue Za Zhi, V96, P1450, DOI 10.3760/cma.j.issn.0376-2491.2016.18.013; Chen JS, 2016, CANCER LETT, V375, P73, DOI 10.1016/j.canlet.2016.02.043; Chen KH, 2016, ONCOTARGET, V7, P74537, DOI 10.18632/oncotarget.12902; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clancy C, 2016, CANCER BIOMARK, V17, P427, DOI 10.3233/CBM-160659; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Dwyer RM, 2011, STEM CELLS, V29, P1149, DOI 10.1002/stem.665; Gilligan KE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061122; Gururajan M, 2014, CLIN CANCER RES, V20, P6559, DOI 10.1158/1078-0432.CCR-14-1784; Heijblom M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11778; Hole P, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2101-8; Holmes MD, 2011, BREAST CANCER RES TR, V130, P657, DOI 10.1007/s10549-011-1651-7; Hwang DW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15636; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Laddha SV, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-10; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Li K, 2017, YONSEI MED J, V58, P234, DOI 10.3349/ymj.2017.58.1.234; Li Z, 2017, J CELL MOL MED, V21, P315, DOI 10.1111/jcmm.12966; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire Mark T, 2010, Rehab Manag, V23, P20; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Momin Eric N., 2010, Current Immunology Reviews, V6, P137; Munoz JL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.60; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ristimaki A, 2002, CANCER RES, V62, P632; Roggan A, 1999, J BIOMED OPT, V4, P36, DOI 10.1117/1.429919; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh-Ranger G, 2002, EUR J SURG ONCOL, V28, P729, DOI 10.1053/ejso.2002.1329; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Xu Z, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3443793; Yamamoto K, 2014, ONCOL REP, V32, P2365, DOI 10.3892/or.2014.3481; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001	51	103	105	2	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2137	2149		10.1038/s41388-017-0116-9	http://dx.doi.org/10.1038/s41388-017-0116-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29367765	Green Submitted			2022-12-26	WOS:000430589000005
J	Trochta, JT; Pons, M; Rudd, MB; Krigbaum, M; Tanz, A; Hilborn, R				Trochta, John T.; Pons, Maite; Rudd, Merrill B.; Krigbaum, Melissa; Tanz, Alexander; Hilborn, Ray			Ecosystem-based fisheries management: Perception on definitions, implementations, and aspirations	PLOS ONE			English	Article							SUSTAINABILITY; FRAMEWORK; POLICIES; BYCATCH	Ecosystem-based fisheries management (EBFM) was developed to move beyond single species management by incorporating ecosystem considerations for the sustainable utilization of marine resources. Due to the wide range of fishery characteristics, including different goals of fisheries management across regions and species, theoretical best practices for EBFM vary greatly. Here we highlight the lack of consensus in the interpretation of EBFM amongst professionals in marine science and its implementation. Fisheries policy-makers and managers, stock assessment scientists, conservationists, and ecologists had very different opinions on the degree to which certain management strategies would be considered EBFM. We then assess the variability of the implementation of EBFM, where we created a checklist of characteristics typifying EBFM and scored fisheries across different regions, species, ecosystems, and fishery size and capacity. Our assessments show fisheries are unlikely to meet all the criteria on the EBFM checklist. Consequentially, it is unnecessary for management to practice all the traits of EBFM, as some may be disparate from the ecosystem attributes or fishery goals. Instead, incorporating some ecosystem-based considerations to fisheries management that are context-specific is a more realistic and useful way for EBFM to occur in practice.	[Trochta, John T.; Pons, Maite; Rudd, Merrill B.; Krigbaum, Melissa; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Tanz, Alexander] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pons, M (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mpons@uw.edu			Walton Family Foundation; David and Luciele Packard Foundation; International Seafood Sustainability Foundation; Environmental Defense; The Nature Conservancy; At-sea Processors Association; Bering Sea Fisheries Research Foundation; Freezer Longline Coalition; Groundfish Forum/Alaska Seafood Coop; Icicle Seafoods; Pacific Seafood Processors Association; United Catcher Boats; American Seafood Group; Arctic Storm Management Group; Blue Harvest; Clearwater Seafoods; Glaciar Pesquera; Glacier Fish Company; Havfisk ASA; HB Grandi; Irvin Johnson; Sea Harvest; Nergard AS; Nueva Pescanova; Ocean Choice International; Pacific Seafood Group; Parleviet Van der Plas; Samherji hf.; San Arawa SA.; Sanford Ltd.; Sealord Group; Trident Seafoods Corp.; United States Seafoods LLC	Walton Family Foundation; David and Luciele Packard Foundation; International Seafood Sustainability Foundation; Environmental Defense; The Nature Conservancy; At-sea Processors Association; Bering Sea Fisheries Research Foundation; Freezer Longline Coalition; Groundfish Forum/Alaska Seafood Coop; Icicle Seafoods; Pacific Seafood Processors Association; United Catcher Boats; American Seafood Group; Arctic Storm Management Group; Blue Harvest; Clearwater Seafoods; Glaciar Pesquera; Glacier Fish Company; Havfisk ASA; HB Grandi; Irvin Johnson; Sea Harvest; Nergard AS; Nueva Pescanova; Ocean Choice International; Pacific Seafood Group; Parleviet Van der Plas; Samherji hf.; San Arawa SA.; Sanford Ltd.; Sealord Group; Trident Seafoods Corp.; United States Seafoods LLC	The funders in this study, including the Walton Family Foundation, the David and Luciele Packard Foundation, the International Seafood Sustainability Foundation, Environmental Defense, The Nature Conservancy, and several fishing companies (At-sea Processors Association, Bering Sea Fisheries Research Foundation, Freezer Longline Coalition, Groundfish Forum/Alaska Seafood Coop, Icicle Seafoods, Pacific Seafood Processors Association, United Catcher Boats, American Seafood Group, Arctic Storm Management Group, Blue Harvest, Clearwater Seafoods, Glaciar Pesquera, Glacier Fish Company, Havfisk ASA, HB Grandi, Irvin & Johnson, Sea Harvest, Nergard AS, Nueva Pescanova, Ocean Choice International, Pacific Seafood Group, Parleviet & Van der Plas, Samherji hf., San Arawa SA., Sanford Ltd., Sealord Group, Trident Seafoods Corp. and United States Seafoods LLC) provided partial funding to pay for the publication of this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baron JB, 2014, U CIN L REV; Blackhart K, 2006, NMFSFSPO69 NOAA, P71; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Brodziak J, 2002, B MAR SCI, V70, P589; Bundy A, 2017, FISH FISH, V18, P412, DOI 10.1111/faf.12184; Chagaris D, 2017, ECOSYSTEM B IN PRESS; Collie J, 2013, B MAR SCI, V89, P107, DOI 10.5343/bms.2011.1134; Essington TE, 2016, BUILDING EFFECTIVE F, P60; Food and Agriculture Organization, 2014, C PROGR DOC SERV; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Gilman E, 2014, FISH FISH, V15, P327, DOI 10.1111/faf.12021; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Janssen MA, 2000, ECOL MODEL, V131, P249, DOI 10.1016/S0304-3800(00)00256-8; Link JS, 2017, ICES J MAR SCI, V74, P379, DOI 10.1093/icesjms/fsw247; Link JS, 2002, FISHERIES, V27, P18; Long RD, 2015, MAR POLICY, V57, P53, DOI 10.1016/j.marpol.2015.01.013; Melvin EF, 1999, CONSERV BIOL, V13, P1386, DOI 10.1046/j.1523-1739.1999.98426.x; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Patrick WS, 2015, FISHERIES, V40, P155, DOI 10.1080/03632415.2015.1024308; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2013, J FISH BIOL, V83, P865, DOI 10.1111/jfb.12122; Pitcher TJ, 2009, MAR POLICY, V33, P223, DOI 10.1016/j.marpol.2008.06.002; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Quinn TJ, 2005, PHILOS T R SOC B, V360, P147, DOI 10.1098/rstb.2004.1577; Rose GA, 2015, CAN J FISH AQUAT SCI, V72, P1789, DOI 10.1139/cjfas-2015-0346; Trumble Robert J., 2000, North American Journal of Fisheries Management, V20, P931, DOI 10.1577/1548-8675(2000)020<0931:EODMRF>2.0.CO;2; U. S. National Research Council, 1998, REP COMM EC MAN SUST; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Witherell D, 2000, ICES J MAR SCI, V57, P771, DOI 10.1006/jmsc.2000.0719	33	54	55	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190467	10.1371/journal.pone.0190467	http://dx.doi.org/10.1371/journal.pone.0190467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381700	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800008
J	Heil, J; Hoebe, CJPA; van Loo, IHM; Cals, JWL; van Liere, GAFS; Dukers-Muijrers, NHTM				Heil, Jeanne; Hoebe, Christian J. P. A.; van Loo, Inge H. M.; Cals, Jochen W. L.; van Liere, Genevieve A. F. S.; Dukers-Muijrers, Nicole H. T. M.			Hepatitis E prevalence in a sexual high-risk population compared to the general population	PLOS ONE			English	Article							ORGAN-TRANSPLANT RECIPIENTS; E VIRUS-INFECTION; DEVELOPED-COUNTRIES; IGG SEROPREVALENCE; NETHERLANDS; DISEASE; TRANSMISSION; INDIVIDUALS	Transmission routes of the hepatitis E virus (HEV) are under debate. Here, we studied possible sexual transmission by comparing HEV prevalence in a Dutch sexual high-risk population (n = 1,482) with that in a general population (n = 1,487) while assessing sociodemo-graphic and sexual risk factors. Overall prevalence of anti-HEV IgG of 18.9% (n = 562) was, adjusting for confounders, similar between the two populations (p = 0.44). Prevalence was higher with each year's increase in age (adjusted OR: 1.03, 95% CI: 1.02-1.04, p<0.01), among men (adjusted OR: 1.24, 95% CI: 1.02-1.50, p = 0.03) and among individuals diagnosed with sexually transmitted infections (adjusted OR: 1.60, 95% CI: 1.02-2.49, p = 0.04). Our results only hint at the possibility of a sexual transmission route for HEV given higher rates in those with chlamydia and/or gonorrheal infections. Sexual transmission is not a dominant transmission route, as its prevalence was not higher for the sexual high-risk population than for the general population.	[Heil, Jeanne; Hoebe, Christian J. P. A.; van Liere, Genevieve A. F. S.; Dukers-Muijrers, Nicole H. T. M.] Publ Hlth Serv GGD South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; van Loo, Inge H. M.; Dukers-Muijrers, Nicole H. T. M.] MUMC, CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Cals, Jochen W. L.] Maastricht Univ, CAPHRI, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Heil, J (corresponding author), Publ Hlth Serv GGD South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.; Heil, J (corresponding author), MUMC, CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	jeanne.heil@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014; Cals, Jochen/A-1262-2007	van Liere, Genevieve/0000-0002-9286-4548; Heil, Jeanne/0000-0002-0057-9599; Cals, Jochen/0000-0001-9550-5674				Abravanel F, 2017, J INFECTION, V74, P310, DOI 10.1016/j.jinf.2016.12.004; Aggarwal R, 2000, J GASTROEN HEPATOL, V15, P9, DOI 10.1046/j.1440-1746.2000.02006.x; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Christensen PB, 2002, J MED VIROL, V66, P49, DOI 10.1002/jmv.2110; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Dalton HR, 2011, EUR J GASTROEN HEPAT, V23, P1200, DOI 10.1097/MEG.0b013e32834ca4da; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Drobeniuc J, 2013, EMERG INFECT DIS, V19, P218, DOI 10.3201/eid1902.120961; Dukers-Muijrers NHTM, 2010, SEX TRANSM INFECT, V86, P315, DOI 10.1136/sti.2009.041954; Eker A, 2009, MIKROBIYOL BUL, V43, P251; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Freidl GS, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.8.30468; Garbuglia AR, 2013, EMERG INFECT DIS, V19, P110, DOI 10.3201/eid1901.120983; Gorgos L, 2013, INFECT DIS CLIN N AM, V27, P811, DOI 10.1016/j.idc.2013.08.002; Hazards E, 2017, EFSA J, V15; Heijne JC, 2016, SEX TRANSM INFECT; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kok A, 2007, Ned Tijdschr Geneeskd, V151, P2367; Koot H, 2015, J CLIN VIROL, V62, P38, DOI 10.1016/j.jcv.2014.11.020; Mansuy JM, 2004, J MED VIROL, V74, P419, DOI 10.1002/jmv.20206; Marschall T, 2008, EUR J GASTROEN HEPAT, V20, P1214, DOI 10.1097/MEG.0b013e32830e289e; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; RIVM, 2007, LCI RICHTL HEP E; Rossi-Tamisier M, 2013, J CLIN VIROL, V56, P62, DOI 10.1016/j.jcv.2012.09.010; Rutjes SA, 2007, J VIROL METHODS, V143, P112, DOI 10.1016/j.jviromet.2007.01.030; Sazzad HMS, 2017, AM J TROP MED HYG; Slavenburg S, 2008, NETH J MED, V66, P13; Slot E, 2012, EUROSURVEILLANCE, V2013, P18, DOI DOI 10.2807/1560-7917.ES2013.18.31.20550; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Van Der Poel WH, 2002, INF B, V13, P299; van Marrewijk CM, 1999, PREVALENCE HEPATITIS; Vriend HJ, 2012, EUR J PUBLIC HEALTH, V22, P819, DOI 10.1093/eurpub/cks013; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Zanetti AR, 1999, J MED VIROL, V57, P356, DOI 10.1002/(SICI)1096-9071(199904)57:4&lt;356::AID-JMV5&gt;3.0.CO;2-D	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191798	10.1371/journal.pone.0191798	http://dx.doi.org/10.1371/journal.pone.0191798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370254	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600099
J	Zhang, M; Zhou, Q; Luo, YC; Nguyen, T; Rosenblatt, MI; Guaiquil, VH				Zhang, Min; Zhou, Qiang; Luo, Yuncin; Nguyen, Tara; Rosenblatt, Mark I.; Guaiquil, Victor H.			Semaphorin3A induces nerve regeneration in the adult cornea-a switch from its repulsive role in development	PLOS ONE			English	Article							GROWTH CONE COLLAPSE; SENSORY AFFERENTS; IN-VIVO; NEURONS; GUIDANCE; 3A; NEUROPILIN-1; INNERVATION; CULTURES; CELLS	The peripheral sensory nerves that innervate the cornea can be easily damaged by trauma, surgery, infection or diabetes. Several growth factors and axon guidance molecules, such as Semaphorin3A (Sema3A) are upregulated upon cornea injury. Nerves can regenerate after injury but do not recover their original density and patterning. Sema3A is a well known axon guidance and growth cone repellent protein during development, however its role in adult cornea nerve regeneration remains undetermined. Here we investigated the neuro-regenerative potential of Sema3A on adult peripheral nervous system neurons such as those that innervate the cornea. First, we examined the gene expression profile of the Semaphorin class 3 family members and found that all are expressed in the cornea. However, upon cornea injury there is a fast increase in Sema3A expression. We then corroborated that Sema3A totally abolished the growth promoting effect of nerve growth factor (NGF) on embryonic neurons and observed signs of growth cone collapse and axonal retraction after 30 min of Sema3A addition. However, in adult isolated trigeminal ganglia or dorsal root ganglia neurons, Sema3A did not inhibited the NGF-induced neuronal growth. Furthermore, adult neurons treated with Sema3A alone produced similar neuronal growth to cells treated with NGF and the length of the neurites and branching was comparable between both treatments. These effects were replicated in vivo, where thy1-YFP neurofluorescent mice subjected to cornea epithelium debridement and receiving intrastromal pellet implantation containing Sema3A showed increased corneal nerve regeneration than those receiving pellets with vehicle. In adult PNS neurons, Sema3A is a potent inducer of neuronal growth in vitro and cornea nerve regeneration in vivo. Our data indicates a functional switch for the role of Sema3A in PNS neurons where the well-described repulsive role during development changes to a growth promoting effect during adulthood. The high expression of Sema3A in the normal and injured adult corneas could be related to its role as a growth factor.	[Zhang, Min; Zhou, Qiang; Luo, Yuncin; Nguyen, Tara; Rosenblatt, Mark I.; Guaiquil, Victor H.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Guaiquil, VH (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	vguaiqui@uic.edu			National Institutes of Health grants from the National Eye Institute [MR R01 EY018594, P30 EY001792]; RPB Unrestricted Departmental Grant; National Institutes of Health Grant from the National Eye Institute [MIR R01 EY018594]; NEI [P30 EY001792]; NATIONAL EYE INSTITUTE [R01EY027912, P30EY001792] Funding Source: NIH RePORTER	National Institutes of Health grants from the National Eye Institute; RPB Unrestricted Departmental Grant; National Institutes of Health Grant from the National Eye Institute; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health grants from the National Eye Institute to MR R01 EY018594 and P30 EY001792 and a RPB Unrestricted Departmental Grant (to VHG) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A National Institutes of Health Grant from the National Eye Institute to MIR R01 EY018594, a NEI P30 EY001792 Core Grant for Vision Research and RPB Unrestricted Departmental Grant supported this work.	Barton WA, 2004, ADV PROTEIN CHEM, V68, P65; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Ben-Zvi A, 2008, CELL SIGNAL, V20, P467, DOI 10.1016/j.cellsig.2007.10.023; Fedoroff S, 2001, PROTOCOLS NEURAL CEL, Vxxii; Guaiquil VH, 2014, P NATL ACAD SCI USA, V111, P17272, DOI 10.1073/pnas.1407227111; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Kaselis A, 2014, CELL MOL NEUROBIOL, V34, P289, DOI 10.1007/s10571-013-0013-x; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Ko JA, 2010, BIOCHEM BIOPH RES CO, V403, P305, DOI 10.1016/j.bbrc.2010.11.022; Kubilus JK, 2010, DEV BIOL, V344, P172, DOI 10.1016/j.ydbio.2010.04.032; Lwigale PY, 2007, DEV BIOL, V306, P750, DOI 10.1016/j.ydbio.2007.04.012; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Morishige N, 2008, EXP EYE RES, V86, P669, DOI 10.1016/j.exer.2008.01.012; Morishige N, 2010, BIOCHEM BIOPH RES CO, V395, P451, DOI 10.1016/j.bbrc.2010.03.124; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Ng TFF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066937; Omoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047716; Pan Z, 2013, FASEB J, V27, P2756, DOI 10.1096/fj.12-225185; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Potiron Vincent, 2005, Sci STKE, V2005, ppe24, DOI 10.1126/stke.2852005pe24; Reza JN, 1999, MOL CELL NEUROSCI, V14, P317, DOI 10.1006/mcne.1999.0786; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Schwamborn JC, 2004, J BIOL CHEM, V279, P30923, DOI 10.1074/jbc.C400082200; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Sleigh James N, 2016, BMC Res Notes, V9, P82, DOI 10.1186/s13104-016-1915-8; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Thiede-Stan NK, 2015, J CELL SCI, V128, P3583, DOI 10.1242/jcs.167981; Wanigasekara Y, 2006, NEUROSCIENCE, V142, P369, DOI 10.1016/j.neuroscience.2006.06.031; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Yu CQ, 2007, INVEST OPHTH VIS SCI, V48, P1535, DOI 10.1167/iovs.06-1192	36	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191962	10.1371/journal.pone.0191962	http://dx.doi.org/10.1371/journal.pone.0191962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370308	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600119
J	de Bruyn, JR; Becker, MA; Steenkamer, J; Wildenberg, ME; Meijer, SL; Buskens, CJ; Bemelman, WA; Lowenberg, M; Ponsioen, CY; van den Brink, GR; D'Haens, GR				de Bruyn, Jessica R.; Becker, Marte A.; Steenkamer, Jessica; Wildenberg, Manon E.; Meijer, Sybren L.; Buskens, Christianne J.; Bemelman, Willem A.; Lowenberg, Mark; Ponsioen, Cyriel Y.; van den Brink, Gijs R.; D'Haens, Geert R.			Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease	PLOS ONE			English	Article							FIBROBLASTS; MECHANISMS; EXPRESSION; ANTIBODIES; PATTERN	Introduction Overt fibrostenotic disease is a relative contraindication for anti-TNF therapy in Crohn's disease. We hypothesized that subclinical fibrosis may also contribute to an incomplete response to anti-TNF therapy before the onset of symptomatic stenosis. Methods In a previous trial, patients with ileocecal Crohn's disease were randomized to either immediate ileocecal resection or medical treatment with Infliximab. In case of insufficient response to Infliximab, the latter underwent secondary ileocecal resection. We compared specimens from those patients undergoing immediate resection (Infliximab naive, n = 20) to those who failed Infliximab therapy (n = 20). Results Infliximab naive and Infliximab failure patients had similar severity of inflammation when assessed by CRP levels (median 14 vs 9 mg/L) and histology (Geboes-D'Haens-score, median 10 vs 11 points). On immunohistochemistry, collagen-III and fibronectin depositions were increased in patients previously exposed to Infliximab compared to patients naive to Infliximab. On mRNA level, procollagen peptidase showed significantly more mucosal mRNA expression in Crohn's disease patients who failed Infliximab. Infliximab responders showed no increase of this marker after 4 weeks of successful Infliximab treatment. Discussion Failure to Infliximab therapy is associated with subclinical fibrosis in Crohn's disease.	[de Bruyn, Jessica R.; Wildenberg, Manon E.; Lowenberg, Mark; Ponsioen, Cyriel Y.; van den Brink, Gijs R.; D'Haens, Geert R.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [de Bruyn, Jessica R.; Becker, Marte A.; Steenkamer, Jessica; Wildenberg, Manon E.; van den Brink, Gijs R.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Meijer, Sybren L.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Buskens, Christianne J.; Bemelman, Willem A.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands; [van den Brink, Gijs R.] GlaxoSmithKline, Med Res Ctr, Stevenage, Herts, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline	D'Haens, GR (corresponding author), Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.	g.dhaens@amc.uva.nl	Bemelman, Wilhelmus Adrianus/AAA-1635-2021	Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Lowenberg, Mark/0000-0002-4975-9945; Wildenberg, Manon Elisabeth/0000-0003-0671-818X; Meijer, Sybren/0000-0002-6953-2406	Academic Medical Center, Amsterdam, the Netherlands	Academic Medical Center, Amsterdam, the Netherlands(Netherlands Government)	This research was fully granted by institutional funding from the Academic Medical Center, Amsterdam, the Netherlands. No extramural funding was received.	Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Bordeleau F, 2015, P NATL ACAD SCI USA, V112, P8314, DOI 10.1073/pnas.1505421112; Bouhnik Y, 2015, J CROHNS COLITIS; Chiorean MV, 2007, AM J GASTROENTEROL, V102, P2541, DOI 10.1111/j.1572-0241.2007.01537.x; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; FARMER RG, 1985, GASTROENTEROLOGY, V88, P1818, DOI 10.1016/0016-5085(85)90006-X; GUTMAN A, 1987, P NATL ACAD SCI USA, V84, P7179, DOI 10.1073/pnas.84.20.7179; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; LAYMAN DL, 1973, ARCH BIOCHEM BIOPHYS, V157, P451, DOI 10.1016/0003-9861(73)90661-9; Leeb SN, 2004, AM J GASTROENTEROL, V99, P335, DOI 10.1111/j.1572-0241.2004.04044.x; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Louis E, 2007, ACTA GASTRO-ENT BELG, V70, P15; PELTONEN L, 1985, J CELL BIOCHEM, V28, P15, DOI 10.1002/jcb.240280104; Ponsioen CY, 2017, LANCET GASTROENTEROL; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Westra WH, 1996, SURG PATHOLOGY DIS I, P52; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553	30	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190999	10.1371/journal.pone.0190999	http://dx.doi.org/10.1371/journal.pone.0190999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364909	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500031
J	Garland, M; Schulze, CJ; Foe, IT; van der Linden, WA; Child, MA; Bogyo, M				Garland, Megan; Schulze, Christopher J.; Foe, Ian T.; van der Linden, Wouter A.; Child, Matthew A.; Bogyo, Matthew			Development of an activity-based probe for acyl-protein thioesterases	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITION; SERINE PROTEASES; POSTTRANSLATIONAL MODIFICATIONS; PALMITOYLATION; CELLS; IDENTIFICATION; ISOCOUMARINS; DERIVATIVES; INVASION	Protein palmitoylation is a dynamic post-translational modification (PTM) important for cellular functions such as protein stability, trafficking, localization, and protein-protein interactions. S-palmitoylation occurs via the addition of palmitate to cysteine residues via a thioester linkage, catalyzed by palmitoyl acyl transferases (PATs), with removal of the palmitate catalyzed by acyl protein thioesterases (APTs) and palmitoyl-protein thioesterases (PPTs). Tools that target the regulators of palmitoylation-PATs, APTs and PPTs-will improve understanding of this essential PTM. Here, we describe the synthesis and application of a cell-permeable activity-based probe (ABP) that targets APTs in intact mammalian cells and the parasite Toxoplasma gondii. Using a focused library of substituted chloroiso-coumarins, we identified a probe scaffold with nanomolar affinity for human APTs (HsAPT1 and HsAPT2) and synthesized a fluorescent ABP, JCP174-BODIPY TMR (JCP174-BT). We use JCP174-BT to profile HsAPT activity in situ in mammalian cells, to detect an APT in T. gondii (TgPPT1). We show discordance between HsAPT activity levels and total protein concentration in some cell lines, indicating that total protein levels may not be representative of APT activity in complex systems, highlighting the utility of this probe.	[Garland, Megan; Bogyo, Matthew] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Garland, Megan; Schulze, Christopher J.; Foe, Ian T.; van der Linden, Wouter A.; Child, Matthew A.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Child, Matthew A.] Imperial Coll London, Dept Life Sci, London, England	Stanford University; Stanford University; Stanford University; Stanford University; Imperial College London	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Child, MA; Bogyo, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Bogyo, M (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.; Bogyo, M (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Child, MA (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	m.child@imperial.ac.uk; mbogyo@stanford.edu		Garland, Megan/0000-0002-5622-5095; Child, Matthew/0000-0002-1565-5638; Bogyo, Matthew/0000-0003-3753-4412	National Institutes of Health [R01 GM111703]; Howard Hughes Medical Institute Medical Research Fellows Program; Stanford University Medical School Medical Scientist Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); Stanford University Medical School Medical Scientist Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by a National Institutes of Health grant R01 GM111703 to MB and the Howard Hughes Medical Institute Medical Research Fellows Program (to MG) and by the Stanford University Medical School Medical Scientist Training Program (to MG). The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bihel F, 2003, BIOORGAN MED CHEM, V11, P3141, DOI 10.1016/S0968-0896(03)00235-9; Child MA, 2013, NAT CHEM BIOL, V9, P651, DOI 10.1038/nchembio.1315; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Deu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011985; Du Toit A, 2014, NAT REV MOL CELL BIO, V15, P295, DOI 10.1038/nrm3787; Haedke U, 2012, BIOORGAN MED CHEM, V20, P633, DOI 10.1016/j.bmc.2011.03.014; Hall CI, 2011, P NATL ACAD SCI USA, V108, P10568, DOI 10.1073/pnas.1105622108; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Hernandez JL, 2017, CELL CHEM BIOL, V24, P87, DOI 10.1016/j.chembiol.2016.12.007; Kathayat RS, 2016, NAT CHEM BIOL; Kemp LE, 2013, J BIOL CHEM, V288, P27002, DOI 10.1074/jbc.M113.460709; Lentz CS, 2016, ACS INFECT DIS, V2, P807, DOI 10.1021/acsinfecdis.6b00092; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; Ravikumar V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01312; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Tom CTMB, 2013, ACS CHEM BIOL, V8, P46, DOI 10.1021/cb300607e; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151	30	14	14	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190255	10.1371/journal.pone.0190255	http://dx.doi.org/10.1371/journal.pone.0190255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364904	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500011
J	Laufenberg, JS; Clark, JD; Chandler, RB				Laufenberg, Jared S.; Clark, Joseph D.; Chandler, Richard B.			Estimating population extinction thresholds with categorical classification trees for Louisiana black bears	PLOS ONE			English	Article							REGRESSION TREES; URSUS-AMERICANUS; LIFE-HISTORY; RECAPTURE; SURVIVAL; DEMOGRAPHY; SCIENCE	Monitoring vulnerable species is critical for their conservation. Thresholds or tipping points are commonly used to indicate when populations become vulnerable to extinction and to trigger changes in conservation actions. However, quantitative methods to determine such thresholds have not been well explored. The Louisiana black bear (Ursus americanus luteolus) was removed from the list of threatened and endangered species under the U.S. Endangered Species Act in 2016 and our objectives were to determine the most appropriate parameters and thresholds for monitoring and management action. Capture mark recapture (CMR) data from 2006 to 2012 were used to estimate population parameters and variances. We used stochastic population simulations and conditional classification trees to identify demographic rates for monitoring that would be most indicative of heighted extinction risk. We then identified thresholds that would be reliable predictors of population viability. Conditional classification trees indicated that annual apparent survival rates for adult females averaged over 5 years ((phi)over-bar(5)) was the best predictor of population persistence. Specifically, population persistence was estimated to be >= 95% over 100 years when ((phi)over-bar(5) >= 0.90, suggesting that this statistic can be used as threshold to trigger management intervention. Our evaluation produced monitoring protocols that reliably predicted population persistence and was cost-effective. We conclude that population projections and conditional classification trees can be valuable tools for identifying extinction thresholds used in monitoring programs.	[Laufenberg, Jared S.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Clark, Joseph D.] Univ Tennessee, US Geol Survey, Southern Appalachian Res Branch, Northern Rocky Mt Sci Ctr, Knoxville, TN 37996 USA; [Chandler, Richard B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Clark, JD (corresponding author), Univ Tennessee, US Geol Survey, Southern Appalachian Res Branch, Northern Rocky Mt Sci Ctr, Knoxville, TN 37996 USA.	jclark1@utk.edu		Chandler, Richard/0000-0003-4930-2790; Clark, Joseph/0000-0002-8547-8112	Louisiana Department of Wildlife and Fisheries [R2219-631]	Louisiana Department of Wildlife and Fisheries	This study was funded by the Louisiana Department of Wildlife and Fisheries (R2219-631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beston JA, 2011, J WILDLIFE MANAGE, V75, P1588, DOI 10.1002/jwmg.195; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROWNIE C, 1983, BIOMETRICS, V39, P437, DOI 10.2307/2531015; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Doak DF, 2015, BIOSCIENCE, V65, P189, DOI 10.1093/biosci/biu215; Freedman AH, 2003, ECOL MODEL, V167, P47, DOI 10.1016/S0304-3800(03)00171-6; Gitzen R.A., 2012, DESIGN ANAL LONG TER; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Hines JE, 2002, J APPL STAT, V29, P573, DOI 10.1080/02664760120108872; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kendall W.L., 2012, DESIGN ANAL LONG TER, P74, DOI DOI 10.1017/CBO9781139022422.007; Laufenberg JS, 2016, WILDL MONOG, V194; Lebreton JD, 2013, J WILDLIFE MANAGE, V77, P12, DOI 10.1002/jwmg.425; Lin Y, 2006, J AM STAT ASSOC, V101, P578, DOI 10.1198/016214505000001230; Lindenmayer DB, 2013, FRONT ECOL ENVIRON, V11, P549, DOI 10.1890/120220; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P298; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; McDonald-Madden E, 2010, TRENDS ECOL EVOL, V25, P547, DOI 10.1016/j.tree.2010.07.002; Mills L. S., 2007, CONSERVATION WILDLIF; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Otis DL, 1978, WILDL MONOG, V62; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Possingham HP, 2012, DESIGN ANAL LONG TER, P498; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Reynolds JH, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5397-x; Royle J. A., 2008, HIERARCHICAL MODELIN; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, R J, V1, P14; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; U.S. Fish and Wildlife Service, 2016, FED REGISTER, V81, P13124; U.S. Fish and Wildlife Service, 1995, LOUIS BLACK BEAR REC; U. S. Fish and Wildlife Service, 2016, POSTD MON PLAN LOUIS; [USFWS] US Fish and Wildlife Service, 1992, FED REGISTER, V57, P588; Williams B.K., 2012, ADAPTIVE MANAGEMENT; Williams BK, 2015, ECOL EVOL, V5, P466, DOI 10.1002/ece3.1363; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191435	10.1371/journal.pone.0191435	http://dx.doi.org/10.1371/journal.pone.0191435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360863	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800032
J	Rodrigues, TC; Oliveira, MLS; Soares-Schanoski, A; Chavez-Rico, SL; Figueiredo, DB; Goncalves, VM; Ferreira, DM; Kunda, NK; Saleem, IY; Miyaji, EN				Rodrigues, Tasson C.; Oliveira, Maria Leonor S.; Soares-Schanoski, Alessandra; Chavez-Rico, Stefanni L.; Figueiredo, Douglas B.; Goncalves, Viviane M.; Ferreira, Daniela M.; Kunda, Nitesh K.; Saleem, Imran Y.; Miyaji, Eliane N.			Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INHALATIVE VACCINATION; COMPLEMENT DEPOSITION; PULMONARY INFECTION; CONJUGATE VACCINE; MICE; POLYSACCHARIDE; TUBERCULOSIS; RESPONSES; DELIVERY	Burden of pneumonia caused by Streptococcus pneumoniae remains high despite the availability of conjugate vaccines. Mucosal immunization targeting the lungs is an attractive alternative for the induction of local immune responses to improve protection against pneumonia. Our group had previously described the development of poly(glycerol adipate-co-omega-pentadecalactone) (PGA-co-PDL) polymeric nanoparticles (NPs) adsorbed with Pneumococcal surface protein A from clade 4 (PspA4Pro) within L-leucine microcarriers (nanocomposite microparticles-NCMPs) for mucosal delivery targeting the lungs (NP/NCMP PspA4Pro). NP/NCMP PspA4Pro was now used for immunization of mice. Inoculation of this formulation induced anti-PspA4Pro IgG antibodies in serum and lungs. Analysis of binding of serum IgG to intact bacteria showed efficient binding to bacteria expressing PspA from clades 3, 4 and 5 (family 2), but no binding to bacteria expressing PspA from clades 1 and 2 (family 1) was observed. Both mucosal immunization with NP/NCMP PspA4Pro and subcutaneous injection of the protein elicited partial protection against intranasal lethal pneumococcal challenge with a serotype 3 strain expressing PspA from clade 5 (PspA5). Although similar survival levels were observed for mucosal immunization with NP/NCMP PspA4Pro and subcutaneous immunization with purified protein, NP/NCMP PspA4Pro induced earlier control of the infection. Conversely, neither immunization with NP/NCMP PspA4Pro nor subcutaneous immunization with purified protein reduced bacterial burden in the lungs after challenge with a serotype 19F strain expressing PspA from clade 1 (PspA1). Mucosal immunization with NP/NCMP PspA4Pro targeting the lungs is thus able to induce local and systemic antibodies, conferring protection only against a strain expressing PspA from the homologous family 2.	[Rodrigues, Tasson C.; Oliveira, Maria Leonor S.; Soares-Schanoski, Alessandra; Chavez-Rico, Stefanni L.; Miyaji, Eliane N.] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil; [Figueiredo, Douglas B.; Goncalves, Viviane M.] Inst Butantan, Lab Especial Desenvolvimento Vacinas, Sao Paulo, SP, Brazil; [Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Resp Infect Grp, Liverpool, Merseyside, England; [Kunda, Nitesh K.; Saleem, Imran Y.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Formulat & Drug Delivery Res, Liverpool, Merseyside, England; [Kunda, Nitesh K.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	Instituto Butantan; Instituto Butantan; Liverpool School of Tropical Medicine; Liverpool John Moores University; University of New Mexico	Miyaji, EN (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil.	eliane.miyaji@butantan.gov.br	Kunda, Nitesh/AAS-8713-2021; Ferreira, Daniela M/AAE-9881-2022; Schanoski, Alessandra/H-8144-2014; Miyaji, Eliane N/D-7642-2012; Saleem, Imran/M-5423-2019; Oliveira, Maria Leonor S/F-4988-2012; Ferreira, Daniela M/AFF-4763-2022; Gonçalves, Viviane/B-9674-2012; da Costa Rodrigues, Tasson/F-7229-2019	Kunda, Nitesh/0000-0002-3063-0375; Schanoski, Alessandra/0000-0002-6514-8458; Miyaji, Eliane N/0000-0003-1689-5366; Saleem, Imran/0000-0003-2382-6668; Ferreira, Daniela M/0000-0002-0594-0902; Gonçalves, Viviane/0000-0002-0980-8116; da Costa Rodrigues, Tasson/0000-0002-1481-0691; Oliveira, Maria Leonor/0000-0003-4849-3062	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303198/2014-1, 140573/2015-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/06255-6, 2014/25436-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; MRC [MR/K01188X/1, MR/M011569/1] Funding Source: UKRI; Medical Research Council [MR/M011569/1, MR/K01188X/1] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (VMG grant 2015/06255-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (ENM grant 303198/2014-1). TCR received an undergraduate studentship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/25436-9) and a MSc studentship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). SLC received a studentship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. DBF received a PhD studentship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (140573/2015-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Anish C, 2014, INT J PHARMACEUT, V466, P198, DOI 10.1016/j.ijpharm.2014.03.025; Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; Figueiredo DB, 2017, APPL MICROBIOL BIOT, V101, P2305, DOI 10.1007/s00253-016-7983-9; Fukuyama Y, 2015, MUCOSAL IMMUNOL, V8, P1144, DOI 10.1038/mi.2015.5; Gordon SB, 2008, VACCINE, V26, P5400, DOI 10.1016/j.vaccine.2008.07.082; group Avftw, 2015, VACCINE, V33, p[3038, 3038]; Haughney SL, 2013, ACTA BIOMATER, V9, P8262, DOI 10.1016/j.actbio.2013.06.006; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunda NK, 2015, INT J PHARMACEUT, V495, P903, DOI 10.1016/j.ijpharm.2015.09.034; Kunda NK, 2013, PHARM RES-DORDR, V30, P325, DOI 10.1007/s11095-012-0891-5; Lima FA, 2012, CLIN VACCINE IMMUNOL, V19, P1382, DOI 10.1128/CVI.00171-12; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Low N, 2015, NEW ENGL J MED, V372, P1519, DOI 10.1056/NEJMoa1407417; Menzel M, 2005, VACCINE, V23, P5113, DOI 10.1016/j.vaccine.2005.05.040; Meyer P, 2006, VACCINE, V24, P5832, DOI 10.1016/j.vaccine.2006.05.002; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Oliveira MLS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010863; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Smith NM, 2017, MUCOSAL IMMUNOLOGY; Tyne AS, 2013, VACCINE, V31, P4322, DOI 10.1016/j.vaccine.2013.07.022; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang Y, 2017, MUCOSAL IMMUNOL, V10, P250, DOI 10.1038/mi.2016.41; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980; Yamamoto M, 1998, J IMMUNOL, V161, P4115	32	27	28	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191692	10.1371/journal.pone.0191692	http://dx.doi.org/10.1371/journal.pone.0191692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360883	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800053
J	Maley, MJ; Minett, GM; Bach, AJE; Zietek, SA; Stewart, KL; Stewart, IB				Maley, Matthew J.; Minett, Geoffrey M.; Bach, Aaron J. E.; Zietek, Stephanie A.; Stewart, Kelly L.; Stewart, Ian B.			Internal and external cooling methods and their effect on body temperature, thermal perception and dexterity	PLOS ONE			English	Article							ICE SLURRY INGESTION; RESPIRATORY HEAT-LOSS; PHYSIOLOGICAL-RESPONSES; CORE TEMPERATURE; COLD IMMERSION; PERFORMANCE; EXERCISE; INTENSITY; RADIATION; HAND	Objective The present study aimed to compare a range of cooling methods possibly utilised by occupational workers, focusing on their effect on body temperature, perception and manual dexterity. Methods Ten male participants completed eight trials involving 30 min of seated rest followed by 30 min of cooling or control of no cooling (CON) (34 degrees C, 58% relative humidity). The cooling methods utilised were: ice cooling vest (CV0), phase change cooling vest melting at 14 degrees C (CV14), evaporative cooling vest (CVEV), arm immersion in 10 degrees C water (AI), portable waterperfused suit (WPS), heliox inhalation (HE) and ice slushy ingestion (SL). Immediately before and after cooling, participants were assessed for fine (Purdue pegboard task) and gross (grip and pinch strength) manual dexterity. Rectal and skin temperature, as well as thermal sensation and comfort, were monitored throughout. Results Compared with CON, SL was the only method to reduce rectal temperature (P = 0.012). All externally applied cooling methods reduced skin temperature (P < 0.05), though CV0 resulted in the lowest skin temperature versus other cooling methods. Participants felt cooler with CV0, CV14, WPS, AI and SL (P < 0.05). AI significantly impaired Purdue pegboard performance (P = 0.001), but did not affect grip or pinch strength (P > 0.05). Conclusion The present study observed that ice ingestion or ice applied to the skin produced the greatest effect on rectal and skin temperature, respectively. AI should not be utilised if workers require subsequent fine manual dexterity. These results will help inform future studies investigating appropriate pre-cooling methods for the occupational worker.	[Maley, Matthew J.; Minett, Geoffrey M.; Bach, Aaron J. E.; Zietek, Stephanie A.; Stewart, Kelly L.; Stewart, Ian B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Exercise & Nutr Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Maley, MJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Exercise & Nutr Sci, Brisbane, Qld, Australia.	matthew.maley@qut.edu.au	Bach, Aaron/AAQ-2258-2020; Maley, Matthew J/AAC-7041-2020; Stewart, Ian B/I-9927-2012; Minett, Geoffrey/L-5757-2017	Bach, Aaron/0000-0002-5581-5018; Maley, Matthew J/0000-0001-5200-7640; Minett, Geoffrey/0000-0003-4617-2820; Stewart, Ian/0000-0003-1741-718X; Stewart, Kelly/0000-0002-3386-7001	US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	This project is financially supported by the US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office. This support does not represent an endorsement of the contents or conclusions of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Bogerd N, 2010, J SPORT SCI, V28, P771, DOI 10.1080/02640411003716942; Bongers Coen C W G, 2017, Temperature (Austin), V4, P60, DOI 10.1080/23328940.2016.1277003; CAIN JB, 1990, RESP PHYSIOL, V79, P145, DOI 10.1016/0034-5687(90)90014-P; Chan APC, 2015, J THERM BIOL, V49-50, P16, DOI 10.1016/j.jtherbio.2015.01.007; Cheung SS, 2003, AVIAT SPACE ENVIR MD, V74, P990; Chi CF, 2012, INT J IND ERGONOM, V42, P113, DOI 10.1016/j.ergon.2011.08.008; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costello JT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/857536; Cramer MN, 2016, AUTON NEUROSCI-BASIC, V196, P3, DOI 10.1016/j.autneu.2016.03.001; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; DeGroot DW, 2013, J THERM BIOL, V38, P305, DOI 10.1016/j.jtherbio.2013.03.010; DILL D. B., 1931, ARBEITSPHYSIOLOGIE, V4, P508; Duffield R, 2010, MED SCI SPORT EXER, V42, P577, DOI 10.1249/MSS.0b013e3181b675da; Filingeri D, 2015, SCAND J MED SCI SPOR, V25, P200, DOI 10.1111/sms.12322; Gagge A.P., 2010, COMPREHENSIVE PHYSL, P69, DOI DOI 10.1002/CPHY.CP090105; GAGGE AP, 1967, ENVIRON RES, V1, P1, DOI 10.1016/0013-9351(67)90002-3; Gagge AP, 1996, HDB PHYSL 4, P45; Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461; Hardy JD, 1938, J NUTR, V15, P477, DOI 10.1093/jn/15.5.477; HARRISON MR, 1977, J PEDIATR SURG, V12, P821, DOI 10.1016/0022-3468(77)90590-5; Havenith G, 1995, Arctic Med Res, V54 Suppl 2, P37; HEUS R, 1995, APPL ERGON, V26, P5, DOI 10.1016/0003-6870(94)00004-I; International Organisation for Standardisation, 2004, 9886 ISO, DOI [10.1016/B978-075067555-0/50157-2, DOI 10.1016/B978-075067555-0/50157-2]; International Organisation for Standardisation, 2001, 12894 ISO; James CA, 2015, SCAND J MED SCI SPOR, V25, P190, DOI 10.1111/sms.12376; Kay D, 1999, J SPORT SCI, V17, P937, DOI 10.1080/026404199365326; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; LOCKHART JM, 1975, J APPL PSYCHOL, V60, P106, DOI 10.1037/h0076269; Minett GM, 2012, EUR J APPL PHYSIOL, V112, P3655, DOI 10.1007/s00421-012-2348-2; Minett GM, 2012, J SPORT SCI, V30, P907, DOI 10.1080/02640414.2012.679677; Minett GM, 2011, MED SCI SPORT EXER, V43, P1760, DOI 10.1249/MSS.0b013e318211be3e; Naito T, 2016, J THERM BIOL, V59, P13, DOI 10.1016/j.jtherbio.2016.04.006; Nybo L, 2014, COMPR PHYSIOL, V4, P657, DOI 10.1002/cphy.c130012; PIANTADOSI CA, 1981, J APPL PHYSIOL, V50, P829, DOI 10.1152/jappl.1981.50.4.829; Price M, 2015, EXTREME PHYSL MED, V4, pA127; Price MJ, 2009, APPL PHYSIOL NUTR ME, V34, P942, DOI 10.1139/H09-078; Pryor RR, 2015, PREHOSP EMERG CARE, V19, P241, DOI 10.3109/10903127.2014.959221; Quod MJ, 2008, J SPORT SCI, V26, P1477, DOI 10.1080/02640410802298268; Ross M, 2013, SPORTS MED, V43, P207, DOI 10.1007/s40279-012-0014-9; Siegel R, 2012, J SPORT SCI, V30, P155, DOI 10.1080/02640414.2011.625968; Siegel R, 2010, MED SCI SPORT EXER, V42, P717, DOI 10.1249/MSS.0b013e3181bf257a; Stevens CJ, 2016, SCAND J MED SCI SPOR, V26, P1209, DOI 10.1111/sms.12555; Stewart IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083740; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; TAPPER D, 1974, J PEDIATR SURG, V9, P597, DOI 10.1016/0022-3468(74)90094-3; Taylor L, 2014, J STRENGTH COND RES, V28, P3416, DOI 10.1519/JSC.0000000000000558; Tokizawa K, 2014, INT J BIOMETEOROL, V58, P1919, DOI 10.1007/s00484-014-0794-8; VINCENT MJ, 1988, AVIAT SPACE ENVIR MD, V59, P738; Xiang JJ, 2015, OCCUP ENVIRON MED, V72, P580, DOI 10.1136/oemed-2014-102706; Zimmermann M, 2017, INT J SPORT NUTR EXE, V27, P220, DOI [10.1123/ijsnem.2016-0028, 10.1123/ijsnem.2015-0215, 10.1123/ijsnem.2016-0215]	52	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191416	10.1371/journal.pone.0191416	http://dx.doi.org/10.1371/journal.pone.0191416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357373	Green Published, gold, Green Submitted			2022-12-26	WOS:000422919500013
J	Sathe, A; Chalaud, G; Oppolzer, I; Wong, KY; von Busch, M; Schmid, SC; Tong, ZC; Retz, M; Gschwend, JE; Schulz, WA; Nawroth, R				Sathe, Anuja; Chalaud, Geraldine; Oppolzer, Immanuel; Wong, Kit Yeng; von Busch, Margarita; Schmid, Sebastian C.; Tong, Zhichao; Retz, Margitta; Gschwend, Juergen E.; Schulz, Wolfgang A.; Nawroth, Roman			Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy	PLOS ONE			English	Article							PHASE-II; BLADDER-CANCER; EVEROLIMUS; TARGET; PHOSPHORYLATION; IDENTIFICATION; NVP-BEZ235; LESSONS	Targeting the PI3K pathway has achieved limited success in cancer therapy. One reason for the disappointing activity of drugs that interfere with molecules that are important player in this pathway is the induction of multiple feedback loops that have been only partially understood. To understand these limitations and develop improved treatment strategies, we comprehensively characterized molecular mechanisms of PI3K pathway signaling in bladder cancer cell lines upon using small molecule inhibitors and RNAi technologies against all key molecules and protein complexes within the pathway and analyzed functional and molecular consequences. When targeting either mTORC1, mTOR, AKT or PI3K, only S6K1 phosphorylation was affected in most cell lines examined. Dephosphorylation of 4E-BP1 required combined inhibition of PI3K and mTORC1, independent from AKT, and resulted in a robust reduction in cell viability. Long-term inhibition of PI3K however resulted in a PDK1-dependent, PIP3 and mTORC2 independent rephosphorylation of AKT. AKT rephosphorylation could also be induced by mTOR or PDK1 inhibition. Combining PI3K/mTOR inhibitors with AKT or PDK1 inhibitors suppressed this rephosphorylation, induced apoptosis, decreased colony formation, cell viability and growth of tumor xenografts. Our findings reveal novel molecular mechanisms that explain the requirement for simultaneous targeting of PI3K, AKT and mTORC1 to achieve effective tumor growth inhibition.	[Sathe, Anuja; Chalaud, Geraldine; Oppolzer, Immanuel; Wong, Kit Yeng; von Busch, Margarita; Schmid, Sebastian C.; Tong, Zhichao; Retz, Margitta; Gschwend, Juergen E.; Nawroth, Roman] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany; [Schulz, Wolfgang A.] Heinrich Heine Univ Duesseldorf, Dept Urol, Med Fac, Dusseldorf, Germany	Technical University of Munich; Heinrich Heine University Dusseldorf	Nawroth, R (corresponding author), Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany.	roman.nawroth@tum.de		Schulz, Wolfgang/0000-0002-2196-463X	Fritz Thyssen Foundation	Fritz Thyssen Foundation	This work was supported by the Fritz Thyssen Foundation, Postdoctoral Fellowship for Anuja Sathe.; AS is supported by a post-doctoral stipend from the Fritz Thyssen Stiftung.	Alfred Witjes J, 2016, EUR UROL; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Brana I, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-161; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Castel P, 2016, CANCER CELL, V30, P229, DOI 10.1016/j.ccell.2016.06.004; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Gerullis H, 2011, ANTI-CANCER DRUG, V22, P940, DOI 10.1097/CAD.0b013e328347a86a; Gingras AC, 2001, GENE DEV, V15, P2852; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Milowsky MI, 2013, BJU INT, V112, P462, DOI 10.1111/j.1464-410X.2012.11720.x; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Niegisch G, 2015, ONCOLOGY-BASEL, V89, P70, DOI 10.1159/000376551; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Ratner M, 2016, NAT BIOTECHNOL, V34, P789, DOI 10.1038/nbt0816-789; Ribatti D, 2014, EXP CELL RES, V328, P314, DOI 10.1016/j.yexcr.2014.06.010; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Ross RL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2570-0; Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330; Sathe A, 2014, BRIT J CANCER, V111, P2103, DOI 10.1038/bjc.2014.534; Sathe A, 2016, J UROLOGY, V195, P771, DOI 10.1016/j.juro.2015.08.082; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Seront E, 2012, ANN ONCOL, V23, P2663, DOI 10.1093/annonc/mds057; Seront E, 2016, BJU INT, V118, P408, DOI 10.1111/bju.13415; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	48	33	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190854	10.1371/journal.pone.0190854	http://dx.doi.org/10.1371/journal.pone.0190854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357370	Green Published, Green Submitted, gold			2022-12-26	WOS:000422919500007
J	Li, JZ; Liu, PC; Yu, WH; Cheng, XQ				Li, Jingzhong; Liu, Pengcheng; Yu, Wenhao; Cheng, Xiaoqiang			The morphing of geographical features by Fourier transformation	PLOS ONE			English	Article							SHAPE; DESCRIPTORS	This paper presents a morphing model of vector geographical data based on Fourier transformation. This model involves three main steps. They are conversion from vector data to Fourier series, generation of intermediate function by combination of the two Fourier series concerning a large scale and a small scale, and reverse conversion from combination function to vector data. By mirror processing, the model can also be used for morphing of linear features. Experimental results show that this method is sensitive to scale variations and it can be used for vector map features' continuous scale transformation. The efficiency of this model is linearly related to the point number of shape boundary and the interceptive value n of Fourier expansion. The effect of morphing by Fourier transformation is plausible and the efficiency of the algorithm is acceptable.	[Li, Jingzhong] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China; [Liu, Pengcheng] Cent China Normal Univ, Coll Urban & Environm Sci, Wuhan, Hubei, Peoples R China; [Yu, Wenhao] China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China; [Cheng, Xiaoqiang] Hubei Univ, Fac Resources & Environm Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Central China Normal University; China University of Geosciences; Hubei University	Li, JZ (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China.	00009232@whu.edu.cn		li, jingzhong/0000-0001-9868-5404	National Key Research and Development Program of China [2017YFB0503601]; National Natural Science Foundation of China [41671448]; China Scholarship Council (CSC) [201706275018]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the National Key Research and Development Program of China under Grant 2017YFB0503601 to JL; the National Natural Science Foundation of China under Grant 41671448 to JL; and China Scholarship Council (CSC) under Grant 201706275018 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Key Research and Development Program of China under Grant 2017YFB0503601; the National Natural Science Foundation of China under Grant 41671448; and China Scholarship Council (CSC) under Grant 201706275018.	Ai TH, 2013, COMPUT ENVIRON URBAN, V41, P219, DOI 10.1016/j.compenvurbsys.2013.07.002; Alexa M, 2000, COMP GRAPH, P157, DOI 10.1145/344779.344859; Boutoura C, 1989, CARTOGRAPHICA, V26, P33, DOI [DOI 10.3138/G237-67W4-15N4-1R59, 10.3138/G237-67W4-15N4-1R59]; Cecconi A, 2002, COMPUT GRAPH FORUM, V21, P787, DOI 10.1111/1467-8659.00636; Clarke KC, 1993, P AUT 11 11 INT S CO, P72; Danciger J, 2009, GEOINFORMATICA, V13, P203, DOI 10.1007/s10707-008-0049-0; Deng M, 2015, T GIS, V19, P653, DOI 10.1111/tgis.12111; Efrat A, 2001, SIAM PROC S, P680; Fritsch E, 1995, LECT NOTES COMPUT SC, V988, P157; Gomes J., 1999, WARPING MORPHING GRA; HUGHES JF, 1992, COMP GRAPH, V26, P43, DOI 10.1145/142920.134004; KAUPPINEN H, 1995, IEEE T PATTERN ANAL, V17, P201, DOI 10.1109/34.368168; Lawford GJ, 2006, INT J GEOGR INF SCI, V20, P31, DOI 10.1080/13658810512331319109; Li J, 2017, INT J E-NAVIG MARIT, V6, P1, DOI 10.1016/j.enavi.2017.05.001; Li JZ, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6060173; Liu PC, 2015, CARTOGRAPHY GEOGRAPH; Nollenburg M, 2008, COMPUT ENVIRON URBAN, V32, P248, DOI 10.1016/j.compenvurbsys.2008.06.004; PERSOON E, 1977, IEEE T SYST MAN CYB, V7, P170, DOI 10.1109/TSMC.1977.4309681; Sederberg T. W., 1993, Computer Graphics Proceedings, P15, DOI 10.1145/166117.166118; SEDERBERG TW, 1992, COMP GRAPH, V26, P25, DOI 10.1145/142920.134001; Surazhsky V., 2003, International Journal of Shape Modeling, V9, P191, DOI 10.1142/S0218654303000115; Taosong He, 1994, Proceedings. Visualization '94 (Cat. No.94CH35707), P85, DOI 10.1109/VISUAL.1994.346333; van Oostrum R, 2004, COMP GEOM-THEOR APPL, V28, P75, DOI 10.1016/j.comgeo.2004.03.006; Whited B., 2009, P ACM SIAM JOINT C G, P187; Yang WW, 2009, COMPUT GRAPH-UK, V33, P414, DOI 10.1016/j.cag.2009.03.007; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	26	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191136	10.1371/journal.pone.0191136	http://dx.doi.org/10.1371/journal.pone.0191136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351344	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300050
J	Teame, H; Addissie, A; Ayele, W; Hirpa, S; Gebremariam, A; Gebreheat, G; Jemal, A				Teame, Hirut; Addissie, Adamu; Ayele, Wondimu; Hirpa, Selamawit; Gebremariam, Alem; Gebreheat, Gdiom; Jemal, Ahmedin			Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study	PLOS ONE			English	Article							PREVALENCE; JIMMA	Background Cervical cancer is the second most prevalent cancer among women in the developing countries including Ethiopia. Precancerous lesions can be developed and risk to the development of cervical cancer over time. Early identification of the precancerous lesion and its risk factor is paramount in preventing cervical cancer. However, the determinants of cervical precancerous lesions are not well documented in Ethiopia. Therefore, this study is conducted to determine factors associated with cervical precancerous lesion among women screened for cervical cancer. Methods A hospital-based unmatched case-control study was conducted in selected health facilities in Addis Ababa from March to April 2016. Data were collected from 114 cases and 229 controls using an interviewer-administered questionnaire, entered to Epi Info version 7, and exported to SPSS version 20 for analysis. Odds ratios with its 95% confidence intervals and two-tailed P-value were calculated. Variables with P-value <= 0.2 in the bivariate analysis were included in the multivariate logistic regression model. Results Women aged 40 +/- 49 years had 2.4-fold higher odds of precancerous lesions compared to those aged 30 +/- 39 (Adjusted Odds Ratio = 2.4, 95% Confidence Interval: 1.27 +/- 4.54). Women having history of sexually transmitted infections were significantly associated with cervical precancerous lesion compared to their counterparts (Adjusted Odds Ratio = 3.20, 95% Confidence Interval: 1.26 +/- 8.10). Similarly, those women who had two or more lifetime sexual partners (Adjusted Odds Ratio = 2.17 95% Confidence Interval: 1.01 +/- 4.67), and women whose husbands had two or more lifetime sexual partners (Adjusted Odds Ratio = 3.03, 95% Confidence Interval: 1.25, 7.33) had higher odds of cervical precancerous lesions. Conclusions Older age, history of multiple sexual partners and sexual transmitted infections were associated with increased risk of precancerous lesion. Therefore, women with higher risk of precancerous lesions should be encouraged to be screened more frequently for cervical cancer.	[Teame, Hirut; Gebremariam, Alem] Adigrat Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Addissie, Adamu; Ayele, Wondimu; Hirpa, Selamawit] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Gebreheat, Gdiom] Adigrat Univ, Dept Nursing, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA	Addis Ababa University; American Cancer Society	Gebremariam, A (corresponding author), Adigrat Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Adigrat, Ethiopia.	alemg25@gmail.com	Abady, Gdiom/AAD-4290-2020	Abady, Gdiom/0000-0003-1775-8216; Gebremariam, Alem/0000-0003-2173-6685; Teame, Hirut/0000-0002-7519-8133; Ayele, Wondimu/0000-0001-5899-347X	Intramural Research Department of the American Cancer Society; Addis Ababa Health Office	Intramural Research Department of the American Cancer Society; Addis Ababa Health Office	This work was supported by the Intramural Research Department of the American Cancer Society. This study was supported by Intramural Research Department of the American Cancer Society.; We would like to thank all data collectors, supervisors, and the study participants who took part in the study and who showed great effort in acquiring and giving appropriate information. We are also grateful to Addis Ababa Health Office for their support to conduct this research. We would also like to thank Mr. John M. Daniel for editing the manuscript.	Abate SM, 2015, CERVICAL CANC OPEN A, V1; Addissie A, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0127-z; [Anonymous], 2014, ETH HUM PAP REL CANC; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; Belete Netsanet, 2015, Gynecol Oncol Res Pract, V2, P6, DOI 10.1186/s40661-015-0012-3; Bezabih M, 2015, ETHIOP J HEALTH SCI, V25, P345, DOI 10.4314/ejhs.v25i4.8; Botelho MC, 2017, LETT DRUG DES DISCOV, V14, P135, DOI 10.2174/1570180813666160720165057; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Dam J, 2017, EUR J MED CHEM, V126, P353, DOI 10.1016/j.ejmech.2016.10.041; Deksissa Zewdie Mulissa, 2015, BMC Res Notes, V8, P618, DOI 10.1186/s13104-015-1594-x; Dulla D, 2017, INT J WOMENS HEALTH, V9, P365, DOI 10.2147/IJWH.S132202; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, GUID CERV CANC UNPUB; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gessesse Zekariase, 2015, Ethiop Med J, VSuppl 2, P17; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Getinet M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0016-2; Jean D., 2015, PAN AFRICAN MED J, V22; Leyh-Bannurah SR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-33; Michael V., 2013, RISK FACTORS CERVICA; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Nesrin R., 2011, INT J HEMATOLOGY ONC, V21; Pathfinder international, 2012, SINGL VIS APPR CERV; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Tefera F, 2016, J CANC ED OFFIC 0413; Tekola F, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-13; Trufelli DC, 2015, REV ASSOC MED BRAS, V61, P411, DOI 10.1590/1806-9282.61.05.411; WHO, 2013, WHO GUID SCREEN TREA; Williamson AL, 2015, J CLIN MED, V4, P579, DOI 10.3390/jcm4040579; Wondimu Yehualashet Tadesse, 2015, Ethiop Med J, V53, P65	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191506	10.1371/journal.pone.0191506	http://dx.doi.org/10.1371/journal.pone.0191506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352278	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300103
J	Molinarolo, S; Lee, S; Leisle, L; Lueck, JD; Granata, D; Carnevale, V; Ahern, CA				Molinarolo, Steven; Lee, Sora; Leisle, Lilia; Lueck, John D.; Granata, Daniele; Carnevale, Vincenzo; Ahern, Christopher A.			Cross-kingdom auxiliary subunit modulation of a voltage-gated sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; protein evolution; membrane biophysics; bioinformatics; electrophysiology; auxiliary subunits; bacterial ion channels; electrical signalling	NA+ CHANNEL; BETA-SUBUNITS; FUNCTIONAL EXPRESSION; CRYSTAL-STRUCTURE; FEBRILE SEIZURES; ALPHA-SUBUNITS; MOLECULAR DETERMINANTS; NEURONAL EXCITABILITY; GENERALIZED EPILEPSY; EXTRACELLULAR DOMAIN	Voltage-gated, sodium ion-selective channels (Na-V) generate electrical signals contributing to the upstroke of the action potential in animals. Na(V)s are also found in bacteria and are members of a larger family of tetrameric voltage-gated channels that includes Ca(V)s, K(V)s, and Na(V)s. Prokaryotic Na(V)s likely emerged from a homotetrameric Ca2+-selective voltage-gated progenerator, and later developed Na+ selectivity independently. The Na-V signaling complex in eukaryotes contains auxiliary proteins, termed beta () subunits, which are potent modulators of the expression profiles and voltage-gated properties of the Na-V pore, but it is unknown whether they can functionally interact with prokaryotic Na-V channels. Herein, we report that the eukaryotic Na(V)1-subunit isoform interacts with and enhances the surface expression as well as the voltage-dependent gating properties of the bacterial Na-V, NaChBac in Xenopus oocytes. A phylogenetic analysis of the -subunit gene family proteins confirms that these proteins appeared roughly 420 million years ago and that they have no clear homologues in bacterial phyla. However, a comparison between eukaryotic and bacterial Na-V structures highlighted the presence of a conserved fold, which could support interactions with the -subunit. Our electrophysiological, biochemical, structural, and bioinformatics results suggests that the prerequisites for -subunit regulation are an evolutionarily stable and intrinsic property of some voltage-gated channels.	[Molinarolo, Steven; Lueck, John D.; Ahern, Christopher A.] Univ Iowa, Iowa Neurosci Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Lee, Sora; Leisle, Lilia] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [Granata, Daniele; Carnevale, Vincenzo] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA	University of Iowa; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ahern, CA (corresponding author), Univ Iowa, Iowa Neurosci Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA.	christopher-ahern@uiowa.edu		Ahern, Christopher/0000-0002-7975-2744	National Institutes of Health NIGMS [GM122420]; American Heart Association Established Investigator [5EIA22180002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM122420] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association Established Investigator(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM122420 ( to C.A.A.) and American Heart Association Established Investigator Grant 5EIA22180002 ( to C.A.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Audenaert D, 2003, NEUROLOGY, V61, P854, DOI 10.1212/01.WNL.0000080362.55784.1C; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Barber AF, 2012, BBA-BIOMEMBRANES, V1818, P2120, DOI 10.1016/j.bbamem.2012.05.002; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brackenbury WJ, 2008, NEUROSCIENTIST, V14, P571, DOI 10.1177/1073858408320293; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; Dixon-Salazar TJ, 2004, J CHILD NEUROL, V19, P597, DOI 10.1177/088307380401900806; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finol-Urdaneta RK, 2014, J GEN PHYSIOL, V143, P157, DOI 10.1085/jgp.201311037; Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2002, J EXP BIOL, V205, P575; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Kasimova MA, 2016, CURR TOP MEMBR, V78, P261, DOI 10.1016/bs.ctm.2016.05.002; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kinde MN, 2016, P NATL ACAD SCI USA, V113, P13762, DOI 10.1073/pnas.1609939113; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Lee S, 2012, CHANNELS, V6, P403, DOI 10.4161/chan.21807; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; MACNAB RM, 1987, BIOPHYS J, V52, P637, DOI 10.1016/S0006-3495(87)83255-1; Makita N, 1996, J NEUROSCI, V16, P7117; Makita N, 1996, CIRC RES, V78, P244, DOI 10.1161/01.RES.78.2.244; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Malhotra JD, 2001, CIRCULATION, V103, P1303; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Micheletti C, 2009, BIOINFORMATICS, V25, P2663, DOI 10.1093/bioinformatics/btp506; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mio K, 2010, PROG BIOPHYS MOL BIO, V103, P111, DOI 10.1016/j.pbiomolbio.2010.05.002; Moran O, 2003, NEUROSCI LETT, V336, P175, DOI 10.1016/S0304-3940(02)01284-3; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Nguyen HM, 2012, P NATL ACAD SCI USA, V109, P18577, DOI 10.1073/pnas.1209142109; Nuss HB, 1995, J GEN PHYSIOL, V106, P1171, DOI 10.1085/jgp.106.6.1171; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ouyang W, 2007, J PHARMACOL EXP THER, V322, P1076, DOI 10.1124/jpet.107.122929; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin N, 2003, EUR J BIOCHEM, V270, P4762, DOI 10.1046/j.1432-1033.2003.03878.x; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Sula A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14205; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; Wallace RH, 2002, NEUROLOGY, V58, P1426, DOI 10.1212/WNL.58.9.1426; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Xiao YF, 2000, AM J PHYSIOL-HEART C, V279, pH35, DOI 10.1152/ajpheart.2000.279.1.H35; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yu FH, 2003, J NEUROSCI, V23, P7577; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zakon HH, 2011, MOL BIOL EVOL, V28, P1415, DOI 10.1093/molbev/msq325; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802; Zimmer T, 2002, J MEMBRANE BIOL, V186, P1, DOI 10.1007/s00232-001-0130-1	101	7	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4981	4992		10.1074/jbc.RA117.000852	http://dx.doi.org/10.1074/jbc.RA117.000852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29371400	hybrid, Green Published			2022-12-26	WOS:000429409300003
J	Zhou, ZQ; Ribas, V; Rajbhandari, P; Drew, BG; Moore, TM; Fluitt, AH; Reddish, BR; Whitney, KA; Georgia, S; Vergnes, L; Reue, K; Liesa, M; Shirihai, O; van der Bliek, AM; Chi, NW; Mahata, SK; Tiano, JP; Hewitt, SC; Tontonoz, P; Korach, KS; Mauvais-Jarvis, F; Hevener, AL				Zhou, Zhenqi; Ribas, Vicent; Rajbhandari, Prashant; Drew, Brian G.; Moore, Timothy M.; Fluitt, Amy H.; Reddish, Britany R.; Whitney, Kate A.; Georgia, Senta; Vergnes, Laurent; Reue, Karen; Liesa, Marc; Shirihai, Orian; van der Bliek, Alexander M.; Chi, Nai-Wen; Mahata, Sushil K.; Tiano, Joseph P.; Hewitt, Sylvia C.; Tontonoz, Peter; Korach, Kenneth S.; Mauvais-Jarvis, Franck; Hevener, Andrea L.			Estrogen receptor alpha protects pancreatic beta-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; HIGH-FAT DIET; INSULIN-RESISTANCE; ER-ALPHA; ISLET TRANSPLANTATION; OXIDATIVE STRESS; ADIPOSE-TISSUE; AUTOPHAGY; FISSION; METABOLISM	Estrogen receptor alpha (ER alpha) action plays an important role in pancreatic beta-cell function and survival; thus, it is considered a potential therapeutic target for the treatment of type 2 diabetes in women. However, the mechanisms underlying the protective effects of ER alpha remain unclear. Because ER alpha regulates mitochondrial metabolism in other cell types, we hypothesized that ER alpha may act to preserve insulin secretion and promote beta-cell survival by regulating mitochondrial-endoplasmic reticulum (EndoRetic) function. We tested this hypothesis using pancreatic islet-specific ER alpha knockout (PER alpha KO) mice and Min6 beta-cells in culture with Esr1 knockdown (KD). We found that Esr1-KD promoted reactive oxygen species production that associated with reduced fission/fusion dynamics and impaired mitophagy. Electron microscopy showed mitochondrial enlargement and a pro-fusion phenotype. Mitochondrial cristae and endoplasmic reticulum were dilated in Esr1-KD compared with ER alpha replete Min6 beta-cells. Increased expression of Oma1 and Chop was paralleled by increased oxygen consumption and apoptosis susceptibility in ER alpha-KD cells. In contrast, ER alpha overexpression and ligand activation reduced both Chop and Oma1 expression, likely by ER alpha binding to consensus estrogen-response element sites in the Oma1 and Chop promoters.	[Zhou, Zhenqi; Ribas, Vicent; Drew, Brian G.; Moore, Timothy M.; Fluitt, Amy H.; Reddish, Britany R.; Whitney, Kate A.; Georgia, Senta; Liesa, Marc; Shirihai, Orian; Hevener, Andrea L.] UCLA, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA; [Rajbhandari, Prashant; Tontonoz, Peter] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rajbhandari, Prashant; Tontonoz, Peter] UCLA, David Geffen Sch Med, Howard Hughes Res Inst, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] UCLA, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [van der Bliek, Alexander M.] UCLA, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Hevener, Andrea L.] Iris Cantor UCLA Womens Hlth Res Ctr, Los Angeles, CA 90095 USA; [Chi, Nai-Wen; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Tiano, Joseph P.; Mauvais-Jarvis, Franck] Tulane Univ, Hlth Sci Ctr, Dept Med & Pharmacol, New Orleans, LA 70112 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Georgia, Senta] Univ Southern Calif, Div Endocrinol, Keck Sch Med, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California	Hevener, AL (corresponding author), UCLA, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, 900 Vet Ave,Warren Hall Ste 24-130, Los Angeles, CA 90095 USA.	ahevener@mednet.ucla.edu	Hewitt, Sylvia/W-8752-2019; Liesa, Marc/K-8590-2019; Ribas, Vicent/K-1390-2014; Mahata, Sushil/AAF-8781-2021; Georgia, Senta/AAP-1971-2020	Hewitt, Sylvia/0000-0001-7713-0805; Liesa, Marc/0000-0002-5909-8570; Ribas, Vicent/0000-0003-3380-2256; Georgia, Senta/0000-0002-2016-7866; Rajbhandari, Prashant/0000-0002-8146-3861; Zhou, Zhenqi/0000-0001-6560-9704; vergnes, laurent/0000-0002-8804-589X; Moore, Timothy/0000-0003-4250-3370	UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation; UCLA CTSI Grant [ULTR000124]; UCLA Claude D. Pepper Older Americans Independence Center; UCSD-UCLA Diabetes Research Center; National Institutes of Health [DK060484, DK109724, P30DK063491, R01 DK074970]; NURSA NDSP [U24DK097748]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108657, U24DK097748, R01DK074970, R01DK099618, K01DK060484, P30DK063491, R01DK089109, R01DK107444, R01DK109724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM109764] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003725] Funding Source: NIH RePORTER	UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation; UCLA CTSI Grant; UCLA Claude D. Pepper Older Americans Independence Center; UCSD-UCLA Diabetes Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NURSA NDSP; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the UCLA Department of Medicine, the UCLA Iris Cantor Women's Health Foundation, UCLA CTSI Grant ULTR000124, the UCLA Claude D. Pepper Older Americans Independence Center, UCSD-UCLA Diabetes Research Center, and National Institutes of Health Grants DK060484, DK109724, and P30DK063491, and NURSA NDSP U24DK097748 (to A. L. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant R01 DK074970.	Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Drew BG, 2015, J BIOL CHEM, V290, P5566, DOI 10.1074/jbc.M114.606459; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Frank A, 2014, FRONT NEUROENDOCRIN, V35, P550, DOI 10.1016/j.yfrne.2014.05.002; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gurlo T, 2016, MOL ENDOCRINOL, V30, P446, DOI 10.1210/me.2015-1255; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kilic G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087941; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim M, 2014, MOL METAB, V3, P642, DOI 10.1016/j.molmet.2014.05.007; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Liu S, 2013, DIABETOLOGIA, V56, P370, DOI 10.1007/s00125-012-2764-1; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Liu SH, 2010, ENDOCRINOLOGY, V151, P859, DOI 10.1210/en.2009-1107; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marchese E, 2015, DIABETES CARE, V38, pE176, DOI 10.2337/dc15-0723; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Rogers NH, 2009, BIOCHEM BIOPH RES CO, V382, P646, DOI 10.1016/j.bbrc.2009.02.154; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Watada H, 2015, MOL ENDOCRINOL, V29, P338, DOI 10.1210/me.2014-1367; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1188, DOI 10.1152/ajpendo.00579.2013; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	59	46	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4735	4751		10.1074/jbc.M117.805069	http://dx.doi.org/10.1074/jbc.M117.805069			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378845	Green Published, hybrid			2022-12-26	WOS:000428848300016
J	Haushalter, KJ; Casteel, DE; Raffeiner, A; Stefan, E; Patel, HH; Taylor, SS				Haushalter, Kristofer J.; Casteel, Darren E.; Raffeiner, Andrea; Stefan, Eduard; Patel, Hemal H.; Taylor, Susan S.			Phosphorylation of protein kinase A (PKA) regulatory subunit RI alpha by protein kinase G (PKG) primes PKA for catalytic activity in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; DILATED CARDIOMYOPATHY; HEART-FAILURE; SMOOTH-MUSCLE; I-ALPHA; HOLOENZYME; ACTIVATION; ISOFORM; STATE; LOCALIZATION	cAMP-dependent protein kinase (PKAc) is a pivotal signaling protein in eukaryotic cells. PKAc has two well-characterized regulatory subunit proteins, RI and RII (each having alpha and beta isoforms), which keep the PKAc catalytic subunit in a catalytically inactive state until activation by cAMP. Previous reports showed that the RI alpha regulatory subunit is phosphorylated by cGMP-dependent protein kinase (PKG) in vitro, whereupon phosphorylated RI alpha no longer inhibits PKAc at normal (1:1) stoichiometric ratios. However, the significance of this phosphorylation as a mechanism for activating type I PKA holoenzymes has not been fully explored, especially in cellular systems. In this study, we further examined the potential of RI alpha phosphorylation to regulate physiologically relevant "desensitization" of PKAc activity. First, the serine 101 site of RI alpha was validated as a target of PKGI alpha phosphorylation both in vitro and in cells. Analysis of a phosphomimetic substitution in RI alpha (S101E) showed that modification of this site increases PKAc activity in vitro and in cells, even without cAMP stimulation. Numerous techniques were used to show that although Ser(101) variants of RI alpha can bind PKAc, the modified linker region of the S101E mutant has a significantly reduced affinity for the PKAc active site. These findings suggest that RI alpha phosphorylation may be a novel mechanism to circumvent the requirement of cAMP stimulus to activate type I PKA in cells. We have thus proposed a model to explain how PKG phosphorylation of RI alpha creates a "sensitized intermediate" state that is in effect primed to trigger PKAc activity.	[Haushalter, Kristofer J.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Haushalter, Kristofer J.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Raffeiner, Andrea; Stefan, Eduard] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Patel, Hemal H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Innsbruck; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu		Stefan, Eduard/0000-0003-3650-4713	National Institutes of Health [R01 GM34921, DK54441, HL091071, HL107200]; Veterans Administration Grant [BX001963]; Austrian Science Fund [P27606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R01HL107200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Grant; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in whole or by part by National Institutes of Health Grants R01 GM34921 and DK54441 (to S.S.T.), HL091071 (to H.H.P.), and HL107200 (to H.H.P.) and Veterans Administration Grant BX001963 (HHP), and the Austrian Science Fund Grant P27606 (ES).	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Boeshans KM, 1999, PROTEIN SCI, V8, P1515, DOI 10.1110/ps.8.7.1515; Boras BW, 2014, J BIOL CHEM, V289, P30040, DOI 10.1074/jbc.M114.568907; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burgoyne JR, 2010, SENSORS-BASEL, V10, P2731, DOI 10.3390/s100402731; Burgoyne JR, 2009, J BIOL CHEM, V284, P29260, DOI 10.1074/jbc.M109.046722; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; GEAHLEN RL, 1982, ADV ENZYME REGUL, V20, P195, DOI 10.1016/0065-2571(82)90016-4; GEAHLEN RL, 1981, J BIOL CHEM, V256, P4536; Gupte RS, 2006, CELL CYCLE, V5, P653, DOI 10.4161/cc.5.6.2576; Han YS, 2013, ARCH BIOCHEM BIOPHYS, V538, P25, DOI 10.1016/j.abb.2013.08.002; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; KEELY SL, 1977, AM J PHYSIOL, V233, pH269, DOI 10.1152/ajpheart.1977.233.2.H269; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Saldanha SA, 2006, ANAL CHEM, V78, P8265, DOI 10.1021/ac061104g; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tschope C, 2016, INT J CARDIOL, V203, P1061, DOI 10.1016/j.ijcard.2015.10.208; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; van Heerebeek L, 2012, CIRCULATION, V126, P830, DOI 10.1161/CIRCULATIONAHA.111.076075; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Walter U, 1989, REV PHYSL BIOCH PHAR, V113, P41; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	42	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4411	4421		10.1074/jbc.M117.809988	http://dx.doi.org/10.1074/jbc.M117.809988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378851	Green Published, hybrid			2022-12-26	WOS:000428204300013
J	Abraham, MA; Rasti, M; Bauer, PV; Lam, TKT				Abraham, Mona A.; Rasti, Mozhgan; Bauer, Paige V.; Lam, Tony K. T.			Leptin enhances hypothalamic lactate dehydrogenase A (LDHA)-dependent glucose sensing to lower glucose production in high-fat-fed rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; DIET-INDUCED OBESITY; ASTROCYTES; SENSITIVITY; METABOLISM; ACTIVATION; NEURONS; ISOENZYMES; MECHANISM; RESPONSES	The responsiveness of glucose sensing per se to regulate whole-body glucose homeostasis is dependent on the ability of a rise in glucose to lower hepatic glucose production and increase peripheral glucose uptake in vivo. In both rodents and humans, glucose sensing is lost in diabetes and obesity, but the site(s) of impairment remains elusive. Here, we first report that shortterm high-fat feeding disrupts hypothalamic glucose sensing to lower glucose production in rats. Second, leptin administration into the hypothalamus of high-fat-fed rats restored hypothalamic glucose sensing to lower glucose production during a pancreatic (basal insulin)-euglycemic clamp and increased wholebody glucose tolerance during an intravenous glucose tolerance test. Finally, both chemical inhibition of hypothalamic lactate dehydrogenase (LDH) (achieved via hypothalamic LDH inhibitor oxamate infusion) and molecular knockdown of LDHA (achieved via hypothalamic lentiviral LDHA shRNA injection) negated the ability of hypothalamic leptin infusion to enhance glucose sensing to lower glucose production in high fat-fed rats. In summary, our findings illustrate that leptin enhances LDHA-dependent glucose sensing in the hypothalamus to lower glucose production in high-fat-fed rodents in vivo.	[Abraham, Mona A.; Rasti, Mozhgan; Bauer, Paige V.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON M5G 1L7, Canada; [Abraham, Mona A.; Bauer, Paige V.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON M5G 1L7, Canada.; Lam, TKT (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.; Lam, TKT (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada.; Lam, TKT (corresponding author), Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada.	tony.lam@uhnres.utoronto.ca			Diabetes Canada Operating Grant [OG-3-15-4901-TL]; Canadian Institutes of Health Research doctoral award; Banting and Best Diabetes Centre graduate scholarship; Ontario graduate scholarship	Diabetes Canada Operating Grant; Canadian Institutes of Health Research doctoral award(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate scholarship; Ontario graduate scholarship(Ontario Graduate Scholarship)	This work was supported by Diabetes Canada Operating Grant OG-3-15-4901-TL (to T.K.T.L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Canadian Institutes of Health Research doctoral award.; Supported by a Banting and Best Diabetes Centre graduate scholarship and an Ontario graduate scholarship.	Abraham MA, 2014, MOL METAB, V3, P202, DOI 10.1016/j.molmet.2013.11.007; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Arrieta-Cruz I, 2013, DIABETES, V62, P1152, DOI 10.2337/db12-0228; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fam BC, 2007, DIABETES OBES METAB, V9, P840, DOI 10.1111/j.1463-1326.2006.00653.x; Filippi BM, 2017, CELL REP, V18, P2301, DOI 10.1016/j.celrep.2017.02.035; Garcia-Caceres C, 2016, CELL, V166, P867, DOI 10.1016/j.cell.2016.07.028; Hawkins M, 2002, DIABETES, V51, P2179, DOI 10.2337/diabetes.51.7.2179; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mevorach M, 1998, J CLIN INVEST, V102, P744, DOI 10.1172/JCI2720; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; THOLEY G, 1981, J NEUROCHEM, V36, P77, DOI 10.1111/j.1471-4159.1981.tb02379.x; VENKOV L, 1976, BRAIN RES, V109, P323, DOI 10.1016/0006-8993(76)90533-3; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Weiss R, 2015, DIABETES CARE, V38, P689, DOI 10.2337/dc14-2183; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yue JTY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13501; Zhu WL, 2010, AM J PHYSIOL-ENDOC M, V298, pE971, DOI 10.1152/ajpendo.00749.2009	34	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4159	4166		10.1074/jbc.RA117.000838	http://dx.doi.org/10.1074/jbc.RA117.000838			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374061	Green Published, hybrid			2022-12-26	WOS:000427587500026
J	Figura, M; Kusmierska, K; Bucior, E; Szlufik, S; Koziorowski, D; Jamrozik, Z; Janik, P				Figura, Monika; Kusmierska, Katarzyna; Bucior, Ewelina; Szlufik, Stanislaw; Koziorowski, Dariusz; Jamrozik, Zygmunt; Janik, Piotr			Serum amino acid profile in patients with Parkinson's disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; HOMOCYSTEINE LEVELS; GLUTATHIONE LEVELS; PLASMA-LEVELS; LEVODOPA; DYSFUNCTION; METABOLISM; GLUTAMATE	Amino acids play numerous roles in the central nervous system, serving as neurotransmitters, neuromodulators and regulators of energy metabolism. The free amino acid profile in serum of Parkinson's disease (PD) patients may be influenced by neurodegeneration, mitochondria) dysfunction, malabsorption in the gastroenteric tract and received treatment. The aim of our study was the evaluation of the profile of amino acid concentrations against disease progression. We assessed the amino acid profile in the serum of 73 patients divided into groups with early PD, late PD with dyskinesia and late PD without dyskinesia. Serum amino acid analysis was performed by high-pressure liquid chromatography with fluorescence detection. We observed some significant differences amongst the groups with respect to concentrations of alanine, arginine, phenylalanine and threonine, although no significant differences were observed between patients with advanced PD with and without dyskinesia. We conclude that this specific amino acid profile could serve as biochemical marker of PD progression.	[Figura, Monika; Szlufik, Stanislaw; Koziorowski, Dariusz] Med Univ Warsaw, Fac Heath Sci, Dept Neurol, Warsaw, Poland; [Kusmierska, Katarzyna] Inst Mother & Child Hlth, Dept Screening & Metab Diagnost, Warsaw, Poland; [Bucior, Ewelina] Inst Psychiat & Neurol, Dept Neurol 1, Warsaw, Poland; [Jamrozik, Zygmunt; Janik, Piotr] Med Univ Warsaw, Dept Neurol, Warsaw, Poland	Medical University of Warsaw; Institute of Psychiatry & Neurology; Medical University of Warsaw	Janik, P (corresponding author), Med Univ Warsaw, Dept Neurol, Warsaw, Poland.	piotr.janik@wum.edu.pl	Bucior, Ewelina/AAH-1685-2019; Janik, Piotr/M-5836-2018	Bucior, Ewelina/0000-0003-1587-5793; Janik, Piotr/0000-0002-2701-191X; Figura, Monika/0000-0002-5332-9905	Medical University of Warsaw [1WC/NM1/13]	Medical University of Warsaw	This research was supported by Medical University of Warsaw grant number 1WC/NM1/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestetti A, 2017, CLIN NUCL MED, V42, P83, DOI 10.1097/RLU.0000000000001470; BLOM W, 1992, Amino Acids (Vienna), V2, P25, DOI 10.1007/BF00806075; BRAHAM J, 1969, BMJ-BRIT MED J, V2, P552, DOI 10.1136/bmj.2.5656.552; Chassain C, 2008, J NEUROCHEM, V105, P874, DOI 10.1111/j.1471-4159.2007.05185.x; Dutkiewicz J, 2015, J NEURAL TRANSM, V122, P1659, DOI 10.1007/s00702-015-1442-0; EDWARDS LL, 1992, NEUROLOGY, V42, P726, DOI 10.1212/WNL.42.4.726; Eisenhofer G, 2014, ANN CLIN BIOCHEM, V51, P38, DOI 10.1177/0004563213487894; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; Gao HC, 2013, MOL NEUROBIOL, V47, P123, DOI 10.1007/s12035-012-8336-z; GRANERUS AK, 1971, BMJ-BRIT MED J, V4, P262, DOI 10.1136/bmj.4.5782.262; Havelund JF, 2017, J NEUROCHEM, V142, P756, DOI 10.1111/jnc.14104; Hiramatsu M, 2017, J NEUROSURG, V127, P679, DOI 10.3171/2016.8.JNS16366; IWASAKI Y, 1992, NEUROSCI LETT, V145, P175, DOI 10.1016/0304-3940(92)90015-Y; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; JENNER P, 1992, ANN NEUROL, V32, pS82, DOI 10.1002/ana.410320714; JimenezJimenez FJ, 1996, J NEUROL SCI, V141, P39, DOI 10.1016/0022-510X(96)00115-3; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Kirbas S, 2016, ACTA CLIN BELG, V71, P71, DOI 10.1080/17843286.2016.1138592; KISH SJ, 1985, NEUROSCI LETT, V58, P343, DOI 10.1016/0304-3940(85)90078-3; Kuhn W, 1998, EUR NEUROL, V40, P225, DOI 10.1159/000007984; Kuiper MA, 2000, J NEURAL TRANSM, V107, P183, DOI 10.1007/s007020050016; Lei S, 2014, ACS CHEM BIOL, V9, P2032, DOI 10.1021/cb400894a; LeWitt PA, 2017, NEUROLOGY, V88, P862, DOI 10.1212/WNL.0000000000003663; LeWitt PA, 2013, MOVEMENT DISORD, V28, P1653, DOI 10.1002/mds.25555; Luan H, 2015, SCI REPORTS, V5; Luan HM, 2015, J PROTEOME RES, V14, P467, DOI 10.1021/pr500807t; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Mally J, 1997, J NEUROL SCI, V151, P159, DOI 10.1016/S0022-510X(97)00119-6; Muller T, 2016, J NEURAL TRANSM, V123, P401, DOI 10.1007/s00702-016-1519-4; Muller T, 2012, NEUROSCI LETT, V521, P37, DOI 10.1016/j.neulet.2012.05.054; Muller T, 2011, MOVEMENT DISORD, V26, P543, DOI 10.1002/mds.23384; Muller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657; Muller T, 2006, EUR J CLIN PHARMACOL, V62, P447, DOI 10.1007/s00228-006-0132-0; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; NUTT JG, 1989, J NEUROL NEUROSUR PS, V52, P481, DOI 10.1136/jnnp.52.4.481; O'Kane RL, 2006, AM J PHYSIOL-ENDOC M, V291, pE412, DOI 10.1152/ajpendo.00007.2006; Cristalli DO, 2012, J NEUROL SCI, V314, P48, DOI 10.1016/j.jns.2011.11.001; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Sharma M, 2015, BASIC CLIN PHARMACOL, V117, P287, DOI 10.1111/bcpt.12424; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053290; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Szadejko K, 2016, J NEUROL SCI, V371, P36, DOI 10.1016/j.jns.2016.09.061; Trupp M, 2014, J PARKINSON DIS, V4, P549, DOI 10.3233/JPD-140389; Valkovic P, 2005, PARKINSONISM RELAT D, V11, P253, DOI 10.1016/j.parkreldis.2005.01.007; Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7; Wuolikainen A, 2016, MOL BIOSYST, V12, P1287, DOI 10.1039/c5mb00711a; Yoon JH, 2014, MOVEMENT DISORD, V29, P1551, DOI 10.1002/mds.26005; Zoccolella S, 2009, MOVEMENT DISORD, V24, P1028, DOI 10.1002/mds.22511	51	42	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191670	10.1371/journal.pone.0191670	http://dx.doi.org/10.1371/journal.pone.0191670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377959	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700026
J	Lasala, JA; Hughes, CR; Wyneken, J				Lasala, Jacob A.; Hughes, Colin R.; Wyneken, Jeanette			Breeding sex ratio and population size of loggerhead turtles from Southwestern Florida	PLOS ONE			English	Article							CARETTA-CARETTA; MULTIPLE PATERNITY; SPERM STORAGE; DERMOCHELYS-CORIACEA; LEATHERBACK TURTLE; HIGH-FREQUENCY; CLIMATE-CHANGE; PATTERNS; ATLANTIC; DNA	Species that display temperature-dependent sex determination are at risk as a result of increasing global temperatures. For marine turtles, high incubation temperatures can skew sex ratios towards females. There are concerns that temperature increases may result in highly female-biased offspring sex ratios, which would drive a future sex ratio skew. Studying the sex ratios of adults in the ocean is logistically very difficult because individuals are widely distributed and males are inaccessible because they remain in the ocean. Breeding sex ratios (BSR) are sought as a functional alternative to study adult sex ratios. One way to examine BSR is to determine the number of males that contribute to nests. Our goal was to evaluate the BSR for loggerhead turtles (Caretta caretta) nesting along the eastern Gulf of Mexico in Florida, from 2013 +/- 2015, encompassing three nesting seasons. We genotyped 64 nesting females (approximately 28% of all turtles nesting at that time) and up to 20 hatchlings from their nests (n = 989) using 7 polymorphic microsatellite markers. We identified multiple paternal contributions in 70% of the nests analyzed and 126 individual males. The breeding sex ratio was approximately 1 female for every 2.5 males. We did not find repeat males in any of our nests. The sex ratio and lack of repeating males was surprising because of female-biased primary sex ratios. We hypothesize that females mate offshore of their nesting beaches as well as en route. We recommend further comparisons of subsequent nesting events and of other beaches as it is imperative to establish baseline breeding sex ratios to understand how growing populations behave before extreme environmental effects are evident.	[Lasala, Jacob A.; Hughes, Colin R.; Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Lasala, JA (corresponding author), Florida Atlantic Univ, Dept Biol, Boca Raton, FL 33431 USA.	jlasala1@fau.edu		Lasala, Jacob/0000-0001-5343-2876	Sea Turtle Grants Program, Sea Turtle Conservancy; Florida License Plate Grants [15-031R, 16-035R]; National Save the Sea Turtle Foundation; Nelligan Sea Turtle Fund; Sea Turtle Grants Program	Sea Turtle Grants Program, Sea Turtle Conservancy; Florida License Plate Grants; National Save the Sea Turtle Foundation; Nelligan Sea Turtle Fund; Sea Turtle Grants Program	The study was funded by grants awarded from the Sea Turtle Grants Program, Sea Turtle Conservancy; Florida License Plate Grants, 15-031R & 16-035R (http://www.helpingseaturtle.org/fundedprojects.php) to JW/JL and the National Save the Sea Turtle Foundation to JL (http://www.savetheseaturtle.org/default.html), as well as funds from the Nelligan Sea Turtle Fund and personal funding. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.; The authors thank the volunteers and the staff of the Sanibel Captiva Conservation Foundation for their help throughout the sampling process, particularly A. Bryant, K. Sloan, and S. Gibbs. We thank E. Lindblad for his efforts to make this study possible. We also thank J. Conrad and the USFWS at the J.N. "Ding" Darling National Wildlife refuge for housing and logistical support. The University of Arizona Genomics Core provided essential technical help. The study was improved by FAU's Marine Turtle Lab members who assisted and provided intellectual discussion. All work was done in accordance with animal care and use protocols approved by the Institutional Animal Care and Usage Committee at Florida Atlantic University (IACUC A13-04). Sample collection was permitted through Florida Fish and Wildlife Conservation Commission (FWC Permits: MTP# 073 and MTP# 15-216). The study was funded by grants awarded from the Sea Turtle Grants Program and the National Save the Sea Turtle Foundation, as well as funds from the Nelligan Sea Turtle Fund and personal funding.	Addison David S., 1996, Marine Turtle Newsletter, V75, P13; [Anonymous], 2015, IUCN RED LIST THREAT; Arendt MD, 2012, MAR BIOL, V159, P127, DOI 10.1007/s00227-011-1829-x; Arendt MD, 2012, MAR BIOL, V159, P101, DOI 10.1007/s00227-011-1793-5; Arendt MD, 2012, MAR BIOL, V159, P113, DOI 10.1007/s00227-011-1826-0; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Bollmer JL, 1999, COPEIA, P475, DOI 10.2307/1447494; BOOTH J, 1972, ANIM BEHAV, V20, P808, DOI 10.1016/S0003-3472(72)80155-6; BOWEN B, 1993, CONSERV BIOL, V7, P834, DOI 10.1046/j.1523-1739.1993.740834.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Casale P, 2016, MAR POLLUT BULL, V110, P238, DOI 10.1016/j.marpolbul.2016.06.057; Ceriani SA, 2015, IUCN RED LIST THREAT; Crim JL, 2002, MOL ECOL, V11, P2097, DOI 10.1046/j.1365-294X.2002.01591.x; Delgado C, 2010, MAR BIOL, V157, P979, DOI 10.1007/s00227-009-1378-8; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eaton C., 2008, NOAA TECHNICAL MEMOR, P233; Ehrhart Llewellyn M., 2007, Florida Scientist, V70, P415; Encalada SE, 1998, MAR BIOL, V130, P567, DOI 10.1007/s002270050278; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; Fitzsimmons NN, 1998, MOL ECOL, V7, P575, DOI 10.1046/j.1365-294x.1998.00355.x; Florida Fish and Wildlife Service, 2016, 2016 FLOR STAT NEST; Fromhage L, 2016, EVOLUTION, V70, P617, DOI 10.1111/evo.12874; Fuentes MMPB, 2012, MITIG ADAPT STRAT GL, V17, P51, DOI 10.1007/s11027-011-9308-8; Gist DH, 1998, J EXP ZOOL, V282, P526, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5<526::AID-JEZ8>3.3.CO;2-Q; HARRY JL, 1988, J HERED, V79, P96, DOI 10.1093/oxfordjournals.jhered.a110480; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2576; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Jensen MP, 2006, MOL ECOL, V15, P2567, DOI 10.1111/j.1365-294X.2006.02951.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jourdan J, 2015, MITIG ADAPT STRAT GL, V20, P121, DOI 10.1007/s11027-013-9482-y; Kawazu I, 2017, CURR HERPETOL, V36, P69, DOI 10.5358/hsj.36.69; Kichler K, 1999, MOL ECOL, V8, P819; Kokko H, 2013, ENTOMOL EXP APPL, V146, P26, DOI 10.1111/j.1570-7458.2012.01296.x; Lasala JA, 2013, ECOL EVOL, V3, P4736, DOI 10.1002/ece3.761; LeBlanc AM, 2012, CHELONIAN CONSERV BI, V11, P108, DOI 10.2744/CCB-0915.1; LeBuff Jr CR, LOGGERHEAD TURTLE E, P216; Maffucci F, 2013, MAR BIOL, V160, P1097, DOI 10.1007/s00227-012-2160-x; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; McNeill JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160911; Moore MK, 2002, MOL ECOL, V11, P281, DOI 10.1046/j.1365-294X.2002.01426.x; MROSOVSKY N, 1992, CAN J ZOOL, V70, P530, DOI 10.1139/z92-080; MROSOVSKY N, 1980, BIOL CONSERV, V18, P271, DOI 10.1016/0006-3207(80)90003-8; Murphy T, 1984, AERIAL GROUND SURVEY, P73; National Marine Fisheries Services (NMFS) United States Fish and Wildlife Service (USFWS), 2011, FED REGISTER, P58868; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips KF, 2014, MAR BIOL, V161, P863, DOI 10.1007/s00227-013-2386-2; Refsnider JM, 2009, J HERPETOL, V43, P74, DOI 10.1670/08-102R.1; Reneker JL, 2016, ECOLOGY, V97, P3257, DOI 10.1002/ecy.1603; Rogers M., 2013, HATCHLING SEX RATIOS; Sakaoka K, 2013, J EXP MAR BIOL ECOL, V439, P136, DOI 10.1016/j.jembe.2012.11.001; Sakaoka K, 2011, CHELONIAN CONSERV BI, V10, P62, DOI 10.2744/CCB-0878.1; Tomillo PS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16789; Sever DM, 2002, J EXP ZOOL, V292, P187, DOI 10.1002/jez.1154; Shamblin BM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3166-1; Shamblin BM, 2011, MOL ECOL RESOUR, V11, P110, DOI 10.1111/j.1755-0998.2010.02910.x; Shamblin BM, 2009, CONSERV GENET, V10, P577, DOI 10.1007/s10592-008-9573-6; Sonmez Bektas, 2016, Journal of the Black Sea Mediterranean Environment, V22, P93; Stewart KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088138; Tedeschi JN, 2014, AUST J ZOOL, V62, P454, DOI 10.1071/ZO14076; Tucker AD, 2010, J EXP MAR BIOL ECOL, V383, P48, DOI 10.1016/j.jembe.2009.11.009; Turtle Expert Working Group, 1998, NMFSSEFSC409 NOAA TU, P96; Turtle Expert Working Group (TEWG), 2009, NOAA TECHNICAL MEMOR, V575, P131; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wibbels T, 2003, CRC MAR BIOL SER, P103; WIBBELS T, 1990, GEN COMP ENDOCR, V79, P154, DOI 10.1016/0016-6480(90)90099-8; WIBBELS T., 1987, ECOLOGY E FLORIDA SE, V53, P65; Witherington B.E., 2009, LOGGERHEAD SEA TURTL, P222; Wright LI, 2013, BEHAV ECOL, V24, P1022, DOI 10.1093/beheco/art003; Wright LI, 2012, MOL ECOL, V21, P3625, DOI 10.1111/j.1365-294X.2012.05616.x; Wyneken, 2001, ANATOMY SEA TURTLES, P172; Wyneken J, 2015, J EXP ZOOL PART B, V324, P465, DOI 10.1002/jez.b.22635; Yue GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012721; Zbinden JA, 2007, MOL ECOL, V16, P3703, DOI 10.1111/j.1365-294X.2007.03426.x	79	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191615	10.1371/journal.pone.0191615	http://dx.doi.org/10.1371/journal.pone.0191615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370223	gold, Green Published			2022-12-26	WOS:000423416600067
J	Freire, GSM; Sampaio, ALL; Lopes, RAF; Nakanishi, M; de Oliveira, CACP				Magalhaes Freire, Gustavo Subtil; Lopes Sampaio, Andre Luiz; Fernandes Lopes, Rafaela Aquino; Nakanishi, Marcio; Costa Pires de Oliveira, Carlos Augusto			Does ear endoscopy provide advantages in the outpatient management of open mastoidectomy cavities?	PLOS ONE			English	Article								Objective To evaluate the use of ear endoscopy in the postoperative management of open mastoidectomy cavities, and to test whether ear endoscopy improves inspection and cleaning compared with ear microscopy. Methods Prospective study. Thirty-two ears were divided into two groups: group 1, examination and cleaning of mastoid cavities under endoscopic visualization after microscopic standard ear cleaning; group 2, examination and cleaning of mastoid cavities under microscopic visualization after endoscope-assisted ear cleaning. We assessed the ability of each method to provide exposure and facilitate cleaning, comparing the benefits of microscopy and endoscopy when used sequentially and vice-versa. Results Endoscopy provided additional benefits for exposure in 61.1% of cases and cleaning in 66.7%. Microscopy provided no additional benefits in terms of exposure in any case, and provided added benefit for cleaning in only 21.4% of cases. Discussion For outpatient postoperative care of open mastoidectomy cavities, ear endoscopy provides greater benefit over ear microscopy than vice-versa. In over half of all cases, endoscopy was able to expose areas not visualized under the microscope. Furthermore, in two-thirds of cases, endoscopy enabled removal of material that could not be cleared under microscopy. Ear endoscopy was superior to microscopy in terms of enabling exposure and cleaning of hard-to-reach sites, due to its wider field of vision. Conclusion Ear endoscopy is a feasible technique for the postoperative management of open mastoidectomy cavities. Ear endoscopy provided superior advantages in terms of exposure and aural cleaning compared with microscopy.	[Magalhaes Freire, Gustavo Subtil; Lopes Sampaio, Andre Luiz; Fernandes Lopes, Rafaela Aquino; Nakanishi, Marcio; Costa Pires de Oliveira, Carlos Augusto] HUB, Dept Otolaryngol, Brasilia, DF, Brazil		Freire, GSM (corresponding author), HUB, Dept Otolaryngol, Brasilia, DF, Brazil.	gustavosmf@gmail.com						Brock TP, 2007, INT J MED INFORM, V76, P829, DOI 10.1016/j.ijmedinf.2006.09.024; Farahani F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132890; Furukawa T, 2014, OTOL NEUROTOL, V35, pE140, DOI 10.1097/MAO.0000000000000298; Jones WS, 2006, INT J PEDIATR OTORHI, V70, P1875, DOI 10.1016/j.ijporl.2006.06.014; Kakehata S, 2006, OTOL NEUROTOL, V27, P14, DOI 10.1097/01.mao.0000181181.47495.a0; Khalil Hisham S, 2003, BMC Ear Nose Throat Disord, V3, P1, DOI 10.1186/1472-6815-3-1; MER SB, 1967, ARCHIV OTOLARYNGOL, V85, P387; Nogueira JF, 2011, BRAZ J OTORHINOLAR, V77, P721, DOI 10.1590/S1808-86942011000600008; Rehl RM, 2012, ENT-EAR NOSE THROAT, V91, P527, DOI 10.1177/014556131209101208; Sade J, 2000, ANN OTO RHINOL LARYN, V109, P372, DOI 10.1177/000348940010900406; Tarabichi M, 1999, ANN OTO RHINOL LARYN, V108, P39, DOI 10.1177/000348949910800106; Tarabichi M, 2013, OTOLARYNG CLIN N AM, V46, P107, DOI 10.1016/j.otc.2012.10.001	12	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191712	10.1371/journal.pone.0191712	http://dx.doi.org/10.1371/journal.pone.0191712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370257	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600084
J	Rossmann, C; Nusshold, C; Paar, M; Ledinski, G; Tafeit, E; Koestenberger, M; Bernhart, EM; Sattler, W; Cvirn, G; Hallstrom, S				Rossmann, Christine; Nusshold, Christoph; Paar, Margret; Ledinski, Gerhard; Tafeit, Erwin; Koestenberger, Martin; Bernhart, Eva Maria; Sattler, Wolfgang; Cvirn, Gerhard; Hallstroem, Seth			Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA. hy926 cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ISCHEMIA-REPERFUSION INJURY; HUMAN ENDOTHELIAL-CELLS; LUNG EPITHELIAL-CELLS; SERUM-LIPOPROTEINS; N-ACETYLCYSTEINE; NADPH OXIDASE; KAPPA-B; COPPER; ATHEROSCLEROSIS	Background Ethyl pyruvate (EP) exerts anti-inflammatory and anti-oxidative properties. The aim of our study was to investigate whether EP is capable of inhibiting the oxidation of LDL, a crucial step in atherogenesis. Additionally, we examined whether EP attenuates the cytotoxic effects of highly oxidized LDL in the human vascular endothelial cell line EA. hy926. Methods Native LDL (nLDL) was oxidized using Cu2+ ions in the presence of increasing amounts of EP. The degree of LDL oxidation was quantified by measuring lipid hydroperoxide (LPO) and malondialdehyde (MDA) concentrations, relative electrophoretic mobilities (REMs), and oxidation-specific immune epitopes. The cytotoxicity of these oxLDLs on EA. hy926 cells was assessed by measuring cell viability and superoxide levels. Furthermore, the cytotoxicity of highly oxidized LDL on EA. hy926 cells under increasing concentrations of EP in the media was assessed including measurements of high energy phosphates (ATP). Results Oxidation of nLDL using Cu2+ ions was remarkably inhibited by EP in a concentration-dependent manner, reflected by decreased levels of LPO, MDA, REM, oxidation-specific epitopes, and diminished cytotoxicity of the obtained oxLDLs in EA. hy926 cells. Furthermore, the cytotoxicity of highly oxidized LDL on EA. hy926 cells was remarkably attenuated by EP added to the media in a concentration-dependent manner reflected by a decrease in superoxide and an increase in viability and ATP levels. Conclusions EP has the potential for an anti-atherosclerotic drug by attenuating both, the oxidation of LDL and the cytotoxic effect of (already formed) oxLDL in EA. hy926 cells. Chronic administration of EP might be beneficial to impede the development of atherosclerotic lesions.	[Rossmann, Christine; Nusshold, Christoph; Paar, Margret; Ledinski, Gerhard; Tafeit, Erwin; Cvirn, Gerhard; Hallstroem, Seth] Med Univ Graz, Inst Physiol Chem, Graz, Austria; [Koestenberger, Martin] Med Univ Graz, Dept Pediat, Graz, Austria; [Bernhart, Eva Maria; Sattler, Wolfgang] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Cvirn, G (corresponding author), Med Univ Graz, Inst Physiol Chem, Graz, Austria.	gerhard.cvirn@medunigraz.at	Koestenberger, Martin/J-5008-2019	Koestenberger, Martin/0000-0003-1766-7859; Rossmann, Christine/0000-0002-1791-1981; Paar, Margret/0000-0001-5494-8890				BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Burkitt MJ, 2000, ARCH BIOCHEM BIOPHYS, V381, P253, DOI 10.1006/abbi.2000.1973; Burkitt MJ, 2001, ARCH BIOCHEM BIOPHYS, V394, P117, DOI 10.1006/abbi.2001.2509; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; ELSAADANI M, 1989, J LIPID RES, V30, P627; EMEIS JJ, 1988, BLOOD, V71, P1669; Epperly M, 2007, RADIAT RES, V168, P552, DOI 10.1667/RR1009.1; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Fang R, 2016, ACTA NEUROCHIR, V158, P1069, DOI 10.1007/s00701-016-2795-3; HAMMER A, 1995, ARTERIOSCL THROM VAS, V15, P704, DOI 10.1161/01.ATV.15.5.704; He RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057732; Hegde KR, 2004, MOL CELL BIOCHEM, V262, P233, DOI 10.1023/B:MCBI.0000038220.47170.d0; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Horl G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148210; Hoerl G, 2014, CHEM PHYS LIPIDS, V184, P38, DOI 10.1016/j.chemphyslip.2014.09.004; Hu XR, 2012, MOL BIOL REP, V39, P227, DOI 10.1007/s11033-011-0730-5; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Johansson AS, 2008, BRIT J PHARMACOL, V154, P1318, DOI 10.1038/bjp.2008.201; Johansson AS, 2009, LIFE SCI, V84, P805, DOI 10.1016/j.lfs.2009.03.012; JURGENS G, 1995, CHEM PHYS LIPIDS, V77, P25, DOI 10.1016/0009-3084(95)02451-N; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kim SW, 2010, NEUROTOX RES, V17, P39, DOI 10.1007/s12640-009-9075-4; Kladna A, 2015, LUMINESCENCE, V30, P1153, DOI 10.1002/bio.2879; Laurindo FRM, 2008, METHOD ENZYMOL, V441, P237, DOI 10.1016/S0076-6879(08)01213-5; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P599, DOI 10.1189/jlb.0908578; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mizutani A, 2010, PULM PHARMACOL THER, V23, P308, DOI 10.1016/j.pupt.2010.03.002; Patel RP, 1999, FREE RADICAL RES, V30, P1, DOI 10.1080/10715769900300011; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; Riesbeck K, 1998, CLIN DIAGN LAB IMMUN, V5, P675, DOI 10.1128/CDLI.5.5.675-682.1998; Rueckschloss U, 2001, CIRCULATION, V104, P1767, DOI 10.1161/hc4001.097056; Sappington PL, 2003, J PHARMACOL EXP THER, V304, P464, DOI 10.1124/jpet.102.043182; Scarpato R, 2011, MUTAT RES-GEN TOX EN, V722, P69, DOI 10.1016/j.mrgentox.2011.03.015; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Stadlbauer V, 2009, AM J PHYSIOL-GASTR L, V296, pG15, DOI 10.1152/ajpgi.90512.2008; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Suha T, 2016, AM J EMERG MED, V34, P1217, DOI 10.1016/j.ajem.2016.03.032; Tawadrous ZS, 2002, SHOCK, V17, P473, DOI 10.1097/00024382-200206000-00006; Thomas SR, 2000, FREE RADICAL BIO MED, V28, P1795, DOI 10.1016/S0891-5849(00)00236-7; Toborek M, 1999, BASIC RES CARDIOL, V94, P295, DOI 10.1007/s003950050156; Turkmen S, 2016, AM J EMERG MED, V34, P1804, DOI 10.1016/j.ajem.2016.06.003; Wang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113983; Xiao HN, 2016, J CARDIOVASC PHARM, V67, P299, DOI 10.1097/FJC.0000000000000353; Xie LP, 2012, BRIT J PHARMACOL, V165, P754, DOI 10.1111/j.1476-5381.2011.01607.x; Zhang J, 2012, ONCOL REP, V27, P1511, DOI 10.3892/or.2012.1623; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Ziouzenkova O, 1998, FREE RADICAL BIO MED, V24, P607, DOI 10.1016/S0891-5849(97)00324-9	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191477	10.1371/journal.pone.0191477	http://dx.doi.org/10.1371/journal.pone.0191477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370236	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600057
J	Sakamoto, R; Yamakawa, T; Takahashi, K; Suzuki, J; Shinoda, MM; Sakamaki, K; Danno, H; Tsuchiya, H; Waseda, M; Takano, T; Minagawa, F; Takai, M; Masutani, T; Nagakura, J; Shigematsu, E; Ishikawa, M; Nakajima, S; Kadonosono, K; Terauchi, Y				Sakamoto, Rika; Yamakawa, Tadashi; Takahashi, Kenichiro; Suzuki, Jun; Shinoda, Minori Matsuura; Sakamaki, Kentaro; Danno, Hirosuke; Tsuchiya, Hirohisa; Waseda, Manabu; Takano, Tatsuro; Minagawa, Fuyuki; Takai, Masahiko; Masutani, Tomohide; Nagakura, Jo; Shigematsu, Erina; Ishikawa, Masashi; Nakajima, Shigeru; Kadonosono, Kazuaki; Terauchi, Yasuo			Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA)	PLOS ONE			English	Article							GLUCOSE-METABOLISM; DURATION; RISK; PREVALENCE; MORTALITY; SEVERITY; MELLITUS; ADULTS; APNEA; DISTURBANCES	Objectives Excessively short and long sleep durations are associated with type 2 diabetes, but there is limited information about the association between sleep quality and diabetes. Accordingly, the present study was performed to investigate this relationship. Materials and methods The subjects were 3249 patients with type 2 diabetes aged 20 years or older. Sleep quality was assessed by using the Pittsburgh Sleep Quality Index (PSQI). A higher global PSQI score indicates worse sleep quality, and a global PSQI score >5 differentiates poor sleepers from good sleepers. Results The mean global PSQI score was 5.94 +/- 3.33, and 47.6% of the patients had a score of 6 or higher. Regarding the components of the PSQI, the score was highest for sleep duration, followed by subjective sleep quality and then sleep latency in decreasing order. When the patients were assigned to HbA1c quartiles (<= 6.5%, 6.6 +/- 7.0%, 7.1 +/- 7.8%, and >= 7.9%), the top quartile had a significantly higher global PSQI score than the other quartiles. The top HbA1c quartile had a sleep duration of only 6.23 +/- 1.42 hours, which was significantly shorter than in the other quartiles. Also, sleep latency was 25.3 +/- 31.8 minutes in the top quartile, which was significantly longer (by approximately 20 minutes) than in the other quartiles. When analysis was performed with adjustment for age, gender, BMI, smoking, and other confounders, the global PSQI score was still significantly higher and sleep duration was shorter in the top HbA1c quartile (HbA1c >= 7.9%). Conclusions Japanese patients with type 2 diabetes were found to have poor subjective sleep quality independently of potential confounders, especially those with inadequate glycemic control. Impairment of sleep quality was associated with both increased sleep latency and a shorter duration of sleep.	[Sakamoto, Rika; Yamakawa, Tadashi; Takahashi, Kenichiro; Suzuki, Jun; Shinoda, Minori Matsuura; Masutani, Tomohide; Nagakura, Jo] Yokohama City Univ, Med Ctr, Dept Endocrinol & Diabet, Yokohama, Kanagawa, Japan; [Sakamaki, Kentaro] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan; [Danno, Hirosuke] Kanazawa Med Clin, Yokohama, Kanagawa, Japan; [Tsuchiya, Hirohisa] Yokosuka City Hosp, Dept Diabet, Yokosuka, Kanagawa, Japan; [Waseda, Manabu; Masutani, Tomohide] Waseda Med Clin, Fujisawa, Kanagawa, Japan; [Takano, Tatsuro] Fujisawa City Hosp, Dept Endocrinol & Diabet, Fujisawa, Kanagawa, Japan; [Minagawa, Fuyuki] Minagawa Med Clin, Yokohama, Kanagawa, Japan; [Takai, Masahiko; Masutani, Tomohide] Takai Med Clin, Kamakura, Kanagawa, Japan; [Nagakura, Jo] Yata Ikeda Clin, Mishima, Shizuoka, Japan; [Shigematsu, Erina] Yokohama Med Ctr, Dept Diabet & Endocrinol, Yokohama, Kanagawa, Japan; [Ishikawa, Masashi] Ishikawa Med Clin, Yokohama, Kanagawa, Japan; [Nakajima, Shigeru] Nakajima Med Clin, Yokosuka, Kanagawa, Japan; [Kadonosono, Kazuaki] Yokohama City Univ, Dept Ophthalmol, Med Ctr, Yokohama, Kanagawa, Japan; [Terauchi, Yasuo] Yokohama City Univ, Dept Endocrinol & Metab, Sch Med, Yokohama, Kanagawa, Japan	Yokohama City University; University of Tokyo; Yokohama City University; Yokohama City University	Yamakawa, T (corresponding author), Yokohama City Univ, Med Ctr, Dept Endocrinol & Diabet, Yokohama, Kanagawa, Japan.	yamakat@yokohama-cu.ac.jp	Terauchi, Yasuo/AAO-4347-2020					Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2011, SURVEY TIME USE LEIS; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bjorkelund C, 2005, DIABETES CARE, V28, P2739, DOI 10.2337/diacare.28.11.2739; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Buysse D J, 1989, Psychiatry Res, V28, P193; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Cohen D, 2006, DIABETES CARE, V29, P786, DOI 10.2337/diacare.29.04.06.dc05-1261; da Cunha MCB, 2008, REV LAT-AM ENFERM, V16, P850, DOI 10.1590/S0104-11692008000500009; Doi Y, 2001, PSYCHIAT CLIN NEUROS, V55, P213, DOI 10.1046/j.1440-1819.2001.00830.x; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Gooneratne NS, 2011, J SLEEP RES, V20, P434, DOI 10.1111/j.1365-2869.2010.00889.x; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; HAMMOND EC, 1964, AM J PUBLIC HEALTH N, V54, P11, DOI 10.2105/AJPH.54.1.11; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Hibi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39640; Kawakami N, 2004, DIABETES CARE, V27, P282, DOI 10.2337/diacare.27.1.282; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lee SWH, 2017, SLEEP MED REV, V31, P91, DOI 10.1016/j.smrv.2016.02.001; Lin CL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001621; Lou PA, 2015, DIABETES RES CLIN PR, V107, P69, DOI 10.1016/j.diabres.2014.09.060; Luyster FS, DIABETES ED, V37, P347; Merlino G, 2007, SLEEP, V30, P866, DOI 10.1093/sleep/30.7.866; Ministry of Health, 2007, LAB WELF NAT HLTH NU; Narisawa H, 2017, NEUROPSYCH DIS TREAT, V13, P1873, DOI 10.2147/NDT.S134814; Nilsson PM, 2004, DIABETES CARE, V27, P2464, DOI 10.2337/diacare.27.10.2464; Ogawa Y, 2003, SLEEP, V26, P986, DOI 10.1093/sleep/26.8.986; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Osonoi Y, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0026-1; Pamidi S, 2010, BEST PRACT RES CL EN, V24, P703, DOI 10.1016/j.beem.2010.08.009; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; SRIDHAR GR, 1994, DIABETES RES CLIN PR, V23, P183, DOI 10.1016/0168-8227(94)90103-1; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tahrani A, 2013, CURR OPIN PULM MED, V19, P631, DOI 10.1097/MCP.0b013e3283659da5; Tamakoshi A, 2004, SLEEP, V27, P51; Tan X, 2017, LANCET DIABETES ENDO; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041; Tsuneki H, 2016, ENDOCRINOLOGY, V157, P4146, DOI 10.1210/en.2016-1404; Tsunoda Tetsuji, 2016, J Clin Med Res, V8, P878; Unruh ML, 2008, J AM GERIATR SOC, V56, P1218, DOI 10.1111/j.1532-5415.2008.01755.x; Veauthier C, 2014, NEUROPSYCH DIS TREAT, V10, P131, DOI 10.2147/NDT.S58970; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; Wolff B, 2008, ATHEROSCLEROSIS, V196, P727, DOI 10.1016/j.atherosclerosis.2006.12.023; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Yoda K, 2015, PLOS ONE, V10	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191771	10.1371/journal.pone.0191771	http://dx.doi.org/10.1371/journal.pone.0191771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364963	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500075
J	Vareki, SM; Salim, KY; Danter, WR; Koropatnick, J				Vareki, Saman Maleki; Salim, Kowthar Y.; Danter, Wayne R.; Koropatnick, James			Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines	PLOS ONE			English	Article							LUNG-CANCER; PACLITAXEL; CARCINOMA; CYTOTOXICITY; CHEMOTHERAPY; GEMCITABINE; COMBINATION; CISPLATIN; SURVIVAL; PLUS	Emerging drug-resistance and drug-associated toxicities are two major factors limiting successful cancer therapy. Combinations of chemotherapeutic drugs have been used in the clinic to improve patient outcome. However, cancer cells can acquire resistance to drugs, alone or in combination. Resistant tumors can also exhibit cross-resistance to other chemotherapeutic agents, resulting in sub-optimal treatment and/or treatment failure. Therefore, developing novel oncology drugs that induce no or little acquired resistance and with a favorable safety profile is essential. We show here that combining COTI-2, a novel clinical stage agent, with multiple chemotherapeutic and targeted agents enhances the activity of these drugs in vitro and in vivo. Importantly, no overt toxicity was observed in the combination treatment groups in vivo. Furthermore, unlike the tested chemotherapeutic drugs, cancer cells did not develop resistance to COTI-2. Finally, some chemo-resistant tumor cell lines only showed mild cross-resistance to COTI-2 while most remained sensitive to it.	[Vareki, Saman Maleki; Koropatnick, James] Lawson Hlth Res Inst, Canc Res Lab Program, London, ON, Canada; [Salim, Kowthar Y.; Danter, Wayne R.] Cotinga Pharmaceut, London, ON, Canada; [Koropatnick, James] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Koropatnick, James] Western Univ, Dept Pathol, London, ON, Canada; [Koropatnick, James] Western Univ, Dept Oncol, London, ON, Canada; [Koropatnick, James] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Koropatnick, J (corresponding author), Lawson Hlth Res Inst, Canc Res Lab Program, London, ON, Canada.; Koropatnick, J (corresponding author), Western Univ, Dept Microbiol & Immunol, London, ON, Canada.; Koropatnick, J (corresponding author), Western Univ, Dept Pathol, London, ON, Canada.; Koropatnick, J (corresponding author), Western Univ, Dept Oncol, London, ON, Canada.; Koropatnick, J (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.	jkoropat@uwo.ca		Koropatnick, James/0000-0001-6144-5941	Cotinga Pharmaceuticals, Inc.; Critical Outcome Technologies Inc.	Cotinga Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd); Critical Outcome Technologies Inc.	Because this work was supported by unrestricted grants from Critical Outcome Technologies Inc. (now known as Cotinga Pharmaceuticals, Inc.) to James Koropatnick, and Critical Outcome Technologies Inc. provided support in the form of salaries for two of the co-authors [KYS, WRD], further explanation is required. KYS and WRD played no role in the study design, data collection, or decision to publish. However, KYS and WRD reviewed the draft manuscript generated solely by SMV (a research associate supervised solely by JK) and JK, and made suggestions to JK with respect to data analysis and text to be included in the final manuscript. JK accepted, accepted with modification, or rejected those suggestions at his sole and exclusive discretion. JK made those decisions purely on the basis of their verifiability, accuracy, conservative interpretation of results, and suitability for publication in this journal: there was no pressure from those authors or Critical Outcome Technologies, Inc., implicit or explicit, to include/exclude data, analysis, or interpretation of data.	Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Britten CD, 1999, CANCER RES, V59, P1049; Broxterman Henk J., 1995, Current Opinion in Oncology, V7, P532, DOI 10.1097/00001622-199511000-00011; Delaney C, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0007-9; Dempke W, 2000, ANTI-CANCER DRUG, V11, P225, DOI 10.1097/00001813-200004000-00001; Fennell DA, 2016, CANCER TREAT REV, V44, P42, DOI 10.1016/j.ctrv.2016.01.003; Ferguson PJ, 2009, CANCER LETT, V274, P279, DOI 10.1016/j.canlet.2008.09.021; Ferguson PJ, 1999, BRIT J PHARMACOL, V127, P1777, DOI 10.1038/sj.bjp.0702728; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Fox JL, 2016, BRIT J CANCER, V115, P5, DOI 10.1038/bjc.2016.111; GUPTA RS, 1988, BRIT J CANCER, V58, P441, DOI 10.1038/bjc.1988.237; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Hirsch FR, 2016, LANCET, V388, P1012, DOI 10.1016/S0140-6736(16)31473-8; Ismae GFV, 2008, CANCER TREAT REV, V34, P81, DOI 10.1016/j.ctrv.2007.08.001; Jain RK, 2012, J CLIN ONCOL, V30, P2684, DOI 10.1200/JCO.2011.36.4752; Kavallaris M, 2001, DRUG RESIST UPDATE, V4, P392, DOI 10.1054/drup.2002.0230; LAPOINTE H, 1992, OTOLARYNG HEAD NECK, V106, P149, DOI 10.1177/019459989210600205; Li CG, 2010, LUNG, V188, P359, DOI 10.1007/s00408-010-9258-z; Lopez JS, 2016, NAT REV CLIN ONCOL; Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609; Moxley KM, 2010, ONCOLOGIST, V15, P1026, DOI 10.1634/theoncologist.2010-0087; Petrelli F, 2015, EUR J CANCER, V51, P800, DOI 10.1016/j.ejca.2015.02.011; Raja FA, 2012, ANN ONCOL, V23, P118, DOI 10.1093/annonc/mds315; Salim KY, 2016, ONCOTARGET, V7, P41363, DOI 10.18632/oncotarget.9133; Salim KY, 2016, EORTC NCI AACR MOL T; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zanardi E, 2015, SEMIN ONCOL, V42, P887, DOI 10.1053/j.seminoncol.2015.09.029	30	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191766	10.1371/journal.pone.0191766	http://dx.doi.org/10.1371/journal.pone.0191766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364966	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500074
J	Kim, EK; Moon, S; Kim, DK; Zhang, XL; Kim, J				Kim, Eun Kyoung; Moon, Sook; Kim, Do Kyeong; Zhang, Xianglan; Kim, Jin			CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma	PLOS ONE			English	Article							STROMAL FIBROBLASTS; EPITHELIAL-CELLS; TUMOR STROMA; TGF-BETA; PROGRESSION; TUMORIGENESIS; GROWTH; METASTASIS; ACTIVATION; TRANSITION	Cancer-associated fibroblasts (CAFs) have emerged as one of the main factors related to cancer progression, however, the conversion mechanism of normal fibroblasts (NOFs) to CAFs has not been well elucidated. The aim of this study was to investigate the underlying mechanism of CAF transformation from NOFs in oral squamous cell carcinoma (OSCC). This study found that NOFs exposed to OSCC cells transformed to senescent cells. The cytokine antibody array showed the highest secretion levels of IL-6 and CXCL1 in NOFs co-cultured with OSCC cells. Despite that both IL-6 and CXCL1 induced the senescent phenotype of CAFs, CXCL1 secretion showed a cancer-specific response to transform NOFs into CAFs in OSCC, whereas IL-6 secretion was eventuated by common co-culture condition. Further, CXCL1 was released from NOFs co-cultured with OSCC cells, however, CXCL1 was undetectable in mono-cultured NOFs or co-cultured OSCC cells with NOFs. Taken together, this study demonstrates that CXCL1 can transform NOFs into senescent CAFs via an autocrine mechanism. These data might contribute to further understanding of CAFs and to development of a potential therapeutic approach targeting cancer cells-CAFs interactions.	[Kim, Eun Kyoung; Moon, Sook; Kim, Do Kyeong; Zhang, Xianglan; Kim, Jin] Yonsei Univ, Coll Dent, Dept Oral Pathol, Oral Canc Res Inst, Seoul, South Korea; [Moon, Sook] Sorabol Coll, Coll Nursing Healthcare, Dept Dent Hyg, Gyeongju, South Korea; [Zhang, Xianglan] Yanbian Univ Hosp, Dept Pathol, Yanji, Jilin, Peoples R China	Yonsei University; Yonsei University Health System; Yanbian University	Kim, J (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Pathol, Oral Canc Res Inst, Seoul, South Korea.	jink@yuhs.ac			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094027]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Priority Research Centers Program through the National Research Foundation of Korea (NRF)(http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology [2009-0094027]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JY, 2014, NEOPLASIA, V16, P928, DOI 10.1016/j.neo.2014.09.003; Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Chaudhri VK, 2013, MOL CANCER RES, V11, P579, DOI 10.1158/1541-7786.MCR-12-0437-T; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Illeperuma RP, 2015, INT J CANCER, V137, P2545, DOI 10.1002/ijc.29636; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Liu J, 2012, J CELL SCI, V125, P376, DOI 10.1242/jcs.089466; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Olumi AF, 1999, CANCER RES, V59, P5002; Opdenakker G, 2004, INT J DEV BIOL, V48, P519, DOI 10.1387/ijdb.041796go; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Son HK, 2015, J CELL BIOCHEM, V116, P2552, DOI 10.1002/jcb.25200; Taddei ML, 2014, MOL ONCOL, V8, P1729, DOI 10.1016/j.molonc.2014.07.009; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Zhang HF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.180; Zhou B, 2014, J ORAL PATHOL MED, V43, P585, DOI 10.1111/jop.12172	30	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0188847	10.1371/journal.pone.0188847	http://dx.doi.org/10.1371/journal.pone.0188847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360827	Green Published, gold, Green Submitted			2022-12-26	WOS:000423161800003
J	Datta, S; Seed, B				Datta, Sandip; Seed, Brian			Influence of multiplicative stochastic variation on translational elongation rates	PLOS ONE			English	Article							SINGLE-MOLECULE LEVEL; GENE-EXPRESSION; MESSENGER-RNA; ESCHERICHIA-COLI; CODON USAGE; PROTEIN EXPRESSION; EUKARYOTIC TRANSLATION; LOGNORMAL-DISTRIBUTION; BIOLOGICAL NOISE; RIBOSOME	Experimental data indicate that stochastic effects exerted at the level of translation contribute substantially to the variation in abundance of proteins expressed at moderate to high levels. This study analyzes the theoretical consequences of fluctuations in residue-specific elongation rates during translation. A simple analytical framework shows that rate variation during elongation gives rise to protein production rates that consist of sums of products of random variables. Simulations show that because the contribution to total variation of products of random variables greatly exceeds that of sums of random variables, the overall distribution exhibits approximately log-normal behavior. Empirical fits of the data can be satisfied by either sums of log-normal distributions, or sums of log-normal and log-logistic distributions. Elongation rate stochastic variation offers an accounting for a major component of biological variation. The analysis provided here highlights a probability distribution that is a natural extension of the Poisson and has broad applicability to many types of multiplicative noise processes.	[Datta, Sandip; Seed, Brian] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Seed, B (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	bseed@ccib.mgh.harvard.edu		Seed, Brian/0000-0002-9279-1940				Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aitken AC., 1939, P ROY SOC EDINB, V58, P161; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Baldi P, 2002, DNA MICROARRAYS GENE; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beaulieu NC, 2004, IEEE T VEH TECHNOL, V53, P479, DOI 10.1109/TVT.2004.823494; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Boehm AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-214; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chou T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198101; Chou T, 2003, BIOPHYS J, V85, P755, DOI 10.1016/S0006-3495(03)74518-4; CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DE BOOR C., 2005, SURV APPROX THEORY, V1, P46; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feller W., 1968, INTRO PROBABILITY TH, V1; Feller W., 2008, INTRO PROBABILITY TH, V2; Fenton LF., 1960, IRE T COMMUN SYST, V8, P57, DOI [DOI 10.1109/TCOM.1960.1097606, 10.1109/TCOM.1960.1097606]; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; HEYDE CC, 1963, J ROY STAT SOC B, V25, P392; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jung K., 2005, REVSTAT-STAT J, V3, P99; Jung K, 2006, REVSTAT-STAT J, V4, P67; Kahan W, 1974, COURSE NOTES A UNPUB, V228A; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Laidler K. J., 1987, CHEM KINETICS; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PHILIPPS GR, 1965, NATURE, V205, P567, DOI 10.1038/205567a0; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Rajkowitsch L, 2004, J MOL BIOL, V335, P71, DOI 10.1016/j.jmb.2003.10.049; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SCHWARTZ SC, 1982, AT&T TECH J, V61, P1441, DOI 10.1002/j.1538-7305.1982.tb04353.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shaw LB, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021910; Shiku H, 2010, FEBS LETT, V584, P4000, DOI 10.1016/j.febslet.2010.08.008; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	65	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191152	10.1371/journal.pone.0191152	http://dx.doi.org/10.1371/journal.pone.0191152			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351322	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300052
J	Spoorenberg, SLW; Wynia, K; Uittenbroek, RJ; Kremer, HPH; Reijneveld, SA				Spoorenberg, Sophie L. W.; Wynia, Klaske; Uittenbroek, Ronald J.; Kremer, Hubertus P. H.; Reijneveld, Sijmen A.			Effects of a population-based, person-centred and integrated care service on health, wellbeing and self-management of community-living older adults: A randomised controlled trial on Embrace	PLOS ONE			English	Article							QUALITY-OF-LIFE; AGING IN-PLACE; ELDERLY-PEOPLE; PERCEIVED CONTROL; CHRONIC ILLNESS; HOME VISITS; MODEL; OUTCOMES; COMPLEX; FRAILTY	Objective To evaluate the effects of the population-based, person-centred and integrated care service 'Embrace' at twelve months on three domains comprising health, wellbeing and self-management among community-living older people. Methods Embrace supports older adults to age in place. A multidisciplinary team provides care and support, with intensity depending on the older adults' risk profile. A randomised controlled trial was conducted in fifteen general practices in the Netherlands. Older adults (>= 75 years) were included and stratified into three risk profiles: Robust, Frail and Complex care needs, and randomised to Embrace or care as usual (CAU). Outcomes were recorded in three domains. The EuroQol-5D-3L and visual analogue scale, INTERMED for the Elderly Self-Assessment, Groningen Frailty Indicator and Katz-15 were used for the domain 'Health.' The Groningen Well-being Indicator and two quality of life questions measured 'Wellbeing.' The Self-Management Ability Scale and Partners in Health scale for older adults (PIH-OA) were used for 'Self-management.' Primary and secondary outcome measurements differed per risk profile. Data were analysed with multilevel mixed-model techniques using intention-to-treat and complete case analyses, for the whole sample and per risk profile. Results 1456 eligible older adults participated (49%) and were randomized to Embrace (n(T0) = 747, n(T1) = 570, mean age 80.6 years (SD 4.5), 54.2% female) and CAU (n(T0) = 709, n (T1) = 561, mean age 80.8 years (SD 4.7), 55.6% female). Embrace participants showed a greater-but clinically irrelevant-improvement in self-management (PIH-OA Knowledge subscale effect size [ES] = 0.14), and a greater-but clinically relevant-deterioration in health (ADL ES = 0.10; physical ADL ES = 0.13) compared to CAU. No differences in change in wellbeing were observed. This picture was also found in the risk profiles. Complete case analyses showed comparable results. Conclusions This study found no clear benefits to receiving person-centred and integrated care for twelve months for the domains of health, wellbeing and self-management in community-living older adults.	[Spoorenberg, Sophie L. W.; Wynia, Klaske; Uittenbroek, Ronald J.; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Wynia, Klaske; Kremer, Hubertus P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen	Spoorenberg, SLW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands.	s.l.w.spoorenberg@umcg.nl		Reijneveld, Sijmen/0000-0002-1206-7523	Netherlands Organisation for Health Research and Development (ZonMw) [314010201]; Dutch Healthcare Authority (NZa) [300-1021]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Healthcare Authority (NZa)	The Embrace study was funded by the Netherlands Organisation for Health Research and Development (ZonMw: grant number 314010201; http://www.zonmw.nl). The health care professionals involved are funded by the Dutch Healthcare Authority (NZa: file number 300-1021; http://www.nza.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Battersby MW., 2003, AUSTR J PRIM HLTH, V9, P41, DOI [10.1071/PY03022, DOI 10.1071/PY03022]; Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Beland F, 2006, J GERONTOL A-BIOL, V61, P367, DOI 10.1093/gerona/61.4.367; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bjornberg A, 2015, EURO HLTH CONSUMER I; Bleijenberg N, 2016, J AM GERIATR SOC, V64, P1779, DOI 10.1111/jgs.14325; Boult C, 2013, J GEN INTERN MED, V28, P612, DOI 10.1007/s11606-012-2287-y; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chen YX, 2014, J SOC PERS RELAT, V31, P141, DOI 10.1177/0265407513488728; Claassens L, 2014, J AGING STUD, V31, P159, DOI 10.1016/j.jaging.2014.09.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Devlin NJ, 2007, EQ 5D VALUE SETS INV, DOI 10.1007/1-4020-5511-0; Eklund K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-76; GUSTAFSSON M, 2013, BMC HLTH SERV RES, V13; Hammar Teija, 2007, Int J Integr Care, V7, pe29; Haywood KL, 2005, J EVAL CLIN PRACT, V11, P315, DOI 10.1111/j.1365-2753.2005.00538.x; Hoogendijk EO, 2016, EUR J INTERN MED, V28, P43, DOI 10.1016/j.ejim.2015.10.023; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Kang M, 2008, J ATHL TRAINING, V43, P215, DOI 10.4085/1062-6050-43.2.215; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Laan W, 2014, J NUTR HEALTH AGING, V18, P848, DOI [10.1007/s12603-014-0558-5, 10.1007/s12603-014-0479-3]; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lin JS, 2012, J AM GERIATR SOC, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Lofqvist C, 2013, GERONTOLOGIST, V53, P919, DOI 10.1093/geront/gnt034; Metzelthin SF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5264; Middel B, 2001, J EVAL CLIN PRACT, V7, P399, DOI 10.1046/j.1365-2753.2001.00298.x; Nolte E, 2008, CARING PEOPLE CHRONI, P222; Nolte E., 2008, CARING PEOPLE CHRONI, P64; Peters LL, 2013, J PSYCHOSOM RES, V74, P518, DOI 10.1016/j.jpsychores.2013.02.003; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Polit DF, 2010, RES NURS HEALTH, V33, P355, DOI 10.1002/nur.20386; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Schols J M G A, 2004, J Am Med Dir Assoc, V5, P207, DOI 10.1097/01.JAM.0000123031.43619.60; Schuurmans H, 2005, QUAL LIFE RES, V14, P2215, DOI 10.1007/s11136-005-8166-9; Singh D, 2006, IMPROVING CARE PEOPL; Sixsmith J, 2014, SOC SCI MED, V106, P1, DOI 10.1016/j.socscimed.2014.01.006; Spoorenberg SLW, 2015, DISABIL REHABIL, V37, P2337, DOI 10.3109/09638288.2015.1024337; Spoorenberg SLW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137803; Spoorenberg SLW, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-62; Steverink N, 2001, GERONTOLOGIST, V41, P236; Steverink N., SELF MANAGEMENT ABIL; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Tappenden P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16200; Toseland RW, 1997, GERONTOLOGIST, V37, P324, DOI 10.1093/geront/37.3.324; Uittenbroek RJ, 2016, J GEN INTERN MED; Uittenbroek RJ, 2016, HEALTH EXPECT, V19, P962, DOI 10.1111/hex.12391; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; Veldman K, HLTH EXPECT; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wiles JL, 2012, GERONTOLOGIST, V52, P357, DOI 10.1093/geront/gnr098; Wolinsky FD, 2003, J GERONTOL B-PSYCHOL, V58, pS212, DOI 10.1093/geronb/58.4.S212; You EC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-395	65	30	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190751	10.1371/journal.pone.0190751	http://dx.doi.org/10.1371/journal.pone.0190751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351295	gold, Green Submitted, Green Published			2022-12-26	WOS:000422911300023
J	Yakabe, M; Ogawa, S; Ota, H; Iijima, K; Eto, M; Ouchi, Y; Akishita, M				Yakabe, Mitsutaka; Ogawa, Sumito; Ota, Hidetaka; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi; Akishita, Masahiro			Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy	PLOS ONE			English	Article							HYDROXY-BETA-METHYLBUTYRATE; UBIQUITIN LIGASES; GENE-EXPRESSION; SATELLITE CELLS; AGED RATS; IMMOBILIZATION; RECOVERY; MURF1; ATROGIN-1; RECEPTOR	Background Interleukin-6 (IL-6) is an inflammatory cytokine. Whether systemic IL-6 affects atrogene expression and disuse-induced skeletal muscle atrophy is unclear. Methods Tail-suspended mice were used as a disuse-induced muscle atrophy model. We administered anti-mouse IL-6 receptor antibody, beta-hydroxy-beta-methylbutyrate (HMB) and vitamin D to the mice and examined the effects on atrogene expression and muscle atrophy. Results Serum IL-6 levels were elevated in the mice. Inhibition of IL-6 receptor suppressed muscle RING finger 1 (MuRF1) expression and prevented muscle atrophy. HMB and vitamin D inhibited the serum IL-6 surge, downregulated the expression of MuRF1 and atrogin-1 in the soleus muscle, and ameliorated atrophy in the mice. Conclusion Systemic IL-6 affects MuRF1 expression and disuse-induced muscle atrophy.	[Yakabe, Mitsutaka; Ogawa, Sumito; Ota, Hidetaka; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Minato Ku, Tokyo, Japan	University of Tokyo; Toranomon Hospital	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	suogawa-tky@umin.ac.jp						AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baptista IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076752; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Choi M, 2013, CYTOKINE, V63, P27, DOI 10.1016/j.cyto.2013.03.018; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Deever DB, 2002, ACTA ASTRONAUT, V50, P445; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayakawa N, 2015, BIOMED RES-TOKYO, V36, P71, DOI 10.2220/biomedres.36.71; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kraemer WJ, 2015, J AM COLL NUTR, V34, P91, DOI 10.1080/07315724.2014.938790; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; Mitsutaka Y, 2015, BIOMEDICAL SCI, V1, P1, DOI DOI 10.11648/J.RNAT.20150101.11; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Noh KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102947; Okamoto T, 2011, J PHYSIOL SCI, V61, P537, DOI 10.1007/s12576-011-0175-6; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Russ DW, 2015, APPL PHYSIOL NUTR ME, V40, P1294, DOI 10.1139/apnm-2015-0391; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Somody L, 1998, EUR J APPL PHYSIOL, V78, P296, DOI 10.1007/s004210050423; Tando T, 2016, J BIOL CHEM, V291, P12184, DOI 10.1074/jbc.M115.680579; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wagatsuma A, 2008, PHYSIOL RES, V57, P613, DOI 10.33549/physiolres.931288; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	54	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191318	10.1371/journal.pone.0191318	http://dx.doi.org/10.1371/journal.pone.0191318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351340	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300071
J	Flo, V; Bosch, J; Arnan, X; Primante, C; Gonzalez, AMM; Barril-Graells, H; Rodrigo, A				Flo, Victor; Bosch, Jordi; Arnan, Xavier; Primante, Clara; Martin Gonzalez, Ana M.; Barril-Graells, Helena; Rodrigo, Anselm			Yearly fluctuations of flower landscape in a Mediterranean scrubland: Consequences for floral resource availability	PLOS ONE			English	Article							POLLINATOR VISITATION RATE; CLIMATE-CHANGE; POPULATION-SIZE; EMERGENCE TIME; SEED SET; PHENOLOGY; DIVERSITY; HYMENOPTERA; TEMPERATURE; COMPETITION	Species flower production and flowering phenology vary from year to year due to extrinsic factors. Inter-annual variability in flowering patterns may have important consequences for attractiveness to pollinators, and ultimately, plant reproductive output. To understand the consequences of flowering pattern variability, a community approach is necessary because pollinator flower choice is highly dependent on flower context. Our objectives were: 1) To quantify yearly variability in flower density and phenology; 2) To evaluate whether changes in flowering patterns result in significant changes in pollen/nectar composition. We monitored weekly flowering patterns in a Mediterranean scrubland community (23 species) over 8 years. Floral resource availability was estimated based on field measures of pollen and nectar production per flower. We analysed inter-annual variation in flowering phenology (duration and date of peak bloom) and flower production, and inter-annual and monthly variability in flower, pollen and nectar species composition. We also investigated potential phylogenetic effects on inter-annual variability of flowering patterns. We found dramatic variation in yearly flower production both at the species and community levels. There was also substantial variation in flowering phenology. Importantly, yearly fluctuations were far from synchronous across species, and resulted in significant changes in floral resources availability and composition at the community level. Changes were especially pronounced late in the season, at a time when flowers are scarce and pollinator visitation rates are particularly high. We discuss the consequences of our findings for pollinator visitation and plant reproductive success in the current scenario of climate change.	[Flo, Victor; Bosch, Jordi; Arnan, Xavier; Primante, Clara; Martin Gonzalez, Ana M.; Barril-Graells, Helena; Rodrigo, Anselm] CREAF, Ctr Ecol Res & Forestry Applicat, Campus UAB, Bellaterra, Spain; [Martin Gonzalez, Ana M.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Univ Pk, Copenhagen O, Denmark; [Rodrigo, Anselm] Autonomous Univ Barcelona, Ecol Unit, Bellaterra, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Copenhagen; Autonomous University of Barcelona	Flo, V (corresponding author), CREAF, Ctr Ecol Res & Forestry Applicat, Campus UAB, Bellaterra, Spain.	v.flo@creaf.uab.cat	Flo, Víctor/AAX-5065-2021; ramon, anna/O-1249-2019; Rodrigo, Anselm/AAH-1553-2022; Arnan, Xavier/N-7829-2013; Gonzalez, Ana M. Martin/A-7827-2010; Rodrigo, Anselm/AFL-9450-2022; Bosch, Jordi/K-8752-2016	Flo, Víctor/0000-0003-1908-4577; Arnan, Xavier/0000-0002-9904-274X; Gonzalez, Ana M. Martin/0000-0001-9429-7180; Bosch, Jordi/0000-0002-8088-9457; Rodrigo, Anselm/0000-0001-6341-0363	Spanish MICINN [CGL2005-00491, CSD2008-0040, CGL2009-12646]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Spanish MICINN supported this study through projects CGL2005-00491, CSD2008-0040 and CGL2009-12646.	Albrectsen BR, 2008, OIKOS, V117, P473, DOI 10.1111/j.2008.0030-1299.16381.x; Aldridge G, 2011, J ECOL, V99, P905, DOI 10.1111/j.1365-2745.2011.01826.x; Arnan X, 2014, BOT J LINN SOC, V175, P395, DOI 10.1111/boj.12173; ARROYO J, 1990, Lagascalia, V16, P25; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bell JM, 2005, ECOLOGY, V86, P762, DOI 10.1890/04-0694; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Bruckman D, 2014, OECOLOGIA, V176, P465, DOI 10.1007/s00442-014-3023-6; Cam W, 2012, PHYLOMATIC V3; CaraDonna PJ, 2014, P NATL ACAD SCI USA, V111, P4916, DOI 10.1073/pnas.1323073111; Chen Y, 2017, J ELECTR COMPUT ENG, V2017, P1, DOI 10.1155/2017/9547869; Crimmins TM, 2010, J ECOL, V98, P1042, DOI 10.1111/j.1365-2745.2010.01696.x; Diekmann M, 1996, CAN J BOT, V74, P528, DOI 10.1139/b96-067; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Ebeling A, 2011, BASIC APPL ECOL, V12, P300, DOI 10.1016/j.baae.2011.04.005; Engel EC, 2003, AM J BOT, V90, P1612, DOI 10.3732/ajb.90.11.1612; Filella I, 2013, SCI REP-UK, V3, DOI 10.1038/srep03434; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez JM, 1999, ECOLOGY, V80, P796, DOI 10.1890/0012-9658(1999)080[0796:GVSITP]2.0.CO;2; Goodell K, 2003, OECOLOGIA, V134, P518, DOI 10.1007/s00442-002-1159-2; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; HERRERA C M, 1987, Anales del Jardin Botanico de Madrid, V44, P49; Hoerling M, 2012, J CLIMATE, V25, P2146, DOI 10.1175/JCLI-D-11-00296.1; Inouye DW, 2003, AM J BOT, V90, P905, DOI 10.3732/ajb.90.6.905; Karron JD, 2006, AM J BOT, V93, P1306, DOI 10.3732/ajb.93.9.1306; Khanduri VP, 2013, SCI WORLD J, DOI 10.1155/2013/350157; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Law B, 2000, AUSTRAL ECOL, V25, P160, DOI 10.1111/j.1442-9993.2000.tb00016.x; Lazaro A, 2013, OECOLOGIA, V173, P881, DOI 10.1007/s00442-013-2652-5; Lazaro A, 2010, AM J BOT, V97, P760, DOI 10.3732/ajb.0900263; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; Gonzalez AMM, 2012, OIKOS, V121, P2001, DOI 10.1111/j.1600-0706.2012.20279.x; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Ohashi K, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P274, DOI 10.1017/CBO9780511542268.015; Oksanen AJ, 2014, PACKAGE VEGAN; Olsen KM, 1997, OECOLOGIA, V109, P114, DOI [10.1007/s004420050065, 10.1007/PL00008811]; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; PETANIDOU T, 1995, AM J BOT, V82, P607, DOI 10.2307/2445419; Petanidou T, 2014, ACTA OECOL, V59, P104, DOI 10.1016/j.actao.2014.06.001; Peterson JH, 2006, ENVIRON ENTOMOL, V35, P1404, DOI 10.1603/0046-225X(2006)35[1404:IORLOS]2.0.CO;2; Petraglia A, 2013, PLANT ECOL DIVERS, V6, P475, DOI 10.1080/17550874.2013.795628; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Rafferty NE, 2013, ECOL EVOL, V3, P3183, DOI 10.1002/ece3.668; Rathcke B., 1983, P305; Revell MLJ, 2016, PACKAGE PHYTOOLS; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Sardans J, 2005, ENVIRON EXP BOT, V53, P1, DOI 10.1016/j.envexpbot.2004.02.007; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Schmid B, 2016, ECOGRAPHY, V39, P619, DOI 10.1111/ecog.01621; SCHMITT J, 1980, EVOLUTION, V34, P934, DOI 10.1111/j.1558-5646.1980.tb04031.x; Seidelmann K, 2006, BEHAV ECOL, V17, P839, DOI 10.1093/beheco/arl017; Sgolastra F, 2010, J INSECT PHYSIOL, V56, P185, DOI 10.1016/j.jinsphys.2009.10.001; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; WALKER AK, 1974, CROP SCI, V14, P235, DOI 10.2135/cropsci1974.0011183X001400020020x; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x; Zywiec M, 2012, OECOLOGIA, V169, P713, DOI 10.1007/s00442-011-2232-5	75	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191268	10.1371/journal.pone.0191268	http://dx.doi.org/10.1371/journal.pone.0191268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346453	gold, Green Published, Green Submitted			2022-12-26	WOS:000422749500039
J	Ramirez-Moya, J; Wert-Lamas, L; Santisteban, P				Ramirez-Moya, Julia; Wert-Lamas, Leon; Santisteban, Pilar			MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN	ONCOGENE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; MOLECULAR PATHOGENESIS; GENETIC ALTERATIONS; EXPRESSION; MIR-146B; PROTEIN; MUTATIONS; STAT3	Recent studies have shown that miR-146b is the most upregulated microRNA in thyroid cancer and has a central role in cancer progression through mechanisms that remain largely unidentified. As phosphoinositide 3-kinase/protein kinase-B (PI3K/AKT) signaling is a fundamental oncogenic driver in many thyroid cancers, we explored a potential role for miR-146b and its target genes in PI3K/AKT activation. Among the predicted target genes of miR-146b, we found the tumor-suppressor phosphatase and tensin homolog (PTEN). Constitutive overexpression of miR-146b in thyroid epithelial cell lines significantly decreased PTEN mRNA and protein levels by direct binding to its 3'-UTR. This was accompanied by PI3K/AKT hyperactivation, leading to the exclusion of FOXO1 and p27 from the nucleus and a corresponding increase in cellular proliferation. Moreover, miR-146b overexpression led to protection from apoptosis and an increased migration and invasion potential, regulating genes involved in epithelial-mesenchymal transition. Notably, with the single exception of E-cadherin expression, all of these outcomes could be reversed by PTEN coexpression. Further analysis showed that miR-146b directly inhibits E-cadherin expression through binding to its 3'-UTR. Interestingly, miR-146b inhibition in human thyroid tumor xenografts, using a synthetic and clinically amenable molecule, blocked tumor growth when delivered intratumorally. Importantly, this inhibition increased PTEN protein levels. In conclusion, our data define a novel mechanism of PI3K/AKT hyperactivation and outline a regulatory role for miR-146b in suppressing PTEN expression, a frequent observation in thyroid cancer. Both events are related to a more aggressive tumoral phenotype. Targeting miR-146b therefore represents a promising therapeutic strategy for the treatment of this disease.	[Ramirez-Moya, Julia; Wert-Lamas, Leon; Santisteban, Pilar] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Ramirez-Moya, Julia; Wert-Lamas, Leon; Santisteban, Pilar] Univ Autonoma Madrid, CSIC, Madrid, Spain; [Santisteban, Pilar] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III	Santisteban, P (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Madrid, Spain.; Santisteban, P (corresponding author), Univ Autonoma Madrid, CSIC, Madrid, Spain.; Santisteban, P (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.	psantisteban@iib.uam.es	Wert-Lamas, Leon/ABD-2880-2020; Ramírez-Moya, Julia/B-9104-2018; Santisteban, Pilar/E-7829-2016	Ramírez-Moya, Julia/0000-0002-2458-2186; Santisteban, Pilar/0000-0002-2758-796X	Ministerio de Economia y Competitividad (MINECO) of Spain [SAF2013-44709-R, SAF2016-75531-R]; Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER) [RD12/0036/0030]; Fundacion Espanola contra el Cancer [GCB14142311CRES]; Ministerio de Educacion Cultura y Deporte; MEC; ISCIII (Spain) [PI14/01980]	Ministerio de Economia y Competitividad (MINECO) of Spain(Spanish Government); Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER); Fundacion Espanola contra el Cancer; Ministerio de Educacion Cultura y Deporte(Spanish Government); MEC(European Commission); ISCIII (Spain)(Instituto de Salud Carlos III)	We are grateful to Andrea Martinez-Cano for her technical assistance, Javier Perez for the artwork and Dr Kenneth McCreath for helpful comments on the manuscript. We thank Dr Jeronimo Blanco (Catalonian Institute for Advance Chemistry-CSIC) and Dr Eugenia Mato (Institut de Reserca de l'Hospital de la Santa Creu i Sant Pau) Barcelona (Spain) for gifting the CMV-Firefly luc-IRES-EGFP and Cal62-Luc cells, respectively. We also thank the Histology Facility at CNB-CSIC for the histological preparation of biological samples. This work was supported by grants SAF2013-44709-R and SAF2016-75531-R from the Ministerio de Economia y Competitividad (MINECO) of Spain, RD12/0036/0030 from Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER), and GCB14142311CRES from Fundacion Espanola contra el Cancer. JR-M holds a FPU fellowship from Ministerio de Educacion Cultura y Deporte. LW-L was funded by an FPI fellowship from MEC and is currently an investigator of the project PI14/01980 from ISCIII (Spain).	Acibucu F, 2014, EXP CLIN ENDOCR DIAB, V122, P137, DOI 10.1055/s-0034-1367025; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Burger ML, 2014, BLOOD, V123, P4089, DOI 10.1182/blood-2013-11-539411; Chou CK, 2016, J CLIN ENDOCR METAB, V101, P4357, DOI 10.1210/jc.2016-2276; Chou CK, 2013, J CLIN ENDOCR METAB, V98, pE196, DOI 10.1210/jc.2012-2666; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Deng XZ, 2015, CELL PHYSIOL BIOCHEM, V35, P71, DOI 10.1159/000369676; Dettmer M, 2013, THYROID, V23, P1383, DOI 10.1089/thy.2012.0632; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fahiminiya S, 2016, NEW ENGL J MED, V375, P2306, DOI 10.1056/NEJMc1613118; Fassina A, 2014, CANCER CYTOPATHOL, V122, P274, DOI 10.1002/cncy.21383; Frisk T, 2002, GENE CHROMOSOME CANC, V35, P74, DOI 10.1002/gcc.10098; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Fuziwara CS, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/743450; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Guigon CJ, 2009, ONCOGENE, V28, P509, DOI 10.1038/onc.2008.407; Hein AL, 2014, INT J ONCOL, V45, P1813, DOI 10.3892/ijo.2014.2614; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lim H, 2017, JAMA-J AM MED ASSOC, V317, P1338, DOI 10.1001/jama.2017.2719; Lima CR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2146-z; Liu CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36990; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu RY, 2017, JAMA ONCOL, V3, P202, DOI 10.1001/jamaoncol.2016.3288; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Medina DL, 1999, ENDOCRINOLOGY, V140, P87, DOI 10.1210/en.140.1.87; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Paes JE, 2008, ENDOCRIN METAB CLIN, V37, P375, DOI 10.1016/j.ecl.2008.01.001; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pirnia F, 2002, CELL DEATH DIFFER, V9, P905, DOI 10.1038/sj.cdd.4401062; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Riesco-Eizaguirre G, 2016, EUR J ENDOCRINOL, V175, pR203, DOI 10.1530/EJE-16-0202; Riesco-Eizaguirre G, 2015, CANCER RES, V75, P4119, DOI 10.1158/0008-5472.CAN-14-3547; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; Sastre-Perona A, 2016, ONCOTARGET, V7, P49435, DOI 10.18632/oncotarget.10356; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sosonkina N, 2014, CANCERS, V6, P526, DOI 10.3390/cancers6010526; Su XY, 2016, ONCOTARGETS THER, V9, P6965, DOI 10.2147/OTT.S116594; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wojtas B, 2014, MOL CELL ENDOCRINOL, V388, P1, DOI 10.1016/j.mce.2014.02.011; Xiang M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004497; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Xu B, 2017, THYROID, V27, P632, DOI 10.1089/thy.2016.0582; Yeager N, 2007, CANCER RES, V67, P959, DOI 10.1158/0008-5472.CAN-06-3524; Zaballos MA, 2013, MOL ENDOCRINOL, V27, P50, DOI 10.1210/me.2012-1032	62	63	64	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	25					3369	3383		10.1038/s41388-017-0088-9	http://dx.doi.org/10.1038/s41388-017-0088-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TC	29353884				2022-12-26	WOS:000436411300004
J	Akhter, MZ; Sharawat, SK; Kumar, V; Kochat, V; Equbal, Z; Ramakrishnan, M; Kumar, U; Mathur, S; Kumar, L; Mukhopadhyay, A				Akhter, Md Zahid; Sharawat, Surender K.; Kumar, Vikash; Kochat, Veena; Equbal, Zaffar; Ramakrishnan, Mallika; Kumar, Umesh; Mathur, Sandeep; Kumar, Lalit; Mukhopadhyay, Asok			Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype	ONCOGENE			English	Article							MARROW-DERIVED CELLS; STEM-CELLS; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; TUMOR PROGRESSION; BREAST-CANCER; THERAPY; CONTRIBUTE; EXOSOMES; CHEMORESISTANCE	Epithelial ovarian carcinoma (EOC) patients often acquire resistance against common chemotherapeutic drugs like paclitaxel and cisplatin. The mechanism responsible for the same is ambiguous. We have identified a putative drug-resistant tumour cell phenotype (EpCAM(+) CD45(+)) in the ascitic fluid of EOC patients, which appears to originate from the primary tumour. These cells represent the major tumour burden and are more drug resistant compared to EpCAM(+) tumour cells due to the over-expression of SIRT1, ABCA1 and BCL2 genes. We have found that the entire EpCAM(+) CD45+ population is highly invasive with signature mesenchymal gene expression and also consists of subpopulations of ovarian cancer stem cells (CD133(+) and CD117(+) CD44(+)). Additionally, we demonstrate that the EpCAM(+) CD45(+) tumour cells over-express major histocompatibility complex class I antigen, which enable them to evade the natural killer cell-mediated immune surveillance. Preliminary evidence obtained in OVCAR-5 cells suggests that exosomes, secreted by non-tumour cells of the ascitic fluid, play an important role in rendering drug resistance and invasive properties to the cancer cells. Identification of such aggressive tumour cells and deciphering their origin is important for designing better drug targets for EOC.	[Akhter, Md Zahid; Sharawat, Surender K.; Kumar, Vikash; Kochat, Veena; Equbal, Zaffar; Ramakrishnan, Mallika; Kumar, Umesh; Mathur, Sandeep; Kumar, Lalit; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi, India; [Mathur, Sandeep] All India Inst Med Sci, Dept Pathol, New Delhi, India; [Kumar, Lalit] All India Inst Med Sci, Dept Med Oncol, New Delhi, India; [Akhter, Md Zahid] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Sharawat, Surender K.] All India Inst Med Sci, Dept Med Oncol, New Delhi, India; [Kochat, Veena] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ramakrishnan, Mallika] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany; [Kumar, Umesh] Univ Delhi, Dept Biochem, Genom Facil, South Campus, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Texas System; UTMD Anderson Cancer Center; University of Delhi	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Stem Cell Biol Lab, New Delhi, India.	ashok@nii.ac.in	Kumar, Umesh/AAX-9989-2021; Kochat, Veena/AAX-1915-2021; Kumar, Umesh/AAQ-9159-2021; Akhter, Zahid/AAA-8410-2022	Kumar, Umesh/0000-0002-4715-7967; Akhter, Zahid/0000-0002-1602-3704; SHARAWAT, SURENDER K/0000-0001-6322-0586; Equbal, Zaffar/0000-0001-7791-1804	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	AM is grateful for the generous support provided by the Department of Biotechnology, Government of India to the Centre of Molecular Medicine, NII. We would like to thank Mr. Nila Ram and Mr. Ajay Sharma for acquiring confocal images. AM would like to thank Dr. Ayub Qadri, Scientist (NII, New Delhi), Prof. NK Mehra (AIIMS, New Delhi) and Dr. Awadhesh Pandit (NCBS, Bangalore) for valuable discussion in some parts of the study. Also, we are thankful to Dr. TR Santhosh Kumar (RGCB, Thiruvananthapuram, Kerala) for providing the OVCAR-5 cell line.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Ahmed N, 2013, J CELL BIOCHEM, V114, P21, DOI 10.1002/jcb.24317; Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Avital I, 2007, STEM CELLS, V25, P2903, DOI 10.1634/stemcells.2007-0409; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Baligar P, 2017, HEPATOLOGY, V65, P1319, DOI 10.1002/hep.29027; Baligar P, 2016, STEM CELLS, V34, P135, DOI 10.1002/stem.2210; Bamias A, 2007, GYNECOL ONCOL, V106, P75, DOI 10.1016/j.ygyno.2007.02.029; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Barker N, 2001, TRENDS MOL MED, V7, P535, DOI 10.1016/S1471-4914(01)02215-8; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Craveiro V, 2013, CANCER MED-US, V2, P751, DOI 10.1002/cam4.115; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Gubbels JAA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-11; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Kim Yonghyun, 2009, Int J Stem Cells, V2, P109; LARIZZA L, 1984, J EXP MED, V160, P1579, DOI 10.1084/jem.160.5.1579; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Li HX, 2014, ARCH GYNECOL OBSTET, V290, P1067, DOI 10.1007/s00404-014-3377-3; Liu CF, 2006, NEOPLASIA, V8, P716, DOI 10.1593/neo.06253; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matte I, 2012, AM J CANCER RES, V2, P566; Olumi AF, 1999, CANCER RES, V59, P5002; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Ozols RF, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2006.03.011; Paley PJ, 2001, CURR OPIN ONCOL, V13, P399, DOI 10.1097/00001622-200109000-00015; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Qian JL, 2016, ONCOL LETT, V11, P1738, DOI 10.3892/ol.2016.4150; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rousalova I, 2010, INT J ONCOL, V37, P1361, DOI 10.3892/ijo_00000788; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shain KH, 2015, ONCOGENE, V34, P4673, DOI 10.1038/onc.2014.403; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Wang RF, 2001, TRENDS IMMUNOL, V22, P269, DOI 10.1016/S1471-4906(01)01896-8; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	54	35	38	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2089	2103		10.1038/s41388-017-0106-y	http://dx.doi.org/10.1038/s41388-017-0106-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29379166				2022-12-26	WOS:000430589000002
J	Kaul, S; Mittal, SK; Roche, PA				Kaul, Sunil; Mittal, Sharad K.; Roche, Paul A.			A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; COMPLEXES; EXPRESSION; TRANSPORT; SELECTION; TURNOVER; SURFACE	Regulation of major histocompatibility complex class II (MHC-II) expression is important not only to maintain a diverse pool of MHC-II-peptide complexes but also to prevent development of autoimmunity. The membrane-associated RING-CH (March) E3 ubiquitin ligase March-I regulates ubiquitination and turnover of MHC-II-peptide complexes in resting dendritic cells (DCs) and B cells. However, activation of either cell type terminates March-I expression, thereby stabilizing MHC-II-peptide complexes. Despite March-I's important role in the biology of antigen-presenting cells (APCs), how expression of March-I mRNA is regulated remains unknown. We now show that both DCs and B cells possess a distinct isoform of March-I whose expression is regulated by a promoter located within the March-I gene. Using March-I promoter fragments to drive expression of GFP, we also identified a core promoter for expression of March-I in DCs and B cells, but not in fibroblasts, kidney cells, or epithelial cells, that contains regulatory regions that down-regulate March-I expression upon activation of DCs. Curiously, we found downstream sequence elements, present in the first coding exon of March-I in APCs, that confer regulation of March-I expression in activated APCs. In summary, our study identifies regulatory regions of the March-I gene that confer APC-specific expression and activation-induced modulation of March-I expression in DCs and B cells.	[Kaul, Sunil; Mittal, Sharad K.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mittal, Sharad K.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Roche, PA (corresponding author), NIH, Bldg 10,Rm 3N103, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011033, ZIABC009404] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health.	AIVASASHVILLI VA, 1983, FEBS LETT, V160, P124, DOI 10.1016/0014-5793(83)80950-8; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cho KJ, 2015, P NATL ACAD SCI USA, V112, P10449, DOI 10.1073/pnas.1507981112; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Lutzko C, 2003, J VIROL, V77, P7341, DOI 10.1128/JVI.77.13.7341-7351.2003; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Mittal SK, 2015, J BIOL CHEM, V290, P27158, DOI 10.1074/jbc.M115.682708; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729	30	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4478	4485		10.1074/jbc.RA118.001775	http://dx.doi.org/10.1074/jbc.RA118.001775			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378848	hybrid, Green Published			2022-12-26	WOS:000428204300019
J	Bird, C; Darling, KF; Russell, AD; Fehrenbacher, JS; Davis, CV; Free, A; Ngwenya, BT				Bird, Clare; Darling, Kate F.; Russell, Ann D.; Fehrenbacher, Jennifer S.; Davis, Catherine V.; Free, Andrew; Ngwenya, Bryne T.			16S rRNA gene metabarcoding and TEM reveals different ecological strategies within the genus Neogloboquadrina (planktonic foraminifer)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURES; SINGLE-CELL GENOMICS; SAN-PEDRO-BASIN; GLOBIGERINA-BULLOIDES; OCEAN ACIDIFICATION; MARINE SNOW; MIXOTROPHIC PROTISTS; GLOBAL DISTRIBUTION; ORBULINA-UNIVERSA; ALGAL SYMBIONTS	Uncovering the complexities of trophic and metabolic interactions among microorganisms is essential for the understanding of marine biogeochemical cycling and modelling climate driven ecosystem shifts. High-throughput DNA sequencing methods provide valuable tools for examining these complex interactions, although this remains challenging, as many microorganisms are difficult to isolate, identify and culture. We use two species of planktonic foraminifera from the climatically susceptible, palaeoceanographically important genus Neogloboquadrina, as ideal test microorganisms for the application of 16S rRNA gene metabarcoding. Neogloboquadrina dutertreiand Neogloboquadrina incompta were collected from the California Current and subjected to either 16S rRNA gene metabarcoding, fluorescence microscopy, or transmission electron microscopy (TEM) to investigate their species-specific trophic interactions and potential symbiotic associations. 53-99% of 16S rRNA gene sequences recovered from two specimens of N. dutertrei were assigned to a single operational taxonomic unit (OTU) from a chloroplast of the phylum Stramenopile. TEM observations confirmed the presence of numerous intact coccoid algae within the host cell, consistent with algal symbionts. Based on sequence data and observed ultrastructure, we taxonomically assign the putative algal symbionts to Pelagophyceae and not Chrysophyceae, as previously reported in this species. In addition, our data shows that N. dutertrei feeds on protists within particulate organic matter (POM), but not on bacteria as a major food source. In total contrast, of OTUs recovered from three N. incompta specimens, 83-95% were assigned to bacterial classes Alteromonadales and Vibrionales of the order Gammaproteo-bacteria. TEM demonstrates that these bacteria are a food source, not putative symbionts. Contrary to the current view that non-spinose foraminifera are predominantly herbivorous, neither N. dutertrei nor N. incompta contained significant numbers of phytoplankton OTUs. We present an alternative view of their trophic interactions and discuss these results within the context of modelling global planktonic foraminiferal abundances in response to high-latitude climate change.	[Bird, Clare; Darling, Kate F.; Ngwenya, Bryne T.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Darling, Kate F.] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Russell, Ann D.; Fehrenbacher, Jennifer S.; Davis, Catherine V.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Free, Andrew] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Fehrenbacher, Jennifer S.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Davis, Catherine V.] Univ South Carolina, Sch Earth Ocean & Environm, Columbia, SC USA	University of Edinburgh; University of St Andrews; University of California System; University of California Davis; University of Edinburgh; Oregon State University; University of South Carolina System; University of South Carolina Columbia	Bird, C (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	clare.bird@ed.ac.uk	Free, Andrew/AAX-2632-2020; Ngwenya, Bryne T/I-9740-2014	Ngwenya, Bryne T/0000-0001-7810-764X; Davis, Catherine/0000-0003-4279-5369; Bird, Clare/0000-0002-7500-5573; Free, Andrew/0000-0002-1787-4965	Natural Environmental Research Council; University of Edinburgh via the Daphne Jackson Trust; National Science Foundation [OCE-1261519]; Division Of Ocean Sciences [1261519] Funding Source: National Science Foundation	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Edinburgh via the Daphne Jackson Trust; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	CB was supported on a Daphne Jackson Fellowship sponsored by Natural Environmental Research Council (wm.nerc.ac.uk) and the University of Edinburgh via the Daphne Jackson Trust. Field collections were supported by the National Science Foundation (www.nsf.gov) grant number OCE-1261519 to ADR and JSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the referees for their constructive comments which have helped to improve this manuscript. This work was supported by NERC and the University of Edinburgh via a Daphne Jackson Fellowship awarded to Clare Bird. Field collections were supported by the NSF (grant number OCE-1251519). The authors would like to sincerely thank Barbel Honisch for collecting foraminifera for this study in July/Aug 2013. Thanks are also extended to Edinburgh Genomics and to Steve Mitchell and Dave Kelly of Edinburgh University for microscopy assistance. The authors acknowledge and thank the USC Wrigley Institute for Environmental Studies for seawater temperature data from the San Pedro Basin.	ANDERSEN RA, 1993, J PHYCOL, V29, P701, DOI 10.1111/j.0022-3646.1993.00701.x; ANDERSON OR, 1979, J MAR BIOL ASSOC UK, V59, P791, DOI 10.1017/S002531540004577X; Anderson OR, 1991, BIOL FORAMINIFERA; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Azetsu-Scott K, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005917; Barrows TT, 2005, QUATERNARY SCI REV, V24, P1017, DOI 10.1016/j.quascirev.2004.07.020; Be A. W. H, 1977, Micropaleontology, V23, P155, DOI 10.2307/1485330; Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; BE AWH, 1982, MAR BIOL, V70, P73, DOI 10.1007/BF00397298; BE AWH, 1983, MICROPALEONTOLOGY, V29, P310, DOI 10.2307/1485737; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Bemis BE, 2002, MAR MICROPALEONTOL, V46, P405, DOI 10.1016/S0377-8398(02)00083-X; Bird C, 2017, BIOGEOSCIENCES, V14, P901, DOI 10.5194/bg-14-901-2017; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen MT, 2005, QUATERNARY SCI REV, V24, P1049, DOI 10.1016/j.quascirev.2004.07.013; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; Cram JA, 2015, ISME J, V9, P563, DOI 10.1038/ismej.2014.153; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001189; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; Dawson SC, 2009, ENVIRON MICROBIOL, V11, P1627, DOI 10.1111/j.1462-2920.2009.01965.x; Decelle J, 2015, MOL ECOL RESOUR, V15, P1435, DOI 10.1111/1755-0998.12401; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FABER WW, 1988, J FORAMIN RES, V18, P334, DOI 10.2113/gsjfr.18.4.334; FEBVRE-CHEVALIER C, 1971, Protistologica, V7, P311; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Field DB, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000970; Fraile I, 2008, BIOGEOSCIENCES, V5, P891, DOI 10.5194/bg-5-891-2008; FUHRMAN JA, 1984, SCIENCE, V224, P1257, DOI 10.1126/science.224.4654.1257; Gast RJ, 2000, J PHYCOL, V36, P172, DOI 10.1046/j.1529-8817.2000.99133.x; GASTRICH MD, 1987, J PHYCOL, V23, P623, DOI 10.1111/j.1529-8817.1987.tb04215.x; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002; Hallock P, 1999, MODERN FORAMINIFERA, P123; Hart MB, 2002, GEOL SOC SPEC PUBL, V194, P115, DOI 10.1144/GSL.SP.2002.194.01.09; Hartmann M, 2012, P NATL ACAD SCI USA, V109, P5756, DOI 10.1073/pnas.1118179109; Hathorne EC, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001742; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Heinz P, 2005, MAR ECOL PROG SER, V304, P77, DOI 10.3354/meps304077; HEMLEBEN C, 1977, Journal of Foraminiferal Research, V7, P1; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Henderson GM, 2002, EARTH PLANET SC LETT, V203, P1, DOI 10.1016/S0012-821X(02)00809-9; Holligan PM, 1996, GLOB CHANGE BIOL, V2, P85, DOI 10.1111/j.1365-2486.1996.tb00053.x; Holzmann M, 1996, J FORAMIN RES, V26, P264, DOI 10.2113/gsjfr.26.3.264; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Iglesias-Rodriguez M., 2002, EOS T AM GEOPHYS UN, V83, P374; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479, DOI 10.4319/lo.2000.45.2.0479; Kopp C, 2015, MBIO HIGHWIRE, V5; KROON D, 1995, J FORAMIN RES, V25, P39, DOI 10.2113/gsjfr.25.1.39; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Leal MC, 2016, MAR GENOM, V29, P1, DOI 10.1016/j.margen.2016.02.003; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Lombard F, 2011, BIOGEOSCIENCES, V8, P853, DOI 10.5194/bg-8-853-2011; Lombard F, 2009, LIMNOL OCEANOGR, V54, P210, DOI 10.4319/lo.2009.54.1.0210; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Manno C, 2012, POLAR BIOL, V35, P1311, DOI 10.1007/s00300-012-1174-7; Martinez J, 1996, AQUAT MICROB ECOL, V10, P223, DOI 10.3354/ame010223; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; Mestre M, 2017, ISME J, V11, P999, DOI 10.1038/ismej.2016.166; Mitra A, 2014, BIOGEOSCIENCES, V11, P995, DOI 10.5194/bg-11-995-2014; Mitra A, 2016, PROTIST, V167, P106, DOI 10.1016/j.protis.2016.01.003; Moran MA, 2015, SCIENCE, V350, DOI 10.1126/science.aac8455; Murray J, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1; Nomaki H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00163; OBIS, DISTR ENV DAT REC PE; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Ploug H, 1999, MAR ECOL PROG SER, V179, P1, DOI 10.3354/meps179001; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Ray JL, 2016, MOL ECOL, V25, P5585, DOI 10.1111/mec.13844; Rebotim A, 2017, BIOGEOSCIENCES, V14, P827, DOI 10.5194/bg-14-827-2017; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Roy T, 2015, BIOGEOSCIENCES, V12, P2873, DOI 10.5194/bg-12-2873-2015; Sadekov AY, 2016, PALEOCEANOGRAPHY, V31, P1440, DOI 10.1002/2016PA002947; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SANDERS RW, 1991, J PROTOZOOL, V38, P76, DOI 10.1111/j.1550-7408.1991.tb04805.x; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sautter LR, 1991, PALEOCEANOGRAPHY, V6, P307, DOI 10.1029/91PA00385; SAUTTER LR, 1991, J FORAMIN RES, V21, P347, DOI 10.2113/gsjfr.21.4.347; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schiebel R., 2017, PLANKTIC FORAMINIFER, DOI DOI 10.1007/978-3-662-50297-6; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Souza CP, 2011, MAR BIOTECHNOL, V13, P823, DOI 10.1007/s10126-011-9388-1; Spero HJ, 1996, MAR MICROPALEONTOL, V28, P231, DOI 10.1016/0377-8398(96)00003-5; Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814; SPERO HJ, 1988, MAR BIOL, V99, P9, DOI 10.1007/BF00644972; SPERO HJ, 1987, J PHYCOL, V23, P307, DOI 10.1111/j.1529-8817.1987.tb04139.x; SPINDLER M, 1984, J FORAMIN RES, V14, P1, DOI 10.2113/gsjfr.14.4.237; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Tsujibo H, 2002, APPL ENVIRON MICROB, V68, P263, DOI 10.1128/AEM.68.1.263-270.2002; Tynan E, 2016, DEEP-SEA RES PT II, V127, P7, DOI 10.1016/j.dsr2.2016.01.001; Uhle ME, 1997, ORG GEOCHEM, V27, P103, DOI 10.1016/S0146-6380(97)00075-2; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Watkins JM, 1996, DEEP-SEA RES PT II, V43, P1257, DOI 10.1016/0967-0645(96)00008-2; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zhang HY, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2931-x; Zhang R, 2007, FEMS MICROBIOL ECOL, V61, P496, DOI 10.1111/j.1574-6941.2007.00353.x; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	124	25	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191653	10.1371/journal.pone.0191653	http://dx.doi.org/10.1371/journal.pone.0191653			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377905	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700025
J	Tweya, H; Oboho, IK; Gugsa, ST; Phiri, S; Rambiki, E; Banda, R; Mwafilaso, J; Munthali, C; Gupta, S; Bateganya, M; Maida, A				Tweya, Hannock; Oboho, Ikwo Kitefre; Gugsa, Salem T.; Phiri, Sam; Rambiki, Ethel; Banda, Rebecca; Mwafilaso, Johnbosco; Munthali, Chimango; Gupta, Sundeep; Bateganya, Moses; Maida, Alice			Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi	PLOS ONE			English	Article							SOUTH-AFRICA; CARE; ART; RETENTION; OUTCOMES; PROGRAM; COHORT; ADULTS; WOMEN	Introduction Although several studies have explored factors associated with loss to follow-up (LTFU) from HIV care, there remains a gap in understanding how these factors vary by setting, volume of patient and patients' demographic and clinical characteristics. We determined rates and factors associated with LTFU in HIV care Lilongwe, Malawi. Methods We conducted a retrospective cohort study of HIV-infected individuals aged 15 years or older at the time of registration for HIV care in 12 ART facilities, between April 2012 and March 2013. HIV-positive individuals who had not started ART (pre-ART patients) were clinically assessed to determine ART eligibility at registration and during clinic follow-up visits. ART-eligible patients were initiated on triple antiretroviral combination. Study data were abstracted from patients' cards, facility ART registers or electronic medical record system from the date of registration for HIV care to a maximum follow-up period of 24 months. Descriptive statistics were undertaken to summarize characteristics of the study patients. Separate univariable and multivariable poisson regression models were used to explore factors associated with LTFU in pre-ART and ART care. Results A total of 10,812 HIV-infected individuals registered for HIV care. Of these patients, 1,907 (18%) and 8,905 (82%) enrolled in pre-ART and ART care, respectively. Of the 1,907 pre-ART patients, 490 (26%) subsequently initiated ART and were included in both the pre-ART and ART analyses. The LTFU rates among patients in pre-ART and ART care were 48 and 26 per 100 person-years, respectively. Of the 9,105 ART patients with reasons for starting ART, 2,451 (27%) were initiated on ART because of pregnancy or breastfeeding (Option B+) status. Multivariable analysis showed that being >= 35 years and female were associated with decreased risk of LTFU in the pre-ART and ART phases of HIV care. However, being in WHO clinical stage 3 (adjusted risk ratio (aRR) 1.35, 95% confidence interval (CI): 1.20-1.51) and stage 4 (aRR 1.87, 95% CI: 1.62-2.18), body mass index <= 18.4 (aRR 1.24, 95% CI: 1.11-1.39) at ART initiation, poor adherence to clinic appointments (aRR 4.55, 95% CI: 4.16-4.97) and receiving HIV care in rural facilities (aRR 2.32, 95% CI: 1.94-2.87) were associated with increased risk of LTFU among ART patients. Being re-initiated on ART once (aRR 0.20, 95% CI: 0.17-0.22), more than once (aRR 0.06, 95% CI: 0.05-0.07), and being enrolled at a low-volume facility (aRR 0.25, 95% CI: 0.20-0.30) were associated with decreased risk of LTFU from ART care. Conclusion A sizeable proportion of ART LTFU occurred among women enrolled during pregnancy or breast-feeding. Non-compliance to clinic and receiving ART in a rural facility or high-volume facility were associated with increased risk of LTFU from ART care. Developing effective interventions that target high-risk subgroups and contexts may help reduce LTFU from HIV care.	[Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Gugsa, Salem T.; Phiri, Sam; Banda, Rebecca; Mwafilaso, Johnbosco] Lighthouse Trust, Lilongwe, Malawi; [Oboho, Ikwo Kitefre; Bateganya, Moses] Ctr Dis Control & Prevent CDC, Div Global HIV&TB, Ctr Global Hlth, Atlanta, GA USA; [Gugsa, Salem T.] I TECH, Lilongwe, Malawi; [Phiri, Sam] Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Coll Med, Lilongwe, Malawi; [Phiri, Sam] Univ North Carolina Chapel Hill, Sch Med, Dept Med, Chapel Hill, NC USA; [Rambiki, Ethel] Minist Hlth, Bwaila Hosp, Lilongwe, Malawi; [Munthali, Chimango] Baobab Hlth Trust, Lilongwe, Malawi; [Gupta, Sundeep; Maida, Alice] Ctr Dis Control & Prevent CDC, Div Global HIV&TB, Ctr Global Hlth, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.; Tweya, H (corresponding author), Lighthouse Trust, Lilongwe, Malawi.	h_tweya@lighthouse.org.mw		Gugsa, Salem/0000-0003-3545-3117	United States Centers for Disease Control and Prevention (CDC); Department for International Development (DFD), UK	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department for International Development (DFD), UK	The United States Centers for Disease Control and Prevention (CDC) funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the staff and numerous donors supporting the 12 ART facilities. We thank the Department for International Development (DFD), UK, for funding the Global Operational Research Fellowship Programme at the International Union Against Tuberculosis and Lung Disease (The Union), Paris, France in which Dr Hannock Tweya works as a senior operational research fellow.	Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Evangeli M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3025-x; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; Malawi Ministry of Health, 2014, CLIN MAN HIV CHILDR; Malawi Ministry of Health, 2016, MIN HLTH INT HIV PRO; Mugavero MJ, 2014, CLIN INFECT DIS, V59, P1471, DOI 10.1093/cid/ciu603; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Plazy M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006927; Rastegar DA, 2003, AIDS CARE, V15, P231, DOI 10.1080/0954012031000068371; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2013, PLOS ONE, V8; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2013, GLOB UPD HIV TREATM; UNAIDS, 2015, GLOB STAT 2015; UNAIDS, 2006, REP GLOB AIDS EP; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078	19	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0188488	10.1371/journal.pone.0188488	http://dx.doi.org/10.1371/journal.pone.0188488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373574	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400002
J	Dai, XX; Liu, MG; Pan, KC; Yang, JL				Dai, Xixi; Liu, Minggang; Pan, Kangcheng; Yang, Jinlong			Surface display of OmpC of Salmonella serovar Pullorum on Bacillus subtilis spores	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; CROSS-REACTIVITY; VACCINE VEHICLES; ANTIGEN; DISEASE; RESISTANCE; BACTERIA; DELIVERY; BINDING	Salmonellosis is a major public health problem throughout the world. Thus, there is a huge need for diversified control strategies for Salmonella infections. In this work, we have assessed the potential use of Bacillus subtilis (B. subtilis) spores for the expression of a major protective antigen of Salmonella serovar Pullorum, OmpC. The expression of OmpC on the surface of spores was determined by immunofluorescence microscopy. Mice immunized with recombinant spores expressing the OmpC antigen presented significant levels of OmpC-specific serum IgG and mucosal SIgA antibodies than in mice immunized with non-recombinant spores (p< 0.01). In addition, oral immunization with recombinant spores was able to induce a significant level of protection in mice against lethal challenge with Salmonella serovar Typhimurium. These results suggest that B. subtilis spores have promising potential in the development of mucosal vaccines against Salmonella infections.	[Dai, Xixi; Yang, Jinlong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Dai, Xixi; Pan, Kangcheng] Sichuan Agr Univ, Coll Vet Med, Chengdu, Sichuan, Peoples R China; [Liu, Minggang] Fujian Luodong Biotechnol Co Ltd, Putian, Fujian, Peoples R China	Sichuan Agricultural University	Yang, JL (corresponding author), Chongqing Acad Anim Sci, Chongqing, Peoples R China.	kfdaikang1989@163.com			Chongqing Academy of Animal Science Fund for Agricultural Development [16407, 16436, 17417];  [2017YFD0500800]	Chongqing Academy of Animal Science Fund for Agricultural Development; 	This work was supported by The National Key Research and Development Program of China (2017YFD0500800, http://www.most.gov.cn/); Chongqing Academy of Animal Science Fund for Agricultural Development (16407, 16436 and 17417, http://ww.cstc.gov.cn/). Jinlong Yang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06; Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; Barnes AGC, 2007, EUR J IMMUNOL, V37, P1538, DOI 10.1002/eji.200636875; Barrow PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575; Das K, 2016, TUBERCULOSIS, V101, pS18, DOI 10.1016/j.tube.2016.09.016; Duc L, 2003, INFECT IMMUN, V71, P2810, DOI 10.1128/IAI.71.5.2810-2818.2003; Duc LH, 2007, VACCINE, V25, P346, DOI 10.1016/j.vaccine.2006.07.037; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; HENRIKSEN AZ, 1989, APMIS, V97, P559, DOI 10.1111/j.1699-0463.1989.tb00831.x; HENRIKSEN AZ, 1987, ACTA PATH MICRO IM B, V95, P315; Hinc K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-22; Hinc K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-2; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hu B, 2011, J VIROL METHODS, V171, P272, DOI 10.1016/j.jviromet.2010.11.023; Lega T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167225; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054; Mauriello EMF, 2004, VACCINE, V22, P1177, DOI 10.1016/j.vaccine.2003.09.031; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paccez JD, 2007, VACCINE, V25, P4671, DOI 10.1016/j.vaccine.2007.04.021; Plomp M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108560; Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048; Prejit, 2013, BIOLOGICALS, V41, P162, DOI 10.1016/j.biologicals.2013.01.003; Prejit Porteen K, 2009, INDIAN J COMP MICROB, V30, p91e4; Nguyen QA, 2014, PROTEIN EXPRES PURIF, V95, P67, DOI 10.1016/j.pep.2013.11.018; ROBLEDO JA, 1990, J UROLOGY, V143, P386, DOI 10.1016/S0022-5347(17)39971-8; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Secundino I, 2006, IMMUNOLOGY, V117, P59, DOI 10.1111/j.1365-2567.2005.02263.x; Shimazu M, 2003, BIOTECHNOL PROGR, V19, P1612, DOI 10.1021/bp0340640; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; SINGH SP, 1995, INFECT IMMUN, V63, P4600, DOI 10.1128/IAI.63.12.4600-4605.1995; TABARAIE B, 1994, MICROBIOL IMMUNOL, V38, P553, DOI 10.1111/j.1348-0421.1994.tb01822.x; von Hunolstein C, 2008, Pharmeuropa Bio, V2008, P7	38	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191627	10.1371/journal.pone.0191627	http://dx.doi.org/10.1371/journal.pone.0191627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370221	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600071
J	Han, JJ; Jang, JH; De Ridder, D; Vanneste, S; Koo, JW; Song, JJ				Han, Jae Joon; Jang, Ji Hye; De Ridder, Dirk; Vanneste, Sven; Koo, Ja-Won; Song, Jae-Jin			Increased parietal circuit-breaker activity in delta frequency band and abnormal delta/theta band connectivity in salience network in hyperacusis subjects	PLOS ONE			English	Article							SINGLE-SIDED DEAFNESS; LATE-ONSET TINNITUS; ELECTROMAGNETIC TOMOGRAPHY; AUDITORY-CORTEX; BRAIN; SOUND; EEG; HYPERSENSITIVITY; SCHIZOPHRENIA; OSCILLATIONS	Recent studies have suggested that hyperacusis, an abnormal hypersensitivity to ordinary environmental sounds, may be characterized by certain resting-state cortical oscillatory patterns, even with no sound stimulus. However, previous studies are limited in that most studied subjects with other comorbidities that may have affected cortical activity. In this regard, to assess ongoing cortical oscillatory activity in idiopathic hyperacusis patients with no comorbidities, we compared differences in resting-state cortical oscillatory patterns between five idiopathic hyperacusis subjects and five normal controls. The hyperacusis group demonstrated significantly higher electrical activity in the right auditory-related cortex for the gamma frequency band and left superior parietal lobule (SPL) for the delta frequency band versus the control group. The hyperacusis group also showed significantly decreased functional connectivity between the left auditory cortex (AC) and left orbitofrontal cortex (OFC), between the left AC and left subgenual anterior cingulate cortex (sgACC) for the gamma band, and between the right insula and bilateral dorsal anterior cingulate cortex (dACC) and between the left AC and left sgACC for the theta band versus the control group. The higher electrical activity in the SPL may indicate a readiness of circuit-breaker activity to shift attention to forthcoming sound stimuli. Also, because of the disrupted salience network, consisting of the dACC and insula, abnormally increased salience to all sound stimuli may emerge, as a consequence of decreased top-down control of the AC by the dACC and dysfunctional emotional weight attached to auditory stimuli by the OFC. Taken together, abnormally enhanced attention and salience to forthcoming sound stimuli may render hyperacusis subjects hyperresponsive to non-noxious auditory stimuli.	[Han, Jae Joon; Jang, Ji Hye; Koo, Ja-Won; Song, Jae-Jin] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Sect Neurosurg, Dept Surg Sci, Dunedin, New Zealand; [Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Lab Clin & Integrat Neurosci, Richardson, TX 75083 USA	Seoul National University (SNU); University of Otago; University of Texas System; University of Texas Dallas	Song, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea.	jjsong96@gmail.com	Song, Jae-Jin/E-4633-2017	Song, Jae-Jin/0000-0002-6631-3232; Vanneste, Sven/0000-0003-1513-5752	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1C1B2007911]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	The National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP), No. 2016R1C1B2007911 (http://www.nrf.re.kr/nrf_eng_cins/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; Andersson G, 2002, INT J AUDIOL, V41, P545, DOI 10.3109/14992020209056075; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bruder GE, 2012, HUM BRAIN MAPP, V33, P1325, DOI 10.1002/hbm.21284; Canive JM, 1998, PSYCHOPHARMACOL BULL, V34, P101; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dommes E, 2009, BRAIN RES, V1304, P129, DOI 10.1016/j.brainres.2009.09.089; Emek-Savas DD, 2016, INT J PSYCHOPHYSIOL, V103, P103, DOI 10.1016/j.ijpsycho.2015.02.006; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Harper J, 2016, PSYCHOPHYSIOLOGY, V53, P712, DOI 10.1111/psyp.12604; Hwang JH, 2009, AM J OTOLARYNG, V30, P432, DOI 10.1016/j.amjoto.2008.08.005; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; Kim K, 2015, J NEUROSCI METH, V255, P22, DOI 10.1016/j.jneumeth.2015.07.020; Kim SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29140; KLEIN AJ, 1990, J SPEECH HEAR DISORD, V55, P339, DOI 10.1044/jshd.5502.339; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Koprivova J, 2011, CLIN NEUROPHYSIOL, V122, P1735, DOI 10.1016/j.clinph.2011.01.051; Lanz S, 2011, J NEURAL TRANSM, V118, P1139, DOI 10.1007/s00702-011-0606-9; Lee SY, 2017, HEARING RES, V354, P9, DOI 10.1016/j.heares.2017.08.002; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303; Moran LV, 2011, SCHIZOPHRENIA BULL, V37, P659, DOI 10.1093/schbul/sbr056; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena AJ, 2010, NEUROSCIENCE, V166, P1194, DOI 10.1016/j.neuroscience.2009.12.063; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; Pascual-Marqui R. D, 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Sahley TL, 2001, HEARING RES, V152, P43, DOI 10.1016/S0378-5955(00)00235-5; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sherlin L, 2005, NEUROSCI LETT, V387, P72, DOI 10.1016/j.neulet.2005.06.069; Siepmann M, 2002, NEUROPSYCHOBIOLOGY, V45, P161, DOI 10.1159/000054958; Song JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123538; Song JJ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00210; Song JJ, 2015, HUM BRAIN MAPP, V36, P1982, DOI 10.1002/hbm.22750; Song JJ, 2015, BRAIN STRUCT FUNCT, V220, P571, DOI 10.1007/s00429-013-0648-x; Song JJ, 2014, OTOL NEUROTOL, V35, P1780, DOI 10.1097/MAO.0000000000000560; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Song JJ, 2013, HEARING RES, V299, P1, DOI 10.1016/j.heares.2013.02.001; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Talairach J., 1988, COPLANAR STEREOTAXIC; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; VERNON JA, 1987, AM J OTOL, V8, P201; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; White DJ, 2012, J COGNITIVE NEUROSCI, V24, P686, DOI 10.1162/jocn_a_00098	56	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191858	10.1371/journal.pone.0191858	http://dx.doi.org/10.1371/journal.pone.0191858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370266	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600107
J	Remeikis, V; Lagzdina, E; Garbaras, A; Gudelis, A; Garankin, J; Plukiene, R; Juodis, L; Duskesas, G; Lingis, D; Abdulajev, V; Plukis, A				Remeikis, Vidmantas; Lagzdina, Elena; Garbaras, Andrius; Gudelis, Arunas; Garankin, Jevgenij; Plukiene, Rita; Juodis, Laurynas; Duskesas, Grigorijus; Lingis, Danielius; Abdulajev, Vladimir; Plukis, Arturas			Rapid analysis method for the determination of C-14 specific activity in irradiated graphite	PLOS ONE			English	Article							RBMK-1500 REACTOR; LITHUANIA; DETECTOR; ASSAY; FTMC; H-3	C-14 is one of the limiting radionuclides used in the categorization of radioactive graphite waste; this categorization is crucial in selecting the appropriate graphite treatment/disposal method. We propose a rapid analysis method for C-14 specific activity determination in small graphite samples in the 1 +/- 100 mu g range. The method applies an oxidation procedure to the sample, which extracts C-14 from the different carbonaceous matrices in a controlled manner. Because this method enables fast online measurement and C-14 specific activity evaluation, it can be especially useful for characterizing C-14 in irradiated graphite when dismantling graphite moderator and reflector parts, or when sorting radioactive graphite waste from decommissioned nuclear power plants. The proposed rapid method is based on graphite combustion and the subsequent measurement of both CO2 and C-14, using a commercial elemental analyser and the semiconductor detector, respectively. The method was verified using the liquid scintillation counting (LSC) technique. The uncertainty of this rapid method is within the acceptable range for radioactive waste characterization purposes. The C-14 specific activity determination procedure proposed in this study takes approximately ten minutes, comparing favorably to the more complicated and time consuming LSC method. This method can be potentially used to radiologically characterize radioactive waste or used in biomedical applications when dealing with the specific activity determination of C-14 in the sample.	[Remeikis, Vidmantas; Lagzdina, Elena; Garbaras, Andrius; Gudelis, Arunas; Garankin, Jevgenij; Plukiene, Rita; Juodis, Laurynas; Duskesas, Grigorijus; Lingis, Danielius; Abdulajev, Vladimir; Plukis, Arturas] Ctr Phys Sci & Technol, Vilnius, Lithuania	Center for Physical Sciences & Technology - Lithuania	Plukiene, R (corresponding author), Ctr Phys Sci & Technol, Vilnius, Lithuania.	rita.plukiene@ftmc.lt	Garbaras, Andrius/K-7841-2012	Garbaras, Andrius/0000-0002-3105-8059; Plukiene, Rita/0000-0003-2394-4760; Lingis, Danielius/0000-0002-3379-1350				Ancius D, 2005, NUKLEONIKA, V50, P113; [Anonymous], 2005, RAD SAF RAD WORK, P89; BATTEN JR, 1989, NUCL INSTRUM METH A, V277, P478, DOI 10.1016/0168-9002(89)90778-X; BRODA R, 1988, APPL RADIAT ISOTOPES, V39, P159, DOI 10.1016/0883-2889(88)90161-X; Cassette P, 2016, APPL RADIAT ISOTOPES, V109, P41, DOI 10.1016/j.apradiso.2015.11.063; DEVLIN DJ, 1986, THERMOCHIM ACTA, V104, P159, DOI 10.1016/0040-6031(86)85195-4; Dunzik-Gougar ML, 2014, J NUCL MATER, V451, P328, DOI 10.1016/j.jnucmat.2014.03.018; Fachinger J, 2008, NUCL ENG DES, V238, P3086, DOI 10.1016/j.nucengdes.2008.02.010; Frolov VV, 2004, ATOM ENERGY+, V97, P781, DOI 10.1007/s10512-004-0008-2; Garbaras A., 2008, LSC, P415; Garbaras A, 2015, MATER SCI-MEDZG, V21, P309, DOI 10.5755/j01.mm.21.2.6873; Goorley T, 2012, NUCL TECHNOL, V180, P298, DOI 10.13182/NT11-135; Gudelis A, 2016, APPL RADIAT ISOTOPES, V109, P85, DOI 10.1016/j.apradiso.2015.11.011; Gudelis A, 2014, APPL RADIAT ISOTOPES, V87, P439, DOI 10.1016/j.apradiso.2013.11.010; Hou XL, 2005, APPL RADIAT ISOTOPES, V62, P871, DOI 10.1016/j.apradiso.2005.01.008; IAEA, 2003, IAEATECDOC1380; Lukauskas D., 2006, Lithuanian Journal of Physics, V46, P497; Maceika E., 2005, Lithuanian Journal of Physics, V45, P383; Molokwane P.E., 2007, P 11 INT C ENV REM R; Narkunas E, 2010, KERNTECHNIK, V75, P185, DOI 10.3139/124.110083; Payne L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164159; Plukiene R, 2014, NUCL ENG DES, V277, P95, DOI 10.1016/j.nucengdes.2014.06.018; Remeikis V, 2010, NUCL ENG DES, V240, P2697, DOI 10.1016/j.nucengdes.2010.06.020; Remeikis V, 2009, NUCL ENG DES, V239, P813, DOI 10.1016/j.nucengdes.2008.11.010; Takahashi R., 1999, P NUCL GRAPH WAST MA, P18; TYKVA R, 1975, J CHROMATOGR, V108, P37, DOI 10.1016/S0021-9673(00)97486-7; World Health Organization, 2014, GEN SAF REQ 3	27	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191677	10.1371/journal.pone.0191677	http://dx.doi.org/10.1371/journal.pone.0191677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370233	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600077
J	Jehangir, N; Yu, CY; Song, J; Shariati, MA; Binder, S; Beyer, J; Santini, V; Poston, K; Liao, YJ				Jehangir, Naz; Yu, Caroline Yizhu; Song, Jeehey; Shariati, Mohammad Ali; Binder, Steven; Beyer, Jill; Santini, Veronica; Poston, Kathleen; Liao, Yaping Joyce			Slower saccadic reading in Parkinson's disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; KING-DEVICK TEST; EYE-MOVEMENTS; GLAUCOMA; DEFICITS; COMPREHENSION; INVOLVEMENT; PREVALENCE; SPEED	Idiopathic Parkinson's Disease (PD) is characterized by degeneration of dopaminergic and other neurons, leading to motor and non-motor deficits. Abnormal eye movements in PD, including fixations, saccades, and convergence, are well described. However, saccadic reading, which requires serial and alternating saccades and fixations, is not well studied, despite its obvious impact on the quality of life. In this study, we assessed saccadic reading using variations of the King-Devick (KD) test, a rapid single digit number naming test, as a way to assess the ability to make serial left-to-right ocular motor movements necessary for reading. We recruited 42 treated PD patients and 80 age-matched controls and compared their reading times with a variety of measures, including age, duration of disease, Unified Parkinson's Disease Rating Scale (UPDRS), the National Eye Institute 25-Item Visual Functioning Questionnaire 25 (VFQ-25), and Montreal Cognitive assessment (MoCA) test. The subjects performed 4 trials of reading 120 single digit numbers aloud as fast as possible without making errors. In each trial, they read 3 pages (KD1, KD2, and KD3), and each page contained 40 numbers per page in 8 lines with 5 numbers/line. We found that PD patients read about 20% slower than controls on all tests (KD1, 2, and 3 tests) (p < 0.02), and both groups read irregularly spaced numbers slower than regularly spaced numbers. Having lines between numbers to guide reading (KD1 tests) did not impact reading time in both PD and controls, but increased visual crowding as a result of decreased spacing between numbers (KD3 tests) was associated with significantly slower reading times in both PD and control groups. Our study revealed that saccadic reading is slower in PD, but controls and PD patients are both impacted by visuospatial planning challenges posed by increased visual crowding and irregularity of number spacing. Reading time did not correlate with UPDRS or MoCA scores in PD patients but significantly correlated with age, duration of disease, and VFQ-25 scores. The presence of convergence insufficiency did not significantly correlate with reading time in PD patients, although on average there was slower reading time in those with convergence insufficiency by 8 s (p = 0.2613). We propose that a simple reading task using 120 single-digit numbers can be used as a screening tool in the clinical setting to assess functional ocular motor difficulties in Parkinson's disease that can have a profound impact on quality of life.	[Jehangir, Naz; Yu, Caroline Yizhu; Song, Jeehey; Shariati, Mohammad Ali; Binder, Steven; Beyer, Jill; Liao, Yaping Joyce] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA; [Santini, Veronica; Poston, Kathleen; Liao, Yaping Joyce] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA	Stanford University; Stanford University	Liao, YJ (corresponding author), Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA.; Liao, YJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	yjliao@stanford.edu	Shariati, Mohammad Ali/HCI-4375-2022	Poston, Kathleen/0000-0003-3424-7143	NANOS Pilot Grant; Michael J Fox foundation for Parkinson's disease research; NIH [AG047366, NS075097]; NATIONAL INSTITUTE ON AGING [P50AG047366] Funding Source: NIH RePORTER	NANOS Pilot Grant; Michael J Fox foundation for Parkinson's disease research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.Liao was supported by the NANOS Pilot Grant; K.L. Poston was supported by the Michael J Fox foundation for Parkinsons disease research and the NIH (AG047366 and NS075097); V. Santini was supported by the NIH (AG047366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Almer Z, 2012, OPHTHALMOLOGY, V119, P178, DOI 10.1016/j.ophtha.2011.06.040; Barone P, 2011, MOVEMENT DISORD, V26, P2483, DOI 10.1002/mds.23919; Bodis-Wollner I, 2013, BEHAV NEUROSCI, V127, P139, DOI 10.1037/a0031225; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Burani C, 2002, BRAIN LANG, V81, P568, DOI 10.1006/brln.2001.2548; Cameron IGM, 2012, NEUROIMAGE, V60, P1156, DOI 10.1016/j.neuroimage.2012.01.057; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Ding W, 2015, EUR REV MED PHARMACO, V19, P2275; Dodick D, 2017, J CHILD NEUROL, V32, P104, DOI 10.1177/0883073816668704; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2017, ALZ DIS ASSOC DIS, V31, P152, DOI 10.1097/WAD.0000000000000157; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Giacomelli G, 2010, EUR J OPHTHALMOL, V20, P389, DOI 10.1177/112067211002000220; Grossman M, 1999, BRAIN COGNITION, V40, P387, DOI 10.1006/brcg.1999.1087; Grotheer M, 2016, NEUROIMAGE, V132, P314, DOI 10.1016/j.neuroimage.2016.02.069; Hainline C, 2017, J NEUROL, V264, P989, DOI 10.1007/s00415-017-8484-1; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; HUNT LA, 1995, OPTOMETRY VISION SCI, V72, P92, DOI 10.1097/00006324-199502000-00008; Ikeda Masahiro, 2017, Am J Neurodegener Dis, V6, P9; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; KENNARD C, 1989, REV NEUROL, V145, P587; Krumholtz I, 2000, Optometry, V71, P426; Law C, 2017, CAN J NEUROL SCI, V44, P562, DOI 10.1017/cjn.2017.39; Lee C, 2003, BRAIN LANG, V85, P347, DOI 10.1016/S0093-934X(03)00063-4; Lemos J, 2016, BRAIN RES, V1648, P469, DOI 10.1016/j.brainres.2016.07.037; LEVIN BE, 1989, NEUROLOGY, V39, P557, DOI 10.1212/WNL.39.4.557; LIEBERMAN P, 1990, J NERV MENT DIS, V178, P360, DOI 10.1097/00005053-199006000-00003; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Lovie-Kitchin JE, 2000, OPHTHAL PHYSL OPT, V20, P360, DOI 10.1016/S0275-5408(99)00088-5; Mailankody P, 2015, PARKINSONISM RELAT D, V21, P1164, DOI 10.1016/j.parkreldis.2015.08.002; Manenti R, 2016, MOVEMENT DISORD, V31, P715, DOI 10.1002/mds.26561; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; Ming WD, 2016, INVEST OPHTH VIS SCI, V57, P5696, DOI 10.1167/iovs.16-20025; Montse A, 2001, J CLIN EXP NEUROPSYC, V23, P592, DOI 10.1076/jcen.23.5.592.1248; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Murata N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170230; Murphy R, 2013, IRISH J MED SCI, V182, P415, DOI 10.1007/s11845-013-0902-5; Nowacka B, 2015, DOC OPHTHALMOL, V131, P95, DOI 10.1007/s10633-015-9503-0; Nowacka B, 2014, MED SCI MONITOR, V20, P2243, DOI 10.12659/MSM.890861; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Pasol J, 2011, CURR OPIN OPHTHALMOL, V22, P124, DOI 10.1097/ICU.0b013e328343c1a3; Piras F, 2009, NEUROPSYCHOLOGIA, V47, P1944, DOI 10.1016/j.neuropsychologia.2009.03.006; Pitcher TL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-17; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P673, DOI 10.1167/iovs.12-10617; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P666, DOI 10.1167/iovs.12-10618; Ramulu PY, 2009, ARCH OPHTHALMOL-CHIC, V127, P82, DOI 10.1001/archophthalmol.2008.523; RASCOL O, 1989, BRAIN, V112, P1193, DOI 10.1093/brain/112.5.1193; Shaunak S, 1999, MOVEMENT DISORD, V14, P80, DOI 10.1002/1531-8257(199901)14:1<80::AID-MDS1014>3.0.CO;2-M; Srivastava A, 2014, INDIAN J OPHTHALMOL, V62, P538, DOI 10.4103/0301-4738.133482; Vinuela-Navarro V, 2017, OPHTHAL PHYSL OPT, V37, P531, DOI 10.1111/opo.12392; Yu CY, 2016, PARKINSONISM RELAT D, V32, P130, DOI 10.1016/j.parkreldis.2016.08.008; Zhang TM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005400	59	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191005	10.1371/journal.pone.0191005	http://dx.doi.org/10.1371/journal.pone.0191005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364897	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500032
J	Levintow, SN; Pence, BW; Ha, TV; Le Minh, N; Sripaipan, T; Latkin, CA; Vu, PT; Quan, VM; Frangakis, C; Go, VF				Levintow, Sara N.; Pence, Brian W.; Tran Viet Ha; Nguyen Le Minh; Sripaipan, Teerada; Latkin, Carl A.; Pham The Vu; Quan, Vu Minh; Frangakis, Constantine; Go, Vivian F.			Prevalence and predictors of depressive symptoms among HIV-positive men who inject drugs in Vietnam	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PSYCHIATRIC-DISORDERS; DISEASE PROGRESSION; SOCIAL SUPPORT; USERS; PEOPLE; WOMEN; EPIDEMIOLOGY; MORTALITY	Background HIV infection is common among people who inject drugs (PWID), and HIV-positive PWID may be particularly vulnerable to depression. This study measured the prevalence of depressive symptoms and the factors associated with severe symptoms among 455 HIV-positive PWID in Thai Nguyen, Vietnam. Methods We used cross-sectional data from PWID in a randomized controlled trial of an intervention to reduce high-risk injecting and sexual behaviors in Thai Nguyen from 2009 +/- 2013. Depressive symptoms were measured with the Center for Epidemiologic Studies Depression Scale (CES-D). We used logistic regression to assess demographic, clinical, and psychosocial predictors of severe depressive symptoms (CES-D >= 23) with prevalence odds ratios (POR) and 95% confidence intervals (CI). Results The prevalence of severe depressive symptoms (CES-D >= 23) was 44%. 25% of participants had mild to moderate depressive symptoms (16 <= CES-D< 23), and 31% experienced no depressive symptoms (CES-D< 16). Not being married, self-rated poor health, greater frequency of injection drug use, history of overdose, no alcohol use, and daily cigarette smoking were positively associated with severe depressive symptoms in unadjusted models and remained predictive in a multivariable model. The strongest predictors of depressive symptoms were self-reported poor health (POR = 2.94, 95% CI: 1.82, 4.76), no current alcohol use (POR = 2.35, 95% CI: 1.47, 3.77), and not currently married or cohabitating (POR = 2.21, 95% CI = 1.40, 3.47). Conclusion Severe depressive symptoms were common among HIV-positive PWID in Thai Nguyen and were strongly associated with demographic, clinical, and psychosocial factors. Interventions that promote social support from family and reduce drug dependence may particularly benefit PWID experiencing severe depressive symptoms. Greater recognition and treatment of depressive symptoms has the potential to enhance quality of life and improve HIV clinical outcomes for PWID.	[Levintow, Sara N.; Pence, Brian W.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Tran Viet Ha; Sripaipan, Teerada; Go, Vivian F.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Nguyen Le Minh; Pham The Vu] Thai Nguyen Ctr Prevent Med, Thai Nguyen, Vietnam; [Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Quan, Vu Minh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Levintow, SN (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	levintow@email.unc.edu		Vu, Quan/0000-0003-4462-0546; Levintow, Sara/0000-0001-5558-526X	National Institutes of Health [T32 AI070114-10]; National Institute on Drug Abuse [R01 DA022962-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, T32AI070114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Traineeship support was provided by the National Institutes of Health (https://www.niaid.nih.gov/): T32 AI070114-10 [SNL]. The parent trial for this study was funded by the National Institute on Drug Abuse (http://www.drugabuse.gov): R01 DA022962-01 [VFG TVH NLM TS CAL PTV VMQ CF]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOG YJ, 1993, AM J DRUG ALCOHOL AB, V19, P219, DOI 10.3109/00952999309002682; Anagnostopoulos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140943; ANGLIN MD, 1989, AM J DRUG ALCOHOL AB, V15, P191, DOI 10.3109/00952998909092720; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Bouhnik AD, 2005, ANTIVIR THER, V10, P53; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Vuong DA, 2011, ASIAN J PSYCHIATR, V4, P65, DOI 10.1016/j.ajp.2011.01.005; Dutta A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9776-3; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Esposito CA, 2009, AM J PUBLIC HEALTH, V99, pS439, DOI 10.2105/AJPH.2008.155168; EVANS DL, 1989, PSYCHOPHARMACOL BULL, V25, P319; FRANKS F, 1990, RES NURS HEALTH, V13, P283, DOI 10.1002/nur.4770130504; Go VF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125909; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Green K, 2010, J PAIN SYMPTOM MANAG, V40, P31, DOI 10.1016/j.jpainsymman.2010.04.006; HERBERT TB, 1993, PSYCHOL BULL, V113, P472, DOI 10.1037/0033-2909.113.3.472; Hershow RB, 2018, SUBST USE MISUSE; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Huynh VAN, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1170-5; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Knowlton AR, 2001, AIDS CARE, V13, P549, DOI 10.1080/09540120120063197; Leggett A, 2012, AGING MENT HEALTH, V16, P780, DOI 10.1080/13607863.2012.667780; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Leserman J, 2007, AM J PSYCHIAT, V164, P1707, DOI 10.1176/appi.ajp.2007.06111775; Li JH, 2015, DRUG ALCOHOL DEPEN, V151, P228, DOI 10.1016/j.drugalcdep.2015.03.028; Li L, 2013, INT J DRUG POLICY, V24, P545, DOI 10.1016/j.drugpo.2013.06.007; Li Yi, 2014, J AIDS Clin Res, V5, P303; Lim T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18637; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Ministry of Health of Vietnam, 2006, WHO AIMS REP MENT HL; Ministry of Health Vietnam, 2011, RES HIV STI INT BIOL; Mizuno Y, 2003, AIDS CARE, V15, P689, DOI 10.1080/09540120310001595177; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Vu NTT, 2017, SUBST USE MISUSE, V52, P1411, DOI 10.1080/10826084.2017.1284233; Nomoto SH, 2015, AIDS CARE, V27, P979, DOI 10.1080/09540121.2015.1017442; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Radloff LS, 1977, APPL PSYCH MEAS, V1, P385, DOI DOI 10.1177/014662167700100306; Semple SJ, 2012, DRUG ALCOHOL DEPEN, V125, P154, DOI 10.1016/j.drugalcdep.2012.04.007; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P493, DOI 10.1080/13548506.2011.579990; Springer SA, 2009, AIDS CARE, V21, P976, DOI 10.1080/09540120802657555; Thai TT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4162-6; Tran TV, 2003, SOC WORK RES, V27, P56, DOI 10.1093/swr/27.1.56; Treisman G, 2007, CLIN INFECT DIS, V45, pS313, DOI 10.1086/522556; Thai TT, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0860-3; United Nations Office on Drugs and Crime (UNODC), 2015, WORLD DRUG REP; Valverde EE, 2007, JAIDS-J ACQ IMM DEF, V46, pS96, DOI 10.1097/QAI.0b013e318157683b; Vietnam Authority of HIV/AIDS Control, 2014, VIETN AIDS RESP PROG	51	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191548	10.1371/journal.pone.0191548	http://dx.doi.org/10.1371/journal.pone.0191548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364928	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500056
J	Bolotin, S; Feld, JJ; Garber, G; Wong, WWL; Guerra, FM; Mazzulli, T				Bolotin, Shelly; Feld, Jordan J.; Garber, Gary; Wong, William W. L.; Guerra, Fiona M.; Mazzulli, Tony			Population-based estimate of hepatitis C virus prevalence in Ontario, Canada	PLOS ONE			English	Article							INFECTION	Background & para;& para;Hepatitis C virus (HCV) is the most burdensome infectious illness in Canada. Current screening strategies miss a significant proportion of cases, leaving many undiagnosed. Elevated HCV prevalence in those born between 1945 and 1965 has prompted calls for birth-cohort screening in this group. However, Canada lacks population-level data to support this recommendation. We performed a serosurvey to obtain population-based HCV prevalence estimates in Ontario residents born between 1945-1974, to generate evidence for birth-cohort screening recommendations.& para;& para;Methods & para;& para;We tested anonymized residual sera in five-year age-sex bands from Ontario for anti-HCV antibody. We performed descriptive epidemiological analysis and used a logistic regression model to determine HCV risk-factors.& para;& para;Results & para;& para;Of 10,006 sera analyzed, 155 (1.55%, 95% confidence interval (CI) 1.32, 1.81) were positive for HCV antibody. Individuals born between 1950-1964 had a significantly higher combined prevalence of 1.92% (95% CI 1.56, 2.34) compared to 1.14% (95% CI 0.69, 1.77) (p = 0.04) for those born between 1970-1974. For males, comprising 107/155 (69.03%) of positive samples, the highest prevalence was 3.00% (95% CI 1.95, 4.39) for the 1960-1964 birth cohort. For females, the highest prevalence was 1.56% (95% CI 0.83, 2.65) for those born between 1955-1959. Male sex was significantly associated with positive HCV serostatus.& para;& para;Interpretation & para;& para;HCV prevalence in Ontario is highest among those in this birth cohort, and higher than previous estimates. The prevalence estimates presented in our study provide important data to underpin birth-cohort screening recommendations.	[Bolotin, Shelly; Garber, Gary; Guerra, Fiona M.; Mazzulli, Tony] Publ Hlth Ontario, Toronto, ON, Canada; [Bolotin, Shelly] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Feld, Jordan J.] Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Feld, Jordan J.] Univ Toronto, Sandra Rotman Ctr Global Hlth, Toronto, ON, Canada; [Garber, Gary] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Wong, William W. L.] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Mazzulli, Tony] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada; [Mazzulli, Tony] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto	Bolotin, S (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Bolotin, S (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	shelly.bolotin@oahpp.ca	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Wong, William W.L./0000-0003-4630-0052	Public Health Ontario Project Initiation Fund	Public Health Ontario Project Initiation Fund	Funding for this study was provided by a Public Health Ontario Project Initiation Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branswell H, 2013, GLOBE MAIL; Buxton JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-225; Canadian Agency for Drugs and Technologies in Health (CADTH), 2015, HOLK OMB PAR RIT DAS; Canadian liver foundation, 2012, POS STAT HEP C TEST; CDC, 2015, TEST REC HEP C VIR I; Grad R, 2017, CAN MED ASSOC J, V189, pE594, DOI 10.1503/cmaj.161521; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Joy JB, 2016, LANCET INFECT DIS, V16, P698, DOI 10.1016/S1473-3099(16)00124-9; Klumpp K, 2011, HEPATITIS C: ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, P293; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Minuk GY, 2003, CAN J GASTROENTEROL, V17, P707, DOI 10.1155/2003/350175; Myers RP, 2008, CAN J GASTROENTEROL, V22, P381, DOI 10.1155/2008/173153; O'Brien SF, 2008, TRANSFUSION, V48, P902, DOI 10.1111/j.1537-2995.2007.01618.x; Ontario Agency for Health Protection and Promotion (Public Health Ontario-PHO) Provincial Infectious Diseases Advisory Committee, 2014, REC PUBL HLTH RESP H; Ontario Ministry of Health and Long-Term Care IntelliHEALTH Ontario, 2012, POPULATION ESTIMATES; Public Health Agency of Canada, 2011, HEP C CAN 2005 2010; Remis RS, 2007, MODELLING INCIDENCE; Rotermann M, 2013, HEALTH REP, V24, P3; Shah HA, 2013, CAN MED ASSOC J, V185, P1325, DOI 10.1503/cmaj.121872; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Statistics Canada, 2016, TABL 051 0001 EST PO; Stewart Lynn A, 2015, CMAJ Open, V3, pE97, DOI 10.9778/cmajo.20140025; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429; Trubnikov Max, 2014, CMAJ Open, V2, pE281, DOI 10.9778/cmajo.20140041; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wong WWL, 2015, CAN MED ASSOC J, V187, pE110, DOI 10.1503/cmaj.140711; Wood E, 2005, PUBLIC HEALTH, V119, P1111, DOI 10.1016/j.puhe.2005.05.006; World Health Organization, 2016, HEP C FACT SHEET	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191184	10.1371/journal.pone.0191184	http://dx.doi.org/10.1371/journal.pone.0191184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360823	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800018
J	Chalkias, S; Gorham, JM; Mazaika, E; Partenov, M; Deng, X; DePalma, S; McKean, D; Seidman, CE; Seidman, JG; Koralnik, IJ				Chalkias, Spyros; Gorham, Joshua M.; Mazaika, Erica; Partenov, Michael; Deng, Xin; DePalma, Steve; McKean, David; Seidman, Christine E.; Seidman, Jonathan G.; Koralnik, Igor J.			ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS; DNA; IMMUNOSUPPRESSION; POLYOMAVIRUSES; MUTATIONS; INFECTION; VARIANT; VIROME; TISSUE	Deep nucleotide sequencing enables the unbiased, broad-spectrum detection of viruses in clinical samples without requiring an a priori hypothesis for the source of infection. However, its use in clinical research applications is limited by low cost-effectiveness given that most of the sequencing information from clinical samples is related to the human genome, which renders the analysis of viral genomes challenging. To overcome this limitation we developed ViroFind, an in-solution target-enrichment platform for virus detection and discovery in clinical samples. ViroFind comprises 165,433 viral probes that cover the genomes of 535 selected DNA and RNA viruses that infect humans or could cause zoonosis. The ViroFind probes are used in a hybridization reaction to enrich viral sequences and therefore enhance the detection of viral genomes via deep sequencing. We used ViroFind to detect and analyze all viral populations in the brain of 5 patients with progressive multifocal leukoencephalopathy (PML) and of 18 control subjects with no known neurological disease. Compared to direct deep sequencing, by using ViroFind we enriched viral sequences present in the clinical samples up to 127-fold. We discovered highly complex polyoma virus JC populations in the PML brain samples with a remarkable degree of genetic divergence among the JC virus variants of each PML brain sample. Specifically for the viral capsid protein VP1 gene, we identified 24 single nucleotide substitutions, 12 of which were associated with amino acid changes. The most frequent (4 of 5 samples, 80%) amino acid change was D66H, which is associated with enhanced tissue tropism, and hence likely a viral fitness advantage, compared to other variants. Lastly, we also detected sparse JC virus sequences in 10 of 18 (55.5%) of control samples and sparse human herpes virus 6B (HHV6B) sequences in the brain of 11 of 18 (61.1%) control subjects. In sum, ViroFind enabled the in-depth analysis of all viral genomes in PML and control brain samples and allowed us to demonstrate a high degree of JC virus genetic divergence in vivo that has been previously underappreciated. ViroFind can be used to investigate the structure of the virome with unprecedented depth in health and disease state.	[Chalkias, Spyros; Deng, Xin; Koralnik, Igor J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Dept Med,Div NeuroImmunol, Boston, MA 02115 USA; [Chalkias, Spyros; Gorham, Joshua M.; Mazaika, Erica; Partenov, Michael; DePalma, Steve; McKean, David; Seidman, Christine E.; Seidman, Jonathan G.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Deng, Xin; Koralnik, Igor J.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Chalkias, Spyros] Biogen, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Rush University; Biogen	Koralnik, IJ (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Dept Med,Div NeuroImmunol, Boston, MA 02115 USA.; Koralnik, IJ (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	igor_koralnik@rush.edu		DePalma, Steven/0000-0002-0381-5016	Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center [U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162]; Howard Hughes Medical Institute [NIH R01 NS047029, NS074995, R21 NS099787]; Biogen; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074995, R01NS047029] Funding Source: NIH RePORTER	Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biogen(Biogen); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center to Dr. S. Chalkias U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, and U01-HL098162, to Dr. J. Seidman, the Howard Hughes Medical Institute to Dr. C. Seidman NIH R01 NS047029 and NS074995, R21 NS099787 and a research grant from Biogen to Dr. I. Koralnik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss J, 2011, PATHOLOGY, V43, P362, DOI 10.1097/PAT.0b013e3283463558; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; Chou SW, 2014, ANTIMICROB AGENTS CH, V58, P4697, DOI 10.1128/AAC.03214-14; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Dang X, 2012, J GEN VIROL, V93, P175, DOI 10.1099/vir.0.037440-0; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Delbue S, 2009, J NEUROVIROL, V15, P51, DOI 10.1080/13550280802425467; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Gheuens S, 2013, ANNU REV PATHOL-MECH, V8, P189, DOI 10.1146/annurev-pathol-020712-164018; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Jelcic I, 2016, ANN NEUROL, V79, P404, DOI 10.1002/ana.24574; Jelcic I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8691; Lam WY, 2010, J CLIN VIROL, V48, P11, DOI 10.1016/j.jcv.2010.01.017; Leibovitch EC, 2014, CURR OPIN VIROL, V9, P127, DOI 10.1016/j.coviro.2014.09.016; Lipkin WI, 2015, VIROLOGY, V479, P194, DOI 10.1016/j.virol.2015.02.006; Marshall LJ, 2012, J GEN VIROL, V93, P651, DOI 10.1099/vir.0.035832-0; Marshall LJ, 2010, J GEN VIROL, V91, P3042, DOI 10.1099/vir.0.023184-0; McCrone JT, 2016, J VIROL, V90, P6884, DOI 10.1128/JVI.00667-16; Merelli E, 1997, J NEUROL, V244, P450, DOI 10.1007/s004150050121; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Nakamichi K, 2013, ARCH VIROL, V158, P639, DOI 10.1007/s00705-012-1532-3; Orton RJ, 2016, REV SCI TECH OIE, V35, P271, DOI 10.20506/rst.35.1.2432; Pal S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S17-S7; Parfenov M, 2015, CURR PROTOC HUM GENE, V86; Perez-Liz G, 2008, ANN NEUROL, V64, P379, DOI 10.1002/ana.21443; Ray U, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1720; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Renzette N, 2014, CURR OPIN VIROL, V8, P109, DOI 10.1016/j.coviro.2014.08.001; Renzette N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003735; Sahoo MK, 2013, J CLIN MICROBIOL, V51, P3700, DOI 10.1128/JCM.01605-13; Sanders VJ, 1996, J NEUROVIROL, V2, P249, DOI 10.3109/13550289609146888; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Takahashi K, 2017, J VIROL, V91, DOI [10.1128/JVI.01335-16, 10.1128/jvi.01335-16]; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Van Loy T, 2015, J VIROL, V89, P1340, DOI 10.1128/JVI.02565-14; Van Loy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070950; Wharton KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155897; WHITE FA, 1992, J VIROL, V66, P5726, DOI 10.1128/JVI.66.10.5726-5734.1992; Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115; Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0186945	10.1371/journal.pone.0186945	http://dx.doi.org/10.1371/journal.pone.0186945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360822	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800001
J	Ogunsemowo, O; Olaleye, DO; Odaibo, GN				Ogunsemowo, Olukunle; Olaleye, David O.; Odaibo, Georgina N.			Genetic diversity of human respiratory syncytial virus circulating among children in Ibadan, Nigeria	PLOS ONE			English	Article							G-PROTEIN; G-GLYCOPROTEIN; ON1 GENOTYPE; EPIDEMIOLOGY; DUPLICATION; SUBGROUP; SEASONS	Human respiratory syncytial virus (HRSV) is the most common viral cause of acute lower respiratory tract infections (LRTIs) in infants and young children however, without an effective vaccine licensed for human use till date. Information on the circulating genotypes of HRSV from regions with high-burden of infection is vital in the global efforts towards the development of protective vaccine. We report here the genotypes of HRSV circulating among children in Ibadan, the first of such from Nigeria. Nasopharyngeal and oropharyngeal swabs collected from 231 children presenting with respiratory infections in some health facilities for care as well as those attending immunization centers for routine vaccination in Ibadan, Nigeria were used for the study. The 2nd hypervariable (HVR2) region of the glycoprotein (G) gene of HRSV was amplified and sequenced using HRSV group specific primers. HRSV was detected in 41 out of the 231 samples. Thirty-three of the isolates were successfully subtyped(22 subtype A and 11 subtype B). Fourteen of the subtype A and all the subtype B were successfully sequenced and genotyped. Phylogenetic analysis showed that genotype ON1 with 72 nucleotide (nt) duplication was the major subgroup A virus (11 of 14) detected together with genotype NA2. All the HRSV subtype B detected belong to the BA genotype with characteristic 60nt duplication. The ON1 genotypes vary considerably from the prototype strain due to amino acid substitutions including T2921 which has not been reported elsewhere. The NA2 genotypes have mutations on four antigenic sites within the HVR2relative to the prototype A2. In conclusion, three genotypes of HRSV were found circulating in Ibadan, Nigeria. Additional study that will include isolates from other parts of the country will be done to determine the extent of genotype diversity of HRSV circulating in Nigeria.	[Ogunsemowo, Olukunle; Olaleye, David O.; Odaibo, Georgina N.] Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria	University of Ibadan	Odaibo, GN (corresponding author), Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria.	foreodaibo@hotmail.com			Medical Education Partnership Initiative in Nigeria (MEPIN) project - National Human Genome Research Institute of the National Institute of Health; Medical Education Partnership Initiative in Nigeria (MEPIN) project - Office of AIDS Research of the National Institute of Health; Health Resources and Services Administration (HRSA); Medical Education Partnership Initiative in Nigeria (MEPIN) project - Fogarty International Center of the National Institute of Health; Office of the U.S. Global AIDS Coordinator [R24TW008878]; FOGARTY INTERNATIONAL CENTER [R24TW008878] Funding Source: NIH RePORTER	Medical Education Partnership Initiative in Nigeria (MEPIN) project - National Human Genome Research Institute of the National Institute of Health; Medical Education Partnership Initiative in Nigeria (MEPIN) project - Office of AIDS Research of the National Institute of Health; Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Medical Education Partnership Initiative in Nigeria (MEPIN) project - Fogarty International Center of the National Institute of Health; Office of the U.S. Global AIDS Coordinator; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Writing of this paper was supported by the Medical Education Partnership Initiative in Nigeria (MEPIN) project funded by Fogarty International Center, the Office of AIDS Research, and the National Human Genome Research Institute of the National Institute of Health, the Health Resources and Services Administration (HRSA) and the Office of the U.S. Global AIDS Coordinator under Award Number R24TW008878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Amarasinghe GK, 2018, ARCH VIROL, V163, P2283, DOI 10.1007/s00705-018-3814-x; Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Cane P, 2007, RESP SYNCYTIAL VIRUS, P89; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fall A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157163; Human S, 2016, FUTUR VIROL; Khan WH, 2014, ORIGINAL RES ARTICLE, V3, P107; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K., 2011, MOL BIOL EVOLU UNPUB; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Zheng YX, 2017, J MED VIROL, V89, P222, DOI 10.1002/jmv.24640	35	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191494	10.1371/journal.pone.0191494	http://dx.doi.org/10.1371/journal.pone.0191494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360861	gold, Green Submitted, Green Published			2022-12-26	WOS:000423161800034
J	Omosun, YO; Blackstock, AJ; Williamson, J; van Eijk, AM; Ayisi, J; Otieno, J; Lal, RB; ter Kuile, FO; Slutsker, L; Shi, YP				Omosun, Yusuf O.; Blackstock, Anna J.; Williamson, John; van Eijk, Anne Maria; Ayisi, John; Otieno, Juliana; Lal, Renu B.; ter Kuile, Feiko O.; Slutsker, Laurence; Shi, Ya Ping			Association of maternal KIR gene content polymorphisms with reduction in perinatal transmission of HIV-1	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOGLOBULIN-LIKE RECEPTORS; ASYMPTOMATIC PREGNANT-WOMEN; NK CELL REPERTOIRE; WESTERN KENYA; RISK-FACTORS; CLASS-I; TYPE-1 TRANSMISSION; PLACENTAL MALARIA	The role of killer cell immunoglobulin-like receptors (KIRs) in the transmission of HIV-1 has not been extensively studied. Here, we investigated the association of KIR gene content polymorphisms with perinatal HIV-1 transmission. The KIR gene family comprising 16 genes was genotyped in 313 HIV-1 positive Kenyan mothers paired with their infants. Gene content polymorphisms were presented as presence of individual KIR genes, haplotypes, genotypes and KIR gene concordance. The genetic data were analyzed for associations with perinatal transmission of HIV. There was no association of infant KIR genes with perinatal HIV-1 transmission. After adjustment for gravidity, viral load, and CD4 cell count, there was evidence of an association between reduction in perinatal HIV-1 transmission and the maternal individual KIR genes KIR2DL2 (adjusted OR = 0.50; 95% CI: 0.24-1.02, P = 0.06), KIR2DL5 (adjusted OR = 0.47; 95% CI: 0.23-0.95, P = 0.04) and KIR2DS5 (adjusted OR = 0.39; 95% CI: 0.18-0.80, P = 0.01). Furthermore, these maternal KIR genes were only significantly associated with reduction in perinatal HIV transmission in women with CD4 cell count >= 350 cells/pl and viral load <10000 copies/ml. Concordance analysis showed that when both mother and child had KIR2DS2, there was less likelihood of perinatal HIV-1 transmission (adjusted OR = 0.44; 95% CI: 0.20-0.96, P = 0.039). In conclusion, the maternal KIR genes KIR2DL2, KIR2DL5, KIR2DS5, and KIR2DS2 were associated with reduction of HIV-1 transmission from mother to child. Furthermore, maternal immune status is an important factor in the association of KIR with perinatal HIV transmission.	[Omosun, Yusuf O.; Blackstock, Anna J.; Williamson, John; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Omosun, Yusuf O.] Atlanta Res & Educ Fdn, Atlanta, GA USA; [van Eijk, Anne Maria; Ayisi, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [van Eijk, Anne Maria; ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool, Merseyside, England; [Otieno, Juliana] Minist Hlth, New Nyanza Prov Gen Hosp, Kisumu, Kenya; [Lal, Renu B.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Liverpool School of Tropical Medicine; Centers for Disease Control & Prevention - USA	Shi, YP (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	Yshi@cdc.gov	Omosun, Yusuf/P-9944-2019; Kuile, Feiko ter/ABD-6681-2020; van Eijk, Anna Maria/AAQ-9894-2021	Omosun, Yusuf/0000-0003-4759-6254; Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	National Office of Public Health Genomics, Centers for Disease Control and Prevention [92129RQ]; Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	National Office of Public Health Genomics, Centers for Disease Control and Prevention; Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	This study was supported by intramural funding from The National Office of Public Health Genomics, Centers for Disease Control and Prevention (Project ID# 92129RQ) and The Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayisi JG, 2000, INT J STD AIDS, V11, P393, DOI 10.1258/0956462001916119; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Brahmbhatt H, 2003, AIDS, V17, P2539, DOI 10.1097/00002030-200311210-00020; Buchanan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088679; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Gouveia PAD, 2013, TROP MED INT HEALTH, V18, P276, DOI 10.1111/tmi.12042; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Faridi RM, 2009, HUM REPROD, V24, P1758, DOI 10.1093/humrep/dep047; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gonzalez A, 2008, TISSUE ANTIGENS, V72, P11, DOI 10.1111/j.1399-0039.2008.01050.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hong HA, 2013, CLIN IMMUNOL, V149, P498, DOI 10.1016/j.clim.2013.09.005; Hou LH, 2010, IMMUNOGENETICS, V62, P491, DOI 10.1007/s00251-010-0458-8; Hou LH, 2009, HUM IMMUNOL, V70, P733, DOI 10.1016/j.humimm.2009.04.028; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Jennes W, 2013, BLOOD, V121, P1157, DOI 10.1182/blood-2012-09-455352; Jennes W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017043; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Khosa E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-7; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092; Marsh SGE, 2003, TISSUE ANTIGENS, V62, P79, DOI 10.1034/j.1399-0039.2003.00072.x; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Msamanga GI, 2009, AM J TROP MED HYG, V80, P508, DOI 10.4269/ajtmh.2009.80.508; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112; Norman PJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003938; Okawa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0697-7; Omosun YO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038617; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parham P, 2003, TISSUE ANTIGENS, V62, P194, DOI 10.1034/j.1399-0039.2003.00126.x; Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541; Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477; Scarlatti G, 2004, AIDS REV, V6, P67; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van Eijk AM, 2002, T ROY SOC TROP MED H, V96, P586, DOI 10.1016/S0035-9203(02)90319-6; Van Eijk AM, 2001, AM J TROP MED HYG, V65, P623, DOI 10.4269/ajtmh.2001.65.623; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Williams AP, 2005, MOL INTERV, V5, P226, DOI 10.1124/mi.5.4.6; Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	56	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191733	10.1371/journal.pone.0191733	http://dx.doi.org/10.1371/journal.pone.0191733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360870	Green Published, Green Accepted, gold			2022-12-26	WOS:000423161800058
J	Chang, HC; Kung, CCH; Chang, TT; Jao, SC; Hsu, YT; Li, WS				Chang, Hui-Chuan; Kung, Camy C. -H.; Chang, Tzu-Ting; Jao, Shu-Chuan; Hsu, Yu-Ting; Li, Wen-Shan			Investigation of the proton relay system operative in human cystosolic aminopeptidase P	PLOS ONE			English	Article							COUPLED ELECTRON-TRANSFER; X-PROLYL-AMINOPEPTIDASE; CIRCULAR-DICHROISM SPECTRA; SITE-DIRECTED MUTANT; ESCHERICHIA-COLI; CHEMICAL RESCUE; ACTIVE-SITE; GUANIDINE-HYDROCHLORIDE; THERMAL-STABILITY; SECONDARY STRUCTURE	Aminopeptidase P, a metalloprotease, targets Xaa-Proline peptides for cleavage [1-4]. There are two forms of human AMPP, a membrane-bound form (hmAMPP) and a soluble cytosolic form (hcAMPP)[5]. Similar to the angiotensin-I-converting enzyme, AMPP plays an important role in the catabolism of inflammatory and vasoactive peptides, known as kinins. The plasma kinin, bradykinin, was used as the substrate to conduct enzymatic activity analyses and to determine the Michaelis constant (K-m) of 174 mu M and the catalytic rate constant (k(cat)) of 10.8 s(-1) for hcAMPP. Significant differences were observed in the activities of Y527F and R535A hcAMPP mutants, which displayed a 6-fold and 13.5-fold for decrease in turnover rate, respectively. Guanidine hydrochloride restored the activity of R535A hcAMPP, increasing the k(cat)/K-m 20-fold, yet it had no impact on the activities of the wild-type or Y527F mutant hcAMPPs. Activity restoration by guanidine derivatives followed the order guanidine hydrochloride >> methyl-guanidine > amino-guanidine > N-ethyl-guanidine. Overall, the results indicate the participation of R535 in the hydrogen bond network that forms a proton relay system. The quaternary structure of hcAMPP was determined by using analytical ultracentrifugation (AUC). The results show that alanine replacement of Arg535 destabilizes the hcAMPP dimer and that guanidine hydrochloride restores the native monomer-dimer equilibrium. It is proposed that Arg535 plays an important role in hcAMMP catalysis and in stabilization of the catalytically active dimeric state.	[Chang, Hui-Chuan; Kung, Camy C. -H.; Chang, Tzu-Ting; Hsu, Yu-Ting; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan; [Jao, Shu-Chuan] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Li, Wen-Shan] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Sun Yat Sen University	Li, WS (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.; Li, WS (corresponding author), Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan.	wenshan@gate.sinica.edu.tw	Li, Wen-Shan/F-1972-2015	Li, Wen-Shan/0000-0002-8359-4582	Academia Sinica; Ministry of Science and Technology (MOST, Taiwan) [MOST 103-2113-M-001-024-MY3, NSC 95-2113-M-001-018-MY3, MOST 105-0210-01-13-01]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology (MOST, Taiwan)	Dr. Wen-Shan Li is grateful for financial support of this study provided by the Academia Sinica and Ministry of Science and Technology (MOST, Taiwan, MOST 103-2113-M-001-024-MY3, NSC 95-2113-M-001-018-MY3 and MOST 105-0210-01-13-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; Bertini I., 2007, BIOL INORGANIC CHEM; Boehlein SK, 1997, J BIOL CHEM, V272, P12384, DOI 10.1074/jbc.272.19.12384; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15129, DOI 10.1021/bi0015865; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; DEHM P, 1970, EUR J BIOCHEM, V17, P364, DOI 10.1111/j.1432-1033.1970.tb01174.x; Drinkwater N, 2016, BIOCHEM J, V473, P3189, DOI 10.1042/BCJ20160550; Ersahin C, 1999, J CARDIOVASC PHARM, V34, P604, DOI 10.1097/00005344-199910000-00019; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; GOWARD CR, 1994, EUR J BIOCHEM, V224, P249, DOI 10.1111/j.1432-1033.1994.tb20018.x; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; Graham SC, 2003, ACTA CRYSTALLOGR D, V59, P897, DOI 10.1107/S0907444903005870; Graham SC, 2008, ARCH BIOCHEM BIOPHYS, V469, P200, DOI 10.1016/j.abb.2007.10.009; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Griffiths J. R., 2016, ANAL PROTEIN POSTTRA; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; HARDY F, 1994, PROTEIN ENG, V7, P425, DOI 10.1093/protein/7.3.425; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HARPEL MR, 1994, BIOCHEMISTRY-US, V33, P5553, DOI 10.1021/bi00184a026; Hayes D, 1995, PROGRAM SEDNTERP SED; Hsu YT, 2008, CHEM BIODIVERS, V5, P1401, DOI 10.1002/cbdv.200890128; Huang LF, 2006, CHEMBIOCHEM, V7, P506, DOI 10.1002/cbic.200500412; Hung JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087134; Iyer S, 2015, FEBS OPEN BIO, V5, P292, DOI 10.1016/j.fob.2015.03.013; Jang JW, 2001, BIOTECHNOL APPL BIOC, V34, P81, DOI 10.1042/BA20010027; Jao SC, 2006, BIOCHEMISTRY-US, V45, P1547, DOI 10.1021/bi051786m; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Kitamura S, 1999, AM J PHYSIOL-HEART C, V276, pH1664, DOI 10.1152/ajpheart.1999.276.5.H1664; Klimacek M, 2012, J BIOL CHEM, V287, P6655, DOI 10.1074/jbc.M111.289223; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; PHILLIPS MA, 1992, PROTEIN SCI, V1, P517; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Reyes AC, 2015, J AM CHEM SOC, V137, P5312, DOI 10.1021/jacs.5b02202; Robbins JM, 2012, BIOCHEMISTRY-US, V51, P6378, DOI 10.1021/bi300138d; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHERMAN MA, 1990, J BIOL CHEM, V265, P10659; Siegbahn PEM, 2010, CHEM REV, V110, P7040, DOI 10.1021/cr100070p; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m; Sprinkle TJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P51, DOI 10.1006/abbi.2000.1792; Sprinkle TJ, 1998, GENOMICS, V50, P114, DOI 10.1006/geno.1998.5302; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TANAKA T, 1992, BIOCHEMISTRY-US, V31, P2259, DOI 10.1021/bi00123a007; TANFORD C, 1966, J BIOL CHEM, V241, P1921; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; WANG WY, 1995, J BIOL CHEM, V270, P13160, DOI 10.1074/jbc.270.22.13160; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; Xiao LL, 2014, RSC ADV, V4, P41807, DOI 10.1039/c4ra08101c	69	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190816	10.1371/journal.pone.0190816	http://dx.doi.org/10.1371/journal.pone.0190816			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351301	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300029
J	Sabry, AH; Hasan, WZW; Ab Kadir, MZA; Radzi, MAM; Shafie, S				Sabry, A. H.; Hasan, W. Z. W.; Ab Kadir, M. Z. A.; Radzi, M. A. M.; Shafie, S.			Field data-based mathematical modeling by Bode equations and vector fitting algorithm for renewable energy applications	PLOS ONE			English	Article							RATIONAL APPROXIMATION; FREQUENCY-DOMAIN; POWER; PREDICTION; FILTERS; CURVES; DESIGN; SYSTEM; SOLAR	The power system always has several variations in its profile due to random load changes or environmental effects such as device switching effects when generating further transients. Thus, an accurate mathematical model is important because most system parameters vary with time. Curve modeling of power generation is a significant tool for evaluating system performance, monitoring and forecasting. Several numerical techniques compete to fit the curves of empirical data such as wind, solar, and demand power rates. This paper proposes a new modified methodology presented as a parametric technique to determine the system's modeling equations based on the Bode plot equations and the vector fitting (VF) algorithm by fitting the experimental data points. The modification is derived from the familiar VF algorithm as a robust numerical method. This development increases the application range of the VF algorithm for modeling not only in the frequency domain but also for all power curves. Four case studies are addressed and compared with several common methods. From the minimal RMSE, the results show clear improvements in data fitting over other methods. The most powerful features of this method is the ability to model irregular or randomly shaped data and to be applied to any algorithms that estimating models using frequency-domain data to provide state-space or transfer function for the model.	[Sabry, A. H.] Univ Putra Malaysia, Dept Control & Automat, Fac Engn, Serdang, Malaysia; [Hasan, W. Z. W.; Ab Kadir, M. Z. A.; Radzi, M. A. M.; Shafie, S.] Univ Putra Malaysia, Dept Elect & Elect Engn, Fac Engn, Serdang, Malaysia; [Sabry, A. H.] Minist Elect, Alqudus Power Plant, Baghdad, Iraq	Universiti Putra Malaysia; Universiti Putra Malaysia	Sabry, AH (corresponding author), Univ Putra Malaysia, Dept Control & Automat, Fac Engn, Serdang, Malaysia.; Hasan, WZW (corresponding author), Univ Putra Malaysia, Dept Elect & Elect Engn, Fac Engn, Serdang, Malaysia.; Sabry, AH (corresponding author), Minist Elect, Alqudus Power Plant, Baghdad, Iraq.	ahs4771384@gmail.com; wanzuha@upm.edu.my	Radzi, Mohd Amran Mohd/I-7637-2013; Hassan, Wan Zuha Wan/AAD-8694-2020; Kadir, Zainal/B-6629-2009; Sabry, Ahmad H./ACN-4519-2022	Radzi, Mohd Amran Mohd/0000-0003-3785-1573; Hassan, Wan Zuha Wan/0000-0003-4691-066X; Kadir, Zainal/0000-0001-7263-2953; Sabry, Ahmad H./0000-0002-2736-5582; Shafie, Suhaidi/0000-0002-8867-2754				Ai B, 2003, RENEW ENERG, V28, P1491, DOI 10.1016/S0960-1481(03)00011-9; Almeida MP, 2015, SOL ENERGY, V115, P354, DOI 10.1016/j.solener.2015.03.006; Andersson G, 2008, EEH POWER SYST L SEP, P183; [Anonymous], 2017, GRID DATA CONSUMPTIO; Chedid R, 1998, IEEE T ENERGY CONVER, V13, P76, DOI 10.1109/60.658207; Chiou-Jye Huang, 2013, International Journal of Smart Grid and Clean Energy, V2, P139; Cho HR, 2013, J AM STAT ASSOC, V108, P7, DOI 10.1080/01621459.2012.722900; De Tommasi L, 2010, AEU-INT J ELECTRON C, V64, P218, DOI 10.1016/j.aeue.2008.12.006; Deschrijver D, 2007, IEEE T ADV PACKAGING, V30, P216, DOI 10.1109/TADVP.2006.879429; Deschrijver D, 2007, IEEE T POWER DELIVER, V22, P1633, DOI 10.1109/TPWRD.2007.899584; Deschrijver D, 2007, IEEE T MICROW THEORY, V55, P736, DOI 10.1109/TMTT.2007.893651; Dhaene T, 2005, ELECTRON LETT, V41, P299, DOI 10.1049/el:20057913; Diaf S, 2007, ENERG POLICY, V35, P5708, DOI 10.1016/j.enpol.2007.06.020; Engineering C, COMP ARX AR MOD ASS; Gerald K B, 1991, Nurse Anesth, V2, P93; GIORSETTO P, 1983, IEEE T POWER AP SYST, V102, P134, DOI 10.1109/TPAS.1983.318006; Grivet-Talocia S, 2004, AEU-INT J ELECTRON C, V58, P293, DOI 10.1078/1434-8411-54100245; Grivet-Talocia S, 2003, IEEE MICROW WIREL CO, V13, P472, DOI 10.1109/LMWC.2003.819378; Gustavsen B, 1999, IEEE T POWER DELIVER, V14, P1052, DOI 10.1109/61.772353; Gustavsen B, 1998, IEEE T POWER DELIVER, V13, P605, DOI 10.1109/61.660941; Gustavsen B, 2006, IEEE T POWER DELIVER, V21, P1587, DOI 10.1109/TPWRD.2005.860281; Gustavsen B, 2008, IEEE T ADV PACKAGING, V31, P664, DOI 10.1109/TADVP.2008.927810; Hastie T., 1986, STAT SCI, V1, P297; Hu C, 2015, ENERGY COORDINATIVE, P1505; Jun T, 2010, PHOTOVOLTAIC ARRAY P, P10; Khalfallah MG, 2007, DESALINATION, V209, P221, DOI 10.1016/j.desal.2007.04.031; Kusiak A, 2009, RENEW ENERG, V34, P583, DOI 10.1016/j.renene.2008.05.032; Lawrence EO, 2010, ANAL WIND POWER LOAD; Lei CU, 2008, I CONF VLSI DESIGN, P469, DOI 10.1109/VLSI.2008.12; Lei CU, 2009, IEEE SIGNAL PROC LET, V16, P533, DOI 10.1109/LSP.2009.2017478; Lorenz E, 2011, PROG PHOTOVOLTAICS, V19, P757, DOI 10.1002/pip.1033; Lu N, 2004, MODELING POWER SYSTE; Lydia M, 2014, RENEW SUST ENERG REV, V30, P452, DOI 10.1016/j.rser.2013.10.030; Lydia M, 2013, IEEE T SUSTAIN ENERG, V4, P827, DOI 10.1109/TSTE.2013.2247641; Mechaqrane A, 2004, NEURAL COMPUT APPL, V13, P32, DOI 10.1007/s00521-004-0401-8; Nouri B, 2010, IEEE T ADV PACKAGING, V33, P293, DOI 10.1109/TADVP.2009.2019965; Olauson J, 2015, RENEW ENERG, V76, P717, DOI 10.1016/j.renene.2014.11.085; Paatero JV, 2006, INT J ENERG RES, V30, P273, DOI 10.1002/er.1136; Pelland S, 2011, SOLAR PHOTOVOLTAIC F; Pelland S, 2013, PROG PHOTOVOLTAICS, V21, P284, DOI 10.1002/pip.1180; Pollock DSG., 2008, SMOOTHING CUBIC SPLI; Price P., 2010, METHODS ANAL ELECT L; RTE, 2017, RTE CUST AR DAIL LOA; Sabry Ahmad H., 2015, Applied Mechanics and Materials, V785, P225, DOI 10.4028/www.scientific.net/AMM.785.225; Sabry A. H., 2015, J APPL MECH MAT, V785, P156; Seppala A., 1996, LOAD RES LOAD ESTIMA, P3; Shokrzadeh S, 2014, IEEE T SUSTAIN ENERG, V5, P1262, DOI 10.1109/TSTE.2014.2345059; Sihvola AH, 2006, SPECIAL PUBL ESA SP, V626, P310; Sohoni V, 2016, CRITICAL REV WIND TU, V2016, P1; Spataru S, 2013, IEEE PHOT SPEC C; Stevens N, 2007, 2007 IEEE WORKSHOP ON SIGNAL PROPAGATION ON INTERCONNECTS, P89, DOI 10.1109/SPI.2007.4512218; Ustuntas T, 2008, J WIND ENG IND AEROD, V96, P611, DOI 10.1016/j.jweia.2008.02.001; Weiliang Liu, 2013, Journal of Software, V8, P2569, DOI 10.4304/jsw.8.10.2569-2574; Wong N, 2007, IEEE INT SYMP CIRC S, P2343, DOI 10.1109/ISCAS.2007.378858; Zhang WP, 2009, IEEE T COMPUT AID D, V28, P1348, DOI 10.1109/TCAD.2009.2024711	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191478	10.1371/journal.pone.0191478	http://dx.doi.org/10.1371/journal.pone.0191478			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351554	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000422911300095
J	Shah, BS; Ashwood, HE; Harrop, SJ; Farrugia, DN; Paulsen, IT; Mabbutt, BC				Shah, Bhumika S.; Ashwood, Heather E.; Harrop, Stephen J.; Farrugia, Daniel N.; Paulsen, Ian T.; Mabbutt, Bridget C.			Crystal structure of a UDP-GlcNAc epimerase for surface polysaccharide biosynthesis in Acinetobacter baumannii	PLOS ONE			English	Article							PROTEIN; MECHANISM; LIPOPOLYSACCHARIDE; EPIDEMIOLOGY; REDUCTASE; SOFTWARE; SEQUENCE; STRAINS; FLAA1; CAPE	With new strains of Acinetobacter baumannii undergoing genomic analysis, it has been possible to define regions of genomic plasticity (RGPs), encoding specific adaptive elements. For a selected RGP from a community-derived isolate of A. baumannii, we outline sequences compatible with biosynthetic machinery of surface polysaccharides, specifically enzymes utilized in the dehydration and conversion of UDP-N-acetyl-D-glucosamine (UDP-D-GlcNAc). We have determined the crystal structure of one of these, the epimerase Ab-WbjB. This dehydratase belongs to the 'extended' short-chain dehydrogenase/reductase (SDR) family, related in fold to previously characterised enzymes CapE and FlaA1. Our 2.65 angstrom resolution structure of Ab-WbjB shows a hexamer, organised into a trimer of chain pairs, with coenzyme NADP+ occupying each chain. Specific active-site interactions between each coenzyme and a lysine quaternary group of a neighbouring chain interconnect adjacent dimers, so stabilising the hexameric form. We show UDP-GlcNAc to be a specific substrate for Ab-WbjB, with binding evident by ITC (K-a = 0.23 mu mol(-1)). The sequence of Ab-WbjB shows variation from the consensus active-site motifs of many SDR enzymes, demonstrating a likely catalytic role for a specific threonine sidechain (as an alternative to tyrosine) in the canonical active site chemistry of these epimerases.	[Shah, Bhumika S.; Ashwood, Heather E.; Farrugia, Daniel N.; Paulsen, Ian T.; Mabbutt, Bridget C.] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Harrop, Stephen J.] Univ New South Wales, Sch Phys, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney	Mabbutt, BC (corresponding author), Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia.	bridget.mabbutt@mq.edu.au	; Paulsen, Ian/K-3832-2012	Ashwood, Heather/0000-0001-9722-629X; Paulsen, Ian/0000-0001-9015-9418; Shah, Bhumika/0000-0001-8968-440X	Australian Research Council grant [FL140100021]	Australian Research Council grant(Australian Research Council)	Australian Research Council grant FL140100021to ITP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brunelle JL, 2014, METHOD ENZYMOL, V541, P151, DOI 10.1016/B978-0-12-420119-4.00012-4; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Dean CR, 1999, J BACTERIOL, V181, P4275, DOI 10.1128/JB.181.14.4275-4284.1999; DeLano WL, 2002, THE PYMOL MOLECULAR; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Farrugia DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058628; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Giguere D, 2015, CARBOHYD RES, V418, P29, DOI 10.1016/j.carres.2015.10.001; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Haseley SR, 1997, EUR J BIOCHEM, V244, P147, DOI 10.1111/j.1432-1033.1997.00147.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Huang H, 2012, J ANTIMICROB CHEMOTH, V67, P2825, DOI 10.1093/jac/dks327; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Kroger C, 2016, GENES, V8; LEE CR, 2017, FRONT CELL INFECT MI, V7; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Merkx-Jacques A, 2004, J BACTERIOL, V186, P2253, DOI 10.1128/JB.186.8.2253-2265.2004; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; Miyafusa T, 2013, BIOSCIENCE REP, V33, P463, DOI 10.1042/BSR20130017; Mulrooney EF, 2005, J BIOL CHEM, V280, P19535, DOI 10.1074/jbc.M500612200; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Pantophlet R, 1999, CLIN DIAGN LAB IMMUN, V6, P323, DOI 10.1128/CDLI.6.3.323-329.1999; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Sennett NC, 2012, BIOCHEMISTRY-US, V51, P9364, DOI 10.1021/bi301067w; Shah BS, 2014, ACTA CRYSTALLOGR F, V70, P1318, DOI 10.1107/S2053230X14019785; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Weber BS, 2016, J BACTERIOL, V198, P880, DOI 10.1128/JB.00906-15; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	57	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191610	10.1371/journal.pone.0191610	http://dx.doi.org/10.1371/journal.pone.0191610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352301	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300120
J	Mundhenk, L; Erickson, NA; Klymiuk, N; Gruber, AD				Mundhenk, Lars; Erickson, Nancy A.; Klymiuk, Nikolai; Gruber, Achim D.			Interspecies diversity of chloride channel regulators, calcium-activated 3 genes	PLOS ONE			English	Article							MEMBRANE-PROTEINS; FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; RESPIRATORY-DISEASE; LUNG METASTASIS; PLUNC GENE; FAMILY; EXPRESSION; CLONING; MCLCA3	Members of the chloride channel regulators, calcium-activated (CLCA) family, have been implicated in diverse biomedical conditions, including chronic inflammatory airway diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, the activation of macrophages, and the growth and metastatic spread of tumor cells. Several observations, however, could not be repeated across species boundaries and increasing evidence suggests that select CLCA genes are particularly prone to dynamic species-specific evolvements. Here, we systematically characterized structural and expressional differences of the CLCA3 gene across mammalian species, revealing a spectrum of gene duplications, e.g., in mice and cows, and of gene silencing via diverse chromosomal modifications in pigs and many primates, including humans. In contrast, expression of a canonical CLCA3 protein from a single functional gene seems to be evolutionarily retained in carnivores, rabbits, guinea pigs, and horses. As an accepted asthma model, we chose the cat to establish the tissue and cellular expression pattern of the CLCA3 protein which was primarily found in mucin-producing cells of the respiratory tract and in stratified epithelia of the esophagus. Our results suggest that, among developmental differences in other CLCA genes, the CLCA3 gene possesses a particularly high dynamic evolutionary diversity with pivotal consequences for humans and other primates that seem to lack a CLCA3 protein. Our data also help to explain previous contradictory results on CLCA3 obtained from different species and warrant caution in extrapolating data from animal models in conditions where CLCA3 may be involved.	[Mundhenk, Lars; Erickson, Nancy A.; Gruber, Achim D.] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany; [Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Erickson, Nancy A.] German Rheumatism Res Ctr Berlin, Berlin, Germany	Free University of Berlin; University of Munich; Deutsches Rheuma-Forschungszentrum (DRFZ)	Mundhenk, L (corresponding author), Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany.	lars.mundhenk@fu-berlin.de	Klymiuk, Nikolai/AAB-8345-2022; Gruber, Achim D./ABA-4514-2021	Klymiuk, Nikolai/0000-0003-3532-1659; 	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB-TR 84 Z1b, MU 3015/1-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) grants SFB-TR 84 Z1b to ADG and MU 3015/1-1 to LM, ADG http://www.dfg.de/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle CD, 2011, BIOCHEM SOC T, V39, P961, DOI 10.1042/BST0390961; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Britto CJ, 2015, AM J RESP CELL MOL, V52, P525, DOI 10.1165/rcmb.2014-0297RT; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Connon CJ, 2004, J HISTOCHEM CYTOCHEM, V52, P415, DOI 10.1177/002215540405200313; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Erickson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131991; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1998, HISTOCHEM CELL BIOL, V110, P43, DOI 10.1007/s004180050263; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; Lee D, 1999, BIOCHEM BIOPH RES CO, V264, P933, DOI 10.1006/bbrc.1999.1583; Leverkoehne I, 2002, HISTOCHEM CELL BIOL, V118, P11, DOI 10.1007/s00418-002-0420-4; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plog S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140050; Plog S, 2012, CELL TISSUE RES, V350, P445, DOI 10.1007/s00441-012-1482-9; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; Roussa E, 2010, J HISTOCHEM CYTOCHEM, V58, P653, DOI 10.1369/jhc.2010.955211; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Williams K, 2016, J PATHOL, V238, P220, DOI 10.1002/path.4658; Yang B, 2015, CANCER-AM CANCER SOC, V121, P1570, DOI 10.1002/cncr.29235; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083943; ZHU DZ, 1992, J CLIN INVEST, V89, P1718, DOI 10.1172/JCI115773; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191512	10.1371/journal.pone.0191512	http://dx.doi.org/10.1371/journal.pone.0191512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346439	gold, Green Submitted, Green Published			2022-12-26	WOS:000422749500058
J	Hanna, JA; Garcia, MR; Lardennois, A; Leavey, PJ; Maglic, D; Fagnan, A; Go, JC; Roach, J; Wang, YD; Finkelstein, D; Hatley, ME				Hanna, Jason A.; Garcia, Matthew R.; Lardennois, Alicia; Leavey, Patrick J.; Maglic, Dino; Fagnan, Alexandre; Go, Jonathan C.; Roach, Jordan; Wang, Yong-Dong; Finkelstein, David; Hatley, Mark E.			PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma	ONCOGENE			English	Article							DOWN-REGULATION; PEDIATRIC RHABDOMYOSARCOMA; MICRORNA THERAPEUTICS; NORMAL ERYTHROPOIESIS; TUMOR PROGRESSION; IN-VIVO; GENE; EXPRESSION; FUSION; CANCER	Rhabdomyosarcoma is the most common soft-tissue sarcoma in childhood and histologically resembles developing skeletal muscle. Alveolar rhabdomyosarcoma (ARMS) is an aggressive subtype with a higher rate of metastasis and poorer prognosis. The majority of ARMS tumors (80%) harbor a PAX3-FOXO1 or less commonly a PAX7-FOXO1 fusion gene. The presence of either the PAX3-FOXO1 or PAX7-FOXO1 fusion gene foretells a poorer prognosis resulting in clinical reclassification as either fusion-positive (FP-RMS) or fusion-negative RMS (FN-RMS). The PAX3/7-FOXO1 fusion genes result in the production of a rogue transcription factors that drive FP-RMS pathogenesis and block myogenic differentiation. Despite knowing the molecular driver of FP-RMS, targeted therapies have yet to make an impact for patients, highlighting the need for a greater understanding of the molecular consequences of PAX3-FOXO1 and its target genes including microRNAs. Here we show FP-RMS patient-derived xenografts and cell lines display a distinct microRNA expression pattern. We utilized both loss-and gain-of function approaches in human cell lines with knockdown of PAX3-FOXO1 in FP-RMS cell lines and expression of PAX3-FOXO1 in human myoblasts and identified microRNAs both positively and negatively regulated by the PAX3-FOXO1 fusion protein. We demonstrate PAX3-FOXO1 represses miR-221/222 that functions as a tumor suppressing microRNA through the negative regulation of CCND2, CDK6, and ERBB3. In contrast, miR-486-5p is transcriptionally activated by PAX3-FOXO1 and promotes FP-RMS proliferation, invasion, and clonogenic growth. Inhibition of miR-486-5p in FP-RMS xenografts decreased tumor growth, illustrating a proof of principle for future therapeutic intervention. Therefore, PAX3-FOXO1 regulates key microRNAs that may represent novel therapeutic vulnerabilities in FP-RMS.	[Hanna, Jason A.; Garcia, Matthew R.; Lardennois, Alicia; Leavey, Patrick J.; Maglic, Dino; Fagnan, Alexandre; Go, Jonathan C.; Roach, Jordan; Hatley, Mark E.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Yong-Dong; Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hatley, ME (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	mark.hatley@stjude.org	Hanna, Jason/ABH-2969-2021; Hanna, Jason A./N-6157-2018; Hatley, Mark Edward/G-8764-2018	Hanna, Jason/0000-0001-7253-7964; Hanna, Jason A./0000-0001-7253-7964; Hatley, Mark Edward/0000-0001-7147-3946; Lardennois, Alicia/0000-0002-5054-7448	National Cancer Institute of the National Institutes of Health [R01CA216344, K08CA151649, 5R25CA23944]; V foundation for Cancer Research; Hyundai Hope on Wheels; Alex's Lemonade Stand Foundation; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944, R01CA216344, K08CA151649] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V foundation for Cancer Research; Hyundai Hope on Wheels; Alex's Lemonade Stand Foundation; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA216344 and K08CA151649 to M.E.H. and 5R25CA23944 to D.M. and J.R. The Hatley lab is also supported by the V foundation for Cancer Research, Hyundai Hope on Wheels, and Alex's Lemonade Stand Foundation and by the American Lebanese Syrian Associated Charities.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Alexander MS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-27; Ayyanathan K, 2000, CANCER RES, V60, P5803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Bersani F, 2016, CANCER RES, V76, P6095, DOI 10.1158/0008-5472.CAN-16-0709; Brioschi M, 2010, NEOPLASIA, V12, P866, DOI 10.1593/neo.10482; Cardinali B, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.10; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005075; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; DAVIS RJ, 1994, CANCER RES, V54, P2869; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Duan FH, 2012, GENE CHROMOSOME CANC, V51, P662, DOI 10.1002/gcc.21953; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Hanna JA, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.159; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hitachi K, 2014, INT J BIOCHEM CELL B, V47, P93, DOI 10.1016/j.biocel.2013.12.003; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kashi VP, 2015, NAT REV CANCER, V15, P426, DOI 10.1038/nrc3961; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; Koelz M, 2011, INT J ONCOL, V38, P503, DOI 10.3892/ijo.2010.857; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Machado E, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500603; Mahajan P, 2015, ONCOGENE, V34, P2681, DOI 10.1038/onc.2014.209; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Matsuzaki J, 2015, J CLIN MED, V4, P1566, DOI 10.3390/jcm4081566; Missiaglia E, 2017, CANCER LETT, V385, P251, DOI 10.1016/j.canlet.2016.10.011; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Narducci MG, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.32; Nordberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050819; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Omura N, 2016, ONCOTARGET, V7, P34977, DOI 10.18632/oncotarget.9009; Parham DM, 2013, WHO CLASSIFICATION T, P130; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Petak I, 2000, CLIN CANCER RES, V6, P4119; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ricci C, 2000, INT J CANCER, V87, P29, DOI 10.1002/1097-0215(20000701)87:1<29::AID-IJC5>3.3.CO;2-A; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saab R, 2006, MOL CANCER THER, V5, P1299, DOI 10.1158/1535-7163.MCT-05-0383; Seyyedi SS, 2016, TUMOR BIOL, V37, P4841, DOI 10.1007/s13277-015-4289-y; Shaham L, 2015, BLOOD, V125, P1292, DOI 10.1182/blood-2014-06-581892; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song LB, 2013, CELL RES, V23, P274, DOI 10.1038/cr.2012.174; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stewart E, 2016, DEV BIOL, V411, P287, DOI 10.1016/j.ydbio.2015.03.001; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Sultan I, 2009, J CLIN ONCOL, V27, P3391, DOI 10.1200/JCO.2008.19.7483; Svoronos AA, 2016, CANCER RES, V76, P3666, DOI 10.1158/0008-5472.CAN-16-0359; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang LS, 2015, BLOOD, V125, P1302, DOI 10.1182/blood-2014-06-581926; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403; Youness RA, 2016, ONCOL LETT, V12, P2567, DOI 10.3892/ol.2016.4914; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	78	25	27	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					1991	2007		10.1038/s41388-017-0081-3	http://dx.doi.org/10.1038/s41388-017-0081-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367756	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000429899400004
J	Moriyama, K; Yoshizawa-Sugata, N; Masai, H				Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao			Oligomer formation and G-quadruplex binding by purified murine Rif1 protein, a key organizer of higher-order chromatin architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-TIMING PROGRAM; CONTROLS DNA-REPLICATION; 5' END RESECTION; MAMMALIAN-CELLS; FISSION YEAST; PHOSPHATASE 1; HUMAN GENOME; TELOMERE FUNCTION; GLOBAL REGULATOR; GEL-FILTRATION	Rap1-interacting protein 1 (Rif1) regulates telomere length in budding yeast. We previously reported that, in metazoans and fission yeast, Rif1 also plays pivotal roles in controlling genome-wide DNA replication timing. We proposed that Rif1 may assemble chromatin compartments that contain specific replication-timing domains by promoting chromatin loop formation. Rif1 also is involved in DNA lesion repair, restart after replication fork collapse, anti-apoptosis activities, replicative senescence, and transcriptional regulation. Although multiple physiological functions of Rif1 have been characterized, biochemical and structural information on mammalian Rif1 is limited, mainly because of difficulties in purifying the full-length protein. Here, we expressed and purified the 2418-amino-acid-long, full-length murine Rif1 as well as its partially truncated variants in human 293T cells. Hydrodynamic analyses indicated that Rif1 forms elongated or extended homo-oligomers in solution, consistent with the presence of a HEAT-type helical repeat segment known to adopt an elongated shape. We also observed that the purified murine Rif1 bound G-quadruplex (G4) DNA with high specificity and affinity, as was previously shown for Rif1 from fission yeast. Both the N-terminal (HEAT-repeat) and C-terminal segments were involved in oligomer formation and specifically bound G4 DNA, and the central intrinsically disordered polypeptide segment increased the affinity for G4. Of note, pulldown assays revealed that Rif1 simultaneously binds multiple G4 molecules. Our findings support a model in which Rif1 modulates chromatin loop structures through binding to multiple G4 assemblies and by holding chromatin fibers together.	[Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp		Masai, Hisao/0000-0003-1268-5302; Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	JSPS KAKENHI [23247031, 26251004]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24114520, 15K07164]; Uehara Memorial Foundation Research Support	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation Research Support	This work was supported by JSPS KAKENHI Grants-in-aid for Scientific Research (A) 23247031 and 26251004, Grant-in-aid for Scientific Research on Priority Areas ("non-coding RNA") 24114520 (to H. M.), and Grant-in-aid for Scientific Research (C) 15K07164 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. Y.), and the Uehara Memorial Foundation Research Support (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Adrian M, 2014, J AM CHEM SOC, V136, P6297, DOI 10.1021/ja4125274; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; [Anonymous], 2016, J NANOMATER, DOI [DOI 10.1016/J.FSIGEN.2016.01.005, DOI 10.1155/2016/2358276]; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Kumar S, 2012, CELL CYCLE, V11, P1183, DOI 10.4161/cc.11.6.19636; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; [李培振 Li Peizhen], 2017, [华中科技大学学报. 自然科学版, Journal of Huazhong University of Science and Technology. Nature Science], V45, P1; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Mattarocci S, 2017, NAT STRUCT MOL BIOL, V24, P588, DOI 10.1038/nsmb.3420; Mattarocci S, 2014, CELL REP, V7, P62, DOI 10.1016/j.celrep.2014.03.010; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Peace JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098501; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2005, P NATL ACAD SCI USA, V102, P634, DOI 10.1073/pnas.0406278102; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Renard-Guillet C, 2014, SEMIN CELL DEV BIOL, V30, P110, DOI 10.1016/j.semcdb.2014.04.014; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Sengar A, 2014, BIOCHEMISTRY-US, V53, P7718, DOI 10.1021/bi500990v; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Suh MH, 2005, ANAL BIOCHEM, V343, P166, DOI 10.1016/j.ab.2005.05.016; Sukackaite R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01910-1; Sukackaite R, 2014, J BIOL CHEM, V289, P13903, DOI 10.1074/jbc.M114.557843; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Tazumi A, 2012, GENE DEV, V26, P2050, DOI 10.1101/gad.194282.112; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Uno S, 2012, METHODS, V57, P214, DOI 10.1016/j.ymeth.2012.06.016; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang HB, 2009, CARCINOGENESIS, V30, P1314, DOI 10.1093/carcin/bgp136; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yamazaki S, 2013, TRENDS GENET, V29, P449, DOI 10.1016/j.tig.2013.05.001; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhang ZZ, 2014, NUCLEIC ACIDS RES, V42, P13186, DOI 10.1093/nar/gku1100; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	74	21	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3607	3624		10.1074/jbc.RA117.000446	http://dx.doi.org/10.1074/jbc.RA117.000446			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29348174	Green Published, hybrid			2022-12-26	WOS:000427030200016
J	Meng, FL; He, ZY; Tang, XW; Zheng, J; Jin, XF; Zhu, Y; Ren, XY; Zhou, M; Wang, M; Gong, SS; Mo, JQ; Shu, Q; Guan, MX				Meng, Feilong; He, Zheyun; Tang, Xiaowen; Zheng, Jing; Jin, Xiaofen; Zhu, Yi; Ren, Xiaoyan; Zhou, Mi; Wang, Meng; Gong, Shasha; Mo, Jun Qin; Shu, Qiang; Guan, Min-Xin			Contribution of the tRNA(Ile) 4317A -> G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A -> G mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A1555G MUTATION; NUCLEAR MODIFIER; BIOCHEMICAL-EVIDENCE; PEDIATRIC SUBJECTS; OXIDATIVE STRESS; CHINESE FAMILIES; C1494T MUTATION; DNA MUTATION; HEARING-LOSS; GENE	The 1555A -> G mutation in mitochondrial 12S rRNA has been associated with aminoglycoside-induced and non-syndromic deafness in many individuals worldwide. Mitochondrial genetic modifiers are proposed to influence the phenotypic expression of m.1555A -> G mutation. Here, we report that a deafness-susceptibility allele (m.4317A -> G) in the tRNA(Ile) gene modulates the phenotype expression of m.1555A -> G mutation. Strikingly, a large Han Chinese pedigree carrying both m.4317A -> G and m.1555A -> G mutations exhibited much higher penetrance of deafness than those carrying only the m.1555A -> G mutation. The m.4317A -> G mutation affected a highly conserved adenine at position 59 in the T-loop of tRNA(Ile). We therefore hypothesized that the m.4317A -> G mutation alters both structure and function of tRNA(Ile). Using lymphoblastoid cell lines derived from members of Chinese families (three carrying both m.1555A -> G and m.4317A -> G mutations, three harboring only m.1555A -> G mutation, and three controls lacking these mutations), we found that the cell lines bearing both m.4317A -> G and m.1555A -> G mutations exhibited more severe mitochondrial dysfunctions than those carrying only the m.1555A -> G mutation. We also found that the m.4317A -> G mutation perturbed the conformation, stability, and aminoacylation efficiency of tRNA(Ile). These m.4317A -> G mutation-induced alterations in tRNA(Ile) structure and function aggravated the defective mitochondrial translation and respiratory phenotypes associated with the m.1555A -> G mutation. Furthermore, mutant cell lines bearing both m.4317A -> G and m.1555A -> G mutations exhibited greater reductions in the mitochondrial ATP levels and membrane potentials and increasing production of reactive oxygen species than those carrying only the m.1555A -> G mutation. Our findings provide new insights into the pathophysiology of maternally inherited deafness arising from the synergy between mitochondrial 12S rRNA and tRNA mutations.	[Meng, Feilong; Zheng, Jing; Zhou, Mi; Wang, Meng; Shu, Qiang; Guan, Min-Xin] Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou 310052, Zhejiang, Peoples R China; [Meng, Feilong; Zheng, Jing; Jin, Xiaofen; Zhou, Mi; Wang, Meng; Gong, Shasha; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Hangzhou 310058, Zhejiang, Peoples R China; [He, Zheyun; Tang, Xiaowen; Ren, Xiaoyan] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Sch Life Sci, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [Zhu, Yi] Wenzhou Med Univ, Dept Otolaryngol, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [He, Zheyun] Ningbo Secondary Hosp, Inst Liver Dis, Ningbo 375010, Zhejiang, Peoples R China; [Gong, Shasha] Taizhou Coll, Sch Med, Taizhou 318000, Zhejiang, Peoples R China; [Mo, Jun Qin] Univ Calif San Diego, Dept Pathol, Rady Childrens Hosp, San Diego, CA 92123 USA	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Taizhou University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Shu, Q (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, 3333 Binsheng Rd, Hangzhou 310000, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	shuqiang@zju.edu.cn; gminxin88@zju.edu.cn	he, zhe/GSJ-2307-2022	Guan, Min-Xin/0000-0001-5067-6736	National Key Technologies R&D Program from the Ministry of Science and Technology of China [2014CB541704]; National Natural Science Foundation of China [83133024, 81700922, 81500804, 81670944]	National Key Technologies R&D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Technologies R&D Program Grant 2014CB541704 from the Ministry of Science and Technology of China (to M.X.G.) and Grants 83133024, 81700922, 81500804, and 81670944 from the National Natural Science Foundation of China (to M.X.G., F.M., S.G., and X. T., respectively). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Degoul F, 1998, HUM MOL GENET, V7, P347, DOI 10.1093/hmg/7.3.347; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Matsunaga T, 2004, LARYNGOSCOPE, V114, P1085, DOI 10.1097/00005537-200406000-00024; Matthijs G, 1996, EUR J HUM GENET, V4, P46; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen ZS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-4; Subathra M, 2016, ANN HUM GENET, V80, P257, DOI 10.1111/ahg.12161; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952; Zhang JL, 2017, J MED IMAG HEALTH IN, V7, P1, DOI 10.1166/jmihi.2017.1978; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028	69	26	26	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3321	3334		10.1074/jbc.RA117.000530	http://dx.doi.org/10.1074/jbc.RA117.000530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348176	hybrid, Green Published			2022-12-26	WOS:000426562800024
J	van Loenhout, JAF; Cuesta, JG; Abello, JE; Isiderio, JM; de Lara-Banquesio, ML; Guha-Sapir, D				van Loenhout, Joris Adriaan Frank; Cuesta, Julita Gil; Abello, Jason Echavez; Mari Isiderio, Juan; Lourdes de Lara-Banquesio, Maria; Guha-Sapir, Debarati			The impact of Typhoon Haiyan on admissions in two hospitals in Eastern Visayas, Philippines	PLOS ONE			English	Article							HURRICANE KATRINA; JAPAN EARTHQUAKE; HEALTH; MANAGEMENT; PNEUMONIA; MORTALITY; TSUNAMI; WOMEN; LEYTE; RISK	Objectives We investigated the short-term impact of Typhoon Haiyan, one of the strongest typhoons ever to make landfall, on the pattern of admissions in two hospitals in Eastern Visayas, the Philippines. Methods This study took place at Eastern Visayas Regional Medical Center (EVRMC) in Tacloban, and Ormoc District Hospital (ODH) in Ormoc. We determined whether there were differences in the pattern of admissions between the week before and the three weeks after Haiyan by using information on sex, age, diagnosis, ward and outcome at discharge from patient records. Results There was a drop in admissions in both hospitals after Haiyan as compared to before. Admissions climbed back to the baseline after ten days in EVRMC and after two weeks in ODH. When comparing the period after Haiyan to the period before, there was a relative increase in male versus female admissions in ODH (OR 2.8, 95%CI1.7-4.3), but not in EVRMC. Patients aged >= 50 years and 0-14 years had the highest relative increase in admissions. There was a relative decrease in admissions for the ICD10 group 'Pregnancy, childbirth and the puerperium' (OR 0.4, 95%CI 0.3-0.6), and an increase in 'Certain infectious and parasitic diseases' (OR 2.1, 95%CI 1.2-3.5), mainly gastroenteritis, and 'Diseases of the respiratory system' (OR 1.8, 95%CI 1.0-3.0), mainly pneumonia, compared to all other diagnosis groups in ODH. Out of all reasons for admission within the study period, 66% belong to these three ICD-10 groups. Data on reasons for admission were not available for EVRMC. Conclusions The observed reduction in patients after the Typhoon calls for ensuring that hospital accessibility should be protected and reinforced, especially for pregnant women, by trying to remove debris in the direct hospital vicinity. Hospitals in areas prone to tropical cyclones should be prepared to treat large numbers of patients with gastroenteritis and pneumonia, as part of their disaster plans.	[van Loenhout, Joris Adriaan Frank; Cuesta, Julita Gil; Abello, Jason Echavez; Guha-Sapir, Debarati] Catholic Univ Louvain, Inst Hlth & Soc, CRED, Brussels, Belgium; [Mari Isiderio, Juan] Eastern Visayas Reg Med Ctr, Tacloban, Philippines; [Lourdes de Lara-Banquesio, Maria] Ormoc Dist Hosp, Ormoc, Philippines	Universite Catholique Louvain	van Loenhout, JAF (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc, CRED, Brussels, Belgium.	Joris.vanloenhout@uclouvain.be	van Loenhout, Joris/AAV-2075-2020; Gil-Cuesta, Julita/AFV-5338-2022	van Loenhout, Joris/0000-0001-7810-7738; Gil-Cuesta, Julita/0000-0002-8291-9701	United States Agency for International Development (USAID), Office of U.S. Disaster Assistance (OFDA) [AID-OFDA-A-15-00036]	United States Agency for International Development (USAID), Office of U.S. Disaster Assistance (OFDA)(United States Agency for International Development (USAID))	This study is part of the EM-DAT project and has been financed by the United States Agency for International Development (USAID), Office of U.S. Disaster Assistance (OFDA), agreement n degrees: AID-OFDA-A-15-00036. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AH, 2009, KIDNEY INT, V75, P1202, DOI 10.1038/ki.2009.5; Bambaren C, 2017, PREHOSP DISASTER MED, V32, P106, DOI 10.1017/S1049023X16001254; Brolin K, 2015, PLOS CURR, V7; Carter Chelsea J., 2013, CNN; Chang MP, 2016, DISASTER MED PUBLIC, V10, P240, DOI 10.1017/dmp.2015.165; CRED, 2017, CTR RES EP DIS INT D; Daito H, 2013, THORAX, V68, P544, DOI 10.1136/thoraxjnl-2012-202658; Doocy S, 2013, PLOS CURR, V5; Guha-Sapir D, 2009, PREHOSP DISASTER MED, V24, P493, DOI 10.1017/S1049023X00007391; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; Kang P, 2012, J TRAUMA ACUTE CARE, V72, P1626, DOI 10.1097/TA.0b013e3182479e07; Ching PK, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/wpsar.2015.6.2.HYN_005, 10.5365/WPSAR.2015.6.2.HYN_005]; Lin G, 2016, WORLD J SURG; Mori N, 2014, GEOPHYS RES LETT, V41, P5106, DOI 10.1002/2014GL060689; OCHA, 8 OCHA; Oni O, 2015, JOGNN-J OBST GYN NEO, V44, P256, DOI 10.1111/1552-6909.12560; Ram PK, 2014, AM J TROP MED HYG, V90, P968, DOI 10.4269/ajtmh.13-0532; Read DJ, 2016, ANZ J SURG, V86, P361, DOI 10.1111/ans.13175; Saito-Obata M, 2016, PLOS CURR, V8; Smith CM, 2005, ACAD EMERG MED, V12, P1201, DOI [10.1111/j.1553-2712.2005.tb01498.x, 10.1197/j.aem.2005.06.024]; Suzuki K, 2016, J OBSTET GYNAECOL RE, V42, P1704, DOI 10.1111/jog.13102; Suzuki K, 2016, J EPIDEMIOL, V26, P76, DOI 10.2188/jea.JE20150055; Ventura RJ, 2015, WEST PAC SURVEILL RE, V6, DOI [10.2471/WPSAR.2014.5.1.010, 10.5365/wpsar.2014.5.1.010]; World Health Organization Western Pacific Region, 1 WHO W PAC REG; World Health Organization (WHO), ICD 10 VERS 2016; Yamanda S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-000865; Yonkers KA, 2014, JAMA PSYCHIAT, V71, P897, DOI 10.1001/jamapsychiatry.2014.558	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191516	10.1371/journal.pone.0191516	http://dx.doi.org/10.1371/journal.pone.0191516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381720	Green Published, gold			2022-12-26	WOS:000423617800023
J	Raposo, L; Severo, M; Santos, AC				Raposo, Luis; Severo, Milton; Santos, Ana Cristina			Adiposity cut-off points for cardiovascular disease and diabetes risk in the Portuguese population: The PORMETS study	PLOS ONE			English	Article							TO-HEIGHT RATIO; BODY-MASS INDEX; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; ABDOMINAL OBESITY; SCREENING TOOL; ALL-CAUSE; PREVALENCE; TISSUE; BMI	Objectives The contribution of adiposity to cardiovascular and diabetes risk justifies the inclusion of an adiposity measure, usually waist circumference, in the definition of metabolic syndrome. However, waist circumference thresholds differ across populations. Our aim was to assess which adiposity measure performs the best in identifying the metabolic syndrome in a sample of Portuguese participants and to estimate cut-off values for these measures. Methods Data were obtained from a cross-sectional study (PORMETS study) conducted in Portugal between 2007 and 2009. A representative sample of non-institutionalized adults, comprising 3,956 participants, aged 18 years and older, was evaluated. A structured questionnaire was administered, collecting information on personal medical history, socio-demographics and behavioral characteristics. Anthropometrics, blood pressure and venous blood samples were also obtained. Metabolic syndrome was defined according to the Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology recommended criteria. Elevated cardiometabolic risk was considered when two or more of the four criteria of metabolic syndrome were present, excluding the waist circumference component. A receiver operating characteristic curve was used to estimate cut-off points. Results This study found that waist-to-height ratio, waist circumference and body adiposity index performed better than other adiposity measures, such as body mass index. The estimated cut-off points for waist-to-height ratio, waist circumference and body adiposity index in women and men were 0.564 / 89 cm / 27.4 and 0.571 / 93.5 cm / 25.5, respectively. Conclusion As waist circumference is currently used as the adiposity measure in the definition of metabolic syndrome and as no relevant differences were observed between this measure and waist-to-height ratio, it is likely that no modification to the metabolic syndrome definition needs to be proposed. Moreover, this study also confirmed the applicability of European cut-off points in the Portuguese population.	[Raposo, Luis; Santos, Ana Cristina] Portuguese Soc Endocrinol Diabet & Metab, Insulin Resistance Study Grp, Lisbon, Portugal; [Raposo, Luis; Severo, Milton; Santos, Ana Cristina] Univ Porto, Inst Saude Publ, EPIUnit, Oporto, Portugal; [Severo, Milton; Santos, Ana Cristina] Univ Porto, Fac Med, Dept Ciencias Saude PUbl & Forenses & Educ Med, Oporto, Portugal	Universidade do Porto; Universidade do Porto	Raposo, L (corresponding author), Portuguese Soc Endocrinol Diabet & Metab, Insulin Resistance Study Grp, Lisbon, Portugal.; Raposo, L (corresponding author), Univ Porto, Inst Saude Publ, EPIUnit, Oporto, Portugal.	luisraposoendo@gmail.com	Severo, Milton/I-3497-2012; Santos, Ana/AAY-2314-2020; santos, ana/GWV-5678-2022	Severo, Milton/0000-0002-5787-4871; Raposo, Luis/0000-0003-1001-6017; Santos, Ana/0000-0002-2992-5299	Bayer Health Care; Fundacao para a Ciencia e a Tecnologia [IF/01060/2015]	Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors received funding from "Bayer Health Care" to Luis Raposo and Fundacao para a Ciencia e a Tecnologia (IF/01060/2015) to Ana Cristina Santos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Athyros VG, 2005, DIABETES OBES METAB, V7, P397, DOI 10.1111/j.1463-1326.2004.00409.x; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Carreira H, 2012, PUBLIC HEALTH NUTR, V15, P972, DOI 10.1017/S1368980012000559; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gast KB, 2015, ATHEROSCLEROSIS, V241, P547, DOI 10.1016/j.atherosclerosis.2015.05.026; Guallar-Castillon P, 2014, REV ESP CARDIOL, V67, P367, DOI [10.1016/j.rec.2013.08.014, 10.1016/j.recesp.2013.08.014]; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lear SA, 2010, EUR J CLIN NUTR, V64, P42, DOI 10.1038/ejcn.2009.70; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lu Y, 2013, LANCET, V383, P970, DOI DOI 10.1016/S0140-6736(13)61836-X; Marcuello C, 2013, ACTA DIABETOL, V50, P615, DOI 10.1007/s00592-013-0468-8; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miccoli R, 2005, NUTR METAB CARDIOVAS, V15, P250, DOI 10.1016/j.numecd.2004.09.002; Moliner-Urdiales D, 2013, OBESITY, V21, P1870, DOI 10.1002/oby.20399; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raposo L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4471-9; Sattar N, 2013, BEST PRACT RES CL EN, V27, P501, DOI 10.1016/j.beem.2013.05.006; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Martinez-Larrad MT, 2011, AV DIABETOL, V27, P168, DOI 10.1016/j.avdiab.2011.09.003; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; Wang ZQ, 2010, NUTR RES REV, V23, P191, DOI 10.1017/S0954422410000120; Zago CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029894	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191641	10.1371/journal.pone.0191641	http://dx.doi.org/10.1371/journal.pone.0191641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377924	gold, Green Submitted, Green Published			2022-12-26	WOS:000423514700022
J	Moreno-Amador, JL; Tellez, N; Marin, S; Aloy-Reverte, C; Semino, C; Nacher, M; Montanya, E				Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Aloy-Reverte, Caterina; Semino, Carlos; Nacher, Montserrat; Montanya, Eduard			Epithelial to mesenchymal transition in human endocrine islet cells	PLOS ONE			English	Article							BETA-CELLS; PANCREATIC ALPHA; EXPRESSION; CONVERSION; DEDIFFERENTIATION; DIFFERENTIATION; PLASTICITY; IDENTITY	Background & para;& para;beta-cells undergo an epithelial to mesenchymal transition (EMT) when expanded in monolayer culture and give rise to highly proliferative mesenchymal cells that retain the potential to redifferentiate into insulin-producing cells.& para;& para;Objective & para;& para;To investigate whether EMT takes place in the endocrine non-beta-cells of human islets.& para;& para;Methodology & para;& para;Human islets isolated from 12 multiorgan donors were dissociated into single cells, purified by magnetic cell sorting, and cultured in monolayer.& para;& para;Results & para;& para;Co-expression of insulin and the mesenchymal marker vimentin was identified within the first passage (p1) and increased subsequently (insulin(+)vimentin(+)7.2 +/- 6% at p1; 43 +/- 15% at p4). The endocrine non-beta-cells did also co-express vimentin (glucagon(+)vimentin(+) 59 +/- 1.5% and 93 +/- 6%, somatostatin+vimentin+ 16 +/- 9.4% and 90 +/- 10% at p1 and p4 respectively; PP(+)vimentin(+) 74 +/- 14% at p1; 88 +/- 12% at p2). The percentage of cells expressing only endocrine markers was progressively reduced (0.6 +/- 0.2% insulin(+), 0.2 +/- 0.1 % glucagon(+), and 0.3 +/- 0.2% somatostatin(+) cells at p4, and 0.7 +/- 0.3% PP+ cells at p2. Changes in gene expression were also indicated of EMT, with reduced expression of endocrine markers and the epithelial marker CDH-1 (p<0.01), and increased expression of mesenchymal markers (CDH-2, SNA12, ZEB1, ZEB2, VIM, NT5E and ACTA2; p<0.05). Treatment with the EMT inhibitor A83-01 significantly reduced the percentage of co-expressing cells and preserved the expression of endocrine markers.& para;& para;Conclusions & para;& para;In adult human islets, all four enocrine islet cell types undergo EMT when islet cells are expanded in monolayer conditions. The presence of EMT in all islet endocrine cells could be relevant to design of strategies aiming to re-differentiate the expanded islet cells towards a beta-cell phenotype.	[Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Nacher, Montserrat; Montanya, Eduard] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Nacher, Montserrat; Montanya, Eduard] CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain; [Aloy-Reverte, Caterina; Semino, Carlos] Univ Ramon Llull, IQS Sch Engn, Barcelona, Spain; [Nacher, Montserrat; Montanya, Eduard] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain; [Montanya, Eduard] Univ Barcelona, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Ramon Llull; Institut Quimic de Sarria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Nacher, M; Montanya, E (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain.; Nacher, M; Montanya, E (corresponding author), CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain.; Nacher, M; Montanya, E (corresponding author), Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain.; Montanya, E (corresponding author), Univ Barcelona, Barcelona, Spain.	montanya@ub.edu; mnacher@belivitgehospital.cat	Semino, Carlos/AAF-2298-2019; Tellez, Noelia/C-1029-2008	Tellez, Noelia/0000-0001-7879-3256; Montanya, Eduard/0000-0003-2518-9076	Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community); European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe"; Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants [PI13/00108, PI16/00462]; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); Fundacio La Marato TV3 Grant [PR084/12]	Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community); European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe"; Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); Fundacio La Marato TV3 Grant	This project was supported by Fundacio La Marato TV3 Grant PR084/12 (EM,CS), Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants PI13/00108 (EM) and PI16/00462 (EM), ACCIO (Catalonia Trade & Investment; Generalitat de Catalunya) in the context of ADVANCE.CAT (EM), and the European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe". SM is the recipient of a predoctoral grant from the Secretariat for Universities and Research of the Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-Othman N, 2017, CELL, P1; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; CIRULLI V, 1994, J CELL SCI, V107, P1429; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Corritore E, 2014, CELL REPROGRAM, V16, P456, DOI 10.1089/cell.2014.0025; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Hunter CS, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00035; Nacher M, 2016, CELL TRANSPLANT, V25, P343, DOI 10.3727/096368915X688119; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roefs M, 2017, J ENDOCRINOL; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Spijker HS, 2015, DIABETES, V64, P2928, DOI 10.2337/db14-1752; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191104	10.1371/journal.pone.0191104	http://dx.doi.org/10.1371/journal.pone.0191104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360826	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800016
J	Nevers, MB; Byappanahalli, MN; Morris, CC; Shively, D; Przybyla-Kelly, K; Spoljaric, AM; Dickey, J; Roseman, EF				Nevers, Meredith B.; Byappanahalli, Murulee N.; Morris, Charles C.; Shively, Dawn; Przybyla-Kelly, Kasia; Spoljaric, Ashley M.; Dickey, Joshua; Roseman, Edward F.			Environmental DNA (eDNA): A tool for quantifying the abundant but elusive round goby (Neogobius melanostomus)	PLOS ONE			English	Article							MOTTLED SCULPIN; LAKE-MICHIGAN; WATER; BIODIVERSITY; DEGRADATION; BIOLOGY; GOBIES; QUANTIFICATION; SURVEILLANCE; TEMPERATURE	Environmental DNA (eDNA) is revolutionizing biodiversity monitoring, occupancy estimates, and real-time detections of invasive species. In the Great Lakes, the round goby (Neogobius melanostomus), an invasive benthic fish from the Black Sea, has spread to encompass all five lakes and many tributaries, outcompeting or consuming native species; however, estimates of round goby abundance are confounded by behavior and habitat preference, which impact reliable methods for estimating their population. By integrating eDNA into round goby monitoring, improved estimates of biomass may be obtainable. We conducted mesocosm experiments to estimate rates of goby DNA shedding and decay. Further, we compared eDNA with several methods of traditional field sampling to compare its use as an alternative/complementary monitoring method. Environmental DNA decay was comparable to other fish species, and first-order decay was lower at 12 degrees C (k = 0.043) than at 19 degrees C (k = 0.058). Round goby eDNA was routinely detected in known invaded sites of Lake Michigan and its tributaries (range log10 4.8 +/- 6.2 CN/L), but not upstream of an artificial fish barrier. Traditional techniques (mark-recapture, seining, trapping) in Lakes Michigan and Huron resulted in fewer, more variable detections than eDNA, but trapping and eDNA were correlated (Pearson R = 0.87). Additional field testing will help correlate round goby abundance with eDNA, providing insight on its role as a prey fish and its impact on food webs.	[Nevers, Meredith B.; Byappanahalli, Murulee N.; Shively, Dawn; Przybyla-Kelly, Kasia; Spoljaric, Ashley M.] US Geol Survey, Great Lakes Sci Ctr, Lake Michigan Ecol Res Stn, Chesterton, IN 46304 USA; [Morris, Charles C.; Dickey, Joshua] Indiana Dunes Natl Lakeshore, Natl Pk Serv, Porter, IN USA; [Roseman, Edward F.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Nevers, MB (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Lake Michigan Ecol Res Stn, Chesterton, IN 46304 USA.	mnevers@usgs.gov		Shively, Dawn/0000-0002-6119-924X; Nevers, Meredith/0000-0001-6963-6734; Byappanahalli, Muruleedhara/0000-0001-5376-597X; Spoljaric, Ashley/0000-0001-6262-030X; Roseman, Edward/0000-0002-5315-9838				Adrian-Kalchhauser I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147558; Amberg JJ, 2015, J GREAT LAKES RES, V41, P367, DOI 10.1016/j.jglr.2015.02.009; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bergstrom MA, 2009, T AM FISH SOC, V138, P1009, DOI 10.1577/T08-095.1; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brozio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170619; Bunnell DB, 2014, BIOSCIENCE, V64, P26, DOI 10.1093/biosci/bit001; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cai W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177724; Chotkowski MA, 1999, J GREAT LAKES RES, V25, P26, DOI 10.1016/S0380-1330(99)70714-8; Cooper MJ, 2009, J FRESHWATER ECOL, V24, P477, DOI 10.1080/02705060.2009.9664321; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Darling JA, 2015, BIOL INVASIONS, V17, P951, DOI 10.1007/s10530-014-0726-x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Egan SP, 2015, ENVIRON SCI TECHNOL, V49, P4113, DOI 10.1021/es5058659; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; French JRP, 2001, J GREAT LAKES RES, V27, P300, DOI 10.1016/S0380-1330(01)70645-4; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Hinlo R, 2017, MANAG BIOL INVASION, V8, P89, DOI 10.3391/mbi.2017.8.1.09; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Ki SJ, 2007, ENVIRON MANAGE, V39, P867, DOI 10.1007/s00267-006-0154-5; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Lauer TE, 2004, T AM FISH SOC, V133, P185, DOI 10.1577/T02-123; Lee VA, 2005, J GREAT LAKES RES, V31, P125, DOI 10.1016/S0380-1330(05)70244-6; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Madenjian CP, 2011, BIOL INVASIONS, V13, P987, DOI 10.1007/s10530-010-9884-7; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; N'Guyen A, 2018, J APPL ECOL, V55, P342, DOI 10.1111/1365-2664.12934; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; Nevers MB, 2011, FECAL BACTERIA, P165; O'Donnell JL, 2017, PEERJ, V5, DOI 10.7717/peerj.3044; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Primer-E Ltd, 2015, PLYM ROUT MULT EC RE, P7; R Core Team, 2021, R LANGUAGE ENV STAT; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; SPSS, 2014, SPSS VERS 23; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suss J, 2009, WATER RES, V43, P3705, DOI 10.1016/j.watres.2009.05.048; SYSTAT, 2009, SYST 13 0; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tsuji S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176608; Tucker AJ, 2016, BIOL INVASIONS, V18, P3205, DOI 10.1007/s10530-016-1209-z; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Whitman RL, 2004, APPL ENVIRON MICROB, V70, P4276, DOI 10.1128/AEM.70.7.4276-4285.2004	59	31	32	7	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191720	10.1371/journal.pone.0191720	http://dx.doi.org/10.1371/journal.pone.0191720			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357382	Green Published, Green Submitted, gold			2022-12-26	WOS:000422919500019
J	Al-Harrasi, I; Al-Yahyai, R; Yaish, MW				Al-Harrasi, Ibtisam; Al-Yahyai, Rashid; Yaish, Mahmoud W.			Differential DNA methylation and transcription profiles in date palm roots exposed to salinity	PLOS ONE			English	Article							PHOENIX-DACTYLIFERA L.; GENOMIC DNA; ARABIDOPSIS; PLANTS; STRESS; 5-METHYLCYTOSINE; RESOLUTION; ADAPTATION; MECHANISMS; EXPRESSION	As a salt-adaptive plant, the date palm (Phoenix dactylifera L.) requires a suitable mechanism to adapt to the stress of saline soils. There is growing evidence that DNA methylation plays an important role in regulating gene expression in response to abiotic stresses, including salinity. Thus, the present study sought to examine the differential methylation status that occurs in the date palm genome when plants are exposed to salinity, and to identify salinity responsive genes that are regulated by DNA methylation. To achieve these, whole-genome bisulfite sequencing (WGBS) was employed and mRNA was sequenced from salinity-treated and untreated roots. The WGBS analysis included 324,987,795 and 317,056,091 total reads of the control and the salinity-treated samples, respectively. The analysis covered about 81% of the total genomic DNA with about 40% of mapping efficiency of the sequenced reads and an average read depth of 17-fold coverage per DNA strand, and with a bisulfite conversion rate of around 99%. The level of methylation within the differentially methylated regions (DMRs) was significantly (p < 0.05, FDR <= 0.05) increased in response to salinity specifically at the mCHG and mCHH sequence contexts. Consistently, the mass spectrometry and the enzyme-linked immunosorbent assay (ELISA) showed that there was a significant (p < 0.05) increase in the global DNA methylation in response to salinity. mRNA sequencing revealed the presence of 6,405 differentially regulated genes with a significant value (p < 0.001, FDR <= 0.05) in response to salinity. Integration of high-resolution methylome and transcriptome analyses revealed a negative correlation between mCG methylation located within the promoters and the gene expression, while a positive correlation was noticed between mCHG/mCHH methylation rations and gene expression specifically when plants grew under control conditions. Therefore, the methylome and transcriptome relationships vary based on the methylated sequence context, the methylated region within the gene, the protein-coding ability of the gene, and the salinity treatment. These results provide insights into interplay among DNA methylation and gene expression, and highlight the effect of salinity on the nature of this relationship, which may involve other genetic and epigenetic players under salt stress conditions. The results obtained from this project provide the first draft map of the differential methylome and transcriptome of date palm when exposed to an abiotic stress.	[Al-Harrasi, Ibtisam; Yaish, Mahmoud W.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Yahyai, Rashid] Sultan Qaboos Univ, Dept Crop Sci, Coll Agr & Marine Sci, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Harrasi, Ibtisam Al/AAX-3483-2020; Al-Yahyai, Rashid/B-9273-2011; Yaish, Mahmoud W/F-7168-2014	Al-Yahyai, Rashid/0000-0001-7628-6218; Yaish, Mahmoud W/0000-0002-5171-3014; Al Harrasi, Ibtisam/0000-0002-7300-6185	Research Council of Oman (TRC) [151]	Research Council of Oman (TRC)	This work was supported by a generous grant from the Research Council of Oman (TRC) number 151	Al Harrasi I, 2017, METHODS MOL BIOL, V1631, P121, DOI 10.1007/978-1-4939-7136-7_7; Al Kharusi L, 2017, FORESTS, V8, DOI 10.3390/f8040136; Al-Lawati A, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018299; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Assaha DVM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00509; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Erdmann RM, 2014, G3; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; Ganie SA, 2016, FUNCT INTEGR GENOMIC, V16, P1, DOI 10.1007/s10142-015-0460-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo XL, 2009, PLANTA, V230, P227, DOI 10.1007/s00425-009-0934-2; Hardcastle TJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-16; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Khan S, 2007, AFR J BIOTECHNOL, V6, P175; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kumar S, 2017, DNA CELL BIOL; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084620; Lu XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139582; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandey G, 2016, PLANT CELL REP; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Song Y, 2015, J EXP BOT; Sperling O, 2014, ENVIRON EXP BOT, V99, P100, DOI 10.1016/j.envexpbot.2013.10.014; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tran H, 2014, ADV BIOINFORMATICS, V2014, P11; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Viggiano L, 2017, RNA TECHNOL, P281, DOI 10.1007/978-3-319-55520-1_15; WAGNER I, 1981, BIOCHIM BIOPHYS ACTA, V654, P52, DOI 10.1016/0005-2787(81)90135-0; Wang J, 2014, PLOS ONE, V9; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Xiao Y, 2012, PLANT OMICS, V5, P584; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01983; Yaish MW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3633-6; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00946; Yaish MW, 2014, METHODS MOL BIOL, V1062, P285, DOI 10.1007/978-1-62703-580-4_16; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Yaish MWF, 2009, PLANT J, V59, P123, DOI 10.1111/j.1365-313X.2009.03860.x; YAISH MW, 2015, FRONT PLANT SCI, V6; Yang M, 2010, PLOS ONE, V5; Yong WS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0075-3; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L., 2007, J WUHAN BOT RES, V1, P19; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Ziller MJ, 2015, NAT METHODS, V12, P230, DOI [10.1038/NMETH.3152, 10.1038/nmeth.3152]	75	28	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191492	10.1371/journal.pone.0191492	http://dx.doi.org/10.1371/journal.pone.0191492			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352281	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300097
J	Myers, KA; McGlade, A; Neubauer, BA; Lal, D; Berkovic, SF; Scheffer, IE; Hildebrand, MS				Myers, Kenneth A.; McGlade, Amelia; Neubauer, Bernd A.; Lal, Dennis; Berkovic, Samuel F.; Scheffer, Ingrid E.; Hildebrand, Michael S.			KANSL1 variation is not a major contributing factor in self-limited focal epilepsy syndromes of childhood	PLOS ONE			English	Article							ROLANDIC EPILEPSY; PROTEIN; ACETYLATION	Background KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur. The epilepsy phenotypic spectrum in KdVS is broad, but most individuals have focal seizures with some having a phenotype resembling the self-limited focal epilepsies of childhood (SFEC). We hypothesized that variants in KANSL1 contribute to pathogenesis of SFEC. Materials and methods We screened KANSL1 for single nucleotide variants in 90 patients with SFEC. We then screened a cohort of 208 patients with two specific SFEC syndromes, childhood epilepsy with centrotemporal spikes (CECTS) and atypical childhood epilepsy with centrotemporal spikes (ACECTS) for KANSL1 variants. The second cohort was also used to evaluate minor allelic variants that appeared overrepresented in the initial cohort. Results One variant, p.Lys104Thr, was predicted damaging and appeared overrepresented in our 90-patient cohort compared to Genome Aggregation Database (gnomAD) allele frequency (0.217 to 0.116, with no homozygotes in gnomAD). However, there was no difference in p. Lys104Thr allele frequency in the follow-up CECTS/ACECTS cohort and controls. Four rare KANSL1 variants of uncertain significance were identified in the CECTS/ACECTS cohort. Discussion Our data do not support a major role for KANSL1 variants in pathogenesis of SFEC.	[Myers, Kenneth A.; McGlade, Amelia; Berkovic, Samuel F.; Scheffer, Ingrid E.; Hildebrand, Michael S.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic, Australia; [Neubauer, Bernd A.] Univ Kinderklin Giessen & Marburg, Abt Kinderneurol Sozialpadiatrie & Epileptol, Giessen, Germany; [Lal, Dennis] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Lal, Dennis] Massachusetts Gen Hosp, Analyt Translat Genet Unit, Boston, MA 02114 USA; [Lal, Dennis] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University Hospital of Giessen & Marburg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Cologne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Myers, KA (corresponding author), Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic, Australia.	sfu.ken1@gmail.com	jiang, yu/HGU-0029-2022; Neubauer, Bernd/AAZ-9391-2020; Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Myers, Kenneth/0000-0001-7831-4593; Hildebrand, Michael/0000-0003-2739-0515; Berkovic, Samuel/0000-0003-4580-841X	Supporting Families with Koolen-de Vries syndrome; Australian National Health and Medical Research Council Program Grant (NHMRC) [628952]; Citizens United for Research in Epilepsy (CURE) [439534]	Supporting Families with Koolen-de Vries syndrome; Australian National Health and Medical Research Council Program Grant (NHMRC); Citizens United for Research in Epilepsy (CURE)	This research was supported by a grant from Supporting Families with Koolen-de Vries syndrome (https://supportingkdvs.org/). Additional support came from an Australian National Health and Medical Research Council Program Grant (NHMRC; https://www.nhmrc.gov.au/; grant number 628952). Dr. Myers also holds a Taking Flight Award from Citizens United for Research in Epilepsy (CURE; http://www.cureepilepsy.org/; grant number 439534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients and their families for contributing to this research. This research was supported by a grant from Supporting Families with Koolen-de Vries syndrome (https://supportingkdvs.org/). Additional support came from an Australian National Health and Medical Research Council Program Grant (NHMRC; https://www.nhmrc.gov.au/; grant number 628952). Dr. Myers also holds a Taking Flight Award from Citizens United for Research in Epilepsy (CURE; http://www.cureepilepsy.org/;grant number 439534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; [Anonymous], 2014, INT LEAG EP; Bali B, 2007, EPILEPSIA, V48, P2266; Bureau Michelle, 2012, EPILEPTIC SYNDROMES; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Myers K. A., 2017, EPILEPSIA; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tan TY, 2009, J MED GENET, V46, P480, DOI 10.1136/jmg.2008.065391	14	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191546	10.1371/journal.pone.0191546	http://dx.doi.org/10.1371/journal.pone.0191546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352316	Green Published, gold			2022-12-26	WOS:000422911300111
J	Stella, JL; Bauer, AE; Croney, CC				Stella, Judith L.; Bauer, Amy E.; Croney, Candace C.			A cross-sectional study to estimate prevalence of periodontal disease in a population of dogs (Canis familiaris) in commercial breeding facilities in Indiana and Illinois	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; GINGIVAL HEALTH; PLAQUE; FREQUENCY; VALIDITY; MODEL; CATS	The objectives of this cross-sectional study were: 1) to estimate the prevalence and characterize the severity of periodontal disease in a population of dogs housed in commercial breeding facilities; 2) to characterize PD preventive care utilized by facility owners; and 3) to assess inter-rater reliability of a visual scoring assessment tool. Adult dogs (N = 445) representing 42 breeds at 24 CB facilities in Indiana and Illinois were assessed. Periodontal disease was scored visually using the American Veterinary Dental Collage 0-IV scale. Inter-rater reliability was assessed on 198 dogs and facility owners were asked to provide information about the preventive care utilized. The overall prevalence of periodontal disease (Grades I-IV) was 86.3% (95% CI: 82.9, 89.3). An ordered logistic regression analysis found age (OR = 1.4; 95% CI 1.24, 1.54; P<0.0001), facility (OR = 1.13; 95% CI 1.09, 1.18; P<0.0001), sex (OR = 1.7; 95% CI 1.12, 2.65; P = 0.013), and non-professional dental scaling (OR = 2.82; 95% CI 1.34, 5.91; P = 0.006) to be statistically significant. Inter-rater reliability analysis found agreement to be 86.2%, with a weighted kappa of 0.4731 (95% CI 0.3847, 0.5615) indicating moderate agreement. Risk of periodontal disease increased with increasing age. Additionally, a trend toward decreasing risk with increasing weight was also found, although it was not statistically significant. The trends identified agree with studies that have evaluated periodontal disease in the companion dog population and do not support the assumption that the dental health of dogs in commercial breeding facilities is worse than that of the population as a whole. Although there were few cases of severe periodontal disease and all facilities employed some type of preventive care in this sample, the large number of dogs with some degree of disease (Grades I-IV) suggests that further investigation of preventive care is warranted.	[Stella, Judith L.] Purdue Univ, USDA, APHIS, W Lafayette, IN 47907 USA; [Bauer, Amy E.; Croney, Candace C.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stella, JL (corresponding author), Purdue Univ, USDA, APHIS, W Lafayette, IN 47907 USA.	Judith.l.stella@aphis.usda.gov			Pet Food Institute; World Pet Association	Pet Food Institute; World Pet Association	This study was supported by funding from Pet Food Institute and World Pet Association. Funding sources did not have any involvement in the design or conduct of the study; collection, analysis, or interpretation of the data; writing or approval of the manuscript; or decision to submit the manuscript for publication.	AAFCO, 2014, AAFCO METHODS SUBSTA; American Veterinary Dental College (AVDC), POS STAT; American Veterinary Dental College (AVDC), HOM CAR; Brown WY, 2005, J VET DENT, V22, P16, DOI 10.1177/089875640502200102; Diez M, 2015, J SMALL ANIM PRACT, V56, P463, DOI 10.1111/jsap.12365; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Glickman LT, 2011, PREV VET MED, V99, P193, DOI 10.1016/j.prevetmed.2011.01.011; Glickman LT, 2009, JAVMA-J AM VET MED A, V234, P486, DOI 10.2460/javma.234.4.486; Harvey C E, 1994, J Vet Dent, V11, P94; Harvey CE, 1998, VET CLIN N AM-SMALL, V28, P1111, DOI 10.1016/S0195-5616(98)50105-2; Hennet P, 2002, J VET DENT, V19, P11, DOI 10.1177/089875640201900101; Hennet P, 2001, J VET DENT, V18, P61, DOI 10.1177/089875640101800201; Hope CK, 2014, SCI WORLD J, DOI 10.1155/2014/374694; Humane Society Veterinary Medical Association (HSVMC), HUSB MED CONC PUPP M; Johnston N., 2006, Veterinary Times, V36, P10; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Logan EI, 2002, J VET DENT, V19, P15, DOI 10.1177/089875640201900102; Logan EI, 2006, VET CLIN N AM-SMALL, V36, P1385, DOI 10.1016/j.cvsm.2006.09.002; Lund EM, 1999, J AM VET MED ASSOC, V214, P1336; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Miller B R, 1994, J Vet Dent, V11, P18; National Research Council, 2006, NUTR REQ DOGS CATS; Niemiec B. A., 2013, Veterinary periodontology, P175; Niemiec BA, 2008, TOP COMPANION ANIM M, V23, P72, DOI 10.1053/j.tcam.2008.02.003; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; Peddle GD, 2009, JAVMA-J AM VET MED A, V234, P1525, DOI 10.2460/javma.234.12.1525; Radnai M, 2004, J CLIN PERIODONTOL, V31, P736, DOI 10.1111/j.1600-051X.2004.00564.x; Rawlinson JE, 2011, JAVMA-J AM VET MED A, V238, P601, DOI 10.2460/javma.238.5.601; Roudebush P, 2005, J VET DENT, V22, P6, DOI 10.1177/089875640502200101; Scannapieco Frank A, 2005, Dent Clin North Am, V49, P533, DOI 10.1016/j.cden.2005.03.002; Smithson A. J., 2008, UK Vet: Companion Animal, V13, P65; TROMP JAH, 1986, J CLIN PERIODONTOL, V13, P164, DOI 10.1111/j.1600-051X.1986.tb01451.x; TROMP JAH, 1986, J CLIN PERIODONTOL, V13, P190, DOI 10.1111/j.1600-051X.1986.tb01458.x; Westfelt E, 1998, J CLIN PERIODONTOL, V25, P536, DOI 10.1111/j.1600-051X.1998.tb02484.x; Whyte A, 2014, VET J, V201, P118, DOI 10.1016/j.tvjl.2014.05.005; Wiggs RB., 1997, VET DENT PRINCIPLES, P186; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x	39	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191395	10.1371/journal.pone.0191395	http://dx.doi.org/10.1371/journal.pone.0191395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346448	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500046
J	Xu, J; Kozlov, G; McPherson, PS; Gehring, K				Xu, Jie; Kozlov, Guennadi; McPherson, Peter S.; Gehring, Kalle			A PH-like domain of the Rab12 guanine nucleotide exchange factor DENND3 binds actin and is required for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; CRYSTAL-STRUCTURE; PROTEINS; FAMILY; GENE; GAPS; SITE; GEFS; SON	Rab GTPases are key regulators of membrane trafficking, and many are activated by guanine nucleotide exchange factors bearing a differentially expressed in normal and neoplastic cells (DENN) domain. By activating the small GTPase Rab12, DENN domain-containing protein 3 (DENND3) functions in autophagy. Here, we identified a structural domain (which we name PHenn) containing a pleckstrin homology subdomain that binds actin and is required for DENND3 function in autophagy. We found that a hydrophobic patch on an extended beta-turn of the PHenn domain mediates an intramolecular interaction with the DENN domain of DENND3. We also show that DENND3 binds actin through a surface of positively charged residues on the PHenn domain. Substitutions that blocked either DENN or actin binding compromised the role of DENND3 in autophagy. These results provide new mechanistic insight into the structural determinants regulating DENND3 in autophagy and lay the foundation for future investigations of the DENN protein family.	[Xu, Jie; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Kozlov, Guennadi; Gehring, Kalle] McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); National Institutes of Health (NIH)/NIGMS, via NSF award [DMR-0225180]; NIH/NCRR award [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)/NIGMS, via NSF award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Tin Pan, Maiwenn Beaugrand, Marie Menade and Veronique Sauve for fragment screening and identifying the crystallization conditions. Diffraction data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health (NIH)/NIGMS, via NSF award DMR-0225180, and the MacCHESS resource is supported by NIH/NCRR award RR-01646.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Caplan S, 2017, J BIOL CHEM, V292, P7283, DOI 10.1074/jbc.H116.772434; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Stiegler AL, 2014, J BIOL CHEM, V289, P25362, DOI 10.1074/jbc.M114.584011; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Xu J, 2017, J BIOL CHEM, V292, P7274, DOI 10.1074/jbc.M116.772434; Xu J, 2015, CELL CYCLE, V14, P2717, DOI 10.1080/15384101.2015.1071136; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4566	4574		10.1074/jbc.RA117.001446	http://dx.doi.org/10.1074/jbc.RA117.001446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29352104	Green Published, hybrid			2022-12-26	WOS:000428204300028
J	Cui, XW; Tan, JM; Shi, YJ; Sun, C; Li, Y; Ji, CB; Wu, J; Zhang, Z; Chen, SY; Guo, XR; Liu, C				Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Li, Yun; Ji, Chenbo; Wu, Jun; Zhang, Zhao; Chen, Siyu; Guo, Xirong; Liu, Chang			The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; SUPPRESSES GLUCONEOGENESIS; EXPRESSION; TRANSCRIPTION; LIVER; ATF4; GLUCOSE-6-PHOSPHATASE; DIFFERENTIATION; HOMEOSTASIS; PREDICTION	Overactivated hepatic gluconeogenesis contributes to the pathogenesis of metabolic disorders, including type 2 diabetes. Precise control of hepatic gluconeogenesis is thus critical for maintaining whole-body metabolic homeostasis. Long non-coding RNAs (lncRNAs) have been shown to play key roles in diseases by regulating diverse biological processes, but the function of lncRNAs in maintaining normal physiology, particularly glucose homeostasis in the liver, remains largely unexplored. We identified a novel liver-enriched long non-coding RNA, Gm10768, and examined its expression patterns under pathophysiological conditions. We further adopted gain-and loss-offunction strategies to explore the effect of Gm10768 on hepatic glucose metabolism and the possible molecular mechanism involved. Our results showed that the expression of Gm10768 was significantly increased in the liver of fasted mice and was induced by gluconeogenic hormonal stimuli. Functionally, overexpression of Gm10768 activated hepatic gluconeogenesis in a cell-autonomous manner. In contrast, depletion of Gm10768 suppressed hepatic glucose production both in vitro and in vivo. Adenovirus-mediated hepatic knockdown of Gm10768 improved glucose tolerance and hyperglycemia of diabetic db/db mice. Mechanistically, Gm10768 sequestrated microRNA-214 (miR-214) to relieve its suppression on activating transcription factor 4 (ATF4), a positive regulator of hepatic gluconeogenesis. Taken together, we identified Gm10768 as a new lncRNA activating hepatic gluconeogenesis through antagonizing miR-214 in mice.	[Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Zhang, Zhao; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Zhang, Zhao; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Cui, Xianwei; Li, Yun; Ji, Chenbo; Guo, Xirong] Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing Maternal & Child Hlth Hosp, Nanjing 210004, Jiangsu, Peoples R China; [Wu, Jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Siyu; Liu, Chang] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 211198, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University	Liu, C (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Liu, C (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.; Chen, SY (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 211198, Jiangsu, Peoples R China.; Guo, XR (corresponding author), Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing 210004, Jiangsu, Peoples R China.	chensiyujimmy@163.com; xrguo@njmu.edu.cn; changliu@njnu.edu.cn		Chen, Siyu/0000-0002-3809-1062; Wu, Jun/0000-0003-4605-1148	National Natural Science Foundation of China [31771298, 31422028, 81670773, 81770837, 81301616]; National Science Foundation of Jiangsu Province of China [BK20161057]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province of China; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 31771298, 31422028, 81670773, 81770837, and 81301616, National Science Foundation of Jiangsu Province of China Grant BK20161057, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Bantubungi K, 2014, DIABETES, V63, P3199, DOI 10.2337/db13-1921; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Cui XW, 2016, FASEB J, V30, P4301, DOI 10.1096/fj.201600694R; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Kaur K, 2015, DIABETES, V64, P3659, DOI 10.2337/db14-1924; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Li MX, 2016, BBA-GENE REGUL MECH, V1859, P871, DOI 10.1016/j.bbagrm.2016.05.003; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Li WQ, 2015, J GERONTOL A-BIOL, V70, P263, DOI 10.1093/gerona/glu040; Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024; Liu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6684; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes RK, 2014, GENE EXPRESSION, V16, P85, DOI 10.3727/105221614X13919976902093; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Ruan XB, 2016, CELL REP, V14, P1867, DOI 10.1016/j.celrep.2016.01.062; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sharabi K, 2015, MOL ASPECTS MED, V46, P21, DOI 10.1016/j.mam.2015.09.003; Thiel G, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-2; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhu X, 2016, BIOCHEM BIOPH RES CO, V469, P319, DOI 10.1016/j.bbrc.2015.11.048; Zhuo S, 2016, DIABETES, V65, P3276, DOI 10.2337/db16-0166	33	20	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4097	4109		10.1074/jbc.M117.812818	http://dx.doi.org/10.1074/jbc.M117.812818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29363576	Green Published, hybrid			2022-12-26	WOS:000427587500021
J	Arakaki, AKS; Pan, WA; Lin, HL; Trejo, J				Arakaki, Aleena K. S.; Pan, Wen-An; Lin, Huilan; Trejo, JoAnn			The alpha-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-RECEPTOR; ACTIVATED RECEPTOR-1; CANCER PROGRESSION; CELL INVASION; PROSTATE-CANCER; TUMOR INVASION; PAR1; UBIQUITINATION; METASTASIS; EXPRESSION	Aberrant G protein-coupled receptor (GPCR) expression and activation has been linked to tumor initiation, progression, invasion, and metastasis. However, compared with other cancer drivers, the exploitation of GPCRs as potential therapeutic targets has been largely ignored, despite the fact that GPCRs are highly druggable. Therefore, to advance the potential status of GPCRs as therapeutic targets, it is important to understand how GPCRs function together with other cancer drivers during tumor progression. We now report that the alpha-arrestin domain-containing protein-3 (ARRDC3) acts as a tumor suppressor in part by controlling signaling and trafficking of the GPCR, protease-activated receptor-1 (PAR1). In a series of highly invasive basal-like breast carcinomas, we found that expression of ARRDC3 is suppressed whereas PAR1 is aberrantly over-expressed because of defective lysosomal sorting that results in persistent signaling. Using a lentiviral doxycycline-inducible system, we demonstrate that re-expression of ARRDC3 in invasive breast carcinoma is sufficient to restore normal PAR1 trafficking through the ALG-interacting protein X (ALIX)-dependent lysosomal degradative pathway. We also show that ARRDC3 re-expression attenuates PAR1-stimulated persistent signaling of c-Jun N-terminal kinase (JNK) in invasive breast cancer. Remarkably, restoration of ARRDC3 expression significantly reduced activated PAR1-induced breast carcinoma invasion, which was also dependent on JNK signaling. These findings are the first to identify a critical link between the tumor suppressor ARRDC3 and regulation of GPCR trafficking and signaling in breast cancer.	[Arakaki, Aleena K. S.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Arakaki, Aleena K. S.; Pan, Wen-An; Lin, Huilan; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Arakaki, Aleena/0000-0002-2900-078X	NIGMS, National Institutes of Health [RO1 GM090689]; NIGMS, National Institutes of Health from the Pharmacological Sciences Training Program [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, T32GM007752] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health from the Pharmacological Sciences Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health, Grant RO1 GM090689 (to J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health, Grant T32 GM007752 from the Pharmacological Sciences Training Program.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bar-Shavit R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081320; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dores MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157587; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flaumenhaft R, 2017, TRENDS PHARMACOL SCI, V38, P701, DOI 10.1016/j.tips.2017.05.001; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Hamilton JR, 2017, ANNU REV PHARMACOL, V57, P349, DOI 10.1146/annurev-pharmtox-011613-140016; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hawes BE, 2015, EUR J PHARMACOL, V762, P221, DOI 10.1016/j.ejphar.2015.05.046; Hernandez NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-47; Huan DW, 2016, INT J CLIN EXP PATHO, V9, P5588; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Korkola JE, 2003, CANCER RES, V63, P7167; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kuzumaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044368; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Puca L, 2014, J CELL SCI, V127, P1359, DOI 10.1242/jcs.142539; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sayyah J, 2014, J BIOL CHEM, V289, P17689, DOI 10.1074/jbc.M113.536227; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Shi XL, 2004, MOL CANCER RES, V2, P395; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh A, 2015, EUR J PHARMACOL, V763, P178, DOI 10.1016/j.ejphar.2015.05.011; Smith TH, 2017, J BIOL CHEM, V292, P13867, DOI 10.1074/jbc.M117.782359; Soung YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03846; Sriram K., 2018, MOL PHARM, DOI [10.1124/mol.117.111062CrossRefMedline, DOI 10.1124/MOL.117.111062CROSSREFMEDLINE]; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang D, 2014, MOL CELL BIOCHEM, V396, P67, DOI 10.1007/s11010-014-2143-y; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yao JJ, 2016, BIOCHEM BIOPH RES CO, V474, P213, DOI 10.1016/j.bbrc.2016.04.107; Zheng Y, 2017, CURR MOL MED, V17, P221, DOI 10.2174/1566524017666170807144711; Zhu LY, 2012, ONCOL REP, V28, P553, DOI 10.3892/or.2012.1851	67	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3350	3362		10.1074/jbc.RA117.001516	http://dx.doi.org/10.1074/jbc.RA117.001516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348172	Green Published, hybrid			2022-12-26	WOS:000426562800026
J	Galinovic, I; Kochova, E; Khalil, A; Villringer, K; Piper, SK; Fiebach, JB				Galinovic, Ivana; Kochova, Elena; Khalil, Ahmed; Villringer, Kersten; Piper, Sophie K.; Fiebach, Jochen B.			The ratio between cerebral blood flow and Tmax predicts the quality of collaterals in acute ischemic stroke	PLOS ONE			English	Article							PERFUSION MRI; BRANCH OCCLUSION; ARTERY TRUNK; DIGITAL MAP; TISSUE FATE; GROWTH	Background In acute ischemic stroke the status of collateral circulation is a critical factor in determining outcome. We propose a less invasive alternative to digital subtraction angiography for evaluating collaterals based on dynamic-susceptibility contrast magnetic resonance imaging. Methods Perfusion maps of Tmax and cerebral blood flow (CBF) were created for 35 patients with baseline occlusion of a major cerebral artery. Volumes of hypoperfusion were defined as having a Tmax delay of > 4 seconds (Tmax4s) and > 6 seconds (Tmax6s) and a CBF drop below 80% of healthy, contralateral tissue. For each patient a ratio between the volume of the CBF and the Tmax based perfusion deficit was calculated. Associations with collateral status and radiological outcome were assessed with the Mann-Whitney-U test, uni- and multivariable logistic regression analyses as well as area under the receiver-operator-characteristic (ROC) curve. Results The CBF/Tmax volume ratios were significantly associated with bad collateral status in crude logistic regression analysis as well as with adjustment for NIHSS at admission and baseline infarct volume (OR = 2.5 95% CI[1.2-5.4] p = 0.020 for CBF/Tmax 4s volume ratio and OR = 1.6 95% CI[1.0-2.6] p = 0.031 for CBF/Tmax6s volume ratio). Moreover, the ratios were significantly correlated to final infarct size (Spearman's rho = 0.711 and 0.619, respectively for the CBF/Tmax4s volume ratio and CBF/Tmax6s volume ration, all p<0.001). The ratios also had a high area under the ROC curve of 0.93 95%CI[0.86-1.00]) and 0.90 95%CI[0.80-1.00]respectiveiy for predicting poor radiological outcome. Conclusions ln the setting of acute ischemic stroke the CBF/Tmax volume ratio can be used to differenti-ate between good and insufficient collateral circulation without the need for invasive procedures like conventional angiography.	[Galinovic, Ivana; Khalil, Ahmed; Villringer, Kersten; Piper, Sophie K.; Fiebach, Jochen B.] Charite Univ Med Berlin, Ctr Stroke Res Berlin CSB, Berlin, Germany; [Kochova, Elena] Charite Univ Med Berlin, Int Grad Program Med Neurosci, Berlin, Germany; [Khalil, Ahmed] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Khalil, Ahmed] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Piper, Sophie K.] Charite Univ Med Berlin, Inst Med Biometr & Clin Epidemiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Galinovic, I (corresponding author), Charite Univ Med Berlin, Ctr Stroke Res Berlin CSB, Berlin, Germany.	ivana.galinovic@charite.de	Khalil, Ahmed/I-3251-2019	Khalil, Ahmed/0000-0003-1752-4305; Fiebach, Jochen B./0000-0002-7936-6958; Galinovic, Ivana/0000-0003-4904-8251; Piper, Sophie K./0000-0002-0147-8992	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin [01 EO 0801, 01EO01301]	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin	The research leading to these results has received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801 and 01EO01301). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves HC, 2016, ARQ NEUROPSIQUIATR; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Bang OY, 2008, NEUROLOGY, V71, P1804, DOI 10.1212/01.wnl.0000335929.06390.d3; Calamante Fernando, 2010, Top Magn Reson Imaging, V21, P75, DOI 10.1097/RMR.0b013e31821e53f5; Calamante F, 2010, STROKE, V41, P1169, DOI 10.1161/STROKEAHA.110.580670; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Galinovic I, 2011, CEREBROVASC DIS, V32, P186, DOI 10.1159/000328663; Jung SL, 2011, J NEUROIMAGING, V21, P225, DOI 10.1111/j.1552-6569.2010.00496.x; Kim SJ, 2014, ANN NEUROL, V76, P356, DOI 10.1002/ana.24211; Lee MJ, 2015, STROKE, V46, P2800, DOI 10.1161/STROKEAHA.115.009828; Olivot JM, 2009, NEUROLOGY, V72, P1140, DOI 10.1212/01.wnl.0000345372.49233.e3; Phan TG, 2005, STROKE, V36, P986, DOI 10.1161/01.STR.0000163087.66828.e9; Phan TG, 2007, STROKE, V38, P1805, DOI 10.1161/STROKEAHA.106.477000; Potreck A, 2017, EUR RADIOL, V27, P618, DOI 10.1007/s00330-016-4415-2; Villringer K, 2016, EUR RADIOL, V26, P1396, DOI 10.1007/s00330-015-3927-5; Zaro-Weber O, 2017, J CEREBR BLOOD F MET, V37, P3176, DOI 10.1177/0271678X16685574	17	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190811	10.1371/journal.pone.0190811	http://dx.doi.org/10.1371/journal.pone.0190811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381701	gold, Green Submitted, Green Published			2022-12-26	WOS:000423617800012
J	Shiraki, N; Sakimoto, S; Sakaguchi, H; Nishida, K; Nishida, K; Kamei, M				Shiraki, Nobuhiko; Sakimoto, Susumu; Sakaguchi, Hirokazu; Nishida, Kentaro; Nishida, Kohji; Kamei, Motohiro			Vitrectomy without prone positioning for rhegmatogenous retinal detachments in eyes with inferior retinal breaks	PLOS ONE			English	Article							PARS-PLANA VITRECTOMY; INTRAOCULAR-LENS IMPLANTATION; NUCLEAR SCLEROTIC CATARACT; COMBINED PHACOEMULSIFICATION; VITREORETINAL SURGERY; 25-GAUGE VITRECTOMY; SCLERAL BUCKLE; GAS TAMPONADE; FACE-DOWN; MANAGEMENT	Purpose To compare the anatomic and functional outcomes of pars plana vitrectomy (PPV) for treating rhegmatogenous retinal detachments (RRDs) between two groups with and without postoperative prone positioning. Methods This retrospective cohort study included 142 eyes of 142 patients with a primary RRD. All patients underwent PPV with 20% sulfur hexafluoride gas tamponade and were divided into two groups: the groups that did and did not maintain a prone position postoperatively. All patients were followed for more than 3 months. The main outcome measures were the best-corrected visual acuity (BCVA), retinal reattachment rate, and postoperative complications. Results Sixty-five eyes were included in the prone position group and 77 eyes in the group without prone positioning; the respective initial reattachment rates were 83.1% and 96.1%, a difference that reach significance (p = 0.011). In the eyes with inferior breaks, the initial reattachment rate was 94.7% (18 eyes) without prone positioning, which was significantly (p = 0.036) better than the 60% (6 eyes) initial reattachment rate in the group with prone positioning. In the eyes without inferior breaks, there was no significant difference in the initial reattachment rates between the two groups. The BCVAs at the 3-month postoperative visit did not differ significantly between the two groups. An epiretinal membrane (ERM) was observed postoperatively in 10 (13.0%) eyes in the group without prone positioning; no ERMs were seen postoperatively in eyes in which the internal limiting membrane (ILM) was peeled during PPV. Conclusions PPV without postoperative prone positioning is associated with a higher reattachment rate in eyes with a RRD, especially those with inferior retinal breaks. PPV with postoperative supine and lateral positioning might be beneficial to manage RRDs associated with inferior retinal breaks if ILM peeling is performed intraoperatively.	[Shiraki, Nobuhiko; Sakimoto, Susumu; Sakaguchi, Hirokazu; Nishida, Kentaro; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Kamei, Motohiro] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi, Japan	Osaka University; Aichi Medical University	Sakimoto, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan.	susumu.sakimoto@ophthal.med.osaka-u.ac.jp		shiraki, nobuhiko/0000-0001-9420-8440; Sakimoto, Susumu/0000-0003-2603-1043				Almony A, 2012, RETINA-J RET VIT DIS, V32, P499, DOI 10.1097/IAE.0b013e31822529cf; Barak Y, 2013, CLIN OPHTHALMOL, V7, P423, DOI 10.2147/OPTH.S40108; Bourla DH, 2010, AM J OPHTHALMOL, V149, P630, DOI 10.1016/j.ajo.2009.11.003; Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; Chen X, 2015, RETINA-J RET VIT DIS, V35, P892, DOI 10.1097/IAE.0000000000000413; dell'Omo R, 2013, GRAEF ARCH CLIN EXP, V251, P485, DOI 10.1007/s00417-012-2059-8; Demetriades AM, 2003, AM J OPHTHALMOL, V135, P291, DOI 10.1016/S0002-9394(02)01972-4; Duvdevan N, 2016, RETINA-J RET VIT DIS, V36, P1064, DOI 10.1097/IAE.0000000000000853; Goto T, 2013, ACTA OPHTHALMOL, V91, P552, DOI 10.1111/j.1755-3768.2012.02455.x; Guillaubey A, 2008, AM J OPHTHALMOL, V146, P128, DOI 10.1016/j.ajo.2008.02.029; Gupta D, 2011, ARCH OPHTHALMOL-CHIC, V129, P1109, DOI 10.1001/archophthalmol.2011.176; Holekamp NM, 2010, AM J OPHTHALMOL, V150, P543, DOI 10.1016/j.ajo.2010.05.013; Honjo M, 1998, OPHTHALMIC SURG LAS, V29, P99; Ibarra MS, 2005, AM J OPHTHALMOL, V139, P831, DOI 10.1016/j.ajo.2004.12.002; Iezzi R, 2013, OPHTHALMOLOGY, V120, P1998, DOI 10.1016/j.ophtha.2013.06.001; Katira RC, 2008, RETINA-J RET VIT DIS, V28, P744, DOI 10.1097/IAE.0b013e318162b031; KOENIG SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P362, DOI 10.1001/archopht.1990.01070050060031; Kuhn F, 2014, OPHTHALMIC RES, V51, P15, DOI 10.1159/000355077; Kunikata H, 2010, EYE, V24, P1071, DOI 10.1038/eye.2010.41; Martinez-Castillo V, 2005, OPHTHALMOLOGY, V112, P1222, DOI 10.1016/j.ophtha.2004.12.046; Martinez-Castillo V, 2005, ARCH OPHTHALMOL-CHIC, V123, P1078, DOI 10.1001/archopht.123.8.1078; MELBERG NS, 1995, OPHTHALMOLOGY, V102, P1466; Scharwey K, 1999, J CATARACT REFR SURG, V25, P693, DOI 10.1016/S0886-3350(99)00022-X; Senn P, 1995, OPHTHALMIC SURG LAS, V26, P420; Tanner V, 2001, BRIT J OPHTHALMOL, V85, P480, DOI 10.1136/bjo.85.4.480; Tosi GM, 2017, RETINA-J RET VIT DIS, V37, P630, DOI 10.1097/IAE.0000000000001221; Wickham L, 2004, BRIT J OPHTHALMOL, V88, P1376, DOI 10.1136/bjo.2004.043687; Wong R, 2011, ACTA OPHTHALMOL, V89, P365, DOI 10.1111/j.1755-3768.2009.01703.x; Zhou CD, 2015, RETINA-J RET VIT DIS, V35, P886, DOI 10.1097/IAE.0000000000000416	29	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191531	10.1371/journal.pone.0191531	http://dx.doi.org/10.1371/journal.pone.0191531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373582	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400014
J	Vatter, T; Maurer, A; Perovic, D; Kopahnke, D; Pillen, K; Ordon, F				Vatter, Thomas; Maurer, Andreas; Perovic, Dragan; Kopahnke, Doris; Pillen, Klaus; Ordon, Frank			Identification of QTL conferring resistance to stripe rust (Puccinia striiformis f. sp hordei) and leaf rust (Puccinia hordei) in barley using nested association mapping (NAM)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADULT-PLANT RESISTANCE; MULTIPLE DISEASE RESISTANCE; GENOME-WIDE ASSOCIATION; GENETIC ARCHITECTURE; SPRING BARLEY; POWDERY MILDEW; VULGARE; POPULATION; VIRULENCE	The biotrophic rust fungi Puccinia hordei and Puccinia striiformis are important barley pathogens with the potential to cause high yield losses through an epidemic spread. The identification of QTL conferring resistance to these pathogens is the basis for targeted breeding approaches aiming to improve stripe rust and leaf rust resistance of modern cultivars. Exploiting the allelic richness of wild barley accessions proved to be a valuable tool to broaden the genetic base of resistance of barley cultivars. In this study, SNP-based nested association mapping (NAM) was performed to map stripe rust and leaf rust resistance QTL in the barley NAM population HEB-25, comprising 1,420 lines derived from BC1S3 generation. By scoring the percentage of infected leaf area, followed by calculation of the area under the disease progress curve and the average ordinate during a two-year field trial, a large variability of resistance across and within HEB-25 families was observed. NAM based on 5,715 informative SNPs resulted in the identification of twelve and eleven robust QTL for resistance against stripe rust and leaf rust, respectively. Out of these, eight QTL for stripe rust and two QTL for leaf rust are considered novel showing no overlap with previously reported resistance QTL. Overall, resistance to both pathogens in HEB-25 is most likely due to the accumulation of numerous small effect loci. In addition, the NAM results indicate that the 25 wild donor QTL alleles present in HEB-25 strongly differ in regard to their individual effect on rust resistance. In future, the NAM concept will allow to select and combine individual wild barley alleles from different HEB parents to increase rust resistance in barley. The HEB-25 results will support to unravel the genetic basis of rust resistance in barley, and to improve resistance against stripe rust and leaf rust of modern barley cultivars.	[Vatter, Thomas; Perovic, Dragan; Kopahnke, Doris; Ordon, Frank] JKI, Inst Resistance Res & Stress Tolerance, Fed Res Ctr Cultivated Plants, Quedlinburg, Germany; [Maurer, Andreas; Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany	Julius Kuhn-Institut; Martin Luther University Halle Wittenberg	Ordon, F (corresponding author), JKI, Inst Resistance Res & Stress Tolerance, Fed Res Ctr Cultivated Plants, Quedlinburg, Germany.	frank.ordon@julius-kuehn.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Ordon, Frank/0000-0002-1695-6395; Perovic, Dragan/0000-0002-0292-1693; Maurer, Andreas/0000-0002-2916-7475	German Research Foundation (DFG) through European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) grant [0R72/10-1 (BARLEY-NAM_ERACAPS13.098), PI339/8-1]	German Research Foundation (DFG) through European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) grant	TV was funded by the German Research Foundation (DFG) through the European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) grant 0R72/10-1 (BARLEY-NAM_ERACAPS13.098). AM was funded by the German Research Foundation (DFG) through the European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) grant PI339/8-1.	Andersen EJ, 2016, EVOL BIOINFORM, V12, P99, DOI 10.4137/EBO.S38085; [Anonymous], 2016, GENETICS, V203, P1453; Backes G, 2003, THEOR APPL GENET, V106, P353, DOI 10.1007/s00122-002-1148-1; Bajgain P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155760; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cakir M, 2003, AUST J AGR RES, V54, P1351, DOI 10.1071/AR02231; Cakir M, 2003, AUST J AGR RES, V54, P1155, DOI 10.1071/AR02238; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Castro A., 2002, Barley Genetics Newsletter, V32, P1; Castro AJ, 2003, THEOR APPL GENET, V107, P922, DOI 10.1007/s00122-003-1329-6; Castro AJ, 2002, CROP SCI, V42, P1701, DOI 10.2135/cropsci2002.1701; Castro AJ, 2012, PLANT BREEDING, V131, P258, DOI 10.1111/j.1439-0523.2011.01930.x; CHEN FQ, 1994, THEOR APPL GENET, V88, P215, DOI 10.1007/BF00225900; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen X. M., 2001, Barley Genetics Newsletter, V31, P31; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1335, DOI 10.1094/Phyto-85-1335; Clifford B., 1985, DIS DISTRIBUTION EPI, P173; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; COTTERILL PJ, 1992, AUST J EXP AGR, V32, P747, DOI 10.1071/EA9920747; Das MK, 2007, CROP PROT, V26, P1422, DOI 10.1016/j.cropro.2006.12.003; Dracatos PM, 2016, PLANT PATHOL, V65, P734, DOI 10.1111/ppa.12448; Draper N.R., 1998, APPL REGRESSION ANAL, P79; DUBIN HJ, 1986, PLANT DIS, V70, P141, DOI 10.1094/PD-70-141; GOLAN T, 1978, EUPHYTICA, V27, P185, DOI 10.1007/BF00039134; Golegaonkar PG, 2009, EUPHYTICA, V166, P183, DOI 10.1007/s10681-008-9814-2; González González Miguel, 2013, Rev. Mex. Cienc. Agríc, V4, P1237; Hayes P., 1996, Journal of Agricultural Genomics, V2, P1; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Herzig P, 2017, J EXPT BOT; Hickey LT, 2011, THEOR APPL GENET, V123, P55, DOI 10.1007/s00122-011-1566-z; Jordan DR, 2011, CROP SCI, V51, P1444, DOI 10.2135/cropsci2010.06.0326; Kicherer S, 2000, THEOR APPL GENET, V100, P881, DOI 10.1007/s001220051365; Klos KE, 2016, PHYTOPATHOLOGY, V106, P1344, DOI 10.1094/PHYTO-09-15-0225-R; Konig J, 2012, MOL BREEDING, V30, P1253, DOI 10.1007/s11032-012-9712-0; Kopahnke D., 2004, Czech Journal of Genetics and Plant Breeding, V40, P86; Kraakman ATW, 2006, MOL BREEDING, V17, P41, DOI 10.1007/s11032-005-1119-8; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li HH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01674; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Logue S, 2000, P 8 INT BARL GEN S A, P197; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mathre D. E., 1997, COMPENDIUM BARLEY DI; Maurer A, 2016, HEREDITY; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCINTOSH RA, 1992, PLANT PATHOL, V41, P523, DOI 10.1111/j.1365-3059.1992.tb02450.x; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Moll E, 1996, MITTEILUNGEN BIOL BU, P4; Munnich C, 2000, PLANT BREEDING, V119, P473, DOI 10.1046/j.1439-0523.2000.00521.x; Nice LM, 2017, CROP SCI, V57, P1199, DOI 10.2135/cropsci2016.10.0850; Nice LM, 2016, GENETICS, V203, P1453, DOI 10.1534/genetics.116.190736; Niks RE, 2000, AGRONOMIE, V20, P769, DOI 10.1051/agro:2000174; Park RF, 2015, ANNU REV PHYTOPATHOL, V53, P565, DOI 10.1146/annurev-phyto-080614-120324; Parlevliet E.J., 1981, STRATEGIES CONTROL C, P47; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Peiffer JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067066; Perovic D, 2004, FUNCT INTEGR GENOMIC, V4, P74, DOI 10.1007/s10142-003-0100-z; Pickering RA, 1998, PLANT BREEDING, V117, P83, DOI 10.1111/j.1439-0523.1998.tb01453.x; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Qi X, 1999, THEOR APPL GENET, V99, P877, DOI 10.1007/s001220051308; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Qi XQ, 2000, MOL BREEDING, V6, P1, DOI 10.1023/A:1009649903383; Rossi C, 2006, MOL BREEDING, V18, P355, DOI 10.1007/s11032-006-9043-0; Rubiales D., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P333; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sandhu KS, 2012, THEOR APPL GENET, V125, P1403, DOI 10.1007/s00122-012-1921-8; Schnaithmann F, 2014, THEOR APPL GENET, V127, P1513, DOI 10.1007/s00122-014-2315-x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweizer P, 2011, MOL PLANT MICROBE IN, V24, P1492, DOI 10.1094/MPMI-05-11-0107; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; Serfling A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01668; Shtaya MJY, 2006, EUR J PLANT PATHOL, V116, P103, DOI 10.1007/s10658-006-9043-2; Singh D, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1799-7; STEFFENSON BJ, 1993, PLANT DIS, V77, P867, DOI 10.1094/PD-77-0867; Stubbs R. W., 1985, CEREAL RUSTS, V2, P61, DOI 10.1016/B978-0-12-148402-6.50011-0; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Tessenow I., 2010, ASSESSMENT RESISTANC, P154; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Toojinda T, 2000, THEOR APPL GENET, V101, P580, DOI 10.1007/s001220051519; Toojinda T, 1998, THEOR APPL GENET, V96, P123, DOI 10.1007/s001220050718; Utz HF, 2000, GENETICS, V154, P1839; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; Vatter T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186803; von Korff M, 2005, THEOR APPL GENET, V111, P583, DOI 10.1007/s00122-005-2049-x; Wellings CR, 2007, AUST J AGR RES, V58, P567, DOI 10.1071/AR07130; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Yan GP, 2008, PHYTOPATHOLOGY, V98, P120, DOI 10.1094/PHYTO-98-1-0120; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Ziems LA, 2014, THEOR APPL GENET, V127, P1199, DOI 10.1007/s00122-014-2291-1; Ziems LA, 2017, PHYTOPATHOLOGY	103	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191666	10.1371/journal.pone.0191666	http://dx.doi.org/10.1371/journal.pone.0191666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370232	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600075
J	Elfekih, S; Etter, P; Tay, WT; Fumagalli, M; Gordon, K; Johnson, E; De Barro, P				Elfekih, S.; Etter, P.; Tay, W. T.; Fumagalli, M.; Gordon, K.; Johnson, E.; De Barro, P.			Genome-wide analyses of the Bemisia tabaci species complex reveal contrasting patterns of admixture and complex demographic histories	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE; INTRODUCED POPULATIONS; BIOLOGICAL INVASIONS; GENETIC DIVERSITY; MITOCHONDRIAL; EVOLUTIONARY; POLYMORPHISM; PHYLOGEOGRAPHY; IDENTIFICATION; HYBRIDIZATION	Once considered a single species, the whitefly, Bemisia tabaci, is a complex of numerous morphologically indistinguishable species. Within the last three decades, two of its members (MED and MEAM1) have become some of the world's most damaging agricultural pests invading countries across Europe, Africa, Asia and the Americas and affecting a vast range of agriculturally important food and fiber crops through both feeding-related damage and the transmission of numerous plant viruses. For some time now, researchers have relied on a single mitochondrial gene and/or a handful of nuclear markers to study this species complex. Here, we move beyond this by using 38,041 genome-wide Single Nucleotide Polymorphisms, and show that the two invasive members of the complex are closely related species with signatures of introgression with a third species (IO). Gene flow patterns were traced between contemporary invasive populations within MED and MEAM1 species and these were best explained by recent international trade. These findings have profound implications for delineating the B. tabaci species status and will impact quarantine measures and future management strategies of this global pest.	[Elfekih, S.; Tay, W. T.; Gordon, K.] CSIRO, Black Mt Labs, Canberra, ACT, Australia; [Elfekih, S.] Univ Cambridge, Dept Zool, Cambridge, England; [Etter, P.; Johnson, E.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Fumagalli, M.] Imperial Coll London, Dept Life Sci, Silwood Pk campus, Ascot, Berks, England; [De Barro, P.] CSIRO Ecosci Precinct, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Cambridge; University of Oregon; Imperial College London; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Elfekih, S (corresponding author), CSIRO, Black Mt Labs, Canberra, ACT, Australia.; Elfekih, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	Samia.elfekih@csiro.au	Tay, Wee Tek/GPF-6142-2022; Tay, Wee Tek/C-1818-2008; Fumagalli, Matteo/H-6448-2019; De Barro, Paul J/C-1724-2008; Elfekih, Samia/AAF-5333-2021; Gordon, Karl H J/A-1976-2008	Tay, Wee Tek/0000-0002-8451-0811; Tay, Wee Tek/0000-0002-8451-0811; Fumagalli, Matteo/0000-0002-4084-2953; Elfekih, Samia/0000-0002-1057-8506; Gordon, Karl H J/0000-0002-4371-0454	CSIRO Office of the Chief Executive (OCE) post-doctoral fellowship [R-4546-1]; European Molecular Biology Organization (EMBO) fellowship [ASTF-6889]; Human Frontier Science Program (HFSP) postdoctoral fellowship [LT000320/2014]	CSIRO Office of the Chief Executive (OCE) post-doctoral fellowship; European Molecular Biology Organization (EMBO) fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP) postdoctoral fellowship(Human Frontier Science Program)	Samia Elfekih was funded by the CSIRO Office of the Chief Executive (OCE) post-doctoral fellowship (R-4546-1) and a European Molecular Biology Organization (EMBO) fellowship ASTF-6889, Matteo Fumagalli was funded by a Human Frontier Science Program (HFSP) postdoctoral fellowship (LT000320/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrews KR, 2016, NATURE REV GENETICS, V17, P92, DOI DOI 10.1038/NRG.2015.28; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Chen WB, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0321-y; Chen WB, 2015, INSECTS, V6, P704, DOI 10.3390/insects6030704; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Barro P, 2007, B ENTOMOL RES, V97, P433, DOI 10.1017/S0007485307005226; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Delatte H, 2005, B ENTOMOL RES, V95, P29, DOI 10.1079/BER2004337; Delatte H, 2011, B ENTOMOL RES, V101, P487, DOI 10.1017/S0007485311000101; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dlugosch KM, 2015, MOL ECOL, V24, P2095, DOI 10.1111/mec.13183; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Elfekih S, 2017, PEST MANAGEMENT SCI; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Filatov DA, 2016, MOL ECOL, V25, P2467, DOI 10.1111/mec.13618; Fu Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177742; Fumagalli M, 2014, BIOINFORMATICS, V30, P1486, DOI 10.1093/bioinformatics/btu041; Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Jenkins PT, 2006, BIOL INVASIONS, V8, P1589, DOI 10.1007/s10530-005-5852-z; Karut K, 2015, J APPL ENTOMOL, V139, P158, DOI 10.1111/jen.12169; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; O'Loughlin SM, 2014, MOL BIOL EVOL, V31, P889, DOI 10.1093/molbev/msu040; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Qin L, 2016, INSECT SCI, V23, P215, DOI 10.1111/1744-7917.12296; Reitzel AM, 2013, MOL ECOL, V22, P2953, DOI 10.1111/mec.12228; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Russello MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1106; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Simberloff D, 2005, TRENDS ECOL EVOL, V20, P216, DOI 10.1016/j.tree.2005.02.008; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takahashi T, 2014, MOL PHYLOGENET EVOL, V80, P137, DOI 10.1016/j.ympev.2014.07.016; Tay WT, 2016, MITOCHONDRIAL DNA A, V27, P972, DOI 10.3109/19401736.2014.926511; Tay WT, 2017, GENOME BIOL EVOL, V9, P2732, DOI 10.1093/gbe/evx173; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Tay WT, 2017, SCI REPORTS, V7; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; Thierry M, 2015, INSECT CONSERV DIVER, V8, P71, DOI 10.1111/icad.12083; Ueda S, 2009, J APPL ENTOMOL, V133, P355, DOI 10.1111/j.1439-0418.2008.01379.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Xie W, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix018; Yang GQ, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0139-1; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	67	33	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190555	10.1371/journal.pone.0190555	http://dx.doi.org/10.1371/journal.pone.0190555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364919	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500018
J	Jardim, E; Eero, M; Silva, A; Ulrich, C; Pawlowski, L; Holmes, SJ; Ibaibarriaga, L; De Oliveira, JAAA; Riveiro, I; Alzorriz, N; Citores, L; Scott, F; Uriarte, A; Carrera, P; Duhamel, E; Mosqueira, I				Jardim, Ernesto; Eero, Margit; Silva, Alexandra; Ulrich, Clara; Pawlowski, Lionel; Holmes, Steven J.; Ibaibarriaga, Leire; De Oliveira, Jose A. A. A.; Riveiro, Isabel; Alzorriz, Nekane; Citores, Leire; Scott, Finlay; Uriarte, Andres; Carrera, Pablo; Duhamel, Erwan; Mosqueira, Iago			Testing spatial heterogeneity with stock assessment models	PLOS ONE			English	Article							COD GADUS-MORHUA; SARDINE SARDINA-PILCHARDUS; NORTH-SEA; ATLANTIC COD; POPULATION-STRUCTURE; GEOGRAPHIC VARIABILITY; NORTHEASTERN ATLANTIC; FISH; DYNAMICS; WEST	This paper describes a methodology that combines meta-population theory and stock assessment models to gain insights about spatial heterogeneity of the meta-population in an operational time frame. The methodology was tested with stochastic simulations for different degrees of connectivity between sub-populations and applied to two case studies, North Sea cod (Gadus morua) and Northeast Atlantic sardine (Sardina pilchardus). Considering that the biological components of a population can be partitioned into discrete spatial units, we extended this idea into a property of additivity of sub-population abundances. If the additivity results hold true for putative sub-populations, then assessment results based on sub-populations will provide information to develop and monitor the implementation of finer scale/local management. The simulation study confirmed that when sub-populations are independent and not too heterogeneous with regards to productivity, the sum of stock assessment model estimates of sub-populations' SSB is similar to the SSB estimates of the meta-population. It also showed that a strong diffusion process can be detected and that the stronger the connection between SSB and recruitment, the better the diffusion process will be detected. On the other hand it showed that weak to moderate diffusion processes are not easy to identify and large differences between sub-populations productivities may be confounded with weak diffusion processes. The application to North Sea cod and Atlantic sardine exemplified how much insight can be gained. In both cases the results obtained were sufficiently robust to support the regional analysis.	[Jardim, Ernesto; Holmes, Steven J.; Alzorriz, Nekane; Scott, Finlay; Mosqueira, Iago] European Commiss, JRC, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy; [Eero, Margit; Ulrich, Clara] Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Silva, Alexandra] IPMA, Av Dr Alfredo Magalhaes Ramalho 6, P-1449006 Lisbon, Portugal; [Pawlowski, Lionel; Duhamel, Erwan] IFREMER, Lab Technol & Biol Halieut, 8 Rue Francois Toullec, F-56100 Lorient, France; [Ibaibarriaga, Leire; Citores, Leire] AZTI Tecnalia, Marine Res Div, Sukarrieta 48395, Bizkaia, Spain; [De Oliveira, Jose A. A. A.] CEFAS, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England; [Riveiro, Isabel; Carrera, Pablo] IEO, Ctr Oceanog Vigo, Subida Radio Faro 50, Vigo 36390, Spain; [Uriarte, Andres] AZTI Tecnalia, Marine Res Div, Pasaia 20110, Gipuzkoa, Spain; [Citores, Leire] BCAM, Mazarredo 14, E-48009 Bilbao, Basque Country, Spain	European Commission Joint Research Centre; EC JRC ISPRA Site; Technical University of Denmark; Instituto Portugues do Mar e da Atmosfera; Ifremer; AZTI; Centre for Environment Fisheries & Aquaculture Science; Spanish Institute of Oceanography; AZTI; Basque Center for Applied Mathematics (BCAM)	Jardim, E (corresponding author), European Commiss, JRC, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.	ernesto.jardim@ec.europa.eu	Ibaibarriaga, Leire/C-2483-2009; Jardim, Ernesto/X-9764-2019; Ulrich, Clara/F-3583-2011; Uriarte, Ainhize/AAF-5750-2021; Eero, Margit/AAK-2845-2021; Silva, Alexandra/I-4326-2017	Ibaibarriaga, Leire/0000-0001-5619-1174; Ulrich, Clara/0000-0001-7598-2051; Uriarte, Ainhize/0000-0002-9596-6451; Eero, Margit/0000-0002-1848-0597; Carrera, Pablo/0000-0001-8819-6690; Jardim, Ernesto/0000-0003-4695-825X; Duhamel, Erwan/0000-0001-6990-628X; Silva, Alexandra/0000-0002-2950-1429; Riveiro, I. (Isabel)/0000-0002-8905-072X; Mosqueira, Iago/0000-0002-3252-0591	European Union Data Collection Framework (EC) [199/2008]; AZTI Foundation; Basque Government BERC programme; Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation [SEV-2013-0323]; PELAGI project - Basque Government (Economic Development and Infrastructure Department)	European Union Data Collection Framework (EC); AZTI Foundation; Basque Government BERC programme(Basque Government); Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation(Spanish Government); PELAGI project - Basque Government (Economic Development and Infrastructure Department)	European Union Data Collection Framework (EC) 199/2008 funded the collection of the data used in this work. LC is supported by a doctoral grant from AZTI Foundation, the Basque Government BERC 2014-2017 programme and by the Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation SEV-2013-0323. LI and AU work was partly supported by the PELAGI project funded by the Basque Government (Economic Development and Infrastructure Department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], QUANTITATIVE FISHERI; [Anonymous], 2006, Q5RS 2002 000818; Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Bernal M, 2007, PROG OCEANOGR, V74, P210, DOI 10.1016/j.pocean.2007.04.018; Beverton RJH, 1957, DYNAMICS EXPLOITATED; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Carrera P, 2003, SCI MAR, V67, P245, DOI 10.3989/scimar.2003.67s1245; Cope JM, 2011, FISH RES, V107, P22, DOI 10.1016/j.fishres.2010.10.002; Correia AT, 2014, FISH RES, V149, P76, DOI 10.1016/j.fishres.2013.09.016; Cressie N., 2011, STAT SPATIO TEMPORAL; Cunningham CL, 2007, AFR J MAR SCI, V29, P347, DOI 10.2989/AJMS.2007.29.3.4.334; de Moor CL, 2015, AFR J MAR SCI, V37, P41, DOI 10.2989/1814232X.2015.1009166; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; Goethel DR, 2015, ICES J MAR SCI, V72, P164, DOI 10.1093/icesjms/fsu014; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Guan WJ, 2013, CAN J FISH AQUAT SCI, V70, P1178, DOI 10.1139/cjfas-2012-0364; Haddon M., 2011, MODELLING QUANTITATI; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Heath MR, 2014, ICES J MAR SCI, V71, P794, DOI 10.1093/icesjms/fst185; Holmes SJ, 2014, ICES J MAR SCI, V71, P1433, DOI 10.1093/icesjms/fsu075; Hulson PJF, 2013, CAN J FISH AQUAT SCI, V70, P1402, DOI 10.1139/cjfas-2013-0020; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Hutchinson WF, 2001, MAR ECOL PROG SER, V223, P251, DOI 10.3354/meps223251; ICES, 2015, BENCHM WORKSH N SEA; ICES, 2015, STOCK ANN COD SUB 4; ICES, 2016, 2016SSGIEOM31 ICES C; ICES, 2017, BENCHM WORKSH PEL ST; ICES, 2006, 2006ACFM36 ICES CM; ICES, 2012, BENCHM WORKSH PEL ST; Jardim E, 2015, ICES J MAR SCI, V72, P232, DOI 10.1093/icesjms/fsu050; Jemaa S, 2015, J SEA RES, V96, P11, DOI 10.1016/j.seares.2014.11.002; Jennings S., 2001, MARINE FISHERIES ECO; Kasapidis P, 2014, BIOLOGY AND ECOLOGY OF SARDINES AND ANCHOVIES, P43; Kell L., 2017, FLIFE METHODS MODELL; Kell LT, 2007, ICES J MAR SCI, V64, P640, DOI 10.1093/icesjms/fsm012; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Li Y, 2015, ICES J MAR SCI, V72, P70, DOI 10.1093/icesjms/fsu057; Garcia-Garcia LM, 2016, FISH RES, V173, P250, DOI 10.1016/j.fishres.2015.10.002; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Nedreaas K., 2008, Fisken og Havet, V5, P1; Nielsen EE, 2009, MAR ECOL PROG SER, V376, P213, DOI 10.3354/meps07798; Oliveira PB, 2008, REMOTE SENS ENVIRON, V112, P3376, DOI 10.1016/j.rse.2007.09.018; Petitgas P., 2010, 306 ICES; Poulsen NA, 2011, MAR ECOL PROG SER, V436, P231, DOI 10.3354/meps09246; Punt AE, 2015, FISH RES, V168, P85, DOI 10.1016/j.fishres.2015.04.002; Quinn T.J., 1999, BIOL RES MANAG SER; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; Silva A, 2008, FISH RES, V90, P56, DOI 10.1016/j.fishres.2007.09.011; Silva A, 2006, ICES J MAR SCI, V63, P663, DOI 10.1016/j.icesjms.2006.01.005; Silva A, 2009, ICES J MAR SCI, V66, P495, DOI 10.1093/icesjms/fsn225; SILVA ALD, 2007, THESIS; Stratoudakis Y, 2007, MAR BIOL, V152, P201, DOI 10.1007/s00227-007-0674-4; Szuwalski CS, 2015, FISH RES, V164, P135, DOI 10.1016/j.fishres.2014.10.020; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x; Wright PJ, 2011, ICES J MAR SCI, V68, P1918, DOI 10.1093/icesjms/fsr111; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Yoneda M, 2004, MAR ECOL PROG SER, V276, P237, DOI 10.3354/meps276237	64	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190791	10.1371/journal.pone.0190791	http://dx.doi.org/10.1371/journal.pone.0190791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364901	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500024
J	Cabral, AL; Jordan, MC; Larson, G; Somers, DJ; Humphreys, DG; McCartney, CA				Cabral, Adrian L.; Jordan, Mark C.; Larson, Gary; Somers, Daryl J.; Humphreys, D. Gavin; McCartney, Curt A.			Relationship between QTL for grain shape, grain weight, test weight, milling yield, and plant height in the spring wheat cross RL4452/'ACDomain'	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CHROMOSOMAL LOCATION; DWARFING GENES; KERNEL SIZE; NORIN 10; SEED SIZE; MAJOR QTL; RICE; LENGTH; WIDTH	Kernel morphology characteristics of wheat are complex and quantitatively inherited. A doubled haploid (DH) population of the cross RL4452/'AC Domain' was used to study the genetic basis of seed shape. Quantitative trait loci (QTL) analyses were conducted on a total of 18 traits: 14 grain shape traits, flour yield (Fyd), and three agronomic traits (Plant height [Plht], 1000 Grain weight [Gwt], Test weight [Twt]), using data from trial locations at Glenlea, Brandon, and Morden in Manitoba, Canada, between 1999 and 2004. Kernel shape was studied through digital image analysis with an Acurum (R) grain analyzer. Plht, Gwt, Twt, Fyd, and grain shape QTL were correlated with each other and QTL analysis revealed that QTL for these traits often mapped to the same genetic locations. The most significant QTL for the grain shape traits were located on chromosomes 4B and 4D, each accounting for up to 24.4% and 53.3% of the total phenotypic variation, respectively. In addition, the most significant QTL for Plht, Gwt, and Twt were all detected on chromosome 4D at the Rht-D1 locus. Rht-D1b decreased Plht, Gwt, Twt, and kernel width relative to the RhtD1a allele. A narrow genetic interval on chromosome 4B contained significant QTL for grain shape, Gwt, and Plht. The 'AC Domain' allele reduced Plht, Gwt, kernel length and width traits, but had no detectable effect on Twt. The data indicated that this variation was inconsistent with segregation at Rht-B1. Numerous QTL were identified that control these traits in this population.	[Cabral, Adrian L.; Jordan, Mark C.; McCartney, Curt A.] Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada; [Larson, Gary] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Somers, Daryl J.] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Humphreys, D. Gavin] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Cabral, Adrian L.] Natl Res Council Canada, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; National Research Council Canada	McCartney, CA (corresponding author), Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada.	Curt.McCartney@agr.gc.ca	CABRAL, ADRIAN L/E-6983-2011	CABRAL, ADRIAN L/0000-0003-4550-7721; McCartney, Curt/0000-0002-9482-3133	Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada	Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada(Genome Canada)	CM and MJ were were funded as part of Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grains Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Botwright T, 2001, AUST J PLANT PHYSIOL, V28, P417; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Cabral AL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0340-1; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; EVANS LE, 1972, CAN J PLANT SCI, V52, P1081, DOI 10.4141/cjps72-184; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FISCHER RA, 1990, EUPHYTICA, V46, P51, DOI 10.1007/BF00057618; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; GALE MD, 1976, HEREDITY, V37, P283, DOI 10.1038/hdy.1976.88; GALE MD, 1975, HEREDITY, V35, P417, DOI 10.1038/hdy.1975.112; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Kokko EG, 2007, Patent No. [US 7218775 B2, 7218775]; Kumar A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.07.0058; LANDER ES, 1989, GENETICS, V121, P185; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; MCVITTIE JA, 1978, HEREDITY, V40, P67, DOI 10.1038/hdy.1978.8; MIRALLES DJ, 1995, FIELD CROP RES, V43, P55, DOI 10.1016/0378-4290(95)00041-N; MORRIS R, 1972, CROP SCI, V12, P247, DOI 10.2135/cropsci1972.0011183X001200020032x; Okamoto Y, 2013, BREEDING SCI, V63, P423, DOI 10.1270/jsbbs.63.423; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PINTHUS MJ, 1983, THEOR APPL GENET, V66, P153, DOI 10.1007/BF00265191; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; REITZ LP, 1968, CROP SCI, V8, P686, DOI 10.2135/cropsci1968.0011183X000800060014x; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; YOUSSEFIAN S, 1992, FIELD CROP RES, V28, P191, DOI 10.1016/0378-4290(92)90040-G; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7	46	39	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190681	10.1371/journal.pone.0190681	http://dx.doi.org/10.1371/journal.pone.0190681			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357369	Green Published, Green Submitted, gold			2022-12-26	WOS:000422919500006
J	Jasinski, M; Kulik, M; Wojciechowska, M; Stolarski, R; Trylska, J				Jasinski, Maciej; Kulik, Marta; Wojciechowska, Monika; Stolarski, Ryszard; Trylska, Joanna			Interactions of 2 '-O-methyl oligoribonucleotides with the RNA models of the 30S subunit A-site	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PEPTIDE NUCLEIC-ACIDS; DOUBLE-STRANDED-RNA; 16S RIBOSOMAL-RNA; VANT-HOFF; CALORIMETRIC ENTHALPIES; AMINOGLYCOSIDE ANTIBIOTICS; SIGNIFICANT DISCREPANCIES; STRUCTURAL BASIS; HYGROMYCIN-B	Synthetic oligonucleotides targeting functional regions of the prokaryotic rRNA could be promising antimicrobial agents. Indeed, such oligonucleotides were proven to inhibit bacterial growth. 2'-O-methylated (2'-O-Me) oligoribonucleotides with a sequence complementary to the decoding site in 16S rRNA were reported as inhibitors of bacterial translation. However, the binding mode and structures of the formed complexes, as well as the level of selectivity of the oligonucleotides between the prokaryotic and eukaryotic target, were not determined. We have analyzed three 2'-O-Me oligoribonucleotides designed to hybridize with the models of the prokaryotic rRNA containing two neighboring aminoglycoside binding pockets. One pocket is the paromomycin/kanamycin binding site corresponding to the decoding site in the small ribosomal subunit and the other one is the close-by hygromycin B binding site whose dynamics has not been previously reported. Molecular dynamics (MD) simulations, as well as isothermal titration calorimetry, gel electrophoresis and spectroscopic studies have shown that the eukaryotic rRNA model is less conformationally stable (in terms of hydrogen bonds and stacking interactions) than the corresponding prokaryotic one. In MD simulations of the eukaryotic construct, the nucleotide U1498, which plays an important role in correct positioning of mRNA during translation, is flexible and spontaneously flips out into the solvent. In solution studies, the 2'-O-Me oligoribonucleotides did not interact with the double stranded rRNA models but all formed stable complexes with the single-stranded prokaryotic target. 2'-O-Me oligoribonucleotides with one and two mismatches bound less tightly to the eukaryotic target. This shows that at least three mismatches between the 2'-O-Me oligoribonucleotide and eukaryotic rRNA are required to ensure target selectivity. The results also suggest that, in the ribosome environment, the strand invasion is the preferred binding mode of 2'-O-Me oligoribonucleotides targeting the aminoglycoside binding sites in 16S rRNA.	[Jasinski, Maciej; Kulik, Marta; Wojciechowska, Monika; Trylska, Joanna] Univ Warsaw, Ctr New Technol, Warsaw, Poland; [Jasinski, Maciej] Univ Warsaw, Coll Inter Fac Individual Studies Math & Nat Sci, Warsaw, Poland; [Stolarski, Ryszard] Univ Warsaw, Fac Phys, Inst Expt Phys, Dept Biophys, Warsaw, Poland; [Kulik, Marta] RIKEN, Wako, Saitama 3510198, Japan	University of Warsaw; University of Warsaw; University of Warsaw; RIKEN	Trylska, J (corresponding author), Univ Warsaw, Ctr New Technol, Warsaw, Poland.	joanna@cent.uw.edu.pl	Kulik, Marta/I-5589-2018; Trylska, Joanna/AAI-6785-2021	Kulik, Marta/0000-0003-2381-7665; Trylska, Joanna/0000-0002-1464-5323; Jasinski, Maciej/0000-0001-6467-2752; Wojciechowska, Monika/0000-0002-6255-6421; Stolarski, Ryszard/0000-0002-3272-5140	National Science Centre [DEC-2014/12/VV/ST5/00589]; CeNT BST funds; European Social Fund [UDA-POKL.04.01.01-00-072/09-00]; Interdisciplinary Centre for Mathematical and Computational Modelling [G31-4, GA65-17]	National Science Centre(National Science Centre, Poland); CeNT BST funds; European Social Fund(European Social Fund (ESF)); Interdisciplinary Centre for Mathematical and Computational Modelling	J. T and M. W. thank the National Science Centre (grant no DEC-2014/12/VV/ST5/00589 in Symfonia call) and CeNT BST funds. M. J. thanks the European Social Fund (contract no UDA-POKL.04.01.01-00-072/09-00). Simulations were performed at the Interdisciplinary Centre for Mathematical and Computational Modelling (grants G31-4 and GA65-17) and Centre of New Technologies, University of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. T and M. W. thank the National Science Centre (grant no DEC-2014/12/W/ST5/00589 in Symfonia call) and CeNT BST funds. M. J. thanks the European Social Fund (contract no UDA-POKL.04.01.01-00-072/09-00). Simulations were performed at the Interdisciplinary Centre for Mathematical and Computational Modelling (grants G31-4 and GA65-17) and Centre of New Technologies, University of Warsaw.	Abelian A, 2004, BIOCHEM J, V383, P201, DOI 10.1042/BJ20040246; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Behrens S, 2003, APPL ENVIRON MICROB, V69, P1748, DOI 10.1128/AEM.69.3.1748-1758.2003; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Blin G, 2010, IEEE ACM T COMPUT BI, V7, P309, DOI 10.1109/TCBB.2008.28; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaires JB, 1997, BIOPHYS CHEM, V64, P15, DOI 10.1016/S0301-4622(96)02205-3; Chandrika NT, 2016, MEDCHEMCOMM, V7, P50, DOI 10.1039/c5md00453e; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dibrov SM, 2010, NUCLEIC ACIDS RES, V38, P4458, DOI 10.1093/nar/gkq159; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FREIRE E, 1990, ANAL CHEM, V62, pA950, DOI 10.1021/ac00217a002; Garneau-Tsodikova S, 2016, MEDCHEMCOMM, V7, P11, DOI 10.1039/c5md00344j; Gorska A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv559; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Gupta P, 2012, BIOCHEMISTRY-US, V51, P63, DOI 10.1021/bi201570a; Hansen J, 2016, PHYS CHEM CHEM PHYS, V18, P10270, DOI 10.1039/c5cp07285a; Hess B, 2002, J CHEM PHYS, V116, P209, DOI 10.1063/1.1421362; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain T, 2016, CELL, V167, P133, DOI 10.1016/j.cell.2016.08.074; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul M, 2004, J AM CHEM SOC, V126, P3447, DOI 10.1021/ja030568i; Kietrys Anna M., 2009, Biotechnologia (Poznan), P48; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Kondo J, 2008, NUCLEIC ACIDS RES, V36, P2654, DOI 10.1093/nar/gkn112; Kulik M, 2015, BIOPHYS J, V108, P655, DOI 10.1016/j.bpj.2014.12.020; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Li M, 2009, BIOCHEMISTRY-US, V48, P8299, DOI 10.1021/bi900982t; Liljas A, 2004, STRUCTURAL ASPECTS P; Liu YF, 1997, BIOPHYS CHEM, V64, P121, DOI 10.1016/S0301-4622(96)02229-6; LIU YF, 1995, PROTEIN SCI, V4, P2559, DOI 10.1002/pro.5560041212; Llano-Sotelo B, 2009, J MOL BIOL, V391, P813, DOI 10.1016/j.jmb.2009.06.069; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mikulecky PJ, 2006, BIOPOLYMERS, V82, P38, DOI 10.1002/bip.20457; Mikulecky PJ, 2006, BIOCHEMISTRY-US, V45, P604, DOI 10.1021/bi0517178; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; Murray JB, 2006, CHEM BIOL, V13, P129, DOI 10.1016/j.chembiol.2005.11.004; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; Narayanan BC, 2014, NUCLEIC ACIDS RES, V42, pD114, DOI 10.1093/nar/gkt980; Noy A, 2009, PHYS CHEM CHEM PHYS, V11, P10596, DOI 10.1039/b912067j; Panecka J, 2015, BIOCHIMIE, V112, P96, DOI 10.1016/j.biochi.2015.02.021; Panecka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111811; Panecka J, 2014, J PHYS CHEM B, V118, P6687, DOI 10.1021/jp5030685; Panecka J, 2011, J PHYS CHEM B, V115, P532, DOI 10.1021/jp106404u; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfister P, 2003, ANTIMICROB AGENTS CH, V47, P1496, DOI 10.1128/AAC.47.5.1496-1502.2003; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Robbins TJ, 2013, J BIOMOL STRUCT DYN, V31, P1311, DOI 10.1080/07391102.2012.732344; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Song K, 2009, J CHEM THEORY COMPUT, V5, P3105, DOI 10.1021/ct9001575; Sulc P, 2015, BIOPHYS J, V108, P1238, DOI 10.1016/j.bpj.2015.01.023; Thoduka SG, 2017, BIOPOLYMERS, V107, DOI 10.1002/bip.23004; Trylska J, 2016, BIOCHEM SOC T, V44, P987, DOI 10.1042/BST20160087; Trylska J, 2013, ACS CHEM BIOL, V8, P1101, DOI 10.1021/cb400163t; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Zeng XC, 2014, J MOL BIOL, V426, P3201, DOI 10.1016/j.jmb.2014.04.029; Zengeya T, 2014, METHODS MOL BIOL, V1050, P83, DOI 10.1007/978-1-62703-553-8_7; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou Y, 2013, NUCLEIC ACIDS RES, V41, P6664, DOI 10.1093/nar/gkt352	84	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191138	10.1371/journal.pone.0191138	http://dx.doi.org/10.1371/journal.pone.0191138			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351348	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300051
J	Chen, HC; Qian, CX; Liang, CY; Kang, WC				Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence			An approach for predicting the compressive strength of cement-based materials exposed to sulfate attack	PLOS ONE			English	Article							CONCRETE STRENGTH; RESISTANCE TEST; PERFORMANCE; MACHINE	In this paper, a support vector machine (SVM) model which can be used to predict the compressive strength of mortars exposed to sulfate attack was established. An accelerated corrosion test was applied to collect compressive strength data. For predicting the compressive strength of mortars, a total of 638 data samples obtained from experiment was chosen as a dataset to establish a SVM model. The values of the coefficient of determination, the mean absolute error, the mean absolute percentage error and the root mean square error were used for evaluating the predictive accuracy. The main factors affecting the predicted compressive strength were obtained by sensitivity analysis. A SVM model was calibrated, validated, and finally established. Moreover, the performance of the SVM model was compared to an artificial neural network (ANN) model. Results show that the prediction values from the SVM model were close to the experimental values; the main factors sensitive to concrete compressive strength were exposure time, water-cement ratio and sulfate ions; the performance of the SVM model was better than the ANN model. The SVM model developed in this study can be potentially used for predicting the compressive strength of cement-based materials servicing in harsh environments.	[Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence] Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence] Southeast Univ, Res Inst Green Construct Mat, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Qian, CX (corresponding author), Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Qian, CX (corresponding author), Southeast Univ, Res Inst Green Construct Mat, Nanjing, Jiangsu, Peoples R China.	cxqian@seu.edu.cn		Qian, Chunxiang/0000-0002-7547-5890; Chen, HuaiCheng/0000-0001-7308-9833	National Program on Key Basic Research Project of China [2015C66551002]	National Program on Key Basic Research Project of China(National Basic Research Program of China)	The authors appreciate the financial support from the National Program on Key Basic Research Project of China (Grant No. 2015C66551002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate the financial support from the National Program on Key Basic Research Project of China (Grant No. 2015CB6551002).	Ahmadi-Nedushan B, 2012, ENG APPL ARTIF INTEL, V25, P1073, DOI 10.1016/j.engappai.2012.01.012; Alshihri MM, 2009, CONSTR BUILD MATER, V23, P2214, DOI 10.1016/j.conbuildmat.2008.12.003; [Anonymous], 2008, 7492008 GBT; [Anonymous], 2003, 500812002 GBT; Bassuoni MT, 2016, CEMENT CONCRETE RES, V79, P395, DOI 10.1016/j.cemconres.2015.02.006; Beddoe RE, 2005, CEMENT CONCRETE RES, V35, P2333, DOI 10.1016/j.cemconres.2005.04.002; Bellmann F, 2006, CEMENT CONCRETE RES, V36, P358, DOI 10.1016/j.cemconres.2005.04.006; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Chauvin Y, 1995, J ASSOC INF SCI TECH, V48, P88; Cheng MY, 2012, AUTOMAT CONSTR, V28, P106, DOI 10.1016/j.autcon.2012.07.004; Chou JS, 2014, CONSTR BUILD MATER, V73, P771, DOI 10.1016/j.conbuildmat.2014.09.054; Davis J, 1996, J COGNITIVE NEUROSCI, V8, P383, DOI 10.1162/jocn.1996.8.4.383a; Gupta SM, 2013, P WORLD ACAD SCI ENG, V25, P1; Kaushik S.K., 1995, CEMENT CONCRETE COMP, V17, P177, DOI [10.1016/0958-9465(95)00015-5, DOI 10.1016/0958-9465(95)00015-5]; Kecman V, 2001, LEAMING SOFT COMPUTI; Lee ST, 2008, CAN J CIVIL ENG, V35, P1210, DOI 10.1139/L08-065; Liong SY, 2000, J COMPUT CIVIL ENG, V14, P1, DOI 10.1061/(ASCE)0887-3801(2000)14:1(1); Loser R, 2016, MATER STRUCT, V49, P3445, DOI 10.1617/s11527-015-0731-2; Park D, 2010, COMPUT-AIDED CIV INF, V14, P357; Poupard O, 2006, CEMENT CONCRETE RES, V36, P504, DOI 10.1016/j.cemconres.2005.11.004; Prasad BKR, 2009, CONSTR BUILD MATER, V23, P117, DOI 10.1016/j.conbuildmat.2008.01.014; Ravi V, 2008, ADV BANKING TECHNOLO; Sarkar M, 1998, PATTERN RECOGN LETT, V19, P43, DOI 10.1016/S0167-8655(97)00151-7; Sobhani J, 2010, CONSTR BUILD MATER, V24, P709, DOI 10.1016/j.conbuildmat.2009.10.037; Steenbergen RDJM, 2012, STRUCT CONCRETE, V13, P27, DOI 10.1002/suco.201100031; Tawie R, 2010, CONSTR BUILD MATER, V24, P1746, DOI 10.1016/j.conbuildmat.2010.02.014; Thomas MDA, 2008, ACI MATER J, V105, P628; Ueda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112659; Vapnik V, 1997, ADV NEUR IN, V9, P281; Yan KZ, 2010, CONSTR BUILD MATER, V24, P1479, DOI 10.1016/j.conbuildmat.2010.01.006; Yassin M, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, INFORMATICS, COMMUNICATION AND ENERGY SYSTEMS (SPICES), DOI 10.1109/DFT.2015.7315143; Yeh IC, 1998, J MATER CIVIL ENG, V10, P263, DOI 10.1061/(ASCE)0899-1561(1998)10:4(263); Yeh IC, 1998, CEMENT CONCRETE RES, V28, P1797, DOI 10.1016/S0008-8846(98)00165-3; Zhan Y, 2015, 5 INT C CIV ENG TRAN	34	21	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191370	10.1371/journal.pone.0191370	http://dx.doi.org/10.1371/journal.pone.0191370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346451	Green Submitted, Green Published, gold			2022-12-26	WOS:000422749500044
J	Caria, S; Magtoto, CM; Samiei, T; Portela, M; Lim, KYB; How, JY; Stewart, BZ; Humbert, PO; Richardson, HE; Kvansakul, M				Caria, Sofia; Magtoto, Charlene M.; Samiei, Tinaz; Portela, Marta; Lim, Krystle Y. B.; How, Jing Yuan; Stewart, Bryce Z.; Humbert, Patrick O.; Richardson, Helena E.; Kvansakul, Marc			Drosophila melanogaster Guk-holder interacts with the Scribbled PDZ1 domain and regulates epithelial development with Scribbled and Discs Large	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANCE-HORAN-SYNDROME; CELL POLARITY; SUPERTERTIARY STRUCTURE; LIGAND SPECIFICITY; SYNDROME PROTEIN; COMPLEX; GENE; LGL; PROLIFERATION; MIGRATION	Epithelial cell polarity is controlled by components of the Scribble polarity module, and its regulation is critical for tissue architecture and cell proliferation and migration. In Drosophila melanogaster, the adaptor protein Guk-holder (Gukh) binds to the Scribbled (Scrib) and Discs Large (Dlg) components of the Scribble polarity module and plays an important role in the formation of neuromuscular junctions. However, Gukh's role in epithelial tissue formation and the molecular basis for the Scrib-Gukh interaction remain to be defined. We now show using isothermal titration calorimetry that the Scrib PDZ1 domain is the major site for an interaction with Gukh. Furthermore, we defined the structural basis of this interaction by determining the crystal structure of the Scrib PDZ1-Gukh complex. The C-terminal PDZ-binding motif of Gukh is located in the canonical ligand-binding groove of Scrib PDZ1 and utilizes an unusually extensive network of hydrogen bonds and ionic interactions to enable binding to PDZ1 with high affinity. We next examined the role of Gukh along with those of Scrib and Dlg in Drosophila epithelial tissues and found that Gukh is expressed in larval-wing and eye-epithelial tissues and co-localizes with Scrib and Dlg at the apical cell cortex. Importantly, we show that Gukh functions with Scrib and Dlg in the development of Drosophila epithelial tissues, with depletion of Gukh enhancing the eye-and wing-tissue defects caused by Scrib or Dlg depletion. Overall, our findings reveal that Scrib's PDZ1 domain functions in the interaction with Gukh and that the Scrib-Gukh interaction has a key role in epithelial tissue development in Drosophila.	[Caria, Sofia; Magtoto, Charlene M.; Samiei, Tinaz; Portela, Marta; Lim, Krystle Y. B.; How, Jing Yuan; Stewart, Bryce Z.; Humbert, Patrick O.; Richardson, Helena E.; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Samiei, Tinaz; Portela, Marta; Richardson, Helena E.] Univ Melbourne, Cell Cycle & Dev Lab, Melbourne, Vic 3002, Australia; [Magtoto, Charlene M.; Humbert, Patrick O.] Univ Melbourne, Cell Cycle & Canc Genet Lab, Res Div, Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Magtoto, Charlene M.; Humbert, Patrick O.; Richardson, Helena E.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3002, Australia; [Humbert, Patrick O.; Richardson, Helena E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Portela, Marta] CSIC, Inst Cajal, E-28002 Madrid, Spain	La Trobe University; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019; Humbert, Patrick O/L-4264-2016; Richardson, Helena E/A-8080-2013; Portela, Marta/B-2315-2018	Kvansakul, Marc/0000-0003-2639-2498; Humbert, Patrick O/0000-0002-1366-6691; Richardson, Helena E/0000-0003-3852-4953; Portela, Marta/0000-0001-7898-962X; Caria, Sofia/0000-0001-7289-2093	National Health and Medical Research Council Australia Project [APP1103871, APP1079133, APP1020056]; Australian Research Council Fellowship [FT130101349]; Cancer Council Victoria; Cancer Council Victoria [APP1041817]; La Trobe University Scholarship; La Trobe University; La Trobe School of Molecular Science funding	National Health and Medical Research Council Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); La Trobe University Scholarship; La Trobe University; La Trobe School of Molecular Science funding	This work was supported in whole or part by National Health and Medical Research Council Australia Project Grant APP1103871 (to M. K., P. O. H., and H. E. R.), Fellowship APP1079133 (to P. O. H.), and APP1020056 (to H. E. R.); Australian Research Council Fellowship FT130101349 (to M. K.); Cancer Council Victoria grant funding (to M. P.) and Project Grant APP1041817 (to H. E. R.); La Trobe University Scholarship (to C. M. M. and K. Y. B. L.), and La Trobe University and La Trobe School of Molecular Science funding (to H. E. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Arnaud C, 2009, FEBS LETT, V583, P2326, DOI 10.1016/j.febslet.2009.06.034; Arquier N, 2001, DEVELOPMENT, V128, P2209; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Brooks SP, 2010, HUM MOL GENET, V19, P2421, DOI 10.1093/hmg/ddq125; Brooks SP, 2004, J MED GENET, V41, P768, DOI 10.1136/jmg.2004.022517; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114235; Grzeschik NA, 2007, DEV BIOL, V311, P106, DOI 10.1016/j.ydbio.2007.08.025; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Gui JH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006424; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Inaki M, 2002, MECH DEVELOP, V116, P3, DOI 10.1016/S0925-4773(02)00119-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Parsons LM, 2014, CURR BIOL, V24, P2073, DOI 10.1016/j.cub.2014.07.075; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Santoni MJ, 2002, TRENDS GENET, V18, P494, DOI 10.1016/S0168-9525(02)02738-5; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stephens R., 2018, J MOL BIOL; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Walsh GS, 2011, DEVELOPMENT, V138, P3033, DOI 10.1242/dev.063842; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009; Yap AS, 2015, DEV CELL, V35, P12, DOI 10.1016/j.devcel.2015.09.012; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	55	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4519	4531		10.1074/jbc.M117.817528	http://dx.doi.org/10.1074/jbc.M117.817528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378849	Green Published, hybrid			2022-12-26	WOS:000428204300023
J	Goemans, CV; Beaufay, F; Wahni, K; Van Molle, I; Messens, J; Collet, JF				Goemans, Camille V.; Beaufay, Francois; Wahni, Khadija; Van Molle, Inge; Messens, Joris; Collet, Jean-Francois			An essential thioredoxin is involved in the control of the cell cycle in the bacterium Caulobacter crescentus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PROTEOLYSIS; STRUCTURE REFINEMENT; PROTEASE COMPLEX; OXIDOREDUCTASE; GLUTAREDOXINS; LOCALIZATION; SPECIFICITY; REDUCTION; DIVISION; REVEALS	Thioredoxins (Trxs) are antioxidant proteins that are conserved among all species. These proteins have been extensively studied and perform reducing reactions on a broad range of substrates. Here, we identified Caulobacter crescentus Trx1 (CCNA_03653; CcTrx1) as an oxidoreductase that is involved in the cell cycle progression of this model bacterium and is required to sustain life. Intriguingly, the abundance of CcTrx1 varies throughout the C. crescentus cell cycle: although the expression of CcTrx1 is induced in stalked cells, right before DNA replication initiation, CcTrx1 is actively degraded by the ClpXP protease in predivisional cells. Importantly, we demonstrated that regulation of the abundance of CcTrx1 is crucial for cell growth and survival as modulating CcTrx1 levels leads to cell death. Finally, we also report a comprehensive biochemical and structural characterization of this unique and essential Trx. The requirement to precisely control the abundance of CcTrx1 for cell survival underlines the importance of redox control for optimal cell cycle progression in C. crescentus.	[Goemans, Camille V.; Collet, Jean-Francois] WELBIO, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Goemans, Camille V.; Beaufay, Francois; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Goemans, Camille V.; Wahni, Khadija; Van Molle, Inge; Messens, Joris; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Wahni, Khadija; Van Molle, Inge; Messens, Joris] VIB, Ctr Struct Biol, B-1050 Brussels, Belgium; [Wahni, Khadija; Van Molle, Inge; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Beaufay, Francois] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Messens, Joris] VIB, Brussels, Belgium; [Collet, Jean-Francois] FRS FNRS, Rech, Brussels, Belgium	WELBIO; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Michigan System; University of Michigan; Flanders Institute for Biotechnology (VIB); Fonds de la Recherche Scientifique - FNRS	Goemans, CV; Collet, JF (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.; Collet, JF (corresponding author), FRS FNRS, Rech, Brussels, Belgium.	camille.goemans@uclouvain.be; jfcollet@uclouvain.be	Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264; Goemans, Camille/0000-0002-5564-1644; Van Molle, Inge/0000-0003-0114-9379; Collet, Jean-Francois/0000-0001-8069-7036	Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO; European Research Council (FP7) ERC Independent Researcher Starting Grant [282335-Sulfenic]; Fonds de la Recherche Scientifique (FRS-FNRS); Omics@VIB Marie Curie COFUND fellowship	Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO(Fonds de la Recherche Scientifique - FNRSWELBIO); European Research Council (FP7) ERC Independent Researcher Starting Grant; Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Omics@VIB Marie Curie COFUND fellowship	This work was supported in part by grants from Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO, European Research Council (FP7/2007-2013) ERC Independent Researcher Starting Grant 282335-Sulfenic, and grants from the Fonds de la Recherche Scientifique (FRS-FNRS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Omics@VIB Marie Curie COFUND fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alexopoulos JA, 2012, J STRUCT BIOL, V179, P202, DOI 10.1016/j.jsb.2012.05.003; Arts IS, 2016, MOL CELL PROTEOMICS, V15, P2125, DOI 10.1074/mcp.M115.056440; Beaufay F, 2015, EMBO J, V34, P1786, DOI 10.15252/embj.201490730; Berndt C, 2015, CHEM SCI, V6, P7049, DOI 10.1039/c5sc01501d; Bhat NH, 2013, MOL MICROBIOL, V88, P1083, DOI 10.1111/mmi.12241; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jenal U, 2009, RES MICROBIOL, V160, P687, DOI 10.1016/j.resmic.2009.09.006; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Joshi KK, 2016, ANNU REV GENET, V50, P423, DOI 10.1146/annurev-genet-120215-035235; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lawaree E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.98, 10.1038/nmicrobiol.2016.98]; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Markovski M, 2013, MOL CELL, V52, P611, DOI 10.1016/j.molcel.2013.11.018; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Martin ME, 2004, MOL MICROBIOL, V54, P60, DOI 10.1111/j.1365-2958.2004.04251.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Narayanan S, 2015, GENE DEV, V29, P1175, DOI 10.1101/gad.257030.114; Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503	44	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3839	3848		10.1074/jbc.RA117.001042	http://dx.doi.org/10.1074/jbc.RA117.001042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29367337	Green Published, hybrid			2022-12-26	WOS:000427030200035
J	Walther, B; Klein, KS; Barton, AK; Semmler, T; Huber, C; Wolf, SA; Tedin, K; Merle, R; Mitrach, F; Guenther, S; Lubke-Becker, A; Gehlen, H				Walther, Birgit; Klein, Katja-Sophia; Barton, Ann-Kristin; Semmler, Torsten; Huber, Charlotte; Wolf, Silver Anthony; Tedin, Karsten; Merle, Roswitha; Mitrach, Franziska; Guenther, Sebastian; Luebke-Becker, Antina; Gehlen, Heidrun			Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coliand Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary "Trojan Horse"	PLOS ONE			English	Article							INFECTION-CONTROL; MOLECULAR CHARACTERIZATION; IDENTIFICATION; SALMONELLOSIS; PREVALENCE; EMERGENCE; OUTBREAK; STRAINS; AMPC	Pathogens frequently associated with multi-drug resistant (MDR) phenotypes, including extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and Acinetobacter baumannii isolated from horses admitted to horse clinics, pose a risk for animal patients and personnel in horse clinics. To estimate current rates of colonization, a total of 341 equine patients were screened for carriage of zoonotic indicator pathogens at hospital admission. Horses showing clinical signs associated with colic (n = 233) or open wounds (n = 108) were selected for microbiological examination of nostril swabs, faecal samples and wound swabs taken from the open wound group. The results showed alarming carriage rates of Gram-negative MDR pathogens in equine patients: 10.7% (34 of 318) of validated faecal specimens were positive for ESBL-E (94%: ESBL-producing Escherichia coli), with recorded rates of 10.5% for the colic and 11 % for the open wound group. 92.7% of the ESBL-producing E. coli were phenotypically resistant to three or more classes of antimicrobials. A. baumanniiwas rarely detected (0.9%), and all faecal samples investigated were negative for Salmonella, both directly and after two enrichment steps. Screening results for the equine nostril swabs showed detection rates for ESBL-E of 3.4% among colic patients and 0.9% in the open wound group, with an average rate of 2.6% (9/340) for both indications. For all 41 ESBL-producing E. coli isolated, abroad heterogeneity was revealed using pulsed-field gel electrophoresis (PFGE) patterns and whole genome sequencing (WGS) -analysis. However, a predominance of sequence type complex (STC)10 and STC1250 was observed, including several novel STs. The most common genes associated with ESBL-production were identified as bla(CTX-M-1) (31/41; 75.6%) and bla(SHV-12) (24.4%). The results of this study reveal a disturbingly large fraction of multi-drug resistant and ESBL-producing E. coli among equine patients, posing a clear threat to established hygiene management systems and work-place safety of veterinary staff in horse clinics.	[Walther, Birgit; Tedin, Karsten; Luebke-Becker, Antina] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany; [Walther, Birgit; Huber, Charlotte] Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany; [Klein, Katja-Sophia; Barton, Ann-Kristin; Gehlen, Heidrun] Free Univ Berlin, Equine Clin, Surg & Radiol, Berlin, Germany; [Semmler, Torsten; Wolf, Silver Anthony] Robert Koch Inst, Microbial Genom NG1, Berlin, Germany; [Merle, Roswitha] Freie Univ t Berlin, Inst Vet Epidemiol & Biostat, Berlin, Germany; [Mitrach, Franziska] Brandenburg Univ Technol Cottbus Senftenberg, Fac Environm & Nat Sci, Inst Biotechnol, Senftenberg, Germany; [Guenther, Sebastian] Free Univ Berlin, Inst Anim & Environm Hyg, Berlin, Germany; [Guenther, Sebastian] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Pharmaceut Biol, Greifswald, Germany	Free University of Berlin; Robert Koch Institute; Free University of Berlin; Robert Koch Institute; Brandenburg University of Technology Cottbus; Free University of Berlin; Ernst Moritz Arndt Universitat Greifswald	Walther, B (corresponding author), Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany.	waltherb@rki.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Guenther, Sebastian/0000-0003-0173-7314; Merle, Roswitha/0000-0002-8688-2926; Mitrach, Franziska/0000-0003-4518-8054; Walther, Birgit/0000-0003-3112-5722	Federal Ministry of Education and Research (MedVet-Staph) [01KI1301F, 03ZZ0805A]; Federal Ministry of Food and Agriculture, VetMAB [2817600112]	Federal Ministry of Education and Research (MedVet-Staph); Federal Ministry of Food and Agriculture, VetMAB	This work was supported by the Federal Ministry of Education and Research (MedVet-Staph, Grant no. 01KI1301F and InfectControl 2020 (IRMRESS) no. 03ZZ0805A) and by Federal Ministry of Food and Agriculture, VetMAB; Grant no. 2817600112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakos I, 2017, J ANTIMICROB CHEMOTH, V72, P1915, DOI 10.1093/jac/dkx072; BAUERFEIND R, 1992, BERL MUNCH TIERARZTL, V105, P38; Bednorz C, 2013, APPL ENVIRON MICROB, V79, P7896, DOI 10.1128/AEM.03138-13; Benedict KM, 2008, JAVMA-J AM VET MED A, V233, P767, DOI 10.2460/javma.233.5.767; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA, V32; CLSI, 2018, M31A3 CLSI; Dolejska M, 2011, J ANTIMICROB CHEMOTH, V66, P757, DOI 10.1093/jac/dkq500; Ekiri AB, 2009, JAVMA-J AM VET MED A, V234, P108, DOI 10.2460/javma.234.1.108; Endimiani A, 2011, J ANTIMICROB CHEMOTH, V66, P2248, DOI 10.1093/jac/dkr289; Ewers C, 2017, INT J ANTIMICROB AG, V49, P37, DOI 10.1016/j.ijantimicag.2016.09.033; Gyles C, 2009, CAN VET J, V50, P339; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Klotz P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171986; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Loncaric I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084048; Maddox TW, 2012, EQUINE VET J, V44, P289, DOI 10.1111/j.2042-3306.2011.00441.x; Morley PS, 2013, J VET INTERN MED, V27, P430, DOI 10.1111/jvim.12060; Muller S, 2014, BERL MUNCH TIERARZTL, V127, P435, DOI 10.2376/0005-9366-127-435; Qin XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061169; Schaer BLD, 2010, J VET INTERN MED, V24, P1138, DOI 10.1111/j.1939-1676.2010.0546.x; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schaufler Katharina, 2015, Infection Ecology & Epidemiology, V5, P25334, DOI 10.3402/iee.v5.25334; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P1289, DOI 10.1093/jac/dks016; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamang MD, 2012, ANTIMICROB AGENTS CH, V56, P2705, DOI 10.1128/AAC.05598-11; Timonin ME, 2017, CAN J MICROBIOL, V63, P246, DOI 10.1139/cjm-2016-0504; van Hoek AHAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129085; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Walther B, 2017, VET MICROBIOL, V200, P71, DOI 10.1016/j.vetmic.2016.05.017; Walther B, 2014, BERL MUNCH TIERARZTL, V127, P486, DOI 10.2376/0005-9366-127-486; Walther B, 2014, BERL MUNCH TIERARZTL, V127, P421, DOI 10.2376/0005-9366-127-421; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Weese JS, 2011, J SMALL ANIM PRACT, V52, P507, DOI 10.1111/j.1748-5827.2011.01140.x; Wieler LH, 2015, ZOONOSES INFECT AFFE, P433, DOI DOI 10.1007/978-94-017-9457-2_17; Willemsen I, 2015, PLOS ONE, V10; Wright JG, 2008, JAVMA-J AM VET MED A, V232, P1863, DOI 10.2460/javma.232.12.1863; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	39	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191873	10.1371/journal.pone.0191873	http://dx.doi.org/10.1371/journal.pone.0191873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381714	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800041
J	Nwankwo, ONO; Mokogwu, N; Agboghoroma, O; Ahmed, FO; Mortimer, K				Nwankwo, Ogonna N. O.; Mokogwu, Ndubuisi; Agboghoroma, Orighomisan; Ahmed, Fahmi O.; Mortimer, Kevin			Knowledge, attitudes and beliefs about the health hazards of biomass smoke exposure amongst commercial food vendors in Nigeria	PLOS ONE			English	Article							HOUSEHOLD AIR-POLLUTION; RESPIRATORY SYMPTOMS; SELF-EFFICACY; GLOBAL BURDEN; LUNG-FUNCTION; RISK-FACTOR; FUEL SMOKE; COOKING; COMMUNITY; BEHAVIOR	Background Exposure to biomass smoke is a major cause of morbidity and mortality in Africa. Commercial food vendors in Nigeria and elsewhere in Africa are commonly exposed to biomass smoke from open fire cooking both at work and home. Little is known about the knowledge, attitudes and beliefs of food vendors about the health hazards of biomass smoke exposure in Nigeria. Methods We did a descriptive cross sectional survey of the knowledge, attitudes and beliefs of commercial food vendors in the cities of Benin and Calabar in Nigeria. We recruited respondents using a multi-stage approach. Structured interviewer-administered questionnaires were used for data collection. Results We recruited 308 participants (164, 53.2% female). The majority 185(60.2%) were married and had post-primary education 206(67.4%). The average monthly income was <30,000 Naira (US$150). Most 198(64.4%) were not aware that biomass smoke exposure is harmful to human health. About three-quarters (221; 71.8%) were unconcerned as to the effect of exposure to fumes from biomass fuels on their health. Less than half of respondents (110, 41.6%) believed biomass smoke was harmful to health. Male gender, being single, having post-primary education and preferring electricity or gas fuels were associated with good knowledge of the adverse health effects of biomass smoke exposure whilst female gender and having good knowledge of the adverse health effects of biomass smoke were associated with positive attitudes towards preventing exposure. Conclusion Commercial food vendors in our study had limited knowledge about the adverse health effects of biomass smoke exposure and negative attitudes towards preventing these adverse health effects. We suggest an educational intervention is needed to improve this knowledge.	[Nwankwo, Ogonna N. O.] Univ Calabar, Dept Community Med, Teaching Hosp, Calabar, Nigeria; [Mokogwu, Ndubuisi] Univ Benin, Dept Community Hlth, Teaching Hosp, Benin, Nigeria; [Agboghoroma, Orighomisan] Jos Univ, Dept Med, Teaching Hosp, Jos, Nigeria; [Ahmed, Fahmi O.] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England	University of Calabar; University of Benin; Addis Ababa University; Liverpool School of Tropical Medicine	Nwankwo, ONO (corresponding author), Univ Calabar, Dept Community Med, Teaching Hosp, Calabar, Nigeria.	drogonnanwankwo@gmail.com	nwankwo, ogonna/AHD-3015-2022; Agboghoroma, Orighomisan/ABA-1496-2020; nwankwo, ogonna N.O./F-7669-2017	nwankwo, ogonna N.O./0000-0001-9683-4920; Mortimer, Kevin/0000-0002-8118-8871	Pan African Thoracic Society-Methods in Epidemiological,Clinical and Operational Research (PATS-MECOR); Medical Research Council [MR/L009242/1] Funding Source: researchfish; MRC [MR/P022006/1, MR/L009242/1] Funding Source: UKRI	Pan African Thoracic Society-Methods in Epidemiological,Clinical and Operational Research (PATS-MECOR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	O.NO.N. and N.M. received funding from the Pan African Thoracic Society-Methods in Epidemiological,Clinical and Operational Research (PATS-MECOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewole OO, 2013, ANN MED HEALTH SCI R, V3, P38, DOI 10.4103/2141-9248.109475; Afolabi OT, 2016, J HEALTH SCI, V16, P3338; Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; Akani AB, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.152; Alim M, 2013, AKMMC J, V4, P20; [Anonymous], 2008, EV HOUS EN HLTH INT; Awopeju OF, 2014, AM J RESP CRIT CARE, V189; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Castello A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132684; Claessen JP, 2008, INT DENT J, V58, P307, DOI [DOI 10.1111/j.1875-595X.2008.tb00208.x, 10.1111/j.1875-595X.2008.tb00208.x, DOI 10.1111/J.1875-595X.2008.TB00208.X]; Dienye P, 2016, AFR HEALTH SCI, V16, P516, DOI 10.4314/ahs.v16i2.20; Dominick GM, 2013, J IMMIGR MINOR HEALT, V15, P533, DOI 10.1007/s10903-012-9666-7; Edelstein M, 2008, BMC Int Health Hum Rights, V8, P10, DOI 10.1186/1472-698X-8-10; Egondi T, 2013, INT J ENV RES PUB HE, V10, P4851, DOI 10.3390/ijerph10104851; Ekeke N, 2017, T ROYAL SOC TROPICAL; FAO, 2007, PROM CHALL INF FOOD; Fransson N, 1999, J ENVIRON PSYCHOL, V19, P369, DOI 10.1006/jevp.1999.0141; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Haron S.A., 2005, INT J CONSUM STUD, V29, P426, DOI [10.1111/j.1470-6431.2005.00460.x, DOI 10.1111/J.1470-6431.2005.00460.X]; IARC, 2016, IARC MONOGRAPHS EVAL, V109; Isara AR, 2014, EURASIAN J MED, V46, P203, DOI 10.5152/eajm.2014.0051; Iwu AC., 2017, OCCUPATIONAL DIS ENV, V5, P11, DOI [10.4236/odem.2017.51002, DOI 10.4236/ODEM.2017.51002]; Jin Y, 2006, SOC SCI MED, V62, P3161, DOI 10.1016/j.socscimed.2005.11.029; Krupa K, 2012, ENV MED, V2012, P15; Lee Alison, 2015, Lancet Respir Med, V3, pe1, DOI 10.1016/S2213-2600(14)70288-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loomis D, 2013, LANCET ONCOL, V14, P1262, DOI 10.1016/S1470-2045(13)70487-X; Mobarak AM, 2012, P NATL ACAD SCI USA, V109, P10815, DOI 10.1073/pnas.1115571109; Mortimer K, 2017, LANCET, V389, P167, DOI 10.1016/S0140-6736(16)32507-7; Mortimer K, 2012, CHEST, V142, P1308, DOI 10.1378/chest.12-1596; National Bureau of Statistics, 2013, ANN ABSTR STAT 2012; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Ngahane BHM, 2015, INT J OCCUP ENV HEAL, V21, P61, DOI 10.1179/2049396714Y.0000000090; Nguyen SP, 2011, APPETITE, V56, P265, DOI 10.1016/j.appet.2011.01.008; Okojie PW, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/701316; Osagbemi G, 2009, INTERNET J EPIDEMIOL, V8; Oyunga-Ogubi M, 2009, AFRICAN J FOOD AGR N, V9, P207; Piddock Katy C, 2014, Ann Am Thorac Soc, V11, P915, DOI 10.1513/AnnalsATS.201311-413OC; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Reynolds KD, 2008, MAXCY ROSENAU LAST P; Semenza JC, 2008, ENVIRON RES, V107, P401, DOI 10.1016/j.envres.2008.03.005; Staiano A, 2012, J SCI MED SPORT, V15, pS177; Thompson LM., 2015, COOKING GASHOW CHILD; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; UNDP & WHO, 2009, ENERGY ACCESS SITUAT; Vulturius G, 201701 STOCKH ENV I; WHO, DEATHS HOUS AIR POLL; WHO, 2016, AMB AIR POLL GLOB AS; World Bank, 2016, GNI PER CAP ATL METH	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191458	10.1371/journal.pone.0191458	http://dx.doi.org/10.1371/journal.pone.0191458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	29377962	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000423514700014
J	Sage, M; Nadeau, M; Forand-Choiniere, C; Mousseau, J; Vandamme, J; Berger, C; Tremblay-Roy, JS; Tissier, R; Micheau, P; Fortin-Pellerin, E				Sage, Michael; Nadeau, Mathieu; Forand-Choiniere, Claudia; Mousseau, Julien; Vandamme, Jonathan; Berger, Claire; Tremblay-Roy, Jean-Sebastien; Tissier, Renaud; Micheau, Philippe; Fortin-Pellerin, Etienne			Assessing the impacts of total liquid ventilation on left ventricular diastolic function in a model of neonatal respiratory distress syndrome	PLOS ONE			English	Article							MECHANICAL VENTILATION; CARDIAC-OUTPUT; HEMODYNAMICS; PRESSURE; NEWBORN; PIGLETS; INJURY	Background Filling the lung with dense liquid perfluorocarbons during total liquid ventilation (TLV) might compress the myocardium, a plausible explanation for the instability occasionally reported with this technique. Our objective is to assess the impacts of TLV on the cardiovascular system, particularly left ventricular diastolic function, in an ovine model of neonatal respiratory distress syndrome. Method Eight newborns lambs, 3.0 +/- 0.4 days (3.2 +/- 0.3kg) were used in this crossover experimental study. Animals were intubated, anesthetized and paralyzed. Catheters were inserted in the femoral and pulmonary arteries. A high-fidelity pressure catheter was inserted into the left ventricle. Surfactant deficiency was induced by repeated lung lavages with normal saline. TLV was then conducted for 2 hours using a liquid ventilator prototype. Thoracic echocardiography and cardiac output assessment by thermodilution were performed before and during TLV. Results Left ventricular end diastolic pressure (LVEDP) (9.3 +/- 2.1 vs. 9.2 +/- 2.4mmHg, p = 0.89) and dimension (1.90 +/- 0.09 vs. 1.86 +/- 0.12cm, p = 0.72), negative dP/dt (-2589 +/- 691 vs. -3115 +/- 866mmHg/s, p = 0.50) and cardiac output (436 +/- 28 vs. 481 +/- 59ml/kg/min, p = 0.26) were not affected by TLV initiation. Left ventricular relaxation time constant (tau) slightly increased from 21.5 +/- 3.3 to 24.9 +/- 3.7ms (p = 0.03). Mean arterial systemic (48 +/- 6 vs. 53 +/- 7mmHg, p = 0.38) and pulmonary pressures (31.3 +/- 2.5 vs. 30.4 +/- 2.3mmHg, p= 0.61) were stable. As expected, the inspiratory phase of liquid cycling exhibited a small but significant effect on most variables (i.e. central venous pressure +2.6 +/- 0.5mmHg, p = 0.001; LVEDP +1.18 +/- 0.12mmHg, p<0.001). Conclusions TLV was well tolerated in our neonatal lamb model of severe respiratory distress syndrome and had limited impact on left ventricle diastolic function when compared to conventional mechanical ventilation.	[Sage, Michael; Forand-Choiniere, Claudia; Tremblay-Roy, Jean-Sebastien; Fortin-Pellerin, Etienne] Univ Sherbrooke, Dept Pediat, Sherbrooke, PQ, Canada; [Sage, Michael; Forand-Choiniere, Claudia; Tremblay-Roy, Jean-Sebastien; Fortin-Pellerin, Etienne] Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada; [Nadeau, Mathieu; Mousseau, Julien; Vandamme, Jonathan; Micheau, Philippe] Univ Sherbrooke, Dept Mech Engn, Sherbrooke, PQ, Canada; [Berger, Claire] Univ Poitiers, Dept Med, Poitiers, France; [Tissier, Renaud] Univ Paris Est Creteil, Ecole Natl Vet Alfort, Equipe 03, INSERM,Unite 955, Paris, France	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Universite de Poitiers; Ecole Nationale Veterinaire d'Alfort (ENVA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Fortin-Pellerin, E (corresponding author), Univ Sherbrooke, Dept Pediat, Sherbrooke, PQ, Canada.; Fortin-Pellerin, E (corresponding author), Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada.	etienne.fortin-pellerin@usherbrooke.ca	Tissier, Renaud/Q-2153-2015	Tissier, Renaud/0000-0001-6602-939X; Fortin-Pellerin, Etienne/0000-0002-1734-3857; Micheau, Philippe/0000-0002-6231-3948	local research center (Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke)	local research center (Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke)	The authors received funding from the local research center (Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoine O, 2011, CRIT CARE MED, V39, P1097, DOI 10.1097/CCM.0b013e31820ead1a; Bagnoli P, 2007, ASAIO J, V53, P549, DOI 10.1097/MAT.0b013e318148449d; Bosse D, 2010, ASAIO J, V56, P557, DOI 10.1097/MAT.0b013e3181f1cd72; Cheifetz IM, 2014, RESP CARE, V59, P1937, DOI 10.4187/respcare.03486; CURTIS SE, 1991, CRIT CARE MED, V19, P225, DOI 10.1097/00003246-199102000-00019; Degraeuwe PLJ, 2000, PEDIATR PULM, V30, P114, DOI 10.1002/1099-0496(200008)30:2<114::AID-PPUL6>3.0.CO;2-0; Degraeuwe PLJ, 2000, INT J ARTIF ORGANS, V23, P754, DOI 10.1177/039139880002301105; Foust R, 1996, PEDIATR PULM, V21, P316, DOI 10.1002/(SICI)1099-0496(199605)21:5<316::AID-PPUL7>3.0.CO;2-K; HERNANDEZ LA, 1989, J APPL PHYSIOL, V66, P2364, DOI 10.1152/jappl.1989.66.5.2364; Jiang L, 2016, ARTIFICIAL ORGANS; Kaushal A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003845.pub3; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; LOWE C, 1979, J APPL PHYSIOL, V47, P1051, DOI 10.1152/jappl.1979.47.5.1051; Micheau P, PROGR MOL ENV BIOENG; Nadeau M, 2017, IEEE T BIOMEDICAL EN; Nadeau M, 2016, IEEE T BIO-MED ENG, V63, P1483, DOI 10.1109/TBME.2015.2496938; Rey-Santano C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056127; Robert R, 2010, IEEE T BIO-MED ENG, V57, P2267, DOI 10.1109/TBME.2009.2031096; Ryu J, 2012, CLIN PERINATOL, V39, P603, DOI 10.1016/j.clp.2012.06.001; Sage M, 2016, CRYOBIOLOGY, V73, P99, DOI 10.1016/j.cryobiol.2016.05.009; Tsagogiorgas C, 2011, PEDIATR PULM, V46, P964, DOI 10.1002/ppul.21461; Vandamme J, 2013, 2013 IEEE INT S MED; Vieillard-Baron A, 2016, INTENS CARE MED, V42, P739, DOI 10.1007/s00134-016-4326-3; Weiswasser J, 1998, J PEDIATR SURG, V33, P1158, DOI 10.1016/S0022-3468(98)90551-6	24	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191885	10.1371/journal.pone.0191885	http://dx.doi.org/10.1371/journal.pone.0191885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377922	gold, Green Published, Green Submitted			2022-12-26	WOS:000423514700039
J	Braun, F; Proenca, M; Adler, A; Riedel, T; Thiran, JP; Sola, J				Braun, Fabian; Proenca, Martin; Adler, Andy; Riedel, Thomas; Thiran, Jean-Philippe; Sola, Josep			Accuracy and reliability of noninvasive stroke volume monitoring via ECG-gated 3D electrical impedance tomography in healthy volunteers	PLOS ONE			English	Article							POLAR PLOT METHODOLOGY; CARDIAC-OUTPUT; HEMODYNAMIC OPTIMIZATION; BICYCLE EXERCISE; EIT; METAANALYSIS; RECOVERY; RECONSTRUCTION; POSITIONS; QUALITY	Cardiac output (CO) and stroke volume (SV) are parameters of key clinical interest. Many techniques exist to measure CO and SV, but are either invasive or insufficiently accurate in clinical settings. Electrical impedance tomography (EIT) has been suggested as a noninvasive measure of SV, but inconsistent results have been reported. Our goal is to determine the accuracy and reliability of EIT-based SV measurements, and whether advanced image reconstruction approaches can help to improve the estimates. Data were collected on ten healthy volunteers undergoing postural changes and exercise. To overcome the sensitivity to heart displacement and thorax morphology reported in previous work, we used a 3D EIT configuration with 2 planes of 16 electrodes and subject-specific reconstruction models. Various EIT-derived SV estimates were compared to reference measurements derived from the oxygen uptake. Results revealed a dramatic impact of posture on the EIT images. Therefore, the analysis was restricted to measurements in supine position under controlled conditions (low noise and stable heart and lung regions). In these measurements, amplitudes of impedance changes in the heart and lung regions could successfully be derived from EIT using ECG gating. However, despite a subject-specific calibration the heart-related estimates showed an error of 0.0 +/- 15.2 mL for absolute SV estimation. For trending of relative SV changes, a concordance rate of 80.9% and an angular error of -1.0 +/- 23.0 degrees were obtained. These performances are insufficient for most clinical uses. Similar conclusions were derived from lung-related estimates. Our findings indicate that the key difficulty in EIT-based SV monitoring is that purely amplitude-based features are strongly influenced by other factors (such as posture, electrode contact impedance and lung or heart conductivity). All the data of the present study are made publicly available for further investigations.	[Braun, Fabian; Proenca, Martin; Sola, Josep] CSEM, Syst Div, CH-2002 Neuchatel, Switzerland; [Braun, Fabian; Proenca, Martin; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, CH-1015 Lausanne, Switzerland; [Adler, Andy] Carleton Univ, Syst & Comp Engn, Ottawa, ON K1S 5B6, Canada; [Riedel, Thomas] Cantonal Hosp Graubuenden, CH-7000 Chur, Switzerland; [Riedel, Thomas] Univ Childrens Hosp, CH-3010 Bern, Switzerland; [Riedel, Thomas] Univ Bern, CH-3010 Bern, Switzerland; [Thiran, Jean-Philippe] Univ Hosp Ctr CHUV, Dept Radiol, CH-1011 Lausanne, Switzerland; [Thiran, Jean-Philippe] Univ Lausanne UNIL, CH-1011 Lausanne, Switzerland	Swiss Center for Electronics & Microtechnology (CSEM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Carleton University; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Braun, F (corresponding author), CSEM, Syst Div, CH-2002 Neuchatel, Switzerland.; Braun, F (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, CH-1015 Lausanne, Switzerland.	fabian.braun@csem.ch		Braun, Fabian/0000-0002-0864-2804; Riedel, Thomas/0000-0002-7153-5251	CSEM Centre Suisse d'Electronique et de Microtechnique SA (CSEM); Swiss National Science Foundation Nano-Tera project OBESENSE [20NA21-1430801]	CSEM Centre Suisse d'Electronique et de Microtechnique SA (CSEM); Swiss National Science Foundation Nano-Tera project OBESENSE	The study described in this manuscript was sponsored by CSEM Centre Suisse d'Electronique et de Microtechnique SA (CSEM). CSEM provided support in the form of salaries for FB, MP and JS and was involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript. FB was further supported by the Swiss National Science Foundation Nano-Tera project OBESENSE (20NA21-1430801, http:/www.nano-tera.ch). The latter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'authors contributions' sections.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 1996, IEEE T MED IMAGING, V15, P170, DOI 10.1109/42.491418; Adler A, 2017, IEEE TRANS BIOMED EN; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 2001, BIOMEDICAL SIGNAL AN, DOI DOI 10.1109/9780470544204; Balleza M, 2007, IFMBE PROC, V17, P572; Braun F., 2018, NONINVASIVE STROKE V; Braun F, 2017, PHYSIOL MEAS IN PRES; Braun F, 2017, IEEE T BIO-MED ENG, V64, P2321, DOI 10.1109/TBME.2017.2659540; Clement RP, 2017, CURR OPIN CRIT CARE, V23, P302, DOI 10.1097/MCC.0000000000000417; Critchley LA, 2013, ARTERY BYPASS; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; CUMMING GR, 1972, J APPL PHYSIOL, V32, P575, DOI 10.1152/jappl.1972.32.5.575; da Silva Ramos FJ, 2017, ANESTH ANAL IN PRESS; Frerichs I, 2017, THORAX, V72, P83, DOI 10.1136/thoraxjnl-2016-208357; Frerichs I, 2011, PHYSIOL MEAS, V32, pL1, DOI 10.1088/0967-3334/32/12/F01; GOLDBERG DI, 1980, J APPL PHYSIOL, V48, P833, DOI 10.1152/jappl.1980.48.5.833; Graham BM, 2006, PHYSIOL MEAS, V27, pS65, DOI 10.1088/0967-3334/27/5/S06; Grychtol B, 2016, PHYSIOL MEAS, V37, P785, DOI 10.1088/0967-3334/37/6/785; Grychtol B, 2013, IEEE ENG MED BIO, P6429, DOI 10.1109/EMBC.2013.6611026; Grychtol B, 2012, IEEE T MED IMAGING, V31, P1754, DOI 10.1109/TMI.2012.2200904; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Hofer CK, 2007, CURR OPIN CRIT CARE, V13, P308, DOI 10.1097/MCC.0b013e3280c56afb; Holder D, 2005, SERIES IN MEDICAL PH; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Joosten A, 2017, BRIT J ANAESTH, V118, P298, DOI 10.1093/bja/aew461; Karsten J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1161-9; Kern JW, 2002, CRIT CARE MED, V30, P1686, DOI 10.1097/00003246-200208000-00002; Mobius J, 2010, CURVES SURFACES, P488; Pikkemaat R, 2015, KARDIOPULMONALES MON; Pikkemaat R, 2014, ANESTH ANALG, V119, P76, DOI 10.1213/ANE.0000000000000241; Poeze M, 2005, CRIT CARE, V9, pR771, DOI 10.1186/cc3902; Proenca M, 2017, NON INVASIVE HEMODYN; Rapin M, 2017, EIT 2017, P24; Saugel B, 2015, BRIT J ANAESTH, V114, P562, DOI 10.1093/bja/aeu447; Saugel B, 2015, ANESTH ANALG, V121, P514, DOI 10.1213/ANE.0000000000000725; Smit HJ, 2006, RESPIRATION, V73, P597, DOI 10.1159/000088694; Stringer WW, 1997, J APPL PHYSIOL, V82, P908, DOI 10.1152/jappl.1997.82.3.908; Takahashi T, 2000, EUR J APPL PHYSIOL, V81, P233, DOI 10.1007/s004210050036; Thurk F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182215; VINCENT JL, 2011, CRIT CARE, V15; Vogt B, 2016, PHYSIOL MEAS, V37, P904, DOI 10.1088/0967-3334/37/6/904; Vonk-Noordegraaf A, 2000, PHYSIOL MEAS, V21, P285, DOI 10.1088/0967-3334/21/2/308; Waldmann AD, 2017, J MED BIOL ENG, V37, P561, DOI 10.1007/s40846-017-0264-y	48	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191870	10.1371/journal.pone.0191870	http://dx.doi.org/10.1371/journal.pone.0191870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373611	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400029
J	Hepp, GR; Kennamer, RA				Hepp, Gary R.; Kennamer, Robert A.			Laying sequence interacts with incubation temperature to influence rate of embryonic development and hatching synchrony in a precocial bird	PLOS ONE			English	Article							DUCKS AIX-SPONSA; WOOD DUCKS; EGG VIABILITY; ADAPTIVE SIGNIFICANCE; MATERNAL ANDROGENS; OXIDATIVE STRESS; GROWTH; SIZE; SELECTION; PATTERNS	Incubation starts during egg laying for many bird species and causes developmental asynchrony within clutches. Faster development of late-laid eggs can help reduce developmental differences and synchronize hatching, which is important for precocial species whose young must leave the nest soon after hatching. In this study, we examined the effect of egg laying sequence on length of the incubation period in Wood Ducks (Aix sponsa). Because incubation temperature strongly influences embryonic development rates, we tested the interactive effects of laying sequence and incubation temperature on the ability of late-laid eggs to accelerate development and synchronize hatching. We also examined the potential cost of faster development on duckling body condition. Fresh eggs were collected and incubated at three biologically relevant temperatures (Low: 34.9 degrees C, Medium: 35.8 degrees C, and High: 37.6 degrees C), and egg laying sequences from 1 to 12 were used. Length of the incubation period declined linearly as laying sequence advanced, but the relationship was strongest at medium temperatures followed by low temperatures and high temperatures. There was little support for including fresh egg mass in models of incubation period. Estimated differences in length of the incubation period between eggs 1 and 12 were 2.7 d, 1.2 d, and 0.7 d at medium, low and high temperatures, respectively. Only at intermediate incubation temperatures did development rates of late-laid eggs increase sufficiently to completely compensate for natural levels of developmental asynchrony that have been reported in Wood Duck clutches at the start of full incubation. Body condition of ducklings was strongly affected by fresh egg mass and incubation temperature but declined only slightly as laying sequence progressed. Our findings show that laying sequence and incubation temperature play important roles in helping to shape embryo development and hatching synchrony in a precocial bird.	[Hepp, Gary R.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Kennamer, Robert A.] Savannah River Ecol Lab, Aiken, SC USA	Auburn University System; Auburn University; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Hepp, GR (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	heppgar@auburn.edu			National Science Foundation [IOB-0615361]; Department of Energy Office of Environmental Management under Award [DE-FC09-075R22506]; Alabama Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Environmental Management under Award(United States Department of Energy (DOE)); Alabama Agricultural Experiment Station	Financial support was provided by National Science Foundation grant IOB-0615361 to G.R.H., the Department of Energy Office of Environmental Management under Award Number DE-FC09-075R22506 to the Georgia Research Foundation, and the Alabama Agricultural Experiment Station to G.R.H. None of the funders had any input into the content of the manuscript, nor required approval prior to submission or publication.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; Ardia DR, 2006, J FIELD ORNITHOL, V77, P339, DOI 10.1111/j.1557-9263.2006.00064.x; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; ARNOLD TW, 1987, AM NAT, V130, P643, DOI 10.1086/284736; ARNOLD TW, 1993, CAN J ZOOL, V71, P1146, DOI 10.1139/z93-156; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; Berntsen HH, 2016, J AVIAN BIOL, V47, P141, DOI 10.1111/jav.00688; Boonstra TA, 2010, CONDOR, V112, P304, DOI 10.1525/cond.2010.090043; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Noguera JC, 2012, BIOL LETTERS, V8, P61, DOI 10.1098/rsbl.2011.0756; Clauser AJ, 2017, J AVIAN BIOL, V48, P479, DOI 10.1111/jav.01056; Coe BH, 2015, J AVIAN BIOL, V46, P385, DOI 10.1111/jav.00581; DAVIES JC, 1983, CAN J ZOOL, V61, P1398, DOI 10.1139/z83-187; DuRant SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P451, DOI 10.1086/661749; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; Eiby YA, 2009, J COMP PHYSIOL B, V179, P875, DOI 10.1007/s00360-009-0370-4; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Flint Paul L., 1994, Wildfowl, V45, P248; FLINT PL, 1992, AUK, V109, P896, DOI 10.2307/4088164; Folk TH, 2003, AUK, V120, P1159, DOI 10.1642/0004-8038(2003)120[1159:EOHUAM]2.0.CO;2; Giam XL, 2016, METHODS ECOL EVOL, V7, P388, DOI 10.1111/2041-210X.12492; Gorman KB, 2005, BIOL LETTERS, V1, P461, DOI 10.1098/rsbl.2005.0346; Griffith SC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150371; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hepp GR, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P171; Hepp GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047777; Hepp GR, 2011, AUK, V128, P258, DOI 10.1525/auk.2011.10189; Hepp GR, 2004, CONDOR, V106, P182, DOI 10.1650/7318; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; Kennamer RA, 1997, AUK, V114, P479, DOI 10.2307/4089248; KENNAMER RA, 1990, CONDOR, V92, P587, DOI 10.2307/1368677; Lack D., 1966, POPULATION STUDIES B; Lemons PR, 2011, BEHAV ECOL, V22, P696, DOI 10.1093/beheco/arr035; Loos ER, 2004, AUK, V121, P587, DOI 10.1642/0004-8038(2004)121[0587:LNAAOO]2.0.CO;2; Manlove CA, 2000, CONDOR, V102, P286, DOI 10.1650/0010-5422(2000)102[0286:PONAIF]2.0.CO;2; Martin TE, 2013, ECOL LETT, V16, P738, DOI 10.1111/ele.12103; McClintock ME, 2014, AUK, V131, P672, DOI 10.1642/AUK-14-57.1; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nelson KJ, 1999, STUD AVIAN BIOL-SER, P137; Nicolai CA, 2004, FUNCT ECOL, V18, P475, DOI 10.1111/j.0269-8463.2004.00860.x; Nord A, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0087; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Odell NS, 2008, THESIS; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Poole A., 2013, BIRDS N AM, DOI [10.2173/bna.169, DOI 10.2173/BNA.169]; Poysa Hannu, 2014, Wildfowl, P192; Ricklefs RE, 2006, P ROY SOC B-BIOL SCI, V273, P2077, DOI 10.1098/rspb.2006.3544; Rohwer VG, 2010, CONDOR, V112, P596, DOI 10.1525/cond.2010.090229; SAS Institute, 2011, SAS STAT 9 3 US GUID; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 2007, AM NAT, V170, P196, DOI 10.1086/519397; Stier A, 2014, OECOLOGIA, V175, P791, DOI 10.1007/s00442-014-2946-2; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; Stoleson SH, 1997, ECOL MONOGR, V67, P131, DOI 10.1890/0012-9615(1997)067[0131:HABRAF]2.0.CO;2; Ton R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00885-3; VINCE MA, 1964, ANIM BEHAV, V12, P531, DOI 10.1016/0003-3472(64)90075-2; Walls JG, 2011, AUK, V128, P663, DOI 10.1525/auk.2011.11124; Wang JM, 2011, AUK, V128, P454, DOI 10.1525/auk.2011.10208; Wang JM, 2009, ANIM BEHAV, V78, P601, DOI 10.1016/j.anbehav.2009.05.022; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Williams TD, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P113; Windsor RL, 2013, J AVIAN BIOL, V44, P305, DOI 10.1111/j.1600-048X.2013.05768.x	65	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191832	10.1371/journal.pone.0191832	http://dx.doi.org/10.1371/journal.pone.0191832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373593	gold, Green Submitted, Green Published			2022-12-26	WOS:000423425400026
J	Arihan, O; Wernly, B; Lichtenauer, M; Franz, M; Kabisch, B; Muessig, J; Masyuk, M; Lauten, A; Schulze, PC; Hoppe, UC; Kelm, M; Jung, C				Arihan, Okan; Wernly, Bernhard; Lichtenauer, Michael; Franz, Marcus; Kabisch, Bjoern; Muessig, Johanna; Masyuk, Maryna; Lauten, Alexander; Schulze, Paul Christian; Hoppe, Uta C.; Kelm, Malte; Jung, Christian			Blood Urea Nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU	PLOS ONE			English	Article							DECOMPENSATED HEART-FAILURE; INTENSIVE-CARE-UNIT; SEVERITY; OUTCOMES; ADMISSION; IMPACT; LEVEL	Purpose Blood urea nitrogen (BUN) was reported to be associated with mortality in heart failure patients. We aimed to evaluate admission BUN concentration in a heterogeneous critically ill patient collective admitted to an intensive care unit (ICU) for prognostic relevance. Methods A total of 4176 medical patients (67 +/- 13 years) admitted to a German ICU between 2004 and 2009 were included. Follow-up of patients was performed retrospectively between May 2013 and November 2013. Association of admission BUN and both intra-hospital and longterm mortality were investigated by Cox regression. An optimal cut-off was calculated by means of the Youden-Index. Results Patients with higher admission BUN concentration were older, clinically sicker and had more pronounced laboratory signs of multi-organ failure including kidney failure. Admission BUN was associated with adverse long-term mortality (HR 1.013; 95% CI 1.012 +/- 1.014; p< 0.001). An optimal cut-off was calculated at 28 mg/dL which was associated with adverse outcome even after correction for APACHE2 (HR 1.89; 95% CI 1.59 +/- 2.26; p< 0.001), SAPS2 (HR 1.85; 95% CI 1.55 +/- 2.21; p< 0.001) and several parameters including creatinine in an integrative model (HR 3.34; 95% CI 2.89 +/- 3.86; p< 0.001). We matched 614 patients with admission BUN > 28 mg/dL to case-controls <= 28mg/dL corrected for APACHE2 scores: BUN above 28 mg/dL remained associated with adverse outcome in a paired analysis with the difference being 5.85% (95% CI 1.23 +/- 10.47%; p = 0.02). Conclusions High BUN concentration at admission was robustly associated with adverse outcome in critically ill patients admitted to an ICU, even after correction for co-founders including renal failure. BUN might constitute an independent, easily available and important parameter for risk stratification in the critically ill.	[Arihan, Okan] Van Yuzuncu Yil Univ, Fac Med, Dept Physiol, Van, Turkey; [Arihan, Okan; Muessig, Johanna; Masyuk, Maryna; Kelm, Malte; Jung, Christian] Univ Duesseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Wernly, Bernhard; Lichtenauer, Michael; Hoppe, Uta C.] Paracelsus Med Univ Salzburg, Clin Internal Med 2, Dept Cardiol, Salzburg, Austria; [Franz, Marcus; Kabisch, Bjoern; Schulze, Paul Christian] Jena Univ Hosp, Clin Internal Med 1, Dept Cardiol, Jena, Germany; [Lauten, Alexander] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany; [Lauten, Alexander] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Berlin, Germany	Yuzuncu Yil University; Paracelsus Private Medical University; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Jung, C (corresponding author), Univ Duesseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.	christian.jung@med.uni-duesseldorf.de	Jung, Christian/AAN-4537-2021; Wernly, Bernhard/AAA-8529-2020; Schulze, Christian/AGJ-7744-2022; Lauten, Alexander/GLT-9500-2022; Lichtenauer, Michael/H-5139-2019; Franz, Marcus/ABA-4688-2021	Jung, Christian/0000-0001-8325-250X; Wernly, Bernhard/0000-0003-4024-0220; Schulze, Christian/0000-0001-9442-7141; Lichtenauer, Michael/0000-0001-8403-3931; Franz, Marcus/0000-0001-6543-4684; Masyuk, Maryna/0000-0003-2856-6893; Kelm, Malte/0000-0003-0060-1052				Akhter MW, 2004, AM J CARDIOL, V94, P957, DOI 10.1016/j.amjcard.2004.06.041; Al-Naamani K, 2008, CAN J GASTROENTEROL, V22, P399, DOI 10.1155/2008/207850; Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014; Dalcomune DM, 2016, CLIN BIOCHEM, V49, P762, DOI 10.1016/j.clinbiochem.2016.04.004; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Faisst M, 2010, J CRIT CARE, V25, P105, DOI 10.1016/j.jcrc.2009.02.002; Filippatos G, 2007, J CARD FAIL, V13, P360, DOI 10.1016/j.cardfail.2007.02.005; Gary T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000948; Kajimoto K, 2016, INT J CARDIOL, V222, P195, DOI 10.1016/j.ijcard.2016.07.255; Kirtane AJ, 2005, J AM COLL CARDIOL, V45, P1781, DOI 10.1016/j.jacc.2005.02.068; Kumar NL, 2017, GASTROINTEST ENDOSC, V86, P1022, DOI 10.1016/j.gie.2017.03.1533; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Liu J, 2017, CARDIOL J; Okazaki H, 2014, J CARDIOL, V64, P441, DOI 10.1016/j.jjcc.2014.03.002; Pan SW, 2013, GERIATR GERONTOL INT, V13, P107, DOI 10.1111/j.1447-0594.2012.00869.x; Previsdomini M, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14090; Tatlisu MA, 2017, J CRIT CARE, V39, P248, DOI 10.1016/j.jcrc.2016.12.019; van Veldhuisen DJ, 2016, EUR HEART J, V37, P2577, DOI 10.1093/eurheartj/ehv588; Wu BU, 2011, ARCH INTERN MED, V171, P669, DOI 10.1001/archinternmed.2011.126	19	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191697	10.1371/journal.pone.0191697	http://dx.doi.org/10.1371/journal.pone.0191697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370259	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600082
J	Kalita, D; Holm, DG; LaBarbera, DV; Petrash, JM; Jayanty, SS				Kalita, Diganta; Holm, David G.; LaBarbera, Daniel V.; Petrash, J. Mark; Jayanty, Sastry S.			Inhibition of a-glucosidase, alpha-amylase, and aldose reductase by potato polyphenolic compounds	PLOS ONE			English	Article							FLESHED POTATOES; ANTIOXIDANT ACTIVITY; ACID-DERIVATIVES; ANTHOCYANINS; PHENOLICS; ENZYME; RED	Diabetes mellitus is a chronic disease that is becoming a serious global health problem. Diabetes has been considered to be one of the major risks of cataract and retinopathy. Synthetic and natural product inhibitors of carbohydrate degrading enzymes are able to reduce type 2 diabetes and its complications. For a long time, potatoes have been portrayed as unhealthy for diabetic patients by some nutritionist due to their high starch content. However, purple and red potato cultivars have received considerable attention from consumers because they have high levels of polyphenolic compounds that have potent antioxidant activities. In this study, we screened the total phenolics (TP) and total anthocyanins (TA) and analyzed the phenolic and anthocyanin compounds in selected potato cultivars and advanced selections with distinct flesh colors (purple, red, yellow and white). Purple and red potato cultivars had higher levels of TP and TA than tubers with other flesh colors. Chlorogenic acid is the predominant phenolic acid, and major anthocyanin is composed of the derivatives of petunidin, peonidin, malvidin and pelargonidin. We tested the potential inhibitory effect of potato extracts on the activities of alpha-amylase and alpha-glucosidase, which were targeted to develop antidiabetic therapeutic agents. We also measured inhibitory effect of potato extracts on aldose reductase (AR) which is a key enzyme that has been a major drug target for the development of therapies to treat diabetic complications. Purple flesh tubers extract showed the most effective inhibition of alpha-amylase, alpha-glucosidase, and aldose reductase with IC50 values 25, 42, and 32 mu g/ml, respectively. Kinetic studies showed that anthocyanins are noncompetitive inhibitors of these enzymes, whereas phenolic acids behaved as mixed inhibitors for alpha-amylase and alpha-glucosidase and noncompetitive inhibitors for AR. This study supports the development of a positive and healthful image of potatoes, which is an important issue for consumers.	[Kalita, Diganta; Holm, David G.; Jayanty, Sastry S.] Colorado State Univ, San Luis Valley Res Ctr, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [LaBarbera, Daniel V.] Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Petrash, J. Mark] Univ Colorado Anschutz Med Campus, Dept Ophthalmol, Aurora, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jayanty, SS (corresponding author), Colorado State Univ, San Luis Valley Res Ctr, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA.	sastry.jayanty@colostate.edu		Jayanty, Sastry/0000-0003-0302-2216	Colorado Potato Administrative Committee Area II, New York, NY; USDA National Institute of Food and Agriculture Special Research Grants Program Potato Breeding Research, New York, NY [2015-34141-23965]; National Institute of Health, New York, NY [EY005856, EY021498, EY028147]; Challenge Grant to the Department of Ophthalmology from Research to Prevent Blindness, New York, NY	Colorado Potato Administrative Committee Area II, New York, NY; USDA National Institute of Food and Agriculture Special Research Grants Program Potato Breeding Research, New York, NY; National Institute of Health, New York, NY; Challenge Grant to the Department of Ophthalmology from Research to Prevent Blindness, New York, NY	This work was partially supported by Colorado Potato Administrative Committee Area II funded Postharvest Program of SSJ; the USDA National Institute of Food and Agriculture Special Research Grants Program Potato Breeding Research Grant No. 2015-34141-23965 (DGH); National Institute of Health Grants EY005856, EY021498, and EY028147 and a Challenge Grant to the Department of Ophthalmology from Research to Prevent Blindness (JMP and DL), New York, NY.	Alim Z, 2017, J ENZYM INHIB MED CH, V32, P277, DOI 10.1080/14756366.2016.1250752; Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654; Charepalli V, 2015, J NUTR BIOCHEM, V26, P1641, DOI 10.1016/j.jnutbio.2015.08.005; Chethan S, 2008, BIOORGAN MED CHEM, V16, P10085, DOI 10.1016/j.bmc.2008.10.003; Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; Ghosh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106039; Giusti MM, 2014, J AGR FOOD CHEM, V62, P4408, DOI 10.1021/jf500655n; Homoki JR, 2016, FOOD CHEM, V194, P222, DOI 10.1016/j.foodchem.2015.07.130; Kalita D., 2014, Journal of Food Processing and Technology, V5, P358; Kim YM, 2005, NUTRITION, V21, P756, DOI 10.1016/j.nut.2004.10.014; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; Kita A, 2013, J FOOD COMPOS ANAL, V32, P169, DOI 10.1016/j.jfca.2013.09.006; Kunapajaru N, 2011, THESIS, pi; Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE; Lebovitz HE, 2001, AM J CARDIOL, V88, p20H, DOI 10.1016/S0002-9149(01)01833-1; LEE YH, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1039/C4CC06435F); Madiwale GP, 2012, J AGR FOOD CHEM, V60, P11088, DOI 10.1021/jf303528p; Nakano T, 1996, BIOCHEMISTRY-US, V35, P11196, DOI 10.1021/bi9608121; Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383; Ncube EN, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0066-z; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Perla V, 2012, LWT-FOOD SCI TECHNOL, V45, P161, DOI 10.1016/j.lwt.2011.08.005; Pillai SS, 2013, AM J POTATO RES, V90, P440, DOI 10.1007/s12230-013-9318-z; Puppala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031399; Ramkumar KM, 2010, MED CHEM RES, V19, P948, DOI 10.1007/s00044-009-9241-5; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Rubilar M, 2011, J AGR FOOD CHEM, V59, P1630, DOI 10.1021/jf103461k; Saraswat M, 2008, ASIA PAC J CLIN NUTR, V17, P558; Shobana S, 2009, FOOD CHEM, V115, P1268, DOI 10.1016/j.foodchem.2009.01.042; Stushnoff C, 2008, AM J POTATO RES, V85, P267, DOI 10.1007/s12230-008-9032-4; Sun LJ, 2016, FOOD CHEM, V208, P51, DOI 10.1016/j.foodchem.2016.03.093; TARLE I, 1993, J BIOL CHEM, V268, P25687; Wang H, 2010, FOOD CHEM, V123, P6, DOI 10.1016/j.foodchem.2010.03.088; Williamson J. R, 1992, HYPERGLYCEMIA DIABET, P691; Xie C, 2011, J AGR FOOD CHEM, V59, P11078, DOI 10.1021/jf203104k; Xu DL, 2015, J AGR FOOD CHEM, V63, P3694, DOI 10.1021/acs.jafc.5b00420; Yao Y, 2010, J AGR FOOD CHEM, V58, P770, DOI [10.1021/jf903234c, 10.1021/jf101415v]; Yawadio R, 2007, FOOD CHEM, V101, P1616, DOI 10.1016/j.foodchem.2006.04.016; Yoshimoto M, 2007, JP, Patent No. [2007119346 A, 2007119346]; You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v	43	121	123	10	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191025	10.1371/journal.pone.0191025	http://dx.doi.org/10.1371/journal.pone.0191025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370193	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600033
J	Yu, LP; Zhang, JQ; Guo, XH; Chen, XY; He, ZS; He, Q				Yu, Liping; Zhang, Junqing; Guo, Xiaohui; Chen, Xiaoyu; He, Zhisong; He, Qun			ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia	PLOS ONE			English	Article							T-CELL DEVELOPMENT; CUSHINGS-SYNDROME; CORTISOL HYPERSECRETION; PRIMARY ALDOSTERONISM; TRANSCRIPTION FACTORS; RECEPTORS; DELETION; TUMORS; GENE; OVEREXPRESSION	To investigate Armadillo repeat-containing 5 (ARMC5) mutations in Chinese patients with familial and sporadic primary bilateral macronodular adrenal hyperplasia (PBMAH), we performed clinical data collection and ARMC5 sequencing for three PBMAH families and 23 sporadic PBMAH patients. ARMC5 pathogenic germline mutations were identified in all 3 PBMAH families. Secondary ARMC5 somatic mutations were found in two adrenal nodules from two PBMAH family members with ARMC5 germline mutations. PBMAH family members with ARMC5 pathogenic germline mutations displayed various clinical manifestations. ARMC5 pathogenic germline mutations were identified in 5 sporadic PBMAH patients among whom one patient displayed both hypercortisolism and primary aldosteronism. We detected a total of 10 ARMC5 pathogenic mutations, of which 8 had not been previously reported. Our results suggest that ARMC5 pathogenic germline mutations are common in familial and sporadic Chinese PBMAH patients, and demonstrate the importance of ARMC5 screening in PBMAH family members to detect patients with insidious PBMAH.	[Yu, Liping; Zhang, Junqing; Guo, Xiaohui; Chen, Xiaoyu] Peking Univ, Hosp 1, Deparment Endocrinol & Metab, Beijing, Peoples R China; [He, Zhisong; He, Qun] Peking Univ, Hosp 1, Dept Urol, Beijing, Peoples R China	Peking University; Peking University	Zhang, JQ (corresponding author), Peking Univ, Hosp 1, Deparment Endocrinol & Metab, Beijing, Peoples R China.	junqing.zhang@pkufh.com						Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albiger NM, 2016, ENDOCRINE; Alencar GA, 2014, J CLIN ENDOCR METAB, V99, pE1501, DOI 10.1210/jc.2013-4237; Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Bourdeau I, 2016, EUR J ENDOCRINOL, V174, P85, DOI 10.1530/EJE-15-0642; Cartier D, 2003, J CLIN ENDOCR METAB, V88, P248, DOI 10.1210/jc.2002-021107; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Di Dalmazi G, 2012, EUR J ENDOCRINOL, V166, P669, DOI 10.1530/EJE-11-1039; Elbelt U, 2015, J CLIN ENDOCR METAB, V100, pE119, DOI 10.1210/jc.2014-2648; Ellmeier W, 2014, CURR TOP MICROBIOL, V381, P21, DOI 10.1007/82_2014_374; Espiard S, 2015, J CLIN ENDOCR METAB, V100, pE926, DOI 10.1210/jc.2014-4204; Faucz FR, 2014, J CLIN ENDOCR METAB, V99, pE1113, DOI 10.1210/jc.2013-4280; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Gagliardi L, 2014, J CLIN ENDOCR METAB, V99, pE1784, DOI 10.1210/jc.2014-1265; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Hu Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13834; Kawate H, 2014, ENDOCR J, V61, P1205, DOI 10.1507/endocrj.EJ14-0155; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011; Lee S, 2005, CLIN ENDOCRINOL, V63, P625, DOI 10.1111/j.1365-2265.2005.02387.x; Louiset E, 2013, NEW ENGL J MED, V369, P2115, DOI 10.1056/NEJMoa1215245; Mulatero P, 2015, J HUM HYPERTENS; Mune T, 2002, J CLIN ENDOCR METAB, V87, P5706, DOI 10.1210/jc.2002-020067; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohashi A, 2001, ENDOCR J, V48, P677, DOI 10.1507/endocrj.48.677; Starker LF, 2014, SURG CLIN N AM, V94, P657, DOI 10.1016/j.suc.2014.02.008; Suzuki S, 2015, ENDOCR PRACT, V21, P1152, DOI 10.4158/EP15756.OR; Vezzosi D, 2012, J CLIN ENDOCR METAB, V97, pE2063, DOI 10.1210/jc.2012-2275; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Zhu J, 2013, FAM CANCER, V12, P657, DOI 10.1007/s10689-013-9642-y; Zilbermint M, 2015, J CLIN ENDOCR METAB, V100, pE900, DOI 10.1210/jc.2014-4167	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191602	10.1371/journal.pone.0191602	http://dx.doi.org/10.1371/journal.pone.0191602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370219	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600065
J	Berrett, AN; Gale, SD; Erickson, LD; Brown, BL; Hedges, DW				Berrett, Andrew N.; Gale, Shawn D.; Erickson, Lance D.; Brown, Bruce L.; Hedges, Dawson W.			Helicobacter pylori moderates the association between 5-MTHF concentration and cognitive function in older adults	PLOS ONE			English	Article							MTHFR C677T POLYMORPHISM; MAJOR DEPRESSIVE DISORDER; REDUCTASE MTHFR; GENE POLYMORPHISMS; US ADULTS; FOLATE; HOMOCYSTEINE; METAANALYSIS; PERFORMANCE; RISK	Objective To explore potential interactions between folate-cycle factors and Helicobacter pylori seropositivity in the prediction of cognitive function. Methods We used data obtained from the 1999-2000 continuous National Health and Nutrition Examination Survey produced by the United States' Centers for Disease Control and Prevention. Using Ordinary Least Squares regression, we tested for associations between multiple folate-cycle factors, Helicobacter pylori seropositivity, and cognitive function assessed by the digit symbol coding subtest of the Wechsler Adult Intelligence Scale-III. We then tested for interactions between each of the folate-cycle factors and Helicobacter pylori in the prediction of cognitive function. Results Although Helicobacter pylori seropositivity, 5-methyltetrahydrofolate, vitamin B-12, and homocysteine were not associated with performance on the digit symbol coding task, Helicobacter pylori seropositivity interacted with 5-methyltetrahydrofolate concentration to predict performance on the digit symbol coding task. The Helicobacter pylori seropositive group performed worse on the digit symbol coding task as 5-methyltetrahydrofolate concentration decreased. Conclusion The interaction between Helicobacter pylori seropositivity and reduced folate-cycle factor 5-methyltetrahydrofolate might impair aspects of cognitive function.	[Berrett, Andrew N.; Gale, Shawn D.; Brown, Bruce L.; Hedges, Dawson W.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Gale, Shawn D.; Hedges, Dawson W.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Erickson, Lance D.] Brigham Young Univ, Dept Sociol, Provo, UT USA	Brigham Young University; Brigham Young University; Brigham Young University	Berrett, AN (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	drew_berrett@byu.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964; Brown, Bruce L./0000-0002-5952-6475				Akcam M, 2010, INDIAN PEDIATR, V47, P119, DOI 10.1007/s13312-010-0017-2; [Anonymous], 1993, INSTR MAN BIOR QUANT; [Anonymous], 2001, HELICOBACTER PYLORI; [Anonymous], 1998, DIG SYMB SUBST EX; Azimova JE, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-103; Bagley PJ, 1997, METHOD ENZYMOL, V281, P16; Baudron CR, 2013, J AM GERIATR SOC, V61, P74, DOI 10.1111/jgs.12065; Berrett AN, 2016, HELICOBACTER, V21, P471, DOI 10.1111/hel.12303; Beydoun MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121390; Beydoun MA, 2013, PSYCHOSOM MED, V75, P486, DOI 10.1097/PSY.0b013e31829108c3; Bousman CA, 2014, AM J MED GENET B, V165, P68, DOI 10.1002/ajmg.b.32209; Brown JP, 2009, HEALTH PSYCHOL, V28, P641, DOI 10.1037/a0015215; Chen J, 2014, GENET MOL RES, V13, P9718, DOI 10.4238/2014.January.24.2; Cheng DM, 2010, NUTR NEUROSCI, V13, P175, DOI 10.1179/147683010X12611460764200; Chieffi PP, 2010, REV INST MED TROP SP, V52, P243, DOI 10.1590/S0036-46652010000500004; Chin AV, 2008, AGE AGEING, V37, P559, DOI 10.1093/ageing/afn144; de Bernard M, 2014, HELICOBACTER, V19, P11, DOI 10.1111/hel.12160; Enders C. K., 2010, APPL MISSING DATA AN; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Foley J., 2008, HELICOBACTER PYLORI; Gale SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116874; Grad YH, 2012, AM J EPIDEMIOL, V175, P54, DOI 10.1093/aje/kwr288; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Ho V, 2013, GENES NUTR, V8, P571, DOI 10.1007/s12263-013-0358-2; Hua Y, 2011, INT J NEUROSCI, V121, P462, DOI 10.3109/00207454.2011.578778; Hultberg B, 2001, INT J GERIATR PSYCH, V16, P873, DOI 10.1002/gps.439; Kim DH, 2015, J AM GERIATR SOC, V63, P1886, DOI 10.1111/jgs.13594; Knowles EEM, 2015, BIOL PSYCHIAT, V78, P786, DOI 10.1016/j.biopsych.2015.01.018; Kountouras J, 2007, AM J CLIN NUTR, V86, P805, DOI 10.1093/ajcn/86.3.805; Kountouras J, 2007, MED HYPOTHESES, V68, P378, DOI 10.1016/j.mehy.2006.06.052; Kwok T, 2011, CLIN NUTR, V30, P297, DOI 10.1016/j.clnu.2010.12.004; Liew SC, 2015, EUR J MED GENET, V58, P1, DOI 10.1016/j.ejmg.2014.10.004; Liu J, 2014, J NEUROL SCI, V337, P61, DOI 10.1016/j.jns.2013.11.017; Liu XD, 2011, J AUTISM DEV DISORD, V41, P938, DOI 10.1007/s10803-010-1120-x; Lok A, 2014, J AFFECT DISORDERS, V166, P115, DOI 10.1016/j.jad.2014.04.048; Malaguarnera Mariano, 2004, Eur J Intern Med, V15, P381, DOI 10.1016/j.ejim.2004.05.008; Marcus Elizabeth A, 2016, Curr Gastroenterol Rep, V18, P33, DOI 10.1007/s11894-016-0509-x; Oberlin LE, 2015, NEUROPSYCHOLOGY, V29, P693, DOI 10.1037/neu0000177; Polito L, 2016, EXP GERONTOL, V76, P9, DOI 10.1016/j.exger.2016.01.005; Prevention C.f.D.C.a., 2011, AN NOT REG 2007 2010; Pu DH, 2013, AUTISM RES, V6, P384, DOI 10.1002/aur.1300; Rai V, 2017, MOL NEUROBIOL, V54, P1173, DOI 10.1007/s12035-016-9722-8; Reutens S, 2002, INT J GERIATR PSYCH, V17, P859, DOI 10.1002/gps.723; Rubin DB, 1987, MULTIPLE IMPUTATION, Vxxix, P258; Schiepers OJG, 2011, GENES BRAIN BEHAV, V10, P354, DOI 10.1111/j.1601-183X.2010.00675.x; SHIPCHANDLER MT, 1995, CLIN CHEM, V41, P991; StataCorp, 2014, STAT STAT SOFTW REL; Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099; Vallelunga A, 2014, NEUROL SCI, V35, P73, DOI 10.1007/s10072-013-1545-z; van den Kommer TN, 2010, NEUROBIOL AGING, V31, P1700, DOI 10.1016/j.neurobiolaging.2008.09.009; Wechsler D., 1997, WECHSLER ADULT INTEL; West RK, 2011, AM J GERIAT PSYCHIAT, V19, P673, DOI 10.1097/JGP.0b013e3181faee37; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Wilson VK, 2014, J AM GERIATR SOC, V62, P636, DOI 10.1111/jgs.12765; Wu XM, 2013, EUR J OBSTET GYN R B, V167, P154, DOI 10.1016/j.ejogrb.2012.11.022	55	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190475	10.1371/journal.pone.0190475	http://dx.doi.org/10.1371/journal.pone.0190475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364915	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500014
J	Cui, B; Wang, CX; Zhao, X; Yao, JW; Zeng, ZH; Wang, Y; Sun, CJ; Liu, GQ; Cui, HX				Cui, Bo; Wang, Chunxin; Zhao, Xiang; Yao, Junwei; Zeng, Zhanghua; Wang, Yan; Sun, Changjiao; Liu, Guoqiang; Cui, Haixin			Characterization and evaluation of avermectin solid nanodispersion prepared by microprecipitation and lyophilisation techniques	PLOS ONE			English	Article							BENZOTRIAZOLE UV-STABILIZERS; CONTROLLED-RELEASE; ABAMECTIN; WATER; NANOSUSPENSIONS; PHOTOSTABILITY; MICROCAPSULES; NANOPARTICLES; FLOCCULATION; FORMULATION	Poorly water-soluble and photosensitive pesticide compounds are difficult to formulate as solvent-free nanoformulations with high efficacy. A avermectin solid nanodispersion with a mean particle size of 188 nm was developed by microprecipitation and lyophilisation techniques. The suspensibility and wetting time of the solid nanodispersion in water were 99.8% and 13 s, respectively, superior to those of conventional water dispersible granules and wettable powders. The anti-photolysis performance of the nanoformulation was twice that of the technical material, and the biological activity against diamondback moths was more than 1.5 times that of the conventional solid formulations while taking LC 50 as the evaluation index. Moreover, the formulation composition substantially decreased the surfactant content and avoided organic solvents. Microprecipitation combined with lyophilisation is an easy and promising method to construct solid nanoformulations for pesticides with poor water solubility and environmental sensitivity. The application of the highly effective solid nanodispersion in crop production will have a great potential in reducing chemical residues and environmental pollution.	[Cui, Bo; Wang, Chunxin; Zhao, Xiang; Yao, Junwei; Zeng, Zhanghua; Wang, Yan; Sun, Changjiao; Liu, Guoqiang; Cui, Haixin] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China.	cuihaixin@caas.cn			National Key Research and Development Program of China [2017YFD0201207, 2016YFD0200502]	National Key Research and Development Program of China	This research was supported by National Key Research and Development Program of China (No. 2017YFD0201207 and 2016YFD0200502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS MW, 1995, PESTIC SCI, V43, P141, DOI 10.1002/ps.2780430207; Cao J, 2015, ACS APPL MATER INTER, V7, P9546, DOI 10.1021/acsami.5b00940; Chingunpituk J., 2007, WALAILAK J SCI TECHN, V4, P139, DOI [10.2004/wjst.v4i2.94, DOI 10.2004/WJST.V4I2.94]; Cowan-Ellsberry C, 2014, CRIT REV ENV SCI TEC, V44, P1893, DOI 10.1080/10739149.2013.803777; Cui B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160877; Cui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135953; Demchak RJ, 1997, J AGR FOOD CHEM, V45, P260, DOI 10.1021/jf960356n; Dickinson E, 1997, J COLLOID INTERF SCI, V185, P515, DOI 10.1006/jcis.1996.4605; Dong LF, 2013, MOD AGR, V12, P14; Fan TF, 2014, J POROUS MAT, V21, P113, DOI 10.1007/s10934-013-9754-7; Fent K, 2014, SCI TOTAL ENVIRON, V482, P125, DOI 10.1016/j.scitotenv.2014.02.109; Gasic S., 2011, Pesticidi i Fitomedicina, V26, P409, DOI 10.2298/PIF1104409G; He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004; He S, 2013, J MATER CHEM B, V1, P1270, DOI 10.1039/c2tb00234e; Hirata-Koizumi Mutsuko, 2009, Congenital Anomalies, V49, P247, DOI 10.1111/j.1741-4520.2009.00248.x; Jia X, 2014, ACS APPL MATER INTER, V6, P19552, DOI 10.1021/am506458t; Kocbek P, 2006, INT J PHARMACEUT, V312, P179, DOI 10.1016/j.ijpharm.2006.01.008; LASOTA JA, 1990, ACT LEIDENS, V59, P217; Lee MK, 2010, INT J PHARMACEUT, V384, P173, DOI 10.1016/j.ijpharm.2009.09.041; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Li H, 2011, CHIN J APPL CHEM, V29, P327; Li SuXia, 2013, Acta Phytophylacica Sinica, V40, P575; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Li ZZ, 2006, J CONTROL RELEASE, V111, P81, DOI 10.1016/j.jconrel.2005.10.020; [刘学涛 Liu Xuetao], 2006, [生态学杂志, Chinese Journal of Ecology], V25, P185; Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X; McClements DJ, 2010, ADV COLLOID INTERFAC, V159, P213, DOI 10.1016/j.cis.2010.06.010; Mishra PR, 2009, INT J PHARMACEUT, V371, P182, DOI 10.1016/j.ijpharm.2008.12.030; Mitri K, 2011, INT J PHARMACEUT, V420, P141, DOI 10.1016/j.ijpharm.2011.08.026; Mogul MG, 1996, RESOUR CONSERV RECY, V16, P289, DOI 10.1016/0921-3449(95)00063-1; Nakata H, 2010, J ENVIRON MONITOR, V12, P2088, DOI 10.1039/c0em00170h; NOLEN GA, 1989, DRUG CHEM TOXICOL, V12, P95, DOI 10.3109/01480548908999147; Pan ZZ, 2015, J NANOMATER, V2015, DOI 10.1155/2015/123496; Pardeike J, 2010, INT J PHARMACEUT, V391, P322, DOI 10.1016/j.ijpharm.2010.03.002; PUTTER I, 1981, EXPERIENTIA, V37, P963, DOI 10.1007/BF01971780; Rezende D, 2016, EXP APPL ACAROL, V69, P297, DOI 10.1007/s10493-016-0039-0; Rundfeldt C, 2013, EUR J PHARM BIOPHARM, V83, P44, DOI 10.1016/j.ejpb.2012.09.018; Santiago LG, 2002, BRAZ J CHEM ENG, V19, P411, DOI 10.1590/S0104-66322002000400009; Serajuddin ATM, 1999, J PHARM SCI-US, V88, P1058, DOI 10.1021/js980403l; Sharma P, 2011, INT J PHARMACEUT, V408, P138, DOI 10.1016/j.ijpharm.2011.01.032; Silva HD, 2012, FOOD BIOPROCESS TECH, V5, P854, DOI 10.1007/s11947-011-0683-7; Talekar M, 2012, EUR J PHARM SCI, V47, P824, DOI 10.1016/j.ejps.2012.09.015; Tanpradit N, 2015, THERIOGENOLOGY, V83, P1553, DOI 10.1016/j.theriogenology.2015.01.035; Tong JH, 1999, PESTICIDES, V38, P38; Valenzuela AI, 2000, J CHROMATOGR A, V871, P57, DOI 10.1016/S0021-9673(99)01190-5; Verma S, 2009, INT J PHARMACEUT, V380, P216, DOI 10.1016/j.ijpharm.2009.07.005; Xu X, 2014, FINE SPEC CHEM, V22, P11; Yan YF, 2013, COLLOID SURFACE B, V102, P341, DOI 10.1016/j.colsurfb.2012.07.043; Yue PF, 2013, INT J PHARMACEUT, V443, P279, DOI 10.1016/j.ijpharm.2012.12.036; Zhang H, 2011, INT J PHARMACEUT, V415, P293, DOI 10.1016/j.ijpharm.2011.05.075; Zhang XG, 2011, J AGR FOOD CHEM, V59, P1308, DOI 10.1021/jf1034459; Zhang Y, 2016, RSC ADV, V6, P69889, DOI 10.1039/c6ra08413c; Zhuang ZX, 2009, CHEM J CHINESE U, V30, P332	53	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191742	10.1371/journal.pone.0191742	http://dx.doi.org/10.1371/journal.pone.0191742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360866	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800059
J	Davison, KM; Holloway, C; Gondara, L; Hatcher, AS				Davison, Karen M.; Holloway, Cliff; Gondara, Lovedeep; Hatcher, Anne S.			Independent associations and effect modification between lifetime substance use and recent mood disorder diagnosis with household food insecurity	PLOS ONE			English	Article							NEGATIVE DRUG-USERS; MENTAL-HEALTH; WELFARE RECIPIENTS; DUAL DIAGNOSIS; NUTRITION; ADULTS; INSUFFICIENCY; INCOME; CONSEQUENCES; DEPRESSION	Poor mental health and substance use are associated with food insecurity, however, their potential combined effects have not been studied. This study explored independent associations and effect modification between lifetime substance use and mood disorder in relation to food insecurity. Poisson regression analysis of data from British Columbia respondents (n = 13,450; 12 years+) in the 2007/08 Canadian Community Health Survey was conducted. Measures included The Household Food Security Survey Module (7.3% food insecure), recent diagnosis of a mood disorder (self-reported; 9.5%), lifetime use of cannabis, cocaine/crack, ecstasy, hallucinogens, and speed, any lifetime substance use, sociodemographic covariates, and the interaction terms of mood disorder by substance. For those with recent diagnosis of a mood disorder the prevalence of lifetime substance use ranged between 1.2 to 5.7% and were significantly higher than those without recent mood disorder diagnosis or lifetime use of substances (p's < 0.05). For respondents with a recent mood disorder diagnosis or who used cannabis, food insecurity prevalence was higher compared to the general sample (p < 0.001); prevalence was lower for cocaine/crack use (p < 0.05). Significant effect modification was found between mood disorder with cannabis, ecstasy, hallucinogen and any substance use over the lifetime (PRs 0.51 to 0.64, p's 0.022 to 0.001). Independent associations were found for cocaine/crack and speed use (PRs 1.68, p's < 0.001) and mood disorder (PRs 2.02, p's < 0.001). Based on these findings and the existing literature, future study about coping and resilience in the context of substance use, mental health, and food insecurity may lead to the development of relevant interventions aimed at mental well-being and food security.	[Davison, Karen M.] Univ British Columbia, Sch Nursing, Vancouver, BC, Canada; [Davison, Karen M.] Kwantlen Polytech Univ, Dept Biol, Hlth Sci Program, Surrey, BC, Canada; [Davison, Karen M.] Univ Hawaii Manoa, Fulbright Canada Res Chair, Honolulu, HI 96822 USA; [Holloway, Cliff] Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Gondara, Lovedeep] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Hatcher, Anne S.] Metropolitan State Univ Denver, Ctr Addict Studies, Dept Human Serv, Denver, CO USA; [Davison, Karen M.] Kwantlen Polytech Univ, Biol Dept, Surrey, BC, Canada	University of British Columbia; University of Hawaii System; University of Hawaii Manoa; Ontario Tech University; Simon Fraser University; Metropolitan State University of Denver	Davison, KM (corresponding author), Univ British Columbia, Sch Nursing, Vancouver, BC, Canada.; Davison, KM (corresponding author), Kwantlen Polytech Univ, Dept Biol, Hlth Sci Program, Surrey, BC, Canada.; Davison, KM (corresponding author), Univ Hawaii Manoa, Fulbright Canada Res Chair, Honolulu, HI 96822 USA.; Davison, KM (corresponding author), Kwantlen Polytech Univ, Biol Dept, Surrey, BC, Canada.	karen.davison@kpu.ca		Holloway, Courtney Jean/0000-0003-3661-1957	Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship; Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program	Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship; Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program	KMD's work was supported by a Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship.& para;& para;This study was part of Karen Davison's postdoctoral work funded by the Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program. Gratitude is extended to Catherine (Katie) Goldie, Brittany Bingham, and Alina Sotskova for their early work on this project that included submitting the proposal to Statistics Canada and initial data analysis.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; *AM DIET ASS DIET, 2000, MAN CLIN DIET; American Dental Association, 2008, METH US METH MOUTH; Anema A, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-20; Baker A, 2004, ADDICTION, V99, P875, DOI 10.1111/j.1360-0443.2004.00741.x; Bove CF, 2006, WOMEN HEALTH, V44, P57, DOI 10.1300/J013v44n01_04; Broussard CA, 2010, J POVERTY, V14, P443, DOI 10.1080/10875549.2010.518003; Brown DR, 2015, SOC SCI MED, V133, P202, DOI 10.1016/j.socscimed.2015.03.058; Canadian Center on Substance Abuse, 2009, SUBSTANCE ABUSE CANA; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Chilton M, 2007, J NUTR EDUC BEHAV, V39, P116, DOI 10.1016/j.jneb.2006.11.005; Coelho JS, 2006, APPETITE, V47, P352, DOI 10.1016/j.appet.2006.05.015; Cornish JW, 1996, ANNU REV PUBL HEALTH, V17, P259; Cortes-Briones JA, 2015, BIOL PSYCHIAT, V78, P805, DOI 10.1016/j.biopsych.2015.03.023; Davis B., 1994, Agriculture and Human Values, V11, P50, DOI 10.1007/BF01530416; Davison KM, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0059-x; Davison KM, 2015, SOC PSYCH PSYCH EPID, V50, P963, DOI 10.1007/s00127-015-1018-1; Davison KM, 2014, GEN HOSP PSYCHIAT, V36, P411, DOI 10.1016/j.genhosppsych.2014.04.001; Davison KM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-80; Davison KM, 2011, J AM COLL NUTR, V30, P547, DOI 10.1080/07315724.2011.10720001; Davison KM, 2012, 2 DIET CAN; Drake RE, 2000, SCHIZOPHRENIA BULL, V26, P105, DOI 10.1093/oxfordjournals.schbul.a033429; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; FOLTIN RW, 1988, APPETITE, V11, P1, DOI 10.1016/S0195-6663(88)80017-5; GELBERG L, 1995, PUBLIC HEALTH REP, V110, P448; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Hadley C, 2012, AM J PHYS ANTHROPOL, V149, P72, DOI 10.1002/ajpa.22161; Hamelin A.-M., 2009, CANADIAN J URBAN RES, V18, P1; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hankin B.L., 2005, DEV PSYCHOPATHOLOGY; Hart CL, 2012, NEUROPSYCHOPHARMACOL, V37, P586, DOI 10.1038/npp.2011.276; Hatcher AS, 2008, NUTR ADDICTIONS GUID; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Health Canada, 2012, HOUS FOOD SEC SURV M; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; HELLER J, 1991, APPETITE, V17, P23, DOI 10.1016/0195-6663(91)90081-3; Hendricks KM, 2010, J AM COLL NUTR, V29, P136, DOI 10.1080/07315724.2010.10719827; Heslin KC, 2003, J HEALTH CARE POOR U, V14, P34, DOI 10.1177/1049208902238822; Huddleston-Casas C, 2009, PUBLIC HEALTH NUTR, V12, P1133, DOI 10.1017/S1368980008003650; Hussain Fahmida, 2012, General Dentistry, V60, P334; Kraybill K, 2003, PROVIDING TREATMENT; Liu XC, 2005, J AFFECT DISORDERS, V86, P195, DOI 10.1016/j.jad.2005.01.016; Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22; Maes M, 2013, ACTA PSYCHIAT SCAND, V127, P344, DOI 10.1111/j.1600-0447.2012.01908.x; Melchior M, 2009, PEDIATRICS, V124, pE564, DOI 10.1542/peds.2009-0583; Muirhead V, 2009, COMMUNITY DENT ORAL, V37, P294, DOI 10.1111/j.1600-0528.2009.00479.x; Pelayo-Teran JM, 2010, PSYCHIAT RES, V179, P291, DOI 10.1016/j.psychres.2009.08.022; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Polivy J, 1996, J AM DIET ASSOC, V96, P589, DOI 10.1016/S0002-8223(96)00161-7; Pryor L, 2016, SOC PSYCH PSYCH EPID, V51, P1073, DOI 10.1007/s00127-016-1249-9; Runnels VivienE., 2011, CANADIAN J COMMUNITY, V30, DOI DOI 10.7870/CJCMH-2011-0011; Saeland M, 2011, BRIT J NUTR, V105, P618, DOI 10.1017/S0007114510003971; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; SANTOLARIAFERNANDEZ FJ, 1995, DRUG ALCOHOL DEPEN, V38, P11, DOI 10.1016/0376-8716(94)01088-3; Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204; Slopen N, 2010, J AM ACAD CHILD PSY, V49, P444, DOI 10.1016/j.jaac.2010.01.018; StataCorp, 2021, STATA STAT SOFTWARE; Statistics Canada, 2015, CAN COMM HLTH SURV A; Statistics Canada Health Statistics Division, 2008, CAN COMM HLTH SURV C; Strike C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1058; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Tang AM, 2011, DRUG ALCOHOL DEPEN, V118, P73, DOI 10.1016/j.drugalcdep.2011.02.020; Tang AM, 2010, AM J DRUG ALCOHOL AB, V36, P78, DOI 10.3109/00952990903544851; Tarasuk V., 2012, HOUSEHOLD FOOD INSEC; Tarasuk V, 2010, APPL PHYSIOL NUTR ME, V35, P172, DOI 10.1139/H10-002; Tomasi D, 2015, HUM BRAIN MAPP, V36, P120, DOI 10.1002/hbm.22617; TRACY JI, 1995, CLIN PSYCHOL REV, V15, P67, DOI 10.1016/0272-7358(95)00001-6; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Volpe GE, 2014, J STUD ALCOHOL DRUGS, V75, P347, DOI 10.15288/jsad.2014.75.347; Weaver LJ, 2009, ECOL FOOD NUTR, V48, P263, DOI 10.1080/03670240903001167; Weiser Mark, 2005, Dialogues Clin Neurosci, V7, P81; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; WIECHA JL, 1991, PUBLIC HEALTH REP, V106, P364; YAGO KB, 1981, J CLIN PSYCHIAT, V42, P193	75	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191072	10.1371/journal.pone.0191072	http://dx.doi.org/10.1371/journal.pone.0191072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360862	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800015
J	Kant, AK; Graubard, BI				Kant, Ashima K.; Graubard, Barry I.			A prospective study of frequency of eating restaurant prepared meals and subsequent 9-year risk of all-cause and cardiometabolic mortality in US adults	PLOS ONE			English	Article							FAST-FOOD CONSUMPTION; OUT-OF-HOME; METABOLIC RISK; DIETARY; ASSOCIATION; ENERGY; OUTCOMES; QUALITY; MENU; ENVIRONMENTS	Restaurant prepared foods are known to be energy-dense and high in fat and sodium, but lower in protective nutrients. There is evidence of higher risk of adiposity, type II diabetes, and heart disease in frequent consumers of restaurant meals. However, the risk of mortality as a long-term health consequence of frequent consumption of restaurant meals has not been examined. We examined the prospective risk of all-cause and coronary heart disease, cerebrovascular disease and diabetes (cardiometabolic) mortality in relation to frequency of eating restaurant prepared meals in a national cohort. We used frequency of eating restaurant prepared meals information collected in the National Health and Nutrition Examination Surveys, conducted from 1999-2004, with mortality follow-up completed through Dec. 31, 2011 (baseline age >= 40y; n = 9107). We estimated the relative hazard of all-cause and cardiometabolic mortality associated with weekly frequency of eating restaurant meals using Cox-proportional hazards regression methods to adjust for multiple covariates. All analyses accounted for complex survey design and included sample weights. Over 33% of all respondents reported eating >= 3 restaurant prepared meals/week. In this cohort, 2200 deaths due to all causes and 665 cardiometabolic deaths occurred over a median follow-up of 9 years. The covariate-adjusted hazard ratio of all cause or cardiometabolic mortality in men and women reporters of <1 or 1-2 restaurant prepared meals did not differ from those reporting >= 3 meals/week (P>0.05). The results were robust to effect modification by baseline BMI, years of education, and baseline morbidity. Expectedly, the 24-h dietary intakes of whole grains, fruits, dietary fiber, folate, vitamin C, potassium and magnesium at baseline were lower, but energy, energy density, and energy from fat were higher in more frequent restaurant meal reporters (P<0.05). Baseline serum HDL cholesterol, folate, and some carotenoids were inversely associated with the frequency of eating restaurant prepared meals (P<0.05); however, serum concentrations of total cholesterol, triglycerides, fasting glucose, insulin, glycated hemoglobin, and c-reactive protein were unrelated (P<0.05). The weekly frequency of eating restaurant prepared meals and prospective risk of mortality after 9 years were not related in this cohort.	[Kant, Ashima K.] CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Biostat Branch, NIH, Bethesda, MD 20892 USA	City University of New York (CUNY) System; Queens College NY (CUNY); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kant, AK (corresponding author), CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA.	ashima.kant@qc.cuny.edu		Kant, Ashima/0000-0003-4141-2063	Professional Staff Congress of the City University of New York [69741-00 47]; intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Professional Staff Congress of the City University of New York; intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Professional Staff Congress of the City University of New York, research award #69741-00 47 (https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190) (Kant); and intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH (Graubard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern M, 2011, J RURAL HEALTH, V27, P367, DOI 10.1111/j.1748-0361.2011.00378.x; Alter DA, 2005, CAN J PUBLIC HEALTH, V96, P173, DOI 10.1007/BF03403684; An R, 2016, EUR J CLIN NUTR, V70, P97, DOI 10.1038/ejcn.2015.104; [Anonymous], 2017, SUD REL 11 0; [Anonymous], IND DIET PHYS ACT BE; Auchincloss AH, 2014, J NUTR EDUC BEHAV, V46, P75, DOI 10.1016/j.jneb.2013.10.008; Bezerra IN, 2012, NUTR REV, V70, P65, DOI 10.1111/j.1753-4887.2011.00459.x; Bleich SN, 2016, AM J PREV MED, V50, pE1, DOI 10.1016/j.amepre.2015.05.007; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Brown WV, 2015, J CLIN LIPIDOL, V9, P3, DOI 10.1016/j.jacl.2014.12.002; Centers for Disease Control and Prevention National Center for Environmental Health Division of Laboratory Sciences, 2012, 2 NAT REP BIOCH IND; Cohen DA, 2014, AM J PUBLIC HEALTH, V104, P586, DOI 10.2105/AJPH.2013.301692; Dominguez LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092354; Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hamano T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056680; Hattori A, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120123; Hearst MO, 2013, AM J PREV MED, V44, P589, DOI 10.1016/j.amepre.2013.01.028; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Kirkpatrick SI, 2014, PUBLIC HEALTH NUTR, V17, P924, DOI 10.1017/S1368980012005563; Korn E. L., 1999, ANAL HLTH SURVEYS; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Krishnan S, 2010, AM J CLIN NUTR, V91, P465, DOI 10.3945/ajcn.2009.28682; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Li FZ, 2009, AM J HEALTH PROMOT, V23, P203, DOI 10.4278/ajhp.071214133; Lin B.-H., 2012, BOOK NUTR QUALITY FO, VEIB-105; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Meyer KA, 2015, HEALTH PLACE, V33, P9, DOI 10.1016/j.healthplace.2015.01.004; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Morgenstern LB, 2009, ANN NEUROL, V66, P165, DOI 10.1002/ana.21726; Nago ES, 2014, CRIT REV FOOD SCI, V54, P1103, DOI 10.1080/10408398.2011.627095; National Center for Health Statistics, QUEST DAT REL DOC; National Center for Health Statistics, NHANES RESP RAT POP; National Center for Health Statistics, 2015, OFF AN EP PUBL US LI; National Center for Health Statistics, 2013, OFF AN EP NCHS 2011; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Parcina M, 2015, NUTR RES PRACT, V9, P165, DOI 10.4162/nrp.2015.9.2.165; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Rudolph TK, 2007, AM J CLIN NUTR, V86, P334, DOI 10.1093/ajcn/86.2.334; Scourboutakos MJ, 2013, JAMA INTERN MED, V173, P1373, DOI 10.1001/jamainternmed.2013.6159; Smith KJ, 2012, EUR J CLIN NUTR, V66, P577, DOI 10.1038/ejcn.2011.202; The Third National Health and Nutrition Examination Survey (NHANES III), 2005, LINK MORT FIL MATCH; Tiwari A, 2017, AM J PREV MED, V52, P616, DOI 10.1016/j.amepre.2017.01.017; URBAN LE, 2014, PREV CHRONIC DIS, V11, P40202, DOI DOI 10.5888/PCD11.140202; Urban LE, 2016, J ACAD NUTR DIET, V116, P590, DOI 10.1016/j.jand.2015.11.009; Wolfson JA, 2015, PUBLIC HEALTH NUTR, V18, P1397, DOI 10.1017/S1368980014001943; Wu HW, 2013, PUBLIC HEALTH NUTR, V16, P87, DOI 10.1017/S136898001200122X; Zong G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002052	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191584	10.1371/journal.pone.0191584	http://dx.doi.org/10.1371/journal.pone.0191584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360850	gold, Green Published			2022-12-26	WOS:000423161800038
J	Gils, T; Bossard, C; Verdonck, K; Owiti, P; Casteels, I; Mashako, M; van Cutsem, G; Ellman, T				Gils, Tinne; Bossard, Claire; Verdonck, Kristien; Owiti, Philip; Casteels, Ilse; Mashako, Maria; van Cutsem, Gilles; Ellman, Tom			Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV	PLOS ONE			English	Article							SUPPLY CHAIN; OUTCOMES; AFRICA; IMPACT; LEVEL	Stockouts of HIV commodities increase the risk of treatment interruption, antiretroviral resistance, treatment failure, morbidity and mortality. The study objective was to assess the magnitude and duration of stockouts of HIV medicines and diagnostic tests in public facilities in Kinshasa, Democratic Republic of the Congo. This was a cross-sectional survey involving visits to facilities and warehouses in April and May 2015. All zonal warehouses, all public facilities with more than 200 patients on antiretroviral treatment (ART) (high-burden facilities) and a purposive sample of facilities with 200 or fewer patients (low-burden facilities) in Kinshasa were selected. We focused on three adult ART formulations, cotrimoxazole tablets, and HIV diagnostic tests. Availability of items was determined by physical check, while stockout duration until the day of the survey visit was verified with stock cards. In case of ART stockouts, we asked the pharmacist in charge what the facility coping strategy was for patients needing those medicines. The study included 28 high-burden facilities and 64 lowburden facilities, together serving around 22000 ART patients. During the study period, a national shortage of the newly introduced first-line regimen Tenofovir-Lamivudine-Efavirenz resulted in stockouts of this regimen in 56% of high-burden and 43% of low-burden facilities, lasting a median of 36 (interquartile range 29 +/- 90) and 44 days (interquartile range 24 +/- 90) until the day of the survey visit, respectively. Each of the other investigated commodities were found out of stock in at least two low-burden and two high-burden facilities. In 30/41 (73%) of stockout cases, the commodity was absent at the facility but present at the upstream warehouse. In 30/57 (54%) of ART stockout cases, patients did not receive any medicines. In some cases, patients were switched to different ART formulations or regimens. Stockouts of HIV commodities were common in the visited facilities. Introduction of new ART regimens needs additional planning.	[Gils, Tinne; Bossard, Claire; van Cutsem, Gilles; Ellman, Tom] Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa; [Verdonck, Kristien] Inst Trop Med, Antwerp, Belgium; [Owiti, Philip] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Owiti, Philip] Int Union TB & Lung Dis, Paris, France; [Casteels, Ilse; Mashako, Maria] Operat Ctr Brussels, Med Sans Frontieres, Kinshasa, DEM REP CONGO	Institute of Tropical Medicine (ITM)	Gils, T (corresponding author), Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa.	tinnegils@gmail.com	Gils, Tinne/GYU-8606-2022; Verdonck, Kristien/AAN-8937-2020; Van Cutsem, Gilles/ABB-1171-2021	Gils, Tinne/0000-0002-5518-9600; Verdonck, Kristien/0000-0003-1153-4078; Van Cutsem, Gilles/0000-0002-8972-4480	United Kingdom's Department for International Development (DFID); The Union; MSF; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	United Kingdom's Department for International Development (DFID); The Union; MSF; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF). The specific SORT IT program which resulted in this publication was implemented by: Medecins Sans Frontieres, Brussels Operational Center, Luxembourg and the Centre for Operational Research, The Union, Paris, France. Mentorship and the coordination/facilitation of these SORT IT workshops were provided through the Centre for Operational Research, The Union, Paris, France; the Operational Research Unit (LuxOR), AMPATH, Eldoret, Kenya; Institute of Tropical Medicine, Antwerp, Belgium; University of Gondar, Ethiopia; School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; Luke International, Malawi office; The Centre for International Health, University of Bergen, Norway; and the Northern State Medical University, Arkhangelsh, Russia. The program was funded by the United Kingdom's Department for International Development (DFID), The Union, MSF and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RAPP DISP IND ACC SU; Assi TM, 2013, VACCINE, V31, P2828, DOI 10.1016/j.vaccine.2013.04.011; Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Berhanemeskel Eyerusalem, 2016, J Pharm Policy Pract, V9, P11, DOI 10.1186/s40545-016-0060-z; Birgli ag, 2017, EV MED SHORT EUR MOR; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Brennan AT, 2017, TROP MED INT HEALTH, V22, P241, DOI 10.1111/tmi.12811; Clay PG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001677; Daff BM, 2014, GLOB HEALTH-SCI PRAC, V2, P245, DOI 10.9745/GHSP-D-13-00171; Fleck F, 2009, B WORLD HEALTH ORGAN, V87, P6, DOI 10.2471/BLT.09.020109; Githinji S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054066; Hassani AS, 2015, JAIDS-J ACQ IMM DEF, V68, pS257, DOI 10.1097/QAI.0000000000000486; Jamieson D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20917; Jiamsakul A, 2016, TROP MED INT HEALTH, V21, P662, DOI 10.1111/tmi.12690; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Joint United Nations Programme on HIV and AIDS, 2014, UNAIDS 90 90 90 AMB; Kaufmann GR, 2011, AIDS, V25, P441, DOI 10.1097/QAD.0b013e3283430013; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Lepere P, 2017, MED SANTE TROP, V27, P117, DOI 10.1684/mst.2017.0675; Malati C, 2017, CURR OPIN HIV AIDS, V12, P408, DOI 10.1097/COH.0000000000000387; Medecins Sans Frontieres, 2017, ET LIEUX DISP INTR E; MESI, 2015, NAT ART PROGR DAT DR; Ministere de la Sante, 2016, PLAN URG TRAIT ARV; Ministere de la Sante, 2013, GUID NAT TRAIT ARX I; Mori A. T., 2014, J PHARM POLICY PRACT, V7, P1; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Raffi F, 2016, J ANTIMICROB CHEMOTH, P1; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Shieshia M, 2014, J GLOBAL HLTH, V4; Smith J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0178-4; Stop Stock Outs. Medecins sans South African HIV Clinicians Society Rural Doctors Association Section27 Treatment Action Campaign Rural Health Advocacy Project, 2015, 3 MED SANS FRONT S A; UCOP+ FORUM SIDA UNAIDS, 2015, PAR US PREST ACC QUA; United Nations Statistics Division, 2016, DRC COUNTR PROF; USAID/DELIVER Project, 2009, DEL TEAM TOPP BRING; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Village Reach, 2015, EXPL NEW DISTR MOD V; WHO, 2016, GLOB REP EARL WARN I; WHO, 2017, M REP TECHN DEF SHOR; World Health Organization, 2014, ACC ANT TREATM LOW M; World Health Organization, 2016, WHA6925 WHO; Yadav P, 2015, HLTH SYSTEMS REFORM, V1, P98	43	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191294	10.1371/journal.pone.0191294	http://dx.doi.org/10.1371/journal.pone.0191294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351338	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300069
J	Sadatsafavi, M; Xie, H; Etminan, M; Johnson, K; FitzGerald, JM				Sadatsafavi, Mohsen; Xie, Hui; Etminan, Mahyar; Johnson, Kate; FitzGerald, J. Mark		Canadian Resp Res Network	The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology	PLOS ONE			English	Article							RECURRENT EVENTS; COPD; PREVENTION	Background There is minimal evidence on the extent to which the occurrence of a severe acute exacerbation of COPD that results in hospitalization affects the subsequent disease course. Previous studies on this topic did not generate causally-interpretable estimates. Our aim was to use corrected methodology to update previously reported estimates of the associations between previous and future exacerbations in these patients. Methods Using administrative health data in British Columbia, Canada (1997-2012), we constructed a cohort of patients with at least one severe exacerbation, defined as an episode of inpatient care with the main diagnosis of COPD based on international classification of diseases (ICD) codes. We applied a random-effects 'joint frailty' survival model that is particularly developed for the analysis of recurrent events in the presence of competing risk of death and heterogeneity among individuals in their rate of events. Previous severe exacerbations entered the model as dummy-coded time-dependent covariates, and the model was adjusted for several observable patient and disease characteristics. Results 35,994 individuals (mean age at baseline 73.7, 49.8% female, average follow-up 3.21 years) contributed 34,271 severe exacerbations during follow-up. The first event was associated with a hazard ratio (HR) of 1.75 (95% CI 1.69-1.82) for the risk of future severe exacerbations. This risk decreased to HR = 1.36 (95% CI 1.30-1.42) for the second event and to 1.18 (95% CI 1.12-1.25) for the third event. The first two severe exacerbations that occurred during follow-up were also significantly associated with increased risk of all-cause mortality. There was substantial heterogeneity in the individual-specific rate of severe exacerbations. Even after adjusting for observable characteristics, individuals in the 97.5th percentile of exacerbation rate had 5.6 times higher rate of severe exacerbations than those in the 2.5th percentile. Conclusions Using robust statistical methodology that controlled for heterogeneity in exacerbation rates among individuals, we demonstrated potential causal associations among past and future severe exacerbations, albeit the magnitude of association was noticeably lower than previously reported. The prevention of severe exacerbations has the potential to modify the disease trajectory.	[Sadatsafavi, Mohsen; Johnson, Kate] Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada; [Sadatsafavi, Mohsen; Etminan, Mahyar; FitzGerald, J. Mark] Univ British Columbia, Fac Med, Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Xie, Hui] Simon Fraser Univ, Fac Hlth Sci, Biostat Div, Burnaby, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University	Sadatsafavi, M (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada.; Sadatsafavi, M (corresponding author), Univ British Columbia, Fac Med, Inst Heart & Lung Hlth, Vancouver, BC, Canada.; Sadatsafavi, M (corresponding author), Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.	msafavi@mail.ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020	Sadatsafayi, Mohsen/0000-0002-0419-7862; , hui/0000-0003-3328-7135	Operating Grant from Canadian Institutes of Health Research (CIHR [142238]; Canadian Respiratory Research Network (CRRN); CIHR - Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-lngelheim Canada Ltd; AstraZeneca Canada Inc.; Novartis Canada Ltd.; GlaxoSmithKline Inc.; New Investigator Award from CIHR; Michael Smith Foundation for Health Research	Operating Grant from Canadian Institutes of Health Research (CIHR; Canadian Respiratory Research Network (CRRN); CIHR - Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-lngelheim Canada Ltd; AstraZeneca Canada Inc.(AstraZeneca); Novartis Canada Ltd.; GlaxoSmithKline Inc.(GlaxoSmithKline); New Investigator Award from CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by an Operating Grant from the Canadian Institutes of Health Research (CIHR, #142238) and funds from the Canadian Respiratory Research Network (CRRN) (Mohsen Sadatsafavi); CRRN is supported by grants from CIHR - Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; and Industry Partners Boehringer-lngelheim Canada Ltd, AstraZeneca Canada Inc., and Novartis Canada Ltd. Funding for training of graduate students and new investigators within the network was supported by the above funding sponsors and as well by GlaxoSmithKline Inc. Mohsen Sadatsafavi is supported by a New Investigator Award from CIHR and a Scholar Award from Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, or preparation of the manuscript.	Aaron SD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5237; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; BC Vital Statistics Agency, 2014, VIT STAT DEATHS V2; British Columbia Ministry of Health, 2014, MED SERV PLAN MSP PA; British Columbia Ministry of Health, 2014, CONS FIL MSP REG PRE; Canadian Institute for Health Information, 2014, DISCH ABSTR DAT HOSP; Canadian Institute for Health Information, 2009, TOO EARL TOO SMALL P; Canadian Thoracic Society, 2010, HUM EC BURD COPD; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Government of Canada SC, 2011, POP URB RUR PROV TER; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Huang XL, 2007, BIOMETRICS, V63, P389, DOI 10.1111/j.1541-0420.2006.00719.x; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kerkhof M, 2015, INT J CHRONIC OBSTR, V10, P2439, DOI 10.2147/COPD.S94259; Khakban A, 2015, CHEST, V148, P640, DOI 10.1378/chest.15-0721; Liu L, 2004, BIOMETRICS, V60, P747, DOI 10.1111/j.0006-341X.2004.00225.x; Lu L, 2008, ANAL CORRELATED RECU; Rennard Stephen I, 2004, Proc Am Thorac Soc, V1, P88, DOI 10.1513/pats.2306026; Sadatsafavi M, 2014, THORAX; Sadatsafavi M, AM J EPIDEMIOL; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Williams JI, 1996, INVENTORY STUDIES AC	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191243	10.1371/journal.pone.0191243	http://dx.doi.org/10.1371/journal.pone.0191243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351331	gold, Green Submitted, Green Published			2022-12-26	WOS:000422911300062
J	Varanasi, SK; Jaggi, U; Hay, N; Rouse, BT				Varanasi, Siva Karthik; Jaggi, Ujjaldeep; Hay, Nissim; Rouse, Barry T.			Hexokinase II may be dispensable for CD4 T cell responses against a virus infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MITOCHONDRIA; LYMPHOCYTES; MICE; HK2	Activation of CD4 T cells leads to their metabolic reprogramming which includes enhanced glycolysis, catalyzed through hexokinase enzymes. Studies in some systems indicate that the HK2 isoform is the most up regulated isoform in activated T cells and in this report the relevance of this finding is evaluated in an infectious disease model. Genetic ablation of HK2 was achieved in only T cells and the outcome was evaluated by measures of T cell function. Our results show that CD4 T cells from both HK2 depleted and WT animals displayed similar responses to in vitro stimulation and yielded similar levels of Th1, Treg or Th17 subsets when differentiated in vitro. A modest increase in the levels of proliferation was observed in CD4 T cells lacking HK2. Deletion of HK2 led to enhanced levels of HK1 indicative of a compensatory mechanism. Finally, CD4 T cell mediated immuno-inflammatory responses to a virus infection were similar between WT and HK2 KO animals. The observations that the expression of HK2 appears non-essential for CD4 T cell responses against virus infections is of interest since it suggests that targeting HK2 for cancer therapy may not have untoward effects on CD4 T cell mediated immune response against virus infections.	[Varanasi, Siva Karthik; Rouse, Barry T.] Univ Tennessee, Dept Genome Sci & Technol, Knoxville, TN 37996 USA; [Jaggi, Ujjaldeep; Rouse, Barry T.] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rouse, BT (corresponding author), Univ Tennessee, Dept Genome Sci & Technol, Knoxville, TN 37996 USA.; Rouse, BT (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA.	btr@utk.edu			National Institutes of Health Grant [EY 005093]; NATIONAL CANCER INSTITUTE [R01CA206167] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000733] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant EY 005093 (to Barry T Rouse).	Anderson M, 2016, ONCOTARGET; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Bhela S, 2014, J IMMUNOL, V192, P2734, DOI 10.4049/jimmunol.1302326; BONNEAU RH, 1989, J VIROL, V63, P1480, DOI 10.1128/JVI.63.3.1480-1484.1989; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Jones LL, 2016, J IMMUNOL, V196, P2973, DOI 10.4049/jimmunol.1402953; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; Kumaraguru U, 2004, J IMMUNOL, V172, P3719, DOI 10.4049/jimmunol.172.6.3719; MARJANOVIC S, 1990, BIOCHIM BIOPHYS ACTA, V1087, P1, DOI 10.1016/0167-4781(90)90113-G; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Ros S, 2013, CANCER DISCOV, V3, P1105, DOI 10.1158/2159-8290.CD-13-0565; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Varanasi SK, 2017, J VIROL, V91, DOI 10.1128/JVI.02367-16; Varanasi SK, 2017, J IMMUNOL	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191533	10.1371/journal.pone.0191533	http://dx.doi.org/10.1371/journal.pone.0191533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352298	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300109
J	Esteve-Arenys, A; Valero, JG; Chamorro-Jorganes, A; Gonzalez, D; Rodriguez, V; Dlouhy, I; Salaverria, I; Campo, E; Colomer, D; Martinez, A; Rymkiewicz, G; Perez-Galan, P; Lopez-Guillermo, A; Roue, G				Esteve-Arenys, A.; Valero, J. G.; Chamorro-Jorganes, A.; Gonzalez, D.; Rodriguez, V.; Dlouhy, I.; Salaverria, I.; Campo, E.; Colomer, D.; Martinez, A.; Rymkiewicz, G.; Perez-Galan, P.; Lopez-Guillermo, A.; Roue, G.			The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL LYMPHOMAS; ANTITUMOR-ACTIVITY; BCL2 INHIBITION; PHASE-I; MYC; BORTEZOMIB; CHEMOTHERAPY; DISTINCT; MCL-1	High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, mostly known as double-hit lymphoma (DHL), is a rare entity characterized by morphologic and molecular features between Burkitt lymphoma and the clinically manageable diffuse large B-cell lymphoma (DLBCL). DHL patients usually undergo a rapidly progressing clinical course associated with resistance to standard chemo-immunotherapy. As a consequence, the prognosis of this entity is particularly poor with a median overall survival inferior to 1 year. ABT-199 (venetoclax) is a potent and selective small-molecule antagonist of BCL-2 recently approved for the treatment of a specific subtype of lymphoid neoplasm. In this study, we demonstrate that single-agent ABT-199 efficiently displaces BAX from BCL-2 complexes but fails to maintain a significant antitumor activity over time in most MYC+/BCL2+ DHL cell lines and primary cultures, as well as in a xenograft mouse model of the disease. We further identify the accumulation of the BCL2-like protein BFL-1 to be a major mechanism involved in acquired resistance to ABT-199. Noteworthy, this phenomenon can be counteracted by the BET bromodomain inhibitor CPI203, since gene expression profiling identifies BCL2A1, the BFL-1 coding gene, as one of the top apoptosis-related gene modulated by this compound. Upon CPI203 treatment, simultaneous downregulation of MYC and BFL-1 further overcomes resistance to ABT-199 both in vitro and in vivo, engaging synergistic caspase-mediated apoptosis in DHL cultures and tumor xenografts. Together, these findings highlight the relevance of BFL-1 in DH lymphoma-associated drug resistance and support the combined use of a BCL-2 antagonist and a BET inhibitor as a promising therapeutic strategy for patients with aggressive DHL.	[Esteve-Arenys, A.; Valero, J. G.; Chamorro-Jorganes, A.; Gonzalez, D.; Roue, G.] CIBERONC, Aggress B Cell Lymphoma Study Grp, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Esteve-Arenys, A.; Valero, J. G.; Chamorro-Jorganes, A.; Gonzalez, D.; Rodriguez, V.; Salaverria, I.; Campo, E.; Colomer, D.; Perez-Galan, P.; Lopez-Guillermo, A.; Roue, G.] CIBERONC, Div Hematol & Oncol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Dlouhy, I.; Lopez-Guillermo, A.] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Campo, E.; Colomer, D.; Martinez, A.] Hosp Clin Barcelona, Dept Pathol, Hematopathol Unit, Barcelona, Spain; [Rymkiewicz, G.] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol, Warsaw, Poland; [Rymkiewicz, G.] Inst Oncol, Warsaw, Poland; [Roue, G.] Vall dHebron Univ Hosp, Lab Expt Hematol, Dept Hematol, Vall dHebron Inst Oncol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Roue, G (corresponding author), CIBERONC, Aggress B Cell Lymphoma Study Grp, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.; Roue, G (corresponding author), CIBERONC, Div Hematol & Oncol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	groue@clinic.ub.es	Jorganes, Aranzazu Chamorro/N-7774-2019; COLOMER, DOLORS/ABG-6894-2020; Miquel, Josep Maria/AAG-3508-2019; Rymkiewicz, Grzegorz/AAB-7301-2019; Campo, Elias/AAC-5593-2019; Esteve-Arenys, Anna/E-5544-2014; ROUÉ, GAËL/D-4759-2014; Chamorro-Jorganes, Aranzazu/B-1871-2019; Lopez-Guillermo, Armando/Z-5684-2019	Jorganes, Aranzazu Chamorro/0000-0002-3505-7221; Campo, Elias/0000-0001-9850-9793; Esteve-Arenys, Anna/0000-0003-1277-5906; ROUÉ, GAËL/0000-0003-0245-2257; Chamorro-Jorganes, Aranzazu/0000-0002-3505-7221; Valero, Juan Garcia/0000-0003-3193-9099; Rymkiewicz, Grzegorz/0000-0002-3478-8014	Fondo de Investigacion Sanitaria [PI12/01847, PI15/00102, PI12/01536]; European Regional Development Fund (ERDF); Redes Tematicas de Investigacion Cooperativa de Cancer from the Instituto de Salud Carlos III [RD12/0036/0004, RD12/0036/0039]; Generalitat de Catalunya [2014SGR346, 2014SGR795]; Ministerio de Ciencia e Innovacion (FPU); Agency for Management of University and Research (AGAUR) [2014 BP-B00177]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Redes Tematicas de Investigacion Cooperativa de Cancer from the Instituto de Salud Carlos III; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (FPU)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agency for Management of University and Research (AGAUR)	The authors thank Jocabed Roldan, Laura Jimenez, and Sandra Cabezas for expert technical assistance. This work was financially supported by Fondo de Investigacion Sanitaria PI12/01847 and PI15/00102 (to G.R.), PI12/01536 (to A.L.-G.), European Regional Development Fund (ERDF) "Una manera de hacer Europa", Redes Tematicas de Investigacion Cooperativa de Cancer from the Instituto de Salud Carlos III RD12/0036/0004 (to D.C.) and RD12/0036/0039 (to E.C.) and Generalitat de Catalunya 2014SGR346 (to D.C.) and 2014SGR795 (to E.C.). A.E.-A. was recipient of a predoctoral fellowship from Ministerio de Ciencia e Innovacion (FPU). A.C.-J. holds a postdoctoral fellowship from The Agency for Management of University and Research (AGAUR, Beatriu de Pinos 2014 BP-B00177). This work was carried out at the Esther Koplowitz Center, Barcelona, under the CERCA Program (Generalitat de Catalunya).	Anderson MA, 2016, THER ADV HEMATOL, V7, P52, DOI 10.1177/2040620715608091; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Bose P, 2017, LEUKEMIA LYMPHOMA, V58, P2026, DOI 10.1080/10428194.2017.1283032; Brown Jennifer R, 2014, Am Soc Clin Oncol Educ Book, pe317, DOI 10.14694/EdBook_AM.2014.34.e317; Cang SD, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0224-3; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Conery AR, 2016, CANCER RES, V76, P1313, DOI 10.1158/0008-5472.CAN-15-1458; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davids MS, 2017, J CLIN ONCOL, V35, P826, DOI 10.1200/JCO.2016.70.4320; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2016, J LEUKOCYTE BIOL, V100, P679, DOI 10.1189/jlb.2RI0616-250R; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Fan GF, 2010, BLOOD, V115, P3559, DOI 10.1182/blood-2009-08-236760; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fresquet V, 2014, BLOOD, V123, P4111, DOI 10.1182/blood-2014-03-560284; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Grygorowicz MA, 2017, CLIN EXP MED, V17, P193, DOI 10.1007/s10238-016-0411-8; Johnson-Farley N, 2015, LEUKEMIA LYMPHOMA, V56, P2146, DOI 10.3109/10428194.2014.981172; Karube K, 2015, SEMIN HEMATOL, V52, P97, DOI 10.1053/j.seminhematol.2015.01.009; Kawano Y, 2003, BLOOD, V101, P532, DOI 10.1182/blood-2002-04-1268; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Li L, 2015, LEUKEMIA, V29, P1702, DOI 10.1038/leu.2015.99; Li SY, 2013, ADV ANAT PATHOL, V20, P315, DOI 10.1097/PAP.0b013e3182a289f2; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Moros A, 2014, LEUKEMIA, V28, P2049, DOI 10.1038/leu.2014.106; Niu XJ, 2016, CLIN CANCER RES, V22, P4440, DOI 10.1158/1078-0432.CCR-15-3057; Oppermann S, 2016, BLOOD, V128, P934, DOI 10.1182/blood-2015-12-687814; Perez-Galan P, 2008, LEUKEMIA, V22, P1712, DOI 10.1038/leu.2008.175; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Siegel MB, 2015, ONCOTARGET, V6, P18921, DOI 10.18632/oncotarget.4214; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Turakhia SK, 2014, AM J CLIN PATHOL, V142, P339, DOI 10.1309/AJCPBWVHTF7RRSA4; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Xu XX, 2013, INT J CLIN EXP PATHO, V6, P788; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304	46	56	59	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1830	1844		10.1038/s41388-017-0111-1	http://dx.doi.org/10.1038/s41388-017-0111-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29353886				2022-12-26	WOS:000429303300002
J	Saladi, SM; Javed, N; Muller, A; Clemons, WM				Saladi, Shyam M.; Javed, Nauman; Muller, Axel; Clemons, William M., Jr.			A statistical model for improved membrane protein expression using sequence-derived features	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STRUCTURAL GENOMICS; MOLECULAR-BIOLOGY; COUPLED RECEPTOR; DATABASE; PREDICTION; TOPOLOGY; CLONING; STABILITY	The heterologous expression of integral membrane proteins (IMPs) remains a major bottleneck in the characterization of this important protein class. IMP expression levels are currently unpredictable, which renders the pursuit of IMPs for structural and biophysical characterization challenging and inefficient. Experimental evidence demonstrates that changes within the nucleotide or amino acid sequence for a given IMP can dramatically affect expression levels, yet these observations have not resulted in generalizable approaches to improve expression levels. Here, we develop a data-driven statistical predictor named IMProve that, using only sequence information, increases the likelihood of selecting an IMP that expresses in Escherichia coli. The IMProve model, trained on experimental data, combines a set of sequence-derived features resulting in an IMProve score, where higher values have a higher probability of success. The model is rigorously validated against a variety of independent data sets that contain a wide range of experimental outcomes from various IMP expression trials. The results demonstrate that use of the model can more than double the number of successfully expressed targets at any experimental scale. IMProve can immediately be used to identify favorable targets for characterization. Most notably, IMProve demonstrates for the first time that IMP expression levels can be predicted directly from sequence.	[Saladi, Shyam M.; Javed, Nauman; Muller, Axel; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009; Saladi, Shyam/B-7307-2016	Clemons, William M/0000-0002-0021-889X; Saladi, Shyam/0000-0001-9701-3059	National Science Foundation [ACI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM125063, DP1GM105385] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Daniel Daley and Thomas Miller's group for discussion, Yaser Abu-Mostafa and Yisong Yue for guidance regarding machine learning, Niles Pierce for providing NUPACK source code (33), Welison Floriano and Naveed Near-Ansari for maintaining local computing resources, and Samuel Schulte for suggesting the model's name. We thank Michiel Niesen, Stephen Marshall, Thomas Miller, Reid van Lehn, James Bowie, and Tom Rapoport for comments on the manuscript. Models and analyses were possible thanks to raw experimental data provided by Daniel Daley and Mikaela Rapp (20); Nir Fluman (29); Edda Kloppmann, Brian Kloss, and Marco Punta from NYCOMPS (2, 3); Pikyee Ma (46); Renaud Wagner (49); Florent Bernaudat (53); and Constance Jeffrey (47). Computational time was provided by Stephen Mayo and Douglas Rees. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575 (108).	Aho K., 2015, ASBIO COLLECTION STA; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bache S.M., 2020, MAGRITTR FORWARD PIP; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Canty A., 2015, BOOT BOOTSTRAP R S P; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Clarke E., 2015, GGBEESWARM CATEGORIC; Cock P., 2009, DOWNLOADING CDS SEQU; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dobrovetsky Elena, 2005, Journal of Structural and Functional Genomics, V6, P33, DOI 10.1007/s10969-005-1363-5; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Garnier S, 2016, VIRIDIS DEFAULT COLO; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Hendrickson WA, 2016, NAT STRUCT MOL BIOL, V23, P464, DOI 10.1038/nsmb.3215; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Jahandideh S, 2014, ACTA CRYSTALLOGR D, V70, P627, DOI 10.1107/S1399004713032070; Joachims T., 2002, P 8 ACM SIGKDD INT C, P133, DOI [10.1145/775047.775067, DOI 10.1145/775047.775067]; Johansson LC, 2017, TRENDS BIOCHEM SCI, V42, P749, DOI 10.1016/j.tibs.2017.06.007; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lechat P, 2008, NUCLEIC ACIDS RES, V36, pD469, DOI 10.1093/nar/gkm1042; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; Madhavan V, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-83; Marshall SS, 2016, CELL REP, V16, P2169, DOI 10.1016/j.celrep.2016.07.042; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Mirzadeh K, 2015, ACS SYNTH BIOL, V4, P959, DOI 10.1021/acssynbio.5b00033; Nannenga BL, 2016, CURR OPIN STRUC BIOL, V40, P128, DOI 10.1016/j.sbi.2016.09.007; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Neuwirth Erich, 2014, CRAN; Niesen MJM, 2017, J BIOL CHEM, V292, P19537, DOI 10.1074/jbc.M117.813469; Norholm MHH, 2013, FEBS LETT, V587, P2352, DOI 10.1016/j.febslet.2013.05.063; Norholm MHH, 2012, BBA-BIOMEMBRANES, V1818, P1091, DOI 10.1016/j.bbamem.2011.08.018; Peden JF., 2000, THESIS U NOTTINGHAM, V90, P73; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Psakis G, 2007, PROTEIN SCI, V16, P2667, DOI 10.1110/ps.073104707; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; R Core Team, 2021, R LANGUAGE ENV STAT; Reis A. C., 2017, BIORXIV; Revolution Analytics and Weston S., 2015, IT PROV IT CONSTR R; Revolution Analytics and Weston S., 2015, FOR PROV FOR LOOP CO; Revolution Analytics and Weston S., 2015, DOMC FOR PAR AD PAR; Revolution Analytics and Weston S., 2015, DOPARALLEL FOR PAR A; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rstudio T, 2020, RSTUDIO INT DEV R; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Schloerke B., 2016, GGALLY EXTENSION GGP; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuler GD, 1996, METHOD ENZYMOL, V266, P141; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Szakonyi G, 2007, J ANTIMICROB CHEMOTH, V59, P1265, DOI 10.1093/jac/dkm036; Tange O, 2011, USENIX MAG, V36, P42, DOI [10.5281/zenodo.16303, DOI 10.5281/ZENODO.16303]; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Tsochantaridis I, 2005, J MACH LEARN RES, V6, P1453; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; vanRossum G., 1995, PYTHON REFERENCE MAN, pR9525; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wang HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21383; Weihs C, 2005, ST CLASS DAT ANAL, P335; Weinert K., 2014, DATAMART UNIFIED ACC; Wickham H., 2015, DPLYR GRAMMAR DATA M; Wickham H., 2015, SCALES SCALE FUNCTIO; Wickham H., MULTIDPLYR PARTITION; Wickham H., 2015, ROXYGEN2 IN SOURCE D; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilke C. O., 2015, COWPLOT STREAMLINED; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Xie Y., 2014, IMPLEMENTING REPRODU; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	108	8	10	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4913	4927		10.1074/jbc.RA117.001052	http://dx.doi.org/10.1074/jbc.RA117.001052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378850	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000428848300030
J	Gao, L; Ji, Y; Lu, Y; Qiu, M; Shen, YJ; Wang, YQ; Kong, XQ; Shao, YF; Sheng, YH; Sun, W				Gao, Li; Ji, Yue; Lu, Yan; Qiu, Ming; Shen, Yejiao; Wang, Yaqing; Kong, Xiangqing; Shao, Yongfeng; Sheng, Yanhui; Sun, Wei			Low-level overexpression of p53 promotes warfarin-induced calcification of porcine aortic valve interstitial cells by activating Slug gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED VASCULAR CALCIFICATION; MATRIX GLA-PROTEIN; OSTEOBLAST MATURATION; SKELETAL DEVELOPMENT; HEART-VALVES; STEM-CELLS; RUNX2; DIFFERENTIATION; EXPRESSION; DISEASE	The most frequently used oral anti-coagulant warfarin has been implicated in inducing calcification of aortic valve interstitial cells (AVICs), whereas the mechanism is not fully understood. The low-level activation of p53 is found to be involved in osteogenic transdifferentiation and calcification of AVICs. Whether p53 participates in warfarin-induced AVIC calcification remains unknown. In this study, we investigated the role of low-level p53 overexpression in warfarin-induced porcine AVIC (pAVIC) calcification. Immunostaining, quantitative PCR, and Western blotting revealed that p53 was expressed in human and pAVICs and that p53 expression was slightly increased in calcific human aortic valves compared with non-calcific valves. Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling staining indicated that apoptosis slightly increased in calcific aortic valves than in non-calcific valves. Warfarin treatment led to a low-level increase of p53 mRNA and protein in both pAVICs and mouse aortic valves. Low-level overexpression of p53 in pAVICs via an adenovirus vector did not affect pAVIC apoptosis but promoted warfarin-induced calcium deposition and expression of osteogenic markers. shRNA-mediated p53 knockdown attenuated the pAVIC calcium deposition and osteogenic marker expression. Moreover, ChIP and luciferase assays showed that p53 was recruited to the slug promoter and activated slug expression in calcific pAVICs. Of note, overexpression of Slug increased osteogenic marker Runx2 expression, but not pAVIC calcium deposition, and Slug knockdown attenuated pAVIC calcification and p53-mediated pAVIC calcium deposition and expression of osteogenic markers. In conclusion, we found that p53 plays an important role in warfarin induced pAVIC calcification, and increased slug transcription by p53 is required for p53-mediated pAVIC calcification.	[Gao, Li; Ji, Yue; Lu, Yan; Qiu, Ming; Shen, Yejiao; Wang, Yaqing; Kong, Xiangqing; Sheng, Yanhui; Sun, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Shao, Yongfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing 210029, Jiangsu, Peoples R China; [Kong, Xiangqing; Sun, Wei] Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sheng, YH; Sun, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	yhsheng@njmu.edu.cn; weisun7919@njmu.edu.cn		Sun, Wei/0000-0003-0833-0445	National Natural Science Foundation of China [81570247, 81627802, 81401121]; Natural Science Foundation of Jiangsu Province for Youth Grant [BK20141024]; Jiangsu Province Six Talent Peaks Project [2015-WSN-29]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province for Youth Grant(Natural Science Foundation of Jiangsu Province); Jiangsu Province Six Talent Peaks Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81570247, 81627802, and 81401121; Natural Science Foundation of Jiangsu Province for Youth Grant BK20141024; Jiangsu Province Six Talent Peaks Project Grant 2015-WSN-29; and funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Azechi T, 2013, J ATHEROSCLER THROMB, V20, P538, DOI 10.5551/jat.15826; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Hadji F, 2016, CIRCULATION, V134, P1848, DOI 10.1161/CIRCULATIONAHA.116.023116; Holden RM, 2007, J NEPHROL, V20, P417; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Koos R, 2005, AM J CARDIOL, V96, P747, DOI 10.1016/j.amjcard.2005.05.014; Koos R, 2009, THROMB HAEMOSTASIS, V101, P706, DOI 10.1160/TH08-09-0611; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Lambertini E, 2009, CELL MOL LIFE SCI, V66, P3641, DOI 10.1007/s00018-009-0149-5; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Li KL, 2012, CARDIOVASC J AFR, V23, pE1, DOI 10.5830/CVJA-2011-069; Li SJ, 2017, INT J CARDIOL, V232, P271, DOI 10.1016/j.ijcard.2017.01.005; Liu HJ, 2010, J CELL BIOCHEM, V111, P529, DOI 10.1002/jcb.22749; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Prives C, 1999, J PATHOL, V187, P112; Raaz U, 2015, CIRC RES, V117, P513, DOI 10.1161/CIRCRESAHA.115.306341; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Suliman Y, 2001, CANCER RES, V61, P6467; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Taylor PM, 2000, J HEART VALVE DIS, V9, P150; Torreggiani E, 2012, J CELL MOL MED, V16, P740, DOI 10.1111/j.1582-4934.2011.01352.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	40	9	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3780	3792		10.1074/jbc.M117.791145	http://dx.doi.org/10.1074/jbc.M117.791145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358327	Green Published, hybrid			2022-12-26	WOS:000427030200030
J	Paul, CPL; Smit, TH; de Graaf, M; Holewijn, RM; Bisschop, A; van de Ven, PM; Mullender, MG; Helder, MN; Strijkers, GJ				Paul, Cornelis P. L.; Smit, Theodoor H.; de Graaf, Magda; Holewijn, Roderick M.; Bisschop, Arno; van de Ven, Peter M.; Mullender, Margriet G.; Helder, Marco N.; Strijkers, Gustav J.			Quantitative MRI in early intervertebral disc degeneration: T1 rho correlates better than T2 and ADC with biomechanics, histology and matrix content	PLOS ONE			English	Article							LOW-BACK-PAIN; WATER-CONTENT; ARTICULAR-CARTILAGE; DIURNAL-VARIATION; DIFFERENT GRADES; ANULUS FIBROSUS; LUMBAR SPINE; T1-RHO; DIFFUSION; KNEE	Introduction Low-back pain (LBP) has been correlated to the presence of intervertebral disc (IVD) degeneration on T2-weighted (T2w) MRI. It remains challenging, however, to accurately stage degenerative disc disease (DDD) based on T2w MRI and measurements of IVD height, particularly for early DDD. Several quantitative MRI techniques have been introduced to detect changes in matrix composition signifying early DDD. In this study, we correlated quantitative T2, T1 rho and Apparent Diffusion Coefficient (ADC) values to disc mechanical behavior and gold standard early DDD markers in a graded degenerated lumbar IVD caprine model, to assess their potential for early DDD detection. Methods Lumbar caprine IVDs were injected with either 0.25 U/ml or 0.5 U/ml Chondroitinase ABC (Cabc) to trigger early DDD-like degeneration. Injection with phosphate-buffered saline (PBS) served as control. IVDs were cultured in a bioreactor for 20 days under axial physiological loading. High-resolution 9.4 T MR images were obtained prior to intervention and after culture. Quantitative MR results were correlated to recovery behavior, histological degeneration grading, and the content of glycosaminoglycans (GAGs) and water. Results Cabc-injected IVDs showed aberrancies in biomechanics and loss of GAGs without changes in water-content. All MR sequences detected changes in matrix composition, with T1 rho showing largest changes pre-to-post in the nucleus, and significantly more than T2 and ADC. Histologically, degeneration due to Cabc injection was mild. T1 rho nucleus values correlated strongest with altered biomechanics, histological degeneration score, and loss of GAGs. Conclusions T2- and T1 rho quantitative MR-mapping detected early DDD changes. T1 rho nucleus values correlated better than T2 and ADC with biomechanical, histological, and GAG changes. Clinical implementation of quantitative MRI, T1 rho particularly, could aid in distinguishing DDD more reliably at an earlier stage in the degenerative process.	[Paul, Cornelis P. L.; Smit, Theodoor H.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands; [Smit, Theodoor H.] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands; [de Graaf, Magda; Holewijn, Roderick M.; Bisschop, Arno] Vrije Univ Amsterdam, Med Ctr, Dept Orthoped Surg, Amsterdam Movement Sci, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Mullender, Margriet G.] Vrije Univ Amsterdam, Med Ctr, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands; [Helder, Marco N.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands; [Strijkers, Gustav J.] Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Smit, TH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands.; Smit, TH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands.	t.h.smit@amc.uva.nl	Smit, Theo/N-7534-2019; Paul/O-8870-2017; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; Strijkers, Gustav/0000-0001-6700-5058	Dutch Government ZonMw Program "Alternatives for life animal testing" [11400090]; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials: BMM project [P2.01]	Dutch Government ZonMw Program "Alternatives for life animal testing"; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials: BMM project	This work is supported by the Dutch Government ZonMw Program "Alternatives for life animal testing": grant number 11400090. The development of the LDCS is co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials: BMM project number P2.01.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Antoniou J, 1998, MAGN RESON MED, V40, P900, DOI 10.1002/mrm.1910400616; Antoniou J, 2013, J MAGN RESON IMAGING, V38, P1402, DOI 10.1002/jmri.24120; Arpinar VE, 2015, EUR SPINE J, V24, P2458, DOI 10.1007/s00586-015-4172-y; Benneker LM, 2005, EUR SPINE J, V14, P27, DOI 10.1007/s00586-004-0759-4; BERNICK S, 1991, SPINE, V16, P520, DOI 10.1097/00007632-199105000-00006; Berry GC, USE STRETCHED EXPONE; Blumenkrantz G, 2006, MAGN RESON IMAGING, V24, P1001, DOI 10.1016/j.mri.2006.04.013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BOOS N, 1994, MAGN RESON IMAGING, V12, P577, DOI 10.1016/0730-725X(94)92452-X; Borthakur A, 2011, SPINE, V36, P2190, DOI 10.1097/BRS.0b013e31820287bf; BOTSFORD DJ, 1994, SPINE, V19, P935, DOI 10.1097/00007632-199404150-00012; Carballido-Gamio J, 2010, MAGN RESON MED, V63, P465, DOI 10.1002/mrm.22201; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262; COVENTRY MB, 1969, CLIN ORTHOP RELAT R, P9; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Detiger SEL, 2013, J ORTHOP RES, V31, P703, DOI 10.1002/jor.22296; Emanuel KS, 2015, EUR CELLS MATER, V29, P330, DOI 10.22203/eCM.v029a25; Emch TM, 2011, SKELETAL RADIOL, V40, P1175, DOI 10.1007/s00256-011-1163-x; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; ERKINTALO MO, 1995, RADIOLOGY, V196, P529, DOI 10.1148/radiology.196.2.7617872; Essen GJv, 2004, P 14 EUR SOC BIOM ES, P224; EURELL JAC, 1990, CLIN ORTHOP RELAT R, P238; Eyre D R, 1979, Int Rev Connect Tissue Res, V8, P227; Farshad-Amacker NA, 2015, EUR J RADIOL, V84, P1768, DOI 10.1016/j.ejrad.2015.04.002; Fenty M, 2013, GLOB SPINE J, V3, P127, DOI 10.1055/s-0033-1347930; GLOVER MG, 1991, J ORTHOP RES, V9, P61, DOI 10.1002/jor.1100090109; Haughton V, 2006, J BONE JOINT SURG AM, V88A, P15, DOI 10.2106/JBJS.F.00010; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; Hutton WC, 2003, AVIAT SPACE ENVIR MD, V74, P73; Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; JENSEN MC, 1994, MAGN RESON QUART, V10, P173; Jensen TS, 2006, SPINE, V31, P1605, DOI 10.1097/01.brs.0000221992.77779.37; Johannessen W, 2006, SPINE, V31, P1253, DOI 10.1097/01.brs.0000217708.54880.51; Johnson WEB, 2003, J ANAT, V203, P605, DOI 10.1046/j.1469-7580.2003.00249.x; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kealey SM, 2005, RADIOLOGY, V235, P569, DOI 10.1148/radiol.2352040437; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; KRAEMER J, 1985, SPINE, V10, P69, DOI 10.1097/00007632-198501000-00011; Krijnen MR, 2006, ACTA ORTHOP, V77, P454, DOI 10.1080/17453670610046398; Kumar Y, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1608-z; Le JN, 2016, ANN NY ACAD SCI, V1383, P34, DOI 10.1111/nyas.13189; Ludescher B, 2008, J MAGN RESON IMAGING, V28, P252, DOI 10.1002/jmri.21390; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MacLean JJ, 2007, J BIOMECH, V40, P55, DOI 10.1016/j.jbiomech.2005.11.013; Malko JA, 1996, J SPINAL DISORD, V9, P129; Manac'h YG, 2013, MAGN RESON IMAGING, V31, P36, DOI 10.1016/j.mri.2012.06.008; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; Matsumura Y, 2009, J ORTHOP SCI, V14, P45, DOI 10.1007/s00776-008-1288-5; Menezes-Reis R, 2015, AM J NEURORADIOL, V36, P606, DOI 10.3174/ajnr.A4125; Menezes-Reis R, 2016, QUANT IMAGING MED SU, V6, P402, DOI 10.21037/qims.2016.08.01; Mulligan KR, 2014, EUR SPINE J; Mulligan KR, 2015, EUR SPINE J, V24, P2395, DOI 10.1007/s00586-014-3582-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwale F, 2008, J MAGN RESON IMAGING, V27, P563, DOI 10.1002/jmri.21242; Nguyen AM, 2008, J BONE JOINT SURG AM, V90A, P796, DOI 10.2106/JBJS.G.00667; PAAJANEN H, 1989, SKELETAL RADIOL, V18, P523, DOI 10.1007/BF00351753; Paul CPL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174278; Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; PECH P, 1985, RADIOLOGY, V156, P699, DOI 10.1148/radiology.156.3.4023228; Roberts N, 1998, CLIN ANAT, V11, P1; Rong Rong, 2008, Chinese Medical Sciences Journal, V23, P158; Rutges JPHJ, 2013, OSTEOARTHR CARTILAGE, V21, P2039, DOI 10.1016/j.joca.2013.10.001; Salminen JJ, 1999, SPINE, V24, P1316, DOI 10.1097/00007632-199907010-00008; Samartzis D, 2015, SPINE J, V15, P1919, DOI 10.1016/j.spinee.2014.09.010; Sarver JJ, 2005, J ORTHOP RES, V23, P150, DOI 10.1016/j.orthres.2004.04.010; SILCOX DH, 1995, SPINE, V20, P807, DOI 10.1097/00007632-199504000-00013; Takashima H, 2012, SKELETAL RADIOL, V41, P163, DOI 10.1007/s00256-011-1144-0; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; Tanaka N, 2001, Spine J, V1, P47, DOI 10.1016/S1529-9430(01)00006-7; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Tibiletti M, 2014, EUR SPINE J, V23, pS375, DOI 10.1007/s00586-014-3177-2; Urban JPG, 2007, J MAGN RESON IMAGING, V25, P419, DOI 10.1002/jmri.20874; van der Veen AJ, 2013, J BIOMECH, V46, P2101, DOI 10.1016/j.jbiomech.2013.05.026; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Vergroesen PA, 2017, J BIOMECH; Vergroesen PPA, 2016, J BIOMECH, V49, P857, DOI 10.1016/j.jbiomech.2015.11.041; Wang CY, 2010, MAGN RESON MED, V64, P1721, DOI 10.1002/mrm.22560; Wang LG, 2015, J MAGN RESON IMAGING, V41, P586, DOI 10.1002/jmri.24677; Wang LG, 2013, EUR J RADIOL, V82, P1946, DOI 10.1016/j.ejrad.2013.05.010; Wang YXJ, 2015, QUANT IMAG MED SURG, V5, P858, DOI 10.3978/j.issn.2223-4292.2015.12.06; Waris E, 2007, SPINE, V32, P681, DOI 10.1097/01.brs.0000257523.38337.96; WEIDENBAUM M, 1992, J ORTHOP RES, V10, P552, DOI 10.1002/jor.1100100410; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Yoon MA, 2016, MAGN RESON IMAGING, V34, P932, DOI 10.1016/j.mri.2016.04.024; Zhang XJ, 2015, MED SCI MONITOR, V21, P1934, DOI 10.12659/MSM.894406; Zobel BB, 2012, SPINE, V37, P1224, DOI 10.1097/BRS.0b013e31824b2450; Zuo J, 2012, SPINE, V37, P214, DOI 10.1097/BRS.0b013e3182294a63	92	41	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191442	10.1371/journal.pone.0191442	http://dx.doi.org/10.1371/journal.pone.0191442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381716	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800019
J	Safreed-Harmon, K; Hetherington, KL; Aleman, S; Alho, H; Dalgard, O; Frisch, T; Gottfredsson, M; Weis, N; Lazarus, JV				Safreed-Harmon, Kelly; Hetherington, Kristina L.; Aleman, Soo; Alho, Hannu; Dalgard, Olav; Frisch, Tove; Gottfredsson, Magnus; Weis, Nina; Lazarus, Jeffrey V.		Hep-Nordic Study Grp	Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study	PLOS ONE			English	Article							FUTURE DISEASE BURDEN; VIRUS-INFECTION; PREVALENCE	Background and aims In the Nordic countries (Denmark, Finland, Iceland, Norway, Sweden), the prevalence of chronic hepatitis C virus (HCV) infection is relatively low in the general population, but is much higher among people who inject drugs (PWID). We conducted an exploratory study to investigate the extent to which these countries have policies supporting key elements of the public health response that is necessary to achieve the global goal of eliminating HCV as a public health threat. Methods Fourteen stakeholders representing government agencies, medical societies, and civil society organisations (CSOs) in the Nordic countries completed a cross-sectional online survey that included 21 policy questions related to national coordination, prevention, testing, linkage to care, and treatment. We summarised the findings in a descriptive analysis, and noted discrepant responses from stakeholders within the same country. Results Stakeholders reported that three of the five study countries have national viral hepatitis strategies, while only Iceland has a national HCV elimination goal. The availability of harm reduction services varies, with opioid substitution therapy provided for the general population throughout all countries, but not needle and syringe programmes. No country has access to anonymous HCV testing in all parts of the country. National HCV treatment guidelines are available in all countries except Finland, and all countries provide publicly funded direct-acting antiviral treatment. Disagreement regarding policies was observed across countries, and CSOs were the stakeholder group that most frequently answered survey questions incorrectly. Conclusion The Nordic region as a whole has not consistently expressed its commitment to tackling HCV, despite the existence of large HCV epidemics among PWID in these countries. Stakeholder alignment and an established elimination goal with an accompanying strategy and implementation plan should be recognised as the basis for coordinated national public health efforts to achieve HCV elimination in the Nordic region and elsewhere.	[Safreed-Harmon, Kelly; Lazarus, Jeffrey V.] Univ Copenhagen, Rigshosp, CHIP, Copenhagen, Denmark; [Safreed-Harmon, Kelly; Hetherington, Kristina L.; Lazarus, Jeffrey V.] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Aleman, Soo] Karolinska Univ Hosp, Karolinska Inst, Dept Infect Dis, Stockholm, Sweden; [Alho, Hannu] Helsinki Univ Hosp, Abdominal Ctr, Helsinki, Finland; [Dalgard, Olav] Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway; [Frisch, Tove] Riksforeningen Hepatit C, Mankarbo, Sweden; [Gottfredsson, Magnus] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland; [Gottfredsson, Magnus] Landspitali Univ Hosp, Dept Internal Med, Div Infect Dis, Reykjavik, Iceland; [Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oslo; University of Iceland; Landspitali National University Hospital; University of Copenhagen; University of Copenhagen	Lazarus, JV (corresponding author), Univ Copenhagen, Rigshosp, CHIP, Copenhagen, Denmark.; Lazarus, JV (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.	Jeffrey.Lazarus@regionh.dk	Weis, Nina/GLT-4232-2022; Lazarus, Jeffrey V./R-6248-2018; Gottfredsson, Magnus/AAD-9086-2020; Safreed-Harmon, Kelly/AAH-7903-2020; Alho, Hannu/AAX-6001-2020; Safreed-Harmon, Kelly/U-2288-2018	Lazarus, Jeffrey V./0000-0001-9618-2299; Safreed-Harmon, Kelly/0000-0003-4312-7389; Safreed-Harmon, Kelly/0000-0003-4312-7389; Hetherington, Kristina Louise/0000-0002-5289-7978; Gottfredsson, Magnus/0000-0003-2465-0422; Weis, Nina/0000-0002-3133-2724	Gilead Sciences [212010336]	Gilead Sciences(Gilead Sciences)	Funding was provided by Gilead Sciences (212010336) to Jeffrey Victor Lazarus, Kelly Safreed-Harmon, and Kristina L. Hetherington. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, HEPATITIS C PREVALEN; [Anonymous], 2017, GLOBAL HEPATITIS REP; [Anonymous], 2014, 2014 NAT REP 2013 DA; [Anonymous], 2014, GLOBAL COMMUNITY HEP; [Anonymous], 2016, ACTION PLAN HLTH SEC; [Anonymous], 2013, GLOBAL POLICY REPORT; [Anonymous], 2016, HUMAN DEV REPORT 201; [Anonymous], 2016, GLOB HLTH SECT STRAT; [Anonymous], 2016, GLOBAL STATE HARM RE; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Dillon John F, 2016, Hepatol Med Policy, V1, P2, DOI 10.1186/s41124-016-0011-y; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Duberg AS, 2015, SCAND J GASTROENTERO, V50, P233, DOI 10.3109/00365521.2014.990505; EASL Recommendations Treatment, 2017, J HEPATOL, V66, P1103, DOI 10.1016/j.jhep.2017.01.021; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; European Liver Patients' Association, 2017, 2016 HEP CORE REP MO; Grebely J, 2015, INT J DRUG POLICY, V26, P1028, DOI 10.1016/j.drugpo.2015.07.005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hickman M, 2016, HEPATITIS C DRUG USE; Hope VD, 2014, EPIDEMIOL INFECT, V142, P270, DOI 10.1017/S0950268813000940; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lazarus Jeffrey V, 2016, Hepatol Med Policy, V1, P3, DOI 10.1186/s41124-016-0009-5; Maticic M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S6-S14; Razavi H, 2017, LANCET GASTROENTEROL, V2, P325, DOI 10.1016/S2468-1253(17)30045-6; Schatz Eberhard, 2016, Hepatol Med Policy, V1, P14, DOI 10.1186/s41124-016-0021-9; Sibley A, 2015, J VIRAL HEPATITIS, V22, P21, DOI 10.1111/jvh.12476; Sillanpaa M, 2014, HEPATIITTI C VIRUSIN, P29; Sustainable Development Knowledge Platform, 2015, SUST DEV GOALS; World Health Organization, 2014, HLTH INT PRIS UPD LI	29	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190146	10.1371/journal.pone.0190146	http://dx.doi.org/10.1371/journal.pone.0190146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381697	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800005
J	Allard, D; Charlebois, R; Gilbert, L; Stagg, J; Chrobak, P				Allard, David; Charlebois, Roxanne; Gilbert, Loise; Stagg, John; Chrobak, Pavel			CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PROTECTIVE IMMUNITY; HUMORAL IMMUNITY; GERMINAL CENTER; CUTTING EDGE; B1B CELLS; CANCER; LYMPHOCYTES; EXPRESSION; MECHANISM	Many individuals at risk of streptococcal infection respond poorly to the pneumococcal polysaccharide vaccine Pneumovax 23. Identification of actionable pathways able to enhance Pneumovax responsiveness is highly relevant. We investigated the contribution of the extra cellular adenosine pathway regulated by the ecto-nucleotidase CD73 in Pneumovaxinduced antibody responses. Using gene-targeted mice, we demonstrated that CD73-or A2a adenosine receptor deficiency significantly delayed isotype switching. Nevertheless, CD73-or A2aR-deficient adult mice ultimately produced antigen-specific IgG3 and controlled Streptococcus pneumoniae infection as efficiently as wild type (WT) mice. Compared to adults, young WT mice failed to control S. pneumoniae infection after vaccination and this was associated with lower levels of CD73 on innate B cells. We hypothesized that pharmacological activation of A2a receptor may improve Pneumovax 23 immunization in young WT mice. Remarkably, administration of the A2a adenosine receptor agonist CGS 21680 significantly increased IgG3 responses and significantly enhanced survival after S. pneumoniae challenge. Our study thus suggests that pharmacological activation of the A2a adenosine receptor could improve the efficacy of Pneumovax 23 vaccination in individuals at risk of streptococcal infection.	[Stagg, John; Chrobak, Pavel] Univ Montreal, CRCHUM, Fac Pharm, Montreal, PQ, Canada; Inst Canc Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Stagg, J; Chrobak, P (corresponding author), Univ Montreal, CRCHUM, Fac Pharm, Montreal, PQ, Canada.	john.stagg@umontreal.ca; pavel.chrobak@hotmail.com		Allard, David/0000-0001-8820-8161	Famille Jean-Guy Sabourin Research Chair in Pharmacology of University of Montreal	Famille Jean-Guy Sabourin Research Chair in Pharmacology of University of Montreal	This work was supported by the Famille Jean-Guy Sabourin Research Chair in Pharmacology of University of Montreal [no grant #].	Abbott RK, 2017, J BIOL CHEM, V292, P1211, DOI 10.1074/jbc.C116.764043; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Allard B, 2016, CURR OPIN PHARMACOL, V29, P7, DOI 10.1016/j.coph.2016.04.001; Almishri W, 2015, J HEPATOL, V63, P943, DOI 10.1016/j.jhep.2015.06.007; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Ash SY, 2013, MED CLIN N AM, V97, P647, DOI 10.1016/j.mcna.2013.03.005; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Daniels Calvin C, 2016, J Pediatr Pharmacol Ther, V21, P27, DOI 10.5863/1551-6776-21.1.27; Ghanem ENB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005126; Haas KM, 2014, J INFECT DIS, V209, P87, DOI 10.1093/infdis/jit442; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hamidzadeh K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00074; Kaku H, 2014, J IMMUNOL, V193, P5904, DOI 10.4049/jimmunol.1400336; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mckay JT, 2015, J IMMUNOL, V194, P2289, DOI 10.4049/jimmunol.1401673; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Pettengill MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00121; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Roth A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152215; Rothstein Thomas L, 2016, Front Immunol, V7, P127, DOI 10.3389/fimmu.2016.00127; Rothstein TL, 2015, ANN NY ACAD SCI, V1362, P143, DOI 10.1111/nyas.12790; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Roy B, 2009, MOL IMMUNOL, V46, P1613, DOI 10.1016/j.molimm.2009.02.026; Salmi M, 2011, FEBS LETT, V585, P1543, DOI 10.1016/j.febslet.2011.04.033; Savage HP, 2015, ANN NY ACAD SCI, V1362, P132, DOI 10.1111/nyas.12799; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Schmiel SE, 2017, J IMMUNOL, V198, P623, DOI 10.4049/jimmunol.1601686; Serra S, 2011, BLOOD, V118, P6141, DOI 10.1182/blood-2011-08-374728; Shriner AK, 2010, J IMMUNOL, V185, P525, DOI 10.4049/jimmunol.0902841; Taillardet M, 2010, J INFECT DIS, V202, P470, DOI 10.1086/653739; Vijayan D, 2017, NAT REV CANCER, V17, P709, DOI 10.1038/nrc.2017.86	34	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191973	10.1371/journal.pone.0191973	http://dx.doi.org/10.1371/journal.pone.0191973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377929	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700047
J	Condic-Jurkic, K; Subramanian, N; Mark, AE; O'Mara, ML				Condic-Jurkic, Karmen; Subramanian, Nandhitha; Mark, Alan E.; O'Mara, Megan L.			The reliability of molecular dynamics simulations of the multidrug transporter P-glycoprotein in a membrane environment	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAINS; PROTEIN STRUCTURE QUALITY; ABC TRANSPORTER; ALTERNATING ACCESS; ATP-BINDING; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DRUG-BINDING; FORCE-FIELD; RESISTANCE	Despite decades of research, the mechanism of action of the ABC multidrug transporter P-glycoprotein (P-gp) remains elusive. Due to experimental limitations, many researchers have turned to molecular dynamics simulation studies in order to investigate different aspects of P-gp function. However, such studies are challenging and caution is required when interpreting the results. P-gp is highly flexible and the time scale on which it can be simulated is limited. There is also uncertainty regarding the accuracy of the various crystal structures available, let alone the structure of the protein in a physiologically relevant environment. In this study, three alternative structural models of mouse P-gp (3G5U, 4KSB, 4M1M), all resolved to 3.8 A, were used to initiate sets of simulations of P-gp in a membrane environment in order to determine: a) the sensitivity of the results to differences in the starting configuration; and b) the extent to which converged results could be expected on the times scales commonly simulated for this system. The simulations suggest that the arrangement of the nucleotide binding domains ( NBDs) observed in the crystal structures is not stable in a membrane environment. In all simulations, the NBDs rapidly associated ( within 10 ns) and changes within the transmembrane helices were observed. The secondary structure within the transmembrane domain was best preserved in the 4M1M model under the simulation conditions used. However, the extent to which replicate simulations diverged on a 100 to 200 ns timescale meant that it was not possible to draw definitive conclusions as to which structure overall was most stable, or to obtain converged and reliable results for any of the properties examined. The work brings into question the reliability of conclusions made in regard to the nature of specific interactions inferred from previous simulation studies on this system involving similar sampling times. It also highlights the need to demonstrate the statistical significance of any results obtained in simulations of large flexible proteins, especially where the initial structure is uncertain.	[Condic-Jurkic, Karmen; Subramanian, Nandhitha; O'Mara, Megan L.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Condic-Jurkic, Karmen; Subramanian, Nandhitha; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, ACT 4072, Australia	Australian National University; University of Queensland	O'Mara, ML (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.	megan.o'mara@anu.edu.au	O'Mara, Megan/ABF-8913-2020; O'Mara, Megan/AAY-5934-2021; O'Mara, Megan L/A-4962-2011; Mark, Alan E/A-8799-2011	O'Mara, Megan/0000-0002-8764-1585; O'Mara, Megan L/0000-0002-8764-1585; Mark, Alan E/0000-0001-5880-4798; Condic-Jurkic, Karmen/0000-0003-2714-8200; Subramanian, Nandhitha/0000-0003-2491-0474	Australian Research Council [DE120101550, DP130102153]; National Health and Medical Research Council [APP1049685]; Australian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	This work was supported by grants from the Australian Research Council (DE120101550 to MLO, DP130102153 to AEM and MLO), the National Health and Medical Research Council (APP1049685 to MLO and AEM), and with the assistance of resources and services from the National Computational Infrastructure (NCI), which is supported by the Australian Government.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; [Anonymous], 2015, MATLAB VERS 8 6 R201; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Chang SY, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4832740; Chufan EE, 2015, ADV CANCER RES, V125, P71, DOI 10.1016/bs.acr.2014.10.003; Columbus L, 2009, BIOPHYS J, V96, p195A, DOI 10.1016/j.bpj.2008.12.1044; Condic-Jurkic K., 2017, MD SIMULATIONS P GLY; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Domicevica L, 2016, BIOPHYS J, V110, p141A, DOI 10.1016/j.bpj.2015.11.800; Domicevica L, 2015, BIOCHEM SOC T, V43, P952, DOI 10.1042/BST20150125; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Ferreira RJ, 2015, J CHEM THEORY COMPUT, V11, P4525, DOI 10.1021/acs.jctc.5b00652; Ferreira RJ, 2013, MOL INFORM, V32, P529, DOI 10.1002/minf.201200175; Ferreira RJ, 2012, J CHEM THEORY COMPUT, V8, P1853, DOI 10.1021/ct300083m; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Huang DB, 1996, P NATL ACAD SCI USA, V93, P7017, DOI 10.1073/pnas.93.14.7017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Jara GE, 2013, J MOL GRAPH MODEL, V46, P10, DOI 10.1016/j.jmgm.2013.09.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; Ledwitch KV, 2016, BIOCHEM PHARMACOL, V118, P96, DOI 10.1016/j.bcp.2016.08.013; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Ma J, 2013, PROTEINS, V81, P1653, DOI 10.1002/prot.24324; Mackay JP, 2017, TRENDS BIOCHEM SCI, V42, P155, DOI 10.1016/j.tibs.2016.11.002; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; McCormick JW, 2015, BIOCHEMISTRY-US, V54, P4374, DOI 10.1021/acs.biochem.5b00018; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; O'Mara ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091916; O'Mara ML, 2012, J CHEM THEORY COMPUT, V8, P3964, DOI 10.1021/ct300254y; Pan AC, 2016, J CHEM THEORY COMPUT, V12, P1360, DOI 10.1021/acs.jctc.5b00913; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Poger D, 2010, J COMPUT CHEM, V31, P1117, DOI 10.1002/jcc.21396; Prajapati R, 2014, BBA-BIOMEMBRANES, V1838, P2882, DOI 10.1016/j.bbamem.2014.07.018; Prajapati R, 2013, J COMPUT AID MOL DES, V27, P347, DOI 10.1007/s10822-013-9650-x; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Sato T, 2009, FEBS J, V276, P3504, DOI 10.1111/j.1742-4658.2009.07072.x; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Subramanian N, 2015, J CHEM INF MODEL, V55, P1202, DOI 10.1021/ci5007382; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; van Gunsteren WF, 2008, CURR OPIN STRUC BIOL, V18, P149, DOI 10.1016/j.sbi.2007.12.007; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Zarrabi N, 2014, METHODS, V66, P168, DOI 10.1016/j.ymeth.2013.07.026; Zhang JQ, 2015, SOFT MATTER, V11, P6633, DOI 10.1039/c5sm01028d; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	80	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191882	10.1371/journal.pone.0191882	http://dx.doi.org/10.1371/journal.pone.0191882			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370310	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600111
J	Kave, G; Fridkin, S; Ayalon, L				Kave, Gitit; Fridkin, Shimon; Ayalon, Liat			Demographic factors and retrieval of object and proper names after age 70	PLOS ONE			English	Article							SELF-RATED HEALTH; OLDER-ADULTS; COGNITIVE RESERVE; METABOLIC DISEASE; WORD RETRIEVAL; MORTALITY; IMPAIRMENT; PREDICTORS; EDUCATION; FAILURES	Purpose This research aimed to investigate whether demographic factors are similarly related to retrieval of object and proper names. Methods The sample included 5,907 individuals above age 70 who participated in the Health and Retirement Study between 2004 and 2012. Participants were asked to name two objects as well as the US President and Vice President. Latent growth curve models examined the associations of age, education, and self-rated health with baseline levels and change trajectories in retrieval. Results Age and education were more strongly related to retrieval of proper names than to retrieval of object names, both for baseline scores and for change trajectory. Similar effects of self-rated health emerged for both types of stimuli. Conclusions The results show that examining object names and proper names together as indication of cognitive status in the HRS might overlook important differences between the two types of stimuli, in both baseline performance and longitudinal change.	[Kave, Gitit] Open Univ, Dept Educ & Psychol, Raanana, Israel; [Fridkin, Shimon; Ayalon, Liat] Bar Ilan Univ, Sch Social Work, Ramat Gan, Israel	Open University Israel; Bar Ilan University	Kave, G (corresponding author), Open Univ, Dept Educ & Psychol, Raanana, Israel.	gkave@012.net.il		Kave, Gitit/0000-0002-4950-5507				Albert ML, 2009, J AM GERIATR SOC, V57, P2300, DOI 10.1111/j.1532-5415.2009.02559.x; Alley D, 2007, RES AGING, V29, P73, DOI 10.1177/0164027506294245; Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Ayalon L, 2009, ARCH INTERN MED, V169, P2156, DOI 10.1001/archinternmed.2009.386; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2004, PSYCHOL SCI, V15, P164, DOI 10.1111/j.0956-7976.2004.01503004.x; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Cadar D, 2012, J AGING RES; Cahana-Amitay D, 2015, J INT NEUROPSYCH SOC, V21, P116, DOI 10.1017/S1355617715000028; Condret-Santi V, 2013, DEMENT GERIATR COGN, V35, P313, DOI 10.1159/000342594; Connor LT, 2004, J GERONTOL B-PSYCHOL, V59, pP203, DOI 10.1093/geronb/59.5.P203; Hanley JR, 2011, PSYCHON B REV, V18, P612, DOI 10.3758/s13423-011-0082-0; Heeringa StevenG., 2009, AGING DEMOGRAPHICS M; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Joubert S, 2010, NEUROPSYCHOLOGIA, V48, P978, DOI 10.1016/j.neuropsychologia.2009.11.019; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Kave G, 2010, PSYCHOL AGING, V25, P719, DOI 10.1037/a0018927; Kay J, 2001, CORTEX, V37, P501, DOI 10.1016/S0010-9452(08)70590-2; Kohler M, 2012, J AM GERIATR SOC, V60, P1286, DOI 10.1111/j.1532-5415.2012.04032.x; Lenehan ME, 2015, PSYCHOGERIATRICS, V15, P154, DOI 10.1111/psyg.12083; Lindenberger U, 2002, J GERONTOL B-PSYCHOL, V57, pP474, DOI 10.1093/geronb/57.6.P474; MacKay D.G., 1990, AGING COGNITION KNOW, V71, P213, DOI [10.1016/S0166-4115(08)60159-4, DOI 10.1016/S0166-4115(08)60159-4]; Maylor EA, 1997, AGING NEUROPSYCHOL C, V4, P211, DOI 10.1080/13825589708256648; McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525; Preacher KJ, CALCULATION CHI SQUA; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Verhaeghen P, 2003, HEALTH PSYCHOL, V22, P559, DOI 10.1037/0278-6133.22.6.559; Zec RF, 2005, J INT NEUROPSYCH SOC, V11, P716, DOI 10.1017/S1355617705050897	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191876	10.1371/journal.pone.0191876	http://dx.doi.org/10.1371/journal.pone.0191876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370264	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600110
J	Thomson, KA; Telfer, B; Awiti, PO; Munge, J; Ngunga, M; Reid, A				Thomson, Kerry A.; Telfer, Barbara; Awiti, Patricia Opondo; Munge, Jane; Ngunga, Mathew; Reid, Anthony			Navigating the risks of prevention of mother to child transmission (PMTCT) of HIV services in Kibera, Kenya: Barriers to engaging and remaining in care	PLOS ONE			English	Article							BREAST-FEEDING WOMEN; ANTIRETROVIRAL THERAPY; DATA-COLLECTION; OPTION B+; ADHERENCE; PROGRAMS; BENEFITS	Within the first year of implementation, 43% of women who tested HIV positive at their first antenatal care visit were no longer retained and being followed in the free prevention of mother to child transmission (PMTCT) of HIV program offered by the Kenyan Ministry of Health and Me A decins Sans Frontieres in the informal settlement of Kibera, Nairobi. This study aimed to explore barriers to enrolling and remaining engaged in PMTCT services throughout the pregnancy and postpartum periods. Qualitative data from 31 focus group discussions and 35 in-depth interviews across six stakeholder groups that included women, men, and PMTCT service providers were analyzed. Using an inductive exploratory approach, four researchers coded the data and identified key themes. Five themes emerged from the data that may influence attrition from PMTCT service in this setting: 1) HIV in the context of Kibera, 2) knowledge of HIV status, 3) knowledge of PMTCT, 4) disclosure of HIV status, and 5) male partner support for PMTCT services. A new HIV diagnosis during pregnancy immediately triggered an ongoing risk assessment of perceived hazards in the home, community, and clinic environments that could occur as a result of female participation in PMTCT services. Male partners were a major influence in this risk assessment, but were generally unaware of PMTCT services. To preserve relationships with male partners, meet community expectations of womanhood, and maintain confidentiality while following recommendations of healthcare providers, women had to continuously weigh the risks and benefits of PMTCT services and interventions. Community-based HIV testing and PMTCT education, male involvement in antenatal care, and counseling customized to assist each woman in her own unique risk assessment, may improve uptake of and retention in care and optimize the HIV prevention benefit of PMTCT interventions.	[Thomson, Kerry A.; Telfer, Barbara; Munge, Jane] Operat Ctr Brussels, MSF, Nairobi, Kenya; [Awiti, Patricia Opondo] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ngunga, Mathew] Survey Res Team, Nairobi, Kenya; [Reid, Anthony] Operat Ctr Brussels, MSF, Luxembourg, Luxembourg	Doctors Without Borders; Karolinska Institutet; Doctors Without Borders	Thomson, KA (corresponding author), Operat Ctr Brussels, MSF, Nairobi, Kenya.	thomson.kerry@gmail.com			Medecins Sans Frontieres Program Funds	Medecins Sans Frontieres Program Funds	This study was fully funded through Medecins Sans Frontieres Program Funds; no specific grants were obtained or funded the current study.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; Burt RS, 2005, BROKERAGE CLOSURE IN; Cleary M, 2014, J ADV NURS, V70, P473, DOI 10.1111/jan.12163; Colombini M, 2014, AIDS CARE, V26, P914, DOI 10.1080/09540121.2013.869539; Erulkar AS M J, 2007, ADOLESCENTS KIBERA S; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Gopalappa C, 2014, AIDS, V28, pS5, DOI 10.1097/QAD.0000000000000083; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Gulaid LA, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17390; Kalembo Fatch W, 2012, ISRN AIDS, V2012, P589817, DOI 10.5402/2012/589817; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kenya National Bureau of Statistics, 2009, KEN POP HOUS CENS; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Krakowiak D, 2016, JAIDS-J ACQ IMM DEF, V72, pS167, DOI 10.1097/QAI.0000000000001053; Lindegren ML, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010119; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Ministry of Health Government of Kenya, 2012, GUIDELINES PREVENTIO, V4th ed; Murithi LK, 2015, AIDS BEHAV, V19, P645, DOI 10.1007/s10461-014-0939-0; Operational Centre Brussels, 2007, INT PROJ DAT; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Reid Tony, 2008, Confl Health, V2, P15, DOI 10.1186/1752-1505-2-15; Strauss A., 1998, BASICS QUALITATIVE R; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; UNAIDS, 2016, AIDS BY THE NUMB; UNAIDS, 2016, FAST TRACK INCR JOUR; UNAIDS, 2021, PREV HIV INF TIM NEW; van Loggerenberg F, 2015, AIDS PATIENT CARE ST, V29, P299, DOI 10.1089/apc.2014.0293; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2006, WHO WHO HIV INF FEED; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434	34	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191463	10.1371/journal.pone.0191463	http://dx.doi.org/10.1371/journal.pone.0191463			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364979	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500048
J	Buxton, AS; Groombridge, JJ; Griffiths, RA				Buxton, Andrew S.; Groombridge, Jim J.; Griffiths, Richard A.			Seasonal variation in environmental DNA detection in sediment and water samples	PLOS ONE			English	Article							GREAT CRESTED NEWT; EXTRACTION METHODS; EXTRACELLULAR DNA; SITE OCCUPANCY; CLAY-MINERALS; EDNA; CONSERVATION; DEGRADATION; PERSISTENCE; ADSORPTION	The use of aquatic environmental DNA (eDNA) to detect the presence of species depends on the seasonal activity of the species in the sampled habitat. eDNA may persist in sediments for longer than it does in water, and analysing sediment could potentially extend the seasonal window for species assessment. Using the great crested newt as a model, we compare how detection probability changes across the seasons in eDNA samples collected from both pond water and pond sediments. Detection of both aquatic and sedimentary eDNA varied through the year, peaking in the summer (July), with its lowest point in the winter (January): in all seasons, detection probability of eDNA from water exceeded that from sediment. Detection probability of eDNA also varied between study areas, and according to great crested newt habitat suitability and sediment type. As aquatic and sedimentary eDNA show the same seasonal fluctuations, the patterns observed in both sample types likely reflect current or recent presence of the target species. However, given the low detection probabilities found in the autumn and winter we would not recommend using either aquatic or sedimentary eDNA for year-round sampling without further refinement and testing of the methods.	[Buxton, Andrew S.; Groombridge, Jim J.; Griffiths, Richard A.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Marlowe Bldg, Canterbury, Kent, England	University of Kent	Buxton, AS (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Marlowe Bldg, Canterbury, Kent, England.	asb40@kent.ac.uk			University of Kent; NERC [NBAF010001] Funding Source: UKRI	University of Kent; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We would like to dedicate this paper to Sir Martin Wood (FRS) and Lady Audrey Wood in the year of their 90th Birthdays for their contribution to science, technology and nature conservation. We would like to thank them for their financial support of their grandson, Andrew Buxton's PhD project of which this paper is part. This work was also made possible with funding directly from the University of Kent where Professor Jim Groombridge and Professor Richard Griffiths, are academic staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Burnham K P, 2003, MODEL SELECT MULTIMO; Buxton AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183371; Buxton AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46294; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Chaves L, 2010, EXTRACTION GENOMIC D; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P1061, DOI 10.1016/S0038-0717(97)00248-4; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Eland LE, 2012, WATER RES, V46, P5355, DOI 10.1016/j.watres.2012.07.023; English Nature, 2001, GREAT CREST NEWT MIT; Fiske IJ, 2011, J STAT SOFTW, V43, P1; GREAVES M. P., 1969, Soil Biology and Biochemistry, V1, P317, DOI 10.1016/0038-0717(69)90014-5; Griffiths R. A., 2016, WC1108 DEFR PROJ; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hinlo R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179251; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; Hunter MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132144; ISAO K, 1990, NATURE, V345, P242, DOI 10.1038/345242a0; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; LaMotte Company, 2017, SOIL TEXT TEST 1067; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lewis B., 2007, NERR001; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; LORENZ MG, 1987, APPL ENVIRON MICROB, V53, P2948, DOI 10.1128/AEM.53.12.2948-2952.1987; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; Maggi F, 2013, J GEOPHYS RES-OCEANS, V118, P2118, DOI 10.1002/jgrc.20086; Marchetti MP, 2004, ECOL APPL, V14, P1507, DOI 10.1890/03-5173; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; Mazerolle M. J., 2017, AICCMODAVG MODEL SEL; Oldham RS, 2000, HERPETOL J, V10, P143; PAGET E, 1992, FEMS MICROBIOL LETT, V97, P31, DOI 10.1111/j.1574-6968.1992.tb05435.x; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; R Development Core Team, 2016, R LANG ENV STAT COMP; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; RECORBET G, 1993, APPL ENVIRON MICROB, V59, P4289, DOI 10.1128/AEM.59.12.4289-4294.1993; Rees Helen C., 2017, BMC Research Notes, V10, P327, DOI 10.1186/s13104-017-2657-y; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Saeki K, 2010, CURRENT RES TECHNOLO, V1, P188; Schmelzle MC, 2016, MOL ECOL RESOUR, V16, P895, DOI 10.1111/1755-0998.12501; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; STEFFAN RJ, 1988, APPL ENVIRON MICROB, V54, P2908, DOI 10.1128/AEM.54.12.2908-2915.1988; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Unglaub B, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0103-3; United States Department of Agriculture, SOIL TEXT CALC; Voros J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170945; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2	67	44	48	9	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191737	10.1371/journal.pone.0191737	http://dx.doi.org/10.1371/journal.pone.0191737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352294	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300126
J	Fang, D; Sun, RY; Wilson, JR				Fang, Di; Sun, Renyuan; Wilson, Jeffrey R.			Joint modeling of correlated binary outcomes: The case of contraceptive use and HIV knowledge in Bangladesh	PLOS ONE			English	Article								Recent advances in statistical methods enable the study of correlation among outcomes through joint modeling, thereby addressing spillover effects. By joint modeling, we refer to simultaneously analyzing two or more different response variables emanating from the same individual. Using the 2011 Bangladesh Demographic and Health Survey, we jointly address spillover effects between contraceptive use (CUC) and knowledge of HIV and other sexually transmitted diseases. Jointly modeling these two outcomes is appropriate because certain types of contraceptive use contribute to the prevention of HIV and STDs and the knowledge and awareness of HIV and STDs typically lead to protection during sexual intercourse. In particular, we compared the differences as they pertained to the interpretive advantage of modeling the spillover effects of joint modeling HIV and CUC as opposed to addressing them separately. We also identified risk factors that determine contraceptive use and knowledge of HIV and STDs among women in Bangladesh. We found that by jointly modeling the correlation between HIV knowledge and contraceptive use, the importance of education decreased. The HIV prevention program had a spillover effect on CUC: what seemed to be impacted by education can be partially contributed to one's exposure to HIV knowledge. The joint model revealed a less significant impact of covariates as opposed to both separate models and standard models. Additionally, we found a spillover effect that would have otherwise been undiscovered if we did not jointly model. These findings further suggested that the simultaneous impact of correlated outcomes can be adequately addressed for the commonality between different responses and deflate, which is otherwise overestimated when examined separately.	[Fang, Di] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Sun, Renyuan] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Wilson, Jeffrey R.] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA	University of Arkansas System; University of Arkansas Fayetteville; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wilson, JR (corresponding author), Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA.	jeffrey.wilson@asu.edu		Fang, Di/0000-0002-0717-7576	National Institute of Health Alzheimer's Consortium [NHS0007]	National Institute of Health Alzheimer's Consortium	The authors appreciate support from the National Institute of Health Alzheimer's Consortium Fellowship Grant (Grant No. NHS0007).	[Anonymous], 2013, DEM HLTH SURV BDHS; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Dunson DB, 2003, BIOMETRICS, V59, P521, DOI 10.1111/1541-0420.00062; Gardiner JC, 4352013 SAS GLOB FOR; Ghebremichael M, 2015, J APPL STAT, V42, P2180, DOI 10.1080/02664763.2015.1022138; Gueorguieva RV, 2001, J AM STAT ASSOC, V96, P1102, DOI 10.1198/016214501753208762; Guo X, 2004, AM STAT, V58, P16, DOI 10.1198/0003130042854; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Hubbard RA, 2009, J AM STAT ASSOC, V104, P912, DOI 10.1198/jasa.2009.ap08423; Irimata K, 2017, J APPL STAT IN PRESS; Khan HR., 2011, J DATA SCI, V9, P93; Khan HTA, 1997, CONTRACEPTION, V55, P91, DOI 10.1016/S0010-7824(96)00278-8; Liang Y, 2009, BIOMETRICS, V65, P377, DOI 10.1111/j.1541-0420.2008.01104.x; Song X, 2002, BIOMETRICS, V58, P742, DOI 10.1111/j.0006-341X.2002.00742.x; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464; Zhu M, 0262014 SAS I INC	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190917	10.1371/journal.pone.0190917	http://dx.doi.org/10.1371/journal.pone.0190917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351328	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300031
J	Sirico, F; Miressi, S; Castaldo, C; Spera, R; Montagnani, S; Di Meglio, F; Nurzynska, D				Sirico, Felice; Miressi, Salvatore; Castaldo, Clotilde; Spera, Rocco; Montagnani, Stefania; Di Meglio, Franca; Nurzynska, Daria			Habits and beliefs related to food supplements: Results of a survey among Italian students of different education fields and levels	PLOS ONE			English	Article							USE DIETARY-SUPPLEMENTS; ENERGY DRINKS; SAFETY; ADULTS	The increasing availability of food supplements, aggressive media advertising, and common beliefs that these substances have only positive effects on health and sport performance indicate a need for continuous monitoring of this phenomenon. The aim of this study was to investigate the habits and beliefs related to diet supplementation among medical, health professional, and other university/high school students by means of a cross-sectional anonymous survey online. Among the respondents aware of supplements, 37.4% were taking or had taken them in the past. Food supplement use was more common among university students (in particular, those in health professional graduate courses) than high school students. Individual sport practice, rather than team sport, was associated with higher likelihood of food supplement use. Multivitamins were most commonly used, while weight-loss formulations were the least popular. Strikingly, filling nutrient gaps was statistically not considered the main reason for taking food supplements. Instead, they were used to enhance mental performance or enhance well-being. There was statistical evidence that students not enrolled in health or medical professional studies strongly agreed more often than medical students that taking food supplements prevents illness. These results indicate a striking difference between the evidence-based and personal reasons for food supplement use. Arguably, it calls for an improvement in education about diet supplementation and a change in attitude of health care providers to its implementation.	[Sirico, Felice; Miressi, Salvatore; Castaldo, Clotilde; Spera, Rocco; Montagnani, Stefania; Di Meglio, Franca; Nurzynska, Daria] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy	University of Naples Federico II	Sirico, F (corresponding author), Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.	sirico.felice@gmail.com	Nurzynska, Daria/A-2161-2010; Sirico, Felice/O-9705-2019; saez, lourdes basurto/AAO-6641-2020	Nurzynska, Daria/0000-0003-1092-6168; Sirico, Felice/0000-0001-6801-3308; Castaldo, Clotilde/0000-0003-1475-5036				Ashar BH, 2007, ARCH INTERN MED, V167, P966, DOI 10.1001/archinte.167.9.966; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Barnes PM, 2008, NATL HLTH STAT REPOR, P1; Biesalski HK, 2017, NUTRITION, V33, P76, DOI 10.1016/j.nut.2016.02.013; Cellini M, 2013, MED SCI SPORT EXER, V45, P23, DOI 10.1249/MSS.0b013e318269904f; Chiba T, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0239-4; Conner M, 2001, SOC SCI MED, V52, P621, DOI 10.1016/S0277-9536(00)00165-9; Council for Responsible Nutrition, CRN 2016 ANN SURV DI; Dickinson A, 2014, J AM COLL NUTR, V33, P176, DOI 10.1080/07315724.2013.875423; Duchan E, 2010, PHYSICIAN SPORTSMED, V38, P171, DOI 10.3810/psm.2010.06.1796; European Food Safety Authority, DIET REF VAL NUTR SU; European Food Safety Authority, US SUPPL OTH MIN VIT; European Food Safety Authority, OP PUBL CONS REL EV; Food and Drug Administration, 2016, FED REG MAY 27, V81, P33742; Frey A, 2017, PUBLIC HEALTH NUTR, V20, P2173, DOI [10.1017/S1368980017001021, 10.1017/s1368980017001021]; Greger JL, 2001, J NUTR, V131, p1339S, DOI 10.1093/jn/131.4.1339S; Haller CA, 2008, J MED TOXICOL, V4, P84, DOI 10.1007/BF03160960; Kang HG, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1361769; Kirk Sara, 1998, Proceedings of the Nutrition Society, V57, p54A; Nichter M, 2006, CULT MED PSYCHIAT, V30, P175, DOI 10.1007/s11013-006-9016-0; Pajor EM, 2017, APPETITE, V114, P161, DOI 10.1016/j.appet.2017.03.036; Rao N, 2017, J MED TOXICOL, V13, P227, DOI 10.1007/s13181-017-0623-7; Richards Gareth, 2016, Journal of Caffeine Research, V6, P49, DOI 10.1089/jcr.2015.0033; Schwingshackl L, 2017, ADV NUTR, V8, P27, DOI 10.3945/an.116.013516; Scientific Committee on Food; Scientific Panel on Dietetic Products Nutrition and Allergies, TOL UPP INT LEV VIT; Sebastian RS, 2007, J AM DIET ASSOC, V107, P1322, DOI 10.1016/j.jada.2007.05.010; The European Food Safety Authority, FOOD SUPPL; Troppmann L, 2002, J AM DIET ASSOC, V102, P818, DOI 10.1016/S0002-8223(02)90183-5; Ulbricht C, 2008, CURR DRUG METAB, V9, P1063, DOI 10.2174/138920008786927785	29	48	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191424	10.1371/journal.pone.0191424	http://dx.doi.org/10.1371/journal.pone.0191424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351568	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300088
J	Browne, AL; Charmsaz, S; Vareslija, D; Fagan, A; Cosgrove, N; Cocchiglia, S; Purcell, S; Ward, E; Bane, F; Hudson, L; Hill, AD; Carroll, JS; Redmond, AM; Young, LS				Browne, Alacoque L.; Charmsaz, Sara; Vareslija, Damir; Fagan, Ailis; Cosgrove, Nicola; Cocchiglia, Sinead; Purcell, Siobhan; Ward, Elspeth; Bane, Fiona; Hudson, Lance; Hill, Arnold D.; Carroll, Jason S.; Redmond, Aisling M.; Young, Leonie S.			Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer	ONCOGENE			English	Article							STEROID-RECEPTOR COACTIVATOR-1; PROTEIN METHYLTRANSFERASE; MEDIATED TRANSACTIVATIONS; P160 COACTIVATORS; GENE-EXPRESSION; SOLID TUMORS; STAT FAMILY; FACTOR-I; ER; METASTASIS	Steroid receptor coactivator 1 (SRC-1) interacts with nuclear receptors and other transcription factors (TFs) to initiate transcriptional networks and regulate downstream genes which enable the cancer cell to evade therapy and metastasise. Here we took a top-down discovery approach to map out the SRC-1 transcriptional network in endocrine resistant breast cancer. First, rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) was employed to uncover new SRC-1 TF partners. Next, RNA sequencing (RNAseq) was undertaken to investigate SRC-1 TF target genes. Molecular and patientderived xenograft studies confirmed STAT1 as a new SRC-1 TF partner, important in the regulation of a cadre of four SRC-1 transcription targets, NFIA, SMAD2, E2F7 and ASCL1. Extended network analysis identified a downstream 79 gene network, the clinical relevance of which was investigated in RNAseq studies from matched primary and local-recurrence tumours from endocrine resistant patients. We propose that SRC-1 can partner with STAT1 independently of the estrogen receptor to initiate a transcriptional cascade and control regulation of key endocrine resistant genes.	[Browne, Alacoque L.; Charmsaz, Sara; Vareslija, Damir; Fagan, Ailis; Cosgrove, Nicola; Cocchiglia, Sinead; Purcell, Siobhan; Ward, Elspeth; Bane, Fiona; Hudson, Lance; Hill, Arnold D.; Young, Leonie S.] Royal Coll Surg, Dept Surg, Endocrine Oncol Res Grp, Dublin, Ireland; [Carroll, Jason S.; Redmond, Aisling M.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge, England	Royal College of Surgeons - Ireland; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Young, LS (corresponding author), Royal Coll Surg, Dept Surg, Endocrine Oncol Res Grp, Dublin, Ireland.	lyoung@rcsi.ie		Ward, Elspeth/0000-0002-7530-2279; Carroll, Jason/0000-0003-3643-0080; Vareslija, Damir/0000-0003-1000-0357; Cosgrove, Nicola/0000-0002-8296-115X	Science Foundation Ireland [08-IN1-B1853, 12/1A/1294]; Health Research Board of Ireland [HRB/POR/2012/101]; Irish Cancer Society Collaborative Cancer Research Centre grant [CCRC13GAL, BREASTPREDICT]; Cancer Research UK [20411] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; Irish Cancer Society Collaborative Cancer Research Centre grant; Cancer Research UK(Cancer Research UK)	We kindly acknowledge the funding support from the Science Foundation Ireland (08-IN1-B1853 and 12/1A/1294), the Health Research Board of Ireland (HRB/POR/2012/101). This work was partly supported by the Irish Cancer Society Collaborative Cancer Research Centre grant, BREASTPREDICT, CCRC13GAL.	Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; BRONZERT DA, 1985, ENDOCRINOLOGY, V117, P1409, DOI 10.1210/endo-117-4-1409; Carroll JS, 2016, EUR J ENDOCRINOL, V175, pR41, DOI 10.1530/EJE-16-0124; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chu JJ, 2015, ONCOTARGET, V6, P31944, DOI 10.18632/oncotarget.5128; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Glasgow SM, 2013, J NEUROSCI, V33, P13560, DOI 10.1523/JNEUROSCI.0321-13.2013; Grabowska MM, 2014, MOL ENDOCRINOL, V28, P949, DOI 10.1210/me.2013-1213; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Kim HJ, 1998, J BIOL CHEM, V273, P28564, DOI 10.1074/jbc.273.44.28564; Kim J, 2016, ONCOTARGET, V7, P85021, DOI 10.18632/oncotarget.13116; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kolde R., 2015, PHEATMAP PRETTY HEAT; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McBryan J, 2015, CLIN CANCER RES, V21, P5371, DOI 10.1158/1078-0432.CCR-14-2155; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; McCartan D, 2012, CANCER RES, V72, P220, DOI 10.1158/0008-5472.CAN-11-1976; McIlroy M, 2010, CANCER RES, V70, P1585, DOI 10.1158/0008-5472.CAN-09-3713; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Priedigkeit N, 2017, JAMA ONCOL, V3, P666, DOI 10.1001/jamaoncol.2016.5630; Qin L, 2014, CANCER RES, V74, P3477, DOI 10.1158/0008-5472.CAN-13-2639; Qin L, 2011, CANCER RES, V71, P1742, DOI 10.1158/0008-5472.CAN-10-3453; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Redmond AM, 2015, ONCOGENE, V34, P3871, DOI 10.1038/onc.2014.323; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Stashi E, 2014, TRENDS ENDOCRIN MET, V25, P337, DOI 10.1016/j.tem.2014.05.004; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Vareslija D, 2017, METHODS MOL BIOL, V1501, P327, DOI 10.1007/978-1-4939-6475-8_17; Vareslija D, 2016, CLIN CANCER RES, V22, P2765, DOI 10.1158/1078-0432.CCR-15-1583; Verfaillie A., 2015, CURR PROTOC BIOINFOR, V52, P1; Vinnedge LMP, 2015, ONCOGENE, V34, P2325, DOI 10.1038/onc.2014.173; Walsh CA, 2014, CANCER RES, V74, P2533, DOI 10.1158/0008-5472.CAN-13-2133; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Wang L, 2016, HORM CANCER-US, V7, P229, DOI 10.1007/s12672-016-0261-6; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wu LL, 2014, ONCOTARGET, V5, P7677, DOI 10.18632/oncotarget.2291; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119	64	20	20	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					2008	2021		10.1038/s41388-017-0042-x	http://dx.doi.org/10.1038/s41388-017-0042-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367763	Green Published, hybrid			2022-12-26	WOS:000429899400005
J	Mikkelsen, SA; Vangheluwe, P; Andersen, JP				Mikkelsen, Stine A.; Vangheluwe, Peter; Andersen, Jens Peter			A Darier disease mutation relieves kinetic constraints imposed by the tail of sarco(endo)plasmic reticulum Ca2+-ATPase 2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; FUNCTIONAL CONSEQUENCES; STEADY-STATE; CA2+ PUMP; ATPASE; EXPRESSION; MUTANTS; CA-2+-ATPASE; ISOFORMS; ATP2A2	The sarco(endo) plasmic reticulum Ca2+-ATPase (SERCA) 2b isoform possesses an extendedCterminus (SERCA2b tail) forming an 11th transmembrane (TM) helix, which slows conformational changes of the Ca2+-pump reaction cycle. Here, we report that a Darier disease (DD) mutation of SERCA2b that changes a glutamate to a lysine in the cytoplasmic loop between TM8 and TM9 (E917K) relieves these kinetic constraints. We analyzed the effects of this mutation on the overall reaction and the individual partial reactions of the Ca2+ pump compared with the corresponding mutations of the SERCA2a and SERCA1a isoforms, lacking the SERCA2b tail. In addition to a reduced affinity for Ca2+, caused by the mutation in all three isoforms examined, we observed a unique enhancing effect on the turnover rates of ATPase activity and Ca2+ transport for the SERCA2b E917K mutation. This relief of kinetic constraints contrasted with inhibitory effects observed for the corresponding SERCA2a and SERCA1a (E918K) mutations. These observations indicated that the E917K/E918K mutations affect the rate-limiting conformational change in isoform-specific ways and that the SERCA2b mutation perturbs the interactions of TM11 with other SERCA2b regions. Mutational analysis of an arginine in TM7 that interacts with the glutamate in SERCA1a crystal structures suggested that in wildtype SERCA2b, the corresponding arginine (Arg-835) may be involved in mediating the conformational restriction by TM11. Moreover, the E917K mutation may disturb TM11 through the cytoplasmic loop between TM10 and TM11. In conclusion, our findings have identified structural elements of importance for the kinetic constraints imposed by TM11.	[Mikkelsen, Stine A.; Andersen, Jens Peter] Aarhus Univ, Dept Biomed, Ole Worms 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Leuven, Belgium	Aarhus University; KU Leuven	Andersen, JP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@biomed.au.dk	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council, Denmark; Novo Nordisk Foundation, Denmark; Lundbeck Foundation, Denmark	Danish Medical Research Council, Denmark(Danish Medical Research Council); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Lundbeck Foundation, Denmark(Lundbeckfonden)	This work was supported in part by the Danish Medical Research Council, the Novo Nordisk Foundation, and the Lundbeck Foundation, Denmark (to J. P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Dally S, 2010, J MOL CELL CARDIOL, V48, P633, DOI 10.1016/j.yjmcc.2009.11.012; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; FORGE V, 1993, J BIOL CHEM, V268, P10961; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Ikeda S, 2003, J INVEST DERMATOL, V121, P475, DOI 10.1046/j.1523-1747.2003.12400.x; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Nellen RGL, 2017, HUM MUTAT, V38, P343, DOI 10.1002/humu.23164; Pani B, 2008, CELL MOL LIFE SCI, V65, P205, DOI 10.1007/s00018-007-7397-z; Peacocke M, 1999, NAT GENET, V21, P252, DOI 10.1038/6758; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PICK U, 1982, J BIOL CHEM, V257, P6111; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Tavadia S, 2004, BRIT J DERMATOL, V151, P440, DOI 10.1111/j.1365-2133.2004.06130.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; VILSEN B, 1989, J BIOL CHEM, V264, P21024; YU X, 1994, J BIOL CHEM, V269, P16656	48	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3880	3889		10.1074/jbc.RA117.000941	http://dx.doi.org/10.1074/jbc.RA117.000941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29363575	Green Published, hybrid			2022-12-26	WOS:000427587500002
J	Harada, Y; Kato, Y; Miyaji, T; Omote, H; Moriyama, Y; Hiasa, M				Harada, Yuika; Kato, Yuri; Miyaji, Takaaki; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki			Vesicular nucleotide transporter mediates ATP release and migration in neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; A2 RECEPTORS; P2 RECEPTORS; IDENTIFICATION; ACTIVATION; ADENOSINE; INHIBITION; CELLS; TRANSLOCATION; CHEMOTAXIS	Neutrophils migrate to sites infected by pathogenic microorganisms. This migration is regulated by neutrophil-secreted ATP, which stimulates neutrophils in an autocrine manner through purinergic receptors on the plasma membrane. Although previous studies have shown that ATP is released through channels at the plasma membrane of the neutrophil, it remains unknown whether it is also released through alternate secretory systems involving vesicular mechanisms. In this study, we investigated the possible involvement of vesicular nucleotide transporter (VNUT), a key molecule for vesicular storage and nucleotide release, in ATP secretion from neutrophils. RT-PCR and Western blotting analysis indicated that VNUT is expressed in mouse neutrophils. Immunohistochemical analysis indicated that VNUT mainly colocalized with matrix metalloproteinase-9 (MMP-9), a marker of tertiary granules, which are secretory organelles. In mouse neutrophils, ATP release was inhibited by clodronate, which is a potent VNUT inhibitor. Furthermore, neutrophils from VNUT-/- mice did not release ATP and exhibited significantly reduced migration in vitro and in vivo. These findings suggest that tertiary granule-localized VNUT is responsible for vesicular ATP release and subsequent neutrophil migration. Thus, these findings suggest an additional mechanism through which ATP is released by neutrophils.	[Harada, Yuika; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Kato, Yuri; Miyaji, Takaaki] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Moriyama, Yoshinori] Matsumoto Dent Univ, Dept Biochem, Siojiri 3990781, Japan	Okayama University; Okayama University; Matsumoto Dental University	Moriyama, Y; Hiasa, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan.; Moriyama, Y (corresponding author), Matsumoto Dent Univ, Dept Biochem, Siojiri 3990781, Japan.	moriya-y@okayama-u.ac.jp; hiasa@okayama-u.ac.jp		Miyaji, Takaaki/0000-0002-7257-7621	Japan Society for the Promotion of Science [15J03354]; Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan [26893154, 17K0733609, 25253008, 16K08230]; Japan Agency for Medical Research and Development (AMED) [JP17gm5910019]; Narishige Neuroscience Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Narishige Neuroscience Research Foundation	This work was supported in part by Japan Society for the Promotion of Science Fellows Grant-in Aid 15J03354 (to Y. H.); Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aid 26893154 (to Y. K.), 17K0733609 (to H. O.), 25253008 (to H. O. and Y. M.), and 16K08230 (to M. H.); the Japan Agency for Medical Research and Development (AMED) Grant JP17gm5910019 (to T. M.); and funds from the Narishige Neuroscience Research Foundation (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Cools-Lartigue J., 2013, J CLIN INVEST, V67484; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Gernez Y, 2010, EUR RESPIR J, V35, P467, DOI 10.1183/09031936.00186109; Harada Y, 2014, BIOL PHARM BULL, V37, P1090, DOI 10.1248/bpb.b14-00275; Hiasa M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12034; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kato Y, 2017, P NATL ACAD SCI USA, V114, pE6297, DOI 10.1073/pnas.1704847114; Kato Y, 2013, BIOL PHARM BULL, V36, P1688; Kukulski F, 2009, CYTOKINE, V46, P166, DOI 10.1016/j.cyto.2009.02.011; Larsson M, 2012, CEREB CORTEX, V22, P1203, DOI 10.1093/cercor/bhr203; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Meshki J, 2004, AM J PHYSIOL-CELL PH, V286, pC264, DOI 10.1152/ajpcell.00287.2003; Moriyama S, 2016, BIOL PHARM BULL, V39, P564, DOI 10.1248/bpb.b15-00872; MORIYAMA Y, 1995, FEBS LETT, V367, P233, DOI 10.1016/0014-5793(95)00559-R; Moriyama Y, 2018, TRENDS PHARMACOL SCI, V39, P13, DOI 10.1016/j.tips.2017.10.007; Moriyama Y, 2017, PURINERG SIGNAL, V13, P387, DOI 10.1007/s11302-017-9568-1; Nakagomi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29761; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Sakamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06689; SALMON JE, 1990, J IMMUNOL, V145, P2235; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SENGELOV H, 1994, BIOCHEM J, V299, P473, DOI 10.1042/bj2990473; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; THIEL M, 1995, J LAB CLIN MED, V126, P275; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544	39	19	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3770	3779		10.1074/jbc.M117.810168	http://dx.doi.org/10.1074/jbc.M117.810168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29363573	Green Published, hybrid			2022-12-26	WOS:000427030200029
J	Guiraud, H; Bedoin, N; Krifi-Papoz, S; Herbillon, V; Caillot-Bascoul, A; Gonzalez-Monge, S; Boulenger, V				Guiraud, Helene; Bedoin, Nathalie; Krifi-Papoz, Sonia; Herbillon, Vania; Caillot-Bascoul, Aurelia; Gonzalez-Monge, Sibylle; Boulenger, Veronique			Don't speak too fast! Processing of fast rate speech in children with specific language impairment	PLOS ONE			English	Article							AUDITORY-CORTEX; INHERITED SPEECH; DEVELOPMENTAL APHASIA; PERCEPTION DEFICITS; COMPRESSED SPEECH; BEAT PERCEPTION; TIME; DYSLEXIA; RHYTHM; PATTERNS	Background Perception of speech rhythm requires the auditory system to track temporal envelope fluctuations, which carry syllabic and stress information. Reduced sensitivity to rhythmic acoustic cues has been evidenced in children with Specific Language Impairment (SLI), impeding syllabic parsing and speech decoding. Our study investigated whether these children experience specific difficulties processing fast rate speech as compared with typically developing (TD) children. Method Sixteen French children with SLI (8-13 years old) with mainly expressive phonological disorders and with preserved comprehension and 16 age-matched TD children performed a judgment task on sentences produced 1) at normal rate, 2) at fast rate or 3) time-compressed. Sensitivity index (d) to semantically incongruent sentence-final words was measured. Results Overall children with SLI perform significantly worse than TD children. Importantly, as revealed by the significant Group x Speech Rate interaction, children with SLI find it more challenging than TD children to process both naturally or artificially accelerated speech. The two groups do not significantly differ in normal rate speech processing. Conclusion In agreement with rhythm-processing deficits in atypical language development, our results suggest that children with SLI face difficulties adjusting to rapid speech rate. These findings are interpreted in light of temporal sampling and prosodic phrasing frameworks and of oscillatory mechanisms underlying speech perception.	[Guiraud, Helene; Bedoin, Nathalie; Boulenger, Veronique] Univ Lyon, CNRS, UMR5596, Lab Dynam Langage, Lyon, France; [Krifi-Papoz, Sonia] Hop Femme Mere Enfant, Serv Neurol Pediat, Bron, France; [Herbillon, Vania] Hop Femme Mere Enfant, Serv Epilepsie Sommeil & Explorat Fonct Neuropedi, Bron, France; [Herbillon, Vania] CNRS, INSERM, Ctr Rech Neurosci Lyon, DYCOG,U1028,UMR5292, Bron, France; [Caillot-Bascoul, Aurelia] CHU Gabriel Montpied, Serv ORL Chirurg Cerv Faciale, Clermont Ferrand, France; [Gonzalez-Monge, Sibylle] Hop Femme Mere Enfant, Serv Reeduc Pediat, Ctr Reference Troubles Apprentissages, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; CHU Lyon	Guiraud, H; Boulenger, V (corresponding author), Univ Lyon, CNRS, UMR5596, Lab Dynam Langage, Lyon, France.	helene.guiraud@univ-lyon2.fr; veronique.boulenger@cnrs.fr	Boulenger, Veronique/P-6339-2015; Boulenger, Véronique/AAQ-2881-2020	Boulenger, Véronique/0000-0001-8701-8278; Guiraud, Helene/0000-0003-0937-5872	ODYSSEE project [11 JSH2 005 1]; French National Research Agency (ANR) [11 JSH2 0051]; LabExASLAN of Universite de Lyon within the program "Investissements d'Avenir" of the French government [ANR-10-LABX-0081, ANR-11-IDEX-0007]	ODYSSEE project; French National Research Agency (ANR)(French National Research Agency (ANR)); LabExASLAN of Universite de Lyon within the program "Investissements d'Avenir" of the French government(French National Research Agency (ANR))	This study was conducted as part of the ODYSSEE project (PI: V.B; no 11 JSH2 005 1) funded by the French National Research Agency (ANR; grant number 11 JSH2 0051, http://www.agence-nationale-recherche.fr/). HG is funded by a doctoral fellowship from the LabExASLAN (ANR-10-LABX-0081) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) of the French government operated by the ANR (http://aslan.universite-lyon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank parents and their children for participating in this study. We also thank Lydie Merle for helping to recruit children with SLI, Emmanuel Ferragne for his help in the construction of the stimuli and Damien Gouy for recording the sentences. This study was conducted as part of the ODYSSEE project (PI: V.B; no 11 JSH2 005 1) funded by the French National Research Agency (ANR). H.G is funded by a doctoral fellowship from the LabEx ASLAN (ANR-10-LABX-0081) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) of the French government operated by the ANR.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Adank P, 2010, NEUROIMAGE, V49, P1124, DOI 10.1016/j.neuroimage.2009.07.032; Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Alcock KJ, 2000, BRAIN LANG, V75, P34, DOI 10.1006/brln.2000.2323; Alho J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00394; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Beattie RL, 2013, J LEARN DISABIL-US, V46, P200, DOI 10.1177/0022219412449421; Bedoin N, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00245; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Bishop DVM, 2014, INT J LANG COMM DIS, V49, P381, DOI 10.1111/1460-6984.12101; Bishop DVM, 2002, AM J MED GENET, V114, P56, DOI 10.1002/ajmg.1630; Boersma P., 2013, PRAAT DOING PHONETIC; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Bowyer-Crane C, 2011, LEARN DISAB, V9, P107; Carr KW, 2014, P NATL ACAD SCI USA, V111, P14559, DOI 10.1073/pnas.1406219111; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chevrie-Muller C., 2001, NOUVELLES EPREUVES E; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corriveau K, 2007, J SPEECH LANG HEAR R, V50, P647, DOI 10.1044/1092-4388(2007/046); Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Cumming R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00672; Cumming R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00972; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; de Weck G., 2003, TROUBLES DYSPHASIQUE; Doelling KB, 2014, NEUROIMAGE, V85, P761, DOI 10.1016/j.neuroimage.2013.06.035; Duez D., 1998, P ESCA SOUND PATT SP, P63; Duez D, 1987, TRAVAUX I PHONETIQUE, V11, P157; Dupoux E, 1997, J EXP PSYCHOL HUMAN, V23, P914, DOI 10.1037/0096-1523.23.3.914; Ferragne E., 2012, ROCME RECORDING ORAL; Fey M. E., 1994, SPECIFIC LANGUAGE IM, P161; Francis AL, 2000, PERCEPT PSYCHOPHYS, V62, P1668, DOI 10.3758/BF03212164; Fraser J, 2010, SCI STUD READ, V14, P8, DOI 10.1080/10888430903242068; Geiser E, 2008, J COGNITIVE NEUROSCI, V20, P541, DOI 10.1162/jocn.2008.20029; Ghitza O, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00138; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gordon-Salant S, 2014, J ACOUST SOC AM, V136, pEL268, DOI 10.1121/1.4895014; Goswami U, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00791; Goswami U, 2012, EMPIR MUSICOL REV, V7, P57, DOI 10.18061/1811/52980; Goswami U, 2013, LAB PHONOL, V4, P67, DOI 10.1515/lp-2013-0004; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Greenberg S, 2003, DYNAMICS SPEECH PROD; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; Guiraud H, 2013, P INT, P2; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; Jacquier-Roux M, 2010, BALE BATTERIE ANAL L; Janse E, 2004, SPEECH COMMUN, V42, P155, DOI 10.1016/j.specom.2003.07.001; Khomsi A., 2007, BILAN INFORM LANGAGE; Khomsi A., 2001, ELO EVALUATION LANGA; Koreman J, 2006, J ACOUST SOC AM, V119, P582, DOI 10.1121/1.2133436; Korkman M, 1998, NEPSY BILAN NEUROPSY; Kotz SA, 2015, CORTEX, V68, P48, DOI 10.1016/j.cortex.2015.02.021; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Law J, 1998, Int J Lang Commun Disord, V33 Suppl, P21; Lefavrais P., 1967, TEST DE LALOUETTE; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Leonard L.B., 2014, INT J LANG COMM DIS, V49, P436; Leonard LB, 2014, CHILDREN WITH SPECIFIC LANGUAGE IMPAIRMENT, 2ND EDITION, P1; Leong V, 2014, HEARING RES, V308, P141, DOI 10.1016/j.heares.2013.07.015; Lete B, 2004, BEHAV RES METH INS C, V36, P156, DOI 10.3758/BF03195560; Leybaert J, 2014, FRONTIERS PSYCHOL, V5; Macmillan NA, 2005, DETECTION THEORY USE; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; Maillart C, 2012, ENTRETIENS ORTHOPHON, P22; Marquardt TP, 2002, J COMMUN DISORD, V35, P31, DOI 10.1016/S0021-9924(01)00068-5; Marquardt TP, 2001, TREATING DISORDERED, P413; Max L, 1997, J SPEECH LANG HEAR R, V40, P1097, DOI 10.1044/jslhr.4005.1097; Mazeau M., 2005, READAPTATION, V522, P8; Mehler J., 2004, CARTOGRAPHY SYNTACTI, V3, P213; Montgomery JW, 2005, INT J LANG COMM DIS, V40, P171, DOI 10.1080/13682820400011069; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Muneaux M, 2004, NEUROREPORT, V15, P1255, DOI 10.1097/01.wnr.0000127459.31232.c4; New B, 2007, APPL PSYCHOLINGUIST, V28, P661, DOI 10.1017/S014271640707035X; Parisse C, 2010, AUTOUR MOT PRATIQUES; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Peelle JE, 2004, BRAIN LANG, V91, P315, DOI 10.1016/j.bandl.2004.05.007; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; Peter B, 2008, CLIN LINGUIST PHONET, V22, P171, DOI 10.1080/02699200701799825; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Port RF, 2003, J PHONETICS, V31, P599, DOI 10.1016/j.wocn.2003.08.001; Rapin I, 1996, J CHILD PSYCHOL PSYC, V37, P643, DOI 10.1111/j.1469-7610.1996.tb01456.x; Rapin I., 1983, NEUROPSYCHOLOGY LANG, P155; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Raven J.C., 1998, ADV PROGR MATRICES; Reilly S, 2014, INT J LANG COMM DIS, V49, P452, DOI 10.1111/1460-6984.12111; Richards S, 2015, J SPEECH LANG HEAR R, V58, P1292, DOI 10.1044/2015_JSLHR-L-13-0306; Robertson EK, 2009, DEVELOPMENTAL SCI, V12, P753, DOI 10.1111/j.1467-7687.2009.00806.x; SANDGREN O., 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Schon D, 2015, ANN NY ACAD SCI, V1337, P32, DOI 10.1111/nyas.12635; Scott SK, 1998, PSYCHOL RES-PSYCH FO, V61, P4, DOI 10.1007/PL00008162; SOLTESZ F, 2013, PLOS ONE, V8; STARK RE, 1995, APPL PSYCHOLINGUIST, V16, P137, DOI 10.1017/S0142716400007050; TALLAL P, 1973, NEUROPSYCHOLOGIA, V11, P389, DOI 10.1016/0028-3932(73)90025-0; TALLAL P, 1975, NEUROPSYCHOLOGIA, V13, P69, DOI 10.1016/0028-3932(75)90049-4; Telkemeyer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00062; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Tierney A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00949; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Tomblin JB, 2014, UNDERSTANDING INDIVI; Tomblin JB, 1999, NEURODEVOPMENTAL DIS; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Wake M, 2013, PEDIATRICS, V132, pE895, DOI 10.1542/peds.2012-3878; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2014, WPPSI 4 CHELLE DINTE; Ziegler JC, 2005, P NATL ACAD SCI USA, V102, P14110, DOI 10.1073/pnas.0504446102; Ziegler JC, 2011, J EXP CHILD PSYCHOL, V110, P362, DOI 10.1016/j.jecp.2011.05.001	118	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191808	10.1371/journal.pone.0191808	http://dx.doi.org/10.1371/journal.pone.0191808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8TF	29373610	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400025
J	Balaguru, K; Doney, SC; Bianucci, L; Rasch, PJ; Leung, LR; Yoon, JH; Lima, ID				Balaguru, Karthik; Doney, Scott C.; Bianucci, Laura; Rasch, Philip J.; Leung, L. Ruby; Yoon, Jin-Ho; Lima, Ivan D.			Linking deep convection and phytoplankton blooms in the northern Labrador Sea in a changing climate	PLOS ONE			English	Article							LARGE MARINE ECOSYSTEMS; THERMOHALINE CIRCULATION; ATLANTIC OCEAN; CMIP5 MODELS; FRESH-WATER; ICE COVER; SATELLITE; CCSM4; GYRE; CHLOROPHYLL	Wintertime convective mixing plays a pivotal role in the sub-polar North Atlantic spring phytoplankton blooms by favoring phytoplankton survival in the competition between light-dependent production and losses due to grazing and gravitational settling. We use satellite and ocean reanalyses to show that the area-averaged maximum winter mixed layer depth is positively correlated with April chlorophyll concentration in the northern Labrador Sea. A simple theoretical framework is developed to understand the relative roles of winter/spring convection and gravitational sedimentation in spring blooms in this region. Combining climate model simulations that project a weakening of wintertime Labrador Sea convection from Arctic sea ice melt with our framework suggests a potentially significant reduction in the initial fall phytoplankton population that survive the winter to seed the region's spring bloom by the end of the 21 st century.	[Balaguru, Karthik; Bianucci, Laura] Pacific Northwest Natl Lab, Marine Sci Lab, Seattle, WA 98109 USA; [Balaguru, Karthik; Rasch, Philip J.; Leung, L. Ruby] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Doney, Scott C.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Doney, Scott C.; Lima, Ivan D.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Bianucci, Laura] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Yoon, Jin-Ho] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Virginia; Woods Hole Oceanographic Institution; Fisheries & Oceans Canada; Gwangju Institute of Science & Technology (GIST)	Balaguru, K (corresponding author), Pacific Northwest Natl Lab, Marine Sci Lab, Seattle, WA 98109 USA.; Balaguru, K (corresponding author), Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA.	karthik.balaguru@pnnl.gov	YOON, JIN-HO/A-1672-2009; Doney, Scott C/F-9247-2010; Rasch, Philip J/F-7978-2018; Lima, Ivan D/A-6823-2016; Leung, Ruby/F-9276-2018	YOON, JIN-HO/0000-0002-4939-8078; Doney, Scott C/0000-0002-3683-2437; Rasch, Philip J/0000-0002-5125-2174; Lima, Ivan D/0000-0001-5345-0652; Leung, Ruby/0000-0002-3221-9467; Bianucci, Laura/0000-0002-4492-8930	Office of Science (BER), U. S. Department of Energy as part of the Regional and Global Climate Modelling (RGCM) Program; DOE by Battelle Memorial Institute [DE-AC05-76RL01830]; NASA Award [NNX15AE65G]	Office of Science (BER), U. S. Department of Energy as part of the Regional and Global Climate Modelling (RGCM) Program; DOE by Battelle Memorial Institute(United States Department of Energy (DOE)); NASA Award	KB, LB, PJR and LRL were supported by the Office of Science (BER), U. S. Department of Energy as part of the Regional and Global Climate Modelling (RGCM) Program. The Pacific Northwest National Laboratory is operated for DOE by Battelle Memorial Institute under contract DE-AC05-76RL01830. SCD acknowledges support from NASA Award NNX15AE65G North Atlantic Aerosol and Marine Ecosystem Study (NAAMES).; The Pacific Northwest National Laboratory is operated for DOE by Battelle Memorial Institute under contract DE-AC05-76RL01830. The sources for various data used in this study are provided in the 'Materials and Methods' section.	Backhaus JO, 2003, MAR ECOL PROG SER, V251, P1, DOI 10.3354/meps251001; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Behrenfeld MJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P526, DOI 10.1002/gbc.20050; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Boss E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044174; Boss E, 2008, LIMNOL OCEANOGR, V53, P2112, DOI 10.4319/lo.2008.53.5_part_2.2112; Brody SR, 2015, ICES J MAR SCI, V72, P1961, DOI 10.1093/icesjms/fsv006; Brody SR, 2014, GEOPHYS RES LETT, V41, P3197, DOI 10.1002/2014GL059707; Carton J.A., 2018, UPDATED REANAL UNPUB; Chanut J, 2008, J PHYS OCEANOGR, V38, P1617, DOI 10.1175/2008JPO3485.1; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Couto AB, 2016, INT J REMOTE SENS, V37, P4337, DOI 10.1080/01431161.2016.1209313; Cullen J.J., 1998, NAT ASI SER G ECOL S, V41, P559; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; D'Asaro EA, 2008, J MARINE SYST, V69, P233, DOI 10.1016/j.jmarsys.2005.08.005; Danabasoglu G, 2012, J CLIMATE, V25, P1361, DOI 10.1175/JCLI-D-11-00091.1; de Boyer Montegut C., 2004, J GEOPHYS RES OCEANS, V109; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Fischer AD, 2014, OCEANOGRAPHY, V27, P222, DOI 10.5670/oceanog.2014.26; Frajka-Williams E, 2010, DEEP-SEA RES PT I, V57, P541, DOI 10.1016/j.dsr.2010.01.003; Frajka-Williams E, 2009, DEEP-SEA RES PT I, V56, P2144, DOI 10.1016/j.dsr.2009.07.008; Franks PJS, 2015, ICES J MAR SCI, V72, P1897, DOI 10.1093/icesjms/fsu175; Gemmell BJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1126; Haine TWN, 2015, GLOBAL PLANET CHANGE, V125, P13, DOI 10.1016/j.gloplacha.2014.11.013; Head EJH, 2000, MAR ECOL PROG SER, V193, P53, DOI 10.3354/meps193053; Henson S, 2013, BIOGEOSCIENCES, V10, P4357, DOI 10.5194/bg-10-4357-2013; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Heuze C, 2017, OCEAN SCI, V13, P609, DOI 10.5194/os-13-609-2017; Heuze C, 2015, J CLIMATE, V28, P2917, DOI 10.1175/JCLI-D-14-00381.1; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Jahn A, 2013, GEOPHYS RES LETT, V40, P1206, DOI 10.1002/grl.50183; Jahn A, 2012, J CLIMATE, V25, P1431, DOI 10.1175/JCLI-D-11-00201.1; Johannessen OM, 1999, SCIENCE, V286, P1937, DOI 10.1126/science.286.5446.1937; Kostadinov TS, 2016, OCEAN SCI, V12, P561, DOI 10.5194/os-12-561-2016; Lacour L, 2015, GEOPHYS RES LETT, V42, P5403, DOI 10.1002/2015GL064540; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Rahmstorf S, 1999, NATURE, V399, P523, DOI 10.1038/21066; Schmidt S, 2007, J PHYS OCEANOGR, V37, P1445, DOI 10.1175/JPO3065.1; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Smayda TJ, 1970, OCEANOGRAPHY MARINE, P8; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Uitz J, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003680; Vavrus SJ, 2012, J CLIMATE, V25, P2696, DOI 10.1175/JCLI-D-11-00220.1; Weaver AJ, 2004, SCIENCE, V304, P400, DOI 10.1126/science.1096503; Wood RA, 1999, NATURE, V399, P572, DOI 10.1038/21170	58	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191509	10.1371/journal.pone.0191509	http://dx.doi.org/10.1371/journal.pone.0191509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370224	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600059
J	Guimaraes, BR; Pimenta, LD; Massini, DA; dos Santos, D; Siqueira, LOD; Simionato, AR; dos Santos, LGA; Neiva, CM; Filho, DMP				Guimaraes, Bianca Rosa; Pimenta, Luciana Duarte; Massini, Danilo Alexandre; dos Santos, Daniel; da Cruz Siqueira, Leandro Oliveira; Simionato, Astor Reis; Almeida dos Santos, Luiz Gustavo; Neiva, Cassiano Merussi; Pessoa Filho, Dalton Muller			Muscle strength and regional lean body mass influence on mineral bone health in young male adults	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; OLDER MEN; OSTEOPOROTIC FRACTURES; AEROBIC EXERCISE; DENSITY; TURNOVER; SEX; METABOLISM	The relationship between muscle strength and bone mineral content (BMC) and bone mineral density (BMD) is supposed from the assumption of the mechanical stress influence on bone tissue metabolism. However, the direct relationship is not well established in younger men, since the enhancement of force able to produce effective changes in bone health, still needs to be further studied. This study aimed to analyze the influence of muscle strength on BMC and BMD in undergraduate students. Thirty six men (24.9 +/- 8.6 y/o) were evaluated for regional and whole-body composition by dual energy X-ray absorptiometry (DXA). One repetition maximum tests (1RM) were assessed on flat bench-press (BP), lat-pull down (LPD), leg-curl (LC), knee extension (KE), and leg-press 45 degrees (LP45) exercises. Linear regression modelled the relationships of BMD and BMC to the regional body composition and 1RM values. Measurements of dispersion and error (R-adj(2) and standard error of estimate (SEE)) were tested, setting. at <= 0.05. The BMD mean value for whole-body was 1.12 +/- 0.09 g/cm(2) and BMC attained 2477.9 +/- 379.2 g. The regional lean mass (LM) in upper-limbs (UL) (= 6.80 +/- 1.21 kg) was related to BMC and BMD for UL (R-adj(2) = 0.74, p<0.01, SEE = 31.0 g and R-adj(2) = 0.63, SEE = 0.08 g/cm(2)), and LM in lower-limbs (LL) (= 19.13 +/- 2.50 kg) related to BMC and BMD for LL (R-adj(2) = 0.68, p<0,01, SEE = 99.3 g and R-adj(2) = 0.50, SEE = 0.20 g/cm(2)). The 1RM in BP was related to BMD (R-adj(2) = 0.51, SEE = 0.09 g/cm(2)), which was the strongest relationship among values of 1RM for men; but, 1RM on LPD was related to BMC (R(adj)(2)j = 0.47, p<0.01, SEE = 44.6 g), and LC was related to both BMC (R-adj(2) = 0.36, p<0.01, SEE = 142.0 g) and BMD (R-adj(2) = 0.29, p<0.01, SEE = 0.23 g/cm(2)). Hence, 1RM for multi-joint exercises is relevant to BMC and BMD in young men, strengthening the relationship between force and LM, and suggesting both to parametrizes bone mineral health.	[Guimaraes, Bianca Rosa] Univ Alfenas Unifenas, Dept Physiotherapy, Divnopolis, MG, Brazil; [Guimaraes, Bianca Rosa; Pimenta, Luciana Duarte; dos Santos, Daniel] Univ Franca Unifran, Postgrad Program Hlth Promot, Sao Paulo, Brazil; [Massini, Danilo Alexandre; da Cruz Siqueira, Leandro Oliveira; Simionato, Astor Reis; Pessoa Filho, Dalton Muller] Sao Paulo State Univ UNESP, Biosci Inst Biosci, Postgrad Program Human Dev & Technol, Sao Paulo, Brazil; [Almeida dos Santos, Luiz Gustavo; Neiva, Cassiano Merussi; Pessoa Filho, Dalton Muller] Sao Paulo State Univ UNESP, Coll Sci, Dept Phys Educ, Sao Paulo, Brazil	Universidad de Franca; Universidade Estadual Paulista; Universidade Estadual Paulista	Filho, DMP (corresponding author), Sao Paulo State Univ UNESP, Biosci Inst Biosci, Postgrad Program Human Dev & Technol, Sao Paulo, Brazil.; Filho, DMP (corresponding author), Sao Paulo State Univ UNESP, Coll Sci, Dept Phys Educ, Sao Paulo, Brazil.	dmpf@fc.unesp.br	Filho, Dalton M Pessôa/B-9649-2012; Massini, Danilo Alexandre/V-3845-2018; Neiva, Cassiano Merussi/M-5273-2016; Santos, Daniel/J-5561-2016	Filho, Dalton M Pessôa/0000-0003-3975-9260; Massini, Danilo Alexandre/0000-0003-1088-0040; Neiva, Cassiano Merussi/0000-0003-1635-3209; Santos, Daniel/0000-0002-5565-2351	CNPq [CsF-PDE: 237942/2012-7]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Authors would like to thank CNPq (CsF-PDE: 237942/2012-7) to the fellowship support to Pessoa Filho, DM. Authors would like to thank all participants in university social program: Gymnasium at Sport Square (PROEX-UNESP-2013, 2014 and 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors would like to thanks CNPq (CsF-PDE: 237942/2012-7) to the fellowship support to Pessoa Filho, D.M. Even, authors would like to thanks all participants in university social program: Gymnasium at Sport Square (PROEX-UNESP-2013, 2014 and 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; Baechle TR, 2008, ESSENTIALS STRENGTH; Bocalini DS, 2009, J AGING HEALTH, V21, P519, DOI 10.1177/0898264309332839; Chien MY, 2000, CALCIFIED TISSUE INT, V67, P443, DOI 10.1007/s002230001180; DALSKY GP, 1988, ANN INTERN MED, V108, P824, DOI 10.7326/0003-4819-108-6-824; de Matos O, 2009, GYNECOL ENDOCRINOL, V25, P616, DOI 10.1080/09513590903015593; Eimori K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156991; Evans EM, 2007, MENOPAUSE, V14, P481, DOI 10.1097/01.gme.0000243570.78570.f7; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Heyward V., 1997, ADV FITNESS ASSESSME; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2; HUGHES VA, 1995, MED SCI SPORT EXER, V27, P967, DOI 10.1249/00005768-199507000-00004; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kohrt WM, 1998, J APPL PHYSIOL, V84, P372, DOI 10.1152/jappl.1998.84.1.372; Lee N, 2009, J BONE MINER METAB, V27, P456, DOI 10.1007/s00774-009-0059-5; Lenora J, 2007, OSTEOPOROSIS INT, V18, P1297, DOI 10.1007/s00198-007-0379-z; Locatelli V, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/235060; Makovey J, 2005, OSTEOPOROSIS INT, V16, P1495, DOI 10.1007/s00198-005-1841-4; Marques EA, 2016, OSTEOPOROSIS INT, V27, P1765, DOI 10.1007/s00198-015-3442-1; MARTIN D, 1993, J BONE MINER RES, V8, P931; Mayhew JL, 1995, MED SCI SPORTS EXERC, V27; Medical Advisory Secretariat, 2006, Ont Health Technol Assess Ser, V6, P1; MENKES A, 1993, J APPL PHYSIOL, V74, P2478, DOI 10.1152/jappl.1993.74.5.2478; Nana A, 2012, INT J SPORT NUTR EXE, V22, P313, DOI 10.1123/ijsnem.22.5.313; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Pertegas Diaz S., 2002, CORU A CAD ATEN PRIM, V9, P209; Proctor DN, 2000, OSTEOPOROSIS INT, V11, P944, DOI 10.1007/s001980070033; Starup-Linde J, 2016, BONE, V82, P69, DOI 10.1016/j.bone.2015.02.019; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097; Vincent KR, 2002, MED SCI SPORT EXER, V34, P17, DOI 10.1097/00005768-200201000-00004; Wang ZM, 2010, PHYS MED BIOL, V55, P2619, DOI 10.1088/0031-9155/55/9/013; Welsh L, 1996, EUR J APPL PHYSIOL O, V74, P511; Zehnacker Carol Hamilton, 2007, J Geriatr Phys Ther, V30, P79	37	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191769	10.1371/journal.pone.0191769	http://dx.doi.org/10.1371/journal.pone.0191769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370260	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600096
J	Landi, F; Calvani, R; Picca, A; Tosato, M; Martone, AM; D'Angelo, E; Serafini, E; Bernabei, R; Marzetti, E				Landi, Francesco; Calvani, Riccardo; Picca, Anna; Tosato, Matteo; Martone, Anna Maria; D'Angelo, Emanuela; Serafini, Elisabetta; Bernabei, Roberto; Marzetti, Emanuele			Impact of habitual physical activity and type of exercise on physical performance across ages in community-living people	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; OLDER-ADULTS; DISABILITY; LIFE; PREVALENCE; SARCOPENIA; FALLS	The maintenance of muscle function into late life protects against various negative health outcomes. The present study was undertaken to evaluate the impact of habitual physical activity and exercise types on physical performance across ages in community-living adults. The Longevity check-up 7+ (Lookup 7+) project is an ongoing cross-sectional survey conducted in unconventional settings (e.g., exhibitions, malls, and health promotion campaigns across Italy) that began on June 1st 2015. The project was designed to raise awareness in the general population on major lifestyle behaviors and risk factors for chronic diseases. Candidate participants are eligible for enrolment if they are at least 18 years of age and provide written informed consent. Physical performance is evaluated through the 5-repetition chair stand test. Analyses were conducted in 6,242 community-living adults enrolled between June 1st 2015 and June 30th 2017, after excluding 81 participants for missing values of the variables of interest. The mean age of the 6,242 participants was 54.4 years (standard deviation 15.2, range 18-98 years), and 3552 (57%) were women. The time to complete the chair stand test was similar from 18 to 40-44 years, and declined progressively across subsequent age groups. Overall, the performance on the chair stand test was better in physically active participants, who completed the test with a mean of 0.5 s less than sedentary enrollees (p < .001). After adjusting for potential confounders, a different distribution of physical performance across exercise intensities was observed, with better performance being recorded in participants engaged in more vigorous activities. Our findings suggest that regular physical activity modifies the age-related pattern of decline in physical performance, with greater benefits observed for more intensive activities. Efforts are needed from health authorities and healthcare providers to promote the large-scale adoption of an active lifestyle throughout the life course.	[Landi, Francesco; Calvani, Riccardo; Picca, Anna; Tosato, Matteo; Martone, Anna Maria; D'Angelo, Emanuela; Serafini, Elisabetta; Bernabei, Roberto; Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Teaching Hosp Agostino Gemelli, Dept Geriatr Neurosci & Orthoped, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Calvani, R (corresponding author), Univ Cattolica Sacro Cuore, Teaching Hosp Agostino Gemelli, Dept Geriatr Neurosci & Orthoped, Rome, Italy.	riccardo.calvani@gmail.com	Marzetti, Emanuele/A-9430-2010; Bernabei, Roberto/AAB-2704-2019; Calvani, Riccardo/K-2011-2018; Tosato, Matteo/J-3863-2018; Picca, Anna/K-2305-2018; martone, anna maria/AAB-7767-2019	Marzetti, Emanuele/0000-0001-9567-6983; Bernabei, Roberto/0000-0002-9197-004X; Calvani, Riccardo/0000-0001-5472-2365; Tosato, Matteo/0000-0001-5750-9746; Picca, Anna/0000-0001-7032-3487; D' Angelo, Emanuela/0000-0003-4763-8725; Martone, Anna Maria/0000-0002-0981-0347	Italia Longeva; Marche Region; Ferrarini; Tedaldi; Fileni; Elanco; Danone Italia; Merck Sharp Dohme Italia; Fondazione Roma (NCDs); Innovative Medicine Initiative Joint Undertaking (IMI-JU) [115621]; Catholic University of the Sacred Heart [D3.2 2013, D3.2 2015]; Centro Studi Achille e Linda Lorenzon"	Italia Longeva; Marche Region(Regione Marche); Ferrarini; Tedaldi; Fileni; Elanco; Danone Italia(Danone Nutricia); Merck Sharp Dohme Italia; Fondazione Roma (NCDs)(Fondazione Roma); Innovative Medicine Initiative Joint Undertaking (IMI-JU); Catholic University of the Sacred Heart; Centro Studi Achille e Linda Lorenzon"	The Lookup 7+ project was supported by Italia Longeva, Marche Region, Ferrarini, Tedaldi, Fileni, Elanco, Danone Italia, and Merck Sharp & Dohme Italia. The study was also partly supported by Fondazione Roma (NCDs call for proposals 2013; A.P., R.B.), Innovative Medicine Initiative Joint Undertaking (IMI-JU #115621; E.M., F.L., M.T., R.B., R.C.), Intramural Research Grant from the Catholic University of the Sacred Heart (D3.2 2013 and D3.2 2015; F.L.), and the nonprofit research foundation "Centro Studi Achille e Linda Lorenzon" (A.P., E.M., R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvani R, 2013, J FRALITY AGING, V2, P38; Cesari M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00192; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2014, CLIN MED, V14, P183, DOI 10.7861/clinmedicine.14-2-183; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fielding RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182155; Garatachea N, 2015, REJUV RES, V18, P57, DOI 10.1089/rej.2014.1623; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall KS, 2017, J GERONTOL A-BIOL, V72, P572, DOI 10.1093/gerona/glw120; Hirsch CH, 2010, J AGING PHYS ACTIV, V18, P313, DOI 10.1123/japa.18.3.313; IACOBUCCI G, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3995; Landi F, 2007, J CLIN EPIDEMIOL, V60, P518, DOI 10.1016/j.jclinepi.2006.09.010; Landi F, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.10.007; Landi F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008281; Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mangani I, 2008, AGING CLIN EXP RES, V20, P234; Marzetti E, 2017, AGING CLIN EXP RES, V29, P35, DOI 10.1007/s40520-016-0705-4; Matsunaga T, 2017, J EPIDEMIOL, V27, P538, DOI 10.1016/j.je.2016.11.004; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Pearson SJ, 2002, MED SCI SPORT EXER, V34, P1199, DOI 10.1097/00005768-200207000-00023; Rapi S, 2009, TRANSL RES, V153, P71, DOI 10.1016/j.trsl.2008.11.010; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Tanaka H, 2003, J APPL PHYSIOL, V95, P2152, DOI 10.1152/japplphysiol.00320.2003; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Vetrano DL, 2013, EUR J PUBLIC HEALTH, V23, P858, DOI 10.1093/eurpub/ckt130; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	30	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191820	10.1371/journal.pone.0191820	http://dx.doi.org/10.1371/journal.pone.0191820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370306	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600102
J	Nuzum, D; Meaney, S; O'Donoghue, K				Nuzum, Daniel; Meaney, Sarah; O'Donoghue, Keelin			The impact of stillbirth on bereaved parents: A qualitative study	PLOS ONE			English	Article							NEONATAL DEATH; PERINATAL LOSS; CARE; EXPERIENCES; PROFESSIONALS; IRELAND; TIME	Purpose To explore the lived experiences and personal impact of stillbirth on bereaved parents. Methods Semi-structured in-depth interviews analysed by Interpretative Phenomenological Analysis (IPA) on a purposive sample of parents of twelve babies born following fetal death at a tertiary university maternity hospital in Ireland with a birth rate of c8,500 per annum and a stillbirth rate of 4.6/1000. Results Stillbirth had a profound and enduring impact on bereaved parents. Four superordinate themes relating to the human impact of stillbirth emerged from the data: maintaining hope, importance of the personhood of the baby, protective care and relationships (personal and professional). Bereaved parents recalled in vivid detail their experiences of care following diagnosis of stillbirth and their subsequent care. The time between diagnosis of a life-limiting anomaly or stillbirth and delivery is highlighted as important for parents as they find meaning in their loss. Conclusions The impact of stillbirth on bereaved parents is immense and how parents are cared for is recalled in precise detail as they revisit their experience. Building on existing literature, these data bring to light the depth of personal experience and impact of stillbirth for parents and provides medical professionals with valuable insights to inform their care of bereaved parents and the importance of clear and sensitive communication.	[Nuzum, Daniel; O'Donoghue, Keelin] Cork Univ, Univ Coll Cork, Dept Obstet & Gynaecol, Matern Hosp, Cork, Ireland; [Meaney, Sarah] Cork Univ, Univ Coll Cork, Natl Perinatal Epidemiol Ctr, Matern Hosp, Cork, Ireland; [O'Donoghue, Keelin] Univ Coll Cork, Dept Obstet & Gynaecol, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland	University College Cork; University College Cork; University College Cork	Nuzum, D (corresponding author), Cork Univ, Univ Coll Cork, Dept Obstet & Gynaecol, Matern Hosp, Cork, Ireland.	Daniel.nuzum@ucc.ie	Nuzum, Daniel/AAS-7841-2020	Nuzum, Daniel/0000-0002-9907-5680; O'Donoghue, Keelin/0000-0002-4616-2887				Badenhorst W, 2007, BEST PRACT RES CL OB, V21, P249, DOI 10.1016/j.bpobgyn.2006.11.004; Bennett SM, 2008, J LOSS TRAUMA, V13, P485, DOI 10.1080/15325020802171268; Biggerstaff D., 2008, QUAL RES PSYCHOL, V5, P214, DOI [10.1080/14780880802314304, DOI 10.1080/14780880802314304]; Burden C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0800-8; Cacciatore J, 2007, J SOC WORK END-LIFE, V3, P59, DOI 10.1300/J457v03n03_06; Cacciatore J, 2010, SOC WORK HEALTH CARE, V49, P134, DOI 10.1080/00981380903158078; Corcoran P, 2016, NATL PERINATAL EPIDE; Downe S, 2013, OBSTET GYNAECOL, V3, P2, DOI DOI 10.1136/BMJ0PEN-2012-002237; Eireann O., 2013, PROTECTION LIFE PREG; Ellis A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0806-2; Erlandsson K, 2011, J SOC WORK END-LIFE, V7, P139, DOI 10.1080/15524256.2011.593152; Flenady V, 2014, BJOG-INT J OBSTET GY, V121, P137, DOI 10.1111/1471-0528.13009; Flenady V, 2008, COCHRANE DATABASE SY; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Froen JF, 2016, LANCET, V387, P574, DOI 10.1016/S0140-6736(15)00818-1; Heazell AEP, 2012, BJOG-INT J OBSTET GY, V119, P987, DOI 10.1111/j.1471-0528.2012.03357.x; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Horey D, 2014, HEALTH EXPECT, V17, P534, DOI 10.1111/j.1369-7625.2012.00782.x; Horey D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009932.pub2; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Meaney S, 2014, HLTH EXPECT; Mills TA, 2014, BJOG-INT J OBSTET GY, V121, P943, DOI 10.1111/1471-0528.12656; Nuzum D, 2018, BJOG-INT J OBSTET GY, V125, P246, DOI 10.1111/1471-0528.14939; Nuzum D, 2014, BJOG-INT J OBSTET GY, V121, P1020, DOI 10.1111/1471-0528.12695; Nuzum D, 2017, PRACT THEOL, V10, P187, DOI 10.1080/1756073X.2017.1296062; Nuzum D, 2017, J RELIG HEALTH, V56, P1081, DOI 10.1007/s10943-017-0365-5; Nuzum D, 2016, BMJ SUPPORT PALLIAT, V6, P194, DOI 10.1136/bmjspcare-2013-000533; O'Connell O, 2015, WOMEN HLTH; O'Connell O, 2016, WOMEN BIRTH, V29, P345, DOI 10.1016/j.wombi.2016.01.003; O'Connell O, 2014, J PALLIAT CARE, V30, P219; OFarrell I, 2017, PERINATAL MORTALITY; Peters MDJ, 2016, J PERINATOL, V36, P3, DOI 10.1038/jp.2015.97; Radestad I., 2011, BRIT J MIDWIFERY, V19, P646; Schott J., 2009, BRIT J MIDWIFERY, V17, P798; Smith JA, 2009, QUAL RES PSYCHOL; Warland J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0602-4	36	46	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191635	10.1371/journal.pone.0191635	http://dx.doi.org/10.1371/journal.pone.0191635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364937	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500063
J	Brown, TA; Galicia, MP; Thiemann, GW; Belt, ST; Yurkowski, DJ; Dyck, MG				Brown, Thomas A.; Galicia, Melissa P.; Thiemann, Gregory W.; Belt, Simon T.; Yurkowski, David J.; Dyck, Markus G.			High contributions of sea ice derived carbon in polar bear (&ITUrsus maritimus&IT) tissue	PLOS ONE			English	Article							BRANCHED ISOPRENOID ALKENES; ALGAE-PRODUCED CARBON; COD BOREOGADUS-SAIDA; WESTERN BARENTS SEA; CUMBERLAND SOUND; H-PRINT; FATTY-ACIDS; BIOMARKER; IDENTIFICATION; PHYTOPLANKTON	Polar bears (Ursus maritimus) rely upon Arctic sea ice as a physical habitat. Consequently, conservation assessments of polar bears identify the ongoing reduction in sea ice to represent a significant threat to their survival. However, the additional role of sea ice as a potential, indirect, source of energy to bears has been overlooked. Here we used the highly branched isoprenoid lipid biomarker-based index (H-Print) approach in combination with quantitative fatty acid signature analysis to show that sympagic (sea ice-associated), rather than pelagic, carbon contributions dominated the marine component of polar bear diet (72-100%; 99% CI, n = 55), irrespective of differences in diet composition. The lowest mean estimates of sympagic carbon were found in Baffin Bay bears, which were also exposed to the most rapidly increasing open water season. Therefore, our data illustrate that for future Arctic ecosystems that are likely to be characterised by reduced sea ice cover, polar bears will not only be impacted by a change in their physical habitat, but also potentially in the supply of energy to the ecosystems upon which they depend. This data represents the first quantifiable baseline that is critical for the assessment of likely ongoing changes in energy supply to Arctic predators as we move into an increasingly uncertain future for polar ecosystems.	[Brown, Thomas A.] Scottish Assoc Marine Sci, Marine Ecol & Chem, Oban, Argyll, Scotland; [Brown, Thomas A.; Belt, Simon T.] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England; [Galicia, Melissa P.] York Univ, Dept Biol, Toronto, ON, Canada; [Thiemann, Gregory W.] York Univ, Fac Environm Studies, Toronto, ON, Canada; [Yurkowski, David J.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Dyck, Markus G.] Govt Nunavut, Dept Environm, Wildlife Res Sect, Igloolik, NU, Canada	UHI Millennium Institute; University of Plymouth; York University - Canada; York University - Canada; University of Manitoba	Brown, TA (corresponding author), Scottish Assoc Marine Sci, Marine Ecol & Chem, Oban, Argyll, Scotland.; Brown, TA (corresponding author), Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England.	thomas.brown@sams.ac.uk	Thiemann, Gregory/J-9517-2013; Galicia, Melissa/AAO-1888-2020	Galicia, Melissa/0000-0002-3505-2762; Yurkowski, David/0000-0003-2264-167X; Thiemann, Gregory/0000-0002-1888-900X; Brown, Thomas/0000-0003-0322-474X	Nunavut General Monitoring Plan; W. Garfield Weston Foundation; Environment and Climate Change Canada; Kenneth M. Molson Foundation; Natural Sciences and Engineering Research Council (NSERC) Canada; Leverhulme Trust [RPG-2014-021]	Nunavut General Monitoring Plan; W. Garfield Weston Foundation; Environment and Climate Change Canada; Kenneth M. Molson Foundation; Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leverhulme Trust(Leverhulme Trust)	H-Print work was funded by the award of a Research Project Grant (RPG-2014-021) from the Leverhulme Trust to STB. QFASA work was funded by the Natural Sciences and Engineering Research Council (NSERC) Canada to GWT, Environment and Climate Change Canada, Kenneth M. Molson Foundation and Nunavut General Monitoring Plan with analysis performed at the Canadian Institute of Fisheries Technology, Dalhousie University. DJY was supported by The W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup S, 2015, IUCN RED LIST THREAT; [Anonymous], 2021, LANG ENV STAT COMP; Belt ST, 2007, ORG GEOCHEM, V38, P16, DOI 10.1016/j.orggeochem.2006.09.013; Belt ST, 2017, ORG GEOCHEM, V110, P65, DOI 10.1016/j.orggeochem.2017.05.007; Belt ST, 2013, ORG GEOCHEM, V62, P33, DOI 10.1016/j.orggeochem.2013.07.002; Belt ST, 2000, CHEM COMMUN, P501, DOI 10.1039/a909670a; Belt ST, 2000, GEOCHIM COSMOCHIM AC, V64, P3839, DOI 10.1016/S0016-7037(00)00464-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Bromaghin JF, 2015, ECOL EVOL, V5, P1249, DOI 10.1002/ece3.1429; Brown TA, 2017, LIMNOL OCEANOGR, V62, P1606, DOI 10.1002/lno.10520; Brown TA, 2016, MAR ECOL PROG SER, V546, P17, DOI 10.3354/meps11668; Brown TA, 2014, LIMNOL OCEANOGR, V59, P1581, DOI 10.4319/lo.2014.59.5.1581; Brown TA, 2014, ENVIRON CHEM LETT, V12, P455, DOI 10.1007/s10311-014-0472-4; Brown TA, 2015, POLAR BIOL, V38, P37, DOI 10.1007/s00300-013-1352-2; Brown TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5197; Brown TA, 2017, J PLANKTON RES, V39, P664, DOI 10.1093/plankt/fbx030; Brown TA, 2017, J EXP MAR BIOL ECOL, V488, P32, DOI 10.1016/j.jembe.2016.12.007; Brown TA, 2012, J PLANKTON RES, V34, P647, DOI 10.1093/plankt/fbs045; Brown TA, 2012, POLAR BIOL, V35, P131, DOI 10.1007/s00300-011-1045-7; Brown TA, 2011, POLAR BIOL, V34, P1857, DOI 10.1007/s00300-010-0942-5; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Cherry SG, 2016, ECOL EVOL, V6, P5032, DOI 10.1002/ece3.2233; Fernandez-Mendez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107452; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; Forest A, 2011, J PLANKTON RES, V33, P161, DOI 10.1093/plankt/fbq103; Galicia MP, 2016, ECOL EVOL, V6, P6005, DOI 10.1002/ece3.2173; Galicia MP, 2015, POLAR BIOL, V38, P1983, DOI 10.1007/s00300-015-1757-1; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Grossi V, 2004, PHYTOCHEMISTRY, V65, P3049, DOI 10.1016/j.phytochem.2004.09.002; Hannah CG, 2009, ARCTIC, V62, P83; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Juul-Pedersen T, 2008, MAR ECOL PROG SER, V353, P13, DOI 10.3354/meps07165; Kohlbach D, 2017, PROG OCEANOGR, V152, P62, DOI 10.1016/j.pocean.2017.02.003; Kohlbach D, 2016, LIMNOL OCEANOGR, V61, P2027, DOI 10.1002/lno.10351; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Marcoux M, 2012, MAR ECOL PROG SER, V471, P283, DOI 10.3354/meps10029; Matley JK, 2013, MAR BIOL, V160, P2993, DOI 10.1007/s00227-013-2289-2; McKinney MA, 2012, ENVIRON SCI TECHNOL, V46, P9914, DOI 10.1021/es302761p; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Meier WN, 2017, SEA ICE, P664; Morata N, 2008, DEEP-SEA RES PT II, V55, P2381, DOI 10.1016/j.dsr2.2008.05.004; MUIR DCG, 1988, ENVIRON SCI TECHNOL, V22, P1071, DOI 10.1021/es00174a012; Obbard ME, 2016, ARCT SCI, V2, P15, DOI 10.1139/as-2015-0027; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0556; Renaud PE, 2008, DEEP-SEA RES PT II, V55, P2372, DOI 10.1016/j.dsr2.2008.05.017; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; SARGENT JR, 1981, MAR BIOL, V62, P131, DOI 10.1007/BF00388175; Sciullo L, 2016, J ZOOL, V300, P45, DOI 10.1111/jzo.12354; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Stern HL, 2016, CRYOSPHERE, V10, P2027, DOI 10.5194/tc-10-2027-2016; Stewart D. B., 2007, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2796, P1; STIRLING I, 1993, ARCTIC, V46, P240; Sun MY, 2007, J MAR RES, V65, P561, DOI 10.1357/002224007782689094; SWG [Scientific Working Group to the Canada-Greenland Joint Commission on Polar Bear], 2016, 2016 REASS BAFF BAY; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; Tremblay JE, 2006, PROG OCEANOGR, V71, P402, DOI 10.1016/j.pocean.2006.10.006; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; VOLKMAN JK, 1994, ORG GEOCHEM, V21, P407, DOI 10.1016/0146-6380(94)90202-X; Werner I, 1997, MAR ECOL PROG SER, V160, P93, DOI 10.3354/meps160093; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Yurkowski DJ, 2016, OECOLOGIA, V180, P631, DOI 10.1007/s00442-015-3384-5	69	32	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191631	10.1371/journal.pone.0191631	http://dx.doi.org/10.1371/journal.pone.0191631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360849	Green Published, gold			2022-12-26	WOS:000423161800044
J	Kim, SY; Kim, MS; Park, B; Kim, JH; Choi, HG				Kim, So Young; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			Lack of sleep is associated with internet use for leisure	PLOS ONE			English	Article							ADOLESCENT SLEEP; MEDIA USE; EMERGING ADULTS; DEPRIVATION; SYMPTOMS; BEHAVIORS; PATTERNS; EXPOSURE; QUALITY	Objective & para;& para;Previous studies have suggested that excessive internet use may cause lack of sleep. However, recent studies have hypothesized that lack of sleep may instigate internet use for leisure. To elucidate the potential effects of sleep time on internet use, we explored the different associations between sleep time and internet use according to its purpose.& para;& para;Methods & para;& para;The population-based, cross-sectional study group from the Korea Youth Risk Behavior Web-based Survey (KYRBWS) collected data from 57,425 middle school students in 2014 and 2015. Sleep time over the past 7 days was classified into the following groups: <7 h (6 h); >= 7 h, <8 h (7 h); >= 8 h, <9 h (8 h); and >= 9 h (9+ h). Internet use time per day was separately surveyed for leisure and for study and categorized as follows: 0 h; > 0 h, <= 1 h (1 h); > 1 h, <= 2 h (2 h); and >2 h (2+ h) per day. Information on age, sex, region of residence, body mass index (BMI), economic level, parental education level, stress level, school performance level, and sleep satisfaction were retrieved. The relationships between sleep time and internet use time for leisure/study were analyzed using multinomial logistic regression with complex sampling. In the subgroup analysis according to sleep satisfaction (good, normal, and poor), the associations of sleep time with internet use for leisure were analyzed using the same methods.& para;& para;Results & para;& para;Compared to 9+ h of sleep, less sleep was related to a long internet use time (2+ h) for leisure (adjusted odds ratio, AOR [95% confidence interval, Cl] of sleep: 8 h = 1.23 [1.14-1.32]; 7 h = 1.42 [1.31-1.54]; and 6 h = 1.56 [1.44-1.70]; P < 0.001). Conversely, a relationship between less sleep and a long internet use time (2+ h) for study was evident only for 6 h of sleep (AOR of sleep: 8 h = 0.84 [0.84-1.04]; 7 h = 1.05 [0.94-1.17]; and 6 h = 1.32 [1.271.59]; P < 0.001). In the subgroup analysis according to sleep satisfaction, less sleep was associated with a long internet use time for leisure in all sleep satisfaction groups, although the relationship was more significant in the lower sleep satisfaction group.& para;& para;Conclusion & para;& para;Less sleep was significantly related to long-term use of the internet for leisure, whereas this association was not definite for internet use for study. Furthermore, poor sleep quality potentiated the relationship between less sleep time and internet use for leisure.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Min-Su] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SK, 2013, HEALTH SERV INSIGHTS, V6, P99, DOI 10.4137/HSI.S11083; An J, 2014, J ADDICT MED, V8, P282, DOI 10.1097/ADM.0000000000000026; [Anonymous], 2009, RELIABILITY VALIDITY; Arora T, 2014, SLEEP MED, V15, P240, DOI 10.1016/j.sleep.2013.08.799; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Barnes JC, 2015, J YOUTH ADOLESCENCE, V44, P489, DOI 10.1007/s10964-014-0137-4; Bartel K, 2016, SLEEP MED, V26, P97, DOI 10.1016/j.sleep.2016.07.007; Bickham DS, 2015, INT J PUBLIC HEALTH, V60, P147, DOI 10.1007/s00038-014-0647-6; Blau Gary, 2006, J Allied Health, V35, P9; Bonnaire C, 2017, PSYCHIAT RES, V255, P104, DOI 10.1016/j.psychres.2017.05.030; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Centers for Disease Control and Prevention, BMI CHILDR TEENS; Chen YL, 2016, J SLEEP RES, V25, P458, DOI 10.1111/jsr.12388; de Bruin EJ, 2017, SLEEP MED REV, V32, P45, DOI 10.1016/j.smrv.2016.02.006; Gamble AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111700; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P17, DOI 10.3928/02793695-20101208-01; Hysing M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006748; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174878; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135753; Kong IG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001965; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lemola S, 2015, J YOUTH ADOLESCENCE, V44, P405, DOI 10.1007/s10964-014-0176-x; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117372; Matos MG, 2016, INT J PSYCHOL, V51, P323, DOI 10.1002/ijop.12167; Meldrum RC, 2015, J YOUTH ADOLESCENCE, V44, P465, DOI 10.1007/s10964-013-0024-4; Paiva T, 2016, SLEEP SCI, V9, P7, DOI 10.1016/j.slsci.2016.02.176; Paiva T, 2015, SLEEP MED, V16, P521, DOI 10.1016/j.sleep.2014.10.010; Park S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1143; Peach HD, 2013, J ADOLESCENT HEALTH, V53, P293, DOI 10.1016/j.jadohealth.2013.03.012; Rikkers W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3058-1; Schneider LA, 2017, J BEHAV ADDICT, V6, P321, DOI 10.1556/2006.6.2017.035; Shochat T, 2010, ACTA PAEDIATR, V99, P1396, DOI 10.1111/j.1651-2227.2010.01821.x; Short MA, 2015, SLEEP MED, V16, P987, DOI 10.1016/j.sleep.2015.03.007; Tavernier R, 2014, J SLEEP RES, V23, P389, DOI 10.1111/jsr.12132; Van den Bulck Jan, 2010, Adolesc Med State Art Rev, V21, P418; Wagner DT, 2012, J APPL PSYCHOL, V97, P1068, DOI 10.1037/a0027557; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yen CF, 2010, INT J EAT DISORDER, V43, P565, DOI 10.1002/eat.20683; Zhang HY, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01482	40	20	21	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191713	10.1371/journal.pone.0191713	http://dx.doi.org/10.1371/journal.pone.0191713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360882	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800054
J	Contreras, C; Villasana, M; Hendzel, MJ; Carrero, G				Contreras, Carlos; Villasana, Minaya; Hendzel, Michael J.; Carrero, Gustavo			Using a model comparison approach to describe the assembly pathway for histone H1	PLOS ONE			English	Article							LINKER HISTONE; FLUORESCENCE RECOVERY; CHROMATIN-STRUCTURE; NUCLEAR PROTEINS; IN-VIVO; BINDING; HETEROCHROMATIN; NUCLEOSOME; EXCHANGE; MOBILITY	Histones H1 or linker histones are highly dynamic proteins that diffuse throughout the cell nucleus and associate with chromatin (DNA and associated proteins). This binding interaction of histone H1 with the chromatin is thought to regulate chromatin organization and DNA accessibility to transcription factors and has been proven to involve a kinetic process characterized by a population that associates weakly with chromatin and rapidly dissociates and another population that resides at a binding site for up to several minutes before dissociating. When considering differences between these two classes of interactions in a mathematical model for the purpose of describing and quantifying the dynamics of histone H1, it becomes apparent that there could be several assembly pathways that explain the kinetic data obtained in living cells. In this work, we model these different pathways using systems of reaction-diffusion equations and carry out a model comparison analysis using FRAP (fluorescence recovery after photobleaching) experimental data from different histone H1 variants to determine the most feasible mechanism to explain histone H1 binding to chromatin. The analysis favors four different chromatin assembly pathways for histone H1 which share common features and provide meaningful biological information on histone H1 dynamics. We show, using perturbation analysis, that the explicit consideration of high- and low-affinity associations of histone H1 with chromatin in the favored assembly pathways improves the interpretation of histone H1 experimental FRAP data. To illustrate the results, we use one of the favored models to assess the kinetic changes of histone H1 after core histone hyperacetylation, and conclude that this post-transcriptional modification does not affect significantly the transition of histone H1 from a weakly bound state to a tightly bound state.	[Contreras, Carlos] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Villasana, Minaya] Univ Simon Bolivar, Dept Comp Cient & Estadist, Caracas, Miranda, Venezuela; [Hendzel, Michael J.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Carrero, Gustavo] Athabasca Univ, Fac Sci & Technol, Ctr Sci, Edmonton, AB, Canada	University of Alberta; Simon Bolivar University; University of Alberta; Athabasca University	Carrero, G (corresponding author), Athabasca Univ, Fac Sci & Technol, Ctr Sci, Edmonton, AB, Canada.	gustavoc@athabascau.ca	Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945; Villasana, Minaya/0000-0002-3909-8549	Athabasca University; Academic Research Fund [21233, 21717]; Canadian Cancer Society Research Institute	Athabasca University; Academic Research Fund(Ministry of Education, Singapore); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by Athabasca University, Academic Research Fund, grant numbers: 21233 and 21717 (url: http//research.athabascau.ca/internal/arf.php) (GC) and Canadian Cancer Society Research Institute (url:http://www. cancer.ca/research/) (MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Burnham K. P., 2002, MODEL SELECTION AND; Campbell RE., 2008, SCHOLARPEDIA, V3, P5410, DOI [10.4249/scholarpedia.5410, DOI 10.4249/SCHOLARPEDIA.5410]; Carrero G, 2004, B MATH BIOL, V66, P1515, DOI 10.1016/j.bulm.2004.02.005; Carrero G, 2004, METHOD ENZYMOL, V375, P415; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Carrero G, 2009, AIP CONF PROC, V1168, P1306, DOI 10.1063/1.3241319; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Dou YL, 2002, J CELL BIOL, V158, P1161, DOI 10.1083/jcb.200202131; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gonzalez-Perez V, 2011, INTEGR BIOL-UK, V3, P197, DOI 10.1039/c0ib00098a; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; KOPPEL DE, 1979, BIOPHYS J, V28, P281, DOI 10.1016/S0006-3495(79)85176-0; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; PERRY CA, 1989, NUCLEIC ACIDS RES, V17, P4275, DOI 10.1093/nar/17.11.4275; Popova EY, 2013, J BIOL CHEM, V288, P17895, DOI 10.1074/jbc.M113.452144; Raghuram N, 2010, BIOCHEMISTRY-US, V49, P4420, DOI 10.1021/bi100296z; Raghuram N, 2009, BIOCHEM CELL BIOL, V87, P189, DOI 10.1139/O08-127; Rao J, 2007, BIOCHEM BIOPH RES CO, V363, P263, DOI 10.1016/j.bbrc.2007.08.120; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Tsibidis GD, 2008, J THEOR BIOL, V253, P755, DOI 10.1016/j.jtbi.2008.04.010; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191562	10.1371/journal.pone.0191562	http://dx.doi.org/10.1371/journal.pone.0191562			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352283	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300114
J	Han, SS; Park, GH; Lim, W; Kim, MS; Na, JI; Park, I; Chang, SE				Han, Seung Seog; Park, Gyeong Hun; Lim, Woohyung; Kim, Myoung Shin; Na, Jung Im; Park, Ilwoo; Chang, Sung Eun			Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomycosis datasets by region-based convolutional deep neural network	PLOS ONE			English	Article							CULTURE	Although there have been reports of the successful diagnosis of skin disorders using deep learning, unrealistically large clinical image datasets are required for artificial intelligence (AI) training. We created datasets of standardized nail images using a region-based convolutional neural network (R-CNN) trained to distinguish the nail from the background. We used R-CNN to generate training datasets of 49,567 images, which we then used to fine-tune the ResNet-152 and VGG-19 models. The validation datasets comprised 100 and 194 images from Inje University (B1 and B2 datasets, respectively), 125 images from Hallym University (C dataset), and 939 images from Seoul National University (D dataset). The AI (ensemble model; ResNet-152 + VGG-19 + feedforward neural networks) results showed test sensitivity/ specificity/ area under the curve values of (96.0 / 94.7 / 0.98), (82.7 / 96.7 / 0.95), (92.3 / 79.3 / 0.93), (87.7 / 69.3 / 0.82) for the B1, B2, C, and D datasets. With a combination of the B1 and C datasets, the AI Youden index was significantly (p = 0.01) higher than that of 42 dermatologists doing the same assessment manually. For B1+C and B2+D dataset combinations, almost none of the dermatologists performed as well as the AI. By training with a dataset comprising 49,567 images, we achieved a diagnostic accuracy for onychomycosis using deep learning that was superior to that of most of the dermatologists who participated in this study.	[Park, Gyeong Hun] Hallym Univ, Dept Dermatol, Dongtan Sacred Heart Hosp, Coll Med, Dongtan, South Korea; [Lim, Woohyung] SK Telecom, HMI Tech Lab, Seoul, South Korea; [Kim, Myoung Shin] Inje Univ, Coll Med, Dept Dermatol, Sanggye Paik Hosp, Seoul, South Korea; [Na, Jung Im] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Park, Ilwoo] Chonnam Natl Univ, Med Sch & Hosp, Dept Radiol, Gwangju, South Korea; [Chang, Sung Eun] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea	Hallym University; SK Group; SK Telecom; Inje University; Seoul National University (SNU); Chonnam National University; University of Ulsan	Chang, SE (corresponding author), Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea.	csesnumd@gmail.com	Han, Seung Seog/AAC-4185-2019; chang, sungeun/AAH-1247-2020		SK Telecom	SK Telecom	The authors received no specific funding for this work. SK Telecom provided support in the form of salaries for author WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; BINDER M, 1994, BRIT J DERMATOL, V130, P460, DOI 10.1111/j.1365-2133.1994.tb03378.x; Borkowski P, 2001, J AM PODIAT MED ASSN, V91, P351, DOI 10.7547/87507315-91-7-351; Canziani A., 2016, ANAL DEEP NEURAL NET, DOI DOI 10.48550/ARXIV.1605.07678; Codella NCF, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2708299; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Girshick R., 2014, CVPR; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Jeelani S, 2015, MYCOSES, V58, P27, DOI 10.1111/myc.12251; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Karimzadegan-Nia M, 2007, AUSTRALAS J DERMATOL, V48, P18, DOI 10.1111/j.1440-0960.2007.00320.x; Lawry MA, 2000, ARCH DERMATOL, V136, P1112, DOI 10.1001/archderm.136.9.1112; Liao H., 2016, DEEP LEARNING APPROA; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Velasquez-Agudelo V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2258-3; Zanardi D, 2008, AN BRAS DERMATOL, V83, P119, DOI 10.1590/S0365-05962008000200003	19	102	109	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191493	10.1371/journal.pone.0191493	http://dx.doi.org/10.1371/journal.pone.0191493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352285	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300098
J	Karthaus, M; Wascher, E; Getzmann, S				Karthaus, Melanie; Wascher, Edmund; Getzmann, Stephan			Proactive vs. reactive car driving: EEG evidence for different driving strategies of older drivers	PLOS ONE			English	Article							FRONTAL THETA; PERFORMANCE; AGE; FATIGUE; ATTENTION; RESPONSES; DEFICITS; ERRORS; ADULTS; SLEEP	Aging is associated with a large heterogeneity in the extent of age-related changes in sensory, motor, and cognitive functions. All these functions can influence the performance in complex tasks like car driving. The present study aims to identify potential differences in underlying cognitive processes that may explain inter-individual variability in driving performance. Younger and older participants performed a one-hour monotonous driving task in a driving simulator under varying crosswind conditions, while behavioral and electrophysiological data were recorded. Overall, younger and older drivers showed comparable driving performance ( lane keeping). However, there was a large difference in driving lane variability within the older group. Dividing the older group in two subgroups with low vs. high driving lane variability revealed differences between the two groups in electrophysiological correlates of mental workload, consumption of mental resources, and activation and sustaining of attention: Older drivers with high driving lane variability showed higher frontal Alpha and Theta activity than older drivers with low driving lane variability and-with increasing crosswind-a more pronounced decrease in Beta activity. These results suggest differences in driving strategies of older and younger drivers, with the older drivers using either a rather proactive and alert driving strategy (indicated by low driving lane variability and lower Alpha and Beta activity), or a rather reactive strategy (indicated by high driving lane variability and higher Alpha activity).	[Karthaus, Melanie; Wascher, Edmund; Getzmann, Stephan] TU Dortmund, Dept Ergon, IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Karthaus, M (corresponding author), TU Dortmund, Dept Ergon, IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany.	karthaus@ifado.de	Wascher, Edmund/B-8457-2019; Wascher, Edmund/N-6848-2019	Wascher, Edmund/0000-0003-3616-9767; Getzmann, Stephan/0000-0002-6382-0183	German Research Foundation (DFG) [KA 412072-1]; Open Access Fund of the Leibniz Association; Open Access Fund of the Technical University of Dortmund	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association; Open Access Fund of the Technical University of Dortmund	This work was supported by a grant awarded to MK by the German Research Foundation (DFG http/www.dfg.de/, KA 412072-1). The publication of this article was supported by the Open Access Fund of the Leibniz Association and by the Open Access Fund of the Technical University of Dortmund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding for this study.	Anstey KJ, 2012, ACCIDENT ANAL PREV, V45, P766, DOI 10.1016/j.aap.2011.10.006; Anstey KJ, 2011, NEUROPSYCHOLOGY, V25, P613, DOI 10.1037/a0023835; Ball K, 2003, J AM GERIATR SOC, V51, P1499, DOI 10.1046/j.1532-5415.2003.51487.x; Belanger A, 2010, ACCIDENT ANAL PREV, V42, P809, DOI 10.1016/j.aap.2009.07.010; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Centofanti SA, 2017, ACCIDENT ANAL PREV, V99, P416, DOI 10.1016/j.aap.2015.11.009; Federal Statistical Office of Germany, 2014, VERK UNF SEN STRASS; Fildes Brian, 2007, Annu Proc Assoc Adv Automot Med, V51, P559; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Garcia JO, 2017, NEUROIMAGE, V150, P239, DOI 10.1016/j.neuroimage.2017.02.057; Gola M, 2013, INT J PSYCHOPHYSIOL, V89, P334, DOI 10.1016/j.ijpsycho.2013.05.007; Goljahani A, 2012, NEUROIMAGE, V60, P774, DOI 10.1016/j.neuroimage.2011.12.001; Grandjean B., 1988, FITTING TASK MAN; Hahn M., 2013, AGE DIFFERENTIATED W, P299, DOI DOI 10.1007/978-3-642-35057-3_13; Hahn M, 2011, BRAIN RES, V1414, P66, DOI 10.1016/j.brainres.2011.07.051; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Horberry T, 2006, ACCIDENT ANAL PREV, V38, P185, DOI 10.1016/j.aap.2005.09.007; Horrey WJ, 2006, J EXP PSYCHOL-APPL, V12, P67, DOI 10.1037/1076-898X.12.2.67; Huang YZ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00368; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071; Karthaus M, 2015, BERICHTE BUNDESANSTA; KELLY JW, 2006, ACM T APPL PERCEPT, V3, P83, DOI DOI 10.1145/1141897.1141898; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Ott Brian R, 2010, Aging health, V6, P77, DOI 10.2217/ahe.09.83; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Park HL, 2003, INT J GERIATR PSYCH, V18, P1121, DOI 10.1002/gps.1023; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pesonen M, 2006, NEUROSCI LETT, V399, P45, DOI 10.1016/j.neulet.2006.01.053; Picot A, 2008, IEEE ENG MED BIO, P3864, DOI 10.1109/IEMBS.2008.4650053; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Staplin L., 2012, 811468A DOT HS; Verwey WB, 1996, J EXP PSYCHOL-APPL, V2, P270, DOI 10.1037/1076-898X.2.3.270; Wascher E, 2016, ACCIDENT ANAL PREV, V91, P157, DOI 10.1016/j.aap.2016.02.029; Wascher E, 2014, BIOL PSYCHOL, V96, P57, DOI 10.1016/j.biopsycho.2013.11.010; West SK, 2010, J GERONTOL A-BIOL, V65, P179, DOI 10.1093/gerona/glp136; Wikman AS, 2005, OPTOMETRY VISION SCI, V82, P716, DOI 10.1097/01.opx.0000174721.33377.b8; Yao DZ, 2017, BRAIN TOPOGR, V30, P161, DOI 10.1007/s10548-016-0543-x; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191500	10.1371/journal.pone.0191500	http://dx.doi.org/10.1371/journal.pone.0191500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352314	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300100
J	Goins, CM; Dajnowicz, S; Smith, MD; Parks, JM; Ronning, DR				Goins, Christopher M.; Dajnowicz, Steven; Smith, Micholas D.; Parks, Jerry M.; Ronning, Donald R.			Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into antigen 85 catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; PANCREATIC LIPASE; INHIBITOR; MECHANISM; THIOESTERASE; ORLISTAT; NEUTRON; SYSTEM	Mycobacterium tuberculosis antigen 85 (Ag85) enzymes catalyze the transfer of mycolic acid ( MA) from trehalose monomycolate to produce the mycolyl arabinogalactan (mAG) or trehalose dimycolate (TDM). These lipids define the protective mycomembrane of mycobacteria. The current model of substrate binding within the active sites of Ag85s for the production of TDM is not sterically and geometrically feasible; additionally, this model does not account for the production of mAG. Furthermore, this model does not address how Ag85s limit the hydrolysis of the acyl-enzyme intermediate while catalyzing acyl transfer. To inform an updated model, we obtained an Ag85 acyl-enzyme intermediate structure that resembles the mycolated form. Here, we present a 1.45-angstrom X-ray crystal structure of M. tuberculosis Ag85C covalently modified by tetrahydrolipstatin (THL), an esterase inhibitor that suppresses M. tuberculosis growth and mimics structural attributes of MAs. The mode of covalent inhibition differs from that observed in the reversible inhibition of the human fatty-acid synthase by THL. Similarities between the Ag85-THL structure and previously determined Ag85C structures suggest that the enzyme undergoes structural changes upon acylation, and positioning of the peptidyl arm of THL limits hydrolysis of the acyl-enzyme adduct. Molecular dynamics simulations of the modeled mycolated-enzyme form corroborate the structural analysis. From these findings, we propose an alternative arrangement of substrates that rectifies issues with the previous model and suggest a direct role for the beta-hydroxy of MA in the second half-reaction of Ag85 catalysis. This information affords the visualization of a complete mycolyltransferase catalytic cycle.	[Goins, Christopher M.; Dajnowicz, Steven; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Dajnowicz, Steven] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Smith, Micholas D.; Parks, Jerry M.] Oak Ridge Natl Lab, UT ORNL, Ctr Biophys Mol, Biosci Div, Oak Ridge, TN 37831 USA; [Smith, Micholas D.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University System of Ohio; University of Toledo; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	Donald.Ronning@utoledo.edu	Parks, Jerry M./B-7488-2009; Smith, Micholas Dean/H-5267-2019	Parks, Jerry M./0000-0002-3103-9333; Smith, Micholas Dean/0000-0002-0777-7539; Ronning, Donald/0000-0003-2583-8849	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; United States Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work used resources of the Compute and Data Environment for Science (CADES) at Oak Ridge National Laboratory, which is managed by UT-Battelle, LLC for the United States Department of Energy under Contract DE-AC05-00OR22725.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2014, J BIOL CHEM, V289, P25041, DOI 10.1074/jbc.M114.581579; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Case D. A., 2016, AMBER 2016; Chen L, 2011, J PHYS CHEM B, V115, P13019, DOI 10.1021/jp206297d; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Copeland R. A., 2005, EVALUATION ENZYME IN, P214; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fako VE, 2014, ACS CATAL, V4, P3444, DOI 10.1021/cs500956m; Favrot L, 2014, J BIOL CHEM, V289, P25031, DOI 10.1074/jbc.M114.582445; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Fisher SZ, 2010, BIOCHEMISTRY-US, V49, P415, DOI 10.1021/bi901995n; Frisch G. W., 2013, GAUSSIAN 09; Goins CM, 2017, ACS INFECT DIS, V3, P378, DOI 10.1021/acsinfecdis.7b00003; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Periole X, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2404954; Ravindran MS, 2014, MOL CELL PROTEOMICS, V13, P435, DOI 10.1074/mcp.M113.029942; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Tomanicek SJ, 2013, J BIOL CHEM, V288, P4715, DOI 10.1074/jbc.M112.436238; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WEIBEL EK, 1987, J ANTIBIOT, V40, P1081, DOI 10.7164/antibiotics.40.1081; Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540	48	13	13	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3651	3662		10.1074/jbc.RA117.001681	http://dx.doi.org/10.1074/jbc.RA117.001681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352107	hybrid, Green Published			2022-12-26	WOS:000427030200019
J	Shobair, M; Popov, KI; Dang, YL; He, H; Stutts, MJ; Dokholyan, NV				Shobair, Mahmoud; Popov, Konstantin I.; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.			Mapping allosteric linkage to channel gating by extracellular domains in the human epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION-CHANNEL; DISCRETE MOLECULAR-DYNAMICS; DELTA-F508 CFTR; NA+ CHANNEL; NETWORKS; MUTATION; INHIBITION; ACTIVATION; STABILITY; PROTEINS	The epithelial sodium channel (ENaC) mediates sodium absorption in lung, kidney, and colon epithelia. Channels in the ENaC/degenerin family possess an extracellular region that senses physicochemical changes in the extracellular milieu and allosterically regulates the channel opening. Proteolytic cleavage activates the ENaC opening, by the removal of specific segments in the finger domains of the alpha- and gamma ENaC-subunits. Cleavage causes perturbations in the extracellular region that propagate to the channel gate. However, it is not known how the channel structure mediates the propagation of activation signals through the extracellular sensing domains. Here, to identify the structure-function determinants that mediate allosteric ENaC activation, we performed MD simulations, thiol modification of residues substituted by cysteine, and voltage-clamp electrophysiology recordings. Our simulations of an ENaC heterotetramer, alpha(1)beta alpha(2)gamma, in the proteolytically cleaved and uncleaved states revealed structural pathways in the alpha-subunit that are responsible for ENaC proteolytic activation. To validate these findings, we performed site-directed mutagenesis to introduce cysteine substitutions in the extracellular domains of the alpha-, beta-, and gamma ENaC-subunits. Insertion of a cysteine at the alpha-subunit Glu(557) site, predicted to stabilize a closed state of ENaC, inhibited ENaC basal activity and retarded the kinetics of proteolytic activation by 2-fold. Our results suggest that the lower palm domain of alpha ENaC is essential for ENaC activation. In conclusion, our integrated computational and experimental approach suggests key structure-function determinants for ENaC proteolytic activation and points toward a mechanistic model for the allosteric communication in the extracellular domains of the ENaC/degenerin family channels.	[Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Popov, Konstantin I.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stutts, MJ (corresponding author), 1113 Marsico Hall, Chapel Hill, NC 27599 USA.; Dokholyan, NV (corresponding author), 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jack_stutts@med.unc.edu; dokh@unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Shobair, Mahmoud/0000-0003-1684-9677	National Institutes of Health Program [P01 HL 110873-04, 110873-01]; National Institutes of Health [R01GM114015, R01GM064803, R01GM123247]; Cystic Fibrosis Foundation Award [STUTTS1610]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114015, R01GM123247, R01GM064803] Funding Source: NIH RePORTER	National Institutes of Health Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Program Project Grants P01 HL 110873-04 (to M. S.) and 110873-01 (to N. V. D. and M. J. S.), National Institutes of Health Grants R01GM114015, R01GM064803, and R01GM123247 (to N. V. D.), and Cystic Fibrosis Foundation Award STUTTS1610. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baker SE, 2011, RESP PHYSIOL NEUROBI, V179, P212, DOI 10.1016/j.resp.2011.08.007; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Berman JM, 2015, CHANNELS, V9, P281, DOI 10.1080/19336950.2015.1073869; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dokholyan NV, 1998, J STAT PHYS, V93, P603, DOI 10.1023/B:JOSS.0000033244.13545.da; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Moreau A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00053; Pedersen SF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00233; Proctor EA, 2016, CURR OPIN STRUC BIOL, V37, P9, DOI 10.1016/j.sbi.2015.11.001; Proctor EA, 2015, CHEM SCI, V6, P1237, DOI 10.1039/c4sc01320d; Ramaswamy SS, 2013, J BIOL CHEM, V288, P35896, DOI 10.1074/jbc.M113.478982; Rauh R, 2013, AM J PHYSIOL-LUNG C, V304, pL43, DOI 10.1152/ajplung.00093.2012; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ritz A, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.2; Rocks JW, 2017, P NATL ACAD SCI USA, V114, P2520, DOI 10.1073/pnas.1612139114; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Scardoni Giovanni, 2015, F1000Res, V4, P484; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Shobair M, 2016, J BIOL CHEM, V291, P3682, DOI 10.1074/jbc.M115.678052; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Swain SM, 2013, J MOL NEUROSCI, V51, P199, DOI 10.1007/s12031-013-9991-x; Yang HY, 2009, CELL RES, V19, P1035, DOI 10.1038/cr.2009.90; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	43	0	0	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3675	3684		10.1074/jbc.RA117.000604	http://dx.doi.org/10.1074/jbc.RA117.000604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358325	Green Published, hybrid			2022-12-26	WOS:000427030200021
J	Awine, T; Malm, K; Peprah, NY; Silal, SP				Awine, Timothy; Malm, Keziah; Peprah, Nana Yaw; Silal, Sheetal P.			Spatio-temporal heterogeneity of malaria morbidity in Ghana: Analysis of routine health facility data	PLOS ONE			English	Article							SCALING-UP; CLIMATE; IMPACT	Background Malaria incidence is largely influenced by vector abundance. Among the many interconnected factors relating to malaria transmission, weather conditions such as rainfall and temperature are known to create suitable environmental conditions that sustain reproduction and propagation of anopheles mosquitoes and malaria parasites. In Ghana, climatic conditions vary across the country. Understanding the heterogeneity of malaria morbidity using data sourced from a recently setup data repository for routine health facility data could support planning. Methods Monthly aggregated confirmed uncomplicated malaria cases from the District Health Information Management System and average monthly rainfall and temperature records obtained from the Ghana Meteorological Agency from 2008 to 2016 were analysed. Univariate time series models were fitted to the malaria, rainfall and temperature data series. After pre-whitening the morbidity data, cross correlation analyses were performed. Subsequently, transfer function models were developed for the relationship between malaria morbidity and rainfall and temperature. Results Malaria morbidity patterns vary across zones. In the Guinea savannah, morbidity peaks once in the year and twice in both the Transitional forest and Coastal savannah, following similar patterns of rainfall at the zonal level. While the effects of rainfall on malaria morbidity are delayed by a month in the Guinea savannah and Transitional Forest zones those of temperature are delayed by two months in the Transitional forest zone. In the Coastal savannah however, incidence of malaria is significantly associated with two months lead in rainfall and temperature. Conclusion Data captured on the District Health Information Management System has been used to demonstrate heterogeneity in the dynamics of malaria morbidity across the country. Timing of these variations could guide the deployment of interventions such as indoor residual spraying, Seasonal Malaria Chemoprevention or vaccines to optimise effectiveness on zonal basis.	[Awine, Timothy; Silal, Sheetal P.] Univ Cape Town, Dept Stat Sci, Modelling & Simulat Hub, Cape Town, South Africa; [Awine, Timothy] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, Stellenbosch, South Africa; [Malm, Keziah; Peprah, Nana Yaw] Minist Hlth, Natl Malaria Control Program, Accra, Ghana; [Silal, Sheetal P.] Univ Oxford, Nuffield Dept Med, Trop Dis Modelling, Oxford, England	University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; University of Oxford	Awine, T (corresponding author), Univ Cape Town, Dept Stat Sci, Modelling & Simulat Hub, Cape Town, South Africa.; Awine, T (corresponding author), Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, Stellenbosch, South Africa.	awinetimothy@gmail.com	Silal, Sheetal/AAB-1873-2020	Silal, Sheetal/0000-0002-3007-5383; Awine, Timothy/0000-0002-7340-6111	Department of Science and Technology National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA)	Department of Science and Technology National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA)	I hereby acknowledge the contributions of the South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa through the support of the Department of Science and Technology National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA) towards TA's PhD studies. The opinions expressed and conclusions arrived at, are those of the author and are not necessarily attributable to SACEMA.	Adaletey DL., 2014, J HLTH INFORM AFR, V2, P103; Ameme DK, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.367.4719; Awine T, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1381471; Awoonor-Williams JK, 2013, GLOB HEALTH-SCI PRAC, V1, P117, DOI 10.9745/GHSP-D-12-00012; Box G. E. P., 2016, TIME SERIES ANAL FOR; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Cleveland R.B., 1990, J OFF STAT, V6, P3; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Darkoh EL, 2017, MALAR RES TREAT, P1; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Ebi KL, 2005, CLIMATIC CHANGE, V73, P375, DOI 10.1007/s10584-005-6875-2; Frenken K, 2005, IRRIGATION AFRIQUE C; Ghana Statistical Service, 2016, PROJ POP SEX 2010 20; Ghana Statistical Service, 2011, GHAN MULP IND CLUST; Ghana Statistical Service Ghana Health Service, 2017, GHAN MAL IND SURV 20; Gyapong M, 2013, INT J EPIDEMIOL, V42, P1686, DOI 10.1093/ije/dyt197; Jaleta KT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-350; Klutse N. A. B., 2014, Open Journal of Ecology, V4, P764, DOI 10.4236/oje.2014.412065; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Lacombe G, 2012, HYDROLOG SCI J, V57, P1594, DOI 10.1080/02626667.2012.728291; McDowell A, 2002, STATA J, V2, P71, DOI 10.1177/1536867X0200200105; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; Nkrumah F, 2014, INT J GEOSCI, V5, P673, DOI DOI 10.4236/IJG.2014.57060; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Paquet T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9735; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; Tiedje KE, 2017, AM J TROP MED HYG, V97, P199, DOI 10.4269/ajtmh.16-0959; United States Agency for International Development, 2015, PRES MAL IN GHAN OP; United States Agency for International Development, 2017, GHAN MAL OP PLAN FY; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191707	10.1371/journal.pone.0191707	http://dx.doi.org/10.1371/journal.pone.0191707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377908	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700029
J	Muszynski, S; Tomaszewska, E; Kwiecien, M; Dobrowolski, P; Tomczyk-Warunek, A				Muszynski, Siemowit; Tomaszewska, Ewa; Kwiecien, Malgorzata; Dobrowolski, Piotr; Tomczyk-Warunek, Agnieszka			Subsequent somatic axis and bone tissue metabolism responses to a low-zinc diet with or without phytase inclusion in broiler chickens	PLOS ONE			English	Article							SUPPLEMENTAL MICROBIAL PHYTASE; GROWTH-PLATE; GEOMETRIC PARAMETERS; ARTICULAR-CARTILAGE; CANCELLOUS BONE; ORGANIC ZINC; PERFORMANCE; DEFICIENCY; PHOSPHORUS; COPPER	Zinc is required for normal bone development and cartilage formation. The purpose of this study was to assess the effect of with adding organic Zn (alone or phytase inclusion) at the reduced dose to growing male Ross 308 chickens on somatic axis and bone tissue metabolism. 200 one-day old broilers were divided into the negative control group fed diet without Zn or phytase inclusion, positive control group receiving Zn in the 100% of daily recommended dose from ZnO, and two experimental groups fed diet introduced Zn in 25% of daily recommendation as a glycine chelate (Zn-Gly) with or without phytase inclusion (500 FTU.kg(-1)). Supplemental organic Zn increased bone Zn and Mg content, serum IGF-1, growth hormone and leptin concentration. Additional phytase inclusion increased body weight gain, blood plasma Ca, Fe, Zn and osteocalcin concentration and tibia ash percentage when compared to the Zn-deprived control. Bone geometry, yield and ultimate strengths were enhanced in both organic Zn supplemented groups, and the overall mechanical strength parameters of bone were better in these groups than in the positive control group supplemented with standard dose of inorganic Zn. Also marked improvements in the thickness of articular and the growth plate cartilages as well as real bone volume and thickness of metaphyseal trabeculae were achieved in all broilers fed Zn-supplemented diet irrespective of phytase inclusion, however, the highest cancellous bone mass and the best trabecular structure were noted after ZnO supplementation. In concludion, although dietary organic Zn given to growing broilers in 25% of daily recommended dose improved general bone properties and mechanical strength, the obtained results do not allow to unambiguously state that organic Zn supplementation at this level, even after phytase inclusion, is sufficient for proper bone development.	[Muszynski, Siemowit] Univ Life Sci Lublin, Fac Prod Engn, Dept Phys, Lublin, Poland; [Tomaszewska, Ewa; Tomczyk-Warunek, Agnieszka] Univ Life Sci Lublin, Fac Vet Med, Dept Anim Physiol, Lublin, Poland; [Kwiecien, Malgorzata] Univ Life Sci Lublin, Dept Bromatol & Food Physiol, Lublin, Poland; [Dobrowolski, Piotr] Marie Curie Sklodowska Univ, Dept Comparat Anat & Anthropol, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin; University of Life Sciences in Lublin; Maria Curie-Sklodowska University	Muszynski, S (corresponding author), Univ Life Sci Lublin, Fac Prod Engn, Dept Phys, Lublin, Poland.	siemowit.muszynski@up.lublin.pl; ewaRST@interia.pl	Dobrowolski, Piotr Jerzy/R-7917-2019; Tomaszewska, Ewa/U-5490-2018; Muszyński, Siemowit/U-4945-2018	Dobrowolski, Piotr Jerzy/0000-0001-5873-9666; Tomaszewska, Ewa/0000-0002-7574-2653; Muszyński, Siemowit/0000-0002-4118-6302; Tomczyk-Warunek, Agnieszka/0000-0002-5007-7327; Kwiecien, Malgorzata/0000-0002-8047-8682				[Anonymous], 2014, ROSS 308 BROILER NUT; Ao T, 2007, BRIT POULTRY SCI, V48, P690, DOI 10.1080/00071660701694072; Ao T., 2006, INT J POULT SCI, V5, P808, DOI [10.3923/ijps.2006.808.811, DOI 10.3923/IJPS.2006.808.811]; AOAC International, 2011, OFFICIAL METHODS ANA; AOYAGI S, 1995, POULTRY SCI, V74, P121, DOI 10.3382/ps.0740121; Bao YM, 2009, BRIT POULTRY SCI, V50, P95, DOI 10.1080/00071660802590377; Bhardwaj P., 2015, J NUTR INTERMED META, V3, P33, DOI [10.1016/j.jnim.2015.12.333, 10.1016/jjnim.2015.12.333, DOI 10.1016/J.JNIM.2015.12.333]; Blicharski T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179693; Cao J, 2002, ANIM FEED SCI TECH, V101, P161, DOI 10.1016/S0377-8401(02)00051-2; Carbonare LD, 2004, J ENDOCRINOL INVEST, V27, P99, DOI 10.1007/BF03350919; Cheraghi S., 2012, ADV BIOL RES, V6, P128, DOI [10.5829/idosi.abr.2012.6.3.65146, DOI 10.5829/ID0SI.ABR.2012.6.3.65146]; CHERYAN M, 1980, CRC CR REV FOOD SCI, V13, P297, DOI 10.1080/10408398009527293; COOK ME, 1984, AVIAN DIS, V28, P1102, DOI 10.2307/1590286; Dobrowolski P, 2017, EXP BIOL MED, V242, P671, DOI 10.1177/1535370217693322; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; EDWARDS HM, 1983, J NUTR, V113, P1568, DOI 10.1093/jn/113.8.1568; Feng J, 2010, BIOL TRACE ELEM RES, V133, P203, DOI 10.1007/s12011-009-8431-9; FERREIRA RMCD, 1991, TERATOLOGY, V44, P441, DOI 10.1002/tera.1420440410; Freeland-Graves JH, 2015, J TRACE ELEM MED BIO, V31, P135, DOI 10.1016/j.jtemb.2014.04.006; FRUHBECK G, 1995, ANAL BIOCHEM, V225, P206, DOI 10.1006/abio.1995.1145; Greiner R, 2010, ENZYMES IN FARM ANIMAL NUTRITION, 2ND EDITION, P96, DOI 10.1079/9781845936747.0096; Hadley KB, 2010, J NUTR BIOCHEM, V21, P297, DOI 10.1016/j.jnutbio.2009.01.002; Humer E, 2015, J ANIM PHYSIOL AN N, V99, P605, DOI 10.1111/jpn.12258; Humer E, 2016, J TRACE ELEM MED BIO, V37, P69, DOI 10.1016/j.jtemb.2016.03.007; Ivanisinova O, 2016, ACTA VET BRNO, V85, P285, DOI 10.2754/avb201685030285; Jondreville C, 2007, ANIMAL, V1, P804, DOI 10.1017/S1751731107000328; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Kwiecien M, 2017, BIOL TRACE ELEM RES, V175, P204, DOI 10.1007/s12011-016-0743-y; Kwiecien M, 2014, ANN ANIM SCI, V14, P127, DOI 10.2478/aoas-2013-0085; LONG PH, 1984, AVIAN DIS, V28, P460, DOI 10.2307/1590353; Mantzoros CS, 1998, J AM COLL NUTR, V17, P270, DOI 10.1080/07315724.1998.10718758; Mavromichalis Ioannis, 2000, Journal of Food Composition and Analysis, V13, P799, DOI 10.1006/jfca.2000.0934; Mohanna C, 1999, ANIM FEED SCI TECH, V77, P241, DOI 10.1016/S0377-8401(98)00254-5; Mohanna C, 1999, BRIT POULTRY SCI, V40, P108, DOI 10.1080/00071669987926; Morgan NK, 2017, POULTRY SCI, V96, P1298, DOI 10.3382/ps/pew394; Muszynski S, 2017, BIOL TRAE E IN PRESS; Muszynski S, 2017, POULTRY SCI, V96, P491, DOI 10.3382/ps/pew301; Park SY, 2004, BIOL TRACE ELEM RES, V101, P147, DOI 10.1385/BTER:101:2:147; Ptak A, 2013, ARCH TIERZUCHT, V56, P1028, DOI 10.7482/0003-9438-56-104; Qian H, 1996, BRIT J NUTR, V76, P263, DOI 10.1079/BJN19960030; Qian H, 1996, POULTRY SCI, V75, P618, DOI 10.3382/ps.0750618; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; ROBERSON KD, 1994, POULTRY SCI, V73, P1312, DOI 10.3382/ps.0731312; Salgueiro MJ, 2002, NUTRITION, V18, P510, DOI 10.1016/S0899-9007(01)00812-7; Salim HM, 2012, BIOL TRACE ELEM RES, V147, P120, DOI 10.1007/s12011-011-9282-8; Samolinska W, 2017, BIOL TRACE ELEM RES, V176, P130, DOI 10.1007/s12011-016-0796-y; Schlegel P, 2013, ANIMAL, V7, P47, DOI 10.1017/S1751731112001000; Scrimgeour AG, 2007, J NUTR BIOCHEM, V18, P813, DOI 10.1016/j.jnutbio.2006.12.018; Sebastian S, 1996, POULTRY SCI, V75, P729, DOI 10.3382/ps.0750729; Seo HJ, 2010, NUTR RES PRACT, V4, P356, DOI 10.4162/nrp.2010.4.5.356; Sharideh H, 2015, IRAN J VET MED, V9, P263; Shelton JL, 2006, J APPL POULTRY RES, V15, P94, DOI 10.1093/japr/15.1.94; Shelton J. L., 2007, International Journal of Poultry Science, V6, P466; Stofanikova J, 2011, ACTA VET-BEOGRAD, V61, P531, DOI 10.2298/AVB1106531S; Swiatkiewicz S, 2008, VET MED-CZECH, V53, P555, DOI 10.17221/1966-VETMED; Swiatkiewicz S, 2001, J ANIM FEED SCI, V10, P317; Tomaszewska E, 2017, BRAZ J POULTRY SCI, V19, P159, DOI 10.1590/1806-9061-2016-0285; Tomaszewska E, 2017, J TRACE ELEM MED BIO, V42, P103, DOI 10.1016/j.jtemb.2017.05.002; Tomaszewska E, 2017, BIOL TRACE ELEM RES, V178, P54, DOI 10.1007/s12011-016-0894-x; Tomaszewska E, 2017, EXP TOXICOL PATHOL, V69, P131, DOI 10.1016/j.etp.2016.12.003; Tomaszewska E, 2016, ANN ANIM SCI, V16, P507, DOI 10.1515/aoas-2015-0087; Tomaszewska E, 2016, J VET MED SCI, V78, P563, DOI 10.1292/jvms.15-0385; Tomaszewska E, 2012, LIVEST SCI, V146, P175, DOI 10.1016/j.livsci.2012.03.008; Wang XB, 2002, J NUTR, V132, P665, DOI 10.1093/jn/132.4.665; Wu YB, 2004, J APPL POULTRY RES, V13, P373, DOI 10.1093/japr/13.3.373; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yi Z, 1996, POULTRY SCI, V75, P540, DOI 10.3382/ps.0750540	68	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191964	10.1371/journal.pone.0191964	http://dx.doi.org/10.1371/journal.pone.0191964			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373588	Green Published, gold, Green Submitted			2022-12-26	WOS:000423425400032
J	Collongues, N; Samama, B; Schmidt-Mutter, C; Chamard-Witkowski, L; Debouverie, M; Chanson, JB; Antal, MC; Benardais, K; de Seze, J; Velten, M; Boehm, N				Collongues, Nicolas; Samama, Brigitte; Schmidt-Mutter, Catherine; Chamard-Witkowski, Ludivine; Debouverie, Marc; Chanson, Jean-Baptiste; Antal, Maria-Cristina; Benardais, Karelle; de Seze, Jerome; Velten, Michel; Boehm, Nelly			Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIES; EPIDERMAL INNERVATION; SENSORY NEUROPATHY; AXONAL SWELLINGS; DISTAL LEG; DENSITY; DEGENERATION; GENDER; AGE	Background Skin biopsy is the most relevant tool to diagnose small-fiber neuropathy. A well-documented normal dataset for intraepidermal nerve fiber in the distal leg is required to improve its diagnostic value. Methods Three hundred healthy subjects were enrolled in the study, after clinical and biological screening to exclude neurological and systemic pathologies. A distal leg biopsy was taken and intraepidermal nerve fiber density after protein gene product-9.5 immunocytochemistry with brightfield microscopy was determined. Morphological variations of intraepidermal nerve fibers, previously described in small-fiber neuropathies, were analyzed. One hundred biopsies were also analyzed at the ultrastructural level. Findings The median number of fibers was lower in men compared to women and decreased with age. Using statistical modeling taking into account age and gender, we calculated the 5th percentile of intraepidermal nerve fiber density as follows: 7.6156 +/- 0.0769 x age (years) + 1.5506 x gender (woman = 1; man = 0). We observed a low frequency of large swellings or horizontal branchings but an increasing frequency of small swellings of intraepidermal nerve fibers and irregular distribution along the dermal-epidermal junction with age. Axonal diameter of unmyelinated fibers of the papillary dermis did not vary with age or gender. Ultrastructural analysis also showed that fiber endings in close apposition to Merkel cells should not be mistaken for small-fiber swellings. Conclusions Our dataset allows accurate calculation of the normal density of intraepidermal nerve fibers for each year of age and provides original morphological observations that improve the diagnostic value of skin biopsy in the distal leg for small-fiber neuropathy.	[Collongues, Nicolas; Chanson, Jean-Baptiste; de Seze, Jerome] Univ Hosp Strasbourg, Dept Neurol, Strasbourg, France; [Collongues, Nicolas; Schmidt-Mutter, Catherine; de Seze, Jerome] Univ Hosp Strasbourg, Clin Invest Ctr, INSERM, U1434, Strasbourg, France; [Collongues, Nicolas; Schmidt-Mutter, Catherine; de Seze, Jerome] Univ Hosp Strasbourg, INSERM, U1119, Biopathol Myelin Neuroprotect & Therapeut Strateg, Strasbourg, France; [Collongues, Nicolas; Samama, Brigitte; Schmidt-Mutter, Catherine; Chanson, Jean-Baptiste; Antal, Maria-Cristina; Benardais, Karelle; de Seze, Jerome; Boehm, Nelly] Univ Hosp Strasbourg, FMTS, Strasbourg, France; [Samama, Brigitte; Antal, Maria-Cristina; Benardais, Karelle; Boehm, Nelly] Univ Strasbourg, Inst Histol, Fac Med, Strasbourg, France; [Chamard-Witkowski, Ludivine] Univ Hosp Besancon, CH Jean Minjoz, Besancon, France; [Debouverie, Marc] Univ Hosp Nancy, Dept Neurol, Nancy, France; [Velten, Michel] Univ Strasbourg, Fac Med, EA3430, Dept Epidemiol & Publ Hlth, Strasbourg, France	CHU Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; CHU Besancon; CHU de Nancy; Universite de Lorraine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Collongues, N (corresponding author), Univ Hosp Strasbourg, Dept Neurol, Strasbourg, France.; Collongues, N (corresponding author), Univ Hosp Strasbourg, Clin Invest Ctr, INSERM, U1434, Strasbourg, France.; Collongues, N (corresponding author), Univ Hosp Strasbourg, INSERM, U1119, Biopathol Myelin Neuroprotect & Therapeut Strateg, Strasbourg, France.; Collongues, N (corresponding author), Univ Hosp Strasbourg, FMTS, Strasbourg, France.	nicolas.collongues@chru-strasbourg.fr	Schmidt-Mutter, Catherine/GPF-4620-2022; collongues, nicolas/J-9830-2016	Schmidt-Mutter, Catherine/0000-0002-8154-117X; collongues, nicolas/0000-0002-3683-5582	French Ministry of Health (PHRC IR) [4961]	French Ministry of Health (PHRC IR)	This study was supported by a grant from the French Ministry of Health (PHRC IR, 2011, HUS No 4961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Roland Bury for expert technical assistance with electron microscopy. We are grateful to all the members of the Clinical Investigation Centers (CIC) that participated in the study (INSERM CIC 1431, Besancon; INSERM CIC1434, Strasbourg). We are indebted to Professor Dufour (Centre d'Investigations Neurocognitives & Neurophysiologiques UMS 3489 CNRS / Universite de Strasbourg) for his collaboration in recruiting elderly subjects for this study. Statistical analysis was conducted by Dr. Michel Velten, University of Strasbourg, Faculty of Medicine, Department of Epidemiology and Public Health-EA3430, Strasbourg, France. This study was supported by a grant from the French Ministry of Health (PHRC IR, 2011, HUS No 4961).	Bakkers M, 2009, NEUROLOGY, V73, P1142, DOI 10.1212/WNL.0b013e3181bacf05; Chang YC, 2004, NEUROREPORT, V15, P149, DOI 10.1097/00001756-200401190-00029; Cheng HT, 2013, J PAIN, V14, P941, DOI 10.1016/j.jpain.2013.03.005; Chien HF, 2001, ACTA NEUROPATHOL, V102, P455; Collongues N, 2009, REV NEUROL-FRANCE, V165, P249, DOI 10.1016/j.neurol.2008.10.014; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Doppler K, 2015, PAIN, V156, P2319, DOI 10.1097/j.pain.0000000000000285; Ebenezer GJ, 2007, J NEUROPATH EXP NEUR, V66, P1059, DOI 10.1097/nen.0b013e31815c8989; Engelstad JK, 2012, NEUROLOGY, V79, P2187, DOI 10.1212/WNL.0b013e3182759608; Goransson LG, 2004, NEUROLOGY, V62, P774, DOI 10.1212/01.WNL.0000113732.41127.8F; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; Herrmann DN, 2004, MUSCLE NERVE, V29, P420, DOI 10.1002/mus.10567; Karlsson P, 2013, J NEUROPATH EXP NEUR, V72, P186, DOI 10.1097/NEN.0b013e318284e849; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KUMAKIRI M, 1978, BRIT J DERMATOL, V99, P65, DOI 10.1111/j.1365-2133.1978.tb01963.x; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lauria G, 1999, J NEUROL SCI, V164, P172, DOI 10.1016/S0022-510X(99)00063-5; Lauria G, 2003, NEUROLOGY, V61, P631, DOI 10.1212/01.WNL.0000070781.92512.A4; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; Nolano M, 2015, J PERIPHER NERV SYST, V20, P387, DOI 10.1111/jns.12146; Philippi N, 2011, REV NEUROL-FRANCE, V167, P607, DOI 10.1016/j.neurol.2011.01.011; Provitera V, 2016, EUR J NEUROL, V23, P333, DOI 10.1111/ene.12842; Rage M, 2011, J NEUROL, V258, P1852, DOI 10.1007/s00415-011-6031-z; Rajan B, 2003, J COMP NEUROL, V457, P24, DOI 10.1002/cne.10460; Reinisch CM, 2005, ANN NEUROL, V58, P88, DOI 10.1002/ana.20527; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701	28	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191614	10.1371/journal.pone.0191614	http://dx.doi.org/10.1371/journal.pone.0191614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370274	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600066
J	Ruppenthal, S; Kleiner, H; Nolte, F; Fabarius, A; Hofmann, WK; Nowak, D; Seifarth, W				Ruppenthal, Sabrina; Kleiner, Helga; Nolte, Florian; Fabarius, Alice; Hofmann, Wolf-Karsten; Nowak, Daniel; Seifarth, Wolfgang			Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROMES; COHESIN PROTEASE SEPARASE; CHROMOSOMAL INSTABILITY; HUMAN CANCERS; CELL-DEATH; OVEREXPRESSION; CENTRIOLES; MUTATIONS; AMPLIFICATION	ESPL1/separase, a cysteine endopeptidase, is a key player in centrosome duplication and mitotic sister chromatid separation. Aberrant expression and/or altered separase proteolytic activity are associated with centrosome amplification, aneuploidy, tumorigenesis and disease progression. Since centrosome alterations are a common and early detectable feature in patients with myelodysplastic syndrome (MDS) and cytogenetic aberrations play an important role in disease risk stratification, we examined separase activity on single cell level in 67 bone marrow samples obtained from patients with MDS, secondary acute myeloid leukemia (sAML), de novo acute myeloid leukemia (AML) and healthy controls by a flow cytometric separase activity assay. The separase activity distribution (SAD) value, a calculated measure for the occurrence of cells with prominent separase activity within the analyzed sample, was tested for correlation with the centrosome, karyotype and gene mutation status. We found higher SAD values in bone marrow cells of sAML patients than in corresponding cells of MDS patients. This concurred with an increased incidence of aberrant centrosome phenotypes in sAML vs. MDS samples. No correlation was found between SAD values and the karyotype/gene mutation status. During follow-up of four MDS patients we observed increasing SAD values after transformation to sAML, in two patients SAD values decreased during azacitidine therapy. Cell culture experiments employing MDS-L cells as an in vitro model of MDS revealed that treatment with rigosertib, a PLK1 inhibitor and therapeutic drug known to induce G2/M arrest, results in decreased SAD values. In conclusion, the appearance of cells with unusual high separase activity levels, as indicated by increased SAD values, concurs with the transformation of MDS to sAML and may reflect separase dysregulation potentially contributing to clonal evolution during MDS progression. Separase activity measurement may therefore be useful as a novel additional molecular marker for disease monitoring.	[Ruppenthal, Sabrina; Kleiner, Helga; Nolte, Florian; Fabarius, Alice; Hofmann, Wolf-Karsten; Nowak, Daniel; Seifarth, Wolfgang] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Ruppenthal, S (corresponding author), Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.	sabrina.ruppenthal@medma.uni-heidelberg.de		Ruppenthal, Sabrina/0000-0002-8700-9432; Nowak, Daniel/0000-0001-7130-7921	Deutsche Jose Carreras Leukamie-Stiftung e.V. [DJCLS R14/11, 20R/2016]; Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Jose Carreras Leukamie-Stiftung e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and Arts; Ruprecht-Karls-Universitat Heidelberg	WS received grants from Deutsche Jose Carreras Leukamie-Stiftung e.V. (www.carreras-stittung.de), no. DJCLS R14/11 and 20R/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Agircan FG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004672; Basu D, 2009, ANAL BIOCHEM, V392, P133, DOI 10.1016/j.ab.2009.05.046; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bhakta-Guha D, 2015, CURR MED CHEM, V22, P685, DOI 10.2174/0929867322666141212114529; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Difilippantonio MJ, 2009, ENVIRON MOL MUTAGEN, V50, P672, DOI 10.1002/em.20532; Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005; Fasan A, 2013, LEUKEMIA, V27, P245, DOI 10.1038/leu.2012.230; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Gabriel U, 2010, CANCER GENET CYTOGEN, V203, P253, DOI 10.1016/j.cancergencyto.2010.07.135; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Giehl M, 2010, EUR J HAEMATOL, V85, P139, DOI [10.1111/j.1600-0609.2010.01459.x, 10.1111/j.1600-0609.2010.1459.x]; Haass W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133769; Haass W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129648; Haass W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042863; Hyoda T, 2015, CANCER SCI, V106, P287, DOI 10.1111/cas.12605; Kennedy JA, 2017, J CLIN ONCOL, V35, P968, DOI 10.1200/JCO.2016.71.0806; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Kumar R, 2017, J CELL BIOCHEM, V118, P1283, DOI 10.1002/jcb.25835; Mannini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18472; Matsuoka A, 2010, LEUKEMIA, V24, P748, DOI 10.1038/leu.2009.296; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Milunovic-Jevtic A, 2016, CURR OPIN BIOTECH, V40, P113, DOI 10.1016/j.copbio.2016.03.011; MITELMAN F, 1976, INT J CANCER, V18, P24, DOI 10.1002/ijc.2910180105; Miyachika Y, 2013, CANCER GENET-NY, V206, P12, DOI 10.1016/j.cancergen.2012.11.004; Mossner M, 2016, BLOOD, V128, P1246, DOI 10.1182/blood-2015-11-679167; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Mukherjee M, 2014, J NEURO-ONCOL, V119, P27, DOI 10.1007/s11060-014-1458-6; Neben K, 2007, INT J CANCER, V120, P1669, DOI 10.1002/ijc.22404; Nicholson JM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00148; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nolte F, 2013, ANN HEMATOL, V92, P1325, DOI 10.1007/s00277-013-1772-7; Patel H, 2009, BRIT J HAEMATOL, V146, P408, DOI 10.1111/j.1365-2141.2009.07772.x; Pati D, 2008, CELL CYCLE, V7, P3481, DOI 10.4161/cc.7.22.7048; Prinzhorn W, 2016, BIOMARK RES, V4, DOI 10.1186/s40364-016-0059-2; Schanz J, 2012, J CLIN ONCOL, V30, P820, DOI 10.1200/JCO.2011.35.6394; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Shastri A, 2017, BLOOD, V129, P1586, DOI 10.1182/blood-2016-10-696062; Simons A, 2013, CYTOGENET GENOME RES, V141, P1, DOI 10.1159/000353118; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Stengel A, LEUKEMIA; Talati C, 2016, CRIT REV ONCOL HEMAT, V98, P200, DOI 10.1016/j.critrevonc.2015.10.013; Valent P, 2007, LEUKEMIA RES, V31, P727, DOI 10.1016/j.leukres.2006.11.009; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105; Zhang NG, 2017, BIOL REV, V92, P2070, DOI 10.1111/brv.12321	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191734	10.1371/journal.pone.0191734	http://dx.doi.org/10.1371/journal.pone.0191734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370237	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600090
J	Ferdin, J; Goricar, K; Dolzan, V; Plemenitas, A; Martin, JN; Peterlin, BM; Deeks, SG; Lenassi, M				Ferdin, Jana; Goricar, Katja; Dolzan, Vita; Plemenitas, Ana; Martin, Jeffrey N.; Peterlin, Boris M.; Deeks, Steven G.; Lenassi, Metka			Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA	PLOS ONE			English	Article							RALTEGRAVIR INTENSIFICATION; TYPE-1 NEF; T-CELLS; INDIVIDUALS; RESERVOIRS; SECRETION; LATENCY; END	Objective To address the role of translationally active HIV reservoir in chronic inflammation and non-AIDS related disorders, we first need a simple and accurate assay to evaluate viral protein expression in virally suppressed subjects. Design We optimized an HIV Nef enzyme-linked immunosorbent assay (ELISA) and used it to quantify plasma Nef levels as an indicator of the leaky HIV reservoir in an HIV-infected cohort. Methods This study accessed 134 plasma samples from a well-characterized cohort study of HIVinfected and uninfected adults in San Francisco (the SCOPE cohort). We optimized an ELISA for detection of plasma Nef in HIV-negative subjects and HIV-infected non-controllers, and evaluated its utility to quantify plasma Nef levels in a cross-sectional study of ART-suppressed and elite controller HIV-infected subjects. Results Here, we describe the performance of an optimized HIV Nef ELISA. When we applied this assay to the study cohort we found that plasma Nef levels were correlated with plasma HIV RNA levels in untreated disease. However, we were able to detect Nef in plasma of approximately half of subjects on ART or with elite control, despite the lack of detectable plasma HIV RNA levels using standard assays. Plasma Nef levels were not consistently associated with CD4+ T-cell count, CD8+ T-cell count, self-reported nadir CD4+ T-cell count or the CD4 +/CD8+ T-cell ratio in HIV-infected subjects. Conclusion Since plasma HIV RNA levels are undetectable in virally suppressed subjects, it is reasonable to assume that viral protein expression in leaky reservoir, and not plasma virions, is the source of Nef accumulating in plasma. To examine this further, improvements of the assay sensitivity, by lowering the background through improvements in the quality of Nef antibodies, and detailed characterization of the HIV reservoirs are needed.	[Ferdin, Jana; Goricar, Katja; Dolzan, Vita; Plemenitas, Ana; Lenassi, Metka] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana, Slovenia; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Peterlin, Boris M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA	University of Ljubljana; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lenassi, M (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana, Slovenia.	metka.lenassi@mf.uni-lj.si		Deeks, Steven/0000-0001-6371-747X; Lenassi, Metka/0000-0002-9488-6855	Slovenian Research Agency (ARRS) [Z3-7198, J3-5499, P1-0170]; UCSF/Gladstone Institute of Virology & Immunology CFAR [P30 AI027763]; CFAR Network of Integrated Systems [R24 AI067039]; Delaney AIDS Research Enterprise (DARE) [AI096109, A127966]; amfAR Institute for HIV Cure Research [amfAR 109301]; National Institutes of Health (NIH) [R01 AI49104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI125104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); UCSF/Gladstone Institute of Virology & Immunology CFAR; CFAR Network of Integrated Systems; Delaney AIDS Research Enterprise (DARE); amfAR Institute for HIV Cure Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by research grants Z3-7198, J3-5499 and P1-0170 funded by the Slovenian Research Agency (ARRS). The SCOPE cohort was supported the UCSF/Gladstone Institute of Virology & Immunology CFAR (P30 AI027763) and the CFAR Network of Integrated Systems (R24 AI067039). Additional support was provided by the Delaney AIDS Research Enterprise (DARE; AI096109, A127966), the amfAR Institute for HIV Cure Research (amfAR 109301) and the National Institutes of Health (NIH; R01 AI49104).	Aqil M, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23129; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015; Bohne J, 2005, NUCLEIC ACIDS RES, V33, P825, DOI 10.1093/nar/gki185; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dominkus PP, 2017, J NEUROVIROL, V23, P713, DOI 10.1007/s13365-017-0552-x; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Lee JH, 2016, EBIOMEDICINE, V6, P103, DOI 10.1016/j.ebiom.2016.03.004; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Luo XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124436; Mann JK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-100; Martrus G, 2016, J VIROL, V90, P9018, DOI 10.1128/JVI.01448-16; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Pereira EA, 2016, TRAFFIC, V17, P976, DOI 10.1111/tra.12412; Peretti S, 2005, MOL THER, V12, P1185, DOI 10.1016/j.ymthe.2005.06.474; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; Rouzioux C, 2013, CURR OPIN HIV AIDS, V8, P170, DOI 10.1097/COH.0b013e32835fc619; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998	28	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191613	10.1371/journal.pone.0191613	http://dx.doi.org/10.1371/journal.pone.0191613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364927	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500061
J	Lazzarotto, V; Medale, F; Larroquet, L; Corraze, G				Lazzarotto, Viviana; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve			Long-term dietary replacement of fishmeal and fish oil in diets for rainbow trout (Oncorhynchus mykiss): Effects on growth, whole body fatty acids and intestinal and hepatic gene expression	PLOS ONE			English	Article							SALMON SALMO-SALAR; BREAM SPARUS-AURATA; LYSOSOMAL CYSTEINE PROTEASES; ATLANTIC SALMON; VEGETABLE-OILS; ANTIGEN PRESENTATION; DISTAL INTESTINE; PROTEIN-SOURCES; PLANT-PRODUCTS; SOYBEAN-MEAL	The effects of replacing fishmeal and fish oil with a plant-based diet were studied in juvenile (10g) and ongrowing (250-350g) rainbow trout from first-feeding. Feed-related differences in the intestinal and hepatic transcriptome were examined in juveniles after 7 months of feeding at 7 degrees C. Based on microarray results obtained for juveniles, the expression of selected genes related to lipid, cholesterol and energy metabolisms, was assessed by RT-qPCR in ongrowing trout after 6 additional months of feeding at 17 degrees C. Plasma glucose and cholesterol, lipid content and fatty acid profile of whole body were analyzed at both stages. After 7 months at 7 degrees C, all juveniles reached the same body weight (10g), while at 13 months ongrowing fish fed the totally plant-based diet exhibited lower body weight (234 vs 330-337g). Body lipid content was higher in juveniles fed the totally plant-based diet (13.2 vs 9.4-9.9%), and plasma cholesterol was about 2-times lower in trout fed the plant-based diets at both stages. Fatty acid profile mirrored that of the respective diet, with low proportions of long-chain n-3 polyunsaturated fatty acids in fish fed plant-based diets. Genes involved in protein catabolism, carbohydrate metabolism and trafficking were down-regulated in the intestines of juveniles fed the plant-based diets. This was not true for ongrowing fish. Genes involved in lipid and cholesterol metabolisms were up-regulated in the livers of fish fed plant-based diets for both stages. In this study, feeding trout a totally plant-based diet from first-feeding affect a relatively low proportion of metabolism-related genes. In the longer term, when fish were reared at a higher temperature, only some of these changes were maintained (i.e. up-regulation of lipid/cholesterol metabolism). Although the plant-based diets tested in this study had no major deficiencies, small adjustments in the feed-formula are needed to further optimize growth performance while sparing marine resources.	[Lazzarotto, Viviana; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve] INRA, UMR 1419 Nutr Metab Aquaculture, Aquapole, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Medale, F (corresponding author), INRA, UMR 1419 Nutr Metab Aquaculture, Aquapole, St Pee Sur Nivelle, France.	francoise.medale@inra.fr	Lazzarotto, Viviana/AAU-6857-2021	Medale, Francoise/0000-0002-8083-1298	FP7 European project ARRAINA [288925]	FP7 European project ARRAINA	This work was supported by the FP7 European project ARRAINA (project no288925) and by the Region Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Baum D, 2005, J FISH BIOL, V67, P1370, DOI 10.1111/j.0022-1112.2005.00832.x; Bell MV, 2003, LIPIDS, V38, P39, DOI 10.1007/s11745-003-1029-5; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; BRAUGE C, 1995, REPROD NUTR DEV, V35, P277, DOI 10.1051/rnd:19950304; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Capasso R, 2005, GASTROENTEROLOGY, V129, P941, DOI 10.1053/j.gastro.2005.06.018; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Corraze G, 2009, CAH AGRIC, V18, P112, DOI 10.1684/agr.2009.0276; Couto A, 2008, COMP BIOCHEM PHYS A, V151, P45, DOI 10.1016/j.cbpa.2008.05.013; De Santis C, 2015, COMP BIOCHEM PHYS D, V15, P1, DOI 10.1016/j.cbd.2015.04.001; FAO, 2016, CONTRIBUTING FOOD SE; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca-Madrigal J, 2005, AQUACULT NUTR, V11, P241, DOI 10.1111/j.1365-2095.2005.00346.x; Fonseca-Madrigal J, 2006, FISH PHYSIOL BIOCHEM, V32, P317, DOI 10.1007/s10695-006-9109-2; Froystad MK, 2008, AQUACULT NUTR, V14, P204, DOI 10.1111/j.1365-2095.2007.00519.x; Gatesoupe FJ, 2001, NUTR FEEDING FISH CR, P197; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gu M, 2014, BRIT J NUTR, V111, P432, DOI 10.1017/S0007114513002717; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Jobling M, 2016, AQUACULT INT, V24, P767, DOI 10.1007/s10499-014-9875-2; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P11; Kokou F, 2016, AQUACULT REP, V3, P82, DOI 10.1016/j.aqrep.2015.12.004; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Lazzarotto V, 2016, BRIT J NUTR, V115, P2079, DOI 10.1017/S0007114516001252; Lazzarotto V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117609; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Li M, 2008, GEN COMP ENDOCR, V155, P668, DOI 10.1016/j.ygcen.2007.08.017; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Limtipsuntorn U, 2014, MAR BIOTECHNOL, V16, P88, DOI 10.1007/s10126-013-9535-y; Matz MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071448; MCCLEARY BV, 1994, J CEREAL SCI, V20, P51, DOI 10.1006/jcrs.1994.1044; Medale F, 2009, CAH AGRIC, V18, P103, DOI 10.1684/agr.2009.0279; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2012, COMP BIOCHEM PHYS B, V161, P283, DOI 10.1016/j.cbpb.2011.12.004; Morais S, 2011, BRIT J NUTR, V106, P1457, DOI 10.1017/S0007114511001954; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Phillips KM, 2002, J FOOD COMPOS ANAL, V15, P123, DOI 10.1006/jfca.2001.1044; Richard N, 2006, AQUACULTURE, V261, P1077, DOI 10.1016/j.aquaculture.2006.07.021; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Sprecher H, 1995, J LIPID RES, V36, P2471; STADTMAN TC, 1957, METHOD ENZYMOL, V3, P392, DOI 10.1016/S0076-6879(57)03403-5; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Taggart JB, 2008, J FISH BIOL, V72, P2071, DOI 10.1111/j.1095-8649.2008.01876.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; Torstensen B. E., 2011, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Woynarovich A, 2011, 561 FOOD AGR ORG UN; Zhou J, 2012, DEV COMP IMMUNOL, V37, P28, DOI 10.1016/j.dci.2011.12.011	69	71	72	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190730	10.1371/journal.pone.0190730	http://dx.doi.org/10.1371/journal.pone.0190730			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364933	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500021
J	Touzain, F; Le Devendec, L; de Boisseson, C; Baron, S; Jouy, E; Perrin-Guyomard, A; Blanchard, Y; Kempf, I				Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Perrin-Guyomard, Agnes; Blanchard, Yannick; Kempf, Isabelle			Characterization of plasmids harboring &ITbla&ITcCTX-M and &ITbla&ITCMY genes in &ITE. coli&IT from French broilers	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTENDED-SPECTRUM; BETA-LACTAMASE; MULTIDRUG-RESISTANCE; SALMONELLA-ENTERICA; DNA-SEQUENCE; VIRULENCE; PREVALENCE; ANIMALS; POULTRY	Resistance to extended-spectrum cephalosporins (ESC) is a global health issue. The aim of this study was to analyze and compare plasmids coding for resistance to ESC isolated from 16 avian commensal and 17 avian pathogenic Escherichia coli (APEC) strains obtained respectively at slaughterhouse or from diseased broilers in 2010-2012. Plasmid DNA was used to transform E. coli DH5alpha, and the resistances of the transformants were determined. The sequences of the ESC-resistance plasmids prepared from transformants were obtained by Illumina (33 plasmids) or PacBio (1 plasmid). Results showed that 29 of these plasmids contained the bla(CTX-M-1) gene and belonged to the IncI1/ST3 type, with 27 and 20 of them carrying the sul2 or tet(A) genes respectively. Despite their diverse origins, several plasmids showed very high percentages of identity. None of the bla(CTX-M-1)-containing plasmid contained APEC virulence genes, although some of them were detected in the parental strains. Three plasmids had the bla(CMY-2) gene, but no other resistance gene. They belonged to IncB/O/K/Z-like or IncFIA/FIB replicon types. The bla(CMY-2) IncFIA/FIB plasmid was obtained from a strain isolated from a diseased broiler and also containing a bla(CTX-M-1) IncI1/ST3 plasmid. Importantly APEC virulence genes (sitA-D, iucA-D, iutA, hlyF, ompT, etsA-C, iss, iroB-E, iroN, cvaA-C and cvi) were detected on the bla(CMY-2) plasmid. In conclusion, our results show the dominance and high similarity of bla(CTX-M-1) IncI1/ST3 plasmids, and the worrying presence of APEC virulence genes on a bla(CMY-2) plasmid.	[Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Blanchard, Yannick; Kempf, Isabelle] ANSES, Ploufragan Lab, Ploufragan, France; [Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Perrin-Guyomard, Agnes; Blanchard, Yannick; Kempf, Isabelle] Univ Bretagne Loire, Rennes, France; [Perrin-Guyomard, Agnes] ANSES, Fougeres Lab, Fougeres, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres	Kempf, I (corresponding author), ANSES, Ploufragan Lab, Ploufragan, France.; Kempf, I (corresponding author), Univ Bretagne Loire, Rennes, France.	isabelle.kempf@anses.fr	Baron, Sandrine/L-7608-2019	Perrin, Agnes/0000-0002-4078-188X; Kempf, Isabelle/0000-0002-8912-3044	France Genomique National infrastructure, "Investissement d'avenir" program [ANR-10-INBS-09]; Conseil Departemental des Cotes d'Armor; ANSES	France Genomique National infrastructure, "Investissement d'avenir" program(French National Research Agency (ANR)); Conseil Departemental des Cotes d'Armor(Region Bretagne); ANSES	This work was supported by ANSES, in the framework of joint research for the CoVetLab (Club 5) network; Conseil Departemental des Cotes d'Armor. Genomics platform at the Nantes (Biogenouest Genomics) core facility for its technical support in Mi-seq NGS sequencing. This Work, for pacbio sequencing part was supported by France Genomique National infrastructure, funded as part of "Investissement d'avenir" program managed by Agence Nationale pour la Recherche (contrat ANR-10-INBS-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum M, 2014, P 10 C SOC FRANC MIC; ANSES, 2016, RAPPORT; Anses-ANMV, 2014, SUIV VENT MED VET CO; Baron S, 2016, VET MICROBIOL, V185, P29, DOI 10.1016/j.vetmic.2016.01.020; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chauvin C, 2013, ANTIMICROB AGENTS CH, V57, P6351, DOI 10.1128/AAC.01460-13; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Dahmen S, 2012, J ANTIMICROB CHEMOTH, V67, P3011, DOI 10.1093/jac/dks308; Day MJ, 2016, J ANTIMICROB CHEMOTH, V71, P1178, DOI 10.1093/jac/dkv485; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; de Toro M, 2013, INT J ANTIMICROB AG, V42, P167, DOI 10.1016/j.ijantimicag.2013.04.016; Dheilly A, 2012, ANTIMICROB AGENTS CH, V56, P189, DOI 10.1128/AAC.05617-11; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; European Food Safety Authority, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4380; Girlich D, 2007, APPL ENVIRON MICROB, V73, P4681, DOI 10.1128/AEM.02491-06; Hansen KH, 2016, APPL ENVIRON MICROB, V82, P4705, DOI 10.1128/AEM.00495-16; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Kubasova T, 2014, PLASMID, V76, P8, DOI 10.1016/j.plasmid.2014.08.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Madec JY, 2015, ANTIMICROB AGENTS CH, V59, P5860, DOI 10.1128/AAC.00819-15; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; Rodriguez I, 2014, INT J ANTIMICROB AG, V43, P553, DOI 10.1016/j.ijantimicag.2014.02.019; Seiffert SN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00407; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016; Smith H, 2015, ANTIMICROB AGENTS CH, V59, P5357, DOI 10.1128/AAC.05006-14; TAKAHASHI S, 1984, J CLIN MICROBIOL, V20, P608, DOI 10.1128/JCM.20.4.608-613.1984; Verdet C, 2009, ANTIMICROB AGENTS CH, V53, P4002, DOI 10.1128/AAC.00753-08; Wang J, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00716; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Wang XR, 2014, J GLOB ANTIMICROB RE, V2, P57, DOI 10.1016/j.jgar.2013.10.004; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412; Zamorano L, 2015, ANTIMICROB AGENTS CH, V59, P5260, DOI 10.1128/AAC.00562-15	46	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0188768	10.1371/journal.pone.0188768	http://dx.doi.org/10.1371/journal.pone.0188768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360838	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800002
J	Gong, H; Wang, H; Wang, YX; Bai, X; Liu, B; He, JF; Wu, JH; Qi, WM; Zhang, WG				Gong, Husile; Wang, Hong; Wang, YueXing; Bai, Xue; Liu, Bin; He, JinFeng; Wu, JiangHong; Qi, WangMei; Zhang, WenGuang			Skin transcriptome reveals the dynamic changes in the Wnt pathway during integument morphogenesis of chick embryos	PLOS ONE			English	Article							PLANAR CELL POLARITY; HAIR FOLLICLE; GENE-EXPRESSION; WNT/BETA-CATENIN; FEATHER BUDS; RNA-SEQ; DIFFERENTIATION; PROLIFERATION; PATTERNS; TIME	Avian species have a unique integument covered with feathers. Skin morphogenesis is a successive and complex process. To date, most studies have focused on a single developmental point or stage. Fewer studies have focused on whole transcriptomes based on the time-course of embryo integument development. To analyze the global changes in gene expression profiles, we sequenced the transcriptome of chicken embryo skin samples from day 6 to day 21 of incubation and identified 5830 differentially expressed genes (DEGs). Hierarchical clustering showed that E6 to E14 is the critical period of feather follicle morphogenesis. According to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the DEGs, two kinds of Wnt signaling pathways (a canonical pathway and a non-canonical pathway) changed during feather follicle and feather morphogenesis. The gene expression level of inhibitors and ligands related to the Wnt signaling pathway varied significantly during embryonic development. The results revealed a staggered phase relationship between the canonical pathway and the non-canonical pathway from E9 to E14. These analyses shed new light on the gene regulatory mechanism and provided fundamental data related to integument morphogenesis of chickens.	[Gong, Husile; Wang, Hong; Wang, YueXing; Bai, Xue; Liu, Bin; Zhang, WenGuang] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China; [Gong, Husile; Wu, JiangHong] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China; [He, JinFeng; Qi, WangMei] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China; [Wu, JiangHong] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University; Chinese Academy of Sciences	Zhang, WG (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China.; Wu, JH (corresponding author), Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China.; Qi, WM (corresponding author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China.; Wu, JH (corresponding author), Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China.	wujianghonglong@126.com; qiwangmei@imau.edu.cn; atcgnmbi@aliyun.com	wu, Jianghong/E-7587-2015	wu, Jianghong/0000-0003-4027-2345	National Natural Science Foundation of China [31260538, 30960246, 31560622, 31672385, 31560623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31260538, 30960246, 31560622, and 31672385 to WZ) and (Grant No. 31560623 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angonin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074666; Bak SS, 2015, EXP DERMATOL, V24, P550, DOI 10.1111/exd.12707; Beaton H, 2016, AM J PHYSL RENAL PHY, V311; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Cai SX, 2014, J CELL PHYSIOL, V229, P791, DOI 10.1002/jcp.24500; Chang H, 2016, DEV BIOL, V409, P181, DOI 10.1016/j.ydbio.2015.10.027; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; DAVIDSON D, 1983, J EMBRYOL EXP MORPH, V74, P245; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284; Fu HD, 2016, J MOL HISTOL, V47, P1; Ghosh S., 2016, ANAL RNA SEQ DATA US, P339; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ishida K, 2016, DEV GROWTH DIFFER, V58, P303, DOI 10.1111/dgd.12275; Johansson JA, 2014, SEMIN CELL DEV BIOL, V25, P3, DOI 10.1016/j.semcdb.2013.12.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim JY, 2005, DIFFERENTIATION, V73, P240, DOI 10.1111/j.1432-0436.2005.00020.x; Komiya Yuko, 2008, Organogenesis, V4, P68; Kwack MH, 2017, EXPT DERMATOLOGY; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Li Y, 2016, CHINESE MED J-PEKING, V129, P1200, DOI 10.4103/0366-6999.181974; Lin CM, 2006, CURR OPIN CELL BIOL, V18, P730, DOI 10.1016/j.ceb.2006.10.009; LINSENMAYER TF, 1972, DEV BIOL, V27, P244, DOI 10.1016/0012-1606(72)90101-7; Liu QY, 2016, BIOL TRACE ELEM RES, V171, P380, DOI 10.1007/s12011-015-0555-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lyros O, 2016, DYSREGULATION WNT5A; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mukhopadhyay A, 2013, DEV BIOL, V373, P373, DOI 10.1016/j.ydbio.2012.10.024; Nalesso G, 2017, ANN RHEUM DIS, V76, P218, DOI 10.1136/annrheumdis-2015-208577; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; SENGEL P, 1990, International Journal of Developmental Biology, V34, P33; Shin D, 2014, J MOL CELL BIOL, V6, P338, DOI 10.1093/jmcb/mju023; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takabayashi Y, 2016, CLIN COSMET INVESTI, V9, P127, DOI 10.2147/CCID.S108187; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van AR, 2012, DEV BIOL, V369, P101; Wang YS, 2010, DEVELOPMENT, V137, P4091, DOI 10.1242/dev.057455; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Xing YZ, 2016, INT J MED SCI, V13, P603, DOI 10.7150/ijms.15571; Xu ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10567; Yan L, 2016, EXPT THERAPEUTIC MED, V12; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; Zhang HH, 2016, BIOCHIMIE, V127, P10, DOI 10.1016/j.biochi.2016.04.015; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	59	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190933	10.1371/journal.pone.0190933	http://dx.doi.org/10.1371/journal.pone.0190933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351308	gold, Green Submitted, Green Published			2022-12-26	WOS:000422911300032
J	Naran, NH; Haagensen, M; Crowther, NJ				Naran, Nitien H.; Haagensen, Mark; Crowther, Nigel J.			Steatosis in South African women: How much and why?	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; UNITED-STATES; ECTOPIC FAT; PREVALENCE; ADIPONECTIN; HOMEOSTASIS; GLUCOSE; PLASMA	Background Globally, steatosis is the commonest type of liver pathology and is closely associated with obesity and the metabolic syndrome. Obesity is common in urban African females but no data is available on hepatic fat content in this population group when compared to other ethnic groups. The aim of this study was therefore to compare hepatic fat content in woman from different ethnic groups in South Africa and to characterise the principle determinants of liver fat. Materials and methods A convenience sample of 106 (48 Indian, 29 African and 29 Caucasian) female volunteers aged 20 +/- 60 years and having no history of cardiometabolic disorders were recruited. Hepatic fat was determined from CT scans using the liver-spleen attenuation ratio (LAR), which decreases with increasing levels of hepatic fat. Anthropometric and cardiometabolic parameters were measured with insulin resistance determined using the HOMA index and dysglycaemia defined as fasting glucose >= 5.60 mmol/L. Results The African subjects had significantly lower hepatic fat content (LAR as median [interquartile range]: 1.35 [1.28, 1.41]) than the Indian (1.22 [1.10, 1.35]; p<0.005) and Caucasian (1.27 [1.16, 1.33]; p<0.05) females even though they had significantly higher BMIs than both groups (p<0.0005 and p<0.05, respectively). Linear regression showed that: subcutaneous abdominal fat was a significant (unstandardised beta = 0.007; p = 0.03) negative, whilst insulin resistance (beta = - 0.97; p = 0.01) and dysglycaemia (beta = - 3.58; p = 0.01) were significant positive determinants of liver fat; higher hepatic fat levels in subjects with the metabolic syndrome were explained by insulin resistance and dysglycaemia. Discussion African ethnicity is associated with low liver fat content. Subcutaneous abdominal fat protects against steatosis, possibly by acting as a triglyceride reservoir. Insulin resistance and dysglycaemia lead to greater hepatic fat deposition and explain higher liver fat levels in subjects with the metabolic syndrome. These observations must be further investigated in longitudinal surveys.	[Naran, Nitien H.; Crowther, Nigel J.] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa; [Haagensen, Mark] Univ Witwatersrand, Donald Gordon Med Ctr, Dept Radiol, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Crowther, NJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa.	nigel.crowther@nhls.ac.za		Crowther, Nigel/0000-0002-5766-1745	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Medical Research Council (http://wm.mrc.ac.za/).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Byrne CD, 2012, DIABETIC MED, V29, P1098, DOI 10.1111/j.1464-5491.2012.03732.x; Byrne CD, 2013, P NUTR SOC, V72, P412, DOI 10.1017/S0029665113001249; Davidson LE, 2006, J APPL PHYSIOL, V100, P864, DOI 10.1152/japplphysiol.00986.2005; Duman DG, 2006, DIGEST DIS SCI, V51, P346, DOI 10.1007/s10620-006-3136-9; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gradidge PJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162247; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Han MAT, 2017, EXPERT REV CLIN PHAR, V10, P379, DOI 10.1080/17512433.2017.1299573; Hart CL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1240; Kruger FC, 2010, SAMJ S AFR MED J, V100, P168, DOI 10.7196/SAMJ.1422; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Middleton MS, 2017, GASTROENTEROLOGY, V153, P753, DOI 10.1053/j.gastro.2017.06.005; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Naran NH, 2003, J SOC ENDOCRINOLOGY, V8, P30; Nguyen GC, 2008, HEPATOLOGY, V47, P1058, DOI 10.1002/hep.22223; Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schneider ALC, 2014, OBESITY, V22, P292, DOI 10.1002/oby.20426; Shisana O, 2014, S AFRICAN NATL HLTH; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Treeprasertsuk S, 2011, DIGEST DIS SCI, V56, P35, DOI 10.1007/s10620-010-1241-2; Waisberg R, 2011, HORM METAB RES, V43, P660, DOI 10.1055/s-0031-1283139; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; ZELBERSAGI S, 2009, J HEPATOL S1, V50, pS375	43	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191388	10.1371/journal.pone.0191388	http://dx.doi.org/10.1371/journal.pone.0191388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351564	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300079
J	Yamamoto, T; Okada, T; Fushimi, Y; Yamamoto, A; Fujimoto, K; Okuchi, S; Fukutomi, H; Takahashi, JC; Funaki, T; Miyamoto, S; Stalder, AF; Natsuaki, Y; Speier, P; Togashi, K				Yamamoto, Takayuki; Okada, Tomohisa; Fushimi, Yasutaka; Yamamoto, Akira; Fujimoto, Koji; Okuchi, Sachi; Fukutomi, Hikaru; Takahashi, Jun C.; Funaki, Takeshi; Miyamoto, Susumu; Stalder, Aurelien F.; Natsuaki, Yutaka; Speier, Peter; Togashi, Kaori			Magnetic resonance angiography with compressed sensing: An evaluation of moyamoya disease	PLOS ONE			English	Article							FREE PRECESSION ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; MR-ANGIOGRAPHY; RECONSTRUCTION; DIAGNOSIS; OPTIMIZATION; ACQUISITION; VESSELS; 3T	Compressed sensing (CS) reconstructions of under-sampled measurements generate missing data based on assumptions of image sparsity. Non-contrast time-of-flight MR angiography (TOF-MRA) is a good candidate for CS based acceleration, as MRA images feature bright trees of sparse vessels over a well-suppressed anatomical background signal. A short scan time derived from CS is beneficial for patients of moyamoya disease (MMD) because of the frequency of MR scans. The purpose of this study was to investigate the reliability of TOF-MRA with CS in the evaluation of MMD. Twenty-two patients were examined using TOF-MRA with CS (CS-TOF) and parallel imaging (PI-TOF). The acceleration factors were 3 (CS3) and 5 (CS5) for CS-TOF, and 3 (PI3) for PI-TOF. Two neuroradiologists evaluated the MMD grading according to stenosis/occlusion scores using the modified Houkin's system, and the visibility of moyamoya vessels (MMVs) using a 3-point scale. Concordance was calculated with Cohen's.. The numbers of MMVs in the basal ganglia were compared using Bland-Altman analysis and Wilcoxon's signed-rank tests. MRA scan times were 4: 07, 3: 53, and 2: 42 for PI3, CS3, and CS5, respectively. CS-reconstruction completed within 10 minutes. MMD grading and MMV visibility scales showed excellent correlation (k>.966). Although the number of MMVs was significantly higher in CS3 than in PI3 (p <.0001) and CS5 (p <.0001), Bland-Altman analysis showed a good agreement between PI3, CS3, and CS5. Compressed sensing can accelerate TOF-MRA with improved visualization of small collaterals in equivalent time (CS3) or equivalent results in a shorter scan time (CS5).	[Yamamoto, Takayuki; Okada, Tomohisa; Fushimi, Yasutaka; Yamamoto, Akira; Fujimoto, Koji; Okuchi, Sachi; Fukutomi, Hikaru; Takahashi, Jun C.; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Takahashi, Jun C.] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Funaki, Takeshi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Stalder, Aurelien F.] Siemens Ltd China, Shanghai, Peoples R China; [Natsuaki, Yutaka] Siemens Med Solut USA Inc, Huntington Beach, CA USA; [Speier, Peter] Siemens Healthcare, Erlangen, Germany	Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Siemens AG; Siemens AG; Siemens AG; Siemens Germany	Okada, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	tomokada@kuhp.kyoto-u.ac.jp	Stalder, Aurelien F/A-7071-2010; Fushimi, Yasutaka/L-8922-2017; Okada, Tomohisa/C-5939-2008	Stalder, Aurelien F/0000-0002-0590-2746; Fushimi, Yasutaka/0000-0002-1982-3168; Fukutomi, Hikaru/0000-0003-4262-3890; Okuchi, Sachi/0000-0002-0831-195X; Okada, Tomohisa/0000-0003-2312-5677; YAMAMOTO, Takayuki/0000-0003-0306-3691	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25120002]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" of The Ministry of Education, Culture, Sports, Science and Technology, Japan was provided to K.T. (MEXT grant number 25120002) ((http://sparse-modeling.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy NO, 2015, MAGN RESON MED, V74, P614, DOI 10.1002/mrm.25803; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Cho BK, 2010, MOYAMOYA DISEASE UPDATE, P1, DOI 10.1007/978-4-431-99703-0; Cukur T, 2009, MAGN RESON MED, V61, P1122, DOI 10.1002/mrm.21907; Fushimi Y, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3774; Fushimi Y, 2016, INVEST RADIOL, V51, P228, DOI 10.1097/RLI.0000000000000226; Gratz M, 2017, EUR RADIOL, V27, P1004, DOI 10.1007/s00330-016-4398-z; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Hutter J, 2015, MAGN RESON MATER PHY, V28, P437, DOI 10.1007/s10334-014-0477-9; Ilicak E, 2016, NMR BIOMED, V29, P532, DOI 10.1002/nbm.3497; Jin QN, 2011, NEUROL MED-CHIR, V51, P195, DOI 10.2176/nmc.51.195; Kang CK, 2016, APPL MAGN RESON, V47, P201, DOI 10.1007/s00723-015-0742-8; Kikuta K, 2008, NEUROSURGERY, V62, P1434, DOI [10.1227/01.NEU.0000232775.06672.F4, 10.1227/01.neu.0000333807.64530.39]; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Mikami T, 2013, J STROKE CEREBROVASC, V22, P862, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.010; Moghari MH, 2016, MAGN RESON MED, V75, P2086, DOI 10.1002/mrm.25800; Okada T, 2009, EUR J RADIOL, V71, P486, DOI 10.1016/j.ejrad.2008.06.005; Okuchi S, 2014, ACAD RADIOL, V21, P812, DOI 10.1016/j.acra.2014.03.007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rapacchi S, 2015, MAGN RESON MED, V74, P474, DOI 10.1002/mrm.25414; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, Neurol Med Chir (Tokyo), V52, P245; Saeki N, 2000, J CLIN NEUROSCI, V7, P112, DOI 10.1054/jocn.1999.0160; Sawada T, 2012, NEURORADIOLOGY, V54, P1089, DOI 10.1007/s00234-012-1020-1; Seo N, 2017, J MAGN RESON IMAGING, V46, P1289, DOI 10.1002/jmri.25672; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Stalder AF, 2015, P 23 ANN M ISMRM TOR, P3606; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Vincenti G, 2014, JACC-CARDIOVASC IMAG, V7, P882, DOI 10.1016/j.jcmg.2014.04.016; Wang J, 2001, P 1 WURZB WORKSH PAR, P89; YAMADA I, 1992, RADIOLOGY, V184, P773, DOI 10.1148/radiology.184.3.1509066; Yamamoto T, 2016, INVEST RADIOL, V51, P372, DOI 10.1097/RLI.0000000000000221	33	27	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189493	10.1371/journal.pone.0189493	http://dx.doi.org/10.1371/journal.pone.0189493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351284	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300009
J	Takayama, K; Suzuki, T; Tanaka, T; Fujimura, T; Takahashi, S; Urano, T; Ikeda, K; Inoue, S				Takayama, Ken-ichi; Suzuki, Takashi; Tanaka, Tomoaki; Fujimura, Tetsuya; Takahashi, Satoru; Urano, Tomohiko; Ikeda, Kazuhiro; Inoue, Satoshi			TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer	ONCOGENE			English	Article							RESPONSIVE FINGER PROTEIN; ANDROGEN RECEPTOR GENE; E3 UBIQUITIN LIGASE; BREAST-CANCER; MUTANT P53; NUCLEAR EXPORT; NONCODING RNA; TUMOR-GROWTH; EFP; 14-3-3-SIGMA	Prostate cancer growth is promoted by the gene regulatory action of androgen receptor (AR) and its downstream signals. The aberrant dysfunction of tumor suppressor p53 has an important role in the prognosis of cancer. We previously found that androgen treatments translocate p53 to the cytoplasm. The mechanism of this translocation depends on sumoylation of p53 by complex of SUMO E3 ligase RanBP2 with androgen-induced GTPase-activating protein-binding protein 2 (G3BP2). Here, we identified tripartite motif-containing protein 25 (TRIM25)/estrogen-responsive finger protein (Efp) as a novel interacting partner of G3BP2 protein complex. Then, we demonstrated that TRIM25 knockdown resulted in p53 downstream activation for cell cycle inhibition and apoptosis induction in LNCaP and 22Rv1 cells. In contrast, overexpression of TRIM25 promoted prostate cancer cell proliferation and inhibited apoptosis by docetaxel treatment in LNCaP cells. We observed that p53 activity was reduced by mechanism of G3BP2-mediated nuclear export in TRIM25-overexpressing prostate cancer cells. We also found TRIM25 is important for G3BP2/RanBP2-mediated p53 modification. Clinically, we newly demonstrated that TRIM25 is a prognostic factor for prostate cancer patients. Expression of TRIM25 is significantly associated with cytoplasmic p53 expression and G3BP2. Moreover, TRIM25 knockdown results in reduced tumor growth and increased p53 activity in the mouse xenograft model of prostate cancer. Thus, our findings show that overexpression of TRIM25 promoted prostate cancer cell proliferation and cell survival by modulating p53 nuclear export mechanism with G3BP2 interaction.	[Takayama, Ken-ichi; Inoue, Satoshi] Tokyo Metropolitan Inst, Dept Funct Biogerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chuo Ku, Chiba, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Div Endocrinol & Metab, Chuo Ku, Chiba, Japan; [Fujimura, Tetsuya] Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo, Japan; [Takahashi, Satoru] Nihon Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo, Japan; [Urano, Tomohiko] Int Univ Hlth & Welf, Dept Geriatr Med, Chiba, Japan; [Ikeda, Kazuhiro; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan	Tohoku University; Chiba University; Chiba University; University of Tokyo; Nihon University; International University of Health & Welfare; Saitama Medical University	Inoue, S (corresponding author), Tokyo Metropolitan Inst, Dept Funct Biogerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo, Japan.; Inoue, S (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan.	sinoue@tmig.or.jp	Takayama, Kenichi/AAK-9238-2020; Urano, Tomohiko/AFS-9574-2022	Tanaka, Tomoaki/0000-0002-9761-1750; Urano, Tomohiko/0000-0002-1771-024X	P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology, Japan; P-CREATE from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science, Japan [15K15581, 15K15353]; Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan; Ministry of Health, Labor and Welfare, Japan; Takeda Science Foundation; Terumo foundation for Life Sciences and Arts; NOVARTIS Foundation for the Promotion of Science, Japan	P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology, Japan; P-CREATE from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Terumo foundation for Life Sciences and Arts; NOVARTIS Foundation for the Promotion of Science, Japan	This work was supported by grants of the P-DIRECT and the P-CREATE from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to SI); grants from the Japan Society for the Promotion of Science, Japan (to KT, grant 15K15581; to SI, grant 15K15353); a grant of the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan (to SI); Grants-in-Aid (to SI) from the Ministry of Health, Labor and Welfare, Japan, and grants from the Takeda Science Foundation (to SI and KT), the Terumo foundation for Life Sciences and Arts (to KT) and the NOVARTIS Foundation for the Promotion of Science (to KT), Japan.	Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Ashikari D, 2017, ONCOGENE, V36, P6272, DOI 10.1038/onc.2017.225; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cai CM, 2013, TRANSL ANDROL UROL, V2, P148, DOI 10.3978/j.issn.2223-4683.2013.09.02; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Henrique R, 2005, DNA CELL BIOL, V24, P264, DOI 10.1089/dna.2005.24.264; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Ikeda K, 1998, GENE, V216, P155, DOI 10.1016/S0378-1119(98)00307-2; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; INOUE S, 1995, GENOMICS, V25, P581, DOI 10.1016/0888-7543(95)80064-S; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Lee NR, 2015, MOL CELLS, V38, P759, DOI 10.14348/molcells.2015.0047; Linja MJ, 2001, CANCER RES, V61, P3550; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nakasato N, 2006, BIOCHEM BIOPH RES CO, V351, P540, DOI 10.1016/j.bbrc.2006.10.061; Orimo A, 1999, P NATL ACAD SCI USA, V96, P12027, DOI 10.1073/pnas.96.21.12027; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Sakuma M, 2005, GYNECOL ONCOL, V99, P664, DOI 10.1016/j.ygyno.2005.07.103; Shimada N, 2004, MOL CELL ENDOCRINOL, V218, P147, DOI 10.1016/j.mce.2003.12.008; Simooka H, 2004, PATHOL INT, V54, P595, DOI 10.1111/j.1440-1827.2004.01668.x; Suzuki T, 2005, CLIN CANCER RES, V11, P6148, DOI 10.1158/1078-0432.CCR-05-0040; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2016, BRIEF FUNCT GENOMICS, V15, P257, DOI 10.1093/bfgp/elv057; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Ueyama K, 2010, CANCER GENE THER, V17, P624, DOI 10.1038/cgt.2010.19; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Urano T, 2004, BIOCHEM BIOPH RES CO, V319, P795, DOI 10.1016/j.bbrc.2004.05.056; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Valentino E, 2017, P NATL ACAD SCI USA, V114, P7623, DOI 10.1073/pnas.1700996114; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang S, 2016, ONCOTARGET, V7, P64921, DOI 10.18632/oncotarget.11915; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yue XT, 2017, J MOL BIOL, V429, P1595, DOI 10.1016/j.jmb.2017.03.030; Zhang P, 2015, ONCOGENE, V34, P5729, DOI 10.1038/onc.2015.21; Zhao KW, 2011, BIOCHEM J, V437, P323, DOI 10.1042/BJ20101388; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	52	55	56	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2165	2180		10.1038/s41388-017-0095-x	http://dx.doi.org/10.1038/s41388-017-0095-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29379164				2022-12-26	WOS:000430589000007
J	Isobe, M; Izawa, K; Sugiuchi, M; Sakanishi, T; Kaitani, A; Takamori, A; Maehara, A; Matsukawa, T; Takahashi, M; Yamanishi, Y; Oki, T; Uchida, S; Uchida, K; Ando, T; Maeda, K; Nakano, N; Yagita, H; Takai, T; Ogawa, H; Okumura, K; Kitamura, T; Kitaura, J				Isobe, Masamichi; Izawa, Kumi; Sugiuchi, Masahiro; Sakanishi, Tamami; Kaitani, Ayako; Takamori, Ayako; Maehara, Akie; Matsukawa, Toshihiro; Takahashi, Mariko; Yamanishi, Yoshinori; Oki, Toshihiko; Uchida, Shino; Uchida, Koichiro; Ando, Tomoaki; Maeda, Keiko; Nakano, Nobuhiro; Yagita, Hideo; Takai, Toshiyuki; Ogawa, Hideoki; Okumura, Ko; Kitamura, Toshio; Kitaura, Jiro			The CD300e molecule in mice is an immune-activating receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; BLOOD MONOCYTE SUBSETS; MAST-CELL ACTIVATION; FCR-GAMMA-CHAIN; FUNCTIONAL-ANALYSIS; LY6C(-) MONOCYTES; APOPTOTIC CELLS; DENDRITIC CELLS; EPSILON-RI; MAIR-II	CD300 molecules (CD300s) belong to paired activating and inhibitory receptor families, which mediate immune responses. Human CD300e (hCD300e) is expressed in monocytes and myeloid dendritic cells and transmits an immune-activating signal by interacting with DNAX-activating protein 12 (DAP12). However, the CD300e ortholog in mice (mCD300e) is poorly characterized. Here, we found that mCD300e is also an immune-activating receptor. We found that mCD300e engagement triggers cytokine production in mCD300e-transduced bone marrow-derived mast cells (BMMCs). Loss of DAP12 and another signaling protein, FcR gamma, did not affect surface expression of transduced mCD300e, but abrogated mCD300e-mediated cytokine production in the BMMCs. Co-immunoprecipitation experiments revealed that mCD300e physically interacts with both FcR gamma and DAP12, suggesting that mCD300e delivers an activating signal via these two proteins. Binding and reporter assays with the mCD300e extracellular domain identified sphingomyelin as a ligand of both mCD300e and hCD300e. Notably, the binding of sphingomyelin to mCD300 estimulated cytokine production in the transduced BMMCs in an FcR gamma- and DAP12-dependent manner. Flow cytometric analysis with an mCD300especific Ab disclosed that mCD300e expression is highly restricted to CD115(+)Ly-6C(low/int) peripheral blood monocytes, corresponding to CD14(dim)/(+)CD16(+) human nonclassical and intermediate monocytes. Loss of FcR gamma or DAP12 lowered the surface expression of endogenous mCD300e in the CD115(+)Ly-6C(low/int) monocytes. Stimulation with sphingomyelin failed to activate the CD115(+)Ly-6C(low/int) mouse monocytes, but induced hCD300e-mediated cytokine production in the CD14(dim)CD16(+) human monocytes. Taken together, these observations indicate that mCD300e recognizes sphingomyelin and thereby regulates nonclassical and intermediate monocyte functions through FcR gamma and DAP12.	[Isobe, Masamichi; Izawa, Kumi; Kaitani, Ayako; Takamori, Ayako; Maehara, Akie; Uchida, Shino; Uchida, Koichiro; Ando, Tomoaki; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Kitaura, Jiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Isobe, Masamichi; Izawa, Kumi; Sugiuchi, Masahiro; Kaitani, Ayako; Matsukawa, Toshihiro; Takahashi, Mariko; Yamanishi, Yoshinori; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Div Stem Cell Signaling,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Sakanishi, Tamami] Juntendo Univ, Grad Sch Med, Res Support Ctr, Lab Cell Biol,Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Matsukawa, Toshihiro] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0600808, Japan; [Yamanishi, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138510, Japan; [Uchida, Shino] Juntendo Univ, Grad Sch Med, Dept Gastroenterol Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Yagita, Hideo] Juntendo Univ, Grad Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan	Juntendo University; University of Tokyo; Juntendo University; Hokkaido University; Tokyo Medical & Dental University (TMDU); Juntendo University; Juntendo University; Tohoku University	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Div Stem Cell Signaling,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.; Kitaura, J (corresponding author), Juntendo Univ, Atopy Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kitamura@ims.u-tokyo.ac.jp; j-kitaura@juntendo.ac.jp	Matsukawa, Toshihiro/A-4194-2016; Kitamura, Toshio/AAA-2071-2021	Matsukawa, Toshihiro/0000-0003-2371-3778; Nakano, Nobuhiro/0000-0002-5317-5950	Japan Society for the Promotion of Science KAKENHI [23390257, 26293231]; Grants-in-Aid for Scientific Research [15K09784] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23390257 and 26293231. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04647-z; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Matsukawa T, 2016, GUT, V65, P777, DOI 10.1136/gutjnl-2014-308900; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Murakami Y, 2014, CELL DEATH DIFFER, V21, P1746, DOI 10.1038/cdd.2014.86; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakahashi C, 2007, J IMMUNOL, V178, P765, DOI 10.4049/jimmunol.178.2.765; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Sakanishi T, 2010, BIOCHEM BIOPH RES CO, V393, P829, DOI 10.1016/j.bbrc.2010.02.092; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shiba E, 2017, J BIOL CHEM, V292, P2924, DOI 10.1074/jbc.M116.768366; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takahashi M, 2013, J BIOL CHEM, V288, P7662, DOI 10.1074/jbc.M112.434746; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zenarruzabeitia O, 2016, SCI REP-UK, V6, DOI 10.1038/srep32693	55	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3793	3805		10.1074/jbc.RA117.000696	http://dx.doi.org/10.1074/jbc.RA117.000696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358324	Green Published, hybrid			2022-12-26	WOS:000427030200031
J	Tutykhina, I; Esmagambetov, I; Bagaev, A; Pichugin, A; Lysenko, A; Shcherbinin, D; Sedova, E; Logunov, D; Shmarov, M; Ataullakhanov, R; Naroditsky, B; Gintsburg, A				Tutykhina, Irina; Esmagambetov, Ilias; Bagaev, Alexander; Pichugin, Alexey; Lysenko, Andrey; Shcherbinin, Dmitry; Sedova, Elena; Logunov, Denis; Shmarov, Maxim; Ataullakhanov, Rayshan; Naroditsky, Boris; Gintsburg, Alexander			Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts	PLOS ONE			English	Article							RECOMBINANT ADENOVIRAL VECTORS; RESPIRATORY SYNCYTIAL VIRUS; MATRIX PROTEIN-2; IMMUNE-RESPONSE; VACCINES; CELLS; IMMUNIZATION; PROTECTION; MICE; H5N1	To avoid outbreaks of influenza virus epidemics and pandemics among human populations, modern medicine requires the development of new universal vaccines that are able to provide protection from a wide range of influenza A virus strains. In the course of development of a universal vaccine, it is necessary to consider that immunity must be generated even against viruses from different hosts because new human epidemic virus strains have their origins in viruses of birds and other animals. We have enriched conserved viral proteins nucleoprotein (NP) and matrix protein 2 (M2) by B and T-cell epitopes not only human origin but also swine and avian origin. For this purpose, we analyzed M2 and NP sequences with respect to changes in the sequences of known T and B-cell epitopes and chose conserved and evolutionarily significant epitopes. Eventually, we found consensus sequences of M2 and NP that have the maximum quantity of epitopes that are 100% coincident with them. Consensus epitope-enriched amino acid sequences of M2 and NP proteins were included in a recombinant adenoviral vector. Immunization with Ad5-tet-M2NP induced strong CD8 and CD4 T cells responses, specific to each of the encoded antigens, i.e. M2 and NP. Eight months after immunization with Ad5-tet-M2NP, high numbers of M2- and NP-responding "effector memory" CD44posCD62neg T cells were found in the mouse spleens, which revealed a long-term T cell immune memory conferred by the immunization. In all, the challenge experiments showed an extraordinarily wide-ranging efficacy of protection by the Ad5-tet-M2NP vaccine, covering 5 different heterosubtypes of influenza A virus (2 human, 2 avian and 1 swine).	[Tutykhina, Irina; Esmagambetov, Ilias; Lysenko, Andrey; Shcherbinin, Dmitry; Sedova, Elena; Logunov, Denis; Shmarov, Maxim; Naroditsky, Boris; Gintsburg, Alexander] Minist Hlth, Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia; [Bagaev, Alexander; Pichugin, Alexey; Ataullakhanov, Rayshan] Fed Med Biol Agcy, Inst Immunol, Moscow, Russia	Ministry of Health of the Russian Federation; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; NRC Institute of Immunology FMBA of Russia	Tutykhina, I (corresponding author), Minist Hlth, Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia.	their@yandex.ru	Lysenko, Andrei A/C-7016-2014; Bagaev, Alexander/AAA-3150-2022; Tutykhina, Irina L/F-9185-2012; Sedova, Elena/S-4206-2017; Ataullakhanov, Ravshan/P-7969-2015; Logunov, Denis/E-8300-2014; Pichugin, Aleksey/A-9770-2015	Sedova, Elena/0000-0001-6959-9988; Ataullakhanov, Ravshan/0000-0002-4767-6409; Gintsburg, Alexander/0000-0003-1769-5059; Shmarov, Maxim/0000-0002-5268-1296; Naroditsky, Boris/0000-0001-5522-8238; Lysenko, Andrei/0000-0002-0230-1822; Dmitrii, Shcherbinin/0000-0002-8518-1669; Logunov, Denis/0000-0003-4035-6581; Esmagambetov, Ilias Bulatovich/0000-0002-2063-2449; Tutykhina, Irina/0000-0001-7667-5432; Pichugin, Aleksey/0000-0001-5356-3331				Alexander J, 2010, HUM IMMUNOL, V71, P468, DOI 10.1016/j.humimm.2010.02.014; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P3173, DOI 10.1073/pnas.1113342109; BLACK RA, 1993, J GEN VIROL, V74, P1673, DOI 10.1099/0022-1317-74-8-1673; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; BUTEL JS, 1966, J BACTERIOL, V92, P433, DOI 10.1002/path.1700920222; Coughlan L, 2015, J PHARM PHARMACOL, V67, P382, DOI 10.1111/jphp.12350; Cox F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145243; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2014, J INFECT DIS, V209, P975, DOI 10.1093/infdis/jit813; Munoz-Medina JE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/813047; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gilbert SC, 2013, INFLUENZA OTHER RESP, V7, P750, DOI 10.1111/irv.12013; Golovina TN, 2002, J IMMUNOL, V168, P2667, DOI 10.4049/jimmunol.168.6.2667; Gottlieb T, 2014, J AUTOIMMUN, V54, P15, DOI 10.1016/j.jaut.2014.07.005; GUINEA R, 1994, FEBS LETT, V343, P242, DOI 10.1016/0014-5793(94)80564-4; Hessel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088340; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Ignareva AV, 2011, VOP VIRUSOL+, V56, P9; Ilyinskii PO, 2007, CELL CYCLE, V6, P2043, DOI 10.4161/cc.6.16.4564; Joseph U, 2017, INFLUENZA OTHER RESP, V11, P74, DOI 10.1111/irv.12412; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075460; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Kui X, 2015, HUM VACC IMMUNOTHER, V11, P1209, DOI 10.1080/21645515.2015.1016674; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Madaan A., 2014, J BIOL METHODS, V1, pe1, DOI [10.14440/jbm.2014.12, DOI 10.14440/JBM.2014.12]; Ohba K, 2007, VACCINE, V25, P4291, DOI 10.1016/j.vaccine.2007.02.074; Price GE, 2014, J VIROL, V88, P6019, DOI 10.1128/JVI.03101-13; Roos A, 2015, VACCINE, V33, P1739, DOI 10.1016/j.vaccine.2015.01.070; Sathiamurthy M, 2003, TISSUE ANTIGENS, V61, P12, DOI 10.1034/j.1399-0039.2003.610102.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sedova E. S., 2010, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P44; Shapshak P, 2011, MOL DIAGN THER, V15, P63, DOI 10.2165/11590660-000000000-00000; Shcherbinin DN, 2014, ACTA NATURAE, V6, P76, DOI 10.32607/20758251-2014-76-84; Sheikh QM, 2016, BIOINFORMATICS, V32, P3233, DOI 10.1093/bioinformatics/btw399; Shmarov MM, 2010, ACTA NATURAE, V2, P111; Smirnov YA, 2000, ACTA VIROL, V44, P1; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Stepanova LA, 2016, ACTA NATURAE, V8, P116, DOI 10.32607/20758251-2016-8-2-116-126; Stepanova LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119520; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Terajima M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-244; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Trombetta C, 2015, VACCINES-BASEL, V3, P172, DOI 10.3390/vaccines3010172; Tutykhina IL, 2013, ANTIVIR RES, V97, P318, DOI 10.1016/j.antiviral.2012.12.021; Zhang H, 2014, VIRUSES-BASEL, V6, P1974, DOI 10.3390/v6051974; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	50	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191574	10.1371/journal.pone.0191574	http://dx.doi.org/10.1371/journal.pone.0191574			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377916	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700018
J	Levanen, R; Thulin, CG; Spong, G; Pohjoismaki, JLO				Levanen, Riikka; Thulin, Carl-Gustaf; Spong, Goran; Pohjoismaki, Jaakko L. O.			Widespread introgression of mountain hare genes into Fennoscandian brown hare populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; LEPUS-EUROPAEUS; ADAPTIVE INTROGRESSION; HYBRIDIZATION; DIVERSITY; TIMIDUS; CONSEQUENCES; EVOLUTION; INVASIONS; INFERENCE	In Fennoscandia, mountain hare (Lepus timidus) and brown hare (Lepus europaeus) hybridize and produce fertile offspring, resulting in gene flow across the species barrier. Analyses of maternally inherited mitochondrial DNA (mtDNA) show that introgression occur frequently, but unavailability of appropriate nuclear DNA markers has made it difficult to evaluate the scale-and significance for the species. The extent of introgression has become important as the brown hare is continuously expanding its range northward, at the apparent expense of the mountain hare, raising concerns about possible competition. We report here, based on analysis of 6833 SNP markers, that the introgression is highly asymmetrical in the direction of gene flow from mountain hare to brown hare, and that the levels of nuclear gene introgression are independent of mtDNA introgression. While it is possible that brown hares obtain locally adapted alleles from the resident mountain hares, the low levels of mountain hare alleles among allopatric brown hares suggest that hybridization is driven by stochastic processes. Interspecific geneflow with the brown hare is unlikely to have major impacts on mountain hare in Fennoscandia, but direct competition may.	[Levanen, Riikka; Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Thulin, Carl-Gustaf; Spong, Goran] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Mol Ecol Grp, Umea, Sweden; [Thulin, Carl-Gustaf] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Spong, Goran] North Carolina State Univ, Coll Nat Resources, Forestry & Environm Resources, Raleigh, NC 27695 USA	University of Eastern Finland; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of North Carolina; North Carolina State University	Pohjoismaki, JLO (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	Jaakko.Pohjoismaki@uef.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Spong, Goran/0000-0002-1246-5046	Swedish Association of Hunting and Management; Swedish Environmental Protection Agency; Faculty of Forest Sciences at SLU; Betty Vaananen Foundation; Finnish Game Foundation; Raija and Ossi Tuuliainen Foundation; Societas pro Fauna et Flora Fennica; Saastamoinen Foundation; University of Eastern Finland doctoral school	Swedish Association of Hunting and Management; Swedish Environmental Protection Agency; Faculty of Forest Sciences at SLU; Betty Vaananen Foundation; Finnish Game Foundation; Raija and Ossi Tuuliainen Foundation; Societas pro Fauna et Flora Fennica; Saastamoinen Foundation; University of Eastern Finland doctoral school	The Swedish Association of Hunting and Management, the Swedish Environmental Protection Agency, the Faculty of Forest Sciences at SLU, Betty Vaananen Foundation (https://www.sll.fi/pohjois-savo/klyy/apurahat), Finnish Game Foundation (http://www.riistasaatio.fi/), Raija and Ossi Tuuliainen Foundation (http://www.tuuliaisensaatio.fi/), Societas pro Fauna et Flora Fennica (http://www.societasfff.fi/), Saastamoinen Foundation (http://saastamoinenfoundation.fi/) and the University of Eastern Finland doctoral school are kindly thanked for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RL, JP and CGT thank all hunters and Finnish food safety authority for helping with sample collections, and A. Pynttari, I. Assimakopoulou, J. Gnjatovic, L. Barbier and P. Mutka for laboratory assistance. The Swedish Association of Hunting and Management, the Swedish Environmental Protection Agency, the Faculty of Forest Sciences at SLU, Betty Vaananen Foundation, Finnish Game Foundation, Raija and Ossi Tuuliainen Foundation, Societas pro Fauna et Flora Fennica, Saastamoinen Foundation and the University of Eastern Finland doctoral school are kindly thanked for funding.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Anderson EC, 2002, GENETICS, V160, P1217; Andrews KR, 2016, NATURE REV GENETICS, V17, P92, DOI DOI 10.1038/NRG.2015.28; Asensio N, 2017, AM J PHYS ANTHROPOL, V163, P716, DOI 10.1002/ajpa.23241; Bay RA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2414; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Chan KMA, 2005, EVOLUTION, V59, P720; Charlesworth B, 2005, GENET RES, V86, P149, DOI 10.1017/S0016672305007743; Corso J, 2016, J EVOLUTION BIOL, V29, P2530, DOI 10.1111/jeb.12982; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Daniels MJ, 2003, WILDLIFE RES, V30, P213, DOI 10.1071/WR02045; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fredsted Tina, 2006, BMC Ecology, V6, P17, DOI 10.1186/1472-6785-6-17; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Gil-Sanchez JM, 2015, ZOOLOGY, V118, P377, DOI 10.1016/j.zool.2015.08.001; Hamilton JA, 2016, CONSERV BIOL, V30, P33, DOI 10.1111/cobi.12574; Harrison RG, 2014, J HERED, V105, P795, DOI 10.1093/jhered/esu033; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansson G, 2007, EUR J WILDLIFE RES, V53, P125, DOI 10.1007/s10344-007-0086-2; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14444; Koju NP, 2017, MOL PHYLOGENET EVOL, V107, P239, DOI 10.1016/j.ympev.2016.11.005; Kumpulainen M, 2017, J ANIM BREED GENET; Lanning DK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182029; Levanen R, 2018, ANN ZOOL FENN, V55, P15, DOI 10.5735/086.055.0103; Lonnberg E, 1905, P ZOOL SOC LOND, V1, P278; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; Marques JP, 2017, SCI REPORTS, V7, P1806; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2014, HEREDITY, V112, P265, DOI 10.1038/hdy.2013.102; Melo-Ferreira J, 2014, GENOME BIOL EVOL, V6, P886, DOI 10.1093/gbe/evu059; Milan-Garcia Y, 2015, HEREDITY, V114, P272, DOI 10.1038/hdy.2014.96; Payseur BA, 2016, MOL ECOL, V25, P2337, DOI 10.1111/mec.13557; Pedersen S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1722; Pritchard JK, 2000, GENETICS, V155, P945; Racimo F, 2017, MOL BIOL EVOL, V34, P296, DOI 10.1093/molbev/msw216; Reid N, 2011, BIOL INVASIONS, V13, P559, DOI 10.1007/s10530-010-9849-x; Smith S, 2017, BIOL J LINN SOC, V120, P891; Smith S, 2011, IMMUNOGENETICS, V63, P743, DOI 10.1007/s00251-011-0539-3; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Thenius E., 1980, GRUNDZUGE FAUNEN VER; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Thulin CG, 2006, WILDLIFE BIOL, V12, P29, DOI 10.2981/0909-6396(2006)12[29:SAAHIA]2.0.CO;2; Thulin CG, 2003, MAMMAL REV, V33, P29, DOI 10.1046/j.1365-2907.2003.00008.x; Thulin CG, 2002, J ZOOL, V258, P299, DOI 10.1017/S0952836902001425; Thulin CG, 2001, ACTA THERIOL, V46, P375, DOI 10.1007/BF03192444; Tigano A, 2016, MOL ECOL, V25, P2144, DOI 10.1111/mec.13606; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Zimova M, 2016, ECOL LETT, V19, P299, DOI 10.1111/ele.12568	62	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191790	10.1371/journal.pone.0191790	http://dx.doi.org/10.1371/journal.pone.0191790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370301	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600098
J	Gorbet, DJ; Sergio, LE				Gorbet, Diana J.; Sergio, Lauren E.			Move faster, think later: Women who play action video games have quicker visually-guided responses with later onset visuomotor-related brain activity	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; GENDER-DIFFERENCES; SEX-DIFFERENCES; CORTICAL CONNECTIONS; PARKINSONS-DISEASE; ACUTE STROKE; MOVEMENTS; ATTENTION; PERFORMANCE; EXPERIENCE	A history of action video game (AVG) playing is associated with improvements in several visuospatial and attention-related skills and these improvements may be transferable to unrelated tasks. These facts make video games a potential medium for skill-training and rehabilitation. However, examinations of the neural correlates underlying these observations are almost non-existent in the visuomotor system. Further, the vast majority of studies on the effects of a history of AVG play have been done using almost exclusively male participants. Therefore, to begin to fill these gaps in the literature, we present findings from two experiments. In the first, we use functional MRI to examine brain activity in experienced, female AVG players during visually-guided reaching. In the second, we examine the kinematics of visually-guided reaching in this population. Imaging data demonstrate that relative to women who do not play, AVG players have less motor-related preparatory activity in the cuneus, middle occipital gyrus, and cerebellum. This decrease is correlated with estimates of time spent playing. Further, these correlations are strongest during the performance of a visuomotor mapping that spatially dissociates eye and arm movements. However, further examinations of the full time-course of visuomotor-related activity in the AVG players revealed that the decreased activity during motor preparation likely results from a later onset of activity in AVG players, which occurs closer to beginning motor execution relative to the non-playing group. Further, the data presented here suggest that this later onset of preparatory activity represents greater neural efficiency that is associated with faster visually-guided responses.	[Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Ctr Vis Res, Toronto, ON, Canada	York University - Canada; York University - Canada	Gorbet, DJ (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.; Gorbet, DJ (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	gorbetd@yorku.ca	Sergio, Lauren/AAK-3274-2020	Gorbet, Diana/0000-0001-6906-2056	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Discovery Grant to LS (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsters JH, 2011, J NEUROSCI, V31, P2305, DOI 10.1523/JNEUROSCI.4358-10.2011; Barrett Kevin M, 2007, J Stroke Cerebrovasc Dis, V16, P34, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.002; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2013, NATURE, V494, P425, DOI 10.1038/494425a; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bejjanki VR, 2014, P NATL ACAD SCI USA, V111, P16961, DOI 10.1073/pnas.1417056111; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; BOOT WR, 2013, FRONT PSYCHOL, V4; Brown GG, 2004, J CLIN EXP NEUROPSYC, V26, P356, DOI 10.1080/13803390490510086; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Carey DP, 1997, CORTEX, V33, P639, DOI 10.1016/S0010-9452(08)70722-6; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chen Y, 2014, J NEUROSCI, V34, P12515, DOI 10.1523/JNEUROSCI.1445-14.2014; Chisholm JD, 2015, ACTA PSYCHOL, V159, P93, DOI 10.1016/j.actpsy.2015.06.001; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; Clark K, 2011, ACTA PSYCHOL, V136, P67, DOI 10.1016/j.actpsy.2010.10.003; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; De Lisi R, 2002, J GENET PSYCHOL, V163, P272, DOI 10.1080/00221320209598683; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dillard C, 2016, DISABIL REHABIL, V8288, P1; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; DORVAL M, 1986, PERCEPT MOTOR SKILL, V62, P159, DOI 10.2466/pms.1986.62.1.159; DUSTMAN RE, 1992, J GERONTOL, V47, pP168, DOI 10.1093/geronj/47.3.P168; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fischer E, 2012, NEURON, V73, P1228, DOI 10.1016/j.neuron.2012.01.022; Fritz SL, 2013, TOP STROKE REHABIL, V20, P218, DOI 10.1310/tsr2003-218; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Gobel EW, 2011, NEUROIMAGE, V58, P1150, DOI 10.1016/j.neuroimage.2011.06.090; Gong DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09763; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2011, EXP BRAIN RES, V212, P315, DOI 10.1007/s00221-011-2731-y; Gorbet DJ, 2010, EXP BRAIN RES, V202, P633, DOI 10.1007/s00221-010-2170-1; Granek JA, 2010, CORTEX, V46, P1165, DOI 10.1016/j.cortex.2009.10.009; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenfield PM, 1994, J APPL DEV PSYCHOL, V15, P105, DOI [10.1016/0193-3973(94)90008-6, DOI 10.1016/0193-3973(94)90008-6]; GREENFIELD PM, 1994, J APPL DEV PSYCHOL, V15, P87, DOI DOI 10.1016/0193-3973(94)90007-8; Grigorova V, 2013, J MOTOR BEHAV, V45, P101, DOI 10.1080/00222895.2012.750590; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Harwell D, 2014, WASHINGTON POST; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; Hubert-Wallander B, 2011, WIRES COGN SCI, V2, P222, DOI 10.1002/wcs.116; Irons JL, 2011, AUST J PSYCHOL, V63, P224, DOI 10.1111/j.1742-9536.2011.00001.x; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Kennedy AM, 2011, J SURG EDUC, V68, P414, DOI 10.1016/j.jsurg.2011.03.009; Kim YH, 2015, J NEUROSCI, V35, P10485, DOI 10.1523/JNEUROSCI.3340-14.2015; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kuhn S, 2014, MOL PSYCHIATR, V19, P842, DOI 10.1038/mp.2013.100; Labiche LA, 2002, ANN EMERG MED, V40, P453, DOI 10.1067/mem.2002.128682; Lacquaniti F, 1997, NEUROIMAGE, V5, P129, DOI 10.1006/nimg.1996.0254; Latham AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00629; Latham AJ, 2014, ATTEN PERCEPT PSYCHO, V76, P2193, DOI 10.3758/s13414-014-0789-x; Lee H, 2012, BEHAV BRAIN RES, V232, P348, DOI 10.1016/j.bbr.2012.03.043; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Li RJ, 2010, J VISION, V10, DOI 10.1167/10.14.33; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Lucas K, 2004, COMMUN RES, V31, P499, DOI 10.1177/0093650204267930; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Monaco S, 2014, CEREB CORTEX, V24, P1540, DOI 10.1093/cercor/bht006; Morris MC, 2015, J SURG EDUC, V72, P198, DOI 10.1016/j.jsurg.2014.09.007; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Okagaki Lynn, 1994, J APPL DEV PSYCHOL, V15, P33, DOI DOI 10.1016/0193-3973(94)90005-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Pitzalis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060241; Quaiser-Pohl C, 2006, PERS INDIV DIFFER, V40, P609, DOI 10.1016/j.paid.2005.07.015; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Schubert T, 2015, ACTA PSYCHOL, V157, P200, DOI 10.1016/j.actpsy.2015.03.005; Sinanaj I, 2015, CONSCIOUS COGN, V36, P327, DOI 10.1016/j.concog.2015.07.012; Spencer A., 2009, J ARTICLES SUPPORT N, V6, P1; Striemer CL, 2015, NEUROPSYCHOLOGIA, V69, P9, DOI 10.1016/j.neuropsychologia.2015.01.024; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; Sungur H, 2012, ACTA PSYCHOL, V139, P327, DOI 10.1016/j.actpsy.2011.12.002; Tanaka S, 2013, PLOS ONE, V8, P4, DOI DOI 10.1371/J0URNAL.P0NE.0066998; Thorson CM, 2011, J LAPAROENDOSC ADV S, V21, P329, DOI 10.1089/lap.2010.0368; Vesia M, 2012, EXP BRAIN RES, V221, P1, DOI 10.1007/s00221-012-3158-9; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982	96	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189110	10.1371/journal.pone.0189110	http://dx.doi.org/10.1371/journal.pone.0189110			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364891	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500004
J	Ono, K; Igata, M; Kondo, T; Kitano, S; Takaki, Y; Hanatani, S; Sakaguchi, M; Goto, R; Senokuchi, T; Kawashima, J; Furukawa, N; Motoshima, H; Araki, E				Ono, Kaoru; Igata, Motoyuki; Kondo, Tatsuya; Kitano, Sayaka; Takaki, Yuki; Hanatani, Satoko; Sakaguchi, Masaji; Goto, Rieko; Senokuchi, Takafumi; Kawashima, Junji; Furukawa, Noboru; Motoshima, Hiroyuki; Araki, Eiichi			Identification of microRNA that represses IRS-1 expression in liver	PLOS ONE			English	Article							INSULIN-RECEPTOR GENE; REVEALS COMMON; RESISTANCE; CELLS; DYSFUNCTION; METABOLISM; INDUCTION; METFORMIN; KNOCKOUT; PROMOTER	MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally regulate gene expression and have been shown to participate in almost every cellular process. Several miRNAs have recently been implicated in glucose metabolism, but the roles of miRNAs in insulin-resistant conditions, such as obesity or type 2 diabetes, are largely unknown. Herein, we focused on miR-222, the expression of which was increased in the livers of high fat/high sucrose diet-fed mice injected with gold thioglucose (G+HFHSD). Overexpression of miR-222 in primary mouse hepatocytes attenuated Akt phosphorylation induced by insulin, indicating that miR-222 negatively regulates insulin signaling. As per in silico analysis, miR-222 potentially binds to the 3' untranslated region (30 UTR) of the IRS-1 gene, a key insulin signaling molecule. In fact, IRS-1 protein expression was decreased in the livers of G+HFHSDfed mice. We further confirmed a direct interaction between miR-222 and the 3' UTR of IRS-1 via luciferase assays. Our findings suggest that up-regulation of miR-222 followed by reduction in IRS-1 expression may be a viable mechanism of insulin resistance in the liver.	[Ono, Kaoru; Igata, Motoyuki; Kondo, Tatsuya; Kitano, Sayaka; Takaki, Yuki; Hanatani, Satoko; Sakaguchi, Masaji; Goto, Rieko; Senokuchi, Takafumi; Kawashima, Junji; Furukawa, Noboru; Motoshima, Hiroyuki; Araki, Eiichi] Kumamoto Univ, Dept Metab Med, Fac Life Sci, Kumamoto, Japan	Kumamoto University	Araki, E (corresponding author), Kumamoto Univ, Dept Metab Med, Fac Life Sci, Kumamoto, Japan.	earaki@gpo.kumamoto-u.ac.jp		Kondo, Tatsuya/0000-0003-4830-8955	Japan Society for the Promotion of Science, Japan [15K09394, 16K09760]; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [16K09760] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (No. 15K09394 to T.K. and No. 16K09760 to M.I.) (https://www.jsps.go.jp/english/e-grants/) and by a grant from the Japan Foundation for Applied Enzymology (to M.I.) (https://www.jfae.or.jp/).	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], W BLOTT PROT; ARAKI E, 1991, J BIOL CHEM, V266, P3944; ARAKI E, 1995, MOL ENDOCRINOL, V9, P1367, DOI 10.1210/me.9.10.1367; ARAKI E, 1987, J BIOL CHEM, V262, P16186; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Coleman CB, 2013, MOL CELL ENDOCRINOL, V374, P125, DOI 10.1016/j.mce.2013.04.019; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Jeong G, 2017, RNA BIOL, V14, P197, DOI 10.1080/15476286.2016.1269994; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li YX, 2009, BIOCHEM BIOPH RES CO, V381, P81, DOI 10.1016/j.bbrc.2009.02.013; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Mathijs K, 2009, DRUG METAB DISPOS, V37, P1305, DOI 10.1124/dmd.108.025775; Matsuda K, 1997, DIABETES, V46, P354, DOI 10.2337/diabetes.46.3.354; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Shi ZH, 2014, ENDOCRINOLOGY, V155, P1982, DOI 10.1210/en.2013-2046; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wang YQ, 2013, BIOTECHNOL LETT, V35, P2013, DOI 10.1007/s10529-013-1309-0; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yang WM, 2014, FEBS LETT, V588, P2170, DOI 10.1016/j.febslet.2014.05.011	35	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191553	10.1371/journal.pone.0191553	http://dx.doi.org/10.1371/journal.pone.0191553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364977	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500057
J	Behan, FP; Maden-Wilkinson, TM; Pain, MTG; Folland, JP				Behan, Fearghal P.; Maden-Wilkinson, Thomas M.; Pain, Matt T. G.; Folland, Jonathan P.			Sex differences in muscle morphology of the knee flexors and knee extensors	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FEMALE TEAM HANDBALL; ANGULAR VELOCITY; TORQUE RATIOS; STRAIN INJURY; YOUNG MEN; LOWER LEG; IN-VIVO; STRENGTH; QUADRICEPS	Introduction & para;& para;Females experience higher risk of anterior cruciate ligament (ACL) injuries; males experience higher risk of hamstring strain injuries. Differences in injury may be partially due to sex differences in knee flexor (KF) to knee extensor (KE) muscle size ratio and the proportional size of constituent muscles.& para;& para;Purpose & para;& para;To compare the absolute and proportional size, and mass distribution, of individual KE and KF muscles, as well as overall size and balance (size ratio) of these muscle groups between the sexes.& para;& para;Methods & para;& para;T1-weighted axial plane MR images (1.5T) of healthy untrained young males and females (32 vs 34) were acquired to determine thigh muscle anatomical cross-sectional area (ACSA). Maximal ACSA (ACSAmax) of constituent muscles, summated for KF and KE muscle groups, and the KF:KE ratio were calculated.& para;& para;Results & para;& para; Females had 25.3% smaller KE ACSAmax (70.9 +/- 12.1 vs 93.6 +/- 10.3 cm(2); P<0.001) and 29.6% smaller KF ACSAmax than males (38.8 +/- 7.3cm(2) vs 55.1 +/- 7.3cm(2); P<0.001). Consequently, females had lower KF:KE ACSA ratio (P = 0.031). There were sex differences in the proportional size of 2/4 KE and 5/6 KF. In females, vastus lateralis (VL), biceps femoris long-head (BFlh) and semimembranosus (SM) were a greater proportion and sartorius (SA), gracilis (GR) and biceps femoris short-head (BFsh) a smaller proportion of their respective muscle groups compared to males (All P<0.05).& para;& para;Conclusion & para;& para;Sex differences in KF:KE ACSAmax ratio may contribute to increased risk of ACL injury in females. Sex discrepancies in absolute and proportional size of SA, GR, VL and BFlh may contribute further anatomical explanations for sex differences in injury incidence.	[Behan, Fearghal P.; Folland, Jonathan P.] Loughborough Univ Technol, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Loughborough, Leics, England; [Behan, Fearghal P.; Pain, Matt T. G.; Folland, Jonathan P.] Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Maden-Wilkinson, Thomas M.] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Collegiate Campus, Sheffield, S Yorkshire, England	Loughborough University; Loughborough University; Sheffield Hallam University	Behan, FP (corresponding author), Loughborough Univ Technol, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Loughborough, Leics, England.; Behan, FP (corresponding author), Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.	F.Behan@lboro.ac.uk		Maden-Wilkinson, Thomas/0000-0002-6191-045X; Behan, Fearghal/0000-0001-9578-5725	Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis; Arthritis Research UK	Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis(Versus Arthritis); Arthritis Research UK(Versus Arthritis)	Arthritis Research UK funded the research.& para;& para; This research was funded by The Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis.	Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Akagi R, 2013, INT J SPORTS MED, V34, P449, DOI 10.1055/s-0032-1327654; Akagi R, 2012, INT J SPORTS MED, V33, P386, DOI 10.1055/s-0031-1299700; Andrade MD, 2012, J SPORT SCI, V30, P547, DOI 10.1080/02640414.2011.644249; Arendt E, 2009, AM J SPORTS MED, V23, P694; Balshaw TG, 2016, J APPL PHYSIOL, V120, P1364, DOI 10.1152/japplphysiol.00091.2016; Barnouin Y, 2014, J MAGN RESON IMAGING, V40, P239, DOI 10.1002/jmri.24370; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; Blackburn JT, 2009, CLIN BIOMECH, V24, P65, DOI 10.1016/j.clinbiomech.2008.10.001; Buchanan TS, 1997, J ORTHOPAED RES, V15, P11, DOI 10.1002/jor.1100150103; Calmels PM, 1997, ARCH PHYS MED REHAB, V78, P1224, DOI 10.1016/S0003-9993(97)90336-1; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; DeMorat G, 2004, AM J SPORT MED, V32, P477, DOI 10.1177/0363546503258928; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Edouard P, 2016, BRIT J SPORT MED, V50, P619, DOI 10.1136/bjsports-2015-095559; Erskine RM, 2014, EUR J APPL PHYSIOL, V114, P1239, DOI 10.1007/s00421-014-2855-4; Evangelidis PE, 2016, EUR J APPL PHYSIOL, V116, P593, DOI 10.1007/s00421-015-3321-7; Hannah R, 2015, EUR J APPL PHYSIOL, V115, P837, DOI 10.1007/s00421-014-3063-y; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Hewett TE, 2008, J SCI MED SPORT, V11, P452, DOI 10.1016/j.jsams.2007.04.009; Hoshikawa Y, 2011, J PHYSIOL ANTHROPOL, V30, P47, DOI 10.2114/jpa2.30.47; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Koulouris G, 2007, AM J SPORT MED, V35, P1500, DOI 10.1177/0363546507301258; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lube J, 2016, SURG RADIOL ANAT, V38, P97, DOI 10.1007/s00276-015-1526-4; MacWilliams BA, 1999, J ORTHOPAED RES, V17, P817, DOI 10.1002/jor.1100170605; Mersmann F, 2015, SCAND J MED SCI SPOR, V25, pe208, DOI 10.1111/sms.12285; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Round JM, 1999, ANN HUM BIOL, V26, P49, DOI 10.1080/030144699282976; Satterthwaite P, 1999, BRIT J SPORT MED, V33, P22, DOI 10.1136/bjsm.33.1.22; Schache AG, 2009, GAIT POSTURE, V29, P332, DOI 10.1016/j.gaitpost.2008.10.054; Serpell BG, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0804-y; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Verrall GM, 2003, AM J SPORT MED, V31, P969, DOI 10.1177/03635465030310063701; Withrow TJ, 2008, J BONE JOINT SURG AM, V90A, P815, DOI 10.2106/JBJS.F.01352; Wretenberg P, 1996, CLIN BIOMECH, V11, P439, DOI 10.1016/S0268-0033(96)00030-7; Wu R, 2016, AGE, V38, DOI 10.1007/s11357-016-9921-2; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	44	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190903	10.1371/journal.pone.0190903	http://dx.doi.org/10.1371/journal.pone.0190903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360834	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000423161800010
J	Verma, V; Kaur, C; Grover, P; Gupta, A; Chaudhary, VK				Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.			Biotin-tagged proteins: Reagents for efficient ELISA-based serodiagnosis and phage display-based affinity selection	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; IN-VIVO; ESCHERICHIA-COLI; HOLOENZYME SYNTHETASE; ANTIBODY FRAGMENTS; FUSION PROTEINS; BRIDGING ELISA; HUMAN SERA; EXPRESSION; PURIFICATION	The high-affinity interaction between biotin and streptavidin has opened avenues for using recombinant proteins with site-specific biotinylation to achieve efficient and directional immobilization. The site-specific biotinylation of proteins carrying a 15 amino acid long Biotin Acceptor Peptide tag (BAP; also known as AviTag) is effected on a specific lysine either by co-expressing the E. coli BirA enzyme in vivo or by using purified recombinant E. coli BirA enzyme in the presence of ATP and biotin in vitro. In this paper, we have designed a T7 promoter-lac operator-based expression vector for rapid and efficient cloning, and high-level cytosolic expression of proteins carrying a C-terminal BAP tag in E. coli with TEV protease cleavable N-terminal deca-histidine tag, useful for initial purification. Furthermore, a robust three-step purification pipeline integrated with well-optimized protocols for TEV protease-based H10 tag removal, and recombinant BirA enzyme-based site-specific in vitro biotinylation is described to obtain highly pure biotinylated proteins. Most importantly, the paper demonstrates superior sensitivities in indirect ELISA with directional and efficient immobilization of biotin-tagged proteins on streptavidin-coated surfaces in comparison to passive immobilization. The use of biotin-tagged proteins through specific immobilization also allows more efficient selection of binders from a phage-displayed naive antibody library. In addition, for both these applications, specific immobilization requires much less amount of protein as compared to passive immobilization and can be easily multiplexed. The simplified strategy described here for the production of highly pure biotin-tagged proteins will find use in numerous applications, including those, which may require immobilization of multiple proteins simultaneously on a solid surface.	[Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, CIIDRET, South Campus, New Delhi, India; [Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, Dept Biochem, South Campus, New Delhi, India	University of Delhi; University of Delhi	Gupta, A; Chaudhary, VK (corresponding author), Univ Delhi, CIIDRET, South Campus, New Delhi, India.; Gupta, A; Chaudhary, VK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	amitagupta@south.du.ac.in; vkchaudhary@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Council of Scientific and Industrial Research, India; Delhi University Research and Development grant; Council of Scientific and Industrial Research (CSIR-NMITLI), India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Delhi University Research and Development grant; Council of Scientific and Industrial Research (CSIR-NMITLI), India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grants from the Department of Biotechnology, Government of India, Council of Scientific and Industrial Research (CSIR-NMITLI), India, and Delhi University Research and Development grant to VKC and AG.W is the recipient of a research fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Bouda LMP, 2003, J IMMUNOL METHODS, V283, P115, DOI 10.1016/j.jim.2003.08.019; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Batra G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-64; Batra G, 2010, PROTEIN EXPRES PURIF, V74, P99, DOI 10.1016/j.pep.2010.04.017; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Chaudhary VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111538; Clavijo A, 2004, J VIROL METHODS, V120, P217, DOI 10.1016/j.jviromet.2004.05.007; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Graslund S, 2017, METHODS MOL BIOL, V1586, P337, DOI 10.1007/978-1-4939-6887-9_22; Gross J, 2006, J IMMUNOL METHODS, V313, P176, DOI 10.1016/j.jim.2006.04.008; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075212; Haque A, 2012, NAT PROTOC, V7, P2127, DOI 10.1038/nprot.2012.132; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; Ikonomova SP, 2016, J IMMUNOL METHODS, V435, P7, DOI 10.1016/j.jim.2016.04.012; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kimura R, 2010, JPN J INFECT DIS, V63, P41; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; LI SJ, 1992, J BIOL CHEM, V267, P855; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Postel A, 2011, ANAL BIOCHEM, V411, P22, DOI 10.1016/j.ab.2010.12.022; Qureshi MH, 2002, PROTEIN EXPRES PURIF, V25, P409, DOI 10.1016/S1046-5928(02)00021-9; Rohman M, 2000, PROTEIN EXPRES PURIF, V20, P45, DOI 10.1006/prep.2000.1271; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Salminen T, 2016, J VIROL METHODS, V228, P67, DOI 10.1016/j.jviromet.2015.11.015; Schetters H, 1999, BIOMOL ENG, V16, P73, DOI 10.1016/S1050-3862(99)00034-0; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Shin SK, 2010, J PHARMACEUT BIOMED, V52, P289, DOI 10.1016/j.jpba.2010.01.022; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Staudt N, 2014, BIOCHEM BIOPH RES CO, V445, P785, DOI 10.1016/j.bbrc.2013.12.033; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Tykvart J, 2012, PROTEIN EXPRES PURIF, V82, P106, DOI 10.1016/j.pep.2011.11.016; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716; Zhong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139695; Zhou FB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15349	45	5	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191315	10.1371/journal.pone.0191315	http://dx.doi.org/10.1371/journal.pone.0191315			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360877	Green Published, gold, Green Submitted			2022-12-26	WOS:000423161800023
J	Jacobi, CLJ; Stein, C				Jacobi, Charlotte Louise Justine; Stein, Christoph			Inflammatory-linked changes in CpG island methylation of three opioid peptide genes in a rat model for pain	PLOS ONE			English	Article							BETA-ENDORPHIN; MESSENGER-RNA; IMMUNE CELLS; PROOPIOMELANOCORTIN GENE; PROSTATE-CANCER; IN-VIVO; EXPRESSION; PROMOTER; DNA; TRANSCRIPTION	Expression of the opioid peptide genes proopiomelanocortin (Pomc), proenkephalin (Penk), and prodynorphin (Pdyn), in immune cells plays a key role in endogenous pain control. In a rat model of painful unilateral paw inflammation, we isolated cells from popliteal lymph nodes and evaluated the role of C(p)G island C5-methylation on the transcriptional activation of those genes. Using methylated DNA immunoprecipitation, we sorted gDNA into methylated (me) and non-me fractions and then determined the C(p)G island methylation status of each fraction via quantitative Real Time-PCR (qRT-PCR). In silico analysis by MethPrimer software identified one C(p)G island in Pdyn and three each in Pomc and Penk. No substantial changes in C5-methylation of any gene were observed. In conclusion, the C(p)G island methylation status does not seem to be a key regulator of opioid gene activation in immune cells during peripheral tissue inflammation.	[Jacobi, Charlotte Louise Justine; Stein, Christoph] Charite Univ Med Berlin, Klin Anasthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany; [Jacobi, Charlotte Louise Justine] Charite Univ Med Berlin, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jacobi, CLJ (corresponding author), Charite Univ Med Berlin, Klin Anasthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany.; Jacobi, CLJ (corresponding author), Charite Univ Med Berlin, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany.	charlotte.jacobi@charite.de		Stein, Christoph/0000-0001-5240-6836	Bundesministerium fur Bildung und Forschung [01EC1403E/F]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/; grant number 01EC1403E/F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Ashour N, 2014, PROSTATE, V74, P1171, DOI 10.1002/pros.22833; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Chadzinska M, 2005, IMMUNOL LETT, V101, P185, DOI 10.1016/j.imlet.2005.05.009; Chan RM, 1997, MOL BRAIN RES, V45, P50, DOI 10.1016/S0169-328X(96)00236-7; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; HEIJNEN CJ, 1991, IMMUNOL REV, V119, P41, DOI 10.1111/j.1600-065X.1991.tb00577.x; Hurd YL, 1996, NEUROSCIENCE, V72, P767, DOI 10.1016/0306-4522(96)00002-4; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LOLAIT SJ, 1986, J CLIN INVEST, V77, P1776, DOI 10.1172/JCI112501; Maddila SC, 2016, J NEUROIMMUNE PHARM, P1; Mizoguchi Y, 2007, HORM RES, V67, P257, DOI 10.1159/000098548; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Olkhov-Mitsel E, 2012, CANCER MED-US, V1, P237, DOI 10.1002/cam4.22; Roperch JP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-566; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Sehgal N, 2011, PAIN PHYSICIAN, V14, P249; Sitte N, 2007, J NEUROIMMUNOL, V183, P133, DOI 10.1016/j.jneuroim.2006.11.033; Smith EM, 2003, ADV EXP MED BIOL, V521, P51; Smith EM, 2008, BRAIN BEHAV IMMUN, V22, P3, DOI 10.1016/j.bbi.2007.08.005; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Taqi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039605; Taqi MM, 2011, ADDICT BIOL, V16, P499, DOI 10.1111/j.1369-1600.2011.00323.x; VINDROLA O, 1994, NEUROPEPTIDES, V27, P235, DOI 10.1016/0143-4179(94)90004-3; WEBER E, 1982, NATURE, V299, P77, DOI 10.1038/299077a0; Yuferov V, 2010, PHARMACOGENET GENOM, V21, P1; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191698	10.1371/journal.pone.0191698	http://dx.doi.org/10.1371/journal.pone.0191698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352321	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300123
J	Nieto, JA; Zhu, J; Duan, B; Li, JS; Zhou, P; Paka, L; Yamin, MA; Goldberg, ID; Narayan, P				Nieto, Jake A.; Zhu, Janice; Duan, Bin; Li, Jingsong; Zhou, Ping; Paka, Latha; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash			A modified elliptical formula to estimate kidney collagen content in a model of chronic kidney disease	PLOS ONE			English	Article							CKD	The extent of scarring or renal interstitial collagen deposition in chronic kidney disease (CKD) can only be ascertained by highly invasive, painful and sometimes risky, tissue biopsy. Interestingly, while CKD-related abnormalities in kidney size can often be visualized using ultrasound, not only does the ellipsoid formula used today underestimate true renal size, but the calculated renal size does not inform tubulointerstitial collagen content. We used coronal kidney sections from healthy mice and mice with kidney disease to develop a new formula for estimating renal parenchymal area. While treating the kidney as an ellipse with the major axis (a) the polar distance, this technique involves extending the minor axis (b) into the renal pelvis to obtain a new minor axis, be. The calculated renal parenchymal area is remarkably similar to the true or measured area. Biochemically determined kidney collagen content revealed a strong and positive correlation with the calculated renal parenchymal area. Picrosirius red staining for tubulointerstitial collagen also correlated with calculated renal parenchymal area. The extent of renal scarring, i.e. kidney interstitial collagen content, can now be computed by making just two axial measurements which can easily be accomplished via noninvasive imaging of this organ.	[Nieto, Jake A.; Zhu, Janice; Duan, Bin; Li, Jingsong; Zhou, Ping; Paka, Latha; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash] Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA		Narayan, P (corresponding author), Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA.	pnarayan@angion.com		Narayan, Prakash/0000-0002-7007-0245	National Institute of Diabetes and Digestive and Kidney Diseases [2R44DK085771-02A1]; Department of Defense [W81XWH-14-1-0411]; Angion Biomedica Corp., NY	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); Angion Biomedica Corp., NY	This study was funded in part by awards 2R44DK085771-02A1 (National Institute of Diabetes and Digestive and Kidney Diseases) and W81XWH-14-1-0411 (Department of Defense) made to PN. Additional funding was provided by Angion Biomedica Corp., NY in the form of salaries for authors BD, JSL, PZ, LP, MAY, IDG and PN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, GFR CALCULATORS SERU; Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; Fleck M, 2002, EXP TOXICOL PATHOL, V54, P15, DOI 10.1078/0940-2993-00227; Greene T, 2014, AM J KIDNEY DIS, V64, P867, DOI 10.1053/j.ajkd.2014.08.019; Hewitson TD, 2016, LIFE SCI, V158, P130, DOI 10.1016/j.lfs.2016.06.022; Hisamichi M, 2017, FASEB J, V31, P72, DOI 10.1096/fj.201600684RR; Khati Nadia J, 2005, Ultrasound Q, V21, P227, DOI 10.1097/01.wnq.0000186666.61037.f6; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Moorthy HK, 2011, INDIAN J UROL, V27, P169, DOI 10.4103/0970-1591.82832; Peters B, 2014, ACTA RADIOL, V55, P890, DOI 10.1177/0284185113506190; RAIJ L, 1989, KIDNEY INT, V36, P582, DOI 10.1038/ki.1989.234; Tuma J, 2006, Praxis (Bern 1994), V95, P721	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190815	10.1371/journal.pone.0190815	http://dx.doi.org/10.1371/journal.pone.0190815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351309	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300028
J	Yeh, CH; Hsieh, LP; Lin, MC; Wei, TS; Lin, HC; Chang, CC; Hsing, CH				Yeh, Ching-Hua; Hsieh, Liang-Po; Lin, Ming-Chung; Wei, Tsui-Shan; Lin, Hui-Ching; Chang, Chia-Cheng; Hsing, Chung-Hsi			Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia	PLOS ONE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; AGED MICE; SYSTEMIC INFLAMMATION; MICROGLIA ACTIVATION; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; BRAIN; EXPRESSION; INVOLVEMENT; DISEASE	Background Peripheral innate immune response may induce sickness behavior through activating microglia, excessive cytokines production, and neuroinflammation. Dexmedetomidine (Dex) has anti-inflammatory effect. We investigated the effects of Dex on lipopolysaccharide (LPS)induced neuroinflammation and sickness behavior in mice. Materials and methods BALB/c mice were intraperitoneally (i.p.) injected with Dex (50 ug/kg) or vehicle. One hour later, the mice were injected (i.p.) with Escherichia coli LPS (0.33 mg/kg) or saline (n = 6 in each group). We analyzed the food and water intake, body weight loss, and sucrose preference of the mice for 24h. We also determined microglia activation and cytokines expression in the brains of the mice. In vitro, we determine cytokines expression in LPS-treated BV-2 microglial cells with or without Dex treatment. Results In the Dex-pretreated mice, LPS-induced sickness behavior (anorexia, weight loss, and social withdrawal) were attenuated and microglial activation was lower than vehicle control. The mRNA expression of TNF-alpha, MCP-1, indoleamine 2, 3 dioxygenase (IDO), caspase-3, and iNOS were increased in the brain of LPS-challenged mice, which were reduced by Dex but not vehicle. Conclusion Dexmedetomidine diminished LPS-induced neuroinflammation in the mouse brain and modulated the cytokine-associated changes in sickness behavior.	[Yeh, Ching-Hua; Hsieh, Liang-Po] Da Yeh Univ, Dept Med Bot & Hlth Applicat, Changhua, Taiwan; [Yeh, Ching-Hua] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yeh, Ching-Hua; Wei, Tsui-Shan; Chang, Chia-Cheng; Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Hsieh, Liang-Po] Cheng Ching Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Ming-Chung; Chang, Chia-Cheng; Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Sch Med, Dept & Inst Physiol, Taipei, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Lin, Hui-Ching] Taipei Med Univ, Coll Med Sci & Technol, Ctr Neurotrauma & Neuroregenerat, Neural Regenerat Med, Taipei, Taiwan	Da Yeh University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chi Mei Hospital; Chi Mei Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan.	hsing@mail.chimei.org.tw			Taiwan Ministry of Science and Technology [MOST 104-2314-B-384-005]	Taiwan Ministry of Science and Technology	This work was supported by grant MOST 104-2314-B-384-005 from the Taiwan Ministry of Science and Technology to CH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantaa R, 2006, EUR J ANAESTH, V23, P361, DOI 10.1017/S0265021506000378; Abraham J, 2008, NEUROBIOL AGING, V29, P614, DOI 10.1016/j.neurobiolaging.2006.11.002; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Bret-Dibat JL, 2000, PHYSIOL BEHAV, V69, P325, DOI 10.1016/S0031-9384(00)00212-2; Buerkle H, 1998, BRIT J ANAESTH, V81, P208, DOI 10.1093/bja/81.2.208; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Craft TKS, 2006, BIOL PSYCHIAT, V60, P812, DOI 10.1016/j.biopsych.2006.03.011; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; De La Garza R, 2005, NEUROSCI BIOBEHAV R, V29, P761, DOI 10.1016/j.neubiorev.2005.03.016; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gertler R, 2001, Proc (Bayl Univ Med Cent), V14, P13; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Golden TR, 2009, ANTIOXID REDOX SIGN, V11, P555, DOI [10.1089/ars.2008.2256, 10.1089/ARS.2008.2256]; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36; Hsing CH, 2012, AM J PHYSIOL-RENAL, V303, pF1443, DOI 10.1152/ajprenal.00143.2012; Huang Y, 2008, NEUROBIOL AGING, V29, P1744, DOI 10.1016/j.neurobiolaging.2007.04.012; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lai YC, 2009, J SURG RES, V154, P212, DOI 10.1016/j.jss.2008.07.010; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Maes M, 2000, PSYCHIAT RES, V96, P245, DOI 10.1016/S0165-1781(00)00216-X; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Ohsawa K, 2000, J CELL SCI, V113, P3073; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Shukry M, 2005, PEDIATR ANESTH, V15, P1098, DOI 10.1111/j.1460-9592.2005.01660.x; Skalisz LL, 2002, PROG NEURO-PSYCHOPH, V26, P879, DOI 10.1016/S0278-5846(01)00333-5; Straub RH, 1997, J NEUROCHEM, V68, P1633; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Venero JL, 2013, DEV NEUROSCI-BASEL, V35, P88, DOI 10.1159/000346155; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1	52	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191070	10.1371/journal.pone.0191070	http://dx.doi.org/10.1371/journal.pone.0191070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351316	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300044
J	Lee, GH; Yoo, KC; An, Y; Lee, HJ; Lee, M; Uddin, N; Kim, MJ; Kim, IG; Suh, Y; Lee, SJ				Lee, Ga-Hang; Yoo, Ki-Chun; An, Yoojeong; Lee, Hae-June; Lee, Minyoung; Uddin, Nizam; Kim, Min-Jung; Kim, In-Gyu; Suh, Yongjoon; Lee, Su-Jae			FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node	ONCOGENE			English	Article							MOLECULAR TARGETS; NOTCH; SRC; STAT5; THERAPY; CHEMOTHERAPY; TRANSDUCER; RECURRENCE; ACTIVATION; EXPRESSION	Basal type breast cancer is the most aggressive and has mesenchymal features with a high metastatic ability. However, the signaling node that determines the basal type features in breast cancer remains obscure. Here, we report that FYN among SRC family kinases is required for the maintenance of basal type breast cancer subtype. Importantly, FYN enhanced NOTCH2 activation in basal type breast cancer cells through STAT5-mediated upregulation of Jagged-1 and DLL4 NOTCH ligands, thereby contributed to mesenchymal phenotypes. In addition, we found that high levels of FYN persist in basal type breast cancer cells by a positive feedback loop between FYN and STAT5. FYN interacted directly with STAT5 and increased p-STAT5 that further acts as a transcription factor for FYN. Taken together, our findings demonstrate a pivotal role of FYN and its downstream effectors in maintaining the basal type features in breast cancer.	[Lee, Ga-Hang; Yoo, Ki-Chun; An, Yoojeong; Uddin, Nizam; Suh, Yongjoon; Lee, Su-Jae] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul, South Korea; [Lee, Ga-Hang] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Lee, Hae-June; Lee, Minyoung] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul, South Korea; [Uddin, Nizam] Univ Punjab, CEMB, Lahore, Pakistan; [Kim, Min-Jung] Korea Inst Radiol & Med Sci, Lab Radiat Exposure & Therapeut, Natl Radiat Emergency Med Ctr, Seoul, South Korea; [Kim, In-Gyu] Korea Atom Energy Res Inst, Environm Radiat Res Grp, Dept Radiat Biol, Daejeon, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Institute of Radiological & Medical Sciences; University of Punjab; Korea Institute of Radiological & Medical Sciences; Korea Atomic Energy Research Institute (KAERI)	Suh, Y; Lee, SJ (corresponding author), Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul, South Korea.	hiswork@hanmail.net; sj0420@hanyang.ac.kr		Ud Din, Nizam/0000-0002-9845-3109	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government [NRF-2016R1E1A1A01942075, NRF-2017M2A2A7070460]	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government	This work was supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program (NRF-2016R1E1A1A01942075 and NRF-2017M2A2A7070460).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Barash I, 2012, CARCINOGENESIS, V33, P2320, DOI 10.1093/carcin/bgs362; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Irwin ME, 2011, CANCER BIOL THER, V12, P718, DOI 10.4161/cbt.12.8.16907; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pullen NA, 2012, J BIOL CHEM, V287, P2045, DOI 10.1074/jbc.M111.311142; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Walker SR, 2014, MOL CELL ENDOCRINOL, V382, P616, DOI 10.1016/j.mce.2013.03.010; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	30	36	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1857	1868		10.1038/s41388-017-0114-y	http://dx.doi.org/10.1038/s41388-017-0114-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29348460				2022-12-26	WOS:000429303300004
J	Liang, HC; Xiao, J; Zhou, ZM; Wu, J; Ge, F; Li, ZC; Zhang, HL; Sun, J; Li, FB; Liu, R; Chen, CS				Liang, Huichun; Xiao, Ji; Zhou, Zhongmei; Wu, Jiao; Ge, Fei; Li, Zongcheng; Zhang, Hailin; Sun, Jian; Li, Fubing; Liu, Rong; Chen, Ceshi			Hypoxia induces miR-153 through the IRE1 alpha-XBP1 pathway to fine tune the HIF1 alpha/VEGFA axis in breast cancer angiogenesis	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; INDUCIBLE FACTOR-1-ALPHA EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; VASCULAR-PERMEABILITY FACTOR; HUMAN ENDOTHELIAL-CELLS; LUNG-CANCER; TUMOR-SUPPRESSOR; TARGETING SNAI1; DOWN-REGULATION; STEM-CELLS	It is well documented that hypoxia activates the hypoxia-inducible factor 1-alpha (HIF1 alpha)/vascular endothelial growth factor A (VEGFA) axis to promote angiogenesis in breast cancer. However, it is unclear how this axis is negatively regulated. In this study, we demonstrated that miR-153 directly inhibits expression of HIF1 alpha by binding to the 3'UTR of HIF1A mRNA, as well as suppresses tube formation of primary human umbilical vein endothelial cells (HUVECs) and breast cancer angiogenesis by decreasing the secretion of VEGFA. Importantly, expression of miR-153 was induced by hypoxiastimulated ER stress, which activates IRE1 alpha and its downstream transcription factor X-box binding protein 1 (XBP1). X-box binding protein 1 directly binds to the promoter of the miR-153 host gene PTPRN and activates transcription. These results indicate that hypoxia induces miR-153 to fine tune the HIF1 alpha/VEGFA axis in breast cancer angiogenesis and miR-153 could be used for breast cancer anti-angiogenesis therapy.	[Liang, Huichun; Zhou, Zhongmei; Zhang, Hailin; Li, Fubing; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China; [Liang, Huichun; Li, Fubing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xiao, Ji; Sun, Jian] Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China; [Wu, Jiao] Kunming Med Univ, Affiliated Hosp 3, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China; [Ge, Fei] Kunming Med Univ, Affiliated Hosp 1, Dept Breast Surg, Kunming, Yunnan, Peoples R China; [Li, Zongcheng] Acad Mil Med Sci, Affiliated Hosp, Translat Med Ctr Stem Cells,Lab Oncol, State Key Lab Prote,Ivy Translat Med Ctr 307, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming University of Science & Technology; Kunming Medical University; Kunming Medical University; Academy of Military Medical Sciences - China	Liu, R; Chen, CS (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China.	liurong@mail.kiz.ac.cn; chenc@mail.kiz.ac.cn	Li, Zongcheng/AAN-1952-2021; Li, Zongcheng/AFP-2645-2022	Li, Zongcheng/0000-0002-5189-5268; Chen, Ceshi/0000-0001-6398-3516	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010303]; National Natural Science Foundation of China [31771516, U1502222, U1602221, 81772847, 81660438]; Yunnan Applied Basic Research Key Projects [2015FA027]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Applied Basic Research Key Projects	We sincerely thank Professor Lingqiang Zhang from the Academy of Chinese Military Medical Sciences and Professor Wen Liu from Xiamen University for providing reagents. This study was supported by a Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010303), National Natural Science Foundation of China (31771516, U1502222, U1602221, 81772847, and 81660438), and the Yunnan Applied Basic Research Key Projects (2015FA027).	Albini A, 2010, CLIN EXP METASTAS, V27, P419, DOI 10.1007/s10585-010-9312-5; Bao BL, 2012, J NUTR BIOCHEM, V23, P635, DOI 10.1016/j.jnutbio.2011.03.007; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Boelens J, 2007, IN VIVO, V21, P215; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen WJ, 2015, INT J CLIN EXP PATHO, V8, P8671; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chitnis N, 2013, TRENDS BIOCHEM SCI, V38, P447, DOI 10.1016/j.tibs.2013.06.012; Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025; Dai L, 2015, INT J CLIN EXP PATHO, V8, P4735; Dioufa N, 2010, ENDOCRINE, V38, P167, DOI 10.1007/s12020-010-9362-0; FOLKMAN J, 1986, CANCER RES, V46, P467; Ghasemi A, 2016, CLIN LAB, V62, P573, DOI 10.7754/Clin.Lab.2015.150738; He X, 2015, ARTERIOSCL THROM VAS, V35, P1623, DOI 10.1161/ATVBAHA.115.305469; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Janaszak-Jasiecka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22775; Kang SG, 2012, CARCINOGENESIS, V33, P661, DOI 10.1093/carcin/bgr320; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li Q, 2016, ONCOTARGET, V7, P29749, DOI 10.18632/oncotarget.8831; Li WT, 2015, BREAST CANCER RES TR, V150, P501, DOI 10.1007/s10549-015-3346-y; Liu F, 2017, ACTA BIOCH BIOPH SIN, V49, P520, DOI 10.1093/abbs/gmx039; Liu R, 2016, GROWTH, V17, P18; Liu R, 2016, THERANOSTICS, V6, P533, DOI 10.7150/thno.14315; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Paridaens A, 2014, LIVER INT, V34, pE10, DOI 10.1111/liv.12457; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Shan NX, 2015, BIOCHEM BIOPH RES CO, V456, P385, DOI 10.1016/j.bbrc.2014.11.093; Urra H, 2014, MOL CELL, V54, P542, DOI 10.1016/j.molcel.2014.05.013; Wang Y, 2011, INT J MOL SCI, V12, P7569, DOI 10.3390/ijms12117569; Wang ZL, 2016, TUMOR BIOL, V37, P15509, DOI 10.1007/s13277-015-3846-8; Wu J, 2016, CANCER LETT, V380, P393, DOI 10.1016/j.canlet.2016.06.024; Wu XW, 2016, AM J CANCER RES, V6, P1563; Wu ZH, 2016, ONCOL REP, V35, P1696, DOI 10.3892/or.2015.4529; Wu ZQ, 2013, PROSTATE, V73, P596, DOI 10.1002/pros.22600; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yang BY, 2016, BIOMED PHARMACOTHER, V84, P845, DOI 10.1016/j.biopha.2016.10.015; Yang W, 2015, ONCOTARGET, V6, P22006, DOI 10.18632/oncotarget.4292; Yuan Y, 2015, INT J CANCER, V136, P1333, DOI 10.1002/ijc.29103; Zeng HF, 2017, BIOCHEM BIOPH RES CO, V487, P140, DOI 10.1016/j.bbrc.2017.04.032; Zhang L, 2013, CANCER RES, V73, P6435, DOI 10.1158/0008-5472.CAN-12-3308; Zou YH, 2016, MOL MED REP, V14, P1033, DOI 10.3892/mmr.2016.5309; Zuo J, 2016, TUMOR BIOL, V37, P16135, DOI 10.1007/s13277-016-5427-x	50	80	85	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					1961	1975		10.1038/s41388-017-0089-8	http://dx.doi.org/10.1038/s41388-017-0089-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367761	Green Published, hybrid			2022-12-26	WOS:000429899400002
J	Wan, F; Kong, LG; Gao, HC				Wan, Fen; Kong, Linggen; Gao, Haichun			Defining the binding determinants of Shewanella oneidensis OxyR: Implications for the link between the contracted OxyR regulon and adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; NEISSERIA-GONORRHOEAE; CATALASE EXPRESSION; INDUCIBLE GENES; DNA; STRESS; ACTIVATION; MECHANISM	It is well-established that OxyR functions as a transcriptional activator of the peroxide stress response in bacteria, primarily based on studies on Escherichia coli. Recent investigations have revealed that OxyRs of some other bacteria can regulate gene expression through both repression and activation or repression only; however, the underlying mechanisms remain largely unknown. Here, we demonstrated in gamma-proteobacterium Shewanella oneidensis regulation of OxyR on expression of major catalase gene katB in a dual-control manner through interaction with a single site in the promoter region. Under non-stress conditions, katB expression was repressed by reduced OxyR (OxyR(red)), whereas when oxidized, OxyR (WOxyR(oxi)) out-competed OxyRred for the site because of substantially enhanced affinity, resulting in a graded response to oxidative stress, from repression to derepression to activation. The OxyR-binding motif is characterized as a combination of the E. coli motif (tetranucle-otides spaced by heptanucleotide) and palindromic structure. We provided evidence to suggest that the S. oneidensis OxyR regulon is significantly contracted compared with those reported, probably containing only five members that are exclusively involved in oxygen reactive species scavenging and iron sequestering. These characteristics probably reflect the adapting strategy of the bacteria that S. oneidensis represents to thrive in redox-stratified microaerobic and anaerobic environments.	[Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563; Kong, Linggen/0000-0003-4055-8626	National Natural Science Foundation of China [41476105]; Natural Science Foundation of Zhejiang Province [LZ17C010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 41476105 and Natural Science Foundation of Zhejiang Province Grant LZ17C010001. The authors declare that they have no conflicts of interest with the contents of this article.	Binnenkade L, 2014, APPL ENVIRON MICROB, V80, P5304, DOI 10.1128/AEM.01480-14; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edwards JS, 2013, P NATL ACAD SCI USA, V110, P2804, DOI 10.1073/pnas.1219701110; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu Huihui, 2014, Environ Microbiol, V16, P3181, DOI 10.1111/1462-2920.12457; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao T, 2015, MOL MICROBIOL, V98, P571, DOI 10.1111/mmi.13141; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jiang YM, 2014, J BACTERIOL, V196, P445, DOI 10.1128/JB.01077-13; Jo I, 2017, J BIOL CHEM, V292, P7223, DOI 10.1074/jbc.M116.743765; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031709; Li M, 2016, J BACTERIOL, V198, P3060, DOI 10.1128/JB.00463-16; Li N, 2014, ENVIRON MICROBIOL, V16, P1821, DOI 10.1111/1462-2920.12418; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Loprasert S, 2000, MOL MICROBIOL, V37, P1504, DOI 10.1046/j.1365-2958.2000.02107.x; Luo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062064; Maciver I, 1996, INFECT IMMUN, V64, P4618, DOI 10.1128/IAI.64.11.4618-4629.1996; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Milse J, 2014, J BIOTECHNOL, V190, P40, DOI 10.1016/j.jbiotec.2014.07.452; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schutz B, 2011, APPL ENVIRON MICROB, V77, P6172, DOI 10.1128/AEM.00606-11; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; Shi MM, 2015, J BACTERIOL, V197, P2179, DOI 10.1128/JB.00154-15; Shi MM, 2014, MOL MICROBIOL, V93, P1269, DOI 10.1111/mmi.12731; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sun LL, 2014, J BIOL CHEM, V289, P14547, DOI 10.1074/jbc.M114.552000; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Teramoto H, 2013, FEBS J, V280, P3298, DOI 10.1111/febs.12312; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Wan F, 2017, SCI REP-UK, V7, DOI 10.1038/srep42609; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Wilson DO, 2001, ELECTROPHORESIS, V22, P1979, DOI 10.1002/1522-2683(200106)22:10<1979::AID-ELPS1979>3.0.CO;2-A; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	47	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4085	4096		10.1074/jbc.RA117.001530	http://dx.doi.org/10.1074/jbc.RA117.001530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367341	hybrid, Green Published			2022-12-26	WOS:000427587500020
J	Mohr, EL; Block, LN; Newman, CM; Stewart, LM; Koenig, M; Semler, M; Breitbach, ME; Teixeira, LBC; Zeng, XK; Weiler, AM; Barry, GL; Thoong, TH; Wiepz, GJ; Dudley, DM; Simmons, HA; Mejia, A; Morgan, TK; Salamat, MS; Kohn, S; Antony, KM; Aliota, MT; Mohns, MS; Hayes, JM; Schultz-Darken, N; Schotzko, ML; Peterson, E; Capuano, S; Osorio, JE; O'Connor, SL; Friedrich, TC; O'Connor, DH; Golos, TG				Mohr, Emma L.; Block, Lindsey N.; Newman, Christina M.; Stewart, Laurel M.; Koenig, Michelle; Semler, Matthew; Breitbach, Meghan E.; Teixeira, Leandro B. C.; Zeng, Xiankun; Weiler, Andrea M.; Barry, Gabrielle L.; Thoong, Troy H.; Wiepz, Gregory J.; Dudley, Dawn M.; Simmons, Heather A.; Mejia, Andres; Morgan, Terry K.; Salamat, M. Shahriar; Kohn, Sarah; Antony, Kathleen M.; Aliota, Matthew T.; Mohns, Mariel S.; Hayes, Jennifer M.; Schultz-Darken, Nancy; Schotzko, Michele L.; Peterson, Eric; Capuano, Saverio, III; Osorio, Jorge E.; O'Connor, Shelby L.; Friedrich, Thomas C.; O'Connor, David H.; Golos, Thaddeus G.			Ocular and uteroplacental pathology in a macaque pregnancy with congenital Zika virus infection	PLOS ONE			English	Article							VAGINAL SECRETIONS; DENGUE VIRUS; RHESUS; INFANTS; URINE; BIRTH; DIAGNOSIS; COLOBOMA; GENETICS; TYLOSIN	Congenital Zika virus (ZIKV) infection impacts fetal development and pregnancy outcomes. We infected a pregnant rhesus macaque with a Puerto Rican ZIKV isolate in the first trimester. The pregnancy was complicated by preterm premature rupture of membranes (PPROM), intraamniotic bacterial infection and fetal demise 49 days post infection (gestational day 95). Significant pathology at the maternal-fetal interface included acute chorioamnionitis, placental infarcts, and leukocytoclastic vasculitis of the myometrial radial arteries. ZIKV RNA was disseminated throughout fetal tissues and maternal immune system tissues at necropsy, as assessed by quantitative RT-PCR for viral RNA. Replicating ZIKV was identified in fetal tissues, maternal uterus, and maternal spleen by fluorescent in situ hybridization for viral replication intermediates. Fetal ocular pathology included a choroidal coloboma, suspected anterior segment dysgenesis, and a dysplastic retina. This is the first report of ocular pathology and prolonged viral replication in both maternal and fetal tissues following congenital ZIKV infection in a rhesus macaque. PPROM followed by fetal demise and severe pathology of the visual system have not been described in macaque congenital ZIKV infection previously. While this case of ZIKV infection during pregnancy was complicated by bacterial infection with PPROM, the role of ZIKV on this outcome cannot be precisely defined, and further nonhuman primate studies will determine if increased risk for PPROM or other adverse pregnancy outcomes are associated with congenital ZIKV infection.	[Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Block, Lindsey N.; Newman, Christina M.; Stewart, Laurel M.; Koenig, Michelle; Semler, Matthew; Breitbach, Meghan E.; Dudley, Dawn M.; Salamat, M. Shahriar; Mohns, Mariel S.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Teixeira, Leandro B. C.; Aliota, Matthew T.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI USA; [Zeng, Xiankun] US Army, Med Res Inst Infect Dis, Frederick, MD USA; [Mohr, Emma L.; Weiler, Andrea M.; Barry, Gabrielle L.; Thoong, Troy H.; Wiepz, Gregory J.; Simmons, Heather A.; Mejia, Andres; Hayes, Jennifer M.; Schultz-Darken, Nancy; Schotzko, Michele L.; Peterson, Eric; Capuano, Saverio, III; Friedrich, Thomas C.; O'Connor, David H.; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Kohn, Sarah] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Antony, Kathleen M.; Golos, Thaddeus G.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mohr, EL (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.	emohr@uwhealth.org; golos@primate.wisc.edu	Teixeira, Leandro B C/H-9272-2015; Simmons, Heather/U-6081-2019; amsalu, ribka/G-8780-2019; Mohr, Emma/ABD-2994-2020; Teixeira, Leandro/AAU-6094-2021; Aliota, Matthew/AAS-6376-2021	Teixeira, Leandro B C/0000-0001-9960-678X; Mohr, Emma/0000-0003-0742-305X; Teixeira, Leandro/0000-0001-9960-678X; Semler, Matthew/0000-0001-7754-6392; Aliota, Matthew/0000-0002-6902-9149; Zeng, Xiankun (Kevin)/0000-0003-3526-8755	National Institutes of Health [R21 HD091163-01, R01 AI116382-01A1S1, P51 0D011106, T32 AI55397]; Pediatric Infectious Diseases Society;  [P51 OD011106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397, R01AI116382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Infectious Diseases Society; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (R21 HD091163-01, R01 AI116382-01A1S1, P51 0D011106, T32 AI55397) and the Pediatric Infectious Diseases Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations, conclusions, and recommendations are those of the author (X. Zeng) and are not necessarily endorsed by the U.S. Army.	Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184; Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168; [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.18655, 10.1001/jama.2016.19328]; Arragain L, 2016, J PEDIAT INF DIS SOC; Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692; Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Blackwood RS, 2008, COMPARATIVE MED, V58, P81; BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728; Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042; BUNTON TE, 1986, VET PATHOL, V23, P431, DOI 10.1177/030098588602300413; Carlson J, 2007, AM J DERMATOPATH, V29, P32, DOI 10.1097/01.dad.0000245198.80847.ff; Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537; Centers for Disease Control and Prevention, PREGN WOM AN LAB EV; Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011; Churchill A, 1996, BRIT J OPHTHALMOL, V80, P669, DOI 10.1136/bjo.80.7.669; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029; de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600; de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001; DOYLE L, 1991, J MED PRIMATOL, V20, P409; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3; Enders AC, 2007, PLACENTA, V28, P794, DOI 10.1016/j.placenta.2006.11.001; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; GRIBNAU AAM, 1985, ADV ANAT EMBRYOL CEL, V91, pUR7; Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600; Ji LW, 2014, J VET PHARMACOL THER, V37, P312, DOI 10.1111/jvp.12092; Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002; Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045; LIN CCL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1651, DOI 10.1001/archopht.1984.01040031341023; LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009; Onwochei BC, 2000, SURV OPHTHALMOL, V45, P175, DOI 10.1016/S0039-6257(00)00151-X; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108; Pereira BB de Souza, 2017, TRANSPL INFECT DIS; *PREV, 2017, OUTCOMES OF PREGNANC; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744; RUTANEN EM, 1993, CLIN CHIM ACTA, V214, P73, DOI 10.1016/0009-8981(93)90304-M; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538; Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580; Tarantal A.F., 2005, ULTRASOUND IMAGING R; TARANTAL AF, 1988, ANAT REC, V222, P177, DOI 10.1002/ar.1092220210; Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9; Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283; Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wong CW., 2019, RETIN CASES BRIEF RE, V13, P171, DOI [DOI 10.1097/ICB.0000000000000552, 10.1097/ICB.0000000000000552]; Yanoff MS, 2015, J W OCULAR PATHOLOGY; Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561; Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474	84	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190617	10.1371/journal.pone.0190617	http://dx.doi.org/10.1371/journal.pone.0190617			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381706	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800010
J	Koldehoff, M; Lindemann, M; Ross, SR; Elmaagacli, AH				Koldehoff, Michael; Lindemann, Monika; Ross, Stefan R.; Elmaagacli, Ahmet H.			Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line	PLOS ONE			English	Article							T-CELLS; TRANSPLANT RECIPIENTS; CMV INFECTION; UP-REGULATION; RELAPSE RISK; BIOLOGY; REPLICATION; EXPRESSION; DISEASE; LEADS	Cytomegalovirus (HCMV) reactivation is found frequently after allogeneic hematopoietic stem cell transplantation (alloSCT) and is associated with an increased treatment-related mortality. Recent reports suggest a link between HCMV and a reduced risk of cancer progression in patients with acute leukemia or lymphoma after alloSCT. Here we show that HCMV can inhibit the proliferation of the acute myeloid leukemia cell line Kasumi-1 and the promyeloid leukemia cell line NB4. HCMV induced a significant up-regulation of HLA-classII-molecules, especially HLA-DR expression and an increase of apoptosis, granzyme B, perforin and IFN-gamma secretion in Kasumi-1 cells cocultured with peripheral blood mononuclear cells (PBMCs). Indolamin-2,3-dioxygenase on the other hand led only to a significant dose dependent effect on IFN-y secretion without effects on proliferation. The addition of CpG-rich oligonucleotides and ganciclovir reversed those antiproliferative effects. We conclude that HCMV can enhance alloreactivity of PBMCs against Kasumi-1 and NB4 cells in vitro. To determine if this phenomenon may be clinically relevant further investigations will be required.	[Koldehoff, Michael; Elmaagacli, Ahmet H.] Univ Hosp Essen, West German Canc Ctr, Dept Bone Marrow Transplantat, Essen, Germany; [Lindemann, Monika] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Ross, Stefan R.] Univ Hosp Essen, Inst Virol, Essen, Germany; [Elmaagacli, Ahmet H.] Asklepios Clin St Georg, Dept Hematol & Stem Cell Transplantat, Hamburg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Asklepios Klinik St. Georg	Koldehoff, M (corresponding author), Univ Hosp Essen, West German Canc Ctr, Dept Bone Marrow Transplantat, Essen, Germany.	michael.koldehoff@uk-essen.de	Koldehoff, Michael/AAO-7018-2021	Lindemann, Monika/0000-0001-6708-4390				Bao XB, 2016, AM J TRANSL RES, V8, P653; Barsegian V, 2015, CANCER IMMUNOL IMMUN, V64, P755, DOI 10.1007/s00262-015-1687-3; Blyth E, 2016, VIRULENCE, V7, P967, DOI 10.1080/21505594.2016.1221022; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560; Brinkmann MM, 2015, MED MICROBIOL IMMUN, V204, P367, DOI 10.1007/s00430-015-0403-4; Busca A, 2015, AM J HEMATOL, V90, pE117, DOI 10.1002/ajh.23998; Chiou SH, 2006, J IMMUNOL, V177, P6199, DOI 10.4049/jimmunol.177.9.6199; Ciaurriz M, 2015, CELL MOL LIFE SCI, V72, P4049, DOI 10.1007/s00018-015-1986-z; Drylewicz J, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0988-4; EINSELE H, 1993, BLOOD, V82, P1672; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Foley B, 2014, IMMUNOL REV, V258, P45, DOI 10.1111/imr.12157; Furset G, 2008, IMMUNOLOGY, V123, P263, DOI 10.1111/j.1365-2567.2007.02695.x; Gabaev I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002432; Goldmacher VS, 2005, APOPTOSIS, V10, P251, DOI 10.1007/s10495-005-0800-z; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hebart H, 2004, HUM IMMUNOL, V65, P432, DOI 10.1016/j.humimm.2004.02.022; Jedema I, 2011, HAEMATOL-HEMATOL J, V96, P1204, DOI 10.3324/haematol.2010.039099; Kaminski H, 2016, AM J TRANSPLANT, V16, P2254, DOI 10.1111/ajt.13791; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koldehoff M, 2017, LEUKEMIA LYMPHOMA, V58, P822, DOI 10.1080/10428194.2016.1217524; Koldehoff M, 2015, LEUKEMIA LYMPHOMA, V56, P3189, DOI 10.3109/10428194.2015.1032968; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; Lilleri D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041648; Lisboa LF, 2012, TRANSPL INFECT DIS, V14, P132, DOI 10.1111/j.1399-3062.2011.00685.x; Locatelli F, 2016, EXPERT REV HEMATOL, V9, P1093, DOI 10.1080/17474086.2016.1242406; Luckau S, 2016, J IMMUNOTHER, V39, P316, DOI 10.1097/CJI.0000000000000137; Maffini E, 2016, EXPERT REV HEMATOL, V9, P585, DOI 10.1080/17474086.2016.1174571; Melenhorst JJ, 2011, BIOL BLOOD MARROW TR, V17, P800, DOI 10.1016/j.bbmt.2010.12.711; Miller-Kittrell M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-4; Munir S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034568; Muntasell A, 2016, J IMMUNOL, V196, P3818, DOI 10.4049/jimmunol.1502438; Pachnio A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005832; Schmidt-Hieber M, 2013, BLOOD, V122, P3359, DOI 10.1182/blood-2013-05-499830; Stevanovic S, 2013, BLOOD, V122, P1963, DOI 10.1182/blood-2012-12-470872; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191482	10.1371/journal.pone.0191482	http://dx.doi.org/10.1371/journal.pone.0191482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377903	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700015
J	Yang, DH; Chen, LH; Chen, ZM				Yang, Dehua; Chen, Linghong; Chen, Zhimin			The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHILDREN; THERAPY; INFECTIONS; CHINA; CELLS	Background Mycoplasma pneumoniae infection is a major cause of community-acquired pneumonia in children. We performed a retrospective study to evaluate the clinical impact of the timing of azithromycin treatment in children with Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. Methods and findings A total of 623 patients were enrolled in this study and were divided into 2 groups according to the timing of azithromycin therapy. Children who received azithromycin within 3 days (72 hours) after the onset of Mycoplasma pneumoniae pneumonia were classified into the early azithromycin treatment group (n = 174), whereas the late azithromycin treatment group (n = 449) comprised children treated with azithromycin more than 72 hours after symptom onset. We evaluated clinical prognosis according to demographic, clinical and laboratory characteristics. Although the early azithromycin treatment group exhibited a longer fever duration after azithromycin administration (7.17 4.12 versus 4.82 3.99 days, P<0.01), the total fever duration exhibited no significant difference (9.02 4.58 versus 9.57 4.91 days, P = 0.212). After azithromycin therapy, the two groups exhibited no significant differences with respect to improvements in the laboratory and radiological findings (all P>0.05). Conclusion The timing of azithromycin treatment is not associated with the clinical prognosis of Mycoplasma pneumoniae pneumonia in children in high macrolide-resistant Mycoplasma pneumoniae prevalence settings.	[Yang, Dehua; Chen, Linghong; Chen, Zhimin] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Linghong] First Peoples Hosp Wenling, Wenling, Zhejiang, Peoples R China	Zhejiang University	Chen, ZM (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	drchenzm@163.com			Wenling Science and Technology Project Fund [2012WLCA0057]	Wenling Science and Technology Project Fund	This work was supported by grant 2012WLCA0057 from the Wenling Science and Technology Project Fund (http://new.wl.gov.cn/colt.0011402190/indexhtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Linghong Chen received the funding.	Aghai ZH, 2007, PEDIATR RES, V62, P483, DOI 10.1203/PDR.0b013e318142582d; Biondi E, 2014, PEDIATRICS, V133, P1081, DOI 10.1542/peds.2013-3729; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Esposito S, 2005, PEDIATR INFECT DIS J, V24, P438, DOI 10.1097/01.inf.0000160949.99560.8d; Key NK, 2009, PEDIATR PULM, V44, P249, DOI 10.1002/ppul.20988; Kogan R, 2003, PEDIATR PULM, V35, P91, DOI 10.1002/ppul.10180; Liu Y, 2009, ANTIMICROB AGENTS CH, V53, P2160, DOI 10.1128/AAC.01684-08; Lu YJ, 2008, J MICROBIOL IMMUNOL, V41, P307; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Matsubara K, 2009, J INFECT CHEMOTHER, V15, P380, DOI 10.1007/s10156-009-0715-7; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Okada T, 2012, CLIN INFECT DIS, V55, P1642, DOI 10.1093/cid/cis784; Pereyre S, 2013, CLIN MICROBIOL INFEC, V19, pE212, DOI 10.1111/1469-0691.12107; Radisic M, 2000, CLIN INFECT DIS, V31, P1507, DOI 10.1086/317498; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Shah SS, 2012, J HOSP MED, V7, P311, DOI 10.1002/jhm.1904; Spuesens EBM, 2012, J CLIN MICROBIOL, V50, P1999, DOI 10.1128/JCM.00400-12; Sugiyama K, 2007, CLIN EXP IMMUNOL, V147, P540, DOI 10.1111/j.1365-2249.2007.03299.x; Suzuki S, 2006, ANTIMICROB AGENTS CH, V50, P709, DOI 10.1128/AAC.50.2.709-712.2006; Tamura A, 2008, J INFECTION, V57, P223, DOI 10.1016/j.jinf.2008.06.012; Uldum SA, 2012, EURO SURVEILL, V17, p[pii, 20073]; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Xin DL, 2009, ANTIMICROB AGENTS CH, V53, P2158, DOI 10.1128/AAC.01563-08; Yamada M, 2012, PEDIATR INFECT DIS J, V31, P409, DOI 10.1097/INF.0b013e318247f3e0; Zhou YL, 2014, ANTIMICROB AGENTS CH, V58, P1034, DOI 10.1128/AAC.01806-13	27	8	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191951	10.1371/journal.pone.0191951	http://dx.doi.org/10.1371/journal.pone.0191951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377957	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700044
J	Schrade, K; Troger, J; Eldahshan, A; Zuhlke, K; Azeez, KRA; Elkins, JM; Neuenschwander, M; Oder, A; Elkewedi, M; Jaksch, S; Andrae, K; Li, JL; Fernandes, J; Muller, PM; Grunwald, S; Marino, SF; Vukicevic, T; Eichhorst, J; Wiesner, B; Weber, M; Kapiloff, M; Rocks, O; Daumke, O; Wieland, T; Knapp, S; von Kries, JP; Klussmann, E				Schrade, Katharina; Troeger, Jessica; Eldahshan, Adeeb; Zuehlke, Kerstin; Azeez, Kamal R. Abdul; Elkins, Jonathan M.; Neuenschwander, Martin; Oder, Andreas; Elkewedi, Mohamed; Jaksch, Sarah; Andrae, Karsten; Li, Jinliang; Fernandes, Joao; Mueller, Paul Markus; Grunwald, Stephan; Marino, Stephen F.; Vukicevic, Tanja; Eichhorst, Jenny; Wiesner, Burkhard; Weber, Marcus; Kapiloff, Michael; Rocks, Oliver; Daumke, Oliver; Wieland, Thomas; Knapp, Stefan; von Kries, Jens Peter; Klussmann, Enno			An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells	PLOS ONE			English	Article							PROTEIN-KINASE-A; VASOPRESSIN-MEDIATED TRANSLOCATION; ANCHORING PROTEINS; WATER REABSORPTION; APICAL MEMBRANE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION	Stimulation of renal collecting duct principal cells with antidiuretic hormone (arginine-vasopressin, AVP) results in inhibition of the small GTPase RhoA and the enrichment of the water channel aquaporin-2 (AQP2) in the plasma membrane. The membrane insertion facilitates water reabsorption from primary urine and fine-tuning of body water homeostasis. Rho guanine nucleotide exchange factors (GEFs) interact with RhoA, catalyze the exchange of GDP for GTP and thereby activate the GTPase. However, GEFs involved in the control of AQP2 in renal principal cells are unknown. The A-kinase anchoring protein, AKAP-Lbc, possesses GEF activity, specifically activates RhoA, and is expressed in primary renal inner medullary collecting duct principal (IMCD) cells. Through screening of 18,431 small molecules and synthesis of a focused library around one of the hits, we identified an inhibitor of the interaction of AKAP-Lbc and RhoA. This molecule, Scaff10-8, bound to RhoA, inhibited the AKAP-Lbc-mediated RhoA activation but did not interfere with RhoA activation through other GEFs or activities of other members of the Rho family of small GTPases, Rac1 and Cdc42. Scaff10-8 promoted the redistribution of AQP2 from intracellular vesicles to the periphery of IMCD cells. Thus, our data demonstrate an involvement of AKAP-Lbc-mediated RhoA activation in the control of AQP2 trafficking.	[Schrade, Katharina; Troeger, Jessica; Eldahshan, Adeeb; Zuehlke, Kerstin; Elkewedi, Mohamed; Jaksch, Sarah; Fernandes, Joao; Mueller, Paul Markus; Grunwald, Stephan; Marino, Stephen F.; Vukicevic, Tanja; Rocks, Oliver; Daumke, Oliver; Klussmann, Enno] Max Delbruck Ctr Mol Med Berlin MDC, Berlin, Germany; [Azeez, Kamal R. Abdul; Elkins, Jonathan M.; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford, England; [Neuenschwander, Martin; Oder, Andreas; Eichhorst, Jenny; Wiesner, Burkhard; von Kries, Jens Peter] Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany; [Andrae, Karsten; Weber, Marcus] ZIB, Berlin, Germany; [Li, Jinliang; Kapiloff, Michael] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt Pharmacol & Toxicol, Heidelberg, Germany; [Wieland, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Heidelberg, Germany; [Knapp, Stefan] Goethe Univ, Inst Pharmaceut Chem, Frankfurt, Germany; [Knapp, Stefan] Goethe Univ, Buchmann Inst, Frankfurt, Germany; [Knapp, Stefan] DKTK German Canc Ctr Network, Partner Site Frankfurt Main, Frankfurt, Germany; [Klussmann, Enno] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oxford; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Zuse Institute Berlin; University of Miami; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Goethe University Frankfurt; Goethe University Frankfurt; German Centre for Cardiovascular Research	Klussmann, E (corresponding author), Max Delbruck Ctr Mol Med Berlin MDC, Berlin, Germany.; Klussmann, E (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	enno.klussmann@mdc-berlin.de	Rocks, Oliver/AFI-7418-2022; Rocks, Oliver/ABG-3341-2020; Knapp, Stefan/AAG-2347-2019; Müller, Paul Markus/Q-4453-2019; Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Rocks, Oliver/0000-0001-6349-9193; Knapp, Stefan/0000-0001-5995-6494; Müller, Paul Markus/0000-0001-9056-4114; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Li, Jinliang/0000-0002-3018-0570; Kapiloff, Michael/0000-0002-7005-6953; Elkins, Jon/0000-0003-2858-8929; Grunwald, Stephan/0000-0003-3978-6277; Marino, Stephen/0000-0001-5696-9679; Klussmann, Jens Peter/0000-0002-8223-7954	Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [G.I.F. I-1210-286.13/2012]; German Centre for Cardiovascular Research [DZHK 81X210012, 618005 SE]; Deutsche Forschungsgemein-schaft [DFG KL1415/7-1]; Bundesministerium fur Bildung and Forschung (BMBF) [16GW0179K]; Max-Delbrueck Centre; Berlin Institute of Health; Leibniz-Forschungsinstitut fur Moleku-lare Pharmakologie	Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); German Centre for Cardiovascular Research; Deutsche Forschungsgemein-schaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max-Delbrueck Centre; Berlin Institute of Health; Leibniz-Forschungsinstitut fur Moleku-lare Pharmakologie	This work was supported by grants from the Else Kroner-Fresenius-Stiftung (2013_A145), the German-Israeli Foundation (G.I.F. I-1210-286.13/2012), the German Centre for Cardiovascular Research (DZHK 81X210012 and 618005 SE), the Deutsche Forschungsgemein-schaft (DFG KL1415/7-1) and the Bundesministerium fur Bildung and Forschung (BMBF; 16GW0179K) to EK. The Screening Unit of the FMP is jointly co financed by the Max-Delbrueck Centre, the Berlin Institute of Health and the Leibniz-Forschungsinstitut fur Moleku-lare Pharmakologie.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Azeez KRA, 2014, BIOCHEM J, V464, P231, DOI 10.1042/BJ20140606; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bogum J, 2013, J AM SOC NEPHROL, V24, P744, DOI 10.1681/ASN.2012030295; Defert O, 2017, EXPERT OPIN THER PAT, V27, P507, DOI 10.1080/13543776.2017.1272579; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2016, CELL CHEM BIOL, V23, P1135, DOI 10.1016/j.chembiol.2016.07.015; Diviani D, 2016, BBA-MOL CELL RES, V1863, P1926, DOI 10.1016/j.bbamcr.2015.11.024; Faust D, 2013, JOVE-J VIS EXP, DOI 10.3791/50366; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Garazd M M, 2004, Bioorg Khim, V30, P324; Gotz F, 2016, BIOCHEM J, V473, P1881, DOI 10.1042/BCJ20160242; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Iolascon A, 2007, NEPHRON PHYSIOL, V105, P33, DOI 10.1159/000098136; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Khan A, 2017, COMPUT BIOL CHEM, V67, P84, DOI 10.1016/j.compbiolchem.2016.12.014; Klussmann E, 2000, REV PHYSIOL BIOCH P, V141, P33, DOI 10.1007/BFb0119577; Klussmann E, 2001, KIDNEY INT, V60, P446, DOI 10.1046/j.1523-1755.2001.060002446.x; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; Klussmann E, 2001, J BIOL CHEM, V276, P20451, DOI 10.1074/jbc.M010270200; Kuwahara M, 2005, KIDNEY INT, V68, P1999, DOI 10.1111/j.1523-1755.2005.00654.x; Li W, 2011, AM J PHYSIOL-RENAL, V301, pF309, DOI 10.1152/ajprenal.00001.2011; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Lutz S, 2013, CELL SIGNAL, V25, P630, DOI 10.1016/j.cellsig.2012.11.016; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McSorley T, 2006, EUR J CELL BIOL, V85, P673, DOI 10.1016/j.ejcb.2006.01.005; Milano S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112385; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Olesen ETB, 2017, AM J PHYSIOL-RENAL, V312, pF744, DOI 10.1152/ajprenal.00010.2017; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Procino G, 2016, CLIN PHARMACOL THER, V99, P528, DOI 10.1002/cpt.305; Procino G, 2011, PFLUG ARCH EUR J PHY, V462, P753, DOI 10.1007/s00424-011-1007-5; Reggi E, 2017, CELL SIGNAL, V40, P143, DOI 10.1016/j.cellsig.2017.09.011; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Schafer G, 2013, ANGEW CHEM INT EDIT, V52, P12187, DOI 10.1002/anie.201304686; Shrimp JH, 2016, ACS MED CHEM LETT, V7, P151, DOI 10.1021/acsmedchemlett.5b00385; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamma G, 2003, J CELL SCI, V116, P3285, DOI 10.1242/jcs.00640; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Vukicevic T, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00023; Wade JB, 2011, AM J PHYSIOL-RENAL, V301, pF308, DOI 10.1152/ajprenal.00248.2011; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	61	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191423	10.1371/journal.pone.0191423	http://dx.doi.org/10.1371/journal.pone.0191423			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373579	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000423425400012
J	Robertson, JW; Struthers, CN; Syme, DA				Robertson, Jason W.; Struthers, Colin N.; Syme, Douglas A.			Enhancement of muscle and locomotor performance by a series compliance: A mechanistic simulation study	PLOS ONE			English	Article							ELASTIC ENERGY-STORAGE; MEDIAL GASTROCNEMIUS-MUSCLE; POWER OUTPUT; JUMPING PERFORMANCE; TENDON COMPLEX; TRICEPS SURAE; IN-VIVO; HINDLIMB MUSCLES; STRAIN-ENERGY; PREY CAPTURE	The objective was to better understand how a series compliance alters contraction kinetics and power output of muscle to enhance the work done on a load. A mathematical model was created in which a gravitational point load was connected via a linear spring to a muscle (based on the contractile properties of the sartorius of leopard frogs, Rana pipiens). The model explored the effects of load mass, tendon compliance, and delay between onset of contraction and release of the load (catch) on lift height and power output as measures of performance. Series compliance resulted in increased lift height over a relatively narrow range of compliances, and the effect was quite modest without an imposed catch mechanism unless the load was unrealistically small. Peak power of the muscle-tendon complex could be augmented up to four times that produced with a muscle alone, however, lift height was not predicted by peak power. Rather, lift height was improved as a result of the compliance synchronizing the time courses of muscle force and shortening velocity, in particular by stabilizing shortening velocity such that muscle power was sustained rather than rising and immediately falling. With a catch mechanism, enhanced performance resulted largely from energy storage in the compliance during the period of catch, rather than increased time for muscle activation before movement commenced. However, series compliance introduced a trade-off between work done before versus after release of the catch. Thus, the ability of tendons to enhance locomotor performance (i.e. increase the work done by muscle) appears dependent not only on their established role in storing energy and increasing power, but also on their ability to modulate the kinetics of muscle contraction such that power is sustained over more of the contraction, and maximizing the balance of work done before versus after release of a catch.	[Robertson, Jason W.; Struthers, Colin N.; Syme, Douglas A.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	University of Calgary	Syme, DA (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.	syme@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada [203190-2012]; University of Calgary	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to DAS (203190-2012) and a University of Calgary Undergraduate Student Research Program in Health and Wellness scholarship to JWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 1998, PHILOS T R SOC B, V353, P1607, DOI 10.1098/rstb.1998.0313; Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; ANDERSON FC, 1993, J BIOMECH, V26, P1413, DOI 10.1016/0021-9290(93)90092-S; Astley HC, 2014, J EXP BIOL, V217, P4372, DOI 10.1242/jeb.110296; Astley HC, 2012, BIOL LETTERS, V8, P386, DOI 10.1098/rsbl.2011.0982; Azizi E, 2010, P ROY SOC B-BIOL SCI, V277, P1523, DOI 10.1098/rspb.2009.2051; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Bennett MB, 1986, J ZOOL, V209, P548, DOI DOI 10.1111/J.1469-7998.1986.TB03609.X; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; BOBBERT MF, 1986, J BIOMECH, V19, P899, DOI 10.1016/0021-9290(86)90185-5; Bobbert MF, 2001, J EXP BIOL, V204, P533; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Danos N, 2016, J APPL PHYSIOL, V121, P1004, DOI 10.1152/japplphysiol.00396.2016; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Farris DJ, 2016, J EXP BIOL, V219, P528, DOI 10.1242/jeb.126854; Galantis A, 2003, P ROY SOC B-BIOL SCI, V270, P1493, DOI 10.1098/rspb.2003.2403; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219, DOI 10.1113/jphysiol.1991.sp018547; Gronenberg W, 1996, J COMP PHYSIOL A, V178, P727, DOI 10.1007/BF00225821; HEITLER WJ, 1974, J COMP PHYSIOL, V89, P93, DOI 10.1007/BF00696166; Henry HT, 2005, J EXP BIOL, V208, P3293, DOI 10.1242/jeb.01764; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; James RS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P176, DOI 10.1086/525290; Josephson RK, 1999, J EXP BIOL, V202, P3369; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; LANNERGREN J, 1987, J MUSCLE RES CELL M, V8, P260, DOI 10.1007/BF01574594; Lappin AK, 2006, J EXP BIOL, V209, P2535, DOI 10.1242/jeb.02276; Lichtwark GA, 2008, J THEOR BIOL, V252, P662, DOI 10.1016/j.jtbi.2008.01.018; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Lutz GJ, 1998, J MUSCLE RES CELL M, V19, P717, DOI 10.1023/A:1005466432372; Lutz GJ, 1996, AM J PHYSIOL-CELL PH, V271, pC563, DOI 10.1152/ajpcell.1996.271.2.C563; MARSH RL, 1994, J EXP BIOL, V188, P131; Navas CA, 1999, J COMP PHYSIOL B, V169, P588, DOI 10.1007/s003600050259; Olson JM, 1998, J EXP BIOL, V201, P2763; Patek SN, 2011, J EXP BIOL, V214, P1973, DOI 10.1242/jeb.038596; Peplowski MM, 1997, J EXP BIOL, V200, P2861; POLLOCK CM, 1994, AM J PHYSIOL, V266, pR1022, DOI 10.1152/ajpregu.1994.266.3.R1022; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; Richards CT, 2012, J THEOR BIOL, V313, P68, DOI 10.1016/j.jtbi.2012.07.033; Roberts TJ, 2016, J EXP BIOL, V219, P266, DOI 10.1242/jeb.124446; Roberts TJ, 2011, PHILOS T R SOC B, V366, P1488, DOI 10.1098/rstb.2010.0326; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Roberts TJ, 2002, J EXP BIOL, V205, P1485; Rosario MV, 2016, P BIOL SCI, V283, P4388; Sawicki GS, 2015, J EXP BIOL, V218, P3700, DOI 10.1242/jeb.126235; Syme DA, 2005, J APPL PHYSIOL, V99, P1308, DOI 10.1152/japplphysiol.00369.2005; Van Wassenbergh S, 2008, J R SOC INTERFACE, V5, P285, DOI 10.1098/rsif.2007.1124	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191828	10.1371/journal.pone.0191828	http://dx.doi.org/10.1371/journal.pone.0191828			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370246	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600104
J	Xu, Y; Shoamanesh, A; Schulman, S; Dowlatshahi, D; Salman, RAS; Moldovan, ID; Wells, PS; AlKherayf, F				Xu, Yan; Shoamanesh, Ashkan; Schulman, Sam; Dowlatshahi, Dar; Salman, Rustam Al-Shahi; Moldovan, Ioana Doina; Wells, Philip Stephen; AlKherayf, Fahad			Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts	PLOS ONE			English	Article							INTRACRANIAL HEMORRHAGE; STROKE PREVENTION; MANAGEMENT; WARFARIN; GUIDELINES; THERAPY; RESUMPTION	Background While oral anticoagulants (OACs) are highly effective for ischemic stroke prevention in atrial fibrillation, intracerebral hemorrhage (ICH) remains the most feared complication of OAC. Clinical controversy remains regarding OAC resumption and its timing for ICH survivors with atrial fibrillation because the balance between risks and benefits has not been investigated in randomized trials. Aims/Hypothesis To survey the practice of stroke neurologists, thrombosis experts and neurosurgeons on OAC re-initiation following OAC-associated ICH. Methods An online survey was distributed to members of the International Society for Thrombosis and Haemostasis, Canadian Stroke Consortium, NAVIGATE-ESUS trial investigators (Clinicatrials.gov identifier NCT02313909) and American Association of Neurological Surgeons. Demographic factors and 11 clinical scenarios were included. Results Two hundred twenty-eight participants from 38 countries completed the survey. Majority of participants were affiliated with academic centers, and >20% managed more than 15 OAC-associated ICH patients/year. Proportion of respondents suggesting OAC anticoagulant resumption varied from 30% (for cerebral amyloid angiopathy) to 98% (for traumatic ICH). Within this group, there was wide distribution in response for timing of resumption: 21.4% preferred to re-start OACs after 1-3 weeks of incident ICH, while 25.3% opted to start after 1-3 months. Neurosurgery respondents preferred earlier OAC resumption compared to stroke neurologists or thrombosis experts in 5 scenarios (p<0.05 by Kendall's tau). Conclusions Wide variations in current practice exist among management of OAC-associated ICH, with decisions influenced by patient-and provider-related factors. As these variations likely reflect the lack of high quality evidence, randomized trials are direly needed in this population.	[Xu, Yan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Shoamanesh, Ashkan] McMaster Univ, Div Neurol, Dept Med, Populat Hlth Res Inst, Hamilton, ON, Canada; [Schulman, Sam] McMaster Univ, Div Hematol, Dept Med, Hamilton, ON, Canada; [Dowlatshahi, Dar] Univ Ottawa, Div Neurol, Dept Med, Ottawa, ON, Canada; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Moldovan, Ioana Doina; AlKherayf, Fahad] Univ Ottawa, Div Neurosurg, Dept Surg, Ottawa, ON, Canada; [Wells, Philip Stephen] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Toronto; McMaster University; Population Health Research Institute; McMaster University; University of Ottawa; University of Edinburgh; University of Ottawa; University of Ottawa	AlKherayf, F (corresponding author), Univ Ottawa, Div Neurosurg, Dept Surg, Ottawa, ON, Canada.	falkherayf@toh.ca	shoamanesh, ashkan/AHE-1772-2022; Shoamanesh, Ashkan/AAS-4682-2021	Dowlatshahi, Dar/0000-0003-1379-3612; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Xu, Yan/0000-0001-7429-4724	MRC [G1002605] Funding Source: UKRI; Chest Heart and Stroke Scotland [Res10/A127] Funding Source: researchfish; British Heart Foundation [PG/14/50/30891, CS/18/2/33719, SP/12/2/29422] Funding Source: Medline; Medical Research Council [G1002605] Funding Source: Medline; The Dunhill Medical Trust [R380R/1114] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chest Heart and Stroke Scotland; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Dunhill Medical Trust(Dunhill Medical Trust)		Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Giruparajah M, 2015, INT J STROKE, V10, P1031, DOI 10.1111/ijs.12509; Halperin JL, 2014, CURR CARDIOL REV, V10, P297, DOI 10.2174/1573403X10666140513104523; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hawryluk GWJ, 2011, WORLD NEUROSURG, V76, P299, DOI 10.1016/j.wneu.2011.03.034; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Holmes DR, 2014, J AM COLL CARDIOL, V63, P291, DOI 10.1016/j.jacc.2013.08.1631; Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Korompoki E, 2017, NEUROLOGY, V89, P687, DOI 10.1212/WNL.0000000000004235; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Lee TWR, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005599.pub5, 10.1002/14651858.CD012144.pub2]; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Maeda K, 2012, J NEUROL SCI, V312, P82, DOI 10.1016/j.jns.2011.08.017; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Pasquini M, 2014, STROKE, V45, P2643, DOI 10.1161/STROKEAHA.114.006202; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309	23	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191137	10.1371/journal.pone.0191137	http://dx.doi.org/10.1371/journal.pone.0191137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370183	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600040
J	Christen, P; Boutroy, S; Ellouz, R; Chapurlat, R; van Rietbergen, B				Christen, Patrik; Boutroy, Stephanie; Ellouz, Rafaa; Chapurlat, Roland; van Rietbergen, Bert			Least-detectable and age-related local in vivo bone remodelling assessed by time-lapse HR-pQCT	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; TRABECULAR BONE; DISTAL RADIUS; IMAGE QUALITY; WOMEN; MICROARCHITECTURE; HISTOMORPHOMETRY; QUANTIFICATION; INTEROBSERVER; POROSITY	We previously developed an image analysis approach for the determination of local sites of bone remodelling using time-lapse in vivo HR-pQCT. The involved image filtering for removing noise was chosen rather aggressively, and also removed some effects of the bone remodelling. In this paper, we quantify these filtering settings using ex vivo reproducibility HR-pQCT images, and determine the least-detectable bone remodelling using in vivo reproducibility HR-pQCT images, as well as testing whether the approach is capable of capturing age-related bone remodelling by use of in vivo long-term HR-pQCT images. We found that a threshold value of 225 mg HA/cm(3) for the filtering led to acceptable results with falsely determined bone remodelling of less than 0.5%, and that the least-detectable bone formation and bone resorption are 2.0 +/- 1.0% and 2.2 +/- 0.7% respectively. We also found that age-related local bone remodelling can be captured satisfactorily in postmenopausal women. The latter revealed new insights into the effect of ageing on bone remodelling, and showed that bone remodelling seems to take place through a few small formation packets and many large resorption volumes leading to a net bone loss. We conclude that local in vivo bone remodelling can be successfully assessed with time-lapse in vivo HR-pQCT capable of assessing age-related changes in bone remodelling.	[Christen, Patrik] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Christen, Patrik; van Rietbergen, Bert] Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, Eindhoven, Netherlands; [Boutroy, Stephanie; Ellouz, Rafaa; Chapurlat, Roland] Univ Lyon, INSERM, UMR 1033, Lyon, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm)	Christen, P (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Christen, P (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, Eindhoven, Netherlands.	patrik.christen@hest.ethz.ch	CHAPURLAT, ROLAND/AAU-1165-2021	Christen, Patrik/0000-0001-8854-0682; Chapurlat, Roland/0000-0001-8214-6385				Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Bala Y, 2015, J BONE MINER RES, V30, P621, DOI 10.1002/jbmr.2388; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; Burghardt AJ, 2007, ANN BIOMED ENG, V35, P1678, DOI 10.1007/s10439-007-9344-4; Burghardt AJ, 2013, J BONE MINER RES, V28, P524, DOI 10.1002/jbmr.1795; Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226; Burt LA, 2016, J BONE MINER RES, V31, P2041, DOI 10.1002/jbmr.2873; Christen P, 2017, CURR OSTEOPOROS REP, V15, P311, DOI 10.1007/s11914-017-0372-1; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; Cohen A, 2010, OSTEOPOROSIS INT, V21, P263, DOI 10.1007/s00198-009-0945-7; COMPSTON JE, 1986, CALCIFIED TISSUE INT, V38, P67, DOI 10.1007/BF02556831; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Dalzell N, 2009, OSTEOPOROSIS INT, V20, P1683, DOI 10.1007/s00198-008-0833-6; Ellouz R, 2014, BONE; Garnero P, 2005, J CLIN ENDOCR METAB, V90, P4829, DOI 10.1210/jc.2005-0364; Laib A, 1998, Technol Health Care, V6, P329; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; MacNeil JA, 2008, MED ENG PHYS, V30, P792, DOI 10.1016/j.medengphy.2007.11.003; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pauchard Y, 2011, PHYS MED BIOL, V56, P6523, DOI 10.1088/0031-9155/56/20/001; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Powell Kim A, 2005, Iowa Orthop J, V25, P123; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Schulte FA, 2011, BONE, V49, P1166, DOI 10.1016/j.bone.2011.08.018; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Verhulp E, 2004, J BIOMECH, V37, P1313, DOI 10.1016/j.jbiomech.2003.12.036; Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012; WRIGHT CDP, 1992, BONE, V13, P205, DOI 10.1016/8756-3282(92)90198-6; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191369	10.1371/journal.pone.0191369	http://dx.doi.org/10.1371/journal.pone.0191369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364934	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500043
J	Friedlander, AM; Ballesteros, E; Bell, TW; Giddens, J; Henning, B; Hune, M; Munoz, A; Salinas-de-Leon, P; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Bell, Tom W.; Giddens, Jonatha; Henning, Brad; Hune, Mathias; Munoz, Alex; Salinas-de-Leon, Pelayo; Sala, Enric			Marine biodiversity at the end of the world: Cape Horn and Diego Ramirez islands	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; KELP MACROCYSTIS-PYRIFERA; TIERRA-DEL-FUEGO; GIANT-KELP; ENVIRONMENTAL CONTROLS; SOUTH-AMERICA; SEA OTTERS; CHILE; PATTERNS; MAGELLAN	The vast and complex coast of the Magellan Region of extreme southern Chile possesses a diversity of habitats including fjords, deep channels, and extensive kelp forests, with a unique mix of temperate and sub-Antarctic species. The Cape Horn and Diego Ramirez archipelagos are the most southerly locations in the Americas, with the southernmost kelp forests, and some of the least explored places on earth. The giant kelp Macrocystis pyrifera plays a key role in structuring the ecological communities of the entire region, with the large brown seaweed Lessonia spp. forming dense understories. Kelp densities were highest around Cape Horn, followed by Diego Ramirez, and lowest within the fjord region of Francisco Coloane Marine Park (mean canopy densities of 2.51 kg m(-2), 2.29 kg m(-2), and 2.14 kg m(-2), respectively). There were clear differences in marine communities among these sub-regions, with the lowest diversity in the fjords. We observed 18 species of nearshore fishes, with average species richness nearly 50% higher at Diego Ramirez compared with Cape Horn and Francisco Coloane. The number of individual fishes was nearly 10 times higher at Diego Ramirez and 4 times higher at Cape Horn compared with the fjords. Drop-cam surveys of mesophotic depths (53 +/- 105 m) identified 30 taxa from 25 families, 15 classes, and 7 phyla. While much of these deeper habitats consisted of soft sediment and cobble, in rocky habitats, echinoderms, mollusks, bryozoans, and sponges were common. The southern hagfish (Myxine australis) was the most frequently encountered of the deep-sea fishes (50% of deployments), and while the Fueguian sprat (Sprattus fuegensis) was the most abundant fish species, its distribution was patchy. The Cape Horn and Diego Ramirez archipelagos represent some of the last intact sub-Antarctic ecosystems remaining and a recently declared large protected area will help ensure the health of this unique region.	[Friedlander, Alan M.; Munoz, Alex; Salinas-de-Leon, Pelayo; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Friedlander, Alan M.; Giddens, Jonatha] Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Ballesteros, Enric] CSIC, Ctr Estudis Avancats CEAB, Blanes, Spain; [Bell, Tom W.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Henning, Brad] Natl Geog Soc, Remote Imaging Team, Washington, DC USA; [Hune, Mathias] Fdn Ictiol, Santiago, Chile; [Salinas-de-Leon, Pelayo] Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Los Angeles; National Geographic Society	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.; Friedlander, AM (corresponding author), Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	Bell, Tom/AAD-2551-2020; Hüne, Mathias/ABE-6000-2020		Brooks Foundation; Keith Campbell Foundation for the Environment; Case Foundation; Leonardo DiCaprio Foundation; Davidoff; Don Quixote Foundation; Roger and Rosemary Enrico Foundation; Helmsley Charitable Trust; Lindblad Expeditions-National Geographic Fund; Philip Stephenson Foundation; Vicki and Roger Sant; Waitt Foundation; National Geographic Society; Chilean Navy; Tercera Zona Naval; Governor Jorge Flies of the Magellan and Chilean Antarctic Region	Brooks Foundation; Keith Campbell Foundation for the Environment; Case Foundation; Leonardo DiCaprio Foundation; Davidoff; Don Quixote Foundation; Roger and Rosemary Enrico Foundation; Helmsley Charitable Trust; Lindblad Expeditions-National Geographic Fund; Philip Stephenson Foundation; Vicki and Roger Sant; Waitt Foundation; National Geographic Society(National Geographic Society); Chilean Navy; Tercera Zona Naval; Governor Jorge Flies of the Magellan and Chilean Antarctic Region	We received funding from The Brooks Foundation, The Keith Campbell Foundation for the Environment, The Case Foundation, Leonardo DiCaprio Foundation, Davidoff, The Don Quixote Foundation, Roger and Rosemary Enrico Foundation, Helmsley Charitable Trust, Lindblad Expeditions-National Geographic Fund, Philip Stephenson Foundation, Vicki and Roger Sant, The Waitt Foundation, and The National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Chilean Navy for sponsoring this expedition, especially to Commander Andres Rodrigo for advice and guidance in planning, as well as the support provided by the Tercera Zona Naval. We would also like to express our gratitude for the support provided by Governor Jorge Flies of the Magellan and Chilean Antarctic Region, along with the Minister of the Environment Marcelo Mena, the former Minister of the Environment Pablo Badenier, and Alejandra Figueroa, the director of the Natural Resources and Biodiversity Division. Additionally, we would like to acknowledge and thank the captain and crew of the M/Y Plan B and the Waitt Foundation for providing the platform for this expedition, as well as their tirelessly work to help make the expedition a success. Finally, we wish to thank and congratulate the President of Chile, Michelle Bachelet, for her leadership in the conservation of Chile's ocean and in her decision to protect the waters around Cabo de Hornos and Diego Ramirez islands to the southern end of the zone economic zone of Chile.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Aguayo-Lobo A, 2008, REV BIOL MAR OCEANOG, V43, P653; Fernandez DA, 2010, BIOL INVASIONS, V12, P2991, DOI 10.1007/s10530-010-9731-x; Alheit J, 2012, HAKE BIOL FISHERIES; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Antezana T, 1999, SCI MAR, V63, P23, DOI 10.3989/scimar.1999.63s123; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; Asche F, 1986, JPN J ICHTHYOL; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Bell TW, 2015, REMOTE SENS ENVIRON, V167, P218, DOI 10.1016/j.rse.2015.05.003; Bernstein WJ, 2009, SPLENDID EXCHANGE TR; Boswall J, 1975, BIOL PENGUINS, P271; Buschmann AH, 1995, THESIS; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Callicott JB, 2007, PHILOS T R SOC B, V362, P321, DOI 10.1098/rstb.2006.1989; Canete JI, 2017, LAT AM J AQUAT RES, V45, P79, DOI 10.3856/vol45-issue1-fulltext-8; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2003, POLAR BIOL, V26, P49, DOI 10.1007/s00300-002-0442-3; Castilla J.C., 1985, P407; Castilla J.C., 1982, Echinoderms, P257; Castilla JC, 2000, REV CHIL HIST NAT, V73, P585; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Ciancio J, 2010, LIMNOL OCEANOGR, V55, P2181, DOI 10.4319/lo.2010.55.5.2181; Ciancio JE, 2008, LIMNOL OCEANOGR, V53, P788, DOI 10.4319/lo.2008.53.2.0788; Clark AH, 2011, CLIPPER SHIP ERA EPI; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Croxall J, 2009, ATLAS MAR PATAGONICO; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Darwin CR, 1832, J REMARKS 1832 1836; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Edgar GJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700419; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; Fleming DK, 2002, HDB MARITIME EC BUSI, P63; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROESE R., 2012, FISHBASE; Gerard VA, 1997, J PHYCOL, V33, P800, DOI 10.1111/j.0022-3646.1997.00800.x; Gobierno de Chile, 2007, CONSERVACION BIODIVE, P136; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Guglielmo Letterio, 1992, Memorie di Biologia Marina e di Oceanografia, V19, P157; HARO D, 2013, I PATAGONIA, V41, P77; Haussermann V., 2009, MARINE BENTHIC FAUNA; Henriquez V, 2016, ICES J MAR SCI, V73, P1074, DOI 10.1093/icesjms/fsv270; Hepburn CD, 2005, MAR ECOL PROG SER, V302, P37, DOI 10.3354/meps302037; HOLBROOK SJ, 1990, B MAR SCI, V47, P104; Hune M, 2015, POLAR BIOL, V38, P1613, DOI 10.1007/s00300-015-1726-8; Hune M, 2012, REV BIOL MAR OCEANOG, V47, P451; J Hidalgo, 1996, ETNOGRAFIA SOC INDIG; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; King PP, 1831, J ROYAL GEOGRAPHICAL, V1, P155; Kirkwood R, 2007, WATERBIRDS, V30, P259, DOI 10.1675/1524-4695(2007)30[259:EOSRAM]2.0.CO;2; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Lloris D., 1991, ICTIOFAUNA CANAL BEA; Ludwig JA., 1998, STAT ECOLOGY; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; McEwan C., 1997, PATAGONIA NATURAL HI; Mead G.W., 1970, SCI EXPLORATION S PA, P236; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Moran E, 2000, J ROY ANTHROPOL INST, V6, P534; MORENO CA, 1984, MAR ECOL PROG SER, V15, P99, DOI 10.3354/meps015099; Navarrete AH, 2014, REV CHIL HIST NAT, V87, DOI 10.1186/0717-6317-87-2; Niklitschek EJ, 2013, REV AQUACULT, V5, P172, DOI 10.1111/raq.12012; Pequeno German, 2000, Ciencia y Tecnologia del Mar, V22, P165; Perez-Matus A, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1808; Pielou E., 1977, MATH ECOLOGY; Pollack G, 2008, MAR POLICY, V32, P233, DOI 10.1016/j.marpol.2007.09.013; Rabassa J, 2000, QUATERN INT, V68, P217, DOI 10.1016/S1040-6182(00)00046-X; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Riccialdelli L, 2017, POLAR BIOL, V40, P807, DOI 10.1007/s00300-016-2007-x; Rios C, 2007, POLAR BIOL, V31, P89, DOI 10.1007/s00300-007-0337-4; Ríos Carlos, 2003, Rev. biol. mar. oceanogr., V38, P1; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Robertson G, 2014, BIOL CONSERV, V169, P319, DOI 10.1016/j.biocon.2013.12.002; Rozzi R, 2008, FRONT ECOL ENVIRON, V6, P131, DOI 10.1890/070020; Rozzi R, 2006, ECOL SOC, V11; Rozzi R, 2012, BIOSCIENCE, V62, P226, DOI 10.1525/bio.2012.62.3.4; Rydell RA, 1952, CAPE HORN PACIFIC RI; SANTELICES B, 1984, MAR ECOL PROG SER, V14, P175, DOI 10.3354/meps014175; Silander Jr JA, 2000, ENCY BIODIVERSITY, V5, P607; Soto D, 2001, ECOL APPL, V11, P1750, DOI 10.2307/3061093; Soto D, 2007, REV CHIL HIST NAT, V80, P81; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tegner MJ, 1996, TRENDS ECOL EVOL, V11, P278, DOI 10.1016/0169-5347(96)30029-3; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tissot BN, 2007, J EXP MAR BIOL ECOL, V352, P50, DOI 10.1016/j.jembe.2007.06.032; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; Vasquez JA, 1997, REV CHIL HIST NAT, V70, P41; VASQUEZ JA, 1984, MAR ECOL PROG SER, V19, P55, DOI 10.3354/meps019055; Vasquez JA, 1984, MEDIO AMBIENTE, V7, P47; Veblen T.T., 1996, ECOLOGY BIOGEOGRAPHY; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vila AR, 2016, ORYX, V50, P308, DOI 10.1017/S0030605314000908; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; Young M, 2016, ECOL MONOGR, V86, P45, DOI 10.1890/15-0267.1; Zappettini EO, 2009, REV ASOC GEOL ARGENT, V64; Zar J. H., 2007, BIOSTATISTICAL ANAL	108	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189930	10.1371/journal.pone.0189930	http://dx.doi.org/10.1371/journal.pone.0189930			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364902	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500007
J	Petersone-Gordina, E; Roberts, C; Millard, AR; Montgomery, J; Gerhards, G				Petersone-Gordina, Elina; Roberts, Charlotte; Millard, Andrew R.; Montgomery, Janet; Gerhards, Guntis			Dental disease and dietary isotopes of individuals from St Gertrude Church cemetery, Riga, Latvia	PLOS ONE			English	Article							SEX-DIFFERENCES; PERIODONTAL-DISEASE; AURICULAR SURFACE; SOUTHERN ONTARIO; CARBON ISOTOPES; HUMAN SKELETONS; AGE ESTIMATION; REVISED METHOD; CARIES RATES; WHITE MALES	This research explores oral health indicators and stable carbon and nitrogen isotope data to explore diet, and differences in diet, between people buried in the four different contexts of the St Gertrude Church cemetery (15th +/- 17th centuries AD): the general cemetery, two mass graves, and a collective mass burial pit within the general cemetery. The main aim is to assess whether people buried in the mass graves were rural immigrants, or if they were more likely to be the victims of plague (or another epidemic) who lived in Riga and its suburbs. The data produced (from dental disease assessments and isotope analyses) were compared within, as well as between, the contexts. Most differences emerged when comparing the prevalence rates of dental diseases and other oral health indicators in males and females between the contexts, while isotope analysis revealed more individual, rather than context-specific, differences. The data suggested that the populations buried in the mass graves were different from those buried in the general cemetery, and support the theory that rural immigrants were buried in both mass graves. Significant differences were observed in some aspects of the data between the mass graves, however, possibly indicating that the people buried in them do not represent the same community.	[Petersone-Gordina, Elina; Roberts, Charlotte; Millard, Andrew R.; Montgomery, Janet] Univ Durham, Dept Archaeol, Durham, England; [Gerhards, Guntis] Univ Latvia, Inst Latvian Hist, Riga, Latvia	Durham University; University of Latvia	Petersone-Gordina, E (corresponding author), Univ Durham, Dept Archaeol, Durham, England.	e.petersone-gordina@hotmail.co.uk	Millard, Andrew/AAE-5302-2022; Roberts, Charlotte Ann/H-2622-2019	Millard, Andrew/0000-0002-8290-7428; Roberts, Charlotte Ann/0000-0002-2259-807X; Petersone-Gordina, Elina/0000-0001-6397-0897	Arts and Humanities Research Council (AHRC) [AH/K502996/1]; Wenner-Gren Foundation; Arts and Humanities Research Council [1372703] Funding Source: researchfish	Arts and Humanities Research Council (AHRC)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Wenner-Gren Foundation; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was funded by the Arts and Humanities Research Council (AHRC), award reference number AH/K502996/1, http://www.ahrc.ac.uk/ (EPG), and the Wenner-Gren Foundation (Wadsworth Fellowship), http://www.wennergren.org/ (EPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Allmae R., 1999, PAPERS ANTHR, V8, p9 ; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; [Anonymous], 1989, CARNEGIE I WASH YR B; [Anonymous], 1808, OEK REP LIEFL; [Anonymous], 2009, ORAL MICROBIOLOGY; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Boldsen J., UNIVERSITY OF LUND I, P77; Bonsall LA, 2015, J ARCHAEOL SCI-REP, V2, P128, DOI 10.1016/j.jasrep.2015.01.009; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Brown T, 2011, P 2011 PART ACC C; Buckberry JL, 2002, AM J PHYS ANTHROPOL, V119, P231, DOI 10.1002/ajpa.10130; Buikstra JE, 1994, AR ARCHEOLOGICAL SUR, V44; Caune A., 1992, PATI RIGA UDENI ARHE; CHISHOLM BS, 1982, SCIENCE, V216, P1131, DOI 10.1126/science.216.4550.1131; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Cucina A, 2003, AM J PHYS ANTHROPOL, V122, P1, DOI 10.1002/ajpa.10267; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dias G, 1997, INT J OSTEOARCHAEOL, V7, P548, DOI 10.1002/(SICI)1099-1212(199709/10)7:5<548::AID-OA369>3.0.CO;2-I; Dumpe L., 1999, ETNOGRAFS HABIL HIST, P118; Dunsdorfs E., 1962, LATVIJAS VESTURE 160; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; Fazekas Istvan G., 1978, FORENSIC FETAL OSTEO; Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307; Frayer D.W., 1984, ANTHROPOLOGICAL KOZL, V28, P47; Freeth C, 2000, HUMAN OSTEOLOGY ARCH, P227; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Genco R J, 1998, Ann Periodontol, V3, P288, DOI 10.1902/annals.1998.3.1.288; Gerhards G., 2009, 1 BALT BIOARCH M BIO; Gernards G., 2005, LATVIJAS VESTURES I, V3, P5; Girotti M, SAN MICHELE TRINO VC, V2; Goodman A.H., 1991, HLTH SOC BIOCULTURAL, V567, P31; Harrison RG, 2003, J ANTHROPOL ARCHAEOL, V22, P227, DOI 10.1016/S0278-4165(03)00037-0; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Hedges REM, 2004, QUATERNARY SCI REV, V23, P959, DOI 10.1016/j.quascirev.2003.06.022; HILLSON S, 1996, DENT ANTHR; Hillson S., 2005, TEETH; Hillson S., 2008, BIOL ANTHR HUMAN SKE, V2, P301; Hueck A., 1845, DARSTELLUNG LANDWIRT; Hugoson A, 2002, J CLIN PERIODONTOL, V29, P247, DOI 10.1034/j.1600-051x.2002.290311.x; Hupel A.W., 1774, TOPOGRAPHISCHE NACHR; Huynh HTT, 2016, MOL ORAL MICROBIOL, V31, P234, DOI 10.1111/omi.12118; ISCAN MY, 1984, AM J PHYS ANTHROPOL, V65, P147, DOI 10.1002/ajpa.1330650206; ISCAN MY, 1984, J FORENSIC SCI, V29, P1094; Janick J, 2005, MAYDICA, V50, P71; Kamate WI, 2017, J CLIN DIAGN RES, V11, pXC1, DOI 10.7860/JCDR/2017/24965.9516; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Katzenberg MA, 2012, J ARCHAEOL SCI, V39, P2612, DOI 10.1016/j.jas.2011.08.010; KATZENBERG MA, 1989, J ARCHAEOL SCI, V16, P319, DOI 10.1016/0305-4403(89)90008-3; Keckler C. N. W., 1997, INTEGRATING ARCHAEOL, P205; Keenleyside A, 2008, INT J OSTEOARCHAEOL, V18, P262, DOI 10.1002/oa.934; Kolderman E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121835; Larsen C.S, 2015, BIOARCHAEOLOGY INTER, DOI DOI 10.1016/j.bone.2012.05.023; LARSEN CS, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P179; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; Lentilius R., 1677, CURLANDIAE QUAEDAM N; LEONARD WR, 1989, HOMO, V39, P65; Limbo J., 2009, PAPERS ANTHR, V18, P234; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Loth SR, 1989, AGE MARKERS HUMAN SK, P105; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; Lukacs J.R., 1989, RECONSTRUCTING LIFE, P261; Lukacs JR, 2008, CURR ANTHROPOL, V49, P901, DOI 10.1086/592111; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lukacs JR, 1996, CURR ANTHROPOL, V37, P147, DOI 10.1086/204481; LUNT DA, 1978, DEV FUNCTION EVOLUTI, P465; Maresh M. M., 1970, HUMAN GROWTH DEV, P157; Martorell R., 1980, SOCIAL BIOL PREDICTO, P81; Mays S., 2010, CHILDHOOD PAST, V3, P63, DOI [10.1179/cip.2010.3.1.63, DOI 10.1179/CIP.2010.3.1.63]; Mays SA, 1997, J ARCHAEOL SCI, V24, P561, DOI 10.1006/jasc.1996.0139; McGovernWilson R, 1996, J ARCHAEOL SCI, V23, P59, DOI 10.1006/jasc.1996.0005; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Mickleburgh HL, 2016, INT J OSTEOARCHAEOL, V26, P290, DOI 10.1002/oa.2421; Milner G.R., 1992, DETERMINATION SKELET; Muktupavela R., 2005, INKULTURACIJAS FIGUR; MURPHY T, 1959, AM J PHYS ANTHROPOL, V17, P167, DOI 10.1002/ajpa.1330170302; Napiersky J.G.L., 1890, BODECKERS CHRONIK LI; O'Connell TC, 1999, AM J PHYS ANTHROPOL, V108, P409, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;409::AID-AJPA3&gt;3.0.CO;2-E; OGDEN JA, 1978, SKELETAL RADIOL, V2, P153, DOI 10.1007/BF00347314; ORLAND FJ, 1954, J DENT RES, V33, P147, DOI 10.1177/00220345540330020201; Palubeckaite Z, 2006, INT J OSTEOARCHAEOL, V16, P355, DOI 10.1002/oa.846; Petersone-Gordina E, 2013, INT J PALEOPATHOL, P3; Petersone-Gordina Elina, 2011, Papers on Anthropology University of Tartu, V20, P327; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Pinhasi R., ADV HUMAN PALAEOPATH, P283; Pollard AM, 2008, ARCHAEOLOGICAL CHEMISTRY, SECOND EDITION, P1, DOI 10.1039/9781847558299; Prangs H., 1932, RIGA KA LATVIJAS GAL, P501; Repository of Ethnographic Material of the Institute of Latvian History, REP ETHN MAT I LATV, V25; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Rusovs B, 1926, LIVONIJAS KRONIKA; Saunders SR, 1997, AM J PHYS ANTHROPOL, V104, P71, DOI 10.1002/(SICI)1096-8644(199709)104:1<71::AID-AJPA5>3.0.CO;2-G; Schaefer MC, 2008, INT J OSTEOARCHAEOL, V18, P536, DOI 10.1002/oa.959; Schoeninger M.J., 1989, HOMO, P38; Schug GR, 2014, AM J PHYS ANTHROPOL, V155, P243, DOI 10.1002/ajpa.22536; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Sivapathasundharam B., 2009, SHAFERS TXB ORAL PAT, P474; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; SPIELMANN KA, 1990, AM ANTIQUITY, V55, P745, DOI 10.2307/281248; Straumite I., 1906, PAREISTIZIGA LATWEES; Stroud G., 1993, CEMETERIES CHURCH PR; Tada A, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0194-z; Tauber H., 1986, MITTEILUNGEN BERLINE, P31; Tonetti MS, 2015, J CLIN PERIODONTOL, V42, pS5, DOI 10.1111/jcpe.12368; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VANDERMERWE NJ, 1978, NATURE, V276, P815, DOI 10.1038/276815a0; VOGEL JC, 1977, AM ANTIQUITY, V42, P238, DOI 10.2307/278984; Watson JT, 2010, AM J HUM BIOL, V22, P92, DOI 10.1002/ajhb.20958; Wilhelmson H, 2017, AM J PHYS ANTHROPOL, V163, P264, DOI 10.1002/ajpa.23204; World Health Organization, 2016, GLOB OR HLTH DAT BAN; Zero DT, 2008, DENT CARIES DIS ITS, P330	119	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191757	10.1371/journal.pone.0191757	http://dx.doi.org/10.1371/journal.pone.0191757			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364968	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000423412500073
J	Richter, Y; Lind, PG; Maass, P				Richter, Yvonne; Lind, Pedro G.; Maass, Philipp			Modeling specific action potentials in the human atria based on a minimal single-cell model	PLOS ONE			English	Article							FIBRILLATION; CURRENTS; INSIGHTS	We present an effective method to model empirical action potentials of specific patients in the human atria based on the minimal model of Bueno-Orovio, Cherry and Fenton adapted to atrial electrophysiology. In this model, three ionic are currents introduced, where each of it is governed by a characteristic time scale. By applying a nonlinear optimization procedure, a best combination of the respective time scales is determined, which allows one to reproduce specific action potentials with a given amplitude, width and shape. Possible applications for supporting clinical diagnosis are pointed out.	[Richter, Yvonne; Lind, Pedro G.; Maass, Philipp] Univ Osnabruck, Fachbereich Phys, Barbarastr 7, D-49076 Osnabruck, Germany	University Osnabruck	Lind, PG (corresponding author), Univ Osnabruck, Fachbereich Phys, Barbarastr 7, D-49076 Osnabruck, Germany.	pelind@uos.de	lind, pedro/G-5124-2010; Maass, Philipp/H-1477-2011	lind, pedro/0000-0002-8176-666X; Maass, Philipp/0000-0002-1268-8688	Deutsche Forschungsgemeinschaft (DFG) [MA1636/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), http://www.dfg.de/foerderung/programme/, Project with reference number MA1636/8-1 to Yvonne Richter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para; The authors thank C. Lenk and G. Seemann for helpful discussions and the Deutsche Forschungsgemeinschaft for financial support (Grant no. MA1636/8-1). They also thank U. Ravens and G. Seemann for providing AP data.	Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cherry EM, 2008, PROG BIOPHYS MOL BIO, V98, P24, DOI 10.1016/j.pbiomolbio.2008.05.002; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Koivumaki JT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001067; Lenk C, 2015, J THEOR BIOL, V366, P13, DOI 10.1016/j.jtbi.2014.10.030; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maleckar MM, 2008, PROG BIOPHYS MOL BIO, V98, P161, DOI 10.1016/j.pbiomolbio.2009.01.010; Nygren A, 1998, CIRC RES, V82, P63; Press William H., 2007, NUMERICAL RECIPES, V3rd; Richter Y., 2017, CINC2017 IN PRESS, V2017; Richter Y, 2017, J THEOR BIOL, V419, P100, DOI 10.1016/j.jtbi.2017.02.008; Seemann G, 2010, COMPUT CARDIOL CONF, V37, P417; Tsujimae K, 2008, AM J PHYSIOL-HEART C, V294, pH793, DOI 10.1152/ajpheart.01229.2007; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P2648, DOI 10.1109/TBME.2011.2160453; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190448	10.1371/journal.pone.0190448	http://dx.doi.org/10.1371/journal.pone.0190448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360837	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800008
J	Sahib, AK; Erb, M; Marquetand, J; Martin, P; Elshahabi, A; Klamer, S; Vulliemoz, S; Scheffler, K; Ethofer, T; Focke, NK				Sahib, Ashish Kaul; Erb, Michael; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Vulliemoz, Serge; Scheffler, Klaus; Ethofer, Thomas; Focke, Niels K.			Evaluating the impact of fast-fMRI on dynamic functional connectivity in an event-based paradigm	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PULSE ARTIFACT; BRAIN; TIME; SYSTEM; BOLD; MRI	The human brain is known to contain several functional networks that interact dynamically. Therefore, it is desirable to analyze the temporal features of these networks by dynamic functional connectivity (dFC). A sliding window approach was used in an event-related fMRI (visual stimulation using checkerboards) to assess the impact of repetition time (TR) and window size on the temporal features of BOLD dFC. In addition, we also examined the spatial distribution of dFC and tested the feasibility of this approach for the analysis of interictal epileptiforme discharges. 15 healthy controls (visual stimulation paradigm) and three patients with epilepsy (EEG-fMRI) were measured with EPI-fMRI. We calculated the functional connectivity degree (FCD) by determining the total number of connections of a given voxel above a predefined threshold based on Pearson correlation. FCD could capture hemodynamic changes relative to stimulus onset in controls. A significant effect of TR and window size was observed on FCD estimates. At a conventional TR of 2.6 s, FCD values were marginal compared to FCD values using sub-seconds TRs achievable with multiband (MB) fMRI. Concerning window sizes, a specific maximum of FCD values (inverted u-shape behavior) was found for each TR, indicating a limit to the possible gain in FCD for increasing window size. In patients, a dynamic FCD change was found relative to the onset of epilepti-form EEG patterns, which was compatible with their clinical semiology. Our findings indicate that dynamic FCD transients are better detectable with sub-second TR than conventional TR. This approach was capable of capturing neuronal connectivity across various regions of the brain, indicating a potential to study the temporal characteristics of interictal epileptiform discharges and seizures in epilepsy patients or other brain diseases with brief events.	[Sahib, Ashish Kaul; Ethofer, Thomas; Focke, Niels K.] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Sahib, Ashish Kaul; Erb, Michael; Scheffler, Klaus; Ethofer, Thomas] Univ Hosp Tuebingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Sahib, Ashish Kaul; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Focke, Niels K.] Univ Hosp Tuebingen, Dept Neurol Epileptol, Tubingen, Germany; [Sahib, Ashish Kaul; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Focke, Niels K.] Hertie Inst Clin Brain Res, Tubingen, Germany; [Sahib, Ashish Kaul] Univ Tubingen, Grad Sch Neural & Behav Sci, Int Max Planck Res Sch, Tubingen, Germany; [Elshahabi, Adham] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Vulliemoz, Serge] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Scheffler, Klaus] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Focke, Niels K.] Univ Med, Clin Neurophysiol, Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; University of Geneva; Max Planck Society	Focke, NK (corresponding author), Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.; Focke, NK (corresponding author), Univ Hosp Tuebingen, Dept Neurol Epileptol, Tubingen, Germany.; Focke, NK (corresponding author), Hertie Inst Clin Brain Res, Tubingen, Germany.; Focke, NK (corresponding author), Univ Med, Clin Neurophysiol, Gottingen, Germany.	niels.focke@med.uni-goettingen.de	Focke, Niels/AAO-7012-2020; Ethofer, Silke/AAC-4570-2022	Ethofer, Silke/0000-0002-6726-0531; Sahib, Ashish Kaul/0000-0003-0622-9634; Scheffler, Klaus/0000-0001-6316-8773	Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project); DFG [CIN EXC 307]; Swiss National Science Foundation [320030-169198]; Gottingen University	Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gottingen University	This work was supported by the Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project 2012-10) and the DFG (CIN EXC 307) for NF. Support for SV was provided by the Swiss National Science Foundation grant 320030-169198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Constable RT, 2001, MAGNET RESON MED, V46, P748, DOI 10.1002/mrm.1253; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di X, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00543; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Hawco CS, 2007, NEUROIMAGE, V35, P1450, DOI 10.1016/j.neuroimage.2006.12.042; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Iannotti GR, 2015, BRAIN TOPOGR, V28, P21, DOI 10.1007/s10548-014-0409-z; Kalcher K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00301; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Khalili-Mahani N, 2013, NEUROIMAGE, V65, P499, DOI 10.1016/j.neuroimage.2012.09.044; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Liao W, 2014, BRAIN CONNECT, V4, P780, DOI 10.1089/brain.2014.0253; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Nierhaus T, 2013, NEUROIMAGE, V74, P70, DOI 10.1016/j.neuroimage.2013.02.016; Sahib AK, 2016, MAGNETIC RESONANCE M; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhang ZG, 2011, IEEE T BIO-MED ENG, V58, P557, DOI 10.1109/TBME.2010.2089686	35	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190480	10.1371/journal.pone.0190480	http://dx.doi.org/10.1371/journal.pone.0190480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357371	Green Published, gold			2022-12-26	WOS:000422919500004
J	Sun, GW; Sima, GZ; Wu, CH; Fan, YZ; Tan, Y; Wang, Z; Cheng, G; Li, J				Sun, Guangwei; Sima, Guozhong; Wu, Chunhui; Fan, Yongzhong; Tan, Yong; Wang, Zhong; Cheng, Gang; Li, Jie			Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt	PLOS ONE			English	Article							DISEASE; MICRORNAS; CLUSTER	Background The activating mutations of micro RNA (miR)-17 have been revealed in tumors such as human non-Hodgkin's lymphoma and T cell leukemia. However, it is unclear about the role of miR-17 in glioma cells. The current study aimed to investigate effects of miR-17 mimics or inhibitor on the viability and migration of rat glioma C6 cells, and explore possible mechanisms. Methods The expression of miR-17 in rat glioma C6 cells and normal brain tissue was detected by quantitative PCR. Protein expression of Cyclin D1 in rat glioma C6 cells and normal brain tissue was measured by Western Blot. Glioma C6 cells were transfected with MiR-17 mimics or inhibitor. Cells that were not transfected (Lipofectamine only) and cells that were transfected with nonsense RNA negative control served as control. MTT assay was utilized to detect cell viability, and cell wound scratch assay was utilized to examine the migration index. In addition, protein expression of Cyclin D1, p-Akt and Akt in MiR-17 mimics or inhibitor- transfected glioma C6 cells was detected by Western Blot. This study had been approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Results The expression of miR-17 was significantly lower, whereas the expression of Cyclin D1 was significantly higher in glioma C6 cells compared to normal brain tissue. MiR-17 mimics decreased the viability and migration of glioma C6 cells markedly at 48 h. In addition, MiR-17 inhibitor increased the viability and migration of glioma C6 cells at 24 and 48 h. The protein expression of Cyclin D1, p-Akt and Akt in glioma C6 cells decreased after transfection with miR-17 mimics for 72 h, and increased after transfection with miR-17 inhibitor for 72 h. Conclusions The reduced miR-17 levels in glioma cells increased cell viability and migration, which correlates with increased expression of Cyclin D1, p-Akt and Akt.	[Sun, Guangwei; Wang, Zhong; Cheng, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Sun, Guangwei; Wang, Zhong; Cheng, Gang; Li, Jie] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China; [Sun, Guangwei; Sima, Guozhong; Wu, Chunhui; Fan, Yongzhong; Tan, Yong; Li, Jie] Danyang Peoples Hosp, Dept Neurosurg, Danyang Shi, Peoples R China	Soochow University - China; Soochow University - China	Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China.; Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China.	wangzhong065@sina.com						Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Karami F, 2016, CHEM BIOL DRUG DES, V87, P317, DOI 10.1111/cbdd.12671; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimura T, 2016, ONCOTARGET, V7, P3559, DOI 10.18632/oncotarget.6518; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu ZR, 2014, ONCOTARGET, V5, P1083, DOI 10.18632/oncotarget.1804	16	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190515	10.1371/journal.pone.0190515	http://dx.doi.org/10.1371/journal.pone.0190515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351283	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300020
J	Chang, HJ; Shin, HS; Kim, TH; Yoo, JY; Teasley, HE; Zhao, JJ; Ha, UH; Jeong, JW				Chang, Hye Jin; Shin, Hee Sung; Kim, Tae Hoon; Yoo, Jung-Yoon; Teasley, Hanna E.; Zhao, Jean J.; Ha, Un-Hwan; Jeong, Jae-Wook			Pik3ca is required for mouse uterine gland development and pregnancy	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; PROGESTERONE-RECEPTOR; BLASTOCYST IMPLANTATION; ENDOMETRIAL CARCINOMA; BIOLOGICAL ROLES; HIGH-FREQUENCY; BREAST-CANCER; GROWTH; FOXA2; MUTATIONS	The PI3K/AKT signaling pathway plays a critical role in the maintenance of equilibrium between cell survival and apoptosis. The Pik3ca gene is mutated in a range of human cancers. It has been found to be oncogenic, and mutations lead to constitutive activation of the PI3K/AKT pathway. The expression patterns of PIK3CA proteins in the uterus of mice during early pregnancy indicate that it may play a role in the regulation of glandular epithelial cells, which is required to support uterine receptivity. To further investigate the role of Pik3ca in uterine function, Pik3ca was conditionally ablated only in the PGR-positive cells (Pgr(cre/+)Pik3ca(f/f); Pik3ca(d/d)). A defect of uterine gland development and decidualization led to subfertility observed in Pik3ca(d/d) mice. Pik3ca(d/d) mice showed significantly decreased uterine weight compared to Pik3ca(f/f) mice. Interestingly, a significant decrease of gland numbers were detected in Pik3ca(d/d) mice compared to control mice. In addition, we found a decrease of Foxa2 expression, which is a known uterine gland marker in Pik3ca(d/d) mice. Furthermore, the excessive proliferation of endometrial epithelial cells was observed in Pik3ca(d/d) mice. Our studies suggest that Pik3ca has a critical role in uterine gland development and female fertility.	[Chang, Hye Jin; Shin, Hee Sung; Kim, Tae Hoon; Yoo, Jung-Yoon; Teasley, Hanna E.; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49546 USA; [Chang, Hye Jin] Seoul Natl Univ, Bundang Hosp, Hlth Promot Ctr, Seongnam, South Korea; [Shin, Hee Sung; Ha, Un-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Yoo, Jung-Yoon] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Teasley, Hanna E.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Michigan State University; Seoul National University (SNU); Korea University; Yonsei University; Yonsei University Health System; Kalamazoo College; Harvard University; Dana-Farber Cancer Institute	Jeong, JW (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49546 USA.; Ha, UH (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea.	haunhwan@korea.ac.kr; jeongj@msu.edu	Ha, Un-Hwan/ABH-8017-2020	Yoo, Jung-Yoon/0000-0001-9366-3863; Jeong, Jae-Wook/0000-0002-5368-6478	NICHD [R01HD084478]; National Research Foundation of Korea [NRF-2016R1A2B4007539]; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084478] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Research Foundation of Korea(National Research Foundation of Korea); BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD R01HD084478 (to J.W.J) and the National Research Foundation of Korea grant (NRF-2016R1A2B4007539) and the BK21 plus program of the Ministry of Education, Korea (to U.H.H).	Acosta-Martinez Maricedes, 2011, Front Endocrinol (Lausanne), V2, P110, DOI 10.3389/fendo.2011.00110; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bartol FF, 1999, J REPROD FERTIL, P287; Bastidas-Ponce A, 2017, MOL METAB, V6, P524, DOI 10.1016/j.molmet.2017.03.007; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; BRANHAM WS, 1985, ENDOCRINOLOGY, V117, P2229, DOI 10.1210/endo-117-5-2229; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cardone L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037526; Carta L, 2004, BIOL REPROD, V71, P444, DOI 10.1095/biolreprod.103.026534; Catasus L, 2008, MODERN PATHOL, V21, P131, DOI 10.1038/modpathol.3800992; Chang C F, 2016, Mol Biol (Mosk), V50, P457, DOI 10.7868/S0026898416030058; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; Ding Y, 2016, CYTOTECHNOLOGY, V68, P2037, DOI 10.1007/s10616-016-9944-7; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Filant J, 2014, INT J DEV BIOL, V58, P107, DOI 10.1387/ijdb.130344ts; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; FINN CA, 1967, J ENDOCRINOL, V39, P593, DOI 10.1677/joe.0.0390593; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Growdon WB, 2011, GYNECOL ONCOL, V121, P212, DOI 10.1016/j.ygyno.2010.11.039; Hu JB, 2004, BIOL REPROD, V70, P1870, DOI 10.1095/biolreprod.103.026336; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jeong JW, 2008, ONCOGENE; Jones SR, 2000, ENDOCRINOLOGY, V141, P637, DOI 10.1210/en.141.2.637; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005278; Kurita T, 2001, DEV BIOL, V240, P194, DOI 10.1006/dbio.2001.0458; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Nelson VLB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3756089; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; RIDER V, 1994, J ENDOCRINOL, V140, P239, DOI 10.1677/joe.0.1400239; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schneider MR, 2008, CYTOKINE GROWTH F R, V19, P173, DOI 10.1016/j.cytogfr.2008.01.003; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vogt PK, 2011, CURR TOP MICROBIOL, V347, P79, DOI 10.1007/82_2010_80; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191433	10.1371/journal.pone.0191433	http://dx.doi.org/10.1371/journal.pone.0191433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346447	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500050
J	Sridharan, J; Haremaki, T; Weinstein, DC				Sridharan, Jyotsna; Haremaki, Tomomi; Weinstein, Daniel C.			Cloning and spatiotemporal expression of Xenopus laevis Apolipoprotein CI	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; TRIGLYCERIDE-RICH LIPOPROTEINS; IN-SITU HYBRIDIZATION; APOC-I; ALZHEIMERS-DISEASE; TRANSGENIC MICE; GENE; INHIBITION; EMBRYOS; HYPERLIPIDEMIA	Apolipoprotein CI (ApoCI) belongs to the Apolipoprotein superfamily, members of which are involved in lipid transport, uptake and homeostasis. Excessive ApoCI has been implicated in atherosclerosis and Alzheimer's disease in humans. In this study we report the isolation of Xenopus laevis apoCI and describe the expression pattern of this gene during early development, using reverse transcription polymerase chain reaction and whole mount in situ hybridization. Xenopus apoCI is enriched in the dorsal ectoderm during gastrulation, and is subsequently expressed in sensory placodes, neural tube and cranial neural crest. These data suggest as yet uncharacterized roles for ApoCI during early vertebrate embryogenesis.	[Sridharan, Jyotsna; Haremaki, Tomomi; Weinstein, Daniel C.] CUNY Queens Coll, Biol Dept, Flushing, NY 11367 USA; [Sridharan, Jyotsna] Thermo Fisher Sci, San Diego, CA USA; [Haremaki, Tomomi] Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10021 USA	City University of New York (CUNY) System; Queens College NY (CUNY); Thermo Fisher Scientific; Rockefeller University	Weinstein, DC (corresponding author), CUNY Queens Coll, Biol Dept, Flushing, NY 11367 USA.	daniel.weinstein@qc.cuny.edu		Weinstein, Daniel/0000-0001-7832-9285	National Institute of General Medical Sciences, National Institutes of Health [R15GM124577]; Queens College of the City University of New York; Queens College; National Institutes of Health; PHS grant [R15GM124577]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM124577] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Queens College of the City University of New York; Queens College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx, National Institutes of Health, R15GM124577 to Daniel C Weinstein and by Queens College of the City University of New York. Funds from Queens College supported the study design, data collection, and analysis. Funds from the National Institutes of Health supported data analysis and preparation of the manuscript.; We are grateful to A. Dickinson for helpful advice on Xenopus face and head anatomy. This work is supported by PHS grant R15GM124577 (to DCW) and by Queens College of the City University of New York.	Abildayeva K, 2008, J LIPID RES, V49, P856, DOI 10.1194/jlr.M700518-JLR200; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; Dickinson A, 2007, SEMIN CELL DEV BIOL, V18, P525, DOI 10.1016/j.semcdb.2007.04.002; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Gould SE, 1997, CELL MOL LIFE SCI, V53, P319, DOI 10.1007/PL00000609; Hamsten A, 2005, J AM COLL CARDIOL, V45, P1013, DOI 10.1016/j.jacc.2004.12.049; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Jong MC, 1999, BIOCHEM J, V338, P281, DOI 10.1042/0264-6021:3380281; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; KNOTT TJ, 1984, NUCLEIC ACIDS RES, V12, P3909, DOI 10.1093/nar/12.9.3909; Koga M, 2007, DEV GROWTH DIFFER, V49, P635, DOI 10.1111/j.1440-169x.2007.00958.x; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; Linker C, 2000, DEV BIOL, V224, P215, DOI 10.1006/dbio.2000.9723; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Poduslo SE, 1998, NEUROCHEM RES, V23, P361, DOI 10.1023/A:1022409617539; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SLACK JMW, 1992, DEVELOPMENT, P143; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Wang Y, 2008, FISH PHYSIOL BIOCHEM, V34, P339, DOI 10.1007/s10695-007-9193-y; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; Westerterp Marit, 2007, Atherosclerosis, V195, pe9, DOI 10.1016/j.atherosclerosis.2007.01.015; Westerterp M, 2006, J LIPID RES, V47, P1203, DOI 10.1194/jlr.M500434-JLR200; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Xu Y, 1999, J LIPID RES, V40, P50	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191470	10.1371/journal.pone.0191470	http://dx.doi.org/10.1371/journal.pone.0191470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346450	gold, Green Published			2022-12-26	WOS:000422749500054
J	Fantini, D; Glaser, AP; Rimar, KJ; Wang, YD; Schipma, M; Varghese, N; Rademaker, A; Behdad, A; Yellapa, A; Yu, YN; Sze, CCL; Wang, L; Zhao, ZB; Crawford, SE; Hu, DQ; Licht, JD; Collings, CK; Bartom, E; Theodorescu, D; Shilatifard, A; Meeks, JJ				Fantini, Damiano; Glaser, Alexander P.; Rimar, Kalen J.; Wang, Yiduo; Schipma, Matthew; Varghese, Nobish; Rademaker, Alfred; Behdad, Amir; Yellapa, Aparna; Yu, Yanni; Sze, Christie Ching-Lin; Wang, Lu; Zhao, Zibo; Crawford, Susan E.; Hu, Deqing; Licht, Jonathan D.; Collings, Clayton K.; Bartom, Elizabeth; Theodorescu, Dan; Shilatifard, Ali; Meeks, Joshua J.			A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer	ONCOGENE			English	Article							SOMATIC ERCC2 MUTATIONS; ARISTOLOCHIC ACID; CELL-LINES; UROTHELIAL CANCER; CLONAL EVOLUTION; COPY NUMBER; GENOME; SIGNATURE; REPAIR; BASAL	The N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model is an attractive model system of muscle-invasive bladder cancer (MIBC) as it recapitulates the histology of human tumors in a background with intact immune system. However, it was unknown whether this carcinogen-induced model also mimicked human MIBC at the molecular and mutational level. In our study, we analyzed gene expression and mutational landscape of the BBN model by next-generation sequencing followed by a bioinformatic comparison to human MIBC using data from The Cancer Genome Atlas and other repositories. BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC. Many variants corresponded to human cancer hotspot mutations, supporting their role as driver mutations. We extracted two novel mutational signatures from the BBN mouse genomes. The integrated analysis of mutation frequencies and signatures highlighted the contribution of aberrations to chromatin regulators and genetic instability in the BBN tumors. Together, our study revealed several similarities between human MIBC and the BBN mouse model, providing a strong rationale for its use in molecular and drug discovery studies.	[Fantini, Damiano; Glaser, Alexander P.; Rimar, Kalen J.; Wang, Yiduo; Yellapa, Aparna; Yu, Yanni; Meeks, Joshua J.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Fantini, Damiano; Glaser, Alexander P.; Rimar, Kalen J.; Wang, Yiduo; Rademaker, Alfred; Shilatifard, Ali; Meeks, Joshua J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Schipma, Matthew; Varghese, Nobish; Sze, Christie Ching-Lin; Wang, Lu; Zhao, Zibo; Hu, Deqing; Collings, Clayton K.; Bartom, Elizabeth; Shilatifard, Ali] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Rademaker, Alfred] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Behdad, Amir] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Crawford, Susan E.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Licht, Jonathan D.] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Dept Surg Urol & Pharmacol, Denver, CO 80202 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Saint Louis University; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Denver	Meeks, JJ (corresponding author), Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA.; Meeks, JJ (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	joshua.meeks@northwestern.edu	Zhao, Zibo/GWQ-3444-2022; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Bartom, Elizabeth/S-4475-2017; Glaser, Alexander/D-5526-2015	Licht, Jonathan/0000-0002-3942-1369; Bartom, Elizabeth/0000-0002-5618-2582; Glaser, Alexander/0000-0003-1781-9023	John P. Hanson Foundation for Cancer Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University;  [BX003692];  [R01 CA180475];  [CA075115];  [R35CA197569]; NATIONAL CANCER INSTITUTE [F31CA228149, T32CA009560, R01CA180475, R35CA197569, R01CA075115, R29CA075115, R50CA221848] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003692] Funding Source: NIH RePORTER	John P. Hanson Foundation for Cancer Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Francesco Favero (Technical University of Denmark) for assistance with the use of the sequenza and copynumber R libraries, Dr. Vania Vidimar (Northwestern University) for insightful discussions and editorial assistance in writing the manuscript, and Dr. Andrea Piunti (Northwestern University) for help with RNA extraction and RNA-seq library preparation. JJM is supported by grant BX003692 and the John P. Hanson Foundation for Cancer Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, JDL is supported by R01 CA180475, DT is supported by CA075115. CKC, EB and AS are supported by R35CA197569 awarded to AS.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calderwood SK, 2013, DISCOV MED, V15, P188; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dadhania V, 2016, EBIOMEDICINE, V12, P105, DOI 10.1016/j.ebiom.2016.08.036; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Glaser AP, 2017, NAT REV UROL, V14, P215, DOI 10.1038/nrurol.2017.11; Goodspeed A, 2016, MOL CANCER RES, V14, P3, DOI 10.1158/1541-7786.MCR-15-0189; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Horstmann M, 2008, GENDER MED, V5, P385, DOI 10.1016/j.genm.2008.11.002; Kardos J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85902; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Kobayashi T, 2015, NAT REV CANCER, V15, P42, DOI 10.1038/nrc3858; Kramer F, 2017, METHODS MOL BIOL, V1525, P123, DOI 10.1007/978-1-4939-6622-6_6; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li X, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3257-x; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29479; Moriya M, 2011, INT J CANCER, V129, P1532, DOI 10.1002/ijc.26077; NAGAO M, 1977, CANCER RES, V37, P399; Nickerson ML, 2017, ONCOGENE, V36, P35, DOI 10.1038/onc.2016.172; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Peterson LA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/284935; Pfister NT, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026054; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Sharma P, 2016, LANCET ONCOL, V17, P1590, DOI 10.1016/S1470-2045(16)30496-X; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Sidorenko VS, 2012, NUCLEIC ACIDS RES, V40, P2494, DOI 10.1093/nar/gkr1095; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; SUMMERHAYES IC, 1979, J NATL CANCER I, V62, P1017; Sze CC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026427; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vasconcelos-Nobrega C, 2012, IN VIVO, V26, P727; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yao RS, 2004, NEOPLASIA, V6, P569, DOI 10.1593/neo.04223; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zhang YW, 2012, BJU INT, V109, P52, DOI 10.1111/j.1464-410X.2011.10283.x	60	60	60	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1911	1925		10.1038/s41388-017-0099-6	http://dx.doi.org/10.1038/s41388-017-0099-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29367767	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000429303300008
J	Zhang, YH; Wester, L; He, JC; Geiger, T; Moerkens, M; Siddappa, R; Helmijr, JA; Timmermans, MM; Look, MP; van Deurzen, CHM; Martens, JWM; Pont, C; de Graauw, M; Danen, EHJ; Berns, EMJJ; Meerman, JHN; Jansen, MPHM; van de Water, B				Zhang, Yinghui; Wester, Lynn; He, Jichao; Geiger, Tamar; Moerkens, Marja; Siddappa, Ram; Helmijr, Jean A.; Timmermans, Mieke M.; Look, Maxime P.; van Deurzen, Caroline H. M.; Martens, John W. M.; Pont, Chantal; de Graauw, Marjo; Danen, Erik H. J.; Berns, Els M. J. J.; Meerman, John H. N.; Jansen, Maurice P. H. M.; van de Water, Bob			IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer	ONCOGENE			English	Article							TAMOXIFEN RESISTANCE; P21-ACTIVATED-KINASE-1 PAK1; ENDOCRINE RESISTANCE; CELL-PROLIFERATION; NEURITE OUTGROWTH; GROWTH-FACTORS; BETA-CATENIN; I RECEPTOR; EXPRESSION; PATHWAY	Antiestrogen resistance in estrogen receptor positive (ER+) breast cancer is associated with increased expression and activity of insulin-like growth factor 1 receptor (IGF1R). Here, a kinome siRNA screen has identified 10 regulators of IGF1R-mediated antiestrogen with clinical significance. These include the tamoxifen resistance suppressors BMPR1B, CDK10, CDK5, EIF2AK1, and MAP2K5, and the tamoxifen resistance inducers CHEK1, PAK2, RPS6KC1, TTK, and TXK. The p21-activated kinase 2, PAK2, is the strongest resistance inducer. Silencing of the tamoxifen resistance inducing genes, particularly PAK2, attenuates IGF1R-mediated resistance to tamoxifen and fulvestrant. High expression of PAK2 in ER+ metastatic breast cancer patients is correlated with unfavorable outcome after first-line tamoxifen monotherapy. Phospho-proteomics has defined PAK2 and the PAK-interacting exchange factors PIX alpha/beta as downstream targets of IGF1R signaling, which are independent from PI3K/ATK and MAPK/ERK pathways. PAK2 and PIX alpha/beta modulate IGF1R signaling-driven cell scattering. Targeting PIX alpha/beta entirely mimics the effect of PAK2 silencing on antiestrogen re-sensitization. These data indicate PAK2/PIX as an effector pathway in IGF1R-mediated antiestrogen resistance.	[Zhang, Yinghui; Wester, Lynn; He, Jichao; Moerkens, Marja; Siddappa, Ram; Pont, Chantal; de Graauw, Marjo; Danen, Erik H. J.; Meerman, John H. N.; van de Water, Bob] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [Geiger, Tamar] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Tel Aviv, Israel; [Helmijr, Jean A.; Timmermans, Mieke M.; Look, Maxime P.; van Deurzen, Caroline H. M.; Martens, John W. M.; Berns, Els M. J. J.; Jansen, Maurice P. H. M.] Dept Med Oncol & Canc Genom Netherlands, Rotterdam, Netherlands; [van Deurzen, Caroline H. M.] Erasmus Univ, Erasmus MC Canc Inst, Dept Pathol, Med Ctr, Rotterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Tel Aviv University; Sackler Faculty of Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Zhang, YH; van de Water, B (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.	y.zhang@lacdr.leidenuniv.nl; b.water@lacdr.leidenuniv.nl	jansen, maurice/E-9927-2013	Geiger, Tamar/0000-0002-9526-197X; danen, erik/0000-0002-0491-6345; Zhang, Yinghui/0000-0003-1635-0278	Top Institute Pharma (Leiden, The Netherlands) [T3-107]; Dutch Cancer Society [UL-2011-5124]	Top Institute Pharma (Leiden, The Netherlands)(Netherlands Government); Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by the research project of Top Institute Pharma (Leiden, The Netherlands) "Nuclear Receptors in Targeted Cancer Therapy" (T3-107) and the research project of Dutch Cancer Society "Novel Protein Kinase Targets in Receptor Tyrosine Kinase-mediated Drug Resistant Breast Cancer" (UL-2011-5124).	Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Arnaldez FI, 2012, HEMATOL ONCOL CLIN N, V26, P527, DOI 10.1016/j.hoc.2012.01.004; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Cleator SJ, 2009, CLIN BREAST CANCER, V9, pS6, DOI 10.3816/CBC.2009.s.001; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Frank SR, 2012, CURR BIOL, V22, P1747, DOI 10.1016/j.cub.2012.07.011; Gao CC, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-55; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Heskamp S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117745; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jin K, 2015, CANCER DISCOV, V5, P944, DOI 10.1158/2159-8290.CD-15-0090; Jin K, 2012, P NATL ACAD SCI USA, V109, P2736, DOI 10.1073/pnas.1018859108; Kok M, 2011, BREAST CANCER RES TR, V125, P1, DOI 10.1007/s10549-010-0798-y; Kok M, 2009, BREAST CANCER RES TR, V113, P275, DOI 10.1007/s10549-008-9939-y; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lacombe J, 2014, CANCER EPIDEM BIOMAR, V23, P1834, DOI 10.1158/1055-9965.EPI-14-0267; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Luey BC, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0482-2; Lundgren K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2150; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Menges CW, 2012, MOL CANCER RES, V10, P1178, DOI 10.1158/1541-7786.MCR-12-0082; Moerkens M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-283; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nheu T, 2004, CELL CYCLE, V3, P71; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Padala RR, 2017, MOL BIOSYST, V13, P830, DOI 10.1039/c6mb00786d; Puigvert JC, 2010, CURRENT PROTOCOLS CE; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Reijm EA, 2014, ANN ONCOL, V25, P2185, DOI 10.1093/annonc/mdu391; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Sachdev D, 2008, J MAMMARY GLAND BIOL, V13, P431, DOI 10.1007/s10911-008-9105-5; Santiago-Medina M, 2013, J CELL SCI, V126, P1122, DOI 10.1242/jcs.112607; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Tabusa H, 2013, MOL CANCER RES, V11, P109, DOI 10.1158/1541-7786.MCR-12-0466; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Wang ZP, 2013, J BIOL CHEM, V288, P20093, DOI 10.1074/jbc.M112.426023; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Winder T, 2014, PHARMACOGENOMICS J, V14, P28, DOI 10.1038/tpj.2013.8; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Ye P, 2010, GLIA, V58, P1031, DOI 10.1002/glia.20984; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060	60	23	27	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1869	1884		10.1038/s41388-017-0027-9	http://dx.doi.org/10.1038/s41388-017-0027-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29353882	Green Published			2022-12-26	WOS:000429303300005
J	Laursen, L; Severinsen, K; Kristensen, KB; Periole, X; Overby, M; Muller, HK; Schiott, B; Sinning, S				Laursen, Louise; Severinsen, Kasper; Kristensen, Kristina Birch; Periole, Xavier; Overby, Malene; Mueller, Heidi Kaastrup; Schiott, Birgit; Sinning, Steffen			Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; MEMBRANE CHOLESTEROL; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; FORCE-FIELD; NEUROTRANSMITTER; MECHANISM; DYNAMICS; PROTEIN; NA+	The serotonin transporter (SERT) is important for reuptake of the neurotransmitter serotonin from the synaptic cleft and is also the target of most antidepressants. It has previously been shown that cholesterol in the membrane bilayer affects the conformation of SERT. Although recent crystal structures have identified several potential cholesterol-binding sites, it is unclear whether any of these potential cholesterol sites are occupied by cholesterol and functionally relevant. In the present study, we focus on the conserved cholesterol site 1 (CHOL1) located in a hydrophobic groove between TM1a, TM5, and TM7. By molecular dynamics simulations, we demonstrate a strong binding of cholesterol to CHOL1 in a membrane bilayer environment. In biochemical experiments, we find that cholesterol depletion induces a more inward-facing conformation favoring substrate analog binding. Consistent with this, we find that mutations in CHOL1 with a negative impact on cholesterol binding induce a more inward-facing conformation, and, vice versa, mutations with a positive impact on cholesterol binding induce a more outward-facing conformation. This shift in transporter conformation dictated by the ability to bind cholesterol in CHOL1 affects the apparent substrate affinity, maximum transport velocity, and turnover rates. Taken together, we show that occupation of CHOL1 by cholesterol is of major importance in the transporter conformational equilibrium, which in turn dictates ligand potency and serotonin transport activity. Based on our findings, we propose a mechanistic model that incorporates the role of cholesterol binding to CHOL1 in the function of SERT.	[Laursen, Louise; Severinsen, Kasper; Kristensen, Kristina Birch; Overby, Malene; Mueller, Heidi Kaastrup; Sinning, Steffen] Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Skovagervej 2, DK-8240 Risskov, Denmark; [Periole, Xavier; Schiott, Birgit] Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark; [Periole, Xavier; Schiott, Birgit] Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, Langelandsgade 140, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Sinning, S (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	steffen.sinning@clin.au.dk	Schiott, Birgit/F-5067-2011	Schiott, Birgit/0000-0001-9937-1562; Laursen, Louise/0000-0001-7758-4487; Overby, Malene/0000-0001-5448-722X; Periole, Xavier/0000-0002-2087-5061; Sinning, Steffen/0000-0001-6971-6929	Lundbeck Foundation; Danish Council for Independent Research, Natural Sciences; Lundbeck Foundation [R34-2011-3868, R126-2012-12576, R126-2012-12453] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation and the Danish Council for Independent Research, Natural Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Bjerregaard H, 2015, J BIOL CHEM, V290, P7747, DOI 10.1074/jbc.M114.573477; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GUILLOT F, 1993, J CARDIOVASC PHARM, V21, P339, DOI 10.1097/00005344-199302000-00022; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hedger G, 2016, J PHYS CHEM B, V120, P8154, DOI 10.1021/acs.jpcb.6b01387; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingolfsson HI, 2016, J CELL SCI, V129, P257, DOI 10.1242/jcs.176040; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Narayan S, 2011, FRONT BIOSCI-LANDMRK, V16, P1797, DOI 10.2741/3822; NORTH P, 1983, J BIOL CHEM, V258, P1242; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papakostas GI, 2004, EUR NEUROPSYCHOPHARM, V14, P135, DOI 10.1016/S0924-977X(03)00099-3; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Periole X, 2017, CHEM REV, V117, P156, DOI 10.1021/acs.chemrev.6b00344; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Renshaw PF, 2009, PHARMACOL BIOCHEM BE, V92, P88, DOI 10.1016/j.pbb.2008.10.017; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; SEEMAN P, 1973, J CELL BIOL, V56, P519, DOI 10.1083/jcb.56.2.519; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sooksawate T, 2001, NEUROPHARMACOLOGY, V40, P178, DOI 10.1016/S0028-3908(00)00159-3; Stolzenberg S, 2017, J BIOL CHEM, V292, P7372, DOI 10.1074/jbc.M116.757153; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; WHITTAKE.VP, 1966, ANN NY ACAD SCI, V137, P982, DOI 10.1111/j.1749-6632.1966.tb50211.x; Wustner D, 2007, MOL BIOL CELL, V18, P211, DOI 10.1091/mbc.E06-05-0445; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	57	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3510	3523		10.1074/jbc.M117.809046	http://dx.doi.org/10.1074/jbc.M117.809046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352106	Green Published, hybrid			2022-12-26	WOS:000427030200005
J	Hong, S; Ka, D; Yoon, SJ; Suh, N; Jeong, M; Suh, JY; Bae, E				Hong, Suji; Ka, Donghyun; Yoon, Seo Jeong; Suh, Nayoung; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung			CRISPR RNA and anti-CRISPR protein binding to the Xanthomonas albilineans Csy1-Csy2 heterodimer in the type I-F CRISPR-Cas system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL SUPPRESSORS; IMMUNE-SYSTEM; INHIBITION; REPEATS; CLASSIFICATION; MECHANISMS; EVOLUTION; BACTERIA; COMPLEX; ADAPTATION	Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide microbial adaptive immunity against bacteriophages. In type I-F CRISPR-Cas systems, multiple Cas proteins (Csy1-4) compose a surveillance complex (Csy complex) with CRISPR RNA (crRNA) for target recognition. Here, we report the biochemical characterization of the Csy1-Csy2 subcomplex from Xanthomonas albilineans, including the analysis of its interaction with crRNA and AcrF2, an anti-CRISPR (Acr) protein from a phage that infects Pseudomonas aeruginosa. The X. albilineans Csy1 and Csy2 proteins (XaCsy1 and XaCsy2, respectively) formed a stable heterodimeric complex that specifically bound the 8-nucleotide (nt) 5'-handle of the crRNA. In contrast, the XaCsy1-XaCsy2 heterodimer exhibited reduced affinity for the 28-nt X. albilineans CRISPR repeat RNA containing the 5'-handle sequence. Chromatographic and calorimetric analyses revealed tight binding between the Acr protein from the P. aeruginosa phage and the heterodimeric subunit of the X. albilineans Csy complex, suggesting that AcrF2 recognizes conserved features of Csy1-Csy2 heterodimers. We found that neither XaCsy1 nor XaCsy2 alone forms a stable complex with AcrF2 and the 5'-handle RNA, indicating that XaCsy1-XaCsy2 heterodimerization is required for binding them. We also solved the crystal structure of AcrF2 to a resolution of 1.34 angstrom, enabling a more detailed structural analysis of the residues involved in the interactions with the Csy1-Csy2 heterodimer. Our results provide information about the order of events during the formation of the multisubunit crRNA-guided surveillance complex and suggest that the Acr protein inactivating type I-F CRISPR-Cas systems has broad specificity.	[Hong, Suji; Ka, Donghyun; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Yoon, Seo Jeong] Seoul Natl Univ, Dept Appl Biol Chem, Seoul 08826, South Korea; [Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Suh, Nayoung] Soon Chun Hyang Univ, Dept Pharmaceut Engn, Asan 31538, South Korea; [Suh, Jeong-Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Nagano 3994598, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Soonchunhyang University; Shinshu University	Bae, E (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.	bae@snu.ac.kr			Cooperative Research Program for Agricultural Science and Technology Development - Rural Development Administration [PJ01111201]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2016R1D1A1A09916821]	Cooperative Research Program for Agricultural Science and Technology Development - Rural Development Administration; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Cooperative Research Program for Agricultural Science and Technology Development funded by Rural Development Administration (Grant PJ01111201) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant NRF-2016R1D1A1A09916821). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006; Harrington LB, 2017, CELL, V170, P1224, DOI 10.1016/j.cell.2017.07.037; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Hynes AP, 2017, NAT MICROBIOL, V2, P1374, DOI 10.1038/s41564-017-0004-7; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Maxwell KL, 2017, MOL CELL, V68, P8, DOI 10.1016/j.molcel.2017.09.002; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Maxwell KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005282; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Peng RC, 2017, CELL RES, V27, P853, DOI 10.1038/cr.2017.79; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Shabbir MAB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01292; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sontheimer EJ, 2017, CURR OPIN MICROBIOL, V37, P120, DOI 10.1016/j.mib.2017.06.003; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yang H, 2017, MOL CELL, V67, P117, DOI 10.1016/j.molcel.2017.05.024	57	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2744	2754		10.1074/jbc.RA117.001611	http://dx.doi.org/10.1074/jbc.RA117.001611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29348170	Green Published, hybrid			2022-12-26	WOS:000426051900011
J	Copeland, LA; Swendsen, CS; Sears, DM; MacCarthy, AA; McNeal, CJ				Copeland, Laurel A.; Swendsen, C. Scott; Sears, Dawn M.; MacCarthy, Andrea A.; McNeal, Catherine J.			Association between triglyceride levels and cardiovascular disease in patients with acute pancreatitis	PLOS ONE			English	Article							HYPERTRIGLYCERIDEMIA	Conventional wisdom supports prescribing ''fibrates before statins'', that is, prioritizing treatment of hypertriglyceridemia (hTG) to prevent pancreatitis ahead of low-density lipoprotein cholesterol to prevent coronary heart disease. The relationship between hTG and acute pancreatitis, however, may not support this approach to clinical management. This study analyzed administrative data from the Veterans Health Administration for evidence of (1) temporal association between assessed triglycerides level and days to acute pancreatitis admission; (2) association between hTG and outcomes in the year after hospitalization for acute pancreatitis; (3) relative rates of prescription of fibrates vs statins in patients with acute pancreatitis; (4) association of prescription of fibrates alone versus fibrates with statins or statins alone with rates of adverse outcomes after hospitalization for acute pancreatitis. Only modest association was found between above-normal or extremely high triglycerides and time until acute pancreatitis. CHD/MI/stroke occurred in 23% in the year following AP, supporting cardiovascular risk management. Fibrates were prescribed less often than statins, defying conventional wisdom, but the high rates of cardiovascular events in the year following AP support a clinical focus on reducing cardiovascular risk factors.	[Copeland, Laurel A.] VA Cent Western Massachusetts Healthcare Syst, Leeds, MA 01053 USA; [Copeland, Laurel A.; McNeal, Catherine J.] Baylor Scott & White Hlth, Dept Med, Temple, TX 91780 USA; [Copeland, Laurel A.] UT Hlth San Antonio, San Antonio, TX 78229 USA; [Swendsen, C. Scott; Sears, Dawn M.] Texas A&M Hlth Sci Ctr, Temple, TX USA; [Swendsen, C. Scott; Sears, Dawn M.] Baylor Scott & White Hlth, Gastroenterol Serv, Dept Internal Med, Temple, TX USA; [MacCarthy, Andrea A.] Cent Texas Vet Hlth Care Syst, Ctr Excellence Res Returning War Vet, Waco, TX USA	Baylor Health Care System; University of Texas System; University of Texas Health San Antonio; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System	Copeland, LA (corresponding author), VA Cent Western Massachusetts Healthcare Syst, Leeds, MA 01053 USA.; Copeland, LA (corresponding author), Baylor Scott & White Hlth, Dept Med, Temple, TX 91780 USA.; Copeland, LA (corresponding author), UT Hlth San Antonio, San Antonio, TX 78229 USA.	LaurelACopeland@gmail.com	Copeland, Laurel A/C-3763-2017	Copeland, Laurel A/0000-0002-9478-0209	Scott & White Research Mentor Award [150103]; Veterans Health Administration [HX-09-335]; Baylor Scott White Health	Scott & White Research Mentor Award; Veterans Health Administration(US Department of Veterans Affairs); Baylor Scott White Health	This study was supported by Scott & White Research Mentor Award #150103, awarded to LAC & CSS, http://researchers.sw.org/academic-research-development/internal-funding; and Veterans Health Administration HX-09-335, awarded to LAC, http://www.hsrd.research.va.gov/funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors LAC, CSS, DS, and CJM are employed by Baylor Scott & White Health, a private not-for-profit health care system. LAC and CSS were awarded a small research grant ($3,000) by Baylor Scott & White Health to help support the salary of a data manager. Baylor Scott & White Health had no role in this study beyond helping support the salaries of these researchers.	Berglund L, J CLIN ENDOL METAB, V97, P2969; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Copeland LA, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0064-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Kushner PA, 2016, POSTGRAD MED, V128, P848, DOI 10.1080/00325481.2016.1243005; Lederle FA, 2012, ANN INTERN MED, V157, P662, DOI 10.7326/0003-4819-157-9-201211060-00011; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Pedersen SB, 2016, JAMA INTERN MED, V176, P1834, DOI 10.1001/jamainternmed.2016.6875; Wang SP, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON POWER AND RENEWABLE ENERGY (ICPRE), P10	11	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0179998	10.1371/journal.pone.0179998	http://dx.doi.org/10.1371/journal.pone.0179998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381696	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800001
J	Schultz, MT				Schultz, Martin T.			Inference of genetic marker concentrations from field surveys to detect environmental DNA using Bayesian updating	PLOS ONE			English	Article								Field studies to detect environmental DNA (eDNA) can be undertaken to infer the presence of a rare or cryptic species in a water body. These studies are implemented by collecting water samples from the water body, processing those samples to isolate genetic material contained in the water sample, and using a laboratory assay to find a species-specific genetic marker within a sample of the genetic material. To date, conventional polymerase chain reaction (PCR) has been one of the most widely used assays in field studies to detect eDNA. This assay is strictly a test for the presence of the genetic marker. It provides no estimate of the concentration of the target genetic marker in the sample or in the environment. Understanding the concentration of a target marker in the environment is a critical first step toward using the results of eDNA field surveys to support inferences about the location and strength of eDNA sources. In this study, the results of eDNA field surveys are combined with a model of the sensitivity of the field survey methods to estimate target marker concentrations using Bayesian updating. The method is demonstrated for Asian carp in the Chicago Area Waterway System (CAWS) using the results of field surveys for eDNA carried out during the period 2009 through 2012, a four-year period during which more than 5,800 two-liter water samples were collected and analyzed using PCR. Concentrations of bighead carp (Hypophthalmichthys nobilis) and silver carp (Hypophthalmichthys molitrix) eDNA are estimated for twenty hydrologic reaches of the CAWS. This study also assesses the sensitivity of these concentration estimates to evidentiary criteria that limit what evidence is used in Bayesian updating based on requirements for sampling intensity and frequency.	[Schultz, Martin T.] US Army Corps Engineers, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39183 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Schultz, MT (corresponding author), US Army Corps Engineers, Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39183 USA.	Martin.T.Schultz@usace.army.mil		Schultz, Martin/0000-0002-0760-0266	U.S. Environmental Protection Agency Great Lakes Restoration Initiative through the Asian Carp Regional Coordinating Committee; U.S. Army Corps of Engineers	U.S. Environmental Protection Agency Great Lakes Restoration Initiative through the Asian Carp Regional Coordinating Committee; U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army)	This study was part of the Environmental DNA Calibration Study funded by the U.S. Environmental Protection Agency Great Lakes Restoration Initiative (http ://greatlakesrestoration.us) through the Asian Carp Regional Coordinating Committee (http://wwwasiancaro.us) and the U.S. Army Corps of Engineers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Box GE, 1992, BAYESIAN INFERENCE S; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; KOLAR CS, 2007, BIGHEAD CARPS BIOL S; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Schultz MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141503; Schultz MT, 2014, PROBABILISTIC ANAL E, P271; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; US Department of Agriculture (USDA), 2015, STREAM REACH HYDR UN; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	20	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190603	10.1371/journal.pone.0190603	http://dx.doi.org/10.1371/journal.pone.0190603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381694	gold, Green Submitted, Green Published			2022-12-26	WOS:000423617800009
J	Hadjichrysanthou, C; Ower, AK; de Wolf, F; Anderson, RM				Hadjichrysanthou, Christoforos; Ower, Alison K.; de Wolf, Frank; Anderson, Roy M.		Alzheimer's Dis Neuroimaging	The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TRANSITION-PROBABILITIES; BIOMARKER CHANGES; BRAIN RESERVE; MARKOV MODEL; RISK-FACTORS; PROGRESSION; DEMENTIA; PREVALENCE; SIMULATION	Alzheimer's disease (AD) is a neurodegenerative disorder characterised by a slow progressive deterioration of cognitive capacity. Drugs are urgently needed for the treatment of AD and unfortunately almost all clinical trials of AD drug candidates have failed or been discontinued to date. Mathematical, computational and statistical tools can be employed in the construction of clinical trial simulators to assist in the improvement of trial design and enhance the chances of success of potential new therapies. Based on the analysis of a set of clinical data provided by the Alzheimer's Disease Neuroimaging Initiative (ADNI) we developed a simple stochastic mathematical model to simulate the development and progression of Alzheimer's in a longitudinal cohort study. We show how this modelling framework could be used to assess the effect and the chances of success of hypothetical treatments that are administered at different stages and delay disease development. We demonstrate that the detection of the true efficacy of an AD treatment can be very challenging, even if the treatment is highly effective. An important reason behind the inability to detect signals of efficacy in a clinical trial in this therapy area could be the high between- and within-individual variability in the measurement of diagnostic markers and endpoints, which consequently results in the misdiagnosis of an individual's disease state.	[Hadjichrysanthou, Christoforos; Ower, Alison K.; de Wolf, Frank; Anderson, Roy M.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [de Wolf, Frank] Janssen Prevent Ctr, Leiden, Netherlands	Imperial College London	Hadjichrysanthou, C (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	c.hadjichrysanthou@imperial.ac.uk		Anderson, Roy/0000-0002-9528-3175	National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Janssen Prevention Centre	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Janssen Prevention Centre	This study was funded by Janssen Prevention Centre, http://www.janssen.com/janssen-prevention-center, funding received by RMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Abner EL, 2012, INT J ALZHEIMERS DIS, V2012, P9, DOI [10.1155/2012/291920, DOI 10.1155/2012/291920]; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; [Anonymous], 2017, LANCET NEUROL, V16, P97, DOI 10.1016/S1474-4422(16)30395-7; Ashford J W, 2001, Curr Psychiatry Rep, V3, P20, DOI 10.1007/s11920-001-0067-1; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Bertsch M, 2015, ARXIV150304669V1; Bloom BS, 2003, GERONTOLOGIST, V43, P158, DOI 10.1093/geront/43.2.158; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Budd D, 2011, CLINICOECONOMIC OUTC, V3, P189, DOI 10.2147/CEOR.S22265; Chibnik LB, 2017, EUR J EPIDEMIOL, V32, P931, DOI 10.1007/s10654-017-0320-5; Craft DL, 2002, B MATH BIOL, V64, P1011, DOI 10.1006/bulm.2002.0304; Craig BA, 2002, HEALTH ECON, V11, P33, DOI 10.1002/hec.654; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Demetrius LA, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00522; Efron B., 1994, INTRO BOOTSTRAP; Forster S, 2012, BIOL PSYCHIAT, V71, P792, DOI 10.1016/j.biopsych.2011.04.023; Fonteijn HM, 2012, NEUROIMAGE, V60, P1880, DOI 10.1016/j.neuroimage.2012.01.062; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Fuh JL, 2004, INT J GERIATR PSYCH, V19, P266, DOI 10.1002/gps.1076; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gauthier S, 2005, ARCH NEUROL-CHICAGO, V62, P1164, DOI 10.1001/archneur.62.7.1164; Gauthier S, 2016, ALZHEIMERS DEMENT, V12, P60, DOI 10.1016/j.jalz.2015.12.003; Green C, 2011, VALUE HEALTH, V14, P621, DOI 10.1016/j.jval.2010.12.008; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Helal M, 2014, J MATH BIOL, V69, P1207, DOI 10.1007/s00285-013-0732-0; Hubbard RA, 2011, J APPL STAT, V38, P2313, DOI 10.1080/02664763.2010.547567; Ito K, 2011, ALZHEIMERS DEMENT, V7, P151, DOI 10.1016/j.jalz.2010.03.018; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jicha GA, 2008, DEMENT GERIATR COGN, V26, P187, DOI 10.1159/000151635; Jones RW, 2004, DRUG AGING, V21, P607, DOI 10.2165/00002512-200421090-00005; Kivipelto M, 2017, SCI AM, V316, P34, DOI 10.1038/scientificamerican0417-32; Knopman D S, 1998, Am J Med, V104, p2S, DOI 10.1016/S0002-9343(98)00022-9; Knopman D.S., 1998, AM J MED, V104, p39S; Kryscio RJ, 2006, NEUROLOGY, V66, P828, DOI 10.1212/01.wnl.0000203264.71880.45; Kryscio RJ, 2013, J BIOMETRICS BIOSTAT, V4; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Macdonald A., 2000, ASTIN BULL, V30, P69, DOI [10.2143/AST.30.1.504627, DOI 10.2143/AST.30.1.504627]; Mar J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-014-0079-9; Mitnitski AB, 2014, STAT METHODS MED RES, V23, P244, DOI 10.1177/0962280211406470; Mortimer JA, 1997, GERIATRICS, V52, pS50; Neumann PJ, 2001, NEUROLOGY, V57, P957, DOI 10.1212/WNL.57.6.957; Ower AK, 2017, EUROPEAN J EPIDEMIOL; Prince M., 2016, WORLD ALZHEIMER REPO; Proctor CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073631; Puri IK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015176; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Rogers JA, 2012, J PHARMACOKINET PHAR, V39, P479, DOI 10.1007/s10928-012-9263-3; Samtani MN, 2012, J CLIN PHARMACOL, V52, P629, DOI 10.1177/0091270011405497; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schneider LS, 2010, J NUTR HEALTH AGING, V14, P295; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Spackman DE, 2012, CURR ALZHEIMER RES, V9, P1050; Spiegel R, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt183; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Stewart A, 1998, INT J GERIATR PSYCH, V13, P445, DOI 10.1002/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.3.CO;2-5; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Whitwell JL, 2012, ARCH NEUROL-CHICAGO, V69, P614, DOI 10.1001/archneurol.2011.3029; Wimo A, 2006, DEMENT GERIATR COGN, V21, P175, DOI 10.1159/000090733; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Yesavage JA, 2002, J PSYCHIAT RES, V36, P281, DOI 10.1016/S0022-3956(02)00020-1; Young AL, 2015, MED IMAGE ANAL, V26, P47, DOI 10.1016/j.media.2015.07.004; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176	72	19	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0190615	10.1371/journal.pone.0190615	http://dx.doi.org/10.1371/journal.pone.0190615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	29377891	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700007
J	Perdomo, S; Anantharaman, D; Foll, M; Abedi-Ardekani, B; Durand, G; Rosa, LAR; Holmila, R; Le Calvez-Kelm, F; Tajara, EH; Wunsch, V; Levi, JE; Vilensky, M; Polesel, J; Holcatova, I; Simonato, L; Canova, C; Lagiou, P; McKay, JD; Brennan, P				Perdomo, Sandra; Anantharaman, Devasena; Foll, Matthieu; Abedi-Ardekani, Behnoush; Durand, Geoffroy; Rosa, Luciana Albina Reis; Holmila, Reetta; Le Calvez-Kelm, Florence; Tajara, Eloiza H.; Wunsch-Filho, Victor; Levi, Jose Eduardo; Vilensky, Marta; Polesel, Jerry; Holcatova, Ivana; Simonato, Lorenzo; Canova, Cristina; Lagiou, Pagona; McKay, James D.; Brennan, Paul			Genomic analysis of head and neck cancer cases from two high incidence regions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; GENETIC LANDSCAPE; TP53 MUTATIONS; NEGATIVE HEAD; ORAL-CANCER; SURVIVAL; HPV; PATHWAY; PREVALENCE	We investigated how somatic changes in HNSCC interact with environmental and host risk factors and whether they influence the risk of HNSCC occurrence and outcome. 180-paired samples diagnosed as HNSCC in two high incidence regions of Europe and South America underwent targeted sequencing (14 genes) and evaluation of copy number alterations (SCNAs). TP53, PIK3CA, NOTCH1, TP63 and CDKN2A were the most frequently mutated genes. Cases were characterized by a low copy number burden with recurrent focal amplification in 11q13.3 and deletion in 15q22. Cases with low SCNAs showed an improved overall survival. We found significant correlations with decreased overall survival between focal amplified regions 4p16, 10q22 and 22q11, and losses in 12p12, 15814 and 15q22. The mutational landscape in our cases showed an association to both environmental exposures and clinical characteristics. We confirmed that somatic copy number alterations are an important predictor of HNSCC overall survival.	[Perdomo, Sandra; Anantharaman, Devasena; Foll, Matthieu; Abedi-Ardekani, Behnoush; Durand, Geoffroy; Holmila, Reetta; Le Calvez-Kelm, Florence; McKay, James D.; Brennan, Paul] IARC, Lyon, France; [Perdomo, Sandra] Univ El Bosque, Inst Nutr Genet & Metab Res, Fac Med, Bogota, Colombia; [Rosa, Luciana Albina Reis; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop SP, Sao Paulo, Brazil; [Tajara, Eloiza H.] Sch Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil; [Wunsch-Filho, Victor] Univ Sao Paulo, Fac Saude PUbl, Sao Paulo, Brazil; [Vilensky, Marta] Inst Angel Roffo, Buenos Aires, DF, Argentina; [Polesel, Jerry] Aviano Natl Canc Inst, CRO, Aviano, Italy; [Holcatova, Ivana] Charles Univ Prague, Prague, Czech Republic; [Simonato, Lorenzo; Canova, Cristina] Lab Publ Hlth & Populat Studies, Padua, Italy; [Lagiou, Pagona] Univ Athens, Med Sch, Athens, Greece; [Anantharaman, Devasena] Raj Gandhi Ctr Biotechnol, Thycaud PO, Trivandrum, Kerala, India; [Holmila, Reetta] Wake Forest Sch Med, Mol Med Sect, Winston Salem, NC USA	World Health Organization; International Agency for Research on Cancer (IARC); Universidad El Bosque; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; IRCCS Aviano (CRO); Charles University Prague; National & Kapodistrian University of Athens; Wake Forest University	Brennan, P (corresponding author), IARC, Lyon, France.	gep@iarc.fr	Foll, Matthieu/A-8561-2014; Filho, Victor Wunsch/C-4475-2012; Abedi-Ardekani, Behnoush/O-7829-2016; Polesel, Jerry/AAA-5750-2019	Foll, Matthieu/0000-0001-9006-8436; Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Polesel, Jerry/0000-0001-9381-1520; Holmila, Reetta/0000-0002-2825-5676; CANOVA, CRISTINA/0000-0001-7027-7935; Perdomo, Sandra/0000-0001-7740-8141; Le Calvez-Kelm, Florence/0000-0003-0063-5068; SIMONATO, LORENZO/0000-0002-9914-1000; Rasul, holem/0000-0003-0579-9029	International Agency for Research on Cancer (IARC); FAPESP (Sao Paulo Research Foundation) [04/12054-9, 10/51168-0]; European Commission	International Agency for Research on Cancer (IARC)(World Health Organization); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been funded by the International Agency for Research on Cancer (IARC). The GENCAPO study was supported by grants from FAPESP (Sao Paulo Research Foundation) (04/12054-9 and 10/51168-0), which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken during the tenure of a Postdoctoral Fellowship to Dr Sandra Perdomo from The International Agency for Research on Cancer, partially supported by the European Commission FP7 Marie Curie Actions-People-Co-funding of regional, national and international programmes (COFUND).	Aeberhard WH, 2014, BIOMETRICS, V70, P920, DOI 10.1111/biom.12212; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608; Anantharaman D, 2013, JNCI-J NATL CANCER I, V105, P536, DOI 10.1093/jnci/djt053; Andor N., 2015, NAT MED; Benjamini Y., 1995, J ROYAL STAT SOC B, V57; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chatenoud L, 2014, ANN ONCOL, V25, P1843, DOI 10.1093/annonc/mdu206; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dai M, 2004, CANCER RES, V64, P468, DOI 10.1158/0008-5472.CAN-03-3284; Ervik M. FL, 2016, CANC TODAY LYON FRAN; Feenstra M, 1999, TISSUE ANTIGENS, V54, P235, DOI 10.1034/j.1399-0039.1999.540304.x; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C; Fernandez-Cuesta L, 2016, EBIOMEDICINE; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gatta G, 2015, EUR J CANC; Gross AM, 2014, NAT GENET, V46, P939, DOI 10.1038/ng.3051; Hayes DN, 2015, J CLIN ONCOL, V33, P3227, DOI 10.1200/JCO.2015.62.1086; Hedberg ML, 2016, J CLIN INVEST, V126, P169, DOI 10.1172/JCI82066; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; Imai FL, 2001, INT J MOL MED, V7, P43; Keck MK, 2015, CLIN CANCER RES, V21, P870, DOI 10.1158/1078-0432.CCR-14-2481; Kim KT, 2016, HEAD NECK-J SCI SPEC, V38, pE2021, DOI 10.1002/hed.24372; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Kreimer AR, 2013, J CLIN ONCOL, V31, P2708, DOI 10.1200/JCO.2012.47.2738; Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Le Calvez-Kelm F, 2016, ONCOTARGET, V7, P78827, DOI 10.18632/oncotarget.12386; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Lopez RVM, 2014, CANCER CAUSE CONTROL, V25, P461, DOI 10.1007/s10552-014-0348-8; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Morris LG, 2016, JAMA ONCOL; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Neskey DM, 2015, CANCER RES, V75, P1527, DOI 10.1158/0008-5472.CAN-14-2735; Oh JE, 2015, J NEUROPATH EXP NEUR, V74, P952, DOI 10.1097/NEN.0000000000000238; Pena-Alonso E, 2008, CANCER LETT, V263, P89, DOI 10.1016/j.canlet.2007.12.029; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Peters HL, 2011, IMMUNOL RES, V51, P39, DOI 10.1007/s12026-011-8238-6; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Reddy RB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147409; Reuschenbach M, 2008, INT J CANCER, V123, P2626, DOI 10.1002/ijc.23837; Rodrigo JP, 2011, HEAD NECK-J SCI SPEC, V33, P1708, DOI 10.1002/hed.21661; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Smeets SJ, 2009, CELL ONCOL, V31, P291, DOI 10.3233/CLO-2009-0471; Squarize C. H., 2013, J CARCINOG MUTAGE S5; Stoepker C, 2015, CANCER RES, V75, P3543, DOI 10.1158/0008-5472.CAN-15-0528; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sweeny L, 2012, LARYNGOSCOPE, V122, P1539, DOI 10.1002/lary.23266; Szymanska K, 2011, CANCER CAUSE CONTROL, V22, P1037, DOI 10.1007/s10552-011-9779-7; Taberna M, 2017, ANN ONCOL; Vairaktaris E, 2006, ANTICANCER RES, V26, P4217; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yanagi H, 2012, BIOCHEM BIOPH RES CO, V418, P104, DOI 10.1016/j.bbrc.2011.12.142; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhou G, 2016, J CELL BIOCHEM, V117, P2682, DOI 10.1002/jcb.25592	64	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191701	10.1371/journal.pone.0191701	http://dx.doi.org/10.1371/journal.pone.0191701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377909	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700027
J	Gu, LJ; Li, LB; Wei, HL; Wang, HT; Su, JJ; Guo, YN; Yu, SX				Gu, Lijiao; Li, Libei; Wei, Hengling; Wang, Hantao; Su, Junji; Guo, Yaning; Yu, Shuxun			Identification of the group IIa WRKY subfamily and the functional analysis of GhWRKY17 in upland cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTORS WRKY18; GENE FAMILY; LEAF SENESCENCE; UPSTREAM REGULATOR; GENOME SEQUENCE; RICE; EXPRESSION; PROTEIN; SUPERFAMILY; DEFENSE	WRKY transcription factors play important roles in plant defense, stress response, leaf senescence, and plant growth and development. Previous studies have revealed the important roles of the group IIa GhWRKY genes in cotton. To comprehensively analyze the group IIa GhWRKY genes in upland cotton, we identified 15 candidate group IIa GhWRKY genes in the Gossypium hirsutum genome. The phylogenetic tree, intron-exon structure, motif prediction and Ka/Ks analyses indicated that most group IIa GhWRKY genes shared high similarity and conservation and underwent purifying selection during evolution. In addition, we detected the expression patterns of several group IIa GhWRKY genes in individual tissues as well as during leaf senescence using public RNA sequencing data and real-time quantitative PCR. To better understand the functions of group IIa GhWRKYs in cotton, GhWRKY17 (KF669857) was isolated from upland cotton, and its sequence alignment, promoter cisacting elements and subcellular localization were characterized. Moreover, the over-expression of GhWRKY17 in Arabidopsis up-regulated the senescence-associated genes AtWRKY53, AtSAG12 and AtSAG13, enhancing the plant's susceptibility to leaf senescence. These findings lay the foundation for further analysis and study of the functions of WRKY genes in cotton.	[Gu, Lijiao; Li, Libei; Wei, Hengling; Wang, Hantao; Su, Junji; Guo, Yaning; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Guo, Yaning] Northwest A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Northwest A&F University - China	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	Ysx195311@163.com	Wang, Han/GPW-9809-2022	Li, Libei/0000-0003-1138-134X	National Key Research and Development Program of China [2016YFD0101006]	National Key Research and Development Program of China	The work was supported by the National Key Research and Development Program of China, grant no. 2016YFD0101006 (http://service.most.gov.cn) to SY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai CP, 2014, CROP J, V2, P87, DOI 10.1016/j.cj.2014.03.001; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chujo T, 2013, PLANT MOL BIOL, V82, P23, DOI 10.1007/s11103-013-0032-5; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Distelfeld A, 2014, J EXP BOT, V65, P3783, DOI 10.1093/jxb/ert477; Dou LL, 2014, MOL GENET GENOMICS, V289, P1103, DOI 10.1007/s00438-014-0872-y; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fan K, 2015, J EXP BOT, V66, P4669, DOI 10.1093/jxb/erv240; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Fischer AM, 2012, CRIT REV PLANT SCI, V31, P124, DOI 10.1080/07352689.2011.616065; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Kalet IJ, 1996, INT J RADIAT ONCOL, V36, P451, DOI 10.1016/S0360-3016(96)00322-7; Kapitonov D, 1999, GLYCOCONJUGATE J, V16, P337, DOI 10.1023/A:1007091926413; Karim A, 2015, TREE PHYSIOL, V35, P1129, DOI 10.1093/treephys/tpv084; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu JQ, 2016, PLANT PHYSIOL, V171, P1427, DOI 10.1104/pp.15.01921; Liu XC, 2011, NUCLEIC ACIDS RES, V39, pD1103, DOI 10.1093/nar/gkq1169; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Liu XF, 2016, PROTOPLASMA, V253, P1265, DOI 10.1007/s00709-015-0885-3; Liu Y, 2011, PLANT GROWTH REGUL, V63, P225, DOI 10.1007/s10725-010-9519-0; Liu ZQ, 2012, J EXP BOT, V63, P6371, DOI 10.1093/jxb/ers293; Ma L, 2016, PHYSIOL PLANTARUM, V158, P106, DOI 10.1111/ppl.12432; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narusaka M, 2010, PLANT BIOTECHNOL-NAR, V27, P349, DOI 10.5511/plantbiotechnology.27.349; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Petitot AS, 2013, PLANT CELL REP, V32, P1263, DOI 10.1007/s00299-013-1440-3; Potschin M, 2014, J PLANT GROWTH REGUL, V33, P106, DOI 10.1007/s00344-013-9380-2; Qin Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063033; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rehmeyer CJ, 2009, CURR GENET, V55, P253, DOI 10.1007/s00294-009-0240-3; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rychlik Wojciech, 2007, V402, P35; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Uzelac B, 2016, PROTOPLASMA, V253, P259, DOI 10.1007/s00709-015-0802-9; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111406; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00676; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yan L, 2013, J PLANT GROWTH REGUL, V32, P399, DOI 10.1007/s00344-012-9310-8; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yu SX, 2005, J INTEGR PLANT BIOL, V47, P334, DOI 10.1111/j.1744-7909.2005.00029.x; Zhang CQ, 2011, PLANTA, V234, P541, DOI 10.1007/s00425-011-1423-y; Zhang HS, 2016, BIOCHEM BIOPH RES CO, V474, P761, DOI 10.1016/j.bbrc.2016.05.034; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zou Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148243	73	40	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191681	10.1371/journal.pone.0191681	http://dx.doi.org/10.1371/journal.pone.0191681			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370286	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600079
J	Jiang, ZG; Winocur, G; Wojtowicz, JM; Shevtsova, O; Fuller, S; Ghanbari, HA				Jiang, Zhi-Gang; Winocur, Gordon; Wojtowicz, J. Martin; Shevtsova, Olga; Fuller, Steven; Ghanbari, Hossein A.			PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats	PLOS ONE			English	Article							3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP; RIBONUCLEOTIDE REDUCTASE INHIBITOR; OXIDATIVE STRESS; PHASE-I; ANTICANCER DRUGS; CANCER; SUPPRESSION; 5-FLUOROURACIL; CAPECITABINE; GEMCITABINE	Chemotherapy-induced cognitive impairment (CICI) occurs in a substantial proportion of treated cancer patients, with no drug currently available for its therapy. This study investigated whether PAN-811, a ribonucleotide reductase inhibitor, can reduce cognitive impairment and related suppression of neurogenesis following chemotherapy in an animal model. Young adult rats in Chemo and Chemo+PAN-811 groups received 3 intraperitoneal (i.p.) injections of methotrexate (MTX) and 5-fluorouracil (5-FU), and those in Saline and Saline+PAN-811 groups received equal volumes of physiological saline at 10-day intervals. PAN-811 in saline was delivered through i.p. injection, 10 min following each saline (Saline+PAN-811 group) or MTX/5-FU (Chemo+ PAN-811 group) treatment, while equal volumes of saline were delivered to Saline and Chemo groups. Over Days 31 +/- 66, rats were administered tests of spatial memory, nonmatching-to-sample rule learning, and discrimination learning, which are sensitive to dysfunction in hippocampus, frontal lobe and striatum, respectively. On Day 97, neurogenesis was immnunohistochemically evaluated by counting doublecortin-positive (DCX+) cells in the dentate gyrus (DG). The results demonstrated that the Chemo group was impaired on the three cognitive tasks, but co-administration of PAN-811 significantly reduced all MTX/5-FUinduced cognitive impairments. In addition, MTX/5-FU reduced DCX+ cells to 67% of that in Saline control rats, an effect that was completely blocked by PAN-811 co-administration. Overall, we present the first evidence that PAN-811 protects cognitive functions and preserves neurogenesis from deleterious effects of MTX/5-FU. The current findings provide a basis for rapid clinical translation to determine the effect of PAN-811 on CICI in human.	[Jiang, Zhi-Gang; Fuller, Steven; Ghanbari, Hossein A.] Panacea Pharmaceut Inc, Gaithersburg, MD 20877 USA; [Winocur, Gordon] Trent Univ, Dept Psychol, Peterborough, ON, Canada; [Winocur, Gordon] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Winocur, Gordon] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Winocur, Gordon] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Wojtowicz, J. Martin; Shevtsova, Olga] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Trent University; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto	Jiang, ZG (corresponding author), Panacea Pharmaceut Inc, Gaithersburg, MD 20877 USA.; Winocur, G (corresponding author), Trent Univ, Dept Psychol, Peterborough, ON, Canada.; Winocur, G (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.; Winocur, G (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Winocur, G (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	zgjiang@panaceapharma.com; gwinocur@research.baycrest.org						Acharya MM, 2015, CANCER RES, V75, P676, DOI 10.1158/0008-5472.CAN-14-2237; Ahles TA, 2003, PSYCHO-ONCOL, V12, P612, DOI 10.1002/pon.742; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Asher A, 2015, CLIN ADV HEMATOL ONC, V13; Baba Y, 2012, EXP THER MED, V4, P452, DOI 10.3892/etm.2012.602; Caron JE, 2009, PEDIATR BLOOD CANCER, V53, P551, DOI 10.1002/pbc.22128; Cheng HD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45135; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; CORY JG, 1994, BIOCHEM PHARMACOL, V48, P335, DOI 10.1016/0006-2952(94)90105-8; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; Feun L, 2002, CANCER CHEMOTH PHARM, V50, P223, DOI 10.1007/s00280-002-0480-0; Finch RA, 2000, BIOCHEM PHARMACOL, V59, P983, DOI 10.1016/S0006-2952(99)00419-0; Formica V, 2006, CANCER CHEMOTH PHARM, V58, P276, DOI 10.1007/s00280-005-0159-4; Gaman AM, 2016, AGING DIS, V7, P307, DOI 10.14336/AD.2015.1022; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Jiang ZG, 2006, P NATL ACAD SCI USA, V103, P1581, DOI 10.1073/pnas.0510573103; Jiang ZG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9392404; Lamberti M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-60; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; LIU MC, 1992, J MED CHEM, V35, P3672, DOI 10.1021/jm00098a012; Ma B, 2008, INVEST NEW DRUG, V26, P169, DOI 10.1007/s10637-007-9085-0; Mackenzie MJ, 2007, INVEST NEW DRUG, V25, P553, DOI 10.1007/s10637-007-9066-3; McDonald RM, 1999, DEBATES PSYCHOL, P66; Miketova Petra, 2005, Biol Res Nurs, V6, P187, DOI 10.1177/1099800404271916; Mizumatsu S, 2003, CANCER RES, V63, P4021; Moore IM, 2015, J PEDIAT HEMATOL ONC, V37, pE86, DOI 10.1097/MPH.0000000000000258; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murren J, 2003, CLIN CANCER RES, V9, P4092; Nelson VM, 2009, J ALZHEIMERS DIS, V17, P611, DOI 10.3233/JAD-2009-1078; Nokia MS, 2012, EUR J NEUROSCI, V36, P3521, DOI 10.1111/ejn.12007; Numazawa S, 2011, BASIC CLIN PHARMACOL, V108, P40, DOI 10.1111/j.1742-7843.2010.00621.x; Pan WY, 2009, CENT EUR J BIOL, V4, P34, DOI 10.2478/s11535-008-0062-1; Raffa RB, 2013, J CLIN PHARM THER, V38, P265, DOI 10.1111/jcpt.12071; Schagen SB, 1999, CANCER, V85, P640, DOI 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G; Vearncombe KJ, 2009, J INT NEUROPSYCH SOC, V15, P951, DOI 10.1017/S1355617709990567; Wadler S, 2004, J CLIN ONCOL, V22, P1553, DOI 10.1200/JCO.2004.07.158; WINOCUR G, 1992, NEUROPSYCHOLOGIA, V30, P769, DOI 10.1016/0028-3932(92)90081-V; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Winocur G, 2018, NEUROSCIENCE, V369, P51, DOI 10.1016/j.neuroscience.2017.10.048; Winocur G, 2016, BEHAV NEUROSCI, V130, P428, DOI 10.1037/bne0000155; Winocur G, 2015, BEHAV BRAIN RES, V281, P239, DOI 10.1016/j.bbr.2014.12.028; Winocur G, 2014, PSYCHOPHARMACOLOGY, V231, P2311, DOI 10.1007/s00213-013-3394-0; Winocur G, 2012, CLIN CANCER RES, V18, P3112, DOI 10.1158/1078-0432.CCR-12-0060; Winocur G, 2011, NEUROPHARMACOLOGY, V61, P1222, DOI 10.1016/j.neuropharm.2011.07.013; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Zhang JQ, 2015, DRUG METAB DISPOS, V43, P411, DOI 10.1124/dmd.114.061820	47	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191866	10.1371/journal.pone.0191866	http://dx.doi.org/10.1371/journal.pone.0191866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370277	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600108
J	Shinmura, K; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Hayashi, H; Inoue, K; Ota, T; Yokogawa, N; Ishii, T; Igarashi, T; Tsuchiya, H				Shinmura, Kazuya; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Inoue, Kei; Ota, Takashi; Yokogawa, Noriaki; Ishii, Takayoshi; Igarashi, Takashi; Tsuchiya, Hiroyuki			A histological examination of spinal reconstruction using a frozen bone autograft	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; EN-BLOC SPONDYLECTOMY; LIQUID-NITROGEN; TUMORS; CRYOABLATION; METASTASES; CARCINOMA; GRAFT	Our aim was to compare the process of bone formation after reconstruction of the vertebral body using a titanium cage with either a liquid nitrogen-treated (frozen) bone autograft or non-treated fresh bone autograft. Twelve canine beagles underwent anterior reconstruction of the 5 th lumbar vertebrae using a titanium cage and bone autograft. Bone formation was compared across four experimental groups: fresh bone autograft groups, with animals sacrificed at either 8 or 16 weeks post-reconstruction, and liquid nitrogen-treated (frozen) bone autograft groups, with animals again sacrificed at either 8 or 16 weeks post-reconstruction. Bone formation was evaluated histologically by calculating the proportion of ` reaction' and 'mature bone' regions at the ends of the cage, its center, and ventral/dorsal sides. The reaction region contained osteocytes with a nucleus and osteoblasts accumulated on the surface of an osteoid, while a laminar structure was visible for mature bone regions. For fresh bone autografts, the reaction and mature bone regions significantly increased from 8 to 16 weeks post-reconstruction. By comparison, for frozen autografts, the reaction bone region did not significantly increase from 8 to 16 weeks post-reconstruction, while the mature bone region did increase over this time period. The proportion of reaction bone was higher at the ends and dorsal side of the cage at 8 weeks, for both graft types, with greater bone formation at the center of the cage at 16 weeks only for the fresh bone autograft. Therefore, bone formation in the anterior spinal reconstruction site tended to be delayed when using a frozen bone autograft compared to a fresh bone autograft. The bone formation process, however, was similar for both groups, beginning at the ends and dorsal side of the cage adjacent to the surrounding vertebral bone.	[Shinmura, Kazuya; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Inoue, Kei; Ota, Takashi; Yokogawa, Noriaki; Ishii, Takayoshi; Igarashi, Takashi; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan	Kanazawa University	Murakami, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan.	hmuraka@med.kanazawa-u.ac.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	JSPS KAKENHI Grant [26861175]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant No. 26861175 to K.Y. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLIN RJ, 1971, CRYOBIOLOGY, V8, P271, DOI 10.1016/0011-2240(71)90050-2; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akamaru Tomoyuki, 2002, Spine (Phila Pa 1976), V27, pE329, DOI 10.1097/00007632-200207010-00024; Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004; Colman MW, 2015, SPINE J, V15, P1728, DOI 10.1016/j.spinee.2015.03.042; Elder BD, 2016, GLOB SPINE J, V6, P21, DOI 10.1055/s-0035-1555657; Garofalo F, 2015, J SURG ONCOL, V112, P544, DOI 10.1002/jso.24026; Garusi C, 2001, MICROSURG, V21, P131, DOI 10.1002/micr.1024; Greco C, 2015, REP PRACT ONCOL RADI, V20, P454, DOI 10.1016/j.rpor.2015.03.004; Hojo Y, 2005, BIOMATERIALS, V26, P2643, DOI 10.1016/j.biomaterials.2004.07.020; Joaquim AF, 2015, ARQ NEURO-PSIQUIAT, V73, P795, DOI 10.1590/0004-282X20150099; Kato S, 2016, J SURG ONCOL, V113, P587, DOI 10.1002/jso.24186; Murakami H, 2014, SPINE J, V14, P1567, DOI 10.1016/j.spinee.2013.09.030; Murakami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064818; Nakanishi K, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P949; Ohta H, 2005, J BONE MINER METAB, V23, P420, DOI 10.1007/s00774-005-0623-6; Osada S, 2007, J SURG ONCOL, V95, P491, DOI 10.1002/jso.20712; Rasband W., 2006, IMAGEJ; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz M, 2013, SPINE, V38, pE59, DOI 10.1097/BRS.0b013e31827ad2ff; Sherman BP, 2010, EUR SPINE J, V19, P2156, DOI 10.1007/s00586-010-1546-z; Shimozaki S, 2014, J ORTHOP SCI, V19, P156, DOI 10.1007/s00776-013-0487-x; Takata M, 2011, CRYOBIOLOGY, V63, P235, DOI 10.1016/j.cryobiol.2011.09.001; Tanzawa Y, 2009, J ORTHOP SCI, V14, P761, DOI 10.1007/s00776-009-1392-1; TOMITA K, 1994, INT ORTHOP, V18, P291; Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325; Yamamoto Norio, 2003, J Orthop Sci, V8, P374, DOI 10.1007/s10776-002-0626-3	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191679	10.1371/journal.pone.0191679	http://dx.doi.org/10.1371/journal.pone.0191679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370240	Green Submitted, Green Published, gold			2022-12-26	WOS:000423416600078
J	Apolloni, A; Nicolas, G; Coste, C; El Mamy, AB; Yahya, B; El Arbi, AS; Gueya, MB; Baba, D; Gilbert, M; Lancelot, R				Apolloni, Andrea; Nicolas, Gaelle; Coste, Caroline; El Mamy, Ahmed Bezeid; Yahya, Barry; El Arbi, Ahmed Salem; Gueya, Mohamed Baba; Baba, Doumbia; Gilbert, Marius; Lancelot, Renaud			Towards the description of livestock mobility in Sahelian Africa: Some results from a survey in Mauritania	PLOS ONE			English	Article							RIFT-VALLEY FEVER; NETWORK; MOVEMENTS; VIRUS; DYNAMICS; OUTBREAK; TRADE; AREA	Understanding spatio-temporal patterns of host mobility is a key factor to prevent and control animal and human diseases. This is utterly important in low-income countries, where animal disease epidemics have strong socio-economic impacts. In this article we analyzed a livestock mobility database, whose data have been collected by the Centre National d'Elevage et de Recherches Veterinaires (CNERV) Mauritania, to describe its patterns and temporal evolution. Data were collected through phone and face-to-face interviews in almost all the regions in Mauritania over a period of roughly two weeks during June 2015. The analysis has shown the existence of two mobility patterns throughout the year: the first related to routine movements from January to August; the second strictly connected to the religious festivity of Tabaski that in 2014 occurred at the beginning of October. These mobility patterns are different in terms of animals involved (fewer cattle and dromedaries are traded around Tabaski), the means of transportation (the volume of animals moved by truck raises around Tabaski) and destinations (most of the animals are traded nationally around Tabaski). Due to the differences between these two periods, public health officers, researchers and other stakeholders should take account of the time of the year when implementing vaccination campaigns or creating surveillance networks.	[Apolloni, Andrea; Coste, Caroline; Lancelot, Renaud] French Agr Res & Int Cooperat Org Dev Cirad, Dept Biol Syst Bios, UMR Anim Hlth Terr Risks & Ecosyst Astre, Campus Int Baillarguet, F-34398 Montpellier, France; [Apolloni, Andrea; Coste, Caroline; Lancelot, Renaud] French Natl Agr Res Ctr Int Dev, Anim Hlth Dept, UMR Astre, Campus Int Baillarguet, F-34398 Montpellier, France; [Apolloni, Andrea] Inst Senegalais Rech Agr, LNERV, Route Front Terre,BP 2057, Dakar, Senegal; [Nicolas, Gaelle] Univ Libre Bruxelles, Spatial Epidemiol Lab, B-1050 Brussels, Belgium; [El Mamy, Ahmed Bezeid; Yahya, Barry; Gueya, Mohamed Baba; Baba, Doumbia] Off Natl Rech & Dev Elevage ONARDEL, BP 167, Nouakchott, Mauritania; [El Arbi, Ahmed Salem] Minist Elevage, BP 167, Nouakchott, Mauritania; [Gilbert, Marius] Fonds Natl Rech Sci, B-1000 Brussels, Belgium	CIRAD; INRAE; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Apolloni, A (corresponding author), French Agr Res & Int Cooperat Org Dev Cirad, Dept Biol Syst Bios, UMR Anim Hlth Terr Risks & Ecosyst Astre, Campus Int Baillarguet, F-34398 Montpellier, France.; Apolloni, A (corresponding author), French Natl Agr Res Ctr Int Dev, Anim Hlth Dept, UMR Astre, Campus Int Baillarguet, F-34398 Montpellier, France.; Apolloni, A (corresponding author), Inst Senegalais Rech Agr, LNERV, Route Front Terre,BP 2057, Dakar, Senegal.	andrea.apolloni@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242	EU Grant [FP7-613996 VMERGE]	EU Grant(European Commission)	This work was funded by EU Grant FP7-613996 VMERGE https://www.vmerge.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, REV SCI TECH OIE, V10, P103; Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bank W, 2017, CLIM CHANG KNOWL POR; Beauguitte L, 2015, NETCOM, V29, P399; Beekhius G, 2006, MAURITANIE PROFIL MA; Berlingerio M, 2013, INTELL DATA ANAL, V17, P27, DOI 10.3233/IDA-120566; Bouslikhane M., 2015, CROSS BORDER MOVEMEN; Butts CT, 2008, J STAT SOFTW, V24, DOI [10.18637/jss.v024.i02, DOI 10.18637/JSS.V024.I02]; CATTAN N, 1995, INT POLIT SCI REV, V16, P237, DOI 10.1177/019251219501600304; Cervigni R, 2016, CONFRONTING DROUGHT, P186, DOI [DOI 10.1596/978-1-4648-0817-3, 10.1596/978-1-4648-0817-3]; Clement V., 1997, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V50, P235; Corniaux C, 2016, NEW EMERGING RURAL W, P60; Davies J, 2006, GLOBAL REV EC PASTOR; Dawson PM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0205; de Jode H., 2010, MODERN MOBILE FUTURE; Diarra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131021; Diaw A., 1999, PETITS RUMINANTS NOR; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; Dyer N, 2008, SECURING PASTORALISM; Edwards J., 2004, IMPORTANCE LIVESTOCK; El Arbi ASSM, 2012, CONTR ET EP PEST PET; El Mamy AB, 2014, VECTOR-BORNE ZOONOT, V14, P856, DOI 10.1089/vbz.2014.1605; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; El-Harrak M, 2011, EMERG INFECT DIS, V17, P2372, DOI 10.3201/eid1712.110587; Fall M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0624-1; Faugere O., 1990, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V43, P261; Giraud T, 2016, FLOWS FLOW SELECTION; Haan C., 2016, PROSPECTS LIVESTOCK; Hammarsten P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164016; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Kamuanga M.J., 2008, LIVESTOCK REGIONAL M; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; L'elevage B., 1994, REV ELEV MED VET PAY, V47, P223; Lancelot R, 2017, P NATL ACAD SCI USA, V114, P938, DOI 10.1073/pnas.1607948114; Lesnoff M, 1999, AGR SYST, V61, P207, DOI 10.1016/S0308-521X(99)00053-0; Maquart M, 2016, TRANSBOUND EMERG DIS, V63, pE281, DOI 10.1111/tbed.12267; Mendes JFF, 2002, EVOLUTION NETWORKS; Ndiaye M, 1998, REV ELEV MED VET PAY, V51, P135; Nicolas G, 2013, ACTA TROP, V126, P19, DOI 10.1016/j.actatropica.2012.12.013; Nystuen JD, 1961, PAPERS REGIONAL SCI, V7; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Pfeiffer CN, 2015, PREV VET MED, V122, P399, DOI 10.1016/j.prevetmed.2015.07.009; Pin-Diop Raphaelle, 2007, Vet Ital, V43, P675; POTRYKOWSKA A, 1993, INTRAURBAN MIGRATION; RCore Team, 2020, R LANG ENV STAT COMP; Sherman DM, 2011, REV SCI TECH OIE, V30, P207; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Soule AO, 2003, MAURITANIE; Talla C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114047; Toure I, 2012, SAHEL ATLAS EVOLUTIO; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Union A, 2010, POL FRAM PAST AFR; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Wane A, 2010, CAH AGRIC, V19, P14, DOI 10.1684/agr.2009.0329; World Organization for Animal Health, 2010, TERR AN HLTH COD	57	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191565	10.1371/journal.pone.0191565	http://dx.doi.org/10.1371/journal.pone.0191565			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364989	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500058
J	Mendall, M; Harpsoe, MC; Kumar, D; Andersson, M; Jess, T				Mendall, Michael; Harpsoe, Maria Christina; Kumar, Devinder; Andersson, Mikael; Jess, Tine			Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort	PLOS ONE			English	Article							CROHNS-DISEASE; OBESITY; WEIGHT	Background Crohn's disease (CD) has traditionally been associated with weight loss and low BMI, yet paradoxically obesity has recently been suggested as a risk factor for CD, but not for ulcerative colitis (UC). We therefore hypothesized that the relation between BMI and CD is U shaped. Aim To conduct a large population-based prospective cohort study of BMI and later risk of IBD, taking age at IBD diagnosis into account. Methods A cohort of 74,512 women from the Danish National Birth Cohort, with BMI measured pre-pregnancy and 18 months after delivery, was followed for 1,022,250 person-years for development of IBD, according to the Danish National Patient Register. Associations were tested by Cox regression. Results Overweight subjects (25 <= BMI<30 kg/m2) had the lowest risk of CD, whereas obesity (BMI >= 30kg/m2) increased the risk of CD at all ages, and low BMI (BMI<18.5kg/m2) associated with CD diagnosed at age 18-<40 years. Hence, using normal weight subjects as the reference, adjusted HRs for risk of developing CD (at age 18-<40 years) were 1.8(95% CI, 0.9-3.7) for underweight, 0.6(0.3-1.2) for overweight, and 1.5(0.8-2.7) for obese individuals (pre-pregnancy BMI). HRs were greater for BMI determined 18 months after delivery. Splines for CD risk according to waist: height ratio confirmed a U-shaped relationship with CD occurring < 40 years, and a linear relationship with CD diagnosed at age 40+. There was no relationship between BMI and risk of UC. Conclusion For the first time, we demonstrate that both high BMI and low BMI are risk factors for CD. Underweight may be a pre-clinical manifestation of disease being present many years before onset with obesity being a true risk factor. This raises the question as to whether there may be two distinct forms of CD.	[Mendall, Michael] Croydon Univ Hosp, Dept Gastroenterol, Thornton Heath, Surrey, Croydon, England; [Mendall, Michael; Kumar, Devinder] St Georges Med Sch, Cranmer Terrace, London, England; [Harpsoe, Maria Christina; Andersson, Mikael; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Harpsoe, Maria Christina] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Jess, Tine] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark	Croydon University Hospital; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Mendall, M (corresponding author), Croydon Univ Hosp, Dept Gastroenterol, Thornton Heath, Surrey, Croydon, England.; Mendall, M (corresponding author), St Georges Med Sch, Cranmer Terrace, London, England.	m.mendall@btinternet.com						Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2000, WHO TECHN REP SER; Canto E, 2007, WORLD J GASTROENTERO, V13, P5446, DOI 10.3748/wjg.v13.i41.5446; Choung RS, 2016, ALIMENT PHARM THER, V43, P1300, DOI 10.1111/apt.13641; Dong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144872; Elsherif Y, 2014, GASTROENT RES PRACT, V2014; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Harpsoe MC, 2014, INT J EPIDEMIOL, V43, P843, DOI 10.1093/ije/dyu045; Holt D. Q, 2017, ALIMENTARY PHARM THE; Hwang C, 2012, INFLAMM BOWEL DIS, V18, P1961, DOI 10.1002/ibd.22906; Joachim Gloria, 1999, Nutrition and Health (Bicester), V13, P69; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Li D, 2016, GASTROENTEROLOGY; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lochhead P, 2016, CLIN GASTROENTEROL H, V14, P818, DOI 10.1016/j.cgh.2016.01.016; Matthys P, 1997, NUTRITION, V13, P763, DOI 10.1016/S0899-9007(97)00185-8; Mendall MA, 2011, DIGEST DIS SCI, V56, P837, DOI 10.1007/s10620-010-1541-6; Moreno-Navarrete JM, 2012, PLOS ONE, V7; Nahon S, 2014, J CROHNS COLITIS, V8, P964, DOI 10.1016/j.crohns.2014.01.023; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Poullis A, 2004, CANCER EPIDEM BIOMAR, V13, P279, DOI 10.1158/1055-9965.EPI-03-0160; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Stelzner K, 2016, EUR J IMMUNOL, V46, P2043, DOI 10.1002/eji.201546263; Sturm A, 2016, J CROHNS COLITIS; TROY LM, 1995, INT J OBESITY, V19, P570; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yi JM, 2015, INTEST RES, V13, P112, DOI 10.5217/ir.2015.13.2.112	32	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190600	10.1371/journal.pone.0190600	http://dx.doi.org/10.1371/journal.pone.0190600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364914	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500020
J	Noyes, N; Cho, KC; Ravel, J; Forney, LJ; Abdo, Z				Noyes, Noelle; Cho, Kyu-Chul; Ravel, Jacques; Forney, Larry J.; Abdo, Zaid			Associations between sexual habits, menstrual hygiene practices, demographics and the vaginal microbiome as revealed by Bayesian network analysis	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BACTERIAL VAGINOSIS; RISK-FACTORS; MULTIVARIATE ANALYSES; NATIONAL-HEALTH; BREAST-CANCER; US GIRLS; WOMEN; FLORA; MENARCHE	The vaginal microbiome plays an influential role in several disease states in reproductive age women, including bacterial vaginosis (BV). While demographic characteristics are associated with differences in vaginal microbiome community structure, little is known about the influence of sexual and hygiene habits. Furthermore, associations between the vaginal microbiome and risk symptoms of bacterial vaginosis have not been fully elucidated. Using Bayesian network (BN) analysis of 16S rRNA gene sequence results, demographic and extensive questionnaire data, we describe both novel and previously documented associations between habits of women and their vaginal microbiome. The BN analysis approach shows promise in uncovering complex associations between disparate data types. Our findings based on this approach support published associations between specific microbiome members (e.g., Eggerthella, Gardnerella, Dialister, Sneathia and Ruminococcaceae), the Nugent score (a BV diagnostic) and vaginal pH (a risk symptom of BV). Additionally, we found that several microbiome members were directly connected to other risk symptoms of BV (such as vaginal discharge, odor, itch, irritation, and yeast infection) including L. jensenii, Corynebacteria, and Proteobacteria. No direct connections were found between the Nugent Score and risk symptoms of BV other than pH, indicating that the Nugent Score may not be the most useful criteria for assessment of clinical BV. We also found that demographics (i.e., age, ethnicity, previous pregnancy) were associated with the presence/absence of specific vaginal microbes. The resulting BN revealed several as-yet undocumented associations between birth control usage, menstrual hygiene practices and specific microbiome members. Many of these complex relationships were not identified using common analytical methods, i.e., ordination and PERMANOVA. While these associations require confirmatory follow-up study, our findings strongly suggest that future studies of the vaginal microbiome and vaginal pathologies should include detailed surveys of participants' sanitary, sexual and birth control habits, as these can act as confounders in the relationship between the microbiome and disease. Although the BN approach is powerful in revealing complex associations within multidimensional datasets, the need in some cases to discretize the data for use in BN analysis can result in loss of information. Future research is required to alleviate such limitations in constructing BN networks. Large sample sizes are also required in order to allow for the incorporation of a large number of variables (nodes) into the BN, particularly when studying associations between metadata and the microbiome. We believe that this approach is of great value, complementing other methods, to further our understanding of complex associations characteristic of microbiome research.	[Noyes, Noelle; Abdo, Zaid] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Cho, Kyu-Chul] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Forney, Larry J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Cho, Kyu-Chul] Naver Corp, Seongnam Si, Gyeonggi Do, South Korea	Colorado State University; Idaho; University of Idaho; University System of Maryland; University of Maryland Baltimore; Idaho; University of Idaho	Abdo, Z (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	zaid.abdo@colostate.edu	Ravel, Jacques/D-2530-2009		Colorado State University Vice President for Research; United States Department of Agriculture-National Institute of Food and Agriculture [2016-67012-24679]; National Institute of Allergies and Infectious Diseases, National Institutes of Health [U19 AI084044, U01 AI070921, UH2AI083264]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	Colorado State University Vice President for Research; United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Allergies and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was partially funded by startup funding to ZA from Colorado State University Vice President for Research, United States Department of Agriculture-National Institute of Food and Agriculture 2016-67012-24679 postdoctoral training grant to ZA and NN https://nifa.usda.gov/ and National Institute of Allergies and Infectious Diseases, National Institutes of Health https://www.niaid.nih.gov/ (grant number U19 AI084044 to RJ, U01 AI070921 to RJ and UH2AI083264 to RJ and LJF).	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Bastian M., 2009, ICWSM, DOI DOI 10.1136/QSHC.2004.010033; Bautista CT, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0074-5; Beigi RH, 2005, J INFECT DIS, V191, P924, DOI 10.1086/428288; Bernstein MN, 2016, BIORXIV; Bhadra A, 2016, ARXIV160400376STAT; Bharwani A, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0771-7; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; CAREY JC, 1991, AM J OBSTET GYNECOL, V164, P728; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coelho T, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00330, 10.3389/fmicb.2015.01528]; Cruz-Ramirez N, 2007, COMPUT BIOL MED, V37, P1553, DOI 10.1016/j.compbiomed.2007.02.003; Donders G, 2017, EUR J CLIN MICROBIOL, V36, P43, DOI 10.1007/s10096-016-2768-8; Donders GGG, 2000, AM J OBSTET GYNECOL, V182, P872, DOI 10.1016/S0002-9378(00)70338-3; Erol O, 2014, EUR J CONTRACEP REPR, V19, P187, DOI 10.3109/13625187.2014.900532; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Farage MA, 2013, REV RECENT CLIN TRIA, V8, P29, DOI 10.2174/1574887111308010005; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Fischer C, 2017, ELIFE, V6, DOI 10.7554/eLife.18855; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gamez JA, 2011, DATA MIN KNOWL DISC, V22, P106, DOI 10.1007/s10618-010-0178-6; Gelman A., 2007, DATA ANAL USING REGR; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gondo F, 2011, GYNECOL OBSTET INVES, V71, P158, DOI 10.1159/000316051; Haggerty CL, 2016, SEX TRANSM INFECT, V92, P441, DOI 10.1136/sextrans-2015-052285; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Hickey RJ, 2013, BJOG-INT J OBSTET GY, V120, P695, DOI 10.1111/1471-0528.12151; Hoffman MK, 2017, INFECT DIS OBSTET GY, V2017; Hojsgaard S, 2012, J STAT SOFTW, V46, P1; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; Jacobson JC, 2014, CONTRACEPTION, V90, P130, DOI 10.1016/j.contraception.2014.04.006; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Kline R.B., 2011, PRINCIPLES PRACTICE; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li XD, 2014, EUR J CLIN MICROBIOL, V33, P1525, DOI 10.1007/s10096-014-2103-1; Livengood Charles H, 2009, Rev Obstet Gynecol, V2, P28; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; MacKay AP, 2001, FAM PLANN PERSPECT, V33, P161, DOI 10.2307/2673719; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MCCORMACK WM, 1977, J INFECT DIS, V136, P740, DOI 10.1093/infdis/136.6.740; Monnat SM, 2014, J HEALTH CARE POOR U, V25, P332, DOI 10.1353/hpu.2014.0050; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Ness RB, 2003, J NATL MED ASSOC, V95, P201; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nunn Kenetta L., 2016, Yale Journal of Biology and Medicine, V89, P331; Nwankwo TO, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0558-9; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Petrova MI, 2017, TRENDS MICROBIOL, V25, P182, DOI 10.1016/j.tim.2016.11.007; Pires CVG, 2016, OBSTET GYNECOL, V127, P273, DOI 10.1097/AOG.0000000000001257; Powell AM, 2015, CLIN OBSTET GYNECOL, V58, P453, DOI 10.1097/GRF.0000000000000124; Pybus V, 1999, MICROBES INFECT, V1, P285, DOI 10.1016/S1286-4579(99)80024-0; R Core Team, 2016, R LANG ENV STAT COMP; Ramoni RB, 2009, STROKE, V40, pS67, DOI 10.1161/STROKEAHA.108.533273; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roehrig S. F., 1993, Proceeding of the Twenty-Sixth Hawaii International Conference on System Sciences (Cat. No.93TH0501-7), P523, DOI 10.1109/HICSS.1993.284352; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Romo LF, 2012, J PEDIATR ADOL GYNEC, V25, P328, DOI 10.1016/j.jpag.2012.06.001; Sauer AG, 2015, CANCER EPIDEMIOL, V39, P650, DOI 10.1016/j.canep.2015.05.002; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Shankar J, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Steck H., 2008, P 24 C UNC ART INT U, P511; Sweeney EL, 2016, J INFECT DIS, V213, P1340, DOI 10.1093/infdis/jiv587; Tibaldi C, 2016, INT J GYNECOL OBSTET, V133, P89, DOI 10.1016/j.ijgo.2015.07.035; Tierney L, 2016, SIMPLE NETWORK WORKS; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wang B, 2014, EUR J CLIN MICROBIOL, V33, P1749, DOI 10.1007/s10096-014-2128-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; Xia YL, 2017, GENES DIS, V4, P138, DOI 10.1016/j.gendis.2017.06.001; Yang NJ, 2017, J MOL BIOL, V429, P587, DOI 10.1016/j.jmb.2016.12.023; Zhou Xia, 2010, Infect Dis Obstet Gynecol, V2010, P737425, DOI 10.1155/2010/737425; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zinaman MJ, 2006, PAEDIATR PERINAT EP, V20, P26, DOI 10.1111/j.1365-3016.2006.00767.x	90	60	61	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191625	10.1371/journal.pone.0191625	http://dx.doi.org/10.1371/journal.pone.0191625			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364944	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500062
J	Bonnet-Serrano, F; Diedisheim, M; Mallone, R; Larger, E				Bonnet-Serrano, Fideline; Diedisheim, Marc; Mallone, Roberto; Larger, Etienne			Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository	PLOS ONE			English	Article							GLUCAGON-RESPONSE; EUROPEAN SUBJECTS; ORGAN DONORS; INSULIN; HYPOGLYCEMIA; OBESITY; HUMANS; HEMIPANCREATECTOMY; HYPERGLYCEMIA; INFILTRATION	Background and aims Abnormal glucagon secretion and functional alterations of the exocrine pancreas have been described in patients with type 1 diabetes (T1D), but their respective anatomical substrata have seldom been investigated. Our aim was to develop an automated morphometric analysis process to characterize the anatomy of alpha-cell and exocrine pancreas in patients with T1D, using the publicly available slides of the Network for Pancreatic Organ Donors (nPOD). Materials and methods The ratio of beta- and alpha-cell area to total tissue area were quantified in 75 patients with T1D (thereafter patients) and 66 control subjects (thereafter controls), on 2 insulin-stained and 4 glucagon-stained slides from both the head and the tail of the pancreas. The beta- and alpha-cell masses were calculated in the 66 patients and the 50 controls for which the pancreas weight was available. Non-exocrine-non-endocrine tissue area (i.e. non-acinar, non-insular tissue) to total tissue area ratio was evaluated on both insulin-and glucagon-stained slides. Results were expressed as mean +/- SD. Results An automated quantification method was set up using the R software and was validated by quantification of beta-cell mass, a well characterized parameter. beta-cell mass was 29.6 +/- 112 mg in patients and 628 +/- 717 mg in controls (p<0.0001). alpha-cell mass was 181 +/- 176 mg in patients and 349 +/- 241mg in controls (p<0.0001). Non-exocrine-non-endocrine area to total tissue area ratio was 39 +/- 9% in patients and 29 +/- 10% in controls (p<0.0001) and increased with age in both groups, with no correlation with diabetes duration in patients. Conclusion The absolute alpha-cell mass was lower in patients compared to controls, in proportion to the decrease in pancreas weight observed in patients. Non-exocrine-non-endocrine area to total tissue area ratio increased with age in both groups but was higher in patients at all ages.	[Bonnet-Serrano, Fideline] DHU AUTHORS, Hop Cochin, AP HP, UF Hormonol, Paris, France; [Bonnet-Serrano, Fideline; Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] DHU AUTHORS, Hop Cochin, AP HP, Serv Diabetol, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] INSERM, U1016, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] Cochin Inst, CNRS, UMR8104, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Larger, E (corresponding author), DHU AUTHORS, Hop Cochin, AP HP, Serv Diabetol, Paris, France.; Larger, E (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Larger, E (corresponding author), INSERM, U1016, Paris, France.; Larger, E (corresponding author), Cochin Inst, CNRS, UMR8104, Paris, France.	etienne.larger@aphp.fr	Mallone, Roberto/H-4430-2013; Diedisheim, Marc/ABC-6996-2020	Mallone, Roberto/0000-0002-9846-8861; 	JDRF	JDRF(Juvenile Diabetes Research Foundation)	This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project sponsored by JDRF. Organ Procurement Organizations partnering with nPOD to provide research resources are listed at www.jdrfnpod.org/for-partners/npod-partners.	Altobelli E, 1998, J CLIN ULTRASOUND, V26, P391, DOI 10.1002/(SICI)1097-0096(199810)26:8<391::AID-JCU3>3.0.CO;2-D; Banarer S, 2002, DIABETES, V51, P958, DOI 10.2337/diabetes.51.4.958; Brown RJ, 2008, DIABETES CARE, V31, P1403, DOI 10.2337/dc08-0575; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Campbell-Thompson ML, 2016, DIABETOLOGIA, V59, P217, DOI 10.1007/s00125-015-3752-z; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Diedisheim M, 2016, J CLIN ENDOCR METAB, V101, P1390, DOI 10.1210/jc.2015-3756; Faerch K, 2016, DIABETES, V65, P3473, DOI 10.2337/db16-0240; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; Fredheim S, 2015, DIABETOLOGIA, V58, P828, DOI 10.1007/s00125-014-3486-3; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Inaishi J, 2016, J CLIN ENDOCR METAB, V101, P2874, DOI 10.1210/jc.2016-1374; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; Kramer CK, 2014, DIABETES CARE, V37, P1076, DOI 10.2337/dc13-2339; Kumar AF, 2008, DIABETES CARE, V31, P1639, DOI 10.2337/dc07-2453; Lam NN, 2017, TRANSPLANTATION, V101, P588, DOI 10.1097/TP.0000000000001155; Larger E, 2012, DIABETIC MED, V29, P1047, DOI 10.1111/j.1464-5491.2012.03597.x; Lund A, 2016, DIABETES, V65, P585, DOI 10.2337/db15-1541; ORCI L, 1976, P NATL ACAD SCI USA, V73, P1338, DOI 10.1073/pnas.73.4.1338; Philippe MF, 2011, PANCREAS, V40, P359, DOI 10.1097/MPA.0b013e3182072032; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RAVAZZOLA M, 1981, DIABETES, V30, P879, DOI 10.2337/diabetes.30.10.879; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Skog O, 2017, DIABETES OBES METAB, P1; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Waguri M, 1997, ENDOCR J, V44, P23, DOI 10.1507/endocrj.44.23	34	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191528	10.1371/journal.pone.0191528	http://dx.doi.org/10.1371/journal.pone.0191528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352311	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300107
J	Grebenko, A; Dremov, V; Barzilovich, P; Bubis, A; Sidoruk, K; Voeikova, T; Gagkaeva, Z; Chernov, T; Korostylev, E; Gorshunov, B; Motovilov, K				Grebenko, Artem; Dremov, Vyacheslav; Barzilovich, Petr; Bubis, Anton; Sidoruk, Konstantin; Voeikova, Tatiyana; Gagkaeva, Zarina; Chernov, Timur; Korostylev, Evgeny; Gorshunov, Boris; Motovilov, Konstantin			Impedance spectroscopy of single bacterial nanofilament reveals water-mediated charge transfer	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; EXTRACELLULAR ELECTRON-TRANSPORT; GEOBACTER-SULFURREDUCENS; PEPTIDE FIBRILS; OUTER-MEMBRANE; NANOWIRES; CONDUCTION; PROTEIN; CYTOCHROME; BIOFILMS	For decades respiratory chain and photosystems were the main firing field of the studies devoted to mechanisms of electron transfer in proteins. The concept of conjugated lateral electron and transverse proton transport during cellular respiration and photosynthesis, which was formulated in the beginning of 1960-s, has been confirmed by thousands of experiments. However, charge transfer in recently discovered bacterial nanofilaments produced by various electrogenic bacteria is regarded currently outside of electron and proton conjugation concept. Here we report the new study of charge transfer within nanofilaments produced by Shewanella oneidensis MR-1 conducted in atmosphere of different relative humidity (RH). We utilize impedance spectroscopy and DC (direct current) transport measurements to find out the peculiarities of conductivity and Raman spectroscopy to analyze the nanofilaments' composition. Data analysis demonstrates that apparent conductivity of nanofilaments has crucial sensitivity to humidity and contains several components including one with unusual behavior which we assign to electron transport. We demonstrate that in the case of Shewanella oneidensis MR-1 charge transfer within these objects is strongly mediated by water. Basing on current data analysis of conductivity we conclude that the studied filaments of Shewanella oneidensis MR-1 are capable of hybrid (conjugated) electron and ion conductivity.	[Grebenko, Artem; Dremov, Vyacheslav; Barzilovich, Petr; Bubis, Anton; Gagkaeva, Zarina; Chernov, Timur; Korostylev, Evgeny; Gorshunov, Boris; Motovilov, Konstantin] Moscow Inst Phys & Technol, Inst lane 9, Dolgoprudnyi, Russia; [Grebenko, Artem; Dremov, Vyacheslav; Bubis, Anton] RAS, Inst Solid State Phys, Acad Osipyana St 2, Chernogolovka, Russia; [Barzilovich, Petr; Chernov, Timur] RAS, Inst Problems Chem Phys, Acad Semenov Ave 1, Chernogolovka, Russia; [Sidoruk, Konstantin; Voeikova, Tatiyana] Inst Genet & Select Ind Microorganisms, Sci Ctr Russian Federat Res, 1st Dorozhniy Pr 1, Moscow, Russia	Moscow Institute of Physics & Technology; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; Russian Academy of Sciences; Institute of Problems of Chemical Physics of the Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Grebenko, A (corresponding author), Moscow Inst Phys & Technol, Inst lane 9, Dolgoprudnyi, Russia.; Grebenko, A (corresponding author), RAS, Inst Solid State Phys, Acad Osipyana St 2, Chernogolovka, Russia.	grebenko@phystech.edu; k.a.motovilov@gmail.com	Voeikova, Tatyana/AAX-5925-2021; Gorshunov, Boris P./J-3928-2013; Gagkayeva, Zarina/F-5297-2018; Motovilov, Konstantin/AAP-1218-2021; Motovilov, Konstantin A/I-8083-2015; Сидорук, Константин/CAH-4222-2022; Grebenko, Artem/I-7377-2015	Voeikova, Tatyana/0000-0001-8864-9266; Gorshunov, Boris P./0000-0001-8882-3930; Gagkayeva, Zarina/0000-0002-6973-4884; Motovilov, Konstantin A/0000-0001-7460-7524; Сидорук, Константин/0000-0001-8952-5409; Grebenko, Artem/0000-0003-3193-4386; Chernov, Timur/0000-0002-7784-7045	OPTEC; Russian Ministry of Education and Science (Program 5 top 100) [N3.9896.2017/BY, 14Y.26.31.0007]; RFBR [16-34-00812, 15-02-04285, 15-52-78023, 16-32-00805, 13-02-12127]; Ministry of Education and Science of the Russian Federation [RFMEFI59417X0014]; Ministry of Education and Science of the Russian Federation	OPTEC; Russian Ministry of Education and Science (Program 5 top 100); RFBR(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work is funded by OPTEC grant for young scientists, Russian Ministry of Education and Science (Program 5 top 100), grant N3.9896.2017/BY and grant No.14Y.26.31.0007, RFBR Grants Nr. 16-34-00812, 15-02-04285, 15-52-78023, 16-32-00805 and 13-02-12127. This work was performed using equipment of MIPT Shared Facilities Center and with financial support from the Ministry of Education and Science of the Russian Federation (Grant No. RFMEFI59417X0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed using equipment of MIPT Shared Facilities Center and with financial support from the Ministry of Education and Science of the Russian Federation. We want to thank Aleksander Van'kov for SERS measurements, Evgeniy Ukshe for impedance interpretation and help with equivalent scheme calculations, Yulia Komarova for Focused Ion Beam FEI Versa 3D operation, Danila Matveev for Carl Zeiss Supra 50 VP electron microscope operation and Ivan Ohrimenko for the assistance with the procedure of extraction and purification of nanofilaments. We also want to thank Galina Tsirlina for fruitful discussions.	Adhikari RY, 2016, RSC ADV, V6, P8363, DOI 10.1039/c5ra28092c; Alvarez-Paggi D, 2014, BBA-BIOENERGETICS, V1837, P1196, DOI 10.1016/j.bbabio.2014.01.019; Amit M, 2014, ADV FUNCT MATER, V24, P5873, DOI 10.1002/adfm.201401111; Amit M, 2014, ISR J CHEM, V54, P703, DOI 10.1002/ijch.201400025; Ashkenasy N, 2006, SMALL, V2, P99, DOI 10.1002/smll.200500252; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, P1, DOI 10.1002/0471716243; Breuer M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1117; Brunel D, 2011, MICROELECTRON ENG, V88, P1569, DOI 10.1016/j.mee.2011.03.011; Canet-Ferrer J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/39/395703; EATON P, 2010, PROGR SURFACE SCI, V41, P3; Edwards PP, 2008, ANGEW CHEM INT EDIT, V47, P6758, DOI 10.1002/anie.200703177; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Firer-Sherwood MA, 2011, J PHYS CHEM B, V115, P11208, DOI 10.1021/jp203603r; Gates BD, 2004, ANNU REV MATER RES, V34, P339, DOI 10.1146/annurev.matsci.34.052803.091100; Gorby Y, 2006, P NATL ACAD SCI USA, V106, P9535; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Ing NL, 2017, PHYS CHEM CHEM PHYS, V19, P21791, DOI 10.1039/c7cp03651e; Ivnitski D, 2016, ANGEW CHEM INT EDIT, V55, P9988, DOI 10.1002/anie.201604833; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Lampa-Pastirk S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23517; Lebedev N, 2015, J POLYM SCI POL PHYS, V53, P1706, DOI 10.1002/polb.23809; Leung KM, 2013, NANO LETT, V13, P2407, DOI 10.1021/nl400237p; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Long Y, 2010, REV ELECT TRANSPORT; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Malvankar NS, 2015, STRUCTURAL BASIS MET, V6, P1; Malvankar NS, 2014, NAT NANOTECHNOL, P1; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Morishita A, 2016, J ELECTROCHEM SOC, V163, pG166, DOI 10.1149/2.1251610jes; Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109; Motovilov KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15693-y; Phan H, 2016, PHYS CHEM CHEM PHYS, V18, P17815, DOI 10.1039/c6cp03583c; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Polizzi NF, 2012, FARADAY DISCUSS, V155, P43, DOI 10.1039/c1fd00098e; Powell M.R., 1970, BIOENERGETICS, V1, P493, DOI [DOI 10.1007/BF01517187, 10.1007/BF01517187]; Preciado-Flores S, 2011, CHEM COMMUN, V47, P4129, DOI 10.1039/c0cc05517d; Ravindranath SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016634; Reardon PN, 2013, J BIOL CHEM, V288, P29260, DOI 10.1074/jbc.M113.498527; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Rienecker SB, 2015, J PHYS CHEM B, V119, P14994, DOI 10.1021/acs.jpcb.5b08970; ROSENBERG B, 1969, ANN NY ACAD SCI, V158, P161, DOI 10.1111/j.1749-6632.1969.tb56221.x; Shah A, 2015, CHEM SOC REV, V44, P1015, DOI 10.1039/c4cs00297k; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; SPIRO TG, 1976, J AM CHEM SOC, V98, P5482, DOI 10.1021/ja00434a013; Stepanova M, 2011, NANOFABRICATION TECH; Subramanian P, 2017, BIORXIV; Uchiyama T, 2006, VIB SPECTROSC, V42, P192, DOI 10.1016/j.vibspec.2006.02.008; Ukshe E, 1975, RUSS CHEM REV, VXLIV, P1979; Wang YM, 2013, LANGMUIR, V29, P950, DOI 10.1021/la303779y; Yardeni JL, 2016, NANOSCALE, V8, P2358, DOI 10.1039/c5nr06750b; Yates MD, 2016, ENERG ENVIRON SCI, V9, P3544, DOI 10.1039/c6ee02106a; Yates MD, 2015, PHYS CHEM CHEM PHYS, V17, P32564, DOI 10.1039/c5cp05152e; Yoho RA, 2014, CHEMSUSCHEM, V7, P3413, DOI 10.1002/cssc.201402589	57	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191289	10.1371/journal.pone.0191289	http://dx.doi.org/10.1371/journal.pone.0191289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351332	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300067
J	Kumar, P; van Son, M; Zheng, TT; Valdink, D; Raap, J; Kros, A; Huber, M				Kumar, Pravin; van Son, Martin; Zheng, Tingting; Valdink, Dayenne; Raap, Jan; Kros, Alexander; Huber, Martina			Coiled-coil formation of the membrane-fusion K/E peptides viewed by electron paramagnetic resonance	PLOS ONE			English	Article							COMPREHENSIVE SOFTWARE PACKAGE; DISTANCE MEASUREMENTS; EPR SPECTROSCOPY; DRUG-DELIVERY; PROTEIN; MODEL; BIOMACROMOLECULES; PEPTAIBOLS; MACHINERY; LIPOSOMES	The interaction of the complementary K (Ac-(KIAALKE)(3)-GW-NH2) and E (Ac-(EIAALEK)(3)-GY-NH2) peptides, components of the zipper of an artificial membrane fusion system (Robson Marsden H. et al. Angew Chemie Int Ed. 2009) is investigated by electron paramagnetic resonance (EPR). By frozen solution continuous-wave EPR and double electron-electron resonance (DEER), the distance between spin labels attached to the K-and to the E-peptide is measured. Three constructs of spin-labelled K-and E-peptides are used in five combinations for low temperature investigations. The K/E heterodimers are found to be parallel, in agreement with previous studies. Also, K homodimers in parallel orientation were observed, a finding that was not reported before. Comparison to room-temperature, solution EPR shows that the latter method is less specific to detect this peptide-peptide interaction. Combining frozen solution cw-EPR for short distances (1.8 nm to 2.0 nm) and DEER for longer distances thus proves versatile to detect the zipper interaction in membrane fusion. As the methodology can be applied to membrane samples, the approach presented suggests itself for in-situ studies of the complete membrane fusion process, opening up new avenues for the study of membrane fusion.	[Kumar, Pravin; van Son, Martin; Huber, Martina] Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Zheng, Tingting; Valdink, Dayenne; Raap, Jan; Kros, Alexander] Leiden Univ, Leiden Inst Chem, Dept Supramol & Biomat Chem, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Huber, M (corresponding author), Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	huber@physics.leidenuniv.nl		kros, alexander/0000-0002-3983-3048; Kumar, Pravin/0000-0002-7966-578X	Foundation for Fundamental Research on Matter; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [10SMPA04]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant [700.58.014]	Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant	This work was supported by the Foundation for Fundamental Research on Matter, which is part of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), grant 10SMPA04 (https://www.nwo.nl/) to PK and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant 700.58.014 (https://www.nwo.nl/) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagneris C, 2015, J BIOL CHEM, V290, P16539, DOI 10.1074/jbc.M114.622928; Bagneris C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3465; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Gahloth D, 2016, STRUCTURE, V24, P2115, DOI 10.1016/j.str.2016.10.006; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Huber M, 2013, R SOC CHEM, P115; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jeschke G, 2002, MACROMOL RAPID COMM, V23, P227, DOI 10.1002/1521-3927(20020301)23:4<227::AID-MARC227>3.0.CO;2-D; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Marsden HR, 2008, J AM CHEM SOC, V130, P9386, DOI 10.1021/ja800254w; Marsden HR, 2009, ANGEW CHEM INT EDIT, V48, P2330, DOI 10.1002/anie.200804493; Milov AD, 2007, CHEM BIODIVERS, V4, P1243, DOI 10.1002/cbdv.200790107; Milov AD, 2016, BIOPOLYMERS, V106, P6, DOI 10.1002/bip.22713; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Rabe M, 2016, BIOPHYS J, V111, P2162, DOI 10.1016/j.bpj.2016.10.010; Rabe M, 2015, BIOPOLYMERS, V104, P65, DOI 10.1002/bip.22598; Rabe M, 2014, LANGMUIR, V30, P7724, DOI 10.1021/la500987c; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V22, P105, DOI 10.1007/BF00196915; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Shi L, 2013, NAT PROTOC, V8, P935, DOI 10.1038/nprot.2013.048; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SUDHOF TC, 1993, CELL, V75, P1; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Versluis F, 2013, J AM CHEM SOC, V135, P8057, DOI 10.1021/ja4031227; Ward R, 2014, BIOPHYS J, V106, P834, DOI [10.1016/j.bpj.2014.01.008, 10.1016/j.bpj.20t4.01.008]; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang J, 2016, ACS CENTRAL SCI, V2, P621, DOI 10.1021/acscentsci.6b00172; Yang J, 2016, ACS NANO, V10, P7428, DOI 10.1021/acsnano.6b01410; Zheng T., 2014, THESIS; Zheng TT, 2015, ORG BIOMOL CHEM, V13, P1159, DOI 10.1039/c4ob02125h	42	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191197	10.1371/journal.pone.0191197	http://dx.doi.org/10.1371/journal.pone.0191197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351320	gold, Green Published			2022-12-26	WOS:000422911300056
J	Merentie, M; Rissanen, R; Lottonen-Raikaslehto, L; Huusko, J; Gurzeler, E; Turunen, MP; Holappa, L; Makinen, P; Yla-Herttuala, S				Merentie, Mari; Rissanen, Riina; Lottonen-Raikaslehto, Line; Huusko, Jenni; Gurzeler, Erika; Turunen, Mikko P.; Holappa, Lari; Makinen, Petri; Yla-Herttuala, Seppo			Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice	PLOS ONE			English	Article							GROWTH FACTOR-D; MYOCARDIAL-INFARCTION; RNA INTERFERENCE; TIPTOP TRIAL; GENE-THERAPY; IN-VIVO; ANGIOGENESIS; INHIBITION; SYSTEM; NEOVASCULARIZATION	Vascular endothelial growth factor-A (VEGF-A) is the master regulator of angiogenesis, vascular permeability and growth. However, its role in mature blood vessels is still not well understood. To better understand the role of VEGF-A in the adult vasculature, we generated a VEGF-A knockdown mouse model carrying a doxycycline (dox)-regulatable short hairpin RNA (shRNA) transgene, which silences VEGF-A. The aim was to find the critical level of VEGF-A reduction for vascular well-being in vivo. In vitro, the dox-inducible lentiviral shRNA vector decreased VEGF-A expression efficiently and dose-dependently in mouse endothelial cells and cardiomyocytes. In the generated transgenic mice plasma VEGF-A levels decreased shortly after the dox treatment but returned back to normal after two weeks. VEGF-A expression decreased shortly after the dox treatment only in some tissues. Surprisingly, increasing the dox exposure time and dose led to elevated VEGF-A expression in some tissues of both wildtype and knockdown mice, suggesting that dox itself has an effect on VEGF-A expression. When the effect of dox on VEGF-A levels was further tested in naive/ non-transduced cells, the dox administration led to a decreased VEGF-A expression in endothelial cells but to an increased expression in cardiomyocytes. In conclusion, the VEGF-A knockdown was achieved in a dox-regulatable fashion with a VEGF-A shRNA vector in vitro, but not in the knockdown mouse model in vivo. Dox itself was found to regulate VEGF-A expression explaining the unexpected results in mice. The effect of dox on VEGF-A levels might at least partly explain its previously reported beneficial effects on myocardial and brain ischemia. Also, this effect on VEGF-A should be taken into account in all studies using dox-regulated vectors.	[Merentie, Mari; Rissanen, Riina; Lottonen-Raikaslehto, Line; Huusko, Jenni; Gurzeler, Erika; Turunen, Mikko P.; Holappa, Lari; Makinen, Petri; Yla-Herttuala, Seppo] Univ Eastern Finland, Fac Hlth Sci, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Eastern Finland, Fac Hlth Sci, AI Virtanen Inst Mol Sci, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland.	seppo.ylaherttuala@uef.fi		Gurzeler, Erika/0000-0002-9772-6654	Finnish Academy of Excellence; ERC; EATRIS infrastructure National Virus Vector Laboratory for lentivirus production; Finnish Cultural Foundation; Aarne Koskelo Foundation; University of Kuopio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; Ida Montin Foundation; Paavo Nurmi Foudation; North Savo Regional Fund	Finnish Academy of Excellence; ERC(European Research Council (ERC)European Commission); EATRIS infrastructure National Virus Vector Laboratory for lentivirus production; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Aarne Koskelo Foundation; University of Kuopio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; Ida Montin Foundation; Paavo Nurmi Foudation; North Savo Regional Fund	This study was supported by Finnish Academy of Excellence, ERC and EATRIS infrastructure National Virus Vector Laboratory for lentivirus production, Finnish Cultural Foundation, Aarne Koskelo Foundation, University of Kuopio Foundation, Finnish Foundation for Cardiovascular Research, Finnish Medical Foundation, Ida Montin Foundation, Paavo Nurmi Foudation, and the North Savo Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cerisano G, 2015, INT J CARDIOL, V197, P147, DOI 10.1016/j.ijcard.2015.06.024; Cerisano G, 2014, EUR HEART J, V35, P184, DOI 10.1093/eurheartj/eht420; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Dijkstra MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06238; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Filleur S, 2003, CANCER RES, V63, P3919; Frka K, 2009, J BIOTECHNOL, V141, P8, DOI 10.1016/j.jbiotec.2009.02.013; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huusko J, 2007, GENERATION OF TRANSG, P91; Karkkainen AM, 2009, BLOOD, V113, P4468, DOI 10.1182/blood-2008-07-171108; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kim B, 2004, AM J PATHOL, V165, P2177, DOI 10.1016/S0002-9440(10)63267-1; Koistinaho M, 2005, J CEREBR BLOOD F MET, V25, P460, DOI 10.1038/sj.jcbfm.9600040; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; Kotimaa AA, 2012, J GENE MED, V14, P182, DOI 10.1002/jgm.2608; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nanda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151539; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ratner M, 2004, NAT BIOTECHNOL, V22, P1198, DOI 10.1038/nbt1004-1198; Reich S, 2003, MOL VIS, V9, P210; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh N, 2007, CORNEA, V26, P65; Smith GA, 2015, J INHERIT METAB DIS; Stechmiller J, 2010, BIOL RES NURS, V11, P336, DOI 10.1177/1099800409346333; Turunen MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089979; Villarreal FJ, 2003, CIRCULATION, V108, P1487, DOI 10.1161/01.CIR.0000089090.05757.34; Wideroe M, 2012, EUR J NEUROSCI, V36, P2006, DOI 10.1111/j.1460-9568.2012.08114.x; Yla-Herttuala S, 2017, EUR HEART J, V38, P1365, DOI 10.1093/eurheartj/ehw547; Yla-Herttuala S, 2017, MOL THER, V25, P1095, DOI 10.1016/j.ymthe.2017.03.027; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023	43	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190981	10.1371/journal.pone.0190981	http://dx.doi.org/10.1371/journal.pone.0190981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351307	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300034
J	Monico, J; Miller, B; Rezeanu, L; May, W; Sullivan, DC				Monico, Jesus; Miller, Brandon; Rezeanu, Luminita; May, Warren; Sullivan, Donna C.			Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma	PLOS ONE			English	Article							FGFR1 AMPLIFICATION; GENE AMPLIFICATION; EXPRESSION; BREAST; HEAD; QUANTITATION; SENSITIVITY; SMOKING; CANCER	Fibroblast growth factor receptor 1 (FGFR1) has been noted to be amplified in a variety of squamous cell carcinomas (SCCa) of the head, neck, and lung and increased copy number (CN) is a predictor of poor outcomes. FGFR1 is a therapeutic target for lung SCCa and inhibition therapy is currently in clinical trials. Absolute quantification of FGFR1 from formalin fixed paraffin embedded (FFPE) tissue of laryngeal SCCa was examined in this retrospective study. A droplet digital polymerase chain reaction (ddPCR) was used for absolute quantitation of the FGFR1 gene CN. Of the 74 samples analyzed, FGFR1 CN analysis revealed 54% of samples had CN greater than 2 copies/cell (1.8 +/- 2.2 copies/cell), and 38% had CN values greater than 3. The mean and standard deviation FGFR1 CN was 4.17 +/- 1.46 CN for African American patients (n = 41) and 3.78 +/- 1.85 CN for Caucasian patients (n = 31). Further, 60.9% of specimens from African Americans demonstrated increased FGFR1 CN compared to 48.4% of Caucasians. Two SCCA samples from Native American demonstrated increased FGFR1 CN (4.19 and 3.01 CN). The level of FGFR1 amplification did not correlate with tumor stage, lymph node staging, or metastasis. In this population, the proportion of patient samples with an FGFR1 amplification was three times higher than in reported for SCCA of the head and neck. Further, increased FGFR1 CN was observed in two racial groups not previously reported: African Americans and Native Americans. However, FGFR1 amplification is not prognostic in laryngeal squamous cell carcinomas.	[Monico, Jesus; Rezeanu, Luminita] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Miller, Brandon] Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA; [May, Warren] Univ Mississippi, Med Ctr, Dept Biostat, Jackson, MS 39216 USA; [Sullivan, Donna C.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Monico, J (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	jmonico@umc.edu		Sullivan, Donna/0000-0001-5413-4176				Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; Craddock KJ, 2013, J THORAC ONCOL, V8, P1371, DOI 10.1097/JTO.0b013e3182a46fe9; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Goke F, 2015, CLIN CANCER RES, V21, P4356, DOI 10.1158/1078-0432.CCR-14-3357; Goke F, 2013, MODERN PATHOL, V26, P1298, DOI 10.1038/modpathol.2013.58; Goke F, 2012, CHEST, V142, P1020, DOI 10.1378/chest.11-2943; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Ipenburg NA, 2016, TARGET ONCOL, V11, P17, DOI 10.1007/s11523-015-0374-9; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim Y, 2015, IEEE T VEH TECHNOL, V64, P2, DOI 10.1109/TVT.2014.2321346; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Nadauld L, 2012, TRANSL MED, V2, P107; Pirker R, 2010, LANCET ONCOL, V11, P121; Russell PA, 2014, MODERN PATHOL, V27, P1621, DOI 10.1038/modpathol.2014.71; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Weiss J, 2010, SCI TRANSL MED, V2, P1; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhu YZ, 2016, EXP MOL PATHOL, V100, P287, DOI 10.1016/j.yexmp.2015.11.027	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0186185	10.1371/journal.pone.0186185	http://dx.doi.org/10.1371/journal.pone.0186185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351293	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300003
J	Sierra, LJ; Brown, AG; Barila, GO; Anton, L; Barnum, CE; Shetye, SS; Soslowsky, LJ; Elovitz, MA				Sierra, Luz-Jeannette; Brown, Amy G.; Barila, Guillermo O.; Anton, Lauren; Barnum, Carrie E.; Shetye, Snehal S.; Soslowsky, Louis J.; Elovitz, Michal A.			Colonization of the cervicovaginal space with Gardnerella vaginalis leads to local inflammation and cervical remodeling in pregnant mice	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; BACTERIAL VAGINOSIS; MEDROXYPROGESTERONE ACETATE; MYCOPLASMA-HOMINIS; MOUSE MODEL; WOMEN; LABOR; PARTURITION; INFECTION; ASSOCIATION	The role of the cervicovaginal (CV) microbiome in regulating cervical function during pregnancy is poorly understood. Gardnerella vaginalis (G. vaginalis) is the most common bacteria associated with the diagnosis of bacterial vaginosis (BV). While BV has been associated with preterm birth (PTB), clinical trials targeting BV do not decrease PTB rates. It remains unknown if G. vaginalis is capable of triggering molecular, biomechanical and cellular events that could lead to PTB. The objective of this study was to determine if cervicovaginal colonization with G. vaginalis, in pregnant mice, induced cervical remodeling and modified cervical function. CD-1 timed-pregnant mice received a 5X10(8) CFU/mL intravaginal inoculation of G. vaginalis or control on embryonic day 12 (E12) and E13. On E15, the mice were sacrificed and cervicovaginal fluid (CVF), amniotic fluid (AF), cervix, uterus, placentas and fetal membranes (FM) were collected. Genomic DNA was isolated from the CVF, placenta, uterus and FM and QPCR was performed to confirm colonization. IL-6 was measured in the CVF and AF and soluble e-cadherin (seCAD) was assessed in the CVF by ELISA. RNA was extracted from the cervices to evaluate IL-10, IL-8, IL-1 beta, TNF-alpha, Tff-1, SPINK-5, HAS-1 and LOX expression via QPCR. Mucicarmine and trichrome staining was used to assess cervical mucin and collagen. Biomechanical properties of the cervix were studied using quasi-static tensile load-to-failure biomechanical tests. G. vaginalis successfully colonized the CV space. This colonization induced immune responses (increased IL-6 levels in CVF and AF, increased mRNA expression of cervical cytokines), altered the epithelial barrier (increased seCAD in the CVF), induced cervical remodeling (increased mucin production, altered collagen) and altered cervical biomechanical properties (a decrease in biomechanical modulus and an increase in maximum strain). The ability of G. vaginalis to induce these molecular, immune, cellular and biomechanical changes suggests that this bacterium may play a pathogenic role in premature cervical remodeling leading to PTB.	[Sierra, Luz-Jeannette; Brown, Amy G.; Barila, Guillermo O.; Anton, Lauren; Elovitz, Michal A.] Univ Penn, Maternal Child Hlth Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barnum, Carrie E.; Shetye, Snehal S.; Soslowsky, Louis J.] Univ Penn, McKay Orthoped Res Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Sierra, LJ (corresponding author), Univ Penn, Maternal Child Hlth Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	luzjeasi@pennmedicine.upenn.edu	Shetye, Snehal/AAJ-3805-2020	Elovitz, Michal/0000-0001-7554-7180; Shetye, Snehal/0000-0001-7469-3039	March of Dimes Prematurity Research Center at the University of Pennsylvania [22-FY17-890]; Maternal and Child Health Research Center at the University of Pennsylvania; Penn Center for Musculoskeletal Disorders [P30 AR069619]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069619] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Center at the University of Pennsylvania; Maternal and Child Health Research Center at the University of Pennsylvania; Penn Center for Musculoskeletal Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This paper was supported in part by the March of Dimes Prematurity Research Center at the University of Pennsylvania (22-FY17-890) (M. A. Elovitr), The Maternal and Child Health Research Center at the University of Pennsylvania and the Penn Center for Musculoskeletal Disorders (P30 AR069619) (L. J. Soslowsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Children's Hospital of Philadelphia Pathology core, especially Socrates Agrio and Elizabeth A. Tomeski. This paper was supported in part by the March of Dimes Prematurity Research Center at the University of Pennsylvania (22-FY17-890), The Maternity and Child Health Research Center at the University of Pennsylvania and the Penn Center for Musculoskeletal Disorders (P30 AR069619).	Abramovici A, 2015, AM J PERINAT, V32, P1119, DOI 10.1055/s-0035-1549294; Akgul Y, 2014, J CLIN INVEST, V124, P5481, DOI 10.1172/JCI78765; Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Al-Harthi L, 1998, J INFECT DIS, V178, P1343, DOI 10.1086/314444; Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; Anton L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03217-7; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Barmeyer C, 2017, J GASTROENTEROL, V52, P1090, DOI 10.1007/s00535-017-1309-2; Barmeyer C, 2015, SEMIN CELL DEV BIOL, V42, P30, DOI 10.1016/j.semcdb.2015.05.006; Barnum CE, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036473; Bastek JA, 2013, OBSTET GYNECOL, V122, P283, DOI 10.1097/AOG.0b013e31829ab714; Behrman RE, 2007, PRETERM BIRTH CAUSES; Brabant G, 2016, J GYNECOL OBST BIO R, V45, P1247, DOI 10.1016/j.jgyn.2016.09.014; Breshears LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0608-0; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Burgmeier C, 2015, J PEDIATR SURG, V50, P478, DOI 10.1016/j.jpedsurg.2014.08.015; Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; de Tejada BM, 1998, MED CLIN-BARCELONA, V110, P201; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Elovitz M, 2004, AM J OBSTET GYNECOL, V190, P693, DOI 10.1016/j.ajog.2003.10.693; Elovitz MA, 2008, J MATERN-FETAL NEO M, V21, P223, DOI 10.1080/14767050801923680; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172522; Hilbert DW, 2017, EUR J CLIN MICROBIOL, V36, P1269, DOI 10.1007/s10096-017-2933-8; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; Isik G, 2016, J CYTOL, V33, P135, DOI 10.4103/0970-9371.188050; Kimberlin DF, 1998, SEMIN PERINATOL, V22, P242, DOI 10.1016/S0146-0005(98)80012-8; Lechuga S, 2017, BBA-MOL CELL RES, V1864, P1183, DOI 10.1016/j.bbamcr.2017.03.007; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Luong ML, 2010, J OBSTET GYNAECOL CA, V32, P313, DOI 10.1016/S1701-2163(16)34474-7; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mielczarek E, 2016, INFECTION, V44, P447, DOI 10.1007/s15010-015-0860-0; Nallasamy S, 2017, ENDOCRINOLOGY, V158, P950, DOI 10.1210/en.2016-1930; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Nelson DB, 2016, ANAEROBE, V42, P67, DOI 10.1016/j.anaerobe.2016.09.001; Nelson DB, 2009, J PERINAT MED, V37, P130, DOI 10.1515/JPM.2009.026; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Reid G, 2003, AM J OBSTET GYNECOL, V189, P1202, DOI 10.1067/S0002-9378(03)00495-2; Robinson LS, 2016, GENOME ANNOUNCEMENTS, V4; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; St John EP, 2009, VIROLOGY, V385, P22, DOI 10.1016/j.virol.2008.08.031; Straach KJ, 2005, GLYCOBIOLOGY, V15, P55, DOI 10.1093/glycob/cwh137; Thorsen P, 2006, J MATERN-FETAL NEO M, V19, P1, DOI 10.1080/14767050500361604; Timmons Brenda C, 2007, Reprod Sci, V14, P53, DOI 10.1177/1933719107309587; Timmons BC, 2007, ENDOCRINOLOGY, V148, P1278, DOI 10.1210/en.2006-0851; Timmons BC, 2014, ENDOCRINOLOGY, V155, P287, DOI 10.1210/en.2013-1304; Vodstrcil LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171856; Yellon SM, 2009, REPROD SCI, V16, P257, DOI 10.1177/1933719108325757; Yoshida K, 2016, ACTA BIOMATER, V36, P195, DOI 10.1016/j.actbio.2016.03.005; Yoshida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112391	69	32	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191524	10.1371/journal.pone.0191524	http://dx.doi.org/10.1371/journal.pone.0191524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346438	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500059
J	Zhang, J; Ye, ZW; Chen, W; Manevich, Y; Mehrotra, S; Ball, L; Janssen-Heininger, Y; Tew, KD; Townsend, DM				Zhang, Jie; Ye, Zhi-wei; Chen, Wei; Manevich, Yefim; Mehrotra, Shikhar; Ball, Lauren; Janssen-Heininger, Yvonne; Tew, Kenneth D.; Townsend, Danyelle M.			S-Glutathionylation of estrogen receptor alpha affects dendritic cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; DIFFERENTIATION; ACTIVATION; NICHE; IDENTIFICATION; PROLIFERATION; LOCALIZATION; TRANSFERASES	Glutathione S-transferase Pi (GSTP) is a thiolase that catalyzes the addition of glutathione (GSH) to receptive cysteines in target proteins, producing an S-glutathionylated residue. Accordingly, previous studies have reported that S-glutathionylation is constitutively decreased in cells from mice lacking GSTP (Gstp1/p2(-/-)). Here, we found that bone marrow-derived dendritic cells (BMDDCs) from Gstp1/p2(-/-) mice have proliferation rates that are greater than those in their WT counterparts (Gstp1/p2(-/-)). Moreover, Gstp1/p2(-/-) BMDDCs had increased reactive oxygen species (ROS) levels and decreased GSH:glutathione disulfide (GSSG) ratios. Estrogen receptor alpha (ER alpha) is linked to myeloproliferation and differentiation, and we observed that its steady-state levels are elevated in Gstp1/p2(-/-) BMDDCs, indicating a link betweenGSTPand ER alpha activities. BMDDCs differentiated by granulocyte-macrophage colony-stimulating factor had elevated ER alpha levels, which were more pronounced in Gstp1/p2(-/-) thanWTmice. When stimulated with lipopolysaccharide for maturation, Gstp1/p2(-/-) BMDDCs exhibited augmented endocytosis, maturation rate, cytokine secretion, and T-cell activation; heightened glucose uptake and glycolysis; increased Akt signaling (in the mTOR pathway); and decreased AMPK-mediated phosphorylation of proteins. Of note, GSTP formed a complex with ER alpha, stimulating ER alpha S-glutathionylation at cysteines 221, 245, 417, and 447; altering ER alpha's binding affinity for estradiol; and reducing overall binding potential (receptor density and affinity) 3-fold. Moreover, in Gstp1/p2(-/-) BMDDCs, ER alpha S-glutathionylation was constitutively decreased. Taken together, these findings suggest that GSTP-mediated S-glutathionylation of ER alpha controls BMDDC differentiation and affects metabolic function in dendritic cells.	[Zhang, Jie; Ye, Zhi-wei; Manevich, Yefim; Ball, Lauren; Tew, Kenneth D.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 70 President St,DDB410, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ South Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Mehrotra, Shikhar] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Chen, Wei] Southeast Univ, Med Sch, Affiliated Hosp 2, Dept Infect Dis, 1-1 Zhongfu Rd, Nanjing 210003, Jiangsu, Peoples R China; [Janssen-Heininger, Yvonne] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Southeast University - China; University of Vermont	Tew, KD (corresponding author), Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 70 President St,DDB410, Charleston, SC 29425 USA.	tewk@musc.edu	Chen, Wei/AAG-9952-2021; Zhang, Jie/F-1540-2011	Chen, Wei/0000-0003-1526-4677; Zhang, Jie/0000-0002-0466-2955; Ball, Lauren/0000-0001-6780-1679	National Institutes of Health [C06 RR015455]; Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Aliau S, 1997, BIOCHEMISTRY-US, V36, P5861, DOI 10.1021/bi963111c; Arai F, 2009, ANN NY ACAD SCI, V1176, P36, DOI 10.1111/j.1749-6632.2009.04561.x; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dasgupta RK, 2003, BLOOD, V102, P2345, DOI 10.1182/blood-2003-02-0444; Everts B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00203; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; EYLAR E, 1993, INT IMMUNOL, V5, P97, DOI 10.1093/intimm/5.1.97; Gate L, 2004, J BIOL CHEM, V279, P8608, DOI 10.1074/jbc.M308613200; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grek CL, 2011, PHARMACOL THERAPEUT, V129, P172, DOI 10.1016/j.pharmthera.2010.09.008; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lin AHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063199; List AF, 1997, BLOOD, V90, P3364, DOI 10.1182/blood.V90.9.3364; Lyons RM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-43; Manevich Y, 2013, FREE RADICAL BIO MED, V54, P62, DOI 10.1016/j.freeradbiomed.2012.10.556; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Otsuki T, 2000, CANCER RES, V60, P1434; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Raza A, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-20; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Townsend DM, 2014, ADV CANCER RES, V122, P177, DOI 10.1016/B978-0-12-420117-0.00005-0; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Ye ZW, 2017, ANTIOXID REDOX SIGN, V26, P248, DOI 10.1089/ars.2015.6486; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107478	48	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4366	4380		10.1074/jbc.M117.814327	http://dx.doi.org/10.1074/jbc.M117.814327			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29374060	Green Published, hybrid			2022-12-26	WOS:000428204300010
J	Frei, B; Eisenach, C; Martinoia, E; Hussein, S; Chen, XZ; Arrivault, S; Neuhaus, HE				Frei, Benedikt; Eisenach, Cornelia; Martinoia, Enrico; Hussein, Shaimaa; Chen, Xing-Zhen; Arrivault, Stephanie; Neuhaus, H. Ekkehard			Purification and functional characterization of the vacuolar malate transporter tDT from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-METABOLISM; DICARBOXYLATE TRANSPORTER; SULFATE TRANSPORTERS; ALUMINUM TOLERANCE; CITRATE SYNTHASE; PLANT-METABOLISM; SALINITY STRESS; SLC13 FAMILY; ION CHANNELS; TONOPLAST	The exact transport characteristics of the vacuolar dicarboxylate transporter tDT from Arabidopsis are elusive. To overcome this limitation, we combined a range of experimental approaches comprising generation/analysis of tDT overexpressors, (CO2)-C-13 feeding and quantification of C-13 enrichment, functional characterization of tDT in proteoliposomes, and electrophysiological studies on vacuoles. tdt knockout plants showed decreased malate and increased citrate concentrations in leaves during the diurnal light-dark rhythm and after onset of drought, when compared with wildtypes. Interestingly, under the latter two conditions, tDT overexpressors exhibited malate and citrate levels opposite to tdt knockout plants. Highly purified tDT protein transports malate and citrate in a 1: 1 antiport mode. The apparent affinity for malate decreased with decreasing pH, whereas citrate affinity increased. This observation indicates that tDT exhibits a preference for dianion substrates, which is supported by electrophysiological analysis on intact vacuoles. tDT also accepts fumarate and succinate as substrates, but not alpha-ketoglutarate, gluconate, sulfate, or phosphate. Taking tDT as an example, we demonstrated that it is possible to reconstitute a vacuolar metabolite transporter functionally in proteoliposomes. The displayed, so far unknown counterexchange properties of tDT now explain the frequently observed reciprocal concentration changes of malate and citrate in leaves from various plant species. tDT from Arabidopsis is the first member of the well-known and widely present SLC13 group of carrier proteins, exhibiting an antiport mode of transport.	[Frei, Benedikt; Neuhaus, H. Ekkehard] Univ Kaiserslautern, Pflanzenphysiol, Erwin Schrodinger Str, D-67653 Kaiserslautern, Germany; [Eisenach, Cornelia; Martinoia, Enrico] Univ Zurich, Inst Pflanzenbiol, CH-8008 Zurich, Switzerland; [Hussein, Shaimaa; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Arrivault, Stephanie] Max Planck Inst Mol Plant Physiol, Wissenschaftspk Potsdam Golm,Muhlenberg 1, D-14476 Potsdam, Germany	University of Kaiserslautern; University of Zurich; University of Alberta; Max Planck Society	Neuhaus, HE (corresponding author), Univ Kaiserslautern, Erwin Schrodinger Str, D-67653 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Hussein, Shaimaa/HHZ-5533-2022; Martinoia, Enrico/AAH-8712-2021	Hussein, Shaimaa/0000-0003-0849-9670	Deutsche Forschungsgemeinschaft (DFG) [IRTG 1830]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the International Research Training Group 1830 (IRTG 1830). The authors declare that they have no conflicts of interest with the contents of this article.	Baetz U, 2016, PLANT PHYSIOL, V172, P1167, DOI 10.1104/pp.16.00183; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; CERANA R, 1995, AUST J PLANT PHYSIOL, V22, P115, DOI 10.1071/PP9950115; CHANG KJ, 1991, BIOCHIM BIOPHYS ACTA, V1092, P29, DOI 10.1016/0167-4889(91)90174-V; Cheffings CM, 1997, J EXP BOT, V48, P623, DOI 10.1093/jxb/48.Special_Issue.623; Cheung CYM, 2014, PLANT PHYSIOL, V165, P917, DOI 10.1104/pp.113.234468; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Emmerlich V, 2003, P NATL ACAD SCI USA, V100, P11122, DOI 10.1073/pnas.1832002100; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Finkemeier Iris, 2009, F1000 Biol Rep, V1, P47, DOI 10.3410/B1-47; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hafke JB, 2003, PLANT J, V35, P116, DOI 10.1046/j.1365-313X.2003.01781.x; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Igamberdiev AU, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01042; IWASAKI I, 1992, PLANT PHYSIOL, V98, P1494, DOI 10.1104/pp.98.4.1494; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Liu JL, 2015, P NATL ACAD SCI USA, V112, pE6571, DOI 10.1073/pnas.1514598112; Liu RL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00186; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Medeiros DB, 2017, PLANT PHYSIOL, V175, P1068, DOI 10.1104/pp.17.00971; Neuhaus HE, 2007, FEBS LETT, V581, P2223, DOI 10.1016/j.febslet.2007.02.003; Oxender D. L., 1972, METABOLIC TRANSPORT, P133; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pantoja O, 2002, J MEMBRANE BIOL, V186, P31, DOI 10.1007/s00232-001-0132-z; Popova TN, 1998, BBA-BIOENERGETICS, V1364, P307, DOI 10.1016/S0005-2728(98)00008-5; RAVEN JA, 1990, PLANT CELL ENVIRON, V13, P721, DOI 10.1111/j.1365-3040.1990.tb01086.x; RENTSCH D, 1991, PLANTA, V184, P532, DOI 10.1007/BF00197903; Rienmuller F, 2012, J BIOL CHEM, V287, P8986, DOI 10.1074/jbc.M111.310367; Scheible WR, 2000, PLANT CELL ENVIRON, V23, P1155, DOI 10.1046/j.1365-3040.2000.00634.x; Schulze WX, 2012, PLANT J, V69, P529, DOI 10.1111/j.1365-313X.2011.04812.x; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; WHITE PJ, 1989, PLANTA, V179, P265, DOI 10.1007/BF00393698; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Ye J, 2017, PLANT CELL, V29, P2249, DOI 10.1105/tpc.17.00211	50	13	13	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4180	4190		10.1074/jbc.RA117.000851	http://dx.doi.org/10.1074/jbc.RA117.000851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367340	Green Published, hybrid			2022-12-26	WOS:000427587500028
J	Nag, A; John, PCS; Crowley, MF; Bomble, YJ				Nag, Ambarish; John, Peter C. St.; Crowley, Michael F.; Bomble, Yannick J.			Prediction of reaction knockouts to maximize succinate production by Actinobacillus succinogenes	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; FLUX BALANCE ANALYSIS; METABOLIC NETWORK; FERMENTATIVE METABOLISM; GENOME; ACID; GROWTH	Succinate is a precursor of multiple commodity chemicals and bio-based succinate production is an active area of industrial bioengineering research. One of the most important microbial strains for bio-based production of succinate is the capnophilic gram-negative bacterium Actinobacillus succinogenes, which naturally produces succinate by a mixed-acid fermentative pathway. To engineer A. succinogenes to improve succinate yields during mixed acid fermentation, it is important to have a detailed understanding of the metabolic flux distribution in A. succinogenes when grown in suitable media. To this end, we have developed a detailed stoichiometric model of the A. succinogenes central metabolism that includes the biosynthetic pathways for the main components of biomass-namely glycogen, amino acids, DNA, RNA, lipids and UDP-N-Acetyl-alpha-D-glucosamine. We have validated our model by comparing model predictions generated via flux balance analysis with experimental results on mixed acid fermentation. Moreover, we have used the model to predict single and double reaction knockouts to maximize succinate production while maintaining growth viability. According to our model, succinate production can be maximized by knocking out either of the reactions catalyzed by the PTA (phosphate acetyltransferase) and ACK (acetyl kinase) enzymes, whereas the double knockouts of PEPCK (phosphoenolpyruvate carboxykinase) and PTA or PEPCK and ACK enzymes are the most effective in increasing succinate production.	[Nag, Ambarish] Natl Renewable Energy Lab, Computat Sci Ctr, Golden, CO USA; [John, Peter C. St.; Crowley, Michael F.; Bomble, Yannick J.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Bomble, YJ (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	Yannick.Bomble@nrel.gov	St. John, Peter/AAQ-1508-2021; crowley, michael/A-4852-2013	St. John, Peter/0000-0002-7928-3722; Bomble, Yannick/0000-0001-7624-8000; crowley, michael/0000-0001-5163-9398; Nag, Ambarish/0000-0001-5174-4673	US Department of Energy's Bioenergy Technologies Office (DOE-BETO) [DE-AC36-08GO28308]; National Renewable Energy Laboratory	US Department of Energy's Bioenergy Technologies Office (DOE-BETO)(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE))	This work was funded by the US Department of Energy's Bioenergy Technologies Office (DOE-BETO), Contract No. DE-AC36-08GO28308 with the National Renewable Energy Laboratory.	Blazeck J, 2010, BIOTECHNOL J, V5, P647, DOI 10.1002/biot.200900247; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Brink HG, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0111-6; Copeland WB, 2012, METAB ENG, V14, P270, DOI 10.1016/j.ymben.2012.03.001; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Guettler MV, 1999, INT J SYST BACTERIOL, V49, P207, DOI 10.1099/00207713-49-1-207; Kajihata S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627014; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; McKinlay JB, 2008, METAB ENG, V10, P55, DOI 10.1016/j.ymben.2007.08.004; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; McKinlay JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-680; McKinlay JB, 2005, APPL ENVIRON MICROB, V71, P6651, DOI 10.1128/AEM.71.11.6651-6656.2005; Nidelet T, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0456-0; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; Rafieenia R, 2014, BRAZ J CHEM ENG, V31, P859, DOI 10.1590/0104-6632.20140314s00002997; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Smith E.A, 2013, FRACTIONATION CHARAC; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Steuer R, 2009, COMPUTATIONAL MODELS; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VanderWerf MJ, 1997, ARCH MICROBIOL, V167, P332; Yang Tae Hoon, 2013, Methods Mol Biol, V985, P297, DOI 10.1007/978-1-62703-299-5_15	32	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0189144	10.1371/journal.pone.0189144	http://dx.doi.org/10.1371/journal.pone.0189144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381705	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800002
J	Zhao, XL; Li, RJ; Jin, H; Jin, HM; Wang, YH; Zhang, WQ; Wang, HC; Chen, WQ				Zhao, Xiaoling; Li, Renjia; Jin, Hui; Jin, Haimin; Wang, Yonghui; Zhang, Wanqi; Wang, Haichao; Chen, Weiqiang			Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; IN-VIVO; INDUCED APOPTOSIS; (-)-EPIGALLOCATECHIN GALLATE; GAMMA COACTIVATOR-1-ALPHA; PSYCHOLOGICAL STRESS; OXIDATIVE STRESS; EGCG PROTECTS; DOWN-SYNDROME; RAT MODEL	Extensive studies suggested epigallocatechin-3-gallate (EGCG) has significant neuroprotection against multiple central neural injuries, but the underlying mechanisms still remain poorly elucidated. Here we provide evidence to support the possible involvement of extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol-3 kinase/protein kinase B (PI3K/AKT) pathways in EGCG-mediated protection against corticosterone-induced neuron injuries. As an essential stress hormone, corticosterone could induce obvious neurotoxicity in primary hippocampal neurons. Pre-treatment with EGCG ameliorated the corticosterone-induced neuronal injuries; however, it was blocked by pharmacological inhibitors for ERK1/2 (U0126) and PI3K/AKT (LY294002). Furthermore, the results confirmed that EGCG restored the corticosterone-induced decrease of ERK1/2 and PI3K/AKT phosphorylation, and attenuated the corticosterone-induced reduction of peroxisome proliferators-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) expression and ATP production. Taken together, these findings indicated that EGCG has significant neuroprotection against corticosterone-induced neuron injuries partly via restoring the ERK1/2 and PI3K/AKT signaling pathways as well as the PGC-1 alpha-mediated ATP production.	[Zhao, Xiaoling; Li, Renjia; Jin, Haimin; Wang, Yonghui; Chen, Weiqiang] Tianjin Inst Hlth & Environm Med, Tianjin, Peoples R China; [Li, Renjia; Jin, Haimin; Zhang, Wanqi] Tianjin Med Univ, Tianjin, Peoples R China; [Li, Renjia] Yanan Hosp Kunming City, Kunming, Yunnan, Peoples R China; [Jin, Hui; Wang, Haichao; Chen, Weiqiang] Feinstein Inst Med Res, Manhasset, NY USA; [Jin, Haimin] Taishan Med Univ, Affiliated Hosp, Tai An, Shandong, Peoples R China; [Wang, Haichao; Chen, Weiqiang] North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA	Tianjin Medical University; Northwell Health; Shandong First Medical University & Shandong Academy of Medical Sciences; Northwell Health; North Shore University Hospital	Wang, HC (corresponding author), Feinstein Inst Med Res, Manhasset, NY USA.; Wang, HC (corresponding author), North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA.	hwang@northwell.edu; tjchenwq@sohu.com	Wang, Haichao/AAU-2237-2021	Wang, Haichao/0000-0002-0211-9000; Chen, Weiqiang/0000-0002-3592-2318	National Nature Science Foundation of China [81372987, 81072294]; National Institute of General Medical Sciences (NIGMS) [R01GM063075, 1R41GM123858]; National Center of Complementary and Alternative Medicine (NCCAM) [R01AT005076]; National Nature Science Foundation of China (NSFC) [81372987, 81072294]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM123858, R01GM063075] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center of Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Nature Science Foundation of China (http://www.nsfc.gov.cn/) (NSFC, No. 81372987 and No. 81072294 to W.C.). H.W. was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075 and 1R41GM123858) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT005076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Nature Science Foundation of China (NSFC, No. 81372987 and No. 81072294 to W.C.). H.W. was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075 and 1R41GM123858) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT005076).	Angelucci L, 2000, EUR J PHARMACOL, V405, P139, DOI 10.1016/S0014-2999(00)00547-1; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bratt AM, 2001, PSYCHONEUROENDOCRINO, V26, P121, DOI 10.1016/S0306-4530(00)00033-0; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen D, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/843906; Chen WQ, 2010, EXP BIOL MED, V235, P577, DOI 10.1258/ebm.2010.009329; Chen WQ, 2009, BEHAV BRAIN RES, V202, P71, DOI 10.1016/j.bbr.2009.03.017; Chen YC, 2016, NEUROPSYCHOPHARMACOL, V41, P197, DOI 10.1038/npp.2015.181; Collier JB, 2016, J BIOL CHEM, V291, P26850, DOI 10.1074/jbc.M116.754762; Cruz CD, 2007, CURR NEUROPHARMACOL, V5, P244, DOI 10.2174/157015907782793630; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ding Mei-li, 2017, CAN J PHYSL PHARM, V5, P1; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; Han J, 2014, NEUROCHEM RES, V39, P1292, DOI 10.1007/s11064-014-1311-5; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Howell KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020198; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Kang H, 2017, ONCOTARGET, V8, P48603, DOI 10.18632/oncotarget.18122; Kennedy DO, 2014, ADV NUTR, V5, P515, DOI 10.3945/an.114.006320; Kondoh M, 2001, LIFE SCI, V69, P2137, DOI 10.1016/S0024-3205(01)01294-2; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Liu BJ, 2011, BRAIN RES, V1375, P59, DOI 10.1016/j.brainres.2010.12.053; Liu JB, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4962351; Liu SM, 2017, APOPTOSIS, V22, P672, DOI 10.1007/s10495-017-1360-8; Liu SF, 2013, CARCINOGENESIS, V34, P627, DOI 10.1093/carcin/bgs364; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; May C, 2006, BIOCHEM PHARMACOL, V71, P1497, DOI 10.1016/j.bcp.2006.02.003; McCarty R, 2016, STRESS, V19, P449, DOI 10.1080/10253890.2016.1192120; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Menard C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00281; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Ortiz-Lopez L, 2016, NEUROSCIENCE, V322, P208, DOI 10.1016/j.neuroscience.2016.02.040; Ou HC, 2010, J APPL PHYSIOL, V108, P1745, DOI 10.1152/japplphysiol.00879.2009; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Satonaka H, 2017, ANTICANCER RES, V37, P6071, DOI 10.21873/anticanres.12055; Seong KJ, 2016, KOREAN J PHYSIOL PHA, V20, P41, DOI 10.4196/kjpp.2016.20.1.41; Shen XY, 2014, INT J ONCOL, V44, P791, DOI 10.3892/ijo.2014.2251; Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4; Song C, 2017, FREE RADICAL BIO MED, V112, P616, DOI 10.1016/j.freeradbiomed.2017.09.005; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sousa N, 2012, TRENDS NEUROSCI, V35, P742, DOI 10.1016/j.tins.2012.08.006; Sutherland BA, 2004, FASEB J, V18, P258, DOI 10.1096/fj.04-2806fje; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valenti D, 2016, BBA-MOL BASIS DIS, V1862, P1093, DOI 10.1016/j.bbadis.2016.03.003; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P542, DOI 10.1016/j.bbadis.2012.12.011; Vyas S., 2016, NEURAL PLAST, V2016, DOI [10.1155/2016/6391686, DOI 10.1155/2016/6391686]; Wagatsuma A, 2011, J PHYSIOL BIOCHEM, V67, P359, DOI 10.1007/s13105-011-0083-5; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang ZH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00271; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Xicota L, 2017, CURR DRUG TARGETS, V18, P174, DOI 10.2174/1389450116666150825113655; Yamamoto N, 2017, NEUROSCIENCE, V362, P70, DOI 10.1016/j.neuroscience.2017.08.030; Yang CS, 2007, TOXICOL APPL PHARM, V224, P265, DOI 10.1016/j.taap.2006.11.024; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yao CY, 2014, MOL MED REP, V9, P69, DOI 10.3892/mmr.2013.1778; Ye QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-82; Yu LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41337; Zhang B, 2008, BRAIN RES, V1198, P141, DOI 10.1016/j.brainres.2007.12.015; Zhang HY, 2012, MOL MED REP, V6, P967, DOI 10.3892/mmr.2012.1041; Zhang JC, 2017, MOL NEUROBIOL, V54, P3652, DOI 10.1007/s12035-016-9924-0; Zhang YB, 2016, EUR J PHARM SCI, V88, P267, DOI 10.1016/j.ejps.2016.03.017; Zhang YQ, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0387-7; Zhao XL, 2017, NEUROSCIENCE, V346, P226, DOI 10.1016/j.neuroscience.2017.01.025; Zheng MZ, 2011, CELL MOL NEUROBIOL, V31, P421, DOI 10.1007/s10571-010-9635-4; Zhou J, 2015, ASN NEURO, V7, DOI 10.1177/1759091415602463; Zhu M, 2006, NEUROSCIENCE, V141, P2019, DOI 10.1016/j.neuroscience.2006.05.011	75	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0192083	10.1371/journal.pone.0192083	http://dx.doi.org/10.1371/journal.pone.0192083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373584	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400035
J	Dunivin, TK; Miller, J; Shade, A				Dunivin, Taylor K.; Miller, Justine; Shade, Ashley			Taxonomically-linked growth phenotypes during arsenic stress among arsenic resistant bacteria isolated from soils overlying the Centralia coal seam fire	PLOS ONE			English	Article							CONTAMINATED SEDIMENTS; OXIDIZING BACTERIA; REDUCING BACTERIA; DIVERSITY; GENES; MICROORGANISMS; MINE; BIOREMEDIATION; RHIZOSPHERE; CULTIVATION	Arsenic (As), a toxic element, has impacted life since early Earth. Thus, microorganisms have evolved many As resistance and tolerance mechanisms to improve their survival outcomes given As exposure. We isolated As resistant bacteria from Centralia, PA, the site of an underground coal seam fire that has been burning since 1962. From a 57.4 E degrees C soil collected from a vent above the fire, we isolated 25 unique aerobic As resistant bacterial strains spanning seven genera. We examined their diversity, resistance gene content, transformation abilities, inhibitory concentrations, and growth phenotypes. Although As concentrations were low at the time of soil collection (2.58 ppm), isolates had high minimum inhibitory concentrations (MICs) of arsenate and arsenite (> 300 mM and 20 mM respectively), and most isolates were capable of arsenate reduction. We screened isolates (PCR and sequencing) using 12 published primer sets for six As resistance genes (AsRGs). Genes encoding arsenate reductase (arsC) and arsenite efflux pumps (arsB, ACR3(2)) were present, and phylogenetic incongruence between 16S rRNA genes and AsRGs provided evidence for horizontal gene transfer. A detailed investigation of differences in isolate growth phenotypes across As concentrations (lag time to exponential growth, maximum growth rate, and maximum OD590) showed a relationship with taxonomy, providing information that could help to predict an isolate's performance given As exposure in situ. Our results suggest that microbiological management and remediation of environmental As could be informed by taxonomically-linked As tolerance, potential for resistance gene transferability, and the rare biosphere.	[Dunivin, Taylor K.; Shade, Ashley] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Dunivin, Taylor K.] Michigan State Univ, Environm & Integrat Toxicol Sci Doctoral Program, E Lansing, MI 48824 USA; [Miller, Justine] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Shade, Ashley] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Shade, A (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.; Shade, A (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	shadeash@msu.edu		Shade, Ashley/0000-0002-7189-3067	Michigan State University; Michigan State Ronald and Sharon Rogowski Fellowship for Food Safety and Toxicology; Gerhardt Award	Michigan State University; Michigan State Ronald and Sharon Rogowski Fellowship for Food Safety and Toxicology; Gerhardt Award	The authors received no specific funding for this work. The project was supported by start-up funds from Michigan State University to AS. Michigan State University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TD acknowledges the Michigan State Ronald and Sharon Rogowski Fellowship for Food Safety and Toxicology and the Gerhardt Award. We thank Robert Hausinger, Terence Marsh, and Tammy Tobin for their comments on a previous version of this work.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Andres J, 2016, FEMS MICROBIOL REV, V40, P299, DOI 10.1093/femsre/fuv050; Bahar MM, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1722-y; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Banerjee S, 2011, J ENVIRON SCI HEAL A, V46, P1736, DOI 10.1080/10934529.2011.623995; Belfiore C, 2013, EXTREMOPHILES, V17, P421, DOI 10.1007/s00792-013-0523-y; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Cavalca L, 2010, SYST APPL MICROBIOL, V33, P154, DOI 10.1016/j.syapm.2010.02.004; Chang JS, 2008, APPL MICROBIOL BIOT, V80, P155, DOI 10.1007/s00253-008-1524-0; Chang JS, 2010, ENVIRON GEOCHEM HLTH, V32, P95, DOI 10.1007/s10653-009-9268-z; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Das S, 2014, J HAZARD MATER, V272, P112, DOI 10.1016/j.jhazmat.2014.03.012; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Edelstein Arthur D, 2014, J Biol Methods, V1; Elick JM, 2011, INT J COAL GEOL, V87, P197, DOI 10.1016/j.coal.2011.06.018; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han FXX, 2003, NATURWISSENSCHAFTEN, V90, P395, DOI 10.1007/s00114-003-0451-2; Heinrich-Salmeron A, 2011, APPL ENVIRON MICROB, V77, P4685, DOI 10.1128/AEM.02884-10; Huang AH, 2010, CAN J MICROBIOL, V56, P236, DOI [10.1139/W10-005, 10.1139/w10-005]; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jackson CR, 2005, SYST APPL MICROBIOL, V28, P727, DOI 10.1016/j.syapm.2005.05.012; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Janzen Christopher, 2008, V13, P299; Jia Y, 2013, ENVIRON SCI TECHNOL, V47, P3141, DOI 10.1021/es303649v; Jobby R, 2016, ENVIRON PROG SUSTAIN, V35, P1642, DOI 10.1002/ep.12406; Kahm M, 2010, J STAT SOFTW, V33, P1; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klaus S, 2017, PHYLOGENETIC ANAL R; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee SH, 2017, ISME J, V11, P1447, DOI 10.1038/ismej.2017.1; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Madsen EL, 2005, NAT REV MICROBIOL, V3, P439, DOI 10.1038/nrmicro1151; Melody SM, 2015, INT J COAL GEOL, V152, P1, DOI 10.1016/j.coal.2015.11.001; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; NELSON LM, 1978, CAN J MICROBIOL, V24, P1468, DOI 10.1139/m78-236; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Overmann J, 2017, ANNU REV MICROBIOL, V71, P711, DOI 10.1146/annurev-micro-090816-093449; Parvatiyar K, 2005, J BACTERIOL, V187, P4853, DOI 10.1128/JB.187.14.4853-4864.2005; Pepi M, 2007, J APPL MICROBIOL, V103, P2299, DOI 10.1111/j.1365-2672.2007.03471.x; Pepi M, 2011, FOLIA MICROBIOL, V56, P29, DOI 10.1007/s12223-011-0010-8; Pepi M, 2016, SCI TOTAL ENVIRON, V562, P588, DOI 10.1016/j.scitotenv.2016.04.097; Pone JDN, 2007, INT J COAL GEOL, V72, P124, DOI 10.1016/j.coal.2007.01.001; Prakash O, 2013, APPL MICROBIOL BIOT, V97, P51, DOI 10.1007/s00253-012-4533-y; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; R Core Team, 2018, R LANG ENV STAT COMP; Ruta M, 2011, CHEM ECOL, V27, P207, DOI 10.1080/02757540.2010.547490; Sacheti P, 2013, RSC ADV, V3, P9705, DOI 10.1039/c3ra40897c; Salcher MM, 2016, AQUAT MICROB ECOL, V77, P183, DOI 10.3354/ame01796; Sarkar A, 2013, ECOTOXICOLOGY, V22, P363, DOI 10.1007/s10646-012-1031-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Simeonova DD, 2004, FEMS MICROBIOL LETT, V237, P249, DOI 10.1111/j.1574-6968.2004.tb09703.x; Smalla K., 2015, CANCER, V121, P1265; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Sun YM, 2004, J MICROBIOL METH, V58, P335, DOI 10.1016/j.mimet.2004.04.015; Suresh K, 2004, INT J SYST EVOL MICR, V54, P1369, DOI 10.1099/ijs.0.03047-0; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Villegas-Torres MF, 2011, INT BIODETERIOR BIOD; Wang L, 2006, APPL ENV MICROBIOL; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zeng XC, 2016, APPL ENVIRON MICROB, V82, P7019, DOI 10.1128/AEM.02190-16; Zhang Y, 2016, FRONT MICROBIOL	67	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191893	10.1371/journal.pone.0191893	http://dx.doi.org/10.1371/journal.pone.0191893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370270	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600115
J	Harm, S; Schildbock, C; Hartmann, J				Harm, Stephan; Schildboeck, Claudia; Hartmann, Jens			Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification	PLOS ONE			English	Article							CHRONIC LIVER-FAILURE; FATTY-ACID; BINDING-SITES; SPIN LABEL; IN-VITRO; CAPRYLATE; ACETYLTRYPTOPHANATE; DISEASE; MODEL	Introduction Human serum albumin (HSA) is a monomeric multi-domain protein that possesses an extraordinary binding capacity. It plays an important role in storing and transporting endogenous substances, metabolites, and drugs throughout the human circulatory system. Clinically, HSA is used to treat a variety of diseases such as hypovolemia, shock, burns, hemorrhage, and trauma in critically ill patients. Pharmaceutical-grade HSA contains the stabilizers sodium caprylate and N-acetyltryptophanate to protect the protein from oxidative stress and to stabilize it for heat treatment which is applied for virus inactivation. Material and methods The aim of this study was to determine if the two stabilizers can be depleted by adsorbent techniques. Several, adsorbents, some of them are in clinical use, were tested in batch and in a dynamic setup for their ability to remove the stabilizers. Furthermore, the removal of the stabilizers was tested using a pediatric high flux dialyzer. Results The outcome of this study shows that activated charcoal based adsorbents are more effective in removal of N-acetylthryptophanate, whereas polystyrene based adsorbents are better for the removal of caprylate from HSA solutions. An adsorbent cartridge which contains a mix of activated charcoal and polystyrene based material could be used to remove both stabilizers effectively. After 4 hours treatment with a high flux dialyzer, N-acetyltryptophanate was totally removed whereas 20% of caprylate remained in the HSA solution.	[Harm, Stephan; Schildboeck, Claudia; Hartmann, Jens] Danube Univ Krems, Dept Hlth Sci & Biomed, Krems, Austria; [Harm, Stephan] Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, Vienna, Austria	Danube University Krems; University of Vienna	Harm, S (corresponding author), Danube Univ Krems, Dept Hlth Sci & Biomed, Krems, Austria.; Harm, S (corresponding author), Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, Vienna, Austria.	stephan.harm@donau-uni.ac.at		Harm, Stephan/0000-0003-1944-9898; Hartmann, Jens/0000-0002-7343-1851	European Commission [WST3-T-91/040-2016]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Lower Austria and the European Commission, grant number WST3-T-91/040-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBROOK JD, 1972, J BIOL CHEM, V247, P7038; Ashrafi-Kooshk MR, 2015, BIOLOGICALS, V43, P333, DOI 10.1016/j.biologicals.2015.07.003; Busund R, 2002, INTENS CARE MED, V28, P1434, DOI 10.1007/s00134-002-1410-7; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Dasgupta A, 2002, CLIN CHEM LAB MED, V40, P986, DOI 10.1515/CCLM.2002.172; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Dominik A, 2014, THER APHER DIAL, V18, P347, DOI 10.1111/1744-9987.12146; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Esmaeili S, 2017, J IRAN CHEM SOC; Faridbod F, 2011, SPECTROCHIM ACTA A, V78, P96, DOI 10.1016/j.saa.2010.09.001; Faroongsarng D, 2014, AAPS PHARMSCITECH, V15, P465, DOI 10.1208/s12249-014-0076-0; Hadem J, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-24; Harm S, 2014, INT J ARTIF ORGANS, V37, P668, DOI 10.5301/ijao.5000354; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Klammt S, 2001, Z Gastroenterol, V39 Suppl 2, P24, DOI 10.1055/s-2001-919056; Klammt S, 2008, LIVER TRANSPLANT, V14, P1333, DOI 10.1002/lt.21504; Klammt S, 2007, EUR J GASTROEN HEPAT, V19, P257, DOI 10.1097/MEG.0b013e3280101f7d; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; KRAGHHANSEN U, 1991, BIOCHEM J, V273, P641, DOI 10.1042/bj2730641; Lissi E, 2009, J PHOTOCH PHOTOBIO B, V94, P77, DOI 10.1016/j.jphotobiol.2008.10.007; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Peszynski P, 2002, LIVER, V22, P40, DOI 10.1034/j.1600-0676.2002.00007.x; Peters T., 1996, ALL ALBUMIN BIOCH GE, Vxx; Saliba F, 2006, CRIT CARE, V10, DOI 10.1186/cc4825; Sheffield WR, 2005, THROMB HAEMOSTASIS, V93, P914, DOI 10.1160/TH04-08-0554; SOLTYS BJ, 1978, J BIOL CHEM, V253, P3029; SOLTYS BJ, 1978, J BIOL CHEM, V253, P3023; Stange J, 2011, ORGANOGENESIS, V7, P64, DOI 10.4161/org.7.1.14069; Stange J, 2011, LIVER TRANSPLANT, V17, P705, DOI 10.1002/lt.22237; Stegmayr BG, 2003, CRIT CARE MED, V31, P1730, DOI 10.1097/01.CCM.0000064742.00981.14; Stiffel M, 2014, THER APHER DIAL, V18, P79, DOI 10.1111/1744-9987.12025; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; YU MW, 1984, VOX SANG, V47, P28, DOI 10.1111/j.1423-0410.1984.tb01558.x	36	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191741	10.1371/journal.pone.0191741	http://dx.doi.org/10.1371/journal.pone.0191741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364955	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500071
J	Ogueta-Alday, A; Morante, JC; Gomez-Molina, J; Garcia-Lopez, J				Ogueta-Alday, Ana; Carlos Morante, Juan; Gomez-Molina, Josue; Garcia-Lopez, Juan			Similarities and differences among half-marathon runners according to their performance level	PLOS ONE			English	Article							FOOT STRIKE PATTERNS; RUNNING ECONOMY; DISTANCE RUNNERS; ENDURANCE RUNNERS; MIDDLE-DISTANCE; CONTACT; COST; DETERMINANTS; VARIABLES; REARFOOT	This study aimed to identify the similarities and differences among half-marathon runners in relation to their performance level. Forty-eight male runners were classified into 4 groups according to their performance level in a half-marathon (min): Group 1 (n = 11, < 70 min), Group 2 (n = 13, < 80 min), Group 3 (n = 13, < 90 min), Group 4 (n = 11, < 105 min). In two separate sessions, training-related, anthropometric, physiological, foot strike pattern and spatio-temporal variables were recorded. Significant differences (p<0.05) between groups (ES = 0.55-3.16) and correlations with performance were obtained (r = 0.34-0.92) in training- related (experience and running distance per week), anthropometric (mass, body mass index and sum of 6 skinfolds), physiological (VO2max, RCT and running economy), foot strike pattern and spatio-temporal variables (contact time, step rate and length). At standardized submaximal speeds (11, 13 and 15 km.h(-1)), no significant differences between groups were observed in step rate and length, neither in contact time when foot strike pattern was taken into account. In conclusion, apart from training-related, anthropometric and physiological variables, foot strike pattern and step length were the only biomechanical variables sensitive to half-marathon performance, which are essential to achieve high running speeds. However, when foot strike pattern and running speeds were controlled (submaximal test), the spatio-temporal variables were similar. This indicates that foot strike pattern and running speed are responsible for spatio-temporal differences among runners of different performance level.	[Ogueta-Alday, Ana; Carlos Morante, Juan; Garcia-Lopez, Juan] Univ Leon, Fac Phys Act & Sports Sci FCAFD, Inst Biomed IBIOMED, Dept Phys Educ & Sports, Leon, Spain; [Gomez-Molina, Josue] Univ Basque Country, UPV EHU, Fac Educ & Sport, Dept Phys Educ & Sports, Leioa, Spain; [Garcia-Lopez, Juan] Spanish Council Sports CSD, High Sport Performance Ctr Leon CAR Leon, Leon, Spain	Universidad de Leon; University of Basque Country	Ogueta-Alday, A (corresponding author), Univ Leon, Fac Phys Act & Sports Sci FCAFD, Inst Biomed IBIOMED, Dept Phys Educ & Sports, Leon, Spain.	aogua@unileon.es	RÁBAGO, JUAN CARLOS MORANTE/ABE-4031-2020; Garcia-Lopez, Juan/A-1191-2009	RÁBAGO, JUAN CARLOS MORANTE/0000-0002-1880-4993; Garcia-Lopez, Juan/0000-0003-2834-3366	Spanish Sports Council (CSD) [157/UPB10/12]; High Sport Performance Centre of Leon (CAR-Leon); Basque Country Government [PRE_2013_1_1109]	Spanish Sports Council (CSD); High Sport Performance Centre of Leon (CAR-Leon); Basque Country Government(Basque Government)	This work was supported by the Spanish Sports Council (CSD) under the project 157/UPB10/12, by a grant of the High Sport Performance Centre of Leon (CAR-Leon); and by the Basque Country Government, under a predoctoral grant number reference PRE_2013_1_1109 (J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Conoboy P, 2006, BRIT J SPORT MED, V40, P601, DOI 10.1136/bjsm.2006.026252; DAVIS JA, 1985, MED SCI SPORT EXER, V17, P6; Di Michele R, 2014, J SCI MED SPORT, V17, P414, DOI 10.1016/j.jsams.2013.05.012; Franz JR, 2012, MED SCI SPORT EXER, V44, P1519, DOI 10.1249/MSS.0b013e3182514a88; Gomez-Molina J, 2017, J STRENGTH COND RES, V31, P2169, DOI 10.1519/JSC.0000000000001679; Gomez-Molina J, 2017, J SPORT SCI MED, V16, P187; Gruber AH, 2013, J APPL PHYSIOL, V115, P194, DOI 10.1152/japplphysiol.01437.2012; Hagan R D, 1987, Br J Sports Med, V21, P3; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hayes P, 2012, J SPORT SCI, V30, P1275, DOI 10.1080/02640414.2012.707326; Helgerud J, 2010, EUR J APPL PHYSIOL, V108, P1099, DOI 10.1007/s00421-009-1218-z; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kasmer ME, 2013, INT J SPORT PHYSIOL, V8, P286, DOI 10.1123/ijspp.8.3.286; Knechtle B, 2009, RES Q EXERCISE SPORT, V80, P262, DOI DOI 10.1080/02701367.2009.10599561; Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Moore IS, 2016, SPORTS MED, V46, P793, DOI 10.1007/s40279-016-0474-4; Mooses M, 2015, J SPORT SCI, V33, P136, DOI 10.1080/02640414.2014.926384; MORGAN DW, 1995, MED SCI SPORT EXER, V27, P404; Ogueta-Alday A, 2014, MED SCI SPORT EXER, V46, P580, DOI 10.1249/MSS.0000000000000139; Ogueta-Alday A, 2013, J STRENGTH COND RES, V27, P1455, DOI 10.1519/JSC.0b013e318269f760; Paavolainen LM, 1999, MED SCI SPORT EXER, V31, P124, DOI 10.1097/00005768-199901000-00020; Piacentini MF, 2013, J STRENGTH COND RES, V27, P2295, DOI 10.1519/JSC.0b013e3182794485; Running USA, 2015, RUNN US ANN HALF MAR; Schubert AG, 2014, SPORTS HEALTH, V6, P210, DOI 10.1177/1941738113508544; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Storen O, 2011, J STRENGTH COND RES, V25, P117, DOI 10.1519/JSC.0b013e3181b62c8a; SVEDENHAG J, 1994, INT J SPORTS MED, V15, P305, DOI 10.1055/s-2007-1021065; Taipale RS, 2013, EUR J APPL PHYSIOL, V113, P325, DOI 10.1007/s00421-012-2440-7; Tartaruga MP, 2012, RES Q EXERCISE SPORT, V83, P367; Tucker R, 2012, BRIT J SPORT MED, V46, P555, DOI 10.1136/bjsports-2011-090548; Zillmann T, 2013, CHINESE J PHYSIOL, V56, P138, DOI 10.4077/CJP.2013.BAB105	36	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191688	10.1371/journal.pone.0191688	http://dx.doi.org/10.1371/journal.pone.0191688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364940	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500068
J	Uthman, RT; Sutton, AJ; Jackson, LJ; Uthman, OA				Uthman, Rashidah T.; Sutton, Andrew J.; Jackson, Louise J.; Uthman, Olalekan A.			Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADHERENCE; HEALTH; HIV; METAANALYSIS; INFECTION; INTERVENTIONS; TRIALS; SF-36	Background & para;& para;Successful antiretroviral therapy (ART) relies on the optimal level of ART adherence to achieve reliable viral suppression, avert HIV drug resistance, and prevent avoidable deaths. It has been shown that there are various groups of people living with HIV at high-risk of nonadherence to ART in sub-Saharan Africa. The objective of this study was to examine the cost effectiveness and value-of-information of directly administered antiretroviral therapy (DAART) versus self-administered ART among people living with HIV, at high risk of nonadherence to ART in sub-Saharan Africa.& para;& para;Methods and findings & para;& para;A Markov model was developed that describes the transition between HIV stages based on the CD4 count, along with direct costs, quality of life and the mortality rate associated with DAART in comparison with self-administered ART. Data used in the model were derived from the published literature. A health system perspective was employed using a life-time time horizon. Probabilistic sensitivity analysis was performed to determine the impact of parameter uncertainty. Value of information analysis was also conducted. The expected cost of self-administered ART and DAART were $5,200 and $15,500 and the expected QALYs gained were 8.52 and 9.75 respectively, giving an incremental cost effectiveness ratio of $8,400 per QALY gained. The analysis demonstrated that the annual cost DAART needs to be priced below $200 per patient to be cost-effective. The probability that DAART was cost-effective was 1% for a willingness to pay threshold of $5,096 for sub-Saharan Africa. The value of information associated with the cost of DAART and its effectiveness was substantial.& para;& para;Conclusions & para;& para;From the perspective of the health care payer in sub-Saharan Africa, DAART cannot be regarded as cost-effective based on current information. The value of information analysis showed that further research will be worthwhile and potentially cost-effective in resolving the uncertainty about whether or not to adopt DAART.	[Uthman, Rashidah T.; Jackson, Louise J.] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England; [Sutton, Andrew J.] Univ Leeds, Leeds Inst Hlth Sci, Hlth Econ Unit, Leeds, W Yorkshire, England; [Uthman, Olalekan A.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England	University of Birmingham; University of Leeds; University of Warwick	Uthman, OA (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England.	olalekan.uthman@warwick.ac.uk	Uthman, Olalekan/N-5584-2019	Uthman, Olalekan/0000-0002-8567-3081; Jackson, Louise/0000-0001-8492-0020	National Institute of Health Research using Official Development Assistance (ODA) funding; Wellcome Trust Institutional Strategic Support Funding	National Institute of Health Research using Official Development Assistance (ODA) funding; Wellcome Trust Institutional Strategic Support Funding	Olalekan Uthman is supported by the National Institute of Health Research using Official Development Assistance (ODA) funding. Olalekan Uthman is supported by Wellcome Trust Institutional Strategic Support Funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Wellcome Trust.	Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; [Anonymous], 2015, COIN NEWS MEDIA; [Anonymous], 2012, REGIONAL FACT SHEETS; [Anonymous], 2014, FACT SHEET GLOBAL ST; [Anonymous], 2014, UNAID GAP REP; ASSA AIDS MODEL, 2008, ASSA2008 AIDS DEM MO; Athan E, 2010, AIDS, V24, P1887, DOI 10.1097/QAD.0b013e32833b25ed; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Briggs A, 2006, DECISION MODELLING H; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Goshu A.T., 2013, J DATA SCI, V11, P269, DOI [10.6339/JDS.201304_11(2).0004, DOI 10.6339/JDS.201304_11(2).0004]; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; McCabe CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010154; Medecins SF, 2015, UNTANGLING WEB ANTIR, P17; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Naimark DMJ, 2008, MED DECIS MAKING, V28, P706, DOI 10.1177/0272989X08315241; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Sun X, 2008, EUR J HEALTH ECON, V9, P313, DOI 10.1007/s10198-007-0078-x; Tang YH, 2008, J ADV NURS, V62, P74, DOI 10.1111/j.1365-2648.2007.04526.x; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Umar N, 2011, J PUBLIC HEALTH AFR, V2, P78, DOI 10.4081/jphia.2011.e19; UNAIDS, 2014, GLOB STAT HARM RED 2; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; World Health Organization, 1994, WHO TUB PROGR FRAM E	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191465	10.1371/journal.pone.0191465	http://dx.doi.org/10.1371/journal.pone.0191465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360841	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800033
J	Zhang, AL; Yang, XM; Li, QX; Yang, Y; Zhao, G; Wang, B; Wu, DC				Zhang, Ailian; Yang, Xiumei; Li, Quanxiao; Yang, Yu; Zhao, Gan; Wang, Bin; Wu, Daocheng			Immunostimulatory activity of water-extractable polysaccharides from &ITCistanche deserticola&IT as a plant adjuvant &ITin vitro&IT and &ITin vivo&IT	PLOS ONE			English	Article							LYCIUM-BARBARUM POLYSACCHARIDES; DENDRITIC CELLS; ANTIINFLAMMATORY ACTIVITY; CISTANCHE-DESERTICOLA; DELTA INULIN; IN-VITRO; VACCINES; GINSENG; IMMUNITY; SCIENCE	A safe and effective vaccine adjuvant is important in modern vaccines. Various Chinese herbal polysaccharides can activate the immune system. Cistanche deserticola (CD) is a traditional Chinese herb and an adjuvant candidate. Here, we confirmed that water-extractable polysaccharides of CD (WPCD) could modulate immune responses in vitro and in vivo. In a dose-dependent manner, WPCD significantly promoted the maturation and function of murine marrow-derived dendritic cells (BM-DCs) through up-regulating the expression levels of MHC-II, CD86, CD80, and CD40, allogenic T cell proliferation, and the yields of IL-12 and TNF-alpha via toll-like receptor4 (TLR4), as indicated by in vitro experiments. In addition, its immunomodulatory activity was also observed in mice. WPCD effectively improved the titers of IgG, IgG(1) and IgG(2a) and markedly enhanced the proliferation of T and B cells, the production of IFN-gamma and IL-4 in CD4(+) T cells and the expression level of IFN-gamma in CD8(+) T cells better than Alum. Furthermore, WPCD could markedly up-regulate the expression levels of CD40 and CD80 on DCs in spleen and down-regulate the Treg frequency. The study suggests that polysaccharides of Cistanche deserticola are a safe and effective vaccine adjuvant for eliciting both humoral immunity and cellular immunity by activating DCs via TLR4 signaling pathway.	[Zhang, Ailian; Yang, Xiumei; Li, Quanxiao; Yang, Yu] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Xinjiang, Peoples R China; [Zhao, Gan; Wang, Bin] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai, Peoples R China; [Wu, Daocheng] Xi An Jiao Tong Univ, Coll Life Sci & Technol, Xian, Shanxi, Peoples R China	Xinjiang University; Fudan University; Xi'an Jiaotong University	Zhang, AL (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Xinjiang, Peoples R China.; Wu, DC (corresponding author), Xi An Jiao Tong Univ, Coll Life Sci & Technol, Xian, Shanxi, Peoples R China.	xjzal@163.com; wudaocheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [31660259, 31360224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31660259, 31360224).	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Bo RN, 2016, INT J BIOL MACROMOL, V85, P294, DOI 10.1016/j.ijbiomac.2015.12.089; Borchers AT, 1997, AM J CLIN NUTR, V66, P1303, DOI 10.1093/ajcn/66.6.1303; Bougandoura A, 2016, FITOTERAPIA, V109, P248, DOI 10.1016/j.fitote.2016.01.010; Chang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122374; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Honda-Okubo Y, 2015, J VIROL, V89, P2995, DOI 10.1128/JVI.02980-14; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; Jin ML, 2014, INT J BIOL MACROMOL, V64, P257, DOI 10.1016/j.ijbiomac.2013.12.002; Kim JY, 2011, CANCER LETT, V313, P226, DOI 10.1016/j.canlet.2011.09.009; Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Lin LW, 2002, J ETHNOPHARMACOL, V83, P177, DOI 10.1016/S0378-8741(02)00147-2; Nan ZD, 2013, FITOTERAPIA, V89, P167, DOI 10.1016/j.fitote.2013.05.008; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12282, DOI 10.1073/pnas.1413559111; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Saade F, 2013, VACCINE, V31, P1999, DOI 10.1016/j.vaccine.2012.12.077; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Su CX, 2014, VET IMMUNOL IMMUNOP, V158, P98, DOI 10.1016/j.vetimm.2013.05.006; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Wang XZ, 2016, CELL MOL IMMUNOL, V13, P849, DOI 10.1038/cmi.2015.64; Wang ZZ, 2013, INT J BIOL MACROMOL, V53, P93, DOI 10.1016/j.ijbiomac.2012.11.009; Wei W, 2016, J ETHNOPHARMACOL, V179, P243, DOI 10.1016/j.jep.2015.12.060; Zhang AL, 2017, VACCINE, V35, P1037, DOI 10.1016/j.vaccine.2017.01.002; Zhang AL, 2011, VACCINE, V29, P6785, DOI 10.1016/j.vaccine.2010.12.061; Zhang QH, 2016, INT J BIOL MACROMOL, V93, P459, DOI 10.1016/j.ijbiomac.2016.08.052; Zhang WJ, 2016, INT J BIOL MACROMOL, V93, P448, DOI 10.1016/j.ijbiomac.2016.08.079	35	20	24	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191356	10.1371/journal.pone.0191356	http://dx.doi.org/10.1371/journal.pone.0191356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360858	gold, Green Submitted, Green Published			2022-12-26	WOS:000423161800025
J	Ates, D; Aldemir, S; Alsaleh, A; Erdogmus, S; Nemli, S; Kahriman, A; Ozkan, H; Vandenberg, A; Tanyolac, B				Ates, Duygu; Aldemir, Secil; Alsaleh, Ahmad; Erdogmus, Semih; Nemli, Seda; Kahriman, Abdullah; Ozkan, Hakan; Vandenberg, Albert; Tanyolac, Bahattin			A consensus linkage map of lentil based on DArT markers from three RIL mapping populations	PLOS ONE			English	Article							EST-SSR MARKERS; HIGH-DENSITY; GENETIC SIMILARITY; ASCOCHYTA BLIGHT; AFLP MARKERS; MICROSATELLITE; QTL; IDENTIFICATION; CONSTRUCTION; RESISTANCE	Background Lentil (Lens culinaris ssp. culinaris Medikus) is a diploid (2n = 2x = 14), self-pollinating grain legume with a haploid genome size of about 4 Gbp and is grown throughout the world with current annual production of 4.9 million tonnes. Materials and methods A consensus map of lentil (Lens culinaris ssp. culinaris Medikus) was constructed using three different lentils recombinant inbred line (RIL) populations, including "CDC Redberry" x "ILL7502" (LR8), "ILL8006" x "CDC Milestone" (LR11) and "PI320937 "x "Eston" (LR39). Results The lentil consensus map was composed of 9,793 DArT markers, covered a total of 977.47 cM with an average distance of 0.10 cM between adjacent markers and constructed 7 linkage groups representing 7 chromosomes of the lentil genome. The consensus map had no gap larger than 12.67 cM and only 5 gaps were found to be between 12.67 cM and 6.0 cM (on LG3 and LG4). The localization of the SNP markers on the lentil consensus map were in general consistent with their localization on the three individual genetic linkage maps and the lentil consensus map has longer map length, higher marker density and shorter average distance between the adjacent markers compared to the component linkage maps. Conclusion This high-density consensus map could provide insight into the lentil genome. The consensus map could also help to construct a physical map using a Bacterial Artificial Chromosome library and map based cloning studies. Sequence information of DArT may help localization of orientation scaffolds from Next Generation Sequencing data.	[Ates, Duygu; Aldemir, Secil; Erdogmus, Semih; Tanyolac, Bahattin] Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey; [Alsaleh, Ahmad; Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, Adana, Turkey; [Nemli, Seda] Gumushane Univ, Dept Bieoengn & Genet, Gumushane, Turkey; [Kahriman, Abdullah] Harran Univ, Fac Agr, Dept Field Crops, Sanli Urfa, Turkey; [Vandenberg, Albert] Univ Saskatchewan, Crop Dev Ctr, Saskatoon, SK, Canada	Ege University; Cukurova University; Gumushane University; Harran University; University of Saskatchewan	Tanyolac, B (corresponding author), Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	ÖZKAN, Hakan/C-8510-2011; Kahraman, Abdullah/AAB-1400-2020; Aldemir, Seçil/AAZ-4351-2020; ALSALEH, Ahmad/AAB-6508-2021; ALSALEH, Ahmad/CAA-2655-2022; Aldemir, Secil/AAE-6246-2019; Tanyolac, Bahattin/J-1321-2019; Tanyolac, Bahattin/AAD-3762-2019	ÖZKAN, Hakan/0000-0003-3530-2626; ALSALEH, Ahmad/0000-0001-7078-3221; ALSALEH, Ahmad/0000-0001-7078-3221; Aldemir, Secil/0000-0003-1025-4875; Tanyolac, Bahattin/0000-0002-4368-0988; Vandenberg, Albert/0000-0001-6177-1392	Scientific and Technological Research Council of Turkey (TUBITAK) [COST-1110446]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK), project no. COST-1110446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) with project no COST-1110446.	Alavi-Kia SS, 2008, BIOTECHNOL BIOTEC EQ, V22, P795, DOI 10.1080/13102818.2008.10817555; Aldemir S, 2017, TURK J AGRIC FOR, V41, P243, DOI 10.3906/tar-1610-33; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Arumuganathan K, 1991, PLANT MOL BIOL REPOR, V9; Ates D., 2016, PLOS ONE, V11; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bayer M, 2011, BIOINFORMATICS, V27, P1307, DOI 10.1093/bioinformatics/btr111; Biswas MK, 2010, GENET RESOUR CROP EV, V57, P963, DOI 10.1007/s10722-010-9533-0; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Branco CJS, 2007, J APPL GENET, V48, P107, DOI 10.1007/BF03194667; D'Onofrio C, 2010, TREE GENET GENOMES, V6, P451, DOI 10.1007/s11295-009-0263-4; Davis GL, 1999, GENETICS, P152; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eujayl I, 1998, THEOR APPL GENET, V97, P83, DOI 10.1007/s001220050869; FAO, 2016, FAO STAT DAT; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Gaur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13387; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Isobe S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-57; Karakoy T, 2012, SCI WORLD J, V2012, P9; Kosambi D.D., 2016, DD KOSAMBI R RAMASWA, P125, DOI [10.1007/978-81-322-3676-4_16, DOI 10.1007/978-81-322-3676-4_16]; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Liu B.-H., 1998, STAT GENOMICS LINKAG; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Lombard V, 2001, THEOR APPL GENET, P103; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Millan T, 2010, EUPHYTICA, V175, P175, DOI 10.1007/s10681-010-0157-4; Paran I, 2004, MOL BREEDING, V13, P251, DOI 10.1023/B:MOLB.0000022526.30914.31; Pootakham W, 2015, FRONT PLANT SCI, P6; Qaim M, 2007, AGR ECON-BLACKWELL, V37, P119, DOI 10.1111/j.1574-0862.2007.00239.x; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Rubeena, 2006, PLANT BREEDING, V125, P506, DOI 10.1111/j.1439-0523.2006.01259.x; Rubeena, 2003, THEOR APPL GENET, V107, P910, DOI 10.1007/s00122-003-1326-9; Satovic Z, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-932; Sen Gupta D, 2016, CROP J, V4, P425, DOI 10.1016/j.cj.2016.06.012; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Shirasawa K, 2013, DNA RES, V20, P173, DOI 10.1093/dnares/dss042; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sudheesh S, 2016, FRONT PLANT SCI, P7; Sudheesh S, 2015, PLANT MOL BIOL REP, V33, P1391, DOI 10.1007/s11105-014-0837-7; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Temel HY, 2014, P PLANT AN GEN C 22, P358; Truco MJ, 2007, THEOR APPL GENET, V115, P735, DOI 10.1007/s00122-007-0599-9; Tullu A, 2008, CROP SCI, V48, P2254, DOI 10.2135/cropsci2007.11.0628; Tullu A, 2006, CAN J PLANT PATHOL, V28, P588, DOI 10.1080/07060660609507337; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Verma P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139666; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Yap IV, 2003, GENETICS, P165	66	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e191375	10.1371/journal.pone.0191375	http://dx.doi.org/10.1371/journal.pone.0191375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351563	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300077
J	Mihaylov, IB; Mellon, EA; Yechieli, R; Portelance, L				Mihaylov, Ivaylo B.; Mellon, Eric A.; Yechieli, Raphael; Portelance, Lorraine			Automated inverse optimization facilitates lower doses to normal tissue in pancreatic stereotactic body radiotherapy	PLOS ONE			English	Article							ORDER CONSTRAINED OPTIMIZATION; MODULATED RADIATION-THERAPY; PROSTATE-CANCER; LUNG IMRT; QUALITY; PLANS	Purpose Inverse planning is trial-and-error iterative process. This work introduces a fully automated inverse optimization approach, where the treatment plan is closely tailored to the unique patient anatomy. The auto-optimization is applied to pancreatic stereotactic body radiotherapy (SBRT). Materials and methods The automation is based on stepwise reduction of dose-volume histograms (DVHs). Five uniformly spaced points, from 1% to 70% of the organ at risk (OAR) volumes, are used. Doses to those DVH points are iteratively decreased through multiple optimization runs. With each optimization run the doses to the OARs are decreased, while the dose homogeneity over the target is increased. The iterative process is terminated when a pre-specified dose heterogeneity over the target is reached. Twelve pancreatic cases were retrospectively studied. Doses to the target, maximum doses to duodenum, bowel, stomach, and spinal cord were evaluated. In addition, mean doses to liver and kidneys were tallied. The auto-optimized plans were compared to the actual treatment plans, which are based on national protocols. Results The prescription dose to 95% of the planning target volume (PTV) is the same for the treatment and the auto-optimized plans. The average difference for maximum doses to duodenum, bowel, stomach, and spinal cord are -4.6 Gy, -1.8 Gy, -1.6 Gy, and -2.4 Gy respectively. The negative sign indicates lower doses with the auto-optimization. The average differences in the mean doses to liver and kidneys are -0.6 Gy, and -1.1 Gy to -1.5 Gy respectively. Conclusions Automated inverse optimization holds great potential for personalization and tailoring of radiotherapy to particular patient anatomies. It can be utilized for normal tissue sparing or for an isotoxic dose escalation.	[Mihaylov, Ivaylo B.; Mellon, Eric A.; Yechieli, Raphael; Portelance, Lorraine] Univ Miami, Dept Radiat Oncol, Miami, FL 33152 USA	University of Miami	Mihaylov, IB (corresponding author), Univ Miami, Dept Radiat Oncol, Miami, FL 33152 USA.	i.mihaylov@med.miami.edu		Mihaylov, Ivaylo/0000-0003-4518-5902	NIH [R01 CA163370]; Philips Radiation Oncology Systems; NATIONAL CANCER INSTITUTE [R01CA163370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips Radiation Oncology Systems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NIH grant R01 CA163370 and in part by Philips Radiation Oncology Systems to IBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen P, 1997, ACTA ONCOL, V36, P1, DOI 10.1080/0284186X.1997.11835454; American Cancer Society, 2016, CANC FACTS FIGURES 2; Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Brown JM, 1998, CANCER RES, V58, P1408; Butler Laura E, 2004, J Appl Clin Med Phys, V5, P16, DOI 10.1120/jacmp.26.146; Chanyavanich V, 2011, MED PHYS, V38, P2515, DOI 10.1118/1.3574874; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Forster J, 2001, MED PHYS, V28, P28, DOI 10.1118/1.1333413; Fredriksson A, 2012, PHYS MED BIOL, V57, P7799, DOI 10.1088/0031-9155/57/23/7799; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Li TR, 2013, MED PHYS, V40, DOI 10.1118/1.4823473; Lu RZ, 2008, PHYS MED BIOL, V53, P6749, DOI 10.1088/0031-9155/53/23/007; Mihaylov IB, 2008, MED PHYS, V35, P3722, DOI 10.1118/1.2956710; Mihaylov IB, 2007, MED PHYS, V34, P1244, DOI 10.1118/1.2712413; Mihaylov IB, 2015, PHYS MED BIOL, V60, P3927, DOI 10.1088/0031-9155/60/10/3927; MIHAYLOV IB, 2014, FRONT ONCOL, V4, P22467; Mihaylov IB, 2012, INT J RADIAT ONCOL, V82, P1292, DOI 10.1016/j.ijrobp.2010.06.020; Mihaylov IB, 2010, INT J RADIAT ONCOL, V77, P285, DOI 10.1016/j.ijrobp.2009.08.021; Mihaylov IB, 2009, RADIOTHER ONCOL, V93, P147, DOI 10.1016/j.radonc.2009.05.008; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063; Niemierko A, 1999, MED PHYS, V26, P1100, DOI DOI 10.1118/1.598063; Petit SF, 2012, RADIOTHER ONCOL, V102, P38, DOI 10.1016/j.radonc.2011.05.025; Purdie TG, 2011, INT J RADIAT ONCOL, V81, P575, DOI 10.1016/j.ijrobp.2010.11.016; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rivera L, 2013, MED PHYS, V40, DOI 10.1118/1.4788653; Song Y, 2016, RADIOTHER ONCOL, V119, P531, DOI 10.1016/j.radonc.2016.04.010; Stabenau H, 2011, MED PHYS, V38, P2731, DOI 10.1118/1.3575416; Wu BB, 2011, INT J RADIAT ONCOL, V79, P1241, DOI 10.1016/j.ijrobp.2010.05.026; Wu QW, 2000, MED PHYS, V27, P701, DOI 10.1118/1.598932; Xhaferllari I, 2013, J APPL CLIN MED PHYS, V14, P176, DOI 10.1120/jacmp.v14i1.4052; Yuan LL, 2015, PHYS MED BIOL, V60, P1831, DOI 10.1088/0031-9155/60/5/1831; Zhang XD, 2011, PHYS MED BIOL, V56, P3873, DOI 10.1088/0031-9155/56/13/009; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	36	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191036	10.1371/journal.pone.0191036	http://dx.doi.org/10.1371/journal.pone.0191036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351303	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300040
J	Qian, QJ; You, ZY; Ye, LP; Che, JQ; Wang, YR; Wang, SH; Zhong, BX				Qian, Qiujie; You, Zhengying; Ye, Lupeng; Che, Jiaqian; Wang, Yiran; Wang, Shaohua; Zhong, Boxiong			High-efficiency production of human serum albumin in the posterior silk glands of transgenic silkworms, Bombyx mori L	PLOS ONE			English	Article							RECOMBINANT PROTEINS; EXPRESSION SYSTEM; H-CHAIN; FIBROIN; COCOON; GENE; SECRETION; SEQUENCE; CELLS	Human serum albumin (HSA) is an important biological preparation with a variety of biological functions in clinical applications. In this study, the mRNA of a fusion transposase derived from the pESNT-PBase plasmid and a pBHSA plasmid containing the HSA gene under the control of a fibroin light chain (FL) promoter were co-injected into fertilized eggs. Fifty-six transgenic silkworm pedigrees expressing theexogenous recombinant HSA (rHSA) in the posterior silk glands (PSGs) with stable inheritance were successfully obtained. The SDS-PAGE and Western blot results confirmed that the rHSA was secreted into the transgenic silkworm cocoon, and the rHSA could be easily extracted with phosphate-buffered saline (PBS). In our research, the isolated highest amount rHSA constituted up to 29.1% of the total soluble protein of the cocoon shell, indicating that the transgenic silkworm produced an average of 17.4 mu g/mg of rHSA in the cocoon shell. The production of soluble rHSA in the PSGs by means of generating transgenic silkworms is a novel approach, whereby a large amount of virus-free and functional HSA can be produced through the simple rearing of silkworms.	[Qian, Qiujie; You, Zhengying; Ye, Lupeng; Che, Jiaqian; Wang, Shaohua; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Qian, Qiujie] Haining Sericulture Technol Extens Stn Zhejiang P, Haining, Zhejiang, Peoples R China; [Wang, Yiran] Zhejiang Univ, Dept Food Sci & Nutr, Fuli Inst Food Sci, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhong, BX (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.	bxzhong@zju.edu.cn	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yixuan/GXW-2866-2022; Wang, Yixuan/GZK-6559-2022	Ye, Lupeng/0000-0003-3901-6598	National Basic Research Program of China [2012CB114601]; China Postdoctoral Science Foundation [2016M591989]	National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the grants from the National Basic Research Program of China (No.2012CB114601) and the China Postdoctoral Science Foundation (No.2016M591989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grants from the National Basic Research Program of China (No.2012CB114601); the China Postdoctoral Science Foundation (No.2016M591989).	Cai C, 2006, J DRUG TARGET, V14, P55, DOI 10.1080/10611860600613324; Chamberland ME, 2001, EMERG INFECT DIS, V7, P552, DOI 10.3201/eid0703.010331; DEGAUDIO AR, 1995, INT J ARTIF ORGANS, V18, P216, DOI 10.1177/039139889501800407; Erstad BL, 1996, PHARMACOTHERAPY, V16, P996; FLEER R, 1991, BIO-TECHNOL, V9, P968, DOI 10.1038/nbt1091-968; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2; GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3; Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021; Kurihara H, 2007, BIOCHEM BIOPH RES CO, V355, P976, DOI 10.1016/j.bbrc.2007.02.055; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Moghaddassi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089631; Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019; Royer C, 2005, TRANSGENIC RES, V14, P463, DOI 10.1007/s11248-005-4351-4; SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Wang F, 2013, TRANSGENIC RES, V22, P925, DOI 10.1007/s11248-013-9695-6; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Ye LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17172; You ZY, 2017, TRANSGENIC RES, V26, P653, DOI 10.1007/s11248-017-0034-1; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191507	10.1371/journal.pone.0191507	http://dx.doi.org/10.1371/journal.pone.0191507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352308	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300104
J	Gong, L; Pan, X; Lim, CB; de Polo, A; Little, JB; Yuan, ZM				Gong, Lu; Pan, Xiao; Lim, Chuan-Bian; de Polo, Anna; Little, John B.; Yuan, Zhi-Min			A functional interplay between Delta 133p53 and Delta Np63 in promoting glycolytic metabolism to fuel cancer cell proliferation	ONCOGENE			English	Article							PLURIPOTENT STEM-CELLS; P53 ISOFORM; RESPONSE ELEMENTS; BREAST-CANCER; DNA-DAMAGE; SENESCENCE; EXPRESSION; DEATH; APOPTOSIS; P53-BETA	Although Delta Np63 is known to promote cancer cell proliferation, the underlying mechanism behind its oncogenic function remains elusive. We report here a functional interplay between Delta Np63 and Delta 133p53. These two proteins are co-overexpressed in a subset of human cancers and cooperate to promote cell proliferation. Mechanistically, Delta 133p53 binds to Delta Np63 and utilizes its transactivation domain to upregulate GLUT1, GLUT4, and PGM expression driving glycolysis. While increased glycolysis provides cancer cells with anabolic metabolism critical for proliferation and survival, it can be harnessed for selective cancer cell killing. Indeed, we show that tumors overexpressing both Delta Np63 and Delta 133p53 exhibit heightened sensitivity to vitamin C that accumulate to a lethal level due to accelerated uptake via overexpressed GLUT1. These observations offer a new therapeutic avenue that could be exploited for clinical applications.	[Gong, Lu; Lim, Chuan-Bian; de Polo, Anna; Yuan, Zhi-Min] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Gong, Lu; Lim, Chuan-Bian; de Polo, Anna; Little, John B.; Yuan, Zhi-Min] John B Little Ctr Radiat Sci, Boston, MA 02115 USA; [Pan, Xiao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Pan, Xiao] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Zhejiang, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Zhejiang University; Zhejiang University	Yuan, ZM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.; Yuan, ZM (corresponding author), John B Little Ctr Radiat Sci, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Gong, Lu/X-2715-2019; Gong, Lu/AAM-3697-2021	Gong, Lu/0000-0001-9151-0767; de Polo, Anna/0000-0002-5607-8048	Morningside Foundation; National Cancer Institute at the National Institute of Health [R01CA85679, R01CA167814, R01CA125144]; Zhu Fund	Morningside Foundation; National Cancer Institute at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Zhu Fund	This work was supported in part by the Morningside Foundation, the Zhu Fund and grants from the National Cancer Institute at the National Institute of Health (R01CA85679, R01CA167814, and R01CA125144).	Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Arsic N, 2015, STEM CELL REP, V4, P531, DOI 10.1016/j.stemcr.2015.02.001; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37281; Gong L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033587; Gong L, 2016, J MOL CELL BIOL, V8, P88, DOI 10.1093/jmcb/mjv069; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hainaut P, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026179; Hofstetter G, 2011, BRIT J CANCER, V105, P1593, DOI 10.1038/bjc.2011.433; Horikawa I, 2017, CELL DEATH DIFFER, V24, P1017, DOI 10.1038/cdd.2017.48; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ji WS, 2015, INT J CLIN EXP PATHO, V8, P10468; Joruiz SM, 2016, COLD SPRING HARBOR P, V6, DOI [10.1101/cshperspect.a02, DOI 10.1101/CSHPERSPECT.A02]; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Liu J, 2015, CANCER LETT, V356, P197, DOI 10.1016/j.canlet.2013.12.025; Marcel V, 2010, ONCOGENE, V29, P2691, DOI 10.1038/onc.2010.26; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Moore HC, 2010, ONCOGENE, V29, P6475, DOI 10.1038/onc.2010.381; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roth I, 2016, ONCOGENE, V35, P4981, DOI 10.1038/onc.2016.45; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Shen L, 2012, CLIN CANCER RES, V18, P1561, DOI 10.1158/1078-0432.CCR-11-3040; Tannapfel A, 2001, J PATHOL, V195, P163, DOI 10.1002/path.947; Turnquist C, 2016, CELL DEATH DIFFER, V23, P1515, DOI 10.1038/cdd.2016.37; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	36	11	11	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2150	2164		10.1038/s41388-017-0117-8	http://dx.doi.org/10.1038/s41388-017-0117-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29371679				2022-12-26	WOS:000430589000006
J	Kong, QR; Banaszynski, LA; Geng, FQ; Zhang, XL; Zhang, JM; Zhang, H; O'Neill, CL; Yan, PD; Liu, ZH; Shido, K; Palermo, GD; Allis, CD; Rafii, S; Rosenwaks, Z; Wen, DC				Kong, Qingran; Banaszynski, Laura A.; Geng, Fuqiang; Zhang, Xiaolei; Zhang, Jiaming; Zhang, Heng; O'Neill, Claire L.; Yan, Peidong; Liu, Zhonghua; Shido, Koji; Palermo, Gianpiero D.; Allis, C. David; Rafii, Shahin; Rosenwaks, Zev; Wen, Duancheng			Histone variant H3.3-mediated chromatin remodeling is essential for paternal genome activation in mouse preimplantation embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3.3 INCORPORATION; GENE-EXPRESSION; SPERM CHROMATIN; FERTILIZATION; OOCYTE; TRANSCRIPTION; REPLACEMENT; METHYLATION; REPLICATION; INHERITANCE	Derepression of chromatin-mediated transcriptional repression of paternal and maternal genomes is considered the first major step that initiates zygotic gene expression after fertilization. The histone variant H3.3 is present in both male and female gametes and is thought to be important for remodeling the paternal and maternal genomes for activation during both fertilization and embryogenesis. However, the underlying mechanisms remain poorly understood. Using our H3.3B-HA-tagged mouse model, engineered to report H3.3 expression in live animals and to distinguish different sources of H3.3 protein in embryos, we show here that sperm-derived H3.3 (sH3.3) protein is removed from the sperm genome shortly after fertilization and extruded from the zygotes via the second polar bodies (PBII) during embryogenesis. We also found that the maternal H3.3 (mH3.3) protein is incorporated into the paternal genome as early as 2 h postfertilization and is detectable in the paternal genome until the morula stage. Knockdown of maternal H3.3 resulted in compromised embryonic development both of fertilized embryos and of androgenetic haploid embryos. Furthermore, we report that mH3.3 depletion in oocytes impairs both activation of the Oct4 pluripotency marker gene and global de novo transcription from the paternal genome important for early embryonic development. Our results suggest that H3.3-mediated paternal chromatin remodeling is essential for the development of preimplantation embryos and the activation of the paternal genome during embryogenesis.	[Kong, Qingran; O'Neill, Claire L.; Palermo, Gianpiero D.; Rosenwaks, Zev; Wen, Duancheng] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Geng, Fuqiang; Shido, Koji; Rafii, Shahin] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Kong, Qingran; Zhang, Xiaolei; Zhang, Jiaming; Zhang, Heng; Yan, Peidong; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin 150030, Heilongjiang, Peoples R China; [Banaszynski, Laura A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Banaszynski, Laura A.] Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Cornell University; Cornell University; Northeast Agricultural University - China; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wen, DC (corresponding author), Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	duw2001@med.cornell.edu		Wen, Duancheng/0000-0002-3160-6289	Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant; National Key Research and Development program of China-Stem cell and Translational Research Grant [2016YFA0100200]; "Academic Backbone" Project of Northeast Agricultural University [15XG19]; China Scholarship Council [201606615019]	Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant; National Key Research and Development program of China-Stem cell and Translational Research Grant; "Academic Backbone" Project of Northeast Agricultural University; China Scholarship Council(China Scholarship Council)	This work was supported in part by a Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant (to D. W., Z. R., and S. R.), the National Key Research and Development program of China-Stem cell and Translational Research Grant 2016YFA0100200 (to Q. K. and Z. L.), and "Academic Backbone" Project of Northeast Agricultural University Grant 15XG19 (to Q. K. and Z. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Scholarship Council Grant 201606615019.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; Castillo J, 2015, ASIAN J ANDROL, V17, P601, DOI 10.4103/1008-682X.153302; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Farley BM, 2008, CRIT REV BIOCHEM MOL, V43, P135, DOI [10.1080/10409230801921338, 10.1080/10409230801921338 ]; Frank D, 2003, GENE, V312, P135, DOI 10.1016/S0378-1119(03)00609-7; Gao SR, 2004, DEV BIOL, V266, P62, DOI 10.1016/j.ydbio.2003.10.003; Gunes S, 2013, TURK J UROL, V39, P181, DOI 10.5152/tud.2013.037; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Henikoff S, 2004, COLD SPRING HARB SYM, V69, P235, DOI 10.1101/sqb.2004.69.235; Henikoff S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019364; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Lin CJ, 2013, DEVELOPMENT, V140, P3624, DOI 10.1242/dev.095513; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Neri QV, 2014, CELL CALCIUM, V55, P24, DOI 10.1016/j.ceca.2013.10.006; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Saade E, 2015, AGING CELL, V14, P322, DOI 10.1111/acel.12332; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Teperek Marta, 2013, Reproductive Medicine and Biology, V12, P133, DOI 10.1007/s12522-013-0155-z; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; WELLMAN SE, 1987, GENE, V59, P29, DOI 10.1016/0378-1119(87)90263-0; Wen DC, 2014, GENESIS, V52, P959, DOI 10.1002/dvg.22827; Wen DC, 2014, NUCLEUS-AUSTIN, V5, P369, DOI 10.4161/nucl.36231; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yang P, 2015, BIOESSAYS, V37, P52, DOI 10.1002/bies.201400072; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zheng JK, 2008, DEV DYNAM, V237, P1463, DOI 10.1002/dvdy.21499	52	24	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3829	3838		10.1074/jbc.RA117.001150	http://dx.doi.org/10.1074/jbc.RA117.001150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358330	Green Published, hybrid			2022-12-26	WOS:000427030200034
J	Zheng, RC; Hachisuka, S; Tomita, H; Imanaka, T; Zheng, YG; Nishiyama, M; Atomi, H				Zheng, Ren-Chao; Hachisuka, Shin-ichi; Tomita, Hiroya; Imanaka, Tadayuki; Zheng, Yu-Guo; Nishiyama, Makoto; Atomi, Haruyuki			An ornithine omega-aminotransferase required for growth in the absence of exogenous proline in the archaeon Thermococcus kodakarensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; AMINO-ACID RACEMASE; BIOCHEMICAL-CHARACTERIZATION; DELTA-AMINOTRANSFERASE; SUBSTRATE-SPECIFICITY; ASPARTATE-AMINOTRANSFERASE; GENE-CLUSTER; PURIFICATION; LYSINE; IDENTIFICATION	Aminotransferases are pyridoxal 5'-phosphate-dependent enzymes that catalyze reversible transamination reactions between amino acids and alpha-keto acids, and are important for the cellular metabolism of nitrogen. Many bacterial and eukaryotic omega-aminotransferases that use L-ornithine (Orn), L-lysine (Lys), or gamma-aminobutyrate (GABA) have been identified and characterized, but the corresponding enzymes from archaea are unknown. Here, we examined the activity and function of TK2101, a gene annotated as a GABA aminotransferase, from the hyperthermophilic archaeon Thermococcus kodakarensis. We overexpressed the TK2101 gene in T. kodakarensis and purified and characterized the recombinant protein and found that it displays only low levels of GABA aminotransferase activity. Instead, we observed a relatively high omega-aminotransferase activity with L-Orn and L-Lys as amino donors. The most preferred amino acceptor was 2-oxoglutarate. To examine the physiological role of TK2101, we created a TK2101 gene-disruption strain (Delta TK2101), which was auxotrophic for proline. Growth comparison with the parent strain KU216 and the biochemical characteristics of the protein strongly suggested that TK2101 encodes an Orn aminotransferase involved in the biosynthesis of L-Pro. Phylogenetic comparisons of the TK2101 sequence with related sequences retrieved from the databases revealed the presence of several distinct protein groups, some of which having no experimentally studied member. We conclude that TK2101 is part of a novel group of Orn aminotransferases that are widely distributed at least in the genus Thermococcus, but perhaps also throughout the Archaea.	[Zheng, Ren-Chao; Hachisuka, Shin-ichi; Tomita, Hiroya; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ Noji Higashi, Coll Life Sci, Dept Biotechnol, Kusatsu 5258577, Japan; [Zheng, Ren-Chao; Zheng, Yu-Guo] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, Hangzhou 310032, Zhejiang, Peoples R China; [Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Hachisuka, Shin-ichi; Imanaka, Tadayuki; Atomi, Haruyuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan	Kyoto University; Zhejiang University of Technology; University of Tokyo; Japan Science & Technology Agency (JST)	Atomi, H (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.; Atomi, H (corresponding author), Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan.	atomi@sbchem.kyoto-u.ac.jp	Tomita, Hiroya/GQY-9725-2022; Hachisuka, Shin-ichi/P-8984-2019	Hachisuka, Shin-ichi/0000-0001-8339-7717; Nishiyama, Makoto/0000-0001-8143-8052; Atomi, Haruyuki/0000-0001-9687-6426	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to H. A.) within the research area "Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms." The authors declare that they have no conflicts of interest with the contents of this article.	ANDREOTTI G, 1994, EUR J BIOCHEM, V220, P543, DOI 10.1111/j.1432-1033.1994.tb18654.x; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gafan C, 2001, MOL BIOCHEM PARASIT, V118, P1, DOI 10.1016/S0166-6851(01)00357-7; He M, 2006, J IND MICROBIOL BIOT, V33, P401, DOI 10.1007/s10295-006-0078-3; Ishibashi T, 2012, EXTREMOPHILES, V16, P819, DOI 10.1007/s00792-012-0477-5; JHEE KH, 1995, J BIOCHEM-TOKYO, V118, P101, DOI 10.1093/oxfordjournals.jbchem.a124863; Kawakami R, 2017, J BIOSCI BIOENG, V124, P23, DOI 10.1016/j.jbiosc.2017.02.004; Kawakami R, 2015, AMINO ACIDS, V47, P1579, DOI 10.1007/s00726-015-2001-6; Lee H, 2015, MED RES REV, V35, P286, DOI 10.1002/med.21328; Legrain C, 2001, METHOD ENZYMOL, V331, P227; MARINO G, 1988, J BIOL CHEM, V263, P12305; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Meng ZH, 2009, PROTEIN EXPRES PURIF, V64, P125, DOI 10.1016/j.pep.2008.10.018; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Rajaram V, 2008, PROTEINS, V70, P429, DOI 10.1002/prot.21567; Rausch C, 2013, PROTEINS, V81, P774, DOI 10.1002/prot.24233; Sakuraba H, 2004, J BACTERIOL, V186, P5513, DOI 10.1128/JB.186.16.5513-5518.2004; Santangelo TJ, 2008, APPL ENVIRON MICROB, V74, P3099, DOI 10.1128/AEM.00305-08; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583; SODA K, 1968, BIOCHEMISTRY-US, V7, P4102, DOI 10.1021/bi00851a045; Stranska J, 2010, BIOCHIMIE, V92, P940, DOI 10.1016/j.biochi.2010.03.026; TAKECHI M, 1994, J BIOCHEM-TOKYO, V116, P955, DOI 10.1093/oxfordjournals.jbchem.a124652; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1994, J BIOCHEM-TOKYO, V115, P309, DOI 10.1093/oxfordjournals.jbchem.a124334; Tomita H, 2014, J BACTERIOL, V196, P1222, DOI 10.1128/JB.01327-13; Tomita H, 2013, MOL MICROBIOL, V90, P307, DOI 10.1111/mmi.12363; Tomita H, 2012, J BACTERIOL, V194, P5434, DOI 10.1128/JB.06624-11; Uchida Y, 2014, EXTREMOPHILES, V18, P589, DOI 10.1007/s00792-014-0642-0; Valmaseda EMMD, 2005, MOL GENET GENOMICS, V274, P272, DOI 10.1007/s00438-005-0018-3; VOELLMY R, 1975, J BACTERIOL, V122, P799, DOI 10.1128/JB.122.3.799-809.1975; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Ward Donald E., 2002, Archaea, V1, P133, DOI 10.1155/2002/959031; XING RY, 1992, J BACTERIOL, V174, P541, DOI 10.1128/jb.174.2.541-548.1992; YASUDA M, 1981, J BACTERIOL, V148, P43, DOI 10.1128/JB.148.1.43-50.1981; Yokooji Y, 2009, J BIOL CHEM, V284, P28137, DOI 10.1074/jbc.M109.009696; YONAHA K, 1992, J BIOL CHEM, V267, P12506; Yoshida A, 2016, J BIOL CHEM, V291, P21630, DOI 10.1074/jbc.M116.743021	43	5	6	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3625	3636		10.1074/jbc.RA117.001222	http://dx.doi.org/10.1074/jbc.RA117.001222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352105	Green Published, hybrid			2022-12-26	WOS:000427030200017
J	Del Vecchio, K; Frick, CT; Gc, JB; Oda, SI; Gerstman, BS; Saphire, EO; Chapagain, PP; Stahelin, RV				Del Vecchio, Kathryn; Frick, Cary T.; Gc, Jeevan B.; Oda, Shun-ichiro; Gerstman, Bernard S.; Saphire, Erica Ollmann; Chapagain, Prem P.; Stahelin, Robert V.			A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; MOLECULAR-DYNAMICS; BINDING PROPERTIES; CRYSTAL-STRUCTURE; NUCLEAR IMPORT; VIRAL-EGRESS; OLIGOMERIZATION; ASSOCIATION; DOMAINS; LOCALIZATION	Ebola virus (EBOV) is a filamentous lipid-enveloped virus that causes hemorrhagic fever with a high fatality rate. Viral protein 40 (VP40) is the major EBOV matrix protein and regulates viral budding from the plasma membrane. VP40 is a transformer/morpheein that can structurally rearrange its native homodimer into either a hexameric filament that facilitates viral budding or an RNA-binding octameric ring that regulates viral transcription. VP40 associates with plasma-membrane lipids such as phosphatidylserine (PS), and this association is critical to budding from the host cell. However, it is poorly understood how different VP40 structures interact with PS, what essential residues are involved in this association, and whether VP40 has true selectivity for PS among different glycerophospholipid head-groups. In this study, we used lipid-binding assays, MD simulations, and cellular imaging to investigate the molecular basis of VP40-PS interactions and to determine whether different VP40 structures (i.e. monomer, dimer, and octamer) can interact with PS-containing membranes. Results from quantitative analysis indicated that VP40 associates with PS vesicles via a cationic patch in the C-terminal domain (Lys(224, 225) and Lys(274, 275)). Substitutions of these residues with alanine reduced PS-vesicle binding by >40-fold and abrogated VP40 localization to the plasma membrane. Dimeric VP40 had 2-fold greater affinity for PS-containing membranes than the monomer, whereas binding of the VP40 octameric ring was reduced by nearly 10-fold. Taken together, these results suggest the different VP40 structures known to form in the viral life cycle harbor different affinities for PS-containing membranes.	[Del Vecchio, Kathryn; Frick, Cary T.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Gc, Jeevan B.; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Oda, Shun-ichiro; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Oda, Shun-ichiro; Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Stahelin, Robert V.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	University of Notre Dame; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Scripps Research Institute; Scripps Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stahelin, RV (corresponding author), Purdue Univ, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	rstaheli@purdue.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863; Saphire, Erica Ollmann/0000-0002-1206-7451; Chapagain, Prem/0000-0002-0999-4975	National Institutes of Health [AI081077, AI121841]; National Institutes of Health CBBI Predoctoral Training Fellowship [T32GM075762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121841, R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health CBBI Predoctoral Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	( This work was supported by National Institutes of Health Grants AI081077 and AI121841 (to R.V.S.) and National Institutes of Health CBBI Predoctoral Training Fellowship T32GM075762 (to K.D. and C.T.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Movies S1 and S2.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2014, VIRUSES-BASEL, V6, P3837, DOI 10.3390/v6103837; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; BROOKS MM, 1995, STAT MED, V14, P2227, DOI 10.1002/sim.4780142006; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Chlibek R., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P99; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Dick RA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00187; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Gc JB, 2016, PROTEIN SCI, V25, P1648, DOI 10.1002/pro.2969; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Han ZY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005220; Han ZY, 2015, J INFECT DIS, V212, pS138, DOI 10.1093/infdis/jiu838; Han ZY, 2003, J VIROL, V77, P1793, DOI 10.1128/JVI.77.3.1793-1800.2003; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jeevan BGC, 2017, BBA-BIOMEMBRANES, V1859, P2012, DOI 10.1016/j.bbamem.2017.07.007; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Lucas N, 2011, J BIOL CHEM, V286, P41265, DOI 10.1074/jbc.M111.300806; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Nanbo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01206; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Radzimanowski J, 2014, PROTEIN SCI, V23, P1519, DOI 10.1002/pro.2541; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Robinson BA, 2014, J VIROL, V88, P5718, DOI 10.1128/JVI.03609-13; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Silva LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039978; Soni SP, 2014, J BIOL CHEM, V289, P33590, DOI 10.1074/jbc.M114.586396; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001	66	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3335	3349		10.1074/jbc.M117.816280	http://dx.doi.org/10.1074/jbc.M117.816280			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348171	Green Published, hybrid			2022-12-26	WOS:000426562800025
J	Gallie, DR				Gallie, Daniel R.			Plant growth and fertility requires functional interactions between specific PABP and elF4G gene family members	PLOS ONE			English	Article							POLY(A) BINDING-PROTEIN; EUKARYOTIC TRANSLATION INITIATION; CAP-INDEPENDENT TRANSLATION; POLY(A)-BINDING PROTEIN; MESSENGER-RNA; ARABIDOPSIS-THALIANA; CYTOPLASMIC EXTRACTS; FACTOR EIFISO4G; YEAST; EIF4B	The initiation of protein synthesis requires the involvement of the eukaryotic translation initiation factor (elF) 4G to promote assembly of the factors needed to recruit a 40S ribosomal subunit to an mRNA. Although many eukaryotes express two elF4G isoforms that are highly similar, those in plants, referred to as elF4G and elFiso4G, are highly divergent in size, sequence, and domain organization. Species of the Brassicaceae and the Cleomaceae also express a divergent elFiso4G isoform, referred to as elFiso4G2, not found elsewhere in the plant kingdom. Despite their divergence, elF4G and elFiso4G interact with elF4A, elF4B, and elF4E isoforms needed for binding an mRNA. elF4G and elFiso4G also interact with the poly(A)-binding protein (PABP) which promotes ribosome recruitment to an mRNA. Increasing the complexity of such an interaction, however, Arabidopsis also expresses three PABP isoforms (PAB2, PAB4, and PAB8) in vegetative and reproductive tissues. In this study, the functional interactions among the elF4G and the widely-expressed PABP isoforms were examined. Loss of PAB2 or PAB8 in combination with loss of elF4G or elFiso4G had little to no effect on growth or fertility whereas pab2 pab8 eif4g or pab2 pab8 eifiso4g 1/2 mutants exhibited smaller stature and reduced fertility. Although the pab4 eifiso4g1 mutant grows normally and is fertile, pab4 eif4g or pab4 eifiso4g2 mutants could not be isolated. Even pab4/PAB4 eif4g/eIF4G heterozygous plants exhibited growth defects and low fertility. Mutant co-inheritance analysis in reciprocal crosses with wild-type plants revealed that most ovaries and pollen from pab4/PAB4 eif4g/elF4G plants were PAB4 eif4g. Similarly, co-inheritance studies with pab4/PAB4 eifiso4g2/elFiso4G2 plants suggested most ovaries were PAB4 eifiso4g2. These results suggest that a functional interaction between PAB4 and elF4G and between PAB4 and elFiso4G2 is required for growth and normal fertility.	[Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu		gALLIE, Daniel/0000-0001-9212-5764	National Science Foundation [DBI-0820047]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This work was supported by grants from the National Science Foundation (DBI-0820047) to DRG and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belostotsky DA, 2003, GENETICS, V163, P311; Belostotsky DA, 1996, PLANT CELL, V8, P1261, DOI 10.1105/tpc.8.8.1261; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Callot C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27940; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Chekanova JA, 2001, CURR BIOL, V11, P1207, DOI 10.1016/S0960-9822(01)00371-2; Chen Z, 2014, J BIOL CHEM, V289, P13926, DOI 10.1074/jbc.M114.555151; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; Cheng SJ, 2010, BIOCHEMISTRY-US, V49, P8251, DOI 10.1021/bi1008529; Ford LP, 1997, MOL CELL BIOL, V17, P398, DOI 10.1128/MCB.17.1.398; Gallie DR, 2017, TRANSLATION, V5, DOI 10.1080/21690731.2017.1295129; Gallie DR, 2016, J BIOL CHEM, V291, P1501, DOI 10.1074/jbc.M115.692939; Gallie DR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0238-4; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; HILSON P, 1993, PLANT PHYSIOL, V103, P525, DOI 10.1104/pp.103.2.525; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Palanivelu R, 2000, PLANT J, V22, P199, DOI 10.1046/j.1365-313x.2000.00720.x; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Peterson R., 2010, International Journal of Plant Biology, V1, P66; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilusz CJ, 2001, RNA, V7, P1416	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191474	10.1371/journal.pone.0191474	http://dx.doi.org/10.1371/journal.pone.0191474			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381712	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800021
J	Qian, P; Jiang, T; Wang, X; Song, F; Chen, C; Shen, XJ				Qian, Ping; Jiang, Tao; Wang, Xin; Song, Fei; Chen, Chen; Shen, Xingjia			bmo-miR-275 down-regulates expression of Bombyx mori sericin gene 2 in vitro	PLOS ONE			English	Article							SILKWORM; BIOGENESIS; MICRORNAS	We hypothesized that bmo-miR-275 has a potential regulatory function regarding the expression of sericin gene 2 (BmSer-2). First, we examined the expression of bmo-miR-275 and its target gene BmSer-2 in seven different tissues from 5th instar day-3 silkworm larvae. The results showed that they were both specifically expressed in the middle silk gland, implying that spatio-temporal conditions are required for bmo-miR-275 to regulate the expression of BmSer-2. To test this hypothesis, we constructed a pri-bmo-miR-275 expressing plasmid pcDNA3.0 [ie7-egfp-pri-bmo-miR-275-SV40] and BmSer-2-3'UTR recombinant reporter plasmids pGL3.0 [A3-luc-Ser-2-3' UTR-SV40]. Finally, BmN cells were harvested and luciferase activity was detected. Results showed that luciferase activity was reduced significantly (P<0.05) in BmN cells co-transfected with pcDNA3.0 [ie1-egfp-pri-bmo-miR-275-SV40] and pGL3.0 [A3-luc-Ser-2-3'UTR-SV40], suggesting that bmo-miR-275 can down-regulate the expression of BmSer-2 in vitro. Our results improve the understanding of the regulatory function of Bombyx mori miRNA on the expression of genes regulating silk formation.	[Qian, Ping; Jiang, Tao; Wang, Xin; Song, Fei; Chen, Chen; Shen, Xingjia] Jiangsu Univ Sci & Technol, Sch Biotechnol, Jiangsu Key Lab Sericultural Biol & Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Qian, Ping; Shen, Xingjia] Chinese Acad Agr Sci, Sericultural Res Inst, Minist Agr, Key Lab Silkworm & Mulberry Genet Improvement, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Shen, XJ (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Jiangsu Key Lab Sericultural Biol & Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Shen, XJ (corresponding author), Chinese Acad Agr Sci, Sericultural Res Inst, Minist Agr, Key Lab Silkworm & Mulberry Genet Improvement, Zhenjiang, Jiangsu, Peoples R China.	shenxjsri@163.com			National Nature Science Foundation of China [31402143, 31672490]; Nature Science Foundation of JiangSu Province [BK20141285]; Doctoral Scientific Research Foundation of Jiangsu University of Science and Technology [1732931702]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province); Doctoral Scientific Research Foundation of Jiangsu University of Science and Technology	This work is funded by the National Nature Science Foundation of China (Grant Nos. 31402143 to PQ, 31672490 to XS), the Nature Science Foundation of JiangSu Province (Grant No. BK20141285 to XS), and the Doctoral Scientific Research Foundation of Jiangsu University of Science and Technology (Grant No. 1732931702 to PQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Chan WC, 2012, GENOMICS, V100, P141, DOI 10.1016/j.ygeno.2012.06.007; Da Sacco L, 2013, INT J MOL SCI, V14, P480, DOI 10.3390/ijms14010480; Ding Jiandong, 2012, Genomics Proteomics & Bioinformatics, V10, P264, DOI 10.1016/j.gpb.2012.09.003; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; He Xiang-jun, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P691; Huang Y, 2012, RUSS J BIOORG CHEM+, V38, P417, DOI 10.1134/S1068162012030168; Huang Y, 2011, MOL BIOL+, V45, P576, DOI 10.1134/S0026893311040133; Huang Y, 2011, J ZHEJIANG UNIV-SC B, V12, P527, DOI 10.1631/jzus.B1000296; Huang Y, 2010, MOL BIOL REP, V37, P3171, DOI 10.1007/s11033-009-9897-4; Jackson RJ, 2007, SCI STKE, V2007, P214; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; [秦俭 Qin Jian], 2010, [蚕业科学, Acta Sericologica Sinica], V36, P645; Sen R, 2014, SCI WORLD J, DOI 10.1155/2014/896206; Song F., 2014, SCI SERICULT, V40, P404; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhao QL, 2007, Z NATURFORSCH C, V62, P875; 薛茜, 2010, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V26, P93	26	8	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190464	10.1371/journal.pone.0190464	http://dx.doi.org/10.1371/journal.pone.0190464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381729	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800007
J	Dufour, C; Claudel, A; Joubarne, N; Merindol, N; Maisonnet, T; Masroori, N; Plourde, MB; Berthoux, L				Dufour, Caroline; Claudel, Alix; Joubarne, Nicolas; Merindol, Natacha; Maisonnet, Tara; Masroori, Nasser; Plourde, Melodie B.; Berthoux, Lionel			Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1	PLOS ONE			English	Article							HUMAN TRIM5-ALPHA; HUMAN-CELLS; IMMUNODEFICIENCY-VIRUS; RESTRICTION; GENERATION; INFECTION; BIOLOGY; SYSTEM; DOMAIN; REF1	The type I interferon (IFN-I)-inducible human restriction factor TRIM5 alpha inhibits the infection of human cells by specific nonhuman retroviruses, such as N-MLV and EIAV, but does not generally target HIV-1. However, the introduction of two aminoacid substitutions, R332G and R355G, in the human TRIM5 alpha (huTRIM5 alpha) domain responsible for retroviral capsid recognition leads to efficient HIV-1 restriction upon stable over-expression. CRISPR-Cas-based approaches to precisely edit DNA could be employed to modify TRIM5 in human cells. Toward this aim, we used a DNA transfection-based CRISPR-Cas9 genome editing protocol to successfully mutate TRIM5 to its potentially HIV-1-restrictive version by homology-directed repair (HDR) in HEK293T cells. Nine clones bearing at least one HDR-edited TRIM5 allele containing both mutations were isolated (5.6% overall efficiency), whereas another one contained only the R332G mutation. Of concern, several of these HDR-edited clones contained on-target undesired mutations, and none had all the alleles corrected. Our study demonstrates the feasibility of editing the TRIM5 gene in human cells and identifies the main challenges to be addressed in order to use this approach to confer protection from HIV-1.	[Dufour, Caroline; Claudel, Alix; Joubarne, Nicolas; Merindol, Natacha; Maisonnet, Tara; Masroori, Nasser; Plourde, Melodie B.; Berthoux, Lionel] Univ Quebec Trois Rivieres, Dept Med Biol, Lab Antiviral Immun, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Berthoux, L (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, Lab Antiviral Immun, Trois Rivieres, PQ, Canada.	berthoux@uqtr.ca	Merindol, Natacha/AAB-3768-2021	Merindol, Natacha/0000-0001-6235-6465; Berthoux, Lionel/0000-0002-7776-5058; Masroori, Nasser/0000-0002-5825-1406	Canadian Institutes of Health Research (CIHR) [MOP-102712]; National Sciences and Engineering Council of Canada [DDG-2015-00016]; CIHR Canada Graduate Scholarships-Master's Program award; Fonds de Recherche du Quebec - Sante (FRQS); CIHR; FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Canada Graduate Scholarships-Master's Program award(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This research received support from the Canadian Institutes of Health Research (CIHR; MOP-102712) and from the National Sciences and Engineering Council of Canada (DDG-2015-00016). CD is the recipient of a CIHR Canada Graduate Scholarships-Master's Program award and a Master's training scholarship from the Fonds de Recherche du Quebec - Sante (FRQS). NMe received postdoctoral fellowships from CIHR and from FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/NMETH.4265, 10.1038/nmeth.4265]; Battivelli E, 2011, J VIROL, V85, P7828, DOI 10.1128/JVI.00648-11; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Berthoux L, 2005, J VIROL, V79, P7883, DOI 10.1128/JVI.79.12.7883-7888.2005; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Jung U, 2015, HUM GENE THER, V26, P664, DOI 10.1089/hum.2015.059; Kan YN, 2017, GENOME RES, V27, P1099, DOI 10.1101/gr.214775.116; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kutluay SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003214; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Malbec M, 2010, VIROLOGY, V405, P414, DOI 10.1016/j.virol.2010.06.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Masroori N, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00233-17; Masroori N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0253-1; Nepveu-Traversy ME, 2014, VIRUS RES, V184, P30, DOI 10.1016/j.virusres.2014.02.013; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pham QT, 2010, GENE THER, V17, P859, DOI 10.1038/gt.2010.40; Pham QT, 2013, VIRUS RES, V173, P306, DOI 10.1016/j.virusres.2013.01.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takeda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121199; Ungerer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39681; Walker JE, 2012, J VIROL, V86, P5719, DOI 10.1128/JVI.06300-11; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042	38	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191709	10.1371/journal.pone.0191709	http://dx.doi.org/10.1371/journal.pone.0191709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373607	Green Submitted, gold, Green Published			2022-12-26	WOS:000423425400021
J	Plytycz, B; Bigaj, J; Osikowski, A; Hofman, S; Falniowski, A; Panz, T; Grzmil, P; Vandenbulcke, F				Plytycz, Barbara; Bigaj, Janusz; Osikowski, Artur; Hofman, Sebastian; Falniowski, Andrzej; Panz, Tomasz; Grzmil, Pawel; Vandenbulcke, Franck			The existence of fertile hybrids of closely related model earthworm species, Eisenia andrei and E-fetida	PLOS ONE			English	Article							FOETIDA SAVIGNY; PHYTOCHELATIN SYNTHASE; MICROSATELLITE MARKERS; HORMOGASTER-ELISAE; CADMIUM EXPOSURE; 1972 OLIGOCHAETA; MITOCHONDRIAL; LUMBRICIDAE; DNA; REPRODUCTION	Lumbricid earthworms Eisenia andrei (Ea) and E. fetida (Ef) are simultaneous hermaphrodites with reciprocal insemination capable of self- fertilization while the existence of hybridization of these two species was still debatable. During the present investigation fertile hybrids of Ea and Ef were detected. Virgin specimens of Ea and Ef were laboratory crossed (Ea+Ef) and their progeny was doubly identified. 1 -identified by species-specific maternally derived haploid mitochondrial DNA sequences of the COI gene being either 'a' for worms hatched from Ea ova or 'f' for worms hatched from Ef ova. 2 +/- identified by the diploid maternal/paternal nuclear DNA sequences of 28s rRNA gene being either 'AA' for Ea, 'FF' for Ef, or AF/FA for their hybrids derived either from the 'aA' or 'fF' ova, respectively. Among offspring of Ea+ Ef pairs in F1 generation there were mainly aAA and fFF earthworms resulted from the facilitated self-fertilization and some aAF hybrids from aA ova but none fFA hybrids from fF ova. In F2 generation resulting from aAF hybrids mated with aAA a new generations of aAA and aAF hybrids were noticed, while aAF hybrids mated with fFF gave fFF and both aAF and fFA hybrids. Hybrids intercrossed together produced plenty of cocoons but no hatchlings independently whether aAF+aAF or aAF+fFA were mated. These results indicated that Ea and Ef species, easy to maintain in laboratory and commonly used as convenient models in biomedicine and ecotoxicology, may also serve in studies on molecular basis of interspecific barriers and mechanisms of introgression and speciation. Hypothetically, their asymmetrical hybridization can be modified by some external factors.	[Plytycz, Barbara; Bigaj, Janusz] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland; [Osikowski, Artur] Agr Univ Krakow, Dept Anim Anat, Krakow, Poland; [Hofman, Sebastian] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Comparat Anat, Krakow, Poland; [Falniowski, Andrzej] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Malacol, Krakow, Poland; [Panz, Tomasz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Grzmil, Pawel] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Genet & Evolut, Krakow, Poland; [Vandenbulcke, Franck] Univ Lille, Ecol Numer & Ecotoxicol, Nord France, Lille, France	Jagiellonian University; Agricultural University Krakow; Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Universite de Lille - ISITE; Universite de Lille	Plytycz, B (corresponding author), Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland.	Barbara.plytycz@uj.edu.pl	Hofman, Sebastian/U-4620-2018; Panz, Tomasz/AAN-4799-2021	Hofman, Sebastian/0000-0001-6044-3055; Plytycz, Barbara/0000-0002-3869-500X; Osikowski, Artur/0000-0001-6646-2687; Vandenbulcke, Franck/0000-0002-9735-1784; Grzmil, Pawel/0000-0001-9780-2007	National Science Centre, Poland [2016/23/B/ NZ8/00748]; Ministry of Science and Higher Education, Poland [K/ZDS/005405]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	Investigations are financially supported by the National Science Centre, Poland (2016/23/B/ NZ8/00748; BP) and Ministry of Science and Higher Education, Poland (K/ZDS/005405).	Albani JR, 2003, PHOTOCHEM PHOTOBIOL, V78, P599, DOI 10.1562/0031-8655(2003)078<0599:FFOEFA>2.0.CO;2; [Anonymous], 2004, GUID TEST CHEM 222; Brulle F, 2006, ENVIRON SCI TECHNOL, V40, P2844, DOI 10.1021/es052299x; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Bundy JG, 2002, FEBS LETT, V521, P115, DOI 10.1016/S0014-5793(02)02854-5; Csuzdi Cs., 1991, P547; Cosin DJD, 2011, SOIL BIOL, V24, P69, DOI 10.1007/978-3-642-14636-7_5; Dominguez J, 2005, PEDOBIOLOGIA, V49, P81, DOI 10.1016/j.pedobi.2004.08.005; Dominguez J, 2003, PEDOBIOLOGIA, V47, P530, DOI 10.1078/0031-4056-00224; Dupont L, 2016, MOL ECOL RESOUR, V16, P883, DOI 10.1111/1755-0998.12517; Dvorak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079257; EC (Environment Canada), 2004, 1RM43 EC EPS; Elvira C, 1996, PEDOBIOLOGIA, V40, P377; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Havill NP, 2017, B ENTOMOL RES, V107, P241, DOI [10.1017/s0007485316000857, 10.1017/S0007485316000857]; Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914; Homa J, 2015, ENVIRON TOXICOL CHEM, V34, P1397, DOI 10.1002/etc.2944; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; ISO (International Organization for Standardization), 2008, 175121 ISO; Jacobsen MW, 2017, HEREDITY, V118, P266, DOI 10.1038/hdy.2016.96; Latif R, 2017, EUR J SOIL BIOL, V81, P55, DOI 10.1016/j.ejsobi.2017.06.007; Luo SM, 2013, J GENET GENOMICS, V40, P549, DOI 10.1016/j.jgg.2013.08.004; Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012; Martinsson Svante, 2017, Molecular Phylogenetics and Evolution, V106, P18, DOI 10.1016/j.ympev.2016.09.011; Monroy F, 2006, CR BIOL, V329, P912, DOI 10.1016/j.crvi.2006.08.001; Novo M, 2008, MOL ECOL RESOUR, V8, P901, DOI 10.1111/j.1755-0998.2008.02105.x; Novo M, 2013, PEDOBIOLOGIA, V56, P97, DOI 10.1016/j.pedobi.2013.01.002; Novo M, 2010, PEDOBIOLOGIA, V53, P375, DOI 10.1016/j.pedobi.2010.07.002; Otomo PV, 2009, B ENVIRON CONTAM TOX, V82, P261, DOI 10.1007/s00128-008-9585-4; Paces J, 2017, MOL ECOL; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Plytycz B, 2016, ISJ-INVERT SURVIV J, V13, P315; Plytycz B, 2015, ISJ-INVERT SURVIV J, V12, P176; Porto PG, 2012, BIOL J LINN SOC, V107, P175, DOI 10.1111/j.1095-8312.2012.01913.x; REINECKE AJ, 1991, BIOL FERT SOILS, V11, P295, DOI 10.1007/BF00335851; Rombke J, 2016, APPL SOIL ECOL, V104, P3, DOI 10.1016/j.apsoil.2015.02.010; Rorat A, 2016, ENVIRON SCI POLLUT R, V23, P3026, DOI 10.1007/s11356-015-5635-8; Rorat A, 2014, J EXP ZOOL PART A, V321, P28, DOI 10.1002/jez.1834; Santocki M, 2016, APPL SOIL ECOL, V104, P163, DOI 10.1016/j.apsoil.2015.08.022; Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010; Schilthuizen M, 2013, J EVOLUTION BIOL, V26, P288, DOI 10.1111/jeb.12056; SHEPPARD P S, 1988, P83; Somers CM, 2011, PEDOBIOLOGIA, V54, P111, DOI 10.1016/j.pedobi.2010.11.002; Souleman D, 2016, EUR J SOIL BIOL, V74, P76, DOI 10.1016/j.ejsobi.2016.03.009; Suleiman H, 2017, BIORESOURCE TECHNOL, V241, P103, DOI 10.1016/j.biortech.2017.05.104; Swiderska B, 2017, DEV COMP IMMUNOL, V67, P404, DOI 10.1016/j.dci.2016.08.011; Takacs V, 2016, FOLIA BIOL-KRAKOW, V64, P275, DOI 10.3409/fb64_4.275; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951	49	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191711	10.1371/journal.pone.0191711	http://dx.doi.org/10.1371/journal.pone.0191711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370238	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600083
J	Lima, SGC; Sousa-Lima, RS; Tokumaru, RS; Nogueira, SLG; Nogueira, SSC				Lima, Stella G. C.; Sousa-Lima, Renata S.; Tokumaru, Rosana S.; Nogueira-Filho, Sergio L. G.; Nogueira, Selene S. C.			Vocal complexity and sociality in spotted paca (Cuniculus paca)	PLOS ONE			English	Article							CTENOMYS-TALARUM RODENTIA; COMMUNICATIVE COMPLEXITY; BEHAVIORAL-RESPONSES; OCTODON-DEGUS; TRACT LENGTH; EVOLUTION; REPERTOIRE; VOCALIZATIONS; CONSTRAINTS; POPULATION	The evolution of sociality is related to many ecological factors that act on animals as selective forces, thus driving the formation of groups. Group size will depend on the payoffs of group living. The Social Complexity Hypothesis for Communication (SCHC) predicts that increases in group size will be related to increases in the complexity of the communication among individuals. This hypothesis, which was confirmed in some mammal societies, may be useful to trace sociality in the spotted paca (Cuniculus paca), a Neotropical caviomorph rodent reported as solitary. There are, however, sightings of groups in the wild, and farmers easily form groups of spotted paca in captivity. Thus, we aimed to describe the acoustic repertoire of captive spotted paca to test the SCHC and to obtain insights about the sociability of this species. Moreover, we aimed to verify the relationship between group size and acoustic repertoire size of caviomorph rodents, to better understand the evolution of sociality in this taxon. We predicted that spotted paca should display a complex acoustic repertoire, given their social behavior in captivity and group sightings in the wild. We also predicted that in caviomorph species the group size would increase with acoustic repertoire, supporting the SCHC. We performed a Linear Discriminant Analysis (LDA) based on acoustic parameters of the vocalizations recorded. In addition, we applied an independent contrasts approach to investigate sociality in spotted paca following the social complexity hypothesis, independent of phylogeny. Our analysis showed that the spotted paca's acoustic repertoire contains seven vocal types and one mechanical signal. The broad acoustic repertoire of the spotted paca might have evolved given the species' ability to live in groups. The relationship between group size and the size of the acoustic repertoires of caviomorph species was confirmed, providing additional support for the SCHC in yet another group of diverse mammals-caviomorph rodents.	[Lima, Stella G. C.; Sousa-Lima, Renata S.] Univ Fed Rio Grande do Norte, Lab Bioacust, Dept Fisiol & Comportamento, Programa Posgrad Psicobiol, Natal, RN, Brazil; [Tokumaru, Rosana S.] Univ Fed Esprito Santo, Dept Psicol Social & Desenvolvimento, Vitoria, ES, Brazil; [Nogueira-Filho, Sergio L. G.; Nogueira, Selene S. C.] Univ Estadual Santa Cruz, Lab Etol Aplicada, Dept Ciencias Biol, Ilheus, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Espirito Santo; Universidade Estadual de Santa Cruz	Nogueira, SSC (corresponding author), Univ Estadual Santa Cruz, Lab Etol Aplicada, Dept Ciencias Biol, Ilheus, BA, Brazil.	seleneuesc@gmail.com	Sousa-Lima, Renata S./O-7550-2015; Nogueira, Selene/W-5237-2019; Nogueira, Selene/I-1843-2013; Nogueira-Filho, Sérgio L.G./F-6264-2014; Sousa-Lima, Renata/AAD-4096-2020	Sousa-Lima, Renata S./0000-0002-2638-1695; Nogueira, Selene/0000-0001-8078-4172; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); UESC; National Council for Scientific and Technological Development (CNPq) [300587/2009-0, 306154/2010-2]; CAPES [88881.119854/2016-01, 88881.119838/2016-01]	Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); UESC; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD), UESC and the National Council for Scientific and Technological Development (CNPq) (Processes #300587/2009-0 and #306154/2010-2). Selene Nogueira and Sergio Nogueira-Filho received grant from CAPES (Processes #88881.119854/2016-01 and #88881.119838/2016-01, respectively). The funding agencies hadno role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Alencar Jr RN, 2011, THESIS; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aquino Rolando, 2009, Rev. peru biol., V16, P67; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Asher MR, 2004, J MAMMAL, V85, P788, DOI 10.1644/BNS-012; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; Beck-King H, 1999, BIOTROPICA, V31, P675, DOI 10.1111/j.1744-7429.1999.tb00417.x; Begall S, 1999, J MAMMAL, V80, P210, DOI 10.2307/1383221; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Boersma P., 2013, PRAAT DOING PHONETIC; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BUSCH C, 1989, J MAMMAL, V70, P204, DOI 10.2307/1381691; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Charif R. A., 2008, RAVEN PRO 1 3 USERS; David-Barrett D, 2013, P R SOC B, V280; DUBOST G, 1988, J ZOOL, V214, P107, DOI 10.1111/j.1469-7998.1988.tb04990.x; Ebensperger LA, 2006, BEHAV ECOL, V17, P410, DOI 10.1093/beheco/arj048; Ebensperger LA, 2002, OIKOS, V98, P491, DOI 10.1034/j.1600-0706.2002.980313.x; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; Ebensperger LA, 2011, J MAMMAL, V92, P21, DOI 10.1644/09-MAMM-S-383.1; Ebenspherger LA, 2001, BEHAV ECOL, V12, P227, DOI 10.1093/beheco/12.2.227; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; EMMONS L, 2016, IUCN RED LIST THREAT; Emmons LH, 1997, NEOTROPICAL RAINFORE, P322; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2003, INFERRING PHYLOGENIE, P1; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Figueroa-de Leon AF, 2016, REV MEX BIODIVERS, V87, P1062, DOI 10.1016/j.rmb.2016.07.009; Fischer J, 2016, ANIM BEHAV, V124, P1; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Francescoli G, SOCIOBIOLOGY CAVIOMO; Freeberg TM, 2006, PSYCHOL SCI, V17, P557, DOI 10.1111/j.1467-9280.2006.01743.x; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; Gallina S, 2012, REV BIOL TROP, V60, P1345; Krause J., 2002, LIVING GROUPS, P1; Leuchtenberger C, 2016, MAMMALIA, P1, DOI DOI 10.1515/MAMMALIA-2015-0129; Leuchtenberger C, 2014, J ACOUST SOC AM, V136, P2861, DOI 10.1121/1.4896518; Lima S., 2016, THESIS; Long CV, 2007, BIOACOUSTICS, V16, P223, DOI 10.1080/09524622.2007.9753579; Maher CR, 2016, SOCIOBIOLOGY OF CAVIOMORPH RODENTS: AN INTEGRATIVE APPROACH, P28; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; May-Collado LJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-136; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; McGarigal K., 2000, MULTIVARIATE STAT WI, P1; MONES A, 1986, Mammalian Species, P1, DOI 10.2307/3503784; Monticelli PF, 2013, BIOACOUSTICS, V22, P49, DOI 10.1080/09524622.2012.711516; Morrell LJ, 2011, P ROY SOC B-BIOL SCI, V278, P605, DOI 10.1098/rspb.2010.1605; Nogueira Filho SLG, 1999, CRIAC PACAS AGOUTI P, P1; Nowak RM, 1999, WALKERS MAMMALS WORL, P1; NOYMEIR I, 1975, J ECOL, V63, P779, DOI 10.2307/2258601; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Patton James L., 2015, P726; Pollard KA, 2012, PHILOS T R SOC B, V367, P1869, DOI 10.1098/rstb.2011.0221; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Queirolo D., 2008, IUCN RED LIST THREAT; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Riede T, 1999, J EXP BIOL, V202, P2859; Rowe DL, 2002, MOL BIOL EVOL, V19, P263, DOI 10.1093/oxfordjournals.molbev.a004080; Rubenstein D. R., 2017, COMP SOCIAL EVOLUTIO; Schleich CE, 2002, J ETHOL, V20, P123, DOI 10.1007/s10164-002-0064-9; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Smith JE, 2017, COMPARATIVE SOCIAL EVOLUTION, P284; SMYTHE N, 1987, APPL ANIM BEHAV SCI, V17, P155, DOI 10.1016/0168-1591(87)90017-7; Smythe N, 1995, DOMESTICACION CRIA P, P1; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tomasco IH, 2017, GENE, V628, P275, DOI 10.1016/j.gene.2017.07.057; Topping MG, 1999, CAN J ZOOL, V77, P480, DOI 10.1139/cjz-77-3-480; Veitl Silke, 2000, Bioacoustics, V11, P129; Verdade Luciano M., 1996, Revista Brasileira de Biologia, V56, P1; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322	79	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190961	10.1371/journal.pone.0190961	http://dx.doi.org/10.1371/journal.pone.0190961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364898	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500029
J	Yuan, X; Wen, B				Yuan, Xia; Wen, Bin			Seed germination response to high temperature and water stress in three invasive Asteraceae weeds from Xishuangbanna, SW China	PLOS ONE			English	Article							AGERATUM-CONYZOIDES L.; HORSEWEED CONYZA-CANADENSIS; ECOLOGY; SAFLUFENACIL; POTENTIALS; EMERGENCE; PLANT	Crassocephalum crepidioides, Conyza canadensis, and Ageratum conyzoides are alien annuals naturalized in China, which produce a large number of viable seeds every year. They widely grow in Xishuangbanna, becoming troublesome weeds that compete with crops for water and nutrients. As seed germination is among the most important life-stages which contribute to plant distribution and invasiveness, its adaptation to temperature and water stress were investigated in these three species. Results showed that: (1) These three species have wide temperature ranges to allow seed germination, i.e., high germination and seedling percentages were achieved between 15 degrees C and 30 degrees C, but germination was seriously inhibited at 35 degrees C; only A. conyzoides demonstrated relative preference for warmer temperatures with approximately 25% germination and seedling percentage at 35 degrees C; (2) light was a vital germination prerequisite for C. crepidioides and A. conyzoides, whereas most C. canadensis seeds germinated in full darkness; (3) Although all three species have good adaptation to bare ground habitat characterized by high temperatures and water stress, including their tolerance to soil surface temperatures of 70 E C in air-dried seeds, A. conyzoides seeds exhibited higher tolerance to both continuous and daily periodic high-temperature treatment at 40 E C, and to water restriction (e.g., ca. 65% seeds germinated to -0.8 MPa created by NaCl), which is consistent with their field behavior in Xishuangbanna. This study suggests that seed high-temperature tolerance contributes to the weed attributes of these three species, and that adaptation to local micro-habitats is a critical determinant for invasiveness of an alien plant.	[Yuan, Xia; Wen, Bin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan, Peoples R China; [Yuan, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wen, B (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan, Peoples R China.	wenb@xtbg.org.cn			National Natural Science Foundation of China [31170626]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Award Number 31170626, Recipient: Bin Wen.	Bajwa AA, 2016, ENVIRON SCI POLLUT R, V23, P24694, DOI 10.1007/s11356-016-7794-7; Baskin CC, 2004, WEED RES, V44, P60, DOI 10.1046/j.1365-3180.2003.00373.x; Bear JL, 2012, AUST J BOT, V60, P615, DOI 10.1071/BT12058; Budd CM, 2017, WEED SCI, V65, P275, DOI 10.1017/wsc.2016.24; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chen GQ, 2009, WEED BIOL MANAG, V9, P123, DOI 10.1111/j.1445-6664.2009.00329.x; Diez JM, 2009, J APPL ECOL, V46, P1210, DOI 10.1111/j.1365-2664.2009.01725.x; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; DiTomaso JM, 1999, WEED SCI, V47, P233, DOI 10.1017/S0043174500091669; Djurdjevic L, 2011, FLORA, V206, P921, DOI 10.1016/j.flora.2011.06.001; Dong Hong-yun, 2010, Journal of Plant Resources and Environment, V19, P48; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Ekeleme F, 2005, WEED SCI, V53, P55, DOI 10.1614/WS-03-147R1; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heger Tina, 2003, Biological Invasions, V5, P313; Hossain MA, 1999, WEED SCI, V47, P651, DOI 10.1017/S0043174500091281; Huang QQ, 2016, ECOL RES, V31, P145, DOI 10.1007/s11284-015-1323-x; Kohli RK, 2006, BIOL INVASIONS, V8, P1501, DOI 10.1007/s10530-005-5842-1; LANG ARG, 1967, AUST J CHEM, V20, P2017, DOI 10.1071/CH9672017; Ma J. S., 2013, CHECKLIST CHINESE IN; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Nakamura I, 2009, WEED BIOL MANAG, V9, P315, DOI 10.1111/j.1445-6664.2009.00356.x; Okunade AL, 2002, FITOTERAPIA, V73, P1, DOI 10.1016/S0367-326X(01)00364-1; Pyseck P, 2007, TRAITS ASS INVASIVEN, P97; Qiang, 2011, CHINAS INVASIVE ALIE; R Core Team, 2021, R LANG ENV STAT; Rashid I, 2007, ANN APPL BIOL, V150, P361, DOI 10.1111/j.1744-7348.2007.00136.x; REJMANEK M, 1995, PLANT INVASIONS, P3; Santos RF, 2016, REV BRAS FARMACOGN, V26, P679, DOI 10.1016/j.bjp.2016.07.002; Schutz W, 2002, ANN BOT-LONDON, V90, P707, DOI 10.1093/aob/mcf250; Shekhar TC, 2012, INT J PHARM PHYTOPHA, V1, P391; Tozzi E, 2014, WEED RES, V54, P178, DOI 10.1111/wre.12065; Waggoner BS, 2011, WEED TECHNOL, V25, P310, DOI 10.1614/WT-D-10-00161.1; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Weaver SE, 2001, CAN J PLANT SCI, V81, P867, DOI 10.4141/P00-196; Wen B, 2015, WEED RES, V55, P155, DOI 10.1111/wre.12134; Wen B, 2016, J PLANT RES, V129, P637, DOI 10.1007/s10265-016-0810-7; Bin W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141567; Xuan TD, 2004, CROP PROT, V23, P915, DOI 10.1016/j.cropro.2004.02.005; Ye J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175948	41	24	25	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191710	10.1371/journal.pone.0191710	http://dx.doi.org/10.1371/journal.pone.0191710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364942	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500069
J	Zhou, J; Bethune, MT; Malkova, N; Sutherland, AM; Comin-Anduix, B; Su, YP; Baltimore, D; Ribas, A; Heath, JR				Zhou, Jing; Bethune, Michael T.; Malkova, Natalia; Sutherland, Alexander M.; Comin-Anduix, Begonya; Su, Yapeng; Baltimore, David; Ribas, Antoni; Heath, James R.			A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication	PLOS ONE			English	Article							IN-VIVO; TRANSCRIPTION FACTOR; DENDRITIC CELLS; LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; HUMAN EFFECTOR; MEMORY; IMMUNOTHERAPY; CANCER; RECEPTOR	For adoptive cell transfer (ACT) immunotherapy of tumor-reactive T cells, an effective therapeutic outcome depends upon cell dose, cell expansion in vivo through a minimally differentiated phenotype, long term persistence, and strong cytolytic effector function. An incomplete understanding of the biological coupling between T cell expansion, differentiation, and response to stimulation hinders the co-optimization of these factors. We report on a biophysical investigation of how the short-term kinetics of T cell functional activation, through molecular stimulation and cell-cell interactions, competes with phenotype differentiation. T cells receive molecular stimulation for a few minutes to a few hours in bulk culture. Following this priming period, the cells are then analyzed at the transcriptional level, or isolated as single cells, with continuing molecular stimulation, within microchambers for analysis via 11-plex secreted protein assays. We resolve a rapid feedback mechanism, promoted by T cell-T cell contact interactions, which strongly amplifies T cell functional performance while yielding only minimal phenotype differentiation. When tested in mouse models of ACT, optimally primed T cells lead to complete tumor eradication. A similar kinetic process is identified in CD8(+) and CD4(+) T cells collected from a patient with metastatic melanoma.	[Zhou, Jing; Bethune, Michael T.; Sutherland, Alexander M.; Su, Yapeng; Baltimore, David; Ribas, Antoni; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Zhou, Jing; Malkova, Natalia; Sutherland, Alexander M.; Su, Yapeng; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Bethune, Michael T.; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Comin-Anduix, Begonya; Ribas, Antoni] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Heath, JR (corresponding author), CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA.; Heath, JR (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	heath@caltech.edu		Su, Yapeng/0000-0002-6305-8467; Heath, James/0000-0001-5356-4385	National Cancer Institute [R01 CA170689, 5U54 CA119347, 1U54 CA199090-01, CA-16042, AI-28697]; Stand Up 2 Cancer [SU2C-AACR-DT1012]; Jean Perkins Foundation; NATIONAL CANCER INSTITUTE [P30CA016042, R35CA197633] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up 2 Cancer; Jean Perkins Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, grant #'s: R01 CA1 70689, 5U54 CA119347, 1U54 CA199090-01, CA-16042, AI-28697; Jean Perkins Foundation; and Stand Up 2 Cancer SU2C-AACR-DT1012.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Bailey RC, 2007, J AM CHEM SOC, V129, P1959, DOI 10.1021/ja065930i; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chodon T, 2014, CLIN CANCER RES, V20, P2457, DOI 10.1158/1078-0432.CCR-13-3017; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Ibarrondo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076829; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Johnson RA., 2007, APPL MULTIVARIATE ST; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Ma C, 2013, CANCER DISCOV, V3, P418, DOI 10.1158/2159-8290.CD-12-0383; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rossi J, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-2990; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Smirnov P, 2006, MAGN RESON MED, V56, P498, DOI 10.1002/mrm.20996; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Vinay DS, 2014, BMB REP, V47, P122, DOI 10.5483/BMBRep.2014.47.3.283; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Xue Q, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0293-7; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu YW, 2014, CLIN CANCER RES, V20, P3, DOI 10.1158/1078-0432.CCR-13-2573	54	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191634	10.1371/journal.pone.0191634	http://dx.doi.org/10.1371/journal.pone.0191634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360859	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800046
J	Darwiche, W; Gay-Queheillard, J; Delanaud, S; El Sabbouri, HE; Khachfe, H; Joumaa, W; Bach, V; Ramadan, W				Darwiche, Walaa; Gay-Queheillard, Jerome; Delanaud, Stephane; El Sabbouri, Hiba El Khayat; Khachfe, Hassan; Joumaa, Wissam; Bach, Veronique; Ramadan, Wiam			Impact of chronic exposure to the pesticide chlorpyrifos on respiratory parameters and sleep apnea in juvenile and adult rats	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDES; DEVELOPMENTAL NEUROTOXICITY; CHOLINESTERASE INHIBITION; TOXICITY; BRAIN; PATHWAYS; CHILDREN; INSECTICIDES; VENTILATION; DIAPHRAGM	The widely used organophosphorus pesticide chlorpyrifos (CPF) is often detected in food. CPF inhibits acetylcholinesterase and can modify muscle contractility and respiratory patterns. We studied the effects of chronic exposure to CPF on respiratory parameters and diaphragm contractility in 21-and 60-days old rats. Pregnant rats were exposed to oral CPF (1 or 5 mg/kg/day: CPF-1 or CPF-5 groups vs vehicle: controls) from gestation onset up to weaning of the pups that were individually gavaged (CPF or vehicle) thereafter. Two developmental time points were studied: weaning (day 21) and adulthood (day 60). Whole-body plethysmography was used to score breathing patterns and apnea index during sleep. Then, diaphragm strips were dissected for the assessment of contractility and acetylcholinesterase activity. Results showed that the sleep apnea index was higher in CPF-exposed rats than in controls. In adult rats, the expiratory time and tidal volume were higher in CPF-exposed animals than in controls. At both ages, the diaphragm's amplitude of contraction and fatigability index were higher in the CPF-5 group, due to lower acetylcholinesterase activity. We conclude that chronic exposure to CPF is associated with higher sleep apnea index and diaphragm contractility, and modifies respiratory patterns in sleeping juvenile and adult rats.	[Darwiche, Walaa; Gay-Queheillard, Jerome; Delanaud, Stephane; El Sabbouri, Hiba El Khayat; Bach, Veronique] INERIS, PeriTox Perinatal & Risques Tox, UMR I 01, Amiens, France; [Darwiche, Walaa; El Sabbouri, Hiba El Khayat; Joumaa, Wissam; Ramadan, Wiam] Lebanese Univ, Fac Sci, Environm Physiotox Grp, Rammal Hassan Rammal Lab,PhyToxE, Nabatieh, Lebanon; [Khachfe, Hassan; Ramadan, Wiam] Lebanese Int Univ, LIBRA, Beirut, Lebanon	Institut National de l'Environnement Industriel et des Risques (INERIS); Lebanese University	Darwiche, W (corresponding author), INERIS, PeriTox Perinatal & Risques Tox, UMR I 01, Amiens, France.; Darwiche, W (corresponding author), Lebanese Univ, Fac Sci, Environm Physiotox Grp, Rammal Hassan Rammal Lab,PhyToxE, Nabatieh, Lebanon.	walaa.darwiche@u-picardie.fr	stepahne, delanaud/AAD-2762-2022; Bach, Veronique/AAD-5958-2022	EL KHAYAT EL SABBOURI, Hiba/0000-0001-7566-1688; Bach, Veronique/0000-0002-0684-0305; Darwiche, Walaa/0000-0002-8647-2468	Agence Universitaire de la Francophonie; Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon); FHU "1000 premiers jours de vie"	Agence Universitaire de la Francophonie; Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon); FHU "1000 premiers jours de vie"	WD received a postgraduate fellowship from the Agence Universitaire de la Francophonie (Bureau Moyen-Orient) and the Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Jean-Pierre Libert, Professor Pierre Tourneux and Dr. Hussein Ghamlouch for valuable discussions. WD received a postgraduate fellowship from the Agence Universitaire de la Francophonie and the Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon). We also thank the FHU "1000 premiers jours de vie" for their financial support.	BARTHOLOMEW PM, 1985, TOXICOL APPL PHARM, V81, P147, DOI 10.1016/0041-008X(85)90129-2; Berton T, 2014, ENVIRON RES, V132, P311, DOI 10.1016/j.envres.2014.03.034; Bird SB, 2003, ACAD EMERG MED, V10, P295, DOI 10.1111/j.1553-2712.2003.tb01338.x; Bolles HG, 1999, J AGR FOOD CHEM, V47, P1817, DOI 10.1021/jf980962d; Bouvier G, 2006, J EXPO SCI ENV EPID, V16, P417, DOI 10.1038/sj.jes.7500473; BURD PF, 1987, J PHYSIOL-LONDON, V391, P429, DOI 10.1113/jphysiol.1987.sp016747; Carey JL, 2013, RESP PHYSIOL NEUROBI, V189, P403, DOI 10.1016/j.resp.2013.07.022; CHAMBERS JE, 1994, LIFE SCI, V54, P1357, DOI 10.1016/0024-3205(94)00515-X; CHAMBERS JE, 1989, J BIOCHEM TOXICOL, V4, P201, DOI 10.1002/jbt.2570040310; Christon J, 1996, J APPL PHYSIOL, V80, P2102, DOI 10.1152/jappl.1996.80.6.2102; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; CURZIDASCALOVA L, 1983, BIOL NEONATE, V44, P325; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farag AT, 2003, REPROD TOXICOL, V17, P203, DOI 10.1016/S0890-6238(02)00121-1; Gaspari RJ, 2011, NEUROTOXICOLOGY, V32, P206, DOI 10.1016/j.neuro.2011.01.005; GILLIS RA, 1988, J PHARMACOL EXP THER, V247, P765; Hara Y, 2013, AM J OTOLARYNG, V34, P537, DOI 10.1016/j.amjoto.2013.01.014; Houze P, 2008, TOXICOL APPL PHARM, V233, P186, DOI 10.1016/j.taap.2008.08.006; Hulse EJ, 2014, AM J RESP CRIT CARE, V190, P1342, DOI 10.1164/rccm.201406-1150CI; Lu CS, 2008, ENVIRON HEALTH PERSP, V116, P537, DOI 10.1289/ehp.10912; McGuire M, 1998, EXP PHYSIOL, V83, P481, DOI 10.1113/expphysiol.1998.sp004131; MENDELSON WB, 1988, PHYSIOL BEHAV, V43, P229, DOI 10.1016/0031-9384(88)90243-0; Moser VC, 1998, TOXICOL SCI, V46, P211, DOI 10.1006/toxs.1998.2526; Nougadere A, 2012, ENVIRON INT, V45, P135, DOI 10.1016/j.envint.2012.02.001; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; POPE CN, 1991, TOXICOLOGY, V68, P51, DOI 10.1016/0300-483X(91)90061-5; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Proskocil BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010562; Qiao D, 2002, ENVIRON HEALTH PERSP, V110, P1097, DOI 10.1289/ehp.021101097; Ramadan W, 2006, RESP PHYSIOL NEUROBI, V150, P52, DOI 10.1016/j.resp.2005.02.011; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Segura P, 1999, N-S ARCH PHARMACOL, V360, P699, DOI 10.1007/s002109900101; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Tang J, 1999, TOXICOL SCI, V51, P265, DOI 10.1093/toxsci/51.2.265; Villa AF, 2007, TOXICOLOGY, V232, P37, DOI 10.1016/j.tox.2006.12.006; Weldon RH, 2011, J ENVIRON MONITOR, V13, P3136, DOI 10.1039/c1em10469a; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; WRIGHT PG, 1954, J PHYSIOL-LONDON, V126, P52, DOI 10.1113/jphysiol.1954.sp005191	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191237	10.1371/journal.pone.0191237	http://dx.doi.org/10.1371/journal.pone.0191237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357379	gold, Green Published, Green Submitted			2022-12-26	WOS:000422919500011
J	Berry, NT; Hubal, M; Wideman, L				Berry, Nathaniel T.; Hubal, Monica; Wideman, Laurie			The effects of an acute exercise bout on GH and IGF-1 in prediabetic and healthy African Americans: A pilot study investigating gene expression	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; HUMAN GROWTH-HORMONE; BODY-COMPOSITION; DIABETES-MELLITUS; BINDING-PROTEINS; DEFICIENT ADULTS; FACTOR-I; INSULIN; RESISTANCE; PATHOPHYSIOLOGY	The incidence of pre-diabetes (PD) and Type-2 Diabetes Mellitus (T2D) is a worldwide epidemic. African American (AA) individuals are disproportionately more likely to become diabetic than other ethnic groups. Over the long-term, metabolic complications related to diabetes result in significant alterations in growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Considering the limited exercise-related studies in the area of gene expression changes with disease progression, the objective of this study was to examine differences in exercise-induced gene expression related to the GH and IGF-1 pathways in peripheral blood mononuclear cells (PBMCs) of healthy (CON) and PD AA individuals. Design: Ten subjects [5 PD (age = 35 +/- 9.3 yr, BMI = 32.1 +/- 4.0, FBG = 101.8 +/- 1.3 mg/dl) and 5 CON (age = 31 +/- 9.4 yr, BMI = 29.4 +/- 5.2, FBG = 82.8 +/- 9.7 mg/dl)] had blood drawn for RNA isolation prior to exercise (Pre), immediately following acute moderate intensity exercise on a treadmill (Post-1), 6-hours post (Post-6), and 24-hours post (Post-24). Isolation of mRNA from PBMCs was performed using ficoll separation, while the profiling of mRNA expression was performed using Illumina beadchip arrays with standard protocols. Scan results were statistically analyzed for a specific list of genes related to GH and IGF-1. GH and IGF-1 protein levels were also assessed in each sample. To address issues of normality, all GH and IGF-1 data were log-transformed prior to analysis. Statistical significance was set at p<0.05. Results: Group differences for GH2 variant 2 (p = 0.070) and GH2 variant 3 (p = 0.059) were coupled with significant alterations in IGF-1 mRNA over time (p = 0.024). A significant interaction between group and time was observed for GHRH mRNA (p = 0.008). No group differences were observed in GH AUC (p = 0.649),.GH (p = 0.331), GHrec (p = 0.294), or IGF-1 AUC (p = 0.865), representing a similar exercise-induced GH and IGF-1 response for both groups. Conclusions: Analysis of GH and IGF-1 related-gene expression indicates that mild elevations in fasting blood glucose and exercise-induced alterations in gene expression are impacted by the prediabetic state.	[Berry, Nathaniel T.; Wideman, Laurie] Univ N Carolina, Greensboro, NC 27412 USA; [Hubal, Monica] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Hubal, Monica] Childrens Natl Med Ctr, Washington, DC 20010 USA	University of North Carolina; University of North Carolina Greensboro; George Washington University; Children's National Health System	Berry, NT (corresponding author), Univ N Carolina, Greensboro, NC 27412 USA.	ntberry@uncg.edu		Berry, Nathaniel/0000-0001-8089-1955; Hubal, Monica/0000-0001-6579-6036	National Institutes of Health - National Center on Minority Health and Health Disparities [P20MD002289]; National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke [2R23HD050846-06]; National Institutes of Health - National Institute of Neurological Disorders and Stroke [1P30HD40677-06]	National Institutes of Health - National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke; National Institutes of Health - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health - National Center on Minority Health and Health Disparities P20MD002289 (TRIAD Center for Health Disparities) (https://www.nimhd.nih.gov) to LW; National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke 2R23HD050846-06 (Core Molecular & Functional Outcome Measures in Rehabilitation Medicine) (https://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx, https://www.ninds.nih.gov); and National Institutes of Health - National Institute of Neurological Disorders and Stroke 1P30HD40677-06 (Intellectual & Developmental Disabilities Research) (https://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; ASPLIN CM, 1989, J CLIN ENDOCR METAB, V69, P239, DOI 10.1210/jcem-69-2-239; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BINNERTS A, 1992, CLIN ENDOCRINOL, V37, P79, DOI 10.1111/j.1365-2265.1992.tb02287.x; Biondi-Zoccai GGL, 2003, J AM COLL CARDIOL, V41, P1071, DOI 10.1016/S0735-1097(03)00088-3; Carlson LA, 2011, EUR J APPL PHYSIOL, V111, P2919, DOI 10.1007/s00421-011-1923-2; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Carroll PV, 1998, CLIN ENDOCRINOL, V49, P739, DOI 10.1046/j.1365-2265.1998.00600.x; Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET; CHONG PKK, 1994, CLIN ENDOCRINOL, V40, P103, DOI 10.1111/j.1365-2265.1994.tb02451.x; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; DELA F, 1993, J PHYSIOL-LONDON, V469, P615, DOI 10.1113/jphysiol.1993.sp019833; Drogan D, 2016, AM J EPIDEMIOL, V183, P553, DOI 10.1093/aje/kwv188; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Green HJ, 2008, AM J PHYSIOL-REG I, V295, pR1238, DOI 10.1152/ajpregu.00171.2008; HANSEN AP, 1971, J CLIN INVEST, V50, P1806, DOI 10.1172/JCI106671; HANSEN AP, 1970, J CLIN INVEST, V49, P1467, DOI 10.1172/JCI106364; HANSEN AP, 1973, DIABETES, V22, P619, DOI 10.2337/diab.22.8.619; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hara K, 2016, EXPERT OPIN THER TAR, V20, P255, DOI 10.1517/14728222.2016.1098618; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; HOFFMAN DM, 1995, J CLIN ENDOCR METAB, V80, P72, DOI 10.1210/jc.80.1.72; HSIEH SD, 1995, INT J OBESITY, V19, P585; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kraniou GN, 2004, EXP PHYSIOL, V89, P559, DOI 10.1113/expphysiol.2004.027409; Moraes PA, 2014, LIFE SCI, V114, P36, DOI 10.1016/j.lfs.2014.07.040; O'Gorman DJ, 2006, DIABETOLOGIA, V49, P2983, DOI 10.1007/s00125-006-0457-3; PRESS M, 1984, NEW ENGL J MED, V310, P810, DOI 10.1056/NEJM198403293101302; Radom-Aizik S, 1985, J APPL PHYSIOL, V104, P236; Radom-Aizik S, 2012, CTS-CLIN TRANSL SCI, V5, P32, DOI 10.1111/j.1752-8062.2011.00384.x; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Takamura T, 2007, BIOCHEM BIOPH RES CO, V361, P379, DOI 10.1016/j.bbrc.2007.07.006; TANNENBAUM GS, 1990, METABOLISM, V39, P35, DOI 10.1016/0026-0495(90)90206-R; Team RDC, 2008, RA LANGUAGE AND ENVI; Wang DD, 2015, INT J CLIN EXP MED, V8, P8243; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Wideman L, 2002, SPORTS MED, V32, P987, DOI 10.2165/00007256-200232150-00003; YALOW RS, 1965, ANN NY ACAD SCI, V131, P357, DOI 10.1111/j.1749-6632.1965.tb34803.x; ZEITLER P, 1991, P NATL ACAD SCI USA, V88, P8920, DOI 10.1073/pnas.88.20.8920; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191331	10.1371/journal.pone.0191331	http://dx.doi.org/10.1371/journal.pone.0191331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351335	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300073
J	Carleton, WC; Campbell, D; Collard, M				Carleton, W. Christopher; Campbell, David; Collard, Mark			Radiocarbon dating uncertainty and the reliability of the PEWMA method of time-series analysis for research on long-term human-environment interaction	PLOS ONE			English	Article							CALIBRATION; DROUGHT	Statistical time-series analysis has the potential to improve our understanding of humanenvironment interaction in deep time. However, radiocarbon dating-the most common chronometric technique in archaeological and palaeoenvironmental research-creates challenges for established statistical methods. The methods assume that observations in a time-series are precisely dated, but this assumption is often violated when calibrated radiocarbon dates are used because they usually have highly irregular uncertainties. As a result, it is unclear whether the methods can be reliably used on radiocarbon-dated time-series. With this in mind, we conducted a large simulation study to investigate the impact of chronological uncertainty on a potentially useful time-series method. The method is a type of regression involving a prediction algorithm called the Poisson Exponentially Weighted Moving Average (PEMWA). It is designed for use with count time-series data, which makes it applicable to a wide range of questions about human-environment interaction in deep time. Our simulations suggest that the PEWMA method can often correctly identify relationships between time-series despite chronological uncertainty. When two time-series are correlated with a coefficient of 0.25, the method is able to identify that relationship correctly 20 +/- 30% of the time, providing the time-series contain low noise levels. With correlations of around 0.5, it is capable of correctly identifying correlations despite chronological uncertainty more than 90% of the time. While further testing is desirable, these findings indicate that the method can be used to test hypotheses about long-term human-environment interaction with a reasonable degree of confidence.	[Carleton, W. Christopher; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Univ Dr, Burnaby, BC, Canada; [Campbell, David] Simon Fraser Univ, Dept Stat & Actuarial Sci, Univ Dr, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Collard, M (corresponding author), Simon Fraser Univ, Dept Archaeol, Univ Dr, Burnaby, BC, Canada.	mcollard@sfu.ca		Campbell, David/0000-0001-8722-4450; Carleton, William/0000-0001-7463-8638; Collard, Mark/0000-0002-2725-4989	Social Sciences and Humanities Research Council of Canada [767-2011-0159, 895-2011-1009]; Natural Sciences and Engineering Research Council of Canada [RGPIN04040-2014]; Canada Research Chairs Program [228117, 231256]; Canada Foundation for Innovation [203808]; British Columbia Knowledge Development Fund [862-804231]; Simon Fraser University [14518]; Simon Fraser University's Community Trust Endowment Fund [14518]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University; Simon Fraser University's Community Trust Endowment Fund	We received financial support from the Social Sciences and Humanities Research Council of Canada (767-2011-0159 and 895-2011-1009), the Natural Sciences and Engineering Research Council of Canada (RGPIN04040-2014), the Canada Research Chairs Program (228117 and 231256), the Canada Foundation for Innovation (203808), the British Columbia Knowledge Development Fund (862-804231), and Simon Fraser University (14518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our anonymous reviewers and academic editor for their advice. We received financial support from the Social Sciences and Humanities Research Council of Canada (767-2011-0159 and 895-2011-1009), the Natural Sciences and Engineering Research Council of Canada (RGPIN04040-2014), the Canada Research Chairs Program (228117 and 231256), the Canada Foundation for Innovation (203808), the British Columbia Knowledge Development Fund (862-804231), and Simon Fraser University's Community Trust Endowment Fund (14518).	Aitken M. J., 1990, SCI BASED DATING ARC; Aitken MJ, 1997, ADV ARC MUS, V2, P1; Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Blaauw M, 2007, HOLOCENE, V17, P283, DOI 10.1177/0959683607075857; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Brandt PT, 2000, AM J POLIT SCI, V44, P823, DOI 10.2307/2669284; Buck C.E., 1996, BAYESIAN APPROACH IN; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Carleton WC, 2017, QUATERNARY SCI REV, V163, P209, DOI 10.1016/j.quascirev.2017.02.022; Carleton WC, 2014, QUATERNARY SCI REV, V105, P151, DOI 10.1016/j.quascirev.2014.09.032; Chatfield C, 2009, ANAL TIME SERIES INT; Cronin TM, 2013, PALEOCLIMATES UNDERS; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Haug G. H., 2001, Science, V293, P1304, DOI 10.1126/science.1059725; Hodell DA, 2005, QUATERNARY SCI REV, V24, P1413, DOI 10.1016/j.quascirev.2004.10.013; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kingman J., 1993, POISSON PROCESSES; Klein JL., 1997, STAT VISIONS TIME HI; Martin Simon, 2008, CHRONICLE MAYA KINGS, V2nd; Mudelsee M, 2014, ATMOS OCEAN SCI LIB, V51, P1, DOI 10.1007/978-3-319-04450-7; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pickup M, 2014, INTRODUCTION TO TIME; Ramsey CB, 2006, ANTIQUITY, V80, P783, DOI 10.1017/S0003598X00094424; RCore Team, 2020, R LANG ENV STAT COMP; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Taylor RE, 1997, CHRONOMETRIC DATING; Telford RJ, 2004, HOLOCENE, V14, P296, DOI 10.1191/0959683604hl707fa; Telford RJ, 2004, QUATERNARY SCI REV, V23, P1, DOI 10.1016/j.quascirev.2003.11.003; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Webster D, 2000, J WORLD PREHIST, V14, P65, DOI 10.1023/A:1007813518630; Wurtzel JB, 2013, GEOPHYS RES LETT, V40, P5954, DOI 10.1002/2013GL058458	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191055	10.1371/journal.pone.0191055	http://dx.doi.org/10.1371/journal.pone.0191055			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351329	gold, Green Submitted, Green Published			2022-12-26	WOS:000422911300042
J	Costa, LA; Foni, NO; Antonioli, E; de Carvalho, RT; Paiao, ID; Lenza, M; Ferretti, M				Costa, Lauro Augusto; Foni, Noel Oizerovici; Antonioli, Eliane; de Carvalho, Rogerio Teixeira; Paiao, Isabela Dias; Lenza, Mario; Ferretti, Mario			Analysis of 500 anterior cruciate ligament reconstructions from a private institutional register	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACL RECONSTRUCTION; MENISCAL TEARS; SURGICAL TECHNIQUE; UNITED-STATES; PARTIAL MENISCECTOMY; SEX-DIFFERENCES; TRENDS; KNEE; OUTCOMES	Purpose The aims of this study are to describe the epidemiological characteristics of anterior cruciate ligament reconstructions in a private hospital in Brazil and to determine trends in medical practice for comparison with previous studies. Methods We retrospectively reviewed the anterior cruciate ligament institutional register to obtain data from all patients who underwent primary anterior cruciate ligament reconstruction from July 2014 to June 2016. Descriptive statistics were used to summarize the sample. Specific statistical tests were used to assess associations between the meniscal lesion and other variables. Results During the study period, 72.6% out of 500 patients were male. The mean age at surgery was 35.1 years. The mean age was higher among females than among males (37.3 +/- 12.1 vs 34.3 +/- 10.8 years). The median time from injury to surgery was 44 days. The most common femoral and tibial fixations used were suspensory fixation (60.8%) and interference screw (96%), respectively. The most commonly used graft was hamstring tendon (70.2%), followed by bone-patellar tendon-bone (28.8%). A meniscal lesion was noted in 44.8% of cases. Partial meniscectomy was performed in 69.5% of meniscal lesions, and meniscal repair was performed in 14.1% of lesions. The mean length of hospital stay was 1.4 days. The proportion of men in the group of patients with an associated meniscal lesion was higher than that in the group of patients without a meniscal lesion (p = 0.007). Conclusions In this study, we identified that the vast majority of surgeries were performed in male patients in all age groups, and patients older than 30 years and with a short time from injury to surgery predominated. Concerning surgical technique, we noted a low rate of meniscal repair and a higher preference for the use of hamstring graft and suspensory fixation on the femoral side.	[Costa, Lauro Augusto; Foni, Noel Oizerovici; Antonioli, Eliane; de Carvalho, Rogerio Teixeira; Paiao, Isabela Dias; Lenza, Mario; Ferretti, Mario] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein	Ferretti, M (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.	mario.ferretti@einstein.br	Antonioli, Eliane/C-9152-2012; Costa, Lauro/AAA-3297-2022; Ferretti, Mario/U-8212-2018; Lenza, Mario/K-3174-2013; de CARVALHO, ROGERIO Teixeira/E-2662-2015	Antonioli, Eliane/0000-0002-8563-877X; Costa, Lauro/0000-0002-7624-6678; de CARVALHO, ROGERIO Teixeira/0000-0001-8387-7104; Lenza, Mario/0000-0003-3497-2206				Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641; Ageberg E, 2010, AM J SPORT MED, V38, P1334, DOI 10.1177/0363546510361218; Ahlden M, 2012, AM J SPORT MED, V40, P2230, DOI 10.1177/0363546512457348; Lopes TJA, 2016, REV BRAS MED ESPORTE, V22, P297, DOI 10.1590/1517-869220162204159074; Andersson D, 2009, ARTHROSCOPY, V25, P653, DOI 10.1016/j.arthro.2009.04.066; Astur DC, 2013, SAO PAULO MED J, V131, P257, DOI 10.1590/1516-3180.2013.1314498; Brambilla L, 2015, AM J SPORT MED, V43, P2966, DOI 10.1177/0363546515608483; Budny J, 2016, J KNEE SURG, V1, P1; Buller LT, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114563664; Martimbianco ALC, 2014, PHYS THER SPORT, V15, P261, DOI 10.1016/j.ptsp.2014.02.008; Coskunsu D, 2010, ACTA ORTHOP TRAUMATO, V44, P458, DOI 10.3944/AOTT.2010.2388; Csintalan Rick P, 2008, Perm J, V12, P17; DeAngelis JP, 2007, CLIN SPORT MED, V26, P587, DOI 10.1016/j.csm.2007.06.005; Desai N, 2014, KNEE SURG SPORT TR A, V22, P379, DOI 10.1007/s00167-013-2803-6; Dhawan A, 2003, AM J SPORT MED, V31, P419, DOI 10.1177/03635465030310031601; Kim Ha Sung, 2013, Knee Surg Relat Res, V25, P165, DOI 10.5792/ksrr.2013.25.4.165; Fetzer Gary B, 2009, J Knee Surg, V22, P180; Ghodadra N, 2013, J KNEE SURG, V26, P185, DOI 10.1055/s-0032-1327450; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Granan LP, 2008, AM J SPORT MED, V36, P308, DOI 10.1177/0363546507308939; Granan LP, 2012, ACTA ORTHOP, V83, P577, DOI 10.3109/17453674.2012.741451; Granan LP, 2009, ACTA ORTHOP, V80, P563, DOI 10.3109/17453670903350107; Hagino T, 2015, ARCH ORTHOP TRAUM SU, V135, P1701, DOI 10.1007/s00402-015-2309-4; Janssen KW, 2012, SCAND J MED SCI SPOR, V22, P495, DOI 10.1111/j.1600-0838.2010.01253.x; Kluczynski MA, 2013, AM J SPORT MED, V41, P2759, DOI 10.1177/0363546513503448; Kvist J, 2014, ARTHROSCOPY, V30, P803, DOI 10.1016/j.arthro.2014.02.036; Leathers MP, 2015, J KNEE SURG, V28, P390, DOI 10.1055/s-0035-1544193; Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3; Lunebourg A, 2016, ARCH ORTHOP TRAUM SU, V136, P1709, DOI 10.1007/s00402-016-2552-3; Lyman S, 2009, J BONE JOINT SURG AM, V91A, P2321, DOI 10.2106/JBJS.H.00539; Magnussen RA, 2010, KNEE SURG SPORT TR A, V18, P98, DOI 10.1007/s00167-009-0919-5; Maletis GB, 2013, BONE JOINT J, V95B, P623, DOI 10.1302/0301-620X.95B5.30872; Maletis GB, 2015, AM J SPORT MED, V43, P641, DOI 10.1177/0363546514561745; Maletis GB, 2013, AM J SPORT MED, V41, P2090, DOI 10.1177/0363546513493589; Mall NA, 2014, AM J SPORT MED, V42, P2363, DOI 10.1177/0363546514542796; McCormack RG, 2006, ARTHROSCOPY, V22, P889, DOI 10.1016/j.arthro.2006.05.004; Mei Y, 2013, CHINESE MED J-PEKING, V126, P4487; Middleton KK, 2014, KNEE SURG SPORT TR A, V22, P1467, DOI 10.1007/s00167-014-2846-3; Mulford JS, 2013, KNEE SURG SPORT TR A, V21, P1882, DOI 10.1007/s00167-012-2212-2; Nordenvall R, 2017, AM J SPORT MED, V45, P535, DOI 10.1177/0363546516672651; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; Noyes FR, 2012, ARTHROSCOPY, V28, P123, DOI 10.1016/j.arthro.2011.08.292; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Parker BR, 2016, AM J SPORT MED, V44, P1717, DOI 10.1177/0363546516638082; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Samuelsson K, 2009, ARTHROSCOPY, V25, P1139, DOI 10.1016/j.arthro.2009.07.021; Sanders TL, 2016, AM J SPORT MED, V44, P1502, DOI 10.1177/0363546516629944; Scillia AJ, 2015, ORTHOPEDICS, P1; Seng K, 2008, ARTHROSCOPY, V24, P914, DOI 10.1016/j.arthro.2008.01.021; Smith JP, 2001, AM J SPORT MED, V29, P415, DOI 10.1177/03635465010290040501; Stein T, 2010, AM J SPORT MED, V38, P1542, DOI 10.1177/0363546510364052; Straw R, 2003, KNEE, V10, P283, DOI 10.1016/S0968-0160(02)00150-3; Tibor L, 2016, J BONE JOINT SURG AM, V98, P1079, DOI 10.2106/JBJS.15.00881; Vascellari A, 2017, KNEE SURG SPORT TR A, V25, P2520, DOI 10.1007/s00167-016-4007-3; Wright RW, 2015, SPORTS HEALTH, V7, P239, DOI 10.1177/1941738113517855; Xie XB, 2015, KNEE, V22, P100, DOI 10.1016/j.knee.2014.11.014; Yoon Kyoung Ho, 2014, Knee Surg Relat Res, V26, P68, DOI 10.5792/ksrr.2014.26.2.68	57	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191414	10.1371/journal.pone.0191414	http://dx.doi.org/10.1371/journal.pone.0191414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351558	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300087
J	Geltsch, N; Elek, Z; Manczinger, L; Vagvolgyi, C; Moskat, C				Geltsch, Nikoletta; Elek, Zoltan; Manczinger, Laszlo; Vagvolgyi, Csaba; Moskat, Csaba			Common cuckoos (Cuculus canorus) affect the bacterial diversity of the eggshells of their great reed warbler (Acrocephalus arundinaceus) hosts	PLOS ONE			English	Article							MICROBIAL DIVERSITY; BROOD PARASITISM; EGGS; INCUBATION; BEHAVIOR; COMMUNITIES; REJECTION; SUCCESS; SURFACE; GROWTH	The common cuckoo (Cuculus canorus) is an avian brood parasite, laying its eggs in the nests of other bird species, where these hosts incubate the parasitic eggs, feed and rear the nestlings. The appearance of a cuckoo egg in a host nest may change the bacterial community in the nest. This may have consequences on the hatchability of host eggs, even when hosts reject the parasitic egg, typically within six days after parasitism. The present study revealed the bacterial community of cuckoo eggshells and those of the great reed warbler (Acrocephalus arundinaceus), one of the main hosts of cuckoos. We compared host eggs from non-parasitized clutches, as well as host and cuckoo eggs from parasitized clutches. As incubation may change bacterial assemblages on eggshells, we compared these egg types in two stages: the egg-laying stage, when incubation has not been started, and the mid-incubation stage (ca. on days 5 +/- 7 in incubation), where heat from the incubating female dries eggshells. Our results obtained by the 16S rRNA gene sequencing technique showed that fresh host and cuckoo eggs had partially different bacterial communities, but they became more similar during incubation in parasitized nests. Cluster analysis revealed that fresh cuckoo eggs and incubated host eggs in unparasitized nests (where no cuckoo effect could have happened) were the most dissimilar from the other groups of eggs. Cuckoo eggs did not reduce the hatchability of great reed warbler eggs. Our results on the cuckoo-great reed warbler relationship supported the idea that brood parasites may change bacterial microbiota in the host nest. Further studies should reveal how bacterial communities of cuckoo eggshells may vary by host-specific races (gentes) of cuckoos.	[Geltsch, Nikoletta; Elek, Zoltan; Moskat, Csaba] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Geltsch, Nikoletta] Univ Szeged, Fac Sci & Informat, Dept Ecol, Szeged, Hungary; [Manczinger, Laszlo; Vagvolgyi, Csaba] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Szeged University; Szeged University	Moskat, C (corresponding author), MTA ELTE MTM Ecol Res Grp, Budapest, Hungary.	moskat@nhmus.hu	Vagvolgyi, Csaba/L-8497-2018; Elek, Zoltan/A-5899-2011	Vagvolgyi, Csaba/0000-0003-0009-7773; Elek, Zoltan/0000-0001-6026-6300	National Research, Development and Innovation Office, Hungary [NN118194]; Hungarian National Science Fund (OTKA) [83217, GINOP-2.3.3.-15-2016-00006]	National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Science Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the National Research, Development and Innovation Office, Hungary to C.M. (grant No. NN118194). Additional funding was provided by the Hungarian National Science Fund (OTKA, No. 83217 to C.M.) and GINOP-2.3.3.-15-2016-00006 (to C. V. and L.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MG, 2009, PLOS ONE, V4, pA67, DOI 10.1371/journal.pone.0007725; Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029; Baggott GK, 2002, OX ORN SER, V13, P179; Benskin CMH, 2015, ECOL EVOL, V5, P821, DOI 10.1002/ece3.1384; Board R. G., 1994, P43; Brandl HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114861; COLLINS MD, 1983, J GEN MICROBIOL, V129, P3427; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cramp S, 1985, HDB EUROPE MIDDLE E; D'Alba L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0687; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Geltsch N, 2016, BIRD STUDY, V63, P46, DOI 10.1080/00063657.2015.1125851; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Goodenough AE, 2010, MICROB ECOL, V59, P221, DOI 10.1007/s00248-009-9591-z; Greenacre M., 2013, MULTIVARIATE ANAL EC; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Hargitai R, 2010, J AVIAN BIOL, V41, P177, DOI 10.1111/j.1600-048X.2009.04818.x; Honza M, 2001, J AVIAN BIOL, V32, P249, DOI 10.1111/j.0908-8857.2001.320307.x; Honza M, 2007, J AVIAN BIOL, V38, P385, DOI 10.1111/j.2007.0908-8857.03901.x; Hugenholtz P, 2002, GENOME BIOL, V3; Igic B, 2017, J ZOOL, V301, P165, DOI 10.1111/jzo.12408; LEE W, 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090581; Li DL, 2016, EVOL ECOL, V30, P905, DOI 10.1007/s10682-016-9850-7; Martinez-Garcia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158158; Aviles JM, 2009, ANIM BEHAV, V78, P993, DOI 10.1016/j.anbehav.2009.07.020; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; Moskat C, 2009, ANIM BEHAV, V77, P1281, DOI 10.1016/j.anbehav.2009.01.030; Moskat C, 2008, J AVIAN BIOL, V39, P663, DOI 10.1111/j.1600-048X.2008.04359.x; Potter BA, 2017, OPEN ORNITHOL J, V2017, P10; Potter Beth A., 2017, Open Ornithology Journal, V10, P23; Potter Beth A., 2014, Open Ornithology Journal, V7, P40, DOI 10.2174/1874453201407010040; Potter Beth A., 2013, Open Ornithology Journal, V6, P32; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Ripley B. D., 1996, PATTERN RECOGNITION; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Singleton DR, 1998, J FIELD ORNITHOL, V69, P71; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler M, 1997, ANIM BEHAV, V54, P1227, DOI 10.1006/anbe.1997.0524; Takasu F, 2009, BIOL J LINN SOC, V98, P291, DOI 10.1111/j.1095-8312.2009.01288.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torok J, 2004, ETHOL ECOL EVOL, V16, P271; Venables WN., 2002, MODERN APPL STAT S, V4; Vishnivetskaya TA, 2009, EXTREMOPHILES, V13, P541, DOI 10.1007/s00792-009-0243-5; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zolei A, 2015, J AVIAN BIOL, V46, P570, DOI 10.1111/jav.00673	51	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191364	10.1371/journal.pone.0191364	http://dx.doi.org/10.1371/journal.pone.0191364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351548	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000422911300075
J	Gopinathan, U; Redalen, KR; Troseid, AM; Kierulf, P; Brandtzaeg, P; Ree, AH; Berg, JP; Ovstebo, R				Gopinathan, Unni; Redalen, Kathrine Roe; Troseid, Anne-Marie; Kierulf, Peter; Brandtzaeg, Petter; Ree, Anne Hansen; Berg, Jens Petter; Ovstebo, Reidun			Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N-meningitidis	PLOS ONE			English	Article							SYSTEMIC MENINGOCOCCAL DISEASE; INDUCED CYTOKINE PRODUCTION; GENE-EXPRESSION PROFILES; NEISSERIA-MENINGITIDIS; SIGNAL-TRANSDUCTION; ENDOTOXIN TOLERANCE; CELL RESPONSES; SEPTIC SHOCK; PHOSPHORYLATION; INTERLEUKIN-10	N. meningitidis induces extensive gene expression changes in human monocytes, suggesting that complex networks of signaling pathways are activated during meningococcal sepsis. These effects are modulated by the anti-inflammatory cytokine interleukin-10 (IL-10). To further study changes in signal transduction suggested by mRNA data, we used kinase substrate arrays to identify composite kinase activities induced by lysates from a primary human monocyte model system. Cell lysates were prepared from monocytes treated with the following experimental conditions: 10 6 N. meningitidis/mL, 25 ng/mL IL-10, 10 6 N. meningitidis/mL in combination with 25 ng/mL IL-10, and vehicle. Lysates were subjected to kinase activity profiling with Tyrosine Kinase PamChip (R) arrays containing 144 kinase peptide substrates. In our experimental model, we were not able to detect a statistically significant large-scale change in ex vivo array peptide phosphorylation by lysates from monocytes treated for 15 minutes. Targets of the IL-10 anti-inflammatory response were not identified. A profound inhibition of array peptide phosphorylation by monocytes treated for 60 minutes was identified, suggesting low activity of a large number of kinases associated with different signaling pathways and immune cell functions, including STAT3 activity, Nf-kappa B and VEGF signaling, and PTEN signaling activity. The peptide representing ZBTB16, which was reduced in phosphorylation by lysates from all three experimental conditions, was in Ingenuity Pathway Analysis identified to be linked to reduced cytokine release and mRNA levels of tumor necrosis factor (TNF), IL-6, and CXCL10. Further studies should investigate changes in tyrosine kinase-mediated signal transduction in human immune cells, in order to evaluate the potential clinical application of kinome profiling in the study of systemic inflammatory responses to pathogens.	[Gopinathan, Unni; Troseid, Anne-Marie; Kierulf, Peter; Brandtzaeg, Petter; Berg, Jens Petter; Ovstebo, Reidun] Oslo Univ Hosp, Sect Res, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway; [Gopinathan, Unni; Kierulf, Peter; Brandtzaeg, Petter; Ree, Anne Hansen; Berg, Jens Petter] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Redalen, Kathrine Roe; Ree, Anne Hansen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [Brandtzaeg, Petter] Oslo Univ Hosp, Dept Pediat, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Gopinathan, U (corresponding author), Oslo Univ Hosp, Sect Res, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway.; Gopinathan, U (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	unni.gnathan@gmail.com	Berg, Jens P/G-1455-2012; Redalen, Kathrine Roe/AAA-6623-2019; Redalen, Kathrine/F-3383-2017	Berg, Jens P/0000-0003-0157-5888; Ree, Anne H./0000-0002-8264-3223; Redalen, Kathrine/0000-0002-1172-4632	Wedel Jarlsbergs Fond; University of Oslo	Wedel Jarlsbergs Fond; University of Oslo	This work was supported by Wedel Jarlsbergs Fond. The University of Oslo's Open Access Publishing Fund covered the open access fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault R, 2011, PROTEOMICS, V11, P4595, DOI 10.1002/pmic.201100296; BEATY CD, 1994, EUR J IMMUNOL, V24, P1278, DOI 10.1002/eji.1830240606; Bjerre A, 2003, J ENDOTOXIN RES, V9, P155, DOI 10.1179/096805103125001559; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brandtzaeg P, 2001, J ENDOTOXIN RES, V7, P401, DOI 10.1177/09680519010070060401; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; de Greeff SC, 2008, EUR J CLIN MICROBIOL, V27, P985, DOI 10.1007/s10096-008-0535-1; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; DONG ZY, 1993, J EXP MED, V177, P1071, DOI 10.1084/jem.177.4.1071; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; GASPERINI S, 1995, BIOCHEM BIOPH RES CO, V209, P87, DOI 10.1006/bbrc.1995.1474; GENG Y, 1994, P NATL ACAD SCI USA, V91, P8602, DOI 10.1073/pnas.91.18.8602; Gopinathan U, 2015, INNATE IMMUN-LONDON, V21, P429, DOI 10.1177/1753425914547743; Gopinathan U, 2012, INFECT IMMUN, V80, P4046, DOI 10.1128/IAI.00386-12; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Henriksson CE, 2006, THROMB HAEMOSTASIS, V96, P29, DOI 10.1160/TH06-01-0052; Hoogendijk AJ, 2011, MOL MED, V17, P741, DOI 10.2119/molmed.2011.00011; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; IPATM of QIAGEN's Ingenuity Pathway Analysis, 2016, CALCULATING INTERPRE; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LEHMANN AK, 1995, INFECT IMMUN, V63, P2109, DOI 10.1128/IAI.63.6.2109-2112.1995; Lund PK, 2000, SCAND J CLIN LAB INV, V60, P357, DOI 10.1080/003655100750019260; Lund PK, 2001, J IMMUNOL METHODS, V252, P45, DOI 10.1016/S0022-1759(01)00330-1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Ovstebo R, 2012, INNATE IMMUN-LONDON, V18, P580, DOI 10.1177/1753425911428230; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Prabhakar U, 2005, DNA CELL BIOL, V24, P410, DOI 10.1089/dna.2005.24.410; Ree AH, 2015, CRIT REV ONCOL HEMAT, V95, P114, DOI 10.1016/j.critrevonc.2015.01.003; Roe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063723; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803; Xiong Y, 2015, J INNATE IMMUN; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013	53	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0181912	10.1371/journal.pone.0181912	http://dx.doi.org/10.1371/journal.pone.0181912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29357362	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300002
J	Liu, JM; Liu, J; Wang, GA; Liu, GY; Zhou, HJ; Fan, Y; Liang, FX; Wang, H				Liu, Jianmin; Liu, Jing; Wang, Guang'an; Liu, Guangya; Zhou, Huanjiao; Fan, Yun; Liang, Fengxia; Wang, Hua			Electroacupuncture at Guanyuan (CV 4), Zusanli (ST 36) and Baihui (DU 20) regulate the aging-related changes in gene expression profile of the hippocampus in sub-acutely aging rats	PLOS ONE			English	Article							BRAIN; DISEASE; MODEL	To investigate the molecular mechanisms of sub-acutely aging and demonstrate the effect of electroacupuncture (EA) at the Guanyuan (CV 4), Zusanli (ST 36) and Baihui (DU 20) acupoint on the sub-acutely aging brain, cDNA microarrays and bioinformatics analyses were carried out. Thirty Sprague-Dawley (SD) male rats were selected and randomly divided into three groups: the control group (C), the sub-acutely aging model group (M) and the electroacupuncture group (M+EA). Sub-acutely aging model rats were obtained by D-galactose s.c. injection continuously for 40 days. Total RNA was extracted from the hippocampus area of brains in three groups for cDNA microarrays. The data of different groups were compared and analyzed by differential expression analysis, Gene ontology (GO) term enrichment, Kyoto Encyclopedia of Genes Genomes (KEGG) pathway enrichment and quantitative real-time PCR. According to the results, 4052 DE genes were identified in our study. Among them, there were 3079 differentially expressed (DE) genes between group M and group C, and these genes are associated with the aging of rats. Moreover, 983 genes were expressed differently in group M+EA compared with group M, revealing that points stimuli could regulate gene expression in brain with aging. Gene ontology (GO) term enrichment and KEGG enrichment were performed to further classify the differential expression genes. Important GO terms and KEGG pathways connected with sub-acutely aging EA effects were identified. At last, 3 significant differentially expressed genes were selected for real-time quantitative PCR to clarify the cDNA microarray results. In conclusion, the cDNA microarray data first compared and analyzed the differences of gene expression profile in the hippocampus of rats in different groups, which contribute to our knowledge on the molecular mechanisms of EA towards sub-acutely aging.	[Liu, Jianmin; Liu, Jing; Liu, Guangya; Zhou, Huanjiao; Fan, Yun; Liang, Fengxia; Wang, Hua] Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China; [Liu, Jianmin; Liu, Jing; Liu, Guangya; Liang, Fengxia; Wang, Hua] Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China; [Wang, Guang'an] Henan Univ Chinese Med, Clin Med Coll 3, Zhengzhou, Henan, Peoples R China	Hubei University of Chinese Medicine; Henan University of Traditional Chinese Medicine	Wang, H (corresponding author), Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China.; Wang, H (corresponding author), Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China.	huang.edu@hotmail.com	Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022		scientific research guidance projects of Hubei province [B2016111]	scientific research guidance projects of Hubei province	This work was supported by 2016 scientific research guidance projects of Hubei province (No. B2016111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by 2016 scientific research guidance projects of Hubei province (NO. B2016111).	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Arnold CR, 2014, EXP GERONTOL, V54, P75, DOI 10.1016/j.exger.2014.01.018; Brasnjevic I, 2006, ALZHEIMERS DEMENTI S, V2, pS619; Cheng HY, 2008, NEUROSCI LETT, V432, P111, DOI 10.1016/j.neulet.2007.12.009; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding XR, 2006, NEUROSCI LETT, V399, P11, DOI 10.1016/j.neulet.2006.01.067; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Hai F, 2005, BEHAV BRAIN RES, V157, P245; Homeier D, 2014, CLIN GERIATR MED, V30, P671, DOI 10.1016/j.cger.2014.08.001; Jiang QQ, 2000, MODERN REHABILITATIO, V4, P1690; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Liang F, 2015, EVID-BASED COMPL ALT, V2015, P530; Liu Jian-Min, 2009, Zhen Ci Yan Jiu, V34, P242; [刘静 Liu Jing], 2014, [电子显微学报, Journal of Chinese Electronic Microscopy Society], V33, P69; Liu JM, 2014, SHANGHAI J ACUPUNCTU, V33, P66; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mcdonald J L, 2015, EVIDENCE BASED COMPL, V2015; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609; Roberts SB, 2001, J GERONTOL A-BIOL, V56, P66, DOI 10.1093/gerona/56.suppl_1.66; Sarkar S, 2006, MECH AGEING DEV, V127, P391, DOI 10.1016/j.mad.2005.12.010; Sidler Corinne, 2013, Frontiers in Genetics, V4, P211, DOI 10.3389/fgene.2013.00211; Stahl EC, 2015, ORGANOGENESIS, V11, P159, DOI 10.1080/15476278.2015.1120046; Tang HT, 2010, SHANGHAI J ACU MOX, V29, P573; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Wang Hua, 2012, Zhen Ci Yan Jiu, V37, P266; Wang Jia-you, 2011, Zhen Ci Yan Jiu, V36, P36; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; World Health Organization, 2002, AC REV AN REP CONTR; [吴焕林 WU Huanlin], 2008, [中医杂志, Journal of Traditional Chinese Medicine], V49, P622; Xiao Ling, 2012, Zhongguo Zhen Jiu, V32, P435; Yang Hua-Yuan, 2008, Zhen Ci Yan Jiu, V33, P186; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu JC, 2005, PHYSIOL BEHAV, V86, P434, DOI 10.1016/j.physbeh.2005.07.015; Zhang XH, 2005, CHINESE J GERONTOLOG, V8, P933; Zhu MF, 2015, EVIDENCE BASED COMPL, V2015; Zhu Ya-zhen, 2007, Fudan Xuebao (Yixueban), V34, P617	39	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191623	10.1371/journal.pone.0191623	http://dx.doi.org/10.1371/journal.pone.0191623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352289	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300121
J	Ireland, L; Santos, A; Campbell, F; Figueiredo, C; Hammond, D; Ellies, LG; Weyer-Czernilofsky, U; Bogenrieder, T; Schmid, M; Mielgo, A				Ireland, Lucy; Santos, Almudena; Campbell, Fiona; Figueiredo, Carlos; Hammond, Dean; Ellies, Lesley G.; Weyer-Czernilofsky, Ulrike; Bogenrieder, Thomas; Schmid, Michael; Mielgo, Ainhoa			Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer	ONCOGENE			English	Article							MOUSE MAMMARY-TUMOR; PANCREATIC-CANCER; ANTICANCER THERAPIES; FACTOR-I; PHASE-I; RESISTANCE; PROGRESSION; MICROENVIRONMENT; MACROPHAGES; DISEASE	Breast cancer remains the leading cause of cancer death in women owing to metastasis and the development of resistance to established therapies. Macrophages are the most abundant immune cells in the breast tumor microenvironment and can both inhibit and support cancer progression. Thus, gaining a better understanding of how macrophages support cancer could lead to the development of more effective therapies. In this study, we find that breast cancer-associated macrophages express high levels of insulin-like growth factors 1 and 2 (IGFs) and are the main source of IGFs within both primary and metastatic tumors. In total, 75% of breast cancer patients show activation of insulin/IGF-1 receptor signaling and this correlates with increased macrophage infiltration and advanced tumor stage. In patients with invasive breast cancer, activation of Insulin/IGF-1 receptors increased to 87%. Blocking IGF in combination with paclitaxel, a chemotherapeutic agent commonly used to treat breast cancer, showed a significant reduction in tumor cell proliferation and lung metastasis in pre-clinical breast cancer models compared to paclitaxel monotherapy. Our findings provide the rationale for further developing the combination of paclitaxel with IGF blockers for the treatment of invasive breast cancer, and Insulin/IGF1R activation and IGF+ stroma cells as potential biomarker candidates for further evaluation.	[Ireland, Lucy; Santos, Almudena; Campbell, Fiona; Figueiredo, Carlos; Schmid, Michael; Mielgo, Ainhoa] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England; [Hammond, Dean] Univ Liverpool, Dept Physiol, Liverpool, Merseyside, England; [Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Weyer-Czernilofsky, Ulrike] Boehringer Ingelheim RCV GmbH & Co KG, Pharmacol & Translat Res, Vienna, Austria; [Bogenrieder, Thomas] Boehringer Ingelheim RCV GmbH & Co KG Med & Trans, Vienna, Austria; [Bogenrieder, Thomas] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadem, Dept Urol, Munich, Germany	University of Liverpool; University of Liverpool; University of California System; University of California San Diego; Boehringer Ingelheim; University of Munich	Mielgo, A (corresponding author), Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England.	amielgo@liverpool.ac.uk	Figueiredo, Carlos Rogerio de/H-1236-2014	Figueiredo, Carlos Rogerio de/0000-0003-3680-4070; Schmid, Michael/0000-0002-3445-0013	Sir Henry Dale research fellowship - Wellcome Trust [102521/Z/13/Z]; Sir Henry Dale research fellowship - Royal Society [102521/Z/13/Z]; Medical Research Council [MR/L000512/1]; North West Cancer Research fund;  [K22CA118182]; MRC [MR/L000512/1, MR/P018920/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [K22CA118182] Funding Source: NIH RePORTER; Medical Research Council [MR/P018920/1] Funding Source: researchfish	Sir Henry Dale research fellowship - Wellcome Trust; Sir Henry Dale research fellowship - Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North West Cancer Research fund; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were supported by a Sir Henry Dale research fellowship to Dr. Ainhoa Mielgo, jointly funded by the Wellcome Trust and the Royal Society (grant number 102521/Z/13/Z), a New Investigator research grant from the Medical Research Council to Dr. Michael Schmid (grant number MR/L000512/1) and North West Cancer Research funding. Generation of primary breast cancer cells was supported by funding provided to Dr. Lesley Ellies (K22CA118182).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bronte V, 2015, NAT MED, V21, P117, DOI 10.1038/nm.3794; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Denduluri SK, 2015, GENES DIS, V2, P13, DOI 10.1016/j.gendis.2014.10.004; DEXTER DL, 1978, CANCER RES, V38, P3174; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Farabaugh SM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00059; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Friedbichler K, 2014, MOL CANCER THER, V13, P399, DOI 10.1158/1535-7163.MCT-13-0598; Gibby K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3174; Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167; Gradishar WJ, 2016, CLIN CANCER RES, V22, P301, DOI 10.1158/1078-0432.CCR-15-0588; Guha M, 2013, NAT REV DRUG DISCOV, V12, P250, DOI 10.1038/nrd3992; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ireland L, 2016, CANCER RES, V76, P6851, DOI 10.1158/0008-5472.CAN-16-1201; Jones RL, 2015, CLIN CANCER RES, V21, P693, DOI 10.1158/1078-0432.CCR-14-0265; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Leek RD, 1996, CANCER RES, V56, P4625; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lodhia KA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00142; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Ma CX, 2013, BREAST CANCER RES TR, V139, P145, DOI 10.1007/s10549-013-2528-8; Maglione JE, 2001, CANCER RES, V61, P8298; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Marquette C, 2012, CURR TREAT OPTION ON, V13, P263, DOI 10.1007/s11864-012-0184-6; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Olson OC, 2013, CELL RES, V23, P179, DOI 10.1038/cr.2012.123; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pulaski BA, 1998, CANCER RES, V58, P1486; Qian BZ, 2015, J EXP MED, V212, P1433, DOI 10.1084/jem.20141555; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Robertson JFR, 2013, LANCET ONCOL, V14, P228, DOI 10.1016/S1470-2045(13)70026-3; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Williams CB, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2015.25; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883	59	38	38	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					2022	2036		10.1038/s41388-017-0115-x	http://dx.doi.org/10.1038/s41388-017-0115-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367764	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000429899400006
J	Lin, YB; Bogdanov, M; Lu, S; Guan, ZQ; Margolin, W; Weiss, J; Zheng, L				Lin, Yibin; Bogdanov, Mikhail; Lu, Shuo; Guan, Ziqiang; Margolin, William; Weiss, Jerrold; Zheng, Lei			The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A(2) attack	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY-INCREASING PROTEIN; GROUP IIA PHOSPHOLIPASE-A2; ESCHERICHIA-COLI; HUMAN NEUTROPHILS; OUTER-MEMBRANE; INFLAMMATORY FLUID; LIPID ASYMMETRY; GROUP-X; GROUP-V; DETERMINANTS	Secretory phospholipases A(2) (sPLA(2)s) are potent components of mammalian innate-immunity antibacterial mechanisms. sPLA(2) enzymes attack bacteria by hydrolyzing bacterial membrane phospholipids, causing membrane disorganization and cell lysis. However, most Gram-negative bacteria are naturally resistant to sPLA(2). Here we report a novel resistance mechanism to mammalian sPLA(2) in Escherichia coli, mediated by a phospholipid repair system consisting of the lysophospholipid transporter LplT and the acyltransferase Aas in the cytoplasmic membrane. Mutation of the lplT or aas gene abolished bacterial lysophospholipid acylation activity and drastically increased bacterial susceptibility to the combined actions of inflammatory fluid components and sPLA(2), resulting in bulk phospholipid degradation and loss of colony-forming ability. sPLA(2)-mediated hydrolysis of the three major bacterial phospholipids exhibited distinctive kinetics and deacylation of cardiolipin to its monoacyl-derivative closely paralleled bacterial death. Characterization of the membrane envelope in lplT-or aas-knockout mutant bacteria revealed reduced membrane packing and disruption of lipid asymmetry with more phosphatidylethanolamine present in the outer leaflet of the outer membrane. Moreover, modest accumulation of lysophospholipids in these mutant bacteria destabilized the inner membrane and rendered outer membrane-depleted spheroplasts much more sensitive to sPLA(2). These findings indicated that LplT/Aas inactivation perturbs both the outer and inner membranes by bypassing bacterial membrane maintenance mechanisms to trigger specific interfacial activation of sPLA(2). We conclude that the LplT/Aas system is important for maintaining the integrity of the membrane envelope in Gram-negative bacteria. Our insights may help inform new therapeutic strategies to enhance host sPLA(2) antimicrobial activity.	[Lin, Yibin; Lu, Shuo; Zheng, Lei] Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Bogdanov, Mikhail] Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Margolin, William] Univ Texas McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Guan, Ziqiang] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	Baylor College of Medicine; Duke University; University of Iowa; University of Iowa; University of Iowa	Zheng, L (corresponding author), Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Guan, Ziqiang/AAE-5110-2019	Weiss, Jerrold/0000-0003-1476-4485	National Institutes of Health [R01 GM097290, R01GM098572, R01GM61074]; European Union Marie Sklodowska-Curie Grant [H2020-MSCA-RISE-2015-690853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061074, R01GM098572, R01GM097290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Marie Sklodowska-Curie Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM097290 and R01GM098572 (to L. Z.) and R01GM61074 (to W. M.), and European Union Marie Sklodowska-Curie Grant H2020-MSCA-RISE-2015-690853 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; Elsbach Peter, 1994, Trends in Microbiology, V2, P324, DOI 10.1016/0966-842X(94)90449-9; Femling JK, 2005, J IMMUNOL, V175, P4653, DOI 10.4049/jimmunol.175.7.4653; FORST S, 1987, BIOCHIM BIOPHYS ACTA, V920, P221, DOI 10.1016/0005-2760(87)90098-1; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gronroos JO, 2002, J INFECT DIS, V185, P1767, DOI 10.1086/340821; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henderson JC, 2016, ANNU REV MICROBIOL, V70, P255, DOI 10.1146/annurev-micro-102215-095308; HSU L, 1991, J BIOL CHEM, V266, P13783; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kucherak OA, 2010, J AM CHEM SOC, V132, P4907, DOI 10.1021/ja100351w; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lin YB, 2016, J BIOL CHEM, V291, P2136, DOI 10.1074/jbc.M115.700419; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Machaidze G, 2003, BIOCHEMISTRY-US, V42, P12570, DOI 10.1021/bi035225b; Madsen LM, 1996, INFECT IMMUN, V64, P2425, DOI 10.1128/IAI.64.7.2425-2430.1996; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Sachdeva S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00070; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; WEINRAUCH Y, 1995, J CLIN INVEST, V95, P1916, DOI 10.1172/JCI117873; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; WEISS J, 1991, J BIOL CHEM, V266, P4162; WEISS J, 1994, J BIOL CHEM, V269, P26331; Weiss JP, 2015, BBA-BIOMEMBRANES, V1848, P3072, DOI 10.1016/j.bbamem.2015.05.018; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Wu YZ, 2010, BIOCHIMIE, V92, P583, DOI 10.1016/j.biochi.2010.01.024; Zarember K, 1997, BLOOD, V89, P672, DOI 10.1182/blood.V89.2.672; Zheng L, 2017, BBA-MOL CELL BIOL L, V1862, P1404, DOI 10.1016/j.bbalip.2016.11.015	44	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3386	3398		10.1074/jbc.RA117.001231	http://dx.doi.org/10.1074/jbc.RA117.001231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348168	Green Published, hybrid			2022-12-26	WOS:000426562800029
J	Chacon, M; Jara, JL; Miranda, R; Katsogridakis, E; Panerai, RB				Chacon, Max; Luis Jara, Jose; Miranda, Rodrigo; Katsogridakis, Emmanuel; Panerai, Ronney B.			Non-linear models for the detection of impaired cerebral blood flow autoregulation	PLOS ONE			English	Article							PRESSURE; DYNAMICS; CO2	The ability to discriminate between normal and impaired dynamic cerebral autoregulation (CA), based on measurements of spontaneous fluctuations in arterial blood pressure (BP) and cerebral blood flow (CBF), has considerable clinical relevance. We studied 45 normal subjects at rest and under hypercapnia induced by breathing a mixture of carbon dioxide and air. Non-linear models with BP as input and CBF velocity (CBFV) as output, were implemented with support vector machines (SVM) using separate recordings for learning and validation. Dynamic SVM implementations used either moving average or autoregressive structures. The efficiency of dynamic CA was estimated from the model's derived CBFV response to a step change in BP as an autoregulation index for both linear and non-linear models. Non-linear models with recurrences (autoregressive) showed the best results, with CA indexes of 5.9 +/- 1.5 in normocapnia, and 2.5 +/- 1.2 for hypercapnia with an area under the receiver-operator curve of 0.955. The high performance achieved by non-linear SVM models to detect deterioration of dynamic CA should encourage further assessment of its applicability to clinical conditions where CA might be impaired.	[Chacon, Max; Luis Jara, Jose; Miranda, Rodrigo] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Katsogridakis, Emmanuel; Panerai, Ronney B.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Panerai, Ronney B.] Univ Leicester, Biomed Res Ctr, Glenfield Hosp, Leicester, Leics, England	Universidad de Santiago de Chile; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Chacon, M (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	max.chacon@usach.cl	Jara, Jose/GQB-5331-2022; Jara, José Luis/J-7254-2015	Jara, José Luis/0000-0002-3348-7017; Katsogridakis, Emmanuel/0000-0001-8551-3910	Vicerrectoria de Investigacion, Desarrollo e Innovacion, Universidad de Santiago de Chile; Direccion de Investigacion Cientifica y Tecnologica (DICYT) [061719CHP]; supercomputing infrastructure of the NLHPC [ECM-02]	Vicerrectoria de Investigacion, Desarrollo e Innovacion, Universidad de Santiago de Chile; Direccion de Investigacion Cientifica y Tecnologica (DICYT); supercomputing infrastructure of the NLHPC	MCh was partially funded by Vicerrectoria de Investigacion, Desarrollo e Innovacion, Universidad de Santiago de Chile. MCh and JLJ were partially funded by Direccion de Investigacion Cientifica y Tecnologica (DICYT) under grant number 061719CHP. Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the NLHPC (ECM-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Ainslie PN, 2007, AM J PHYSIOL-HEART C, V292, pH976, DOI 10.1152/ajpheart.00639.2006; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; Chacon M, 2008, PHYSIOL MEAS, V29, P1179, DOI 10.1088/0967-3334/29/10/003; Chacon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108281; Chacon M, 2011, MED ENG PHYS, V33, P180, DOI 10.1016/j.medengphy.2010.09.023; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Claassen JAHR, 2009, J APPL PHYSIOL, V106, P153, DOI 10.1152/japplphysiol.90822.2008; Domingo C, 2010, SENSORS-BASEL, V10, P4655, DOI 10.3390/s100504655; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Hu K, 2008, PHYSICA A, V387, P2279, DOI 10.1016/j.physa.2007.11.052; Hu K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002601; Katsogridakis E, 2013, J CEREBR BLOOD F MET, V33, P519, DOI 10.1038/jcbfm.2012.191; Kuznetsova A, 2016, IMERTEST TESTS RANDO; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; Meyer D, 2014, R PACKAGE VERSION, V1, P6; Mitsis GD, 2004, IEEE T BIO-MED ENG, V51, P1932, DOI 10.1109/TBME.2004.834272; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347; Panerai RB, 1999, PHYSIOL MEAS, V20, P265, DOI 10.1088/0967-3334/20/3/304; Panerai RB, 2004, MED ENG PHYS, V26, P43, DOI 10.1016/j.medengphy.2003.08.001; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Peng TY, 2010, IEEE T BIO-MED ENG, V57, P960, DOI 10.1109/TBME.2009.2024265; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos EG, 2006, PHYSIOL MEAS, V27, P35, DOI 10.1088/0967-3334/27/1/004; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; Simpson DM, 2001, ANN BIOMED ENG, V29, P18, DOI 10.1114/1.1335537; Sorond FA, 2009, ULTRASOUND MED BIOL, V35, P21, DOI 10.1016/j.ultrasmedbio.2008.08.001; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191825	10.1371/journal.pone.0191825	http://dx.doi.org/10.1371/journal.pone.0191825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381724	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800037
J	Nishida, A; Thiel, V; Nakagawa, M; Ayukawa, S; Yamamura, M				Nishida, Akifumi; Thiel, Vera; Nakagawa, Mayuko; Ayukawa, Shotaro; Yamamura, Masayuki			Effect of light wavelength on hot spring microbial mat biodiversity	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; SP-NOV.; GEN. NOV.; CHLOROFLEXUS-AURANTIACUS; MOLECULAR CHARACTERIZATION; BIOMASS PRODUCTION; COMMUNITY; HYDROGEN; MEMBER; 3-HYDROXYPROPIONATE	Hot spring associated phototrophic microbial mats are purely microbial communities, in which phototrophic bacteria function as primary producers and thus shape the community. The microbial mats at Nakabusa hot springs in Japan harbor diverse photosynthetic bacteria, mainly Thermosynechococcus, Chloroflexus, and Roseiflexus, which use light of different wavelength for energy conversion. The aim of this study was to investigate the effect of the phototrophs on biodiversity and community composition in hot spring microbial mats. For this, we specifically activated the different phototrophs by irradiating the mats with different wavelengths in situ. We used 625, 730, and 890 nm wavelength LEDs alone or in combination and confirmed the hypothesized increase in relative abundance of different phototrophs by 16S rRNA gene sequencing. In addition to the increase of the targeted phototrophs, we studied the effect of the different treatments on chemotrophic members. The specific activation of Thermosynechococcus led to increased abundance of several other bacteria, whereas wavelengths specific to Chloroflexus and Roseiflexus induced a decrease in >50% of the community members as compared to the dark conditions. This suggests that the growth of Thermosynechococcus at the surface layer benefits many community members, whereas less benefit is obtained from an increase in filamentous anoxygenic phototrophs Chloroflexus and Roseiflexus. The increases in relative abundance of chemo-trophs under different light conditions suggest a relationship between the two groups. Aerobic chemoheterotrophs such as Thermus sp. and Meiothermus sp. are thought to benefit from aerobic conditions and organic carbon in the form of photosynthates by Thermosyne-chococcus, while the oxidation of sulfide and production of elemental sulfur by filamentous anoxygenic phototrophs benefit the sulfur-disproportionating Caldimicrobium thiodismutans. In this study, we used an experimental approach under controlled environmental conditions for the analysis of natural microbial communities, which proved to be a powerful tool to study interspecies relationships in the microbiome.	[Nishida, Akifumi] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa, Japan; [Thiel, Vera] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo, Japan; [Nakagawa, Mayuko] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo, Japan; [Ayukawa, Shotaro] Waseda Univ, Waseda Res Inst Sci & Engn, Tokyo, Japan; [Yamamura, Masayuki] Tokyo Inst Technol, Dept Comp Sci, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Metropolitan University; Tokyo Institute of Technology; Waseda University; Tokyo Institute of Technology	Yamamura, M (corresponding author), Tokyo Inst Technol, Dept Comp Sci, Yokohama, Kanagawa, Japan.	my@c.titech.ac.jp	; Nakagawa, Mayuko/A-8762-2016	Nishida, Akifumi/0000-0003-0296-6637; Nakagawa, Mayuko/0000-0003-3611-8118	Sasakawa Scientific Research Grant from The Japan Science Society [28-446]; ELSI Origins Network (EON) Fellowship from the John Templeton Foundation; Institute for Fermentation, Osaka (IFO), Japan	Sasakawa Scientific Research Grant from The Japan Science Society; ELSI Origins Network (EON) Fellowship from the John Templeton Foundation; Institute for Fermentation, Osaka (IFO), Japan(Institute for Fermentation (IFO))	AN was supported by the Sasakawa Scientific Research Grant from The Japan Science Society (28-446). http:/www.jss.or.jp/. MN was supported by ELSI Origins Network (EON) Fellowship grant from the John Templeton Foundation. http:/www.elsi.jp/en/. MN was supported by the Institute for Fermentation, Osaka (IFO), Japan. http://www.ifo.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar P, 2004, INT J SYST EVOL MICR, V54, P33, DOI 10.1099/ijs.0.02790-0; Albuquerque L, 2008, INT J SYST EVOL MICR, V58, P773, DOI 10.1099/ijs.0.65294-0; Albuquerque L, 2006, SYST APPL MICROBIOL, V29, P450, DOI 10.1016/j.syapm.2005.12.004; Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachar A, 2008, FEMS MICROBIOL ECOL, V65, P434, DOI 10.1111/j.1574-6941.2008.00534.x; Becraft ED, 2011, APPL ENVIRON MICROB, V77, P7689, DOI 10.1128/AEM.05927-11; Beeder J, 1995, ARCH MICROBIOL, V164, P331, DOI 10.1007/BF02529979; Bernstein HC, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00181-16; Bernstein HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16004; Bertilsson S, 2005, VIE MILIEU, V55, P225; Bolhuis H, 2014, FEMS MICROBIOL ECOL, V90, P335, DOI 10.1111/1574-6941.12408; Boomer SM, 2002, APPL ENVIRON MICROB, V68, P346, DOI 10.1128/AEM.68.1.346-355.2002; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dong L, 2014, ANTON LEEUW INT J G, V105, P899, DOI 10.1007/s10482-014-0144-1; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everroad RC, 2012, MICROBES ENVIRON, V27, P374, DOI 10.1264/jsme2.ME11350; Ferris MJ, 2003, APPL ENVIRON MICROB, V69, P2893, DOI 10.1128/AEM.69.5.2893-2898.2003; FOGG GE, 1983, BOT MAR, V26, P3, DOI 10.1515/botm.1983.26.1.3; Franks J, 2009, EARTH-SCI REV, V96, P163, DOI 10.1016/j.earscirev.2008.10.004; HANADA S, 1995, INT J SYST BACTERIOL, V45, P676, DOI 10.1099/00207713-45-4-676; Hanada S, 2002, INT J SYST EVOL MICR, V52, P187, DOI 10.1099/00207713-52-1-187; Hanada S., 2003, MICROBES ENVIRON, V18, P51, DOI [10.1264/jsme2.18.51, DOI 10.1264/JSME2.18.51]; Hayashi NR, 1999, INT J SYST BACTERIOL, V49, P783, DOI 10.1099/00207713-49-2-783; Hays SG, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0048-5; Hirayama H, 2005, INT J SYST EVOL MICR, V55, P467, DOI 10.1099/ijs.0.63389-0; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; HOLO H, 1989, ARCH MICROBIOL, V151, P252, DOI 10.1007/BF00413138; Imachi H, 2008, INT J SYST EVOL MICR, V58, P2258, DOI 10.1099/ijs.0.65727-0; Jensen SI, 2011, ISME J, V5, P317, DOI 10.1038/ismej.2010.131; Kato K, 2004, GEOMICROBIOL J, V21, P91, DOI 10.1080/01490450490266334; Kim YM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00209; Kimura H, 2010, MICROBES ENVIRON, V25, P140, DOI 10.1264/jsme2.ME09181; Kimura H, 2010, ENVIRON MICROBIOL, V12, P480, DOI 10.1111/j.1462-2920.2009.02089.x; Kirilovsky D, 2004, J BIOL CHEM, V279, P52869, DOI 10.1074/jbc.M408206200; Klatt CG, 2007, ENVIRON MICROBIOL, V9, P2067, DOI 10.1111/j.1462-2920.2007.01323.x; Klatt CG, 2013, ISME J, V7, P1775, DOI 10.1038/ismej.2013.52; Kojima H, 2016, INT J SYST EVOL MICR, V66, P1828, DOI 10.1099/ijsem.0.000947; Kubo K, 2011, SYST APPL MICROBIOL, V34, P293, DOI 10.1016/j.syapm.2010.12.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu ZF, 2012, ISME J, V6, P1869, DOI 10.1038/ismej.2012.24; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MADIGAN MT, 1975, J BACTERIOL, V122, P782, DOI 10.1128/JB.122.2.782-784.1975; MADIGAN MT, 1974, ARCH MICROBIOL, V100, P97, DOI 10.1007/BF00446309; Madigan MT, 2005, GEOTHERMAL BIOL GEOC, V1, P203; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nakagawa T, 2003, APPL ENVIRON MICROB, V69, P7044, DOI 10.1128/AEM.69.12.7044-7057.2003; Nakagawa T, 2002, J GEN APPL MICROBIOL, V48, P211, DOI 10.2323/jgam.48.211; Nubel U, 2002, APPL ENVIRON MICROB, V68, P4593, DOI 10.1128/AEM.68.9.4593-4603.2002; Otaki H, 2012, MICROBES ENVIRON, V27, P293, DOI 10.1264/jsme2.ME11348; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Podosokorskaya OA, 2011, INT J SYST EVOL MICR, V61, P2697, DOI 10.1099/ijs.0.026070-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RIORDAN C, 1988, SOL CELLS, V24, P313, DOI 10.1016/0379-6787(88)90083-X; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Sievert SM, 2000, INT J SYST EVOL MICR, V50, P1239, DOI 10.1099/00207713-50-3-1239; Stuart RK, 2016, ISME J, V10, P1240, DOI 10.1038/ismej.2015.180; Tank M., 2017, MODERN TOPICS PHOTOT, P87, DOI [10.1007/978-3-319-46261-5_3, DOI 10.1007/978-3-319-46261-5_3]; Tank M, 2015, INT J SYST EVOL MICR, V65, P1426, DOI 10.1099/ijs.0.000113; Thiel V, 2016, FRONT MICROBIOL, P7; Thiel V, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00943; Thiel V, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00860-14; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; van der Meer MTJ, 2010, J BACTERIOL, V192, P3033, DOI 10.1128/JB.01610-09; van der Meer MTJ, 2005, APPL ENVIRON MICROB, V71, P3978, DOI 10.1128/AEM.71.7.3978-3986.2005; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wong MT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00961; Zhang XQ, 2010, INT J SYST EVOL MICR, V60, P834, DOI 10.1099/ijs.0.007690-0; Zhao C, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.4	72	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191650	10.1371/journal.pone.0191650	http://dx.doi.org/10.1371/journal.pone.0191650			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381713	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800028
J	Hibino, A; Saito, R; Taniguchi, K; Zaraket, H; Shobugawa, Y; Matsui, T; Suzuki, H				Hibino, Akinobu; Saito, Reiko; Taniguchi, Kiyosu; Zaraket, Hassan; Shobugawa, Yugo; Matsui, Tamano; Suzuki, Hiroshi		Japanese HRSV Collaborative Study	Molecular epidemiology of human respiratory syncytial virus among children in Japan during three seasons and hospitalization risk of genotype ON1	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; GROUP-A; G-PROTEIN; SOUTH-AFRICA; HYPERVARIABLE REGION; CIRCULATION PATTERNS; PREVAILING GENOTYPE; CONSECUTIVE SEASONS; RAPID REPLACEMENT; TRACT INFECTION	We investigated the genetic diversity, the circulation patterns, and risk for hospital admission of human respiratory syncytial virus (HRSV) strains in Japan between 2012 through 2015. During the study period, 744 HRSV-positive cases were identified by rapid diagnostic test. Of these, 572 samples were positive by real-time PCR; 400 (69.9%) were HRSV-A, and 172 (30.1%) were HRSV-B. HRSV-A and -B alternated as the dominant strain in the subsequent seasons. Phylogenetic tree analysis of the second hyper-variable region of the G protein classified the HRSV-A specimens into NA1 (n = 242) and ON1 (n = 114) genotypes and the HRSV-B specimens into BA9 (n = 60), and BA10 (n = 27). The ON1 genotype, containing a 72-nucleotide duplication in the G protein's second hyper-variable region, was first detected in the 2012-2013 season but it predominated and replaced the older NA1 HRSV-A in the 2014-2015 season, which also coincided with a record number of HRSV cases reported to the National Infectious Disease Surveillance in Japan. The risk of hospitalization was 6.9 times higher for the ON1 genotype compared to NA1. In conclusion, our data showed that the emergence and predominance of the relatively new ON1 genotype in Japan was associated with a record high number of cases and increased risk for hospitalization.	[Hibino, Akinobu; Saito, Reiko; Zaraket, Hassan; Shobugawa, Yugo] Niigata Univ, Div Int Hlth Publ Hlth, Grad Sch Med & Dent Sci, Niigata, Japan; [Taniguchi, Kiyosu] Natl Mie Hosp, Pediat, Tsu, Mie, Japan; [Zaraket, Hassan] Amer Univ Beirut, Dept Pathol Immunol & Microbiol, Fac Med, Beirut, Lebanon; [Zaraket, Hassan] Amer Univ Beirut, Ctr Infect Dis Res, Fac Med, Beirut, Lebanon; [Matsui, Tamano] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Suzuki, Hiroshi] Niigata Seiryo Univ, Sch Nursing, Niigata, Japan	Niigata University; American University of Beirut; American University of Beirut; National Institute of Infectious Diseases (NIID)	Saito, R (corresponding author), Niigata Univ, Div Int Hlth Publ Hlth, Grad Sch Med & Dent Sci, Niigata, Japan.	jasmine@med.niigata-u.ac.jp		Zaraket, Hassan/0000-0003-3807-6409	Study Group, Enforcement of Infectious Disease Surveillance and Risk Assessment for Emerging and Re-emerging Diseases - Ministry of Health, Labour and Welfare, and Sciences, Japan; Niigata Prefectural Medical Association; JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Agency for Medical Research and Development (AMED) in Japan	Study Group, Enforcement of Infectious Disease Surveillance and Risk Assessment for Emerging and Re-emerging Diseases - Ministry of Health, Labour and Welfare, and Sciences, Japan; Niigata Prefectural Medical Association; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED) in Japan(Japan Agency for Medical Research and Development (AMED))	This work was funded by the Study Group, Enforcement of Infectious Disease Surveillance and Risk Assessment for Emerging and Re-emerging Diseases (Principal Investigators, Dr. Tamano Matsui and formerly Dr. Kiyoshu Taniguchi), supported by a Grant in-Aid by the Ministry of Health, Labour and Welfare, and Sciences, Japan. It was also supported by Niigata Prefectural Medical Association; JSPS Core-to-core Program, B.Asia-Africa Science Platforms sourced from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Kakenhi (Grants in-Aid for Scientific Research) from MEXT; the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from MEXT and Japan Agency for Medical Research and Development (AMED) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2015, J VIROL, V89, P3444, DOI 10.1128/JVI.03391-14; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Agoti CN, 2012, J INFECT DIS, V206, P1532, DOI 10.1093/infdis/jis570; Ahmed A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166145; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Biswas D, 2013, J MED VIROL, V85, P1639, DOI 10.1002/jmv.23636; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Calderon A, 2017, J MED VIROL, V89, P767, DOI 10.1002/jmv.24703; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2015, INFECT GENET EVOL, V33, P163, DOI 10.1016/j.meegid.2015.04.025; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Deng L, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1391; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129369; Etemadi MR, 2013, EVOL BIOINFORM, V9, DOI 10.4137/EBO.S10999; Fall A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157163; Fan RY, 2017, J MED VIROL, V89, P213, DOI 10.1002/jmv.24619; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Hu PW, 2017, J MED VIROL, V89, P32, DOI 10.1002/jmv.24603; Ivancic-Jelecki J, 2015, INTERVIROLOGY, V58, P172, DOI 10.1159/000382018; Kadji FMN, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0565-8; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Do LAH, 2015, J GEN VIROL, V96, P3470, DOI 10.1099/jgv.0.000298; Malasao R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142192; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Moreira FB, 2017, J MED VIROL; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Nagasawa K, 2015, INFECT GENET EVOL, V36, P217, DOI 10.1016/j.meegid.2015.09.020; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Oladokun R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1572-5; Otieno JR, 2017, EMERG INFECT DIS, V23, P264, DOI 10.3201/eid2302.161149; Otieno JR, 2016, J VIROL, V90, P4990, DOI 10.1128/JVI.03105-15; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2014, EURO SURVEILL, V19; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Ren L, 2015, J MED VIROL, V87, P1, DOI 10.1002/jmv.23960; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Shi T, 2015, J GLOB HEALTH, V5, P203, DOI 10.7189/jogh.05.020416; Shobugawa Y, 2017, EPIDEMIOL INFECT, V145, P272, DOI 10.1017/S095026881600220X; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Slovic A, 2016, INFECT GENET EVOL, V44, P76, DOI 10.1016/j.meegid.2016.06.036; Song JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04824-0; Suzuki Y, 2009, J CLIN MICROBIOL, V47, P623, DOI 10.1128/JCM.01760-08; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2015, J VIROL, V89, P7776, DOI 10.1128/JVI.00467-15; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Venter M, 2002, J MED VIROL, V68, P452, DOI 10.1002/jmv.10225; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2016, INFECT GENET EVOL, V43, P213, DOI 10.1016/j.meegid.2016.04.034; Vieira SE, 2017, CITY, V2017; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Yoshihara K, 2016, INFECT GENET EVOL, V45, P437, DOI 10.1016/j.meegid.2016.10.010; Yoshihara K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27856; Zhang XB, 2014, WORLD J PEDIATR, V10, P360, DOI 10.1007/s12519-014-0513-x; Zheng YX, 2017, J MED VIROL, V89, P222, DOI 10.1002/jmv.24640	79	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0192085	10.1371/journal.pone.0192085	http://dx.doi.org/10.1371/journal.pone.0192085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377949	gold, Green Published, Green Submitted			2022-12-26	WOS:000423514700054
J	Liang, JF; An, J; Gao, JQ; Zhang, XY; Yu, FH				Liang, Jin-Feng; An, Jing; Gao, Jun-Qin; Zhang, Xiao-Ya; Yu, Fei-Hai			Effects of arbuscular mycorrhizal fungi and soil nutrient addition on the growth of Phragmites australis under different drying-rewetting cycles	PLOS ONE			English	Article							WETLAND VEGETATION; SEEDLING GROWTH; PLANT-GROWTH; NITROGEN; BIOMASS; PHOSPHORUS; FOREST; INOCULATION; ENRICHMENT; RESPONSES	The frequency of soil drying-rewetting cycles is predicted to increase under future global climate change, and arbuscular mycorrhizal fungi (AMF) are symbiotic with most plants. However, it remains unknown how AMF affect plant growth under different frequencies of soil drying-rewetting cycles. We subjected a clonal wetland plant Phragmites australis to three frequencies of drying-rewetting cycles (1, 2, or 4 cycles), two nutrient treatments (with or without), and two AMF treatments (with or without) for 64 days. AMF promoted the growth of P. australis, especially in the 2 cycles of the drying-rewetting treatment. AMF had a significant positive effect on leaf mass and number of ramets in the 2 cycles of the drying-rewetting treatment with nutrient addition. In the 2 cycles of drying-rewetting treatment without nutrient addition, AMF increased leaf area and decreased belowground to aboveground biomass ratio. These results indicate that AMF may assist P. australis in coping with medium frequency of drying-rewetting cycles, and provide theoretical guidance for predicting how wetland plants respond to future global climate change.	[Liang, Jin-Feng; An, Jing; Gao, Jun-Qin; Zhang, Xiao-Ya; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Yu, Fei-Hai] Taizhou Univ, Zhejiang Prov Key Lab Plant Evolutionary Ecol & C, Taizhou 318000, Zhejiang, Peoples R China	Beijing Forestry University; Taizhou University	Gao, JQ (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	gaojq@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	National Natural Science Foundation of China [41571084, 41373069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (41571084 and 41373069).	Adam E, 2010, WETL ECOL MANAG, V18, P281, DOI 10.1007/s11273-009-9169-z; Allen EB, 2003, ECOL APPL, V13, P1701, DOI 10.1890/02-5309; Amiri R, 2017, SYMBIOSIS, V73, P15, DOI 10.1007/s13199-016-0466-z; [Anonymous], 2012, J AM SCI; Belanger G, 2016, CAN J PLANT SCI, V96, P413, DOI 10.1139/cjps-2015-0245; Bogaert F, 2017, PEST MANAG SCI, V73, P1648, DOI 10.1002/ps.4505; Delavaux CS, 2017, MYCORRHIZA, V27, P311, DOI 10.1007/s00572-016-0749-5; FITTER AH, 1988, NEW PHYTOL, V110, P201, DOI 10.1111/j.1469-8137.1988.tb00253.x; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Green H, 1999, APPL ENVIRON MICROB, V65, P1428; Grilli G, 2014, PLANT ECOL, V215, P1513, DOI 10.1007/s11258-014-0410-3; Holste EK, 2017, MYCORRHIZA, V27, P211, DOI 10.1007/s00572-016-0744-x; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Ipsilantis I, 2007, APPL SOIL ECOL, V35, P261, DOI 10.1016/j.apsoil.2006.09.003; Jin L, 2017, SYMBIOSIS, V72, P81, DOI 10.1007/s13199-016-0444-5; Kannenberg SA, 2015, WETLANDS, V35, P633, DOI 10.1007/s13157-015-0653-3; Li XiaoYu, 2015, Acta Prataculturae Sinica, V24, P99; Liang X, 2016, AQUAT BOT, V130, P50, DOI 10.1016/j.aquabot.2015.10.003; Liao XL, 2016, SCI TOTAL ENVIRON, V556, P136, DOI 10.1016/j.scitotenv.2016.02.203; Liu ZL, 2014, APPL SOIL ECOL, V84, P185, DOI 10.1016/j.apsoil.2014.07.010; Luo SZ, 2017, INT J APPL EARTH OBS, V58, P107, DOI 10.1016/j.jag.2017.01.016; Meng LB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00339; Meyerson LA, 2016, BIOL INVASIONS, V18, P2531, DOI 10.1007/s10530-016-1200-8; Morillas L, 2015, GLOBAL CHANGE BIOL, V21, P3854, DOI 10.1111/gcb.12956; Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012; Oliveira RS, 2001, MYCORRHIZA, V10, P241, DOI 10.1007/s005720000087; Packer JG, 2017, J ECOL, V105, P1123, DOI 10.1111/1365-2745.12797; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; Quinn LD, 2007, WEED SCI, V55, P319, DOI 10.1614/WS-06-139; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Sarkar A, 2016, COMMUN SOIL SCI PLAN, V47, P87, DOI 10.1080/00103624.2015.1108432; Shi AD, 2015, GEODERMA, V243, P168, DOI 10.1016/j.geoderma.2014.12.019; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Soetaert K, 2004, AQUAT BOT, V79, P211, DOI 10.1016/j.aquabot.2004.02.001; Stevens KJ, 2011, MYCORRHIZA, V21, P279, DOI 10.1007/s00572-010-0334-2; Taranet P, 2017, NUTR CYCL AGROECOSYS, V108, P309, DOI 10.1007/s10705-017-9858-6; Tarraf W, 2017, IND CROP PROD, V102, P144, DOI 10.1016/j.indcrop.2017.03.010; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Uddin MDN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11205-0; Wang YT, 2010, PLANT SOIL, V331, P181, DOI 10.1007/s11104-009-0244-2; Wasson K, 2017, BIOL CONSERV, V212, P1, DOI 10.1016/j.biocon.2017.05.019; Xie XY, 2014, APPL SOIL ECOL, V75, P162, DOI 10.1016/j.apsoil.2013.11.009; Xu ZY, 2016, PEDOSPHERE, V26, P592, DOI 10.1016/S1002-0160(15)60067-4; Zhang BB, 2016, PLANT SOIL, V398, P47, DOI 10.1007/s11104-015-2635-x; Zhang Q, 2014, SCI WORLD J, DOI 10.1155/2014/923610	46	12	12	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191999	10.1371/journal.pone.0191999	http://dx.doi.org/10.1371/journal.pone.0191999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377943	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700050
J	Devadas, K; Biswas, S; Ragupathy, V; Lee, S; Dayton, A; Hewlett, I				Devadas, Krishnakumar; Biswas, Santanu; Ragupathy, Viswanath; Lee, Sherwin; Dayton, Andrew; Hewlett, Indira			Modulation of HIV replication in monocyte derived macrophages (MDM) by steroid hormones	PLOS ONE			English	Article							ECTOCERVICAL TISSUE EXPLANTS; SIV VAGINAL TRANSMISSION; UTERINE EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; SEX-BASED DIFFERENCES; IMMUNODEFICIENCY-VIRUS; MENSTRUAL-CYCLE; CORECEPTOR EXPRESSION; DISEASE PROGRESSION; REPRODUCTIVE-TRACT	Significant sex specific differences in the progression of HIV/AIDS have been reported. Several studies have implicated steroid hormones in regulating host factor expression and modulating HIV transmission and replication. However, the exact mechanism exerted by steroid hormones estrogen and progesterone in the regulation of HIV-1 replication is still unclear. Results from the current study indicated a dose dependent down regulation of HIV-1 replication in monocyte derived macrophages pre-treated with high concentrations of estrogen or progesterone. To elucidate the molecular mechanisms associated with the down regulation of HIV-1 replication by estrogen and progesterone we used PCR arrays to analyze the expression profile of host genes involved in antiviral responses. Several chemokines, cytokines, transcription factors, interferon stimulated genes and genes involved in type-1 interferon signaling were down regulated in cells infected with HIV-1 pre-treated with high concentrations of estrogen or progesterone compared to untreated HIV-1 infected cells or HIV-1 infected cells treated with low concentrations of estrogen or progesterone. The down regulation of CXCL9, CXCL10 and CXCL11 chemokines and IL-1 beta, IL-6 cytokines in response to high concentrations of estrogen and progesterone pre-treatment in HIV-1 infected cells was confirmed at the protein level by quantitating chemokine and cytokine concentrations in the culture supernatant. These results demonstrate that a potent anti-inflammatory response is mediated by pre-treatment with high concentrations of estrogen and progesterone. Thus, our study suggests a strong correlation between the down-modulation of anti-viral and pro-inflammatory responses mediated by estrogen and progesterone pre-treatment and the down regulation of HIV-1 replication. These findings may be relevant to clinical observations of sex specific differences in patient populations and point to the need for further investigation.	[Devadas, Krishnakumar; Biswas, Santanu; Ragupathy, Viswanath; Lee, Sherwin; Dayton, Andrew; Hewlett, Indira] US FDA, Lab Mol Virol, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Devadas, K; Hewlett, I (corresponding author), US FDA, Lab Mol Virol, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Krishnakumar.Devadas@fda.hhs.gov; Indira.Hewlett@fda.hhs.gov	Ragupathy, Viswanath/ABA-3444-2021	Biswas, Santanu/0000-0003-4056-4305	Office of Women's Health, FDA	Office of Women's Health, FDA	This work was supported by a grant from the Office of Women's Health, FDA.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Asin SN, 2004, J INFECT DIS, V190, P236, DOI 10.1086/421910; Asin SN, 2008, AIDS RES HUM RETROV, V24, P701, DOI 10.1089/aid.2007.0108; Asin SN, 2009, J INFECT DIS, V200, P965, DOI 10.1086/605412; BENHAIJ N, 2015, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0129425; Boucher A, 2000, MOL HUM REPROD, V6, P618, DOI 10.1093/molehr/6.7.618; BREEN EC, 1990, J IMMUNOL, V144, P480; Brotman RM, 2014, VACCINE, V32, P1543, DOI 10.1016/j.vaccine.2013.10.010; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; CHAO TC, 1995, CELL IMMUNOL, V160, P43, DOI 10.1016/0008-8749(95)80007-6; Correale J, 1998, J IMMUNOL, V161, P3365; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Giannoni E, 2011, INFECT IMMUN, V79, P2690, DOI 10.1128/IAI.00076-11; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; HTTPS, 2009, JID, P21910, DOI DOI 10.1086/421910; Ito A, 2001, J IMMUNOL, V167, P542, DOI 10.4049/jimmunol.167.1.542; KALKHOVEN E, 1995, INT J CANCER, V61, P80, DOI 10.1002/ijc.2910610114; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; KOLESNITCHENKO V, 1992, AIDS RES HUM RETROV, V8, P1977, DOI 10.1089/aid.1992.8.1977; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lee YW, 2004, CARDIOVASC RES, V63, P139, DOI 10.1016/j.cardiores.2004.03.006; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Long EM, 2000, NAT MED, V6, P71; Macura SL, 2016, JAIDS-J ACQ IMM DEF, V71, P474, DOI 10.1097/QAI.0000000000000891; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Ngcapu S, 2015, J REPROD IMMUNOL, V110, P14, DOI 10.1016/j.jri.2015.03.007; O'Brien SM, 2007, NEUROIMMUNOMODULAT, V14, P84, DOI 10.1159/000107423; Ochiel DO, 2008, CURR WOMENS HEALTH R, V4, P102, DOI 10.2174/157340408784246395; Ragupathy V, 2016, J MOL ENDOCRINOL, V57, P185, DOI 10.1530/JME-16-0138; Ragupathy V, 2013, J STEROID BIOCHEM, V138, P63, DOI 10.1016/j.jsbmb.2013.03.002; Richardson BA, 2007, AIDS, V21, P749, DOI 10.1097/QAD.0b013e328032790f; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; RODRIGUEZGARCIA M, 2013, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0062069; Rollenhagen C, 2011, MUCOSAL IMMUNOL, V4, P671, DOI 10.1038/mi.2011.34; ROLLENHAGEN C, 2015, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0131919; Rollenhagen C, 2010, JAIDS-J ACQ IMM DEF, V54, P463, DOI 10.1097/QAI.0b013e3181e5e12c; Rosner W, 2010, MOL CELL ENDOCRINOL, V316, P79, DOI 10.1016/j.mce.2009.08.009; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Sheffield JS, 2009, REPROD SCI, V16, P20, DOI 10.1177/1933719108325510; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Solar Paula, 2013, J Mol Signal, V8, P1, DOI 10.1186/1750-2187-8-1; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Sun YX, 2012, IMMUNOL LETT, V146, P25, DOI 10.1016/j.imlet.2012.04.007; Tasker C, 2014, VIRAL IMMUNOL, V27, P140, DOI 10.1089/vim.2013.0120; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Vassiliadou N, 1999, J IMMUNOL, V162, P7510; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Wang C, 2014, INT J MOL SCI, V15, P15412, DOI 10.3390/ijms150915412; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Zhang MJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-82; AIDS PATIENT CARE ST, P211	62	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191916	10.1371/journal.pone.0191916	http://dx.doi.org/10.1371/journal.pone.0191916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373606	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400030
J	Illias, HA; Liang, WZ				Illias, Hazlee Azil; Liang, Wee Zhao			Identification of transformer fault based on dissolved gas analysis using hybrid support vector machine-modified evolutionary particle swarm optimisation	PLOS ONE			English	Article							DIAGNOSIS; SYSTEM; REGRESSION; NETWORKS	Early detection of power transformer fault is important because it can reduce the maintenance cost of the transformer and it can ensure continuous electricity supply in power systems. Dissolved Gas Analysis (DGA) technique is commonly used to identify oil-filled power transformer fault type but utilisation of artificial intelligence method with optimisation methods has shown convincing results. In this work, a hybrid support vector machine (SVM) with modified evolutionary particle swarm optimisation (EPSO) algorithm was proposed to determine the transformer fault type. The superiority of the modified PSO technique with SVM was evaluated by comparing the results with the actual fault diagnosis, unoptimised SVM and previous reported works. Data reduction was also applied using stepwise regression prior to the training process of SVM to reduce the training time. It was found that the proposed hybrid SVM-Modified EPSO (MEPSO)-Time Varying Acceleration Coefficient (TVAC) technique results in the highest correct identification percentage of faults in a power transformer compared to other PSO algorithms. Thus, the proposed technique can be one of the potential solutions to identify the transformer fault type based on DGA data on site.	[Illias, Hazlee Azil; Liang, Wee Zhao] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Illias, HA (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.	h.illias@um.edu.my	Illias, Hazlee/K-2630-2015	Illias, Hazlee Azil/0000-0002-5061-1809	Ministry of Higher Education Malaysia [H -16001-D00048]; University of Malaya [PG236-2016A]; University of Malaya, Malaysia [H -16001-D00048]; PPP [PG236-2016A]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); University of Malaya(Universiti Malaya); University of Malaya, Malaysia(Universiti Malaya); PPP	This work was supported by the Ministry of Higher Education Malaysia H -16001-D00048) to HAI and University of Malaya PG236-2016A to HAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Ministry of Higher Education Malaysia and University of Malaya, Malaysia for supporting this work through HIR research grant (grant no.: H -16001-D00048) and PPP (grant no: PG236-2016A).	Abdullah MN, 2015, TURK J ELECTR ENG CO, V23, P2304, DOI 10.3906/elk-1307-204; An-xin Z, 2014, INT S EL INS MAT; Anaissi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157330; Bacha K, 2012, ELECTR POW SYST RES, V83, P73, DOI 10.1016/j.epsr.2011.09.012; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ding S., 2010, INTEL INF MANAGE, V2, P354, DOI DOI 10.4236/IIM.2010.26043; Dreidy M, 2017, ENERGIES, V10, DOI 10.3390/en10020150; Farquad MAH, 2010, EXPERT SYST APPL, V37, P5577, DOI 10.1016/j.eswa.2010.02.055; Fei SW, 2009, EXPERT SYST APPL, V36, P11352, DOI 10.1016/j.eswa.2009.03.022; Fei SW, 2009, ENERG CONVERS MANAGE, V50, P1604, DOI 10.1016/j.enconman.2009.02.004; Gholami A, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/aa61b6; Ghunem RA, 2012, IEEE T DIELECT EL IN, V19, P414, DOI 10.1109/TDEI.2012.6180233; Guo GD, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/aa637f; Hammestrom P, 1993, IEEE SPECTRUM; Handreck K., 1991, Engineering Applications of Artificial Intelligence, V4, P11, DOI 10.1016/0952-1976(91)90065-E; Huang YC, 2003, IEE P-SCI MEAS TECH, V150, P25, DOI 10.1049/ip-smt:20020454; Illias HA, 2017, SWARM EVOL COMPUT, V36, P18, DOI 10.1016/j.swevo.2017.03.003; Illias HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129363; Ing K. G., 2015, Applied Mechanics and Materials, V785, P541, DOI 10.4028/www.scientific.net/AMM.785.541; Jamian JJ, 2014, TURK J ELECTR ENG CO, V22, P1323, DOI 10.3906/elk-1212-173; Kennedy J., 1995, P P ICNN 95 INT C NE, DOI [10.1109/ICNN.1995.488968, DOI 10.1109/ICNN.1995.488968]; Kim SW, 2013, IEEE T DIELECT EL IN, V20, P685, DOI 10.1109/TDEI.2013.6508773; Lee TY, 2007, IEEE T ENERGY CONVER, V22, P774, DOI 10.1109/TEC.2006.878239; Li D, 2017, MEASUREMENT SCI TECH, V28; Liao RJ, 2012, IET GENER TRANSM DIS, V6, P142, DOI 10.1049/iet-gtd.2011.0165; Lo SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122855; Ma DY, 2013, ENG APPL ARTIF INTEL, V26, P937, DOI 10.1016/j.engappai.2012.03.017; Malabanan R., 2014, TENCON 2014 2014 IEE, P1; Mehta AK, 2013, INT C POW EN CONTR 2; Mehta AK, 2013, 2013 INTERNATIONAL CONFERENCE ON POWER, ENERGY AND CONTROL (ICPEC), P181, DOI 10.1109/ICPEC.2013.6527647; Miranda V, 2002, C EV COMP 2002, V2002; Ratnaweera A, 2004, IEEE T EVOLUT COMPUT, V8, P240, DOI [10.1109/TEVC.2004.826071, 10.1109/tevc.2004.826071]; Setiawan NA, 2012, PROCEEDINGS OF 2012 IEEE INTERNATIONAL CONFERENCE ON CONDITION MONITORING AND DIAGNOSIS (IEEE CMD 2012), P950, DOI 10.1109/CMD.2012.6416311; Shah AM, 2013, IEEE T POWER DELIVER, V28, P1508, DOI 10.1109/TPWRD.2012.2227979; Shintemirov A, 2009, IEEE T SYST MAN CY C, V39, P69, DOI 10.1109/TSMCC.2008.2007253; Souza LM, 2012, ENG APPL ARTIF INTEL, V25, P980, DOI 10.1016/j.engappai.2011.12.007; Srinivasan D, 2000, ENG APPL ARTIF INTEL, V13, P407, DOI 10.1016/S0952-1976(00)00012-9; Taha IBM, 2015, NORTH AMER POW SYMP; Thilagar SH, 2002, ENG APPL ARTIF INTEL, V15, P429, DOI 10.1016/S0952-1976(02)00087-8; Van Belle V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164568; Wang Z., 2000, ARTIFICIAL INTELLIGE; Wang ZY, 2000, 2000 IEEE POWER ENGINEERING SOCIETY WINTER MEETING - VOLS 1-4, CONFERENCE PROCEEDINGS, P1261, DOI 10.1109/PESW.2000.850127; Wei CH, 2014, IET ELECTR POWER APP, V8, P320, DOI 10.1049/iet-epa.2014.0085; Wesolowsky GO, 1976, MULTIPLE REGRESSION; Yang HT, 1998, IEEE T POWER SYST, V13, P946, DOI 10.1109/59.708845; Zakaria F, 2012, IEEE INT C CONTR SYS; Zhao X., 2015, 27 CHIN CONTR DEC C; Zheng HB, 2011, IET ELECTR POWER APP, V5, P691, DOI 10.1049/iet-epa.2010.0298	48	18	19	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191366	10.1371/journal.pone.0191366	http://dx.doi.org/10.1371/journal.pone.0191366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370230	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600050
J	Kroll, JL; Werchan, CA; Rosenfield, D; Ritz, T				Kroll, Juliet L.; Werchan, Chelsey A.; Rosenfield, David; Ritz, Thomas			Acute ingestion of beetroot juice increases exhaled nitric oxide in healthy individuals	PLOS ONE			English	Article							DIETARY NITRATE; BLOOD-PRESSURE; ADULTS; SUPPLEMENTATION; PERFORMANCE; SMOKING; ASTHMA; NASAL	Background and objective Nitric oxide (NO) plays an important role in the airways' innate immune response, and the fraction of exhaled NO at a flow rate of 50mL per second (FENO50) has been utilized to capture NO. Deficits in NO are linked to loss of bronchoprotective effects in airway challenges and predict symptoms of respiratory infection. While beetroot juice supplements have been proposed to enhance exercise performance by increasing dietary nitrate consumption, few studies have examined the impact of beetroot juice or nitrate supplementation on airway NO in contexts beyond an exercise challenge, which we know influences FENO50. Methods We therefore examined the influence of a beetroot juice supplement on FENO50 in healthy males and females (n = 38) during periods of rest and in normoxic conditions. FENO50, heart rate, blood pressure, and state affect were measured at baseline, 45 minutes, and 90 minutes following ingestion of 70ml beetroot juice (6.5 mmol nitrate). Identical procedures were followed with ingestion of 70ml of water on a control day. Results After beetroot consumption, average values of the natural log of FENO50 (lnF(E)NO(50)) increased by 21.3% (Cohen's d = 1.54, p < .001) 45 minutes after consumption and by 20.3% (Cohen's d = 1.45, p < .001) 90 min after consumption. On the other hand, only very small increases in FENO50 were observed after consumption of the control liquid (less than 1% increase). A small subset (n = 4) of participants completed an extended protocol lasting over 3 hours, where elevated levels of FENO50 persisted. No significant changes in cardiovascular measures were observed with this small single dose of beetroot juice. Conclusion As NO serves a key role in innate immunity, future research is needed to explore the potential clinical utility of beetroot and dietary nitrate to elevate FENO50 and prevent respiratory infection.	[Kroll, Juliet L.; Werchan, Chelsey A.; Rosenfield, David; Ritz, Thomas] Southern Methodist Univ, Dallas, TX 75275 USA	Southern Methodist University	Ritz, T (corresponding author), Southern Methodist Univ, Dallas, TX 75275 USA.	tritz@smu.edu			Southern Methodist University Research Council [401259]	Southern Methodist University Research Council	This work was supported by the Southern Methodist University Research Council Grant (No. 401259). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-67; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Dahgam S, 2014, J MED GENET, V51, P449, DOI 10.1136/jmedgenet-2013-101897; Dressel H, 2008, RESP MED, V102, P962, DOI 10.1016/j.rmed.2008.02.012; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Gomersal T, 2016, PEDIATR PULM, V51, P316, DOI 10.1002/ppul.23371; Hobbs DA, 2012, BRIT J NUTR, V108, P2066, DOI 10.1017/S0007114512000190; Hohensinn B, 2016, NITRIC OXIDE-BIOL CH, V60, P10, DOI 10.1016/j.niox.2016.08.006; Kapil V, 2010, HYPERTENSION, V56, P274, DOI 10.1161/HYPERTENSIONAHA.110.153536; Krantz C, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa61aa; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacLeod KE, 2015, INT J SPORT NUTR EXE, V25, P359, DOI 10.1123/ijsnem.2014-0129; Malinovschi A, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.28517; Maniscalco M, 2016, MED DEVICES-EVID RES, V9, P151, DOI 10.2147/MDER.S91201; Marteus H, 2005, THORAX, V60, P219, DOI 10.1136/thx.2004.030635; Olin AC, 2001, RESP MED, V95, P153, DOI 10.1053/rmed.2000.1010; PERSSON MG, 1995, BRIT J PHARMACOL, V116, P2957, DOI 10.1111/j.1476-5381.1995.tb15950.x; Proud D, 2005, CURR OPIN ALLERGY CL, V5, P37, DOI 10.1097/00130832-200502000-00008; Ritz T, 2014, ANN ALLERG ASTHMA IM, V112, P302, DOI 10.1016/j.anai.2013.11.022; Rouhos A, 2010, INT ARCH ALLERGY IMM, V152, P226, DOI 10.1159/000283029; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Shannon OM, 2016, NITRIC OXIDE-BIOL CH, V59, P63, DOI 10.1016/j.niox.2016.08.001; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; Trueba A, 2016, BIOL PSYCHOL, V118, P44, DOI 10.1016/j.biopsycho.2016.04.009; Tulic MK, 2000, EUR RESPIR J, V15, P870, DOI 10.1183/09031936.00.15587000; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zetterquist W, 1999, EUR RESPIR J, V13, P327, DOI 10.1034/j.1399-3003.1999.13b18.x	31	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191030	10.1371/journal.pone.0191030	http://dx.doi.org/10.1371/journal.pone.0191030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370244	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600034
J	Oppenheim, SJ; Feindt, W; DeSalle, R; Goldstein, PZ				Oppenheim, Sara J.; Feindt, Wiebke; DeSalle, Rob; Goldstein, Paul Z.			De Novo characterization of transcriptomes from two North American Papaipema stem-borers (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; P-ELEMENTS; GENES; EVOLUTION; GENOME; DROSOPHILA; PLANT; DATABASE; RETROTRANSPOSONS; INSECTS	Stem-borers in the genus Papaipema (Lepidoptera: Noctuidae) range from highly polyphagous agricultural pests to specialists on more than 20 families of flowering plants, many of them highly toxic. Papaipema is the largest genus of noctuids endemic to North America and provides an excellent study system for the evolution of noctuid host plant use. To improve the availability of genomic resources for such investigations, we performed de novo transcriptome sequencing and assembly for two specialist Papaipema with unusual larval hosts: P. speciosissima, which is associated with ferns, and the undescribed P. "sp. 4," which is associated with bamboo. The resulting transcriptomes were similar in terms of completeness, gene count, and gene identity, but we identified some 8,000 genes (similar to 17% of each transcriptome) not shared between the two species. While some of these have identifiable orthologs in other Lepidoptera, similar to 5% of each transcriptome consists of species-specific genes. We examine the function of these genes and find that almost half have retrotransposon-related functional domains. The potential role of species-specific genes is discussed, and the expansion of certain retrotransposon families in Papaipema is examined.	[Oppenheim, Sara J.; DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Feindt, Wiebke] Univ Vet Med Hannover, ITZ, Div Ecol & Evolut, Hannover, Germany; [Goldstein, Paul Z.] USDA, Natl Museum Nat Hist, Systemat Entomol Lab, Washington, DC 20250 USA	American Museum of Natural History (AMNH); University of Veterinary Medicine Hannover, Foundation; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA)	Oppenheim, SJ (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA.	soppenheim@amnh.org	Oppenheim, Sara/A-4641-2014	Oppenheim, Sara/0000-0003-1109-3639				Adrion JR, 2017, GENOME BIOL EVOL, V9, P1329, DOI 10.1093/gbe/evx050; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI 10.1111/j.1558-5646.1983.tb05524.x; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bomfleur B, 2014, SCIENCE, V343, P1376, DOI 10.1126/science.1249884; Burt A, 2008, GENES CONFLICT BIOL, P228; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Chen B, 2007, J EVOLUTION BIOL, V20, P2056, DOI 10.1111/j.1420-9101.2007.01348.x; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goke J, 2016, EMBO REP, V17, P1131, DOI 10.15252/embr.201642743; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HENDRIX SD, 1980, AM NAT, V115, P171, DOI 10.1086/283554; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Koga A, 2006, MOL BIOL EVOL, V23, P1414, DOI 10.1093/molbev/msl003; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Laissue PP, 2008, ADV EXP MED BIOL, V628, P102, DOI 10.1007/978-0-387-78261-4_7; Le Goff G, 2017, PEST MANAG SCI, V73, P493, DOI 10.1002/ps.4470; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Mahdavi A, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.8101; Mailafiya DM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0115; Majorek KA, 2014, RNASE H LIKE SUPERFA; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McBride AE, 2017, 2 PAPAIPEMA LIFE HIS, V59; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McLysaght A, 2016, NAT REV GENET, V17, P567, DOI 10.1038/nrg.2016.78; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Negi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01448; Ono H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2247-0; Preisser EL, 2005, J PLANT INTERACT, V1, P197, DOI 10.1080/17429140601040570; Price MN, 2010, FASTTREE COMPUTING L; Pruitt KD, 2007, NUCL ACIDS RES; Rambaut A., 2016, FIGTREE V4 1 3; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; Schlotterer C, 2015, TRENDS GENET, V31, P215, DOI 10.1016/j.tig.2015.02.007; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Seddigh S, 2016, TURK J BIOL, V40, P69, DOI 10.3906/biy-1412-88; Servant G, 2012, NUCLEIC ACIDS RES, V40, P5271, DOI 10.1093/nar/gks166; Simao FA, 2015, BIOINFORMATICS; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Tripp HJ, 2011, NUCLEIC ACIDS RES, V39, P8792, DOI 10.1093/nar/gkr576; US Department of Agriculture AaPHIS, 2017, PLANT PESTS DIS PROG; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	70	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191061	10.1371/journal.pone.0191061	http://dx.doi.org/10.1371/journal.pone.0191061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364900	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500034
J	Schwarz, KRL; de Castro, FC; Schefer, L; Botigelli, RC; Paschoal, DM; Fernandes, H; Leal, CLV				Schwarz, Katia R. L.; de Castro, Fernanda C.; Schefer, Leticia; Botigelli, Ramon C.; Paschoal, Daniela M.; Fernandes, Hugo; Leal, Claudia L. V.			The role of cGMP as a mediator of lipolysis in bovine oocytes and its effects on embryo development and cryopreservation	PLOS ONE			English	Article							DIFFERENT CULTURE-SYSTEMS; PHOSPHODIESTERASE TYPE 5; IN-VITRO PRODUCTION; ADIPOSE-TISSUE; BLASTOCYST DEVELOPMENT; NATRIURETIC PEPTIDES; LIPID DROPLETS; FATTY-ACID; CYCLIC-GMP; LINOLEIC-ACID	This study aimed to determine the influence of cyclic guanosine 3'5'-monophosphate (cGMP) and cGMP-dependent kinase (PKG) during in vitro maturation (IVM) on lipolysis-related parameters in bovine cumulus-oocyte complexes (COCs), and on embryo development and cryosurvival. COCs were matured with cGMP/PKG modulators and assessed for metaphase II rates (MII), cGMP levels, lipid content in oocytes (OO), transcript abundance for genes involved in lipolysis (ATGL) and lipid droplets (PLIN2) in cumulus cells (CC) and OO, and presence of phosphorylated (active) hormone sensitive lipase (HSLser563) in OO. Embryo development, lipid contents and survival to vitrification were also assessed. Phosphodiesterase 5 inhibition (PDE5; cGMP-hydrolyzing enzyme) with 10(-5)M sildenafil (SDF) during 24 h IVM increased cGMP in COCs (56.9 vs 9.5 fMol/COC in untreated controls, p<0.05) and did not affect on maturation rate (84.3 +/- 6.4% MII). Fetal calf serum (FCS) in IVM medium decreased cGMP in COCs compared to bovine serum albumin (BSA) + SDF (19.6 vs 66.5 fMol/COC, respectively, p<0.05). FCS increased lipid content in OO (40.1 FI, p<0.05) compared to BSA (34.6 FI), while SDF decreased (29.8 and 29.6 FI, with BSA or FCS, respectively p<0.05). PKG inhibitor (KT5823) reversed this effect (38.9 FI, p<0.05). ATGL and PLIN2 transcripts were detected in CC and OO, but were affected by cGMP and PKG only in CC. HSLser563 was detected in OO matured with or without modulators. Reduced lipid content in embryos were observed only when SDF was added during IVM and IVC (27.6 FI) compared to its use in either or none of the culture periods (34.2 FI, p<0.05). Survival to vitrification was unaffected by SDF. In conclusion, cGMP and PKG are involved in lipolysis in OO and possibly in CC and embryos; serum negatively affects this pathway, contributing to lipid accumulation, and cGMP modulation may reduce lipid contents in oocytes and embryos, but without improving embryo cryotolerance.	[Schwarz, Katia R. L.; de Castro, Fernanda C.; Schefer, Leticia; Paschoal, Daniela M.; Fernandes, Hugo; Leal, Claudia L. V.] Univ Sao Paulo, FZEA, Dept Med Vet, Pirassununga, SP, Brazil; [Botigelli, Ramon C.] Univ Estadual Paulista, IBB, Dept Farmacol, UNESP, Botucatu, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Schwarz, KRL; Leal, CLV (corresponding author), Univ Sao Paulo, FZEA, Dept Med Vet, Pirassununga, SP, Brazil.	ka.lancellotti@hotmail.com; clvleal@usp.br	Botigelli, Ramon/ABF-2847-2020; Leal, Cláudia/F-3518-2012	Botigelli, Ramon/0000-0002-2796-6062; Leal, Cláudia/0000-0002-9061-2574	 [2013/15374-3];  [2015/20379-0]	; 	This work was supported by Grant numbers 2013/15374-3 ; 2015/20379-0, www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Accorsi MF, 2016, ZYGOTE, V24, P485, DOI 10.1017/S0967199415000428; Al Darwich A, 2014, ANIM REPROD SCI, V145, P105, DOI 10.1016/j.anireprosci.2014.01.010; Al Darwich A, 2010, PROSTAG OTH LIPID M, V93, P30, DOI 10.1016/j.prostaglandins.2010.06.002; Armani A, 2011, TRENDS ENDOCRIN MET, V22, P404, DOI 10.1016/j.tem.2011.05.004; Auclair S, 2013, AM J PHYSIOL-ENDOC M, V304, pE599, DOI 10.1152/ajpendo.00469.2012; Barcelo-Fimbres M, 2007, MOL REPROD DEV, V74, P1406, DOI 10.1002/mrd.20700; Barcelo-Fimbres M, 2011, THERIOGENOLOGY, V75, P434, DOI 10.1016/j.theriogenology.2010.09.007; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bilodeaul-Goeseels S, 2007, THERIOGENOLOGY, V68, P693, DOI 10.1016/j.theriogenology.2007.05.063; Campos-Chillon LE, 2006, THERIOGENOLOGY, V65, P1200, DOI 10.1016/j.theriogenology.2005.07.015; Corbin JD, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01686-2; del Collado M, 2016, REPROD FERT DEVELOP, V28, P1721, DOI 10.1071/RD15067; DELOOS F, 1991, MOL REPROD DEV, V28, P255, DOI 10.1002/mrd.1080280307; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; De La Torre-Sanchez JF, 2006, REPROD FERT DEVELOP, V18, P597, DOI 10.1071/RD05064; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fu XW, 2011, THERIOGENOLOGY, V75, P268, DOI 10.1016/j.theriogenology.2010.08.013; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Krisher RL, 2015, REPROD FERT DEVELOP, V27, P602, DOI 10.1071/RD14359; Krisher RL, 1999, BIOL REPROD, V60, P1345, DOI 10.1095/biolreprod60.6.1345; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Schwarz KRL, 2014, THERIOGENOLOGY, V81, P556, DOI 10.1016/j.theriogenology.2013.11.008; Langin D, 2006, CR BIOL, V329, P598, DOI 10.1016/j.crvi.2005.10.008; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonergan P, 2003, Reprod Biomed Online, V7, P657; Marquez YC, 2005, REPROD DOMEST ANIM, V40, P553, DOI 10.1111/j.1439-0531.2005.00632.x; Maurice DH, 2003, P W PHARMACOL SOC, V46, P32; Men HS, 2006, THERIOGENOLOGY, V66, P2008, DOI 10.1016/j.theriogenology.2006.05.018; Morato R, 2010, REPROD FERT DEVELOP, V22, P1141, DOI 10.1071/RD10013; Moro C, 2007, AM J PHYSIOL-REG I, V293, pR612, DOI 10.1152/ajpregu.00162.2007; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Nicacio AC, 2012, ZYGOTE, V20, P117, DOI 10.1017/S0967199410000717; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Paschoal DM, 2017, THERIOGENOLOGY, V87, P108, DOI 10.1016/j.theriogenology.2016.08.011; Paschoal DM, 2014, ZYGOTE, V22, P146, DOI 10.1017/S0967199412000354; Pereira RM, 2007, ANIM REPROD SCI, V98, P293, DOI 10.1016/j.anireprosci.2006.03.015; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Romek M, 2011, THERIOGENOLOGY, V75, P42, DOI 10.1016/j.theriogenology.2010.06.040; Sanchez-Lazo L, 2014, MOL ENDOCRINOL, V28, P1502, DOI 10.1210/me.2014-1049; Sasseville M, 2008, ENDOCRINOLOGY, V149, P5568, DOI 10.1210/en.2008-0547; Sastre D, 2014, THERIOGENOLOGY, V81, P326, DOI 10.1016/j.theriogenology.2013.10.002; Schwarz KRL, 2017, REPROD FERT DEVELOP, V29, P1593, DOI 10.1071/RD15512; Sengenes C, 2005, M S-MED SCI, V21, P29; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Sengenes C, 2002, INT J OBESITY, V26, P24, DOI 10.1038/sj.ijo.0801845; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Spricigo JFW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130164; Sudano MJ, 2013, ANIM REPROD, V10, P160; Sudano MJ, 2014, ZYGOTE, V22, P124, DOI 10.1017/S0967199412000196; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Wang S, 2008, FRONT BIOSCI, V13, P7087, DOI 10.2741/3212; Yamashita S, 1999, CYTOTECHNOLOGY, V31, P121, DOI 10.1023/A:1008044827145; Yang X, 2010, REPROD FERT DEVELOP, V22, P1262, DOI 10.1071/RD10091; Zhang RN, 2014, REPROD DOMEST ANIM, V49, P875, DOI 10.1111/rda.12386	72	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191023	10.1371/journal.pone.0191023	http://dx.doi.org/10.1371/journal.pone.0191023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360833	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800014
J	Atkinson, TP; Centor, RM; Xiao, L; Wang, FCC; Cui, XQ; Van der Pol, W; Morrow, CD; Ratliff, AE; Crabb, DM; Totten, AH; Estrada, CA; Faircloth, MB; Waites, KB				Atkinson, T. Prescott; Centor, Robert M.; Xiao, Li; Wang, Fuchenchu; Cui, Xiangqin; Van der Pol, William; Morrow, Casey D.; Ratliff, Amy E.; Crabb, Donna M.; Totten, Arthur H.; Estrada, Carlos A.; Faircloth, Michael B.; Waites, Ken B.			Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity	PLOS ONE			English	Article							PHARYNGITIS; INFECTIONS; PREVALENCE; SEQUENCES	Fusobacterium necrophorum (Fn), a gram-negative anaerobe, is increasingly implicated as an etiologic agent in older adolescents and young adults with sore throat. Inadequately treated Fn pharyngitis may result in suppurative complications such as peritonsillar abscess and Lemierre's syndrome. Data from the literature suggest that the incidence of life-threating complications in these age groups from Fn pharyngitis (Lemierre's syndrome) in the United States exceeds those associated with group A beta-hemolytic streptococcal (GAS) pharyngitis (acute rheumatic fever). Using real-time PCR, we previously reported about a 10% prevalence of Fn in asymptomatic medical students and about 20% in students complaining of sore throat at a university student health clinic (p = 0.009). In this study, a comprehensive microbiome analysis of the same study samples confirms that Fn pharyngitis was more common than GAS pharyngitis. Eighteen patients were found to have Fn OTU values exceeding an arbitrary cutoff value of 0.1, i.e. greater than 10% of total sequences, with five subjects reaching values above 0.7. By contrast only 9 patients had GAS OTU values greater than 0.1 and none exceeded 0.6. When the data were analyzed using five separate assessments of alpha diversity, in each case for Fn there were statistically significant differences between Fn positive_high (OTU abundance >0.1) vs control, Fn positive_high vs Fn negative (OTU abundance = 0), Fn positive_high vs Fn positive_low (OTU abundance >0 and <0.1). When the data were analyzed using three beta diversity indexes (Bray-Curtis, weighted unifrac, and unweighted unifrac), there were statistically significant differences between Fn positive_high (OTU abundance >= 0.1) vs control for all three. Statistically significant differences remained if we chose somewhat different OTU abundance cutoffs of 0.05 or 0.15. We conclude that Fn appears to play a dominant role in bacterial pharyngitis in the older adolescent and young adult age groups and that the development of a productive mucosal infection with Fn is linked to a significant decrease in the diversity of the associated tonsillar microbiome.	[Atkinson, T. Prescott] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35487 USA; [Centor, Robert M.; Xiao, Li; Estrada, Carlos A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Wang, Fuchenchu; Cui, Xiangqin] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Van der Pol, William] Univ Alabama Birmingham, Sch Med, Ctr Clin & Translat Sci, Birmingham, AL USA; [Morrow, Casey D.] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Ratliff, Amy E.; Crabb, Donna M.; Waites, Ken B.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL USA; [Totten, Arthur H.] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Faircloth, Michael B.] Univ Alabama Birmingham, Sch Med, Dept Family & Community Med, Birmingham, AL USA; [Cui, Xiangqin] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Rollins School Public Health	Atkinson, TP (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35487 USA.	patkinson@peds.uab.edu	Totten, Arthur H/AAD-6643-2019	Totten, Arthur H/0000-0002-2979-7522; Atkinson, Thomas/0000-0003-2528-6976	UAB Depts of Pediatrics and Medicine	UAB Depts of Pediatrics and Medicine	This work was internally funded by the UAB Depts of Pediatrics and Medicine (to TPA).	Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; Amess JA, 2007, BRIT J BIOMED SCI, V64, P63, DOI 10.1080/09674845.2007.11732757; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Batty A, 2005, J INFECTION, V51, P299, DOI 10.1016/j.jinf.2004.09.013; Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Brazier JS, 2006, ANAEROBE, V12, P165, DOI 10.1016/j.anaerobe.2005.11.003; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2015, ANN INTERN MED, V162, P241, DOI 10.7326/M14-1305; Centor RM, 2009, ANN INTERN MED, V151, P812, DOI 10.7326/0003-4819-151-11-200912010-00011; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Jensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056418; JOUSIMIESSOMER H, 1993, CLIN INFECT DIS, V16, pS292, DOI 10.1093/clinids/16.Supplement_4.S292; Klug TE, 2016, EUR J CLIN MICROBIOL, V27, P27; Klug TE, 2009, CLIN INFECT DIS, V49, P1467, DOI 10.1086/644616; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar R, 2014, CURR PROTOC HUM GENE, V82, P1, DOI [DOI 10.1002/0471142905.HG1808S82, 10.1002/0471142905.hg1808s82]; Kumar R, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0622-2; Kuppalli K, 2012, LANCET INFECT DIS, V12, P808, DOI 10.1016/S1473-3099(12)70089-0; Linder JA, 2015, ANN INTERN MED, V162, P878, DOI 10.7326/L15-5100-2; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludlam H, 2009, J MED MICROBIOL, V58, P1264, DOI 10.1099/jmm.0.006718-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenney Erin A., 2017, Microbial Ecology in Health and Disease, V28, P1335165, DOI 10.1080/16512235.2017.1335165; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; She R, 2017, CURR MICROBIOL, V26; Van TT, 2017, J CLIN MICROBIOL, V55, P1147, DOI 10.1128/JCM.02174-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wood MR, 2017, AM J TROP MED HYG, V96, P1274, DOI 10.4269/ajtmh.16-0581	33	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189423	10.1371/journal.pone.0189423	http://dx.doi.org/10.1371/journal.pone.0189423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351278	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300008
J	Pankratova, EV; Kalyakulina, AI; Krivonosov, MI; Denisov, SV; Taute, KM; Zaburdaev, VY				Pankratova, Evgeniya V.; Kalyakulina, Alena I.; Krivonosov, Mikhail I.; Denisov, Sergei V.; Taute, Katja M.; Zaburdaev, Vasily Yu.			Chemotactic drift speed for bacterial motility pattern with two alternating turning events	PLOS ONE			English	Article							MARINE-BACTERIA; PROKARYOTES; PERSISTENCE; DIRECTION; TRACKING; KINETICS	Bacterial chemotaxis is one of the most extensively studied adaptive responses in cells. Many bacteria are able to bias their apparently random motion to produce a drift in the direction of the increasing chemoattractant concentration. It has been recognized that the particular motility pattern employed by moving bacteria has a direct impact on the efficiency of chemotaxis. The linear theory of chemotaxis pioneered by de Gennes allows for calculation of the drift velocity in small gradients for bacteria with basic motility patterns. However, recent experimental data on several bacterial species highlighted the motility pattern where the almost straight runs of cells are interspersed with turning events leading to the reorientation of the cell swimming directions with two distinct angles following in strictly alternating order. In this manuscript we generalize the linear theory of chemotaxis to calculate the chemotactic drift speed for the motility pattern of bacteria with two turning angles. By using the experimental data on motility parameters of V. alginolyticus bacteria we can use our theory to relate the efficiency of chemotaxis and the size of bacterial cell body. The results of this work can have a straightforward extension to address most general motility patterns with alternating angles, speeds and durations of runs.	[Pankratova, Evgeniya V.; Kalyakulina, Alena I.; Krivonosov, Mikhail I.; Denisov, Sergei V.] Lobachevsky State Univ, Inst Informat Technol Math & Mech, Nizhnii Novgorod, Russia; [Denisov, Sergei V.] Univ Augsburg, Dept Theoret Phys, Augsburg, Germany; [Taute, Katja M.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Zaburdaev, Vasily Yu.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Zaburdaev, Vasily Yu.] Lobachevsky State Univ, Inst Supercomp Technol, Nizhnii Novgorod, Russia	Lobachevsky State University of Nizhni Novgorod; University of Augsburg; Harvard University; Max Planck Society; Lobachevsky State University of Nizhni Novgorod	Pankratova, EV (corresponding author), Lobachevsky State Univ, Inst Informat Technol Math & Mech, Nizhnii Novgorod, Russia.	evgenia.pankratova@itmm.unn.ru	Kalyakulina, Alena I./O-7818-2017; Pankratova, Evgeniya V./M-2733-2016; Zaburdaev, Vasily/B-8194-2017; Taute, Katja/AAC-6942-2019; Krivonosov, Mikhail/AAJ-5810-2020; Denisov, Sergey V/B-8340-2008	Kalyakulina, Alena I./0000-0001-9277-502X; Pankratova, Evgeniya V./0000-0003-4214-7230; Zaburdaev, Vasily/0000-0001-8234-3442; Taute, Katja/0000-0003-2230-717X; Krivonosov, Mikhail/0000-0002-1169-5149; 	Russian Science Foundation (RSF) [16-12-10496]	Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	The authors acknowledge financial support by the Russian Science Foundation (RSF project 16-12-10496, http://rscf.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindal T, 2011, BIOPHYS J, V100, P32, DOI 10.1016/j.bpj.2010.11.029; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berg HC, 2013, NAT PHYS, V9, P460, DOI 10.1038/nphys2678; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bubendorfer S, 2014, P NATL ACAD SCI USA, V111, P11485, DOI 10.1073/pnas.1405820111; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Eisenbach M, 2004, CHEMOTAXIS, DOI DOI 10.1142/P303; GRABERT H, 1977, Z PHYS B CON MAT, V26, P389, DOI 10.1007/BF01570749; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kafri Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238101; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kupferman R, 2004, J STAT PHYS, V114, P291, DOI 10.1023/B:JOSS.0000003113.22621.f0; Liu B, 2014, P NATL ACAD SCI USA, V111, P11252, DOI 10.1073/pnas.1407636111; Locsei JT, 2007, J MATH BIOL, V55, P41, DOI 10.1007/s00285-007-0080-z; O'Toole G, 2010, ANNU REV MICROBIOL, V54, P49; Son K, 2016, P NATL ACAD SCI USA, V113, P8624, DOI 10.1073/pnas.1602307113; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; Stocker R, 2011, P NATL ACAD SCI USA, V108, P2635, DOI 10.1073/pnas.1019199108; Taktikos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081936; Taute KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9776; Theves M, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/28007; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xie L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141654; Xie L, 2015, BIOPHYS J, V108, P766, DOI 10.1016/j.bpj.2014.11.3479; Xie L, 2014, BIOPHYS J, V107, P1712, DOI 10.1016/j.bpj.2014.07.058; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	31	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190434	10.1371/journal.pone.0190434	http://dx.doi.org/10.1371/journal.pone.0190434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351336	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300018
J	Szczepny, A; Carey, K; McKenzie, L; Jayasekara, WSN; Rossello, F; Gonzalez-Rajal, A; Mccaw, AS; Popovski, D; Wang, D; Sadler, AJ; Mahar, A; Russell, PA; Wright, G; McCloy, RA; Garama, DJ; Gough, DJ; Baylin, SB; Burgess, A; Cain, JE; Watkins, DN				Szczepny, Anette; Carey, Kirstyn; McKenzie, Lisa; Jayasekara, W. Samantha N.; Rossello, Fernando; Gonzalez-Rajal, Alvaro; Mccaw, Andrew S.; Popovski, Dean; Wang, Die; Sadler, Anthony J.; Mahar, Annabelle; Russell, Prudence A.; Wright, Gavin; McCloy, Rachael A.; Garama, Daniel J.; Gough, Daniel J.; Baylin, Stephen B.; Burgess, Andrew; Cain, Jason E.; Watkins, D. Neil			The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; DIRECT TARGET GENE; CANCER 1 HIC1; DNA-DAMAGE; BREAST-CANCER; LUNG ADENOCARCINOMA; DRIVES PROGRESSION; MI-2/NURD COMPLEX; P53; INSTABILITY	Hypermethylated-in-Cancer 1 (Hic1) is a tumor suppressor gene frequently inactivated by epigenetic silencing and loss-of-heterozygosity in a broad range of cancers. Loss of HIC1, a sequence-specific zinc finger transcriptional repressor, results in deregulation of genes that promote a malignant phenotype in a lineage-specific manner. In particular, upregulation of the HIC1 target gene SIRT1, a histone deacetylase, can promote tumor growth by inactivating TP53. An alternate line of evidence suggests that HIC1 can promote the repair of DNA double strand breaks through an interaction with MTA1, a component of the nucleosome remodeling and deacetylase (NuRD) complex. Using a conditional knockout mouse model of tumor initiation, we now show that inactivation of Hic1 results in cell cycle arrest, premature senescence, chromosomal instability and spontaneous transformation in vitro. This phenocopies the effects of deleting Brca1, a component of the homologous recombination DNA repair pathway, in mouse embryonic fibroblasts. These effects did not appear to be mediated by deregulation of Hic1 target gene expression or loss of Tp53 function, and rather support a role for Hic1 in maintaining genome integrity during sustained replicative stress. Loss of Hic1 function also cooperated with activation of oncogenic KRas in the adult airway epithelium of mice, resulting in the formation of highly pleomorphic adenocarcinomas with a micropapillary phenotype in vivo. These results suggest that loss of Hic1 expression in the early stages of tumor formation may contribute to malignant transformation through the acquisition of chromosomal instability.	[Szczepny, Anette; Carey, Kirstyn; McKenzie, Lisa; Jayasekara, W. Samantha N.; Mccaw, Andrew S.; Popovski, Dean; Wang, Die; Sadler, Anthony J.; Garama, Daniel J.; Gough, Daniel J.; Cain, Jason E.] Hudson Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Szczepny, Anette; Carey, Kirstyn; McKenzie, Lisa; Popovski, Dean; Wang, Die; Sadler, Anthony J.; Garama, Daniel J.; Gough, Daniel J.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Rossello, Fernando] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Rossello, Fernando] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Gonzalez-Rajal, Alvaro; Burgess, Andrew; Watkins, D. Neil] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Mahar, Annabelle] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia; [Russell, Prudence A.] St Vincents Hosp Melbourne, Dept Pathol, Fitzroy, Vic, Australia; [Wright, Gavin] St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic, Australia; [Baylin, Stephen B.] Johns Hopkins, Sidney Kimmel Canc Ctr, Baltimore, MD USA; [Watkins, D. Neil] UNSW Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Watkins, D. Neil] St Vincents Hosp, Dept Thorac Med, Sydney, NSW, Australia	Hudson Institute of Medical Research; Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; Garvan Institute of Medical Research; University of Sydney; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; Johns Hopkins University; University of New South Wales Sydney; St Vincents Hospital Sydney	Cain, JE (corresponding author), Hudson Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia.; Watkins, DN (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia.; Watkins, DN (corresponding author), UNSW Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia.; Watkins, DN (corresponding author), St Vincents Hosp, Dept Thorac Med, Sydney, NSW, Australia.	jason.cain@hudson.org.au; n.watkins@garvan.org.au	Gonzalez-Rajal, Alvaro/ABA-6874-2020; sadler, anthony/ABA-5572-2020; Rossello, Fernando/B-1208-2015; Burgess, Andrew/H-3339-2019; Wang, Die/H-8860-2017	Gonzalez-Rajal, Alvaro/0000-0002-9230-0339; sadler, anthony/0000-0002-7970-8030; Rossello, Fernando/0000-0003-3885-8777; Burgess, Andrew/0000-0003-4536-9226; Wang, Die/0000-0001-7628-7309; Gough, Daniel/0000-0001-5725-8668; McCloy, Rachael/0000-0001-7791-4044; Carey, Kirstyn/0000-0003-4743-2700; McKenzie, Lisa/0000-0002-1432-6496; Gough, Daniel/0000-0001-6479-1735	National Health and Medical Research Council (NHMRC) of Australia [GNT10838550]; Victorian Cancer Agency [TS10-01]; National Institutes of Health [NCI-RO1 NS054085]; Petre Foundation; Victorian Government's Operational Infrastructure Support Program; NHMRC [GNT1063914]; Cancer Institute NSW Fellowship [10/FRL/3-02]; Patricia Helen Guest Fellowship; National Health and Medical Research Council of Australia [GNT1063914, GNT1083855]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054085] Funding Source: NIH RePORTER; National Breast Cancer Foundation [IIRS-18-103] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Petre Foundation; Victorian Government's Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Fellowship; Patricia Helen Guest Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Breast Cancer Foundation	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (Project Grant GNT10838550, The Victorian Cancer Agency (TS10-01), The National Institutes of Health (NCI-RO1 NS054085), The Petre Foundation, and the Victorian Government's Operational Infrastructure Support Program. Dr Gough is supported by an NHMRC Career Development Fellowship (GNT1063914). Dr Burgess is supported by Cancer Institute NSW Fellowship (10/FRL/3-02) and a Patricia Helen Guest Fellowship. The contents of this manuscript are solely the responsibility of the participating institutions and individual authors, and do not reflect the views of these funding agencies. We thank Dr Dominique LePrince for the gift of the Hic1-FLAG expression vector. National Health and Medical Research Council of Australia (GNT1083855): J.E.C., D.N.W.; (GNT1063914): D.J.G. National Institutes of Health (NINDS RO1 NS054085): D.N.W., S.B.B. The Petre Foundation: D.N.W. Cancer Institute of NSW Fellowship (10/FRL/3-02) and the Patricia Helen Guest Fellowship: A.B.	Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Badea TC, 2003, J NEUROSCI, V23, P2314; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Briggs KJ, 2008, CANCER RES, V68, P8654, DOI 10.1158/0008-5472.CAN-08-1904; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Britschgi C, 2008, BRIT J HAEMATOL, V141, P179, DOI 10.1111/j.1365-2141.2008.06992.x; Cain Jason E., 2013, Sarcoma, V2013, P608964, DOI 10.1155/2013/608964; Caldon CE, 2013, CELL CYCLE, V12, P606, DOI 10.4161/cc.23512; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2005, CELL CYCLE, V4, P10, DOI 10.4161/cc.4.1.1361; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Cheng GC, 2014, CANCER RES, V74, P862, DOI 10.1158/0008-5472.CAN-13-2420; Cohen SM, 2010, NUCLEIC ACIDS RES, V38, P6906, DOI 10.1093/nar/gkq559; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dehennaut V, 2013, J BIOL CHEM, V288, P10254, DOI 10.1074/jbc.M112.421610; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 1998, BBA-GENE STRUCT EXPR, V1443, P230, DOI 10.1016/S0167-4781(98)00219-X; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Heng HH, 2013, CANCER METAST REV, V32, P325, DOI 10.1007/s10555-013-9427-7; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janeckova L, 2015, MOL CANCER RES, V13, P1139, DOI 10.1158/1541-7786.MCR-15-0033; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Leibiger C, 2013, J HISTOCHEM CYTOCHEM, V61, P306, DOI 10.1369/0022155413476868; Li DQ, 2010, CELL CYCLE, V9, P2071, DOI 10.4161/cc.9.11.11735; Li P, 2015, ONCOTARGET, V6, P38151, DOI 10.18632/oncotarget.5832; Lin YM, 2013, CELL CYCLE, V12, P2266, DOI 10.4161/cc.25365; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mannava S, 2013, AM J PATHOL, V182, P142, DOI 10.1016/j.ajpath.2012.09.011; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Melki JR, 1999, CANCER RES, V59, P3730; Mermoud JE, 2011, CELL CYCLE, V10, P4017, DOI 10.4161/cc.10.23.18558; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Nagy A, 2008, CSH PROTOC, P2014; Paget S, 2017, ONCOTARGET, V8, P2916, DOI 10.18632/oncotarget.13807; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pinte S, 2004, ONCOGENE, V23, P4023, DOI 10.1038/sj.onc.1207504; Prakash R, 2015, COLD SPRING HARB PER, V7; Rood BR, 2002, CANCER RES, V62, P3794; Russell PA, 2013, J THORAC ONCOL, V8, P461, DOI 10.1097/JTO.0b013e3182828fb8; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Stephen JK, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0005-3; Stevens JB, 2013, CANCER METAST REV, V32, P391, DOI 10.1007/s10555-013-9428-6; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Szczepny A, 2017, ONCOGENE, V23, P2314; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Thomas A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6282; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; Ung M, 2016, CLIN LUNG CANCER, V17, P391, DOI 10.1016/j.cllc.2016.03.001; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wallace MD, 2014, ONCOGENE, V33, P3688, DOI 10.1038/onc.2013.339; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	71	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1939	1948		10.1038/s41388-017-0022-1	http://dx.doi.org/10.1038/s41388-017-0022-1			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29367758	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000429303300010
J	Buren, C; Logters, T; Oezel, L; Rommelfanger, G; Scholz, AO; Windolf, J; Windolf, CD				Bueren, Carina; Loegters, Tim; Oezel, Lisa; Rommelfanger, Golnessa; Scholz, Armin Olaf; Windolf, Joachim; Windolf, Ceylan Daniela			Effect of hyperbaric oxygen therapy (HBO) on implant-associated osteitis in a femur fracture model in mice	PLOS ONE			English	Article							EXPERIMENTAL STAPHYLOCOCCAL OSTEOMYELITIS; IMMUNE EVASION; AUREUS; DIAGNOSIS; BIOFILM	Hyperbaric oxygen therapy (HBO) is applied very successfully in treatment of various diseases such as chronic wounds. It has been already suggested as adjunctive treatment option for osteitis by immune- and fracture modulating effects. This study evaluates the importance of HBO in an early implant-associated localized osteitis caused by Staphylococcus aureus (SA) compared to the standard therapy. In a standardized murine model the left femur of 120 BALB/c mice were osteotomized and fixed by a titanium locking plate. Osteitis has been induced with a defined amount of SA into the fracture gap. Debridement and lavages were progressed on day 7, 14, 28 and 56 to determine the local bacterial growth and the immune reaction. Hyperbaric oxygen (2 ATA, 90%) was applied for 90 minutes on day 7 to 21 for those mice allocated to HBO therapy. To evaluate the effect of HBO therapy the following groups were analyzed: Two sham-groups (12 mice / group) with and without HBO therapy, two osteotomy groups (24 mice / group) with plate osteosynthesis of the femur with and without HBO therapy, and two osteotomy SA infection groups (24 mice / group) with and without HBO therapy. Fracture healing was also quantified on day 7, 14, 28 and 56 by a.p. x-ray and bone healing markers from blood samples. Progression of infection was assessed by estimation of colony-forming units (CFU) and immune response was analyzed by determination of polymorphonuclear neutrophils (PMN), Interleukin (IL) - 6, and the circulating free DNA (cfDNA) in lavage samples. Osteitis induced significantly higher IL-6, cfDNA- and PMN-levels in the lavage samples (on day 7 and 14, each p < 0.05). HBO-therapy did not have a significant influence on the CFU and immune response compared to the standard therapy (each p > 0.05). At the same time HBO-therapy was associated with a delayed bone healing assessed by x-ray radiography and a higher rate of non-union until day 28. In conclusion, osteitis led to significantly higher bacterial count and infection parameters. HBO-therapy neither had a beneficial influence on local infection nor on immune response or fracture healing compared to the standard therapy in an osteitis mouse model.	[Bueren, Carina; Loegters, Tim; Oezel, Lisa; Rommelfanger, Golnessa; Scholz, Armin Olaf; Windolf, Joachim; Windolf, Ceylan Daniela] Heinrich Heine Univ, Med Fac, Dept Trauma & Hand Surg, Dusseldorf Moorenstr 5, Dusseldorf, Germany; [Loegters, Tim] St Antonius Hosp Cologne, Dept Trauma Hand & Orthoped Surg, Schillerstr 23, Cologne, Germany	Heinrich Heine University Dusseldorf	Buren, C (corresponding author), Heinrich Heine Univ, Med Fac, Dept Trauma & Hand Surg, Dusseldorf Moorenstr 5, Dusseldorf, Germany.	carina.bueren@med.uni-duesseldorf.de			AO Foundation [S-15-123L]	AO Foundation	Project no. S-15-123L was supported by the AO Foundation to TL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazak A, 2005, J DIABETES COMPLICAT, V19, P138, DOI 10.1016/j.jdiacomp.2004.06.001; Benito D, 2014, FOODBORNE PATHOG DIS, V11, P354, DOI 10.1089/fpd.2013.1689; Birt MC, 2017, J ORTHOP, V14, P45, DOI 10.1016/j.jor.2016.10.004; Frommelt L, 2004, ORTHOPADE, V33, P822, DOI 10.1007/s00132-004-0677-5; Garzoni C, 2011, EMBO MOL MED, V3, P115, DOI 10.1002/emmm.201100123; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; HAMBLEN DL, 1968, J BONE JOINT SURG AM, VA 50, P1129, DOI 10.2106/00004623-196850060-00004; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jacqueline C, 2014, J ANTIMICROB CHEMOTH, V69, P37, DOI 10.1093/jac/dku254; Jorgensen NP, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5020021; Kawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072603; Kendall AC, 2013, WOUND REPAIR REGEN, V21, P860, DOI 10.1111/wrr.12108; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lipsky B, 2010, AM COLL PHYS MED 7, VXVI, P1; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Ma YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047255; MADER JT, 1978, J INFECT DIS, V138, P312, DOI 10.1093/infdis/138.3.312; MADER JT, 1980, J INFECT DIS, V142, P915, DOI 10.1093/infdis/142.6.915; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Mendel V, 2004, UNDERSEA HYPERBAR M, V31, P407; Mendel V, 1999, UNDERSEA HYPERBAR M, V26, P169; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052; Schmidt HGK, 2011, Z ORTHOP UNFALLCHIR, V149, P449, DOI 10.1055/s-0030-1270970; Shandley S, 2012, J ORTHOP RES, V30, P203, DOI 10.1002/jor.21522; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tiemann AH, 2012, UNFALLCHIRURG, V115, P480, DOI 10.1007/s00113-012-2187-y; Tiemann AH, 2011, PATHOLOGE, V32, P200, DOI 10.1007/s00292-011-1417-3; Wagner C, 2003, SHOCK, V20, P503, DOI 10.1097/01.shk.0000093542.78705.e3; Walter G, 2012, DTSCH ARZTEBL INT, V109, P257, DOI [10.3238/arztebl.012.0257, 10.3238/arztebl.2012.0257]; Windolf CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115940; Windolf CD, 2013, J ORTHOP RES, V31, P2013, DOI 10.1002/jor.22446; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	34	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191594	10.1371/journal.pone.0191594	http://dx.doi.org/10.1371/journal.pone.0191594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377928	Green Published, gold, Green Submitted			2022-12-26	WOS:000423514700019
J	Guo, LN; Li, Y; Hsueh, PR; Wang, P; Zhao, YP; Xu, YC				Guo, Li-Na; Li, Ying; Hsueh, Po-Ren; Wang, Peng; Zhao, Yu-Pei; Xu, Ying-Chun			Microbiological characteristics of a novel species most closely related to 'Bergeyella cardium' as a pathogen of infectious endocarditis	PLOS ONE			English	Article							CELLULITIS; AGENTS; BITE	Infectious endocarditis (IE) can be caused by various pathogens, from dominating agents such as viridans group streptococci and staphylococci to rare species that are less virulent and not typically considered to be pathogens. In this study, we have isolated a novel species from a patient with problem of IE which was genetically most closely related to ` Bergeyella cardium', a causative pathogen of IE first reported in Korea in 2015 as a new species of the genus Bergeyella, with a similarity of 98.8% in 16S rRNA sequences. Microbiological characteristics, including morphology, biochemical identification and antimicrobial susceptibility profiling, of this novel species were determined. This fastidious Gram- negative bacillus could only be identified successfully by molecular sequencing analysis at present, and it exhibited low minimum inhibitory concentrations to the antibiotics tested except for aminoglycosides. Phylogeny analysis revealed this novel species clustered well with 'B. cardium' and other close species of genus Bergeyella.	[Guo, Li-Na; Li, Ying; Wang, Peng; Xu, Ying-Chun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Guo, Li-Na; Li, Ying; Wang, Peng; Zhao, Yu-Pei; Xu, Ying-Chun] Chinese Acad Med Sci, Beijing, Peoples R China; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Zhao, Yu-Pei] Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xu, YC (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China.; Zhao, YP; Xu, YC (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.; Zhao, YP (corresponding author), Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China.	zhao8028@263.net; xycpumch@139.com	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225	National Research Special Fund for Public Welfare Industry of Health of China [201402001]	National Research Special Fund for Public Welfare Industry of Health of China	This work was funded by the National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001), http://www.nhfpc.gov.cn/zwgkzt/pkjjy1/201302/9cb220c8a5704c0a9ebf5ef65a337544.shtml. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JC, 1997, ANTIMICROB AGENTS CH, V41, P1301, DOI 10.1128/AAC.41.6.1301; Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD; CLSI, 2008, MM18A CLSI; FASS RJ, 1980, REV INFECT DIS, V2, P841; Hayashi H, 2006, FEMS MICROBIOL LETT, V257, P202, DOI 10.1111/j.1574-6968.2006.00171.x; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Kesson AM, 2007, PAEDIATR RESPIR REV, V8, P231, DOI 10.1016/j.prrv.2007.07.005; Oren A, 2016, INT J SYST EVOL MICR, V66, P2469, DOI [10.1099/ijsem.0.001150, 10.1099/ijsem.0.001042, 10.1099/ijsem.0.001149]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shukla SK, 2004, J CLIN MICROBIOL, V42, P290, DOI 10.1128/JCM.42.1.290-293.2004; Sohn KM, 2015, DIAGN MICR INFEC DIS, V81, P213, DOI 10.1016/j.diagmicrobio.2014.12.001; Sohpal Vipan Kumar, 2010, Int J Bioinform Res Appl, V6, P230, DOI 10.1504/IJBRA.2010.034072; Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x; Yi JM, 2016, PEDIATR INFECT DIS J, V35, P214, DOI 10.1097/INF.0000000000000971; Zamora L, 2016, SYST APPL MICROBIOL, V39, P160, DOI 10.1016/j.syapm.2016.03.006	15	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191715	10.1371/journal.pone.0191715	http://dx.doi.org/10.1371/journal.pone.0191715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370239	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600085
J	Patel, D; Shimomura, A; Majumdar, S; Holley, MC; Hashino, E				Patel, Dharmeshkumar; Shimomura, Atsushi; Majumdar, Sreeparna; Holley, Matthew C.; Hashino, Eri			The histone demethylase LSD1 regulates inner ear progenitor differentiation through interactions with Pax2 and the NuRD repressor complex	PLOS ONE			English	Article							RENAL-COLOBOMA SYNDROME; PLURIPOTENT STEM-CELLS; NEURAL PRECURSORS; BRAIN-DEVELOPMENT; GENE-EXPRESSION; BREAST-CANCER; BRCT-DOMAIN; METHYLATION; TRANSCRIPTION; DISEASE	The histone demethylase LSD1 plays a pivotal role in cellular differentiation, particularly in silencing lineage-specific genes. However, little is known about how LSD1 regulates neurosensory differentiation in the inner ear. Here we show that LSD1 interacts directly with the transcription factor Pax2 to form the NuRD co-repressor complex at the Pax2 target gene loci in a mouse otic neuronal progenitor cell line (VOT-N33). VOT-N33 cells expressing a Pax2-response element reporter were GFP-negative when untreated, but became GFP positive after forced differentiation or treatment with a potent LSD inhibitor. Pharmacological inhibition of LSD1 activity resulted in the enrichment of mono-and di-methylation of H3K4, upregulation of sensory neuronal genes and an increase in the number of sensory neurons in mouse inner ear organoids. Together, these results identify the LSD1/ NuRD complex as a previously unrecognized modulator for Pax2-mediated neuronal differentiation in the inner ear.	[Patel, Dharmeshkumar; Shimomura, Atsushi; Majumdar, Sreeparna; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Patel, Dharmeshkumar; Shimomura, Atsushi; Majumdar, Sreeparna; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Holley, Matthew C.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Patel, Dharmeshkumar] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities	Hashino, E (corresponding author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Hashino, E (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	ehashino@iupui.edu		Majumdar, Sreeparna/0000-0002-3564-3853	National Institutes of Health [R01 DC013294, R01DC015788]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015788, R01DC013294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants R01 DC013294 and R01DC015788. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Benito-Gonzalez A, 2014, J NEUROSCI, V34, P12865, DOI 10.1523/JNEUROSCI.1494-14.2014; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Burton Q, 2004, DEV BIOL, V272, P161, DOI 10.1016/j.ydbio.2004.04.024; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chen P, 2002, DEVELOPMENT, V129, P2495; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Culhane JC, 2007, CURR OPIN CHEM BIOL, V11, P561, DOI 10.1016/j.cbpa.2007.07.014; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Kim WY, 2001, DEVELOPMENT, V128, P417; Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lawoko-Kerali G, 2004, DEV DYNAM, V231, P801, DOI 10.1002/dvdy.20187; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; Layman WS, 2013, HEARING RES, V304, P167, DOI 10.1016/j.heares.2013.07.017; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Liu PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7830; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Masuda M, 2012, DEV BIOL, V372, P68, DOI 10.1016/j.ydbio.2012.09.002; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Nicholl AJ, 2005, EUR J NEUROSCI, V22, P343, DOI 10.1111/j.1460-9568.2005.04213.x; NORNES HO, 1990, DEVELOPMENT, V109, P797; Ouyang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062192; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Puligilla C, 2009, CURR OPIN GENET DEV, V19, P368, DOI 10.1016/j.gde.2009.06.004; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schimmenti LA, 1997, AM J HUM GENET, V60, P869; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sekiya T, 2015, P NATL ACAD SCI USA, V112, pE3431, DOI 10.1073/pnas.1501835112; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shimomura A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135060; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	52	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191689	10.1371/journal.pone.0191689	http://dx.doi.org/10.1371/journal.pone.0191689			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370269	Green Published, Green Accepted, gold			2022-12-26	WOS:000423416600081
J	Hermes, C; Keller, K; Nicholas, RE; Segelbacher, G; Schaefer, HM				Hermes, Claudia; Keller, Klaus; Nicholas, Robert E.; Segelbacher, Gernot; Martin Schaefer, H.			Projected impacts of climate change on habitat availability for an endangered parakeet	PLOS ONE			English	Article							UPSLOPE SHIFTS; BIODIVERSITY; CONSERVATION; RESTORATION; EXTINCTION; RANGE; CHRONOSEQUENCE; DISTRIBUTIONS; VULNERABILITY; VEGETATION	In tropical montane cloud forests, climate change can cause upslope shifts in the distribution ranges of species, leading to reductions in distributional range. Endemic species with small ranges are particularly vulnerable to such decreases in range size, as the population size may be reduced significantly. To ensure the survival of cloud forest species in the long term, it is crucial to quantify potential future shifts in their distribution ranges and the related changes in habitat availability in order to assure the long-term effectiveness of conservation measures. In this study, we assessed the influence of climate change on the availability of forested habitat for the endemic El Oro parakeet. We investigated the future range shift by modelling the climatic niche of the El Oro parakeets and projecting it to four different climate change scenarios. Depending on the intensity of climate change, the El Oro parakeets shift their range between 500 and 1700 m uphill by the year 2100. On average, the shift is accompanied by a reduction in range size to 15% and a reduction in forested habitat to only 10% of the original extent. Additionally, the connectivity between populations in different areas is decreasing in higher altitudes. To prevent a population decline due to habitat loss following an upslope range shift, it will be necessary to restore habitat across a large elevational span in order to allow for movement of El Oro parakeets into higher altitudes.	[Hermes, Claudia; Segelbacher, Gernot; Martin Schaefer, H.] Univ Freiburg, Fac Environm & Nat Resources, Chair Wildlife Ecol & Management, Freiburg, Germany; [Keller, Klaus; Nicholas, Robert E.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Martin Schaefer, H.] Fdn Jocotoco, Quito, Ecuador	University of Freiburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University	Hermes, C (corresponding author), Univ Freiburg, Fac Environm & Nat Resources, Chair Wildlife Ecol & Management, Freiburg, Germany.	claudia.hermes@wildlife.uni-freiburg.de	Segelbacher, Gernot/F-3633-2011; Keller, Klaus/A-6742-2013	Segelbacher, Gernot/0000-0002-8024-7008; Hermes, Claudia/0000-0002-5106-0869; Nicholas, Robert/0000-0003-2615-2574	Loro Parque Foundation; DFG [Scha 1008/7-1]; NSF through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement [GEO-1240507]; Penn State Center for Climate Risk Management; German Research Foundation (DFG); National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement [GEO-1240507]; University of Freiburg; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	Loro Parque Foundation; DFG(German Research Foundation (DFG)); NSF through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement; Penn State Center for Climate Risk Management; German Research Foundation (DFG)(German Research Foundation (DFG)); National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement; University of Freiburg; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by Loro Parque Foundation, by DFG (Scha 1008/7-1), and by NSF through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507 as well as the Penn State Center for Climate Risk Management. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies.; We are grateful to Cesar Garzon and his colleagues for providing us with their observational data of the parakeets in the years 2011 and 2012. This study was partially supported by the German Research Foundation (DFG), the National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO1240507 and the Penn State Center for Climate Risk Management. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the authors and do not necessarily reflect the views of the funding entities.	Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; AIDE TM, 1995, FOREST ECOL MANAG, V77, P77, DOI 10.1016/0378-1127(95)03576-V; Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Beissinger SR, 2008, ECOL MONOGR, V78, P185, DOI 10.1890/07-0018.1; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Birdlife International, SPEC FACTSH PYRRH OR; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chaves-Campos J, 2004, ORNITOL NEOTROP, V15, P433; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DeWalt SJ, 2003, FOREST ECOL MANAG, V182, P139, DOI 10.1016/S0378-1127(03)00029-X; Dietrich M., 2003, THESIS; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Edenhofer O., 2014, CONTRIBUTION WORKING; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Forrest JL, 2012, BIOL CONSERV, V150, P129, DOI 10.1016/j.biocon.2012.03.001; Foster P, 2001, EARTH-SCI REV, V55, P73, DOI 10.1016/S0012-8252(01)00056-3; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Fundacio Jocotoco, BUEN IMP BIOL; GENTRY AH, 1992, OIKOS, V63, P19, DOI 10.2307/3545512; Hermes C, 2017, BIRD CONSER IN PRESS; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill GE, 1998, AUK, V115, P240, DOI 10.2307/4089135; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holl KD, 2000, RESTOR ECOL, V8, P339, DOI 10.1046/j.1526-100x.2000.80049.x; Hulber K, 2016, GLOBAL CHANGE BIOL, V22, P2608, DOI 10.1111/gcb.13232; Jantz SM, 2015, CONSERV BIOL, V29, P1122, DOI 10.1111/cobi.12549; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Klauke N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169165; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Morueta-Holme N, 2015, P NATL ACAD SCI USA, V112, P12741, DOI 10.1073/pnas.1509938112; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nogue S, 2009, CLIMATIC CHANGE, V94, P77, DOI 10.1007/s10584-009-9554-x; Ocampo-Penuela N, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601367; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RIDGELY RS, 1988, WILSON BULL, V100, P173; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Schaefer HM, 2003, CYANOPSITTA, V71, P10; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sriver RL, 2015, GEOPHYS RES LETT, V42, P5468, DOI 10.1002/2015GL064546; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zeh JA, 2012, GLOBAL CHANGE BIOL, V18, P1833, DOI 10.1111/j.1365-2486.2012.02640.x	63	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191773	10.1371/journal.pone.0191773	http://dx.doi.org/10.1371/journal.pone.0191773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364949	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500076
J	Sahin, K; Orhan, C; Tuzcu, M; Hayirli, A; Komorowski, JR; Sahin, N				Sahin, Kazim; Orhan, Cemal; Tuzcu, Mehmet; Hayirli, Armagan; Komorowski, James R.; Sahin, Nurhan			Effects of dietary supplementation of arginine-silicate-inositol complex on absorption and metabolism of calcium of laying hens	PLOS ONE			English	Article							IMPROVE EGGSHELL QUALITY; VITAMIN-D; GENE-EXPRESSION; BONE LOSS; QUAIL; RATS; DEFICIENCY; EXCHANGER; MEMBRANE; PROTEIN	The effects of supplementation of arginine-silicate-inositol complex (ASI; 49.5-8.2-25 g/kg, respectively) to laying hens were investigated with respect to eggshell quality, calcium (Ca) balance, and expression of duodenal proteins related to Ca metabolism (calbindin and tight junction proteins). A total of 360 laying hens, 25 weeks old, were divided into 3 groups consisting of 6 replicate of cages, 20 birds per cage. The groups were fed a basal diet and the basal diet supplemented with 500 or 1000 mg ASI complex per kilogram for 90 days. Data were analyzed by ANCOVA using data during the first week of the adaptation period as covariates. As the ASI complex supplementation level increased, there were increases in feed intake (P < 0.0001), egg production (P < 0.001), egg weight (P < 0.0001) and eggshell weight (P < 0.001) weight, and shell thickness (P < 0.001) and decreases in feed conversion ratio and cracked egg percentage (P < 0.0001 for both). Concentrations of serum osteocalcin (P < 0.0001), vitamin D (P < 0.0001), calcium (P < 0.001), phosphorus (P < 0.001), and alkaline phosphatase (P < 0.008) as well as amounts of calcium retention (P < 0.0001) and eggshell calcium deposition (P < 0.001), and Ca balance (P < 0.0001) increased, whereas amount of calcium excretion (P<0.001) decreased linearly in a dose-dependent manner. The ASI complex supplementation increased expressions of calcium transporters (calbindin-D28k, N sodium-calcium exchanger, plasma membrane calcium ATPase, and vitamin D receptor) and tight junction proteins (zonula occludens-1 and occludin) in the duodenum in a linear fashion (P < 0.0001 for all). In conclusion, provision of dietary ASI complex to laying hens during the peak laying period improved eggshell quality through improving calcium utilization as reflected by upregulation of genes related to the calcium metabolism. Further studies are needed to elucidate the contribution of each of the ASI complex ingredients.	[Sahin, Kazim; Orhan, Cemal; Sahin, Nurhan] Firat Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Elazig, Turkey; [Tuzcu, Mehmet] Firat Univ, Fac Sci, Div Biol, Elazig, Turkey; [Hayirli, Armagan] Ataturk Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Erzurum, Turkey; [Komorowski, James R.] Nutr 21 Inc, Sci & Regulatory Affairs, New York, NY USA	Firat University; Firat University; Ataturk University	Sahin, K (corresponding author), Firat Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Elazig, Turkey.	nsahinkm@yahoo.com	Sahin, Kazim/D-5625-2009; Sahin, Nurhan/D-5626-2009; sahin, nurhan/ABF-8007-2020; Orhan, Cemal/Q-2086-2015; Tuzcu, Mehmet/H-2953-2018	Sahin, Kazim/0000-0001-9542-5244; sahin, nurhan/0000-0001-9487-1154; Orhan, Cemal/0000-0003-4138-7689; Tuzcu, Mehmet/0000-0002-1329-3143	Turkish Academy of Sciences (Ankara, Turkey); Small and Medium Business Development and Support Administration of Turkey (KOSGEB)	Turkish Academy of Sciences (Ankara, Turkey)(Turkish Academy of Sciences); Small and Medium Business Development and Support Administration of Turkey (KOSGEB)	The study was funded by Small and Medium Business Development and Support Administration of Turkey (KOSGEB) and also in part by Turkish Academy of Sciences (Ankara, Turkey)". Moreover, tested product was donated by "Nutrition 21 Inc". "The funder provided support in the form of salaries for authors [J.R.K], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.& para;& para;The study was funded by Small and Medium Business Development and Support Administration of Turkey (KOSGEB) and also in part by Turkish Academy of Sciences (Ankara, Turkey).	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Bar A., 2009, COMP BIOCHEM PHYS A, V152, P447, DOI [DOI 10.1016/j.cbpa.2008.11.020, 10.1016/j.cbpa.2008.11.020]; CARLISLE EM, 1986, CIBA F SYMP, V121, P123; Centeno VA, 2004, COMP BIOCHEM PHYS A, V139, P133, DOI 10.1016/j.cbpb.2004.08.002; Centeno V, 2011, ARCH BIOCHEM BIOPHYS, V509, P191, DOI 10.1016/j.abb.2011.03.011; Chirayath MV, 1998, AM J PHYSIOL-GASTR L, V274, pG389, DOI 10.1152/ajpgi.1998.274.2.G389; Clementi G, 2001, PHARMACOL TOXICOL, V88, P16, DOI 10.1034/j.1600-0773.2001.088001016.x; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Ebeid TA, 2012, POULTRY SCI, V91, P2282, DOI 10.3382/ps.2011-01898; EISEN EJ, 1962, POULTRY SCI, V41, P1461, DOI 10.3382/ps.0411461; Enko D, 2015, BIOCHEM MEDICA, V25, P203, DOI 10.11613/BM.2015.020; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fiore CE, 2000, EUR J PHARMACOL, V408, P323, DOI 10.1016/S0014-2999(00)00800-1; Gordon RW, 1998, POULTRY SCI, V77, P290, DOI 10.1093/ps/77.2.290; Harms R. H., 1996, Journal of Applied Poultry Research, V5, P1, DOI 10.1093/japr/5.1.1; Hwang I, 2013, INT J MOL SCI, V14, P22997, DOI 10.3390/ijms141122997; Jensen TP, 2004, DEV BRAIN RES, V152, P129, DOI 10.1016/j.devbrainres.2004.06.004; Jiang MJ, 2015, BRIT POULTRY SCI, V56, P740, DOI 10.1080/00071668.2015.1113499; Jurgens M. H., 1996, ANIMAL FEEDING NUTR; Lavelin I, 2000, POULTRY SCI, V79, P1014, DOI 10.1093/ps/79.7.1014; National Research Council, 1994, NUTR REQ POULTR; Neijat M, 2011, POULTRY SCI, V90, P2383, DOI 10.3382/ps.2011-01401; Onderci M, 2006, BRIT POULTRY SCI, V47, P209, DOI 10.1080/00071660600611052; Pavlovski Z., 2012, Biotechnology in Animal Husbandry, V28, P393; Pearson D A, 1976, CHEM ANAL FOOD, V7th; Proctor SD, 2005, DIABETOLOGIA, V48, P1925, DOI 10.1007/s00125-005-1862-8; Proctor SD, 2007, METABOLISM, V56, P1318, DOI 10.1016/j.metabol.2007.05.022; Rivoira MA, 2012, COMP BIOCHEM PHYS A, V162, P397, DOI 10.1016/j.cbpa.2012.04.016; Ruuskanen S, 2014, ENVIRON SCI POLLUT R, V21, P3304, DOI 10.1007/s11356-013-2299-0; Sahin K, 2006, POULTRY SCI, V85, P486, DOI 10.1093/ps/85.3.486; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; SAS, 2002, SAS US GUID STAT; Seaborn CD, 2002, BIOL TRACE ELEM RES, V89, P251, DOI 10.1385/BTER:89:3:251; Singh J., 2007, J APPL PACKAGING RES, V2, P45; STRIEM S, 1991, MOL CELL ENDOCRINOL, V75, P169, DOI 10.1016/0303-7207(91)90232-H; TRIPPEL SB, 1998, CLIN ORTHOP S, V355, P301; VISSER JJ, 1994, MED HYPOTHESES, V43, P339, DOI 10.1016/0306-9877(94)90113-9; Wasserman RH, 2004, J NUTR, V134, P3137, DOI 10.1093/jn/134.11.3137; Wasserman RH, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P411; Xiao JF, 2014, POULTRY SCI, V93, P380, DOI 10.3382/ps.2013-03354; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	43	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0189329	10.1371/journal.pone.0189329	http://dx.doi.org/10.1371/journal.pone.0189329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360830	Green Submitted, gold, Green Published			2022-12-26	WOS:000423161800004
J	Yuasa, N; Nagata, E; Fujii, N; Ito, M; Tsukamoto, H; Takizawa, S				Yuasa, Naoki; Nagata, Eiichiro; Fujii, Natsuko; Ito, Masatoshi; Tsukamoto, Hideo; Takizawa, Shunya			Serum apolipoprotein E may be a novel biomarker of migraine	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; ALZHEIMERS-DISEASE; GENE; POLYMORPHISM; ASSOCIATION; PROTEIN; ALLELE; RISK	Migraine attacks alter various molecules that might be related to the pathophysiology of migraine, such as serotonin, calcitonin gene-related peptide, and nitric oxide. The underlying pathophysiology of migraine is as yet unclear. We explored key proteins related to the pathogenesis of migraine here. Serum was collected from two patients with migraine with aura (MA) and seven patients with migraine without aura (MO) during attack-free periods and migraine attacks. Samples were analyzed using 2-dimensional gel electrophoresis. Nineteen protein spots were altered between the attack-free versus migraine attack periods. Mass spectrometric analysis was performed to identify the proteins within each of the 19 altered spots. Thirty-six proteins were significantly altered in samples collected during attack-free periods versus migraine attacks. The protein with the statistically most significant MASCOT/Mowse score (268 +/- 112) among lipoproteins was apolipoprotein (ApoE). In the MA and MO groups, ApoE protein levels were significantly higher during migraine attack than during the attack-free period (p<0.05). ApoE protein levels were also significantly increased in the MA group during the attack-free period compared to healthy controls and patients with tension type headaches (p<0.01). Migraine alters ApoE levels, especially in MA. ApoE might play an important role in the pathophysiology of migraine, and may act as a diagnostic biomarker of migraine.	[Yuasa, Naoki] Isehara Kyodo Hosp, Dept Internal Med, Div Neurol, Isehara, Kanagawa, Japan; [Nagata, Eiichiro; Fujii, Natsuko; Takizawa, Shunya] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan; [Ito, Masatoshi; Tsukamoto, Hideo] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Nagata, E (corresponding author), Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan.	enagata@is.icc.u-tokai.ac.jp		Nagata, Eiichiro/0000-0001-6902-8309				Bellei E, 2017, SCI REP-UK, V7, DOI 10.1038/srep41723; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Choudhuri R, 2002, ANN NEUROL, V51, P499, DOI 10.1002/ana.10158; Colton CA, 2002, ANN NY ACAD SCI, V962, P212, DOI 10.1111/j.1749-6632.2002.tb04070.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fusayasu E, 2007, PAIN, V128, P209, DOI 10.1016/j.pain.2006.09.017; Gupta R, 2009, J HEADACHE PAIN, V10, P115, DOI 10.1007/s10194-008-0094-y; Hashikawa-Hobara N, 2012, J PHARMACOL SCI, V119, P117, DOI 10.1254/jphs.12R02CP; Hashikawa-Hobara N, 2011, J PHARMACOL EXP THER, V338, P694, DOI 10.1124/jpet.111.181487; Imamura K, 2008, HEADACHE, V48, P135, DOI 10.1111/j.1526-4610.2007.00958.x; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kowa H, 2000, AM J MED GENET, V96, P762, DOI 10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X; Landy SH, 2004, PRIMARY CARE, V31, P429, DOI 10.1016/j.pop.2004.02.013; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Loder E, 2006, HEADACHE, V46, P1046, DOI 10.1111/j.1526-4610.2006.00498.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marziniak M, 2005, NEUROLOGY, V64, P157, DOI 10.1212/01.WNL.0000148597.52312.9E; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Miao JY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0385-2; MOSKOWITZ MA, 1992, TRENDS PHARMACOL SCI, V13, P307, DOI 10.1016/0165-6147(92)90097-P; Nagata E, 2009, NEUROSCI RES, V64, P104, DOI 10.1016/j.neures.2009.02.001; Oterino A, 2007, J HEADACHE PAIN, V8, P231, DOI 10.1007/s10194-007-0399-2; Paterna S, 2000, EUR NEUROL, V43, P133, DOI 10.1159/000008151; Rainero I, 2002, NEUROSCI LETT, V317, P111, DOI 10.1016/S0304-3940(01)02432-6; Ramon C, 2017, CURR OPIN NEUROL, V30, P281, DOI 10.1097/WCO.0000000000000440; Riesco N, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0618-8; Rothrock JF, 2006, HEADACHE, V46, P726, DOI 10.1111/j.1526-4610.2006.00428.x; Shibata M, 2017, J CEREBR BLOOD F MET, V37, P1182, DOI 10.1177/0271678X17690537; Starling AJ, 2015, MAYO CLIN PROC, V90, P408, DOI 10.1016/j.mayocp.2015.01.010; van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190620	10.1371/journal.pone.0190620	http://dx.doi.org/10.1371/journal.pone.0190620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357368	Green Submitted, Green Published, gold			2022-12-26	WOS:000422919500005
J	Brown, CA				Brown, Christopher A.			Corrective binaural processing for bilateral cochlear implant patients	PLOS ONE			English	Article							INTERAURAL LEVEL DIFFERENCES; SOUND SOURCE LOCALIZATION; SPEECH RECOGNITION; TIME DIFFERENCES; HORIZONTAL-PLANE; NORMAL-HEARING; FINE-STRUCTURE; SENSITIVITY; LISTENERS; NOISE	Although bilateral cochlear implant users receive input to both ears, they nonetheless have relatively poor localization abilities in the horizontal plane. This is likely because of the two binaural cues, they have good sensitivity to interaural differences of level (inter-aural level differences, or ILDs), but not those of time (inter-aural time differences; ITDs). Here, localization performance is assessed in six bilateral cochlear implant patients when instantaneous ITDs are measured and converted to ILDs, a strategy that results in larger-thantypical ILDs. The added ILDs are corrective, in that they are derived from individual listener performance across both frequency and azimuth, so that they are small where a listener performs well, and increase as performance deviates from ideal. Results show significantly improved localization performance as a result of this strategy, with two of the six listeners achieving levels of performance typically observed in NH listeners.	[Brown, Christopher A.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15217 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, CA (corresponding author), Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15217 USA.	cbrown1@pitt.edu		Brown, Christopher/0000-0001-7550-3014	National Institutes of Health [R01DC008329]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grant number R01DC008329 from the National Institutes of Health, awarded to author CB.	[Anonymous], 2017, EARPLUG; Baumgartel RM, 2017, J ACOUST SOC AM, V141, P2338, DOI 10.1121/1.4979114; Brown CA, 2014, EAR HEARING, V35, P580, DOI 10.1097/AUD.0000000000000044; Brown CA, 2013, ADV EXP MED BIOL, V787, P247, DOI 10.1007/978-1-4614-1590-9_28; Brown CA, 2011, J ACOUST SOC AM, V130, pEL358, DOI 10.1121/1.3647263; Brown CA, 2010, HEARING RES, V266, P52, DOI 10.1016/j.heares.2009.08.011; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Day ML, 2013, J NEUROSCI, V33, P15837, DOI 10.1523/JNEUROSCI.2034-13.2013; Dietz M, 2016, NETWORK-COMP NEURAL, V27, P186, DOI 10.1080/0954898X.2016.1219411; Dorman MF, 2016, AUDIOL NEURO-OTOL, V21, P127, DOI 10.1159/000444740; Dorman MF, 2014, EAR HEARING, V35, P633, DOI 10.1097/AUD.0000000000000057; Francart T, 2007, J ACOUST SOC AM, V122, P2826, DOI 10.1121/1.2783130; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Goupell MJ, 2013, J ACOUST SOC AM, V133, pEL101, DOI 10.1121/1.4776772; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Grantham DW, 2008, LARYNGOSCOPE, V118, P145, DOI 10.1097/MLG.0b013e31815661f9; Hancock KE, 2012, J NEUROPHYSIOL, V108, P714, DOI 10.1152/jn.00269.2012; Hancock KE, 2010, J NEUROSCI, V30, P14068, DOI 10.1523/JNEUROSCI.3213-10.2010; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Imennov NS, 2013, HEARING RES, V298, P60, DOI 10.1016/j.heares.2013.01.004; JAVER AR, 1995, J OTOLARYNGOL, V24, P111; Jones H, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514554574; Jones HG, 2016, EAR HEARING, V37, pE341, DOI 10.1097/AUD.0000000000000297; Kan A, 2015, EAR HEARING, V36, pE62, DOI 10.1097/AUD.0000000000000135; Kelvasa D, 2015, TRENDS HEAR, V19, DOI 10.1177/2331216515616378; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Macaulay EJ, 2010, J ACOUST SOC AM, V127, P1440, DOI 10.1121/1.3294654; Moore BCJ, 2016, J ACOUST SOC AM, V140, P2817, DOI 10.1121/1.4965299; Noel VA, 2013, J ACOUST SOC AM, V133, P2314, DOI 10.1121/1.4794372; Perreau A, 2010, J AM ACAD AUDIOL, V21, P110, DOI 10.3766/jaaa.21.2.5; Savel S, 2014, HUM FACTORS, V56, P772, DOI 10.1177/0018720813503366; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; Yost WA, 2013, J ACOUST SOC AM, V133, P2876, DOI 10.1121/1.4799803; Young PT, 1928, J EXP PSYCHOL, V11, P399, DOI 10.1037/h0073089; Zahorik P, 2006, J ACOUST SOC AM, V120, P343, DOI 10.1121/1.2208429	40	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0187965	10.1371/journal.pone.0187965	http://dx.doi.org/10.1371/journal.pone.0187965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351279	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300005
J	Wu, HX; Zhang, BJ; Li, J; Liu, QY; Zhao, TT				Wu, Hongxun; Zhang, Bingjie; Li, Jie; Liu, Qianyun; Zhao, Tingting			Echogenic foci with comet-tail artifact in resected thyroid nodules: Not an absolute predictor of benign disease	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; PSAMMOMA BODIES; ULTRASOUND; PITFALLS; SONOGRAPHY; MALIGNANCY; MANAGEMENT; FEATURES; PEARLS	The purpose of this study was to evaluate the frequency of echogenic foci with comet-tail artifact in histologically proven thyroid nodules, and to determine the types of echogenic foci with comet-tail artifact that are associated with malignancy. We retrospectively analyzed the sonographic findings of echogenic foci with comet-tail artifact, present in thyroid nodules in 63 patients who underwent surgery for thyroid nodules at our institution between January 2016 and September 2016. The sonographic findings (appearance and background of echogenic foci, shape of comet-tail artifact) in benign and malignant nodules were compared. Seventy-one (7.4%) nodules with ultrasound finding of echogenic foci with comet-tail artifact were encountered in 962 thyroid nodules of 556 patients; 25 of these were benign, and 46 were malignant. Among the echogenic foci with comet-tail artifact categories, those (11/11, 100%) freely distributed in cystic components were all in benign nodules, whereas those (48/67, 71.6%) any part of echogenic foci or comet-tail artifact associated with solid components, were more common in malignant nodules (P < 0.001). There was no statistically significant difference in the appearance of echogenic foci and the shape of comet-tail between the benign and malignant nodules (P = 0.139, P = 0.626, respectively). Echogenic foci with comet-tail artifact freely distributed in cystic component may predict a benign nodule; those associated with solid components cannot be considered a benign finding.	[Wu, Hongxun; Zhang, Bingjie; Li, Jie; Liu, Qianyun; Zhao, Tingting] Jiangyuan Hosp, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Dept Ultrasound,Jiangsu Inst Nucl Med,Minist Hlth, Wuxi, Jiangsu, Peoples R China		Wu, HX (corresponding author), Jiangyuan Hosp, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Dept Ultrasound,Jiangsu Inst Nucl Med,Minist Hlth, Wuxi, Jiangsu, Peoples R China.	whxmd@outlook.com	Wu, Hong xun/AAD-8875-2022	Wu, Hong xun/0000-0003-2837-2458	Wuxi Municipal Science and Technology Development Planning Funds [CSE31N1622]; Wuxi Health and Family Planning Commission Planning Funds [MS 201633]	Wuxi Municipal Science and Technology Development Planning Funds; Wuxi Health and Family Planning Commission Planning Funds	The work was supported by Wuxi Municipal Science and Technology Development Planning Funds [grant number CSE31N1622] to HW; and Wuxi Health and Family Planning Commission Planning Funds [grant number MS 201633] to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 1996, J CLIN ULTRASOUND, V24, P129, DOI 10.1002/(SICI)1097-0096(199603)24:3<129::AID-JCU4>3.0.CO;2-J; Bonavita JA, 2009, AM J ROENTGENOL, V193, P207, DOI 10.2214/AJR.08.1820; Chan BK, 2003, J ULTRAS MED, V22, P1083, DOI 10.7863/jum.2003.22.10.1083; Das DK, 2009, DIAGN CYTOPATHOL, V37, P534, DOI 10.1002/dc.21081; DUGAN JM, 1987, ACTA CYTOL, V31, P330; Feldman MK, 2009, RADIOGRAPHICS, V29, P1179, DOI 10.1148/rg.294085199; FIORELLA RM, 1993, DIAGN CYTOPATHOL, V9, P351, DOI 10.1002/dc.2840090321; Ginat DT, 2010, ULTRASOUND Q, V26, P171, DOI 10.1097/RUQ.0b013e3181efa710; Grant EG, 2015, J AM COLL RADIOL, V12, P1272, DOI 10.1016/j.jacr.2015.07.011; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hoang JK, 2007, RADIOGRAPHICS, V27, P847, DOI 10.1148/rg.273065038; JOHANNESSEN JV, 1980, LAB INVEST, V43, P287; Klang K, 2015, ULTRASOUND Q, V31, P69, DOI 10.1097/RUQ.0000000000000079; Li Volsi VA, 1990, SURG PATHOLOGY THYRO, P138; Malhi H, 2014, AM J ROENTGENOL, V203, P1310, DOI 10.2214/AJR.13.11934; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Patel BN, 2013, SEMIN ULTRASOUND CT, V34, P226, DOI 10.1053/j.sult.2012.11.001; Reading Carl C, 2005, Ultrasound Q, V21, P157, DOI 10.1097/01.ruq.0000174750.27010.68; Tahvildari AM, 2016, J ULTRAS MED, V35, pe27; Teng W., 2012, CHIN J ENDOCRINOL ME, V28, P779, DOI [10.3760/cma.j.issn.1000-6699.2012.10.002, DOI 10.3760/CMA.J.ISSN.1000-6699.2012.10.002]; Triggiani V, 2008, THYROID, V18, P1017, DOI 10.1089/thy.2008.0082	22	5	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191505	10.1371/journal.pone.0191505	http://dx.doi.org/10.1371/journal.pone.0191505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352286	Green Submitted, gold, Green Published			2022-12-26	WOS:000422911300102
J	Russo, A; Czarnecki, AA; Dean, M; Modi, DA; Lantvit, DD; Hardy, L; Baligod, S; Davis, DA; Wei, JJ; Burdette, JE				Russo, Angela; Czarnecki, Austin A.; Dean, Matthew; Modi, Dimple A.; Lantvit, Daniel D.; Hardy, Laura; Baligod, Seth; Davis, David A.; Wei, Jian-Jun; Burdette, Joanna E.			PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation	ONCOGENE			English	Article							GRADE SEROUS CARCINOMA; FOCAL ADHESION KINASE; INTRAEPITHELIAL CARCINOMA; SURFACE EPITHELIUM; BORDERLINE TUMORS; MOUSE MODEL; CANCER; EXPRESSION; ORIGIN; TRANSFORMATION	The signaling events involved in the onset of ovarian cancer from the fallopian tube epithelium (FTE) are crucial for early detection and treatment of the disease, but they remain poorly defined. Conditional homozygous knockout of PTEN mediated by PAX8-cre recombinase was sufficient to drive endometrioid and serous borderline ovarian carcinoma, providing the first model of FTE-derived borderline tumors. In addition, heterozygous PTEN deletion in the FTE resulted in hyperplasia, providing a model to study early events of human ovarian pathogenesis. To uncover the mechanism underlying the invasion of cancerous oviductal cells to the ovary, PTEN-deficient murine oviductal cells were developed and tagged with green fluorescent protein. Loss of PTEN increased cell migration, invasion, and upregulated WNT4, a key regulator of Mullerian duct development during embryogenesis. Further investigation revealed that WNT4 was required for increased migration and colonization of the ovary by PTEN-deficient oviductal cells in a a-catenin independent manner. Human tumor microarrays and ovarian cancer cells lines confirmed WNT4 expression in cancer and its role in migration. Together, these findings provide a novel model to study the mechanism of fallopian tube tumor initiation and invasion to the ovary mediated by loss of PTEN, which may help to define early events of human ovarian carcinogenesis.	[Russo, Angela; Czarnecki, Austin A.; Dean, Matthew; Modi, Dimple A.; Lantvit, Daniel D.; Hardy, Laura; Baligod, Seth; Davis, David A.; Burdette, Joanna E.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA; [Davis, David A.] J Hopkins Med Inst, Reference Histol Lab, Dept Pathol, Baltimore, MD USA; [Wei, Jian-Jun] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Northwestern University	Burdette, JE (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	joannab@uic.edu	WEI, JJ/AAN-2638-2020	Dean, Matthew/0000-0001-5014-9311	Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation; American Cancer Society [ACS RSG-12-230-01-TBG]; NIH [UG3 ES029073-01, T32 AT007533]; NATIONAL CANCER INSTITUTE [R21CA208610] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT007533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [UG3ES029073] Funding Source: NIH RePORTER	Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Tell Every Amazing Lady (T.E.A.L.) About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation, The American Cancer Society ACS RSG-12-230-01-TBG, the NIH UG3 ES029073-01 and the NIH T32 AT007533. We would also like to thank the Northwestern NUseq Core Facility and Dr. Matthew Schipma.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boone JD, 2016, LAB INVEST, V96, P249, DOI 10.1038/labinvest.2015.150; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Cho KR, 2009, ARCH PATHOL LAB MED, V133, P1775, DOI 10.1043/1543-2165-133.11.1775; Coffman LG, 2016, TRANSL RES, V175, P92, DOI 10.1016/j.trsl.2016.03.016; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Eddie SL, 2015, ONCOTARGET, V6, P20500, DOI 10.18632/oncotarget.3985; Endsley MP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00154; Fathalla MF, 2013, FACTS VIEWS VIS OBGY, V5, P292; Filippone MG, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-21; Haley J, 2016, ONCOTARGET, V7, P32810, DOI 10.18632/oncotarget.9053; Hanrahan AJ, 2014, CANCER DISCOV, V2, P56; Hilliard TS, 2013, INT J MOL SCI, V14, P4762, DOI 10.3390/ijms14034762; Karthikeyan S, 2016, ONCOTARGET, V7, P69871, DOI 10.18632/oncotarget.11499; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King SM, 2013, CARCINOGENESIS, V34, P1125, DOI 10.1093/carcin/bgt003; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Kurman RJ, 2011, AM J SURG PATHOL, V35, P1605, DOI 10.1097/PAS.0b013e318229449f; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Laury AR, 2011, AM J SURG PATHOL, V35, P1759, DOI 10.1097/PAS.0b013e318233b0f7; Li J, 2011, MODERN PATHOL, V24, P1488, DOI 10.1038/modpathol.2011.106; Martins FC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0526-8; McDaniel AS, 2015, JAMA ONCOL, V1, P1128, DOI 10.1001/jamaoncol.2015.1618; Modi DA, 2017, ONCOGENE, V36, P3015, DOI 10.1038/onc.2016.455; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1585, DOI 10.1210/en.2011-2121; Ng A, 2015, NAT REV MOL CELL BIO, V16, P625, DOI 10.1038/nrm4056; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Prunskaite-Hyyrylainen R, 2016, HUM MOL GENET, V25, P1059, DOI 10.1093/hmg/ddv621; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Quartuccio SM, 2015, INT J CANCER, V137, P1528, DOI 10.1002/ijc.29528; Quartuccio SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065067; ROBEY SS, 1989, INT J GYNECOL PATHOL, V8, P214, DOI 10.1097/00004347-198909000-00004; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Sherman-Baust CA, 2014, J PATHOL, V233, P228, DOI 10.1002/path.4353; Shield-Artin KL, 2012, PROTEOM CLIN APPL, V6, P170, DOI 10.1002/prca.201100008; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Sukerkar PA, 2011, BIOCONJUGATE CHEM, V22, P2304, DOI 10.1021/bc2003555; Tada M, 2000, DEVELOPMENT, V127, P2227; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; Vang R, 2013, HISTOPATHOLOGY, V62, P44, DOI 10.1111/his.12046; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Wu R, 2016, J PATHOL, V240, P341, DOI 10.1002/path.4783; Yang-Hartwich Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06116; Zhai YL, 2017, J PATHOL, V243, P16, DOI 10.1002/path.4927; Zhang L, 2016, ONCOGENE, V35, P5010, DOI 10.1038/onc.2016.53	54	41	43	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					1976	1990		10.1038/s41388-017-0097-8	http://dx.doi.org/10.1038/s41388-017-0097-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367766	Green Accepted			2022-12-26	WOS:000429899400003
J	Tan, EHP; Sng, MK; How, ISB; Chan, JSK; Chen, JP; Tan, CK; Wahli, W; Tan, NS				Tan, Eddie Han Pin; Sng, Ming Keat; How, Ivan Shun Bo; Chan, Jeremy Soon Kiat; Chen, Jiapeng; Tan, Chek Kun; Wahli, Walter; Tan, Nguan Soon			ROS release by PPAR beta/delta-null fibroblasts reduces tumor load through epithelial antioxidant response	ONCOGENE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; COLON CARCINOGENESIS; MEDIATED INHIBITION; OXIDATIVE STRESS; IMMUNE CELLS; LUNG INJURY; INFLAMMATION; MICE; GAMMA	Tumor stroma has an active role in the initiation, growth, and propagation of many tumor types by secreting growth factors and modulating redox status of the microenvironment. Although PPAR beta/delta in fibroblasts was shown to modulate oxidative stress in the wound microenvironment, there has been no evidence of a similar effect in the tumor stroma. Here, we present evidence of oxidative stress modulation by intestinal stromal PPAR beta/delta, using a FSPCre-Pparb/d(-/-) mouse model and validated it with immortalized cell lines. The FSPCre-Pparb/d(-/-) mice developed fewer intestinal polyps and survived longer when compared with Pparb/d(fl/fl) mice. The pre-treatment of FSPCre-Pparb/d(-/-) and Pparb/d(fl/fl) with antioxidant N-acetyl-cysteine prior DSS-induced tumorigenesis resulted in lower tumor load. Gene expression analyses implicated an altered oxidative stress processes. Indeed, the FSPCre-Pparb/d(-/-) intestinal tumors have reduced oxidative stress than Pparb/d(fl/fl) tumors. Similarly, the colorectal cancer cells and human colon epithelial cells also experienced lower oxidative stress when co-cultured with fibroblasts depleted of PPAR beta/delta expression. Therefore, our results establish a role for fibroblast PPAR beta/delta in epithelial-mesenchymal communication for ROS homeostasis.	[Tan, Eddie Han Pin; Sng, Ming Keat; How, Ivan Shun Bo; Chan, Jeremy Soon Kiat; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sng, Ming Keat; Chen, Jiapeng; Tan, Chek Kun; Wahli, Walter; Tan, Nguan Soon] Nanyang Technol Univ, Lee Kong Chian Sch Med, Novena Campus, Singapore, Singapore; [Wahli, Walter] INRA ToxAlim, UMR1331, Chemin Tournefeuille, Toulouse 3, France; [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Tan, Nguan Soon] Inst Mol & Cell Biol, Proteos, Agcy Sci Technol & Res, Singapore, Singapore; [Tan, Nguan Soon] KK Womens & Children Hosp, KK Res Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; INRAE; University of Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); KK Women's & Children's Hospital	Tan, EHP; Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Tan, NS (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Novena Campus, Singapore, Singapore.; Tan, NS (corresponding author), Inst Mol & Cell Biol, Proteos, Agcy Sci Technol & Res, Singapore, Singapore.; Tan, NS (corresponding author), KK Womens & Children Hosp, KK Res Ctr, Singapore, Singapore.	HTAN024@e.ntu.edu.sg; nstan@ntu.edu.sg	Wahli, Walter/I-3194-2019; Tan, Nguan Soon/A-2220-2011; Wahli, Walter/B-1398-2009; Sng, Ming Keat/J-7266-2013	Tan, Nguan Soon/0000-0003-0136-7341; Wahli, Walter/0000-0002-5966-9089; Tan, Eddie Han Pin/0000-0002-4475-0255; Sng, Ming Keat/0000-0002-5529-4371	Singapore Ministry of Education under Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2014-T2-1-012]; Academic Research Fund Tier 1 [RG134/15]; Lee Kong Chian School of Medicine, Nanyang Technological University Start-up Grant	Singapore Ministry of Education under Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); Academic Research Fund Tier 1; Lee Kong Chian School of Medicine, Nanyang Technological University Start-up Grant(Nanyang Technological University)	This work was supported by Singapore Ministry of Education under Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2014-T2-1-012) and Academic Research Fund Tier 1 (RG134/15) to NST, and by the Lee Kong Chian School of Medicine, Nanyang Technological University Start-up Grant to WW.	Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Borland MG, 2017, TOXICOL SCI, V159, P436, DOI 10.1093/toxsci/kfx147; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; Chan JSK, 2018, ONCOGENE, V37, P160, DOI 10.1038/onc.2017.319; Chan JSK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.492; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Iglesias J, 2012, J CLIN INVEST, V122, P4105, DOI 10.1172/JCI42127; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Kim ER, 2014, WORLD J GASTROENTERO, V20, P9872, DOI 10.3748/wjg.v20.i29.9872; Kim HJ, 2011, J BIOL CHEM, V286, P44585, DOI 10.1074/jbc.M111.222562; Kim MY, 2012, BIOCHEM PHARMACOL, V84, P1627, DOI 10.1016/j.bcp.2012.09.008; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu J, 2011, PPAR RES, V2011, DOI 10.1155/2011/372854; Liu X, 2016, GENE DEV, V30, P1943, DOI 10.1101/gad.283499.116; Manda G, 2015, REDOX BIOL, V5, P347, DOI 10.1016/j.redox.2015.06.014; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; Montagner A, 2014, EMBO MOL MED, V6, P80, DOI 10.1002/emmm.201302666; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Okada H, 2003, KIDNEY INT, V64, P1722, DOI 10.1046/j.1523-1755.2003.00290.x; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Peters JM, 2015, TRENDS ENDOCRIN MET, V26, P595, DOI 10.1016/j.tem.2015.09.004; Pickup MW, 2015, MOL ONCOL, V9, P179, DOI 10.1016/j.molonc.2014.08.004; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Reddy RC, 2010, AM J RESP CRIT CARE, V182, P134, DOI 10.1164/rccm.201004-0457ED; Roncoroni L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-40; Saw CLL, 2011, EXPERT OPIN THER TAR, V15, P281, DOI 10.1517/14728222.2011.553602; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Udagawa T, 2010, CURR OPIN PHARMACOL, V10, P369, DOI 10.1016/j.coph.2010.06.010; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2014, P NATL ACAD SCI USA, V111, P7084, DOI 10.1073/pnas.1324233111; Wang XL, 2015, J CONTROL RELEASE, V197, P138, DOI 10.1016/j.jconrel.2014.11.001; Yu SQ, 2012, PROSTATE, V72, P437, DOI 10.1002/pros.21445; Zhang WB, 2017, CARCINOGENESIS, V38, P748, DOI 10.1093/carcin/bgx035; ZUO X, 2014, JNCI-J NATL CANCER I, V106, P52, DOI DOI 10.1093/JNCI/DJU052; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	54	10	10	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					2067	2078		10.1038/s41388-017-0109-8	http://dx.doi.org/10.1038/s41388-017-0109-8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367760	Green Published, hybrid			2022-12-26	WOS:000429899400009
J	Bule, P; Cameron, K; Prates, JAM; Ferreira, LMA; Smith, SP; Gilbert, HJ; Bayer, EA; Najmudin, S; Fontes, CMGA; Alves, VD				Bule, Pedro; Cameron, Kate; Prates, Jose A. M.; Ferreira, Luis M. A.; Smith, Steven P.; Gilbert, Harry J.; Bayer, Edward A.; Najmudin, Shabir; Fontes, Carlos M. G. A.; Alves, Victor D.			Structure-function analyses generate novel specificities to assemble the components of multienzyme bacterial cellulosome complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COHESIN-DOCKERIN INTERACTION; DUAL BINDING MODE; ACETIVIBRIO-CELLULOLYTICUS; PROTEIN; SCAFFOLDIN; SURFACE; DOMAIN; NANOMACHINES; CONTAINS	The cellulosome is a remarkably intricate multienzyme nano-machine produced by anaerobic bacteria to degrade plant cell wall polysaccharides. Cellulosome assembly is mediated through binding of enzyme-borne dockerin modules to cohesin modules of the primary scaffoldin subunit. The anaerobic bacterium Acetivibrio cellulolyticus produces a highly intricate cellulosome comprising an adaptor scaffoldin, ScaB, whose cohesins interact with the dockerin of the primary scaffoldin (ScaA) that integrates the cellulosomal enzymes. The ScaB dockerin selectively binds to cohesin modules in ScaC that anchors the cellulosome onto the cell surface. Correct cellulosome assembly requires distinct specificities displayed by structurally related type-I cohesin-dockerin pairs that mediate ScaC-ScaB and ScaA-enzyme assemblies. To explore the mechanism by which these two critical protein interactions display their required specificities, we determined the crystal structure of the dockerin of a cellulosomal enzyme in complex with a ScaA cohesin. The data revealed that the enzyme-borne dockerin binds to the ScaA cohesin in two orientations, indicating two identical cohesin-binding sites. Combined mutagenesis experiments served to identify amino acid residues that modulate type-I cohesin-dockerin specificity in A. cellulolyticus. Rational design was used to test the hypothesis that the ligand-binding surfaces of ScaA-and ScaB-associated dockerins mediate cohesin recognition, independent of the structural scaffold. Novel specificities could thus be engineered into one, but not both, of the ligand-binding sites of ScaB, whereas attempts at manipulating the specificity of the enzyme-associated dockerin were unsuccessful. These data indicate that dockerin specificity requires critical interplay between the ligand-binding surface and the structural scaffold of these modules.	[Bule, Pedro; Cameron, Kate; Prates, Jose A. M.; Ferreira, Luis M. A.; Najmudin, Shabir; Fontes, Carlos M. G. A.; Alves, Victor D.] ULisboa, CIISA Fac Med Vet, Polo Univ Alto do Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Universidade de Lisboa; Queens University - Canada; Newcastle University - UK; Weizmann Institute of Science	Fontes, CMGA; Alves, VD (corresponding author), ULisboa, CIISA Fac Med Vet, Polo Univ Alto do Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt; vdalves@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Bule, Pedro/W-6838-2019	Prates, José A M/0000-0003-1032-5987; Bule, Pedro/0000-0003-2531-9926; Fontes, Carlos/0000-0002-1219-9753; Alves, Victor Diogo/0000-0002-8430-4380; Smith, Steven/0000-0003-2710-4400; Najmudin, Shabir/0000-0002-0429-5454	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012, PTDC/BIA-MIC/5947/2014]; European Union Seventh Framework Programme under the WallTraC project [263916]; BioStruct-X [283570]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/86821/2012]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union Seventh Framework Programme under the WallTraC project; BioStruct-X; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) through Grants PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012, and PTDC/BIA-MIC/5947/2014, from the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (Grant Agreement 263916) and from BioStruct-X (Grant Agreement 283570). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by individual fellowships SFRH/BD/86821/2012 from Fundacao para a Ciencia e Tecnologia.	Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bras JLA, 2012, J BIOL CHEM, V287, P44394, DOI 10.1074/jbc.M112.407700; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Ding SY, 1999, J BACTERIOL, V181, P6720, DOI 10.1128/JB.181.21.6720-6729.1999; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KHAN AW, 1980, J GEN MICROBIOL, V121, P499; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Stahl SW, 2012, P NATL ACAD SCI USA, V109, P20431, DOI 10.1073/pnas.1211929109; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2004, J BACTERIOL, V186, P5782, DOI 10.1128/JB.186.17.5782-5789.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	33	8	8	2	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4201	4212		10.1074/jbc.RA117.001241	http://dx.doi.org/10.1074/jbc.RA117.001241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367338	hybrid, Green Published			2022-12-26	WOS:000427587500030
J	Monne, M; Daddabbo, L; Gagneul, D; Obata, T; Hielscher, B; Palmieri, L; Miniero, DV; Fernie, AR; Weber, APM; Palmieri, F				Monne, Magnus; Daddabbo, Lucia; Gagneul, David; Obata, Toshihiro; Hielscher, Bjoern; Palmieri, Luigi; Miniero, Daniela Valeria; Fernie, Alisdair R.; Weber, Andreas P. M.; Palmieri, Ferdinando			Uncoupling proteins 1 and 2 (UCP1 and UCP2) from Arabidopsis thaliana are mitochondrial transporters of aspartate, glutamate, and dicarboxylates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; CARRIER FAMILY 25; BASIC-AMINO-ACIDS; BACTERIAL EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; MALATE-DEHYDROGENASE; TISSUE DISTRIBUTION; ORGAN DISTRIBUTION; COENZYME-A	The Arabidopsis thaliana genome contains 58 members of the solute carrier family SLC25, also called the mitochondrial carrier family, many of which have been shown to transport specific metabolites, nucleotides, and cofactors across the mitochondrial membrane. Here, two Arabidopsis members of this family, AtUCP1 and AtUCP2, which were previously thought to be uncoupling proteins and hence named UCP1/PUMP1 and UCP2/PUMP2, respectively, are assigned with a novel function. They were expressed in bacteria, purified, and reconstituted in phospholipid vesicles. Their transport properties demonstrate that they transport amino acids (aspartate, glutamate, cysteine sulfinate, and cysteate), dicarboxylates (malate, oxaloacetate, and 2-oxoglutarate), phosphate, sulfate, and thiosulfate. Transport was saturable and inhibited by mercurials and other mitochondrial carrier inhibitors to various degrees. AtUCP1 and AtUCP2 catalyzed a fast counterexchange transport as well as a low uniport of substrates, with transport rates of AtUCP1 being much higher than those of AtUCP2 in both cases. The aspartate/glutamate heteroexchange mediated by AtUCP1 and AtUCP2 is electroneutral, in contrast to that mediated by the mammalian mitochondrial aspartate glutamate carrier. Furthermore, both carriers were found to be targeted to mitochondria. Metabolite profiling of single and double knockouts shows changes in organic acid and amino acid levels. Notably, AtUCP1 and AtUCP2 are the first reported mitochondrial carriers in Arabidopsis to transport aspartate and glutamate. It is proposed that the primary function of AtUCP1 and AtUCP2 is to catalyze an aspartate(out)/glutamate(in) exchange across the mitochondrial membrane and thereby contribute to the export of reducing equivalents from the mitochondria in photorespiration.	[Monne, Magnus; Daddabbo, Lucia; Palmieri, Luigi; Miniero, Daniela Valeria; Palmieri, Ferdinando] Univ Bari, Lab Biochem & Mol Biol, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy; [Monne, Magnus] Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy; [Gagneul, David; Hielscher, Bjoern; Weber, Andreas P. M.] Heinrich Heine Univ, Inst Plant Biochem, Cluster Excellence Plant Sci CEPLAS, Univ Str 1, D-40225 Dusseldorf, Germany; [Obata, Toshihiro; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, Dept Willmitzer, Muhlenberg 1, D-14476 Potsdam, Germany; [Palmieri, Luigi; Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom, Via Orabona 4, I-70125 Bari, Italy; [Gagneul, David] Univ Lille, INRA, ISA, Univ Artois,Univ Littoral Cote Opale,EA 7394,ICV, F-59000 Lille, France	Universita degli Studi di Bari Aldo Moro; Italfarmaco; University of Basilicata; Heinrich Heine University Dusseldorf; University of Cologne; Max Planck Society; Universita degli Studi di Bari Aldo Moro; INRAE; Universite d'Artois; Universite de Lille - ISITE; Universite de Lille	Palmieri, F (corresponding author), Univ Bari, Lab Biochem & Mol Biol, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	ferdpalmieri@gmail.com	Miniero, Daniela Valeria/P-9786-2019; Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011; Obata, Toshihiro/AAX-4353-2020; Monné, Magnus/D-5642-2012	Miniero, Daniela Valeria/0000-0002-3324-9692; Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672; Obata, Toshihiro/0000-0001-8931-7722; Monné, Magnus/0000-0003-2344-3878	Italian Human ProteomeNet Grant [RBRN07BMCT_009]; iGRAD-Plant doctoral fellowship [IRTG 1525]; Max-Planck-Society; Cluster of Excellence on Plant Science CEPLAS [EXC 1028]; CRC [1208]; Center of Excellence on Comparative Genomics	Italian Human ProteomeNet Grant; iGRAD-Plant doctoral fellowship; Max-Planck-Society(Max Planck Society); Cluster of Excellence on Plant Science CEPLAS; CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Center of Excellence on Comparative Genomics	This work was supported by grants from the Center of Excellence on Comparative Genomics and Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an iGRAD-Plant doctoral fellowship (IRTG 1525).; Work in the laboratory of this author was supported by the Max-Planck-Society.; Supported by the Cluster of Excellence on Plant Science CEPLAS (EXC 1028) and CRC 1208.	Agrimi G, 2012, J BIOENERG BIOMEMBR, V44, P333, DOI 10.1007/s10863-012-9445-0; Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; Bernhardt K, 2012, PLANT J, V69, P1, DOI 10.1111/j.1365-313X.2011.04775.x; Borecky J, 2001, FEBS LETT, V505, P240, DOI 10.1016/S0014-5793(01)02835-6; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Cavero S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/j.1365-2958.2003.03742.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cousins AB, 2008, PLANT PHYSIOL, V148, P786, DOI 10.1104/pp.108.122622; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; DRY IB, 1987, BIOCHEM J, V245, P669, DOI 10.1042/bj2450669; Elia G, 2003, J VIROL METHODS, V109, P139, DOI 10.1016/S0166-0934(03)00064-8; Vercesi AE, 2006, ANNU REV PLANT BIOL, V57, P383, DOI 10.1146/annurev.arplant.57.032905.105335; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Forner J, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-28; Gigolashvili T, 2012, PLANT CELL, V24, P4187, DOI 10.1105/tpc.112.101964; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; JOURNET EP, 1981, PLANT PHYSIOL, V67, P467, DOI 10.1104/pp.67.3.467; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Linden P, 2016, J EXP BOT, V67, P3123, DOI 10.1093/jxb/erw030; Linka M, 2005, TRENDS PLANT SCI, V10, P461, DOI 10.1016/j.tplants.2005.08.002; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Monne M, 2015, BBA-BIOENERGETICS, V1847, P1220, DOI 10.1016/j.bbabio.2015.06.015; Monne M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Nikolovski N, 2012, PLANT PHYSIOL, V160, P1037, DOI 10.1104/pp.112.204263; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Palmieri L, 2006, BBA-BIOENERGETICS, V1757, P1277, DOI 10.1016/j.bbabio.2006.03.025; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448; Rieder B, 2011, PLANT CELL, V23, P1932, DOI 10.1105/tpc.111.084574; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stael S, 2011, FEBS LETT, V585, P3935, DOI 10.1016/j.febslet.2011.10.039; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Waadt R., 2008, CSH PROTOC, V2008; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558	75	51	53	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4213	4227		10.1074/jbc.RA117.000771	http://dx.doi.org/10.1074/jbc.RA117.000771			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29371401	Green Published, hybrid			2022-12-26	WOS:000427587500031
J	Bonanomi, S; Pulcinella, J; Fortuna, CM; Moro, F; Sala, A				Bonanomi, Sara; Pulcinella, Jacopo; Fortuna, Caterina Maria; Moro, Fabrizio; Sala, Antonello			Elasmobranch bycatch in the Italian Adriatic pelagic trawl fishery	PLOS ONE			English	Article							DOGFISH SQUALUS-ACANTHIAS; SPINY DOGFISH; DASYATIS-VIOLACEA; SEA-TURTLE; CATCH; CONSERVATION; PATTERNS; STINGRAY; IMPACTS; SEABIRD	Elasmobranchs are among the most threatened long-lived marine species worldwide, and incidental capture is a major source of mortality. The northern central Adriatic Sea, though one of the most overfished basins of the Mediterranean Sea, supports a very valuable marine biodiversity, including elasmobranchs. This study assesses the impact of the northern central Adriatic pelagic trawl fishery on common smooth-hound (Mustelus mustelus), spiny dogfish (Squalus acanthias), common eagle ray (Myliobatis aquila), and pelagic stingray (Pteroplatytrygon violacea) by examining incidental catches recorded between 2006 and 2015. The distribution of bycatch events was evaluated using geo-referenced data. Generalized Linear Models were computed to standardize the catch of the four species and to predict the relative abundance of bycatch events. Data analysis shows that most bycatch events involving all four species occurred in the northern Adriatic Sea. The models predicted significant, distinct temporal patterns of standardized catches in line with previous investigations. Water depth, season, and fishing region were the best predictors to explain bycatch events. The present data suggest that the northern Adriatic may be an important nursery area for several elasmobranchs. They also highlight the urgent need for a better understanding of the interactions between elasmobranchs and fisheries to develop and apply suitable, ad hoc management measures.	[Bonanomi, Sara; Pulcinella, Jacopo; Moro, Fabrizio; Sala, Antonello] Italian Natl Res Council CNR, Inst Marine Sci ISMAR, Ancona, Italy; [Fortuna, Caterina Maria] Italian Natl Inst Environm Protect & Res ISPRA, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Istituto di Scienze Marine (ISMAR-CNR); Italian Institute for Environmental Protection & Research (ISPRA)	Bonanomi, S (corresponding author), Italian Natl Res Council CNR, Inst Marine Sci ISMAR, Ancona, Italy.	sara.bonanomi@an.ismar.cnr.it	Fortuna, Caterina Maria/J-7796-2016; Bonanomi, Sara/Q-4026-2018; Sala, Antonello/B-8517-2016	Fortuna, Caterina Maria/0000-0003-3036-5337; Bonanomi, Sara/0000-0002-2236-9015; Sala, Antonello/0000-0001-7066-1152; Pulcinella, Jacopo/0000-0003-4142-5067	Italian Ministry of Agriculture, Food and Forestry Policies (General Directorate for Fisheries and Aquaculture) [007525]; Italian obligations to the Council Regulation (EC) [812/2004]	Italian Ministry of Agriculture, Food and Forestry Policies (General Directorate for Fisheries and Aquaculture); Italian obligations to the Council Regulation (EC)	The research was supported by the Italian Ministry of Agriculture, Food and Forestry Policies (General Directorate for Fisheries and Aquaculture, Agreement No. 007525) in compliance with the Italian obligations to the Council Regulation (EC) 812/2004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all independent observers and fishermen involved in the scientific and monitoring programme funded in compliance with the Regulations (EC) 812/2004. We also would like to thank the anonymous reviewers for their constructive comments and criticism. This research was supported by the Italian Ministry of Agriculture Food and Forestry (General Directorate of Fishery and Aquaculture, DG PEMAC I, Agreement No.007525).	[Anonymous], 2013, QUANTITATIVE FISHERI; [Anonymous], IUCN RED LIST THREAT; Barausse A, 2014, ICES J MAR SCI, V71, P1593, DOI 10.1093/icesjms/fst222; Bombace G., 2011, ELEMENTI BIOL PESCA; Bonanomi S, 2017, CHONDRICHTHYES MULTI; Bottaro M, 2009, IUCN INT UNION CONSE; Bradai M. N., 2012, ELASMOBRANCHS MEDITE; Brcic J, 2015, FISH RES, V172, P352, DOI 10.1016/j.fishres.2015.07.035; Burnham K P, 2003, MODEL SELECT MULTIMO; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Compagno LJ., 1984, SHARKS WORLD 2, V4; Crespo GOrtuno, 2017, ICES J MARINE SCI; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; de Wit M, 2001, SCI TOTAL ENVIRON, V273, P147, DOI 10.1016/S0048-9697(00)00851-2; DEGOBBIS D, 1990, OCEANOL ACTA, V13, P31; Dell'Apa A, 2013, OCEAN COAST MANAGE, V80, P65, DOI 10.1016/j.ocecoaman.2013.04.007; Demirhan SA, 2007, EKOLOJI, V16, P1; Dent F., 2015, FAO FISH AQUAC TECH, P18; Domingo A, 2005, SCI MAR, V69, P161, DOI 10.3989/scimar.2005.69n1161; Dulvy N., 2014, ELLIFE, P2, DOI [10.7554/eLife00590, DOI 10.7554/ELIFE00590]; Ebert D.A., 2013, FAO SPECIES CATALOGU, V7; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01057; Ferretti M., 1981, FAO FISHERIES REPORT; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Fortuna CM, 2010, CHEM ECOL, V26, P65, DOI 10.1080/02757541003627662; General Fisheries Commission for the Mediterranean (GFCM), 2015, REP WORK GROUP STOCK; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gracan R, 2013, MAR BIOL RES, V9, P198, DOI 10.1080/17451000.2012.729956; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jardas I., 1996, JADRANSKA IHTIOFAVNA; Jardas I., 2008, RED BOOK SEA FISHES; Klein-MacPhee G., 2002, BIGELOW SCHROEDERS F, P54; Komoroske LM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00083; La Mesa G, 2016, MAR COAST FISH, V8, P382, DOI 10.1080/19425120.2016.1167795; Lanfredi C, VALUTAZIONE PESCATO, P28; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lipej L, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P291; Lipej L, 2013, J MAR BIOL ASSOC UK, V93, P285, DOI 10.1017/S0025315412000197; Lipizer M, 2014, OCEAN SCI, V10, P771, DOI 10.5194/os-10-771-2014; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lucchetti A., 2015, SUSTAINABLE FISHERIE; Lucchetti A, 2010, REV FISH BIOL FISHER, V20, P141, DOI 10.1007/s11160-009-9126-1; Manfredi C., 2010, Biologia Marina Mediterranea, V17, P254; Mannini A., 2012, Biologia Marina Mediterranea, V19, P1; Marini M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004370; Marino IAM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12919; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Mavric Borut, 2004, Annales Series Historia Naturalis, V14, P181; Mazzoldi C, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.18; McFarlane GA, 2003, FISH B-NOAA, V101, P358; Molina JM, 2012, REV FISH BIOL FISHER, V22, P719, DOI 10.1007/s11160-012-9269-3; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Morello EB, 2009, OCEANOGR MAR BIOL, V47, P209; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; R Core Team, 2018, R LANG ENV STAT COMP; Relini G., 2010, Biologia Marina Mediterranea, V17, P186; Romano B, 2014, LAND USE POLICY, V38, P26, DOI 10.1016/j.landusepol.2013.10.001; Rondinini C., 2013, LISTA ROSSA IUCN VER; Sala A, 2016, VALUTAZIONE CATTURE; Sala A, 2013, VALUTAZIONE CATTURE; Sala A, 2011, AQUAT LIVING RESOUR, V24, P183, DOI 10.1051/alr/2011109; Serena F., 2005, FIELD IDENTIFICATION; Serena F, 2016, IUCN RED LIST THREAT; Serena Fabrizio, 1997, Quaderni della Civica Stazione Idrobiologica di Milano, V22, P17; Soldo A., 2006, P INT WORKSH MED CAR, P128; Soldo A, 2006, CURRENT STATUS SHARK; STECF, 2016, REP SCI TECHN EC C 2; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; Umani SF, 1996, SCI MAR, V60, P65; UNEP-MAP-RAC/SPA, 2014, MED REG WOR IN PRESS; Walters C, 2003, CAN J FISH AQUAT SCI, V60, P1433, DOI 10.1139/F03-152; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	76	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191647	10.1371/journal.pone.0191647	http://dx.doi.org/10.1371/journal.pone.0191647			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	29377920	Green Submitted, gold, Green Published			2022-12-26	WOS:000423514700024
J	Maccabi, A; Shin, A; Namiri, NK; Bajwa, N; St John, M; Taylor, ZD; Grundfest, W; Saddik, GN				Maccabi, Ashkan; Shin, Andrew; Namiri, Nikan K.; Bajwa, Neha; St John, Maie; Taylor, Zachary D.; Grundfest, Warren; Saddik, George N.			Quantitative characterization of viscoelastic behavior in tissue-mimicking phantoms and ex vivo animal tissues	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; VIBRO-ACOUSTOGRAPHY; BREAST; FORCE	Viscoelasticity of soft tissue is often related to pathology, and therefore, has become an important diagnostic indicator in the clinical assessment of suspect tissue. Surgeons, particularly within head and neck subsites, typically use palpation techniques for intra-operative tumor detection. This detection method, however, is highly subjective and often fails to detect small or deep abnormalities. Vibroacoustography (VA) and similar methods have previously been used to distinguish tissue with high-contrast, but a firm understanding of the main contrast mechanism has yet to be verified. The contributions of tissue mechanical properties in VA images have been difficult to verify given the limited literature on viscoelastic properties of various normal and diseased tissue. This paper aims to investigate viscoelasticity theory and present a detailed description of viscoelastic experimental results obtained in tissue-mimicking phantoms (TMPs) and ex vivo tissues to verify the main contrast mechanism in VA and similar imaging modalities. A spherical-tip micro-indentation technique was employed with the Hertzian model to acquire absolute, quantitative, point measurements of the elastic modulus (E), long term shear modulus (eta), and time constant (tau) in homogeneous TMPs and ex vivo tissue in rat liver and porcine liver and gallbladder. Viscoelastic differences observed between porcine liver and gallbladder tissue suggest that imaging modalities which utilize the mechanical properties of tissue as a primary contrast mechanism can potentially be used to quantitatively differentiate between proximate organs in a clinical setting. These results may facilitate more accurate tissue modeling and add information not currently available to the field of systems characterization and biomedical research.	[Maccabi, Ashkan; Grundfest, Warren] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Maccabi, Ashkan; Bajwa, Neha; Taylor, Zachary D.; Grundfest, Warren; Saddik, George N.] CASIT, Los Angeles, CA 90095 USA; [Shin, Andrew] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Shin, Andrew] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90024 USA; [Namiri, Nikan K.; Bajwa, Neha; Taylor, Zachary D.; Grundfest, Warren; Saddik, George N.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [St John, Maie] David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA USA	University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maccabi, A (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.; Maccabi, A (corresponding author), CASIT, Los Angeles, CA 90095 USA.	AshkanMaccabi@gmail.com	Namiri, Nikan/AAW-6616-2021	Maccabi, Ashkan/0000-0002-6048-6669; Namiri, Nikan/0000-0003-2943-9546	U.S. Public Health Service, National Eye Institute [EY008313, EY000331]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	U.S. Public Health Service, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by U.S. Public Health Service, National Eye Institute: grants EY008313 and EY000331 to Andrew Shin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo MA, 2010, IEEE T MED IMAGING, V29, P1012, DOI 10.1109/TMI.2009.2039225; Alizad A, 2004, IEEE T MED IMAGING, V23, P307, DOI 10.1109/TMI.2004.824241; Alizad A, 2006, ULTRASONICS, V44, pE217, DOI 10.1016/j.ultras.2006.06.021; [Anonymous], 2001, CAMB MA; Asner L, 2016, BIOMECH MODEL MECHAN, V15, P1121, DOI 10.1007/s10237-015-0748-z; Brouwer I, 2001, MED MEETS VIRTUAL RE; Cao R, 2013, MED PHYS, V40, DOI 10.1118/1.4773315; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chen AI, 2016, MED PHYS, V43, P3117, DOI 10.1118/1.4951729; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Chua WK, 2009, CELL MOL BIOENG, V2, P49, DOI 10.1007/s12195-009-0049-7; Cournane S, 2010, PHYS MED BIOL, V55, P5965, DOI 10.1088/0031-9155/55/19/022; Dunmire B, 2013, ULTRASOUND MED BIOL, V39, P300, DOI 10.1016/j.ultrasmedbio.2012.09.016; Epstein JB, 2012, J AM DENT ASSOC, V143, P1332, DOI 10.14219/jada.archive.2012.0096; Fatemi M, 1999, P NATL ACAD SCI USA, V96, P6603, DOI 10.1073/pnas.96.12.6603; Fatemi M, 2000, PHYS MED BIOL, V45, P1449, DOI 10.1088/0031-9155/45/6/304; Fatemi M, 2003, P IEEE, V91, P1503, DOI 10.1109/JPROC.2003.817865; Fatemi M, 2002, TOP APPL PHYS, V84, P257; Gao F, 2017, APPL PHYS LETT, V110, DOI DOI 10.1063/1.4974326; Hall TJ, 1997, IEEE T ULTRASON FERR, V44, P1355, DOI 10.1109/58.656639; Hamhaber U, 2003, MAGNET RESON MED, V49, P71, DOI 10.1002/mrm.10343; Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kazemirad S, 2016, IEEE T ULTRASON FERR, V63, P1399, DOI 10.1109/TUFFC.2016.2583785; Kelly P, 2008, SOLID MECH PART, V1, P301; Kerdok AE, 2006, J BIOMECH, V39, P2221, DOI 10.1016/j.jbiomech.2005.07.005; Kobayashi H, 1996, J APPL PHYS, V80, P122, DOI 10.1063/1.362767; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313; Lee E. H., 1960, J APPL MECH, V27, P438; Liu YB, 2016, MED PHYS, V43, P3987, DOI 10.1118/1.4953185; Maccabi A, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4942049; Maccabi A, SPIE MEDICAL IMAGING; Maccabi Ashkan, 2014, Stud Health Technol Inform, V196, P262; Madsen EL, 2005, PHYS MED BIOL, V50, P5597, DOI 10.1088/0031-9155/50/23/013; Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243; Nasopoulou A, 2017, BIOMECH MODEL MECHAN, V16, P971, DOI 10.1007/s10237-016-0865-3; Oyen ML, 2005, J MATER RES, V20, P2094, DOI 10.1557/JMR.2005.0259; Pavan TZ, 2010, PHYS MED BIOL, V55, P2679, DOI 10.1088/0031-9155/55/9/017; Popov VL, 2010, CONTACT MECHANIC AND FRICTION: PHYSICAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1007/978-3-642-10803-7; Shin A, 2015, INVEST OPHTH VIS SCI, V56, P243, DOI 10.1167/iovs.14-15510; Streitberger KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110588; Urban MW, 2011, CURR MED IMAGING, V7, P350; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Vigneswaran N, 2014, ORAL MAXIL SURG CLIN, V26, P123, DOI 10.1016/j.coms.2014.01.001; Wang MH, 2009, ULTRASOUND MED BIOL, V35, P1709, DOI 10.1016/j.ultrasmedbio.2009.04.019; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054; Yoo L, 2014, J BIOMECH, V47, P1899, DOI 10.1016/j.jbiomech.2014.02.011; Yoo L, 2011, INVEST OPHTH VIS SCI, V52, P3475, DOI 10.1167/iovs.10-6867; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	50	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191919	10.1371/journal.pone.0191919	http://dx.doi.org/10.1371/journal.pone.0191919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373598	Green Published, gold, Green Submitted			2022-12-26	WOS:000423425400031
J	Huang, HI; Chio, CC; Lin, JY				Huang, Hsing-I; Chio, Chi-Chong; Lin, Jhao-Yin			Inhibition of EV71 by curcumin in intestinal epithelial cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; ENTEROVIRUS 71 REPLICATION; IN-VITRO; VIRUS-REPLICATION; DOWN-REGULATION; MOUTH-DISEASE; PKC-DELTA; PATHWAY; ACTIVATION; VIVO	EV71 is a positive-sense single-stranded RNA virus that belongs to the Picornaviridae family. EV71 infection may cause various symptoms ranging from hand-foot-and-mouth disease to neurological pathological conditions such as aseptic meningitis, ataxia, and acute transverse myelitis. There is currently no effective treatment or vaccine available. Various compounds have been examined for their ability to restrict EV71 replication. However, most experiments have been performed in rhabdomyosarcoma or Vero cells. Since the gastrointestinal tract is the entry site for this pathogen, we anticipated that orally ingested agents may exert beneficial effects by decreasing virus replication in intestinal epithelial cells. In this study, curcumin (diferuloylmethane, C21H20O6), an active ingredient of turmeric (Curcuma longa Linn) with anti-cancer properties, was investigated for its anti-enterovirus activity. We demonstrate that curcumin treatment inhibits viral translation and increases host cell viability. Curcumin does not exert its anti-EV71 effects by modulating virus attachment or virus internal ribosome entry site (IRES) activity. Furthermore, curcumin-mediated regulation of mitogen-activated protein kinase (MAPK) signaling pathways is not involved. We found that protein kinase C delta (PKC delta) plays a role in virus translation in EV71-infected intestinal epithelial cells and that curcumin treatment decreases the phosphorylation of this enzyme. In addition, we show evidence that curcumin also limits viral translation in differentiated human intestinal epithelial cells. In summary, our data demonstrate the anti-EV71 properties of curcumin, suggesting that ingestion of this phytochemical may protect against enteroviral infections.	[Huang, Hsing-I; Chio, Chi-Chong; Lin, Jhao-Yin] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Huang, Hsing-I] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Huang, Hsing-I; Chio, Chi-Chong; Lin, Jhao-Yin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Huang, Hsing-I] Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Huang, HI (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Huang, HI (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.; Huang, HI (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.; Huang, HI (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan.	hihuang@mail.cgu.edu.tw		HUANG, HSING-I/0000-0003-4348-7851	Ministry of Science and Technology (MOST), Taiwan [104-2320-B-182-024-MY3]; Chang Gung University Memorial Hospital, Taiwan [CMRPD1C0601-3, CMRPD1G0431, BMRPB33]	Ministry of Science and Technology (MOST), Taiwan; Chang Gung University Memorial Hospital, Taiwan	This work was supported by grants to Hsing-I Huang from the Ministry of Science and Technology (MOST), Taiwan (104-2320-B-182-024-MY3) and Chang Gung University Memorial Hospital, Taiwan (CMRPD1C0601-3, CMRPD1G0431, and BMRPB33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MR, 2009, BIOCHEM BIOPH RES CO, V382, P620, DOI 10.1016/j.bbrc.2009.03.087; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299; Appiah-Opong R, 2007, TOXICOLOGY, V235, P83, DOI 10.1016/j.tox.2007.03.007; Battaini F, 2005, ANN NY ACAD SCI, V1057, P177, DOI 10.1196/annals.1356.011; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Cao AL, 2015, J ASIAN NAT PROD RES, V17, P56, DOI 10.1080/10286020.2014.951923; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chandran B, 2012, PHYTOTHER RES, V26, P1719, DOI 10.1002/ptr.4639; Chen MH, 2012, INT J MOL MED, V30, P1021, DOI 10.3892/ijmm.2012.1096; Cho JA, 2015, NUTR RES PRACT, V9, P117, DOI 10.4162/nrp.2015.9.2.117; Chuang SE, 2000, CARCINOGENESIS, V21, P331, DOI 10.1093/carcin/21.2.331; Cohen E, 1999, J CELL SCI, V112, P2657; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Fan Y, 2014, NEUROL RES, V36, P53, DOI 10.1179/1743132813Y.0000000267; Gao M, 2014, ANTIVIR RES, V106, P80, DOI 10.1016/j.antiviral.2014.03.009; Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177; Hasmeda M, 1996, PHYTOCHEMISTRY, V42, P599, DOI 10.1016/0031-9422(96)00091-X; Ho JY, 2016, J ANTIMICROB CHEMOTH, V71, P1922, DOI 10.1093/jac/dkw101; Huang Y, 2003, LETT APPL MICROBIOL, V36, P213, DOI 10.1046/j.1472-765X.2003.01303.x; Kankanamalage ACG, 2015, J MED CHEM, V58, P3144, DOI 10.1021/jm5019934; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Leong SY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004686; Li X, 2015, VIRUSES-BASEL, V7, P4756, DOI 10.3390/v7082841; LIU JY, 1993, CARCINOGENESIS, V14, P857, DOI 10.1093/carcin/14.5.857; Lui YLE, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-267; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meng CL, 1989, J MED SCI, V10, P131; Mun SH, 2009, J PHARMACOL SCI, V111, P13, DOI 10.1254/jphs.09134FP; Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6; Peng HJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-147; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Si XN, 2007, J VIROL, V81, P3142, DOI 10.1128/JVI.02028-06; Stoicov C, 2009, INT J ANTIMICROB AG, V33, P473, DOI 10.1016/j.ijantimicag.2008.10.032; Tsai FJ, 2011, FOOD CHEM, V128, P312, DOI 10.1016/j.foodchem.2011.03.022; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/503165; Wang MJ, 2016, ONCOTARGET, V7, P8797, DOI 10.18632/oncotarget.7122; WILS P, 1994, CELL BIOL TOXICOL, V10, P393, DOI 10.1007/BF00755788; Wong WR, 2005, LIFE SCI, V78, P82, DOI 10.1016/j.lfs.2005.04.076; Yang YJ, 2013, INT J MOL SCI, V14, P9618, DOI 10.3390/ijms14059618; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110429; Zhao HY, 2014, VIROLOGY, V468, P96, DOI 10.1016/j.virol.2014.07.040; Zhu M, 2015, VIRUSES-BASEL, V7, P1344, DOI 10.3390/v7031344	51	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191617	10.1371/journal.pone.0191617	http://dx.doi.org/10.1371/journal.pone.0191617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370243	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600068
J	Nannucci, S; Rinnoci, V; Pracucci, G; MacKinnon, AD; Pescini, F; Adib-Samii, P; Bianchi, S; Dotti, MT; Federico, A; Inzitari, D; Markus, HS; Pantoni, L				Nannucci, Serena; Rinnoci, Valentina; Pracucci, Giovanni; MacKinnon, Andrew D.; Pescini, Francesca; Adib-Samii, Poneh; Bianchi, Silvia; Dotti, Maria Teresa; Federico, Antonio; Inzitari, Domenico; Markus, Hugh S.; Pantoni, Leonardo			Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; WHITE-MATTER CHANGES; SUBCORTICAL INFARCTS; LACUNAR LESIONS; LEUKOENCEPHALOPATHY; DISABILITY; AGE; ENCEPHALOPATHY; PREVALENCE; STROKE	Background and purpose The frequency, clinical correlates, and risk factors of cerebral microbleeds (CMB) in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) are still poorly known. We aimed at determining the location and number of CMB and their relationship with clinical manifestations, vascular risk factors, drugs, and other neuroimaging features in CADASIL patients. Methods We collected clinical data by means of a structured proforma and centrally evaluated CMB on magnetic resonance gradient echo sequences applying the Microbleed Anatomical Rating Scale in CADASIL patients seen in 2 referral centers in Italy and United Kingdom. Results We evaluated 125 patients. CMB were present in 34% of patients and their presence was strongly influenced by the age. Twenty-nine percent of the patients had CMB in deep subcortical location, 22% in a lobar location, and 18% in infratentorial regions. After adjustment for age, factors significantly associated with a higher total number of CMB were hemorrhagic stroke, dementia, urge incontinence, and statins use (this latter not confirmed by multivariate analysis). Infratentorial and deep CMB were associated with dementia and urge incontinence, lobar CMB with hemorrhagic stroke, dementia, and statins use. Unexpectedly, patients with migraine, with or without aura, had a lower total, deep, and lobar number of CMB than patients without migraine. Discussion CMB formation in CADASIL seems to increase with age. History of hemorrhagic stroke, dementia, urge incontinence, and statins use are associated with a higher number of CMB. However, these findings need to be confirmed by longitudinal studies.	[Nannucci, Serena; Rinnoci, Valentina; Pracucci, Giovanni; Inzitari, Domenico] Univ Florence, NEUROFARBA Dept, Florence, Italy; [MacKinnon, Andrew D.] St Georges Univ Hosp NHS Fdn Trust, Atkinson Morley Reg Neurosci Ctr, London, England; [Pescini, Francesca] Azienda Osped Univ Careggi, Stroke Unit, Florence, Italy; [Adib-Samii, Poneh] St Georges Univ London, Clin Neurosci, London, England; [Bianchi, Silvia; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Med Surg & Neurol Sci, Siena, Italy; [Inzitari, Domenico] Italian Natl Res Council, Inst Neurosci, Florence, Italy; [Markus, Hugh S.] Univ Cambridge, Stroke Res Grp, Dept Clin Neurosci, Cambridge, England; [Pantoni, Leonardo] Univ Milan, L Sacco Dept Biomed & Clin Sci, Milan, Italy; [Nannucci, Serena] San Jacopo Hosp, Neurol Unit, Pistoia, Italy	University of Florence; St Georges University London; University of Florence; Azienda Ospedaliero Universitaria Careggi; St Georges University London; University of Siena; Consiglio Nazionale delle Ricerche (CNR); University of Cambridge; University of Milan; Ospedale San Jacopo di Pistoia	Pantoni, L (corresponding author), Univ Milan, L Sacco Dept Biomed & Clin Sci, Milan, Italy.	leonardo.pantoni@unimi.it	Pescini, Francesca/I-4080-2012; Inzitari, Domenico/AAH-8722-2020	Pescini, Francesca/0000-0003-4565-5601; 	Associazione per la Ricerca sulle Demenze (ARD) ONLUS, Department of Neurology, Luigi Sacco Hospital, Milan, Italy; MRC [G0900295] Funding Source: UKRI; Medical Research Council [G0900295] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish	Associazione per la Ricerca sulle Demenze (ARD) ONLUS, Department of Neurology, Luigi Sacco Hospital, Milan, Italy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The publication costs were supported by the non-profit organization Associazione per la Ricerca sulle Demenze (ARD) ONLUS, Department of Neurology, Luigi Sacco Hospital, Milan, Italy.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 1975, Stroke, V6, P564; [Anonymous], 1994, Circulation, V89, P1333; Auer DP, 2001, RADIOLOGY, V218, P443, DOI 10.1148/radiology.218.2.r01fe24443; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chalmers J, 1999, J HYPERTENS, V17, P151; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Liem MK, 2009, NEUROLOGY, V72, P143, DOI 10.1212/01.wnl.0000339038.65508.96; Liem MK, 2007, STROKE, V38, P923, DOI 10.1161/01.STR.0000257968.24015.bf; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Noh SM, 2014, CEREBROVASC DIS, V37, P188, DOI 10.1159/000357798; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Poggesi A, 2008, J AM GERIATR SOC, V56, P1638, DOI 10.1111/j.1532-5415.2008.01832.x; Rinnoci V, 2013, J NEUROL SCI, V330, P45, DOI 10.1016/j.jns.2013.04.002; Schon F, 2003, J NEUROL NEUROSUR PS, V74, P249, DOI 10.1136/jnnp.74.2.249; Singhal S, 2005, AM J NEURORADIOL, V26, P2481; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; van den Boom R, 2003, RADIOLOGY, V229, P683, DOI 10.1148/radiol.2293021354; van den Boom R, 2002, RADIOLOGY, V224, P791, DOI 10.1148/radiol.2243011123; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Viswanathan A, 2007, NEUROLOGY, V69, P172, DOI 10.1212/01.wnl.0000265221.05610.70; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Viswanathan A, 2006, BRAIN, V129, P2375, DOI 10.1093/brain/awl177; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Yao M, 2012, STROKE, V43, P3252, DOI 10.1161/STROKEAHA.112.664854	32	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190878	10.1371/journal.pone.0190878	http://dx.doi.org/10.1371/journal.pone.0190878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370179	gold, Green Accepted, Green Published			2022-12-26	WOS:000423416600026
J	Lee, YH				Lee, Young-Hoon			Socioeconomic differences among community-dwelling diabetic adults screened for diabetic retinopathy and nephropathy: The 2015 Korean Community Health Survey	PLOS ONE			English	Article							COST-EFFECTIVENESS; NATIONAL-HEALTH; EYE CARE; COMPLICATIONS; MORTALITY; ASSOCIATION; PREVALENCE; BEHAVIORS; MELLITUS; BARRIERS	We investigated the association between socioeconomic status (SES) and screening for diabetic retinopathy (DR) and diabetic nephropathy (DN) in community-dwelling diabetics. We analyzed data from 22,134 people with diabetes aged >= 19 years at the time of the nationwide 2015 Korean Community Health Survey. Multiple logistic regression analysis was used to explore the relationship between SES and screening for DR and DN both before and after adjustment for health behaviors, comorbidities, and educational level. Of all diabetic subjects, 33.9% and 38.1% underwent DR and DN screening, respectively. In the fully adjusted model, the extent of the DR and DN screening trended significantly lower as the educational level fell. Monthly household income was positively associated with DR screening, but a lower odds ratio (OR) for DN screening was evident only when the lowest and highest income groups were compared. Compared with managers/professionals, agricultural/forestry/fishery workers (OR 0.81, 95% confidence interval [CI] 0.69-0.96) and mechanical/manual laborers (OR 0.83, 95% CI 0.7-0.97) had lower ORs for DN screening. Residents in rural (compared with urban) areas and widows/widowers (compared with members of couples) were significantly less likely to undergo screening for DR and DN. Similar findings were obtained when the analysis was limited to those who had been educated about diabetes. In conclusion, socioeconomic inequalities were evident in terms of screening for DR and DN in community-dwelling Korean diabetics, regardless of whether they had reported receiving diabetes education. Tailored public health policies (and societal attention) are required to aid the socioeconomically disadvantaged.	[Lee, Young-Hoon] Wonkwang Univ, Dept Prevent Med, Sch Med, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Iksan, Jeonbuk, South Korea	Wonkwang University; Wonkwang University; Wonkwang University	Lee, YH (corresponding author), Wonkwang Univ, Dept Prevent Med, Sch Med, Iksan, Jeonbuk, South Korea.; Lee, YH (corresponding author), Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Jeonbuk, South Korea.; Lee, YH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Iksan, Jeonbuk, South Korea.	lyh8275@hanmail.net		Lee, Young-Hoon/0000-0003-1367-025X	Wonkwang University	Wonkwang University	This study was supported by Wonkwang University in 2017 to YHL.; This study was supported by Wonkwang University in 2017.	American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; [Anonymous], 2014, DIABETES CARE, V37, pS5, DOI 10.2337/dc14-S005; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Byun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062991; Choi Seong-Woo, 2008, J Prev Med Public Health, V41, P272, DOI 10.3961/jpmph.2008.41.4.272; DIABETES I, 2014, J DIABETES INVEST, DOI DOI 10.HTTPS://D0I.0RG/10.1111/JDI.12655; DIABETES I, 2017, J DIABETES INVEST, DOI DOI 10.HTTPS://D0I.0RG/10.1111/JDI.12655; DIABETES I, 2008, J DIABETES INVEST, DOI DOI 10.HTTPS://D0I.0RG/10.1111/JDI.12655; Do YK, 2011, INT J QUAL HEALTH C, V23, P397, DOI 10.1093/intqhc/mzr035; Evans JR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011234.pub2; Funakoshi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176087; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hartnett ME, 2005, ARCH OPHTHALMOL-CHIC, V123, P387, DOI 10.1001/archopht.123.3.387; HTTPS, 1969, DSF, DOI DOI 10.1186/1472-6963-10-169; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Kanjee R, 2016, CAN J OPHTHALMOL, V51, P467, DOI 10.1016/j.jcjo.2016.05.002; Kim TH, 2012, J KOREAN MED SCI, V27, P876, DOI 10.3346/jkms.2012.27.8.876; King AC, 1998, ANN BEHAV MED, V20, P64, DOI 10.1007/BF02884450; Ko KD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-689; Kowalski A, 2014, OCHSNER J, V14, P369; Lewis K, 2007, OPHTHAL EPIDEMIOL, V14, P375, DOI 10.1080/09286580701375195; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Maberley D, 2003, CAN MED ASSOC J, V168, P160; Mirowsky J, 2005, LOND REV EDUC, V3, P205, DOI 10.1080/14748460500372366; Ramsey Fred, 2008, Morbidity and Mortality Weekly Report, V57, P1; Rawshani A, 2016, JAMA INTERN MED, V176, P1146, DOI 10.1001/jamainternmed.2016.2940; Rim THT, 2013, J KOREAN MED SCI, V28, P814, DOI 10.3346/jkms.2013.28.6.814; SARAN R, 2017, AM J KIDNEY DIS S1, V69; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; SI DM, 2010, BMC HEALTH SERV RES, V10; Skaggs Julie B, 2017, N C Med J, V78, P121, DOI 10.18043/ncm.78.2.121; Song SJ, 2017, SURVEY; Tao XM, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0376-7; UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848; van Eijk KND, 2012, DIABETES RES CLIN PR, V96, P10, DOI 10.1016/j.diabres.2011.11.003; Venkataraman K, 2013, CLIN ENDOCRINOL, V78, P865, DOI 10.1111/j.1365-2265.2012.04480.x; Woodward MA, 2015, TELEMED E-HEALTH, V21, P271, DOI 10.1089/tmj.2014.0115; Young BA, 2008, AM J MANAG CARE, V14, P15	38	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191496	10.1371/journal.pone.0191496	http://dx.doi.org/10.1371/journal.pone.0191496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364972	Green Submitted, gold, Green Published			2022-12-26	WOS:000423412500054
J	McCarthy, K; Fielding, K; Churchyard, GJ; Grant, AD				McCarthy, Kerrigan; Fielding, Katherine; Churchyard, Gavin J.; Grant, Alison D.			Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; XPERT MTB/RIF; TB; IMPLEMENTATION; MULTICENTER; ALGORITHM; SETTINGS; ACCURACY; BURDEN; IMPACT	Background The extent and circumstances under which empiric tuberculosis (TB) treatment (treatment without microbiological confirmation at treatment initiation) is administered in primary health care settings in South Africa are not well described. Methods We used data from a pragmatic evaluation of Xpert MTB/RIF in which persons undergoing TB investigations by PHC nurses were followed for six months. Following Xpert or smear-microscopy at enrolment, investigations for tuberculosis were undertaken at the discretion of health care workers. We identified persons whose TB treatment was initiated empirically (no microbiological confirmation at time of treatment initiation at a primary health care facility) and describe pathways to treatment initiation. Results Of 4665 evaluable participants, 541 persons were initiated on treatment of whom 167 (31%) had negative sputum tests at enrolment. Amongst these 167, the median number of participant visits to health care providers prior to treatment initiation was 3 (interquartile range [IQR] 2 +/- 4). Chest radiography, sputum culture or hospital referral was done in 106/167 (63%). Reasons for TB treatment start were: 1) empiric (n = 82, 49%); 2) a positive laboratory test (n = 49, 29%); 3) referral and treatment start at a higher level of care (n = 28, 17%); and 4) indeterminable (n = 8, 5%). Empiric treatment accounted for 15% (82/541) of all TB treatment initiations and 1.7% (82/4665) of all persons undergoing TB investigations. Chest radiography findings compatible with TB (63/82 [77%]) were the basis for treatment initiation amongst the majority of empirically treated participants. Microbiological confirmation of TB was subsequently obtained for 11/82 (13%) empirically-treated participants. Median time to empiric treatment start was 3.9 weeks (IQR 1.4 +/- 11 weeks) after enrolment. Conclusion Uncommon prescription of empiric TB treatment with reliance on chest radiography in a nurse-managed programme underscores the need for highly sensitive TB diagnostics suitable for point-of-care, and strong health systems to support TB diagnosis in this setting.	[McCarthy, Kerrigan; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [McCarthy, Kerrigan; Fielding, Katherine; Churchyard, Gavin J.; Grant, Alison D.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [McCarthy, Kerrigan] Natl Inst Communicable Dis, Johannesburg, South Africa; [Fielding, Katherine; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, TB Ctr, London, England; [Churchyard, Gavin J.] South African Med Res Council, Advancing Treatment & Care, Johannesburg, South Africa; [Grant, Alison D.] Univ KwaZulu Natal, Africa Hlth Res Inst, Sch Nursing & Publ Hlth, Durban, South Africa	University of Witwatersrand; National Institute for Communicable Diseases (NICD); University of London; London School of Hygiene & Tropical Medicine; South African Medical Research Council; Africa Health Research Institute; University of Kwazulu Natal	McCarthy, K (corresponding author), Aurum Inst, Johannesburg, South Africa.; McCarthy, K (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; McCarthy, K (corresponding author), Natl Inst Communicable Dis, Johannesburg, South Africa.	kerriganm@nicd.ac.za		Churchyard, Gavin/0000-0002-4269-3699; Fielding, Katherine/0000-0002-6524-3754; McCarthy, Kerrigan/0000-0001-8958-9795	Bill and Melinda Gates Foundation [OPP1034523]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Bill and Melinda Gates Foundation (Grant ID# OPP1034523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo ST, 2012, TROP MED INT HEALTH, V17, P884, DOI 10.1111/j.1365-3156.2012.03003.x; [Anonymous], 2015, US LAT FLOW UR LIP A; Calligaro GL, 2017, LANCET INFECT DIS, V17, P441, DOI 10.1016/S1473-3099(16)30384-X; Cattamanchi A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0668-0; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Dorman SE, 2017, LANCET INFECT DIS; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Griesel R, C RETR OPP INF BOST; Hanrahan CF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw068; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Karat AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166158; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002472; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Loveday M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094016; Maraba N, 2016, T ROY SOC TROP MED H, V110, P510, DOI 10.1093/trstmh/trw058; Mbonze NB, 2016, INT J TUBERC LUNG D, V20, P240, DOI 10.5588/ijtld.15.0177; McCarthy KM, 2016, JAIDS-J ACQ IMM DEF, V71, pE119, DOI 10.1097/QAI.0000000000000907; Modi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167685; Muyoyeta M, 2015, PLOS ONE, V10; Muyoyeta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093757; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Nakiyingi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133756; National Department of Health, 2009, NAT TUB MAN GU ID TS; National Department of Health, 2014, NAT TUB MAN GUID TSH; Shete PB, 2015, INT J TUBERC LUNG D, V19, P912, DOI 10.5588/ijtld.14.0166; Tafuma TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088654; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Walusimbi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-507; WHO, 2016, US LOOP MED IS AMPL; WHO, 2007, IMPR DIAGN TREATM SM; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2017, WHO M REP TECHN EXP	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191608	10.1371/journal.pone.0191608	http://dx.doi.org/10.1371/journal.pone.0191608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364960	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000423412500060
J	Varshney, AK; Kuzmicheva, GA; Lin, J; Sunley, KM; Bowling, RA; Kwan, TY; Mays, HR; Rambhadran, A; Zhang, YF; Martin, RL; Cavalier, MC; Simard, J; Shivaswamy, S				Varshney, Avanish K.; Kuzmicheva, Galina A.; Lin, Jian; Sunley, Kevin M.; Bowling, Rodney A., Jr.; Kwan, Tzu-Yu; Mays, Heather R.; Rambhadran, Anu; Zhang, Yanfeng; Martin, Rebecca L.; Cavalier, Michael C.; Simard, John; Shivaswamy, Sushma			A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia	PLOS ONE			English	Article							NASAL CARRIAGE; CELL-WALL; HUMAN-IGG; BINDING; COLONIZATION; INFECTIONS; VANCOMYCIN; NEUTRALIZATION; PREVALENCE; MODULATION	Staphylococcus aureus can cause devastating and life-threatening infections. With the increase in multidrug resistant strains, novel therapies are needed. Limited success with active and passive immunization strategies have been attributed to S. aureus immune evasion. Here, we report on a monoclonal antibody, 514G3, that circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). SpA tightly binds most subclasses of immunoglobulins via their Fc region, neutralizing effector function. The organism can thus shield itself with a protective coat of serum antibodies and render humoral immunity ineffective. The present antibody reactivity was derived from an individual with natural anti-SpA antibody titers. The monoclonal antibody is of an IgG3 subclass, which differs critically from other immunoglobulin subclasses since its Fc is not bound by SpA. Moreover, it targets a unique epitope on SpA that allows it to bind in the presence of serum antibodies. Consequently, the antibody opsonizes S. aureus and maintains effector function to enable natural immune mediated clearance. The data presented here provide evidence that 514G3 antibody is able to successfully rescue mice from S. aureus mediated bacteremia.	[Varshney, Avanish K.; Kuzmicheva, Galina A.; Lin, Jian; Sunley, Kevin M.; Bowling, Rodney A., Jr.; Kwan, Tzu-Yu; Mays, Heather R.; Rambhadran, Anu; Zhang, Yanfeng; Martin, Rebecca L.; Cavalier, Michael C.; Simard, John; Shivaswamy, Sushma] XBiotech USA Inc, Austin, TX USA; [Varshney, Avanish K.] Luye Pharma USA, Woburn, MA USA; [Lin, Jian] WuXi AppTec Shanghai Co, Shanghai, Peoples R China; [Rambhadran, Anu] Regeneron Pharmaceut Inc, Rensselaer, NY USA	Regeneron	Shivaswamy, S (corresponding author), XBiotech USA Inc, Austin, TX USA.	sshivaswamy@xbiotech.com	Kuzmicheva, Galina A/C-4917-2009	Kuzmicheva, Galina A/0000-0001-7581-4242	XBiotech USA Inc.	XBiotech USA Inc.	XBiotech USA Inc. provided support in the form of salaries for authors A.K.V, G.A.K, J.L, K.M.S, R.A.B, T.K, H.R.M, A.R, Y.Z, R.L.M, M.C.C, J.S, S.S, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section. No additional external funding was received for this study.	Aguilar JL, 2016, VIRULENCE, P1; Aguilar JL, 2014, J CLIN MICROBIOL, V52, P2536, DOI 10.1128/JCM.00387-14; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Becker S, 2014, P NATL ACAD SCI USA, V111, P1574, DOI 10.1073/pnas.1317181111; Brown AE, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00507; Cazares-Dominguez V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00369; Coates R, 2014, FUTURE MICROBIOL, V9, P75, DOI 10.2217/fmb.13.145; Cunnion KM, 2003, INFECT IMMUN, V71, P656, DOI 10.1128/IAI.71.2.656-662.2003; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1153; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; Francois B, 2017, CLIN MICROBIOL INFEC; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Gauduchon V, 2004, J INFECT DIS, V189, P346, DOI 10.1086/380909; Gupta SB, 2016, CLIN INFECT DIS, V63, P730, DOI 10.1093/cid/ciw364; Gutfraind A, 2015, JAMA PEDIATR, V169, P341, DOI 10.1001/jamapediatrics.2014.3804; Herwaldt L A, 1993, Perit Dial Int, V13 Suppl 2, pS301; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Hong XF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00951; INGANAS M, 1980, SCAND J IMMUNOL, V12, P23, DOI 10.1111/j.1365-3083.1980.tb00037.x; INGANAS M, 1981, SCAND J IMMUNOL, V13, P343, DOI 10.1111/j.1365-3083.1981.tb00143.x; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Le VTM, 2016, ANTIMICROB AGENTS CH, V60, P5640, DOI 10.1128/AAC.00710-16; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Liese JG, 1996, LANCET, V347, P220, DOI 10.1016/S0140-6736(96)90403-1; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; McGuinness WA, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010032; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; Monaco M, 2016, CURR TOP MICROBIOL I; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Nohlden S, 2008, THESIS; O'Halloran DP, 2015, INFECT IMMUN, V83, P1598, DOI 10.1128/IAI.03122-14; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; PETERSON PK, 1977, INFECT IMMUN, V15, P760, DOI 10.1128/IAI.15.3.760-764.1977; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Salgado-Pabon W, 2014, NAT REV MICROBIOL, V12, P585, DOI 10.1038/nrmicro3308; Sause WE, 2016, TRENDS PHARMACOL SCI, V37, P231, DOI 10.1016/j.tips.2015.11.008; SJOHOLM I, 1975, EUR J BIOCHEM, V51, P55, DOI 10.1111/j.1432-1033.1975.tb03906.x; SORRELL TC, 1982, ANN INTERN MED, V97, P344, DOI 10.7326/0003-4819-97-3-344; Sparrow E, 2016, VACCINE, V34, P5442, DOI 10.1016/j.vaccine.2016.08.057; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Subrt N, 2011, J ANTIMICROB CHEMOTH, V66, P979, DOI 10.1093/jac/dkr043; Thomsen IP, 2017, J INFECT DIS, V215, P1124, DOI 10.1093/infdis/jix071; Tuchscherr LPN, 2008, INFECT IMMUN, V76, P5738, DOI 10.1128/IAI.00874-08; VANLOGHEM E, 1982, SCAND J IMMUNOL, V15, P275; Varshney AK, 2014, MBIO, V5, DOI 10.1128/mBio.01007-14; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Whitehouse J, 2016, VACCINE, V34, P1792, DOI 10.1016/j.vaccine.2016.02.034; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Yang DL, 2016, ANAL BIOCHEM, V508, P78, DOI 10.1016/j.ab.2016.06.024; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149460; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Ziakas PD, 2014, CRIT CARE MED, V42, P433, DOI 10.1097/CCM.0b013e3182a66bb8	61	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190537	10.1371/journal.pone.0190537	http://dx.doi.org/10.1371/journal.pone.0190537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364906	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500017
J	Winzi, M; Vila, NC; Paszkowski-Rogacz, M; Ding, L; Noack, S; Theis, M; Butter, F; Buchholz, F				Winzi, Maria; Vila, Nuria Casas; Paszkowski-Rogacz, Maciej; Ding, Li; Noack, Svenja; Theis, Mirko; Butter, Falk; Buchholz, Frank			The long noncoding RNA lncR492 inhibits neural differentiation of murine embryonic stem cells	PLOS ONE			English	Article							BINDING PROTEIN HUR; MOUSE EMBRYOS; SELF-RENEWAL; PLURIPOTENCY; EXPRESSION; TARGET; SCREEN; IDENTIFICATION; TRANSLATION; ANNOTATION	RNA interference (RNAi) screens have been shown to be valuable to study embryonic stem cell (ESC) self-renewal and they have been successfully applied to identify coding as well as noncoding genes required for maintaining pluripotency. Here, we used an RNAi library targeting >640 long noncoding RNAs (lncRNA) to probe for their role in early cell differentiation. Utilizing a Sox1-GFP ESC reporter cell line, we identified the lncRNA lncR492 as lineage-specific inhibitor of neuroectodermal differentiation. Molecular characterization showed that lncR492 interacts with the mRNA binding protein HuR and facilitates its inhibitory function by activation of Wnt signaling. Thus, lncRNAs modulate the fate decision of pluripotent stem cells.	[Winzi, Maria; Paszkowski-Rogacz, Maciej; Ding, Li; Noack, Svenja; Theis, Mirko; Buchholz, Frank] Tech Univ Dresden, Univ Canc Ctr, Fac Med Carl Gustav Carus, Med Syst Biol, Dresden, Germany; [Vila, Nuria Casas; Butter, Falk] Inst Mol Biol IMB gGmbH, Quantitat Prote, Mainz, Germany; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Buchholz, Frank] Heidelberg & German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Partner Site Dresden, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Natl Ctr Tumor Dis NCT, Dresden, Germany; [Winzi, Maria] Tech Univ Dresden, BioTEC, Cellular Machines, Dresden, Germany	Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institute of Molecular Biology (IMB); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Buchholz, F (corresponding author), Tech Univ Dresden, Univ Canc Ctr, Fac Med Carl Gustav Carus, Med Syst Biol, Dresden, Germany.; Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Buchholz, F (corresponding author), Heidelberg & German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Partner Site Dresden, Dresden, Germany.; Buchholz, F (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Natl Ctr Tumor Dis NCT, Dresden, Germany.	frank.buchholz@tu-dresden.de	Vila, Núria Casas/AAB-2093-2021; Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344; Casas Vila, Nuria/0000-0003-4233-0529; Butter, Falk/0000-0002-7197-7279	EMBO-LTF; European Commission FP7 (Maria Curie Actions, EMBOCOFUND) [GA-2010-267146]	EMBO-LTF(European Molecular Biology Organization (EMBO)); European Commission FP7 (Maria Curie Actions, EMBOCOFUND)	M.W. is supported by an EMBO-LTF and co-funded by the European Commission FP7 (Maria Curie Actions, EMBOCOFUND2010, GA-2010-267146).; M.W. was supported by an EMBO-LTF and co-funded by the European Commission FP7 (Maria Curie Actions, EMBOCOFUND2010, GA-2010-267146).	Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Chakraborty D, 2012, NAT METHODS, V9, P360, DOI [10.1038/NMETH.1894, 10.1038/nmeth.1894]; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Latorre E, 2016, CANCER RES, V76, P2626, DOI 10.1158/0008-5472.CAN-15-2018; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu L, 2014, MOL BIOL CELL, V25, P3308, DOI 10.1091/mbc.E14-03-0853; Luo S, 2016, CELL STEM CELL; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Scheibe M, 2012, NUCLEIC ACIDS RES, V40, P9897, DOI 10.1093/nar/gks746; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wray J, 2012, TRENDS CELL BIOL, V22, P159, DOI 10.1016/j.tcb.2011.11.004; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027	45	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191682	10.1371/journal.pone.0191682	http://dx.doi.org/10.1371/journal.pone.0191682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364956	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500067
J	Kim, YG; Choi, JI; Kim, MN; Cho, DH; Oh, SK; Kook, H; Park, HS; Lee, KN; Baek, YS; Roh, SY; Shim, J; Park, SM; Shim, WJ; Kim, YH				Kim, Yun Gi; Choi, Jong-Il; Kim, Mi-Na; Cho, Dong-Hyuk; Oh, Suk-Kyu; Kook, Hyungdon; Park, Hee-Soon; Lee, Kwang No; Baek, Yong-Soo; Roh, Seung-Young; Shim, Jaemin; Park, Seong-Mi; Shim, Wan Joo; Kim, Young-Hoon			Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study	PLOS ONE			English	Article							RISK STRATIFICATION; STROKE; THROMBOEMBOLISM; RIVAROXABAN; APIXABAN; EDOXABAN; SMOKE; AF	Spontaneous echo-contrast (SEC) and thrombus observed in trans-esophageal echocardiography (TEE) is known as a strong surrogate marker for future risk of ischemic stroke in patients with atrial fibrillation (AF) or atrial flutter (AFL). The efficacy of non-vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin to prevent SEC or thrombus in patients with AF or AFL is currently unknown. AF or AFL patients who underwent direct current cardioversion (DCCV) and pre-DCCV TEE evaluation from January 2014 to October 2016 in a single center were analyzed. The prevalence of SEC and thrombus were compared between patients who received NOAC and those who took warfarin. NOAC included direct thrombin inhibitor and factor Xa inhibitors. Among 1,050 patients who were considered for DCCV, 424 patients anticoagulated with warfarin or NOAC underwent TEE prior to DCCV. Eighty patients who were anticoagulated for less than 21 days were excluded. Finally, 344 patients were included for the analysis (180 warfarin users vs. 164 NOAC users). No significant difference in the prevalence of SEC (44.4% vs. 43.9%; p = 0.919), dense SEC (13.9% vs. 15.2%; p = 0.722), or thrombus (2.2% vs. 4.3%; p = 0.281) was observed between the warfarin group and the NOAC group. In multivariate analysis, there was no association between NOAC and risk of SEC (odds ratio [OR]: 1.4, 95% CI: 0.796-2.297, p = 0.265) or thrombus (OR: 3.4, 95% CI: 0.726-16.039, p = 0.120). In conclusion, effectiveness of NOAC is comparable to warfarin in preventing SEC and thrombus in patients with AF or AFL undergoing DCCV. However, numerical increase in the prevalence of thrombus in NOAC group warrants further evaluation.	[Choi, Jong-Il] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea; Korea Univ, Med Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, JI (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.	jongilchoi@korea.ac.kr	Baek, Yong-Soo/GXF-3223-2022; Kim, Young-Hoon/AAO-5792-2021	Baek, Yong-Soo/0000-0002-6086-0446; Kim, Mi-Na/0000-0001-6589-5122; Kim, Young-Hoon/0000-0002-4254-647X; Choi, Jong-Il/0000-0001-6617-508X	Korean Society of Cardiology [2015-05-01]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A02061859]; Ministry of Science, ICT & Future Planning [NRF-2012R1A1A1013260]; Korea University Anam Hospital; Korea University	Korean Society of Cardiology; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea University Anam Hospital; Korea University	This work was supported by a Korea University Grant (J-IC) and a grant of Korea University Anam Hospital (J-IC) and in part by a grant from the Korean Society of Cardiology (2015-05-01 to J-IC), and grants from Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A02061859 to J-IC) and the Ministry of Science, ICT & Future Planning (NRF-2012R1A1A1013260 to J-IC).	ARNOLD AZ, 1992, J AM COLL CARDIOL, V19, P851, DOI 10.1016/0735-1097(92)90530-Z; Asinger RW, 1999, J AM SOC ECHOCARDIOG, V12, P1088, DOI 10.1016/S0894-7317(99)70106-9; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Black IW, 2000, ECHOCARDIOGR-J CARD, V17, P373, DOI 10.1111/j.1540-8175.2000.tb01153.x; Calenda BW, 2016, NAT REV CARDIOL, V13, P549, DOI 10.1038/nrcardio.2016.106; Camm AJ, 2012, EUR HEART J, V33; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Choi JI, 2016, KOREAN CIRC J, V46, P335, DOI 10.4070/kcj.2016.46.3.335; Choi JI, 2008, CIRC J, V72, P2051, DOI 10.1253/circj.CJ-08-0428; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ezekowitz MD, 2016, AM HEART J, V179, P59, DOI 10.1016/j.ahj.2016.06.008; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kim MN, 2015, INT HEART J, V56, P286, DOI 10.1536/ihj.14-380; Kim Y, 2016, IEEE C ELECTR PERFOR, P11, DOI 10.1109/EDAPS.2016.7893112; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Komatsu T, 2014, INT HEART J, V55, P119, DOI 10.1536/ihj.13-242; Lee JM, 2014, AM J CARDIOL, V113, P963, DOI 10.1016/j.amjcard.2013.11.058; Lip GYH, 2016, AM HEART J, V178, P126, DOI 10.1016/j.ahj.2016.05.007; Lowe GDO, 2003, PATHOPHYSIOL HAEMO T, V33, P455, DOI 10.1159/000083845; MERINO A, 1992, J AM COLL CARDIOL, V20, P1661, DOI 10.1016/0735-1097(92)90463-W; Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel SV, 2008, CLIN CARDIOL, V31, P148, DOI 10.1002/clc.20172; Peverill RE, 1996, CIRCULATION, V94, P331, DOI 10.1161/01.CIR.94.3.331; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Soncini M, 1997, Minerva Med, V88, P501; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Vazquez FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142222; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; WEINBERG DM, 1989, AM J CARDIOL, V63, P745, DOI 10.1016/0002-9149(89)90264-6; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yamashita T, 2015, J CARDIOL, V65, P175, DOI 10.1016/j.jjcc.2014.07.013; YASAKA M, 1991, BRIT HEART J, V66, P22; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005	39	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191648	10.1371/journal.pone.0191648	http://dx.doi.org/10.1371/journal.pone.0191648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360845	Green Published, gold, Green Submitted			2022-12-26	WOS:000423161800048
J	Menigoz, K; Nathan, A; Heesch, KC; Turrell, G				Menigoz, Karen; Nathan, Andrea; Heesch, Kristiann C.; Turrell, Gavin			Neighbourhood disadvantage, geographic remoteness and body mass index among immigrants to Australia: A national cohort study 2006-2014	PLOS ONE			English	Article							ETHNIC RESIDENTIAL SEGREGATION; UNITED-STATES; BUILT ENVIRONMENT; SOCIOECONOMIC DISADVANTAGE; RACIAL/ETHNIC DIFFERENCES; HEALTH INEQUALITIES; STRUCTURAL RACISM; BMI TRAJECTORIES; WEIGHT STATUS; OBESITY	Obesity is socioeconomically, geographically and ethnically patterned. Understanding these elements of disadvantage is vital in understanding population obesity trends and the development of effective and equitable interventions. This study examined the relationship between neighbourhood socioeconomic disadvantage and geographic remoteness with prospective trends in mean body mass index (BMI) among immigrants to Australia. Longitudinal data (2006-2014) from a national panel survey of Australian adults was divided into an immigrant-only sample (n = 4,293, 52.6% women and 19,404 person-year observations). The data were analysed using multi-level random effects linear regression modelling that controlled for individual socioeconomic and demographic factors. Male immigrants living in the most disadvantaged neighbourhoods had significantly higher mean BMI compared with those living in the least disadvantaged. Over time, mean BMI increased for all groups except for men living in the least disadvantaged neighbourhoods, for whom mean BMI remained almost static (0.1 kg/m(2) increase from 2006 to 2014), effectively widening neighbourhood inequalities. Among women, mean BMI was also significantly higher in the most compared with the least, disadvantaged neighbourhoods (beta = 2.08 kg/m(2); 95%Cl: 1.48, 2.68). Neighbourhood inequalities were maintained over time as mean BMI increased for all groups at a similar rate. Male and female immigrants residing in outer regional areas had significantly higher mean BMI compared with those living in major cities; however, differences were attenuated and no longer significant following adjustment for ethnicity, individual socioeconomic position and neighbourhood disadvantage. Over time, mean BMI increased in all male and female groups with no differences based on geographic remoteness. Obesity prevention policy targeted at immigrant cohorts needs to include area-level interventions that address inequalities in BMI arising from neighbourhood disadvantage, and be inclusive of immigrants living outside Australia's major cities.	[Menigoz, Karen; Heesch, Kristiann C.; Turrell, Gavin] QUT, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Menigoz, Karen; Heesch, Kristiann C.; Turrell, Gavin] QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Nathan, Andrea; Turrell, Gavin] ACU, Inst Hlth & Ageing, Melbourne, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Australian Catholic University	Menigoz, K (corresponding author), QUT, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.; Menigoz, K (corresponding author), QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.	karen.menigoz@hdr.qut.edu.au	Heesch, Kristiann C/J-1288-2012	Heesch, Kristiann C/0000-0003-1931-3683; Turrell, Gavin/0000-0002-3576-8744; Menigoz, Karen/0000-0002-5875-7941	Australian Government Department of Social Services (DSS)	Australian Government Department of Social Services (DSS)(Australian Government)	This paper uses unit record data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The HILDA Project was initiated and is funded by the Australian Government Department of Social Services (DSS) and is managed by the Melbourne Institute of Applied Economic and Social Research (Melbourne Institute). The findings and views reported in this paper, however, are those of the author and should not be attributed to either DSS or the Melbourne Institute.	Albrecht SS, 2015, ANN EPIDEMIOL, V25, P767, DOI 10.1016/j.annepidem.2015.07.003; Anikeeva O, 2010, ASIA-PAC J PUBLIC HE, V22, P159, DOI 10.1177/1010539509358193; Astell-Burt T, 2013, SOC SCI MED, V93, P70, DOI 10.1016/j.socscimed.2013.06.006; Australian Bureau of Statistics, 2015, NATL HLTH SURV 1 RES; Australian Bureau of Statistics, 2011, TECHN PAP SOC EC IND; Australian Bureau of Statistics, 2016, MIGR AUSTR 2014 15; Australian Bureau of Statistics, 2011, REM STRUCT, V5; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Becares Laia, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2012.300832; Befort CA, 2012, J RURAL HEALTH, V28, P392, DOI 10.1111/j.1748-0361.2012.00411.x; Bonevski B, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-42; Burdette AM, 2012, J ADOLESCENT HEALTH, V50, P30, DOI 10.1016/j.jadohealth.2011.03.009; Chiu M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007232; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Cleland V, 2010, MED J AUSTRALIA, V192, P137, DOI 10.5694/j.1326-5377.2010.tb03451.x; Cozier YvetteC, 2014, AM J EPIDEMIOL; Do DP, 2007, ECON HUM BIOL, V5, P179, DOI 10.1016/j.ehb.2007.03.006; Do DP, 2017, HEALTH PLACE, V46, P201, DOI 10.1016/j.healthplace.2017.05.010; El-Sayed AM, 2011, OBES REV, V12, pe516, DOI 10.1111/j.1467-789X.2010.00829.x; Feng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141499; Feng XQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007052; Feng XQ, 2014, PREV MED, V69, P172, DOI 10.1016/j.ypmed.2014.09.015; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Guo SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115627; Hauck K, 2011, HEALTH PLACE, V17, P78, DOI 10.1016/j.healthplace.2010.08.016; Hugo G., 2014, RURAL CHANGE AUSTR, P57; Johnston R, 2007, ANN ASSOC AM GEOGR, V97, P713, DOI 10.1111/j.1467-8306.2007.00579.x; Jokela M, 2009, SOC SCI MED, V68, P867, DOI 10.1016/j.socscimed.2008.12.022; Kershaw KN, 2013, AM J EPIDEMIOL, V177, P299, DOI 10.1093/aje/kws372; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kirby JB, 2012, AM J PUBLIC HEALTH, V102, P1572, DOI 10.2105/AJPH.2011.300452; Lau R, 2008, AUST J RURAL HEALTH, V16, P5, DOI 10.1111/j.1440-1584.2007.00933.x; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004; Menigoz K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3608-6; Moloney KL, 2015, HEALTH PLACE, V31, P199, DOI 10.1016/j.healthplace.2014.12.006; Mujahid MS, 2008, AM J EPIDEMIOL, V167, P1349, DOI 10.1093/aje/kwn047; Mujahid MS, 2017, HEALTH PLACE, V44, P61, DOI 10.1016/j.healthplace.2017.01.005; Mujahid MS, 2005, OBES RES, V13, P1412, DOI 10.1038/oby.2005.171; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicholson LM, 2012, J YOUTH ADOLESCENCE, V41, P53, DOI 10.1007/s10964-011-9685-z; Organization for Economic Co-operation and Development, 2017, OB UPD 2017; Osypuk TL, 2010, HEALTH PLACE, V16, P1113, DOI 10.1016/j.healthplace.2010.07.002; Patterson KAE, 2017, ANN EPIDEMIOL, V27, P169, DOI 10.1016/j.annepidem.2017.01.007; Patterson KAE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1278; Rachele JN, 2017, PREV MED, V105, P271, DOI 10.1016/j.ypmed.2017.09.017; Rasbash J, 2013, MLWIN VERSION 2 27; Renzaho A, 2016, AUST HEALTH REV, V40, P3, DOI 10.1071/AH14132; Richmond TK, 2015, INT J OBESITY, V39, P546, DOI 10.1038/ijo.2014.147; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Ruel E, 2010, HEALTH PLACE, V16, P191, DOI 10.1016/j.healthplace.2009.09.009; Smith NR, 2012, EUR J PUBLIC HEALTH, V22, P508, DOI 10.1093/eurpub/ckr070; Summerfield M, 2015, HILDA USER MANUAL PL; The University of Adelaide Hugo Centre for Migration and Population Research, 2015, ARIA ACC REM IND AUS; Turrell G, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0151-7; Turrell G, 2013, HEALTH PLACE, V19, P89, DOI 10.1016/j.healthplace.2012.10.008; Ullmann SH, 2013, SOC SCI MED, V90, P40, DOI 10.1016/j.socscimed.2013.04.024; UNDP, 2015, HUM DEV REP, P1; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Watson N, 2011, METHODOLOGY HILDA TO; Watson N, 2002, ASSESSING QUALITY HI; Watson N, 2015, FACTORS AFFECTING RE; Watson N, 2012, LONGITUDINAL CROSS S; Watson N, 2012, LONGITUD LIFE COURSE, V3, P369; Wen M, 2012, HEALTH PLACE, V18, P1314, DOI 10.1016/j.healthplace.2012.09.002	67	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191729	10.1371/journal.pone.0191729	http://dx.doi.org/10.1371/journal.pone.0191729			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360878	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800055
J	Rudi, G; Bailly, JS; Vinatier, F				Rudi, Gabrielle; Bailly, Jean-Stephane; Vinatier, Fabrice			Using geomorphological variables to predict the spatial distribution of plant species in agricultural drainage networks	PLOS ONE			English	Article							DISTRIBUTION MODELS; MANAGEMENT REGIMES; SORGHUM-HALEPENSE; ARABLE WEEDS; DITCH BANKS; VEGETATION; DISPERSAL; VARIABILITY; LANDSCAPES; EROSION	To optimize ecosystem services provided by agricultural drainage networks (ditches) in headwater catchments, we need to manage the spatial distribution of plant species living in these networks. Geomorphological variables have been shown to be important predictors of plant distribution in other ecosystems because they control the water regime, the sediment deposition rates and the sun exposure in the ditches. Whether such variables may be used to predict plant distribution in agricultural drainage networks is unknown. We collected presence and absence data for 10 herbaceous plant species in a subset of a network of drainage ditches (35 km long) within a Mediterranean agricultural catchment. We simulated their spatial distribution with GLM and Maxent model using geomorphological variables and distance to natural lands and roads. Models were validated using k-fold cross-validation. We then compared the mean Area Under the Curve (AUC) values obtained for each model and other metrics issued from the confusion matrices between observed and predicted variables. Based on the results of all metrics, the models were efficient at predicting the distribution of seven species out of ten, confirming the relevance of geomorphological variables and distance to natural lands and roads to explain the occurrence of plant species in this Mediterranean catchment. In particular, the importance of the landscape geomorphological variables, ie the importance of the geomorphological features encompassing a broad environment around the ditch, has been highlighted. This suggests that agro-ecological measures for managing ecosystem services provided by ditch plants should focus on the control of the hydrological and sedimentological connectivity at the catchment scale. For example, the density of the ditch network could be modified or the spatial distribution of vegetative filter strips used for sediment trapping could be optimized. In addition, the vegetative filter strips could constitute new seed bank sources for species that are affected by the distance to natural lands and roads.	[Rudi, Gabrielle; Bailly, Jean-Stephane; Vinatier, Fabrice] Univ Montpellier, INRA, IRD, Montpellier SupAgro,LISAH, Montpellier, France; [Rudi, Gabrielle] Univ Montpellier, AgroParisTech, CIRAD, IRD,IRSTEA,Montpellier SupAgro,G Eau, Montpellier, France; [Bailly, Jean-Stephane] AgroParisTech, Paris, France	INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech	Rudi, G (corresponding author), Univ Montpellier, INRA, IRD, Montpellier SupAgro,LISAH, Montpellier, France.; Rudi, G (corresponding author), Univ Montpellier, AgroParisTech, CIRAD, IRD,IRSTEA,Montpellier SupAgro,G Eau, Montpellier, France.	gabrielle.rudi@supagro.fr	Vinatier, Fabrice/AAF-7014-2020	Vinatier, Fabrice/0000-0003-3693-4422; Bailly, Jean-Stephane/0000-0003-4163-5275	INRA institution via the EcoServ metaprogram; Agropolis Fondation through the "Investissements d'avenir" programme (LabexAgro) [1605-034, ANR-10-LABX-0001-01]; Montpellier Supagro via the EcoServ metaprogram; INRA institution	INRA institution via the EcoServ metaprogram; Agropolis Fondation through the "Investissements d'avenir" programme (LabexAgro)(French National Research Agency (ANR)); Montpellier Supagro via the EcoServ metaprogram; INRA institution	Authors are grateful to the INRA institution who partly funded the experimental work exposed in this paper within the 'Pari-Scientifique: Hydro-ecologie des fosses agricoles' project (INRA-EA) to FV. This project was also funded by Agropolis Fondation under the reference ID 1605-034 through the "Investissements d'avenir" programme (LabexAgro:ANR-10-LABX-0001-01) to FV. Lastly, the project was also supported by funds from a PhD grant provided by Montpellier Supagro and the INRA institution via the EcoServ metaprogram to GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para;The authors thank Marie-Noelle Moresmau, Jeanne Dollinger, Benoit Bellot, and Alexandre Bassini for their valuable field work. Marie-Noelle Moresmau created the GIS application for the survey using App Inventor. We also thank Laurent Prevot and Guillaume Coulouma for their expertise and advice regarding the study area. Authors are grateful to the INRA institution who partly funded the experimental work exposed in this paper within the 'Pari-Scientifique: Hydro-ecologie des fosses agricoles' project (INRA-EA). This project was also funded by Agropolis Fondation under the reference ID 1605-034 through the "Investissements d'avenir" programme (Labex Agro:ANR-10-LABX-0001-01). Lastly, the project was also supported by funds from a PhD grant provided by Montpellier Supagro and the INRA institution via the EcoServ metaprogram. Authors thank the three anonymous referees for helpful comments and suggestions on the manuscript, and Bruce Jaffee for the English revision.	Alignier A, 2013, ECOL COMPLEX, V15, P17, DOI 10.1016/j.ecocom.2013.01.007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2016, DISMO SPECIES DISTRI; [Anonymous], 1998, INDEX BOT ECOLOGIQUE; Baddeley A, 2015, SPATIAL POINT PATTER; Bailly JS, 2008, INT J REMOTE SENS, V29, P3489, DOI 10.1080/01431160701469057; Balandier P, 2013, FORESTRY, V86, P39, DOI 10.1093/forestry/cps066; Bassa M, 2012, BIODIVERS CONSERV, V21, P1101, DOI 10.1007/s10531-012-0245-y; Arnold RLB, 1988, FUNCT ECOL, V2, P311, DOI 10.2307/2389403; Bennett ER, 2005, ENVIRON TOXICOL CHEM, V24, P2121, DOI 10.1897/04-357R.1; Bivand, 2016, RGEOS INTERFACE GEOM; Bivand R., 2016, RGDAL BINDINGS GEOSP; Bivand R., 2016, MAPTOOLS TOOLS READI; Blomqvist M. M., 2006, Journal for Nature Conservation (Jena), V14, P16, DOI 10.1016/j.jnc.2005.08.003; Blomqvist MM, 2009, BASIC APPL ECOL, V10, P368, DOI 10.1016/j.baae.2008.08.007; Blomqvist MM, 2003, BIOL CONSERV, V109, P391, DOI 10.1016/S0006-3207(02)00165-9; Brenning A., 2008, HAMBURGER BEITRAEGE, V19, P23; Castaldelli G, 2015, AGR ECOSYST ENVIRON, V212, P253, DOI 10.1016/j.agee.2015.07.009; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Clarke SJ, 2015, J NAT CONSERV, V24, P93, DOI 10.1016/j.jnc.2014.10.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cordeau S, 2012, AGR ECOSYST ENVIRON, V155, P35, DOI 10.1016/j.agee.2012.03.022; Coulouma G., 2008, CARTE SOLS BASSE VAL; Cousens R, 2004, OIKOS, V107, P251, DOI 10.1111/j.0030-1299.2004.13188.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; David M, 2014, GEOMORPHOLOGY, V214, P10, DOI 10.1016/j.geomorph.2014.03.016; DGFAR, 2008, CIRC 2008 MES AGR NE; Dollinger J, 2016, SCI TOTAL ENVIRON, V573, P716, DOI 10.1016/j.scitotenv.2016.08.168; Dollinger J, 2015, AGRON SUSTAIN DEV, V35, P999, DOI 10.1007/s13593-015-0301-6; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duan RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112764; DUNAWAY D, 1994, GEOMORPHOLOGY, V9, P47, DOI 10.1016/0169-555X(94)90030-2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2017, REFERENCE MODULE LIF; Favre-Bac L, 2014, ACTA OECOL, V61, P57, DOI 10.1016/j.actao.2014.10.006; Firbank LG, 2008, PHILOS T R SOC B, V363, P777, DOI 10.1098/rstb.2007.2183; Gaba S, 2010, AGR ECOSYST ENVIRON, V138, P318, DOI 10.1016/j.agee.2010.06.005; Gabriel D, 2005, PERSPECT PLANT ECOL, V7, P85, DOI 10.1016/j.ppees.2005.04.001; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gumiere SJ, 2011, HYDROL PROCESS, V25, P1717, DOI 10.1002/hyp.7931; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOLT JS, 1995, WEED SCI, V43, P474, DOI 10.1017/S0043174500081509; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Jayet H., 2001, ECONOMETRIE DONNEES, P58; Konsuer KM, 2016, GEOMORPHOLOGY, V252, P80, DOI 10.1016/j.geomorph.2015.08.002; Kroger R., 2010, ACTA ECOLOGICA SINIC, V30, P280; Lagacherie P, 2006, ECOL INDIC, V6, P265, DOI 10.1016/j.ecolind.2005.02.003; Lancaster LT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0046; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lelievre F, 2011, EVOLUTION CLIMAT SUD; Leng X, 2011, J NAT CONSERV, V19, P166, DOI 10.1016/j.jnc.2010.11.003; Leonard J, 1998, CATENA, V32, P209, DOI 10.1016/S0341-8162(98)00049-6; Levavasseur F, 2015, J LAND USE SCI, V10, P256, DOI 10.1080/1747423X.2014.884644; Levavasseur F, 2016, LAND USE POLICY, V50, P441, DOI 10.1016/j.landusepol.2015.08.033; Levavasseur F, 2014, AGR WATER MANAGE, V140, P14, DOI 10.1016/j.agwat.2014.03.012; Levavasseur F, 2012, HYDROL PROCESS, V26, P3393, DOI 10.1002/hyp.8422; Levavasseur F., 2012, THESIS; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; Maheu-Giroux M, 2007, LANDSCAPE ECOL, V22, P285, DOI 10.1007/s10980-006-9024-z; Maidment D. R., 1996, 3 INT C GIS ENV MOD; Manhoudt AGE, 2007, AGR ECOSYST ENVIRON, V119, P353, DOI 10.1016/j.agee.2006.08.004; Manolaki P, 2016, RIVER RES APPL, V32, P639, DOI 10.1002/rra.2878; Margoum C, 2006, CHEMOSPHERE, V63, P1835, DOI 10.1016/j.chemosphere.2005.10.032; Meineri E, 2012, ECOL MODEL, V231, P1, DOI 10.1016/j.ecolmodel.2012.01.021; Merritt DM, 2010, FRESHWATER BIOL, V55, P206, DOI 10.1111/j.1365-2427.2009.02206.x; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; MINSHALL GW, 1985, CAN J FISH AQUAT SCI, V42, P1045, DOI 10.1139/f85-130; Moore MT, 2010, ENVIRON POLLUT, V158, P175, DOI 10.1016/j.envpol.2009.07.024; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moresmau M. N., 2013, THESIS; Needelman BA, 2007, J SOIL WATER CONSERV, V62, P207; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; Pebesma E.J., 2005, R NEWS, V5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Petit S, 2011, AGRON SUSTAIN DEV, V31, P309, DOI 10.1051/agro/2010020; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; QGIS Development Team, 2016, QGIS GEOGR INF SYST; R Development Core Team, 2016, R LANG ENV STAT COMP; Rivaes R, 2013, ECOHYDROLOGY, V6, P413, DOI 10.1002/eco.1287; Saco PM, 2007, HYDROL EARTH SYST SC, V11, P1717, DOI 10.5194/hess-11-1717-2007; San Martin C, 2016, FOREST ECOL MANAG, V379, P37, DOI 10.1016/j.foreco.2016.08.001; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Solymos P, 2016, PBAPPLY ADDING PROGR; Soomers H, 2010, FRESHWATER BIOL, V55, P2032, DOI 10.1111/j.1365-2427.2010.02460.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas RE, 2014, J HYDRAUL RES, V52, P311, DOI 10.1080/00221686.2013.876453; Twisk W, 2003, AQUAT ECOL, V37, P191, DOI 10.1023/A:1023944028022; Valladares F, 2015, FRONT PLANT SCI, P6; van Dijk WFA, 2014, BIOL CONSERV, V171, P91, DOI 10.1016/j.biocon.2014.01.006; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	103	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191397	10.1371/journal.pone.0191397	http://dx.doi.org/10.1371/journal.pone.0191397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360857	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800027
J	Yu, X; Stallone, JN; Heaps, CL; Han, GC				Yu, Xuan; Stallone, John N.; Heaps, Cristine L.; Han, Guichun			The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; KINASE CASCADES; HEART-DISEASE; AGONIST; REQUIRES; GPR30; TONE; VASOCONSTRICTION; STIMULATION; INVOLVEMENT	Estrogen exerts protective effects against cardiovascular diseases in premenopausal women, but is associated with an increased risk of both coronary heart disease and stroke in older postmenopausal women. Studies have shown that activation of the G-protein-coupled estrogen receptor 1 (GPER) can cause either relaxation or contraction of arteries. It is highly likely that these dual actions of GPER may contribute to the seemingly paradoxical effects of estrogen in regulating coronary artery function. The objective of this study was to test the hypothesis that activation of GPER enhances agonist-stimulated porcine coronary artery contraction via epidermal growth factor receptor (EGFR) transactivation and its downstream extracellular signal-regulated kinases (ERK1/2) pathway. Isometric tension studies and western blot were performed to determine the effect of GPER activation on coronary artery contraction. Our findings demonstrated that G-1 caused concentration-dependent relaxation of ET-1 -induced contraction, while pretreatment of arterial rings with G-1 significantly enhanced ET-1-induced contraction. GPER antagonist, G-36, significantly inhibited both the G-1-induced relaxation effect and G-1 -enhanced ET-1 contraction. Gallein, a G beta gamma inhibitor, significantly increased G-1-induced relaxation, yet inhibited G-1-enhanced ET-1-mediated contraction. Similarly, inhibition of EGFR with AG 1478 or inhibition of Src with phosphatase 2 further increased G-1-induced relaxation responses in coronary arteries, but decreased G-1-enhanced ET-1-induced contraction. Western blot experiments in porcine coronary artery smooth muscle cells (PCASMC) showed that G-1 increased tyrosine phosphorylation of EGFR, which was inhibited by AG-1478. Furthermore, enzyme-linked immunosorbent assays showed that the level of heparin-binding EGF (HB-EGF) released by ET-1 treatment increased two-fold; whereas pre-incubation with G-1 further increased ET-1-induced HB-EGF release to four-fold over control conditions. Lastly, the role of ERK1/2 was determined by applying the MEK inhibitor, PD98059, in isometric tension studies and detecting phospho-ERK1/2 in immunoblotting. PD98059 potentiated G-1-induced relaxation response, but blocked G-1-enhanced ET-1-induced contraction. By western blot, G-1 treatment decreased phospho-ERK1/2, however, in the presence of the adenylyl cyclase inhibitor, SQ22536, G-1 significantly increased ERK1/2 phosphorylation in PCASMC. These data demonstrate that activation of GPER induces relaxation via cAMP as well as contraction via a mechanism involving transactivation of EGFR and the phosphorylation of ERK1/2 in porcine coronary arteries.	[Yu, Xuan; Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Coll Vet Med & Biomed Sci, Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Han, GC (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Vet Physiol & Pharmacol, College Stn, TX 77843 USA.; Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Han, Guichun/0000-0001-5269-0363; Yu, Xuan/0000-0003-3343-7105	American Heart Association [15BGIA25060013]	American Heart Association(American Heart Association)	Funded by grant number: 15BGIA25060013. URLs: http://www.heart.org/HEARTORG/ American Heart Association. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AH, 2011, MICROVASC RES, V81, P135, DOI 10.1016/j.mvr.2010.11.001; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Batenburg WW, 2012, CARDIOVASC RES; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Bhattacharya I, 2011, EUR J PHARMACOL, V658, P22, DOI 10.1016/j.ejphar.2010.09.053; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; CHAMLEYCAMPBELL JH, 1981, J CELL BIOL, V89, P379, DOI 10.1083/jcb.89.2.379; Debortoli AR, 2017, J MOL ENDOCRINOL, V59, P171, DOI 10.1530/JME-16-0117; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Feng J, 2010, SURGERY, V147, P798, DOI 10.1016/j.surg.2009.11.016; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Griol-Charhbili V, 2011, HYPERTENSION, V57, P238, DOI 10.1161/HYPERTENSIONAHA.110.153619; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Hodis HN, 2014, J STEROID BIOCHEM, V142, P68, DOI 10.1016/j.jsbmb.2013.06.011; Iwasaki H, 1999, ENDOCRINOLOGY, V140, P4659, DOI 10.1210/en.140.10.4659; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kopetz Scott, 2007, Gastrointest Cancer Res, V1, pS37; Kurt AH, 2013, EUR J PHARMACOL, V702, P71, DOI 10.1016/j.ejphar.2013.01.020; Lekontseva ON, 2010, MENOPAUSE, V17, P516, DOI 10.1097/gme.0b013e3181c91f04; Li F, 2013, ACTIVATION GPER INDU; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064771; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Low AK, 2002, AM J MED SCI, V324, P180, DOI 10.1097/00000441-200210000-00003; Lucchesi PA, 2004, CIRCULATION, V110, P3587, DOI 10.1161/01.CIR.0000148780.36121.47; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Nagareddy PR, 2010, CARDIOVASC RES, V87, P177, DOI 10.1093/cvr/cvq030; Nagareddy PR, 2009, CARDIOVASC RES, V84, P368, DOI 10.1093/cvr/cvp230; Nakao F, 2002, CIRC RES, V91, P953, DOI 10.1161/01.RES.0000042702.04920.BF; Overland AC, 2015, J BIOL CHEM, V290, P9941, DOI 10.1074/jbc.C115.647073; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Yu XY, 2011, CHEMOSPHERE, V85, P1284, DOI 10.1016/j.chemosphere.2011.07.031; Yu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173085; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191418	10.1371/journal.pone.0191418	http://dx.doi.org/10.1371/journal.pone.0191418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360846	Green Published, gold, Green Submitted			2022-12-26	WOS:000423161800030
J	Ghandhi, SA; Turner, HC; Shuryak, I; Dugan, GO; Bourland, JD; Olson, JD; Tooze, JA; Morton, SR; Batinic-Haberle, I; Cline, JM; Amundson, SA				Ghandhi, Shanaz A.; Turner, Helen C.; Shuryak, Igor; Dugan, Gregory O.; Bourland, J. Daniel; Olson, John D.; Tooze, Janet A.; Morton, Shad R.; Batinic-Haberle, Ines; Cline, J. Mark; Amundson, Sally A.			Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; RHESUS MACAQUES; ANIMAL-MODELS; IONIZING-RADIATION; MICRONUCLEUS ASSAY; TRANSGLUTAMINASE 2; DOSE IRRADIATION; PROTEIN; BIODOSIMETRY; EXPOSURE	We investigated the cytogenetic and gene expression responses of peripheral blood cells of non-human primates (NHP, Macaca mulatta) that were whole-thorax irradiated with a single dose of 10 Gy. In this model, partial irradiation of NHPs in the thoracic region (Whole Thorax Lung Irradiation, WTLI) allows the study of late radiation-induced lung injury, while avoiding acute radiation syndromes related to hematopoietic and gastrointestinal injury. A transient drop in circulating lymphocytes and platelets was seen by 9 days, followed by elevations in respiratory rate, circulating neutrophils, lymphocytes, and monocytes at 60 +/- 100 days, corresponding to computed tomography (CT) and histologic evidence of pneumonitis, and elective euthanasia of four animals. To evaluate long-term DNA damage in NHP peripheral blood lymphocytes after 10 Gy WTLI, we used the cytokinesis-block micronucleus (CBMN) assay to measure chromosomal aberrations as post-mitotic micronuclei in blood samples collected up to 8 months after irradiation. Regression analysis showed significant induction of micronuclei in NHP blood cells that persisted with a gradual decline over the 8-month study period, suggesting long-term DNA damage in blood lymphocytes after WTLI. We also report transcriptomic changes in blood up to 30 days after WTLI. We isolated total RNA from peripheral blood at 3 days before and then at 2, 5 and 30 days after irradiation. We identified 1187 transcripts that were significantly changed across the 30-day time course. From changes in gene expression, we identified biological processes related to immune responses, which persisted across the 30-day study. Response to oxygen-containing compounds and bacteria were implicated by gene-expression changes at the earliest day 2 and latest, day 30 time-points. Gene expression changes suggest a persistent altered state of the immune system, specifically response to infection, for at least a month after WTLI.	[Ghandhi, Shanaz A.; Turner, Helen C.; Shuryak, Igor; Morton, Shad R.; Amundson, Sally A.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA; [Dugan, Gregory O.; Bourland, J. Daniel; Olson, John D.; Tooze, Janet A.; Cline, J. Mark] Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC USA; [Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Columbia University; Wake Forest University; Wake Forest Baptist Medical Center; Duke University	Ghandhi, SA (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA.	sg2423@cumc.columbia.edu	Ghandhi, Shanaz/C-5930-2016		Center for High-Throughput Minimally-Invasive Radiation Biodosimetry; National Institute of Allergy and Infectious Diseases [U19 A1067773]; Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases [U19 AI A167798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, U19AI067773] Funding Source: NIH RePORTER	Center for High-Throughput Minimally-Invasive Radiation Biodosimetry; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for High-Throughput Minimally-Invasive Radiation Biodosimetry, National Institute of Allergy and Infectious Diseases (https://www.niaid.nil.gov/) grant number U19 A1067773 and the Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) grant number U19 AI A167798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6593; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 2011, GUIDE FOR THE CARE A; Batinic-Haberle I, 2014, ANTIOXID REDOX SIGN, V20, P2372, DOI 10.1089/ars.2012.5147; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Broustas CG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3436-1; Budworth H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048619; BUTTURINI A, 1988, LANCET, V2, P471; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Daadi MM, 2014, STEM CELLS DEV, V23, P83, DOI 10.1089/scd.2014.0374; Dillman JF, 2005, TOXICOL SCI, V87, P306, DOI 10.1093/toxsci/kfi243; DOCK DS, 1961, J CLIN INVEST, V40, P317, DOI 10.1172/JCI104259; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Farese AM, 2015, HEALTH PHYS, V109, P414, DOI 10.1097/HP.0000000000000348; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2010, HEALTH PHYS, V98, P234, DOI 10.1097/HP.0b013e3181b85044; Ganapathy S, 2014, J BIOL CHEM, V289, P5340, DOI 10.1074/jbc.M113.531020; Gao Y., 2017, IONICS, V7, P1, DOI DOI 10.1016/J.GENE.2017.03.021; Garofalo M, 2014, HEALTH PHYS, V106, P56, DOI 10.1097/HP.0b013e3182a32b3f; Ghandhi SA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0097-x; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gregoire E, 2006, INT J RADIAT BIOL, V82, P493, DOI 10.1080/09553000600840930; Grow DA, 2016, STEM CELL RES, V17, P352, DOI 10.1016/j.scr.2016.08.013; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Haber S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025092; Hematti P, 2005, EXP HEMATOL, V33, P980, DOI 10.1016/j.exphem.2005.06.008; Hong SG, 2016, MOL THER, V24, P1165, DOI 10.1038/mt.2016.131; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskow RC, 2012, P NATL ACAD SCI USA, V109, P12656, DOI 10.1073/pnas.1205199109; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; MacVittie TJ, 2015, HEALTH PHYS, V109, P342, DOI 10.1097/HP.0000000000000352; MacVittie TJ, 2012, HEALTH PHYS, V103, P411, DOI 10.1097/HP.0b013e31826525f0; MacVittie TJ, 2012, HEALTH PHYS, V103, P427, DOI 10.1097/HP.0b013e318266eb4c; MacVittie TJ, 2012, HEALTH PHYS, V103, P340, DOI 10.1097/HP.0b013e318261175a; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Park JG, 2017, RADIAT RES, V187, P708, DOI 10.1667/RR14655.1; Paul S, 2015, RADIAT RES, V184, P24, DOI 10.1667/RR14044.1; Paul S, 2014, RADIAT RES, V182, P380, DOI 10.1667/RR13466.1; Petibone DM, 2008, MUTAT RES-GEN TOX EN, V653, P76, DOI 10.1016/j.mrgentox.2008.03.012; Port M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030541; Prado C, 2015, HEALTH PHYS, V109, P367, DOI 10.1097/HP.0000000000000336; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao RP, 2001, CANCER RES, V61, P7413; Simon R, 2007, CANCER INFORM, V3, P11; Singh VK, 2017, EXPERT OPIN DRUG DIS, V12, P695, DOI 10.1080/17460441.2017.1323863; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Song J, 2016, VIRUS RES, V214, P1, DOI 10.1016/j.virusres.2016.01.002; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Thierens H, 2005, RADIAT PROT DOSIM, V113, P408, DOI 10.1093/rpd/nch483; Thrall KD, 2015, HEALTH PHYS, V109, P502, DOI 10.1097/HP.0000000000000339; U. S Department of Health and Human Services FDA Center for Devices and Radiological Health, 2016, GUID IND FOOD DRUG A; VANDYK J, 1981, INT J RADIAT ONCOL, V7, P461, DOI 10.1016/0360-3016(81)90131-0; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	66	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191402	10.1371/journal.pone.0191402	http://dx.doi.org/10.1371/journal.pone.0191402			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351567	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300084
J	Peltier, E; Bernard, M; Trujillo, M; Prodhomme, D; Barbe, JC; Gibon, Y; Marullo, P				Peltier, Emilien; Bernard, Margaux; Trujillo, Marine; Prodhomme, Duyen; Barbe, Jean-Christophe; Gibon, Yves; Marullo, Philippe			Wine yeast phenomics: A standardized fermentation method for assessing quantitative traits of Saccharomyces cerevisiae strains in enological conditions	PLOS ONE			English	Article							SULFITE EFFLUX; OXYGEN; GLYCEROL; VOLATILE; NITROGEN; IDENTIFICATION; DOMESTICATION; VARIANTS; ESTERS; MET2	This work describes the set up of a small scale fermentation methodology for measuring quantitative traits of hundreds of samples in an enological context. By using standardized screw cap vessels, the alcoholic fermentation kinetics of Saccharomyces cerevisiae strains were measured by following their weight loss over the time. This dispositive was coupled with robotized enzymatic assays for measuring metabolites of enological interest in natural grape juices. Despite the small volume used, kinetic parameters and fermentation end products measured are similar with those observed in larger scale vats. The vessel used also offers the possibility to assay 32 volatiles compounds using a headspace solid-phase micro-extraction coupled to gas chromatography and mass spectrometry. The vessel shaking applied strongly impacted most of the phenotypes investigated due to oxygen transfer occuring in the first hours of the alcoholic fermentation. The impact of grape must and micro-oxygenation was investigated illustrating some relevant genetic x environmental interactions. By phenotyping a wide panel of commercial wine starters in five grape juices, broad phenotypic correlations between kinetics and metabolic end products were evidentiated. Moreover, a multivariate analysis illustrates that some grape musts are more able than others to discriminate commercial strains since some are less robust to environmental changes.	[Peltier, Emilien; Bernard, Margaux; Trujillo, Marine; Barbe, Jean-Christophe; Marullo, Philippe] Univ Bordeaux, ISVV, INRA, bordeaux INP,USC 1366 INRA,Unite Rech Enol,EA4577, Villenave Dornon, France; [Peltier, Emilien; Bernard, Margaux; Marullo, Philippe] Biolaffort, Bordeaux, France; [Trujillo, Marine] Pernod Ricard, Creteil, France; [Prodhomme, Duyen; Gibon, Yves] Univ Bordeaux, INRA, UMR 1332, Fruit Biol & Pathol, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Peltier, E (corresponding author), Univ Bordeaux, ISVV, INRA, bordeaux INP,USC 1366 INRA,Unite Rech Enol,EA4577, Villenave Dornon, France.; Peltier, E (corresponding author), Biolaffort, Bordeaux, France.	emilien.peltier@u-bordeaux.fr		Nurmi, Petteri/0000-0001-8262-6434; Gibon, Yves/0000-0001-8161-1089; Marullo, Philippe/0000-0002-3594-5173; Peltier, Emilien/0000-0002-1773-5308	Region d'Aquitaine	Region d'Aquitaine	This work was funded by Region d'Aquitaine (https://www.nouvelle-aquitaine.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094246; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Alfenore S, 2004, APPL MICROBIOL BIOT, V63, P537, DOI 10.1007/s00253-003-1393-5; Almeida P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5044; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; ANDERSON RG, 1975, J I BREWING, V81, P111, DOI 10.1002/j.2050-0416.1975.tb03671.x; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Antalick G, 2010, FOOD CHEM, V121, P1236, DOI 10.1016/j.foodchem.2010.01.011; Bean GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085177; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bertrand A, 1984, SCI ALIMENTS; Blateyron L, 2001, J BIOSCI BIOENG, V91, P184, DOI 10.1263/jbb.91.184; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Borneman AR, 2016, G3-GENES GENOM GENET, V6, P957, DOI 10.1534/g3.115.025692; Borneman AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004161; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Campbell-Sills H, 2015, GENOME BIOL EVOL, V7, P1506, DOI 10.1093/gbe/evv084; Cubillos FA, 2017, G3-GENES GENOM GENET, V7, P1693, DOI 10.1534/g3.117.042127; da Silva T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123834; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Delfini C., 1991, VITIC ENOL SCI, V46, P142; du Toit W. J., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P76; Dufour M, 2013, APPL MICROBIOL BIOT, V97, P5893, DOI 10.1007/s00253-013-4739-7; Fornairon-Bonnefond C, 2003, J BIOSCI BIOENG, V95, P496, DOI 10.1016/S1389-1723(03)80051-8; Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020; Garcia-Rios E, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3572-2; GARDNER N, 1993, APPL ENVIRON MICROB, V59, P2022, DOI 10.1128/AEM.59.7.2022-2028.1993; Gibbons JG, 2015, CURR OPIN GENET DEV, V35, P1, DOI 10.1016/j.gde.2015.07.003; Huang C, 2014, APPL MICROBIOL BIOT, V98, P7125, DOI 10.1007/s00253-014-5789-1; Husnik JI, 2007, AM J ENOL VITICULT, V58, P42; Julien A, 2000, AM J ENOL VITICULT, V51, P215; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Malcorps P, 1991, J AM SOC BREWING CHE; Marsit S, 2015, MOL BIOL EVOL; Marsit S, 2017, NAT REV GENET; Marti-Raga M, 2016, FOOD MICROBIOL, V54, P106, DOI 10.1016/j.fm.2015.10.009; Marti-Raga M, 2017, G3-GENES GENOM GENET, V7, P399, DOI 10.1534/g3.116.037283; Marullo P, 2007, FEMS YEAST RES, V7, P1295, DOI 10.1111/j.1567-1364.2007.00281.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Nardi T, 2010, MICROBIOL-SGM, V156, P1686, DOI 10.1099/mic.0.036723-0; Noble J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0245-1; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; R Core Team, 2016, R FDN STAT COMP; Reddy LVA, 2011, FOOD BIOPROD PROCESS, V89, P487, DOI 10.1016/j.fbp.2010.11.007; Remize F, 2000, J APPL MICROBIOL, V88, P371, DOI 10.1046/j.1365-2672.2000.00964.x; Saayman M, 2006, BIOCH MALIC ACID MET; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; STITT M, 1989, METHOD ENZYMOL, V174, P518; Torrens J, 2008, INT J FOOD MICROBIOL, V124, P48, DOI 10.1016/j.ijfoodmicro.2008.02.023; Valero E, 2002, FOOD CHEM, V78, P57, DOI 10.1016/S0308-8146(01)00361-2; Varela C, 2012, FOOD CHEM, V135, P2863, DOI 10.1016/j.foodchem.2012.06.127; Volschenk H, 2003, CURR GENET, V43, P379, DOI 10.1007/s00294-003-0411-6; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2014, YEAST PHENOMICS LARG; Wilkening S, 2014, GENETICS, V196, P853, DOI 10.1534/genetics.113.160291; Zimmer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086298	62	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190094	10.1371/journal.pone.0190094	http://dx.doi.org/10.1371/journal.pone.0190094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351285	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300015
J	Toth, EN; Lohith, A; Mondal, M; Guo, J; Fukamizu, A; Pourmand, N				Toth, Eszter N.; Lohith, Akshar; Mondal, Manas; Guo, Jia; Fukamizu, Akiyoshi; Pourmand, Nader			Single-cell nanobiopsy reveals compartmentalization of mRNAs within neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL PROTEIN-SYNTHESIS; INTRAAXONAL TRANSLATION; TRANSCRIPTOME ANALYSIS; LOCAL TRANSLATION; LOCALIZATION; TRANSPORT; EXPRESSION; IDENTIFICATION; REPERTOIRE; MECHANISMS	In highly polarized cells such as neurons, compartmentalization of mRNA and of local protein synthesis enables remarkably fast, precise, and local responses to external stimuli. These responses are highly important for neuron growth cone guidance, synapse formation, and regeneration following injury. Because an altered spatial distribution of mRNA can result in mental retardation or neurodegenerative diseases, subcellular transcriptome analysis of neurons could be a useful tool for studying these conditions, but current techniques, such as in situ hybridization, bulk microarray, and RNA-Seq, impose tradeoffs between spatial resolution and multiplexing. To obtain a comprehensive analysis of the cell body versus neurite transcriptome from the same neuron, we have recently developed a label-free, single-cell nanobiopsy platform based on scanning ion conductance microscopy that uses electrowetting within a quartz nanopipette to extract cellular material from living cells with minimal disruption of the cellular membrane and milieu. In this study, we used this platform to collect samples from the cell bodies and neurites of human neurons and analyzed the mRNA pool with multiplex RNA sequencing. The minute volume of a nanobiopsy sample allowed us to extract samples from several locations in the same cell and to map the various mRNA species to specific subcellular locations. In addition to previously identified transcripts, we discovered new sets of mRNAs localizing to neurites, including nuclear genes such as Eomes and Hmgb3. In summary, our single-neuron nanobiopsy analysis provides opportunities to improve our understanding of intracellular mRNA transport and local protein composition in neuronal growth, connectivity, and function.	[Toth, Eszter N.; Fukamizu, Akiyoshi] Univ Tsukuba, Sch Integrat & Global Majors, PhD Program Human Biol, Ibaraki 3058577, Japan; [Toth, Eszter N.; Fukamizu, Akiyoshi] Univ Tsukuba, Dept Life & Environm Sci, Tsukuba Adv Res Alliance, Life Sci Ctr, Ibaraki 3058577, Japan; [Toth, Eszter N.; Lohith, Akshar; Pourmand, Nader] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Biomol Engn, 1156 High St, Santa Cruz, CA 95064 USA; [Mondal, Manas; Guo, Jia] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Mondal, Manas; Guo, Jia] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA	University of Tsukuba; University of Tsukuba; University of California System; University of California Santa Cruz; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Pourmand, N (corresponding author), Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Biomol Engn, 1156 High St, Santa Cruz, CA 95064 USA.	pourmand@soe.ucsc.edu		Pourmand, Nader/0000-0003-0251-9060; Lohith, Akshar/0000-0001-7523-5259; Guo, Jia/0000-0001-8036-5349; Toth, Eszter/0000-0002-4262-1695	National Institutes of Health [P01-35HG000205]; NINDS, National Institutes of Health [R21NS082927]; National Institutes of Health's Follow the Same Cell Prize; MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan [23116001, 23116004]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000205, P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health's Follow the Same Cell Prize(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant P01-35HG000205; NINDS, National Institutes of Health Grant R21NS082927; the National Institutes of Health's Follow the Same Cell Prize; and Grants-in-Aid for Scientific Research on Innovative Areas (23116001 and 23116004) from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Actis P, 2014, ACS NANO, V8, P546, DOI 10.1021/nn405097u; Ainsley JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5510; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Condeelis J, 2005, BIOL CELL, V97, P97; Cosker KE, 2013, J NEUROSCI, V33, P5195, DOI 10.1523/JNEUROSCI.3862-12.2013; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Crino P, 1998, P NATL ACAD SCI USA, V95, P2313, DOI 10.1073/pnas.95.5.2313; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Francis C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-883; Gomes C, 2014, DEV NEUROBIOL, V74, P218, DOI 10.1002/dneu.22123; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Katz ZB, 2016, ELIFE, V5, DOI 10.7554/eLife.10415; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Kratz A, 2014, GENOME RES, V24, P1396, DOI 10.1101/gr.164095.113; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Minis A, 2014, DEV NEUROBIOL, V74, P365, DOI 10.1002/dneu.22140; Moccia R, 2003, J NEUROSCI, V23, P9409; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; OKAZAKI T, 1995, NEUROBIOL AGING, V16, P883, DOI 10.1016/0197-4580(95)02001-2; Pfeiffer-Guglielmi B, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-70; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Radeva MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106733; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Weatheritt RJ, 2014, NAT STRUCT MOL BIOL, V21, P833, DOI 10.1038/nsmb.2876; Wehrens R, 2007, J STAT SOFTW, V21, P1; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Xiao L, 2015, ANAL METHODS-UK, V7, P7290, DOI 10.1039/c5ay00500k; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	67	23	24	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4940	4951		10.1074/jbc.M117.800763	http://dx.doi.org/10.1074/jbc.M117.800763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378846	hybrid, Green Published			2022-12-26	WOS:000428848300032
J	NavaneethaKrishnan, S; Rosales, JL; Lee, KY				NavaneethaKrishnan, Saranya; Rosales, Jesusa L.; Lee, Ki-Young			Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASE-5; OXIDATIVE STRESS; NEURONAL APOPTOSIS; REPERFUSION INJURY; DNA-DAMAGE; DRP1; PHOSPHORYLATION; FISSION; PROTEIN; FRAGMENTATION	Cdk5, which plays a role in the development and progression of many human cancers, localizes in the mitochondria, a key determinant of apoptotic cell death. Cdk5 is upregulated in breast cancer cells but it was shown that Cdk5 loss increases chemotherapy-induced apoptosis. However, the molecular mechanism by which Cdk5 loss promotes cell death remains unclear. Here, we investigate the possibility that Cdk5 loss activates the intrinsic apoptotic pathway in breast cancer cells. We demonstrate that Cdk5-deficient breast cancer cells exhibit increased mitochondrial depolarization, mitochondrial ROS levels, and mitochondrial fragmentation that is associated with an increase in both intracellular Ca2+ level and calcineurin activity, and DRP1 S637 dephosphorylation. These events accompany increased apoptosis, indicating that Cdk5 loss promotes mitochondria-mediated apoptosis. To define this apoptotic pathway, we utilized various inhibitors of mitochondrial function. Apoptosis is completely prevented by mPTP inhibition, almost fully inhibited by blocking ROS and unaffected by inhibition of mitochondrial fission, suggesting that apoptosis in breast cancer cells due to Cdk5 loss occurs via a novel mPTP-dependent mechanism that acts primarily through ROS increase.	[NavaneethaKrishnan, Saranya; Lee, Ki-Young] Univ Calgary, Arnie Charbonneau Canc Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Rosales, Jesusa L.] Univ Calgary, Snyder Inst Chron Dis, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary	Lee, KY (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Dept Cell Biol & Anat, Calgary, AB, Canada.	kylee@ucalgary.ca		Rosales, Jesusa/0000-0002-2543-3801	CIHR [MOP-123400]; NSERC [RGPIN/312985-2011]; Alberta Cancer Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Foundation	We thank Novartis Pharma AG and Dr. BC Lee for providing SfA and HeLa mitoDSRed2 cells, respectively. We also thank Drs. Timothy Shutt, Karl Riabowol, Susan Lees-Miller, and Derek McKay for their critical reviews of the manuscript. This work was supported in part by grants from the CIHR (MOP-123400) and NSERC (RGPIN/312985-2011) to K-YL and an Alberta Cancer Foundation graduate studentship to SN.	Abdullah C, 2011, CELL CYCLE, V10, P977, DOI 10.4161/cc.10.6.15079; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bolin C, 2012, CELL MOL LIFE SCI, V69, P951, DOI 10.1007/s00018-011-0811-6; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cho B, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.36; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elwi AN, 2012, INT J BIOCHEM CELL B, V44, P1366, DOI 10.1016/j.biocel.2012.05.004; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Halestrap AP, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00234; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hirsch T, 1997, BIOSCIENCE REP, V17, P67, DOI 10.1023/A:1027339418683; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jahani-Asl A, 2015, HUM MOL GENET, V24, P4573, DOI 10.1093/hmg/ddv188; Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; Levacque Z, 2012, CELL CYCLE, V11, P4093, DOI 10.4161/cc.21886; Liang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02932; Liu JL, 2011, MED ONCOL, V28, P673, DOI 10.1007/s12032-010-9510-7; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rosdah AA, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.235; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Sun KH, 2008, J NEUROCHEM, V107, P265, DOI 10.1111/j.1471-4159.2008.05616.x; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Turner C, 2003, CELL DEATH DIFFER, V10, P302, DOI 10.1038/sj.cdd.4401170; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0019879; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Weishaupt JH, 2003, MOL CELL NEUROSCI, V24, P489, DOI 10.1016/S1044-7431(03)00221-5; Wesierska-Gadek J, 2005, MOL CANCER THER, V4, P113; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Zhang SY, 2015, 2015 IEEE WORKSHOP ON ENVIRONMENTAL, ENERGY AND STRUCTURAL MONITORING SYSTEMS (EESMS), P1, DOI [10.1109/EESMS.2015.7175842, 10.1109/INTMAG.2015.7156970]; Zhu YX, 2011, BLOOD, V117, P3847, DOI 10.1182/blood-2010-08-304022	57	39	40	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1788	1804		10.1038/s41388-017-0103-1	http://dx.doi.org/10.1038/s41388-017-0103-1			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29348461	hybrid, Green Published			2022-12-26	WOS:000428632600008
J	Long, BB; Ye, BH; Liu, QL; Zhang, S; Ye, J; Zou, LN; Shi, JY				Long, Bibo; Ye, Binhui; Liu, Qinglin; Zhang, Shu; Ye, Jien; Zou, Lina; Shi, Jiyan			Characterization of Penicillium oxalicum SL2 isolated from indoor air and its application to the removal of hexavalent chromium	PLOS ONE			English	Article							CR(VI) REDUCTION; CONTAMINATED SOIL; BACTERIAL-GROWTH; CARBON NANOCOMPOSITES; RESISTANT-BACTERIA; ETHYL CELLULOSE; HEAVY-METALS; IN-VITRO; CHROMATE; BIOREMEDIATION	Removal of toxic Cr(VI) by microbial reduction is a promising approach to reducing its ecotoxicological impact. To develop bioremediation technologies, many studies have evaluated the application of microorganisms isolated from Cr(VI)-contaminated sites. Nonetheless, little attention has been given to microbes from the environments without a history of Cr(VI) contamination. In this study, we aimed to characterize the Cr(VI) tolerance and removal abilities of a filamentous fungus strain, SL2, isolated from indoor air. Based on phenotypic characterization and rDNA sequence analysis, SL2 was identified as Penicillium oxalicum, a species that has not been extensively studied regarding Cr(VI) tolerance and reduction abilities. SL2 showed high tolerance to Cr(VI) on solid and in liquid media, facilitating its application to Cr(VI)-contaminated environments. Growth curves of SL2 in the presence of 0,100, 400, or 1000 mg/L Cr(VI) were well simulated by the modified Gompertz model. The relative maximal colony diameter and maximal growth rate decreased as Cr(VI) concentration increased, while the lag time increased. SL2 manifested remarkable efficacy of removing Cr(VI). Mass balance analysis indicated that SL2 removed Cr(VI) by reduction, and incorporated 0.79 mg of Cr per gram of dry biomass. In electroplating wastewater, the initial rate of Cr(VI) removal was affected by the initial contaminant concentration. In conclusion, P. oxalicum SL2 represents a promising new candidate for Cr(VI) removal. Our results significantly expand the knowledge on potential application of this microorganism.	[Long, Bibo; Ye, Binhui; Liu, Qinglin; Zhang, Shu; Ye, Jien; Zou, Lina; Shi, Jiyan] Zhejiang Univ, Dept Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Shi, Jiyan] Key Lab Water Pollut Control & Environm Safety, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Shi, JY (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou, Zhejiang, Peoples R China.; Shi, JY (corresponding author), Key Lab Water Pollut Control & Environm Safety, Hangzhou, Zhejiang, Peoples R China.	shijiyan@zju.edu.cn	liu, qingqing/HHD-0360-2022; Liu, Qing/GWC-9222-2022	Shi, Jiyan/0000-0002-1601-8657	National Natural Science Foundation of China [U1532103, 41422107]; National Key Research and Development Program of China [2016YFD0800401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Natural Science Foundation of China (U1532103, 41422107), National Key Research and Development Program of China (2016YFD0800401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Aguilar FJ, 2006, CAN J MICROBIOL, V52, P809, DOI 10.1139/W06-037; Anahid S, 2011, SCI IRAN, V18, P502, DOI 10.1016/j.scient.2011.05.015; Arevalo-Rangel DL, 2013, BIOINORG CHEM APPL, V2013, DOI 10.1155/2013/909412; Badar U, 2000, BIOTECHNOL LETT, V22, P829, DOI 10.1023/A:1005649113190; Cardenas-Gonzalez JF, 2010, BIOINORG CHEM APPL, V2010, DOI 10.1155/2010/676243; Chatterjee T, 2015, BBA-GEN SUBJECTS, V1850, P299, DOI 10.1016/j.bbagen.2014.10.022; Chen HY, 2015, SCI TOTAL ENVIRON, V512, P143, DOI 10.1016/j.scitotenv.2015.01.025; Chen XC, 2009, BIORESOURCE TECHNOL, V100, P330, DOI 10.1016/j.biortech.2008.04.051; Cheng H.G., 2014, PLOS ONE, V9; Cheng YJ, 2012, ELEMENTS, V8, P107, DOI 10.2113/gselements.8.2.107; Cheng YJ, 2010, ENVIRON SCI TECHNOL, V44, P6357, DOI 10.1021/es100198v; Chirwa EN, 2000, WATER RES, V34, P2376, DOI 10.1016/S0043-1354(99)00363-2; Coreno-Alonso A, 2014, BIORESOURCE TECHNOL, V158, P188, DOI 10.1016/j.biortech.2014.02.036; Coreno-Alonso A, 2009, CHEMOSPHERE, V76, P43, DOI 10.1016/j.chemosphere.2009.02.031; Deng XH, 2013, J HAZARD MATER, V248, P107, DOI 10.1016/j.jhazmat.2012.12.051; Dhal B, 2013, J HAZARD MATER, V250, P272, DOI 10.1016/j.jhazmat.2013.01.048; Guemiza K, 2017, J HAZARD MATER, V333, P194, DOI 10.1016/j.jhazmat.2017.03.021; Hu Q, 2017, ACS SUSTAINABLE CHEM; Hu SQ, 2016, ENVIRON SCI POLLUT R, V23, P15227, DOI 10.1007/s11356-016-6701-6; Huang JN, 2017, IND ENG CHEM RES, V56, P10689, DOI 10.1021/acs.iecr.7b02835; Karthik C, 2017, J HAZARD MATER, V333, P42, DOI 10.1016/j.jhazmat.2017.03.037; Kilic NK, 2010, BIORESOURCE TECHNOL, V101, P2134, DOI 10.1016/j.biortech.2009.11.008; Leitao AL, 2009, INT J ENV RES PUB HE, V6, P1393, DOI 10.3390/ijerph6041393; Li XZ, 2017, J HAZARD MATER, V330, P1, DOI 10.1016/j.jhazmat.2017.01.047; Liu HY, 2017, BIORESOURCE TECHNOL, V232, P344, DOI 10.1016/j.biortech.2017.02.064; Long DY, 2013, J MICROBIOL BIOTECHN, V23, P1123, DOI 10.4014/jmb.1301.01004; Long DY, 2013, J HAZARD MATER, V256, P24, DOI 10.1016/j.jhazmat.2013.04.020; Ma Y, 2017, POLYMER; Mabrouk MEM, 2014, BIOTECHNOL BIOTEC EQ, V28, P659, DOI 10.1080/13102818.2014.937092; Malaviya P, 2014, CRIT REV MICROBIOL, P1; Malaviya P, 2016, CRIT REV MICROBIOL, V42, P607, DOI 10.3109/1040841X.2014.974501; Gutierrez AM, 2010, INT J PHYTOREMEDIAT, V12, P317, DOI 10.1080/15226510902968118; McClain CN, 2016, CHEM GEOL, V426, P135, DOI 10.1016/j.chemgeo.2016.01.021; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Munoz AHS, 2005, BIOL TRACE ELEM RES, V106, P265, DOI 10.1385/BTER:106:3:265; Narayani M, 2013, CRIT REV ENV SCI TEC, V43, P955, DOI 10.1080/10643389.2011.627022; Nowicka AM, 2013, J PHYS CHEM B, V117, P1021, DOI 10.1021/jp3109094; Pechova A, 2007, VET MED-CZECH, V52, P1, DOI 10.17221/2010-VETMED; Pei QH, 2009, WORLD J MICROB BIOT, V25, P1085, DOI 10.1007/s11274-009-9989-2; Poljsak B, 2010, J BASIC MICROB, V50, P21, DOI 10.1002/jobm.200900170; Qiu B, 2015, J MATER CHEM A, V3, P9817, DOI 10.1039/c5ta01227a; Qiu B, 2014, ACS APPL MATER INTER, V6, P19816, DOI 10.1021/am505170j; Qiu B, 2014, J MATER CHEM A, V2, P17454, DOI 10.1039/c4ta04040f; Qiu B, 2014, ACS SUSTAIN CHEM ENG, V2, P2070, DOI 10.1021/sc5003209; Qiu B, 2014, RSC ADV, V4, P29855, DOI 10.1039/c4ra01700e; ROMANENKO V I, 1977, Mikrobiologiya, V46, P414; Samuel J, 2013, BIODEGRADATION, V24, P829, DOI 10.1007/s10532-013-9631-8; Sarangi A, 2008, BIORESOURCE TECHNOL, V99, P4130, DOI 10.1016/j.biortech.2007.08.059; Shoaib M, 2014, J HYDROL, V515, P47, DOI 10.1016/j.jhydrol.2014.04.055; Sun XF, 2009, J COLLOID INTERF SCI, V335, P11, DOI 10.1016/j.jcis.2009.03.088; URONE PF, 1955, ANAL CHEM, V27, P1354, DOI 10.1021/ac60104a048; Varadharajan C, 2017, ENVIRON SCI TECHNOL, V51, P4918, DOI 10.1021/acs.est.6b06044; Wang CF, 2017, POLYMER, V131, P263, DOI 10.1016/j.polymer.2017.10.049; Wise SS, 2016, TOXICOL APPL PHARM, V296, P54, DOI 10.1016/j.taap.2016.02.015; Wise SS, 2016, AQUAT TOXICOL, V171, P30, DOI 10.1016/j.aquatox.2015.12.004; Wu SL, 2016, J HAZARD MATER, V316, P34, DOI 10.1016/j.jhazmat.2016.05.017; Xu WH, 2009, T NONFERR METAL SOC, V19, P1336, DOI 10.1016/S1003-6326(08)60446-X; Yang LQ, 2016, TOXICOL LETT, V243, P1, DOI 10.1016/j.toxlet.2015.11.031; Yu G, 2017, ADV COMPOSITES HYBRI; Zakaria ZA, 2007, J HAZARD MATER, V146, P30, DOI 10.1016/j.jhazmat.2006.11.052; Zhang L, 2017, J ELECTROCHEM SOC, V164, pH651, DOI 10.1149/2.1531709jes; Zhong L, 2017, WATER RES, V115, P130, DOI 10.1016/j.watres.2017.03.003; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	63	15	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191484	10.1371/journal.pone.0191484	http://dx.doi.org/10.1371/journal.pone.0191484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381723	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800022
J	Tobolowsky, FA; Wada, N; Martinez-Maza, O; Magpantay, L; Koletar, SL; Palella, FJ; Brown, TT; Lake, JE				Tobolowsky, F. A.; Wada, N.; Martinez-Maza, O.; Magpantay, L.; Koletar, S. L.; Palella, F. J., Jr.; Brown, T. T.; Lake, J. E.			Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COLLAGEN DEPOSITION; PLATELET ACTIVATION; HYALURONIC-ACID; LIVER; AIDS; PREDICTORS; MECHANISMS; MORTALITY; COHORT	Introduction Lymphoid tissue fibrosis may contribute to incomplete immune reconstitution on antiretroviral therapy (ART) via local CD4(+) T lymphocyte (CD4) depletion. Hyaluronic acid (HA) increases with fibrotic burden. CXCL4 concentrations increase in response to pro-fibrotic stimuli, but lower CXCL4 concentrations in HIV-infected individuals may reflect successful immune evasion by HIV. We investigated relationships between circulating HA and CXCL4 concentrations and immune reconstitution on ART in HIV-infected Multicenter AIDS Cohort Study participants. Methods HIV-infected men on ART for >1 year with cryopreserved plasma samples and suppressed post-ART HIV-1 RNA were included. Men with post-ART CD4 <200 cells/mm(3) were defined as immunologic non-responders (n = 25). Age-/race-matched men with post-ART CD4 >500 cells/mm(3) served as controls (n = 49). HA and CXCL4 concentrations were measured via ELISA. Results Median pre-ART CD4 was 297 cells/mm(3) for non-responders vs 386 cells/mm(3) for controls. Median post-ART CD4 was 141 cells/mm(3) for non-responders and 815 cells/mm(3) for controls. HIV infection duration was 23 years, with median time on ART 13 years for non-responders vs 11 years for controls. Pre-ART HA and CXCL4 concentrations did not vary by eventual immune reconstitution status. Post-ART HA concentrations tended to be higher (85 vs 36 ng/mL, p = 0.07) and CXCL4 concentrations were lower (563 vs 1459 ng/mL, p = 0.01) among non-responders. Among men with paired pre-/post-ART samples, non-responders had greater HA increases and CXCL4 decreases than controls (HA: 50 vs 12 ng/mL, p = 0.04; CXCL4: -1258 vs -405 ng/mL, p = 0.01). Conclusions Higher circulating concentrations of HA and lower concentrations of CXCL4 are associated with failure of immune reconstitution on ART.	[Tobolowsky, F. A.] Univ Colorado, Div Infect Dis, Dept Internal Med, Denver, CO 80202 USA; [Tobolowsky, F. A.; Lake, J. E.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA; [Wada, N.] Johns Hopkins Univ, Div Gen Epidemiol & Methodol, Dept Epidemiol, Baltimore, MD USA; [Martinez-Maza, O.; Magpantay, L.] Univ Calif Los Angeles, Dept Obstet & Gynecol, Epidemiol Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Koletar, S. L.] Ohio State Univ, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA; [Palella, F. J., Jr.] Northwestern Univ, Dept Internal Med, Div Infect Dis, Chicago, IL 60611 USA; [Brown, T. T.] Johns Hopkins Univ, Dept Internal Med, Div Endocrinol, Baltimore, MD USA; [Lake, J. E.] Univ Calif Los Angeles, Dept Internal Med, Div Infect Dis, Los Angeles, CA USA	University of Colorado System; University of Colorado Denver; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University; Northwestern University; Johns Hopkins University; University of California System; University of California Los Angeles	Tobolowsky, FA (corresponding author), Univ Colorado, Div Infect Dis, Dept Internal Med, Denver, CO 80202 USA.; Tobolowsky, FA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA.	farrell.tobolowsky@ucdenver.edu	Martinez-Maza, Otoniel/B-2667-2009	Martinez-Maza, Otoniel/0000-0003-1364-0675	UCLA AIDS Institute [NIH [K23 AI110532-01A1, R01 AI093520-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI035039, K23AI110532] Funding Source: NIH RePORTER	UCLA AIDS Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The sponsor is the UCLA AIDS Institute, and the grant numbers are the following: NIH [K23 AI110532-01A1 (Lake), R01 AI093520-01A1 (Brown). There are no URLs for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmuth DM, 2015, AIDS, V29, P877, DOI 10.1097/QAD.0000000000000636; Auerbach DJ, 2012, P NATL ACAD SCI USA, V109, P9569, DOI 10.1073/pnas.1207314109; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Baselga J, 2008, BIOMARKERS, V13, P217, DOI [10.1080/13547500701676019, 10.1080/13547500701676019 ]; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Griesbeck M, 2016, CLIN SCI, V130, P1435, DOI 10.1042/CS20160112; Guo L., 2017, MUCOSAL IMMUNOLOGY; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Hsue P. Y., 2016, INFLAMMATION FIBROSI; Jeon JH, 2001, CYTOKINE, V16, P102, DOI 10.1006/cyto.2001.0895; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KATZ IR, 1992, INT IMMUNOL, V4, P183, DOI 10.1093/intimm/4.2.183; Li F, 2012, BRAZ J INFECT DIS, V16, P9, DOI 10.1016/S1413-8670(12)70267-2; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; Montoya JL, 2017, JAIDS-J ACQ IMM DEF, V74, P134, DOI 10.1097/QAI.0000000000001230; Papanastasopoulou C, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22010; Park SH, 2011, CLIN BIOCHEM, V44, P1396, DOI 10.1016/j.clinbiochem.2011.08.1151; Plaeger SF, 2012, AIDS RES HUM RETROV, V28, P469, DOI [10.1089/aid.2011.0213, 10.1089/AID.2011.0213]; Sanchez JL, 2015, J INFECT DIS, V211, P1068, DOI 10.1093/infdis/jiu586; Schwarz KB, 2003, J PEDIATR GASTR NUTR, V37, P187, DOI 10.1097/00005176-200308000-00019; Seven G, 2011, TURK J GASTROENTEROL, V22, P305, DOI 10.4318/tjg.2011.0217; Tsegaye TS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-48; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191606	10.1371/journal.pone.0191606	http://dx.doi.org/10.1371/journal.pone.0191606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381717	gold, Green Submitted, Green Published			2022-12-26	WOS:000423617800026
J	Ciesinski, L; Guenther, S; Pieper, R; Kalisch, M; Bednorz, C; Wieler, LH				Ciesinski, Lisa; Guenther, Sebastian; Pieper, Robert; Kalisch, Martin; Bednorz, Carmen; Wieler, Lothar H.			High dietary zinc feeding promotes persistence of multi-resistant E. coli in the swine gut	PLOS ONE			English	Article							FED PHARMACOLOGICAL LEVELS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; GROWTH-PERFORMANCE; WEANLING PIGS; CARBAPENEM RESISTANCE; OXIDE; PIGLETS; COPPER	High levels of zinc oxide are used frequently as feed additive in pigs to improve gut health and growth performance and are still suggested as an alternative to antimicrobial growth promoters. However, we have recently described an increase of multi-resistant E. coli in association to zinc feeding in piglets. This previous study focused on clonal diversity of E. coli, observing the effect on multi-resistant strains by chance. To shed further light into this highly important topic and falsify our previous findings, we performed a zinc pig feeding trial where we specifically focused on in-depth analysis of antimicrobial resistant E. coli. Under controlled experimental conditions, piglets were randomly allocated to a high dietary zinc (zinc group) and a background zinc feeding group (control group). At different ages samples were taken from feces, digesta, and mucosa and absolute E. coli numbers were determined. A total of 2665 E. coli isolates were than phenotypically tested for antimicrobial resistance and results were confirmed by minimum inhibitory concentration testing for random samples. In piglets fed with high dietary zinc, we detected a substantial increase of multi-resistant E. coli in all gut habitats tested, ranging from 28.9-30.2% multi-resistant E. coli compared to 5.8-14.0% in the control group. This increase was independent of the total number of E. coli. Interestingly, the total amount of the E. coli population decreased over time. Thus, the increase of the multi-resistant E. coli populations seems to be linked with persistence of the resistant population, caused by the influence of high dietary zinc feeding. In conclusion, these findings corroborate our previous report linking high dietary zinc feeding of piglets with the occurrence of antimicrobial resistant E. coli and therefore question the feeding of high dietary zinc oxide as alternative to antimicrobial growth promoters.	[Ciesinski, Lisa; Guenther, Sebastian; Kalisch, Martin; Bednorz, Carmen; Wieler, Lothar H.] Free Univ Berlin, Inst Microbiol & Epizoot, Dept Vet Med, Ctr Infect Med, Berlin, Germany; [Pieper, Robert] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Berlin, Germany; [Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Guenther, Sebastian] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Pharmaceut Biol, Greifswald, Germany; [Bednorz, Carmen] Ludwig Maximilians Univ Munchen, Fac Vet Med, Inst Physiol Chem, Munich, Germany	Free University of Berlin; Free University of Berlin; Robert Koch Institute; Ernst Moritz Arndt Universitat Greifswald; University of Munich	Ciesinski, L (corresponding author), Free Univ Berlin, Inst Microbiol & Epizoot, Dept Vet Med, Ctr Infect Med, Berlin, Germany.	Lisa.Rabes@fu-berlin.de	; Guenther, Sebastian/O-5005-2014	Wieler, Lothar H./0000-0003-4365-3717; Pieper, Robert/0000-0002-0292-1482; Guenther, Sebastian/0000-0003-0173-7314	Research Training Group 1121 - German Research Foundation [GRK1121]; German Research Foundation [SFB 852, SFB852/2, SFB852/1]; German Research Foundation (DFG-Grant) [GU 1283/3-1]; Open Access Publication Fund of the Freie Universitat Berlin	Research Training Group 1121 - German Research Foundation; German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG-Grant)(German Research Foundation (DFG)); Open Access Publication Fund of the Freie Universitat Berlin	This work and LC were supported by the Research Training Group 1121 (GRK1121), funded by the German Research Foundation (http://www.dfg.de/en/). The animal feeding trial was financed and CB was supported by the Collaborative Research Center SFB 852 (grant SFB852/2 and SFB852/1, respectively), also funded by the German Research Foundation. SG was supported by a grant of the German Research Foundation (DFG-Grant GU 1283/3-1). We acknowledge support by the Open Access Publication Fund of the Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezcua R, 2008, CAN VET J, V49, P39; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Becerra-Castro C, 2015, SCI TOTAL ENVIRON, V530, P367, DOI 10.1016/j.scitotenv.2015.05.102; Bednorz C, 2013, APPL ENVIRON MICROB, V79, P7896, DOI 10.1128/AEM.03138-13; Bednorz C, 2013, INT J MED MICROBIOL, V303, P396, DOI 10.1016/j.ijmm.2013.06.004; Bengtsson B, 2006, ANIM BIOTECHNOL, V17, P147, DOI 10.1080/10495390600956920; Bondzio Angelika, 2013, PLoS One, V8, pe81202, DOI 10.1371/journal.pone.0081202; Boudry C, 2008, ANIMAL, V2, P730, DOI 10.1017/S175173110800164X; Calistri P, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12145; Case CL, 2002, J ANIM SCI, V80, P1917; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Clinical and Laboratory Standards Institute formerly NCCLS, 2002, M31A2 NCCLS; Clinical Laboratory Standards Institute, 2013, M100S23 CLSI; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Ewers C, 2014, J ANTIMICROB CHEMOTH, V69, P1224, DOI 10.1093/jac/dkt516; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Federation of Veterinarians of Europe, 2014, FVE POS PAP US ZINC; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; HAHN JD, 1993, J ANIM SCI, V71, P3020, DOI 10.2527/1993.71113020x; Han YK, 2010, ASIAN AUSTRAL J ANIM, V23, P1057, DOI 10.5713/ajas.2010.90569; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hill GM, 2000, J ANIM SCI, V78, P1010; Holzel CS, 2012, ENVIRON RES, V113, P21, DOI 10.1016/j.envres.2012.01.002; Hollis GR, 2005, J ANIM SCI, V83, P2123; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Karweina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143098; Lalles JP, 2009, ANIMAL, V3, P1625, DOI 10.1017/S175173110900398X; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Liu P, 2014, J ANIM SCI, V92, P5009, DOI 10.2527/jas.2013-6690; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091091; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marguerettaz M, 2014, MICROB PATHOGENESIS, V77, P36, DOI 10.1016/j.micpath.2014.10.011; Mathew AG, 1997, J ANIM SCI, V75, P1009; Mathew AG, 1998, J ANIM SCI, V76, P2138; McNally A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006280; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; OU JT, 1972, J BACTERIOL, V11, P177, DOI 10.1128/JB.111.1.177-185.1972; OU JT, 1973, J BACTERIOL, V115, P648, DOI 10.1128/JB.115.2.648-654.1973; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Perron K, 2004, J BIOL CHEM, V279, P8761, DOI 10.1074/jbc.M312080200; Pettigrew JE, 2006, ANIM BIOTECHNOL, V17, P207, DOI 10.1080/10495390600956946; Pieper R., 2006, Archiva Zootechnica, V9, P28; Pieper R, 2008, MICROB ECOL, V56, P474, DOI 10.1007/s00248-008-9366-y; Schaufler K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00336; Schell TC, 1996, J ANIM SCI, V74, P1584; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; Shelton NW, 2011, J ANIM SCI, V89, P2440, DOI 10.2527/jas.2010-3432; Shelton NW, 2009, EFFECTS COPPER SULFA; Slifierz MJ, 2015, ZOONOSES PUBLIC HLTH, V62, P301, DOI 10.1111/zph.12150; Sprent P., 1989, APPL NONPARAMETRIC S; Starke IC, 2014, FEMS MICROBIOL ECOL, V87, P416, DOI 10.1111/1574-6941.12233; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vogwill T, 2015, EVOL APPL, V8, P284, DOI 10.1111/eva.12202; Walk CL, 2013, J ANIM SCI, V91, P286, DOI 10.2527/jas.2012-5430; Woodworth JC, 2005, J ANIMAL VET ADV, V4, P688; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Yazdankhah S, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.25862; Zetzsche A, 2016, J TRACE ELEM MED BIO, V35, P1, DOI 10.1016/j.jtemb.2016.01.006	71	45	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191660	10.1371/journal.pone.0191660	http://dx.doi.org/10.1371/journal.pone.0191660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373597	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400018
J	Friedman, LE; Gilmore, TD; Finnerty, JR				Friedman, Lauren E.; Gilmore, Thomas D.; Finnerty, John R.			Intraspecific variation in oxidative stress tolerance in a model cnidarian: Differences in peroxide sensitivity between and within populations of Nematostella vectensis	PLOS ONE			English	Article							STARLET SEA-ANEMONE; CENTRAL ATLANTIC-OCEAN; HYDROGEN-PEROXIDE; PHOTOCHEMICAL FORMATION; ELEVATED-TEMPERATURES; ANTIOXIDANT; POLYCHAETA; EXPOSURE; WATERS; EMBRYOGENESIS	Nematostella vectensis is a member of the phylum Cnidaria, a lineage that includes anemones, corals, hydras, and jellyfishes. This estuarine anemone is an excellent model system for investigating the evolution of stress tolerance because it is easy to collect in its natural habitat and to culture in the laboratory, and it has a sequenced genome. Additionally, there is evidence of local adaptation to environmental stress in different N. vectensis populations, and abundant protein-coding polymorphisms have been identified, including polymorphisms in proteins that are implicated in stress responses. N. vectensis can tolerate a wide range of environmental parameters, and has recently been shown to have substantial intraspecific variation in temperature preference. We investigated whether different clonal lines of anemones also exhibit differential tolerance to oxidative stress. N. vectensis populations are continually exposed to reactive oxygen species (ROS) generated during cellular metabolism and by other environmental factors. Fifteen clonal lines of N. vectensis collected from four different estuaries were exposed to hydrogen peroxide. Pronounced differences in survival and regeneration were apparent between clonal lines collected from Meadowlands, NJ, Baruch, SC, and Kingsport, NS, as well as among 12 clonal lines collected from a single Cape Cod marsh. To our knowledge, this is the first example of intraspecific variability in oxidative stress resistance in cnidarians or in any marine animal. As oxidative stress often accompanies heat stress in marine organisms, resistance to oxidative stress could strongly influence survival in warming oceans. For example, while elevated temperatures trigger bleaching in corals, oxidative stress is thought to be the proximal trigger of bleaching at the cellular level.	[Friedman, Lauren E.; Gilmore, Thomas D.; Finnerty, John R.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Friedman, Lauren E.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Finnerty, JR (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	jrf3@bu.edu		Finnerty, John/0000-0001-8576-6774	National Science Foundation [MCB-0920461, IOS-1354935]; Division Of Integrative Organismal Systems [1354935] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported National Science Foundation MCB-0920461 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=0924749&HistoricalAwards=false) and National Science Foundation IOS-1354935 (https://www. nst.gov/awardsearch/showAward?AWD_ID=13549358,HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 1999, ANTARCT SCI, V11, P131, DOI 10.1017/S095410209900019X; Abele D, 1998, MAR ECOL PROG SER, V163, P179, DOI 10.3354/meps163179; Abele D, 1998, COMP BIOCHEM PHYS B, V120, P425, DOI 10.1016/S0305-0491(98)10028-7; Abele-Oeschger D, 1997, LIMNOL OCEANOGR, V42, P1406, DOI 10.4319/lo.1997.42.6.1406; Abele-Oeschger D., 1995, VERH DTSCH ZOOL GES, V88, P93; ABELEOESCHGER D, 1994, MAR ECOL PROG SER, V106, P101, DOI 10.3354/meps106101; AbeleOeschger D, 1997, COMP BIOCHEM PHYS C, V117, P123, DOI 10.1016/S0742-8413(97)00059-5; Ambrosone A, 2014, NANOTOXICOLOGY, V8, P508, DOI 10.3109/17435390.2013.802386; Borell EM, 2014, ECOL EVOL, V4, P441, DOI 10.1002/ece3.946; Botman Daniel, 2012, BMC Res Notes, V5, P555, DOI 10.1186/1756-0500-5-555; Buchner T, 2001, COMP BIOCHEM PHYS B, V129, P109, DOI 10.1016/S1096-4959(01)00311-6; COOPER WJ, 1987, J GEOPHYS RES-OCEANS, V92, P2970, DOI 10.1029/JC092iC03p02970; COOPER WJ, 1989, ENVIRON SCI TECHNOL, V23, P1425, DOI 10.1021/es00069a017; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; da Rosa CE, 2008, BRAZ J MED BIOL RES, V41, P117; da Rosa CE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P641, DOI 10.1086/430229; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; Darling JA, 2004, MOL ECOL, V13, P2969, DOI 10.1111/j.1365-294X.2004.02313.x; Darling JA, 2006, MOL ECOL NOTES, V6, P803, DOI 10.1111/j.1471-8286.2006.01350.x; DEWIT R, 1989, NETH J SEA RES, V23, P271, DOI 10.1016/0077-7579(89)90048-3; Dowd WW, 2015, J EXP BIOL, V218, P1956, DOI 10.1242/jeb.114926; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Dubuc TQ, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0044-2; Fischer AHL, 2013, INTEGR COMP BIOL, V53, P832, DOI 10.1093/icb/ict091; Freire CA, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P41; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Genikhovich G., 2009, COLD SPRING HARB PRO, V2009, P5282, DOI DOI 10.1101/PDB.PR0T5282; Genikhovich G., 2009, COLD SPRING HARB PRO, V2009, pt5281; Hakkinen PJ, 2004, CAN J FISH AQUAT SCI, V61, P1520, DOI 10.1139/F04-098; HAND C, 1994, ESTUARIES, V17, P501, DOI 10.2307/1352679; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Higuchi T., 2009, P 11 INT COR REEF S, P926; Higuchi T, 2012, P 12 INT COR REEF S, p4C_3; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Jimenez AG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2273; Koenigstein S, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-21; Layden MJ, 2013, NAT PROTOC, V8, P924, DOI 10.1038/nprot.2013.009; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Linan-Cabello MA, 2010, MAR ECOL-EVOL PERSP, V31, P407, DOI 10.1111/j.1439-0485.2009.00349.x; Madeira D, 2013, COMP BIOCHEM PHYS A, V166, P237, DOI 10.1016/j.cbpa.2013.06.008; MILLER WL, 1994, MAR CHEM, V48, P17, DOI 10.1016/0304-4203(94)90059-0; MOORE CA, 1993, J GEOPHYS RES-OCEANS, V98, P2289, DOI 10.1029/92JC02767; MORSE DE, 1977, SCIENCE, V196, P298, DOI 10.1126/science.403609; Nesa B, 2008, 11 INT COR REEF S FT; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2013, MOL ECOL, V22, P2953, DOI 10.1111/mec.12228; Reitzel AM, 2008, BIOL INVASIONS, V10, P1197, DOI 10.1007/s10530-007-9196-8; Reitzel AM, 2007, INVERTEBR BIOL, V126, P99, DOI 10.1111/j.1744-7410.2007.00081.x; Reitzel AM, 2013, MAR ECOL PROG SER, V484, P115, DOI 10.3354/meps10281; Reitzel AM, 2010, ESTUAR COAST, V33, P930, DOI 10.1007/s12237-009-9231-3; Reynolds RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058212; Ross C, 2007, J PHYCOL, V43, P466, DOI 10.1111/j.1529-8817.2007.00346.x; SAKUGAWA H, 1990, ENVIRON SCI TECHNOL, V24, P1452, DOI 10.1021/es00080a002; Stefanik DJ, 2013, NAT PROTOC, V8, P916, DOI 10.1038/nprot.2013.044; Stefanik DJ, 2013, NAT PROTOC, V8, P892, DOI 10.1038/nprot.2012.151; Storch D, 2001, COMP BIOCHEM PHYS C, V128, P391, DOI 10.1016/S1532-0456(00)00209-X; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Sullivan JC, 2008, BIOINFORMATIC AND MO; Tulin S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-16; Vione D, 2003, ANN CHIM-ROME, V93, P477; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Yuan JC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000908; Yuan JC, 2000, ATMOS ENVIRON, V34, P3973, DOI 10.1016/S1352-2310(00)00167-9; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; ZIKA RG, 1985, GEOCHIM COSMOCHIM AC, V49, P1173, DOI 10.1016/0016-7037(85)90008-0	67	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0188265	10.1371/journal.pone.0188265	http://dx.doi.org/10.1371/journal.pone.0188265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373572	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400001
J	Umebashi, K; Tokito, A; Yamamoto, M; Jougasaki, M				Umebashi, Katsuyuki; Tokito, Akinori; Yamamoto, Masayoshi; Jougasaki, Michihisa			Interleukin-33 induces interleukin-8 expression via JNK/c-Jun/AP-1 pathway in human umbilical vein endothelial cells	PLOS ONE			English	Article							N-TERMINAL KINASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY CYTOKINE PRODUCTION; GENE-EXPRESSION; IL-33; ST2; ADHESION; DISEASE; ATHEROSCLEROSIS; PROLIFERATION	Interleukin (IL)-33 is a member of the IL-1 cytokine family with dual functions as a traditional cytokine and as a transcriptional regulator. We recently reported that IL-33 up-regulated growth regulated oncogene (GRO)-alpha/CXCL1 expression in human vascular endothelial cells. The aim of this study was to investigate the effect of IL-33 on the expression of IL-8/CXCL8, another member of the CXC-chemokine family, and to elucidate its signaling pathways in human umbilical vein endothelial cells (HUVECs). Immunocytochemical staining and Western immunoblot analysis revealed that IL-33 augmented IL-8 protein expression in HUVECs. Real time reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) showed that IL-33 significantly increased IL-8 mRNA and secretion in a dose-and time-dependent manner. IL-33 preferentially stimulated proliferating subconfluent cells, and increased IL-8 secretion to a higher level compared with confluent cells. IL-33 also stimulated phosphorylations of c-Jun N-terminal kinase (JNK) and c-Jun, and enhanced activator protein (AP)-1 DNA-binding activity, all of which were suppressed by SP600125, a JNK inhibitor. Moreover, IL-33-induced IL-8 mRNA and secretion were also suppressed by SP600125. Transfection of c-Jun small interfering RNA into cultured HUVECs significantly reduced the IL-33-induced increase in IL-8 secretion from HUVECs. The present study demonstrates that IL-33 induces IL-8 expression via JNK/c-Jun/AP-1 pathway in human vascular endothelial cells, and provides a new insight into the role of IL-33-induced IL-8 in the pathophysiology of atherosclerosis and vascular inflammation.	[Umebashi, Katsuyuki; Tokito, Akinori; Yamamoto, Masayoshi; Jougasaki, Michihisa] Natl Hosp Org Kagoshima Med Ctr, Inst Clin Res, Kagoshima, Japan; [Umebashi, Katsuyuki; Yamamoto, Masayoshi; Jougasaki, Michihisa] Kagoshima Univ, Cooperat Dept Innovat Med, Neurohumoral Biol, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Jougasaki, Michihisa] Natl Hosp Org Kagoshima Med Ctr, 8-1 Shiroyama Cho, Kagoshima, Japan	Kagoshima University	Jougasaki, M (corresponding author), Natl Hosp Org Kagoshima Med Ctr, Inst Clin Res, Kagoshima, Japan.; Jougasaki, M (corresponding author), Kagoshima Univ, Cooperat Dept Innovat Med, Neurohumoral Biol, Grad Sch Med & Dent Sci, Kagoshima, Japan.; Jougasaki, M (corresponding author), Natl Hosp Org Kagoshima Med Ctr, 8-1 Shiroyama Cho, Kagoshima, Japan.	jougasaki@kagomc2.hosp.go.jp			National Hospital Organization Collaborative Clinical Research	National Hospital Organization Collaborative Clinical Research	The present study was supported by a grant from National Hospital Organization Collaborative Clinical Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2010, MOL CELL BIOCHEM, V335, P75, DOI 10.1007/s11010-009-0244-9; Apostolopoulos J, 1996, ARTERIOSCL THROM VAS, V16, P1007, DOI 10.1161/01.ATV.16.8.1007; Ashlin TG, 2014, INT J BIOCHEM CELL B, V46, P113, DOI 10.1016/j.biocel.2013.11.008; Aukrust P, 2001, J AM COLL CARDIOL, V37, P485, DOI 10.1016/S0735-1097(00)01110-4; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chen WT, 2015, ELIFE, V4, DOI 10.7554/eLife.07270; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hu WT, 2014, MOL HUM REPROD, V20, P358, DOI 10.1093/molehr/gat094; Ichiki T, 2008, AM J PHYSIOL-HEART C, V294, pH750, DOI 10.1152/ajpheart.00161.2007; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kamekura R, 2012, CLIN EXP ALLERGY, V42, P218, DOI 10.1111/j.1365-2222.2011.03867.x; Krause A, 1998, J BIOL CHEM, V273, P23681, DOI 10.1074/jbc.273.37.23681; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Pollheimer J, 2013, ARTERIOSCL THROM VAS, V33, pE47, DOI 10.1161/ATVBAHA.112.253427; Romuk E, 2002, EUR J CLIN INVEST, V32, P657, DOI 10.1046/j.1365-2362.2002.01053.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rus HG, 1996, ATHEROSCLEROSIS, V127, P263, DOI 10.1016/S0021-9150(96)05968-0; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shang J, 2015, BIOCHEM CELL BIOL, V93, P359, DOI 10.1139/bcb-2014-0163; Shen JY, 2015, SEMIN ARTHRITIS RHEU, V45, P18, DOI 10.1016/j.semarthrit.2015.02.001; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Stojkovic S, 2014, J THROMB HAEMOST, V12, P948, DOI 10.1111/jth.12581; Stojkovic S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25171; STRIETER RM, 1992, AM J PATHOL, V141, P1279; Tanabe T, 2014, CLIN EXP ALLERGY, V44, P540, DOI 10.1111/cea.12283; Tokito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068801; van der Vorst EPC, 2015, J MOL MED, V93, P963, DOI 10.1007/s00109-015-1317-8; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Wang YG, 2015, CELL PHYSIOL BIOCHEM, V35, P292, DOI 10.1159/000369696; Wu HX, 2014, BIOCHEM BIOPH RES CO, V450, P110, DOI 10.1016/j.bbrc.2014.05.073; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yamamoto M, 2017, AM J PHYSIOL-REG I, V313, pR272, DOI 10.1152/ajpregu.00435.2016; Ye XL, 2015, ONCOL REP, V33, P2746, DOI 10.3892/or.2015.3898	46	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191659	10.1371/journal.pone.0191659	http://dx.doi.org/10.1371/journal.pone.0191659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373608	Green Submitted, Green Published, gold			2022-12-26	WOS:000423425400017
J	De Dreu, CKW; van Dijk, MA				De Dreu, Carsten K. W.; van Dijk, Mathijs A.			Climatic shocks associate with innovation in science and technology	PLOS ONE			English	Article							CREATIVITY; TEMPERATURE; EXPLORATION; COMPETITION; NECESSITY; DIFFUSION; MOTHER; WAR	Human history is shaped by landmark discoveries in science and technology. However, across both time and space the rate of innovation is erratic: Periods of relative inertia alternate with bursts of creative science and rapid cascades of technological innovations. While the origins of the rise and fall in rates of discovery and innovation remain poorly understood, they may reflect adaptive responses to exogenously emerging threats and pressures. Here we examined this possibility by fitting annual rates of scientific discovery and technological innovation to climatic variability and its associated economic pressures and resource scarcity. In time-series data from Europe (1500-1900CE), we indeed found that rates of innovation are higher during prolonged periods of cold (versus warm) surface temperature and during the presence (versus absence) of volcanic dust veils. This negative temperature - innovation link was confirmed in annual time-series for France, Germany, and the United Kingdom (1901-1965CE). Combined, across almost 500 years and over 5,000 documented innovations and discoveries, a 0.5 degrees C increase in temperature associates with a sizable 0.30-0.60 standard deviation decrease in innovation. Results were robust to controlling for fluctuations in population size. Furthermore, and consistent with economic theory and micro-level data on group innovation, path analyses revealed that the relation between harsher climatic conditions between 1500-1900CE and more innovation is mediated by climate-induced economic pressures and resource scarcity.	[De Dreu, Carsten K. W.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [De Dreu, Carsten K. W.] Univ Amsterdam, Ctr Expt Econ & Polit Decis Making, Amsterdam, Netherlands; [van Dijk, Mathijs A.] Erasmus Univ, Rotterdam Sch Management, Rotterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Erasmus University Rotterdam	De Dreu, CKW (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; De Dreu, CKW (corresponding author), Univ Amsterdam, Ctr Expt Econ & Polit Decis Making, Amsterdam, Netherlands.	c.k.w.de.dreu@fsw.leidenuniv.nl	De Dreu, Carsten K.W./X-7762-2019	De Dreu, Carsten K.W./0000-0003-3692-4611				Aghion P, 2005, Q J ECON, V120, P701, DOI 10.1093/qje/120.2.701; Allen Robert C., 2001, EXPLORATIONS EC HIST, V38, P4; Arrow K., 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024; Ashraf Q, 2015, REV ECON STAT, V97, P589, DOI 10.1162/REST_a_00461; Baer M, 2006, J APPL PSYCHOL, V91, P963, DOI 10.1037/0021-9010.91.4.963; Baltagi B. H., 2008, ECONOMETRIC ANAL PAN, DOI DOI 10.1108/IJSHE-06-2013-0065; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bolt J, 2014, ECON HIST REV, V67, P627, DOI 10.1111/1468-0289.12032; BOLTON MK, 1993, ORGAN SCI, V4, P57, DOI 10.1287/orsc.4.1.57; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Comin D. A., 2009, 15319 NAT BUR EC RES; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; De Dreu CKW, 2006, J MANAGE, V32, P83, DOI 10.1177/0149206305277795; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Dillehay TD, 2004, P NATL ACAD SCI USA, V101, P4325, DOI 10.1073/pnas.0400538101; Elliott G, 1996, ECONOMETRICA, V64, P813, DOI 10.2307/2171846; European Commission, 2013, INN UN POCK GUID EUR; Gilligan I, 2010, J ARCHAEOL METHOD TH, V17, P15, DOI 10.1007/s10816-009-9076-x; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Guiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009972; Harrington JR, 2014, P NATL ACAD SCI USA, V111, P7990, DOI 10.1073/pnas.1317937111; Hayes AF, 2010, MULTIVAR BEHAV RES, V45, P627, DOI 10.1080/00273171.2010.498290; Hsiang S, 2016, ANNU REV RESOUR ECON, V8, P43, DOI 10.1146/annurev-resource-100815-095343; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Jacks DS, 2006, EXPLOR ECON HIST, V43, P383, DOI 10.1016/j.eeh.2005.05.001; Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108; Kennett DJ, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0458; Kolodny O, 2015, P NATL ACAD SCI USA, V112, pE6762, DOI 10.1073/pnas.1520492112; Kreindler GE, 2014, P NATL ACAD SCI USA, V111, P10881, DOI 10.1073/pnas.1400842111; LAMB HH, 1970, PHILOS T R SOC S-A, V266, P425, DOI 10.1098/rsta.1970.0010; Lavie D, 2010, ACAD MANAG ANN, V4, P109, DOI 10.1080/19416521003691287; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Luterbacher J, 2001, ATMOS SCI LETT, V2, P114, DOI 10.1006/asle.2001.0044; Luterbacher J, 2006, DATA CONTRIBUTION SE, V2006-060; Mann M.X., 2000, EARTH INTERACT, V4, P4; McRobie A, 2005, PHILOS T R SOC A, V363, P1263, DOI 10.1098/rsta.2005.1567; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; Moser P, 2014, AM ECON REV, V104, P3222, DOI 10.1257/aer.104.10.3222; Newell A., 1972, HUMAN PROBLEM SOLVIN; Nohria N, 1996, ACAD MANAGE J, V39, P1245, DOI 10.2307/256998; Ochoa G, 1995, TIMELINE BOOK SCI; Olmstead AL, 2011, P NATL ACAD SCI USA, V108, P480, DOI 10.1073/pnas.1008279108; Porter ME, 2000, ECON DEV Q, V14, P15, DOI 10.1177/089124240001400105; RAMPINO MR, 1988, ANNU REV EARTH PL SC, V16, P73, DOI 10.1146/annurev.ea.16.050188.000445; Reader SM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0182; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Rosen AM, 2012, P NATL ACAD SCI USA, V109, P3640, DOI 10.1073/pnas.1113931109; Roskes M, 2012, J PERS SOC PSYCHOL, V103, P242, DOI 10.1037/a0028442; SIMONTON DK, 1975, J PERS SOC PSYCHOL, V32, P1119, DOI 10.1037/0022-3514.32.6.1119; SIMONTON DK, 1980, SCIENTOMETRICS, V2, P251, DOI 10.1007/BF02016346; SITKIN SB, 1992, RES ORGAN BEHAV, V14, P231; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Voss GB, 2008, ACAD MANAGE J, V51, P147; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Williams N, 1969, CHRONOLOGY MODERN WO; Williams N, 1965, CHRONOLOGY EXPANDING; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	59	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190122	10.1371/journal.pone.0190122	http://dx.doi.org/10.1371/journal.pone.0190122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364910	Green Published, gold			2022-12-26	WOS:000423412500010
J	Henriques, SF; Patissier, C; Bourg, N; Fecchio, C; Sandona, D; Marsolier, J; Richard, I				Henriques, Sara F.; Patissier, Cecile; Bourg, Nathalie; Fecchio, Chiara; Sandona, Doriana; Marsolier, Justine; Richard, Isabelle			Different outcome of sarcoglycan missense mutation between human and mouse	PLOS ONE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; ALPHA-SARCOGLYCAN; BETA-SARCOGLYCAN; GAMMA-SARCOGLYCAN; DEFICIENT MICE; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; QUALITY-CONTROL; SMOOTH-MUSCLE	Sarcoglycanopathies are rare autosomic limb girdle muscular dystrophies caused by mutations in one of the genes coding for sarcoglycan (alpha, beta, delta, and gamma-sarcoglycans). Sarcoglycans form a complex, which is an important part of the dystrophin-associated glycoprotein complex that protects sarcolemma against muscle contraction-induced damages. Absence of one of the sarcoglycan at the plasma membrane induces the disappearance of the whole complex and perturbs muscle fiber membrane integrity. We previously demonstrated that point mutations in the human sarcoglycan genes affects the folding of the corresponding protein, which is then retained in the endoplasmic reticulum by the protein quality control and prematurely degraded by the proteasome. Interestingly, modulation of the quality control using pharmacological compounds allowed the rescue of the membrane localization of the mutated sarcoglycan. Two previously generated mouse models, knock-in for the most common sarcoglycan mutant, R77C alpha-sarcoglycan, failed in reproducing the dystrophic phenotype observed in human patients. Based on these results and the need to test therapies for these fatal diseases, we decided to generate a new knock-in mouse model carrying the missense mutation T151R in the beta-sarcoglycan gene since this is the second sarcoglycan protein with the most frequently reported missense mutations. Muscle analysis, performed at the age of 4 and 9-months, showed the presence of the mutated beta-sarcoglycan protein and of the other components of the dystrophin-associated glycoprotein complex at the muscle membrane. In addition, these mice did not develop a dystrophic phenotype, even at a late stage or in condition of stress-inducing exercise. We can speculate that the absence of phenotype in mouse may be due to a higher tolerance of the endoplasmic reticulum quality control for amino-acid changes in mice compared to human.	[Henriques, Sara F.; Patissier, Cecile; Bourg, Nathalie; Marsolier, Justine; Richard, Isabelle] Univ Paris Saclay, Univ Evry, INSERM, INTEGRARE,Genethon, Evry, France; [Fecchio, Chiara; Sandona, Doriana] Univ Padua, Dept Biomed Sci, Via U Bassi, Padua, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Padua	Richard, I (corresponding author), Univ Paris Saclay, Univ Evry, INSERM, INTEGRARE,Genethon, Evry, France.	richard@genethon.fr	Richard, isabelle/J-8298-2013; sandona, dorianna/AAB-9480-2020	Marsolier, Justine/0000-0001-8464-9306	Fondation de France; AFM-Telethon [18620]	Fondation de France(Fondation de France); AFM-Telethon(Association Francaise contre les Myopathies)	This work was supported by Fondation de France, https://www.fondationdefrance.org/fr; and AFM-Telethon 18620, http://www.afm-telethon.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Bartoli M, 2008, HUM MOL GENET, V17, P1214, DOI 10.1093/hmg/ddn029; Davidson D J, 2001, Trends Genet, V17, pS29, DOI 10.1016/S0168-9525(01)02452-0; Draviam RA, 2006, TRAFFIC, V7, P793, DOI 10.1111/j.1600-0854.2006.00433.x; Duclos F, 1998, NEUROMUSCULAR DISORD, V8, P30, DOI 10.1016/S0960-8966(97)00135-1; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Elsea Sarah H, 2002, ILAR J, V43, P66; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gastaldello S, 2008, AM J PATHOL, V173, P170, DOI 10.2353/ajpath.2008.071146; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Israeli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28097; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Lavelle GM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5258727; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Marsolier J, 2017, NEUROMUSCULAR DISORD, V27, P683, DOI 10.1016/j.nmd.2017.02.011; McCaffrey K, 2016, ESSAYS BIOCHEM, V60, P227, DOI 10.1042/EBC20160003; Melacini P, 1999, MUSCLE NERVE, V22, P473, DOI 10.1002/(SICI)1097-4598(199904)22:4<473::AID-MUS8>3.0.CO;2-5; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.3.CO;2-W; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Sasaoka T, 2003, NEUROMUSCULAR DISORD, V13, P193, DOI 10.1016/S0960-8966(02)00220-1; Semplicini C, 2015, NEUROLOGY, V84, P1772, DOI 10.1212/WNL.0000000000001519; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soheili T, 2012, HUM MUTAT, V33, P429, DOI 10.1002/humu.21659; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989; Sun Gui-Lian, 2006, Neurosci Bull, V22, P85; Wang RB, 2010, AM J PHYSIOL-REG I, V299, pR259, DOI 10.1152/ajpregu.00060.2010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler MT, 2002, COLD SPRING HARB SYM, V67, P389, DOI 10.1101/sqb.2002.67.389; Zanotti S, 2007, MATRIX BIOL, V26, P615, DOI 10.1016/j.matbio.2007.06.004	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191274	10.1371/journal.pone.0191274	http://dx.doi.org/10.1371/journal.pone.0191274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360879	Green Submitted, Green Published, gold			2022-12-26	WOS:000423161800021
J	Knytl, M; Kalous, L; Rylkova, K; Choleva, L; Merila, J; Rab, P				Knytl, Martin; Kalous, Lukas; Rylkova, Katerina; Choleva, Lukas; Merila, Juha; Rab, Petr			Morphologically indistinguishable hybrid Carassius female with 156 chromosomes: A threat for the threatened crucian carp, C. carassius, L	PLOS ONE			English	Article							CARASSIUS-AURATUS-GIBELIO; FRESH-WATER FISH; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENE; PRUSSIAN CARP; 5S RDNA; DETECT HYBRIDIZATION; TELEOSTEI CYPRINIDAE; MOLECULAR APPROACH; 28S RDNA	The crucian carp Carassius carassius (Linnaeus, 1758), is native to many European freshwaters. Despite its wide distribution, the crucian carp is declining in both the number and sizes of populations across much of its range. Here we studied 30 individuals of a putative pure population from Helsinki, Finland. Despite clear external morphological features of C. carassius, an individual was of a higher ploidy level than the others. We therefore applied a set of molecular genetic (S7 nuclear and cytochrome b mitochondrial genes) and cytogenetic tools (sequential fluorescent 4', 6-diamidino-2-phenylindole [DAPI], Chromomycin A(3) [CMA(3)], C-banding and in situ hybridization [FISH] with both 5S and 28S ribosomal DNA probes) to determine its origin. While all examined characteristics of a diploid representative male (CCAHe2Fi) clearly corresponded to those of C. carassius, a triploid individual (CCAHe1Fi) was more complex. Phylogenetic analysis revealed that the nuclear genome of CCAHe1Fi contained three haploid sets: two C. gibelio and one C. carassius. However the mitochondrial DNA was that of C. gibelio, demonstrating its hybrid origin. The FISH revealed three strong (more intensive) 5S rDNA loci, confirming the triploid status, and an additional 24 weak (less intensive) signals were observed in the chromosome complement of CCAHe1Fi. On the other hand, only two strong and 16 weak 5S rDNA signals were visible on the chromosomes of the CCAHe2Fi male. 28S rDNA FISH revealed four strong signals in both CCAHe1Fi and CCAHe2Fi individuals. CMA(3) staining revealed four to six CMA(3)-positive bands of CCAHe1Fi, while that of diploids contained only two to four. The fact that a polyploid hybrid Carassius female with a strong invasive potential may share morphological characters typical for endangered C. carassius highlights a need to combine genetic investigations of Carassius cryptic diversity with conservation measures of C. carassius in Europe.	[Knytl, Martin] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Kalous, Lukas] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Rylkova, Katerina] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Genet & Breeding, Prague, Czech Republic; [Choleva, Lukas; Rab, Petr] Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Choleva, Lukas] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Ostrava, Czech Republic; [Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	Charles University Prague; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Ostrava; University of Helsinki	Knytl, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	martin.knytl@natur.cuni.cz	Rylková, Kateřina/ABA-2891-2021; Kalous, Lukáš/B-2952-2013; Merila, Juha/A-4061-2008; Knytl, Martin/V-7793-2017	Rylková, Kateřina/0000-0003-4838-9599; Kalous, Lukáš/0000-0001-5518-1505; Merila, Juha/0000-0001-9614-0072; Knytl, Martin/0000-0002-6325-6957	Charles University [SW: 244-260435, UNCE: 204013]; Academy of Finland [218343]; Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation [CAS: 15-19947Y, M200451271]; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA" [20152007, EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE]; Charles University [SW: 244-260435, UNCE: 204013]; Academy of Finland [218343]; Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation [CAS: 15-19947Y, M200451271]; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA" [20152007, EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE];  [RVO: 67985904]	Charles University; Academy of Finland(Academy of Finland); Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA"; Charles University; Academy of Finland(Academy of Finland); Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA"; 	The research was funded by Charles University grant SW: 244-260435 (MK), UNCE: 204013 (MK), Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA": 20152007 (LK), project EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE and with the institutional support RVO: 67985904 (LC, PR). Further support was provided by the Czech Academy of Sciences (CAS; [http://www.cas.cz]:) M200451271 (LC) within the program for internal support of projects of international cooperation CAS: 15-19947Y from The Czech Science Foundation (LC), and Academy of Finland: 218343 (JM).	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves-Costa FA, 2008, GENET MOL BIOL, V31, P303, DOI 10.1590/S1415-47572008000200025; Avise JC, 2015, P NATL ACAD SCI USA, V112, P8867, DOI 10.1073/pnas.1501820112; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barus V., 1995, FAUNA CR SR MIHULOVC, P623; Bertollo LAC, 2015, FISH CYTOGENETIC TEC, P21, DOI DOI 10.1201/B18534-4; Boron A, 2011, ACTA ICHTHYOL PISCAT, V41, P19, DOI 10.3750/AIP2011.41.1.04; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Cherfas N.B., 1966, GENETIKA+, V5, P16; Choleva L, 2013, CYTOGENET GENOME RES, V140, P151, DOI 10.1159/000353464; Chow S, 1998, MOL ECOL, V7, P1255; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; ECONOMIDIS PS, 1995, BIOL CONSERV, V72, P201, DOI 10.1016/0006-3207(94)00083-3; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Gromicho M, 2005, CYTOGENET GENOME RES, V109, P507, DOI 10.1159/000084211; GUERRA MD, 1986, REV BRAS GENET, V9, P741; Gui J, 1992, CHINESE SCI BULL, V37, P255; GUI JF, 1993, CHINESE SCI BULL, V38, P332; GUI JF, 1993, CHINESE SCI BULL, V38, P327; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanfling B, 2005, FRESHWATER BIOL, V50, P403, DOI 10.1111/j.1365-2427.2004.01330.x; Haynes GD, 2012, ANIM CONSERV, V15, P83, DOI 10.1111/j.1469-1795.2011.00490.x; Helfman GS, 2007, FISH CONSERVATION GU; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inafuku J, 2000, CHROMOSOME RES, V8, P193, DOI 10.1023/A:1009292610618; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Jeffries DL, 2017, ECOL EVOL, V7, P2871, DOI 10.1002/ece3.2831; Jeffries DL, 2016, MOL ECOL, V25, P2997, DOI 10.1111/mec.13613; Jiang Y, 1983, ACTA HYDROBIOL SIN; JOTTERAN.M, 1974, EXPERIENTIA, V30, P1003, DOI 10.1007/BF01938973; Kalous L, 2007, J FISH BIOL, V70, P132, DOI 10.1111/j.1095-8649.2006.01290.x; Kalous L, 2013, J FISH BIOL, V82, P703, DOI 10.1111/j.1095-8649.2012.03492.x; Kalous L, 2012, ICHTHYOL EXPLOR FRES, V23, P11; Kalous L, 2011, FOLIA ZOOL, V60, P115; Knytl M, 2013, CYTOGENET GENOME RES, V139, P276, DOI 10.1159/000350689; Knytl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177087; Knytl M, 2013, COMP CYTOGENET, V7, P205, DOI 10.3897/CompCytogen.v7i3.5411; KOMIYA H, 1979, J BIOCHEM-TOKYO, V86, P1067, DOI 10.1093/oxfordjournals.jbchem.a132601; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Lusk S, 2004, FOLIA ZOOL, V53, P215; Lusk S., 2017, RED LIST LAMPREYS FI, V34, P51; Luskova V., 2010, Russian Journal of Biological Invasions, V1, P176, DOI 10.1134/S2075111710030069; Mandrak NE, 2010, AQUAT ECOSYST HEALTH, V13, P255, DOI 10.1080/14634988.2010.507150; Mantovani M, 2005, GENETICA, V123, P211, DOI 10.1007/s10709-004-2281-3; Mezhzherin SV, 2012, CYTOL GENET+, V46, P28, DOI 10.3103/S0095452712010069; NAITO E, 1992, J FORENSIC SCI, V37, P396; OJIMA Y, 1979, P JPN ACAD B-PHYS, V55, P346, DOI 10.2183/pjab.55.346; Papousek I, 2008, J FISH BIOL, V72, P1230, DOI 10.1111/j.1095-8649.2007.01783.x; Payseur BA, 2016, MOL ECOL, V25, P2337, DOI 10.1111/mec.13557; Penaz M., 1979, Acta Scientiarum Naturalium Academiae Scientiarum Bohemoslovacae Brno, V13, P1; Rab P, 2007, FISH CYTOGENETICS, P229; Roberts DG, 2009, J EVOLUTION BIOL, V22, P27, DOI 10.1111/j.1420-9101.2008.01620.x; Rylkova K, 2013, AQUACULTURE, V380, P13, DOI 10.1016/j.aquaculture.2012.11.027; Rylkova K, 2010, AQUACULTURE, V302, P36, DOI 10.1016/j.aquaculture.2010.02.003; Savini D, 2010, J APPL ICHTHYOL, V26, P1, DOI 10.1111/j.1439-0426.2010.01503.x; Sayer CD, 2011, J FISH BIOL, V79, P1608, DOI 10.1111/j.1095-8649.2011.03059.x; Sember A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0532-9; Simkova A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0438-6; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Spoz A, 2014, COMP CYTOGENET, V8, P233, DOI 10.3897/CompCytogen.v8i3.7718; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Symonova R., 2015, FISH CYTOGENETIC TEC, P118; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Takada M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-7; Toledo LFA., 2015, FISH CYTOGENETIC TEC, P92, DOI DOI 10.1201/618534-15; Toth B, 2005, J FISH BIOL, V66, P784, DOI 10.1111/j.0022-1112.2005.00644.x; TYMOWSKA J, 1982, CYTOGENET CELL GENET, V34, P149, DOI 10.1159/000131803; Volker M, 2007, CYTOGENET GENOME RES, V116, P116, DOI 10.1159/000097429; Wheeler A, 2000, FISHERIES MANAG ECOL, V7, P315, DOI 10.1046/j.1365-2400.2000.007004315.x; Wouters J, 2012, J FISH BIOL, V80, P2595, DOI 10.1111/j.1095-8649.2012.03312.x; Wyatt PMW, 2006, J FISH BIOL, V69, P52, DOI 10.1111/j.1095-8649.2006.01104.x; Xiao J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-20; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Zhang C, 2011, J FISH CHINA, V35, P1370; Zhang Q, 2000, J FISH BIOL, V56, P388, DOI 10.1111/j.1095-8649.2000.tb02113.x; Zhao J, 2004, AQUACULTURE, V237, P117, DOI 10.1016/j.aquaculture.2004.05.001; Zhu HP, 2006, CHROMOSOME RES, V14, P767, DOI 10.1007/s10577-006-1083-0; Zhu HP, 2007, AQUACULTURE, V265, P109, DOI 10.1016/j.aquaculture.2006.10.026	81	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190924	10.1371/journal.pone.0190924	http://dx.doi.org/10.1371/journal.pone.0190924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360831	gold, Green Published, Green Submitted			2022-12-26	WOS:000423161800011
J	Noyce, RS; Lederman, S; Evans, DH				Noyce, Ryan S.; Lederman, Seth; Evans, David H.			Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; NUCLEOTIDE-LEVEL; GENOMIC ANALYSIS; RECOMBINATION; REACTIVATION; REPLICATION; RESOLUTION; ORIGINS; BASE	Edward Jenner and his contemporaries believed that his variolae vaccinae originated in horses and molecular analyses show that modern vaccinia virus (VACV) strains share common ancestry with horsepox virus (HPXV). Given concerns relating to the toxicity of modern VACV vaccines, we asked whether an HPXV-based vaccine might provide a superior alternative. Since HPXV may be extinct and the only specimen of HPXV that has been identified is unavailable for investigation, we explored whether HPXV could be obtained by large-scale gene synthesis. Ten large (10 +/- 30 kb) fragments of DNA were synthesized based on the HPXV sequence along with two 157 nt VACV terminal sequences, and were recombined into a live synthetic chimeric HPXV (scHPXV) in cells infected with Shope fibroma virus (SFV). Sequencing of the 212 kbp scHPXV confirmed it encoded a faithful copy of the input DNA. We believe this is the first complete synthesis of a poxvirus using synthetic biology approaches. This scHPXV produced smaller plaques, produced less extracellular virus and exhibited less virulence in mice than VACV, but still provided vaccine protection against a lethal VACV challenge. Collectively, these findings support further development of scHPXV as a novel replication-proficient smallpox vaccine.	[Noyce, Ryan S.; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Noyce, Ryan S.; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Lederman, Seth] Tonix Pharmaceut Inc, New York, NY USA	University of Alberta; University of Alberta	Evans, DH (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Evans, DH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	devans@ualberta.ca	; Evans, David/M-1912-2016	Lederman, Seth/0000-0003-2781-1455; Evans, David/0000-0001-5871-299X	Canadian Institutes for Health Research; Natural Sciences & Engineering Research Council of Canada; Alberta Innovates; Canada Foundation for Innovation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Ms. M. Desaulniers for her excellent technical assistance and members of our laboratory, and the poxvirus and synthetic biology research communities, for thoughtful discussions. The advice and guidance received from representatives of the Canadian federal agencies responsible for biosafety and biosecurity is also gratefully acknowledged. DE thanks the Canadian Institutes for Health Research, Natural Sciences & Engineering Research Council of Canada, Alberta Innovates, and the Canada Foundation for Innovation for long-term research support.	[Anonymous], 2015, WHOHSEPED20151; BAROUDY BM, 1982, COLD SPRING HARB SYM, V47, P723, DOI 10.1101/SQB.1983.047.01.083; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Bell G., 1807, A TREATISE ON THE CO, pxii; Breitbach CJ, 2015, CURR OPIN VIROL, V13, P49, DOI 10.1016/j.coviro.2015.03.016; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; DELANGE AM, 1987, J VIROL, V61, P1957, DOI 10.1128/JVI.61.6.1957-1963.1987; Esparza J, 2013, VET REC, V173, P272, DOI 10.1136/vr.f5587; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Jezek Z, 1988, HUMAN MONKEYPOX; JOKLIK WK, 1960, VIROLOGY, V11, P168, DOI 10.1016/0042-6822(60)90060-X; Loy JG., 1801, AN ACCOUNT OF SOME E; Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15; MERCHLINSKY M, 1990, J VIROL, V64, P5029, DOI 10.1128/JVI.64.10.5029-5035.1990; Murphy JG, 2003, LANCET, V362, P1378, DOI 10.1016/S0140-6736(03)14635-1; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Potts KG, 2017, EMBO MOL MED, V9, P638, DOI 10.15252/emmm.201607296; Qin L, 2015, J VIROL, V89, P1809, DOI 10.1128/JVI.02797-14; Qin L, 2014, J VIROL, V88, P5277, DOI 10.1128/JVI.00022-14; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; Rintoul JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024643; SAM CK, 1981, ANN INST PASTEUR VIR, V132, P135, DOI 10.1016/S0769-2617(81)80016-0; SCHEIFLINGER F, 1992, P NATL ACAD SCI USA, V89, P9977, DOI 10.1073/pnas.89.21.9977; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrick L, 2017, NEW ENGL J MED, V377, P1491, DOI 10.1056/NEJMc1707600; Senkevicha TG, 2015, P NATL ACAD SCI USA, V112, P10908, DOI 10.1073/pnas.1514809112; SHCHELKUNOV SN, 1993, FEBS LETT, V327, P321, DOI 10.1016/0014-5793(93)81013-P; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Yao XD, 2003, J VIROL, V77, P7281, DOI 10.1128/JVI.77.13.7281-7290.2003; Yao Xiao-Dan, 2004, Methods Mol Biol, V269, P51	38	111	117	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0188453	10.1371/journal.pone.0188453	http://dx.doi.org/10.1371/journal.pone.0188453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351298	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300006
J	William, D; Walther, M; Schneider, B; Linnebacher, M; Classen, CF				William, Doreen; Walther, Madlin; Schneider, Bjoern; Linnebacher, Michael; Classen, Carl Friedrich			Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; EXPRESSION; CONCOMITANT; GLIOMA	Glioblastoma multiforme (GBM) is a highly heterogeneous and aggressive brain tumor with a dismal prognosis. Development of resistance towards cytostatic drugs like the GBM standard drug temozolomide is a severe problem in GBM treatment. One potential source of GBM relapse could be so called cancer stem like cells (CSCs). These represent an undifferentiated subpopulation of cells with high potential for tumor initiation. Furthermore, it has been shown that differentiated GBM cells can regain CSC properties when exposed to continuous temozolomide treatment in vitro. In this study, treatment of several primary GBM cell lines with clinically relevant doses of temozolomide increased their tumorigenicity as determined by colony formation assays in soft agar. Increased tumorigenicity is a known property of CSCs. Hence, therapy options that specifically target CSCs are under investigation. CSCs appear to be particularly dependent on mitochondria biogenesis which may represent a useful target for CSC elimination. Toxicity towards mitochondria is a known side effect of several antibiotics. Thus, addition of antibiotics like doxycycline may represent a useful tool to inhibit CSCs in GBM. Here, we show that combining temozolomide treatment of primary GBM cells with doxycycline could counteract the increase of tumorigenicity induced by temozolomide treatment.	[William, Doreen; Walther, Madlin; Classen, Carl Friedrich] Univ Med Rostock, Univ Childrens & Adolescents Hosp, Rostock, Germany; [Schneider, Bjoern] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Linnebacher, Michael] Univ Med Rostock, Dept Surg, Schillingallee Rostock, Germany	University of Rostock; University of Rostock	William, D (corresponding author), Univ Med Rostock, Univ Childrens & Adolescents Hosp, Rostock, Germany.	doreenwilliam@web.de	Linnebacher, Michael/AAT-3763-2021; William, Doreen/AHA-1288-2022	Linnebacher, Michael/0000-0001-8054-1402; 				Auffinger B, 2014, CELL DEATH DIFFER, V21, P1119, DOI 10.1038/cdd.2014.31; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Blough MD, 2010, NEURO-ONCOLOGY, V12, P756, DOI 10.1093/neuonc/noq032; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; BRADSHAW A, 2016, FRONT SURG, V3; Cheng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.450; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; de Vries T, 2001, GLYCOBIOLOGY, V11, p119R, DOI 10.1093/glycob/11.10.119R; DOLECEK TA, 2005, NEUROONCOLOGY S5, V14, P1, DOI DOI 10.1093/NEUONC/N0S218; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kenney-Herbert E, 2015, STEM CELL TRANSL MED, V4, P822, DOI 10.5966/sctm.2014-0047; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Lamb R, 2014, ONCOTARGET, V5, P11029, DOI 10.18632/oncotarget.2789; Lattova E, 2010, J PROTEOME RES, V9, P1533, DOI 10.1021/pr9010266; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Mejias-Luque R, 2007, CANCER SCI, V98, P1000, DOI 10.1111/j.1349-7006.2007.00484.x; Moullan N., 2015, CELL REP; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shu H, 2011, ACTA BIOCH BIOPH SIN, V43, P528, DOI 10.1093/abbs/gmr038; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tivnan A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00218; Vasseur JA, 2012, GLYCOBIOLOGY, V22, P1684, DOI 10.1093/glycob/cws108; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang-Gillam A., 2007, J CANC MOL, V3, P147; Yamamuro S, 2015, INT J ONCOL, V47, P91, DOI 10.3892/ijo.2015.2992; Yang XS, 2010, J CELL PHYSIOL, V225, P612, DOI 10.1002/jcp.22250; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191511	10.1371/journal.pone.0191511	http://dx.doi.org/10.1371/journal.pone.0191511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352318	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300105
J	Wang, XK; Li, JS				Wang, Xiukun; Li, Jinsong			An intermediate cell state allows rerouting of cell fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							XEN-LIKE STATE	Somatic cell reprogramming into pluripotent stem cells using transcriptional factors or chemical compounds has been shown to include an intermediate cell state with epithelial features. Two recent papers show that this intermediate state can be redirected to create other differentiated cell typesspecifically hepatocytes and neuronsusing chemical cocktails. These results shed new light on a critical intermediate in cell fate conversion with mechanistic and practical implications.	[Wang, Xiukun; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Xiukun; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, Jinsong] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Li, JS (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Li, JS (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Li, JS (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	jsli@sibcb.ac.cn		li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2014CB964803, 2015AA020307]; National Natural Science Foundation of China [31530048, 31601163, 81672117]; Chinese Academy of Sciences [XDB19010204, OYZDJ-SSW-SMC023]; Shanghai Municipal Commission for Science and Technology [16JC1420500, 17JC1400900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology	This work was supported by grants from the Ministry of Science and Technology of China (2014CB964803 and 2015AA020307), National Natural Science Foundation of China (31530048, 31601163, and 81672117), Chinese Academy of Sciences (XDB19010204 and OYZDJ-SSW-SMC023), and Shanghai Municipal Commission for Science and Technology (16JC1420500 and 17JC1400900). The authors declare that they have no conflicts of interest with the contents of this article.	Cao ST, 2017, J BIOL CHEM, V292, P19122, DOI 10.1074/jbc.M117.812537; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2017, CELL STEM CELL, V21, P264, DOI 10.1016/j.stem.2017.05.019; Li X, 2017, NATL SCI REV, V4, P7, DOI 10.1093/nsr/nww060; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Smith ZD, 2016, NAT REV MOL CELL BIO, V17, P139, DOI 10.1038/nrm.2016.6; Xie X, 2017, CURR OPIN GENET DEV, V46, P104, DOI 10.1016/j.gde.2017.07.003; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017	10	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19133	19134		10.1074/jbc.H117.812537	http://dx.doi.org/10.1074/jbc.H117.812537			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29373866	hybrid, Green Published			2022-12-26	WOS:000415848000036
J	Chen, TY; Lee, SH; Dhar, SS; Lee, MG				Chen, Tsai-Yu; Lee, Sung-Hun; Dhar, Shilpa S.; Lee, Min Gyu			Protein arginine methyltransferase 7-mediated microRNA-221 repression maintains Oct4, Nanog, and Sox2 levels in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; POSTTRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; PLURIPOTENCY FACTORS; ANIMAL DEVELOPMENT; EXPRESSION; DIFFERENTIATION; MIR-221; PROLIFERATION; RESISTANCE	The stemness maintenance of embryonic stem cells (ESCs) requires pluripotency transcription factors, including Oct4, Nanog, and Sox2. We have previously reported that protein arginine methyltransferase 7 (PRMT7), an epigenetic modifier, is an essential pluripotency factor that maintains the stemness of mouse ESCs, at least in part, by down-regulating the expression of the anti-stemness microRNA (miRNA) miR-24-2. To gain greater insight into the molecular basis underlying PRMT7-mediated maintenance of mouse ESC stemness, we searched for new PRMT7-down-regulated anti-stemness miRNAs. Here, we show that miR-221 gene-encoded miR-221-3p and miR-221-5p are anti-stemness miRNAs whose expression levels in mouse ESCs are directly repressed by PRMT7. Notably, both miR-221-3p and miR-221-5p targeted the 3'untranslated regions of mRNA transcripts of the major pluripotency factors Oct4, Nanog, and Sox2 to antagonize mouse ESC stemness. Moreover, miR-221-5p silenced also the expression of its own transcriptional repressor PRMT7. Transfection of miR-221-3p and miR-221-5p mimics induced spontaneous differentiation of mouse ESCs. CRISPR-mediated deletion of the miR-221 gene, as well as specific antisense inhibitors of miR-221-3p and miR221-5p, inhibited the spontaneous differentiation of PRMT7depleted mouse ESCs. Taken together, these findings reveal that the PRMT7-mediated repression of miR-221-3p and miR221- 5p expression plays a critical role in maintaining mouse ESC stemness. Our results also establish miR-221-3p and miR221- 5p as anti-stemness miRNAs that target Oct4, Nanog, and Sox2 mRNAs in mouse ESCs.	[Chen, Tsai-Yu; Lee, Sung-Hun; Dhar, Shilpa S.; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Chen, Tsai-Yu; Lee, Min Gyu] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lee, MG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mglee@mdanderson.org		Chen, Tsai-Yu/0000-0001-6150-6361	National Institutes of Health through M. D. Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA207109, R01CA207098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095659] Funding Source: NIH RePORTER	National Institutes of Health through M. D. Anderson's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the research staff in the Flow Cytometry & Cellular Imaging Facility, which is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA016672. We also thank Ann Sutton (Department of Scientific Publications, M. D. Anderson) for the editorial assistance.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Fornari F, 2014, MOL CANCER RES, V12, P203, DOI 10.1158/1541-7786.MCR-13-0312-T; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gulla A, 2016, CLIN CANCER RES, V22, P1222, DOI 10.1158/1078-0432.CCR-15-0489; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Hamada N, 2012, NEUROCHEM INT, V60, P743, DOI 10.1016/j.neuint.2012.03.010; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee SH, 2016, NUCLEIC ACIDS RES, V44, P10603, DOI 10.1093/nar/gkw788; Li J, 2015, STEM CELL REV REP, V11, P39, DOI 10.1007/s12015-014-9543-y; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Li N, 2016, MOL CELL, V63, P470, DOI 10.1016/j.molcel.2016.06.035; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Ma YN, 2015, EMBO J, V34, P361, DOI 10.15252/embj.201489957; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pandey A, 2015, J NEUROCHEM, V133, P640, DOI 10.1111/jnc.13089; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	52	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3925	3936		10.1074/jbc.RA117.000425	http://dx.doi.org/10.1074/jbc.RA117.000425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29378844	Green Published, hybrid			2022-12-26	WOS:000427587500007
J	Biervoye, A; Meert, G; Apperly, IA; Samson, D				Biervoye, Aurelie; Meert, Gaelle; Apperly, Ian A.; Samson, Dana			Assessing the integrity of the cognitive processes involved in belief reasoning by means of two nonverbal tasks: Rationale, normative data collection and illustration with brain-damaged patients	PLOS ONE			English	Article							SELF-PERSPECTIVE INHIBITION; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; SEX-DIFFERENCES; MENTAL STATE; MIND TASKS; NEUROPSYCHOLOGICAL EVIDENCE; EXECUTIVE FUNCTIONS; ALZHEIMERS-DISEASE; LOBE CONTRIBUTIONS	Every day, we engage in social interactions with other people which require understanding their as well as our own mental states. Such capacity is commonly referred to as Theory of Mind (ToM). Disturbances of ToM are often reported in diverse pathologies which affect brain functioning and lead to problems in social interactions. Identifying ToM deficits is thus crucial to guide the clinicians in the establishment of adequate rehabilitation strategies for patients. Previous studies have demonstrated that ToM is not a unitary function yet currently there are very few standardized tests which allow identifying the type of cognitive processes affected when a patient exhibits a ToM deficit. In the current study, we present two belief reasoning tasks which have been used in previous research to disentangle two types of processes involved in belief reasoning: self-perspective inhibition and the spontaneous inference of another person's belief. A three-step procedure was developed to provide clinicians with the tools to interpret the patients' performances on the tasks. First, these tasks were standardized and normative data was collected on a sample of 124 healthy participants aged between 18 and 74. Data collected showed a decrease in performance as a function of age only in the task that loaded most in spontaneous other-perspective demands. There was however no effect of gender or educational level. Cut-off scores to identify deficits were then calculated for the different age groups separately. Secondly, the three-step procedure was applied to 21 brain-damaged patients and showed a large diversity of profiles, including selective deficits of the two targeted ToM processes. The diversity of profiles shows the importance to take into account the multiple facets of ToM during the diagnosis and rehabilitation of patients with suspected ToM deficits.	[Biervoye, Aurelie; Meert, Gaelle; Samson, Dana] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Biervoye, Aurelie; Meert, Gaelle; Samson, Dana] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Apperly, Ian A.] Univ Birmingham, Birmingham, W Midlands, England	Universite Catholique Louvain; Universite Catholique Louvain; University of Birmingham	Samson, D (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.; Samson, D (corresponding author), Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium.	dana.samson@uclouvain.be	; Apperly, Ian/N-9165-2018	Samson, Dana/0000-0001-7428-0031; Apperly, Ian/0000-0001-9485-563X	Fonds speciaux de recherche of the Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique FNRS [1.A009.13F]; Medical Research Council [GA0400299]; Leverhulme Trust [F/00094/AH]; MRC [G0400299] Funding Source: UKRI; Medical Research Council [G0400299] Funding Source: researchfish	Fonds speciaux de recherche of the Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique FNRS(Fonds de la Recherche Scientifique - FNRS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Fonds speciaux de recherche of the Universite catholique de Louvain (FSR 2012), by the Fonds de la Recherche Scientifique FNRS under Grant number 1.A009.13F, the Medical Research Council (GA0400299) and The Leverhulme Trust (F/00094/AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulafia-Brakha T, 2011, J NEUROPSYCHOL, V5, P39, DOI 10.1348/174866410X533660; Abraham A, 2010, SOC NEUROSCI-UK, V5, P1, DOI 10.1080/17470910903166853; American Psychiatric Association, 2013, DIAG STAT MAN MENT D; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Biervoye A, 2016, SOC COGN AFFECT NEUR; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Bosco F.M., 2016, FRONT PSYCHOL, V7, P319; Bosco FM, 2014, ALCOHOL ALCOHOLISM, V49, P299, DOI 10.1093/alcalc/agt148; Bosco FM, 2009, CONSCIOUS COGN, V18, P306, DOI 10.1016/j.concog.2008.06.006; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Chiavarino C, 2010, COGNITION, V117, P203, DOI 10.1016/j.cognition.2010.08.012; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawford JR, 2003, CORTEX, V39, P357, DOI 10.1016/S0010-9452(08)70117-5; de Partz MP, 2001, LEXIS TESTS POUR VAL; Desgranges B, 2012, REV NEUROPSYCHOLOGIE, V4, DOI [DOI 10.3917/rne.043.0216, 10.3917/rne.043.0216]; Duval C, 2011, CONSCIOUS COGN, V20, P627, DOI 10.1016/j.concog.2010.10.025; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Ekman P., 1976, PICTURES FACIAL AFFE; Field A., 2015, DISCOVERING STAT USI, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Happe FGE, 1998, DEV PSYCHOL, V34, P358, DOI 10.1037/0012-1649.34.2.358; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hartwright CE, 2015, NEUROPSYCHOLOGIA, V67, P183, DOI 10.1016/j.neuropsychologia.2014.12.015; Hartwright CE, 2012, NEUROIMAGE, V61, P921, DOI 10.1016/j.neuroimage.2012.03.012; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Krach S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-9; Le Bouc R, 2012, BRAIN, V135, P3026, DOI 10.1093/brain/aws237; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Leslie AM, 1998, DEVELOPMENTAL SCI, V1, P247, DOI 10.1111/1467-7687.00038; Li XM, 2013, INT J PSYCHOL, V48, P715, DOI 10.1080/00207594.2012.673724; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Maurage F, 2015, ALCOHOL CLIN EXP RES, V39, P980, DOI 10.1111/acer.12717; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; Mitchell RLC, 2015, NEUROPSYCHOLOGIA, V70, P1, DOI 10.1016/j.neuropsychologia.2015.02.018; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Phillips LH, 2011, COGNITION, V120, P236, DOI 10.1016/j.cognition.2011.05.003; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; Sabbagh MA, 2004, J COGNITIVE NEUROSCI, V16, P415, DOI 10.1162/089892904322926755; Saltzman J, 2000, J INT NEUROPSYCH SOC, V6, P781, DOI 10.1017/S1355617700677056; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Samson D, 2007, NEUROPSYCHOLOGIA, V45, P2561, DOI 10.1016/j.neuropsychologia.2007.03.013; Samson D, 2015, CORTEX, V70, P189, DOI 10.1016/j.cortex.2014.12.021; Samson D, 2009, J NEUROPSYCHOL, V3, P3, DOI 10.1348/174866408X377883; Sandoz M, 2014, AGING MENT HEALTH, V18, P815, DOI 10.1080/13607863.2014.899974; Sarfati Y, 2003, COMIC STRIP TASK ATT; Schneider D, 2014, COGNITION, V133, P43, DOI 10.1016/j.cognition.2014.05.016; Schneider D, 2013, COGNITION, V129, P410, DOI 10.1016/j.cognition.2013.08.004; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Slessor G, 2007, PSYCHOL AGING, V22, P639, DOI 10.1037/0882-7974.22.3.639; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Veroude K, 2014, SOC COGN AFFECT NEUR, V9, P513, DOI 10.1093/scan/nst015; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; White S, 2009, CHILD DEV, V80, P1097, DOI 10.1111/j.1467-8624.2009.01319.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Young AW, 2002, FACIAL EXPRESSIONS E	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0190295	10.1371/journal.pone.0190295	http://dx.doi.org/10.1371/journal.pone.0190295			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU1NX	29381730	Green Published, gold			2022-12-26	WOS:000423617800006
J	Khirfan, G; Naal, T; Abuhalimeh, B; Newman, J; Heresi, GA; Dweik, RA; Tonelli, AR				Khirfan, Ghaleb; Naal, Tawfeq; Abuhalimeh, Batool; Newman, Jennie; Heresi, Gustavo A.; Dweik, Raed A.; Tonelli, Adriano R.			Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension	PLOS ONE			English	Article							6-MINUTE WALK TEST; PROGNOSTIC VALUE; PULSE OXIMETRY; OXYGEN DESATURATION; MORTALITY; EXERCISE	Background The prevalence and prognostic implications of hypoxemia either at rest or during six-minute walk test (6MWT) in patients with idiopathic or heritable pulmonary arterial hypertension (IPAH or HPAH) have not been systemically studied. Objectives We sought to determine the prevalence, phenotypic and prognostic implications of hypoxemia in patients with IPAH and HPAH. Methods Patients with IPAH or HPAH were identified from the Cleveland Clinic Pulmonary Hypertension Registry. Pulse oximetry (SpO(2)) at rest and during 6MWT was used to define hypoxemia at rest or during activities when measurements were lower than 90%, respectively. Results A total of 292 patients (age 50.6 +/- 18.0 years, 73% females) with IPAH (88%) and HPAH (12%) were included. Of them, 143 (49%) had SpO(2) >90% at rest and during 6MWT, 89 (31%) subjects had hypoxemia during 6MWT and 60 (20%) had hypoxemia at rest. Patients with hypoxemia had older age, greater body mass index, higher prevalence of cardiovascular risk factors, worse functional capacity and pulmonary function tests but less severe pre-capillary pulmonary hypertension. Individuals with hypoxemia either at rest or during the initial 6MWT had worse long-term survival when compared to subjects without hypoxemia, even when adjusting fora great number of potential confounders. (HR: 2.5 (95% CI: 1.54-3.98)) Conclusions Hypoxemia in patients with IPAH and HPAH is associated with more comorbidities, less severe pre-capillary pulmonary hypertension and worse survival.	[Khirfan, Ghaleb] Cleveland Clin, Dept Internal Med, Med Inst, Cleveland, OH 44106 USA; [Naal, Tawfeq; Abuhalimeh, Batool; Newman, Jennie] Cleveland Clin, Cleveland, OH 44106 USA; [Heresi, Gustavo A.; Dweik, Raed A.; Tonelli, Adriano R.] Cleveland Clin, Dept Pulm & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Khirfan, G (corresponding author), Cleveland Clin, Dept Internal Med, Med Inst, Cleveland, OH 44106 USA.	Khirfang@ccf.org	Khirfan, Ghaleb/AAK-3759-2021	Khirfan, Ghaleb/0000-0001-8506-4676; Tonelli, Adriano/0000-0002-2321-9545	National Institute of Health, NIH [R01HL130307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130307] Funding Source: NIH RePORTER	National Institute of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.R.T. is supported by National Institute of Health, NIH grant #R01HL130307, https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casanova C, 2008, CHEST, V134, P746, DOI 10.1378/chest.08-0520; Chan ED, 2013, RESP MED, V107, P789, DOI 10.1016/j.rmed.2013.02.004; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Hoeper MM, 2007, EUR RESPIR J, V29, P944, DOI 10.1183/09031936.00134506; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Paciocco G, 2001, EUR RESPIR J, V17, P647, DOI 10.1183/09031936.01.17406470; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Tonelli AR, 2013, AM J RESP CRIT CARE, V188, P365, DOI 10.1164/rccm.201209-1640OC; Trip P, 2013, EUR RESPIR J, V42, P1575, DOI 10.1183/09031936.00184412; van Gestel AJR, 2012, RESPIRATION, V84, P353, DOI 10.1159/000332833; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; WEBB RK, 1991, ANAESTHESIA, V46, P207, DOI 10.1111/j.1365-2044.1991.tb09411.x; Wouters PF, 2002, ANESTH ANALG, V94, pS13; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001	20	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191869	10.1371/journal.pone.0191869	http://dx.doi.org/10.1371/journal.pone.0191869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377954	gold, Green Published, Green Submitted			2022-12-26	WOS:000423514700036
J	Costa, OYD; Tupinamba, DD; Bergmann, JC; Barreto, CC; Quirino, BF				de Assis Costa, Ohana Yonara; Tupinamba, Daiva Domenech; Bergmann, Jessica Carvalho; Barreto, Cristine Chaves; Quirino, Betania Ferraz			Fungal diversity in oil palm leaves showing symptoms of Fatal Yellowing disease	PLOS ONE			English	Article							BUD ROT; SP NOV.; IDENTIFICATION; SEARCH	Oil palm (Elaeis guineensis Jacq.) is an excellent source of vegetable oil for biodiesel production; however, there are still some limitations for its cultivation in Brazil such as Fatal Yellowing (FY) disease. FY has been studied for many years, but its causal agent has never been determined. In Colombia and nearby countries, it was reported that the causal agent of Fatal Yellowing (Pudricio A n del Cogollo) is the oomycete Phytophthora palmivora, however, several authors claim that Fatal Yellowing and Pudricio A n del Cogollo (PC) are different diseases. The major aims of this work were to test, using molecular biology tools, Brazilian oil palm trees for the co-occurrence of the oomycete Phytophthora and FY symptoms, and to characterize the fungal diversity in FY diseased and healthy leaves by next generation sequencing. Investigation with specific primers for the genus Phytophthora showed amplification in only one of the samples. Analysis of the fungal ITS region demonstrated that, at the genus level, different groups predominated in all symptomatic samples, while Pyrenochaetopsis and unclassified fungi predominated in all asymptomatic samples. Our results show that fungal communities were not the same between samples at the same stage of the disease or among all the symptomatic samples. This is the first study that describes the evolution of the microbial community in the course of plant disease and also the first work to use high throughput next generation sequencing to evaluate the fungal community associated with leaves of oil palm trees with and without symptoms of FY.	[de Assis Costa, Ohana Yonara; Bergmann, Jessica Carvalho; Quirino, Betania Ferraz] Embrapa Agroenergy, Brasilia, DF, Brazil; [Tupinamba, Daiva Domenech] Embrapa Sede, Brasilia, DF, Brazil; [Bergmann, Jessica Carvalho; Barreto, Cristine Chaves; Quirino, Betania Ferraz] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil; [de Assis Costa, Ohana Yonara] Netherlands Inst Ecol NIOO KNAW, Microbial Ecol Dept, Wageningen, Gelderland, Netherlands	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Quirino, BF (corresponding author), Embrapa Agroenergy, Brasilia, DF, Brazil.; Quirino, BF (corresponding author), Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil.	betania.quirino@embrapa.br	Quirino, Betania F/H-8835-2013; Barreto, Cristine Chaves/G-2846-2013; KNAW, NIOO-KNAW/A-4320-2012	Barreto, Cristine Chaves/0000-0001-5067-1329; Carvalho Bergmann, Jessica/0000-0002-6678-1853; KNAW, NIOO-KNAW/0000-0002-3835-159X; Quirino, Betania/0000-0002-7578-6314	FINEP (Dendepalm); FINEP/CNPq	FINEP (Dendepalm); FINEP/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by a grant from FINEP (Dendepalm) and OYAC received a fellowship from FINEP/CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, ENERGIA RENOVAVEL RE; Ayala LS, 1999, PESQUISA AMARELECIME, P319; Bergamin Filho Armando, 1998, Fitopatologia Brasileira, V23, P391; Bergmann JC, 2013, RENEW SUST ENERG REV, V21, P411, DOI 10.1016/j.rser.2012.12.058; BEUTHER E, 1992, J PHYTOPATHOL, V136, P297, DOI 10.1111/j.1439-0434.1992.tb01312.x; Boari AdJ, 2013, ESTUDOS FITOPATOGENO; Boari AJ, 2008, ESTUDOS REALIZADOS A; Boari AJ, 2012, 45 C BRAS FIT MAN AM; Brant LNC, 2017, SUSTAINABLE DEV ENER; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Carnauba JP, 2006, REV BRAS FRUTIC; Celestino Filho P, C BRAS ENT; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Corley RHV., 2015, OIL PALM, DOI DOI 10.1002/9781118953297; De Franqueville H, 2003, EXP AGR, V39, P225, DOI 10.1017/S0014479703001315; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; Dickie IA, 2012, ECOL LETT, V15, P133, DOI 10.1111/j.1461-0248.2011.01722.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drenth A, 2006, AUSTRALAS PLANT PATH, V35, P147, DOI 10.1071/AP06018; Dupont FH, 2015, REV ELECT GEST ED TE, V19; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giraldo A, 2015, PERSOONIA, V34, P10, DOI 10.3767/003158515X685364; Guevara LAA, 1999, REV PALMAS, V20, P7; Holmer L, 1997, MYCOL RES, V101, P714, DOI 10.1017/S0953756296003243; Jeewon R, 2003, MYCOL RES, V107, P1392, DOI 10.1017/S095375620300875X; Kaewwichian R, 2015, INT J SYST EVOL MICR, V65, P1297, DOI 10.1099/ijs.0.000101; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kielak AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00231; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lakomy P., 2016, FOR RES PAP, V77; Landell MF, 2014, INT J SYST EVOL MICR, V64, P1970, DOI 10.1099/ijs.0.059345-0; Laranjeira Francisco F., 1998, Fitopatologia Brasileira, V23, P397; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martinez G., 2010, PALMAS, V31, P334; MELLO F. O. T., 2007, INFORM EC SAO PAULO, V37, P28; Narvaez M. K., 2012, THESIS; Nieto LEP, 1996, REV PALMAS, V17; Oliveira RJVd, 2014, DIVERSIDADE IDENTIFI; Pinruan U, 2010, FUNGAL DIVERS, V41, P71, DOI 10.1007/s13225-010-0029-1; Quadros AFF, 2015, 19 SEM IN CIENT 3 SE; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rodrigues KF, 1994, MYCOL, V86; Rungjindamai N, 2008, FUNGAL DIVERS; Sarria G.A., 2008, PALMAS, V29, P31; Sarria-Villa GA, 2013, REV PALMAS, V34, P11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silva HM, 1989, RELATONO AVALIAC TRA, P5; Souza RLR, AMARELECIMENTO FATAL; Stackebrandt E, 1993, HDB NEW BACTERIAL SY; Swinburne T. R., 1993, Planter, V69, P15; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Torres G. A., 2008, REV PALMAS COLOMBIA, V29, P3; Treu Roland, 1998, Mycologist, V12, P10, DOI 10.1016/S0269-915X(98)80095-5; Tupinamba DD, 2016, ARCHAEA, V2016, DOI 10.1155/2016/3762159; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Zadoks JC, 1990, COMMENTS SPEAR ROT F	61	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191884	10.1371/journal.pone.0191884	http://dx.doi.org/10.1371/journal.pone.0191884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370299	gold, Green Submitted, Green Published			2022-12-26	WOS:000423416600112
J	Kim, J; Choi, SH; Ham, SJ; Cho, YC; Lee, SI; Kang, J; Woo, DC; Lee, WS; Yoo, JS; Kim, KW; Choi, Y				Kim, Jinil; Choi, Sang Hyun; Ham, Su Jung; Cho, Young Chul; Lee, Seul-I; Kang, Jeeheon; Woo, Dong-Cheol; Lee, Weon Sub; Yoo, Jin-San; Kim, Kyung Won; Choi, Yoonseok			Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; PHASE-III; BEVACIZUMAB; INHIBITION; VEGFR-2/KDR; STRATEGIES; DOCETAXEL; TARGETS	Purpose Targeting of vascular endothelial growth factor receptors (VEGFRs) has potential anti-angiogenic effects because VEGFR-2 is the major signaling regulator of VEGF/VEGFR pathways. We aimed to elucidate the drug mechanism and anti-tumor efficacy of TTAC-0001, a novel, fully human anti-VEGFR-2/KDR monoclonal antibody, in mouse orthotopic breast cancer model using multi-modal bioimaging. Materials and methods We used orthotopic xenograft tumor model in which human breast cancer cells (MDA-MB231) were injected into the right mammary fat pad of Balb/c nude mice. We investigated its biodistribution using serial fluorescence imaging after injecting fluorescent-labelled-drug and mode of action using Matrigel plug angiogenesis assays. The anti-tumor efficacy of drug was assessed using ultrasonography and bioluminescence imaging. Histopathologic analyses, including hematoxylin and eosin staining and immunohistochemistry with anti-CD31 and anti-Ki-67 antibodies, were performed. Each experiment had four groups: control, bevacizumab 10 mg/kg (BVZ-10 group), TTAC-0001 2 mg/kg (TTAC-2 group), and TTAC-0001 10 mg/kg (TTAC-10 group). Results The TTAC-10 group showed good tumor targeting that lasted for at least 6 days and had a good anti-angiogenic effect with decreased hemoglobin content and fewer CD31-positive cells in the Matrigel plug. Compared with BVZ-10 and TTAC-2 groups, the TTAC-10 group showed the strongest anti-tumor efficacy, inhibiting tumor growth as detected by ultrasonography and bioluminescence imaging. The TTAC-10 group also showed the lowest viable tumor and micro-vessel areas and the lowest Ki-67 index in histopathologic analyses. Conclusion We firstly demonstrated that TTAC-0001 effectively inhibited tumor growth and neovascularization in mouse orthotopic breast cancer model. It may provide a future treatment option for breast cancer.	[Kim, Jinil; Choi, Sang Hyun; Kim, Kyung Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Jinil; Choi, Sang Hyun; Kim, Kyung Won] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Jinil; Ham, Su Jung; Cho, Young Chul; Lee, Seul-I; Kang, Jeeheon; Woo, Dong-Cheol; Kim, Kyung Won] Asan Med Ctr, Asan Inst Life Sci, Bioimaging Ctr, Seoul, South Korea; PharmAbcine Inc, Daejeon Bioventure Town, Daejeon, South Korea; [Choi, Yoonseok] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Med Res Inst, Gangwon Do, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, KW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, KW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.; Kim, KW (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Bioimaging Ctr, Seoul, South Korea.; Choi, Y (corresponding author), Univ Ulsan, Coll Med, Gangneung Asan Hosp, Med Res Inst, Gangwon Do, South Korea.	medimash@gmail.com; yschoi21rad@gmail.com	Choi, Sang Hyun/AAE-4828-2022	Choi, Sang Hyun/0000-0002-6898-6617; Kim, Kyung Won/0000-0002-1532-5970	Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education [HI14C1090, 2016R1D1A1A02937258]; Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1090]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1A02937258]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This study was supported by the Ministry of Health & Welfare, Republic of Korea; contract grant number (HI14C1090), a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1A02937258). The funding organization did not play a role in the study design,This study was supported by the Ministry of Health & Welfare, Republic of Korea; contract grant number (HI14C1090), a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1A02937258). The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding organization provided financial support in the form of authors' salaries [J. Kim, S. J. Ham, J Kang, Y. Choi], and research materials. The PharmAbcine employees (W. S. Lee, J-S Yoo) provided the antiangiogenic agent, TTAC-0001, and participated in the study design and critical revision of the manuscript. They did not have access to the data collection and analysis.; This study was supported by Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea; contract grant number (HI14C1090) and a grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1A02937258).	Aalders KC, 2017, CANCER TREAT REV, V53, P98, DOI 10.1016/j.ctrv.2016.12.009; Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; BAGULEY BC, 1991, EUR J CANCER, V27, P482, DOI 10.1016/0277-5379(91)90391-P; Brekken RA, 1998, CANCER RES, V58, P1952; Cardoso F, 2017, BREAST, V31, P244, DOI 10.1016/j.breast.2016.10.001; Dufort S, 2010, BBA-BIOMEMBRANES, V1798, P2266, DOI 10.1016/j.bbamem.2010.03.016; El-Deiry WS, 2006, J CLIN ONCOL, V24, P3261, DOI 10.1200/JCO.2006.06.5623; Fontanella C, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.14; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gianni L, 2013, J CLIN ONCOL, V31, P1719, DOI 10.1200/JCO.2012.44.7912; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kim DG, 2015, MABS-AUSTIN, V7, P1195, DOI 10.1080/19420862.2015.1086854; Kocaturk B, 2015, JOVE-J VIS EXP, DOI 10.3791/51967; Kuhlmann J, 1999, INT J CLIN PHARM TH, V37, P575; Lee SH, 2011, ARCH PHARM RES, V34, P1223, DOI 10.1007/s12272-011-0821-9; Lee SJ, 2017, INVEST NEW DRUGS; Lee WS, 2015, MABS-AUSTIN, V7, P957, DOI 10.1080/19420862.2015.1045168; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Mancini P, 2014, CANCERS, V6, P2187, DOI 10.3390/cancers6042187; Michishita M, 2016, J VET MED SCI, V78, P685, DOI 10.1292/jvms.15-0550; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qiu Wanglong, 2013, Methods Mol Biol, V980, P215, DOI 10.1007/978-1-62703-287-2_11; Rezaee R, 2017, EXPERT OPIN DRUG DIS, V12, P237, DOI 10.1080/17460441.2017.1281245; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tampellini M, 2016, EXPERT OPIN INV DRUG, V25, P507, DOI 10.1517/13543784.2016.1161754; Virostko J, 2009, METHODS MOL BIOL, V574, P15, DOI 10.1007/978-1-60327-321-3_2; Virostko J, 2009, MOL IMAGING BIOL, V11, P204, DOI 10.1007/s11307-008-0193-9; Weber WA, 2008, NAT CLIN PRACT ONCOL, V5, P44, DOI 10.1038/ncponc0982; Weidner N, 1999, J PATHOL, V189, P297; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Zhu ZP, 2002, CURR CANCER DRUG TAR, V2, P135, DOI 10.2174/1568009023333881; Zhu ZP, 1999, CANCER LETT, V136, P203, DOI 10.1016/S0304-3835(98)00324-3	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0187063	10.1371/journal.pone.0187063	http://dx.doi.org/10.1371/journal.pone.0187063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370209	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600002
J	Chaddock-Heyman, L; Weng, TB; Kienzler, C; Erickson, KI; Voss, MW; Drollette, ES; Raine, LB; Kao, SC; Hillman, CH; Kramer, AF				Chaddock-Heyman, Laura; Weng, Timothy B.; Kienzler, Caitlin; Erickson, Kirk I.; Voss, Michelle W.; Drollette, Eric S.; Raine, Lauren B.; Kao, Shih-Chun; Hillman, Charles H.; Kramer, Arthur F.			Scholastic performance and functional connectivity of brain networks in children	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; DEFAULT NETWORK; COGNITIVE CONTROL; PHYSICAL-ACTIVITY; CORTEX; ARCHITECTURE; TASK; FMRI; ACHIEVEMENT	One of the keys to understanding scholastic success is to determine the neural processes involved in school performance. The present study is the first to use a whole-brain connectivity approach to explore whether functional connectivity of resting state brain networks is associated with scholastic performance in seventy-four 7- to 9-year-old children. We demonstrate that children with higher scholastic performance across reading, math and language have more integrated and interconnected resting state networks, specifically the default mode network, salience network, and frontoparietal network. To add specificity, core regions of the dorsal attention and visual networks did not relate to scholastic performance. The results extend the cognitive role of brain networks in children as well as suggest the importance of network connectivity in scholastic success.	[Chaddock-Heyman, Laura; Kienzler, Caitlin; Kramer, Arthur F.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Weng, Timothy B.; Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Drollette, Eric S.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Raine, Lauren B.; Kao, Shih-Chun; Hillman, Charles H.; Kramer, Arthur F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Hillman, Charles H.] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA; [Kramer, Arthur F.] Northeastern Univ, Off Provost, Boston, MA 02115 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Greensboro; Northeastern University; Northeastern University; Northeastern University	Chaddock-Heyman, L (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	lchaddo2@illinois.edu	Kramer, Arthur/AAB-2937-2019; Hillman, Charles/AAD-4828-2019	Kramer, Arthur/0000-0001-5870-2724; Hillman, Charles/0000-0002-3722-5612; KAO, SHIH-CHUN/0000-0001-8880-0851	National Institute of Child Health and Human Development Grant [HD069381]	National Institute of Child Health and Human Development Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development Grant HD069381.	Andersson J. R., 2007, TR07JA1 NONLINEAR OP; Andersson JLR, 2007, TR07JA2 NONLINEAR RE; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birnbaum AS, 2002, AM J HEALTH BEHAV, V26, P284, DOI 10.5993/AJHB.26.4.5; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chaddock-Heyman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134115; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Evans TM, 2015, J NEUROSCI, V35, P11743, DOI 10.1523/JNEUROSCI.0216-15.2015; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GERNSBACHER MA, 1993, PSYCHOL SCI, V4, P294, DOI 10.1111/j.1467-9280.1993.tb00567.x; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grieco LA, 2009, MED SCI SPORT EXER, V41, P1921, DOI 10.1249/MSS.0b013e3181a61495; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillman CH, 2012, DEV COGN NEUROS-NETH, V2, pS90, DOI 10.1016/j.dcn.2011.07.004; Jensen A.R., 1998, G FACTOR SCI MENTAL; JENSEN AR, 1992, PERS INDIV DIFFER, V13, P869, DOI 10.1016/0191-8869(92)90004-9; Kaufman A.S., 2004, KAUFMAN TEST ED ACHI; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kuncel NR, 2007, SCIENCE, V315, P1080, DOI 10.1126/science.1136618; Kuncel NR, 2004, J PERS SOC PSYCHOL, V86, P148, DOI 10.1037/0022-3514.86.1.148; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Mahar MT, 2006, MED SCI SPORT EXER, V38, P2086, DOI 10.1249/01.mss.0000235359.16685.a3; Marek S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002328; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passolunghi MC, 2001, J EXP CHILD PSYCHOL, V80, P44, DOI 10.1006/jecp.2000.2626; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Voss MW, 2016, NEUROIMAGE, V131, P113, DOI 10.1016/j.neuroimage.2015.10.044; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Weng TB, 2016, BRAIN PLAST, P1; Woodcock R. W., 1997, WOODCOCK JOHNSON TES; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	67	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190073	10.1371/journal.pone.0190073	http://dx.doi.org/10.1371/journal.pone.0190073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364911	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500009
J	Counihan, TD; Waite, IR; Casper, AF; Ward, DL; Sauer, JS; Irwin, ER; Chapman, CG; Ickes, BS; Paukert, CP; Kosovich, JJ; Bayer, JM				Counihan, Timothy D.; Waite, Ian R.; Casper, Andrew F.; Ward, David L.; Sauer, Jennifer S.; Irwin, Elise R.; Chapman, Colin G.; Ickes, Brian S.; Paukert, Craig P.; Kosovich, John J.; Bayer, Jennifer M.			Can data from disparate long-term fish monitoring programs be used to increase our understanding of regional and continental trends in large river assemblages?	PLOS ONE			English	Article							ENDANGERED HUMPBACK CHUB; UPPER MISSISSIPPI RIVER; ALTERED FLOW REGIMES; LOWER COLUMBIA RIVER; COLORADO RIVER; ILLINOIS RIVER; GRAND-CANYON; ENVIRONMENTAL FLOWS; BIOTIC INTEGRITY; TALLAPOOSA RIVER	Understanding trends in the diverse resources provided by large rivers will help balance tradeoffs among stakeholders and inform strategies to mitigate the effects of landscape scale stressors such as climate change and invasive species. Absent a cohesive coordinated effort to assess trends in important large river resources, a logical starting point is to assess our ability to draw inferences from existing efforts. In this paper, we use a common analytical framework to analyze data from five disparate fish monitoring programs to better understand the nature of spatial and temporal trends in large river fish assemblages. We evaluated data from programs that monitor fishes in the Colorado, Columbia, Illinois, Mississippi, and Tallapoosa rivers using non-metric dimensional scaling ordinations and associated tests to evaluate trends in fish assemblage structure and native fish biodiversity. Our results indicate that fish assemblages exhibited significant spatial and temporal trends in all five of the rivers. We also document native species diversity trends that were variable within and between rivers and generally more evident in rivers with higher species richness and programs of longer duration. We discuss shared and basin-specific landscape level stressors. Having a basic understanding of the nature and extent of trends in fish assemblages is a necessary first step towards understanding factors affecting biodiversity and fisheries in large rivers.	[Counihan, Timothy D.] US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Washington, DC 20242 USA; [Waite, Ian R.] US Geol Survey, Oregon Water Sci Ctr, Portland, OR USA; [Casper, Andrew F.] Illinois Nat Hist Survey, Illinois River Biol Stn, Havana, IL USA; [Ward, David L.] US Geol Survey, Southwest Biol Sci Ctr, Grand Canyon Monitoring & Res Ctr, Flagstaff, AZ 86001 USA; [Sauer, Jennifer S.; Ickes, Brian S.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA; [Irwin, Elise R.] Auburn Univ, US Geol Survey, Sch Forestry & Wildlife Sci, Alabama Cooperat Fish & Wildlife Res Unit, Auburn, AL 36849 USA; [Chapman, Colin G.] Oregon Dept Fish & Wildlife, Ocean Salmon & Columbia River Program, Clackamas, OR USA; [Paukert, Craig P.] Univ Missouri, US Geol Survey, Sch Nat Resources, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO USA; [Kosovich, John J.] US Geol Survey, Core Sci Analyt Synth & Lib, Lakewood, CO 80225 USA; [Bayer, Jennifer M.] US Geol Survey, Northwest Reg & Pacific Northwest Aquat Monitorin, Seattle, WA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Illinois Natural History Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Auburn University System; Auburn University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Counihan, TD (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Washington, DC 20242 USA.	tcounihan@usgs.gov	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; Paukert, Craig/0000-0002-9369-8545; Casper, Andrew/0000-0003-3450-0209; Bayer, Jennifer/0000-0001-9564-3110	US Bureau of Reclamation through the Glen Canyon Dam Adaptive Management Program; Bonneville Power Administration [1986-050-00]; Federal Aid in Sport Fish Restoration Act; state of Oregon; Federal Aid in Sport Fish Restoration Act [P.L. 81-6814]; Illinois Department of Natural Resources; U.S. Army Corps of Engineers Upper Mississippi River Restoration Program; Alabama Department of Conservation and Natural Resources; Alabama Power Company; USGS; Wildlife Management Institute; USFWS; USGS Ecosystems Mission Area; USGS Core Science Systems Mission Area	US Bureau of Reclamation through the Glen Canyon Dam Adaptive Management Program; Bonneville Power Administration; Federal Aid in Sport Fish Restoration Act; state of Oregon; Federal Aid in Sport Fish Restoration Act; Illinois Department of Natural Resources; U.S. Army Corps of Engineers Upper Mississippi River Restoration Program; Alabama Department of Conservation and Natural Resources; Alabama Power Company; USGS(United States Geological Survey); Wildlife Management Institute; USFWS(US Fish & Wildlife Service); USGS Ecosystems Mission Area; USGS Core Science Systems Mission Area	Funding for the work on the Colorado River was provided by the US Bureau of Reclamation through the Glen Canyon Dam Adaptive Management Program. Work on the Columbia River was funded by the Bonneville Power Administration (project number 1986-050-00), the Federal Aid in Sport Fish Restoration Act administered by the U.S. Fish and Wildlife Service (USFWS), and the state of Oregon. The Illinois River portion of this project was supported by the Federal Aid in Sport Fish Restoration Act (P.L. 81-6814, Dingell-Johnson/Wallop-Breaux), with funds administered by the US Fish and Wildlife Service and the Illinois Department of Natural Resources. Fish monitoring activities on the Mississippi River were funded by the U.S. Army Corps of Engineers Upper Mississippi River Restoration Program. Work on the Tallapoosa River was funded by the Alabama Department of Conservation and Natural Resources and the Alabama Power Company. The USGS provided funding for activities directly related to the formation of this manuscript.; We would like to acknowledge the assistance of the many staff at the Alabama Cooperative Fish and Wildlife Research Unit (Alabama CFWRU), Columbia River Intertribal Fish Commission, Illinois River Biological Station of the Illinois Natural History Survey, Oregon Department of Fish and Wildlife, USGS Grand Canyon Monitoring and Research Center, USGS Upper Midwest Environmental Science Center, and Washington Department of Fish and Wildlife that participated in the design, conduct, and processing of the long-term monitoring data we present. We also acknowledge Andrea Ostroff of the USGS Ecosystems Mission Area and Alexa McKerrow of the USGS Core Science Systems Mission Area for facilitating the contract that funded this manuscript. Funding for the work on the Colorado River was provided by the US Bureau of Reclamation through the Glen Canyon Dam Adaptive Management Program. Work on the Columbia River was funded by the Bonneville Power Administration (project number 1986-050-00), the Federal Aid in Sport Fish Restoration Act administered by the U.S. Fish and Wildlife Service (USFWS), and the state of Oregon. The Illinois River portion of this project was supported by the Federal Aid in Sport Fish Restoration Act (P.L. 81-6814, Dingell-Johnson/Wallop-Breaux), with funds administered by the USFWS and the Illinois Department of Natural Resources and under the authorization of the University of Illinois Institutional Animal Care and Use Committee permit number 14023. Fish monitoring activities on the Mississippi River were funded by the U.S. Army Corps of Engineer's Upper Mississippi River Restoration Program. Work on the Tallapoosa River was funded by the Alabama Department of Conservation and Natural Resources and the Alabama Power Company. The Cooperators of the Alabama Unit are: USGS; Alabama Agricultural Experiment Station, Auburn University, Wildlife Management Institute; Alabama Department of Natural Resources, Division of Wildlife and Freshwater Fisheries and; USFWS. The Tallapoosa research was conducted using live animals under Auburn University IACUC protocol # 96-0256. The participating CFWRUs are sponsored jointly by the USGS, the Wildlife Management Institute and the USFWS in addition to state and university cooperators: the Alabama Department of Conservation Natural Resources and Auburn University (Alabama CFWRU), and Missouri Department of Conservation and University of Missouri (Missouri CFWRU). The USGS provided funding for activities directly related to the formation of this manuscript. We also thank Barry Johnson (retired), Katie Pierson, and Meghan Dethloff of the USGS for their assistance with the project. The use of trade, firm, or corporation names in this publication is for informational use only and does not constitute an official endorsement or approval by the U. S. Government.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Alexander J.S., 2012, BRIEF HIST SUMMARY E; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; ALLAN JD, 1993, BIOSCIENCE, V43, P32, DOI 10.2307/1312104; Angradi TR, 2009, ENVIRON MONIT ASSESS, V152, P425, DOI 10.1007/s10661-008-0327-1; Angradi TR, 2009, ECOL INDIC, V9, P748, DOI 10.1016/j.ecolind.2008.09.007; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Avery LA, 2015, N AM J FISH MANAGE, V35, P671, DOI 10.1080/02755947.2015.1040560; BAIN M B, 1985, North American Journal of Fisheries Management, V5, P499, DOI 10.1577/1548-8659(1985)5<499:QSSFHA>2.0.CO;2; Barko VA, 2004, AM MIDL NAT, V152, P369, DOI 10.1674/0003-0031(2004)152[0369:IEGASP]2.0.CO;2; BHOWMIK NG, 1989, J HYDROL, V105, P187, DOI 10.1016/0022-1694(89)90103-0; Boschung H. T., 2004, FISHES ALABAMA; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Carlisle D. M., 2013, US GEOLOGICAL SURVEY, P120; Christensen NS, 2004, CLIMATIC CHANGE, V62, P337, DOI 10.1023/B:CLIM.0000013684.13621.1f; Coggins LG, 2011, T AM FISH SOC, V140, P456, DOI 10.1080/00028487.2011.572009; Counihan TD, 2014, SCI TOTAL ENVIRON, V484, P331, DOI 10.1016/j.scitotenv.2014.03.013; Delong Michael D., 2011, River Systems, V19, P177, DOI 10.1127/1868-5749/2011/019-0036; Delong MD, 2010, HYDROBIOLOGIA, V640, P89, DOI 10.1007/s10750-009-0065-6; Gido KB, 2004, BIOL CONSERV, V118, P121, DOI 10.1016/j.biocon.2003.07.015; Gloss S., 2005, STATE COLORADO RIVER, V1282; Gorley R.N., 2006, USER MANUAL TUTORIAL; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Hesse Larry W., 1993, North American Journal of Fisheries Management, V13, P360, DOI 10.1577/1548-8675(1993)013<0360:AAHFTM>2.3.CO;2; Humphries P, 2002, FRESHWATER BIOL, V47, P1307, DOI 10.1046/j.1365-2427.2002.00871.x; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Irwin E. R., 2014, P 1 INT S EN MECH AB; Irwin ER, 2002, CONSERV BIOL, V16, P1212, DOI 10.1046/j.1523-1739.2002.00514.x; Irwin ER, 2009, P 3 INT C RES WAT, P65; Irwin ER, 2011, 20111 ALCFWRU AL DEP; Jager HI, 2001, ENVIRON BIOL FISH, V60, P347, DOI 10.1023/A:1011036127663; Johnson B. L., 2008, 2008T002 LTRMP US GE; Gomez MJ, 2012, SCI TOTAL ENVIRON, V420, P134, DOI 10.1016/j.scitotenv.2012.01.029; Kammerer J. C., 1990, LARGEST RIVERS US; Korman J, 2004, RIVER RES APPL, V20, P379, DOI 10.1002/rra.749; Korman J, 2016, CAN J FISH AQUAT SCI, V73, P105, DOI 10.1139/cjfas-2015-0101; Kosnik L, 2008, ENERG POLICY, V36, P3252, DOI 10.1016/j.enpol.2008.05.009; L?pez-L?pez, 2012, NEW ADV CONTRIBUTION, DOI [10.5772/54825, DOI 10.5772/54825]; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lohner TW, 2013, ENVIRON MONIT ASSESS, V185, P9385, DOI 10.1007/s10661-013-3258-4; Maret TR, 2002, T AM FISH SOC, V131, P865, DOI 10.1577/1548-8659(2002)131<0865:FAAEVA>2.0.CO;2; McClelland MA, 2006, J FRESHWATER ECOL, V21, P91, DOI 10.1080/02705060.2006.9664101; McClelland MA, 2012, FISHERIES, V37, P340, DOI 10.1080/03632415.2012.704815; Melis TS, 2012, RIVER RES APPL, V28, P764, DOI 10.1002/rra.1503; Nakagawa H, 2014, ECOL FRESHW FISH, V23, P208, DOI 10.1111/eff.12070; Nilsen E, 2014, SCI TOTAL ENVIRON, V484, P344, DOI 10.1016/j.scitotenv.2013.04.012; O'Hara TM, 2008, 2008T001 LTRMP US GE; Olden JD, 2010, FRESHWATER BIOL, V55, P86, DOI 10.1111/j.1365-2427.2009.02179.x; Parker J, 2015, RIVER RES APPL; Parsons M, 2007, GEOMORPHOLOGY, V89, P127, DOI 10.1016/j.geomorph.2006.07.016; Pegg MA, 2004, ECOL FRESHW FISH, V13, P125, DOI 10.1111/j.1600-0633.2004.00046.x; Peterson JT, 2001, T AM FISH SOC, V130, P911, DOI 10.1577/1548-8659(2001)130<0911:TROFAT>2.0.CO;2; Pierce CL, 2014, RIVER RES APPL, V30, P427, DOI 10.1002/rra.2654; Pitlo J, 1998, USDA TECHNICAL B, V7; Poff NL, 2010, FRESHWATER BIOL, V55, P194, DOI 10.1111/j.1365-2427.2009.02272.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 2003, RIVER FLOWS WATER WA; Policansky D., 2002, RECREATIONAL FISHERI, P74, DOI DOI 10.1002/9780470995402.CH6; Pracheil BM, 2013, FRONT ECOL ENVIRON, V11, P124, DOI 10.1890/120179; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Rasmussen JL, 1979, COMPENDIUM FISHERY I; Ratcliff EN, 2014, 2013P00191 US ARM CO; Robinson AT, 2001, N AM J FISH MANAGE, V21, P809, DOI 10.1577/1548-8675(2001)021<0809:JGONFI>2.0.CO;2; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sanderson BL, 2009, BIOSCIENCE, V59, P245, DOI 10.1525/bio.2009.59.3.9; Sass GG, 2017, FISHERIES, V42, P197, DOI 10.1080/03632415.2017.1276344; Schloesser Joshua T., 2012, Endangered Species Research, V16, P211, DOI 10.3354/esr00399; Simenstad CA, 2011, COLUMBIA RIVER ESTUA, pi; Solley WB., 1998, ESTIMATED USE WATER, V1200; Solomon LE, 2016, BIOL INVASI IN PRESS; THEILING C, 1999, ECOLOGICAL STATUS TR; Thorp JH, 2010, RIVERINE ECOSYSTEM S; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; TRAVNICHEK VH, 1994, J FRESHWATER ECOL, V9, P207, DOI 10.1080/02705060.1994.9664888; Tucker JK, 1996, J FRESHWATER ECOL, V11, P363, DOI 10.1080/02705060.1996.9664459; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; U. S. Columbia Basin Tribes and Canadian First Nations, 2014, FISH PASS REINTR US; US Environmental Protection Agency (USEPA), 2013, 20460EPA841D130 OFF; Vernieu WS, 2013, 20131066 US GEOL SUR; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Waite IR, 2000, T AM FISHERIES SOC, V129; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Walters DM, 2003, HYDROBIOLOGIA, V494, P5, DOI 10.1023/A:1025412804074; Ward DL, 2017, FISHERIES, V42, P100, DOI 10.1080/03632415.2017.1276330; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Whittier TR, 2007, T AM FISH SOC, V136, P718, DOI 10.1577/T06-128.1; Williams B.K., 2012, ADAPTIVE MANAGEMENT; Yackulic CB, 2014, ECOL EVOL, V4, P1006, DOI 10.1002/ece3.990; Yin Y, 1995, 95T003 LTRMP NAT BIO; Zimmerman MP, 1999, T AM FISH SOC, V128, P1036, DOI 10.1577/1548-8659(1999)128<1036:FHOSBW>2.0.CO;2	91	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191472	10.1371/journal.pone.0191472	http://dx.doi.org/10.1371/journal.pone.0191472			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364953	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500050
J	Nakagawa, P; Romero, CA; Jiang, X; D'Ambrosio, M; Bordcoch, G; Peterson, EL; Harding, P; Yang, XP; Carretero, OA				Nakagawa, Pablo; Romero, Cesar A.; Jiang, Xu; D'Ambrosio, Martin; Bordcoch, Ginette; Peterson, Edward L.; Harding, Pamela; Yang, Xiao-Ping; Carretero, Oscar A.			Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; HEART-FAILURE; HYPERTENSIVE-RATS; KNOCKOUT MICE; INFLAMMATION; MACROPHAGES; INHIBITION; ACTIVATION; FIBROSIS; REPAIR	The natural peptide N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) decreases inflammation in chronic diseases such as hypertension and heart failure. However, Ac-SDKP effects on acute inflammatory responses during myocardial infarction (MI) are unknown. During the first 72 hours post-MI, neutrophils, M1 macrophages (pro-inflammatory), and M2 macrophages (pro-resolution) and release of myeloperoxidase (MPO) and matrix metalloproteinases (MMP) are involved in cardiac rupture. We hypothesized that in the acute stage of MI, Ac-SDKP decreases the incidence of cardiac rupture and mortality by preventing immune cell infiltration as well as by decreasing MPO and MMP expression. MI was induced by ligating the left descending coronary artery in C57BL/6 mice. Vehicle or Ac-SDKP (1.6 mg/kg/d) was infused via osmotic minipump. Cardiac immune cell infiltration was assessed by flow cytometry, cardiac MPO and MMP levels were measured at 24-48 hrs post-MI. Cardiac rupture and mortality incidence were determined at 7 days post-MI. In infarcted mice, Ac-SDKP significantly decreased cardiac rupture incidence from 51.0% (26 of 51 animals) to 27.3% (12 of 44) and mortality from 56.9% (29 of 51) to 31.8% (14 of 44). Ac-SDKP reduced M1 macrophages in cardiac tissue after MI, without affecting M2 macrophages and neutrophils. Ac-SDKP decreased MMP-9 activation in infarcted hearts with no changes on MPO expression. Ac-SDKP prevents cardiac rupture and decreases mortality post-acute MI. These protective effects of Ac-SDKP are associated with decreased pro-inflammatory M1 macrophage infiltration and MMP-9 activation.	[Nakagawa, Pablo; Romero, Cesar A.; Jiang, Xu; D'Ambrosio, Martin; Bordcoch, Ginette; Harding, Pamela; Yang, Xiao-Ping; Carretero, Oscar A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Peterson, Edward L.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Carretero, OA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA.	ocarret1@comcast.net			NIH [HL028982]; American Heart Association pre-doctoral fellowship [AHA 13PRE17100074]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL028982 to Oscar A. Carretero, and American Heart Association pre-doctoral fellowship AHA 13PRE17100074 to Pablo Nakagawa.	Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gonzalez GE, 2014, CLIN SCI, V126, P85, DOI 10.1042/CS20120619; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hinkel R, 2015, J MOL CELL CARDIOL, V87, P113, DOI 10.1016/j.yjmcc.2015.07.004; Hulsmans M, 2016, J MOL CELL CARDIOL, V93, P149, DOI 10.1016/j.yjmcc.2015.11.015; Liao TD, 2015, AM J PHYSIOL-RENAL, V308, pF1146, DOI 10.1152/ajprenal.00039.2015; Liao TD, 2010, HYPERTENSION, V55, P459, DOI 10.1161/HYPERTENSIONAHA.109.144568; Liu WX, 2015, CELL PHYSIOL BIOCHEM, V35, P2483, DOI 10.1159/000374048; Liu YH, 2002, HYPERTENSION, V39, P375, DOI 10.1161/hy02t2.102796; Ma XW, 2014, INT J CARDIOL, V175, P376, DOI 10.1016/j.ijcard.2014.05.016; Nakagawa P, 2012, AM J PHYSIOL-HEART C, V303, pH1114, DOI 10.1152/ajpheart.00300.2011; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Peng HM, 2014, AM J PHYSIOL-HEART C, V307, pH741, DOI 10.1152/ajpheart.00129.2014; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rhaleb NE, 2001, HYPERTENSION, V37, P827, DOI 10.1161/01.HYP.37.3.827; Sane DC, 2009, CARDIOL REV, V17, P293, DOI 10.1097/CRD.0b013e3181bf4ab4; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Yang XP, 1999, HYPERTENSION, V34, P24, DOI 10.1161/01.HYP.34.1.24; Zhu LP, 2016, AM J PHYSIOL-HEART C, V310, pH1176, DOI 10.1152/ajpheart.00252.2015	25	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190300	10.1371/journal.pone.0190300	http://dx.doi.org/10.1371/journal.pone.0190300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364896	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500012
J	Rahali, S; Li, Y; Anand-Srivastava, MB				Rahali, Sofiane; Li, Yuan; Anand-Srivastava, Madhu B.			Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; GI-ALPHA PROTEINS; NUCLEOTIDE REGULATORY PROTEIN; ENDOGENOUS ANGIOTENSIN-II; ENHANCED EXPRESSION; CLEARANCE RECEPTOR; ADENYLATE-CYCLASE; IN-VITRO; PROLIFERATION; PATHWAYS	Earlier studies have shown the implication of growth factor receptor activation in angiotensin II (Ang II)-induced hyperproliferation of aortic VSMC as well as in hyperproliferation of VSMC from spontaneously hypertensive rats (SHR). We previously showed that NPR-C specific agonist C-ANP4-23 attenuates the hyperproliferation of VSMC from SHR through the inhibition of MAP kinase, Gia protein signaling and overexpression of cell cycle proteins. The aim of the present study was to investigate if C-ANP4-23-mediated attenuation of hyperproliferation of VSMC from SHR also involves growth factor receptor activation and upstream signaling molecules. For this study, C-ANP 4 +/- 23 (10 nmole/kg body weight) was injected intraperitoneally into 2 week-old prehypertensive SHR and Wistar Kyoto (WKY) rats twice per week for 6 weeks. The blood pressure in SHR was significantly attenuated by C-ANP4-23 treatment. In addition, C-ANP4-23 treatment also attenuated the hyperproliferation of VSMC from SHR as well as the enhanced phosphorylation of EGF-R, PDGF-R, IGF-R and c-Src. Furthermore, the enhanced levels of superoxide anion, NADPH oxidase activity, and enhanced expression of Nox4, Nox1, Nox2 and P47 phox in SHR compared to WKY rats was also significantly attenuated by CANP4- 23 treatment. In addition, N-acetyl cysteine (NAC), a scavenger of O-2(-), inhibitors of growth factor receptors and of c-Src, all inhibited the overexpression of cell cycle proteins cyclin D1 and cdk4 in VSMC from SHR. These results suggest that in vivo treatment of SHR with C-ANP4-23 inhibits the enhanced oxidative stress, c-Src and EGF-R, PDGF-R, IGF-R activation which through the inhibition of overexpression of cell cycle proteins result in the attenuation of hyperproliferation of VSMC.	[Rahali, Sofiane; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ, Canada.	madhu.anand-srivastava@umontreal.ca			Heart and Stroke Foundation of Canada (HSFC) [G-15-0009078]	Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This work was supported by the Heart and Stroke Foundation of Canada (HSFC) [G-15-0009078]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931; ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; Arejian M, 2009, AM J PHYSIOL-HEART C, V296, pH1859, DOI 10.1152/ajpheart.01108.2008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CAHILL PA, 1991, BIOCHEM BIOPH RES CO, V179, P1606, DOI 10.1016/0006-291X(91)91758-5; Caniffi C, 2010, PEPTIDES, V31, P1309, DOI 10.1016/j.peptides.2010.03.030; Chabrashvili T, 2002, HYPERTENSION, V39, P269, DOI 10.1161/hy0202.103264; Daou GB, 2016, CAN J PHYSIOL PHARM, V94, P49, DOI 10.1139/cjpp-2015-0146; El Andalousi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076183; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; Griendling KK, 1997, CIRCULATION, V96, P3264; HAMET P, 1988, J HYPERTENS, V6, pS36, DOI 10.1097/00004872-198812040-00007; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; Kubo A, 1996, J CARDIOVASC PHARM, V27, P58, DOI 10.1097/00005344-199601000-00010; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; Lelievre V, 2001, J BIOL CHEM, V276, P43668, DOI 10.1074/jbc.M107341200; Levin ER, 1998, NEW ENGL J MED, V339, P321; LEVIN ER, 1991, AM J PHYSIOL, V261, pR453, DOI 10.1152/ajpregu.1991.261.2.R453; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; LIAU G, 1989, J BIOL CHEM, V264, P10315; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Lu MH, 2006, CLIN EXP HYPERTENS, V28, P463, DOI 10.1080/10641960600798747; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Mbong N, 2012, AM J PHYSIOL-HEART C, V302, pH1591, DOI 10.1152/ajpheart.00627.2011; McKillop IH, 1999, EUR J GASTROEN HEPAT, V11, P761, DOI 10.1097/00042737-199907000-00014; MICHEL JB, 1990, J CARDIOVASC PHARM, V16, pS4, DOI 10.1097/00005344-199006161-00003; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Prins BA, 1996, J BIOL CHEM, V271, P14156, DOI 10.1074/jbc.271.24.14156; Ren M, 2017, HUMAN MOL GENETICS; Sandoval YHG, 2011, CELL SIGNAL, V23, P1716, DOI 10.1016/j.cellsig.2011.06.006; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089; Satoh C, 2001, J CARDIOVASC PHARM, V37, P108, DOI 10.1097/00005344-200101000-00013; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Touyz RM, 2005, CIRC RES, V97, P1216, DOI 10.1161/01.RES.0000196745.09234.36	42	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191743	10.1371/journal.pone.0191743	http://dx.doi.org/10.1371/journal.pone.0191743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364969	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500072
J	Sogorski, M; Geisel, T; Priesemann, V				Sogorski, Mathias; Geisel, Theo; Priesemann, Viola			Correlated microtiming deviations in jazz and rock music	PLOS ONE			English	Article							RANGE TEMPORAL CORRELATIONS; NOISE; TIME; SYNCHRONIZATION; SPECTRA; SCIENCE	Musical rhythms performed by humans typically show temporal fluctuations. While they have been characterized in simple rhythmic tasks, it is an open question what is the nature of temporal fluctuations, when several musicians perform music jointly in all its natural complexity. To study such fluctuations in over 100 original jazz and rock/pop recordings played with and without metronome we developed a semi-automated workflow allowing the extraction of cymbal beat onsets with millisecond precision. Analyzing the inter-beat interval (IBI) time series revealed evidence for two long-range correlated processes characterized by power laws in the IBI power spectral densities. One process dominates on short timescales (t < 8 beats) and reflects microtiming variability in the generation of single beats. The other dominates on longer timescales and reflects slow tempo variations. Whereas the latter did not show differences between musical genres (jazz vs. rock/pop), the process on short time-scales showed higher variability for jazz recordings, indicating that jazz makes stronger use of microtiming fluctuations within a measure than rock/pop. Our results elucidate principles of rhythmic performance and can inspire algorithms for artificial music generation. By studying microtiming fluctuations in original music recordings, we bridge the gap between minimalistic tapping paradigms and expressive rhythmic performances.	[Sogorski, Mathias; Geisel, Theo; Priesemann, Viola] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Geisel, Theo; Priesemann, Viola] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Sogorski, Mathias; Geisel, Theo] Georg August Univ, Dept Phys, Gottingen, Germany	Max Planck Society; University of Gottingen	Priesemann, V (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.; Priesemann, V (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.	v.priesemann@gmx.de	Priesemann, Viola/R-3042-2017	Priesemann, Viola/0000-0001-8905-5873	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	All authors were supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beggs JM, 2003, J NEUROSCI, V23, P11167; Birkes D, 1993, WILEY SERIES PROBABI; Broyden C.G., 1970, IMA J APPL MATH, V6, P222, DOI [10.1093/imamat/6.3.222, DOI 10.1093/IMAMAT/6.3.222]; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; Delignieres D, 2004, HUM MOVEMENT SCI, V23, P87, DOI 10.1016/j.humov.2004.07.001; Delignieres D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007822; Ding MZ, 2002, BRAIN COGNITION, V48, P98, DOI 10.1006/brcg.2001.1306; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Hennig H., 2014, P NATL ACAD SCI USA, V2014, P1; Hennig H, 2012, PHYS TODAY, V65, P64, DOI 10.1063/PT.3.1650; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Huron D.B., 2006, SWEET ANTICIPATION M; Levina A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15140; Levitin DJ, 2012, P NATL ACAD SCI USA, V109, P3716, DOI 10.1073/pnas.1113828109; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Marom S, 2010, PROG NEUROBIOL, V90, P16, DOI 10.1016/j.pneurobio.2009.10.003; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; MUSHA T, 1985, IEEE T BIO-MED ENG, V32, P578, DOI 10.1109/TBME.1985.325457; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; Priesemann V, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00108; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Rasanen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127902; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Smit DJA, 2013, J NEUROSCI, V33, P11212, DOI 10.1523/JNEUROSCI.2816-12.2013; Torre K, 2008, BIOL CYBERN, V99, P159, DOI 10.1007/s00422-008-0247-8; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; West BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051917; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0186361	10.1371/journal.pone.0186361	http://dx.doi.org/10.1371/journal.pone.0186361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364920	Green Published, gold, Green Submitted			2022-12-26	WOS:000423412500001
J	Li, YM; Zhou, CH; Li, J; Liu, JY; Lin, LM; Li, L; Cao, DL; Li, Q; Wang, Z				Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Cao, Donglin; Li, Qing; Wang, Zhong			Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells	PLOS ONE			English	Article							T-CELLS; STRESS-RESPONSE; COLON-CANCER; PHASE-I; IMMUNOTHERAPY; CONSTRUCT; THERAPY; BLINATUMOMAB; EXPRESSION; PANKOMAB	Muc1 is one of the most studied tumor antigens. However, antibodies or antibody-toxin conjugates against Muc1 have not shown significant efficacy for tumors with Muc1 overexpression. In this study, we employed bispecific antibody approach to target Muc1 positive tumor cells. A novel bispecific antibody, Muc1-Bi-1, was constructed by linking single domain antibodies, anti-Muc1-VHH and anti-CD16-VHH. Muc1-Bi-2, the humanized form of Muc1-Bi-1, was also constructed by grafting. Both Muc1-Bi bispecific antibodies can be efficiently expressed and purified from bacteria. In vitro, the Muc1-Bi bispecific antibodies can recruit Natural Killer (NK) cells to drive potent and specific cell killing of Muc1-overexpressing tumor cells. In xenograft model, the Muc1-Bi bispecific antibodies can suppress tumor growth in the presence of human peripheral blood mononuclear cells (PBMC). These data suggested that the single domain based Muc1-Bi may provide a valid strategy for targeting tumors with Muc1 overexpression.	[Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Li, Qing; Wang, Zhong] Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Li, Qing; Wang, Zhong] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China; [Cao, Donglin] Guangdong Second Prov Gen Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, Q; Wang, Z (corresponding author), Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; Li, Q; Wang, Z (corresponding author), Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China.	liqing66@mail.sysu.edu.cn; wangzh357@mail.sysu.edu.cn			Department of Science and Technology of Guangdong Province (P.R.China), China [20160503]	Department of Science and Technology of Guangdong Province (P.R.China), China	This work was supported by the Department of Science and Technology of Guangdong Province (P.R.China) (20160503), China.	[Anonymous], 1998, TUMOUR BIOL J INT S1, V19, P1; Azhdarzadeh M, 2016, COLLOID SURFACE B, V143, P224, DOI 10.1016/j.colsurfb.2016.02.058; Bachanova Veronika, 2014, Critical Reviews in Oncogenesis, V19, P133; Betge J, 2016, VIRCHOWS ARCH, V469, P255, DOI 10.1007/s00428-016-1970-5; Chen SQ, 2016, HUM VACC IMMUNOTHER, V12, P2491, DOI 10.1080/21645515.2016.1187802; Chiu ML, 2016, CURR OPIN STRUC BIOL, V38, P163, DOI 10.1016/j.sbi.2016.07.012; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; David JM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1117738; Dong B, 2016, CANCER BIOL THER, V17, P364, DOI 10.1080/15384047.2016.1139266; Fiedler W, 2016, EUR J CANCER, V63, P55, DOI 10.1016/j.ejca.2016.05.003; Genitsch V, 2016, PROSTATE CANCER P D, V19, P242, DOI 10.1038/pcan.2016.11; Goebeler ME, 2016, J CLIN ONCOL, V34, P1104, DOI 10.1200/JCO.2014.59.1586; Goulart LR, 2004, REPROD BIOMED ONLINE, V8, P477, DOI 10.1016/S1472-6483(10)60933-9; Hiraki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26643; Ismaili A, 2007, BIOTECHNOL APPL BIOC, V47, P11, DOI 10.1042/BA20060071; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Lees Catherine J, 2016, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V37, P15, DOI 10.1515/prilozi-2016-0001; Li AF, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0201-4; Li L, 2015, J IMMUNOTHER, V38, P350, DOI 10.1097/CJI.0000000000000099; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Manoutcharian K, 2016, CURRENT NEUROPHARMAC; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Oak E, 2015, EXPERT OPIN INV DRUG, V24, P715, DOI 10.1517/13543784.2015.1021415; Oberst MD, 2014, MABS-AUSTIN, V6, P1571, DOI 10.4161/19420862.2014.975660; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Reis CA, 1998, INT J CANCER, V79, P402, DOI 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6; Reusch U, 2004, INT J CANCER, V112, P509, DOI 10.1002/ijc.20417; Rossi DL, 2014, MABS-AUSTIN, V6, P381, DOI 10.4161/mabs.27385; Rozan C, 2013, MOL CANCER THER, V12, P1481, DOI 10.1158/1535-7163.MCT-12-1012; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Singh R, 2007, CANCER BIOL THER, V6, P481, DOI 10.4161/cbt.6.4.4201; Souza-Fonseca-Guimaraes F, 2016, DISCOV MED, V21, P197; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Zhu M, 2016, CLIN PHARMACOKINET, V55, P1271, DOI 10.1007/s40262-016-0405-4	36	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191024	10.1371/journal.pone.0191024	http://dx.doi.org/10.1371/journal.pone.0191024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357376	Green Submitted, Green Published, gold			2022-12-26	WOS:000422919500009
J	Britch, SC; Linthicum, KJ; Aldridge, RL; Breidenbaugh, MS; Latham, MD; Connelly, PH; Rush, MJE; Remmers, JL; Kerce, JD; Silcox, CA				Britch, Seth C.; Linthicum, Kenneth J.; Aldridge, Robert L.; Breidenbaugh, Mark S.; Latham, Mark D.; Connelly, Peter H.; Rush, Mattie J. E.; Remmers, Jennifer L.; Kerce, Jerry D.; Silcox, Charles A.		US Navy Entomology Ctr Ex	Aerial ULV control of Aedes aegypti with naled (Dibrom) inside simulated rural village and urban cryptic habitats	PLOS ONE			English	Article							LOW-VOLUME APPLICATIONS; THERMAL FOG; ZIKA VIRUS; INSECTICIDE; DIPTERA; DENGUE; TRANSMISSION; PERFORMANCE; CULICIDAE; EFFICACY	We conducted aerial fixed wing ultra low volume (ULV) spray trials with naled to investigate penetration of exposed and simulated cryptic habitat within opened buildings, partially sealed buildings, and outdoor locations targeting sentinel adult Aedes aegypti mosquitoes in north central Florida. Mortality was observed in open and closed buildings and outdoors, even in mosquitoes placed in cryptic habitats. Observations on the impact of building type, mosquito exposure method such as placement in cryptic habitat, and spray nozzle size on mosquito mortality are described and analyzed.	[Britch, Seth C.; Linthicum, Kenneth J.; Aldridge, Robert L.; Rush, Mattie J. E.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Breidenbaugh, Mark S.; Remmers, Jennifer L.] Youngstown Air Reserve Stn, Aerial Spray Branch, 910 Airlift Wing,757 Airlift Squadron, Vienna, OH USA; [Latham, Mark D.] Manatee Cty Mosquito Control Dist, West Palmetto, FL USA; [Connelly, Peter H.; Silcox, Charles A.] AMVAC Environm Prod, Newport Beach, CA USA; [Kerce, Jerry D.] Camp Blanding Joint Training Ctr, Starke, FL USA; [US Navy Entomology Ctr Ex] US Navy, Entomol Ctr Excellence, Naval Air Stn, Jacksonville, FL USA	United States Department of Agriculture (USDA); United States Department of Defense; United States Navy; US Navy Naval Air Systems Command	Britch, SC (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	seth.britch@ars.usda.gov	Aldridge, Robert L./J-9828-2019	Aldridge, Robert L./0000-0001-7656-365X	US Department of Agriculture, Agricultural Research Service [NP-104, 6036-32000-050-00D]; Department of Defense Deployed Warfighter Protection Program Project [6036-32000-050-671]; US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP)	US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Defense Deployed Warfighter Protection Program Project; US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP)(United States Department of Defense)	Funding from the US Department of Agriculture, Agricultural Research Service NP-104, Project 6036-32000-050-00D and the Department of Defense Deployed Warfighter Protection Program Project 6036-32000-050-671. AMVAC Environmental Products provided support in the form of salaries for authors (PHC and CAS) and provided Dibrom. The specific roles of these authors are articulated in the "author contributions" section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The membership of the US Navy Entomology Center of Excellence Team was (alphabetically) Hanayo Arimoto, Christopher Dooling, Carl Doud, Kevin Justice, Jennifer Knapp, Marcus McDonough, Peter Nunn, Dominick Spatola, Paulo Torresalvarado, Brent Turnwall, Matthew Yans. We thank Bryan Smith and Christopher Swain (USDA-ARS-CMAVE) for expert production of insectary specimens for this study. This research was supported by the US Department of Agriculture (USDA)-Agricultural Research Service and the US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA, the DOD, the US Navy, the US Air Force, the Florida Army National Guard, or the DWFP. The USDA is an equal opportunity provider and employer.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; AFREHNUAMAH K, 1988, INSECT SCI APPL, V9, P629, DOI 10.1017/S1742758400005129; Aldridge RL, 2012, J AM MOSQUITO CONTR, V28, P65, DOI 10.2987/11-6195.1; Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724; BILANIN AJ, 1989, T ASAE, V32, P327; Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1; Breidenbaugh M, 2009, ARMY MED DEP J   JUL, P1; Britch SC, 2011, J MED ENTOMOL, V48, P1145, DOI 10.1603/ME11025; Britch SC, 2010, J AM MOSQUITO CONTR, V26, P183, DOI 10.2987/09-5948.1; Burkett DA, 1996, J AM MOSQUITO CONTR, V12, P380; Chaskopoulou A, 2011, J AM MOSQUITO CONTR, V27, P414, DOI 10.2987/11-6177.1; Chen Y. S., 1984, Journal of the Florida Anti-Mosquito Association, V55, P46; Clark G. G., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P192; Conlon J. M., 1990, Journal of the Florida Anti-Mosquito Association, V61, P19; Cooper JF, 1996, CROP PROT, V15, P249, DOI 10.1016/0261-2194(95)00113-1; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Farooq M, 2013, J AM MOSQUITO CONTR, V29, P389, DOI 10.2987/13-6333.1; Fritz B. K., 2008, AGR ENG, VX, P10; FUKUTO T. R., 1971, Pesticides in the environment. Volume 1, Part I., V1, P145; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hudson J E, 1986, Bull Pan Am Health Organ, V20, P294; Jokanovic M, 2001, TOXICOLOGY, V166, P139, DOI 10.1016/S0300-483X(01)00463-2; Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2; Kramer LD, 2017, INNOVATIVE APPROACH; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; LOFGREN CS, 1970, B WORLD HEALTH ORGAN, V42, P15; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Matthews G. A., 1996, Pesticide Outlook, V7, P24; Merk W, 1971, WHOVBC71317; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Newhart K., 2006, ENV FATE MALATHION; Phanthumachinda B, 1976, WHOVBC76651117; Ponlawat A, 2017, J AM MOSQUITO CONTR, V33, P116, DOI 10.2987/16-6594.1; Reiter I. P., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P192; Reiter P., 1992, Journal of the American Mosquito Control Association, V8, P315; Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SUNDARAM A, 1991, J ENVIRON SCI HEAL B, V26, P115, DOI 10.1080/03601239109372727; Teske ME, 1999, ASAE CSAE SCGR ANN I; Travis BV, 1968, P 55 ANN M NEW JERS, V55, P122; United States of America Department of Health and Human Services Centers for Disease Control and Prevention, 1987, EFF AER APPL DIBR 14; WHO Pesticide Evaluation Scheme (WHOPES) Communicable Disease Control Prevention and Eradication, 2003, SPAC SPRAY APPL INS; Wooster M. T., 1989, Journal of the Florida Anti-Mosquito Association, V60, P62	44	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191555	10.1371/journal.pone.0191555	http://dx.doi.org/10.1371/journal.pone.0191555			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352307	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300113
J	Gerli, MFM; Guyette, JP; Evangelista-Leite, D; Ghoshhajra, BB; Ott, HC				Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Evangelista-Leite, Daniele; Ghoshhajra, Brian Burns; Ott, Harald Christian			Perfusion decellularization of a human limb: A novel platform for composite tissue engineering and reconstructive surgery	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ORTHOTOPIC TRANSPLANTATION; BIOLOGIC SCAFFOLD; MATRIX; REGENERATION; FLAPS; GENERATION; DESIGN	Muscle and fasciocutaneous flaps taken from autologous donor sites are currently the most utilized approach for trauma repair, accounting annually for 4.5 million procedures in the US alone. However, the donor tissue size is limited and the complications related to these surgical techniques lead to morbidities, often involving the donor sites. Alternatively, recent reports indicated that extracellular matrix (ECM) scaffolds boost the regenerative potential of the injured site, as shown in a small cohort of volumetric muscle loss patients. Perfusion decellularization is a bioengineering technology that allows the generation of clinical-scale ECM scaffolds with preserved complex architecture and with an intact vascular template, from a variety of donor organs and tissues. We recently reported that this technology is amenable to generate full composite tissue scaffolds from rat and non-human primate limbs. Translating this platform to human extremities could substantially benefit soft tissue and volumetric muscle loss patients providing tissue-and species-specific grafts. In this proof-ofconcept study, we show the successful generation a large-scale, acellular composite tissue scaffold from a full cadaveric human upper extremity. This construct retained its morphological architecture and perfusable vascular conduits. Histological and biochemical validation confirmed the successful removal of nuclear and cellular components, and highlighted the preservation of the native extracellular matrix components. Our results indicate that perfusion decellularization can be applied to produce human composite tissue acellular scaffolds. With its preserved structure and vascular template, these biocompatible constructs, could have significant advantages over the currently implanted matrices by means of nutrient distribution, size-scalability and immunological response.	[Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Evangelista-Leite, Daniele; Ott, Harald Christian] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Ghoshhajra, Brian Burns; Ott, Harald Christian] Harvard Med Sch, Boston, MA 02115 USA; [Ghoshhajra, Brian Burns] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Ghoshhajra, Brian Burns] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Ott, Harald Christian] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Ott, Harald Christian] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gerli, Mattia Francesco Maria] UCL, Great Ormond St Inst Child Hlth, London, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of London; University College London	Ott, HC (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Ott, HC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ott, HC (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA.; Ott, HC (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	hott@mgh.harvard.edu	Gerli, Mattia Francesco Maria/AAL-2430-2021; da Silva, Daniele Evangelista Leite/AAK-8662-2020; Ghoshhajra, Brian/J-2114-2016	Gerli, Mattia Francesco Maria/0000-0002-9331-7394; da Silva, Daniele Evangelista Leite/0000-0002-2755-0091; Ghoshhajra, Brian/0000-0002-3865-3432	National Institute of Health [NIH 2 U42 0 D011158, NIH P30 AR066261]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011158] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by departmental funds. The National Disease Research Interchange and the MGH Skeletal core facilities received support from the National Institute of Health with the grants NIH 2 U42 0 D011158 and NIH P30 AR066261, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Philipp T. Moser, Jonathan M. Charest, Sarah E. Gilpin, Antonio Citro, Xi Ren and Claire M. Crowley for the helpful discussions. We acknowledge the use of tissues procured by the National Disease Research Interchange (NDRI; NIH 2 U42 OD011158) and thank the MGH Skeletal Core Facility for the mu CT scan and analysis (NIH P30 AR066261).	Agostini T, 2013, J CRANIO MAXILL SURG, V41, P15, DOI 10.1016/j.jcms.2012.05.003; ASPS ASoPS, 2017, 2016 PLAST SURG STAT; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Brewer MB, 2015, AM SURGEON, V81, P1163; Charest JM, 2015, BIOMATERIALS, V52, P79, DOI 10.1016/j.biomaterials.2015.02.016; Chaturvedi V, 2016, J TISSUE ENG REGENER; Chiron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036173; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dimitrievska S, 2015, ACTA BIOMATER, V13, P177, DOI 10.1016/j.actbio.2014.11.015; Duisit J, 2017, ANN SURG, V266, P754, DOI 10.1097/SLA.0000000000002396; Dziki J, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.8; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Freedman BR, 2015, BBA-MOL CELL RES, V1853, P3153, DOI 10.1016/j.bbamcr.2015.04.015; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874; Guyette JP, 2014, NAT PROTOC, V9, P1451, DOI 10.1038/nprot.2014.097; Hajimiri M, 2015, J BIOMED MATER RES A, V103, P819, DOI 10.1002/jbm.a.35193; Hitchcock T, 2008, ANN NY ACAD SCI, V1131, P44, DOI 10.1196/annals.1413.004; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Jank BJ, 2017, TISSUE ENG PT A, V23, P696, DOI [10.1089/ten.tea.2016.0487, 10.1089/ten.TEA.2016.0487]; Jank BJ, 2015, BIOMATERIALS, V61, P246, DOI 10.1016/j.biomaterials.2015.04.051; Juhas M, 2016, METHODS, V99, P81, DOI 10.1016/j.ymeth.2015.10.002; Kitano K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00779-y; Klebuc Michael, 2013, Methodist Debakey Cardiovasc J, V9, P95; Ko SH, 2015, J VASC SURG, V61, P1521, DOI 10.1016/j.jvs.2015.01.036; Lee SH, 2016, CLIN ORTHOP SURG, V8, P444, DOI 10.4055/cios.2016.8.4.444; Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885; Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Mast BA, 1996, ANN PLAS SURG, V36, P569, DOI 10.1097/00000637-199606000-00002; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; McDiarmid SV, 2011, HAND CLIN, V27, P545, DOI 10.1016/j.hcl.2011.08.007; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Peloso A, 2016, ANN SURG, V264, P169, DOI 10.1097/SLA.0000000000001364; Perniconi B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00255; Piccoli M, 2016, BIOMATERIALS, V74, P245, DOI 10.1016/j.biomaterials.2015.10.005; Porzionato A, 2015, INT J MOL SCI, V16, P14808, DOI 10.3390/ijms160714808; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Richard PL, 2010, CELL TRANSPLANT, V19, P67, DOI [10.3727/096368909X578812, 10.3727/096368909X478812]; Schaverien MV, 2014, HAND CLIN, V30, P165, DOI 10.1016/j.hcl.2014.01.001; Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Siemionow MZ, 2011, ANN PLAS SURG, V66, P410, DOI 10.1097/SAP.0b013e3182121db9; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Swiontkowski MF, 2002, J TRAUMA, V52, P641, DOI 10.1097/00005373-200204000-00005; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Teodori L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00218; Urbani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179341; Werner NL, 2017, TRANSPLANTATION, V101, pe68, DOI 10.1097/TP.0000000000001500; Zhang J, 2016, BIOMATERIALS, V89, P114, DOI 10.1016/j.biomaterials.2016.02.040; Zhou H, 2017, ANN SURG	62	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191497	10.1371/journal.pone.0191497	http://dx.doi.org/10.1371/journal.pone.0191497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352303	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300099
J	Greiner, S; Jud, A; Aurich, M; Geisenberger, C; Uhlmann, L; Hilbel, T; Kieser, M; Katus, HA; Mereles, D				Greiner, Sebastian; Jud, Andreas; Aurich, Matthias; Geisenberger, Christoph; Uhlmann, Lorenz; Hilbel, Thomas; Kieser, Meinhard; Katus, Hugo A.; Mereles, Derliz			Prognostic relevance of elevated pulmonary arterial pressure assessed non-invasively: Analysis in a large patient cohort with invasive measurements in near temporal proximity	PLOS ONE			English	Article							DOPPLER-ECHOCARDIOGRAPHY; HEART-FAILURE; EUROPEAN ASSOCIATION; SYSTOLIC PRESSURES; AMERICAN SOCIETY; HYPERTENSION; DIAGNOSIS; REGISTRY; CATHETERIZATION; GUIDELINES	Background The clinical relevance of non-invasively derived pulmonary arterial pressure (PAP) by Doppler echocardiography (DE) has been questioned in the past. However, transthoracic echocardiography is used as a cornerstone examination for patients with dyspnea and suspected pulmonary hypertension (PH). This study aimed to evaluate the prognostic value of non-invasive assessed PAP in a large population of patients with known or suspected cardiopulmonary disease. Methods The analyses are based on data of patients of a tertiary cardiology center that received right heart catheterization (RHC) as well as non-invasively assessed PAP by DE within five days, and includes serological and clinical parameters in a retrospective follow-up for up to eight years. Results Of 1,237 patients, clinical follow-up was possible in 1,038 patients who were included in the statistical analysis. The mean-follow up time was 1,002 days. The composite endpoint of heart transplantation (HTx) or death occurred in n = 308 patients. Elevated PAP measured non-invasively as well as invasively had significant prognostic impact (hazard ratio (HR) 2.32; 95% confidence interval (CI) 1.78-3.04; chi(2) = 37.9; p<0.001 versus HR 2.84; 95% CI 2.11-3.82; chi(2) = 51.9; p<0.001, respectively). By multivariate analysis, NYHA functional class, N-terminal pro-brain natriuretic peptide, cardiac troponin T, left ventricular ejection fraction, and right ventricular dysfunction remained independently predictive. Incremental prognostic information in a multimodal approach was highly relevant. Conclusions In this comprehensive study, elevated pulmonary arterial pressure measured by DE offers similar prognostic information on survival or need for HTx as right heart catheterization. Furthermore, the addition of functional capacity and serological biomarkers delivered incremental prognostic information.	[Greiner, Sebastian; Jud, Andreas; Aurich, Matthias; Hilbel, Thomas; Katus, Hugo A.; Mereles, Derliz] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Geisenberger, Christoph] Heidelberg Univ, Div Expt Neurosurg, Heidelberg, Germany; [Uhlmann, Lorenz; Kieser, Meinhard] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Greiner, S (corresponding author), Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany.	sebastian.greiner@med.uni-heidelberg.de	Uhlmann, Lorenz/AAL-9839-2020; Aurich, Matthias/ABF-6976-2021	Mereles, Derliz/0000-0001-9601-7103				Amsallem M, 2016, J AM SOC ECHOCARDIOG, V29, P93, DOI 10.1016/j.echo.2015.11.001; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Batal O, 2012, AM J CARDIOL, V109, P1514, DOI 10.1016/j.amjcard.2012.01.366; Bossone E, 2013, J AM SOC ECHOCARDIOG, V26, P1, DOI 10.1016/j.echo.2012.10.009; Bursi F, 2012, J AM COLL CARDIOL, V59, P222, DOI 10.1016/j.jacc.2011.06.076; Carbone R, 2005, Eur Rev Med Pharmacol Sci, V9, P331; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; D'Alto M, 2013, INT J CARDIOL, V168, P4058, DOI 10.1016/j.ijcard.2013.07.005; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Farber HJ, 2015, CHEST, V148, P573, DOI 10.1378/chest.15-0767; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Giannitsis E, 2009, HERZ, V34, P600, DOI 10.1007/s00059-009-3306-6; Greiner S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001103; Kalogeropoulos AP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000363; Kiatchoosakun S, 2011, CLIN CARDIOL, V34, P488, DOI 10.1002/clc.20920; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; Kusunose K, 2013, CIRC-CARDIOVASC IMAG, V6, P167, DOI 10.1161/CIRCIMAGING.112.000162; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lewis GD, 2009, J AM COLL CARDIOL, V53, P1127, DOI 10.1016/j.jacc.2009.01.006; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; Matthan NR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005066; Merlos P, 2013, EUR J INTERN MED, V24, P562, DOI 10.1016/j.ejim.2013.04.009; Opitz CF, 2016, J AM COLL CARDIOL, V68, P368, DOI 10.1016/j.jacc.2016.05.047; Rich JD, 2013, CHEST, V143, P1536, DOI 10.1378/chest.13-0297; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Rudski LG, 2013, CHEST, V143, P1533, DOI 10.1378/chest.13-0296; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Vachiery JL, 2013, J AM COLL CARDIOL, V62, pD100, DOI 10.1016/j.jacc.2013.10.033; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191206	10.1371/journal.pone.0191206	http://dx.doi.org/10.1371/journal.pone.0191206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351312	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300057
J	Keenan, KG; Senefeld, JW; Hunter, SK				Keenan, Kevin G.; Senefeld, Jonathon W.; Hunter, Sandra K.			Girls in the boat: Sex differences in rowing performance and participation	PLOS ONE			English	Article							GENDER; MEN; RUNNERS; WOMEN; AGE; COMPETITIVENESS; EVOLUTION; DISTANCE; MASS	Men outperform women in many athletic endeavors due to physiological and anatomical differences (e.g. larger and faster muscle); however, the observed sex differences in elite athletic performance are typically larger than expected, and may reflect sex-related differences in opportunity or incentives. As collegiate rowing in the United States has been largely incentivized for women over the last 20 years, but not men, the purpose of this study was to examine sex differences in elite rowing performance over that timeframe. Finishing times from grand finale races for collegiate championship on-water performances (n = 480) and junior indoor performances (n = 1,280) were compared between men and women across 20 years (1997 +/- 2016), weight classes (heavy vs. lightweight) and finishing place. Participation of the numbers of men and women rowers were also quantified across years. Men were faster than women across all finishing places, weight classes and years of competition and performance declined across finishing place for both men and women (P<0.001). Interestingly, the reduction in performance time across finishing place was greater (P<0.001) for collegiate men compared to women in the heavyweight division. This result is opposite to other sports (e.g. running and swimming), and to lightweight rowing in this study, which provides women fewer incentives than in heavyweight rowing. Correspondingly, participation in collegiate rowing has increased by similar to 113 women per year (P<0.001), with no change (P = 0.899) for collegiate men. These results indicate that increased participation and incentives within collegiate rowing for women vs. men contribute to sex differences in athletic performance.	[Keenan, Kevin G.] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA; [Keenan, Kevin G.] Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA; [Senefeld, Jonathon W.; Hunter, Sandra K.] Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53233 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Marquette University	Keenan, KG (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.; Keenan, KG (corresponding author), Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA.	keenan@uwm.edu	Senefeld, Jack/ABF-1286-2020	Senefeld, Jonathon/0000-0001-8116-3538				Anderson T, 1996, SPORTS MED, V22, P76, DOI 10.2165/00007256-199622020-00003; Deaner RO, 2006, EVOL HUM BEHAV, V27, P63, DOI 10.1016/j.evolhumbehav.2005.04.005; Deaner RO., 2016, EVOL BEHAV SCI, V10, P73, DOI [DOI 10.1037/EBS0000049, 10.1037/ebs0000049]; Deaner RO, 2015, MED SCI SPORT EXER, V47, P607, DOI 10.1249/MSS.0000000000000432; Deaner RO, 2014, EVOL PSYCHOL-US, V12, P848, DOI 10.1177/147470491401200501; Deaner RO, 2013, ARCH SEX BEHAV, V42, P413, DOI 10.1007/s10508-012-9965-z; Deaner RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049168; Deaner RO, 2011, EVOL PSYCHOL-US, V9, P600; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; Hunter SK, 2016, MED SCI SPORT EXER, V48, P2247, DOI 10.1249/MSS.0000000000000928; Hunter SK, 2013, MED SCI SPORT EXER, V45, P148, DOI 10.1249/MSS.0b013e31826900f6; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Joyner M J, 1993, Exerc Sport Sci Rev, V21, P103; Lepers R, 2011, MED SCI SPORT EXER, V43, P134, DOI 10.1249/MSS.0b013e3181e57997; MAYHEW JL, 1990, EUR J APPL PHYSIOL, V60, P133, DOI 10.1007/BF00846033; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; NCAA, 2015, STUD ATHL PART NCAA; Rust CA, 2013, PERCEPT MOTOR SKILL, V116, P690, DOI 10.2466/30.06.PMS.116.2.690-706; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld J, 2016, INT J SPORT PHYSIOL, V11, P635, DOI 10.1123/ijspp.2015-0418; SPARLING PB, 1980, RES Q EXERCISE SPORT, V51, P542, DOI 10.1080/02701367.1980.10608077; Stefani RT, 2006, J SPORT SCI, V24, P1329, DOI 10.1080/02640410500520559; Unterweger CM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2209-2; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Zamparo P, 2006, EUR J APPL PHYSIOL, V97, P52, DOI 10.1007/s00421-006-0133-9	27	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191504	10.1371/journal.pone.0191504	http://dx.doi.org/10.1371/journal.pone.0191504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352279	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300101
J	Jiang, LY; Jiang, W; Tian, N; Xiong, YN; Liu, J; Wei, J; Wu, KY; Luo, J; Shi, XJ; Song, BL				Jiang, Lu-Yi; Jiang, Wei; Tian, Na; Xiong, Yan-Ni; Liu, Jie; Wei, Jian; Wu, Kai-Yue; Luo, Jie; Shi, Xiong-Jie; Song, Bao-Liang			Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; CHOLESTEROL-METABOLISM; ENDOPLASMIC-RETICULUM; SENSING DOMAIN; INSIG-1; GP78; CELLS; ABSORPTION; TRANSPORT	Cholesterol biosynthesis is tightly regulated in the cell. For example, high sterol concentrations can stimulate degradation of the rate-limiting cholesterol biosynthetic enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase, HMGCR). HMGCR is broken down by the endoplasmic reticulum membrane-associated protein complexes consisting of insulin-induced genes (Insigs) and the E3 ubiquitin ligase gp78. Here we found that HMGCR degradation is partially blunted in Chinese hamster ovary (CHO) cells lacking gp78 (gp78-KO). To identify other ubiquitin ligase(s) that may function together with gp78 in triggering HMGCR degradation, we performed a small-scale short hairpin RNA-based screening targeting endoplasmic reticulum-localized E3s. We found that knockdown of both ring finger protein 145 (Rnf145) and gp78 genes abrogates sterol-induced degradation of HMGCR in CHO cells. We also observed that RNF145 interacts with Insig-1 and -2 proteins and ubiquitinates HMGCR. Moreover, the tetrapeptide sequence YLYF in the sterol-sensing domain and the Cys-537 residue in the RING finger domain were essential for RNF145 binding to Insigs and RNF145 E3 activity, respectively. Of note, amino acid substitutions in the YLYF or of Cys-537 completely abolished RNF145-mediated HMGCR degradation. In summary, our study reveals that RNF145, along with gp78, promotes HMGCR degradation in response to elevated sterol levels and identifies residues essential for RNF145 function.	[Jiang, Lu-Yi; Jiang, Wei; Tian, Na; Xiong, Yan-Ni; Liu, Jie; Wei, Jian; Wu, Kai-Yue; Luo, Jie; Shi, Xiong-Jie; Song, Bao-Liang] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Shi, XJ; Song, BL (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.	xjshi@whu.edu.cn; blsong@whu.edu.cn	tian, na/GVR-9226-2022	Wei, Jian/0000-0002-4368-9763; Song, Bao-Liang/0000-0002-6397-5935; Luo, Jie/0000-0003-1899-3111	Ministry of Science and Technology of China [2016YFA0500100]; National Natural Science Foundation of China [31600651, 31430044, 31690102, 31771568, 31701030]; China Postdoctoral Science Foundation [2016M592380]; 111 Project of the Ministry of Education of China [B16036]; Natural Science Foundation of Hubei Province [2016CFA012, 2017CFB617]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0500100), the National Natural Science Foundation of China (31600651, 31430044, 31690102, 31771568, and 31701030), the China Postdoctoral Science Foundation (2016M592380), the 111 Project of the Ministry of Education of China (B16036), and the Natural Science Foundation of Hubei Province (2016CFA012 and 2017CFB617). The authors declare that they have no conflicts of interest with the contents of this article.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Cook ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172721; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zhang L., 2017, ELIFE, V6	36	39	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4047	4055		10.1074/jbc.RA117.001260	http://dx.doi.org/10.1074/jbc.RA117.001260			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374057	Green Published, hybrid			2022-12-26	WOS:000427587500017
J	Hirai, S; Yokoyama, E; Wakui, T; Ishige, T; Nakamura, M				Hirai, Shinichiro; Yokoyama, Eiji; Wakui, Taku; Ishige, Taichiro; Nakamura, Masaki			Enterohemorrhagic Escherichia coli O157 subclade 8b strains in Chiba Prefecture, Japan, produced larger amounts of Shiga toxin 2 than strains in subclade 8a and other clades	PLOS ONE			English	Article							EVOLUTIONARY ANALYSIS; EMERGENCE; GENE; BACTERIOPHAGES; SUBPOPULATIONS; DIVERGENCE; VIRULENCE; VARIANTS; SEROTYPE	Enterohemorrhagic Escherichia coli O157 (O157) strains can be classified into clades (one of several phylogenetic groups) by single nucleotide polymorphisms (SNPs): these are clade 1, clade 2, clade 3, descendant and ancestral clades 4/5, clade 6, clade 7, clade 8, clade 9, and clade 12. Some recent studies showed that some O157 strains in clade 8 produced a larger amount of Shiga toxin (Stx) 2 than other strains. In this study, 1121 epidemiologically unlinked strains of O157 isolated in Chiba Prefecture, Japan were classified into clades during 1996-2014. Clade 8 strains were further classified into subclade 8a (67 strains) and subclade 8b (48 strains) using SNP analysis. In the absence of mitomycin C (MMC), subclade 8a strains in this study produced significantly greater amounts of Stx2 than subclade 8b strains. However, in the presence of MMC, the levels of Stx2 production in subclade 8b strains were significantly greater than subclade 8a strains. On the other hand, a recent study reported that the Stx2 production level in O157 strains was determined mainly by the subtypes of Stx2a phage (phi Stx2_alpha, beta, gamma, delta, epsilon, and &zeta). Using O157 strains in this study, the Stx2a phages were classified into these subtypes. In this study, all strains of subclades 8a and 8b carried phi Stx2a_gamma and phi Stx2a_delta, respectively. Some strains in clade 6 also carried phi Stx2a_delta. In the presence of MMC, subclade 8b strains produced significantly greater amounts of Stx2 than clade 6 strains carrying phi Stx2_delta. In this study, we propose that Stx2 production in subclade 8b strains in the presence of MMC might be enhanced due to genetic factors other than phi Stx2_delta.	[Hirai, Shinichiro; Yokoyama, Eiji; Nakamura, Masaki] Chiba Prefectural Inst Publ Hlth, Div Bacteriol, Chiba, Japan; [Wakui, Taku] Chiba Prefectural Inst Publ Hlth, Div Epidemiol, Chiba, Japan; [Ishige, Taichiro] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Tokyo, Japan	Tokyo University of Agriculture	Hirai, S (corresponding author), Chiba Prefectural Inst Publ Hlth, Div Bacteriol, Chiba, Japan.	s.hri10@pref.chiba.lg.jp			Daido Life Welfare Foundation for Regional Health and Welfare Research in fiscal; Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture in fiscal [14A-18]; JSPS KAKENHI [26460540]	Daido Life Welfare Foundation for Regional Health and Welfare Research in fiscal; Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture in fiscal; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this study was supported by a Grant from the Daido Life Welfare Foundation for Regional Health and Welfare Research in fiscal 2016 (Grant Number: None, URL: http://www.daido-life-welfare.or.jp/subsidize/welfare/index. htm, and Receiver: SH), by the Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture in fiscal 2014 (Grant Number: 14A-18, URL: http://www.nodaigenome.org/gabase/index.html?lang=ja, and Receiver: EY), and by JSPS KAKENHI (Grant Number: 26460540, URL: http:/www.jsps.go.jp/j-grantsinaid/index.html, and Receiver: EY). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Amigo N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166883; Amigo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127710; Delannoy S, 2015, J CLIN MICROBIOL, V53, P486, DOI 10.1128/JCM.02290-14; Etoh Y, 2014, INFECT GENET EVOL, V24, P140, DOI 10.1016/j.meegid.2014.03.013; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; GASTON MA, 1989, J CLIN PATHOL, V42, P763, DOI 10.1136/jcp.42.7.763; Griffing SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131967; Hirai S, 2015, LETT APPL MICROBIOL, V61, P267, DOI 10.1111/lam.12448; Hirai S, 2014, J APPL MICROBIOL, V117, P1191, DOI 10.1111/jam.12604; Hirai S, 2013, INFECT GENET EVOL, V18, P94, DOI 10.1016/j.meegid.2013.05.006; Ichimura K, 2017, MICROBIOLOG IN PRESS; Kim JY, 2001, J BACTERIOL, V183, P6885, DOI 10.1128/JB.183.23.6885-6897.2001; Kusumoto M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1152; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; lyoda S, 2014, OPEN FORUM INFECT DI, V1; lzumiya H., 2010, MICROBIOL IMMUNOL, V54, P569; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Melton-Celsa A, 2012, CURR TOP MICROBIOL, V357, P67, DOI 10.1007/82_2011_176; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Monday SR, 2001, J INFECT DIS, V184, P918, DOI 10.1086/323154; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Ogura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16663; Ooka T, 2009, J CLIN MICROBIOL, V47, P2888, DOI 10.1128/JCM.00792-09; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Serra-Moreno R, 2008, J BACTERIOL, V190, P4722, DOI 10.1128/JB.00069-08; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Shaikh N, 2007, FEMS MICROBIOL LETT, V273, P58, DOI 10.1111/j.1574-6968.2007.00781.x; Shimizu T, 2015, INFECT GENET EVOL, V33, P176, DOI 10.1016/j.meegid.2015.04.027; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wang GH, 2002, J CLIN MICROBIOL, V40, P3613, DOI 10.1128/JCM.40.10.3613-3619.2002; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Yin S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1934-1; Yokoyama E, 2017, CURR MICROBIOL, V74, P425, DOI 10.1007/s00284-017-1208-z; Yokoyama E, 2015, VET MICROBIOL, V175, P312, DOI 10.1016/j.vetmic.2014.11.024; Yokoyama E, 2012, INFECT GENET EVOL, V12, P1724, DOI 10.1016/j.meegid.2012.07.003; Yokoyama E, 2011, J FOOD PROTECT, V74, P1324, DOI 10.4315/0362-028X.JFP-10-461	43	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191834	10.1371/journal.pone.0191834	http://dx.doi.org/10.1371/journal.pone.0191834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381715	Green Submitted, Green Published, gold			2022-12-26	WOS:000423617800040
J	Li, HS; Lin, YL; Chen, XH; Bai, Y; Wang, CQ; Xu, XP; Wang, Y; Lai, ZX				Li, Hansheng; Lin, Yuling; Chen, Xiaohui; Bai, Yu; Wang, Congqiao; Xu, Xiaoping; Wang, Yun; Lai, Zhongxiong			Effects of blue light on flavonoid accumulation linked to the expression of miR393, miR394 and miR395 in longan embryogenic calli	PLOS ONE			English	Article							SECONDARY METABOLISM; ANTHOCYANIN BIOSYNTHESIS; RED-LIGHT; ARABIDOPSIS; AUXIN; OVEREXPRESSION; MICRORNAS; GROWTH; PLANTS; CLOCK	While flavonoid metabolism's regulation under light conditions by structural genes and transcription factors is understood, the roles of microRNAs (miRNAs) in this pathway have been rarely reported. In this paper, the accurate control of light was firstly enabled through the specially designed plant growth chamber which ensures consistency and accuracy of the cultivation of longan ECs and the repeatability of the experiments. Then, longan ECs were cultured in this chamber for 25 days. The change of growth rate of longan ECs was compared under different light qualities (dark, blue, green, white, green), intensities (16, 32, 64, 128, 256 mu mol.m(-2).s(-1)), and durations (8 h, 12 h, 16 h, 20h, 24h). Results indicated that longan ECs had a high growth rate in the condition of blue or green light, at intensity ranged from 16 mu mol.m(-2).s(-1) to 64 mu mol.m(-2).s(-1), and duration from 8 h to 16 h. In addition, the contents of total flavonoids, rutin, and epicatechin were determined. Results indicated that flavonoid contents of longan ECs reached the highest value under blue light, at 32 mu mol.m(-2).s(-1) and 12h/d. Blue light promoted the accumulation of epicatechin, but inhibited the synthesis of rutin. Finally, the expressions of flavonoid pathway genes, miRNAs and target genes were analyzed by qPCR. These results indicated that miR393 and its target gene DITIR1-3, miR394 and its target gene DIAIMT12, and miR395 and its target gene DIAPS1 had a negative regulating relationship under blue light in longan ECs. Furthermore, miR393, miR394, and miR395 acted on target genes, which negatively regulated flavonoid key genes DIFLS and positively regulated key genes DICHS, DICHI, DIF3' H, DIDFR, DILAR, and finally affected the accumulation of flavonoids. The treatment of longan ECs under the blue light at the intensity of 32 mu mol.m(-2).s(-1) for 12 h/d inhibited the expression of miR393, miR394 and miR395, which promoted the expression of target genes and the accumulation of flavonoids and epicatechin, but inhibited the synthesis of rutin.	[Li, Hansheng; Lin, Yuling; Chen, Xiaohui; Bai, Yu; Wang, Congqiao; Xu, Xiaoping; Wang, Yun; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com			National Natural Science Foundation of China [31572088, 3167212]; Science and Technology Plan Major Projects of Fujian Province [2015NZ0002-1]; Natural Science Funds for Distinguished Young Scholar in Fujian Province [2015J06004]; program for New Century Excellent Talents in Fujian Province University [20151104]; Program for High-level University Construction of the Fujian Agriculture and Forestry University [612014028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Major Projects of Fujian Province; Natural Science Funds for Distinguished Young Scholar in Fujian Province; program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET)); Program for High-level University Construction of the Fujian Agriculture and Forestry University	This work was funded by the National Natural Science Foundation of China (31572088,3167212), the Science and Technology Plan Major Projects of Fujian Province (2015NZ0002-1), the Natural Science Funds for Distinguished Young Scholar in Fujian Province (2015J06004), the program for New Century Excellent Talents in Fujian Province University (20151104) and the Program for High-level University Construction of the Fujian Agriculture and Forestry University (612014028).	Aman O., 2014, EFFECT DIFFERENT LIG; Bulgakov VP, 2015, BIOTECHNOL LETT, V37, P1719, DOI 10.1007/s10529-015-1863-8; Chen ZH, 2015, PLANT CELL PHYSIOL, V56, P73, DOI 10.1093/pcp/pcu149; [陈志长 CHEN Zhichang], 2011, [土壤, Soils], V43, P433; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Docimo T, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01233; [董慧雪 Dong Huixue], 2014, [热带作物学报, Chinese Journal of Tropical Crops], V35, P2374; Farre EM, 2012, CURR OPIN PLANT BIOL, V15, P293, DOI 10.1016/j.pbi.2012.01.013; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Hectors K, 2012, PHYSIOL PLANTARUM, V145, P594, DOI 10.1111/j.1399-3054.2012.01590.x; Jeon MW, 2005, PLANT GROWTH REGUL, V45, P139, DOI 10.1007/s10725-005-0337-8; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kanazawa K, 2012, J AGR FOOD CHEM, V60, P4359, DOI 10.1021/jf300107s; Kim JS, 2010, PLANTA, V232, P545, DOI 10.1007/s00425-010-1189-7; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Kun LI, 2011, ACTA HORTICULTURAE S, V57, P133; Kuo TCY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0537-y; Lai Ruilian, 2016, Chinese Journal of Applied and Environmental Biology, V22, P95, DOI 10.3724/SP.J.1145.2015.05051; Lai ZhongXiong, 1997, Journal of Fujian Agricultural University, V26, P271; Lai ZX, 2000, FOR SCI, V67, P415; Li JY, 2014, TRENDS PLANT SCI, V19, P750, DOI 10.1016/j.tplants.2014.08.006; Lin K, 2016, NO HORTICULTURE, P198; [林魁 Lin Kui], 2015, [植物学报, Chinese Bulletin of Botany], V50, P263; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Lin YL, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix023; [陆海洋 Lu Haiyang], 2015, [植物生理学报, Plant Physiology Journal], V51, P909; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Nishimura T, 2009, PLANT CELL PHYSIOL, V50, P1874, DOI 10.1093/pcp/pcp129; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Pei XP, 2011, CHINESE J EXPT TRADI, V17, P94; Qiao Xianli, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P69; Qiao Y, 2017, MOL GENET GENOMICS, V292, P37, DOI 10.1007/s00438-016-1253-5; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Son KH, 2013, HORTSCIENCE, V48, P988; Sudjaroen Y, 2012, PHYTOCHEMISTRY, V77, P226, DOI 10.1016/j.phytochem.2011.12.008; Sun P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171173; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Wang Chun-li, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P1055; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; Wei Y, 2011, TRANSPORT RES REC, P10, DOI 10.3141/2256-02; Xi YU, 2011, J SHIHEZI U, V29, P416; Xia Tao, 2009, Scientia Agricultura Sinica, V42, P2899; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhao De-Xiu, 1999, Acta Phytophysiologica Sinica, V25, P127; [周芳名 Zhou Fangming], 2013, [中草药, Chinese Traditional and Herbal Drugs], V44, P232; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534; Zuo Wensong, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2406	52	22	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191444	10.1371/journal.pone.0191444	http://dx.doi.org/10.1371/journal.pone.0191444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381727	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800020
J	von Babo, M; Chmiel, C; Muggler, SA; Rakusa, J; Schuppli, C; Meier, P; Fischler, M; Urner, M				von Babo, Michelle; Chmiel, Corinne; Muggler, Simon Andreas; Rakusa, Julia; Schuppli, Caroline; Meier, Philipp; Fischler, Manuel; Urner, Martin			Transfusion practice in anemic, non-bleeding patients: Cross-sectional survey of physicians working in general internal medicine teaching hospitals in Switzerland	PLOS ONE			English	Article							BLOOD-CELL TRANSFUSION; CLINICAL-PRACTICE GUIDELINE; ACUTE LUNG INJURY; CRITICAL-CARE; RECOMMENDATIONS; STRATEGIES; MANAGEMENT; MULTICENTER; DEFINE; PLASMA	Background Transfusion practice might significantly influence patient morbidity and mortality. Between European countries, transfusion practice of red blood cells (RBC) greatly differs. Only sparse data are available on transfusion practice of general internal medicine physicians in Switzerland. Methods In this cross-sectional survey, physicians working in general medicine teaching hospitals in Switzerland were investigated regarding their self-reported transfusion practice in anemic patients without acute bleeding. The definition of anemia, transfusion triggers, knowledge on RBC transfusion, and implementation of guidelines were assessed. Results 560 physicians of 71 hospitals (64%) responded to the survey. Anemia was defined at very diverging hemoglobin values (by 38% at a hemoglobin <130 g/L for men and by 57% at <120 g/L in non-pregnant women). 62% and 43% respectively, did not define anemia in men and in women according to the World Health Organization. Fifty percent reported not to transfuse RBC according to international guidelines. Following factors were indicated to influence the decision to transfuse: educational background of the physicians, geographical region of employment, severity of anemia, and presence of known coronary artery disease. 60% indicated that their knowledge on Transfusion-related Acute Lung Injury (TRALI) did not influence transfusion practice. 50% of physicians stated that no local transfusion guidelines exist and 84% supported the development of national recommendations on transfusion in non-acutely bleeding, anemic patients. Conclusion This study highlights the lack of adherence to current transfusion guidelines in Switzerland. Identifying and subsequently correcting this deficit in knowledge translation may have a significant impact on patient care.	[von Babo, Michelle; Chmiel, Corinne; Muggler, Simon Andreas; Rakusa, Julia; Fischler, Manuel; Urner, Martin] Waid City Hosp, Dept Internal Med, Zurich, Switzerland; [Chmiel, Corinne] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Schuppli, Caroline] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Meier, Philipp] Swiss Fed Inst Environm Sci & Technol EAWAG, Appl Aquat Ecol, Dubendorf, Switzerland; [Urner, Martin] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Toronto	Urner, M (corresponding author), Waid City Hosp, Dept Internal Med, Zurich, Switzerland.; Urner, M (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.	martin.urner@gmail.com	Urner, Martin/AAK-5701-2020	Urner, Martin/0000-0003-1133-4885; Chmiel, Corinne/0000-0002-5249-6592				Achermann R, 2011, CLIN MICROBIOL INFEC, V17, P855, DOI 10.1111/j.1469-0691.2010.03348.x; Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Ansari S, 2012, BLOOD TRANSFUS-ITALY, V10, P28, DOI 10.2450/2011.0108-10; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bates D, 2007, IME4 PACKAGE R PACKA, V2; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bivand RS, 2008, USE R, P1; Blajchman MA, 2001, TRANSFUS CLIN BIOL, V8, P207, DOI 10.1016/S1246-7820(01)00136-7; Bundesarztekammer B, 2013, QUERSCHN LEITL BAK T; Calder L, 1997, CAN MED ASSOC J, V156, pS1; Carson JL, 2014, HEMATOL-AM SOC HEMAT, P548, DOI 10.1182/asheducation-2014.1.548; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Christensen RHB, 2014, TUTORIAL FITTING CUM; Christensen RHB, 2010, ORDINAL REGRESSION M, P22; Corwin HL, 2004, CRIT CARE, V8, pS42, DOI 10.1186/cc2411; Souza Diego Agra de, 2013, Rev. Bras. Hematol. Hemoter., V35, P263, DOI 10.5581/1516-8484.20130070; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Fontana S, 2014, TRANSFUS MED HEMOTH, V41, P182, DOI 10.1159/000363540; Gajic O, 2006, CRIT CARE MED, V34, pS109, DOI 10.1097/01.CCM.0000214311.56231.23; Giangrande PLF, 2000, BRIT J HAEMATOL, V110, P758, DOI 10.1046/j.1365-2141.2000.02139.x; Gombotz H, 2007, TRANSFUSION, V47, P1468, DOI 10.1111/j.1537-2995.2007.01286.x; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Goodnough LT, 2015, AM J HEMATOL, V90, P927, DOI 10.1002/ajh.24101; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2005, CRIT CARE MED, V33, P7, DOI 10.1097/01.CCM.0000151047.33912.A3; Hebert PC, 2003, JAMA-J AM MED ASSOC, V289, P1941, DOI 10.1001/jama.289.15.1941; HILL SR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002042.PUB2; Hovaguimian F, 2016, ANESTHESIOLOGY, V125, P46, DOI 10.1097/ALN.0000000000001162; Janssen M, 2014, COLLECTION TESTING U; Janssen MP, 2013, COLLECTION TESTING U; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; Kraft E, 2013, SCHWEIZERISCHE ARZTE, V94, P453; Lee JS, 2010, NAT MED, V16, P381, DOI 10.1038/nm0410-381; Lewin-Koh N.J., 2011, MAPTOOLS TOOLS READI; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P49, DOI 10.2450/2008.0020-08; Liumbruno GM, 2011, BLOOD TRANSFUS-ITALY, V9, P189, DOI 10.2450/2011.0075-10; Liumbruno GM, 2011, BLOOD TRANSFUS-ITALY, V9, P19, DOI 10.2450/2010.0074-10; Madjdpour C, 2006, MINERVA ANESTESIOL, V72, P283; McAvoy BR, 1996, BRIT MED J, V313, P732; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Politsmakher A, 2013, AM J MED, V126, P894, DOI 10.1016/j.amjmed.2013.06.013; Shander A, 2013, BLOOD TRANSFUS-ITALY, V11, P193, DOI 10.2450/2012.0195-12; Simon TL, 1998, ARCH PATHOL LAB MED, V122, P130; Spahn Donat R, 2004, Best Pract Res Clin Anaesthesiol, V18, P661, DOI 10.1016/j.bpa.2004.05.002; Steensma DP, 2007, MAYO CLIN PROC, V82, P958, DOI 10.4065/82.8.958; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Vamvakas EC, 2010, TRANSFUS MED REV, V24, P77, DOI 10.1016/j.tmrv.2009.11.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	54	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191752	10.1371/journal.pone.0191752	http://dx.doi.org/10.1371/journal.pone.0191752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU1NX	29381721	Green Published, Green Accepted, gold			2022-12-26	WOS:000423617800033
J	Zhang, YJ; Shen, FC; Mojarad, MR; Li, DC; Liu, SJ; Tao, C; Yu, Y; Liu, HF				Zhang, Yuji; Shen, Feichen; Mojarad, Majid Rastegar; Li, Dingcheng; Liu, Sijia; Tao, Cui; Yu, Yue; Liu, Hongfang			Systematic identification of latent disease-gene associations from PubMed articles	PLOS ONE			English	Article							NETWORK MEDICINE; LYMPHOMA; INTERPRET; ONTOLOGY; PATHWAY; MODELS; ASTHMA; CELLS	Recent scientific advances have accumulated a tremendous amount of biomedical knowledge providing novel insights into the relationship between molecular and cellular processes and diseases. Literature mining is one of the commonly used methods to retrieve and extract information from scientific publications for understanding these associations. However, due to large data volume and complicated associations with noises, the interpretability of such association data for semantic knowledge discovery is challenging. In this study, we describe an integrative computational framework aiming to expedite the discovery of latent disease mechanisms by dissecting 146,245 disease-gene associations from over 25 million of PubMed indexed articles. We take advantage of both Latent Dirichlet Allocation (LDA) modeling and network-based analysis for their capabilities of detecting latent associations and reducing noises for large volume data respectively. Our results demonstrate that (1) the LDA-based modeling is able to group similar diseases into disease topics; (2) the disease-specific association networks follow the scale-free network property; (3) certain subnetwork patterns were enriched in the disease-specific association networks; and (4) genes were enriched in topic-specific biological processes. Our approach offers promising opportunities for latent disease-gene knowledge discovery in biomedical research.	[Zhang, Yuji] Univ Maryland, Div Biostat & Bioinformat, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Zhang, Yuji] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Shen, Feichen; Mojarad, Majid Rastegar; Li, Dingcheng; Liu, Sijia; Yu, Yue; Liu, Hongfang] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Tao, Cui] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Yu, Yue] Jilin Univ, Sch Publ Hlth, Dept Med Informat, Changchun, Jilin, Peoples R China; [Li, Dingcheng] Baidu USA, Sunnyvale, CA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston; Jilin University; Baidu	Zhang, YJ (corresponding author), Univ Maryland, Div Biostat & Bioinformat, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.; Zhang, YJ (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.	yuzhang@som.umaryland.edu		Zhang, Yuji/0000-0002-5429-6762; Tao, Cui/0000-0002-4267-1924	National Cancer Institute [P30 CA 134274-04]; Cancer Prevention & Research Institute of Texas (CPRIT) [CPRIT R1307]; National Institutes of Health [1K99LM012021-01A1, R01LM011368, R01GM102282, R01LM 011829]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention & Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the National Cancer Institute grant P30 CA 134274-04 to the University of Maryland Baltimore, the Cancer Prevention & Research Institute of Texas (CPRIT) Rising Star Award (CPRIT R1307), and grants from National Institutes of Health (1K99LM012021-01A1, R01LM011368, R01GM102282, and R01LM 011829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S., 2001, IEEE DATA ENG B, V24, P35; Arnold CW, 2010, AMIA ANN S P; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Asuncion A., 2009, P 25 C UNCERTAINTY A, P27, DOI DOI 10.1080/10807030390248483; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bian J, 2012, P 2012 INT WORKSH SM; Bisgin H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S6; Bisgin H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S11; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brownjohn PW, 2017, STEM CELL REP, V8, P870, DOI 10.1016/j.stemcr.2017.02.006; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; CHEN J, 2009, BMC BIOINFORMATICS, V10; Chen X, 2011, BIOINF BIOM BIBM 201; CHEN Y, 2012, BMC GENOMICS S3, V13; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; EHRIG M, 2007, SEMAT WEB BEYOND COM, V4, P1; Frick JM, 2015, BIORXIV; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldman JS, 2005, ARCH NEUROL-CHICAGO, V62, P1624, DOI 10.1001/archneur.62.10.1624; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Gu SY, 2013, J THORAC DIS, V5, pE243, DOI 10.3978/j.issn.2072-1439.2011.04.07; Harrold JM, 2013, CLIN PHARMACOL THER, V94, P651, DOI 10.1038/clpt.2013.176; Hersh WR, 2006, TREC 2006 GENOMICS T; Hojen AR, 2012, METHOD INFORM MED, V51, P529, DOI 10.3414/ME11-02-0023; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Keller CW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00570; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kilicoglu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-486; Klementieva O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14726; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lanoiselee HM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002270; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Nanavaty P, 2014, CANCER CONTROL, V21, P9, DOI 10.1177/107327481402100102; Newman D, 2009, LECT NOTES ARTIF INT, V5866, P270, DOI 10.1007/978-3-642-10439-8_28; OGILVIE MM, 1980, BRIT MED J, V281, P1527, DOI 10.1136/bmj.281.6254.1527-a; Piro RM, 2012, FEBS J, V279, P678, DOI 10.1111/j.1742-4658.2012.08471.x; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramage D., 2009, P 2009 C EMP METH NA, V1, P248, DOI DOI 10.3115/1699510.1699543; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Rindflesch Thomas C., 2011, Information Services & Use, V31, P15, DOI 10.3233/ISU-2011-0627; Roukos DH, 2014, CURR PHARM DESIGN, V20, P11, DOI 10.2174/138161282001140113122438; Salvadores M, 2013, SEMANT WEB, V4, P277, DOI 10.3233/SW-2012-0086; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shan HH, 2008, IEEE DATA MINING, P530, DOI 10.1109/ICDM.2008.91; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Wang BJ, 2017, P NATL ACAD SCI USA, V114, pE3129, DOI 10.1073/pnas.1618804114; Wang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017243; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wu Y, 2012, PACIFIC S BIOCOMPUTI; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zhang YJ, 2012, IEEE ACM T COMPUT BI, V9, P1190, DOI 10.1109/TCBB.2012.50; Zhang YJ, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-33; Zhang YJ, 2013, INT J DATA MIN BIOIN, V7, P284, DOI 10.1504/IJDMB.2013.053309; Zhao J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00058; Zhou MH, 2015, MOL CLIN ONCOL, V3, P859, DOI 10.3892/mco.2015.561; Zhu D, INCREMENTAL APPROACH; Zhu J., 2009, P 26 ANN INT C MACH; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	68	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191568	10.1371/journal.pone.0191568	http://dx.doi.org/10.1371/journal.pone.0191568			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373609	gold, Green Published, Green Submitted			2022-12-26	WOS:000423425400015
J	Hong, J; Lee, JH; Yhim, HY; Choi, WI; Bang, SM; Lee, H; Oh, D				Hong, Junshik; Lee, Ju Hyun; Yhim, Ho-Young; Choi, Won-Il; Bang, Soo-Mee; Lee, Heeyoung; Oh, Doyeun			Incidence of venous thromboembolism in Korea from 2009 to 2013	PLOS ONE			English	Article							DEEP-VEIN-THROMBOSIS; ASSESSMENT SERVICE DATABASE; POPULATION-BASED-COHORT; PULMONARY-EMBOLISM; ORAL RIVAROXABAN; EPIDEMIOLOGY; PREDICTORS; PREVALENCE; RECURRENCE; MORTALITY	The incidence of venous thromboembolism (VTE) is lower in Asian populations than in Western populations. The objective of the present study was to evaluate the annual age-and sex-adjusted incidence (ASR) of VTE from 2009 to 2013 in South Korea. In addition, annual change in the pattern of VTE treatment during the study period was estimated because a new direct oral anticoagulant (DOAC) had become available and was covered by health insurance in Korea beginning in January 2013. VTE cases from 2009 to 2013 were retrospectively identified based on both diagnostic and medication codes of anticoagulants used for initial treatment using the Korean Health Insurance Review and Assessment Service (HIRA) databases. The incidence of VTE increased yearly. It was significantly higher in the older population than in the younger population, and it was higher in females than in males. In 2009, ASRs of VTE, deep vein thrombosis, and pulmonary embolism were 21.3, 8.1, and 13.2 cases per 100,000 individuals, respectively in 2009. These increased to 29.2, 12.7, and 16.6 cases per 100,000, respectively, in 2013. Prescription rates of warfarin and low-molecular +/- weight heparin decreased with the introduction of a new anticoagulant in 2013. The proportion of subjects who underwent mechanical procedures decreased annually. The ASR of VTE in Korea continuously increased from 2009 to 2013, reflecting an increased awareness and detection of VTE as well as improved survival of patients with cancer and other morbidities. Following its introduction, DOAC rapidly replaced other anticoagulants for the treatment of VTE.	[Hong, Junshik] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Ju Hyun; Bang, Soo-Mee] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Yhim, Ho-Young] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea; [Choi, Won-Il] Keimyung Univ, Dungan Med Ctr, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Heeyoung] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Pub Hlth, Seongnam, South Korea; [Oh, Doyeun] CHA Univ, CHA Bundang Med Ctr, Sch Med, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Jeonbuk National University; Keimyung University; Seoul National University (SNU); Pochon Cha University	Bang, SM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	smbang7@snu.ac.kr	lee, hy/GRS-0797-2022	Hong, Junshik/0000-0002-7829-397X	Korean Society on Thrombosis and Hemostasis [KSTH 2016-002]	Korean Society on Thrombosis and Hemostasis	This work was supported by a grant (KSTH 2016-002) from the Korean Society on Thrombosis and Hemostasis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alotaibi GS, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.041; Angchaisuksiri P, 2011, THROMB HAEMOSTASIS, V106, P585, DOI 10.1160/TH11-03-0184; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bouee S, 2016, THROMB J, V14, DOI 10.1186/s12959-016-0078-0; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Cheuk BLY, 2004, BRIT J SURG, V91, P424, DOI 10.1002/bjs.4454; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Delluc A, 2016, THROMB HAEMOSTASIS, V116, P967, DOI 10.1160/TH16-03-0205; Desai A, 2016, LUNG, V194, P605, DOI 10.1007/s00408-016-9898-8; Fernandez MM, 2015, CLINICOECONOMIC OUTC, V7, P451, DOI 10.2147/CEOR.S85635; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2017, THROMB HAEMOSTASIS, V117, P390, DOI 10.1160/TH16-07-0509; Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Jang MJ, 2011, J THROMB HAEMOST, V9, P2519, DOI 10.1111/j.1538-7836.2011.04518.x; Jang MJ, 2011, J THROMB HAEMOST, V9, P85, DOI 10.1111/j.1538-7836.2010.04108.x; Johansson M, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-6; Khorana AA, 2013, CANCER-AM CANCER SOC, V119, P648, DOI 10.1002/cncr.27772; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Lee CH, 2011, CIRC J, V75, P1998, DOI 10.1253/circj.CJ-10-0992; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Leung V, 2006, THROMB RES, V118, P763, DOI 10.1016/j.thromres.2005.12.014; Margaglione M, 2011, THROMB HAEMOSTASIS, V105, P221, DOI 10.1160/TH10-08-0510; Molina JAD, 2009, ANN ACAD MED SINGAP, V38, P470; Ng HJ, 2009, THROMB HAEMOSTASIS, V101, P1095, DOI 10.1160/TH08-11-0755; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Roberts KM, 2015, THROMBOSIS, V2015, P414523; Sakon M, 2006, J THROMB HAEMOST, V4, P581, DOI 10.1111/j.1538-7836.2006.01786.x; Sakuma M, 2009, CIRC J, V73, P305, DOI 10.1253/circj.CJ-08-0372; Spencer FA, 2009, J THROMB THROMBOLYS, V28, P401, DOI 10.1007/s11239-009-0378-3; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; White RH, 2005, THROMB HAEMOSTASIS, V93, P298, DOI 10.1160/TH04-08-0506	32	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191897	10.1371/journal.pone.0191897	http://dx.doi.org/10.1371/journal.pone.0191897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370290	gold, Green Published, Green Submitted			2022-12-26	WOS:000423416600116
J	Lauritzen, G; Nordfjaern, T				Lauritzen, Grethe; Nordfjaern, Trond			Changes in opiate and stimulant use through 10 years: The role of contextual factors, mental health disorders and psychosocial factors in a prospective SUD treatment cohort study	PLOS ONE			English	Article							SUSTAINED HEROIN ABSTINENCE; FOLLOW-UP OUTCOMES; DRUG-ABUSE; TREATMENT RETENTION; LONG-TERM; DEPENDENCE; CHILDHOOD; SEVERITY; PATTERNS; COCAINE	Aim To examine temporal changes in opiate and stimulant use among patients in substance abuse treatment over a ten-year observation period and to explore the role of contextual factors, mental health disorders and psychosocial factors on these changes. Methods A cohort of 481 patients was prospectively interviewed at admission to treatment and after 1, 2, 7 and 10 years. The sample was recruited from 20 facilities in the Greater Oslo region, Norway. Results The majority of patients were poly-drug users and 80% had used both opiates and stimulants the last 30 days prior to treatment admission. Last-month use of heroin, other opiates, cocaine and amphetamines declined from 80% to 34% at the end of the observation period. The most substantial reduction was observed between baseline and one-year follow-up. Use of heroin decreased the most from 62% to 16% after 10 years (a reduction of 74%), and the reduction continued from one-year follow-up throughout the observation period. The most important multivariate risk factors for sustained use of these drugs were male gender, having one or both biological parents with severe alcohol or drug problems, having an antisocial personality disorder, and living together with a person who abuses alcohol or drugs. Employment was associated with reduced risk of drug use at 7-year follow-up. Conclusions There was a substantial reduction in opiate and stimulant use from baseline to all follow-up assessments, most greatly for heroin. Findings regarding sustained use could suggest familial transmission and the challenges of preventive strategies and treatment efforts in an intergenerational context. Co-occurrence between drug abuse and mental health problems highlights the need of highly specialized competence in SUD treatment.	[Lauritzen, Grethe] Norwegian Inst Publ Hlth, Dept Drug Policy, Oslo, Norway; [Nordfjaern, Trond] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Nordfjaern, Trond] St Olavs Univ Hosp, Dept Res & Dev, Clin Subst Use & Addict Med, Trondheim, Norway	Norwegian Institute of Public Health (NIPH); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Lauritzen, G (corresponding author), Norwegian Inst Publ Hlth, Dept Drug Policy, Oslo, Norway.	grethe.lauritzen@fhi.no	Nordfjaern, Trond/B-8391-2013					Andreas JB, 2015, ADDICT BEHAV, V48, P71, DOI 10.1016/j.addbeh.2015.05.001; Anglin MD, 1997, PSYCHOL ADDICT BEHAV, V11, P308, DOI 10.1037/0893-164X.11.4.308; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bickel WK, 2000, REFRAMING HLTH BEHAV; Brecht ML, 2008, DRUG ALCOHOL DEPEN, V96, P193, DOI 10.1016/j.drugalcdep.2008.01.021; Brorson HH, 2013, CLIN PSYCHOL REV, V33, P1010, DOI 10.1016/j.cpr.2013.07.007; Coolidge FL, 2004, BEHAV GENET, V34, P75, DOI 10.1023/B:BEGE.0000009486.97375.53; Cosden M, 2006, CRIME DELINQUENCY, V52, P599, DOI 10.1177/0011128705284287; Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Darke S, 2005, J SUBST ABUSE TREAT, V28, P255, DOI 10.1016/j.jsat.2005.01.006; Darke S, 2007, ADDICT BEHAV, V32, P1897, DOI 10.1016/j.addbeh.2007.01.014; Darke S, 2006, ADDICT DISORD TREAT, V5, P9, DOI 10.1097/01.adt.0000210702.63165.81; Darke S, 2015, J STUD ALCOHOL DRUGS, V76, P909, DOI 10.15288/jsad.2015.76.909; Gerdner A, 2009, NORD J PSYCHIAT, V63, P160, DOI 10.1080/08039480802514366; Gjersing L, 2013, DRUG ALCOHOL DEPEN, V133, P121, DOI 10.1016/j.drugalcdep.2013.05.022; Gossop M, 2002, ADDICT BEHAV, V27, P155, DOI 10.1016/S0306-4603(00)00174-X; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; Gossop M, 2002, ADDICTION, V97, P1259, DOI 10.1046/j.1360-0443.2002.00227.x; Gossop M, 1999, DRUG ALCOHOL DEPEN, V57, P89, DOI 10.1016/S0376-8716(99)00086-1; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Hubbard RL, 1989, DRUG ABUSE TREATMENT; Kendler KS, 2015, PSYCHOL MED, V45, P87, DOI 10.1017/S0033291714001093; Kendler KS, 1998, PSYCHOL MED, V28, P625, DOI 10.1017/S0033291798006643; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Lauritzen G, 62012 SIRUS; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Melberg M, 2003, 4 SIRUS; Millon T., 1987, MILLON CLIN MULTIAXI; Norwegian Patient Registry, 2015, ACT DAT PSYCH SERV A; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Ravndal E, 1998, J SUBST ABUSE TREAT, V15, P135; Ravndal E, 2015, J ADDICT RES THER, V6, P1; Robins LN, 1980, YB SUBSTANCE USE ABU; Simpson DD, 2002, ARCH GEN PSYCHIAT, V59, P538, DOI 10.1001/archpsyc.59.6.538; Simpson DD, 1997, PSYCHOL ADDICT BEHAV, V11, P294, DOI 10.1037/0893-164X.11.4.294; SIMPSON DD, 1982, ADV ALCOHOL SUBSTANC, V0002; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; Teesson M, 2015, ADDICTION, V110, P986, DOI 10.1111/add.12860	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190381	10.1371/journal.pone.0190381	http://dx.doi.org/10.1371/journal.pone.0190381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8QE	29370197	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600009
J	Mueller, MA; Drake, D; Allen, ML				Mueller, Marcus A.; Drake, David; Allen, Maximilian L.			Coexistence of coyotes (Canis latrans) and red foxes (Vulpes vulpes) in an urban landscape	PLOS ONE			English	Article							HABITAT USE; HOME-RANGE; URBANIZATION; CARNIVORES	Urban environments are increasing worldwide and are inherently different than their rural counterparts, with a variety of effects on wildlife due to human presence, increased habitat fragmentation, movement barriers, and access to anthropogenic food sources. Effective management of urban wildlife requires an understanding of how urbanization affects their behavior and ecology. The spatial activity and interactions of urban wildlife, however, have not been as rigorously researched as in rural areas. From January 2015 to December 2016, we captured, radio-collared, and tracked 11 coyotes and 12 red foxes in Madison, WI. Within our study area, coyotes strongly selected home ranges with high proportions of natural areas; conversely, red foxes selected home ranges with open space and moderately developed areas. Use of highly developed areas best explained variation among individual home range sizes and inversely affected home range size for coyotes and red foxes. Coyote and red fox home ranges showed some degree of spatial and temporal overlap, but generally appeared partitioned by habitat type within our study area. Coyotes and red foxes were both active at similar times of the day, but their movement patterns differed based on species-specific habitat use. This spatial partitioning may promote positive co-existence between these sympatric canids in urban areas, and our findings of spatial activity and interactions will better inform wildlife managers working in urban areas.	[Mueller, Marcus A.; Drake, David; Allen, Maximilian L.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mueller, MA (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	marcus.mueller313@gmail.com	Allen, Maximilian/ABG-9307-2020	Allen, Maximilian/0000-0001-8976-889X	Milwaukee (WI) County Parks [MSN193561]; Wisconsin Alumni Research Foundation [MSN184534]; University of Wisconsin Madison Lakeshore Nature Preserve Student Engagement Grant; University of Wisconsin Foundation Urban Canid Fund; University of Wisconsin-Madison Graduate School and Department of Forest and Wildlife Ecology; Milwaukee County Parks	Milwaukee (WI) County Parks; Wisconsin Alumni Research Foundation; University of Wisconsin Madison Lakeshore Nature Preserve Student Engagement Grant; University of Wisconsin Foundation Urban Canid Fund; University of Wisconsin-Madison Graduate School and Department of Forest and Wildlife Ecology; Milwaukee County Parks	This work was supported by Milwaukee (WI) County Parks (http://county.milwaukee.gov/Parks), grant number MSN193561 (DD); Wisconsin Alumni Research Foundation (https://www.warf.org/), grant number MSN184534 (DD); University of Wisconsin Madison Lakeshore Nature Preserve Student Engagement Grant (https://lakeshorepreserve.wisc.edu/engagement-grants.htm), no grant number (DD); and University of Wisconsin Foundation Urban Canid Fund (https://www.supportuw.org/), no grant number (DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the University of Wisconsin-Madison Graduate School and Department of Forest and Wildlife Ecology, and Milwaukee County Parks for funding our research. We thank K. Lindau, H. Hovanec, M. Torkelson, and the many other students and members of the public who assisted with trapping and fieldwork.	ABLES ED, 1969, J WILDLIFE MANAGE, V33, P145, DOI 10.2307/3799662; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker PJ, 2007, BEHAV ECOL, V18, P716, DOI 10.1093/beheco/arm035; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bekoff M, 2003, WILD MAMMALS N AM BI, P467; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceia-Hasse A, 2017, GLOBAL ECOL BIOGEOGR, V26, P592, DOI 10.1111/geb.12564; Crooks Kevin R., 2010, P185; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Cypher BL., 2003, WILD MAMMALS N AM BI, P511; Gehrt S. D., 2011, CITIES ENV, V4, P3; Gehrt S. D., 2010, URBAN CARNIVORES ECO; Gehrt Stanley D., 2010, P79; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; Gese EM, 1996, J MAMMAL, V77, P377, DOI 10.2307/1382811; Gloor S, 2001, MAMM BIOL, V66, P155; Gompper ME, 2002, BIOSCIENCE, V52, P185, DOI 10.1641/0006-3568(2002)052[0185:TCITSE]2.0.CO;2; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Litvaitis JA, 1992, ECOLOGY MANAGEMENT E, P73; McCleery R., 2012, WILDLIFE TECHNIQUES, P169; McCleery RA, 2014, URBAN WILDLIFE CONSE, P1; McIntyre N.E., 2014, URBAN WILDLIFE CONSE, P103; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Millspaugh J.J., 2012, WILDLIFE TECHNIQUES, P480; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Moore G. C., 1992, ECOLOGY MANAGEMENT E, P23; Newsome SD, 2015, OECOLOGIA, V178, P115, DOI 10.1007/s00442-014-3205-2; Nilon C., 2014, URBAN WILDLIFE CONSE, P91, DOI 10.1007/978-1-4899-7500-3_6; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ruggles S., 2019, DATABASE; Ryan AM, 2014, URBAN WILDL CONSERV, P149; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; SARGEANT AB, 1987, J WILDLIFE MANAGE, V51, P285, DOI 10.2307/3801004; SARGEANT AB, 1989, J MAMMAL, V70, P631, DOI 10.2307/1381437; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHMUTZ JA, 1990, J WILDLIFE MANAGE, V54, P506, DOI 10.2307/3809666; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Soulsbury Carl D., 2010, P63; Teagle WG, 1969, LONDON NAT, V46, P44; The Association of Fish and Wildlife Agencies, 2017, BEST MAN PRACT; United Nations, 2014, DEMOGR RES; VOIGT DR, 1983, J WILDLIFE MANAGE, V47, P852, DOI 10.2307/3808625; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Warren P. S., 2010, URBAN ECOL, P172; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590	54	49	53	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190971	10.1371/journal.pone.0190971	http://dx.doi.org/10.1371/journal.pone.0190971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364916	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500030
J	Tang, MJ; Zhang, MK; Yan, SH; Xia, LP; Yang, ZB; Du, CL; Cui, HL; Wei, DS				Tang, Mingjie; Zhang, Mingkun; Yan, Shihan; Xia, Liangping; Yang, Zhongbo; Du, Chunlei; Cui, Hong-Liang; Wei, Dongshan			Detection of DNA oligonucleotides with base mutations by terahertz spectroscopy and microstructures	PLOS ONE			English	Article							TIME-DOMAIN SPECTROSCOPY; FIELD ENHANCEMENT; DAMAGE RESPONSE; LABEL-FREE; RADIATION; DYNAMICS; WATER; GENE; METAMATERIALS; NUCLEOTIDES	DNA oligonucleotides with a 5-base mutation at the 3'-terminus were investigated by terahertz (THz) spectroscopy in a marker-free manner. The four single-stranded oligonucleotides with 17nt have been detected with specificity on a microfluidic chip, and corroborated by spectral measurements with split-ring resonators. The number of hydrogen bonds formed between the oligonucleotide and its surrounding water molecules, deemed a key contribution to the THz absorption of biological solutions, was explored by molecular dynamics simulations to explain the experimental findings. Our work underlies the feasibility of THz spectroscopy combined with microstructures for marker-free detection of DNA, which may form the basis of a prospective diagnostic tool for studying genic mutation.	[Tang, Mingjie; Zhang, Mingkun; Yan, Shihan; Xia, Liangping; Yang, Zhongbo; Du, Chunlei; Cui, Hong-Liang; Wei, Dongshan] Chinese Acad Sci, Chongqing Key Lab Multiscale Mfg Technol, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China; [Cui, Hong-Liang] Jilin Univ, Coll Instrumentat Sci & Elect Engn, Changchun, Jilin, Peoples R China	Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Jilin University	Wei, DS (corresponding author), Chinese Acad Sci, Chongqing Key Lab Multiscale Mfg Technol, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China.	dswei@cigit.ac.cn	Wei, Dongshan/D-6814-2017	Wei, Dongshan/0000-0003-3999-3911; Yang, Zhongbo/0000-0002-7365-0819; Yan, Shihan/0000-0001-9814-769X	National 973 Program of China [2015CB755401]; National Natural Science Foundation of China [21407145, 31400625, 61605206]; National Key Research and Development Program of China [2017YFF0106303, 2016YFC0101300, 2016YFC0101002]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work has been partially supported by a National 973 Program (No. 2015CB755401) of China, National Natural Science Foundation of China (21407145, 31400625, 61605206), and the National Key Research and Development Program of China (2017YFF0106303, 2016YFC0101300, 2016YFC0101002).	Alexandrov BS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01184; Berrier A, 2012, OPT EXPRESS, V20, P5052, DOI 10.1364/OE.20.005052; Bogomazova AN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07749; Brown ER, 2010, IEEE SENS J, V10, P755, DOI 10.1109/JSEN.2009.2039522; Bye JW, 2014, J PHYS CHEM A, V118, P83, DOI 10.1021/jp407410g; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang YT, 2010, OPT EXPRESS, V18, P9561, DOI 10.1364/OE.18.009561; Chen T, 2012, SENSORS-BASEL, V12, P2742, DOI 10.3390/s120302742; Cheon H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37103; Cistaro A, 2017, J NEUROL, V264, P170, DOI 10.1007/s00415-016-8327-5; Heugen U, 2006, P NATL ACAD SCI USA, V103, P12301, DOI 10.1073/pnas.0604897103; Hong JT, 2013, J PHYS CHEM LETT, V4, P3950, DOI 10.1021/jz4020053; Howell D, 2002, STAT METHODS PSYCHOL; Kraus C, 2017, INT J CANCER, V140, P95, DOI 10.1002/ijc.30428; Larramendy ML, 1998, CYTOMETRY, V31, P174, DOI 10.1002/(SICI)1097-0320(19980301)31:3<174::AID-CYTO4>3.3.CO;2-V; Lee DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15459; Leitner DM, 2008, HFSP J, V2, P314, DOI 10.2976/1.2976661; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Mazur K, 2011, J PHYS CHEM B, V115, P2563, DOI 10.1021/jp111764p; Milley GM, 2016, NEUROMUSCULAR DISORD, V26, P706, DOI 10.1016/j.nmd.2016.07.012; OZAKI H, 1992, NUCLEIC ACIDS RES, V20, P5205, DOI 10.1093/nar/20.19.5205; Pal SK, 2002, J PHYS CHEM B, V106, P12376, DOI 10.1021/jp0213506; Park DJ, 2009, OPT EXPRESS, V17, P12493, DOI 10.1364/OE.17.012493; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Perez A, 2015, J CHEM THEORY COMPUT, V11, P4770, DOI 10.1021/acs.jctc.5b00662; Qin XJ, 2016, BIOSENS BIOELECTRON, V85, P957, DOI 10.1016/j.bios.2016.05.076; Rahman A, 2010, INT SOC OPTICAL ENG, V7568, P35; Saha SC, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067006; Saha SC, 2012, IEEE T THZ SCI TECHN, V2, P113, DOI 10.1109/TTHZ.2011.2177172; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Seo MA, 2009, NAT PHOTONICS, V3, P152, DOI 10.1038/NPHOTON.2009.22; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shih K, 2017, J APPL PHYS, V121, DOI 10.1063/1.4973492; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201; Sun YW, 2011, BIOPHYS J, V100, P225, DOI 10.1016/j.bpj.2010.11.020; Tan NY, 2015, PHYS CHEM CHEM PHYS, V17, P5999, DOI 10.1039/c4cp04477k; Titova LV, 2013, BIOMED OPT EXPRESS, V4, P559, DOI 10.1364/BOE.4.000559; Wang SJ, 2016, IEEE PHOTONIC TECH L, V28, P986, DOI 10.1109/LPT.2016.2522473; Wu XJ, 2013, BIOSENS BIOELECTRON, V42, P626, DOI 10.1016/j.bios.2012.10.095; Xu Y, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4934504; Yang X, 2016, J BIOPHOTONICS, V9, P1050, DOI 10.1002/jbio.201500270; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Zhang M, 2016, MOL SIMULAT, V42, P1; Zhang XC, 2002, PHYS MED BIOL, V47, P3667, DOI 10.1088/0031-9155/47/21/301; Zhu ZR, 1997, CYTOMETRY, V28, P206	48	26	29	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191515	10.1371/journal.pone.0191515	http://dx.doi.org/10.1371/journal.pone.0191515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364930	gold, Green Published, Green Submitted			2022-12-26	WOS:000423412500055
J	Tseng, SH; Lee, JY; Chou, YL; Sheu, ML; Lee, YW				Tseng, Sung-Hui; Lee, Jiun-Yih; Chou, Yi-Lin; Sheu, Mei-Ling; Lee, Yuan-Wen			Association between socioeconomic status and cerebral palsy	PLOS ONE			English	Article							UNITED-KINGDOM; PREVALENCE; INEQUALITIES; SURVIVAL; REGISTER; CHILDREN; CHINA	Background The present study investigated the annual prevalence of cerebral palsy (CP) among children aged <7 years in Taiwan and the association between socioeconomic status and CP prevalence. Methods Data from the Taiwan National Health Insurance Research Database for the 2002-2008 period were used in this population-based study. Severe and total CP were defined according to catastrophic illness certificate and medical claim records, respectively. The annual CP prevalence was calculated as the number of children with CP among all children aged <7 years. Results From 2002 to 2008, the annual prevalence of total and severe CP ranged from 1.9 to 2.8 and from 1.1 to 1.4 per 1000 children, respectively. Boys were 30% more likely to have CP than girls [adjusted relative risk (RR) and 95% confidence interval (CI) ranged from 1.3 (1.2-1.4) to 1.4 (1.2-1.5)]. Low family income was associated with a higher CP prevalence [adjusted RR (95% CI) ranged from 5.1 (4.2-6.2) to 6.4 (5.4-7.6)]. The prevalence of CP in rural area was higher than that in urban or suburban areas. The mortality rate of severe CP ranged from 12.2-22.7 per 1000 children within the 7 years study period. Conclusions The prevalence of CP in Taiwan is similar to that in Western countries. A higher prevalence of CP is associated with male sex, low income, and rural residential location. Our findings provide insights into CP epidemiology among the Chinese population.	[Tseng, Sung-Hui] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Tseng, Sung-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lee, Jiun-Yih] Shin Kong Wu Ho Su Mem Hosp, Qual Manage Ctr, Taipei, Taiwan; [Chou, Yi-Lin] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Sheu, Mei-Ling] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lee, Yuan-Wen] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Lee, Yuan-Wen] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, YW (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan.; Lee, YW (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	m102093020@tmu.edu.tw			Health Promotion Administration, Ministry of Health and Welfare [DOH98-HP-1205]	Health Promotion Administration, Ministry of Health and Welfare	This study was funded by the Health Promotion Administration, Ministry of Health and Welfare (DOH98-HP-1205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2010, ALCOHOL ALCOHOLISM, V45, P592, DOI 10.1093/alcalc/agq063; Arneson CL, 2004, DISABIL HLTH J, V2, P45, DOI DOI 10.1016/J.DHJ0.2008.08.001; Chounti A, 2013, ACTA PAEDIATR, V102, P712, DOI 10.1111/apa.12240; Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268; Clark SM, 2008, CLIN OBSTET GYNECOL, V51, P775, DOI 10.1097/GRF.0b013e3181870994; Dolk H, 2001, PAEDIATR PERINAT EP, V15, P359, DOI 10.1046/j.1365-3016.2001.00351.x; Dolk H, 2010, PAEDIATR PERINAT EP, V24, P149, DOI 10.1111/j.1365-3016.2009.01083.x; Donald KA, 2014, SEMIN PEDIATR NEUROL, V21, P30, DOI 10.1016/j.spen.2014.01.001; El-Tallawy HN, 2014, NEUROPSYCH DIS TREAT, V10, P1267, DOI 10.2147/NDT.S59599; Friis C, 2015, DAN MED J, V62; He P, 2017, J PAEDIATR CHILD H, V53, P480, DOI 10.1111/jpc.13444; Hemming K, 2005, PEDIATRICS, V116, P1383, DOI 10.1542/peds.2005-0259; Himmelmann K, 2014, ACTA PAEDIATR, V103, P618, DOI 10.1111/apa.12614; Hjern A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-49; Kakooza-Mwesige A, 2017, LANCET GLOB HEALTH, V5, pE1275, DOI 10.1016/S2214-109X(17)30374-1; Lang TC, 2012, PEDIATRICS, V129, pE992, DOI 10.1542/peds.2011-2283; Lee YW, 2014, CANCER-AM CANCER SOC, V120, P1338, DOI 10.1002/cncr.28579; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu JM, 1999, INT J EPIDEMIOL, V28, P949, DOI 10.1093/ije/28.5.949; McIntyre S, 2013, DEV MED CHILD NEUROL, V55, P499, DOI 10.1111/dmcn.12017; National Health Insurance Administration Ministry of Health and Welfare, UN HLTH COV TAIW; National Health Insurance Administration Ministry of Health and Welfare, PAT CAT ILLN RAR DIS; NHRI, NAT HLTH INS RES DAT; Oskoui M, 2016, DEV MED CHILD NEUROL, V58, P160, DOI 10.1111/dmcn.12808; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Robertson CMT, 2017, CAN J NEUROL SCI, V44, P366, DOI 10.1017/cjn.2017.33; Sellier E, 2016, DEV MED CHILD NEUROL, V58, P85, DOI 10.1111/dmcn.12865; Smithers-Sheedy H, 2016, DEV MED CHILD NEUROL, V58, P5, DOI 10.1111/dmcn.13026; Solaski M, 2014, DEV MED CHILD NEUROL, V56, P1043, DOI 10.1111/dmcn.12456; Strauss D, 1999, DEV MED CHILD NEUROL, V41, P580, DOI 10.1017/S001216229900122X; World Health Organization, GLOB HLTH OBS GHO DA; Wu YW, 2011, PEDIATRICS, V127, pE674, DOI 10.1542/peds.2010-1656; Yam W. K. L., 2006, Hong Kong Medical Journal, V12, P180	34	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191724	10.1371/journal.pone.0191724	http://dx.doi.org/10.1371/journal.pone.0191724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364952	Green Submitted, Green Published, gold			2022-12-26	WOS:000423412500070
J	Osadchii, OE				Osadchii, Oleg E.			Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals	PLOS ONE			English	Article							RECTIFIER K+-CURRENT; ELECTROCARDIOGRAPHIC T-WAVE; VENTRICULAR REPOLARIZATION; TRANSMURAL DISPERSION; ANTIARRHYTHMIC-DRUGS; CHANNEL BLOCKADE; RATE DEPENDENCE; QT INTERVAL; I-KS; FLECAINIDE	Non-uniform shortening of the action potential duration (APD(90)) in different myocardial regions upon heart rate acceleration can set abnormal repolarization gradients and promote arrhythmia. This study examined whether spatial heterogeneities in APD(90) restitution can be amplified by drugs with clinically proved proarrhythmic potential (dofetilide, quinidine, procainamide, and flecainide) and, if so, whether these effects can translate to the appropriate changes of the ECG metrics of ventricular repolarization, such as JT intervals. In isolated, perfused guinea-pig heart preparations, monophasic action potentials and volume-conducted ECG were recorded at progressively increased pacing rates. The APD(90) measured at distinct ventricular sites, as well as the JTpeak and JTend values were plotted as a function of preceding diastolic interval, and the maximum slopes of the restitution curves were determined at baseline and upon drug administration. Dofetilide, quinidine, and procainamide reverse rate-dependently prolonged APD(90) and steepened the restitution curve, with effects being greater at the endocardium than epicardium, and in the right ventricular (RV) vs. the left ventricular (LV) chamber. The restitution slope was increased to a greater extent for the JTend vs. the JTpeak interval. In contrast, flecainide reduced the APD(90) restitution slope at LV epicardium without producing effect at LV endocardium and RV epicardium, and reduced the JTpeak restitution slope without changing the JTend restitution. Nevertheless, with all agents, these effects translated to the amplified epicardial-to-endocardial and the LV-to-RV non-uniformities in APD(90) restitution, paralleled by the increased JTend vs. JTpeak difference in the restitution slope. In summary, these findings suggest that arrhythmic drug profiles are partly attributable to the accentuated regional heterogeneities in APD(90) restitution, which can be indirectly determined through ECG assessments of the JTend vs. JTpeak dynamics at variable pacing rates.	[Osadchii, Oleg E.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Osadchii, Oleg E.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Aalborg University	Osadchii, OE (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Osadchii, OE (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.	osadchiy@hst.aau.dk		Osadchii, Oleg/0000-0003-0222-3227	Department of Health Science and Technology, University of Aalborg	Department of Health Science and Technology, University of Aalborg	This work was supported by the Department of Health Science and Technology, University of Aalborg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author appreciates financial support from the Department of Health Science and Technology, University of Aalborg.	Abi-Gerges N, 2004, FUND CLIN PHARMACOL, V18, P139, DOI 10.1111/j.1472-8206.2004.00230.x; ANASTASIOUNANA MI, 1987, AM HEART J, V113, P1071, DOI 10.1016/0002-8703(87)90914-8; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Banville I, 2002, J CARDIOVASC ELECTR, V13, P1141, DOI 10.1046/j.1540-8167.2002.01141.x; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; Bryant SM, 1998, CARDIOVASC RES, V40, P322, DOI 10.1016/S0008-6363(98)00133-3; Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883; Clayton RH, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-54; CONARD GJ, 1984, AM J CARDIOL, V53, pB41, DOI 10.1016/0002-9149(84)90501-0; Crow RS, 2003, CIRCULATION, V108, P1985, DOI 10.1161/01.CIR.0000095027.28753.9D; Dorenkamp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054768; Dorian P, 2000, EUROPACE, V2, P277, DOI 10.1053/eupc.2000.0114; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Frommeyer G, 2016, NAT REV CARDIOL, V13, P36, DOI 10.1038/nrcardio.2015.110; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Grom A, 2005, EUROPACE, V7, P113, DOI 10.1016/j.eupc.2005.01.001; Higgins AY, 2015, AM J CARDIOL, V116, P1845, DOI 10.1016/j.amjcard.2015.09.042; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Izumi D, 2012, HEART RHYTHM, V9, P796, DOI 10.1016/j.hrthm.2011.11.046; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; KARAGUEUZIAN HS, 1993, CIRCULATION, V87, P1661, DOI 10.1161/01.CIR.87.5.1661; KOCHWESER J, 1971, J AMER MED ASSOC, V215, P1454, DOI 10.1001/jama.215.9.1454; KURZ RW, 1994, EUR HEART J, V15, P547, DOI 10.1093/oxfordjournals.eurheartj.a060541; Laurita KR, 1998, CIRCULATION, V98, P2774, DOI 10.1161/01.CIR.98.24.2774; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; Meijborg VMF, 2014, CIRC-ARRHYTHMIA ELEC, V7, P524, DOI 10.1161/CIRCEP.113.001622; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; MILNER PG, 1985, AM J CARDIOL, V56, P588, DOI 10.1016/0002-9149(85)91016-1; Minchole A, 2011, IEEE T BIO-MED ENG, V58, P1172, DOI 10.1109/TBME.2010.2097597; Mounsey JP, 2000, CIRCULATION, V102, P2665; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Ng GA, 2009, HEART RHYTHM, V6, P696, DOI 10.1016/j.hrthm.2009.01.035; Nicolson WB, 2014, HEART, V100, P1878, DOI 10.1136/heartjnl-2014-305672; Opthof T, 2007, HEART RHYTHM, V4, P341, DOI 10.1016/j.hrthm.2006.11.022; Osadchii O, 2007, PHARMACOL RES, V55, P287, DOI 10.1016/j.phrs.2006.12.005; Osadchii OE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172683; Osadchii OE, 2014, SCAND CARDIOVASC J, V48, P357, DOI 10.3109/14017431.2014.976256; Osadchii OE, 2014, FUND CLIN PHARMACOL, V28, P382, DOI 10.1111/fcp.12046; Osadchii OE, 2013, CAN J PHYSIOL PHARM, V91, P306, DOI 10.1139/cjpp-2012-0379; Osadchii OE, 2012, CARDIOVASC DRUG THER, V26, P489, DOI 10.1007/s10557-012-6405-1; Osaka T, 2011, J CARDIOVASC ELECTR, V22, P669, DOI 10.1111/j.1540-8167.2010.01990.x; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; PANIDIS IP, 1983, J AM COLL CARDIOL, V2, P798, DOI 10.1016/S0735-1097(83)80225-3; Pedersen HS, 2007, AM J CARDIOL, V100, P876, DOI 10.1016/j.amjcard.2007.04.020; Ridley JM, 2003, BIOCHEM BIOPH RES CO, V306, P388, DOI 10.1016/S0006-291X(03)00980-X; RODEN DM, 1988, CIRC RES, V62, P1055, DOI 10.1161/01.RES.62.5.1055; Sabir IN, 2008, PFLUG ARCH EUR J PHY, V455, P637, DOI 10.1007/s00424-007-0326-z; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Shattock MJ, 2017, CARDIOVASC RES, V113, P817, DOI 10.1093/cvr/cvx063; Soltysinska E, 2011, PFLUG ARCH EUR J PHY, V462, P529, DOI 10.1007/s00424-011-1005-7; STRASBERG B, 1981, AM J CARDIOL, V47, P1309, DOI 10.1016/0002-9149(81)90264-2; Tsai SF, 2014, HEART RHYTHM, V11, P485, DOI 10.1016/j.hrthm.2013.11.017; VARRO A, 1993, BASIC RES CARDIOL, V88, P93; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; VONSAVIGNY L, 1981, BASIC RES CARDIOL, V76, P276; Wang DW, 1996, J MOL CELL CARDIOL, V28, P893, DOI 10.1006/jmcc.1996.0084; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Wu S, 2005, J CARDIOVASC ELECTR, V16, P872, DOI 10.1111/j.1540-8167.2005.40811.x; Xia YL, 2005, HEART RHYTHM, V2, P162, DOI 10.1016/j.hrthm.2004.11.011; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Zulqarnain MA, 2015, AM J CARDIOL, V116, P74, DOI 10.1016/j.amjcard.2015.03.038	70	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191514	10.1371/journal.pone.0191514	http://dx.doi.org/10.1371/journal.pone.0191514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352276	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300106
J	Tran, BX; Nguyen, LH; Tran, TT; Latkin, CA				Bach Xuan Tran; Long Hoang Nguyen; Tung Thanh Tran; Latkin, Carl A.			Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; QUALITY-OF-LIFE; MEDICATION ADHERENCE; COST-EFFECTIVENESS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; SERVICE UTILIZATION; INTERNET ADDICTION; RISK BEHAVIORS	Introduction Methadone maintenance treatment (MMT) services may reduce the risk of HIV transmission if patients completely adhere to the treatment. Identifying adherence patterns and potential related factors is vital for the sustainability of MMT program in Vietnam. This study examined social and structural factors associated with adherence to MMT among patients in different service delivery models. Materials and methods A total of 510 patients at three MMT clinics in Hanoi were interviewed. Measures of self-reported adherence included the number of missed doses in the past 7 days and the level of adherence in the past 30 days using a visual analog scale (VAS) scoring from 0 (non-adherence) to 100 (perfect adherence). Multivariate regressions were employed to identify factors associated with non-adherence to MMT. Results A total of 17.7% of participants reported incomplete MMT adherence in the last 30 days and 8.3% reported missing a dose in the last seven days, respectively. Living with HIV/AIDS, poor self-care and usual activities, and disclosure of health issues to spouses or intimate partners were associated with non-adherence. Those patients with pain or depression were more likely to report better adherence. Disclosing health status to spouse/partner increased the risk of incomplete adherence, while disclosing to friends reduced the number of missed dose in the last seven days. Patients attending clinics with comprehensive services had a lower VAS score of adherence compared to those enrolling in clinics with only MMT and general health care. Conclusions Sustaining the compliance of patients to MMT is principal in the rapid expansion of this service in Vietnam. It is necessary to address the complexity of health care demands of drug users, their difficulties to be rehabilitated into workforce and society, and the stigmatization to maximize the outcomes of MMT program.	[Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Tung Thanh Tran] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vietnam National University Hanoi; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	bach.jhu@gmail.com						Tran BX, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2405-y; Tran BX, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3983-z; Tran BX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168687; Tran BX, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0485-8; Tran BX, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0091-4; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Barclay TR, 2007, HEALTH PSYCHOL, V26, P40, DOI 10.1037/0278-6133.26.1.40; Boyd J, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0159-9; Control VAoHA, 2015, ANN REV HIV AIDS CON; Control VAoHA, 2016, ANN REV HIV AIDS CON; Dima AL, 2014, SOC SCI MED, V108, P166, DOI 10.1016/j.socscimed.2014.02.045; Fekete EM, 2009, BRAIN BEHAV IMMUN, V23, P693, DOI 10.1016/j.bbi.2009.01.007; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Greenwald MK, 2002, EXP CLIN PSYCHOPHARM, V10, P39, DOI 10.1037//1064-1297.10.1.39; Haskew M, 2008, J SUBST ABUSE TREAT, V35, P109, DOI 10.1016/j.jsat.2007.08.013; Havens JR, J SUBSTANCE ABUSE TR, V36, P306; Herget Greg, 2005, HIV AIDS Policy Law Rev, V10, P23; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kermode M, 2011, B WORLD HEALTH ORGAN, V89, P243, DOI 10.2471/BLT.11.086850; Khalsa JH, 2010, AM J ADDICTION, V19, P96, DOI 10.1111/j.1521-0391.2009.00010.x; Larance B, 2012, NONADHERENCE OPIOID; Latkin CA, 1999, AM J DRUG ALCOHOL AB, V25, P463, DOI 10.1081/ADA-100101873; Latkin CA, 2016, AIDS EDUC PREV, V28, P417, DOI 10.1521/aeap.2016.28.5.417; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Nguyen LH, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0115-4; Nguyen LH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0633-9; Lucas GM, 2004, CLIN INFECT DIS, V38, pS409, DOI 10.1086/421405; Lucas GM, 2007, AIDS PATIENT CARE ST, V21, P564, DOI 10.1089/apc.2006.0192; McCance-Katz EF, 1998, J ACQ IMMUN DEF SYND, V18, P435, DOI 10.1097/00042560-199808150-00004; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Musa R, 2012, ASIA-PAC J PUBLIC HE, V24, P826, DOI 10.1177/1010539511404396; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Nguyen LH, 2015, AIDS BEHAV; Nguyen LH, 2017, AIDS BEHAV; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Pharmacists OCo, 2014, METH MAINT TREATM MM; Raffa JD, DRUG ALCOHOL DEPENDE, V89, P306; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rao R, 2013, B WORLD HEALTH ORGAN, V91, P150, DOI 10.2471/BLT.12.111815; Riegel B, 2009, EUR J CARDIOVASC NUR, V8, P337, DOI 10.1016/j.ejcnurse.2009.06.003; Rotzinger A, PATIENT ED COUNSELIN, V99, P1413; Roux P, 2014, CURR PHARM DESIGN, V20, P4097, DOI 10.2174/13816128113199990623; Serovich JM, 2008, AIDS BEHAV, V12, P227, DOI 10.1007/s10461-007-9295-7; Shen JC, 2016, J ADDICT MED, V10, P40, DOI 10.1097/ADM.0000000000000180; Tran BX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2897-0; Tran Bach Xuan, 2013, Int J Drug Policy, V24, pe105, DOI 10.1016/j.drugpo.2013.07.007; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Tran BX, 2016, PLOS ONE, V11; Tran BX, 2015, PLOS ONE, V10; Tran BX, 2012, PLOS ONE, V7; Hoang TV, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0075-9; Ushie BA, 2012, AIDS PATIENT CARE ST, V26, P674, DOI 10.1089/apc.2011.0304; Van Nguyen H, 2017, HARM REDUCT J, V14; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; WHO Office for Europe, 2012, PRACT GUID TOOLK IMP; Wolff K, 2002, THER DRUG MONIT, V24, P457, DOI 10.1097/00007691-200208000-00001; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang MWB, 2017, ASIAN J PSYCHIATR, V28, P15, DOI 10.1016/j.ajp.2017.03.025; Zhang MWB, 2017, HEALTHC INFORM RES, V23, P109, DOI 10.4258/hir.2017.23.2.109; Zhao M, 2015, TXB ADDICTION TREATM, P531; Zhou KN, 2017, J ADDICT MED, V11, P28, DOI 10.1097/ADM.0000000000000263; Zhou KN, 2014, ADDICT BEHAV, V39, P22, DOI 10.1016/j.addbeh.2013.09.001	65	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190941	10.1371/journal.pone.0190941	http://dx.doi.org/10.1371/journal.pone.0190941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346444	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500022
J	Gifford, SC; Strachan, BC; Xia, H; Voros, E; Torabian, K; Tomasino, TA; Griffin, GD; Lichtiger, B; Aung, FM; Shevkoplyas, SS				Gifford, Sean C.; Strachan, Briony C.; Xia, Hui; Voros, Eszter; Torabian, Kian; Tomasino, Taylor A.; Griffin, Gary D.; Lichtiger, Benjamin; Aung, Fleur M.; Shevkoplyas, Sergey S.			A portable system for processing donated whole blood into high quality components without centrifugation	PLOS ONE			English	Article							RED-CELL STORAGE; PLATELET-RICH PLASMA; TRANSFUSION; ACTIVATION; LESION; INFLAMMATION; FILTRATION; APHERESIS; COMPLEX; FRESH	Background The use of centrifugation-based approaches for processing donated blood into components is routine in the industrialized world, as disparate storage conditions require the rapid separation of 'whole blood' into distinct red blood cell (RBC), platelet, and plasma products. However, the logistical complications and potential cellular damage associated with centrifugation/apheresis manufacturing of blood products are well documented. The objective of this study was to evaluate a proof-of-concept system for whole blood processing, which does not employ electromechanical parts, is easily portable, and can be operated immediately after donation with minimal human labor. Methods and findings In a split-unit study (n = 6), full (similar to 500mL) units of freshly-donated whole blood were divided, with one half processed by conventional centrifugation techniques and the other with the new blood separation system. Each of these processes took 2-3 hours to complete and were performed in parallel. Blood products generated by the two approaches were compared using an extensive panel of cellular and plasma quality metrics. Comparison of nearly all RBC parameters showed no significant differences between the two approaches, although the portable system generated RBC units with a slight but statistically significant improvement in 2,3-diphosphoglyceric acid concentration (p < 0.05). More notably, several markers of platelet damage were significantly and meaningfully higher in products generated with conventional centrifugation: the increase in platelet activation (assessed via P-selectin expression in platelets before and after blood processing) was nearly 4-fold higher for platelet units produced via centrifugation, and the release of pro-inflammatory mediators (soluble CD40-ligand, thromboxane B2) was significantly higher for centrifuged platelets as well (p < 0.01). Conclusion This study demonstrated that a simple, passive system for separating donated blood into components may be a viable alternative to centrifugation-particularly for applications in remote or resource-limited settings, or for patients requiring highly functional platelet product.	[Gifford, Sean C.] Halcyon Biomed Inc, Friendswood, TX USA; [Strachan, Briony C.; Xia, Hui; Voros, Eszter; Torabian, Kian; Tomasino, Taylor A.; Shevkoplyas, Sergey S.] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Griffin, Gary D.; Lichtiger, Benjamin; Aung, Fleur M.] MD Anderson Canc Ctr, Dept Lab Med, Sect Transfus Med, Blood Donor Ctr, Houston, TX USA	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center	Shevkoplyas, SS (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	sshevkoplyas@uh.edu	Xia, Hui/F-5052-2016	Xia, Hui/0000-0002-3547-4631; Shevkoplyas, Sergey/0000-0002-8203-8365	U.S. Army [W81XWH-11-C-0008]; National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute) [R01HL117329]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117329] Funding Source: NIH RePORTER	U.S. Army(United States Department of DefenseUnited States Army); National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Small Business Technology Transfer award from the U.S. Army (W81XWH-11-C-0008; CORs: Dr. Jill Sondeen, Dr. Daniel Darlington; PI: S.C.G.), and a 2012 National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute R01HL117329, PI: S.S. S.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.C.G. and S.S.S. are part-owners of Halcyon Biomedical Incorporated, a startup company which would benefit from commercialization of the technology described in this manuscript. This funder provided support in the form of salaries for authors S.C.G. and S.S.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basu D, 2014, INDIAN J ANAESTH, V58, P529, DOI 10.4103/0019-5049.144647; Bennett-Guerrero E, 2014, TRANSFUSION, V54, P2544, DOI 10.1111/trf.12660; Bianchi M, 2016, BLOOD TRANSFUS-ITALY, V14, P214, DOI 10.2450/2015.0154-15; Brune T, 2009, ADV HEMATOL, V2009; Brune T, 2007, TRANSFUSION, V47, P2271, DOI 10.1111/j.1537-2995.2007.01456.x; Cauwenberghs S, 2007, TRANSFUS MED REV, V21, P287, DOI 10.1016/j.tmrv.2007.05.004; Cholette JM, 2012, PEDIATR CRIT CARE ME, V13, P290, DOI 10.1097/PCC.0b013e31822f173c; Doctor A, 2012, SEMIN PERINATOL, V36, P248, DOI 10.1053/j.semperi.2012.04.005; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Duck FA, 2013, PHYS PROPERTIES TISS; Fung MK, 2014, TECHNICAL MANUAL, V18th; Garraud O, 2017, J THORAC DIS, V9, pE146, DOI 10.21037/jtd.2017.02.03; Garraud O, 2017, TRANSFUS APHER SCI, V56, P98, DOI 10.1016/j.transci.2016.12.030; Getz TM, 2016, TRANSFUSION, V10, P13511; Ghandforoush P, 2010, DECIS SUPPORT SYST, V50, P32, DOI 10.1016/j.dss.2010.06.005; Gifford SC, 2014, LAB CHIP, V14, P4496, DOI 10.1039/c4lc00785a; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Hess JR, 2014, VOX SANG, V107, P1, DOI 10.1111/vox.12130; Hess JR, 2011, TRANSFUSION, V51, p1S, DOI 10.1111/j.1537-2995.2010.02956.x; Hess JR, 2003, TRANSFUSION, V43, P1622, DOI 10.1046/j.1537-2995.2003.00576.x; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hornsey VS, 2005, VOX SANG, V89, P81, DOI 10.1111/j.1423-0410.2005.00660.x; Huang R, 2008, PRENATAL DIAG, V28, P892, DOI 10.1002/pd.2079; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kim-Shapiro DB, 2011, TRANSFUSION, V51, P844, DOI 10.1111/j.1537-2995.2011.03100.x; LaLonde A, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4936371; Levin E, 2008, TRANSFUSION, V48, P2331, DOI 10.1111/j.1537-2995.2008.01836.x; Leytin V, 2004, TRANSFUSION, V44, P1487, DOI 10.1111/j.1537-2995.2004.04042.x; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Medicines EDftQo, 2013, HEALTHCARE GUID PREP; Metcalfe P, 1997, BRIT J HAEMATOL, V98, P86, DOI 10.1046/j.1365-2141.1997.1572983.x; Nobili M, 2008, ASAIO J, V54, P64, DOI 10.1097/MAT.0b013e31815d6898; Ooley P, 2015, STANDARDS BLOOD BANK; Pagana K.D., 2013, MOSBYS MANUAL DIAGNO; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Piacentini N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3640045; Pierskalla WP, 2005, SUPPLY CHAIN MANAG, P103; Pribush A, 2010, COLLOID SURFACE B, V75, P224, DOI 10.1016/j.colsurfb.2009.08.037; Pribush A, 2010, COLLOID SURFACE B, V75, P214, DOI 10.1016/j.colsurfb.2009.08.036; Rapido F, 2017, J CLIN INVEST, V127, P375, DOI 10.1172/JCI90837; Reinhart WH, 2015, TRANSFUSION, V55, P1872, DOI 10.1111/trf.13052; Roback JD, 2016, VOX SANG, V111, P357, DOI 10.1111/vox.12441; Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; Sohrabi S, 2017, ARTIFICIAL ORGANS; Tynngard N, 2009, TRANSFUS APHER SCI, V41, P97, DOI 10.1016/j.transci.2009.07.001; van der Meer PF, 2016, TRANSFUSION MED, V26, P339, DOI 10.1111/tme.12325; van der Meer PF, 2013, TRANSFUS APHER SCI, V48, P129, DOI 10.1016/j.transci.2013.02.004; Vo TD, 2001, TRANSFUSION MED, V11, P45, DOI 10.1046/j.1365-3148.2001.00280.x; Whitaker B. I., 2015, 2013 AABB BLOOD COLL; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Xia H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35943; Zaheer HA, 2016, TRANSFUS APHER SCI, V55, P186, DOI 10.1016/j.transci.2016.09.007; Zhang JN, 2002, THROMB HAEMOSTASIS, V88, P817, DOI 10.1055/s-0037-1613308; Zhang ZY, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3659016; Zimring JC, 2015, BLOOD, V125, P2185, DOI 10.1182/blood-2014-11-567750	57	9	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190827	10.1371/journal.pone.0190827	http://dx.doi.org/10.1371/journal.pone.0190827			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346441	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500018
J	Chen, ZR; Lin, SB; Li, JL; Ni, W; Guo, RF; Lu, JR; Kaye, FJ; Wu, LZ				Chen, Zirong; Lin, Shuibin; Li, Jian-Liang; Ni, Wei; Guo, Ruifeng; Lu, Jianrong; Kaye, Frederic J.; Wu, Lizi			CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells	ONCOGENE			English	Article							LONG NONCODING RNAS; SIGNALING PATHWAY; GENE-EXPRESSION; SALIVARY; CANCER; TRANSLOCATION; ONCOGENE; PROLIFERATION; TRANSCRIPTOME; ACTIVATION	Mucoepidermoid carcinoma (MEC) arises in many glandular tissues and contributes to the most common malignant salivary gland cancers. MEC is specifically associated with a unique t(11; 19) translocation and the resulting CRTC1-MAML2 fusion is a major oncogenic driver for MEC initiation and maintenance. However, the molecular basis underlying the CRTC1-MAML2 oncogenic functions remains elusive. Through gene expression profiling analysis, we observed that LINC00473, a long non-coding RNA (lncRNA), was the top down-regulated target in CRTC1-MAML2-depleted human MEC cells. LncRNAs belong to a new class of non-coding RNAs with emerging roles in tumorigenesis and progression, but remain poorly characterized. In this study, we investigated the role of LINC00473 in mediating CRTC1-MAML2 oncogenic activity in human MEC. We found that LINC00473 transcription was significantly induced in human CRTC1-MAML2-positive MEC cell lines and primary MEC tumors, and was tightly correlated with the CRTC1-MAML2 RNA level. LINC00473 induction was dependent on the ability of CRTC1-MAML2 to activate CREB-mediated transcription. Depletion of LINC00473 significantly reduced the proliferation and survival of human MEC cells in vitro and blocked the in vivo tumor growth in a human MEC xenograft model. RNA in situ hybridization analysis demonstrated a predominantly nuclear localization pattern for LINC00473 in human MEC cells. Furthermore, gene expression profiling revealed that LINC00473 depletion resulted in differential expression of genes important in cancer cell growth and survival. LINC00473 likely regulates gene expression in part through its ability to bind to a cAMP signaling pathway component NONO, enhancing the ability of CRTC1-MAML2 to activate CREB-mediated transcription. Our overall results demonstrate that LINC00473 is a downstream target and an important mediator of the CRTC1-MAML2 oncoprotein. Therefore, LINC00473 acts as a promising biomarker and therapeutic target for human CRTC1-MAML2-positive MECs.	[Chen, Zirong; Ni, Wei; Wu, Lizi] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Chen, Zirong; Ni, Wei; Lu, Jianrong; Kaye, Frederic J.; Wu, Lizi] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL 32611 USA; [Lin, Shuibin] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou, Guangdong, Peoples R China; [Li, Jian-Liang] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL USA; [Ni, Wei; Wu, Lizi] Univ Florida, UF Genet Inst, Gainesville, FL 32611 USA; [Guo, Ruifeng] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Lu, Jianrong] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kaye, Frederic J.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sun Yat Sen University; Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wu, LZ (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.; Wu, LZ (corresponding author), Univ Florida, UF Hlth Canc Ctr, Gainesville, FL 32611 USA.; Wu, LZ (corresponding author), Univ Florida, UF Genet Inst, Gainesville, FL 32611 USA.	lzwu@ufl.edu	Li, J L/E-6100-2018; Guo, Ruifeng/AAK-2072-2020; Li, Jian-Liang/AAE-9315-2019; Lu, Jianrong/F-5240-2013	Li, J L/0000-0002-6487-081X; Li, Jian-Liang/0000-0002-6487-081X; Lu, Jianrong/0000-0002-4969-6040; Wu, Lizi/0000-0002-0076-2617	NIH National Institute of Dental and Craniofacial Research [R01DE023641]; NIH National Cancer Institute [R21CA187730]; NATIONAL CANCER INSTITUTE [R21CA187730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023641] Funding Source: NIH RePORTER	NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by the NIH National Institute of Dental and Craniofacial Research (R01DE023641) and the NIH National Cancer Institute (R21CA187730).	Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Amelio AL, 2014, P NATL ACAD SCI USA, V111, pE3260, DOI 10.1073/pnas.1319176111; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Bell D, 2012, CURR ONCOL REP, V14, P166, DOI 10.1007/s11912-012-0220-5; Birkeland AC, 2017, ORAL ONCOL, V68, P5, DOI 10.1016/j.oraloncology.2017.02.025; Cabanski CR, 2015, RNA BIOL, V12, P628, DOI 10.1080/15476286.2015.1038012; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chen J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1827-3; Chen Z, 2014, ONCOGENE, V33, P3869, DOI 10.1038/onc.2013.348; Chen ZR, 2016, J CLIN INVEST, V126, P2267, DOI 10.1172/JCI85250; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Dickson Iain, 2016, Nat Rev Gastroenterol Hepatol, V13, P122, DOI 10.1038/nrgastro.2016.21; Dinh TA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44653; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Eveson JW, 2011, PERIODONTOL 2000, V57, P150, DOI 10.1111/j.1600-0757.2011.00385.x; Fehr A, 2008, GENE CHROMOSOME CANC, V47, P203, DOI 10.1002/gcc.20522; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Liang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22744; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; NORDKVIST A, 1994, CANCER GENET CYTOGEN, V74, P77, DOI 10.1016/0165-4608(94)90001-9; Reitmair A, 2012, PHYSIOL GENOMICS, V44, P152, DOI 10.1152/physiolgenomics.00089.2011; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saade RE, 2016, JAMA OTOLARYNGOL, V142, P234, DOI 10.1001/jamaoto.2015.3270; Seethala RR, 2010, AM J SURG PATHOL, V34, P1106, DOI 10.1097/PAS.0b013e3181de3021; Tirado Y, 2007, GENE CHROMOSOME CANC, V46, P708, DOI 10.1002/gcc.20458; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; Warner KA, 2013, ORAL ONCOL, V49, P1059, DOI 10.1016/j.oraloncology.2013.08.004; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Wu YH, 2014, TUMOR BIOL, V35, P11887, DOI 10.1007/s13277-014-2453-4; Zhen S, 2017, ONCOTARGET, V8, P9634, DOI 10.18632/oncotarget.14176	41	35	36	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	14					1885	1895		10.1038/s41388-017-0104-0	http://dx.doi.org/10.1038/s41388-017-0104-0			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GB8CU	29353885	Green Accepted			2022-12-26	WOS:000429303300006
J	Ghannam-Shahbari, D; Jacob, E; Kakun, RR; Wasserman, T; Korsensky, L; Sternfeld, O; Kagan, J; Bublik, DR; Aviel-Ronen, S; Levanon, K; Sabo, E; Larisch, S; Oren, M; Hershkovitz, D; Perets, R				Ghannam-Shahbari, Dima; Jacob, Eyal; Kakun, Reli Rachel; Wasserman, Tanya; Korsensky, Lina; Sternfeld, Ofir; Kagan, Juliana; Bublik, Debora Rosa; Aviel-Ronen, Sarit; Levanon, Keren; Sabo, Edmond; Larisch, Sarit; Oren, Moshe; Hershkovitz, Dov; Perets, Ruth			PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma	ONCOGENE			English	Article							CELL-CYCLE ARREST; FALLOPIAN-TUBE; TUMOR SUPPRESSION; THYROID-HORMONE; CANCER; P53; EXPRESSION; P21; PROTEIN; MUTANT	High grade serous carcinoma (HGSC) is the most common subtype of ovarian cancer and it is now widely accepted that this disease often originates from the fallopian tube epithelium. PAX8 is a fallopian tube lineage marker with an essential role in embryonal female genital tract development. In the adult fallopian tube, PAX8 is expressed in the fallopian tube secretory epithelial cell (FTSEC) and its expression is maintained through the process of FTSEC transformation to HGSC. We now report that PAX8 has a pro-proliferative and anti-apoptotic role in HGSC. The tumor suppressor gene TP53 is mutated in close to 100% of HGSC; in the majority of cases, these are missense mutations that endow the mutant p53 protein with potential gain of function (GOF) oncogenic activities. We show that PAX8 positively regulates the expression of TP53 in HGSC and the pro-proliferative role of PAX8 is mediated by the GOF activity of mutant p53. Surprisingly, mutant p53 transcriptionally activates the expression of p21, which localizes to the cytoplasm of HGSC cells where it plays a noncanonical, pro-proliferative role. Together, our findings illustrate how TP53 mutations in HGSC subvert a normal regulatory pathway into a driver of tumor progression.	[Ghannam-Shahbari, Dima; Jacob, Eyal; Kakun, Reli Rachel; Wasserman, Tanya; Korsensky, Lina; Sternfeld, Ofir; Perets, Ruth] Technion Israel Inst Technol, Clin Res Inst Rambam, Div Oncol, Rambam Hlth Care Campus, Haifa, Israel; [Kagan, Juliana; Larisch, Sarit] Univ Haifa, Dept Biol, Cell Death Res Lab, Fac Sci, Haifa, Israel; [Bublik, Debora Rosa; Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Aviel-Ronen, Sarit] Sheba Med Ctr, Dept Pathol, Talpiot Med Leadership Program, Ramat Gan, Israel; [Levanon, Keren] Sheba Med Ctr, Sheba Canc Res Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel; [Levanon, Keren] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Sabo, Edmond] Technion Israel Inst Technol, Dept Pathol, Rambam Hlth Care Campus, Haifa, Israel; [Hershkovitz, Dov] Tel Aviv Univ, Dept Pathol, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Ramat Aviv, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; University of Haifa; Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Perets, R (corresponding author), Technion Israel Inst Technol, Clin Res Inst Rambam, Div Oncol, Rambam Hlth Care Campus, Haifa, Israel.	Ru_Perets@rambam.health.gov.il		Hershkovitz, Dov/0000-0002-7954-4486; Oren, Moshe/0000-0003-4311-7172; Levanon, Keren/0000-0002-5122-064X	The Israel Science Foundation [1901/13]; Israel Cancer Research Fund; The European Commission [PCIG13-GA-2013-618174]; Israel Cancer Association [20150894, 20170117]; The women's health grant at Rambam; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation [822/12]; Hymen Milgrom Trust	The Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; The European Commission(European CommissionEuropean Commission Joint Research Centre); Israel Cancer Association; The women's health grant at Rambam; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation(Israel Science Foundation); Hymen Milgrom Trust	The work presented here was funded by The Israel Science Foundation (1901/13), Israel Cancer Research Fund, The European Commission (PCIG13-GA-2013-618174), Israel Cancer Association (20150894, 20170117), The women's health grant at Rambam (all to R.P.), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to M.O.), Israel Science Foundation (822/12) (to S.L.), The Hymen Milgrom Trust (to S.L.). We would like to thank Prof. Ronny Drapkin (University of Pennsylvania) for FT237 immortalized FTSEC line and Prof. Reuven Agami (AVL, Nederland Cancer Institute) for retroviral p21 shRNA construct.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Al-Hujaily EM, 2015, CANCER PREV RES, V8, P1163, DOI 10.1158/1940-6207.CAPR-15-0121-T; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Au AYM, 2006, ENDOCRINOLOGY, V147, P367, DOI 10.1210/en.2005-0147; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bijron JG, 2013, AM J SURG PATHOL, V37, P1123, DOI 10.1097/PAS.0b013e318282da7f; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Brachova P, 2013, INT J MOL SCI, V14, P19257, DOI 10.3390/ijms140919257; Carcangiu ML, 2004, INT J GYNECOL PATHOL, V23, P35, DOI 10.1097/01.pgp.0000101082.35393.84; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chan DW, 2017, ONCOGENE, V36, P1404, DOI 10.1038/onc.2016.307; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elias KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87988; HARPER JW, 1993, CELL, V75, P805; Hua G, 2016, ONCOGENE, V35, P2247, DOI 10.1038/onc.2015.288; Iwanicki MP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86829; Kar SP, 2017, BRIT J CANCER, V116, P524, DOI 10.1038/bjc.2016.426; Laury AR, 2011, AM J SURG PATHOL, V35, P816, DOI 10.1097/PAS.0b013e318216c112; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Li CG, 2011, ONCOGENE, V30, P4824, DOI 10.1038/onc.2011.190; Li X, 2012, ONCOGENE, V31, P3419, DOI 10.1038/onc.2011.511; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Mhawech-Fauceglia P, 2012, GYNECOL ONCOL, V127, P198, DOI 10.1016/j.ygyno.2012.06.012; Mittag J, 2007, ENDOCRINOLOGY, V148, P719, DOI 10.1210/en.2006-1054; Nonaka D, 2008, AM J SURG PATHOL, V32, P1566, DOI 10.1097/PAS.0b013e31816d71ad; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P140, DOI 10.1097/PAP.0b013e318253465d; Oren O, 2017, STEM CELL REV REP, V13, P17, DOI 10.1007/s12015-016-9691-3; Perets R, 2016, CANCER RES, V76, P10, DOI 10.1158/0008-5472.CAN-15-1382; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Perets R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046467; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Quartuccio SM, 2015, INT J CANCER, V137, P1528, DOI 10.1002/ijc.29528; Rodgers LH, 2016, ONCOTARGET, V7, P32785, DOI 10.18632/oncotarget.9051; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tong GX, 2011, DIAGN CYTOPATHOL, V39, P567, DOI 10.1002/dc.21426; Tung CS, 2009, MODERN PATHOL, V22, P1243, DOI 10.1038/modpathol.2009.92; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wistuba J, 2007, J ENDOCRINOL, V192, P99, DOI 10.1677/JOE-06-0054; Xia X, 2015, EUR J GYNAECOL ONCOL, V36, P662; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	60	32	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2213	2224		10.1038/s41388-017-0040-z	http://dx.doi.org/10.1038/s41388-017-0040-z			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29379162				2022-12-26	WOS:000431100200001
J	Konno, H; Yamauchi, S; Berglund, A; Putney, RM; Mule, JJ; Barber, GN				Konno, Hiroyasu; Yamauchi, Shota; Berglund, Anders; Putney, Ryan M.; Mule, James J.; Barber, Glen N.			Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production	ONCOGENE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE RECOGNITION; INFECTION; SYNTHASE; CGAS	The production of cytokines in response to DNA-damage events may be an important host defense response to help prevent the escape of pre-cancerous cells. The innate immune pathways involved in these events are known to be regulated by cellular molecules such as stimulator of interferon genes (STING), which controls type I interferon and pro-inflammatory cytokine production in response to the presence of microbial DNA or cytosolic DNA that has escaped from the nucleus. STING signaling has been shown to be defective in a variety of cancers, such as colon cancer and melanoma, actions that may enable damaged cells to escape the immunosurveillance system. Here, we report through examination of databases that STING signaling may be commonly suppressed in a greater variety of tumors due to loss-of-function mutation or epigenetic silencing of the STING/cGAS promoter regions. In comparison, RNA activated innate immune pathways controlled by RIGI/ MDA5 were significantly less affected. Examination of reported missense STING variants confirmed that many exhibited a loss-of-function phenotype and could not activate cytokine production following exposure to cytosolic DNA or DNAdamage events. Our data imply that the STING signaling pathway may be recurrently suppressed by a number of mechanisms in a considerable variety of malignant disease and be a requirement for cellular transformation.	[Konno, Hiroyasu; Yamauchi, Shota; Barber, Glen N.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Berglund, Anders; Putney, Ryan M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Mule, James J.] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol, Tampa, FL USA; [Mule, James J.] H Lee Moffitt Canc Ctr & Res Inst, Immunol Programs, Tampa, FL USA	University of Miami; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Barber, GN (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.	gbarber@med.miami.edu		Berglund, Anders/0000-0002-0393-3530	NCI [R01CA194404]; NCI-NIH [1R01 CA148995, 1R01 CA184845, P30 CA076292, P50 CA168536]; Cindy and Jon Gruden Fund; Chris Sullivan Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [P50CA168536, R01CA184845, R01CA148995, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079336] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cindy and Jon Gruden Fund; Chris Sullivan Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NCI (R01CA194404) (G.N. Barber) and NCI-NIH (1R01 CA148995, 1R01 CA184845, P30 CA076292, P50 CA168536), Cindy and Jon Gruden Fund, Chris Sullivan Fund, and Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (J. J. Mule). We thank the staff of the Moffitt Cancer Center Cancer Informatics and Collaborative Data Services.	Ahn J, 2015, ONCOGENE, V34, P5302, DOI 10.1038/onc.2014.457; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kolodkin-Gal D, 2009, GENE THER, V16, P905, DOI 10.1038/gt.2009.44; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Song SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39858; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Teschendorff AE, 2012, GENOME MED, V4, DOI 10.1186/gm323; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	31	92	94	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	15					2037	2051		10.1038/s41388-017-0120-0	http://dx.doi.org/10.1038/s41388-017-0120-0			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GC6KH	29367762	Green Accepted			2022-12-26	WOS:000429899400007
J	Lao, YM; Yang, K; Wang, ZJ; Sun, XQ; Zou, Q; Yu, XY; Cheng, JK; Tong, XM; Yeh, ETH; Yang, J; Yi, J				Lao, Yimin; Yang, Kai; Wang, Zhaojun; Sun, Xueqing; Zou, Qiang; Yu, Xiaoyan; Cheng, Jinke; Tong, Xuemei; Yeh, Edward T. H.; Yang, Jie; Yi, Jing			DeSUMOylation of MKK7 kinase by the SUMO2/3 protease SENP3 potentiates lipopolysaccharide-induced inflammatory signaling in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MILD OXIDATIVE STRESS; TOLL-LIKE RECEPTORS; REACTIVE OXYGEN; INNATE IMMUNITY; GENE-EXPRESSION; RESPONSE GENES; DE-SUMOYLATION; TRANSCRIPTION FACTORS	Protein SUMOylation has been reported to play a role in innate immune response, but the enzymes, substrates, and consequences of the specific inflammatory signaling events are largely unknown. Reactive oxygen species (ROS) are abundantly produced during macrophage activation and required for Toll-like receptor 4 (TLR4)-mediated inflammatory signaling. Previously, we demonstrated that SENP3 is a redox-sensitive SUMO2/3 protease. To explore any links between reversible SUMOylation and ROS-related inflammatory signaling in macrophage activation, we generated mice with Senp3 conditional knock-out in myeloid cells. In bacterial lipopolysaccharide (LPS)-induced in vitro and in vivo inflammation models, we found that SENP3 deficiency markedly compromises the activation of TLR4 inflammatory signaling and the production of proinflammatory cytokines in macrophages exposed to LPS. Moreover, Senp3 conditional knock-out mice were significantly less susceptible to septic shock. Of note, SENP3 deficiency was associated with impairment in JNK phosphorylation. We found that MKK7, which selectively phosphorylates JNK, is a SENP3 substrate and that SENP3-mediated deSUMOylation of MKK7 may favor its binding to JNK. Importantly, ROS-dependent SENP3 accumulation and MKK7 deSUMOylation rapidly occurred after LPS stimulation. In conclusion, our findings indicate that SENP3 potentiates LPS-induced TLR4 signaling via deSUMOylation of MKK7 leading to enhancement in JNK phosphorylation and the downstream events. Therefore this work provides novel mechanistic insights into redox regulation of innate immune responses.	[Lao, Yimin; Yang, Kai; Sun, Xueqing; Cheng, Jinke; Tong, Xuemei; Yang, Jie; Yi, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai 200025, Peoples R China; [Wang, Zhaojun; Zou, Qiang; Yu, Xiaoyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China; [Yeh, Edward T. H.] Univ Missouri, Dept Internal Med, Columbia, MO 65211 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai 200025, Peoples R China.; Yi, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	yangjieyj@shsmu.edu.cn; yijing@shsmu.edu.cn	Wang, Zhaojun/GKS-9141-2022	Wang, Zhaojun/0000-0003-2853-1850	National Natural Science Foundation of China [31230037, 31471263]; Ministry of Science and Technology of China [2013CB910900]; Ministry of Education of China [20130073110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 31230037 and 31471263, Ministry of Science and Technology of China Grant 2013CB910900, and the Ministry of Education of China Grant 20130073110002. The authors declare that they have no conflicts of interest with the contents of this article.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Barnett TC, 2015, CURR OPIN IMMUNOL, V36, P1, DOI 10.1016/j.coi.2015.04.002; Begitt A, 2011, BLOOD, V118, P1002, DOI 10.1182/blood-2011-04-347930; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bogachek MV, 2015, CANCER RES, V75, P11, DOI 10.1158/0008-5472.CAN-14-2824; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Chattopadhyay S, 2015, EMBO REP, V16, P1535, DOI 10.15252/embr.201540337; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S1; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cui Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006156; Decque A, 2016, NAT IMMUNOL, V17, P140, DOI 10.1038/ni.3342; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doiron K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00151-6; Domingues P, 2015, CELL REP, V13, P1467, DOI 10.1016/j.celrep.2015.10.001; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fu JH, 2011, MOL IMMUNOL, V48, P415, DOI 10.1016/j.molimm.2010.09.003; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hu MM, 2017, J EXP MED, V214, P973, DOI 10.1084/jem.20161015; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE635, DOI 10.1073/pnas.1522826113; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leavy O, 2014, NAT REV IMMUNOL, V14, P357, DOI 10.1038/nri3685; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu X, 2013, ACTA BIOMATER, V9, P7506, DOI 10.1016/j.actbio.2013.03.039; Liu Y, 2012, J CHENGDU MED COLL, V7, P3, DOI DOI 10.1371/J0URNAL.P0NE.0042332; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Murofushi Y, 2015, MOL IMMUNOL, V64, P63, DOI 10.1016/j.molimm.2014.10.027; Murphy M, 2015, J BIOL CHEM, V290, P19218, DOI 10.1074/jbc.M115.640128; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Ren YH, 2014, ONCOTARGET, V5, P7093, DOI 10.18632/oncotarget.2197; Rosonina E, 2017, TRANSCR-AUSTIN, V8, P220, DOI 10.1080/21541264.2017.1311829; Sahin U, 2014, NUCLEUS-PHILA, V5, P499, DOI 10.4161/19491034.2014.970104; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sarkar K, 2015, BLOOD, V126, P1670, DOI 10.1182/blood-2015-05-646182; Schilling EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02049-16; Shao L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9917; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sun H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5980; Tempe D, 2014, ONCOGENE, V33, P921, DOI 10.1038/onc.2013.4; Tomasi ML, 2016, AM J PATHOL, V186, P2326, DOI 10.1016/j.ajpath.2016.05.007; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514; Wang M., 2016, COMPUT VIS MEDIA, V2, P3, DOI DOI 10.1007/s41095-016-0037-5; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Z, 2016, ONCOGENE, V35, P5826, DOI 10.1038/onc.2016.124	87	21	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3965	3980		10.1074/jbc.M117.816769	http://dx.doi.org/10.1074/jbc.M117.816769			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29352108	Green Published, hybrid			2022-12-26	WOS:000427587500010
J	Sasaki, M; Chubachi, S; Kameyama, N; Sato, M; Haraguchi, M; Miyazaki, M; Takahashi, S; Nakano, T; Kuroda, Y; Betsuyaku, T; Matsuo, K				Sasaki, Mamoru; Chubachi, Shotaro; Kameyama, Naofumi; Sato, Minako; Haraguchi, Mizuha; Miyazaki, Masaki; Takahashi, Saeko; Nakano, Takayoshi; Kuroda, Yukiko; Betsuyaku, Tomoko; Matsuo, Koichi			Effects of long-term cigarette smoke exposure on bone metabolism, structure, and quality in a mouse model of emphysema	PLOS ONE			English	Article							MINERAL DENSITY; COPD; MICE; CELLS; NICOTINE; FRACTURE; MUSCLE; COHORT; RISK; GENE	Smoking is a common risk factor for both chronic obstructive pulmonary disease (COPD) and osteoporosis. In patients with COPD, severe emphysema is a risk factor for vertebral fracture; however, the effects of smoking or emphysema on bone health remain largely unknown. We report bone deterioration in a mouse model of emphysema induced by nose-only cigarette smoke (CS) exposure. Unexpectedly, short-term exposure for 4-weeks decreased bone turnover and increased bone volume in mice. However, prolonged exposure for 20- and 40-weeks reversed the effects from suppression to promotion of bone resorption. This long-term CS exposure increased osteoclast number and impaired bone growth, while it increased bone volume. Strikingly, long-term CS exposure deteriorated bone quality of the lumbar vertebrae as illustrated by disorientation of collagen fibers and the biological apatite c-axis. This animal model may provide a better understanding of the mechanisms underlying the deterioration of bone quality in pulmonary emphysema caused by smoking.	[Sasaki, Mamoru; Chubachi, Shotaro; Kameyama, Naofumi; Sato, Minako; Haraguchi, Mizuha; Miyazaki, Masaki; Takahashi, Saeko] Keio Univ, Div Pulm Med, Sch Med, Tokyo, Japan; [Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka, Japan; [Kuroda, Yukiko; Matsuo, Koichi] Keio Univ, Lab Cell & Tissue Biol, Sch Med, Tokyo, Japan	Keio University; Osaka University; Keio University	Matsuo, K (corresponding author), Keio Univ, Lab Cell & Tissue Biol, Sch Med, Tokyo, Japan.	kmatsuo@keio.jp	Kuroda, Yukiko/L-6332-2013; NAKANO, Takayoshi/F-8140-2011; Matsuo, Koichi/K-5695-2012	Kuroda, Yukiko/0000-0002-5335-4238; Matsuo, Koichi/0000-0002-1490-8955; Nakano, Takayoshi/0000-0001-8052-1698	Grants-in-Aid for Scientific Research [16K08506] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akhter MP, 2005, CALCIFIED TISSUE INT, V77, P319, DOI 10.1007/s00223-005-0072-1; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Chubachi S, 2015, RESPIROLOGY, V20, P286, DOI 10.1111/resp.12429; Cielen N, 2016, AM J RESP CELL MOL, V54, P674, DOI 10.1165/rcmb.2015-0181OC; Duckers JM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-101; Gao SG, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-131; Guo JD, 2013, BRIT J PHARMACOL, V168, P1412, DOI 10.1111/bph.12036; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Kallala R, 2013, EXPERT OPIN DRUG SAF, V12, P209, DOI 10.1517/14740338.2013.770471; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Ma DJ, 2012, J PROTEOME RES, V11, P3548, DOI 10.1021/pr2012158; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Morikawa D, 2014, J SHOULDER ELB SURG, V23, P628, DOI 10.1016/j.jse.2014.01.041; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Nuti R, 2009, OSTEOPOROSIS INT, V20, P989, DOI 10.1007/s00198-008-0770-4; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Rothem DE, 2009, J BONE MINER METAB, V27, P555, DOI 10.1007/s00774-009-0075-5; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Sasaki M, 2015, AM J PHYSIOL-LUNG C, V308, pL1039, DOI 10.1152/ajplung.00366.2014; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059402; Tuukkanen J, 2000, J BONE MINER RES, V15, P1905, DOI 10.1359/jbmr.2000.15.10.1905; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Wong PKK, 2007, CLIN SCI, V113, P233, DOI 10.1042/CS20060173; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Yohannes AM, 2011, RESP CARE, V56, P644, DOI 10.4187/respcare.01002; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y; Yoshikawa M, 2001, CHEST, V119, P93, DOI 10.1378/chest.119.1.93	30	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191611	10.1371/journal.pone.0191611	http://dx.doi.org/10.1371/journal.pone.0191611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381718	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800027
J	Lin, JD; Hsu, CH; Wu, CZ; Hsieh, AT; Hsieh, CH; Liang, YJ; Chen, YL; Pei, D; Chang, JB				Lin, Jiunn-Diann; Hsu, Chun-Hsien; Wu, Chung-Ze; Hsieh, An-Tsz; Hsieh, Chang-Hsun; Liang, Yao-Jen; Chen, Yen-Lin; Pei, Dee; Chang, Jin-Biou			Effect of body mass index on diabetogenesis factors at a fixed fasting plasma glucose level	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN SENSITIVITY; RELATIVE CONTRIBUTIONS; GENDER-DIFFERENCES; METABOLIC SYNDROME; DIABETES-MELLITUS; RESISTANCE; SECRETION; IDENTIFICATION; OBESITY	Aim The present study evaluated the relative influence of body mass index (BMI) on insulin resistance (IR), first-phase insulin secretion (FPIS), second-phase insulin secretion (SPIS), and glucose effectiveness (GE) at a fixed fasting plasma glucose level in an older ethnic Chinese population. Methods In total, 265 individuals aged 60 years with a fasting plasma glucose level of 5.56 mmol/L were enrolled. Participants had BMIs of 20.0 +/- 34.2 kg/m(2). IR, FPIS, SPIS, and GE were estimated using our previously developed equations. Pearson correlation analysis was conducted to assess the correlations between the four diabetogenesis factors and BMI. A general linear model was used to determine the differences in the percentage of change among the four factor slopes against BMI. Results Significant correlations were observed between BMI and FPIS, SPIS, IR, and GE in both women and men, which were higher than those reported previously. In men, BMI had the most profound effect on SPIS, followed by IR, FPIS, and GE, whereas in women, the order was slightly different: IR, followed by FPIS, SPIS, and GE. Significant differences were observed among all these slopes, except for the slopes between FPIS and SPIS in women (p = 0.856) and IR and FPIS in men (p = 0.258). Conclusions The contribution of obesity to all diabetes factors, except GE, was higher than that reported previously. BMI had the most profound effect on insulin secretion in men and on IR in women in this 60-year-old cohort, suggesting that lifestyle modifications for obesity reduction in women remain the most important method for improving glucose metabolism and preventing future type 2 diabetes mellitus.	[Lin, Jiunn-Diann; Wu, Chung-Ze; Hsieh, An-Tsz] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med,Coll Med,Div Endocr, Taipei, Taiwan; [Hsu, Chun-Hsien] Fu Jen Catholic Univ, Cardinal Tien Hosp, Sch Med, Dept Family Med, New Taipei, Taiwan; [Hsieh, Chang-Hsun] Triserv Gen Hosp, Natl Def Med Sch, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Liang, Yao-Jen] Fu Jen Catholic Univ, Dept Life Sci, New Taipei, Taiwan; [Chen, Yen-Lin] Fu Jen Catholic Univ, Cardinal Tien Hosp, Sch Med, Dept Pathol, New Taipei, Taiwan; [Pei, Dee] Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Internal Med, New Taipei, Taiwan; [Chang, Jin-Biou] Triserv Gen Hosp, Natl Def Med Ctr, Div Clin Pathol, Dept Pathol, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital	Chang, JB (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Div Clin Pathol, Dept Pathol, Taipei, Taiwan.	paperstudy@yahoo.com.tw		Wu, Chung-Ze/0000-0001-6118-6070	Taipei Medical University [TMU105-AE1-B04]	Taipei Medical University	This work was supported by a grant from Taipei Medical University (TMU105-AE1-B04) to JDL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, OBSTET GYNECOL, V104, p5S; Basu A, 1997, DIABETES, V46, P421, DOI 10.2337/diabetes.46.3.421; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bloomgarden ZT, 1998, CLIN THER, V20, P216, DOI 10.1016/S0149-2918(98)80086-6; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Caumo A, 2004, AM J PHYSIOL-ENDOC M, V287, pE371, DOI 10.1152/ajpendo.00139.2003; Cheal KL, 2004, DIABETES, V53, P1195, DOI 10.2337/diabetes.53.5.1195; Chen YL, 2016, METAB SYNDR RELAT D, V14, P386, DOI 10.1089/met.2015.0136; Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353; Chiu KC, 2001, J CLIN ENDOCR METAB, V86, P1620, DOI 10.1210/jc.86.4.1620; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Hanley AJG, 2003, DIABETES, V52, P2740, DOI 10.2337/diabetes.52.11.2740; Hawkins M, 2003, DIABETES, V52, P2748, DOI 10.2337/diabetes.52.11.2748; Healy SJ, 2015, DIABETES CARE, V38, P228, DOI 10.2337/dc14-1803; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kautzky-Willer A, 2012, OBESITY, V20, P1966, DOI 10.1038/oby.2011.384; KAUTZKYWILLER A, 1992, METABOLISM, V41, P1304, DOI 10.1016/0026-0495(92)90100-O; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Lin JD, 2014, ANN ACAD MED SINGAP, V43, P113; Lin JD, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/675245; Lin Y., 2015, INT J DIABETES CLIN, V2, P113; Lopez X, 2009, DIABETES OBES METAB, V11, P123, DOI 10.1111/j.1463-1326.2008.00913.x; MCKEIGUE PM, 1993, ARTERIOSCLER THROMB, V13, P1187, DOI 10.1161/01.ATV.13.8.1187; Moller JB, 2014, J CLIN ENDOCR METAB, V99, P4273, DOI 10.1210/jc.2014-1724; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Schuster DP, 1998, AM J MED SCI, V316, P361, DOI 10.1097/00000441-199812000-00002; van Haeften TW, 2000, METABOLISM, V49, P1318, DOI 10.1053/meta.2000.9526; van Haeften TW, 1998, DIABETES CARE, V21, P278, DOI 10.2337/diacare.21.2.278; van Haeften TW, 2002, DIABETES, V51, pS265, DOI 10.2337/diabetes.51.2007.S265; Vega GL, 2001, AM HEART J, V142, P1108, DOI 10.1067/mhj.2001.119790; Wandell PE, 2014, DIABETES RES CLIN PR, V106, pE90, DOI 10.1016/j.diabres.2014.09.013; Wang SL, 1997, DIABETOLOGIA, V40, P1431, DOI 10.1007/s001250050846; Wu CZ, 2014, J DIABETES INVEST, V5, P290, DOI 10.1111/jdi.12155	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0189115	10.1371/journal.pone.0189115	http://dx.doi.org/10.1371/journal.pone.0189115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377927	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700004
J	Pan, P; Zhao, F; Ning, JK; Zhang, L; Ouyang, XZ; Zang, H				Pan, Ping; Zhao, Fang; Ning, Jinkui; Zhang, Ling; Ouyang, Xunzhi; Zang, Hao			Impact of understory vegetation on soil carbon and nitrogen dynamic in aerially seeded Pinus massoniana plantations	PLOS ONE			English	Article							LITTER DECOMPOSITION; MICROBIAL BIOMASS; ORGANIC-CARBON; N MINERALIZATION; FOREST; CHINA; CO2; GRASSLAND; ECOSYSTEM; REMOVAL	Understory vegetation plays a vital role in regulating soil carbon (C) and nitrogen (N) characteristics due to differences in plant functional traits. Different understory vegetation types have been reported following aerial seeding. While aerial seeding is common in areas with serious soil erosion, few studies have been conducted to investigate changes in soil C and N cycling as affected by understory vegetation in aerially seeded plantations. Here, we studied soil C and N characteristics under two naturally formed understory vegetation types (Dicranopteris and graminoid) in aerially seeded Pinus massoniana Lamb plantations. Across the two studied understory vegetation types, soil organic C was significantly correlated with all measured soil N variables, including total N, available N, microbial biomass N and water-soluble organic N, while microbial biomass C was correlated with all measured variables except soil organic C. Dicranopteris and graminoid differed in their effects on soil C and N process. Except water-soluble organic C, all the other C and N variables were higher in soils with graminoids. The higher levels of soil organic C, microbial biomass C, total N, available N, microbial biomass N and water-soluble organic N were consistent with the higher litter and root quality (C/N) of graminoid vegetation compared to Dicranopteris. Changes in soil C and N cycles might be impacted by understory vegetation types via differences in litter or root quality.	[Pan, Ping; Ning, Jinkui; Zhang, Ling; Ouyang, Xunzhi; Zang, Hao] Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China; [Zhao, Fang] Jiujiang Univ, Coll Tourism & Terr Resources, Jiujiang, Peoples R China	Jiangxi Agricultural University; Jiujiang University	Zhang, L; Ouyang, XZ (corresponding author), Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China.	lingzhang09@126.com; oyxz_2003@hotmail.com	Zhang, Ling/AAH-2429-2020	Ouyang, Xunzhi/0000-0002-5920-4425; Pan, Ping/0000-0002-1867-3313	National Natural Science Foundation of China [31360181, 31160159]; Jiangxi Agricultural University [9232306047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Agricultural University	This study was financially supported by the National Natural Science Foundation of China (No. 31360181 and 31160159) and Jiangxi Agricultural University (No. 9232306047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAREA JM, 1974, J APPL BACTERIOL, V37, P583, DOI 10.1111/j.1365-2672.1974.tb00483.x; Blazier MA, 2005, FOREST SCI, V51, P449; Bradleycook JI, 2014, AGU FALL M; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chastain RA, 2006, FOREST ECOL MANAG, V231, P63, DOI 10.1016/j.foreco.2006.04.040; Chen J, 2000, SOIL BIOL BIOCHEM, V32, P47, DOI 10.1016/S0038-0717(99)00124-8; Cheng DL, 2015, ANN BOT-LONDON, V115, P303, DOI 10.1093/aob/mcu238; Deng BL, 2016, J SOIL SEDIMENT, V16, P777, DOI 10.1007/s11368-015-1307-z; [丁松 Ding Song], 2014, [水土保持研究, Research of Soil and Water Conservation], V21, P31; Fang HJ, 2014, APPL SOIL ECOL, V81, P1, DOI 10.1016/j.apsoil.2014.04.007; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Ge JL, 2017, PLANT SOIL, V412, P345, DOI 10.1007/s11104-016-3077-9; Gurlevik N, 2004, SOIL SCI SOC AM J, V68, P272, DOI 10.2136/sssaj2004.0272; Inoue T, 2017, ECOLOGICAL RES, P1; Jacob CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173758; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5; Jensen LS, 1997, SOIL BIOL BIOCHEM, V29, P1043, DOI 10.1016/S0038-0717(97)00014-X; Khalili B, 2016, APPL SOIL ECOL, V107, P144, DOI 10.1016/j.apsoil.2016.05.018; Knops JMH, 2002, ECOL LETT, V5, P454, DOI 10.1046/j.1461-0248.2002.00332.x; Langley JA, 2003, ECOLOGY, V84, P2302, DOI 10.1890/02-0282; Liang BC, 1996, BIOL FERT SOILS, V21, P10, DOI 10.1007/BF00335987; Liu Ying-chun, 2008, Shengtaixue Zazhi, V27, P705; Lu R, 2000, METHODS SOIL AGROCHE; Martin-Olmedo P, 1999, BIOL FERT SOILS, V29, P386, DOI 10.1007/s003740050569; Matsushima M, 2007, PLANT SOIL, V292, P243, DOI 10.1007/s11104-007-9220-x; Merbold L, 2014, GLOBAL CHANGE BIOL, V20, P1913, DOI 10.1111/gcb.12518; Minick KJ, 2014, FOREST ECOL MANAG, V319, P161, DOI 10.1016/j.foreco.2014.02.013; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Ren W, 2012, GLOBAL CHANGE BIOL, V18, P2945, DOI 10.1111/j.1365-2486.2012.02741.x; Roy A, 2003, SOIL BIOL BIOCHEM, V35, P365, DOI 10.1016/S0038-0717(02)00286-9; Sauheitl L, 2010, PLANT SOIL, V334, P353, DOI 10.1007/s11104-010-0387-1; Shrestha RK, 2015, NEW FOREST, V46, P167, DOI 10.1007/s11056-014-9454-4; Sierra J, 1997, SOIL BIOL BIOCHEM, V29, P1557, DOI 10.1016/S0038-0717(96)00288-X; Sohng J, 2017, FOREST ECOL MANAG, V389, P331, DOI 10.1016/j.foreco.2016.12.013; Stokdyk JP, 2016, PLANT SOIL, V409, P65, DOI 10.1007/s11104-016-2916-z; Tateno M, 1997, AM NAT, V149, P723, DOI 10.1086/286017; Teng QH, 2009, J MICROBIOL, V47, P135, DOI 10.1007/s12275-008-0184-1; Wan SZ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00017.1; Wang FM, 2014, J FOREST RES-JPN, V19, P238, DOI 10.1007/s10310-013-0395-0; Wang QK, 2011, APPL SOIL ECOL, V47, P210, DOI 10.1016/j.apsoil.2010.12.004; Wu JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06262; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Xiao X, 2015, FORESTS, V6, P1748, DOI 10.3390/f6061748; Yildiz O, 2011, FOREST ECOL MANAG, V262, P586, DOI 10.1016/j.foreco.2011.04.015; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Zhang LX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003608; Zhang L, 2017, FOREST ECOL MANAG, V385, P189, DOI 10.1016/j.foreco.2016.11.045; Zhang L, 2016, PEDOSPHERE, V26, P567, DOI 10.1016/S1002-0160(15)60066-2; [赵芳 Zhao Fang], 2016, [生态学报, Acta Ecologica Sinica], V36, P2637; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020	53	18	22	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191952	10.1371/journal.pone.0191952	http://dx.doi.org/10.1371/journal.pone.0191952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377926	Green Submitted, Green Published, gold			2022-12-26	WOS:000423514700045
J	Schousboe, JT; Kats, AM; Langsetmo, L; Taylor, BC; Vo, TN; Kado, DM; Fink, HA; Ensrud, KE				Schousboe, John T.; Kats, Allyson M.; Langsetmo, Lisa; Taylor, Brent C.; Vo, Tien N.; Kado, Deborah M.; Fink, Howard A.; Ensrud, Kristine E.			Associations of recent weight loss with health care costs and utilization among older women	PLOS ONE			English	Article							PHYSICAL FUNCTION; BODY-COMPOSITION; OBESITY; ADULTS; METAANALYSIS; OVERWEIGHT; MORTALITY; VALIDITY; COHORT; HIP	The association of weight loss with health care costs among older women is uncertain. Our study aim was to examine the association of objectively measured weight change with subsequent total health care (THC) costs and other health care utilization among older women. Our study population included 2,083 women (mean age 80.2 years) enrolled in the Study of Osteoporotic Fractures and U.S. Medicare Fee for Service. Weight loss and gain were defined, respectively, as >= 5% decrease and >= 5% increase in body weight, and weight maintenance as <5% change in body weight over a period of 4.5 years. THC costs, outpatient costs, hospitalizations, and skilled nursing facility [SNF] utilization were estimated from Medicare claims for 1 year after the period during which weight change was measured. The associations of weight change with THC and outpatient costs were estimated using generalized linear models with gamma variance and log link functions, and with hospitalizations and SNF utilization using logistic models. Adjusted for age and current body mass index (BMI), weight loss compared with weight maintenance was associated with a 35% increase in THC costs ($2148 [95% CI, 745 to 3552], 2014 U.S. dollars), a 15% increase in outpatient costs ($329 [95% C.I. -1 to 660]), and odds ratios of 1.42 (95% CI, 1.14 to 1.76) for >= 1 hospital stay and 1.45 (95% CI, 1.03 to 2.03) for >= 1 SNF stay. These associations did not vary by BMI category. After additional adjustment for multi-morbidity and functional status, associations of weight loss with all four outcomes were no longer significant. In conclusion, >= 5% weight loss among older women is not associated with increased THC and outpatient costs, hospitalization, and SNF utilization, irrespective of BMI category after accounting for multi morbidity and impaired functional status that accompany weight loss.	[Schousboe, John T.] HealthPartners, HealthPartners Inst, Minneapolis, MN 55440 USA; [Schousboe, John T.] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Kats, Allyson M.; Langsetmo, Lisa; Taylor, Brent C.; Vo, Tien N.; Fink, Howard A.; Ensrud, Kristine E.] Univ Minnesota, Minneapolis, MN USA; [Taylor, Brent C.; Fink, Howard A.; Ensrud, Kristine E.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Taylor, Brent C.; Fink, Howard A.; Ensrud, Kristine E.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Kado, Deborah M.] Univ Calif San Diego, San Diego, CA 92103 USA; [Fink, Howard A.] Minneapolis VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California San Diego; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Schousboe, JT (corresponding author), HealthPartners, HealthPartners Inst, Minneapolis, MN 55440 USA.; Schousboe, JT (corresponding author), Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.	sch0600@umn.edu	Langsetmo, Lisa/T-2619-2017; Taylor, Brent C/A-8069-2009	Langsetmo, Lisa/0000-0003-2245-1657; Taylor, Brent C/0000-0002-2140-8377; Kado, Deborah/0000-0002-2582-5573; Schousboe, John/0000-0002-9329-0750; Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health; National Institute on Aging (NIA) [R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, R01 AG027576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035584, R01AR035582, R01AR035583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005394, R01AG005407, R01AG027576, R01AG027574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Study of Osteoporotic Fractures (SOF) is supported by National Institutes of Health funding. The National Institute on Aging (NIA) provides support under the following grant numbers: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576. The funding agencies had no direct role in the conduct of the study; the collection, management, analyses and interpretation of the data; or preparation or approval of the manuscript.	Beavers KM, 2015, J NUTR HEALTH AGING, V19, P87, DOI 10.1007/s12603-015-0438-7; Bliddal H, 2014, OBES REV, V15, P578, DOI 10.1111/obr.12173; Cheng Feon W., 2015, Journal of Nutrition in Gerontology and Geriatrics, V34, P343, DOI 10.1080/21551197.2015.1090362; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ENSRUD KE, 1994, J AM GERIATR SOC, V42, P481, DOI 10.1111/j.1532-5415.1994.tb04968.x; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Fabbri E, 2015, J AM GERIATR SOC, V63, P1791, DOI 10.1111/jgs.13608; Fitti J E, 1987, Vital Health Stat 1, P1; Fougere B, 2017, J NUTR HEALTH AGING, V21, P933, DOI 10.1007/s12603-017-0971-7; Han TS, 2013, BEST PRACT RES CL EN, V27, P509, DOI 10.1016/j.beem.2013.04.012; Harkonen R, 1993, J Hand Ther, V6, P259; Kovalchik S, 2009, PUBLIC HEALTH NUTR, V12, P1072, DOI 10.1017/S1368980008003728; LYONS JS, 1989, INT J PSYCHIAT MED, V19, P203; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Nicklas BJ, 2015, AM J CLIN NUTR, V101, P991, DOI 10.3945/ajcn.114.105270; Pack QR, 2014, MAYO CLIN PROC, V89, P1368, DOI 10.1016/j.mayocp.2014.04.033; Pizzato S, 2015, EUR J CLIN NUTR, V69, P1113, DOI 10.1038/ejcn.2015.19; Pregibon D., 1980, APPLIED STATISTICS, V29, P15, DOI [DOI 10.2307/2346405, 10.2307/2346405]; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Reinders I, 2015, J AM GERIATR SOC, V63, P1615, DOI 10.1111/jgs.13524; Ryan D, 2014, OBESITY, V22, pS1, DOI 10.1002/oby.20819; Schousboe JT, 2016, HEALTH SERV RES, V51, P205, DOI 10.1111/1475-6773.12318; Schousboe JT, 2014, HEALTH SERV RES, V49, P929, DOI 10.1111/1475-6773.12151; Schousboe JT, 2016, PREFRACTURE INDIVIDU; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Wilkins TL, 2012, OBESITY, V20, P1240, DOI 10.1038/oby.2011.86; Wolf AM, 2008, DIABETES OBES METAB, V10, P1248, DOI 10.1111/j.1463-1326.2008.00895.x	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191642	10.1371/journal.pone.0191642	http://dx.doi.org/10.1371/journal.pone.0191642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	29377919	gold, Green Published, Green Submitted			2022-12-26	WOS:000423514700023
J	Xu, FQ; Li, A; Lan, JJ; Wang, YM; Yan, MJ; Lian, SY; Wu, X				Xu, Fa Qiong; Li, Ang; Lan, Jing Jing; Wang, Yue Ming; Yan, Mei Jiao; Lian, Sen Yang; Wu, Xu			Study of formation of green eggshell color in ducks through global gene expression	PLOS ONE			English	Article							HEME OXYGENASE-1; FATTY-ACID; BRAIN; TRANSPORTERS; BILIVERDIN; SINGLE; ABCB7; KEGG; SKIN; RNA	The green eggshell color produced by ducks is a threshold trait that can be influenced by various factors, such as hereditary, environment and nutrition. The aim of this study was to investigate the genetic regulation of the formation of eggs with green shells in Youxian ducks. We performed integrative analysis of mRNAs and miRNAs expression profiling in the shell gland samples from ducks by RNA-Seq. We found 124 differentially expressed genes that were associated with various pathways, such as the ATP-binding cassette (ABC) transporter and solute carrier supper family pathways. A total of 31 differentially expressed miRNAs were found between ducks laying green eggs and white eggs. KEGG pathway analysis of the predicted miRNA target genes also indicated the functional characteristics of these miRNAs; they were involved in the ABC transporter pathway and the solute carrier (SLC) supper family. Analysis with qRT-PCR was applied to validate the results of global gene expression, which showed a correlation between results obtained by RNA-seq and RTq-PCR. Moreover, a miRNA-mRNA interaction network was established using correlation analysis of differentially expressed mRNA and miRNA. Compared to ducks that lay white eggs, ducks that lay green eggs include six up-regulated miRNAs that had regulatory effects on 35 down-regulated genes, and seven down-regulated miRNAs which influenced 46 up regulated genes. For example, the ABC transporter pathway could be regulated by expressing gga-miR-144-3p (up-regulated) with ABCG2 (up-regulated) and other miRNAs and genes. This study provides valuable information about mRNA and miRNA regulation in duck shell gland tissues, and provides foundational information for further study on the eggshell color formation and marker-assisted selection for Youxian duck breeding.	[Xu, Fa Qiong; Li, Ang; Lan, Jing Jing; Wang, Yue Ming; Yan, Mei Jiao; Lian, Sen Yang; Wu, Xu] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Wu, X (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China.	wuxufafu@163.com			National Natural Science Foundation of China [31001005]; Fujian Provincial Natural Science Foundation [2016J01092]; Earmarked Fund for Modern Agro-industry Technology Research System of China [CaRS-43]; Agricultural industrialization project of Fujian Province [fjzycxny2017011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Natural Science Foundation; Earmarked Fund for Modern Agro-industry Technology Research System of China; Agricultural industrialization project of Fujian Province	This project was supported by the National Natural Science Foundation of China (31001005), Fujian Provincial Natural Science Foundation (2016J01092), the Earmarked Fund for Modern Agro-industry Technology Research System of China (CaRS-43), and Agricultural industrialization project of Fujian Province (fjzycxny2017011).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Campo JL, 2007, DIFFERENCES WHITE TI, P105; Cassey P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012054; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Enright AJ, 2004, GENOME BIOL, V5; Farnsworth G M., 1955, BREEDING EGG QUALITY, V3, P16; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; GOWE RS, 1965, POULTRY SCI, V44, P264, DOI 10.3382/ps.0440264; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kim JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1514-4; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; LANG MR, 1987, WORLD POULTRY SCI J, V43, P238, DOI 10.1079/WPS19870016; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lv XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157463; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; SCHWARTZ S, 1980, INT J BIOCHEM, V12, P935, DOI 10.1016/0020-711X(80)90188-3; Sharifi K, 2011, HISTOCHEM CELL BIOL, V136, P501, DOI 10.1007/s00418-011-0865-4; Siefferman L, 2006, BEHAV ECOL SOCIOBIOL, V59, P651, DOI 10.1007/s00265-005-0092-x; Soh T, 1999, JAPANESE J ZOOTECHNI, V70, P170; Tamura Ai, 2007, Folia Pharmacologica Japonica, V130, P270, DOI 10.1254/fpj.130.270; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallim TQD, 2013, CIRC RES, V112, P1602, DOI 10.1161/CIRCRESAHA.112.300648; Wakabayashi K, 2006, DRUG METAB REV, V38, P371, DOI 10.1080/03602530600727947; Wan SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31050; Wang XT, 2007, POULTRY SCI, V86, P2236, DOI 10.1093/ps/86.10.2236; Wang XT, 2010, J APPL ANIM RES, V38, P229, DOI 10.1080/09712119.2010.10539516; Wang Z., 2013, PLOS GENETICS, V9, DOI 10.1371/journal.pgen.1003183; Wang ZP, 2011, POULTRY SCI, V90, P836, DOI 10.3382/ps.2010-01143; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Yuan Qing-Yan, 2007, Yichuan, V29, P265; [张宝乐 Zhang Baole], 2010, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V41, P1082; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhang W., 2012, PLOS ONE, V7; Zhao R, 2006, POULTRY SCI, V85, P546, DOI 10.1093/ps/85.3.546; Zhao R, ANAL SNP MARKERS CHI; Zheng CW, 2014, ANIM SCI J, V85, P506, DOI 10.1111/asj.12182; Zhou L, 2010, PLOS ONE, V5	56	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191564	10.1371/journal.pone.0191564	http://dx.doi.org/10.1371/journal.pone.0191564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377917	Green Submitted, gold, Green Published			2022-12-26	WOS:000423514700017
J	Brussoni, M; George, MA; Jin, A; Amram, O; McCormick, R; Lalonde, CE				Brussoni, Mariana; George, M. Anne; Jin, Andrew; Amram, Ofer; McCormick, Rod; Lalonde, Christopher E.			Hospitalizations due to unintentional transport injuries among Aboriginal population of British Columbia, Canada: Incidence, changes over time and ecological analysis of risk markers	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES; OFF-RESERVE; ROAD; DEATHS; TRAUMA; INTERVENTIONS; EXPOSURE; RATES	Background Worldwide, Indigenous people have disproportionately higher rates of transport injuries. We examined disparities in injury-related hospitalizations resulting from transport incidents for three population groups in British Columbia (BC): total population, Aboriginal off-reserve, and Aboriginal on-reserve populations. We also examined sociodemographic, geographic and ethnic risk markers for disparities. Methods We identified Aboriginal people through BC's universal health care insurance plan insurance premium group and birth and death record notations. We calculated crude incidence rate and Standardized Relative Risk (SRR) of hospitalization for unintentional transport injury, standardized for age, gender and Health Service Delivery Area (HSDA), relative to the total population of BC. We tested hypothesized associations of geographic, socio-economic, and employment-related characteristics of Aboriginal communities with SRR of transport injury by multivariable linear regression. Results During the period 1991-2010, the SRR for the off-reserve Aboriginal population was 1.77 (95% CI: 1.71 to 1.83); and 2.00 (95% CI: 1.93 to 2.07) among those living on-reserve. Decline in crude rate and SRRs was observed over this period among both the Aboriginal and total populations of BC, but was proportionally greater among the Aboriginal population. The best-fitting multivariable risk marker model was an excellent fit (R-2 = 0.912, p<0.001), predicted SRRs very close to observed values, and retained the following terms: urban residence, population per room, proportion of the population with a high school certificate, proportion of the population employed; and multiplicative interactions of Aboriginal ethnicity with population per room and proportion of the population employed. Conclusions Disparities in risk of hospitalization due to unintentional transport injury have narrowed. Aboriginal ethnicity modifies the effects of socioeconomic risk factors. Continued improvement of socioeconomic conditions and implementation of culturally relevant injury prevention interventions are needed.	[Brussoni, Mariana; George, M. Anne] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Brussoni, Mariana; George, M. Anne] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Brussoni, Mariana; George, M. Anne] British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Brussoni, Mariana] British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada; [Amram, Ofer] Washington State Univ, Dept Nutr & Exercise Physiol, Elson S Floyd Coll Med, Vancouver, BC, Canada; [McCormick, Rod] Thompson Rivers Univ, Fac Human Social & Educ Dev, Kamloops, BC, Canada; [Lalonde, Christopher E.] Univ Victoria, Dept Psychol, Victoria, BC, Canada	University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; Washington State University; University of Victoria	Brussoni, M (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.; Brussoni, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Brussoni, M (corresponding author), British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada.; Brussoni, M (corresponding author), British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada.	mbrussoni@bcchr.ubc.ca	Brussoni, Mariana/U-9404-2018; Jin, Andrew/H-5725-2019	Brussoni, Mariana/0000-0002-1495-816X; Jin, Andrew/0000-0002-8708-2381; George, M. Anne/0000-0001-7129-2117; Lalonde, Christopher/0000-0002-0446-0464	Canadian Institutes of Health Research, Institute of Aboriginal People's Health [81043]; British Columbia Children's Hospital Research Institute; British Columbia Region, First Nations; Inuit Health Program, Health Canada	Canadian Institutes of Health Research, Institute of Aboriginal People's Health(Canadian Institutes of Health Research (CIHR)); British Columbia Children's Hospital Research Institute; British Columbia Region, First Nations; Inuit Health Program, Health Canada	This research was funded by the Canadian Institutes of Health Research, Institute of Aboriginal People's Health (http://www.cihr.irsc.gc ca/e/8668.html), funding reference: AHR #81043. Salary support for authors was provided by the British Columbia Children's Hospital Research Institute (MB and MAG) and by the British Columbia Region, First Nations and Inuit Health Program, Health Canada (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Salary support for authors was provided by the British Columbia Children's Hospital Research Institute (MB and MAG) and by the British Columbia Region, First Nations and Inuit Health Program, Health Canada (AJ). The authors thank Anna Low, Sherylyn Arabsky and Kelly Sanderson of Population Data BC for assistance with data access and linkage, and Stewart Deyell of Statistics Canada for assistance in obtaining custom tabulations of Census data.	Ahlm K, 2010, INT J CIRCUMPOL HEAL, V69, P129, DOI 10.3402/ijch.v69i2.17432; [Anonymous], 2015, PARACHUTE COST INJUR; BC Vital Statistics Agency, 2011, VIT STAT BIRTHS POP; BC Vital Statistics Agency, 2011, VIT STAT DEATHS POP; Braver ER, 2003, ACCIDENT ANAL PREV, V35, P295, DOI 10.1016/S0001-4575(01)00106-3; *BRIT COL VIT STAT, 2004, REG AN HLTH STAT STA; Brussoni M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3078-x; Brussoni M, 2015, PREV SCI, V16, P560, DOI 10.1007/s11121-014-0503-1; Canadian Institute for Health Information, 2011, DISCH ABSTR DAT HOSP; CHIPMAN ML, 1993, ACCIDENT ANAL PREV, V25, P207, DOI 10.1016/0001-4575(93)90061-Z; Clapham K, 2008, INJURY, V39, pS19, DOI 10.1016/S0020-1383(08)70025-1; Desapriya E, 2011, ASIA-PAC J PUBLIC HE, V23, P1005, DOI 10.1177/1010539510361787; DesMeules M, 2006, HLTH ARE RURAL CANAD; Ellis BH, 2003, J PSYCHOACTIVE DRUGS, V35, P89, DOI 10.1080/02791072.2003.10399999; Falster MO, 2013, ACCIDENT ANAL PREV, V54, P32, DOI 10.1016/j.aap.2013.01.015; George MA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2262-x; George MA, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0629-4; George M Anne, 2015, Inj Epidemiol, V2, P7; George MA, 2015, HEALTH REP, V26, P3; George MA, 2013, INT J CIRCUMPOL HEAL, V72, P441, DOI 10.3402/ijch.v72i0.21182; Ghani Y, 2014, PROCD SOC BEHV, V155, P63, DOI 10.1016/j.sbspro.2014.10.257; Gomez D, 2010, J TRAUMA, V69, P633, DOI 10.1097/TA.0b013e3181b8ef81; Hosking J, 2013, AUST NZ J PUBL HEAL, V37, P162, DOI 10.1111/1753-6405.12034; Insurance Corporation of British Columbia, 2015, CORP ACT ADV AN REP; Ishikawa T, 2014, AM J PUBLIC HEALTH, V104, pE1, DOI 10.2105/AJPH.2013.301683; Jin A, 2016, J RACIAL ETHN HLTH D, P1; Jin A, J HLTH CARE POOR UND, V28, P952; Jin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121694; Jin A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-710; Kahn HA, 1989, ADJUSTMENT DATA USE, P95; Kim K, 2012, INJURY PREV, V18, P264, DOI 10.1136/injuryprev-2011-040306; Pan SW, 2015, J TRANSP HEALTH, V2, P595, DOI 10.1016/j.jth.2015.09.003; Peden M., 2004, WORLD REPORT ROAD TR; Provincial Health Officer, 2016, RUBB MEETS ROAD RED; Public Health Agency of Canada, 2012, INJ IN REV; Rajabali F., 2015, EC BURDEN INJURY BRI, DOI [10.14288/1.0397291, DOI 10.14288/1.0397291]; Rakauskas ME, 2009, ACCIDENT ANAL PREV, V41, P931, DOI 10.1016/j.aap.2009.05.008; Short MM, 2013, CAN J RURAL MED, V18, P86; Short MM, 2014, CAN J PUBLIC HEALTH, V105, pE296, DOI 10.17269/cjph.105.4176; Simons R, 2010, J TRAUMA, V69, P11, DOI 10.1097/TA.0b013e3181e17b39; Spoerri A, 2011, ACCIDENT ANAL PREV, V43, P40, DOI 10.1016/j.aap.2010.06.009; Stephan K, 2011, ACCIDENT ANAL PREV, V43, P1062, DOI 10.1016/j.aap.2010.12.011; Stott Tim, 2015, TRUTH REC COMM CAN C, V3; Truth and Reconciliation Commission of Canada, 2015, HON TRUTH REC FUT SU; Turner Cathy, 2003, Inj Control Saf Promot, V10, P123, DOI 10.1076/icsp.10.3.123.14560; U.S. Department of Transportation National Highway Traffic Safety Administration, 1996, RURAL AND URBAN CRAS; Wood DS, 2006, ADDICTION, V101, P393, DOI 10.1111/j.1360-0443.2006.01347.x; World Health Organisation, 2018, NONC DIS COUNTR PROF	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191384	10.1371/journal.pone.0191384	http://dx.doi.org/10.1371/journal.pone.0191384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8TF	29373595	Green Published, gold, Green Submitted			2022-12-26	WOS:000423425400010
J	Norouzi, S; Adulcikas, J; Sohal, SS; Myers, S				Norouzi, Shaghayegh; Adulcikas, John; Sohal, Sukhwinder Singh; Myers, Stephen			Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GLYCOGEN-SYNTHASE KINASE-3; INTRACELLULAR ZINC; MAP KINASE; RESISTANCE; PHOSPHORYLATION; INHIBITION; ROLES; IONS; PROLIFERATION	Zinc is a metal ion that is an essential cell signaling molecule. Highlighting this, zinc is an insulin mimetic, activating cellular pathways that regulate cellular homeostasis and physiological responses. Previous studies have linked dysfunctional zinc signaling with several disease states including cancer, obesity, cardiovascular disease and type 2 diabetes. The present study evaluated the insulin-like effects of zinc on cell signaling molecules including tyrosine, PRSA40, Akt, ERK1/2, SHP-2, GSK-3 beta and p38, and glucose oxidation in human and mouse skeletal muscle cells. Insulin and zinc independently led to the phosphorylation of these proteins over a 60-minute time course in both mouse and human skeletal muscle cells. Similarly, utilizing a protein array we identified that zinc could active the phosphorylation of p38, ERK1/2 and GSK-3B in human and ERK1/2 and GSK-3B in mouse skeletal muscle cells. Glucose oxidation assays were performed on skeletal muscle cells treated with insulin, zinc, or a combination of both and resulted in a significant induction of glucose consumption in mouse (p<0.01) and human (p<0.05) skeletal muscle cells when treated with zinc alone. Insulin, as expected, increased glucose oxidation in mouse (p<0.001) and human (0.001) skeletal muscle cells, however the combination of zinc and insulin did not augment glucose consumption in these cells. Zinc acts as an insulin mimetic, activating key molecules implicated in cell signaling to maintain glucose homeostasis in mouse and human skeletal muscle cells. Zinc is an important metal ion implicated in several biological processes. The role of zinc as an insulin memetic in activating key signaling molecules involved in glucose homeostasis could provide opportunities to utilize this ion therapeutically in treating disorders associated with dysfunctional zinc signaling.	[Norouzi, Shaghayegh; Adulcikas, John; Sohal, Sukhwinder Singh; Myers, Stephen] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Newnham Campus, Launceston, Tas, Australia	University of Tasmania	Myers, S (corresponding author), Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Newnham Campus, Launceston, Tas, Australia.	stephen.myers@utas.edu.au		Adulcikas, John/0000-0001-9193-6709; Myers, Stephen/0000-0003-4793-3820	Clifford Craig Medical Research Trust Grant, Tasmania, Australia	Clifford Craig Medical Research Trust Grant, Tasmania, Australia	This work was funded by Clifford Craig Medical Research Trust Grant, Tasmania, Australia. The funding allowed for the purchasing of reagents for this study.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Ackland ML, 2006, GENES NUTR, V1, P41, DOI 10.1007/BF02829935; Barthel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P175, DOI 10.1016/j.abb.2007.04.015; Bellomo E, 2014, METALLOMICS, V6, P1229, DOI 10.1039/c4mt00086b; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Ding HW, 2016, BIOCHEM BIOPH RES CO, V478, P798, DOI 10.1016/j.bbrc.2016.08.028; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P1356, DOI 10.1271/bbb.120107; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Igarashi M, 2000, EUR J CLIN INVEST, V30, P668; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Islam MR, 2016, DIABETES RES CLIN PR, V115, P39, DOI 10.1016/j.diabres.2016.03.010; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mannell H, 2007, CURR FNZYME INHIB, V3, P264; Maret Wolfgang, 2017, Prev Nutr Food Sci, V22, P1, DOI 10.3746/pnf.2017.22.1.1; MAY JM, 1982, J BIOL CHEM, V257, P4362; McNulty TJ, 1999, BIOCHEM J, V339, P555, DOI 10.1042/0264-6021:3390555; Metabolism K., 2014, DAN MED J, V61, pB4890; Miranda ER, 2004, BIOL TRACE ELEM RES, V101, P19, DOI 10.1385/BTER:101:1:19; Myers SA, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/167503; Myers SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079316; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Nimmanon T, 2017, METALLOMICS, V9, P471, DOI 10.1039/c6mt00286b; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ohashi K, 2015, EXP CELL RES, V333, P228, DOI 10.1016/j.yexcr.2015.03.003; Peppa M, 2010, SKELETAL MUSCLE INSU; Rutter GA, 2016, P NUTR SOC, V75, P61, DOI 10.1017/S0029665115003237; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tang SG, 2001, DIABETES, V50, P83, DOI 10.2337/diabetes.50.1.83; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Vardatsikos G, 2013, J INORG BIOCHEM, V120, P8, DOI 10.1016/j.jinorgbio.2012.11.006; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wiza C, 2014, ARCH PHYSIOL BIOCHEM, V120, P64, DOI 10.3109/13813455.2014.894076; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Wu YT, 2016, J NUTR BIOCHEM, V34, P126, DOI 10.1016/j.jnutbio.2016.05.008; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang W, 2011, PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND ENGINEERING CONFERENCE 2010, VOL 1, P7	49	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191727	10.1371/journal.pone.0191727	http://dx.doi.org/10.1371/journal.pone.0191727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373583	Green Published, gold, Green Accepted			2022-12-26	WOS:000423425400023
J	Gruda, MC; Ruggeberg, KG; O'Sullivan, P; Guliashvili, T; Scheirer, AR; Golobish, TD; Capponi, VJ; Chan, PP				Gruda, Maryann C.; Ruggeberg, Karl-Gustav; O'Sullivan, Pamela; Guliashvili, Tamaz; Scheirer, Andrew R.; Golobish, Thomas D.; Capponi, Vincent J.; Chan, Phillip P.			Broad adsorption of sepsis- related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb (R) sorbent porous polymer beads	PLOS ONE			English	Article							POLYMYXIN-B HEMOPERFUSION; SHORT-TERM SURVIVAL; SEPTIC SHOCK; REMOVAL; HEMOADSORPTION; THERAPY; HEMOFILTRATION; INFLAMMATION; PERITONITIS; ADSORBENT	Objective Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. In sepsis and septic shock, pathogen-associated molecular pattern molecules (PAMPS), such as bacterial exotoxins, cause direct cellular damage and/or trigger an immune response in the host often leading to excessive cytokine production, a maladaptive systemic inflammatory response syndrome response (SIRS), and tissue damage that releases DAMPs, such as activated complement and HMGB-1, into the bloodstream causing further organ injury. Cytokine reduction using extracorporeal blood filtration has been correlated with improvement in survival and clinical outcomes in experimental studies and clinical reports, but the ability of this technology to reduce a broader range of inflammatory mediators has not been well-described. This study quantifies the size-selective adsorption of a wide range of sepsis-related inflammatory bacterial and fungal PAMPs, DAMPs and cytokines, in a single compartment, in vitro whole blood recirculation system. Measurements and main results Purified proteins were added to whole blood at clinically relevant concentrations and recirculated through a device filled with CytoSorb (R) hemoadsorbent polymer beads (CytoSorbents Corporation, USA) or control (no bead) device in vitro. Except for the TNF-a trimer, hemoadsorption through porous polymer bead devices reduced the levels of a broad spectrum of cytokines, DAMPS, PAMPS and mycotoxins by more than 50 percent. Conclusions This study demonstrates that CytoSorb (R) hemoadsorbent polymer beads efficiently remove a broad spectrum of toxic PAMPS and DAMPS from blood providing an additional means of reducing the uncontrolled inflammatory cascade that contributes to a maladaptive SIRS response, organ dysfunction and death in patients with a broad range of life-threatening inflammatory conditions such as sepsis, toxic shock syndrome, necrotizing fasciitis, and other severe inflammatory conditions.	[Gruda, Maryann C.; Ruggeberg, Karl-Gustav; O'Sullivan, Pamela; Guliashvili, Tamaz; Scheirer, Andrew R.; Golobish, Thomas D.; Capponi, Vincent J.; Chan, Phillip P.] CytoSorbents Corp, Monmouth Jct, NJ 08852 USA; [Scheirer, Andrew R.] Ethicon US LLC, Somerville, NJ USA		Gruda, MC (corresponding author), CytoSorbents Corp, Monmouth Jct, NJ 08852 USA.	mgruda@cytosorbents.com	guliashvili, tamaz/M-2732-2016	guliashvili, tamaz/0000-0002-9707-3497	CytoSorbents Corporation; DARPA; SSC [N66001-12-C-4199]; ACC-APG [W911QY-16-P-0048]	CytoSorbents Corporation; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); SSC; ACC-APG	All authors are employed by CytoSorbents Corporation and receive salary and stock compensation. This study is based upon work supported by DARPA and SSC Pacific under Contract N66001-12-C-4199, work supported by the ACC-APG under Contract W911QY-16-P-0048 and work supported by CytoSorbents Corporation. The content of this publication does not constitute approval by the government of the findings or conclusions herein. Authors Phillip P. Chan, MD, PhD and Vincent J. Capponi, MS, serve as the Chief Executive Officer and Chief Operating Officer of CytoSorbents Corporation, respectively. Hence, as stated in the author contributions, CytoSorbents Corporation had a role in the study design, decision to publish and editing of the manuscript.	Barnthip N, 2009, BIOMATERIALS, V30, P6495, DOI 10.1016/j.biomaterials.2009.08.016; Basu R, 2014, INDIAN J CRIT CARE M, V18, P822, DOI 10.4103/0972-5229.146321; Becker KL, 2010, BRIT J PHARMACOL, V159, P253, DOI 10.1111/j.1476-5381.2009.00433.x; Bellomo R, 2001, WORLD J SURG, V25, P677, DOI 10.1007/s002680020030; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Born F., 2014, KARDIOTECHNIK, V2, P1; Bruenger F, 2015, INT J ARTIF ORGANS, V38, P113, DOI 10.5301/ijao.5000382; Cutuli SL, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0178-9; Dhanasekaran D., 2011, AFLATOXINS BIOCH MOL; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frimmel S, 2014, LIVER TRANSPLANT, V20, P1523, DOI 10.1002/lt.24005; Gerard C, 2003, NEW ENGL J MED, V348, P167, DOI 10.1056/NEJMcibr022995; Hetz H, 2014, INT J ARTIF ORGANS, V37, P422, DOI 10.5301/ijao.5000315; Hinz B, 2015, INT J ARTIF ORGANS, V38, P461, DOI 10.5301/ijao.5000429; Honore PM, 2004, CRIT CARE MED, V32, P896, DOI 10.1097/01.CCM.0000115262.31804.46; Honore PM, 2002, CRIT CARE, V6, P394; Ito T, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0065-0; Joannes-Boyau O, 2013, INTENS CARE MED, V39, P1535, DOI 10.1007/s00134-013-2967-z; Kellum JA, 2004, CRIT CARE MED, V32, P801, DOI 10.1097/01.CCM.0000114997.39857.69; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kogelmann K, 2015, INFECTION, V43, pS51; Krishnan A, 2005, J BIOMED MATER RES A, V75A, P445, DOI 10.1002/jbm.a.30444; Kumar S., 2015, CRIT CARE S1, V19, pP130, DOI DOI 10.1186/cc14210; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Laddomada T, 2016, CRIT CARE S2, V20, pP193; Lees N, 2015, CRIT CARE MED, V43, P311; Matsumura M, 1998, Nihon Ishinkin Gakkai Zasshi, V39, P167; Mitzner SR, 2013, BLOOD PURIFICAT, V35, P314, DOI 10.1159/000351206; Morena MD, 2003, KIDNEY INT, V63, P1150, DOI 10.1046/j.1523-1755.2003.00839.x; Morgera S, 2006, CRIT CARE MED, V34, P2099, DOI 10.1097/01.CCM.0000229147.50592.F9; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; Payen DM, 2015, INTENS CARE MED, V41, P975, DOI 10.1007/s00134-015-3751-z; Peng ZY, 2008, CRIT CARE MED, V36, P1573, DOI 10.1097/CCM.0b013e318170b9a7; Peng ZY, 2014, CRIT CARE, V18, DOI 10.1186/cc13969; Ramachandran G, 2014, VIRULENCE, V5, P213, DOI 10.4161/viru.27024; Reiter K, 2002, BLOOD PURIFICAT, V20, P380, DOI 10.1159/000063108; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; Schadler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187015; Shum HP, 2016, HONG KONG MED J, V22, P478, DOI 10.12809/hkmj164876; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun YX, 2012, J ANIM VET ADV, V11, P1977, DOI 10.3923/javaa.2012.1977.1981; Svahn KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093685; Tarakcioglu M, 2003, MEDIAT INFLAMM, V12, P15, DOI 10.1080/0962935031000096935; Tomescu DR, 2016, INT J ARTIF ORGANS, V39, P136, DOI 10.5301/ijao.5000489; Trager K, 2016, INT J ARTIF ORGANS, V39, P141, DOI 10.5301/ijao.5000492; Trager Karl, 2016, Case Rep Crit Care, V2016, P9852073, DOI 10.1155/2016/9852073; van der Linde GW, 2015, NETHERLANDS J CRIT C, V24, P27; Villa G, 2014, BLOOD PURIFICAT, V38, P167, DOI 10.1159/000369155; Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059; Wang XW, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/s13019-014-0133-5; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436	53	103	108	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191676	10.1371/journal.pone.0191676	http://dx.doi.org/10.1371/journal.pone.0191676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370247	Green Published, Green Submitted, gold			2022-12-26	WOS:000423416600076
J	Lechuga-Sancho, AM; Gallego-Andujar, D; Ruiz-Ocana, P; Visiedo, FM; Saez-Benito, A; Schwarz, M; Segundo, C; Mateos, RM				Lechuga-Sancho, Alfonso M.; Gallego-Andujar, David; Ruiz-Ocana, Pablo; Visiedo, Francisco M.; Saez-Benito, Ana; Schwarz, Monica; Segundo, Carmen; Mateos, Rosa M.			Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INFLAMMATION MARKERS; N-ACETYLCYSTEINE; DISEASE; GLUTATHIONE; CHILDREN	Objectives Oxidative stress and inflammation have been postulated as underlying mechanisms for the development of obesity-related insulin resistance. This association however, remains elusive especially in childhood. We sought to investigate this relation by measuring oxidative stress and antioxidant response biomarkers, before and during an oral glucose tolerance test (OGTT), in different biological samples from obese children. Subjects 24 children were recruited for the study, (18 obese and 6 controls). After OGTT, the obese group was subdivided in two, according to whether or not carbohydrate metabolic impairment (Ob.IR+, Ob. IR-; respectively) was found. Different biomarkers were analyzed after fasting (T = 0) and during an OGTT (T = 60 and 120 min). Lipoperoxides were measured in plasma, erythrocytes, and urine; while advanced glycation end products were determined in plasma, and redox status (GSH/GSSG ratio) in erythrocytes. Results We found marked differences in the characterization of the oxidative status in urine and erythrocytes, and in the dynamics of the antioxidant response during OGTT. Specifically, Ob. IR+ children show increased oxidative stress, deficient antioxidant response and a significant imbalance in redox status, in comparison to controls and Ob. IR-children. Conclusion Obese children with insulin resistance show increased levels of oxidative stress biomarkers, and a stunted antioxidant response to an OGTT leading to increased oxidative stress after a single glucose load, as detected in erythrocytes, but not in plasma. We propose erythrocytes as sensors of early and acute changes in oxidative stress associated with insulin resistance in childhood obesity. This is a pilot study, performed with a limited sample size, so data should be interpreted with caution until reproduced.	[Lechuga-Sancho, Alfonso M.; Gallego-Andujar, David; Visiedo, Francisco M.; Mateos, Rosa M.] Puerta del Mar Univ Hosp, Res Unit, Cadiz, Spain; [Lechuga-Sancho, Alfonso M.; Ruiz-Ocana, Pablo; Mateos, Rosa M.] Puerta del Mar Univ Hosp, Dept Pediat, Cadiz, Spain; [Lechuga-Sancho, Alfonso M.] Cadiz Univ, Sch Med, Dept Child & Mother Hlth & Radiol, Cadiz, Spain; [Saez-Benito, Ana] Puerta del Mar Univ Hosp, Clin Anal Dept, Cadiz, Spain; [Schwarz, Monica; Segundo, Carmen] Cadiz Univ, Salus Infirmorum Fac Nursing, Cadiz, Spain; [Mateos, Rosa M.] Cadiz Univ, Sch Med, Dept Biotechnol Biomed & Publ Hlth, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Mateos, RM (corresponding author), Puerta del Mar Univ Hosp, Res Unit, Cadiz, Spain.; Mateos, RM (corresponding author), Puerta del Mar Univ Hosp, Dept Pediat, Cadiz, Spain.; Mateos, RM (corresponding author), Cadiz Univ, Sch Med, Dept Biotechnol Biomed & Publ Hlth, Cadiz, Spain.	rosa.mateos@uca.es	Mateos, RM/N-8149-2019; Visiedo, Francisco/T-5048-2019; Ruiz-Ocaña, Pablo/D-7924-2019; Mateos, Rosa María/M-5213-2015; Rodriguez, Monica Schwarz/M-4614-2015; Lechuga-Sancho, Alfonso/M-2712-2015; Segundo, Carmen/A-7841-2012	Visiedo, Francisco/0000-0001-7834-0169; Ruiz-Ocaña, Pablo/0000-0003-0395-6828; Mateos, Rosa María/0000-0002-9853-1103; Lechuga-Sancho, Alfonso/0000-0001-5861-6041; Segundo, Carmen/0000-0003-2884-0557; Saez-Benito, Ana/0000-0002-7864-9147; Schwarz Rodriguez, Monica/0000-0002-8445-0337				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Albuali Waleed H, 2014, World J Clin Pediatr, V3, P6, DOI 10.5409/wjcp.v3.i1.6; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Atabek ME, 2004, J PEDIATR ENDOCR MET, V17, P1063; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Buege J A, 1978, Methods Enzymol, V52, P302; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Ceriello A, 2010, DIABETIC MED, V27, P968, DOI 10.1111/j.1464-5491.2010.02931.x; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Dalmau Serra J, 2007, An Pediatr (Barc), V66, P294; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Garca Cuartero B, 2003, AN PEDIAT BARC SPAIN, V2007, P66; Han E, 2017, DIABETES METAB J, V41, P430, DOI 10.4093/dmj.2017.41.6.430; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Kilic E, 2016, MED SCI MONITOR, V22, P3673, DOI 10.12659/MSM.897965; Lima Severina C. V. C, 2004, J. Pediatr. (Rio J.), V80, P23, DOI 10.1590/S0021-75572004000100006; Matusik P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/315747; Pace BS, 2003, AM J HEMATOL, V73, P26, DOI 10.1002/ajh.10321; Paltoglou G, 2017, ENDOCRINE, V55, P925, DOI 10.1007/s12020-017-1227-3; Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Ruperez AI, 2013, ANTIOXID REDOX SIGN, V19, P1970, DOI 10.1089/ars.2013.5386; Strobel NA, 2011, INT J CARDIOL, V147, P191, DOI 10.1016/j.ijcard.2010.08.008; Szkudlinska MA, 2016, J DIABETES COMPLICAT, V30, P618, DOI 10.1016/j.jdiacomp.2016.02.003; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Unoki H, 2008, CURR PHARM DESIGN, V14, P987, DOI 10.2174/138161208784139747; van der Crabben SN, 2011, METABOLISM, V60, P99, DOI 10.1016/j.metabol.2010.08.003; Vehapoglu A, 2016, REDOX REP, V21, P271, DOI 10.1080/13510002.2015.1133035; Viroonudomphol Duangkamol, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P325; WESTWOOD A, 1986, ANN CLIN BIOCHEM, V23, P92, DOI 10.1177/000456328602300111; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	36	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0191547	10.1371/journal.pone.0191547	http://dx.doi.org/10.1371/journal.pone.0191547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370267	Green Published, gold, Green Submitted			2022-12-26	WOS:000423416600060
J	Chou, CC; Lee, HL; Chang, PC; Wo, HT; Wen, MS; Yeh, SJ; Lin, FC; Hwang, YT				Chou, Chung-Chuan; Lee, Hui-Ling; Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Yeh, San-Jou; Lin, Fen-Chiung; Hwang, Yi-Ting			Left atrial emptying fraction predicts recurrence of atrial fibrillation after radiofrequency catheter ablation	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; TERM-FOLLOW-UP; SUBSTRATE; IMPACT; ECHOCARDIOGRAPHY; SUCCESS; VOLUME; RISK; SIZE; 1ST	Background Compared with left atrial (LA) dimension, LA emptying fraction (LAEF) has received less emphasis as a predictor of atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA). In addition, patients experiencing post-RFCA AF recurrence may respond to previously ineffective antiarrhythmic drugs (AADs). Classifying these patients into a third RFCA outcome category is recommended. Objective To identify predictors of RFCA outcome classified into three categories, and to build proportional odds logistic regression models for clinical applicability to predict AF recurrence. Methods Data were retrospectively collected from 483 consecutive patients with drug-refractory AF undergoing RFCA (328 men; age 58.4 +/- 11.5 years; 383 paroxysmal). Patients were classified into 3 groups based on the last RFCA outcome: group 1, free from AF without AADs; group 2, free from AF with AADs; and group 3, recurrence of AADs-refractory atrial tachyarrhythmia. Results After a mean follow-up duration of 64.5 +/- 43.2 months and mean ablation procedure number of 1.37 +/- 0.68, the RFCA outcome showed 76.0%, 9.5% and 14.5% of patients in groups 1, 2, and 3, respectively. In multivariate analysis, LAEF was the most stable and important predictor of AF recurrence, followed by body mass index, stroke, AF duration, mitral regurgitation, and LA linear ablation. For patients undergoing repeat RFCA, LAEF was the only independent predictor (cutoffs: 43% and 35% for groups 1 and 3, respectively). Conclusion LAEF provides optimal prognostic information regarding the risk stratification of AF patients undergoing RFCA.	[Chou, Chung-Chuan; Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Yeh, San-Jou; Lin, Fen-Chiung] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Linkou, Taiwan; [Chou, Chung-Chuan; Wen, Ming-Shien; Yeh, San-Jou; Lin, Fen-Chiung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Hui-Ling] Chang Gung Mem Hosp, Dept Anesthesia, Taipei, Taiwan; [Hwang, Yi-Ting] Natl Taipei Univ, Dept Stat, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Taipei University	Hwang, YT (corresponding author), Natl Taipei Univ, Dept Stat, Taipei, Taiwan.	hwangyt@gm.ntpu.edu.tw	Chou, Chung-Chuan/AAZ-9776-2021; Chang, Po-Cheng/ABA-4979-2020	Chang, Po-Cheng/0000-0002-6901-5951				Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Allessie MA, 2001, CIRCULATION, V103, P769; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Biering-Sorensen T, 2014, JACC-CARDIOVASC IMAG, V7, P962, DOI 10.1016/j.jcmg.2014.02.003; Cai LY, 2013, INT J CARDIOL, V164, P82, DOI 10.1016/j.ijcard.2011.06.094; Costa FM, 2015, INT J CARDIOL, V184, P56, DOI 10.1016/j.ijcard.2015.01.060; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008; Dodson JA, 2014, CIRC-CARDIOVASC IMAG, V7, P586, DOI 10.1161/CIRCIMAGING.113.001472; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961, DOI 10.1016/0735-1097(94)90644-0; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gaita F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P269, DOI 10.1161/CIRCEP.108.774885; Gertz ZM, 2011, EUROPACE, V13, P1127, DOI 10.1093/europace/eur098; Gianluca Epicoco M., 2014, JOURNAL OF ATRIAL FI, V6, P50; Komatsu Y, 2012, PACE, V35, P1436, DOI 10.1111/pace.12009; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Letsas KP, 2013, INT J CARDIOL, V164, P94, DOI 10.1016/j.ijcard.2011.06.092; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; Luong CL, 2016, AM J CARDIOL, V118, P1345, DOI 10.1016/j.amjcard.2016.07.066; McCready JW, 2011, EUROPACE, V13, P355, DOI 10.1093/europace/euq434; Mehrzad R, 2014, INT J MOL SCI, V15, P15146, DOI 10.3390/ijms150915146; Miyazaki S, 2011, J CARDIOVASC ELECTR, V22, P621, DOI 10.1111/j.1540-8167.2010.01984.x; Montserrat S, 2014, EUR HEART J-CARD IMG, V15, P515, DOI 10.1093/ehjci/jet194; Montserrat S, 2015, HEART RHYTHM, V12, P11, DOI 10.1016/j.hrthm.2014.08.032; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; Shin SH, 2008, J AM SOC ECHOCARDIOG, V21, P697, DOI 10.1016/j.echo.2007.10.022; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Teh AW, 2012, HEART RHYTHM, V9, P473, DOI 10.1016/j.hrthm.2011.11.013; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Verma A, 2010, EUR HEART J, V31, P1344, DOI 10.1093/eurheartj/ehq041; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; Yang CH, 2017, INT J CARDIOL, V228, P449, DOI 10.1016/j.ijcard.2016.11.020; Yao Y, 2007, HEART RHYTHM, V4, P1497, DOI 10.1016/j.hrthm.2007.07.028	35	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191196	10.1371/journal.pone.0191196	http://dx.doi.org/10.1371/journal.pone.0191196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364912	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500037
J	Perger, R; Rubio, GD				Perger, Robert; Rubio, Gonzalo D.			A wolf in sheep's clothing: The description of a fly resembling jumping spider of the genus Scoturius Simon, 1901 (Araneae: Salticidae: Huriini)	PLOS ONE			English	Article							SOUTHERN BOLIVIAN ANDES; COLEOPTERA; MIMICRY; CLASSIFICATION; CERAMBYCIDAE; BEETLES; GENERA; FLIES	Fly resemblance in arthropods is much less common than e.g., resemblance to ants or wasps, and has been mainly observed in beetles. Putative fly mimicry in arachnids has been reported only from the jumping spider genus Saitis. However, recent literature has attributed the fly-resembling characteristics in Saitis to sexual signalling during courtship. The lack of observation of fly mimicry in spiders is not surprising as flies belong to the most important prey item group of spiders. In this study, a new fly-resembling species of the jumping spider tribe Huriini, Scoturius dipterioides sp.nov., from the pre-Andean Chiquitano forest at the Bolivian orocline is described and illustrated. The new species was tentatively placed into Scoturius because the epigynum has a single large elliptical opening. Scoturius dipterioides sp.nov. is distinguished from all other species of this tribe by a combination of following characteristics: epigynum with a large anterior elliptical atrium and initial portion of the copulation ducts dilated as a chamber (shared with Urupuyu); relatively joined copulation openings and short copulation ducts; kidney-shaped spermathecae, advanced at the atrium level. Several somatic features, two of them found exclusively in S.dipterioides sp.nov., increase the resemblance to flies. The Huriini are currently the only spider tribe that is suggested to feature fly mimics.	[Perger, Robert] Colecc Boliviana Fauna, La Paz, Bolivia; [Rubio, Gonzalo D.] Natl Res Council Argentina CONICET, Expt Stn Agr EEA INTA, Misiones, Argentina	Universidad Mayor de San Andres	Perger, R (corresponding author), Colecc Boliviana Fauna, La Paz, Bolivia.	robertperger@hotmail.com	Perger, Robert/K-7790-2019	Perger, Robert/0000-0001-9930-9638				Abrahamczyk S, 2014, ECOGRAPHY, V37, P500, DOI 10.1111/j.1600-0587.2013.00417.x; Cloudsley-Thompson J.L., 1995, Bulletin of the British Arachnological Society, V10, P81; Cushing P. E., 2012, PSYCHE-J ENTOMOL, V2012, P1, DOI DOI 10.1155/2012/151989; CUTLER B, 1981, STUD NEOTROP FAUNA E, V16, P51, DOI 10.1080/01650528109360581; DREES OSKAR, 1952, ZEITSCHR TIERPSYCHOL, V9, P169; Edwards G.B., 1984, Peckhamia, V2, P46; Exline H., 1962, Bulletin of the Museum of Comparative Zoology, V127, P75; Gaimari SD, 2010, ZOOTAXA, P1; GALIANO ME, 1987, J ARACHNOL, V15, P285; HESPENHEIDE HA, 1973, J ENTOMOL SER A, V48, P49; Hill David E., 2012, Peckhamia, V99.1, P1; Hill David Edwin, 2009, Peckhamia, V74.1, P1; Huang JN, 2011, P ROY SOC B-BIOL SCI, V278, P1356, DOI 10.1098/rspb.2010.1896; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; Jocque Rudy, 1994, Journal of African Zoology, V108, P321; LEVI HERBERT W., 1965, PSYCHE, V72, P152, DOI 10.1155/1965/94978; Maddison WP, 2015, J ARACHNOL, V43, P231, DOI 10.1636/arac-43-03-231-292; MATHER MH, 1987, SCIENCE, V236, P308, DOI 10.1126/science.236.4799.308; MORRISON N H, 1981, Australian Entomological Magazine, V8, P22; Nelson Ximena J., 2011, P99; Pekar S, 2012, EVOLUTION, V66, P776, DOI 10.1111/j.1558-5646.2011.01471.x; Perger R, 2017, ANN ENTOMOL SOC AM, V110, P403, DOI 10.1093/aesa/sax040; Perger R, 2016, ZOOTAXA, V4084, P277, DOI 10.11646/zootaxa.4084.2.7; Perger R, 2015, J HYMENOPT RES, V45, P65, DOI 10.3897/JHR.45.5003; Perger R, 2012, ZOOTAXA, P49; Perger R, 2013, PAN-PAC ENTOMOL, V89, P209, DOI 10.3956/2013-19.1; Perger R, 2010, ZOOKEYS, P29, DOI 10.3897/zookeys.48.417; Ramirez MJ, 2014, B AM MUS NAT HIST, P1; Rota J, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000045; Ruiz GRS, 2015, ZOOTAXA, V4040, P251, DOI 10.11646/zootaxa.4040.3.1; Ruxton GD, 2004, P ROY SOC B-BIOL SCI, V271, P2135, DOI 10.1098/rspb.2004.2816; Vanin SA, 2012, ZOOTAXA, P55, DOI 10.11646/zootaxa.3413.1.5; Wearing Oliver H., 2014, Arachnology, V16, P219	33	9	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190582	10.1371/journal.pone.0190582	http://dx.doi.org/10.1371/journal.pone.0190582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364905	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500019
J	Sutanto, EN; Scaffidi, A; Garrett, LW; Looi, K; Foo, CJ; Tessari, MA; Janssen, RA; Fischer, DF; Stick, SM; Kicic, A				Sutanto, Erika N.; Scaffidi, Amelia; Garrett, Luke W.; Looi, Kevin; Foo, Clara J.; Tessari, Michela A.; Janssen, Richard A.; Fischer, David F.; Stick, Stephen M.; Kicic, Anthony		AREST CF	Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SENSITIVE FLUORESCENT INDICATORS; SMALL-MOLECULE CORRECTORS; PLURIPOTENT STEM-CELLS; CFTR EXPRESSION; CHLORIDE; PROTEIN; LUNG; TRAFFICKING; GENERATION	Background & para;& para;Mutations in the cystic fibrosis transmembrane regulator (CFTR) gene can reduce function of the CFTR ion channel activity and impair cellular chloride secretion. The gold standard method to assess CFTR function of ion transport using the Using chamber requires a high number of airway epithelial cells grown at air-liquid interface, limiting the application of this method for high throughput screening of potential therapeutic compounds in primary airway epithelial cells (pAECs) featuring less common CFTR mutations. This study assessed an alternative approach, using a small scale halide assay that can be adapted for a personalized high throughput setting to analyze CFTR function of pAEC.& para;& para;Methods & para;& para;Pediatric pAECs derived from children with CF (pAEC(CF) ) were established and expanded as monolayer cultures, before seeding into 96 well plates for the halide assay. Cells were then transduced with an adenoviral construct containing yellow fluorescent protein (eYFP) reporter gene, alone or in combination with either wild-type CFTR (WT-CFTR) or p.Phe508-del CFTR. Four days post transduction, cells were stimulated with forskolin and genistein, and assessed for quenching of the eYFP signal following injection of iodide solution into the assay media.& para;& para;Results & para;& para;Data showed that pAEC(CF) can express eYFP at high efficiency following transduction with the eYFP construct. The halide assay was able to discriminate functional restoration of CFTR in pAEC(CF) treated with either WT-CFTR construct or the positive controls syntaxin 8 and B-cell receptor-associated protein 31 shRNAs.& para;& para;Significance & para;& para;The current study demonstrates that the halide assay can be adapted for pediatric pAEC(CF) to evaluate restoration of CFTR function. With the ongoing development of small molecules to modulate the folding and/or activity of various mutated CFTR proteins, this halide assay presents a small-scale personalized screening platform that could assess therapeutic potential of molecules across a broad range of CFTR mutations.	[Sutanto, Erika N.; Garrett, Luke W.; Looi, Kevin; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Sutanto, Erika N.; Stick, Stephen M.; Kicic, Anthony] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Scaffidi, Amelia] Univ Western Australia, Off Res Enterprise, Nedlands, WA, Australia; [Foo, Clara J.; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA, Australia; [Tessari, Michela A.; Janssen, Richard A.] Galapagos BV, NL-2300 AC Leiden, Netherlands; [Fischer, David F.] Charles River Labs, Leiden, Netherlands; [Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA, Australia; Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia; [AREST CF] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Galapagos NV; University of Western Australia; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute	Kicic, A (corresponding author), Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia.; Kicic, A (corresponding author), Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia.; Kicic, A (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA, Australia.; Kicic, A (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA, Australia.	Anthony.Kicic@telethonkids.org.au	Stick, Stephen/AAA-5945-2021; Stick, Stephen/GZG-7584-2022; Kicic, Anthony/ABA-1252-2021; Garratt, Luke Wisely/N-2371-2013	Stick, Stephen/0000-0002-5386-8482; Kicic, Anthony/0000-0002-0008-9733; Garratt, Luke Wisely/0000-0001-9381-326X; Sutanto, Erika/0000-0002-4224-2839; Fischer, David/0000-0002-6690-0197	National Health and Medical Research Council of Australia [303145, 458513, 513730]; Charles River Laboratory; Cystic Fibrosis Foundation Therapeutics [SLY04A0, STICK09A0]; Australian Cystic Fibrosis Research Trust; Galapagos BV Laboratory	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Charles River Laboratory; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Australian Cystic Fibrosis Research Trust; Galapagos BV Laboratory	This work was supported by a grant from the Australian Cystic Fibrosis Research Trust, National Health and Medical Research Council of Australia (303145; 458513, 513730) and Cystic Fibrosis Foundation Therapeutics (SLY04A0, STICK09A0). Michela A. Tessari and Richard A. Janssen are employees of Galapagos BV, and David F. Fischer is from Charles River Laboratories. Both Galapagos BV and Charles River Laboratories provided research materials and financial support to the relevant authors (MA Tessari, RA Janssen and DF Fischer) and did not play a role in the study design, data collection and analysis, decision to publish and the preparation of the manuscript. Those authors were involved in reviewing the manuscript prior to submission. Stephen M. Stick is a National Health and Medical Research Council of Australia Practitioner Fellow. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0015-6; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Butler CR, 2016, AM J RESP CRIT CARE, P1; Cholon DM, 2015, NIH PUBLIC ACCESS, V6; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dekkers JF, 2016, EUR RESPIR J, V48, P451, DOI 10.1183/13993003.01192-2015; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doull IJM, 2001, ARCH DIS CHILD, V85, P62, DOI 10.1136/adc.85.1.62; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Granio O, 2007, AM J RESP CELL MOL, V37, P631, DOI 10.1165/rcmb.2007-0026TE; Hild M, 2016, CURR PROTOC STEM CEL, V37, DOI [10.1002/cpsc.1, DOI 10.1002/CPSC.1]; Ikpa PT, 2014, INT J BIOCHEM CELL B, V52, P192, DOI 10.1016/j.biocel.2014.02.008; Jayaraman S, 1999, AM J PHYSIOL-CELL PH, V277, pC1008, DOI 10.1152/ajpcell.1999.277.5.C1008; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; Kicic A, INTRINSIC BIOCH FUNC; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lane C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-53; Leavesley SJ, 2016, CYTOM PART A, V89A, P325, DOI 10.1002/cyto.a.22851; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; Maitra R, 2013, J BIOMOL SCREEN, V18, P1132, DOI 10.1177/1087057113488420; Mansoura MK, 1999, HUM GENE THER, V10, P861, DOI 10.1089/10430349950018274; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Morales MM, 1999, BRAZ J MED BIOL RES, V32, P1021, DOI 10.1590/S0100-879X1999000800013; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2015, MOL PHARMACOL, V88, P791, DOI 10.1124/mol.115.099689; Ramachandran S, 2016, J BIOL CHEM, V291, P25489, DOI 10.1074/jbc.M116.754283; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Tan Q, 2017, BIOMATERIALS, V113, P118, DOI 10.1016/j.biomaterials.2016.10.046; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155	46	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191618	10.1371/journal.pone.0191618	http://dx.doi.org/10.1371/journal.pone.0191618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360847	Green Published, Green Submitted, gold			2022-12-26	WOS:000423161800041
J	Cataldo, DM; Migliano, AB; Vinicius, L				Cataldo, Dana Michelle; Migliano, Andrea Bamberg; Vinicius, Lucio			Speech, stone tool-making and the evolution of language	PLOS ONE			English	Article							COMMUNICATION; GESTURE; ORIGIN; BRAIN	The 'technological hypothesis' proposes that gestural language evolved in early hominins to enable the cultural transmission of stone tool-making skills, with speech appearing later in response to the complex lithic industries of more recent hominins. However, no flintknapping study has assessed the efficiency of speech alone (unassisted by gesture) as a tool-making transmission aid. Here we show that subjects instructed by speech alone underperform in stone tool-making experiments in comparison to subjects instructed through either gesture alone or 'full language' (gesture plus speech), and also report lower satisfaction with their received instruction. The results provide evidence that gesture was likely to be selected over speech as a teaching aid in the earliest hominin tool-makers; that speech could not have replaced gesturing as a tool-making teaching aid in later hominins, possibly explaining the functional retention of gesturing in the full language of modern humans; and that speech may have evolved for reasons unrelated to tool-making. We conclude that speech is unlikely to have evolved as tool-making teaching aid superior to gesture, as claimed by the technological hypothesis, and therefore alternative views should be considered. For example, gestural language may have evolved to enable tool-making in earlier hominins, while speech may have later emerged as a response to increased trade and more complex inter-and intra-group interactions in Middle Pleistocene ancestors of Neanderthals and Homo sapiens; or gesture and speech may have evolved in parallel rather than in sequence.	[Cataldo, Dana Michelle; Migliano, Andrea Bamberg; Vinicius, Lucio] UCL, Dept Anthropol, London, England	University of London; University College London	Vinicius, L (corresponding author), UCL, Dept Anthropol, London, England.	l.vinicius@ucl.ac.uk		Migliano, Andrea/0000-0003-4364-2735				Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Blegen N, 2017, J HUM EVOL, V103, P1, DOI 10.1016/j.jhevol.2016.11.002; Bolhuis JJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001934; Callahan E., 1979, BASICS BIFACE KNAPPI; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Corballis MC, 2009, ANN NY ACAD SCI, V1156, P19, DOI 10.1111/j.1749-6632.2009.04423.x; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Dunbar RIM, 2003, LANGUAGE EVOLUTION, P219; Fitch WT, 2017, SCI ADV, V2; Gatewood J., 1985, DIRECTIONS COGNITIVE, P199; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lieberman P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002064; MCNEILL D, 1985, PSYCHOL REV, V92, P350, DOI 10.1037/0033-295X.92.3.350; McNeill D., 1992, HAND MIND WHAT GESTU; MONTAGU A, 1976, ANN NY ACAD SCI, V280, P266, DOI 10.1111/j.1749-6632.1976.tb25493.x; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Ohnuma K, 1997, ANTHROPOL SCI, V105, P159, DOI 10.1537/ase.105.159; Putt SS, 2014, LITHIC TECHNOL, V39, P96, DOI 10.1179/0197726114Z.00000000036; REYNOLDS PC, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P407; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Steele J, 2012, PHILOS T R SOC B, V367, P4, DOI 10.1098/rstb.2011.0295; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Tomasello M, 2008, JEAN NICOD LECT, P1; Wiessner PW, 2014, P NATL ACAD SCI USA, V111, P14027, DOI 10.1073/pnas.1404212111	30	24	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191071	10.1371/journal.pone.0191071	http://dx.doi.org/10.1371/journal.pone.0191071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351319	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300045
J	Fernandez-Navarro, P; Aragones, MT; Ley, V				Fernandez-Navarro, Pablo; Aragones, Maria Teresa; Ley, Victoria			Leisure-time physical activity and prevalence of non-communicable pathologies and prescription medication in Spain	PLOS ONE			English	Article							AEROBIC EXERCISE; MORTALITY; ADULTS; HEALTH; CHOLESTEROL; FITNESS; OBESITY; CANCER; WOMEN; RISK	Our aims were to describe physical activity (PA) behaviour in Spain and to examine its association with the prevalence of some of the major non-communicable diseases and with the use of prescription medication. Individualized secondary data retrieved from the 2014 European Health Interview Survey (EHIS) for Spain were used to conduct a cross-sectional epidemiological study (n = 18926). PA was assessed by two different measures: a specific designed variable for EHIS and a leisure time PA frequency-based query of the national survey. Diseases analyzed were hypertension, diabetes, hypercholesterolemia, depression and anxiety. The use of prescription medication was also included in the study. Weighted percentages were computed and contingency tables were calculated to describe PA by levels of the traits and sociodemographic characteristics. Chi-square test was used to compare percentages between groups and weighted logistic regression models were used to assess the relationship between PA and the prevalence of the disease. About 73% of the Spanish population performs no PA at all or only occasionally during their leisure time, and only one third meets minimum PA international guidelines (>= 150min/week). Men are considerably more active than women and less PA is observed as the education level decreases and as age increases. The risk of the diseases evaluated was up to three times higher among inactive individuals. This study provides national population-based estimations highlighting the impact of PA in Spain, not only in the prevalence of some of the major non-communicable diseases but also in reducing prescription medication, and the potential sex and socioeconomic influence.	[Fernandez-Navarro, Pablo] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Fernandez-Navarro, Pablo] Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Aragones, Maria Teresa; Ley, Victoria] Spanish Agcy Hlth Protect Sports, Natl Sports Council, Dept Sports & Hlth, Madrid, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Fernandez-Navarro, P (corresponding author), Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Fernandez-Navarro, P (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain.; Ley, V (corresponding author), Spanish Agcy Hlth Protect Sports, Natl Sports Council, Dept Sports & Hlth, Madrid, Spain.	pfernandezn@isciii.es; victoria.ley@aei.gob.es	Ley, Victoria/I-8862-2017; Navarro, Pablo Fernandez/E-8893-2018	Ley, Victoria/0000-0003-2740-1560; Navarro, Pablo Fernandez/0000-0001-9427-2581; Gonzalez Palacios, Javier/0000-0002-8099-8469; Gonzalez Sanchez, Mario/0000-0003-0229-3559	Spain's Health Research Fund, Institute de Salud Carlos III [EPY 1271/15]	Spain's Health Research Fund, Institute de Salud Carlos III	This work was supported by EPY 1271/15 from Spain's Health Research Fund, Institute de Salud Carlos III; https://portalfis.isciii.es/es/Paginas/inicio.aspx. PFN is the PI of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Becofsky KM, 2015, AM J EPIDEMIOL, V181, P311, DOI 10.1093/aje/kwu330; Booth FW, 2015, DIABETOLOGIA, V58, P1730, DOI 10.1007/s00125-015-3617-5; Bull F, 2015, BRIT J SPORT MED, V49, P749, DOI 10.1136/bjsports-2013-093200; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Craft Lynette L., 2004, Prim Care Companion J Clin Psychiatry, V6, P104; Devaux M, 2013, EUR J PUBLIC HEALTH, V23, P464, DOI 10.1093/eurpub/ckr058; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Eurostat, 2015, EUR HLTH INT SURV ME; Finger JD, 2015, ARCH PUBLIC HEALTH, V73, P1; Fishman EI, 2016, MED SCI SPORT EXER, V48, P1303, DOI 10.1249/MSS.0000000000000885; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Gordon B, 2014, CURR SPORT MED REP, V13, P253, DOI 10.1249/JSR.0000000000000073; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; ISCA (International Sport and Culture Association) & CEBR (Centre for Economics and Business Research), 2015, EC COST PHYS IN EUR; Katzmarzyk PT, 2016, ANN INTERN MED, V164, P620, DOI 10.7326/M16-0269; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; Laske C, 2010, INT J NEUROPSYCHOPH, V13, P595, DOI 10.1017/S1461145709991234; Lee DC, 2015, J AM COLL CARDIOL, V65, P420, DOI 10.1016/j.jacc.2014.11.022; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; Marques A, 2015, PREV MED, V81, P333, DOI 10.1016/j.ypmed.2015.09.018; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Romero V, 2007, PSYCHOSOMATICS, V54, P525; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Smith AD, 2016, DIABETOLOGIA, V59, P2527, DOI 10.1007/s00125-016-4079-0; Smith Mark A, 2011, Front Psychiatry, V2, P82, DOI 10.3389/fpsyt.2011.00082; Therneau TM, 2016, SURVIVAL SURVIVAL AN, P128; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; Wahid A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002495; WHO, 2015, GLOB REC PHYS ACT HL; WHO, 2015, WHO GLOBAL HEALTH OB; World Health Organization, GLOB DAT BOD MASS IN	38	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191542	10.1371/journal.pone.0191542	http://dx.doi.org/10.1371/journal.pone.0191542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352280	gold, Green Published, Green Submitted			2022-12-26	WOS:000422911300110
J	Holten, V; MacNeilage, PR				Holten, Vivian; MacNeilage, Paul R.			Optic flow detection is not influenced by visual-vestibular congruency	PLOS ONE			English	Article							SUPERIOR TEMPORAL AREA; SELF-MOTION; MST NEURONS; DIRECTIONAL ANISOTROPY; RESPONSE SELECTIVITY; SQUIRREL-MONKEY; POSTURAL SWAY; FIELD STIMULI; SENSITIVITY; PERCEPTION	Optic flow patterns generated by self-motion relative to the stationary environment result in congruent visual-vestibular self-motion signals. Incongruent signals can arise due to object motion, vestibular dysfunction, or artificial stimulation, which are less common. Hence, we are predominantly exposed to congruent rather than incongruent visual-vestibular stimulation. If the brain takes advantage of this probabilistic association, we expect observers to be more sensitive to visual optic flow that is congruent with ongoing vestibular stimulation. We tested this expectation by measuring the motion coherence threshold, which is the percentage of signal versus noise dots, necessary to detect an optic flow pattern. Observers seated on a hexapod motion platform in front of a screen experienced two sequential intervals. One interval contained optic flow with a given motion coherence and the other contained noise dots only. Observers had to indicate which interval contained the optic flow pattern. The motion coherence threshold was measured for detection of laminar and radial optic flow during leftward/rightward and fore/aft linear self-motion, respectively. We observed no dependence of coherence thresholds on vestibular congruency for either radial or laminar optic flow. Prior studies using similar methods reported both decreases and increases in coherence thresholds in response to congruent vestibular stimulation; our results do not confirm either of these prior reports. While methodological differences may explain the diversity of results, another possibility is that motion coherence thresholds are mediated by neural populations that are either not modulated by vestibular stimulation or that are modulated in a manner that does not depend on congruency.	[Holten, Vivian] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [MacNeilage, Paul R.] Univ Nevada, Dept Psychol, Cognit & Brain Sci Program, Reno, NV 89557 USA	University of Munich; Nevada System of Higher Education (NSHE); University of Nevada Reno	Holten, V (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany.	vivian.holten@lrz.uni-muenchen.de			German Research Foundation [MA 6233/1-1]; German Ministry of Education and Research [01 E0 1401]	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (www.dfg.de) under grant code MA 6233/1-1 to Paul R. MacNeilage and the German Ministry of Education and Research (www.bmbf.de) under grant code 01 E0 1401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; DEBRUYN B, 1990, PERCEPTION, V19, P21, DOI 10.1068/p190021; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; EDWARDS M, 1993, PERCEPTION, V22, P1013, DOI 10.1068/p221013; Edwards M, 2007, PERCEPTION, V36, P113, DOI 10.1068/p5626; Edwards M, 2010, PERCEPTION, V39, P1303, DOI 10.1068/p6653; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garzorz IT, 2017, CURR BIOL, V27, P2856, DOI 10.1016/j.cub.2017.08.011; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; HARRIS LR, 1981, NATURE, V293, P139, DOI 10.1038/293139a0; Holten V, 2015, PERCEPTION, V44, P477, DOI 10.1068/p7925; Holten V, 2013, EXP BRAIN RES, V228, P117, DOI 10.1007/s00221-013-3543-z; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Paris R, 2017, ATTEN PERCEPT PSYCHO, V79, P1182, DOI 10.3758/s13414-017-1299-4; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAYMOND JE, 1994, VISION RES, V34, P1029, DOI 10.1016/0042-6989(94)90007-8; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Shirai N, 2012, VISION RES, V62, P201, DOI 10.1016/j.visres.2012.04.008; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talsma D, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00019; Turano KA, 1999, VISION RES, V39, P1177, DOI 10.1016/S0042-6989(98)00174-6; Uesaki M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00775; VANDEGRIND WA, 1983, J OPT SOC AM, V73, P1674, DOI 10.1364/JOSA.73.001674; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wei KL, 2010, J VISION, V10, DOI 10.1167/10.14.4	48	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191693	10.1371/journal.pone.0191693	http://dx.doi.org/10.1371/journal.pone.0191693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29352317	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300122
J	Villain, H; Benkahoul, A; Birmes, P; Ferry, B; Roullet, P				Villain, Helene; Benkahoul, Aicha; Birmes, Philippe; Ferry, Barbara; Roullet, Pascal			Influence of early stress on memory reconsolidation: Implications for post-traumatic stress disorder treatment	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CHILDHOOD SEXUAL-ABUSE; NORADRENERGIC ACTIVITY; MATERNAL SEPARATION; PRENATAL STRESS; FEAR MEMORY; PROTEIN-SYNTHESIS; TRAUMA REACTIVATION; OFFSPRING EVIDENCE; EMOTIONAL-STRESS	Post-traumatic stress disorder (PTSD) is a common consequence of exposure to a life-threatening event. Currently, pharmacological treatments are limited by high rates of relapse, and novel treatment approaches are needed. We have recently demonstrated that propranolol, a beta-adrenergic antagonist, inhibited aversive memory reconsolidation in animals. Following this, in an open-label study 70% of patients with PTSD treated with propranolol during reactivation of traumatic memory exhibited full remission. However, the reason why 30% of these patients did not respond positively to propranolol treatment is still unclear. One of the major candidates as factor of treatment resistance is the patient's early-life traumatic history. To test the role of this factor, mice with pre-or postnatal stress are being tested in fear conditioning and in a new behavioral task, the "city-like", specifically designed as a mouse model of PTSD. After reactivation of the traumatic event, mice received propranolol injection to block the noradrenergic system during memory reconsolidation. Results show that, in the "city-like" test, control mice strongly avoided the shock compartment but also the compartments containing cues associated with the electric shocks. Injection of propranolol after reactivation greatly reduced the memory of the traumatic event, but this effect was not present when mice had received pre-or postnatal stress. Moreover, propranolol produced only a very weak effect in the fear conditioning test, and never changed the corticosterone level whatever the behavioral experiment. Taken together our results suggest that our new behavioural paradigm is well adapted to PTSD study in mice, and that early stress exposure may have an impact on propranolol PTSD treatment outcome. These data are critical to understanding the effect of propranolol treatment, in order to improve the therapeutic protocol currently used in humans.	[Villain, Helene; Benkahoul, Aicha; Roullet, Pascal] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Ctr Biol Integrat,CNRS, Toulouse, France; [Birmes, Philippe] Univ Toulouse, Toulouse NeuroImaging Ctr, INSERM, UPS, Toulouse, France; [Ferry, Barbara] Univ Claude Bernard Lyon 1, Ctr Res Neurosci Lyon, UMR CNRS 5292, INSERM,U1028, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Roullet, P (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Ctr Biol Integrat,CNRS, Toulouse, France.	pascal.roullet@univ-tlse3.fr	Ferry, Barbara/N-6685-2014	Ferry, Barbara/0000-0001-5191-3035	CNRS; University Paul Sabatier of Toulouse; LABEX Cortex of Universite de Lyon within the program "Investissements d'Avenir" [NR-11-LABX-0042, ANR-11-IDEX-0007]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier of Toulouse; LABEX Cortex of Universite de Lyon within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This study was supported by CNRS and the University Paul Sabatier of Toulouse and by the LABEX Cortex (Grant NR-11-LABX-0042) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Solene Thomas and Tiphaine Bailly for technical assistance. We thank the ABC animal facility and ANEXPLO for housing mice. This study was supported by CNRS and the University Paul Sabatier of Toulouse and by the LABEX Cortex (Grant NR-11-LABX-0042) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency.	ADER R, 1973, DEV PSYCHOBIOL, V6, P547, DOI 10.1002/dev.420060611; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Benoit JD, 2015, BEHAV BRAIN RES, V281, P1, DOI 10.1016/j.bbr.2014.12.001; Bernardi RE, 2006, NEUROREPORT, V17, P1443, DOI 10.1097/01.wnr.0000233098.20655.26; Betts KS, 2015, J AFFECT DISORDERS, V175, P241, DOI 10.1016/j.jad.2015.01.011; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Bogoch Y, 2007, J NEUROCHEM, V101, P1018, DOI 10.1111/j.1471-4159.2006.04402.x; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Brunet A, 2014, CAN J PSYCHIAT, V59, P228, DOI 10.1177/070674371405900408; Brunet A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00074; Brunet A, 2011, J CLIN PSYCHOPHARM, V31, P547, DOI 10.1097/JCP.0b013e318222f360; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Cannizzaro E, 2005, BEHAV BRAIN RES, V161, P320, DOI 10.1016/j.bbr.2005.02.022; Conversi D, 2014, PHARMACOL BIOCHEM BE, V122, P158, DOI 10.1016/j.pbb.2014.04.001; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Daumas S, 2004, EUR J NEUROSCI, V20, P597, DOI 10.1111/j.1460-9568.2004.03484.x; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Diergaarde L, 2006, BEHAV BRAIN RES, V170, P333, DOI 10.1016/j.bbr.2006.02.014; Fenoglio KA, 2005, ENDOCRINOLOGY, V146, P4090, DOI 10.1210/en.2004-1285; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; Gazarini L, 2013, LEARN MEMORY, V20, P210, DOI 10.1101/lm.030007.112; Hannan SM, 2015, J INTERPERS VIOLENCE, P1; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Karatzias A, 2007, EUR ARCH PSY CLIN N, V257, P40, DOI 10.1007/s00406-006-0682-2; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Koseki Hiroyo, 2007, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V27, P19; Kosten TA, 2007, NEUROBIOL LEARN MEM, V88, P167, DOI 10.1016/j.nlm.2007.03.011; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Lee EJ, 2011, J NEUROSCI, V31, P7131, DOI 10.1523/JNEUROSCI.4692-10.2011; Lehmann J, 1998, PHARMACOL BIOCHEM BE, V59, P873, DOI 10.1016/S0091-3057(97)00529-7; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; Liu H, 2017, JAMA PSYCHIAT, V74, P270, DOI 10.1001/jamapsychiatry.2016.3783; Lonergan M, 2014, J AGGRESS MALTREAT T, V23, P494, DOI 10.1080/10926771.2014.904467; Markham JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00173; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Marshall RD, 1998, J CLIN PSYCHOPHARM, V18, P10, DOI 10.1097/00004714-199802000-00003; Matsumoto M, 2005, HIPPOCAMPUS, V15, P775, DOI 10.1002/hipo.20100; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Narahari T, 2015, DEV PSYCHOBIOL, P1; Nasehi M, 2017, BEHAV BRAIN RES, V331, P76, DOI 10.1016/j.bbr.2017.04.055; National Institute for Clinical Excellence (NICE), 2005, POSTTR STRESS DIS MA; Navalta CP, 2006, J NEUROPSYCH CLIN N, V18, P45, DOI 10.1176/appi.neuropsych.18.1.45; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Resick PA, 2003, CNS SPECTR, V8, P340, DOI 10.1017/S1092852900018605; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Robinson MJF, 2007, BEHAV BRAIN RES, V182, P129, DOI 10.1016/j.bbr.2007.05.023; Roozendaal B, 2004, NEUROBIOL LEARN MEM, V81, P150, DOI 10.1016/j.nlm.2003.10.001; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Roozendaal B, 2006, NEUROBIOL LEARN MEM, V86, P249, DOI 10.1016/j.nlm.2006.03.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Schwabe L, 2010, J NEUROSCI, V30, P8190, DOI 10.1523/JNEUROSCI.0734-10.2010; Schwabe L, 2009, PSYCHONEUROENDOCRINO, V34, P446, DOI 10.1016/j.psyneuen.2008.10.009; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; Tang ZL, 2012, TOXICOL LETT, V208, P1, DOI 10.1016/j.toxlet.2011.10.001; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Vallee M, 1997, J NEUROSCI, V17, P2626; van Stegeren AH, 2008, ACTA PSYCHOL, V127, P532, DOI 10.1016/j.actpsy.2007.10.004; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Villain H, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00049; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2005, J CLIN ENDOCR METAB, V90, P4115, DOI 10.1210/jc.2005-0550; Yehuda R, 1998, AM J PSYCHIAT, V155, P841; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	93	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191563	10.1371/journal.pone.0191563	http://dx.doi.org/10.1371/journal.pone.0191563			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29352277	Green Published, Green Submitted, gold			2022-12-26	WOS:000422911300115
J	Chrostek, E; Teixeira, L				Chrostek, Ewa; Teixeira, Luis			Within host selection for faster replicating bacterial symbionts	PLOS ONE			English	Article							GENE AMPLIFICATION; WOLBACHIA STRAIN; EVOLUTION; DROSOPHILA; VIRULENT	Wolbachia is a widespread, intracellular symbiont of arthropods, able to induce reproductive distortions and antiviral protection in insects. Wolbachia can also be pathogenic, as is the case with wMelPop, a virulent variant of the endosymbiont of Drosophila melanogaster. An extensive genomic amplification of the 20kb region encompassing eight Wolbachia genes, called Octomom, is responsible for wMelPop virulence. The Octomom copy number in wMelPop can be highly variable between individual D. melanogaster flies, even when comparing siblings arising from a single female. Moreover, Octomom copy number can change rapidly between generations. These data suggest an intra-host variability in Octomom copy number between Wolbachia cells. Since wMelPop Wolbachia with different Octomom copy numbers grow at different rates, we hypothesized that selection could act on this intra-host variability. Here we tested if total Octomom copy number changes during the lifespan of individual Drosophila hosts, revealing selection for different Wolbachia populations. We performed a time course analysis of Octomom amplification in flies whose mothers were controlled for Octomom copy number. We show that despite the Octomom copy number being relatively stable it increases slightly throughout D. melanogaster adult life. This indicates that there is selection acting on the intra-host variation in the Octomom copy number over the lifespan of individual hosts. This within host selection for faster replicating bacterial symbionts may be in conflict with between host selection against highly pathogenic Wolbachia.	[Chrostek, Ewa; Teixeira, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Teixeira, Luis] Univ Lisbon, Fac Med, Lisbon, Portugal; [Chrostek, Ewa] Max Planck Inst Infect Biol, Berlin, Germany	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Max Planck Society	Teixeira, L (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.; Teixeira, L (corresponding author), Univ Lisbon, Fac Med, Lisbon, Portugal.	lteixeira@igc.gulbenkian.pt	Chrostek, Ewa/AAA-4218-2022; Teixeira, Luis/H-6106-2013	Teixeira, Luis/0000-0001-8326-6645; Chrostek, Ewa/0000-0003-1825-372X	Fundacao para a Ciencia e Tecnologia [PTDC/BEX-GMG/3128/2014]; EMBO Long Term Fellowship [EMBO ALTF 1497-2015]; Marie Curie Actions by the European Commission (LTFCOFUND) [GA-2013-609409]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions by the European Commission (LTFCOFUND)	LT's lab is funded by the Fundacao para a Ciencia e Tecnologia (www.fct.pt) grant PTDC/BEX-GMG/3128/2014. EC is supported by EMBO Long Term Fellowship EMBO ALTF 1497-2015 (http://www.embo.org), co-funded by Marie Curie Actions by the European Commission (LTFCOFUND2013, GA-2013-609409) (ec.europa.eu/research/mariecurieactions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Chrostek E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006540; Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ohno S., 1970, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds KT, 2003, GENETICS, V164, P1027; Rohrscheib CE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005888; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN., 2006, BIOMETRICS, V67, P391, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Young BC, 2017, ELIFE, V6, DOI 10.7554/eLife.30637	21	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191530	10.1371/journal.pone.0191530	http://dx.doi.org/10.1371/journal.pone.0191530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346449	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500060
J	Egashira, K; Sumita, Y; Zhong, WJ; Takashi, I; Ohba, S; Nagai, K; Asahina, I				Egashira, Kazuhiro; Sumita, Yoshinori; Zhong, Weijian; Takashi, I; Ohba, Seigo; Nagai, Kazuhiro; Asahina, Izumi			Bone marrow concentrate promotes bone regeneration with a suboptimal-dose of rhBMP-2	PLOS ONE			English	Article							PLATELET-RICH PLASMA; PROGENITOR CELLS; POOR PLASMA; RECONSTRUCTION; SUBSTITUTES; COMBINATION; MORBIDITY; PROTEINS; EFFICACY; FIBRIN	Bone marrow concentrate (BMC), which is enriched in mononuclear cells (MNCs) and platelets, has recently attracted the attention of clinicians as a new optional means for bone engineering. We previously reported that the osteoinductive effect of bone morphogenetic protein-2 (BMP-2) could be enhanced synergistically by co-transplantation of peripheral blood (PB)-derived platelet-rich plasma (PRP). This study aims to investigate whether BMC can effectively promote bone formation induced by low-dose BMP-2, thereby reducing the undesirable side-effects of BMP-2, compared to PRP. Human BMC was obtained from bone marrow aspirates using an automated blood separator. The BMC was then seeded onto beta-TCP granules pre-adsorbed with a suboptimal-dose (minimum concentration to induce bone formation at 2 weeks in mice) of recombinant human (rh) BMP-2. These specimens were transplanted subcutaneously to the dorsal skin of immunodeficient-mice and the induction of ectopic bone formation was assessed 2 and 4 weeks post-transplantation. Transplantations of five other groups [PB, PRP, platelet-poor plasma (PPP), bone marrow aspirate (BM), and BM-PPP] were employed as experimental controls. Then, to clarify the effects on vertical bone augmentation, specimens from the six groups were transplanted for on-lay placement on the craniums of mice. The results indicated that BMC, which contained an approximately 2.5-fold increase in the number of MNCs compared to PRP, could accelerate ectopic bone formation until 2 weeks post-transplantation. On the cranium, the BMC group promoted bone augmentation with a suboptimal-dose of rhBMP-2 compared to other groups. Particularly in the BMC specimens harvested at 4 weeks, we observed newly formed bone surrounding the TCP granules at sites far from the calvarial bone. In conclusion, the addition of BMC could reduce the amount of rhBMP-2 by one-half via its synergistic effect on early-phase osteoinduction. We propose here that BMC transplantation facilitates the clinical use of rhBMP-2 as an alternative strategy for bone engineering.	[Egashira, Kazuhiro; Sumita, Yoshinori; Takashi, I; Ohba, Seigo; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Unit Translat Med, Nagasaki, Japan; [Sumita, Yoshinori] Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Unit Translat Med, Nagasaki, Japan; [Zhong, Weijian] Dalian Med Univ, Coll Stomatol, Dept Oral & Maxillofacial Surg, Dalian, Liaoning, Peoples R China; [Nagai, Kazuhiro] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan	Nagasaki University; Nagasaki University; Dalian Medical University; Nagasaki University	Sumita, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Unit Translat Med, Nagasaki, Japan.; Sumita, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Unit Translat Med, Nagasaki, Japan.	y-sumita@nagasaki-u.ac.jp	Ohba, Seigo/ABE-3239-2020		Japan Society for Promotion of Science [24890163, 25670863]; Grants-in-Aid for Scientific Research [15H05044] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Research Activity Start-up Scientific Research (24890163; funded to KE) and for Challenging Exploratory Research (25670863; funded to IS and YS) from Japan Society for Promotion of Science.; The authors wish to thank Ms. Naoko Sakashita (Nagasaki University) for providing technical assistance with the experiments. This work was supported by Grants-in-Aid for Research Activity Start-up Scientific Research (24890163) and for Challenging Exploratory Research (25670863) from the Japan Society for Promotion of Science. All authors declare that there are no conflicts of interest.	Anavi Y, 2011, J ORAL IMPLANTOL, V37, P379, DOI 10.1563/AAID-JOI-D-09-00128.1; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833; Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018; Boyne PJ, 1998, BRIT J ORAL MAX SURG, V36, P84, DOI 10.1016/S0266-4356(98)90173-5; Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005; Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825; El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302; Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd; Galliera E, 2012, J BIOL REGUL HOMEOST, V26, P35; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Hamdan AAS, 2009, CLIN ORAL IMPLAN RES, V20, P616, DOI 10.1111/j.1600-0501.2008.01687.x; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hokugo A, 2014, BIOMATERIALS, V35, P5565, DOI 10.1016/j.biomaterials.2014.03.018; Imam MA, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2017007; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.TEB.2015.0357, 10.1089/ten.teb.2015.0357]; Kelly MP, 2016, J ORAL MAXIL SURG, V74, P928, DOI 10.1016/j.joms.2015.11.027; Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471; Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567; Masuda T, 2015, J HARD TISSUE BIOL, V24, P7, DOI 10.2485/jhtb.24.7; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Nakatani Y, 2017, ARCH ORAL BIOL, V73, P172, DOI 10.1016/j.archoralbio.2016.10.006; Nandi SK, 2010, INDIAN J MED RES, V132, P15; Nishimoto S, 2012, INDIAN J PLAST SURG, V45, P109, DOI 10.4103/0970-0358.96599; Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Pettine KA, 2015, STEM CELLS, V33, P146, DOI 10.1002/stem.1845; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x; Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66; Sauerbier S, 2011, TISSUE ENG PT A, V17, P2187, DOI [10.1089/ten.tea.2010.0516, 10.1089/ten.TEA.2010.0516]; Schaaf H, 2010, ORAL SURG ORAL MED O, V109, P52, DOI 10.1016/j.tripleo.2009.08.023; Schmelzeisen R, 2010, BR J ORAL MAXILLOFAC, V49, P4980; Schorn L, 2017, HEAD FACE MED, V13, DOI 10.1186/s13005-017-0146-0; Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609; Skowronskim PP, 2003, MUSC ORTHOP J, V6, P58; Sununliganon L, 2014, J CRANIO MAXILL SURG, V42, P1753, DOI 10.1016/j.jcms.2014.06.011; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x; Wojtowicz Andrzej, 2007, N Y State Dent J, V73, P41; Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096; Yoshida K, 2013, BIO-MED MATER ENG, V23, P163, DOI 10.3233/BME-130741; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031722	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191099	10.1371/journal.pone.0191099	http://dx.doi.org/10.1371/journal.pone.0191099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346436	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500026
J	Avelino-Silva, TJ; Campora, F; Curiati, JAE; Jacob-Filho, W				Avelino-Silva, Thiago Junqueira; Campora, Flavia; Esper Curiati, Jose Antonio; Jacob-Filho, Wilson			Prognostic effects of delirium motor subtypes in hospitalized older adults: A prospective cohort study	PLOS ONE			English	Article							MORTALITY; SEVERITY; OUTCOMES; ASSOCIATION; DEMENTIA; AROUSAL; INDEX; RISK	Objectives To investigate the association between delirium motor subtypes and hospital mortality and 12-month mortality in hospitalized older adults. Design Prospective cohort study conducted from 2009 to 2015. Setting Geriatric ward of a university hospital in Sao Paulo, Brazil. Participants We included 1,409 consecutive admissions of acutely ill patients aged 60 years and over. We excluded admissions for end-of-life care, with missing data on the main variables, length of stay shorter than 48 hours, or when consent to participate was not given. Main outcomes and measures Delirium was detected using the Confusion Assessment Method and categorized in hypoactive, hyperactive, or mixed delirium. Primary outcomes were time to death in the hospital, and time to death in 12 months (for the discharged sample). Comprehensive geriatric assessment was performed at admission and included socio-demographic, clinical, functional, cognitive, and laboratory variables. Further clinical data were documented upon death or discharge. Multivariate analyses used Cox proportional hazards models adjusted for possible confounders. Results We included 1,409 admissions, with a mean age of 80 years. The proportion of in-hospital deaths was 19%, with a cumulative mortality of 38% in 12 months. Delirium occurred in 47% of the admissions. Hypoactive delirium was the predominant motor subtype (53%), followed by mixed delirium (30%) and hyperactive delirium (17%). Hospital mortality rates were respectively 33%, 34% and 15%. We verified that hypoactive and mixed delirium were independently associated with hospital mortality, with respective hazard ratios of 2.43 (95%CI = 1.64-3.59) and 2.31 (95%CI = 1.53-3.50). Delirium motor subtypes were not independently predictive of 12-month mortality. Conclusions One in three acutely ill hospitalized older adults who suffered hypoactive or mixed delirium died in the hospital. Clinicians should be aware that hypoactive symptoms of delirium, whether shown exclusively or in alternation with hyperactive symptoms, are indicative of a worse prognosis in this population.	[Avelino-Silva, Thiago Junqueira; Campora, Flavia; Esper Curiati, Jose Antonio; Jacob-Filho, Wilson] Univ Sao Paulo, Med Sch, Dept Internal Med, Div Geriatr, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Avelino-Silva, TJ (corresponding author), Univ Sao Paulo, Med Sch, Dept Internal Med, Div Geriatr, Sao Paulo, SP, Brazil.	thiago.silva@fm.usp.br	Avelino-Silva, Thiago J/J-8794-2013	Avelino-Silva, Thiago J/0000-0001-9347-0519	CAPES Foundation, Ministry of Education, Brazilian Federal Government	CAPES Foundation, Ministry of Education, Brazilian Federal Government	TJAS developed part of this project as a visiting scholar at the University of California San Francisco, supported by a scholarship from the CAPES Foundation, Ministry of Education, Brazilian Federal Government. None of the authors reported a potential, real, or perceived conflict of interest or additional financial disclosures.	Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Avelino-Silva TJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-129; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Camus MV, 2000, J GERIATR PSYCH NEUR, V13, P38, DOI 10.1177/089198870001300106; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DeCrane SK, 2011, CLIN NURS RES, V20, P404, DOI 10.1177/1054773811419497; Eubank KJ, 2014, ANN INTERN MED, V160, P574, DOI 10.7326/M14-0553; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Han JH, 2017, AM J GERIAT PSYCHIAT, V25, P233, DOI 10.1016/j.jagp.2016.05.016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Inouye S., 2003, SHORT CONFUSION ASSE; Inouye S. K., 2003, CONFUSION ASSESSMENT; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, DEMENT GERIATR COGN, V10, P393, DOI 10.1159/000017177; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Jackson TA, 2015, INT J GERIATR PSYCHI; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kelly KG, 2001, AM J GERIAT PSYCHIAT, V9, P72, DOI 10.1176/appi.ajgp.9.1.72; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; Kim SY, 2015, PSYCHOSOM MED, V77, P903, DOI 10.1097/PSY.0000000000000239; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; LIPOWSKI ZJ, 1983, AM J PSYCHIAT, V140, P1426; LIPTZIN B, 1992, BRIT J PSYCHIAT, V161, P843, DOI 10.1192/bjp.161.6.843; Marcantonio E, 2002, J AM GERIATR SOC, V50, P850, DOI 10.1046/j.1532-5415.2002.50210.x; McCusker J, 2004, J AM GERIATR SOC, V52, P1744, DOI 10.1111/j.1532-5415.2004.52471.x; Meagher DJ, 2011, J PSYCHOSOM RES, V71, P395, DOI 10.1016/j.jpsychores.2011.06.001; Morandi A, 2017, AM J GERIAT PSYCHIAT, V25, P1064, DOI 10.1016/j.jagp.2017.05.003; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Peritogiannis V, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/416792; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Siddiqi N, 2006, CLIN MED, V6, P540, DOI 10.7861/clinmedicine.6-6-540; Slor CJ, 2013, J PSYCHOSOM RES, V74, P444, DOI 10.1016/j.jpsychores.2012.12.007; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Tieges Z, 2013, AM J GERIAT PSYCHIAT, V21, P1244, DOI 10.1016/j.jagp.2013.05.003; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yang F, 2008, GERONTOLOGIST, V48, P96	39	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191092	10.1371/journal.pone.0191092	http://dx.doi.org/10.1371/journal.pone.0191092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU1NX	29381733	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800014
J	Karam, J; Bibiloni, MD; Tur, JA				Karam, Joanne; del Mar Bibiloni, Maria; Tur, Josep A.			Polyphenol estimated intake and dietary sources among older adults from Mallorca Island	PLOS ONE			English	Article							MAJOR FOOD SOURCES; ANTIOXIDANT CAPACITY; POPULATION; COHORT; RISK; OIL	The aim was the assessment of the polyphenol estimated intake and dietary sources among older adults from Mallorca Island. The study was carried out (2013-2014) in 211 participants dwelling women (n= 112) and men (n = 99). Polyphenol intake was calculated from two non-consecutive 24-h recall diets using the Polyphenol Explorer. The mean daily intake of polyphenol was 332.7 mg/d (SD: 237.9; median: 299 mg/d). Highest polyphenol intake was observed among females, 64-67 y.o. people, higher income and educational level, alcohol consumers, and physically active people. Most polyphenols consumed were flavo- noids, and among them the major subclass was flavanols. Alcoholic beverages were the major contributors to the total polyphenol intake (118.3 mg/d, SD: 127.5), and red wine contributed 17.7% of total polyphenols consumed. Polyphenol intake was highest among alcohol drinkers, high educational level, high income, and physical active people. Flavonoids were the highest ingested polyphenols. Alcoholic beverages were the major contributors to the total polyphenol intake, mainly red wine.	[Karam, Joanne; del Mar Bibiloni, Maria; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [Karam, Joanne; del Mar Bibiloni, Maria; Tur, Josep A.] CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Palma De Mallorca, Spain; [Karam, Joanne] Univ Balamand, Fac Hlth Sci, Balamand Al Kurah, Lebanon; [del Mar Bibiloni, Maria; Tur, Josep A.] CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University Balamand; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.; Tur, JA (corresponding author), CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Palma De Mallorca, Spain.; Tur, JA (corresponding author), CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.	pep.tur@uib.es	KARAM, JOANNE/GOP-0518-2022; del Mar Bibiloni, Maria/M-3123-2014; Tur, Josep/AAE-5748-2020	KARAM, JOANNE/0000-0003-2637-1347; del Mar Bibiloni, Maria/0000-0001-8926-9206; Tur, Josep/0000-0002-6940-0761	Instituto de Salud Carlos III [PI14/00636, PI17/01827, RD06/0045/1004, CB12/03/30038]; EU-COST Action [CA16112]; Balearic Islands Gov. [35/2011]; EU-FEDER funds	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU-COST Action(European Cooperation in Science and Technology (COST)European Commission); Balearic Islands Gov.; EU-FEDER funds(European Commission)	This work was supported by the Instituto de Salud Carlos III (Projects PI14/00636 and PI17/01827, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038), EU-COST Action CA16112, Grant of support to research groups no. 35/2011 (Balearic Islands Gov.) and EU-FEDER funds. Joanne Karam was a fellow of the EU-HERMES Program. The funding sponsors had no role in the design of the study, in the collection, analyses, or interpretation of the data; in the writing of the manuscript, and in the decision to publish the results.	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer, 2009, MAHD MAHM REC PAT AL, V3, P73; Dragsted LO, 1997, EUR J CANCER PREV, V6, P522, DOI 10.1097/00008469-199712000-00006; ESQUIUS M, 1993, MED CLIN-BARCELONA, V100, P692; Freedman LS, 2006, INT J EPIDEMIOL, V35, P1011, DOI 10.1093/ije/dyl085; Godos J, 2017, INT J FOOD SCI NUTR, V68, P750, DOI 10.1080/09637486.2017.1285870; Gomez C, 2007, GUIA VISUAL ALIMENTO, P27; Grosso G, 2017, AM J EPIDEMIOL, V185, P1304, DOI 10.1093/aje/kww207; Grosso G, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600930; Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Huang CL, 2008, J AM COLL SURGEONS, V207, P407, DOI 10.1016/j.jamcollsurg.2008.02.018; Kiefer I, 2013, J MENS HLTH GENDER, V2, P194; Liu YJ, 2014, CLIN NUTR, V33, P59, DOI 10.1016/j.clnu.2013.03.011; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Miranda AM, 2016, BRIT J NUTR, V115, P1061, DOI 10.1017/S0007114515005061; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Perez-Jimenez J, 2010, J AGR FOOD CHEM, V58, P4959, DOI 10.1021/jf100128b; Prior R. L., 2013, AM J BIOMEDICAL SCI, V5, P126, DOI DOI 10.5099/AJ130200126; Rajamurugan R, 2012, NAT PROD RES, V26, P2208, DOI 10.1080/14786419.2011.637215; Rienks J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040415; Rodriguez JC, 2016, J AGR FOOD CHEM, V64, P852, DOI 10.1021/acs.jafc.5b04990; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; [SEGG (Sociedad Espanola de Geriatria y Gerontologia) SENPE (Sociedad Espanola de Nutricion Parenteral v Enteral)], GAL NIGR; Taguchi C, 2015, NUTRIENTS, V7, P10269, DOI 10.3390/nu7125530; Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008; USDA food composition databases, US DEP AGR AGR RES S; Williamson G, 2008, BRIT J NUTR, V99, pS55, DOI 10.1017/S0007114508006867	31	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191573	10.1371/journal.pone.0191573	http://dx.doi.org/10.1371/journal.pone.0191573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381732	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800025
J	Robertson, MJ; Soibam, B; O'Leary, JG; Sampaio, LC; Taylor, DA				Robertson, Matthew J.; Soibam, Benjamin; O'Leary, Jacqueline G.; Sampaio, Luiz C.; Taylor, Doris A.			Recellularization of rat liver: An in vitro model for assessing human drug metabolism and liver biology	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PORCINE LIVER; TISSUE; ORGAN; DECELLULARIZATION; TRANSPLANTATION; SCAFFOLD; MATRIX; DIFFERENTIATION; HEPATOCYTES	Liver-like organoids that recapitulate the complex functions of the whole liver by combining cells, scaffolds, and mechanical or chemical cues are becoming important models for studying liver biology and drug metabolism. The advantages of growing cells in three-dimensional constructs include enhanced cell-cell and cell-extracellular matrix interactions and preserved cellular phenotype including, prevention of de-differentiation. In the current study, biomimetic liver constructs were made via perfusion decellularization of rat liver, with the goal of maintaining the native composition and structure of the extracellular matrix. We optimized our decellularization process to produce liver scaffolds in which immunogenic residual DNA was removed but glycosaminoglycans were maintained. When the constructs were recellularized with rat or human liver cells, the cells remained viable, capable of proliferation, and functional for 28 days. Specifically, the cells continued to express cytochrome P450 genes and maintained their ability to metabolize a model drug, midazolam. Microarray analysis showed an upregulation of genes involved in liver regeneration and fibrosis. In conclusion, these liver constructs have the potential to be used as test beds for studying liver biology and drug metabolism.	[Robertson, Matthew J.] Texas Heart Inst, Sci Stem Cell, Houston, TX 77025 USA; [Soibam, Benjamin] Univ Houston Downtown, Dept Comp Sci & Engn Technol, Houston, TX USA; [Soibam, Benjamin] Baylor Univ, Med Ctr, Dept Comp Sci & Engn Technol, Dallas, TX USA; [O'Leary, Jacqueline G.] Baylor Univ, Med Ctr, Annette C & Harold C Simmons Transplant Inst, Dallas, TX USA; [Sampaio, Luiz C.; Taylor, Doris A.] Texas Heart Inst, Regenerat Med Res Labs, Houston, TX 77025 USA	Texas Heart Institute; University of Houston System; University of Houston; University of Houston Downtown; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Texas Heart Institute	Taylor, DA (corresponding author), Texas Heart Inst, Regenerat Med Res Labs, Houston, TX 77025 USA.	dtaylor@texasheart.org	kazemi, azar/C-2404-2018	kazemi, azar/0000-0002-1829-0590				Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033; Chang R, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045004; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; De Bartolo L, 2009, BIOMATERIALS, V30, P2531, DOI 10.1016/j.biomaterials.2009.01.011; De Kock J, 2011, ARCH TOXICOL, V85, P607, DOI 10.1007/s00204-011-0706-1; Fraczek J, 2013, ARCH TOXICOL, V87, P577, DOI 10.1007/s00204-012-0983-3; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058; Kajbafzadeh AM, 2013, TISSUE ENG PART C-ME, V19, P642, DOI [10.1089/ten.TEC.2012.0334, 10.1089/ten.tec.2012.0334]; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046; Mueller D, 2014, TOXICOL IN VITRO, V28, P104, DOI 10.1016/j.tiv.2013.06.024; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; Shackel NA, 2002, HEPATOLOGY, V36, P1313, DOI 10.1053/jhep.2002.36950; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698; Tamai M, 2011, J BIOSCI BIOENG, V112, P495, DOI 10.1016/j.jbiosc.2011.07.005; Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vasanthan KS, 2012, BIOTECHNOL ADV, V30, P742, DOI 10.1016/j.biotechadv.2012.01.004; WRIGHT MC, 1994, BIOCHEM BIOPH RES CO, V201, P973, DOI 10.1006/bbrc.1994.1797; Xia L, 2012, BIOMATERIALS, V33, P7925, DOI 10.1016/j.biomaterials.2012.06.078; Yagi Hiroshi, 2009, Critical Reviews in Biomedical Engineering, V37, P377, DOI 10.1615/CritRevBiomedEng.v37.i4-5.40; Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270	32	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191892	10.1371/journal.pone.0191892	http://dx.doi.org/10.1371/journal.pone.0191892			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377912	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700042
J	Steenkamp, PJ; van Heerden, H; van Schalkwyk, OL				Steenkamp, Pieter Johan; van Heerden, Henriette; van Schalkwyk, Ockert Louis			Ecological suitability modeling for anthrax in the Kruger National Park, South Africa	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; MAXIMUM-ENTROPY; NICHE; DISTRIBUTIONS	The spores of the soil-borne bacterium, Bacillus anthracis, which causes anthrax are highly resistant to adverse environmental conditions. Under ideal conditions, anthrax spores can survive for many years in the soil. Anthrax is known to be endemic in the northern part of Kruger National Park (KNP) in South Africa (SA), with occasional epidemics spreading southward. The aim of this study was to identify and map areas that are ecologically suitable for the harboring of B. anthracis spores within the KNP. Anthrax surveillance data and selected environmental variables were used as inputs to the maximum entropy (Maxent) species distribution modeling method. Anthrax positive carcasses from 1988-2011 in KNP (n = 597) and a total of 40 environmental variables were used to predict and evaluate their relative contribution to suitability for anthrax occurrence in KNP. The environmental variables that contributed the most to the occurrence of anthrax were soil type, normalized difference vegetation index (NDVI) and precipitation. Apart from the endemic Pafuri region, several other areas within KNP were classified as ecologically suitable. The outputs of this study could guide future surveillance efforts to focus on predicted suitable areas for anthrax, since the KNP currently uses passive surveillance to detect anthrax outbreaks.	[Steenkamp, Pieter Johan] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Onderstepoort, South Africa; [van Heerden, Henriette; van Schalkwyk, Ockert Louis] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Onderstepoort, South Africa; [van Schalkwyk, Ockert Louis] Off State Veterinarian, Skukuza, South Africa	University of Pretoria; University of Pretoria	van Heerden, H (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Onderstepoort, South Africa.	Henriette.vanheerden@up.ac.za		van heerden, henriette/0000-0002-3577-1273; /0000-0003-4365-4904				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Barro AS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004689; Batjes NH, 2009, SOIL USE MANAGE, V25, P124, DOI 10.1111/j.1475-2743.2009.00202.x; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bothma J.D.P., 2005, INTENSIVE WILDLIFE P; BRAACK LEO, 1986, ONDERSTEPOORT J VET, V53, P13; Chikerema SM, 2013, PREV VET MED, V111, P25, DOI 10.1016/j.prevetmed.2013.04.006; De Vos V., 1973, Kuedoe, V16, P11; De Vos V., 1990, SALISBURY MED B S, V678, P19; De Vos V., 1996, SALISBURY MED B, V87, P26; Dijkshoorn J, 2008, 200804 ISRIC; DRAGON DC, 1995, CAN VET J, V36, P295; Dudik M, 2004, P 17 ANN C LEARN THE; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EPISTIS, 2017, SR001022017 EPISTIS; Foundation PP, 2008, GREATER LIMPOPO T FR; Gertenbach W.P.D., 1984, Koedoe, V26, P9; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; Herkt M, 2007, MODELLING HABITAT SU; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Hughes DA, 2003, J HYDROL, V270, P167, DOI 10.1016/S0022-1694(02)00290-1; Joyner TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009596; Mullins JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072451; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Tarkesh M, 2012, ENVIRON ECOL STAT, V19, P437, DOI 10.1007/s10651-012-0194-3; Turner WC, 2016, SCI REPORTS, P6; Turner WC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1785; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; USGS, 2017, US GEOL SURV 2017; VAN NESS G. B., 1959, Journal of Soil and Water Conservation, V14, P70; van Ness GB, 1959, SOIL CONSERV, V2, P206; VAN NESS GLENN, 1956, JOUR AMER VET MED ASSOC, V128, P7; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Venter F. J., 1990, CLASSIFICATION LAND; Venter FJ, 2003, KRUGER EXPERIENCE EC, V83, P129; Vos V. de, 2004, Infectious diseases of livestock. Volume Three, P1788; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Young N., 2011, MAXENT MODEL V3 33 T	43	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191704	10.1371/journal.pone.0191704	http://dx.doi.org/10.1371/journal.pone.0191704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU0AV	29377918	Green Published, Green Submitted, gold			2022-12-26	WOS:000423514700028
J	Espitia, O; Chatelais, M; Steenman, M; Charrier, C; Maurel, B; Georges, S; Houlgatte, R; Verrecchia, F; Ory, B; Lamoureux, F; Heymann, D; Goueffic, Y; Quillard, T				Espitia, Olivier; Chatelais, Mathias; Steenman, Marja; Charrier, Celine; Maurel, Blandine; Georges, Steven; Houlgatte, Remi; Verrecchia, Franck; Ory, Benjamin; Lamoureux, Francois; Heymann, Dominique; Goueffic, Yann; Quillard, Thibaut			Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; IN-VITRO; EXTRACELLULAR-MATRIX; CAP RUPTURE; CORONARY; MICROCALCIFICATION; GROWTH; ATHEROGENESIS; HYPERTENSION; ASSOCIATION	Vascular calcification is a strong and independent predictive factor for cardiovascular complications and mortality. Our previous work identified important discrepancies in plaque composition and calcification types between carotid and femoral arteries. The objective of this study is to further characterize and understand the heterogeneity in vascular calcification among vascular beds, and to identify molecular mechanisms underlying this process. We established ECLAGEN biocollection that encompasses human atherosclerotic lesions and healthy arteries from different locations (abdominal, thoracic aorta, carotid, femoral, and infrapopliteal arteries) for histological, cell isolation, and transcriptomic analysis. Our results show that lesion composition differs between these locations. Femoral arteries are the most calcified arteries overall. They develop denser calcifications (sheet-like, nodule), and are highly susceptible to osteoid metaplasia. These discrepancies may derive from intrinsic differences between SMCs originating from these locations, as microarray analysis showed specific transcriptomic profiles between primary SMCs isolated from each arterial bed. These molecular differences translated into functional disparities. SMC from femoral arteries showed the highest propensity to mineralize due to an increase in basal TGF beta signaling. Our results suggest that biological heterogeneity of resident vascular cells between arterial beds, reflected by our transcriptomic analysis, is critical in understanding plaque biology and calcification, and may have strong implications in vascular therapeutic approaches.	[Espitia, Olivier; Chatelais, Mathias; Charrier, Celine; Maurel, Blandine; Georges, Steven; Verrecchia, Franck; Ory, Benjamin; Lamoureux, Francois; Goueffic, Yann; Quillard, Thibaut] INSERM, UMR 1238, Nantes, France; [Espitia, Olivier; Chatelais, Mathias; Charrier, Celine; Maurel, Blandine; Georges, Steven; Verrecchia, Franck; Ory, Benjamin; Lamoureux, Francois; Goueffic, Yann; Quillard, Thibaut] Univ Nantes, Nantes Atlantique Univ, Fac Med, Lab Sarcome Osseux & Remodelage Tissus Osseux Cal, Nantes, France; [Espitia, Olivier; Maurel, Blandine; Goueffic, Yann; Quillard, Thibaut] CHU Hotel Dieu, Nantes, France; [Steenman, Marja] Univ Nantes, Nantes Atlantique Univ, INSERM, Inst Thorax,Fac Med,UMR 1087, Nantes, France; [Houlgatte, Remi] INSERM, Fac Med, U954, Nancy, France; [Houlgatte, Remi] Univ Hosp Nancy, DRCI, Nancy, France; [Heymann, Dominique] Inst Cancerol Ouest, Site Rene Gauducheau,Blvd Prof Jacques Monod, St Herblain, France; [Heymann, Dominique] Univ Sheffield, INSERM, European Assoc Lab, Dept Oncol & Metab,Sarcoma Res Unit,Med Sch, Sheffield, S Yorkshire, England; [Heymann, Dominique] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Sheffield; Nantes Universite	Quillard, T (corresponding author), INSERM, UMR 1238, Nantes, France.; Quillard, T (corresponding author), Univ Nantes, Nantes Atlantique Univ, Fac Med, Lab Sarcome Osseux & Remodelage Tissus Osseux Cal, Nantes, France.; Quillard, T (corresponding author), CHU Hotel Dieu, Nantes, France.	thibaut.quillard@univ-nantes.fr	Verrecchia, Franck/G-5535-2018; Heymann, Dominique/AAC-6014-2019; Steenman, Marja/D-3618-2015; Houlgatte, Remi/P-3020-2017; Georges, Steven/AAZ-2717-2020; Quillard, Thibaut/K-8150-2015; Lamoureux, Francois/K-8021-2015; Espitia, Olivier/AAC-1056-2021; Steenman, Marja/S-8433-2019; ory, benjamin r/K-8231-2015	Verrecchia, Franck/0000-0003-4920-2554; Heymann, Dominique/0000-0001-7777-0669; Steenman, Marja/0000-0003-4547-4448; Georges, Steven/0000-0003-0804-0253; Quillard, Thibaut/0000-0002-8096-2597; Lamoureux, Francois/0000-0002-2738-0758; Espitia, Olivier/0000-0003-0821-9990; Steenman, Marja/0000-0003-4547-4448; Maurel, Blandine/0000-0001-8957-6951; ory, benjamin/0000-0002-2622-7356; CHARRIER, Celine/0000-0002-4487-5066	Programme Hospitalier de Recherche Clinique [PROG/11/58]; European Commission (FP7 People: Marie-Curie Actions) [627418]; Fondation de l'Avenir pour la Recherche Medicale Appliquee [ET4-720]; Centre Hospitalier Universitaire de Nantes; Agence Nationale de la Recherche [ANR-16-CE14-0012-01]	Programme Hospitalier de Recherche Clinique; European Commission (FP7 People: Marie-Curie Actions); Fondation de l'Avenir pour la Recherche Medicale Appliquee; Centre Hospitalier Universitaire de Nantes; Agence Nationale de la Recherche(French National Research Agency (ANR))	This study has been supported by the Programme Hospitalier de Recherche Clinique (PROG/11/58) to YG, the European Commission (FP7 People: Marie-Curie Actions, grant 627418, https://ec.europa.eu/research/mariecurieactions/) to TQ, the Fondation de l'Avenir pour la Recherche Medicale Appliquee (ET4-720, http://www.fondationdelavenir.org/) to TQ, the Centre Hospitalier Universitaire de Nantes to TQ, and the Agence Nationale de la Recherche (ANR-16-CE14-0012-01, www.agence-nationale-recherche.fr) to BO. Thibaut Quillard's salary has been provided by the Fondation Lefoulon Delalande (http://lefoulon-delalande.institut-de-france.fr/), the European commission (FP7 People: Marie-Curie Actions, grant 627418, https://ec.europa.eu/research/mariecurieactions/), and the Centre Hospitalier Universitaire de Nantes. Steven George's salary has been provided by the Agence Nationale de la Recherche (ANR-16-CE14-0012-01, www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; Beazley KE, 2015, ARTERIOSCL THROM VAS, V35, P573, DOI 10.1161/ATVBAHA.114.304393; Chen Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156686; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; Davaine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107642; Davaine JM, 2015, EUR J VASC ENDOVASC; Dayoub S, 2003, J ORAL PATHOL MED, V32, P232, DOI 10.1034/j.1600-0714.2003.00030.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974; Garimella R, 2004, BONE, V34, P961, DOI 10.1016/j.bone.2004.02.010; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Goueffic Y, 2013, REV MED INTERNE, V34, P61, DOI 10.1016/j.revmed.2012.10.364; Han KH, 2015, VASC MED, V20, P527, DOI 10.1177/1358863X15597076; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Heymann MF, 2012, CYTOKINE, V58, P300, DOI 10.1016/j.cyto.2012.02.004; Hutcheson JD, 2016, NAT MATER, V15, P335, DOI 10.1038/nmat4519; Joly L, 2016, J NUTR HEALTH AGING, V20, P347, DOI 10.1007/s12603-015-0574-0; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kelly-Arnold A, 2013, P NATL ACAD SCI USA, V110, P10741, DOI 10.1073/pnas.1308814110; Lee B, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90517; Lee K, 2014, BIOCHEM BIOPH RES CO, V451, P436, DOI 10.1016/j.bbrc.2014.08.007; Leroux-Berger M, 2011, J BONE MINER RES, V26, P1543, DOI 10.1002/jbmr.382; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Liu DM, 2014, CELL PHYSIOL BIOCHEM, V33, P129, DOI 10.1159/000356656; Majesky Mark W, 2003, Curr Atheroscler Rep, V5, P208, DOI 10.1007/s11883-003-0026-x; Maldonado N, 2013, J BIOMECH, V46, P396, DOI 10.1016/j.jbiomech.2012.10.040; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Pikilidou M, 2015, J VASC RES, V52, P32, DOI 10.1159/000381098; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Schmidt A, 2006, EUR J CLIN INVEST, V36, P473, DOI 10.1111/j.1365-2362.2006.01658.x; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Sulkava M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41483; Thomas IC, 2016, J AM SOC HYPERTENS, V10, P167, DOI 10.1016/j.jash.2015.12.003; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Yahagi K, 2016, NAT REV CARDIOL, V13, P79, DOI 10.1038/nrcardio.2015.164; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e	45	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191976	10.1371/journal.pone.0191976	http://dx.doi.org/10.1371/journal.pone.0191976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373585	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400033
J	Guo, MY; Wang, H; Chen, YH; Xia, MZ; Zhang, C; Xu, DX				Guo, Min-Yin; Wang, Hua; Chen, Yuan-Hua; Xia, Mi-Zhen; Zhang, Cheng; Xu, De-Xiang			N-acetylcysteine alleviates cadmium-induced placental endoplasmic reticulum stress and fetal growth restriction in mice	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; MOUSE STRAINS; PRETERM BIRTH; ASSOCIATION; INSUFFICIENCY; PREGNANCY; PREECLAMPSIA; GLUTATHIONE; POPULATION; TOXICITY	Cadmium (Cd) is a developmental toxicant that induces fetal growth restriction (FGR). Placental endoplasmic reticulum (ER) stress is associated with FGR. This study investigated the effects of N-acetylcysteine (NAC) on Cd-induced placental ER stress and FGR. Pregnant mice were intraperitoneally injected with CdCl2 daily from gestational day (GD) 13 to GD17. As expected, Cd reduced fetal weight and crown-rump length. Cd decreased the internal space of blood vessels in the placental labyrinth layer and inhibited placental cell proliferation. Several genes of growth factors, such as Vegf-a, placental growth factor, Igf1 and Igf1r, and several genes of nutrient transport pumps, such as Glut1, Fatp1 and Snat2, were down-regulated in placenta of Cd-treated mice. Moreover, Cd evoked placental ER stress. Of interest, NAC alleviated Cd-induced FGR. Additional experiment showed that NAC inhibited Cd-induced impairment of placental development and placental ER stress. Therefore, NAC may be exploited for prevention of Cd-induced placental insufficiency and FGR.	[Guo, Min-Yin; Wang, Hua; Chen, Yuan-Hua; Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China; [Chen, Yuan-Hua] Anhui Med Univ, Dept Histol & Embryol, Hefei, Anhui, Peoples R China; [Xia, Mi-Zhen] Anhui Med Univ, Life Sci Coll, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, H; Xu, DX (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China.	wanghuadev@126.com; xudex@126.com			National Natural Science Foundation of China [81473016, 81471467, 81630084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China (81473016, 81471467, 81630084).	AHOKAS RA, 1980, AM J OBSTET GYNECOL, V136, P216, DOI 10.1016/0002-9378(80)90599-2; Balansky R, 2006, P NATL ACAD SCI USA, V103, P7823, DOI 10.1073/pnas.0601412103; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Chen S, 2014, NEUROPATH APPL NEURO, V40, P759, DOI 10.1111/nan.12103; Chen YH, 2016, J IMMUNOL, V197, P4762, DOI 10.4049/jimmunol.1601331; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Deng XP, 2010, J HAZARD MATER, V180, P722, DOI 10.1016/j.jhazmat.2010.04.099; Dimasuay KG, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00012; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hong J, 2016, ENVIRON POLLUT, V212, P9, DOI 10.1016/j.envpol.2016.01.001; Hovland DN, 1999, TERATOLOGY, V60, P13, DOI 10.1002/(SICI)1096-9926(199907)60:1<13::AID-TERA6>3.0.CO;2-B; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Ji YL, 2013, ASIAN J ANDROL, V15, P290, DOI 10.1038/aja.2012.129; Ji YL, 2011, TOXICOL SCI, V124, P446, DOI 10.1093/toxsci/kfr232; Ji YL, 2011, TOXICOL LETT, V205, P69, DOI 10.1016/j.toxlet.2011.05.233; Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008; Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005; Luo B, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.78; Mizuuchi M, 2016, J PATHOL, V238, P550, DOI 10.1002/path.4678; Paniagua-Castro N, 2007, REPROD TOXICOL, V23, P92, DOI 10.1016/j.reprotox.2006.08.011; Robinson JF, 2009, TOXICOL SCI, V107, P206, DOI 10.1093/toxsci/kfn221; Rushworth GF, 2014, PHARMACOL THERAPEUT, V141, P150, DOI 10.1016/j.pharmthera.2013.09.006; Selvaratnam J, 2013, AM J PHYSIOL-ENDOC M, V305, pE727, DOI 10.1152/ajpendo.00157.2013; Shaikh ZA, 1999, TOXICOL LETT, V104, P137, DOI 10.1016/S0378-4274(98)00358-0; Walker CK, 2015, JAMA PEDIATR, V169, P154, DOI 10.1001/jamapediatrics.2014.2645; Wang H, 2016, ENVIRON POLLUT, V216, P851, DOI 10.1016/j.envpol.2016.06.058; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22631; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SH, 2009, TOXICOL SCI, V108, P124, DOI 10.1093/toxsci/kfn266; Wang Z, 2012, TOXICOL APPL PHARM, V259, P236, DOI 10.1016/j.taap.2012.01.001; Wei X, 2015, NEUROTOXICOLOGY, V46, P19, DOI 10.1016/j.neuro.2014.11.007; Williams CJ, 2017, J PATHOL, V242, P246, DOI 10.1002/path.4893; Yang J, 2016, ENVIRON INT, V94, P300, DOI 10.1016/j.envint.2016.06.003; Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zhang GB, 2016, TOXICOL APPL PHARM, V306, P79, DOI 10.1016/j.taap.2016.07.007; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360	37	34	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2018	13	1							e0191667	10.1371/journal.pone.0191667	http://dx.doi.org/10.1371/journal.pone.0191667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8TF	29373603	Green Published, Green Submitted, gold			2022-12-26	WOS:000423425400019
J	Benede, S; Berin, MC				Benede, Sara; Berin, M. Cecilia			Mast cell heterogeneity underlies different manifestations of food allergy in mice	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; INDUCED ANAPHYLAXIS; CONNECTIVE-TISSUE; INDUCED DIARRHEA; BARRIER FUNCTION; IGE; SUSCEPTIBILITY; SENSITIZATION; PROTEINS; PATHOGENESIS	Food can trigger a diverse array of symptoms in food allergic individuals from isolated local symptoms affecting skin or gut to multi-system severe reactions (systemic anaphylaxis). Although we know that gastrointestinal and systemic manifestations of food allergy are mediated by tissue mast cells (MCs), it is not clear why allergen exposure by the oral route can result in such distinct clinical manifestations. Our aim was to assess the contribution of mast cell subsets to different manifestations of food allergy. We used two common models of IgE-mediated food allergy, one resulting in systemic anaphylaxis and the other resulting in acute gastrointestinal symptoms, to study the immune basis of allergic reactions. We used responders and non-responders in each model system, as well as naive controls to identify the association of mast cell activation with clinical reactivity rather than sensitization. Systemic anaphylaxis was uniquely associated with activation of connective tissue mast cells (identified by release of mouse mast cell protease (MMCP) -7 into the serum) and release of histamine, while activation of mucosal mast cells (identified by release of MMCP-1 in the serum) did not correlate with symptoms. Gastrointestinal manifestations of food allergy were associated with an increase of MMCP-1-expressing mast cells in the intestine, and evidence of both mucosal and connective tissue mast cell activation. The data presented in this paper demonstrates that mast cell heterogeneity is an important contributor to manifestations of food allergy, and identifies the connective tissue mast cell subset as key in the development of severe systemic anaphylaxis.	[Benede, Sara; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA.	cecilia.berin@mssm.edu	Benedé, Sara/H-6147-2013	Benedé, Sara/0000-0002-9288-9438; berin, cecilia/0000-0002-9051-9249	NIH [R01AI093577]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by NIH grant R01AI093577. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Arias K, 2009, J ALLERGY CLIN IMMUN, V124, P307, DOI 10.1016/j.jaci.2009.03.012; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Berin MC, 2006, ALLERGY, V61, P64, DOI 10.1111/j.1398-9995.2006.01012.x; Boos AC, 2014, ALLERGY, V69, P943, DOI 10.1111/all.12416; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Cildir G, 2017, J EXP MED, V214, P2491, DOI 10.1084/jem.20170910; Ekoff M, 2007, J IMMUNOL, V178, P4177, DOI 10.4049/jimmunol.178.7.4177; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Friend DS, 1998, J IMMUNOL, V160, P5537; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Han HW, 2014, J CLIN INVEST, V124, P5442, DOI 10.1172/JCI77798; HEAVEY DJ, 1988, J IMMUNOL, V140, P1953; Hogan SP, 2012, SEMIN IMMUNOPATHOL, V34, P643, DOI 10.1007/s00281-012-0320-1; Khodoun MV, 2011, P NATL ACAD SCI USA, V108, P12413, DOI 10.1073/pnas.1105695108; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Martos G, 2011, J ALLERGY CLIN IMMUN, V127, P990, DOI 10.1016/j.jaci.2011.01.057; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Sampson HA, 2006, ANN EMERG MED, V47, P373, DOI 10.1016/j.annemergmed.2006.01.018; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Smit J, 2016, TOXICOL LETT, V262, P62, DOI 10.1016/j.toxlet.2016.09.005; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	41	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2018	13	1							e0190453	10.1371/journal.pone.0190453	http://dx.doi.org/10.1371/journal.pone.0190453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8QE	29370173	Green Submitted, gold, Green Published			2022-12-26	WOS:000423416600011
J	Espinoza-Varas, B; Hilton, J; Guo, SX				Espinoza-Varas, Blas; Hilton, Jeremiah; Guo, Shaoxuan			Object-based attention modulates the discrimination of level increments in stop-consonant noise bursts	PLOS ONE			English	Article							INTENSITY DISCRIMINATION; BACKWARD-MASKING; AMPLITUDE; SPEECH; TIME; INTELLIGIBILITY; ARTICULATION; PERCEPTION; ASPIRATION; PLACE	This study tested the hypothesis that object-based attention modulates the discrimination of level increments in stop-consonant noise bursts. With consonant-vowel-consonant (CvC) words consisting of an approximate to 80-dB vowel (v), a pre-vocalic (Cv) and a post-vocalic (vC) stop-consonant noise burst (approximate to 60-dB SPL), we measured discrimination thresholds (LDTs) for level increments (Delta L) in the noise bursts presented either in CvC context or in isolation. In the 2-interval 2-alternative forced-choice task, each observation interval presented a CvC word (e.g., /paek//paek/), and normal-hearing participants had to discern Delta L in the Cv or vC burst. Based on the linguistic word labels, the auditory events of each trial were perceived as two auditory objects (Cv-v-vC and Cv-v-vC) that group together the bursts and vowels, hindering selective attention to Delta L. To discern Delta L in Cv or vC, the events must be reorganized into three auditory objects: the to-be-attended pre-vocalic (Cv-Cv) or post-vocalic burst pair (vC-vC), and the to-be-ignored vowel pair (v-v). Our results suggest that instead of being automatic this reorganization requires training, in spite of using familiar CvC words. Relative to bursts in isolation, bursts in context always produced inferior Delta L discrimination accuracy (a context effect), which depended strongly on the acoustic separation between the bursts and the vowel, being much keener for the object apart from (post-vocalic) than for the object adjoining (pre-vocalic) the vowel (a temporal-position effect). Variability in CvC dimensions that did not alter the noise-burst perceptual grouping had minor effects on discrimination accuracy. In addition to being robust and persistent, these effects are relatively general, evincing in forced-choice tasks with one or two observation intervals, with or without variability in the temporal position of Delta L, and with either fixed or roving CvC standards. The results lend support to the hypothesis.	[Espinoza-Varas, Blas; Hilton, Jeremiah] Univ Oklahoma, Hlth Sci Ctr, Dept Commun Sci & Disorders, Oklahoma City, OK 73106 USA; [Hilton, Jeremiah] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Guo, Shaoxuan] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Espinoza-Varas, B (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Commun Sci & Disorders, Oklahoma City, OK 73106 USA.	blas-espinoza-varas@ouhsc.edu			Oklahoma Center for the Advancement of Science Technology [HSO-005, OCAST HSO-005]; Presbyterian Health Foundation [PHF-142]	Oklahoma Center for the Advancement of Science Technology; Presbyterian Health Foundation	This work was supported by Oklahoma Center for the Advancement of Science & Technology (HSO-005) (https://www.ok.gov/ocast/). This was the main funding source (including data collection, personnel salaries, equipment, travel, supplies). Presbyterian Health Foundation (PHF-142), http://www.phfokc.com/, funded Research Assistant Stipends.; Portions of this work were presented at the 171st meeting of the Acoustical Society of America, Salt Lake City, USA, and at the 2017 meeting of the American Auditory Society, Scottsdale, Arizona, USA. The research was supported by grants from the Oklahoma Center for the Advancement of Science and Technology (OCAST HSO-005) and the Presbyterian Health Foundation (PHF-142).	Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Billig AJ, 2013, CURR BIOL, V23, P1585, DOI 10.1016/j.cub.2013.06.042; Bregman A.S., 1990, AUDITORY SCENE ANAL; BUUS S, 1990, J ACOUST SOC AM, V87, P2643, DOI 10.1121/1.399057; BUUS S, 1991, J ACOUST SOC AM, V90, P1371, DOI 10.1121/1.401928; Espinoza-Varas B., 1992, AUDITORY PROCESSING, P253; FORREST TG, 1987, J ACOUST SOC AM, V82, P1933, DOI 10.1121/1.395689; GERKEN GM, 1990, J ACOUST SOC AM, V88, P767, DOI 10.1121/1.399726; Goossens T, 2009, J ACOUST SOC AM, V125, P3882, DOI 10.1121/1.3119626; Green DM, 1966, SIGNAL DETECTION THE; Hedrick MS, 2000, J SPEECH LANG HEAR R, V43, P1174, DOI 10.1044/jslhr.4305.1174; Hickson L, 1999, J Am Acad Audiol, V10, P549; Hickson L, 1997, J Am Acad Audiol, V8, P322; Jenstad LM, 2005, J SPEECH LANG HEAR R, V48, P651, DOI 10.1044/1092-4388(2005/045); Kahneman D., 1981, PERCEPTUAL ORG, P181; KLATT DH, 1975, J SPEECH HEAR RES, V18, P686, DOI 10.1044/jshr.1804.686; Lewis DE, 2007, PERCEPT PSYCHOPHYS, V69, P1140, DOI 10.3758/BF03193951; Mackersie CL, 2007, J SPEECH LANG HEAR R, V50, P554, DOI 10.1044/1092-4388(2007/038); Oberfeld D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099745; OHDE RN, 1983, J ACOUST SOC AM, V74, P706, DOI 10.1121/1.389856; Orr SB, 2010, J ACOUST SOC AM, V128, P3105, DOI 10.1121/1.3493426; PENNER MJ, 1974, J ACOUST SOC AM, V56, P179, DOI 10.1121/1.1903250; PICKETT JM, 1959, J ACOUST SOC AM, V31, P127, DOI 10.1121/1.1930194; Plack CJ, 1996, J ACOUST SOC AM, V100, P1031, DOI 10.1121/1.416289; Plack CJ, 1996, J ACOUST SOC AM, V100, P1024, DOI 10.1121/1.416288; REPP BH, 1985, J EXP PSYCHOL HUMAN, V11, P799; REPP BH, 1979, LANG SPEECH, V22, P173, DOI 10.1177/002383097902200207; RESNICK SB, 1979, J ACOUST SOC AM, V66, P674, DOI 10.1121/1.383273; Roverud E, 2015, J ACOUST SOC AM, V137, P1318, DOI 10.1121/1.4908243; Sabin AT, 2013, J ACOUST SOC AM, V134, P2136, DOI 10.1121/1.4816410; Swets JA, 1964, SIGNAL DETECTION REC; Whitmer WM, 2011, EAR HEARING, V32, P391, DOI 10.1097/AUD.0b013e318202b620; WOOD CC, 1975, PERCEPT PSYCHOPHYS, V17, P346, DOI 10.3758/BF03199344; ZENG FG, 1991, HEARING RES, V55, P223, DOI 10.1016/0378-5955(91)90107-K	35	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190956	10.1371/journal.pone.0190956	http://dx.doi.org/10.1371/journal.pone.0190956			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364931	Green Submitted, gold, Green Published			2022-12-26	WOS:000423412500028
J	Graham, AD; Lundgrin, EL; Lin, MC				Graham, Andrew D.; Lundgrin, Erika L.; Lin, Meng C.			The Berkeley Dry Eye Flow Chart: A fast, functional screening instrument for contact lens-induced dryness	PLOS ONE			English	Article							SURFACE-DISEASE-INDEX; TEAR FILM STABILITY; HYDROGEL LENS; PREDICTING SUCCESS; VISUAL ANALOG; IN-VIVO; SYMPTOMS; WEARERS; QUESTIONNAIRES; PERFORMANCE	Purpose In this article, we introduce a novel flow chart-based screening tool for the categorization of contact lens-induced dryness (CLIDE) and its impact on daily visual activities: the Berkeley Dry Eye Flow Chart (DEFC). Methods One hundred thirty (130) experienced soft contact lens wearers discontinued lens wear for 24 hrs, passed a baseline screening and eye health examination, completed the Ocular Surface Disease Index (OSDI) then were dispensed fresh pairs of their habitual lenses. After 6 hrs of wear, subjects were administered a battery of symptom questionnaires, and underwent non +/- invasive tear breakup time (NITBUT) measurement, grading of distortion in reflected topographer mires, grading of lens surface wettability, and a fluorescein examination of the ocular surface. Subjects returned after at least 48 hrs and repeated all assessments after 6 hrs of wear of a second fresh pair of habitual lenses. Results The repeatability of the DEFC between visits was within 1%, and Limits of Agreement and Coefficient of Repeatability were comparable to those of the other CLIDE assessments. Higher DEFC score was significantly related to shorter pre-lens NITBUT, higher OSDI score, and higher Visual Analog Scale (VAS) ratings of average and end-of-day severity and frequency of dryness (all p < 0.001). For CLIDE as diagnosed based on DEFC score, the highest sensitivities and specificities were achieved by the OSDI and VAS ratings; pre-lens NITBUT exhibited good sensitivity but poor specificity. The optimum pre-lens NITBUT diagnostic threshold was found to be <= 2.0 sec for debilitating CLIDE, and the OSDI threshold was >= 11.4. Conclusions The DEFC provides a means of quickly categorizing CLIDE patients based on severity and frequency of symptoms, and on the degree to which symptoms impact daily life. The DEFC has several potential advantages as a CLIDE screening and monitoring tool, has good repeatability, and is significantly related to commonly employed clinical assessments for CLIDE.	[Graham, Andrew D.; Lundgrin, Erika L.; Lin, Meng C.] Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lin, MC (corresponding author), Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA.	mlin@berkeley.edu			Morton D. Sarver Research Fund; Roberta Smith Research Fund; Clinical Research Center Unrestricted Fund	Morton D. Sarver Research Fund; Roberta Smith Research Fund; Clinical Research Center Unrestricted Fund	This work was supported by the Morton D. Sarver Research Fund, Roberta Smith Research Fund and Clinical Research Center Unrestricted Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-111; Albach Karin A., 1994, Ophthalmologe, V91, P229; Alves M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097921; Amparo F, 2015, OPHTHALMOLOGY, V122, P1498, DOI 10.1016/j.ophtha.2015.02.037; BandeenRoche R, 1997, INVEST OPHTH VIS SCI, V38, P2469; Begley CG, 2000, OPTOMETRY VISION SCI, V77, P40, DOI 10.1097/00006324-200001000-00012; Begley CG, 2001, CORNEA, V20, P610, DOI 10.1097/00003226-200108000-00011; Best N., 2013, THESIS; Best N, 2013, CONTACT LENS ANTERIO, V36, P232, DOI 10.1016/j.clae.2013.02.013; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruce AS, 1995, CLIN EXP OPTOM, V78, P168; Chalmers R, 2008, OPTOMETRY VISION SCI, V85, P778, DOI 10.1097/OPX.0b013e318181a90d; Chalmers RL, 2012, OPTOMETRY VISION SCI, V89, P1435, DOI 10.1097/OPX.0b013e318269c90d; Chen JT, 2011, INVEST OPHTH VIS SCI, V52, P1200, DOI 10.1167/iovs.10-5349; Chui WS, 2000, OPHTHAL PHYSL OPT, V20, P480, DOI 10.1111/j.1475-1313.2000.tb01126.x; Djalilian AR, 2010, EYE CONTACT LENS, V36, P144, DOI 10.1097/ICL.0b013e3181d94e96; Dougherty BE, 2011, INVEST OPHTH VIS SCI, V52, P8630, DOI 10.1167/iovs.11-8027; Elliott M, 1998, Cont Lens Anterior Eye, V21, P98, DOI 10.1016/S1367-0484(98)80002-7; Emir B, 2000, STAT MED, V19, P511, DOI 10.1002/(SICI)1097-0258(20000229)19:4<511::AID-SIM353>3.0.CO;2-3; FABER E, 1991, OPTOMETRY VISION SCI, V68, P380, DOI 10.1097/00006324-199105000-00010; Farris R L, 1983, CLAO J, V9, P23; Fonn D, 1999, OPTOMETRY VISION SCI, V76, P700, DOI 10.1097/00006324-199910000-00021; GOLDING TR, 1990, OPTOMETRY VISION SCI, V67, P461, DOI 10.1097/00006324-199006000-00011; Gulati A, 2006, AM J OPHTHALMOL, V142, P125, DOI 10.1016/j.ajo.2006.02.038; Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240; Jalbert I, 2015, CURR OPHTHALMOL REP, V3, P106, DOI DOI 10.1007/S40135-015-0070-Z; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Khanal S, 2008, OPTOMETRY VISION SCI, V85, P732, DOI 10.1097/OPX.0b013e318181ae1c; Khanal S, 2008, INVEST OPHTH VIS SCI, V49, P1407, DOI 10.1167/iovs.07-0635; Lau JKK, 2016, CONTACT LENS ANTERIO, V39, P461, DOI 10.1016/j.clae.2016.07.001; Lemp MA, 2007, OCUL SURF, V5, P75; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; McMonnies C W, 1987, J Am Optom Assoc, V58, P296; McMonnies C W, 1986, J Am Optom Assoc, V57, P512; MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P441; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michel M, 2009, OPHTHAL PHYSL OPT, V29, P479, DOI 10.1111/j.1475-1313.2009.00658.x; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Ngo W, 2013, CORNEA, V32, P1204, DOI 10.1097/ICO.0b013e318294b0c0; Nichols JJ, 2013, INVEST OPHTH VIS SCI, V54, P7, DOI 10.1167/iovs.13-13212; Nichols JJ, 2005, INVEST OPHTH VIS SCI, V46, P1911, DOI 10.1167/iovs.04-1294; Nichols JJ, 2002, CORNEA, V21, P469, DOI 10.1097/00003226-200207000-00007; Nichols JJ, 2003, INVEST OPHTH VIS SCI, V44, P68, DOI 10.1167/iovs.02-0377; Tran N, 2013, CONTACT LENS ANTERIO, V36, P281, DOI 10.1016/j.clae.2013.06.001; Oden NL, 1998, ADV EXP MED BIOL, V438, P807; Pak A. W. P., 2005, PREVENTING CHRONIC D, V2, P1; Papas EB, 1997, OPHTHAL PHYSL OPT, V17, P492, DOI 10.1111/j.1475-1313.1997.tb00088.x; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Simpson TL, 2008, OPTOMETRY VISION SCI, V85, P692, DOI 10.1097/OPX.0b013e318181ae36; Sindt CW, 2007, OCUL SURF, V5, P294, DOI 10.1016/S1542-0124(12)70095-2; Sweeney DF, 2013, EXP EYE RES, V117, P28, DOI 10.1016/j.exer.2013.08.010; Tan LL, 2016, J CLIN EXP OPHTHALMO, V7, P587; Tang FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153047; TERRY RL, 1993, OPTOMETRY VISION SCI, V70, P234, DOI 10.1097/00006324-199303000-00011; Truong TN, 2014, OPTOMETRY VISION SCI, V91, P133, DOI 10.1097/OPX.0000000000000138; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Versura P, 2007, EYE, V21, P229, DOI 10.1038/sj.eye.6702204; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; Willen CM, 2008, EYE CONTACT LENS, V34, P43, DOI 10.1097/ICL.0b013e3180676d44; Yeh TN, 2015, OPTOMETRY VISION SCI, V92, pE264, DOI 10.1097/OPX.0000000000000649; Yeniad B, 2010, EYE CONTACT LENS, V36, P140, DOI 10.1097/ICL.0b013e3181d94e82; Yeo S, 2014, J CLIN RES OPHTHALMO, V1; YOUNG G, 1991, OPHTHAL PHYSL OPT, V11, P53, DOI 10.1111/j.1475-1313.1991.tb00195.x; Young G, 2012, OPTOMETRY VISION SCI, V89, P1125, DOI 10.1097/OPX.0b013e3182640af8; Young G, 2011, CONTACT LENS ANTERIO, V34, P64, DOI 10.1016/j.clae.2010.08.005; Zhang XB, 2011, OPHTHALMOLOGY, V118, P902, DOI 10.1016/j.ophtha.2010.08.033	67	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190752	10.1371/journal.pone.0190752	http://dx.doi.org/10.1371/journal.pone.0190752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364947	Green Published, Green Submitted, gold			2022-12-26	WOS:000423412500022
J	Belqaid, K; Tishelman, C; Orrevall, Y; Mansson-Brahme, E; Bernhardson, BM				Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Mansson-Brahme, Eva; Bernhardson, Britt-Marie			Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer	PLOS ONE			English	Article							SELF-REPORTED TASTE; PATIENTS RECEIVING CHEMOTHERAPY; NECK-CANCER; OF-LIFE; IMPACT; COMPLEMENTARY; DYSFUNCTION; DYSGEUSIA; MEDICINE; HEAD	Taste and smell alterations have been recognized as common symptoms in relation to various cancers. However, previous research suggests that patients do not receive sufficient support in managing taste and smell alterations. Therefore, the objective of this study is to investigate how persons with experience from lung cancer-related taste and smell alterations reason about resources and strategies offered and used to manage these symptoms. Data from semi-structured individual interviews with 13 women and four men were analyzed with qualitative content analysis. We used Kleinman's now classic medical anthropological model of local health care systems, consisting of the personal, professional, and folk sector, to interpret and understand how people respond to sickness experiences in their daily lives. By presenting the findings using this model, we demonstrate that most strategies for dealing with taste and smell alterations were undertaken in the personal sector, i.e. in participants' daily lives, on an individual level and in interaction with family, social networks and communities. Taste and smell alterations implied two overarching challenges: 1) adjusting to no longer being able to trust information provided by one's own senses of taste and/or smell, and 2) coming to terms with taste and smell alterations as a part of having lung cancer. Health care professionals' involvement was described as limited, but appeared to fulfil most participants' expectations. However, through provision of normalizing information, practical advice, and to some extent, emotional support, health care professionals had potential to influence strategies and resources used for dealing with taste and smell alterations. With this study, we further the understanding of how people deal with lung cancer-related taste and smell alterations and discuss the role of health care professionals for this process.	[Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Bernhardson, Britt-Marie] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Belqaid, Kerstin; Orrevall, Ylva] Karolinska Univ Hosp, Funct Area Clin Nutr, Stockholm, Sweden; [Tishelman, Carol; Bernhardson, Britt-Marie] Karolinska Univ Hosp, Ctr Innovat, Stockholm, Sweden; [Mansson-Brahme, Eva] Karolinska Univ Hosp, Canc Theme, Stockholm, Sweden; [Mansson-Brahme, Eva] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Bernhardson, Britt-Marie] Karolinska Inst, Dept Learning Informat Management & Eth, Div Innovat Care, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Belqaid, K (corresponding author), Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden.; Belqaid, K (corresponding author), Karolinska Univ Hosp, Funct Area Clin Nutr, Stockholm, Sweden.; Belqaid, K (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Div Innovat Care, Stockholm, Sweden.	kerstin.belqaid@ki.se	Tishelman, Carol/AAB-8936-2020	Tishelman, Carol/0000-0003-4161-0342; Orrevall, Ylva/0000-0001-7393-7257; Bernhardson, Britt-Marie/0000-0001-6907-3134	Health Care Science Postgraduate School, Karolinska Institutet [2286/2009-532]; Strategic Research Program in Health Care Sciences [1976/2010]; CancerRehabFonden [F-C-001211]; Swedish Research Council [2009-33868-68207-63]	Health Care Science Postgraduate School, Karolinska Institutet; Strategic Research Program in Health Care Sciences; CancerRehabFonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Economic support was provided by the Swedish Research Council 2009-33868-68207-63 (https://www.vr.se/), the Strategic Research Program in Health Care Sciences 1976/2010 (http://ki.se/en/research/strategic-research-area-health-care-science-sfo-v), CancerRehabFonden F-C-001211 (https://www.cancerrehabfonden.se/) and the Health Care Science Postgraduate School, Karolinska Institutet 2286/2009-532 (http://ki.se/en/nvs/doctoral-school-in-health-care-sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Camacho M, 2016, QUAL LIFE RES, V25, P1495, DOI 10.1007/s11136-015-1185-2; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Belqaid K, 2016, EUR J ONCOL NURS, V21, P232, DOI 10.1016/j.ejon.2015.10.009; Belqaid K, 2014, ACTA ONCOL, V53, P1405, DOI 10.3109/0284186X.2014.895035; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardson BM, 2009, CANCER NURS, V32, P45, DOI 10.1097/01.NCC.0000343368.06247.74; Boltong A, 2015, CHEM PERCEPT, P1; Boltong A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103512; Boltong A, 2011, CANCER FORUM, V35, P81; Boltong A, 2012, SUPPORT CARE CANCER, V20, P2765, DOI 10.1007/s00520-012-1398-7; Brisbois TD, 2011, J PAIN SYMPTOM MANAG, V41, P673, DOI 10.1016/j.jpainsymman.2010.06.022; Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; de Vries YC, 2016, SUPPORT CARE CANCER, V24, P3119, DOI 10.1007/s00520-016-3128-z; Epstein JB, 2016, SUPPORT CARE CANCER, V24, P1917, DOI 10.1007/s00520-016-3083-8; Epstein JB, 2010, ORAL ONCOL, V46, P77, DOI 10.1016/j.oraloncology.2009.11.008; Gamper EM, 2012, J PAIN SYMPTOM MANAG, V44, P880, DOI 10.1016/j.jpainsymman.2011.11.011; Hok J, 2009, THESIS; Hopkinson JB, 2007, J ADV NURS, V59, P454, DOI 10.1111/j.1365-2648.2007.04283.x; Hovan AJ, 2010, SUPPORT CARE CANCER, V18, P1081, DOI 10.1007/s00520-010-0902-1; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Kleinman A., 1980, PATIENTS HEALERS CON; Koizumi T, 2015, LUNG CANCER, V88, P112, DOI 10.1016/j.lungcan.2015.01.018; Kubrak C, 2013, HEAD NECK-J SCI SPEC, V35, P695, DOI 10.1002/hed.23023; Lancely A, 2001, CANC NURSING CARE CO, P100; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lovgren M, 2011, EUR J ONCOL NURS, V15, P311, DOI 10.1016/j.ejon.2010.10.004; McGreevy J, 2014, SUPPORT CARE CANCER, V22, P2635, DOI 10.1007/s00520-014-2215-2; National Center for Complementary and Integrative Health, 2016, COMPL ALT INT HLTH W; Regional Cancer Center Uppsala Orebro, 2015, CLIN CAR PROGR LUNG; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Sanchez-Lara K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-15; Sirois FM, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-16; Speck RM, 2013, SUPPORT CARE CANCER, V21, P549, DOI 10.1007/s00520-012-1551-3; Spotten L, 2016, SUPPORT CARE CANCER, V24, P3201, DOI 10.1007/s00520-016-3133-2; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Thorne T, 2015, SUPPORT CARE CANCER, V23, P2843, DOI 10.1007/s00520-015-2827-1; Tishelman C, 1993, THESIS; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191117	10.1371/journal.pone.0191117	http://dx.doi.org/10.1371/journal.pone.0191117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360871	Green Submitted, gold, Green Published			2022-12-26	WOS:000423161800017
J	Sala, A				Sala, Antonello			Influence of tow duration on catch performance of trawl survey in the Mediterranean Sea	PLOS ONE			English	Article							FISHERY; SIZE; SELECTIVITY; CODENDS; PLAICE; MESH; COD	The aim of this study was to assess the effect of tow duration on catch per unit of swept area (CPUE), trawl catch performance, and the proportion of the species caught in a trawl survey. Longer tows are expected to have a greater probability of catching species. An average of 26 species were caught in the first 30 minutes, whereas only about one additional species was caught in the next 30 minutes in longer tows. The shorter tows involved a decrement in catch weight for 11 of the 12 target species sampled, demonstrating that tow duration did affect catch per unit of swept area CPUE. The shorter tows were associated with a significant reduction of the overall CPUE in terms of weight of the main target species and of the total catch (circa 60%). The same strong reduction of around 70% was found in particular for European hake (Merluccius merluccius) and surmullet (Mullus spp) and 50% for Nephrops (Nephrops norvegicus). The shorter tows were less efficient in catching large-sized hake, surmullet, Nephrops, Atlantic horse mackerel (Trachurus trachurus), and poor cod (Trisopterus minutus), even though the difference was significant only for Nephrops. Regardless of the p-value statistic, these findings suggest that the continuity of survey time series would be severely impaired by changing tow duration. Further work is required to explore a way to reduce tow duration without reducing CPUE.	[Sala, Antonello] CNR, Italian Natl Res Council, Inst Marine Sci ISMAR, Ancona, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Sala, A (corresponding author), CNR, Italian Natl Res Council, Inst Marine Sci ISMAR, Ancona, Italy.	a.sala@ismar.cnr.it	Sala, Antonello/B-8517-2016	Sala, Antonello/0000-0001-7066-1152				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertrand J., 1997, ICES ANN SCI C, P1; Brcic J, 2014, SCI MAR, V78, P135, DOI 10.3989/scimar.03819.24A; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cotter AJR, 1997, 1997Y24 ICES CM, V24, P1; Dremiere PY, 1999, AQUAT LIVING RESOUR, V12, P207, DOI 10.1016/S0990-7440(00)88471-5; Efron B, 1982, JACKKNIFE BOOTSTRAP; Eigaard OR, 2012, AQUAT LIVING RESOUR, V25, P15, DOI 10.1051/alr/2011152; Ferno A, 1994, MARINE FISH BEHAV CA; Finney DJ, 1971, STAT METHOD BIOL ASS; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; Frandsen RP, 2011, FISH RES, V111, P116, DOI 10.1016/j.fishres.2011.07.003; Goddard PD, 1997, THESIS; GODO OR, 1990, FISH RES, V9, P165, DOI 10.1016/0165-7836(90)90062-Z; HE P, 1988, J FISH BIOL, V33, P255, DOI 10.1111/j.1095-8649.1988.tb05468.x; He P., 2010, BEHAV MARINE FISHES; Herrmann B, 2013, ICES J MAR SCI, V70, P850, DOI 10.1093/icesjms/fst032; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088819; MCCONNAUGHEY RA, 1993, FISH B-NOAA, V91, P107; Notti E, 2016, MAR COAST FISH, V8, P81, DOI 10.1080/19425120.2015.1095827; PENNINGTON M, 1994, BIOMETRICS, V50, P725, DOI 10.2307/2532786; Sala A, 2016, CANADIAN J FISHERIES; Sala A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160354; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Somerton DA, 2002, FISH RES, V55, P63, DOI 10.1016/S0165-7836(01)00293-4; Tokac A, 2014, FISH RES, V150, P76, DOI 10.1016/j.fishres.2013.10.015; Walsh SJ, 1991, 84 SCR NW ATL FISH O; Wardle CS., 1993, BEHAV TELEOST FISHES, P463, DOI DOI 10.1007/978-1-4684-8261-4_18; Wienbeck H, 2014, FISH RES, V150, P28, DOI 10.1016/j.fishres.2013.10.007; Wileman D.A., 1996, ICES COOP RES REP, V132, P126	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191662	10.1371/journal.pone.0191662	http://dx.doi.org/10.1371/journal.pone.0191662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357381	Green Submitted, Green Published, gold			2022-12-26	WOS:000422919500018
J	Geroldinger, A; Sauter, SK; Heinze, G; Endel, G; Dorda, W; Duftschmid, G				Geroldinger, Angelika; Sauter, Simone Katja; Heinze, Georg; Endel, Gottfried; Dorda, Wolfgang; Duftschmid, Georg			Mortality and continuity of care - Definitions matter! A cohort study in diabetics	PLOS ONE			English	Article							SYSTEM; HOSPITALIZATION; COSTS	Objective To demonstrate that when investigating the relevance of continuity of care for patient outcomes, different definitions can lead to contradicting results. Methods We used claims data from the regional public health insurer of Lower Austria covering the period from 2008 to 2011. The study sample included subjects with repeated dispensings of anti-diabetic drugs. The continuity of care index was calculated firstly based on a patient's contacts with general practitioners (primary COCl) and secondly based on contacts at all medical disciplines (total COCl). The association of the two continuity of care measures with mortality was assessed in separate univariable and multivariable Cox regression models. Results Our study sample consisted of 51,717 patients with a median observation time of 3.65 years. The data showed that a high total COCI was associated with increased mortality, while there was no association between primary COCI and mortality. Conclusions Measures of continuity of care are highly sensitive to the type of medical disciplines taken into account. The continuity of care index calculated from contacts at all medical disciplines might measure diversity rather than continuity of care.	[Geroldinger, Angelika; Sauter, Simone Katja; Heinze, Georg; Dorda, Wolfgang; Duftschmid, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Endel, Gottfried] Main Assoc Austrian Social Secur Org, Vienna, Austria	Medical University of Vienna	Geroldinger, A (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	angelika.geroldinger@gmx.at	Endel, Gottfried/Y-5456-2019	Endel, Gottfried/0000-0003-2071-4572; Geroldinger, Angelika/0000-0002-4659-4911; Heinze, Georg/0000-0003-1147-8491	Main Association of Austrian Social Security Organizations	Main Association of Austrian Social Security Organizations	This work was supported by the Main Association of Austrian Social Security Organizations, which provided access to a research data base containing administrative data and supported the authors AG, SKS and WD financially.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2012, WAHL SICH GES BER JE; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1975, J MED EDUC, V50, P965; Chen CC, 2011, AM J MANAG CARE, V17, P420; Cheng SH, 2011, HEALTH POLICY PLANN, V26, P157, DOI 10.1093/heapol/czq035; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Duftschmid G, 2016, C HLTH EXPL COMPL IN; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leleu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071669; Lustman A, 2016, PRIM CARE DIABETES, V10, P165, DOI 10.1016/j.pcd.2015.10.001; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Reid R.J., 2002, DEFUSING CONFUSION C; Rinner C, 2016, INT J MED INFORM, V92, P44, DOI 10.1016/j.ijmedinf.2016.05.001; Shin DW, 2014, ANN FAM MED, V12, P534, DOI 10.1370/afm.1685; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Team RC, 2015, R LANG ENV STAT COMP; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; WHO Collaborating Centre for Drug Statistics Methodology, 2015, GUID ATC CLASS DDD A; Worrall G, 2011, CAN FAM PHYSICIAN, V57, pE16	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191386	10.1371/journal.pone.0191386	http://dx.doi.org/10.1371/journal.pone.0191386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351547	Green Submitted, Green Published, gold			2022-12-26	WOS:000422911300078
J	Peek, J; Harvey, C; Gray, D; Rosenberg, D; Kolla, L; Levy-Myers, R; Yin, R; McMurry, JL; Kerscher, O				Peek, Jennifer; Harvey, Catherine; Gray, Dreux; Rosenberg, Danny; Kolla, Likhitha; Levy-Myers, Reuben; Yin, Rui; McMurry, Jonathan L.; Kerscher, Oliver			SUMO targeting of a stress-tolerant Ulp1 SUMO protease	PLOS ONE			English	Article							YEAST KLUYVEROMYCES-MARXIANUS; UBIQUITIN; SUMOYLATION; LOCALIZATION; ISOPEPTIDASE; PROGRESSION; MECHANISM; PROTEINS; SEQUENCE; PATHWAY	SUMO proteases of the SENP/Ulp family are master regulators of both sumoylation and desumoylation and regulate SUMO homeostasis in eukaryotic cells. SUMO conjugates rapidly increase in response to cellular stress, including nutrient starvation, hypoxia, osmotic stress, DNA damage, heat shock, and other proteotoxic stressors. Nevertheless, little is known about the regulation and targeting of SUMO proteases during stress. To this end we have undertaken a detailed comparison of the SUMO-binding activity of the budding yeast protein Ulp1 (ScUlp1) and its ortholog in the thermotolerant yeast Kluyveromyces marxianus, KmUlp1. We find that the catalytic UD domains of both ScUlp1 and KmUlp1 show a high degree of sequence conservation, complement a ulp1 Delta mutant in vivo, and process a SUMO precursor in vitro. Next, to compare the SUMO-trapping features of both SUMO proteases we produced catalytically inactive recombinant fragments of the UD domains of ScUlp1 and KmUlp1, termed ScUTAG and KmUTAG respectively. Both ScUTAG and KmUTAG were able to efficiently bind a variety of purified SUMO isoforms and bound immobilized SUMO1 with nanomolar affinity. However, KmUTAG showed a greatly enhanced ability to bind SUMO and SUMO-modified proteins in the presence of oxidative, temperature and other stressors that induce protein misfolding. We also investigated whether a SUMO-interacting motif (SIM) in the UD domain of KmULP1 that is not conserved in ScUlp1 may contribute to the SUMO-binding properties of KmUTAG. In summary, our data reveal important details about how SUMO proteases target and bind their sumoylated substrates, especially under stress conditions. We also show that the robust pan-SUMO binding features of KmUTAG can be exploited to detect and study SUMO-modified proteins in cell culture systems.	[Peek, Jennifer; Harvey, Catherine; Gray, Dreux; Rosenberg, Danny; Kolla, Likhitha; Levy-Myers, Reuben; Yin, Rui; Kerscher, Oliver] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [McMurry, Jonathan L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA USA	William & Mary; University System of Georgia; Kennesaw State University	Kerscher, O (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	opkers@wm.edu		Kolla, Likhitha/0000-0002-1169-906X; Peek, Jennifer/0000-0002-1239-8752; Harvey, Catherine/0000-0002-9466-1517; Levy-Myers, Reuben/0000-0003-4024-2947; Yin, Rui/0000-0001-5330-8306; Kerscher, Oliver/0000-0001-6603-9352	Commonwealth Research Commercialization Fund (CRCF) [MF16-034-LS]; National Institute of General Medical Sciences R15 grant [GM120691]; Broderick Family/Goldman Sachs TDAP award; Alcoa Foundation Summer Fellowship Award; HHMI Science and Research Program at William and Mary	Commonwealth Research Commercialization Fund (CRCF); National Institute of General Medical Sciences R15 grant; Broderick Family/Goldman Sachs TDAP award; Alcoa Foundation Summer Fellowship Award; HHMI Science and Research Program at William and Mary	This work was supported by the Commonwealth Research Commercialization Fund (CRCF) award (grant no. MF16-034-LS) to OK, National Institute of General Medical Sciences R15 grant GM120691 to JLM, a Broderick Family/Goldman Sachs TDAP award to OK, an Alcoa Foundation Summer Fellowship Award to DG, and support from the HHMI Science and Research Program at William and Mary to DG, JP, CH, RLM, LK, and DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre KO, 2011, J BIOL CHEM, V286, P36142, DOI 10.1074/jbc.M111.268847; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Boudreau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045918; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Eckhoff J, 2015, J BIOL CHEM, V290, P12268, DOI 10.1074/jbc.M114.622217; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Fu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004579; Guo WH, 2011, J CANCER RES CLIN, V137, P533, DOI 10.1007/s00432-010-0920-x; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim YM, 2011, J NEUROL SCI, V307, P157, DOI 10.1016/j.jns.2011.04.015; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lewicki MC, 2015, J PROTEOMICS, V118, P39, DOI 10.1016/j.jprot.2014.11.012; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; McNally BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002277; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Nie MH, 2015, J BIOL CHEM, V290, P22678, DOI 10.1074/jbc.M115.673038; Oliver Kerscher, 2016, ELS; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinheiro R, 2002, APPL MICROBIOL BIOT, V58, P842, DOI 10.1007/s00253-001-0927-y; Pinto MP, 2012, BBA-MOL CELL RES, V1823, P1958, DOI 10.1016/j.bbamcr.2012.07.010; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vigodner M, 2013, HUM REPROD, V28, P210, DOI 10.1093/humrep/des317; Wang Q, 2013, ONCOGENE, V32, P2493, DOI 10.1038/onc.2012.250; Westerbeck JW, 2014, MOL BIOL CELL, V25, P1, DOI 10.1091/mbc.E13-05-0291; Willson V., 2009, SUMO REGULATION CELL; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yamamoto H, 2015, J BIOL CHEM, V290, P29506, DOI 10.1074/jbc.M115.684233; Zhang HJ, 2013, CELL BIOCHEM BIOPHYS, V67, P1081, DOI 10.1007/s12013-013-9612-x; Zhang QS, 2016, ONCOL LETT, V12, P217, DOI 10.3892/ol.2016.4558; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	53	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191391	10.1371/journal.pone.0191391	http://dx.doi.org/10.1371/journal.pone.0191391			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351565	Green Published, gold, Green Submitted			2022-12-26	WOS:000422911300081
